PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	BEERS, EP; CALLIS, J				BEERS, EP; CALLIS, J			UTILITY OF POLYHISTIDINE-TAGGED UBIQUITIN IN THE PURIFICATION OF UBIQUITIN-PROTEIN CONJUGATES AND AS AN AFFINITY LIGAND FOR THE PURIFICATION OF UBIQUITIN-SPECIFIC HYDROLASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING ENZYME; HIGHER-PLANT; DEGRADATION; EXPRESSION; YEAST; CLONING; PATHWAY; INVIVO; CELLS; ACTS	The purification and biochemical characterization of protein substrates of the ubiquitin-dependent pathway of proteolysis is made difficult in part by the low steady state levels of ubiquitin-protein conjugates. We report here on the use of a polyhistidine-tagged ubiquitin molecule (HisUb) for the purification of ubiquitin-protein conjugates by metal chelate chromatography. When Escherichia coli extracts containing expressed HisUb were passed through a nitrilotriacetic acid-agarose column containing immobilized Ni2+ ions (Ni-NTA column), HisUb was retained. After washing to remove unbound and nonspecifically bound proteins, a pH 4.5 wash was used to elute highly purified HisUb. Purified HisUb and wild-type ubiquitin were tested for their ability to form Ni2+-binding ubiquitin-protein conjugates in a wheat germ in vitro conjugation reaction. In some experiments, wheat germ extracts were preincubated with iodoacetamide to inhibit ubiquitin activating and conjugating enzymes. Only those conjugation assays containing HisUb and an ATP-regenerating system not pretreated with iodoacetamide produced significant levels of multiple Ni2+-binding ubiquitin-protein conjugates. We also examined the potential of HisUb as an affinity ligand for the purification of higher plant ubiquitin-specific hydrolases. As a test, a crude lysate of E. coli expressing a yeast ubiquitin-specific hydrolase (Yuh1) was passed through a Ni-NTA column containing bound HisUb. Yuh1 was retained on the column and was specifically eluted when the column was equilibrated with buffer containing wild-type ubiquitin.	UNIV CALIF DAVIS,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616	University of California System; University of California Davis				Callis, Judy/0000-0002-0622-078X				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1992, J BIOL CHEM, V267, P23364; BEERS EP, 1992, J BIOL CHEM, V267, P15432; BUTT TR, 1988, J BIOL CHEM, V263, P16364; Callis J., 1989, OXFORD SURV PLANT MO, V6, P1; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; DOHERTY FJ, 1989, BIOCHEM J, V263, P47, DOI 10.1042/bj2630047; DUERKSENHUGHES PJ, 1989, BIOCHEMISTRY-US, V28, P8530, DOI 10.1021/bi00447a039; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; EYTAN E, 1993, J BIOL CHEM, V268, P4668; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HADARI T, 1992, J BIOL CHEM, V267, P719; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JONNALAGADDA S, 1989, J BIOL CHEM, V264, P10637; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAGNANI M, 1991, J BIOL CHEM, V266, P21018; MILLER HI, 1989, BIO-TECHNOL, V7, P698, DOI 10.1038/nbt0789-698; MORI S, 1993, J BIOL CHEM, V268, P577; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; PICKART CM, 1985, J BIOL CHEM, V260, P7903; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SHANKLIN J, 1987, P NATL ACAD SCI USA, V84, P359, DOI 10.1073/pnas.84.2.359; SULLIVAN ML, 1990, PLANT PHYSIOL, V94, P710, DOI 10.1104/pp.94.2.710; VIERSTRA RD, 1987, PLANT PHYSIOL, V84, P332, DOI 10.1104/pp.84.2.332; VIERSTRA RD, 1985, J BIOL CHEM, V260, P2015; VIERSTRA RD, 1988, BIOCHEMISTRY-US, V27, P3290, DOI 10.1021/bi00409a025	33	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21645	21649						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408016				2022-12-27	WOS:A1993MC80900035
J	CASCIO, M; SCHOPPA, NE; GRODZICKI, RL; SIGWORTH, FJ; FOX, RO				CASCIO, M; SCHOPPA, NE; GRODZICKI, RL; SIGWORTH, FJ; FOX, RO			FUNCTIONAL EXPRESSION AND PURIFICATION OF A HOMOMERIC HUMAN-ALPHA-1 GLYCINE RECEPTOR IN BACULOVIRUS-INFECTED INSECT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRYCHNINE-BINDING-SITE; GATED ION CHANNELS; RAT SPINAL-CORD; MEMBRANE-PROTEINS; SUBUNIT; SOLUBILIZATION; LOCALIZATION; BIOLOGY; NEURONS; SYSTEM	The human alpha1 glycine receptor (GlyR) was expressed in Sf9 insect cells infected with a recombinant Autographa californica nuclear polyhedrosis baculovirus. Previous studies had indicated that transient expression of this subunit in Xenopus oocytes or human kidney cell lines is sufficient to form active agonist-gated chloride channels. Expression of the alpha1 GlyR protein resulted in functional channels present on the cell surface of infected Sf9 cells as evidenced by whole-cell patch-clamping and single-channel recordings. These channels were gated by glycine, but not in the presence of strychnine. An immunoreactive 48-kDa protein could be easily visualized on Coomassie-stained sodium dodecyl sulfate-polyacrylamide gels of whole-cell lysates with maximal expression 3 days postinfection. The alpha1 GlyR protein was solubilized from a membrane fraction of infected Sf9 cells in 1% digitonin and 0.1% deoxycholate and purified by affinity chromatography using aminostrychnine agarose, yielding 0.33 mg/liter of cells. Given the low natural abundance of the native channel, the development of this expression system now provides sufficient purified channel protein for future biochemical and biophysical characterization. Since the glycine receptor shares sequence and structural homology with other members of a ligand-gated channel superfamily, further characterization may establish general rules governing the structure and mechanism of these membrane protein channels.	YALE UNIV, HOWARD HUGHES MED INST, NEW HAVEN, CT 06511 USA; YALE UNIV, DEPT MOLEC BIOPHYS & BIOCHEM, NEW HAVEN, CT 06511 USA; YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University					NINDS NIH HHS [NS21501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021501] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETZ H, 1987, TRENDS NEUROSCI, V10, P113, DOI 10.1016/0166-2236(87)90055-5; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BETZ H, 1988, NEUROCHEM INT, V13, P137, DOI 10.1016/0197-0186(88)90048-4; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BHATTACHARYYA A, 1981, INT J BIOCH BIOPHYS, V18, P421; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; DIESENHOFFER J, 1985, NATURE, V318, P618; GOSWAMI BB, 1991, BIOTECHNIQUES, V10, P626; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HAGA K, 1985, NATURE, V316, P731, DOI 10.1038/316731a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HJELMELAND LM, 1990, METHOD ENZYMOL, V182, P253; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KLAIBER K, 1990, NEURON, V5, P221, DOI 10.1016/0896-6273(90)90311-3; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; KUHSE J, 1991, ANN NY ACAD SCI, V625, P129, DOI 10.1111/j.1749-6632.1991.tb33836.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; PARKER EM, 1991, J BIOL CHEM, V266, P519; PFEIFFER F, 1981, BRAIN RES, V226, P273, DOI 10.1016/0006-8993(81)91099-4; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; ROSENMUND P, 1961, CHEM BER-RECL, V94, P3342, DOI 10.1002/cber.19610941223; RUIZGOMEZ A, 1990, BIOCHEMISTRY-US, V29, P7033, DOI 10.1021/bi00482a012; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; Sambrook J, 1989, MOL CLONING LABORATO; Schertler G. F. X., 1992, CURR OPIN STRUC BIOL, V2, P534, DOI DOI 10.1016/0959-440X(92)90083-J; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; VASUDEVAN S, 1991, FEBS LETT, V283, P52, DOI 10.1016/0014-5793(91)80551-D; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; [No title captured]	43	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22135	22142						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408073				2022-12-27	WOS:A1993MC80900103
J	FRANKLIN, AE; HOFFMAN, NE				FRANKLIN, AE; HOFFMAN, NE			CHARACTERIZATION OF A CHLOROPLAST HOMOLOG OF THE 54-KDA SUBUNIT OF THE SIGNAL RECOGNITION PARTICLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI 4.5S RNA; METHIONINE-RICH DOMAIN; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; SRP-RNA; SEQUENCE RECOGNITION; NASCENT PREPROLACTIN; NUCLEOTIDE-SEQUENCE; BINDING-PROTEINS; TRANSPORT	Proteins and RNAs homologous to components of the eukaryotic signal recognition particle (SRP) have been identified in a number of prokaryotic organisms. Here we report the isolation of an Arabidopsis thaliana cDNA, FFC (fifty-four chloroplast homologue), that encodes a chloroplast protein (54CP) homologous to the 54-kDa subunit of the signal recognition particle. 54CP shares 27% identity with mammalian SRP54 and 44% identity with the Escherichia coli ffh gene product suggesting a prokaryotic origin for this gene. FFC is a nuclear gene encoding a 62-kDa cytoplasmically synthesized precursor that is capable of being imported into isolated chloroplasts and processed to a 53-kDa stromal polypeptide. Antibodies generated against a portion of 54CP recognize an endogenous 53-kDa chloroplast protein that sediments at 4 S and 70 S, the latter form may be associated with ribosomes. The FFC transcript is most abundant in green shoot tissue whereas etiolated buds and roots have transcript levels about 30 and 10%, respectively, relative to light grown green shoots. By analogy with the eukaryotic signal recognition particle which targets secretory proteins to the endoplasmic reticulum, it is speculated that 54CP may target chloroplast proteins to either the thylakoid or envelope membranes.	CARNEGIE INST WASHINGTON,DEPT PLANT BIOL,290 PANAMA ST,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305	Carnegie Institution for Science; Stanford University					NIGMS NIH HHS [GM42609-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM042609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSHAM DC, 1991, J BIOL CHEM, V266, P23606; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BROWN S, 1987, CELL, V49, P825, DOI 10.1016/0092-8674(87)90620-9; BYSTROM AS, 1983, EMBO J, V2, P899, DOI 10.1002/j.1460-2075.1983.tb01519.x; CASHMORE AR, 1982, METHODS CHLOROPLAST, P387; CHUA NH, 1976, J CELL BIOL, V71, P497, DOI 10.1083/jcb.71.2.497; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FRITSCH A, 1973, ANAL BIOCHEM, V55, P57, DOI 10.1016/0003-2697(73)90290-X; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HERZ J, 1990, FEBS LETT, V276, P103, DOI 10.1016/0014-5793(90)80518-N; HUANG LQ, 1993, J BIOL CHEM, V268, P6560; HUANG LQ, 1992, PLANT PHYSIOL, V99, P247, DOI 10.1104/pp.99.1.247; JAGENDORF AT, 1990, PLANT SCI, V70, P137; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KIM JM, 1991, J BIOL CHEM, V266, P14931; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; LINGELBACH K, 1988, NUCLEIC ACIDS RES, V16, P9431, DOI 10.1093/nar/16.20.9431; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; LUTCKE H, 1992, EMBO J, V11, P1543, DOI 10.1002/j.1460-2075.1992.tb05199.x; LUTKE H, 1993, J CELL BIOL, V121, P977; MEADOWS JW, 1991, PLANT MOL BIOL, V17, P1241, DOI 10.1007/BF00028739; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; PORITZ MA, 1988, CELL, V55, P4, DOI 10.1016/0092-8674(88)90003-7; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; SAEMBROOK J, 1989, MOL CLONING LABORATO; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAMUELSSON T, 1992, NUCLEIC ACIDS RES, V20, P5763, DOI 10.1093/nar/20.21.5763; SAMUELSSON T, 1990, NUCLEIC ACIDS RES, V18, P4938, DOI 10.1093/nar/18.16.4938; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI Y, 1993, FEBS LETT, V316, P93, DOI 10.1016/0014-5793(93)81743-J; SCHMIDT GW, 1986, ANNU REV BIOCHEM, V55, P879; STRUB K, 1990, MOL CELL BIOL, V10, P777, DOI 10.1128/MCB.10.2.777; STRUB K, 1989, P NATL ACAD SCI USA, V86, P9794; Timko MP, 1985, MOL BIOL PHOTOSYNTHE, P381; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1982, NATURE, V299, P69; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	47	129	131	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22175	22180						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408079				2022-12-27	WOS:A1993MC80900109
J	ROBINSON, R; ROBINSON, LJ; JAMES, DE; LAWRENCE, JC				ROBINSON, R; ROBINSON, LJ; JAMES, DE; LAWRENCE, JC			GLUCOSE-TRANSPORT IN L6 MYOBLASTS OVEREXPRESSING GLUT1 AND GLUT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; MUSCLE-CELLS; 3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; OKADAIC ACID; PROTEIN-PHOSPHORYLATION; INSULIN REGULATION; SKELETAL-MUSCLE; ISOFORMS; STIMULATION	The roles of the glucose transporter isoforms, GLUT1 and GLUT4, in mediating insulin-stimulated glucose transport were investigated by stably overexpressing the transporters in L6 myoblasts. Levels of GLUT1 and GLUT4 in myoblasts from the cell lines having the highest content of these transporters were approximately 16- and 30-fold higher, respectively, than levels in nontransfected cells. The basal rate of 2-deoxy[H-3]glucose uptake was severalfold higher in cells overexpressing GLUT1 than in the parent L6 myoblasts or in control cell lines that were generated by transfecting cells with expression vectors lacking transporter insert. The basal rate was not elevated in any of the lines expressing GLUT4. The net increase in 2-deoxy[H-3]glucose uptake produced by insulin was larger in both the GLUT1 and GLUT4 cells than in the control cells. Insulin increased uptake in GLUT4 cells by as much as 6-fold; whereas, the fold increase over basal uptake produced by insulin in GLUT1 cells was comparable to that (2-fold) observed in the control myocytes. Thus, both GLUT1 and GLUT4 can mediate insulin-stimulated glucose transport in L6 myoblasts, although GLUT4 is needed to observe large percentage increases comparable to those observed in skeletal muscle fibers in vivo. In contrast to insulin, the protein phosphatase inhibitors, okadaic acid and calyculin A, inhibited glucose transport in cells expressing either GLUT1 or GLUT4. Calyculin A, which produced a half-maximum effect at 10 nM, was approximately 100 times more potent than okadaic acid in decreasing both basal and insulin-stimulated 2-deoxyglucose uptake. Inhibition of uptake by calyculin A was associated with a decrease in the cell surface concentration of both GLUT1 and GLUT4. These results indicate that increased protein phosphorylation can lead to inhibition of transport mediated by both GLUT1 and GLUT4.	WASHINGTON UNIV, SCH MED,DEPT MOLEC BIOL & PHARMACOL,BOX 8103, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)				James, David/0000-0001-5946-5257	NIAMS NIH HHS [AR41180] Funding Source: Medline; NIDDK NIH HHS [DK28312, DK42503] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028312, R01DK042503] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASANO T, 1992, J BIOL CHEM, V267, P19636; ASANO T, 1992, BIOCHEM J, V288, P189, DOI 10.1042/bj2880189; BEGUINOT F, 1985, J BIOL CHEM, V260, P5892; BILAN PJ, 1992, BIOCHEM BIOPH RES CO, V186, P1129, DOI 10.1016/0006-291X(92)90864-H; BILAN PJ, 1991, ADV EXP MED BIOL, V293, P273; BLOCK NE, 1991, J CLIN INVEST, V88, P1546, DOI 10.1172/JCI115465; BOYLE WA, 1991, AM J PHYSIOL, V260, pH1236, DOI 10.1152/ajpheart.1991.260.4.H1236; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; BURANT CF, 1987, BIOCHEM BIOPH RES CO, V147, P100, DOI 10.1016/S0006-291X(87)80092-X; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; CHARTIER L, 1991, CELL MOTIL CYTOSKEL, V18, P26, DOI 10.1002/cm.970180104; CZECH MP, 1982, CELL, V31, P8, DOI 10.1016/0092-8674(82)90399-3; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HARRIS DS, 1992, P NATL ACAD SCI USA, V89, P7556, DOI 10.1073/pnas.89.16.7556; HARRISON SA, 1990, J BIOL CHEM, V265, P20106; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; KOTLIAR N, 1992, MOL ENDOCRINOL, V6, P337, DOI 10.1210/me.6.3.337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; LAWRENCE JC, 1981, J BIOL CHEM, V256, P6213; LAWRENCE JC, 1992, P NATL ACAD SCI USA, V89, P3493, DOI 10.1073/pnas.89.8.3493; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; RICHTER EA, 1984, AM J PHYSIOL, V246, pE476, DOI 10.1152/ajpendo.1984.246.6.E476; ROBINSON LJ, 1992, AM J PHYSIOL, V263, pE383, DOI 10.1152/ajpendo.1992.263.2.E383; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; SHINOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SILVERMAN M, 1991, ANNU REV BIOCHEM, V60, P757, DOI 10.1146/annurev.bi.60.070191.003545; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH RL, 1984, J BIOL CHEM, V259, P2201; TANTI JF, 1991, J BIOL CHEM, V266, P2099; WALKER PS, 1990, J BIOL CHEM, V265, P1516; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; ZAPF J, 1981, CURR TOP CELL REGUL, V19, P257; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	45	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22119	22126						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408071				2022-12-27	WOS:A1993MC80900101
J	SHAPIRO, RA; PALMER, D; CISLO, T				SHAPIRO, RA; PALMER, D; CISLO, T			A DELETION MUTATION IN THE 3RD CYTOPLASMIC LOOP OF THE MOUSE M1 MUSCARINIC ACETYLCHOLINE-RECEPTOR UNMASKS CRYPTIC G-PROTEIN BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-2-ADRENERGIC RECEPTOR; PHOSPHOLIPASE-C; FUNCTIONAL EXPRESSION; AGONIST BINDING; ALPHA-SUBUNIT; ACTIVATION; REGION; HYDROLYSIS; GENE; TRANSFORMATION	Mutations were introduced in the highly conserved carboxyl-terminal region of the third cytoplasmic loop of the mouse m1 muscarinic acetylcholine receptor (mAChR) gene by site-directed mutagenesis. The effects of these mutations on ligand binding and on mAChR coupling to phosphoinositide turnover have been examined following expression in mouse Y1 adrenal carcinoma cells, Chinese hamster ovary (CHO) cells, and Rat-2 fibroblasts. Point mutations in the region proximal to the sixth transmembrane domain had no effect on antagonist binding but did result in decreased agonist affinity. A deletion of four amino acids in the same region effectively uncoupled the receptor from phosphoinositol turnover in Y1 adrenal carcinoma cells but had no effect in either CHO cells or Rat-2 fibroblasts. Differential sensitivity to pertussis toxin indicates that the m1 mAChR can interact with multiple G-proteins in CHO cells and Rat-2 cells via distinct recognition sites on the receptor. These data demonstrate multiple G-proteins can interact with an individual receptor, that the same receptor may couple to different second messenger pathways, and that these responses can vary in a cell type-specific manner.			SHAPIRO, RA (corresponding author), BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,3005 1ST AVE,SEATTLE,WA 98121, USA.							ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOYER JL, 1992, J BIOL CHEM, V267, P25451; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DICKINSON KEJ, 1992, EUR J PHARM-MOLEC PH, V225, P291, DOI 10.1016/0922-4106(92)90102-2; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LEE CH, 1992, J BIOL CHEM, V267, P16044; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SHAPIRO RA, 1989, P NATL ACAD SCI USA, V86, P9039, DOI 10.1073/pnas.86.22.9039; STRADER CD, 1987, J BIOL CHEM, V262, P16439; VANDERHEYDEN P, 1987, BIOCHEM PHARMACOL, V36, P4119, DOI 10.1016/0006-2952(87)90569-7; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; WONG SKF, 1990, J BIOL CHEM, V265, P6219	30	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21734	21738						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408028				2022-12-27	WOS:A1993MC80900049
J	TYTLER, EM; SEGREST, JP; EPAND, RM; NIE, SQ; EPAND, RF; MISHRA, VK; VENKATACHALAPATHI, YV; ANANTHARAMAIAH, GM				TYTLER, EM; SEGREST, JP; EPAND, RM; NIE, SQ; EPAND, RF; MISHRA, VK; VENKATACHALAPATHI, YV; ANANTHARAMAIAH, GM			RECIPROCAL EFFECTS OF APOLIPOPROTEIN AND LYTIC PEPTIDE ANALOGS ON MEMBRANES - CROSS-SECTIONAL MOLECULAR SHAPES OF AMPHIPATHIC-ALPHA HELIXES CONTROL MEMBRANE STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; A-I; WASP VENOM; SECONDARY STRUCTURE; INVERTED PHASES; MASTOPARAN; PROTEINS; PHOSPHATIDYLCHOLINE; MELITTIN; CELLS	Apolipoprotein (class A) amphipathic helixes are postulated to act as detergents by virtue of their cross-section being wedge-shaped. Using computer analysis of naturally occurring class A and lytic (class L) amphipathic helixes, we designed two archetypical model peptides. Analogs of these two peptides, incorporating substitutions or modifications of interfacial or basic residues, had the following effects. Class A peptides stabilized bilayer structure, reduced leakage from large unilamellar vesicles and erythrocytes, and inhibited lysis induced by class L peptides. Class L peptides destabilized bilayer structure in model membranes and increased binding of class A peptides to erythrocytes. The ability of class L analogs to lyse membranes and induce inverted lipid phases was reduced by either decreasing the bulk of an interfacial residue, increasing the angle subtended by the polar face, or increasing the bulk of the basic residues. The ability of the class A analog to stabilize bilayer structure and inhibit erythrocyte lysis by class L peptides was enhanced by methylating the Lys residues. These results can be explained by a model that we term the reciprocal wedge hypothesis. By analogy to the reciprocal effects of phospholipid shapes on membrane structure, we propose that the wedge shape of class A helixes stabilizes membrane bilayers, whereas the inverted wedge shape of class L helixes destabilizes membrane bilayers, and, thus, one class will neutralize the effect of the other class on membranes.	UNIV ALABAMA,MED CTR,DEPT MED,ATHEROSCLEROSIS RES UNIT,D630,DREB 3,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,DEPT BIOCHEM,BIRMINGHAM,AL 35294; MCMASTER UNIV,DEPT BIOCHEM,HAMILTON L8N 3Z5,ONTARIO,CANADA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; McMaster University			, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Mishra, Vinod/0000-0002-4527-1512; Tytler, Ewan/0000-0002-4552-8170	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067632, P01HL034343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028928] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL67632, P01 HL34343] Funding Source: Medline; NIAID NIH HHS [R01 AI28928] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKERLOF E, 1991, BIOCHEMISTRY-US, V30, P8986; Anantharamaiah G. M., 1990, ADV EXP MED BIOL, V285, P131; ANANTHARAMAIAH GM, 1986, METHOD ENZYMOL, V128, P627; ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; ARGIOLAS A, 1983, J BIOL CHEM, V258, P3697; ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403; BECHINGER B, 1992, BIOPHYS J, V62, P12, DOI 10.1016/S0006-3495(92)81763-0; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BLACKBURN WD, 1991, J LIPID RES, V32, P1911; BRASSEUR R, 1991, J BIOL CHEM, V266, P16120; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; CULLIS PR, 1985, BIOCH LIPIDS MEMBRAN, P25; DEWAAL A, 1991, FEBS LETT, V293, P219, DOI 10.1016/0014-5793(91)81191-A; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; EPAND RM, 1977, BIOCHIM BIOPHYS ACTA, V491, P296, DOI 10.1016/0005-2795(77)90065-4; HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; IBDAH JA, 1988, BIOCHEMISTRY-US, V27, P7155, DOI 10.1021/bi00418a073; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; JOHN E, 1991, BIOPHYS J, V60, P319, DOI 10.1016/S0006-3495(91)82056-2; JONES MK, 1992, J LIPID RES, V33, P287; JORGENSEN EV, 1989, J BIOL CHEM, V264, P9215; JOYCEBRADY M, 1991, J BIOL CHEM, V266, P6859; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KANELLIS P, 1980, J BIOL CHEM, V255, P1464; LIU DX, 1990, BIOCHEMISTRY-US, V29, P3637, DOI 10.1021/bi00467a008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OWENS RJ, 1990, J CLIN INVEST, V86, P1142, DOI 10.1172/JCI114819; OZAKI Y, 1990, BIOCHEM BIOPH RES CO, V170, P779, DOI 10.1016/0006-291X(90)92159-W; PERIANIN A, 1989, J IMMUNOL, V143, P1669; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; ROSENFELD SI, 1983, J CLIN INVEST, V71, P795, DOI 10.1172/JCI110833; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1992, J LIPID RES, V33, P141; SEGREST JP, 1991, MOL CONFORMATION BIO, P597; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; SILVIUS JR, 1985, BIOCHEMISTRY-US, V24, P5388, DOI 10.1021/bi00341a017; SMALL DM, 1992, PLASMA LIPOPROTEINS, P57; TALL AR, 1977, J BIOL CHEM, V252, P4701; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; VANGORKOM LCM, 1992, BIOCHEMISTRY-US, V31, P671, DOI 10.1021/bi00118a006; VENKATACHALAPAT.YV, 1990, PEPTIDES CHEM BIOL, P672; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; YOKOKAWA N, 1989, BIOCHEM BIOPH RES CO, V158, P712, DOI 10.1016/0006-291X(89)92779-4; YUI Y, 1988, J CLIN INVEST, V82, P803, DOI 10.1172/JCI113682	48	99	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22112	22118						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408070				2022-12-27	WOS:A1993MC80900100
J	LEE, CW; PARK, DJ; LEE, KH; KIM, CG; RHEE, SG				LEE, CW; PARK, DJ; LEE, KH; KIM, CG; RHEE, SG			PURIFICATION, MOLECULAR-CLONING, AND SEQUENCING OF PHOSPHOLIPASE-C-BETA-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; LIGHT-MEDIATED BREAKDOWN; INOSITOL-TRISPHOSPHATE; BOVINE BRAIN; BETA-GAMMA; COMPLETE CDNA; C ISOZYMES; G-PROTEINS; DROSOPHILA; SUBUNITS	We have characterized inositol phospholipid-specific phospholipase C (PLC) isozymes in bovine retina. Chromatography of a retinal homogenate on a heparin column partially resolved six peaks of PLC activity, which differed in their relative selectivities for the substrates phosphatidyl 4,5-bisphosphate (PIP2) and phosphatidylinositol (PI). Five of the peaks were shown to correspond to the known PLC isozymes PLC-beta1, PLC-beta3, PLC-gamma1, PLC-delta1, and PLC-delta2. PLC-beta1, PLC-beta3, PLC-gamma1, and PLC-delta1 in the retinal fractions were identified by immunoblotting with isozyme-specific antibodies, and PLC-delta2 was identified by direct sequencing of tryptic peptides. PLC-gamma2 and PLC-beta2 were not detectable by immunoblot analysis. In addition to five of the seven mammalian PLC isozymes identified to date, bovine retina contained a previously unidentified PLC, which exhibited the highest selectivity for PIP2 over PI. The new PLC was purified from a retinal particulate fraction to yield a preparation that contained a major protein band with an apparent molecular mass of 130 kDa on SDS-polyacrylamide gels. Sequence analysis of 12 tryptic peptides derived from the 130-kDa protein suggested that the primary structure of the new PLC is similar to those members of beta-type PLC isozymes, especially to that of PLC-norpA, which was originally identified in Drosophila eye. The new enzyme was thus named PLC-beta4. A search of a rat brain cDNA library with the polymerase chain reaction and oligonucleotide primers based on common PLC amino acid sequences resulted in the cloning of a rat brain cDNA corresponding to a previously uncharacterized PLC. The cDNA encoded a putative polypeptide of 1176 amino acids, with a calculated molecular mass of 134,532 daltons, that contained the sequences of all 12 tryptic peptides of PLC-beta4. Furthermore, the deduced amino acid sequence of the encoded protein was more related to PLC-norpA than to any of the three mammalian PLC-beta isozymes. These results suggest that the brain cDNA encodes PLC-beta4, which is likely a mammalian homolog of PLC-norpA.	NHLBI,BIOCHEM LAB,9000 ROCKVILLE PIKE,BLDG 3,RM 122,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Park, Do-Joon/J-2736-2012					Anderson R.E., 1988, Progress in Retinal Research, V8, P211, DOI 10.1016/0278-4327(88)90026-0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BROWN JE, 1987, BIOCHEM BIOPH RES CO, V146, P1392, DOI 10.1016/0006-291X(87)90804-7; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAROZZI AJ, 1993, EUR J BIOCHEM, V210, P521; DRAYER AL, 1992, J BIOL CHEM, V267, P18387; EMARI Y, 1989, J BIOL CHEM, V264, P21885; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; GEHM BD, 1990, BIOCHEMISTRY-US, V29, P5447, DOI 10.1021/bi00475a006; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; GHALAYINI AJ, 1991, J NEUROCHEM, V57, P1405, DOI 10.1111/j.1471-4159.1991.tb08307.x; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; INOUE H, 1985, BIOCHEM BIOPH RES CO, V132, P513, DOI 10.1016/0006-291X(85)91163-5; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; LEE KY, 1987, P NATL ACAD SCI USA, V84, P5540, DOI 10.1073/pnas.84.16.5540; MATHEWS HR, 1988, NATURE, V334, P67; MELDRUM E, 1991, EUR J BIOCHEM, V196, P159, DOI 10.1111/j.1432-1033.1991.tb15799.x; MILLAR FA, 1988, BIOCHIM BIOPHYS ACTA, V970, P205, DOI 10.1016/0167-4889(88)90180-2; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; OHTA S, 1988, FEBS LETT, V242, P31, DOI 10.1016/0014-5793(88)80979-7; PARK D, 1992, J BIOL CHEM, V267, P16048; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RYU SH, 1987, J BIOL CHEM, V262, P12511; SHORTRIDGE RD, 1991, J BIOL CHEM, V266, P12474; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, J BIOL CHEM, V263, P14497; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; SZUTS EZ, 1986, BIOCHEM J, V240, P929, DOI 10.1042/bj2400929; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WU DQ, 1992, J BIOL CHEM, V267, P1811; ZHU LQ, 1993, J BIOL CHEM, V268, P15994	45	113	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21318	21327						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407970				2022-12-27	WOS:A1993MA28800098
J	NORTHROP, JP; ULLMAN, KS; CRABTREE, GR				NORTHROP, JP; ULLMAN, KS; CRABTREE, GR			CHARACTERIZATION OF THE NUCLEAR AND CYTOPLASMIC COMPONENTS OF THE LYMPHOID-SPECIFIC NUCLEAR FACTOR OF ACTIVATED T-CELLS (NF-AT) COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TRANSCRIPTION FACTOR-AP-1; PROTEIN COMPLEXES; ANTIGEN RECEPTOR; CYCLOSPORINE-A; LEUCINE ZIPPER; GROWTH-FACTORS; FOS; GENE; AP-1	The lymphoid-specific transcription complex, NF-AT, is involved in early gene activation in T cells and is assembled from a pre-existing, T cell restricted cytoplasmic factor and an inducible ubiquitous nuclear component within 30 min after activation through the antigen receptor. Recent studies have implicated the family of AP1 factors as components of the murine NF-AT complex. Evidence is provided here that the nuclear component of human NF-AT contains the phorbol ester-inducible transcription factor AP1 (Jun/Fos). We further characterize which AP1 family members can assume this role. Antisera to Fos inhibits NF-AT DNA binding as does an oligonucleotide containing a binding site for AP1. Constitutive expression in vivo of Fos, and to a lesser extent Fra-1, eliminates the requirement for phorbol 12-myristate 13-acetate (PMA) stimulation, leaving NF-AT-directed transcription responsive to calcium ionophore alone. Overexpression of cJun or JunD, but not JunB, also eliminates the requirement for PMA, indicating that many but not all Jun- and Fos-related proteins functionally activate NF-AT-dependent transcription in the presence of the cytoplasmic component. NF-AT DNA binding can be reconstituted in vitro using semi-purified AP1 proteins mixed with cytosol from T lymphocytes. Fos proteins are not needed for this reconstitution, and although JunB is not functional, it can participate in the NF-AT DNA binding complex. Finally, we have partially purified the cytoplasmic component of NF-AT and show by elution and renaturation from SDS-polyacrylamide gel electrophoresis gels that it has a molecular mass between 94 and 116 kDa and may have multiple differentially modified forms.	STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,BECKMAN CTR MOLEC & GENET MED,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University				Ullman, Katharine/0000-0003-3693-2830	NATIONAL CANCER INSTITUTE [R37CA039612, R01CA039612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033942] Funding Source: NIH RePORTER; NCI NIH HHS [CA39612] Funding Source: Medline; NHLBI NIH HHS [HL33942] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAUMHUETER S, 1988, EMBO J, V7, P2485, DOI 10.1002/j.1460-2075.1988.tb03095.x; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; OGARRA A, 1988, IMMUNOL TODAY, V9, P45, DOI 10.1016/0167-5699(88)91259-5; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	38	352	364	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2917	2923						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428966				2022-12-27	WOS:A1993KK81500097
J	POGULIS, RJ; FREYTAG, SO				POGULIS, RJ; FREYTAG, SO			CONTRIBUTION OF SPECIFIC CIS-ACTING ELEMENTS TO ACTIVITY OF THE MOUSE PRO-ALPHA-2(I) COLLAGEN ENHANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; GENE-EXPRESSION; 1ST INTRON; SYNERGISTIC ACTIVATION; REGULATORY ELEMENTS; FACTORS INTERACT; TRANSGENIC MICE; DNA-SEQUENCES; II GENE; PROMOTER	Intronic transcriptional regulatory regions are found in several collagen genes. We demonstrate here the importance of two distinct cis-acting elements for the activity of a transcriptional enhancer located in the first intron of the mouse pro-alpha2(I) collagen gene. Enhancer subfragments were tested for their ability to stimulate a linked promoter following transient transfection into NIH/3T3 fibroblasts. A 92-base pair subfragment retained significant enhancer activity. DNase I footprinting identified a binding site for a nuclear factor (designated CIBF-I) within this subfragment. Electrophoretic mobility-shift experiments demonstrated that an oligonucleotide containing 18 base pairs from the protected region was sufficient for specific binding of CIBF-I and suggested that CIBF-I may be related to a protein(s) that binds to the rat c-mos enhancer. A second cis-acting element, identified by electrophoretic mobility-shift and methylation interference experiments, bound affinity-purified Sp1 and an Sp1-like protein present in crude nuclear extracts. Small deletion mutations in either the CIBF-I or Sp1 site abolished factor binding in vitro and reduced enhancer activity in vivo. Our results represent the first identification of specific cis-acting elements required for full activity of the pro-alpha2(I) collagen enhancer.	HENRY FORD HOSP,MOLEC BIOL RES PROGRAM,EDUC & RES BLDG,RM 7041,2799 W GRAND BLVD,DETROIT,MI 48202; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan								ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; BOAST S, 1990, J BIOL CHEM, V265, P13351; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BORNSTEIN P, 1988, MOL CELL BIOL, V8, P4851, DOI 10.1128/MCB.8.11.4851; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; BURBELO PD, 1991, J BIOL CHEM, V266, P22297; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; DECROMBRUGGHE B, 1991, ANN RHEUM DIS, V50, P872, DOI 10.1136/ard.50.Suppl_4.872; DECROMBRUGGHE B, 1990, ANN NY ACAD SCI, V580, P88, DOI 10.1111/j.1749-6632.1990.tb17921.x; DHAWAN J, 1990, J BIOL CHEM, V265, P9015; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOLDSTEIN RH, 1991, AM J PHYSIOL, V261, pL29, DOI 10.1152/ajplung.1991.261.2.L29; HERRMANN K, 1991, J INVEST DERMATOL, V97, P219, DOI 10.1111/1523-1747.ep12480157; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KHILLAN JS, 1986, P NATL ACAD SCI USA, V83, P725, DOI 10.1073/pnas.83.3.725; KILLEN PD, 1988, J BIOL CHEM, V263, P12310; KINDY MS, 1988, J BIOL CHEM, V263, P11426; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; LISKA DJ, 1990, CELL REGUL, V1, P487, DOI 10.1091/mbc.1.6.487; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; NAKSHATRI H, 1990, VIROLOGY, V178, P92, DOI 10.1016/0042-6822(90)90382-2; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PHAN SH, 1989, LUNG CELL BIOL, P907; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; ROSSI P, 1987, P NATL ACAD SCI USA, V84, P5590, DOI 10.1073/pnas.84.16.5590; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT A, 1985, NATURE, V314, P286, DOI 10.1038/314286a0; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHERWOOD AL, 1990, BIOCHEM J, V265, P895, DOI 10.1042/bj2650895; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; VANDERHOORN FA, 1987, J MOL BIOL, V193, P255, DOI 10.1016/0022-2836(87)90217-8; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; VUUST J, 1985, EUR J BIOCHEM, V151, P449, DOI 10.1111/j.1432-1033.1985.tb09122.x; WEINER FR, 1989, BIOCHEMISTRY-US, V28, P4094, DOI 10.1021/bi00435a070; YAMADA Y, 1990, ANN NY ACAD SCI, V580, P81, DOI 10.1111/j.1749-6632.1990.tb17920.x; YANG BS, 1991, MOL CELL BIOL, V11, P2291, DOI 10.1128/MCB.11.4.2291; ZIYADEH FN, 1990, AM J PHYSIOL, V259, pF704, DOI 10.1152/ajprenal.1990.259.4.F704	42	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2493	2499						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428926				2022-12-27	WOS:A1993KK81500039
J	STEINRAUF, LK; HAMILTON, JA; BRADEN, BC; MURRELL, JR; BENSON, MD				STEINRAUF, LK; HAMILTON, JA; BRADEN, BC; MURRELL, JR; BENSON, MD			X-RAY CRYSTAL-STRUCTURE OF THE ALA-109-]THR VARIANT OF HUMAN TRANSTHYRETIN WHICH PRODUCES EUTHYROID HYPERTHYROXINEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOL-BINDING PROTEIN; HUMAN-SERUM PREALBUMIN; THYROXINE-BINDING; HUMAN-PLASMA; PRE-ALBUMIN; MACROMOLECULAR STRUCTURES; LIGAND-BINDING; DYNAMICS; RESOLUTION; REFINEMENT	The structure of the Ala-109 --> Thr mutation of human transthyretin, a nonamyloidogenic variant with enhanced thyroxine binding, has been determined by x-ray diffraction to a resolution of 1.7 angstrom. The model, including 175 solvent water molecules, has been refined by constrained least squares to an R-value of 0.157. The standard deviations for protein geometry are 0.016 angstrom for bond distances, 0.5-degrees for bond angles, 0.031 angstrom for 1-4 distances, and 0.005 angstrom for deviations of planar groups from their least squares plane. The estimated error in protein atomic coordinates is 0.12 angstrom. Residue 109 extends inward between the two beta sheets which form the major component of the monomer, as does the side chain of residue 30 in the amyloidogenic Met-30 variant. Comparison of the Thr-109 structure with that of the normal shows that the extra atoms of the threonine fit into empty space between sheets and make no extensive changes to the molecular conformation. The substitution at 109 causes small local changes in the secondary structure of the A, G, and H strands resulting in a shift of residues 15-17, 108-110, and 117 in each monomer. The thyroxine-binding sites of the Thr-109 and Met-30 variants and of the normal protein are compared, and the results suggest that the variation in affinity for thyroxine between the three proteins may arise from differences in the size of the binding pocket.	INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	STEINRAUF, LK (corresponding author), INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034881, R01DK042111] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00750] Funding Source: Medline; NIDDK NIH HHS [NIDDK-42111, NIDDK-34881] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; BLAKE CCF, 1977, NATURE, V268, P115, DOI 10.1038/268115a0; BLAKE CCF, 1991, ARQ MED, V3, P41; BLANEY JM, 1982, J MED CHEM, V25, P785, DOI 10.1021/jm00349a004; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; CASE DA, 1979, J MOL BIOL, V132, P343, DOI 10.1016/0022-2836(79)90265-1; CHENG SY, 1977, BIOCHEMISTRY-US, V16, P3707, DOI 10.1021/bi00635a031; CODY V, 1974, J AM CHEM SOC, V96, P6720, DOI 10.1021/ja00828a030; Cody V, 1978, Recent Prog Horm Res, V34, P437; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CRUICKSHANK DWJ, 1949, ACTA CRYSTALLOGR, V2, P65, DOI 10.1107/S0365110X49000175; DAMAS AM, 1989, 1ST INT S FAM AM POL, P33; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; FEX G, 1984, EUR J CLIN INVEST, V14, P146, DOI 10.1111/j.1365-2362.1984.tb02104.x; FRAUENFELDER H, 1973, 5TH MOSSB EFF P INT, P401; HAMILTON JA, 1993, J BIOL CHEM, V268, P2416; HELLER J, 1973, J BIOL CHEM, V248, P6308; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MOSES AC, 1990, J CLIN INVEST, V86, P2025, DOI 10.1172/JCI114938; MURRAYRUST P, 1979, J AM CHEM SOC, V101, P4373; MURRELL JR, 1992, J BIOL CHEM, V267, P16595; PETERSON PA, 1971, J BIOL CHEM, V246, P44; RAZ A, 1970, J BIOL CHEM, V245, P1903; REFETOFF S, 1986, J CLIN ENDOCR METAB, V63, P1432, DOI 10.1210/jcem-63-6-1432; ROBBINS J, 1960, PHYSIOL REV, V40, P415, DOI 10.1152/physrev.1960.40.3.415; Robbins J, 1978, Recent Prog Horm Res, V34, P477; SCHONER BE, 1984, P NATL ACAD SCI-BIOL, V81, P5403, DOI 10.1073/pnas.81.17.5403; STEINRAUF LK, 1991, BIOCHEM BIOPH RES CO, V179, P804, DOI 10.1016/0006-291X(91)91888-J; TRAGARDH L, 1980, J BIOL CHEM, V255, P9243	38	71	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2425	2430						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428916				2022-12-27	WOS:A1993KK81500029
J	MACHIDA, S; SAITO, M				MACHIDA, S; SAITO, M			PURIFICATION AND CHARACTERIZATION OF MEMBRANE-BOUND CHITIN SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SYNTHETASE PARTICLES; CANDIDA-ALBICANS; PLASMA-MEMBRANE; CONCANAVALIN-A; S-CEREVISIAE; MUCOR-ROUXII; GENE; PROTEINS; CHITOSOMES	The membrane-bound chitin synthase, a key enzyme of chitin biosynthesis, was purified, for the first time to homogeneity as a zymogen form. Digitonin could solubilize the enzyme from microsomal fraction of the filamentous fungus Absidia glauca, with 60-70% of the enzyme activity. The solubilized form of the enzyme was effectively purified by a sequence of chelating Sepharose, concanavalin A-Sepharose, and Mono Q column. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the purified enzyme gave a single band with a molecular weight of 30,000. IgG prepared against this 30-kDa species on SDS-polyacrylamide gel electrophoresis immunoprecipitated chitin synthase. The purified enzyme existed as a zymogen, was converted into active form by treatment with trypsin, and the limited digestion with trypsin produced a little smaller polypeptide (28.5 kDa) of which the amino-terminal sequence was identical to the zymogen. The purified enzyme was the glycoprotein and showed a requirement for Mg2+. N-Acetylglucosamine stimulated the enzyme activity approximately 5-fold and polyoxin D, an analogue of substrate, and UDP, a by-product of enzyme reaction, strongly inhibited the enzyme activity.			MACHIDA, S (corresponding author), NATL FOOD RES INST, 2-1-2 KANNONDAI, TSUKUBA, IBARAKI 305, JAPAN.							ADAMS DJ, 1980, BIOTECHNOL LETT, V2, P75; AINOUZ IL, 1987, PHYTOCHEMISTRY, V26, P1435, DOI 10.1016/S0031-9422(00)81829-4; AUYOUNG J, 1990, MOL MICROBIOL, V4, P197, DOI 10.1111/j.1365-2958.1990.tb00587.x; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bartnicki-Garcia S, 1973, MICROBIAL DIFFERENTI, P245; BOWEN AR, 1992, P NATL ACAD SCI USA, V89, P519, DOI 10.1073/pnas.89.2.519; BRACKER CE, 1976, P NATL ACAD SCI USA, V73, P4570, DOI 10.1073/pnas.73.12.4570; BUCHEL DE, 1980, NATURE, V283, P541, DOI 10.1038/283541a0; BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; CABIB E, 1989, J CELL BIOL, V108, P1665, DOI 10.1083/jcb.108.5.1665; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; CABIB E, 1988, MICROBIOL SCI, V5, P370; CABIB E, 1981, BIOL CARBOHYDRATES, V1, P51; Cabib E.., 1981, ENCY PLANT PHYSL N B, V13, P395; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; CREAN EV, 1977, BIOCHEM BIOPH RES CO, V75, P488, DOI 10.1016/0006-291X(77)91068-3; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DICKINSON K, 1991, BIOCHIM BIOPHYS ACTA, V1073, P177, DOI 10.1016/0304-4165(91)90199-Q; DURAN A, 1975, P NATL ACAD SCI USA, V72, P3952, DOI 10.1073/pnas.72.10.3952; FRITSCH A, 1973, ANAL BIOCHEM, V55, P57, DOI 10.1016/0003-2697(73)90290-X; HUMPHREYS AM, 1984, J GEN MICROBIOL, V130, P1359; KANG MS, 1984, J BIOL CHEM, V259, P4966; KIKUCHI H, 1981, ANAL BIOCHEM, V115, P109, DOI 10.1016/0003-2697(81)90532-7; Kobata A., 1984, BIOL CARBOHYDRATES, V2, P87; KOBAYASHI T, 1988, NIPPON NOGEIK KAISHI, V62, P1463; KOGA D, 1983, INSECT BIOCHEM, V13, P295, DOI 10.1016/0020-1790(83)90052-5; KONDO M, 1991, ELECTROPHORESIS, V12, P685, DOI 10.1002/elps.1150120918; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEALMORALES CA, 1988, P NATL ACAD SCI USA, V85, P8516, DOI 10.1073/pnas.85.22.8516; LENDING CR, 1991, EXP MYCOL, V15, P11, DOI 10.1016/0147-5975(91)90003-V; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MASSON JM, 1987, EUR J MED CHEM, V22, P377, DOI 10.1016/0223-5234(87)90024-9; MONTGOMERY GWG, 1984, J GEN MICROBIOL, V130, P291; PITT JI, 1985, FUNGI FOOD SPOILAGE, P147; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; RUIZHERRERA J, 1987, ARCH MICROBIOL, V149, P156, DOI 10.1007/BF00425082; RUIZHERRERA J, 1976, J GEN MICROBIOL, V97, P241, DOI 10.1099/00221287-97-2-241; SBURLATI A, 1986, J BIOL CHEM, V261, P5147; SILVERMAN SJ, 1989, YEAST, V5, P459, DOI 10.1002/yea.320050605; SMITH TL, 1989, P NATL ACAD SCI USA, V86, P7063, DOI 10.1073/pnas.86.18.7063; TEEPE H, 1988, FEBS LETT, V234, P100, DOI 10.1016/0014-5793(88)81312-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UENO M, 1991, J BIOL CHEM, V266, P3146; VALDIVIESO MH, 1991, J CELL BIOL, V114, P101, DOI 10.1083/jcb.114.1.101; WANG YC, 1992, J BIOL CHEM, V267, P2728; YAMAUCHI D, 1990, FEBS LETT, V260, P127, DOI 10.1016/0014-5793(90)80083-U; YARDEN O, 1991, GENE DEV, V5, P2420, DOI 10.1101/gad.5.12b.2420	47	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1702	1707						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420947				2022-12-27	WOS:A1993KH62000032
J	CHUANG, TH; XU, XM; KNAUS, UG; HART, MJ; BOKOCH, GM				CHUANG, TH; XU, XM; KNAUS, UG; HART, MJ; BOKOCH, GM			GDP DISSOCIATION INHIBITOR PREVENTS INTRINSIC AND GTPASE ACTIVATING PROTEIN-STIMULATED GTP HYDROLYSIS BY THE RAC GTP-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							OXIDASE	The majority of the GTP-binding proteins of the Ras superfamily hydrolyze GTP to GDP very slowly. A notable exception to this are the Rac proteins, which have intrinsic GTPase rates at least 50-fold those of Ras or Rho. A protein (or proteins) capable of inhibiting this GTPase activity exists in human neutrophil cytosol. Since Rac appears to exist normally in neutrophils as a cytosolic protein complexed to (Rho)GDI, we examined the ability of (Rho)GDI to inhibit GTP hydrolysis by Rac. (Rho)GDI produced a concentration-dependent inhibition of GTP hydrolysis by Rac1 that paralleled its ability to inhibit GDP dissociation from the Rac protein. Maximal inhibition occurred at or near equimolar concentrations of the GDI and the Rac substrate. The ability of two molecules exhibiting GTPase activating protein (GAP) activity toward Rac to stimulate GTP hydrolysis was also inhibited by the presence of (Rho)GDI. The inhibitory effect of the GDI could be overcome by increasing the GAP concentration to levels equal to that of the GDI. (Rho)GDI weakly, but consistently, inhibited GTPgammaS (guanosine 5'-3-O-(thio) triphosphate) dissociation from Rac1, confirming an interaction of (Rho)GDI with the GTP-bound form of the protein. These data describe an additional activity of (Rho)GDI and suggest a mechanism by which Rac might be maintained in an active form in vivo in the presence of regulatory GAPs.	Scripps Res Inst, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA; CORNELL UNIV, DEPT BIOCHEM, ITHACA, NY 14853 USA; CORNELL UNIV, DEPT CELL & MOLEC BIOL, ITHACA, NY 14853 USA; CORNELL UNIV, DEPT PHARMACOL, ITHACA, NY 14853 USA	Scripps Research Institute; Scripps Research Institute; Cornell University; Cornell University; Cornell University			Chuang, Tsung-Hsien/F-9679-2010	xu, xuemin/0000-0002-7426-272X; Hart, Matthew/0000-0002-2683-480X	NHLBI NIH HHS [HL48008] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; FRY M J, 1992, Current Biology, V2, P78, DOI 10.1016/0960-9822(92)90207-Q; GRAND RJA, 1991, BIOCHEM J, V279, P609, DOI 10.1042/bj2790609; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, J BIOL CHEM, V266, P20846; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HORI Y, 1991, ONCOGENE, V6, P515; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; LEONARD D, 1992, J BIOL CHEM, V267, P22860; MARTIN GA, 1992, SCIENCE, V255, P192, DOI 10.1126/science.1553544; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; QUILLIAM LA, 1989, FEBS LETT, V247, P221, DOI 10.1016/0014-5793(89)81339-0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; UEDA T, 1990, J BIOL CHEM, V265, P9373; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P	27	113	115	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					775	778						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419353				2022-12-27	WOS:A1993KG07700006
J	RETSKY, KL; FREEMAN, MW; FREI, B				RETSKY, KL; FREEMAN, MW; FREI, B			ASCORBIC-ACID OXIDATION PRODUCT(S) PROTECT HUMAN LOW-DENSITY-LIPOPROTEIN AGAINST ATHEROGENIC MODIFICATION - ANTIOXIDANT RATHER THAN PROOXIDANT ACTIVITY OF VITAMIN-C IN THE PRESENCE OF TRANSITION-METAL IONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; SMOOTH-MUSCLE CELLS; HUMAN-BLOOD PLASMA; MONOCYTE-MACROPHAGES; LIPID-PEROXIDATION; ATHEROSCLEROSIS; ACCUMULATION; DEGRADATION; EXPRESSION; SUPEROXIDE	The oxidative modification of low density lipoprotein (LDL) has been proposed as an important causative event in the development of human atherosclerosis. As a corollary of this hypothesis, antioxidants that can prevent LDL oxidation may inhibit atherosclerosis. Oxidative modification of LDL in vitro, either induced by Cu2+ or mediated by cultured arterial wall cells in media containing trace amounts of transition metal ions, is strongly inhibited by vitamin C (L-ascorbic acid (AA)). AA, however, is known to act as a prooxidant rather than an antioxidant in the presence of transition metal ions. We observed that AA is oxidized rapidly when incubated with Cu2+ and LDL, leading to transient formation of dehydro-L-ascorbic acid (DHA). Although AA and DHA can no longer be detected after 3.5 h of incubation, LDL resists oxidative modification for at least 20 h, as assessed by anodic gel electrophoretic mobility. Remarkably, DHA protects LDL more effectively against both Cu2+-induced lipid peroxidation and shifts in electrophoretic mobility than does AA; indeed, AA per se, without oxidation to DHA, offers no protection. By inhibiting oxidative modification of LDL, AA and DHA prevent uptake of LDL by macrophages via the scavenger receptor pathway. When LDL is incubated with DHA followed by gel filtration, LDL remains protected against subsequent Cu2+-induced oxidative modification, suggestive of stable modification of LDL in the presence of DHA. In contrast, DHA is ineffective against a metal ion-independent type of oxidative stress, viz. aqueous peroxyl radicals; under these conditions, only AA is able to inhibit lipid peroxidation in LDL. Our data indicate that vitamin C protects LDL against atherogenic modification by two different mechanisms that may act in concert: (i) free radical scavenging by AA prevents aqueous oxidants from attacking and oxidizing LDL, and (ii) stable modification of LDL by DHA or decomposition product(s) thereof imparts increased resistance to metal ion-dependent oxidation.	HARVARD UNIV, SCH PUBL HLTH, DEPT NUTR, 665 HUNTINGTON AVE, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital					NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005446] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL145098, R01HL045098] Funding Source: NIH RePORTER; NCRR NIH HHS [SO7RR05446] Funding Source: Medline; NHLBI NIH HHS [HL-45098] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; BEDWELL S, 1989, BIOCHEM J, V262, P707, DOI 10.1042/bj2620707; BENDICH A, 1986, ADV FREE RADICAL BIO, V2, P419, DOI 10.1016/S8755-9668(86)80021-7; BJORKHEM I, 1991, ARTERIOSCLER THROMB, V11, P15, DOI 10.1161/01.ATV.11.1.15; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CATHCART MK, 1985, J LEUKOCYTE BIOL, V38, P341, DOI 10.1002/jlb.38.2.341; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DASGUPTA A, 1992, LIFE SCI, V50, P875, DOI 10.1016/0024-3205(92)90206-5; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; ESTERBAUER H, 1989, ANN NY ACAD SCI, V570, P254; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FREI B, 1991, AM J CLIN NUTR, V54, pS1113, DOI 10.1093/ajcn/54.6.1113s; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Gaby S. K., 1991, VITAMIN INTAKE HLTH, p71 103; GAZIANO JM, 1992, ANN NY ACAD SCI, V669, P249; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; HARATS D, 1990, ATHEROSCLEROSIS, V85, P47, DOI 10.1016/0021-9150(90)90181-H; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; JIALAL I, 1991, J CLIN INVEST, V87, P597, DOI 10.1172/JCI115035; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; KUZUYA M, 1992, BIOCHIM BIOPHYS ACTA, V1123, P334, DOI 10.1016/0005-2760(92)90015-N; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MINETTI M, 1992, BIOCHEM J, V282, P459, DOI 10.1042/bj2820459; NIEMELA K, 1987, J CHROMATOGR, V399, P235, DOI 10.1016/S0021-9673(00)96125-9; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, P1, DOI 10.1002/clc.4960141302; SHIN DB, 1990, J CARBOHYD CHEM, V9, P461, DOI 10.1080/07328309008543846; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; Stocker R, 1991, OXIDATIVE STRESS OXI, P213; TAKAGI M, 1988, J NUTR SCI VITAMINOL, V34, P141; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; TSAO CS, 1991, AM J CLIN NUTR, V54, pS1274, DOI 10.1093/ajcn/54.6.1274s; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; [No title captured]	48	248	251	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1304	1309						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419332				2022-12-27	WOS:A1993KG07700081
J	GUELIN, E; CHEVALLIER, J; RIGOULET, M; GUERIN, B; VELOURS, J				GUELIN, E; CHEVALLIER, J; RIGOULET, M; GUERIN, B; VELOURS, J			ATP SYNTHASE OF YEAST MITOCHONDRIA - ISOLATION AND DISRUPTION OF THE ATP-EPSILON-GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; SACCHAROMYCES-CEREVISIAE; ADENOSINE-TRIPHOSPHATASE; BOVINE MITOCHONDRIA; RAPID METHOD; RAT-LIVER; SUBUNIT; PROTEIN; DICYCLOHEXYLCARBODIIMIDE; COMPLEX	The nuclear gene encoding the subunit epsilon of the catalytic sector F1 of the yeast Saccharomyces cerevisiae ATP synthase was cloned and sequenced. Degenerated oligonucleotide primers were constructed from primary structure data. A part of the ATPepsilon gene was amplified by polymerase chain reaction from yeast genomic DNA. From the amplified DNA sequence a nondegenerated oligonucleotide probe was constructed and used for isolating a 2040-base pair EcoRI fragment bearing the whole gene. A 186-base pair open reading frame encoding a 62-amino acid polypeptide is described. The deduced amino acid sequence was one amino acid longer than the mature protein. A null mutant was constructed. The mutant strain was unable to grow on glycerol medium. The mutant mitochondria had no detectable oligomycin-sensitive ATPase activity. The catalytic sector appeared unstable during purification but F0-subunits were still bound to F1. The mutation promoted a highly oligomycin-sensitive uncoupling of the mitochondrial respiration rate.	UNIV BORDEAUX 2,CNRS,INST BIOCHIM CELLULAIRE,1 RUE CAMILLE ST SAENS,F-33077 BORDEAUX,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux								ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626; AGGELER R, 1990, J BIOL CHEM, V265, P16389; ANSORGE W, 1983, ELECTROPHORESIS 82, P235; ARENDS H, 1984, EMBO J, V3, P377, DOI 10.1002/j.1460-2075.1984.tb01815.x; ARSELIN G, 1991, J BIOL CHEM, V266, P723; BAIRD BA, 1977, J BIOL CHEM, V252, P4743; BEECHEY RB, 1975, BIOCHEM J, V148, P533, DOI 10.1042/bj1480533; BOUILLAUD F, 1986, J BIOL CHEM, V261, P1487; CAIN K, 1977, BIOCHEM J, V162, P575, DOI 10.1042/bj1620575; DECHATEAUBODEAU GA, 1976, BIOCHIMIE PARIS, V58, P601; DUPUIS A, 1991, BIOCHEMISTRY-US, V30, P2954, DOI 10.1021/bi00225a032; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; GAROFF H, 1981, ANAL BIOCHEM, V115, P450, DOI 10.1016/0003-2697(81)90031-2; GLASER E, 1982, EUR J BIOCHEM, V121, P525, DOI 10.1111/j.1432-1033.1982.tb05818.x; Guerin B, 1979, Methods Enzymol, V55, P149; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HEALY AM, 1990, CURR GENET, V18, P105, DOI 10.1007/BF00312597; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JOHNSTON JR, 1988, YEAST PRACTICAL APPR, P107; KIMURA T, 1989, J BIOL CHEM, V264, P3183; KOPECKY J, 1983, EUR J BIOCHEM, V131, P17, DOI 10.1111/j.1432-1033.1983.tb07226.x; LARDY HA, 1953, J BIOL CHEM, V210, P357; LEE CP, 1966, REGULATION METABOLIC, P218; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MAZAT JP, 1986, BIOCHIM BIOPHYS ACTA, V849, P7, DOI 10.1016/0005-2728(86)90090-3; MCEWEN JE, 1985, J BACTERIOL, V161, P831, DOI 10.1128/JB.161.3.831-835.1985; NORAIS N, 1991, J BIOL CHEM, V266, P16541; PAUL MF, 1992, EUR J BIOCHEM, V205, P163, DOI 10.1111/j.1432-1033.1992.tb16764.x; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; PEDERSEN PL, 1981, J BIOL CHEM, V256, P1362; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; PENIN F, 1990, BIOCHEMISTRY-US, V29, P9358, DOI 10.1021/bi00492a008; RIGOULET M, 1987, EUR J BIOCHEM, V168, P275, DOI 10.1111/j.1432-1033.1987.tb13417.x; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SIKORSKI RS, 1989, GENETICS, V122, P19; TAKESHIGE K, 1976, H-S Z PHYSIOL CHEM, V357, P1605, DOI 10.1515/bchm2.1976.357.2.1605; VELOURS J, 1987, EUR J BIOCHEM, V164, P579, DOI 10.1111/j.1432-1033.1987.tb11166.x; VINAS O, 1990, BIOCHEM J, V265, P312; WALKER JE, 1987, J MOL BIOL, V197, P89, DOI 10.1016/0022-2836(87)90611-5; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; WRIGHT RM, 1986, J BIOL CHEM, V261, P7183	48	56	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					161	167						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416924				2022-12-27	WOS:A1993KE60300025
J	CAO, YJ; SKURAT, AV; DEPAOLIROACH, AA; ROACH, PJ				CAO, YJ; SKURAT, AV; DEPAOLIROACH, AA; ROACH, PJ			INITIATION OF GLYCOGEN-SYNTHESIS - CONTROL OF GLYCOGENIN BY GLYCOGEN-PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; SYNTHASE; KINASE; BIOSYNTHESIS; BIOGENESIS; GLUCOSE; PROTEIN; LIVER	Glycogen biosynthesis involves a specific initiation event, mediated by a specialized protein, glycogenin. Glycogenin undergoes self-glucosylation to generate an oligosaccharide primer, which, when long enough, supports the action of glycogen synthase to elongate the polysaccharide chain, leading ultimately to the formation of glycogen. We report that primed glycogenin is also a substrate for glycogen phosphorylase. Phosphorylase removed glucose from the oligosaccharide attached to glycogenin in a phosphorolysis reaction that required phosphate and produced glucose 1-phosphate. The phosphorylated form, phosphorylase a, was much more effective than the dephosphorylated phosphorylase b. However, in the presence of the allosteric effector AMP, phosphorylase b also catalyzed the phosphorolysis reaction. Glucose, an allosteric inhibitor of phosphorylase, inhibited the reaction. Glycogen, but not a short oligosaccharide (maltopentaose), also inhibited the reaction. Treatment of fully primed glycogenin with phosphorylase converted the glycogenin to a form with slightly lower apparent molecular weight, which was less effective as a substrate for glycogen synthase. These results suggest a novel role for phosphorylase in the control of glycogen biosynthesis. We propose that the glucosylation level of glycogenin would be determined by the balance between the self-glucosylation reaction and the opposing action of phosphorylase. The level of glucosylation would in turn determine whether or not glycogenin was an effective primer for glycogen synthase. In this way, several known controls of phosphorylase activity, such as epinephrine, glucagon, and insulin, could influence not only the elongation/degradation stage of glycogen metabolism but also its initiation.			CAO, YJ (corresponding author), INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202, USA.				NIDDK NIH HHS [DK27221] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, R37DK027221] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD Z, 1986, ARCH BIOCHEM BIOPHYS, V250, P329, DOI 10.1016/0003-9861(86)90734-4; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; CAO YJ, 1993, J BIOL CHEM, V268, P14687; CARTER J, 1978, CARBOHYD RES, V61, P395, DOI 10.1016/S0008-6215(00)84499-7; COHEN P, 1907, EUR J BIOCHEM, V34, P1; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; EXTON JH, 1986, ADV CYCLIC NUCL PROT, V20, P211; HEMS DA, 1980, PHYSIOL REV, V60, P1; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMAKO J, 1988, FASEB J, V2, P3097, DOI 10.1096/fasebj.2.15.2973423; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; PITCHER J, 1987, EUR J BIOCHEM, V169, P497, DOI 10.1111/j.1432-1033.1987.tb13637.x; REBERS PA, 1986, CARBOHYD RES, V153, P132, DOI 10.1016/S0008-6215(00)90202-7; REINER JM, 1959, BEHAVIOR ENZYME SYST, P54; ROACH PJ, 1978, J CYCLIC NUCL PROT, V4, P245; ROBYT JF, 1987, BIOCH TECHNIQUES, P218; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; SMYTHE C, 1990, EUR J BIOCHEM, V189, P199, DOI 10.1111/j.1432-1033.1990.tb15477.x; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; STALMANS W, 1976, CURR TOP CELL REGUL, V11, P51; STALMANS W, 1983, HDB EXPT PHARM, V66, P291; THOMA JA, 1971, ENZYMES, V5, P115; Wang J. H, 1972, ENZYMES, V7, P435; WHELAN WJ, 1986, BIOESSAYS, V5, P136, DOI 10.1002/bies.950050312	28	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21717	21721						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408025				2022-12-27	WOS:A1993MC80900046
J	EADARA, JK; LUTTER, LC				EADARA, JK; LUTTER, LC			RNA-POLYMERASE LOCATIONS IN THE SIMIAN VIRUS-40 TRANSCRIPTION COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMATURE TERMINATION; SV40 MINICHROMOSOMES; T-ANTIGEN; C-MYC; DNA; CELLS; ELONGATION; INVITRO; GENE; MECHANISM	Transcription complexes of simian virus 40 can be isolated from cells late in infection in a form that retains the ability to continue transcription in vitro. These complexes have been investigated previously to gain information about the nucleoprotein structure of a transcribing gene. However, several studies have reported that the RNA polymerase molecules in such complexes are located almost entirely at the 5' end of the transcription unit. This would indicate that these complexes cannot be those which were in the process of transcribing mRNA in the cell, because the transcribing complexes would be expected to contain polymerases that were distributed throughout the transcription unit at the time of extraction. Since this issue is important to the interpretation of studies which characterize the extracted complexes, we have determined the polymerase locations using two new approaches. The first employs a new application of a procedure in which the transcription complex DNA is radioactively tagged by transcription in vitro. The second is a new method, which analyzes run-off transcripts generated in vitro. Both methods demonstrate that the polymerases are distributed throughout the genome in the transcription complexes. This result indicates that these complexes were in the process of transcribing mRNA at the time of cell lysis.	HENRY FORD HOSP,MOLEC BIOL RES PROGRAM,2799 W GRAND BLVD,DETROIT,MI 48202	Henry Ford Health System; Henry Ford Hospital								ACHESON NH, 1981, MOL BIOL TUMOR VIR 2, P61; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BONILLA PJ, 1991, NUCLEIC ACIDS RES, V19, P3965, DOI 10.1093/nar/19.14.3965; CHIKARAISHI DM, 1981, J VIROL, V37, P511, DOI 10.1128/JVI.37.1.511-517.1981; CHODER M, 1988, NUCLEIC ACIDS RES, V16, P895, DOI 10.1093/nar/16.3.895; CHODER M, 1984, EMBO J, V3, P2929, DOI 10.1002/j.1460-2075.1984.tb02234.x; CHODER M, 1988, J BIOL CHEM, V263, P12994; COCHETME.M, 1974, BIOCHIM BIOPHYS ACTA, V353, P160, DOI 10.1016/0005-2787(74)90182-8; EDENBERG HJ, 1980, NUCLEIC ACIDS RES, V8, P573, DOI 10.1093/nar/8.3.573; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; GARIGLIO P, 1979, J MOL BIOL, V131, P75, DOI 10.1016/0022-2836(79)90302-4; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; HADLOCK KG, 1990, J MOL BIOL, V215, P53, DOI 10.1016/S0022-2836(05)80094-4; HADLOCK KG, 1987, J BIOL CHEM, V262, P15527; HADLOCK KG, 1988, DNA PROTEIN ENG TECH, V1, P9; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; LAUB O, 1976, VIROLOGY, V75, P346, DOI 10.1016/0042-6822(76)90033-7; LAUB O, 1980, P NATL ACAD SCI-BIOL, V77, P3297, DOI 10.1073/pnas.77.6.3297; LAUB O, 1979, VIROLOGY, V92, P310, DOI 10.1016/0042-6822(79)90136-3; LLOPIS R, 1981, J VIROL, V38, P82, DOI 10.1128/JVI.38.1.82-90.1981; LLOPIS R, 1982, J VIROL, V44, P864, DOI 10.1128/JVI.44.3.864-870.1982; LUTTER LC, 1992, MOL CELL BIOL, V12, P5004, DOI 10.1128/MCB.12.11.5004; LUTTER LC, 1989, P NATL ACAD SCI USA, V86, P8712, DOI 10.1073/pnas.86.22.8712; MANIATIS T, 1982, MOL CLONING LABORATO, P380; PETRYNIAK B, 1987, CELL, V48, P289, DOI 10.1016/0092-8674(87)90432-6; PFEIFFER P, 1983, EMBO J, V2, P185, DOI 10.1002/j.1460-2075.1983.tb01403.x; SALZMAN NP, 1986, PAPOVAVIRIDAE, P27; SHANI M, 1977, J VIROL, V23, P20, DOI 10.1128/JVI.23.1.20-28.1977; SKOLNIKDAVID H, 1982, P NATL ACAD SCI-BIOL, V79, P2743, DOI 10.1073/pnas.79.9.2743; SPENCER CA, 1990, ONCOGENE, V5, P777; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; UCKER DS, 1984, J BIOL CHEM, V259, P7416; van Holde K. E., 1989, SPRINGER SERIES MOL, P355	33	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22020	22027						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408059				2022-12-27	WOS:A1993MC80900087
J	MILNER, RE; BUSAAN, JL; HOLMES, CFB; WANG, JH; MICHALAK, M				MILNER, RE; BUSAAN, JL; HOLMES, CFB; WANG, JH; MICHALAK, M			PHOSPHORYLATION OF DYSTROPHIN - THE CARBOXYL-TERMINAL REGION OF DYSTROPHIN IS A SUBSTRATE FOR IN-VITRO PHOSPHORYLATION BY P34(CDC2) PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CARDIAC SARCOLEMMAL VESICLES; CYSTEINE-RICH DOMAIN; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; NONMUSCLE TISSUES; CELL-CYCLE; GENE; BINDING; ASSOCIATION	In this paper, we report that p34cdc2 protein kinase phosphorylates recombinant fragments of skeletal muscle dystrophin with a maximal incorporation of 1.8 mol of P(i)/mol of protein. Phosphorylation of both serine and threonine residues occurs within the carboxyl-terminal 201 amino acids of dystrophin, with phosphothreonine localized to within 25 residues of the carboxyl terminus. Supporting these in vitro studies, we also show that native dystrophin is phosphorylated by p34cdc2 kinase in isolated sarcolemmal vesicles. Sequence analysis indicates two consensus sites for p34cdc2 protein kinase within the carboxyl-terminal 201 amino acids of dystrophin. Importantly, neither of these sites is conserved in dystrophin-related protein, and only one site is conserved in the 71-kDa alternative product of the Duchenne muscular dystrophy gene, despite an otherwise extremely high degree of sequence conservation between these proteins. Importantly, in this study we also show that dystrophin is phosphorylated in vivo in rat skeletal muscle primary cultures, and we suggest that further investigation of both in vivo and in vitro phosphorylation of this protein will comprise an important part in determination of its function(s).	UNIV ALBERTA, DEPT BIOCHEM, CARDIOVASC DIS RES GRP, 424 HERITAGE MED RES CTR, EDMONTON T6G 2S2, AB, CANADA; UNIV ALBERTA, DEPT BIOCHEM, MRC, PROT STRUCT GRP, EDMONTON T6G 2S2, AB, CANADA; UNIV CALGARY, FAC MED,DEPT MED BIOCHEM,MRC,SIGNAL TRANSDUCT GRP, CALGARY T2N 4N1, AB, CANADA	University of Alberta; University of Alberta; University of Calgary								AHMAD Z, 1982, J BIOL CHEM, V257, P8348; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; CHEN XY, 1991, BIOCHEM J, V279, P467, DOI 10.1042/bj2790467; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; CHOU YH, 1991, J BIOL CHEM, V266, P7325; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; HOFFMAN EP, 1991, ANN NEUROL, V30, P605, DOI 10.1002/ana.410300414; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; JONES LR, 1988, METHOD ENZYMOL, V157, P85; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KEMP BE, 1979, J BIOL CHEM, V254, P2638; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KLAMUT HJ, 1989, BRIT MED BULL, V45, P681, DOI 10.1093/oxfordjournals.bmb.a072352; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEW J, 1992, J BIOL CHEM, V267, P13383; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; MAK AS, 1991, J BIOL CHEM, V266, P6678; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MICHALAK M, 1980, J BIOL CHEM, V255, P1327; MICHALAK M, 1990, J BIOL CHEM, V265, P5869; MILNER RE, 1992, BIOCHEM J, V288, P1037, DOI 10.1042/bj2881037; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; WOLF M, 1985, J BIOL CHEM, V260, P5718; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	43	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21901	21905						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408045				2022-12-27	WOS:A1993MC80900071
J	NEUENSCHWANDER, PF; FIORE, MM; MORRISSEY, JH				NEUENSCHWANDER, PF; FIORE, MM; MORRISSEY, JH			FACTOR-VII AUTOACTIVATION PROCEEDS VIA INTERACTION OF DISTINCT PROTEASE-COFACTOR AND ZYMOGEN-COFACTOR COMPLEXES - IMPLICATIONS OF A 2-DIMENSIONAL ENZYME-KINETIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							COAGULATION FACTOR-VII; FACTOR-DEPENDENT AUTOACTIVATION; BOVINE FACTOR-VII; TISSUE FACTOR; BLOOD-COAGULATION; FACTOR-X; HAGEMAN-FACTOR; FACTOR-XII; ACTIVATION; PROTHROMBINASE	Tissue factor (TF), an integral membrane protein, enhances the feedback activation of factor VII by factor VIIa (factor VII autoactivation). We found that, in contrast to the other known membrane-dependent coagulation activation reactions, TF-dependent factor VII autoactivation occurred preferentially on neutral phospholipid vesicles relative to negatively charged vesicles containing phosphatidylserine. This reaction was best described by a novel mechanism in which the enzyme and substrate are each bound to separate cofactor (TF) molecules. This unusual mechanism of substrate presentation to a membrane-bound protease predicts that the reaction rate will be directly dependent on the surface density, and hence lateral diffusion, of factor VII.TF and factor VIIa.TF complexes, obeying obligatorily two-dimensional enzyme kinetics. This prediction was confirmed, yielding a two-dimensional second-order rate constant (k2D) of 4.9 (+/- 0.8) x 10(6) m2 mol-1 s-1. Since intact cells normally sequester acidic phospholipids away from the outer leaflet of the plasma membrane, this reaction mechanism should permit factor VII autoactivation to predominate on unactivated/undamaged cell surfaces when other clotting reactions are dormant.	OKLAHOMA MED RES FDN, CARDIOVASC BIOL RES PROGRAM, 825 NE 13TH ST, OKLAHOMA CITY, OK 73104 USA	Oklahoma Medical Research Foundation			Morrissey, James H/H-4933-2011; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008710, R01HL047014] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL-47014, F32 HL-08710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; CARSON SD, 1993, BLOOD COAGUL FIBRIN, V4, P281, DOI 10.1097/00001721-199304000-00010; FIORE MM, 1992, BLOOD, V80, P3127; Fiske CH, 1925, J BIOL CHEM, V66, P375; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P4189, DOI 10.1021/bi00638a009; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; MASYS DR, 1982, BLOOD, V60, P1143; MILLER BC, 1985, BLOOD, V65, P845; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MORRISSEY JH, 1993, BLOOD, V81, P734; MORRISSEY JH, 1988, THROMB RES, V50, P481, DOI 10.1016/0049-3848(88)90197-1; NAKAGAKI T, 1991, BIOCHEMISTRY-US, V30, P10819, DOI 10.1021/bi00109a001; NEMERSON Y, 1988, BLOOD, V71, P1; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NEUENSCHWANDER PF, 1992, J BIOL CHEM, V267, P14477; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3; PEDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P9331, DOI 10.1021/bi00450a013; RADCLIFFE R, 1976, J BIOL CHEM, V251, P4797; RADCLIFFE R, 1975, J BIOL CHEM, V250, P388; RAPAPORT SI, 1991, ANN NY ACAD SCI, V614, P51; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; ROSING J, 1980, J BIOL CHEM, V255, P274; SMALL DM, 1967, J LIPID RES, V8, P551; TANS G, 1983, J BIOL CHEM, V258, P8215; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; YAMAMOTO M, 1992, J BIOL CHEM, V267, P19089	33	110	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21489	21492						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407997				2022-12-27	WOS:A1993MC80900010
J	BALDARI, CT; HEGUY, A; TELFORD, JL				BALDARI, CT; HEGUY, A; TELFORD, JL			RAS PROTEIN-ACTIVITY IS ESSENTIAL FOR T-CELL ANTIGEN RECEPTOR SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; INTERLEUKIN-2 GENE; CYCLOSPORINE-A; CHLORAMPHENICOL ACETYLTRANSFERASE; LYMPHOCYTES-T; ONCOGENIC RAS; PHORBOL ESTER; ACTIVATION; EXPRESSION; PHOSPHORYLATION	In a Jurkat cell model of T-cell activation an interleukin-2 promoter/reporter gene construct was activated by antigen receptor agonism in combination with the lymphokine interleukin-1. Antigen receptor signals could be mimicked by suboptimal activation of protein kinase C (PKC) with phorbol esters in combination with calcium mobilization by an ionophore. In cotransfection experiments, oncogenic ras obviated the need for PKC stimulation but did not replace either the calcium signal or interleukin-1. Activated ras expression also replaced the requirement for PKC stimulation in activation of the T-cell transcription factor NF-AT. A dominant inhibitory ras mutant specifically blocked antigen receptor agonism, indicating that ras activity is required for antigen receptor signaling. In addition, an inhibitor of PKC blocked both activated ras and phorbol ester stimulation, suggesting a role for ras upstream of PKC.	IMMUNOBIOL RES INST, VIA FIORENTINA 1, I-53100 SIENA, ITALY; UNIV SIENA, DEPT EVOLUT BIOL, I-53100 SIENA, ITALY	University of Siena			Telford, John Laird/ABG-8144-2020	Baldari, Cosima/0000-0002-4414-6744				ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; BALDARI CT, 1991, J BIOL CHEM, V266, P19103; BALDARI CT, 1992, J BIOL CHEM, V267, P4289; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CASAGLI MC, 1989, PREP BIOCHEM, V19, P23, DOI 10.1080/10826068908544894; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DENTE L, 1985, DNA CLONING PRACTICA, V1, P101; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; ESPEL E, 1990, EMBO J, V9, P929, DOI 10.1002/j.1460-2075.1990.tb08191.x; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FUJITA T, 1986, CELL, V46, P401, DOI 10.1016/0092-8674(86)90660-4; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HEGUY A, 1991, CELL GROWTH DIFFER, V2, P311; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCHIA G, 1990, MOL CELL BIOL, V10, P2731, DOI 10.1128/MCB.10.6.2731; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PRICE BD, 1989, J BIOL CHEM, V264, P16638; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	48	73	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2693	2698						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428943				2022-12-27	WOS:A1993KK81500065
J	LI, J; BROYLES, SS				LI, J; BROYLES, SS			RECRUITMENT OF VACCINIA VIRUS-RNA POLYMERASE TO AN EARLY GENE PROMOTER BY THE VIRAL EARLY TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; INITIATION; MECHANISM; INVITRO; EXPRESSION; COMPLEX; ATP; PURIFICATION; REPLICATION; REQUIREMENT	Transcription of vaccinia virus early genes in vitro requires the virally encoded RNA polymerase and early transcription factor, VETF. VETF is a promoter-binding protein with DNA-dependent ATPase activity. We have investigated the functional role of VETF in transcription activation by analyzing the interaction between the RNA polymerase and promoter DNA. Using a gel shift assay, a novel protein-DNA complex was detected that required both RNA polymerase and VETF. The complex was suggested to be a transcription initiation complex by its ability to incorporate P-32-labeled nucleotides in combinations compatible with synthesis of a short RNA chain. Competition binding studies indicated that the RNA polymerase associated specifically with a viral early promoter. These experiments demonstrate that VETF activates transcription by directly recruiting the RNA polymerase to the promoter. Sedimentation analysis showed that VETF and RNA polymerase did not form a stable complex unless promoter DNA was present, indicating that protein-protein contacts are not the sole basis for initiation complex assembly. DNase I cleavage and methylation interference analyses revealed a hyperreactive site in the center of the promoter. Radiolabeling of RNA in the RNA polymerase-promoter complex did not occur when AMP-PNP (adenyl-5'-yl imidodiphosphate) was substituted for ATP, suggesting that ATP hydrolysis is required for the initiation of transcription. A model is proposed to account for these findings.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus								BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; BROYLES SS, 1987, MOL CELL BIOL, V7, P7, DOI 10.1128/MCB.7.1.7; BROYLES SS, 1988, J BIOL CHEM, V263, P10761; BROYLES SS, 1991, J BIOL CHEM, V266, P15539; BROYLES SS, 1991, J BIOL CHEM, V266, P15545; BROYLES SS, 1990, J VIROL, V64, P1523, DOI 10.1128/JVI.64.4.1523-1529.1990; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; CHAMBERLIN MJ, 1974, ANNU REV BIOCHEM, V43, P721, DOI 10.1146/annurev.bi.43.070174.003445; CONAWAY JW, 1990, J BIOL CHEM, V265, P7552; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; FIRE A, 1984, J BIOL CHEM, V259, P2509; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GERSHON PD, 1990, P NATL ACAD SCI USA, V87, P4401, DOI 10.1073/pnas.87.11.4401; GERSHOWITZ A, 1978, VIROLOGY, V88, P149; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HAGLER J, 1992, J VIROL, V66, P2982, DOI 10.1128/JVI.66.5.2982-2989.1992; HAGLER J, 1992, J BIOL CHEM, V267, P7644; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUSTU S, 1989, MICROBIOL REV, V53, P367, DOI 10.1128/MMBR.53.3.367-376.1989; LUSE DS, 1987, J BIOL CHEM, V262, P14990; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; QUICK SD, 1990, VIROLOGY, V178, P603, DOI 10.1016/0042-6822(90)90362-U; Sambrook J, 1989, MOL CLONING LABORATO; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; VANDEUSEN J, 1989, OCCUP THER J RES, V9, P243, DOI 10.1177/153944928900900405; VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VOS JC, 1991, CELL, V65, P105, DOI 10.1016/0092-8674(91)90412-R; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6069, DOI 10.1073/pnas.84.17.6069; [No title captured]	44	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2773	2780						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428951				2022-12-27	WOS:A1993KK81500077
J	SUZUKI, K; WOOL, IG				SUZUKI, K; WOOL, IG			THE PRIMARY STRUCTURE OF RAT RIBOSOMAL-PROTEIN L23A - THE APPLICATION OF HOMOLOGY SEARCH TO THE IDENTIFICATION OF GENES FOR MAMMALIAN AND YEAST RIBOSOMAL-PROTEINS AND A CORRELATION OF RAT AND YEAST RIBOSOMAL-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SCHIZOSACCHAROMYCES-POMBE; NUCLEOTIDE-SEQUENCE; POINT MUTATIONS; MESSENGER-RNA; AMINO-ACIDS; SITE; L25; DOMAIN	The amino acid sequence of the rat 60 S ribosomal subunit protein L23a was deduced from the sequence of nucleotides in a recombinant cDNA. Ribosomal protein L23a has 156 amino acids and a molecular weight of 17,684. Hybridization of the L23a cDNA to digests of nuclear DNA suggests that there are 18-20 copies of the L23a gene. The mRNA for the protein is about 600 nucleotides in length. Rat L23a is related to the yeast Saccharomyces cerevisiae L25, to the archaebacterial Methanococcus vannielii L23, to eubacterial Escherichia coli L23, and to other members of the L23 family of ribosomal proteins. A novel application of a routine homology search procedure was employed to identify a nucleotide sequence that could be used to design an oligodeoxynucleotide probe to screen a library for a cDNA that encodes rat L23a; this same procedure uncovered a number of previously unidentified genes for yeast ribosomal proteins in the Gen-Bank DNA data base. In a correlation of rat and yeast ribosomal proteins 48 pairs are shown to be related.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637	University of Chicago					NIGMS NIH HHS [GM-21769] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021769] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA Y, 1989, FEBS LETT, V247, P242, DOI 10.1016/0014-5793(89)81344-4; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BOORSTEIN WR, 1990, J BIOL CHEM, V265, P18912; CHAN YL, 1991, BIOCHEM BIOPH RES CO, V178, P1153, DOI 10.1016/0006-291X(91)91013-3; CHAN YL, 1987, J BIOL CHEM, V262, P12879; CHAN YL, 1990, ARCH BIOCHEM BIOPHYS, V283, P546, DOI 10.1016/0003-9861(90)90682-O; CHAN YL, 1987, NUCLEIC ACIDS RES, V15, P9451, DOI 10.1093/nar/15.22.9451; CHAN YL, 1988, J BIOL CHEM, V263, P2891; CHAN YL, 1987, J BIOL CHEM, V262, P1111; DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, V5, P1; DEVI KRG, 1989, BIOCHEM BIOPH RES CO, V162, P364, DOI 10.1016/0006-291X(89)92005-6; ELBARADI TTAL, 1987, BIOCHIMIE, V69, P939, DOI 10.1016/0300-9084(87)90227-6; ELBARADI TTAL, 1985, EMBO J, V4, P2101, DOI 10.1002/j.1460-2075.1985.tb03898.x; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; GERAGHTY DE, 1990, J EXP MED, V171, P1, DOI 10.1084/jem.171.1.1; GLUCK A, 1989, EUR J BIOCHEM, V182, P105, DOI 10.1111/j.1432-1033.1989.tb14805.x; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; KIMURA M, 1985, EUR J BIOCHEM, V150, P491, DOI 10.1111/j.1432-1033.1985.tb09049.x; KOPKE AKE, 1988, FEBS LETT, V239, P313, DOI 10.1016/0014-5793(88)80942-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUWANO Y, 1985, J BIOCHEM-TOKYO, V97, P983, DOI 10.1093/oxfordjournals.jbchem.a135175; LEVY S, 1991, P NATL ACADS CI US, V88, P319; OTAKA E, 1982, BIOCHEMISTRY-US, V21, P4545, DOI 10.1021/bi00262a005; OTAKA E, 1983, MOL GEN GENET, V191, P519, DOI 10.1007/BF00425772; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RUTGERS CA, 1991, J MOL BIOL, V218, P375, DOI 10.1016/0022-2836(91)90719-M; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SUZUKI K, 1990, BIOCHEM BIOPH RES CO, V171, P519, DOI 10.1016/0006-291X(90)91176-S; TEKAMPOLSON P, 1988, GENE, V73, P153, DOI 10.1016/0378-1119(88)90321-6; VESTER B, 1984, J MOL BIOL, V179, P431, DOI 10.1016/0022-2836(84)90074-3; WOOL IG, 1990, RIBOSOME, P203; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M; WOOLFORD JL, 1989, YEAST, V5, P439, DOI 10.1002/yea.320050604; WOUDT LP, 1987, CURR GENET, V12, P193, DOI 10.1007/BF00436878; ZURAWSKI G, 1985, NUCLEIC ACIDS RES, V13, P4521, DOI 10.1093/nar/13.12.4521	39	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2755	2761						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428950				2022-12-27	WOS:A1993KK81500074
J	TRUANT, R; XIAO, H; INGLES, CJ; GREENBLATT, J				TRUANT, R; XIAO, H; INGLES, CJ; GREENBLATT, J			DIRECT INTERACTION BETWEEN THE TRANSCRIPTIONAL ACTIVATION DOMAIN OF HUMAN P53 AND THE TATA BOX-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RNA POLYMERASE-II; CRITICAL STRUCTURAL ELEMENTS; SELECTIVE BINDING; CELLULAR P53; GENE; EXPRESSION; INVITRO; CELLS; VP16; ASSOCIATION	The human p53 tumor suppressor gene product can activate transcription by RNA polymerase II in the yeast, Saccharomyces cerevisiae, as well as in human cells. Several viral transcriptional activator proteins have been shown to directly contact TBP, the TATA box-binding subunit of the general initiation factor, TFIID. In this report, we use protein affinity chromatography to show that the cellular transcription factor, p53, interacts directly and specifically with yeast TBP. The TBP binding domain of p53 was localized to its N-terminal 73 amino acids. This highly acidic portion of p53 functions as a transcriptional activation domain and is deleted in some tumors induced by the Friend leukemia virus. A human tumor-derived oncogenic point mutation of p53, which lies outside the activation domain of p53, but reduces its ability to activate transcription, greatly reduced the ability of p53 to bind yeast TBP in vitro. This mutation probably affects the overall conformation of the protein and indirectly interferes with the ability of p53 to contact TBP and activate transcription. In contrast, a mutated oncogenic form of p53 that is unaffected in its ability to activate transcription bound yeast TBP as well as wild type p53. The human TBP activity in a HeLa extract also bound to the activation domain of p53. Our data support a general model in which DNA-bound activator proteins activate transcription by interacting with TBP.	UNIV TORONTO,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5G 1L6,ONTARIO,CANADA	University of Toronto; University of Toronto								BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; CORTES P, 1992, MOL CELL BIOL, V12, P413, DOI 10.1128/MCB.12.1.413; CRESS A, 1991, GENE, V103, P235, DOI 10.1016/0378-1119(91)90278-J; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; FIELDS S, 1990, SCIENCE, V249, P1049; FINKELSTEIN A, 1992, NATURE, V355, P464, DOI 10.1038/355464a0; FLORES O, 1989, J BIOL CHEM, V264, P8913; FORMOSA T, 1991, METHOD ENZYMOL, V208, P24; GREENBLATT J, 1991, CELL, V66, P1067, DOI 10.1016/0092-8674(91)90027-V; HA I, 1991, NATURE, V352, P688; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HORIKOSHI M, 1992, P NATL ACAD SCI USA, V89, P1060, DOI 10.1073/pnas.89.3.1060; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; JOHNSON P, 1991, MOL CELL BIOL, V11, P1; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; KERN SE, 1991, ONCOGENE, V6, P131; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LEVINE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1032, P119, DOI 10.1016/0304-419X(90)90015-S; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; PETERSON MG, 1991, NATURE, V354, P369; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RAYCROFT L, 1991, MOL CELL BIOL, V11, P6067, DOI 10.1128/MCB.11.12.6067; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; SAMBROOK J, 1989, MOL CLONING LABORATO, P60; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; STEINMEYER K, 1988, ONCOGENE, V3, P501; STILLMAN B, 1986, CANCER SURV, V5, P389; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0	44	227	234	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2284	2287						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428901				2022-12-27	WOS:A1993KK81500005
J	CHENCLELAND, TA; SMITH, MM; LE, SY; STERNGLANZ, R; ALLFREY, VG				CHENCLELAND, TA; SMITH, MM; LE, SY; STERNGLANZ, R; ALLFREY, VG			NUCLEOSOME STRUCTURAL-CHANGES DURING DEREPRESSION OF SILENT MATING-TYPE LOCI IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOGEN BROMIDE PEPTIDES; ACTIVE DNA-SEQUENCES; AMINO-ACID SEQUENCE; THYMUS HISTONE-III; SACCHAROMYCES-CEREVISIAE; AFFINITY-CHROMATOGRAPHY; REVERSIBLE CHANGES; GENETIC-EVIDENCE; CORE PARTICLE; C-FOS	Mutant a and alpha yeast cells were created with histone H3 containing cysteine in place of alanine 110. Because transcriptionally active nucleosomes ''unfold'' to reveal the histone H3-thiol groups at the center of the core, the active nucleosomes of the mutant strain can be isolated by mercury-affinity chromatography. We compared the unbound and mercury-bound nucleosomes of haploid H3-mutant strains expressing either the MATalpha or the MATa mating-type locus. In a MATalpha strain, the Hg-bound nucleosomes are enriched in MATalpha DNA but lack the DNA of the transcriptionally silent HMRa mating-type locus. Conversely, in a MATa strain, the Hg-bound nucleosomes are enriched in MATa DNA sequences but deficient in HMLalpha DNA. When the SIR3 gene, known to be required for silencing of the repressed mating-type loci, is mutated in the MATalpha strain, transcription of the HMRa ensues, and its nucleosomes, as well as those of the MATalpha locus, are retained by the organomercurial column. It follows that derepression of the silent mating-type locus, caused by the sir3 null mutation, is accompanied by an unfolding of its nucleosomes to reveal the histone H3 SH groups at their centers. Nucleosomes of the pheromone-encoding gene MFA2, a gene that is expressed in MATa cells but not in MATalpha cells, are bound to the organomercurial column when isolated from MATa cells but not from MATalpha cells. Thus, there is a good correlation between nucleosome unfolding and the renewed transcriptional activity at mating-type loci, and at MFA2, which had been silenced for prolonged periods. A close temporal correlation between nucleosome refolding and the cessation of transcription is not always observed in yeast, however, in contrast to observations in mammalian cells. For example, nucleosomes of the GAL1 gene are maintained in a ''poised'' or ''primed'' thiol-reactive state even when the gene is not being transcribed (Chen, T. A., Smith, M. M., Le, S., Sternglanz, R., and Allfrey, V. G. (1991) J. Biol. Chem. 266, 6489-6498). It follows that the unfolding of the nucleosome cores of the yeast H3 mutant is regulated by factors that are not temporally linked to the recruitment or traverse of the RNA polymerase complex, but which may determine the rate at which different domains of chromatin adapt to the need for transcription of the associated DNA sequences.	ROCKEFELLER UNIV,CELL BIOL LAB,NEW YORK,NY 10021; UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794	Rockefeller University; University of Virginia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [R01CA014908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM028220, R01GM028220] Funding Source: NIH RePORTER; NCI NIH HHS [CA14908] Funding Source: Medline; NIGMS NIH HHS [GM17383, GM28220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; ALFREY VG, 1991, METHOD CELL BIOL, V35, P315; ALLEGRA P, 1987, J MOL BIOL, V196, P379, DOI 10.1016/0022-2836(87)90698-X; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; BOFFA LC, 1990, EUR J BIOCHEM, V194, P811, DOI 10.1111/j.1432-1033.1990.tb19474.x; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRANDT WF, 1981, EUR J BIOCHEM, V121, P501; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CHAN S, 1988, J BIOL CHEM, V2633, P15643; CHEN TA, 1991, J BIOL CHEM, V266, P6489; CHEN TA, 1990, J MOL BIOL, V212, P481, DOI 10.1016/0022-2836(90)90327-I; CHEN TA, 1987, P NATL ACAD SCI USA, V84, P5252, DOI 10.1073/pnas.84.15.5252; DELANGE RJ, 1973, J BIOL CHEM, V248, P3261; FELDMAN JB, 1984, J MOL BIOL, V178, P815, DOI 10.1016/0022-2836(84)90313-9; HABER JE, 1979, GENETICS, V93, P13; HEREFORD LM, 1977, CELL, V10, P453, DOI 10.1016/0092-8674(77)90032-0; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; JOHNSON EM, 1978, ARCH BIOCHEM BIOPHYS, V191, P537, DOI 10.1016/0003-9861(78)90392-2; JOHNSON EM, 1987, J BIOL CHEM, V262, P6943; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; KLAR AJS, 1981, NATURE, V289, P239, DOI 10.1038/289239a0; KLAR AJS, 1981, CELL, V25, P517, DOI 10.1016/0092-8674(81)90070-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOCHLEAR L, 1990, NUCLEIC ACIDS RES, V18, P7015; LOHR D, 1979, P NATL ACAD SCI USA, V76, P4285, DOI 10.1073/pnas.76.9.4285; MANIATIS T, 1975, BIOCHEMISTRY-US, V14, P3787, DOI 10.1021/bi00688a010; MARDIAN JKW, 1978, BIOCHEMISTRY-US, V17, P3825, DOI 10.1021/bi00611a023; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; NASMYTH KA, 1981, NATURE, V289, P244, DOI 10.1038/289244a0; OLIVA R, 1990, NUCLEIC ACIDS RES, V18, P2739, DOI 10.1093/nar/18.9.2739; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; PRIOR CP, 1983, CELL, V34, P1033, DOI 10.1016/0092-8674(83)90561-5; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; RINE J, 1987, GENETICS, V116, P9; RINE J, 1979, GENETICS, V93, P837; ROSE AB, 1992, IN PRESS GENES DEV; Sambrook J, 1989, MOL CLONING LABORATO; SCHULTZ LD, 1978, BIOCHEMISTRY-US, V17, P750, DOI 10.1021/bi00597a031; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; SMITH MM, 1988, J CELL BIOL, V106, P557, DOI 10.1083/jcb.106.3.557; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STERNER R, 1987, NUCLEIC ACIDS RES, V15, P4375, DOI 10.1093/nar/15.11.4375; STJOHN TP, 1981, J MOL BIOL, V152, P285, DOI 10.1016/0022-2836(81)90244-8; STONE EM, 1991, MOL CELL BIOL, V11, P2253, DOI 10.1128/MCB.11.4.2253; STRATHERN JN, 1979, CELL, V18, P309, DOI 10.1016/0092-8674(79)90050-3; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; van Holde K.E., 1988, CHROMATIN; WALKER J, 1990, J BIOL CHEM, V265, P5736; YAU P, 1982, EUR J BIOCHEM, V129, P281, DOI 10.1111/j.1432-1033.1982.tb07050.x	55	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1118	1124						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419318				2022-12-27	WOS:A1993KG07700055
J	MARKOVICH, D; STANGE, G; BERTRAN, J; PALACIN, M; WERNER, A; BIBER, J; MURER, H				MARKOVICH, D; STANGE, G; BERTRAN, J; PALACIN, M; WERNER, A; BIBER, J; MURER, H			2 MESSENGER-RNA TRANSCRIPTS (RBAT-1 AND RBAT-2) ARE INVOLVED IN SYSTEM B0,+-RELATED AMINO-ACID-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECOTROPIC RETROVIRUS RECEPTOR; BRUSH-BORDER VESICLES; EXPRESSION; PROTEIN; CLONING; TRANSLATION; NA+/GLUCOSE; PATHWAYS; OOCYTES; CDNA	Previously, we isolated a cDNA clone (rBAT-1) of 2.2 kilobase pairs (kb) from a rabbit kidney cortex cDNA library, encoding a protein involved in sodium-independent transport Of L-dibasic amino acids, L-cystine, and some neutral amino acids via a system related to b0,+-like activity (Bertran, J., Werner, A., Moore, M. L., Stange, G., Markovich, D., Biber, J., Testar, X., Zorzano, A., Palacin, M., and Murer, H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5601-5605). In Northern blot hybridization using an rBAT-1 cDNA probe, 2.2- and 3.9-kb mRNA species were observed. Here we describe the isolation of a 3.9-kb cDNA clone (rBAT-2) by expression cloning using Xenopus laevis oocytes corresponding to the 3.9-kb mRNA species. On the basis of sequence analysis, in vitro translation (major protein of approximately 78 kDa), and functional analysis (expression of transport function), we conclude that rBAT-1- and rBAT-2-related proteins are identical: 677 amino acids in length, with most likely only one transmembrane-spanning domain. There are seven differences in the nucleotide composition within a common overlap of 2189 nucleotides, resulting in 2 amino acid replacements. In comparison with rBAT-1, rBAT-2 has 26 additional nucleotides at the 5'-end, an identical location of the first polyadenylation signal, and approximately 1.7 kb of 3'-untranslated sequence (rich in AT(U) motifs) prior to a poly(A) tail of 63 adenines. We conclude that rBAT-1 and rBAT-2 encode the same protein and that the major difference seems to be related to the use of different polyadenylation signals.			MARKOVICH, D (corresponding author), UNIV ZURICH,DEPT PHYSIOL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.		Palacín, Manuel/G-9786-2015; Markovich, Daniel/F-7884-2012	Palacin, Manuel/0000-0002-8670-293X				ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; BERTRAN J, 1992, BIOCHEM J, V281, P717, DOI 10.1042/bj2810717; CAMPA MJ, 1989, J CELL PHYSIOL, V141, P645, DOI 10.1002/jcp.1041410324; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HOLLAND EC, 1986, J BIOL CHEM, V261, P1286; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KWON HM, 1992, J BIOL CHEM, V267, P6297; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAGAGNIN S, 1992, J BIOL CHEM, V267, P15384; MIRCHEFF AK, 1982, J MEMBRANE BIOL, V64, P113, DOI 10.1007/BF01870773; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; STEVENS BR, 1984, ANNU REV PHYSIOL, V46, P417; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; TSE CM, 1992, J BIOL CHEM, V267, P9340; VANWINKLE LJ, 1988, BIOCHIM BIOPHYS ACTA, V947, P173, DOI 10.1016/0304-4157(88)90024-X; VANWINKLE LJ, 1988, J BIOL CHEM, V263, P3150; WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	30	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1362	1367						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419338				2022-12-27	WOS:A1993KG07700090
J	MULLER, SJ; CARADONNA, S				MULLER, SJ; CARADONNA, S			CELL-CYCLE REGULATION OF A HUMAN CYCLIN-LIKE GENE ENCODING URACIL-DNA GLYCOSYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E2F TRANSCRIPTION FACTOR; YEAST HO GENE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; MESSENGER-RNA; M-PHASE; PROTEIN-KINASE; BINDING FACTOR	The predicted amino acid sequence of a human cDNA encoding uracil-DNA glycosylase activity shows striking similarity to the cyclin protein family. To characterize the expression of this DNA repair enzyme, we have isolated the corresponding genomic clone. This gene is contained within 4.2 kilobases and is composed of only two exons. Sequence analysis of the upstream region shows that it contains two cell cycle box (CCB) regulatory elements which are also found in yeast cyclin genes. Deletional analysis of the promoter reveals the presence of a repressor region located from position -812 to -603. An inverted CCB element (alpha-CCB) and an SP1-like binding site are contained within this region. When uracil-DNA glycosylase mRNA levels are examined in vivo, a 2-3-fold increase is associated with G1 phase in both HeLa S3 and WI38 cells. To examine the role of the 209-base pair repressor region in mediating cell cycle regulation, this fragment was used in gel shift assays with cellular extracts prepared from various stages of the cell cycle. Several specific complexes are formed during S and G2 phases which are not present during M and G1 phases. Two of the complexes are the result of alpha-CCB binding as they can be specifically disrupted by the addition of an oligo-nucleotide containing the alpha-CCB binding site. Immunoprecipitation studies reveal that uracil-DNA glycosylase protein levels are also elevated during G1 phase. Additionally, we show that the 36-kDa uracil-DNA glycosylase protein is turned over during the course of one cell cycle. These results demonstrate coordinate regulation of uracil-DNA glycosylase at both the transcriptional and the post-transcriptional levels as a function of the cell cycle.	UNIV MED & DENT NEW JERSEY, SCH OSTEOPATH MED, DEPT MOLEC BIOL, 401 S CENT PLAZA, STRATFORD, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center			Caradonna, Salvatore/AFU-8514-2022	Caradonna, Salvatore/0000-0002-2104-581X	NCI NIH HHS [CA42605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS BJ, 1989, CELL, V57, P21, DOI 10.1016/0092-8674(89)90168-2; Ashihara T, 1979, Methods Enzymol, V58, P248; BASERGA R, 1985, BIOL CELL REPRODUCTI; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; ENOCH T, 1991, CELL, V65, P921, DOI 10.1016/0092-8674(91)90542-7; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; FRIEDBERG EC, 1985, DNA REPAIR, P141; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HARLOW E, 1988, ANTIBODIES LABORATOR, P678; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HIEBERT SW, 1991, J VIROL, V65, P3547, DOI 10.1128/JVI.65.7.3547-3552.1991; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; LIRETTE R, 1990, J CELL BIOCHEM, V43, P339, DOI 10.1002/jcb.240430406; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; MULLER SJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P197, DOI 10.1016/0167-4781(91)90055-Q; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NASMYTH K, 1985, CELL, V42, P225, DOI 10.1016/S0092-8674(85)80118-5; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; OLSEN LC, 1991, NUCLEIC ACIDS RES, V19, P4473, DOI 10.1093/nar/19.16.4473; OLSEN LC, 1989, EMBO J, V8, P3121, DOI 10.1002/j.1460-2075.1989.tb08464.x; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAULWEBER B, 1991, J BIOL CHEM, V266, P21956; PERCIVAL KJ, 1989, J BIOL CHEM, V264, P2593; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PINES J, 1987, EMBO J, V6, P2987, DOI 10.1002/j.1460-2075.1987.tb02604.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; REED SI, 1991, TRENDS GENET, V7, P95, DOI 10.1016/0168-9525(91)90064-W; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SALIER JP, 1990, J BIOL CHEM, V265, P7062; Sambrook J, 1989, MOL CLONING LABORATO; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SCHIESTL RH, 1989, MOL CELL BIOL, V9, P1882, DOI 10.1128/MCB.9.5.1882; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; TOBEY RA, 1975, NATURE, V254, P245, DOI 10.1038/254245a0; VARSHNEY U, 1988, J BIOL CHEM, V263, P7776; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; WORRAD DM, 1988, J VIROL, V62, P4774, DOI 10.1128/JVI.62.12.4774-4777.1988	70	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1310	1319						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419333				2022-12-27	WOS:A1993KG07700082
J	HEEMSKERK, JWM; VIS, P; FEIJGE, MAH; HOYLAND, J; MASON, WT; SAGE, SO				HEEMSKERK, JWM; VIS, P; FEIJGE, MAH; HOYLAND, J; MASON, WT; SAGE, SO			ROLES OF PHOSPHOLIPASE-C AND CA2+-ATPASE IN CALCIUM RESPONSES OF SINGLE, FIBRINOGEN-BOUND PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROTID ACINAR-CELLS; FURA-2-LOADED HUMAN-PLATELETS; INTRACELLULAR CALCIUM; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; TUMOR PROMOTER; RAT PLATELETS; CA2+ RELEASE; OSCILLATIONS; THAPSIGARGIN	Fura-2-loaded platelets were immobilized on fibrinogen, and cytosolic free calcium concentration ([Ca2+]i) was measured by video imaging of the fluorescence signal. In the immobilized, single platelets, ADP and low doses of thrombin evoked repetitive spikes of [Ca2+]i, whereas higher thrombin concentrations gave elevated plateaus in [Ca2+]i. Stimulation of the cells with thrombin after the addition of ADP changed the frequency of spiking, but not the maximal levels of [Ca2+]i reached. In suspensions of platelets, ADP and low doses of thrombin evoked transient elevation of myo-inositol phosphates, suggesting that the initiation of spiking was due to stimulation of phospholipase C. In platelet suspensions, the Ca2+-ATPase inhibitor thapsigargin (TGC) evoked a gradual rise in [Ca2+]i, which was potentiated by preactivation of the platelets and inhibited by prostaglandin E1 and nitroprusside. In single platelets, TG induced a sudden increase in [Ca2+]i after a long but variable delay, followed by a phase of slow oscillations. The effects of preactivation with ADP were 2-fold: the delay time before the response to TG was shortened and the maximal level of [Ca2+]i reached with TG was higher than the level of the preceding Ca2+ spikes. Apparently, Ca2+ responses induced by the inhibition of Ca2+-ATPases are potentiated by prior elevation of [Ca2+]i and reduced by substances that inhibit agonist-evoked increases in [Ca2+]i. The data point to a mechanism of Ca2+-induced Ca2+ release and the presence of TG-sensitive and TG-insensitive Ca2+ stores in platelets. Rapid spiking may involve both pools, whereas the latter alone may account for the slow TG-evoked oscillations.	UNIV LIMBURG,DEPT HUMAN BIOL,6200 MD MAASTRICHT,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,DEPT PHYSIOL,NIJMEGEN,NETHERLANDS; INST ANIM PHYSIOL & GENET RES,DEPT NEUROENDOCRINOL,CAMBRIDGE CB2 4AT,ENGLAND; UNIV CAMBRIDGE,PHYSIOL LAB,CAMBRIDGE CB2 3EG,ENGLAND	Hasselt University; Maastricht University; Radboud University Nijmegen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	HEEMSKERK, JWM (corresponding author), UNIV LIMBURG,CTR BIOMED,DEPT BIOCHEM,POB 616,6200 MD MAASTRICHT,NETHERLANDS.		Heemskerk, Johan/AAM-8323-2021	Heemskerk, Johan/0000-0002-2848-5121; Sage, Stewart/0000-0001-8578-3558				ALONSO MT, 1991, BIOCHEM J, V280, P783, DOI 10.1042/bj2800783; AVDONIN PV, 1991, EUR J BIOCHEM, V198, P267, DOI 10.1111/j.1432-1033.1991.tb16011.x; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BERRIDGE MJ, 1991, CELL CALCIUM, V12, P63, DOI 10.1016/0143-4160(91)90009-4; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BRUNE B, 1991, J BIOL CHEM, V266, P19232; DANIEL JL, 1986, FEBS LETT, V206, P299, DOI 10.1016/0014-5793(86)81000-6; DRUMMOND AH, 1987, PLATELETS BIOL PATHO, V3, P373; ELY JA, 1991, J BIOL CHEM, V266, P18635; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FISHER GJ, 1985, BIOCHEM BIOPH RES CO, V129, P958, DOI 10.1016/0006-291X(85)91984-9; FOSKETT JK, 1991, J BIOL CHEM, V266, P14535; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; HECKER M, 1989, BIOCHEM BIOPH RES CO, V159, P961, DOI 10.1016/0006-291X(89)92202-X; HEEMSKERK JWM, 1991, FEBS LETT, V284, P223, DOI 10.1016/0014-5793(91)80690-5; HEEMSKERK JWM, 1992, BIOCHEM J, V283, P379, DOI 10.1042/bj2830379; HEEMSKERK JWM, 1991, BIOCHEM J, V278, P399, DOI 10.1042/bj2780399; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KROLL MH, 1989, BLOOD, V74, P1181; LAPETINA EG, 1987, METHOD ENZYMOL, V141, P176; LLOPIS J, 1991, BIOCHEM J, V277, P553, DOI 10.1042/bj2770553; MAHOUTSMITH MP, 1992, J BIOL CHEM, V267, P3060; MASON WT, 1990, METHODS NEUROSCIENCE, V3, P109; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MUALLEM S, 1991, BIOCHEM J, V279, P367, DOI 10.1042/bj2790367; NELSON CB, 1990, AM J PHYSIOL, V259, pC675; NISHIO H, 1991, CELL CALCIUM, V12, P177, DOI 10.1016/0143-4160(91)90019-B; PAPP B, 1991, J BIOL CHEM, V266, P14593; PETERSEN OH, 1991, CELL CALCIUM, V12, P135, DOI 10.1016/0143-4160(91)90015-7; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SAGE SO, 1990, BIOCHEM J, V265, P675, DOI 10.1042/bj2650675; SAGE SO, 1985, FEBS LETT, V188, P135, DOI 10.1016/0014-5793(85)80890-5; SAGE SO, 1987, J BIOL CHEM, V262, P16364; SARGEANT P, 1992, CELL CALCIUM, V13, P553, DOI 10.1016/0143-4160(92)90035-Q; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; SWANN K, 1991, FEBS LETT, V278, P175, DOI 10.1016/0014-5793(91)80110-O; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VICKERS JD, 1990, EUR J BIOCHEM, V193, P521, DOI 10.1111/j.1432-1033.1990.tb19367.x; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9	43	73	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					356	363						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416943				2022-12-27	WOS:A1993KE60300055
J	MUMMANENI, P; BISHOP, PL; TURKER, MS				MUMMANENI, P; BISHOP, PL; TURKER, MS			A CIS-ACTING ELEMENT ACCOUNTS FOR A CONSERVED METHYLATION PATTERN UPSTREAM OF THE MOUSE ADENINE PHOSPHORIBOSYLTRANSFERASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENOVO DNA METHYLATION; EMBRYONIC-DEVELOPMENT; CELL-LINE; CPG; EXPRESSION; GENOMES; ISLANDS; TISSUES	A 2.1-kilobase pair region located just upstream of the mouse aprt (adenine phosphoribosyltransferase) gene has a methylation pattern that is conserved in mouse tissues and culture cell lines. This upstream region includes four HpaII/MspI sites. Two of these sites are fully methylated, one is partially methylated, and one is unmethylated. Transfection experiments have demonstrated that the conserved methylation pattern can be reproduced in a mouse embryonal carcinoma stem cell line via de novo methylation (Turker, M. S., Mummaneni, P., and Bishop, P. L. (1991) Somat. Cell Mol. Genet. 17, 151-157). To examine the molecular basis of the conserved methylation pattern, a plasmid-based deletion analysis was conducted by removing and rearranging specific portions of the upstream region. Unmethylated versions of these plasmid constructs were then transfected into the mouse stem cell line and the methylation status of the remaining HpaII/MspI sites determined with a Southern blot analysis. By using this approach, a cis-acting sequence within the upstream region of approximately 0.8 kilobase pairs was identified which appears responsible for the conserved methylation pattern. We use the term ''de novo methylation center'' to denote this sequence. Based on the results obtained, a model is offered to explain the formation of the conserved methylation pattern in the upstream region.	UNIV KENTUCKY, COLL MED,MARKEY CANC CTR,DEPT PATHOL,800 ROSE ST, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, COLL MED, DEPT MICROBIOL & IMMUNOL, LEXINGTON, KY 40536 USA	University of Kentucky; University of Kentucky					NIA NIH HHS [AG08199] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG008199] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOLDEN AH, 1986, MOL CELL BIOL, V54, P915; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CEDAR H, 1990, BIOCHIM BIOPHYS ACTA, V1049, P1, DOI 10.1016/0167-4781(90)90076-E; COOPER GE, 1992, SOMAT CELL MOLEC GEN, V18, P215, DOI 10.1007/BF01233858; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DOERFLER W, 1990, UCLA SYM BI, V128, P329; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3370; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; MONK M, 1990, TRENDS GENET, V6, P110, DOI 10.1016/0168-9525(90)90124-O; MONK M, 1987, DEVELOPMENT, V99, P371; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Perbal B., 1988, PRACTICAL GUIDE MOL; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; SAPIENZA C, 1991, BIOCHIM BIOPHYS ACTA, V1072, P51, DOI 10.1016/0304-419X(91)90006-7; SELKER EU, 1990, TRENDS BIOCHEM SCI, V15, P103, DOI 10.1016/0968-0004(90)90193-F; SHEMER R, 1991, P NATL ACAD SCI USA, V88, P11300, DOI 10.1073/pnas.88.24.11300; SHEMER R, 1991, J BIOL CHEM, V266, P23676; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; SOLTER D, 1988, ANNU REV GENET, V22, P127; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; SZYF M, 1990, MOL CELL BIOL, V10, P4396, DOI 10.1128/MCB.10.8.4396; SZYF M, 1989, P NATL ACAD SCI USA, V86, P6853, DOI 10.1073/pnas.86.18.6853; SZYF M, 1991, BIOCHEM CELL BIOL, V69, P764, DOI 10.1139/o91-117; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; TURKER MS, 1991, SOMAT CELL MOLEC GEN, V17, P151, DOI 10.1007/BF01232972; TURKER MS, 1989, SOMAT CELL MOLEC GEN, V15, P159, DOI 10.1007/BF01535077; TURKER MS, 1989, J BIOL CHEM, V264, P11632; WARD C, 1987, J BIOL CHEM, V262, P11057	36	70	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					552	558						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416960				2022-12-27	WOS:A1993KE60300084
J	HOGG, PJ; OWENSBY, DA; CHESTERMAN, CN				HOGG, PJ; OWENSBY, DA; CHESTERMAN, CN			THROMBOSPONDIN-1 IS A TIGHT-BINDING COMPETITIVE INHIBITOR OF NEUTROPHIL CATHEPSIN-G - DETERMINATION OF THE KINETIC MECHANISM OF INHIBITION AND LOCALIZATION OF CATHEPSIN-G BINDING TO THE THROMBOSPONDIN-1 TYPE-3 REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET THROMBOSPONDIN; ADHESIVE GLYCOPROTEIN; LEUKOCYTE ELASTASE; PROTEINASES; DEGRADATION; FIBRONECTIN; GENE; ACTIVATION; COLLAGEN; MOUSE	Thrombospondin 1 was recently shown to bind to and inhibit the activity of neutrophil elastase (Hogg, P. J., Owensby, D. A., Mosher, D. F., Misenheimer, T. M., and Chesterman, C. N. (1993) J. Biol. Chem. 268, 7139-7146). This finding led us to question whether thrombospondin 1 also binds and inhibits the other major serine proteinase of neutrophils, cathepsin G. In a competitive binding assay, cathepsin G bound to thrombospondin 1 reversibly and saturably with a dissociation constant in the low nanomolar range. The kinetic mechanism of inhibition of cathepsin G activity by thrombospondin 1 was determined using the synthetic cathepsin G substrate, Suc-Ala-Ala-Pro-Phe-p-nitroanilide, and is consistent with hyperbolic tight-binding inhibition in which thrombospondin 1 binds cathepsin G and the Michaelis cathepsin G-substrate complex and weakens, but does not abolish, the efficiency of hydrolysis of Suc-Ala-Ala-Pro-Phe-p-nitroanilide. In the presence of 2 mM calcium ions, 2.9 +/-0.4 mol of cathepsin G interacted with 1 mol of thrombospondin 1 trimer with a site-binding constant of 7.0 +/- 3.5 nM, which reduced the efficiency of hydrolysis of Suc-Ala-Ala-Pro-Phe-p-nitroanilide 8.5 +/- 1.4-fold. A lower limit for the on rate constant of 5 x 10(6) M-1 s-1 was established. The affinity of binding and stoichiometry for the interaction between cathepsin G and thrombospondin 1 was enhanced in the absence of calcium ions. In the presence of EDTA, 5.3 +/- 0.5 mol of cathepsin G interacted with 1 mol of thrombospondin 1 with a site-binding constant of 2.1 +/- 1.6 nM, implying the existence of two binding sites for cathepsin G on each subunit of thrombospondin 1, one or both of which is variably exposed and sensitive to calcium ions. Thrombospondin 1 protected fibronectin from cleavage by cathepsin G and blocked cathepsin G-mediated platelet aggregation. In summary, the binding of cathepsin G to thrombospondin 1 is tight, reversible, and close enough to the active site of cathepsin G to perturb the interactions of a small synthetic substrate and exclude a macromolecular protein substrate and platelets. Using defined proteolytic fragments and different conformers of thrombospondin 1, the binding sites for cathepsin G have been localized to the thrombospondin 1 type 3 repeats.			HOGG, PJ (corresponding author), UNIV NEW S WALES, PRINCE WALES HOSP, CTR THROMBOSIS & VASC RES, DEPT HAEMATOL, HIGH ST, SYDNEY, NSW 2031, AUSTRALIA.			Hogg, Philip/0000-0001-6486-2863				BAICI A, 1987, BIOCHEM J, V244, P793, DOI 10.1042/bj2440793; BALE MD, 1985, J BIOL CHEM, V260, P7502; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Bieth JG, 1986, REGULATION MATRIX AC, P217; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BORNSTEIN P, 1991, P NATL ACAD SCI USA, V88, P8636, DOI 10.1073/pnas.88.19.8636; CAPODICI C, 1989, INFLAMMATION, V13, P245, DOI 10.1007/BF00914392; DIXIT VM, 1984, J BIOL CHEM, V259, P100; DUGGLEBY RG, 1984, COMPUT BIOL MED, V14, P447, DOI 10.1016/0010-4825(84)90045-3; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; GALVIN NJ, 1987, J CELL BIOL, V104, P1413, DOI 10.1083/jcb.104.5.1413; HECK LW, 1990, AM J PATHOL, V136, P1267; HOGG PJ, 1993, J BIOL CHEM, V268, P7139; HOGG PJ, 1992, BIOCHEMISTRY-US, V31, P265, DOI 10.1021/bi00116a036; IDELL S, 1989, CHEST, V96, P1125, DOI 10.1378/chest.96.5.1125; JAKOBSEN E, 1973, Thrombosis Research, V3, P145, DOI 10.1016/0049-3848(73)90065-0; KREIS C, 1989, J IMMUNOL, V143, P1961; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAV J, 1984, EUR J BIOCHEM, V145, P151, DOI 10.1111/j.1432-1033.1984.tb08534.x; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LAWLER J, 1991, J BIOL CHEM, V266, P8039; LAWLER J, 1986, BLOOD, V67, P1197; LAWLER J, 1986, ANN NY ACAD SCI, V485, P271; LOTTENBURG R, 1983, BIOCHIM BIOPHYS ACTA, V142, P558; Morrison J.F., 1985, COMMENTS MOL CELL BI, V2, P347; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; MOSHER DF, 1990, ANNU REV MED, V41, P85; MOSHER DF, 1992, ADV MOL CELL BIOL, V7, P1; MURPHYULLRICH JE, 1985, BLOOD, V66, P1098; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; OKADA Y, 1989, FEBS LETT, V249, P253; PETERSON MW, 1989, J LAB CLIN MED, V113, P297; REILLY CF, 1982, J BIOL CHEM, V257, P8619; REILLY CF, 1980, BIOCHIM BIOPHYS ACTA, V621, P147, DOI 10.1016/0005-2795(80)90070-7; ROCHAT T, 1988, AM J PHYSIOL, V255, pC603, DOI 10.1152/ajpcell.1988.255.5.C603; SAKLATVALA J, 1980, BIOCHIM BIOPHYS ACTA, V615, P167, DOI 10.1016/0005-2744(80)90020-0; SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105; SEEMULLER U, 1986, PROTEINASE INHIBITOR, P337; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; SOMMERHOFF CP, 1990, J CLIN INVEST, V85, P682, DOI 10.1172/JCI114492; SPEZIALE MV, 1990, J BIOL CHEM, V265, P17859; STARKEY PM, 1977, BIOCHIM BIOPHYS ACTA, V483, P386, DOI 10.1016/0005-2744(77)90066-3; SUCHARD SJ, 1991, J IMMUNOL, V146, P3945; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; SZEDLACSEK SE, 1988, BIOCHEM J, V254, P311, DOI 10.1042/bj2540311; VAGAS JR, 1982, PROSTAGLANDINS, V23, P292; VARTIO T, 1981, J BIOL CHEM, V256, P471; VOS HL, 1992, J BIOL CHEM, V267, P12192; WIGHT TN, 1985, J HISTOCHEM CYTOCHEM, V33, P295, DOI 10.1177/33.4.3884704	51	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21811	21818						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408036				2022-12-27	WOS:A1993MC80900059
J	LIN, BF; HUANG, RFS; SHANE, B				LIN, BF; HUANG, RFS; SHANE, B			REGULATION OF FOLATE AND ONE-CARBON METABOLISM IN MAMMALIAN-CELLS .3. ROLE OF MITOCHONDRIAL FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; CHINESE-HAMSTER CELLS; SUBCELLULAR-LOCALIZATION; DEPENDENT ENZYMES; OVARY CELLS; GLYCINE; SERINE; IDENTIFICATION; DEHYDROGENASE; ORGANELLES	Wild-type Chinese hamster ovary (CHO) cells and CHO cell transfectants expressing human folylpoly-gamma-glutamate synthetase (FPGS) activity contain mitochondrial FPGS activity of higher specific activity than the cytosolic isozyme. Expression of mitochondrial FPGS activity is required for folate accumulation by mitochondria. The mitochondrial folate pool in CHO cells is not in equilibrium with the cytosolic pool and contains folylpolyglutamates of longer glutamate chain length than cytosolic folates. The inability of AUX-coli, a CHO cell expressing high levels of Escherichia coli FPGS activity and containing pteroyltriglutamate, to support glycine synthesis is due to a lack of mitochondrial FPGS activity. AUX-coli cells lack mitochondrial folate despite containing high levels of cytosolic folate.	UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				LIN, BI-FONG/0000-0003-2260-6081	NCI NIH HHS [CA-41991] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; BERGMEYER HU, 1965, METHOD ENZYMAT AN, P752; BRODY T, 1975, FED PROC, V34, P905; CHACE SC, 1987, THESIS J HOPKINS U B; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; CONTRACTOR SF, 1972, BIOCHEM J, V128, P11, DOI 10.1042/bj1280011; COOK RJ, 1979, BIOCHEM J, V178, P651, DOI 10.1042/bj1780651; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; CYBULSKI RL, 1981, BIOCHIM BIOPHYS ACTA, V646, P329, DOI 10.1016/0005-2736(81)90339-4; CYBULSKI RL, 1976, BIOCHEMISTRY-US, V15, P3183, DOI 10.1021/bi00660a004; GARROW TA, 1992, P NATL ACAD SCI USA, V89, P9151, DOI 10.1073/pnas.89.19.9151; HOFFBRAN.AV, 1969, BIOCHIM BIOPHYS ACTA, V192, P479, DOI 10.1016/0304-4165(69)90397-3; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KIM JS, 1993, J BIOL CHEM, V268, P21680; LEWIS KF, 1978, ARCH BIOCHEM BIOPHYS, V185, P443, DOI 10.1016/0003-9861(78)90187-X; LOWE KE, 1993, J BIOL CHEM, V268, P21665; LOWRY OH, 1957, METHOD ENZYMOL, V4, P366, DOI 10.1016/0076-6879(57)04065-3; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; MCGUIRE JJ, 1979, DEV BIOCHEM, V4, P471; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; PFENDNER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P503, DOI 10.1016/0003-9861(80)90382-3; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SHANE B, 1989, VITAM HORM, V45, P263; SHIN YS, 1976, BIOCHIM BIOPHYS ACTA, V444, P794; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; SUSSMAN DJ, 1986, ANAL BIOCHEM, V158, P371, DOI 10.1016/0003-2697(86)90563-4; TAYLOR RT, 1985, MUTAT RES, V151, P293, DOI 10.1016/0027-5107(85)90082-X; TAYLOR RT, 1977, ARCH BIOCHEM BIOPHYS, V181, P331, DOI 10.1016/0003-9861(77)90512-4; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; WANG FK, 1967, BIOCHEM Z, V346, P458; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109; ZHONG XH, 1990, MOL CELL BIOL, V10, P770, DOI 10.1128/MCB.10.2.770	36	87	89	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21674	21679						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408020				2022-12-27	WOS:A1993MC80900039
J	MAIER, R; GANU, V; LOTZ, M				MAIER, R; GANU, V; LOTZ, M			INTERLEUKIN-11, AN INDUCIBLE CYTOKINE IN HUMAN ARTICULAR CHONDROCYTES AND SYNOVIOCYTES, STIMULATES THE PRODUCTION OF THE TISSUE INHIBITOR OF METALLOPROTEINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HEMATOPOIETIC PROGENITORS; PLATE CHONDROCYTES; MOLECULAR-CLONING; CARTILAGE; EXPRESSION; CULTURE; BIOSYNTHESIS; MODULATION; IDENTITY	This study on the regulation of interleukin (IL)-11 expression in human connective tissue cells shows that IL-11 expression is not restricted to cells of hematopoietic orgin but can also be induced in articular chondrocytes and synoviocytes. IL-11 mRNA was induced in chondrocytes in response to transforming growth factor (TGF)-beta1 and IL-1beta. Stimulation with IL-6 or growth factors, such as basic fibroblast growth factor, leukemia inhibitory factor, and platelet-derived growth factor-AA, had only weak or no detectable effects. Activation of protein kinase C by phorbol esters and inhibition of protein synthesis by cyclohexamide increased IL-11 transcripts, whereas calcium ionophore A23817 or dibutyryl cyclic AMP had no effect. Immunoprecipitations revealed the synthesis of IL-11 protein in response to TGF-beta1, IL-1beta, as well as phorbol 12-myristate 13-acetate, and a synergistic action of TGF-beta1 and IL-1beta was observed. Similar findings on IL-11 expression were made in synoviocytes. Analysis of effects on cell function showed that IL-11 stimulated the production of the tissue inhibitor of metalloproteinases in chondrocytes and synoviocytes but did not affect chondrocyte proliferation or increase stromelysin activity. These results suggest that IL-11 does not contribute to connective tissue degradation but conversely induces protective effects in joint tissue.	UNIV CALIF SAN DIEGO,DEPT MED,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093; CIBA GEIGY CORP,SUMMIT,NJ 07901	University of California System; University of California San Diego; Novartis					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39799] Funding Source: Medline; NIA NIH HHS [AG07996] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAUMANN H, 1991, J BIOL CHEM, V266, P20424; BRUNO E, 1991, EXP HEMATOL, V19, P378; CHANDRASEKHAR S, 1988, BIOCHEM BIOPH RES CO, V157, P1352, DOI 10.1016/S0006-291X(88)81024-6; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GUERNE PA, 1990, J IMMUNOL, V144, P499; GUERNE PA, 1989, ANN NY ACAD SCI, V557, P558; HARVEY AK, 1991, EXP CELL RES, V195, P376, DOI 10.1016/0014-4827(91)90387-A; KAWASHIMA I, 1991, FEBS LETT, V283, P199, DOI 10.1016/0014-5793(91)80587-S; LOTZ M, 1992, J IMMUNOL, V148, P466; LOTZ M, 1992, J CLIN INVEST, V90, P888, DOI 10.1172/JCI115964; LOTZ M, 1991, J BIOL CHEM, V266, P2017; LOTZ M, 1992, BIOL REGULATION CHON, P237; Maniatis T., 1982, MOL CLONING; MURPHY G, 1985, J BIOL CHEM, V260, P3079; MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765; MUSASHI M, 1991, BLOOD, V78, P1448; OKEEFE RJ, 1988, CALCIFIED TISSUE INT, V43, P352, DOI 10.1007/BF02553278; OKEEFE RJ, 1988, ENDOCRINOLOGY, V122, P2953, DOI 10.1210/endo-122-6-2953; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; SCHIBLER KR, 1992, BLOOD, V80, P900; SKANTZE KA, 1985, CANCER RES, V45, P4416; VILLIGER PM, 1992, J CLIN INVEST, V90, P488, DOI 10.1172/JCI115885; VIVIEN D, 1990, J CELL PHYSIOL, V143, P534, DOI 10.1002/jcp.1041430319	25	136	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21527	21532						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408003				2022-12-27	WOS:A1993MC80900018
J	SHIMOZAWA, O; SAKAGUCHI, M; OGAWA, H; HARADA, N; MIHARA, K; OMURA, T				SHIMOZAWA, O; SAKAGUCHI, M; OGAWA, H; HARADA, N; MIHARA, K; OMURA, T			CORE GLYCOSYLATION OF CYTOCHROME-P-450 (AROM) - EVIDENCE FOR LOCALIZATION OF N-TERMINUS OF MICROSOMAL CYTOCHROME-P-450 IN THE LUMEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; HUMAN PLACENTAL AROMATASE; ENCODING HUMAN AROMATASE; ENDOPLASMIC-RETICULUM; MEMBRANE TOPOLOGY; SIGNAL; PURIFICATION; PROTEINS; SYSTEM; IDENTIFICATION	It was found that cytochrome P-450(arom) purified from human placenta microsomes is glycosylated, and the sugar chain was cleaved with endoglycosidase H (Endo H). The core glycosylation of P-450(arom) was examined with two heterologous expression systems, cultured insect cells and in vitro translation system. The P-450(arom) protein expressed in the insect cells was glycosylated, and the sugar chain was sensitive to Endo H. It was also glycosylated when translated with the wheat germ cell-free system in the presence of rough microsomal membrane, and the sugar chain could be removed by Endo H treatment. Since the P-450(arom) molecule has two potential glycosylation sites (Asn-12 and Asn-180), we replaced each of the 2 asparagine residues with alanine by site-directed mutagenesis and examined the glycosylation of the two mutant proteins in the cell-free system. The core glycosylation did not occur when the Asn-12 residue was mutated, whereas the mutant protein with modified Asn-180 residue was glycosylated. These results demonstrated that the potential glycosylation site (Asn-12) in the N-terminal portion of P-450(arom) is the site of glycosylation. We conclude that the N terminus of P-450(arom) is translocated across the endoplasmic reticulum membrane to be glycosylated at the luminal side.	KYUSHU UNIV,GRAD SCH MED SCI,DEPT MOLEC BIOL,HIGASHI KU,FUKUOKA 812,JAPAN; FUJITA HLTH UNIV,INST COMPREHENS MED SCI,TOYOAKE,AICHI 47011,JAPAN	Kyushu University; Fujita Health University								ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; BERNHARDT R, 1988, BIOCHEM INT, V17, P1143; BLACK SD, 1992, FASEB J, V6, P680, DOI 10.1096/fasebj.6.2.1537456; BURAND JP, 1980, VIROLOGY, V101, P286, DOI 10.1016/0042-6822(80)90505-X; CORBIN CJ, 1988, P NATL ACAD SCI USA, V85, P8948, DOI 10.1073/pnas.85.23.8948; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GABATHULER R, 1990, J CELL BIOL, V111, P1803, DOI 10.1083/jcb.111.5.1803; HARADA N, 1988, BIOCHEM BIOPH RES CO, V156, P725, DOI 10.1016/S0006-291X(88)80903-3; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; HARADA N, 1992, J BIOL CHEM, V267, P4781; HIWATASHI A, 1980, BIOCHEM BIOPH RES CO, V97, P1443, DOI 10.1016/S0006-291X(80)80027-1; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Omura T., 1993, CYTOCHROME P 450; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; ROBBINS PW, 1977, CELL, V12, P893, DOI 10.1016/0092-8674(77)90153-2; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; SAKAGUCHI M, 1992, J BIOCHEM, V112, P243, DOI 10.1093/oxfordjournals.jbchem.a123884; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SAKAGUCHI M, 1993, FRONTIERS BIOTRANSFO, V8, P59; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; SETHUMADHAVAN K, 1991, MOL CELL ENDOCRINOL, V78, P25, DOI 10.1016/0303-7207(91)90182-R; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; SZCZESNASKORUPA E, 1993, J BIOL CHEM, V268, P1757; TAN L, 1986, EUR J BIOCHEM, V156, P243, DOI 10.1111/j.1432-1033.1986.tb09574.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERGERES G, 1991, BIOCHIM BIOPHYS ACTA, V1063, P235, DOI 10.1016/0005-2736(91)90376-J; VIALARD J, 1990, J VIROL, V64, P37, DOI 10.1128/JVI.64.1.37-50.1990; WALTER P, 1983, METHOD ENZYMOL, V96, P84; YAMAMOTO A, 1985, J CELL BIOL, V101, P1733, DOI 10.1083/jcb.101.5.1733	41	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21399	21402						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407981				2022-12-27	WOS:A1993MA28800109
J	VOGEL, JP; LEE, JN; KIRSCH, DR; ROSE, MD; SZTUL, ES				VOGEL, JP; LEE, JN; KIRSCH, DR; ROSE, MD; SZTUL, ES			BREFELDIN-A CAUSES A DEFECT IN SECRETION IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PERIPHERAL MEMBRANE-PROTEIN; GOLGI-APPARATUS; EARLY EVENT; YEAST; CELLS; BIOSYNTHESIS; DISSOCIATION; BINDING; GENE	Brefeldin A (BFA) blocks secretion in mammalian cells and causes the redistribution of Golgi resident membrane proteins to the endoplasmic reticulum (Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992) J. Cell Biol. 116, 1071-1080). The target(s) of BFA and its mechanism of action remain unknown. The yeast Saccharomyces cerevisiae represents an ideal organism in which to identify the BFA targets, since many molecules essential for vesicular traffic have been already identified taking advantage of the powerful genetics of this system. Unfortunately, wild type S. cerevisiae strains are largely insensitive to BFA (Hayashi, T., Takatsuki, A., and Tamura, G. (1982) Agric. Biol. Chem. 46, 2241-2248). Here we demonstrate that an erg6 mutant (Gaber, R., Copple, D., Kennedy, B., Vidal, M., and Bard, M. (1989) Mol. Cell. Biol. 9, 3447-3456) defective in the biosynthesis of ergosterol is sensitive to BFA. Treatment of erg6 cells with BFA results in an arrest in growth and causes a block in secretion similar to that seen in mammalian cells treated with BFA. Our data suggest that the changes in the erg6 strain allows BFA entry and that this strain can be used to examine the molecular mechanism of BFA action.	PRINCETON UNIV, DEPT MOLEC BIOL, PRINCETON, NJ 08544 USA; AMER CYANAMID CO, PRINCETON, NJ 08549 USA	Princeton University; American Cyanamid Company				Rose, Mark/0000-0003-1112-4765	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037739] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM037739, GM-37739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNING A, 1992, J BIOL CHEM, V267, P7726; BYERS B, 1991, METHOD ENZYMOL, V194, P602; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; GABER RF, 1989, MOL CELL BIOL, V9, P3447, DOI 10.1128/MCB.9.8.3447; HAYASHI T, 1982, AGR BIOL CHEM TOKYO, V46, P2241, DOI 10.1080/00021369.1982.10865421; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LIU ES, 1992, J BIOL CHEM, V267, P7128; NARULA N, 1992, J CELL BIOL, V117, P27, DOI 10.1083/jcb.117.1.27; NEWMAN AP, 1987, J CELL BIOL, V105, P1587, DOI 10.1083/jcb.105.4.1587; ORCI L, 1991, CELL, V64, P1183; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rose MD., 1990, METHODS YEAST GENETI; ROTHBLATT J, 1989, METHOD CELL BIOL, V32, P3; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SCHEKMAN R, 1985, ANNU REV CELL BIOL, V1, P115, DOI 10.1146/annurev.cellbio.1.1.115; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Sykes R.A., 1983, US Patent, Patent No. [4,420,474, 4420474]; ULMER JB, 1989, P NATL ACAD SCI USA, V86, P6992, DOI 10.1073/pnas.86.18.6992; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885	23	57	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3040	3043						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428980				2022-12-27	WOS:A1993KM16100007
J	FREEDMAN, JH; SLICE, LW; DIXON, D; FIRE, A; RUBIN, CS				FREEDMAN, JH; SLICE, LW; DIXON, D; FIRE, A; RUBIN, CS			THE NOVEL METALLOTHIONEIN GENES OF CAENORHABDITIS-ELEGANS - STRUCTURAL ORGANIZATION AND INDUCIBLE, CELL-SPECIFIC EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; METAL RESPONSE ELEMENT; MESSENGER-RNA; C-ELEGANS; DEVELOPMENTAL REGULATION; CATALYTIC SUBUNIT; BINDING PROTEIN; LEADER SEQUENCE; AUTO-REGULATION; CDNA CLONING	Two genes (mtl-1 and mtl-2) that encode the novel metallothioneins (MTs) of Caenorhabditis elegans (CeMTs) were cloned and characterized. Both genes contain a single intron that interrupts codon 6 and short 3'-untranslated regions. However, their promoter regions are distinctively non-homologous. The mtl-2 promoter contains a TATAA box and a single putative metal regulatory element. These elements are absent in the mtl-1 promoter. Nevertheless, both CeMT1 and CeMT2 mRNAs are induced by cadmium and contain precisely initiated, 5'-untranslated sequences. The inducibility and cell type specificity of metallothionein gene expression were investigated in transgenic C. elegans that carry the lacZ (beta-galactosidase) reporter gene under the control of an mtl-1 or mtl-2 promoter sequence. Upon treatment of transgenic C. elegans with cadmium or heat stress, the mtl-2:lacZ fusion gene is abundantly and exclusively expressed in the intestinal cells of larvae and adult animals. Expression is not detected in the absence of metal or heat shock. In contrast, an mtl-1:lacZ construct is constitutively expressed in the pharynx and induced by cadmium and heat shock in the intestinal cells of C. elegans larvae. The metal-inducible expression of the mt1-1:lacZ gene is attenuated in adult transgenic nematodes. Thus, the activity of each mtl promoter is modulated by metals as well as developmental and environmental factors.	CARNEGIE INST WASHINGTON, DEPT EMBRYOL, BALTIMORE, MD 21210 USA	Carnegie Institution for Science	FREEDMAN, JH (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, ATRAN LABS, BRONX, NY 10461 USA.			Fire, Andrew/0000-0001-6217-8312	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK044597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022792] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 44597] Funding Source: Medline; NIGMS NIH HHS [GM 22792, R01 GM037706, GM 37706] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRENNER S, 1974, GENETICS, V77, P71; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; CUMMINS C, 1988, MOL CELL BIOL, V8, P5339, DOI 10.1128/MCB.8.12.5339; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; FOSTER R, 1991, J BIOL CHEM, V266, P9866; FOSTER R, 1988, J BIOL CHEM, V263, P11528; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GRIFFITH BB, 1983, NUCLEIC ACIDS RES, V11, P901, DOI 10.1093/nar/11.3.901; GROSS RE, 1990, J BIOL CHEM, V265, P6896; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HAMER DH, 1985, SCIENCE, V228, P685, DOI 10.1126/science.3887570; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HU E, 1991, J BIOL CHEM, V266, P19796; HU ED, 1990, J BIOL CHEM, V265, P5072; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; IMAGAWA M, 1990, BIOCHEM J, V268, P237, DOI 10.1042/bj2680237; JAHROUDI N, 1990, J BIOL CHEM, V265, P6506; JONES D, 1986, J BIOL CHEM, V261, P2006; Kagi J H, 1987, Experientia Suppl, V52, P25; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LAND H, 1981, NUCLEIC ACIDS RES, V9, P2251, DOI 10.1093/nar/9.10.2251; LU XY, 1990, J BIOL CHEM, V265, P3293; MACMORRIS M, 1992, MOL CELL BIOL, V12, P1652, DOI 10.1128/MCB.12.4.1652; MARONI G, 1986, GENETICS, V112, P493; MEHRA RK, 1989, J BIOL CHEM, V264, P19747; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NEMER M, 1991, J BIOL CHEM, V266, P6586; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEI J, 1990, J BIOL CHEM, V265, P14061; PETERSON MG, 1984, EUR J BIOCHEM, V143, P507, DOI 10.1111/j.1432-1033.1984.tb08399.x; PUSTELL J, 1984, NUCLEIC ACIDS RES, V12, P643, DOI 10.1093/nar/12.1Part2.643; REEDER RH, 1983, CELL, V35, P449, DOI 10.1016/0092-8674(83)90178-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT CJ, 1986, P NATL ACAD SCI USA, V83, P3346, DOI 10.1073/pnas.83.10.3346; SEARLE PF, 1990, NUCLEIC ACIDS RES, V18, P4683, DOI 10.1093/nar/18.16.4683; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SILAR P, 1990, J MOL BIOL, V215, P217, DOI 10.1016/S0022-2836(05)80340-7; SLICE LW, 1990, J BIOL CHEM, V265, P256; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; SUL HS, 1984, J BIOL CHEM, V259, P1201; SULSTON J, 1988, NEMATODE CAENORHABDI, P123; SZCZYPKA MS, 1989, MOL CELL BIOL, V9, P421, DOI 10.1128/MCB.9.2.421; WILSON RK, 1990, BIOTECHNIQUES, V8, P184; WRIGHT CF, 1988, J BIOL CHEM, V263, P1570; [No title captured]	54	136	148	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2554	2564						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428932				2022-12-27	WOS:A1993KK81500046
J	LIN, CS; CHEN, ZP; PARK, T; GHOSH, K; LEAVITT, J				LIN, CS; CHEN, ZP; PARK, T; GHOSH, K; LEAVITT, J			CHARACTERIZATION OF THE HUMAN L-PLASTIN GENE PROMOTER IN NORMAL AND NEOPLASTIC-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ACTIN GENES; HUMAN-FIBROBLASTS; ESTROGEN-RECEPTOR; EXPRESSION VECTOR; TRANSFORMATION; PROTEIN; IDENTIFICATION; POLYPEPTIDE; TRANSCRIPTS; ACTIVATION	Plastins are a family of human actin-binding proteins (isoforms) which are abundantly expressed in all normal replicating mammalian cells. One isoform, L-plastin, is constitutively expressed at high levels in hemopoietic cell types while T-plastin is constitutively expressed in all non-hemopoietic cells of solid tissues that have replicative potential (fibroblasts, endothelial cells, epithelial cells, melanocytes, etc.). L-plastin is, however, constitutively synthesized in many types of malignant human cells of solid tissues suggesting that its expression is induced during tumorigenesis. The frequency of L-plastin induction in some cancers of the steroid-regulated female reproductive tract (breast, ovary, uterus, and placenta) appears to be especially high (79% in a limited survey). To learn the mechanism of L-plastin gene activation accompanying tumorigenesis, we have begun to characterize the promoter and regulatory elements of the L-plastin gene. Transcription initiation from this promoter was found to occur at multiple sites and as near as 10 base pairs from the 3'-side of the TATAAA box. The promoter and its flanking DNA were cloned and sequenced to identify potential regulatory elements that participate in the induction of the L-plastin gene in neoplastic cells. Examination of upstream sequences revealed the existence of two potential progesterone, one potential estrogen, and four potential Ets-1 responsive elements flanking the promoter. A 315-base pair fragment spanning the TATAAA box and a potential Sp1-binding site exhibited maximum promoter activity using CAT as a reporter while longer promoter fragments extending into upstream flanking sequences spanning the hormone receptor-response elements exhibited reduced promoter activity. An expression vector, pHLPPr-1-neo, was constructed using a 5.1-kilobase pair EcoRI-HindIII fragment of the L-plastin gene that contained the potential upstream regulatory elements, the TATAAA box, and part of the first exon. This promoter could direct the constitutive expression of the reporter beta-galactosidase at high frequency in transfected colonies of transformed cells that express L-plastin constitutively; by contrast, this promoter was virtually inactive in transfected colonies of normal fibroblasts and it exhibited a low frequency of constitutive activation in transfected colonies of in vitro SV40-transformed fibroblasts which did not exhibit L-plastin expression. The utility of this recombinant promoter in determining the mechanism(s) that leads to activation of the L-plastin gene in tumor cells is discussed. The potential significance of regulation of the L-plastin gene by reproductive hormones in cancers arising in hormone-responsive tissues is also discussed.	PALO ALTO MED RES FDN,RES INST,CANC CELL BIOL LAB,PALO ALTO,CA 94301; ADEZA BIOMED,SUNNYVALE,CA 94089	Palo Alto Medical Foundation Research Institute					NCI NIH HHS [CA34763, CA49423] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049423, R01CA034763] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; BERG JM, 1989, CELL, V57, P1065, DOI 10.1016/0092-8674(89)90042-1; BERNSTEIN L, 1992, AM J EPIDEMIOL, V135, P142, DOI 10.1093/oxfordjournals.aje.a116267; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; CELIS JE, 1990, ELECTROPHORESIS, V11, P1072, DOI 10.1002/elps.1150111203; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; GOLDSTEIN D, 1985, CANCER RES, V45, P5643; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEAVITT J, 1982, CARCINOGENESIS, V3, P61, DOI 10.1093/carcin/3.1.61; LEAVITT J, 1986, MOL CELL BIOL, V6, P2721, DOI 10.1128/MCB.6.7.2721; LEAVITT J, 1987, MOL CELL BIOL, V7, P2467, DOI 10.1128/MCB.7.7.2467; LEAVITT J, 1987, MOL CELL BIOL, V7, P2457, DOI 10.1128/MCB.7.7.2457; LEAVITT J, 1980, J BIOL CHEM, V255, P1650; LEWIN B, 1980, GENE EXPRESSION; LIN CS, 1990, MOL CELL BIOL, V10, P1818, DOI 10.1128/MCB.10.4.1818; LIN CS, 1988, MOL CELL BIOL, V8, P4659, DOI 10.1128/MCB.8.11.4659; LIN CS, 1993, J BIOL CHEM, V168, P2781; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; SALIER JP, 1989, BIOTECHNIQUES, V7, P30; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SETH A, 1992, CELL GROWTH DIFFER, V3, P327; SZERKERESBARTHO J, 1992, IMMUNOSUPPRESSION PR; SZERKERESBARTHO J, 1989, J REPROD IMMUNOL, V16, P239; VARMA M, 1987, EXP CELL RES, V173, P163, DOI 10.1016/0014-4827(87)90342-9	31	56	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2793	2801						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428953				2022-12-27	WOS:A1993KK81500079
J	GANNON, PM; KUMAMOTO, CA				GANNON, PM; KUMAMOTO, CA			MUTATIONS OF THE MOLECULAR CHAPERONE PROTEIN SECB WHICH ALTER THE INTERACTION BETWEEN SECB AND MALTOSE-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXPORTED PROTEIN; LEADER PEPTIDE; GENE; TRANSLOCATION; MEMBRANE; CONFORMATION; RETARDATION; SUFFICIENT; PREPROTEIN	SecB is a 16-kDa cytosolic chaperone protein that is required for efficient export of particular proteins in Escherichia coli. To identify regions of SecB that contribute to efficient protein export, we isolated secB point mutants that are defective for protein export in vivo. We obtained missense mutations at residues Leu75 (SecBL75Q), Cys76 (SecBC76Y), and Glu77 (SecBE77K) in the center of the secB gene. In vivo, mutant SecBL75Q and SecBE77K proteins are capable of binding to precursor maltose-binding protein (MBP) and preventing the formation of export-incompetent precursor MBP; however, export of MBP is still defective. In vitro, purified SecBL75Q and SecBE77K proteins bound to unfolded MBP and blocked its refolding. SecBL75Q and SecBE77K were more effective than wild-type SecB at blocking the refolding of unfolded MBP, suggesting that SecBL75Q and SecBE77K have a higher affinity for unfolded MBP.	TUFTS UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, 136 HARRISON AVE, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02111 USA	Tufts University; Tufts University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036415] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANEYX F, 1992, J BIOL CHEM, V267, P11637; BIEKER KL, 1990, CELL, V61, P833, DOI 10.1016/0092-8674(90)90193-I; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; FAUST JR, 1991, J BIOL CHEM, V266, P9961; FERENCI T, 1978, FEBS LETT, V94, P213, DOI 10.1016/0014-5793(78)80940-5; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1990, J BIOENERG BIOMEMBR, V22, P337, DOI 10.1007/BF00763171; KUMAMOTO CA, 1989, P NATL ACAD SCI USA, V86, P5320, DOI 10.1073/pnas.86.14.5320; KUMAMOTO CA, 1983, J BACTERIOL, V154, P253, DOI 10.1128/JB.154.1.253-260.1983; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUMAMOTO CA, 1989, GENE, V75, P167, DOI 10.1016/0378-1119(89)90393-4; KUMAMOTO CA, 1989, J BIOL CHEM, V264, P2242; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; LEE C, 1989, J BACTERIOL, V171, P4609, DOI 10.1128/jb.171.9.4609-4616.1989; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LIU G, 1988, J BIOL CHEM, V263, P14790; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; Silhavy T. J., 1984, EXPT GENE FUSIONS; STRUHL K, 1983, GENE, V26, P231, DOI 10.1016/0378-1119(83)90193-2; THOM JR, 1988, J BACTERIOL, V170, P5654, DOI 10.1128/jb.170.12.5654-5661.1988; TRUN NJ, 1988, J BACTERIOL, V170, P5928, DOI 10.1128/jb.170.12.5928-5930.1988; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P2728, DOI 10.1073/pnas.86.8.2728; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P2248, DOI 10.1073/pnas.86.7.2248; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533	34	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1590	1595						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420934				2022-12-27	WOS:A1993KH62000017
J	KISPAL, G; SUMEGI, B; DIETMEIER, K; BOCK, I; GAJDOS, G; TOMCSANYI, T; SANDOR, A				KISPAL, G; SUMEGI, B; DIETMEIER, K; BOCK, I; GAJDOS, G; TOMCSANYI, T; SANDOR, A			CLONING AND SEQUENCING OF A CDNA-ENCODING SACCHAROMYCES-CEREVISIAE CARNITINE ACETYLTRANSFERASE - USE OF THE CDNA IN GENE DISRUPTION STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINE-ACETYLTRANSFERASE; YEAST; TRANSFORMATION; STIMULATION; EXPRESSION	cDNA encoding for carnitine acetyltransferase (CAT) of yeast S. cerevisiae was isolated by screening a yeast cDNA lambdagt11 library with antibody. The whole coding sequence was obtained from the cDNA and from a YEP 13 DNA clone identified using the cDNA as probe. The coding sequence consists of 670 residues, which amounts to a molecular mass of 77,300 kDa. This cDNA was used successfully to disrupt the gene for the mitochondrial isoenzyme of CAT, which was shown by measuring the enzyme activity and by immunoblot. The acetylcarnitine content of these cells decreased significantly. A search in the PIR protein data base revealed that besides the known carnitine acyltransferases, choline acyltransferases are highly homologous to yeast CAT. The mitochondrial CAT-deficient (CAT-) cells were able to grow on different fermentable and nonfermentable carbon sources, even on acetate at the same rate as the parental strain. In contrast to these, C-13 NMR studies revealed significant differences between parental and CAT- cells. In CAT- cells [3-C-13]pyruvate was converted mainly to lactate and acetate, whereas in the parental cells alanine and tricarboxylic acid cycle intermediates were found as the main products of pyruvate metabolism beside acetate. These results suggest diminished flux through the pyruvate dehydrogenase complex in the absence of mitochondrial CAT in yeast cells.	JANUS PANNONIUS UNIV,DEPT ZOOL,PECS,HUNGARY; UNIV MUNICH,INST PHYSIOL CHEM,W-8000 MUNICH 2,GERMANY	University of Pecs; University of Munich	KISPAL, G (corresponding author), UNIV MED SCH PECS,INST BIOCHEM,SZIGETI 12,H-7624 PECS,HUNGARY.							BERRARD S, 1987, P NATL ACAD SCI USA, V84, P9280, DOI 10.1073/pnas.84.24.9280; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; BREMER J, 1962, J BIOL CHEM, V237, P2228; BRICE A, 1989, J NEUROSCI RES, V23, P266, DOI 10.1002/jnr.490230304; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Chalmers R, 1983, BIOCHEM SOC T, V11, P724; CHATTERJEE B, 1988, BIOCHEMISTRY-US, V27, P9000, DOI 10.1021/bi00425a018; CHILDRESS CC, 1966, J BIOL CHEM, V242, P754; DAUM G, 1982, J BIOL CHEM, V257, P3028; Davis R W, 1980, Methods Enzymol, V65, P404; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; DIDONATO S, 1979, NEUROLOGY, V29, P1578, DOI 10.1212/WNL.29.12.1578; EMAUS RK, 1983, J BIOL CHEM, V258, P3160; FINIOCCHIARO G, 1991, P NATL ACAD SCI USA, V88, P661; FRITZ IB, 1963, ADV LIPID RES, V1, P285; FRITZ IB, 1963, J BIOL CHEM, V238, P2509; HELMS C, 1987, METHOD ENZYMOL, V153, P69; HOPPEL CL, 1976, ENZYMES BIOL MEMBR, V2, P119; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KISPAL G, 1991, BIOCHIM BIOPHYS ACTA, V1085, P217, DOI 10.1016/0005-2760(91)90097-2; KOHLHAW GB, 1977, J BACTERIOL, V129, P1159, DOI 10.1128/JB.129.2.1159-1161.1977; LYSIAK W, 1988, NUTRITION, V4, P215; Maniatis T., 1982, MOL CLONING; MARQUIS NR, 1965, J BIOL CHEM, V240, P2193; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANDOR A, 1989, J CHROMATOGR-BIOMED, V497, P250, DOI 10.1016/0378-4347(89)80025-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708; WOELTJE KF, 1990, J BIOL CHEM, V265, P10720	31	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1824	1829						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420957				2022-12-27	WOS:A1993KH62000051
J	KONG, CT; YET, SF; LEVER, JE				KONG, CT; YET, SF; LEVER, JE			CLONING AND EXPRESSION OF A MAMMALIAN NA+ AMINO-ACID COTRANSPORTER WITH SEQUENCE SIMILARITY TO NA+ GLUCOSE COTRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; LLC-PK1 CLONES; CARRIER GENE; TRANSPORT; NA+/GLUCOSE; CELLS; RECEPTOR; PROTEIN; SYSTEM	We describe the full-length sequence and functional expression of a cDNA cloned from LLC-PK1 cells, which appears to encode a mammalian Na+-dependent neutral amino acid transporter with properties characteristic of system A. This sequence, designated SAAT1, is 76% identical and 89% similar in amino acid sequence to the Na+-dependent glucose transporter SGLT1 of the same species. A leucine zipper region was detected in both SAAT1 and SGLT1. The message for SAAT1 was a single 2.4-kilobase species in kidney, but mRNA species of 2.4 and 3.7 kilobases were observed in LLC-PK1 cells as well as in intestine. Transcripts were also found in spleen, liver, and muscle. Expression of SAAT1 in COS-7 cells resulted in increased levels of Na+-dependent uptake of 2-(methylamino)isobutyric acid, a specific substrate for the system A amino acid transporter. Uptake due to cDNA expression was inhibited by a range of amino acids that are transported by system A and exhibited a k(m) of 0.8 +/- 0.2 mM. These results suggest that the system A amino acid transporter is closely related to the Na+/glucose transporter SGLT1.	UNIV TEXAS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,POB 20708,HOUSTON,TX 77225	University of Texas System			Yet, Shaw-Fang/B-1067-2010; Yet, Shaw-Fang/O-8583-2019	Yet, Shaw-Fang/0000-0001-9097-3962	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027400, R37DK027400] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27400] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMSLER K, 1982, AM J PHYSIOL, V242, pC94, DOI 10.1152/ajpcell.1982.242.1.C94; Battey, 1986, BASIC METHODS MOL BI; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHRISTENSEN HN, 1965, J BIOL CHEM, V240, P3609; COADY MJ, 1990, AM J PHYSIOL, V259, pC605, DOI 10.1152/ajpcell.1990.259.4.C605; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; DEGUCHI Y, 1990, J BIOL CHEM, V265, P21704; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOYLE FA, 1992, BIOCHEM J, V281, P95, DOI 10.1042/bj2810095; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P18, DOI 10.1016/0968-0004(90)90125-U; GUIDOTTI GG, 1978, BIOCHIM BIOPHYS ACTA, V515, P329, DOI 10.1016/0304-4157(78)90009-6; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; JACKOWSKI S, 1990, J BACTERIOL, V172, P3842, DOI 10.1128/jb.172.7.3842-3848.1990; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; KWON HM, 1992, J BIOL CHEM, V267, P6297; Maniatis T, 1989, DECONTAMINATION DILU; MCCORMICK JI, 1988, P NATL ACAD SCI USA, V85, P7877, DOI 10.1073/pnas.85.21.7877; MENDLEIN J, 1988, FASEB J, V2, pA1021; NAKAO T, 1987, MOL GEN GENET, V208, P70, DOI 10.1007/BF00330424; OHSAWA M, 1988, J BACTERIOL, V170, P5185, DOI 10.1128/jb.170.11.5185-5191.1988; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; PAJOR AM, 1992, J BIOL CHEM, V267, P3557; SCRIVER CR, 1987, AM J HUM GENET, V40, P401; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; VANDENBOSCH L, 1989, J CELL PHYSIOL, V141, P483, DOI 10.1002/jcp.1041410306; WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; WHITE MK, 1989, NATURE, V340, P103, DOI 10.1038/340103b0; WOHLWEND A, 1986, AM J PHYSIOL, V250, pC682, DOI 10.1152/ajpcell.1986.250.5.C682; YONEYAMA Y, 1988, AM J PHYSIOL, V255, pC816, DOI 10.1152/ajpcell.1988.255.6.C816	38	124	129	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1509	1512						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420925				2022-12-27	WOS:A1993KH62000003
J	SAGITOV, V; NIKIFOROV, V; GOLDFARB, A				SAGITOV, V; NIKIFOROV, V; GOLDFARB, A			DOMINANT LETHAL MUTATIONS NEAR THE 5' SUBSTRATE BINDING-SITE AFFECT RNA-POLYMERASE PROPAGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAC UV5 PROMOTER; ESCHERICHIA-COLI; BETA-SUBUNIT; NUCLEOTIDE-SEQUENCE; TERNARY COMPLEXES; GENE ORGANIZATION; CORE SUBUNITS; RPOB GENE; TRANSCRIPTION; INITIATION	The segment Asp1064-Lys1073 in the beta subunit of Escherichia coli RNA polymerase is evolutionarily conserved and is located near the ''5' face'' of the nucleotide binding pocket as was shown by affinity labeling with priming substrates (Grachev, M. A., Lukhtamov, E. A., Mustaev, A. A., Zaychikov, E. F., Abdukayumov, M. N., Rabinov, I. V., Richter, V. I., Skoblov, Y. S., and Chistyakov, P. G. (1989) Eur. J. Biochem. 180, 577-585). We engineered single Xaa --> Ala or Ala --> Ser substitutions of eight evolutionarily conserved amino acids in this segment as well as a multiple alanine (KRNK) substitution of four of these residues. The KRNK mutation as well as four of the single substitutions were dominant lethal, two of the single mutations were recessive lethal, and two were viable. RNA polymerase bearing the dominant mutations was prepared for biochemical study by in vitro reconstitution from subunits. All of the mutant enzymes formed stable, specific promoter complexes, capable of initiating RNA synthesis. However, the KRNK polymerase was totally blocked in initiation-to-elongation transition, whereas the four point mutants displayed allele-specific changes in promoter clearance rate. Each of the four mutations changed, in a specific way, both the pattern of short oligomers generated in abortive initiation and the pattern of RNA polymerase pausing during elongation. Thus, the mutations appear to distort but not destroy the active center and to alter, in allele-specific manner, the coupling between the catalytic reaction and RNA polymerase propagation along the template.	RUSSIAN ACAD SCI, INST MOLEC GENET, MOSCOW 123182, RUSSIA; COLUMBIA UNIV COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA	Russian Academy of Sciences; Columbia University					NIGMS NIH HHS [GM30717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGHOFER B, 1988, NUCLEIC ACIDS RES, V16, P8113, DOI 10.1093/nar/16.16.8113; BORODIN AM, 1988, DOKL AKAD NAUK SSSR+, V302, P1261; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Burgess R.R., 1987, RNA POLYM REGULATION, P3; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CHAN PT, 1990, J BIOL CHEM, V265, P4091; FALKENBURG D, 1987, J MOL BIOL, V195, P929, DOI 10.1016/0022-2836(87)90496-7; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HEINZ DW, 1992, P NATL ACAD SCI USA, V89, P3751, DOI 10.1073/pnas.89.9.3751; HEUMANN H, 1986, EUR J BIOCHEM, V158, P575, DOI 10.1111/j.1432-1033.1986.tb09793.x; HUDSON GS, 1988, J MOL BIOL, V200, P639, DOI 10.1016/0022-2836(88)90477-9; IWABE N, 1991, J MOL EVOL, V32, P70, DOI 10.1007/BF02099931; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; JIN DJ, 1988, J MOL BIOL, V202, P245, DOI 10.1016/0022-2836(88)90455-X; JOHNSTON DE, 1976, RNA POLYM, P101; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; KASHLEV M, 1990, SCIENCE, V248, P1006, DOI 10.1126/science.1693014; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LEE JY, 1989, J BACTERIOL, V171, P3002, DOI 10.1128/jb.171.6.3002-3007.1989; LEE JY, 1991, CELL, V66, P793, DOI 10.1016/0092-8674(91)90122-F; LEFFERS H, 1989, J MOL BIOL, V206, P1, DOI 10.1016/0022-2836(89)90519-6; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MALIK S, 1985, J MOL BIOL, V185, P83, DOI 10.1016/0022-2836(85)90184-6; MALIK S, 1984, J BIOL CHEM, V259, P3292; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; OESCHGER MP, 1980, MOL GEN GENET, V178, P293, DOI 10.1007/BF00270475; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; OVCHINNIKOV YA, 1981, EUR J BIOCHEM, V116, P621, DOI 10.1111/j.1432-1033.1981.tb05381.x; OVCHINNIKOV YA, 1983, MOL GEN GENET, V190, P344, DOI 10.1007/BF00330662; PUHLER G, 1989, NUCLEIC ACIDS RES, V17, P4517, DOI 10.1093/nar/17.12.4517; SCHULTZ W, 1981, NUCLEIC ACIDS RES, V24, P6889; SEVERINOV K, 1992, J BIOL CHEM, V267, P12813; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STUDIER FW, 1979, J MOL BIOL, V135, P917, DOI 10.1016/0022-2836(79)90520-5; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; ZALENSKAYA K, 1990, GENE, V89, P7, DOI 10.1016/0378-1119(90)90199-2; ZILLIG W, 1976, RNA POLYMERASE, P101	45	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2195	2202						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420987				2022-12-27	WOS:A1993KH62000104
J	PAYNE, JM; DAHMUS, ME				PAYNE, JM; DAHMUS, ME			PARTIAL-PURIFICATION AND CHARACTERIZATION OF 2 DISTINCT PROTEIN-KINASES THAT DIFFERENTIALLY PHOSPHORYLATE THE CARBOXYL-TERMINAL DOMAIN OF RNA-POLYMERASE SUBUNIT-IIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REPEAT DOMAIN; CALF THYMUS; CELL-CYCLE; WHEAT-GERM; TRANSCRIPTION; INITIATION; PROMOTER; ELONGATION; COMPLEXES	RNA polymerase II is a multisubunit enzyme composed of two large subunits of molecular weight in excess of 100,000 and a collection of 8-10 smaller subunits. The largest subunit, designated IIa, contains at its carboxyl terminus a highly repetitive domain consisting of tandem repeats of the consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser. Extensive phosphorylation within this COOH-terminal domain (CTD) gives rise to subunit IIo which has a markedly reduced mobility in SDS-polyacrylamide gel electrophoresis (PAGE) relative to subunit IIa. Recent evidence suggests that RNA polymerase IIA, containing an unphosphorylated CTD, is involved in preinitiation complex assembly, whereas RNA polymerase IIO is involved in elongation. Consequently, CTD phosphorylation is thought to occur after RNA polymerase II has bound to the promoter by a protein kinase that stably associates with the preinitiation complex. We present here the partial purification and characterization of two distinct CTD kinases from a HeLa cell transcription extract. These CTD kinases, designated CTDK1 and CTDK2, are fractionated by chromatography on Mono Q. CTDK1 catalyzes the incorporation of approximately 33 pmol of phosphate/pmol of calf thymus RNA polymerase subunit IIa, almost exclusively on serine. CTDK2 catalyzes the incorporation of approximately 50 pmol of phosphate/pmol of calf thymus subunit IIa, predominantly on serine; appreciable phosphate transfer onto threonine is also observed. Phosphorylation by CTDK2, but not CTDK1, results in a complete mobility shift in SDS-PAGE of subunit IIa to the position of IIo. CTDK1 can utilize ATP, dATP, or GTP as phosphate donor, whereas CTDK2 can utilize only ATP or dATP. The apparent K(m) for ATP is 30 muM for CTDK1 and 60 muM for CTDK2. CTDK1 and CTDK2 also differ in their protein substrate specificity. CTDK1 phosphorylates casein whereas CTDK2 does not. Neither kinase phosphorylates phosvitin or histone H1 to an appreciable extent. CTDK1 and CTDK2 do not appear to be related to cdc2 kinases as determined by their inability to phosphorylate H1 and their failure to react with antibodies directed against the cdc2 kinase. These results establish that a partially fractionated HeLa transcription extract contains two distinct CTD kinases that differ in their nucleotide requirements and in their patterns of CTD phosphorylation.	UNIV CALIF DAVIS, DEPT BIOCHEM & BIOPHYS, DAVIS, CA 95616 USA	University of California System; University of California Davis					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033300] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 33300] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARIAS JA, 1989, J BIOL CHEM, V264, P3223; ARIAS JA, 1991, J BIOL CHEM, V266, P8055; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CISEK LJ, 1991, METHOD ENZYMOL, V200, P301; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; DAHMUS ME, 1983, J BIOL CHEM, V258, P2303; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; GUILFOYLE TJ, 1989, PLANT CELL, V1, P827, DOI 10.1105/tpc.1.8.827; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; KIM WY, 1986, J BIOL CHEM, V261, P14219; KIM WY, 1988, J BIOL CHEM, V263, P18880; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE JM, 1991, GENE EXPRESSION, V1, P149; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LEGAGNEUX V, 1990, EUR J BIOCHEM, V193, P121, DOI 10.1111/j.1432-1033.1990.tb19312.x; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; SPENCER CA, 1990, ONCOGENE, V5, P777; STONE N, 1992, J BIOL CHEM, V267, P6353; TEISSERE M, 1977, FEBS LETT, V82, P77, DOI 10.1016/0014-5793(77)80889-2; WEIL PA, 1979, J BIOL CHEM, V254, P6163; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	44	68	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					80	87						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416977				2022-12-27	WOS:A1993KE60300014
J	BIRD, GS; PUTNEY, JW				BIRD, GS; PUTNEY, JW			INHIBITION OF THAPSIGARGIN-INDUCED CALCIUM-ENTRY BY MICROINJECTED GUANINE-NUCLEOTIDE ANALOGS - EVIDENCE FOR THE INVOLVEMENT OF A SMALL G-PROTEIN IN CAPACITATIVE CALCIUM-ENTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LACRIMAL ACINAR-CELLS; RAT-LIVER MICROSOMES; CA-2+ RELEASE; INOSITOL TRISPHOSPHATE; INTRACELLULAR CALCIUM; GTP; POOLS; STIMULATION	Injection of mouse lacrimal acinar cells with the non-hydrolyzable analogue of GTP, GTPgammaS (guanosine 5'-3-O-(thio)triphosphate), caused a rapid release of intracellular calcium but failed to activate calcium entry. Injection of GTPgammaS together with the inositol 1,4,5-trisphosphate receptor inhibitor, heparin, did not induce calcium release but blocked the activation of capacitative calcium entry by thapsigargin. Injection of GDPbetaS (guanosine 5'-O-(thio)diphosphate) produced similar effects. The inhibitory effects of GDPbetaS were prevented if an equal concentration of GTP was included in the injection pipette. These findings suggest that one of the steps linking the depletion of intracellular calcium pools to calcium entry across the plasma membrane requires the hydrolysis of GTP and may involve a small G-protein.			BIRD, GS (corresponding author), NIEHS,CELLULAR & MOLEC PHARMACOL LAB,CALCIUM REGULAT SECT,RES TRIANGLE PK,NC 27709, USA.		Bird, Gary/AAI-8186-2021; Putney, James/F-7247-2019	Bird, Gary/0000-0003-1389-8748; Putney, James/0000-0002-3379-4789				BIAN JH, 1991, J BIOL CHEM, V266, P8801; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BIRD GS, 1992, J BIOL CHEM, V267, P18382; COCKCROFT S, 1987, J CELL BIOL, V105, P2745, DOI 10.1083/jcb.105.6.2745; CULLEN PJ, 1988, FEBS LETT, V228, P57, DOI 10.1016/0014-5793(88)80584-2; DAWSON AP, 1985, FEBS LETT, V185, P147, DOI 10.1016/0014-5793(85)80759-6; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GILL DL, 1986, NATURE, V320, P461, DOI 10.1038/320461a0; GILL DL, 1990, G PROTEINS CALCIUM M, P95; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; LLANO I, 1987, PFLUG ARCH EUR J PHY, V409, P499, DOI 10.1007/BF00583807; NILSSON T, 1988, FEBS LETT, V229, P211, DOI 10.1016/0014-5793(88)80829-9; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V180, P755, DOI 10.1016/S0006-291X(05)81130-1; PAROD RJ, 1980, AM J PHYSIOL, V239, pG99, DOI 10.1152/ajpgi.1980.239.2.G99; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; THOMAS AP, 1988, J BIOL CHEM, V263, P2704	23	187	188	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21486	21488						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407996				2022-12-27	WOS:A1993MC80900009
J	HABUCHI, O; MATSUI, Y; KOTOYA, Y; AOYAMA, Y; YASUDA, Y; NODA, M				HABUCHI, O; MATSUI, Y; KOTOYA, Y; AOYAMA, Y; YASUDA, Y; NODA, M			PURIFICATION OF CHONDROITIN 6-SULFOTRANSFERASE SECRETED FROM CULTURED CHICK-EMBRYO CHONDROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSAMINOGLYCAN SULFOTRANSFERASE ACTIVITIES; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; FIBROBLAST GROWTH-FACTOR; HUMAN-SERUM; GOLGI RETENTION; TRANSMEMBRANE DOMAIN; HEPARAN-SULFATE; FUCOSYL-TRANSFERASE; SQUID CARTILAGE; ANIMAL SERA	Chondroitin 6-sulfotransferase, which transfers sulfate from 3'-phosphoadenylyl sulfate to position 6 of N-acetylgalactosamine in chondroitin, was purified 1,430-fold to apparent homogeneity with a 22% yield from the serum-free culture medium of chick embryo chondrocytes by affinity chromatography on heparin-Sepharose CL-6B, wheat germ agglutinin-agarose, and 3',5'-ADP-agarose. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified enzyme showed a single broad protein band with an apparent molecular weight of 75,000. Since the purified enzyme has an apparent molecular weight of 160,000 as judged by gel chromatography on Superose 12, the active form of chondroitin 6-sulfotransferase may be a dimer. The purified enzyme transferred sulfate to chondroitin, chondroitin sulfate, and corneal keratan sulfate. Chondroitin sulfate E from squid cartilage, dermatan sulfate, and heparan sulfate hardly served as acceptors of the sulfotransferase. The sulfated product derived from keratan sulfate was degraded by keratanase but not by chondroitinase ABC.			HABUCHI, O (corresponding author), AICHI UNIV EDUC,DEPT LIFE SCI,KARIYA 448,JAPAN.			Habuchi, Osami/0000-0001-9591-5374				AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; FUJITAYAMAGUCHI Y, 1981, J BIOL CHEM, V256, P2701; GOHLER D, 1984, EUR J BIOCHEM, V138, P301, DOI 10.1111/j.1432-1033.1984.tb07915.x; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HABUCHI O, 1971, J BIOL CHEM, V246, P7357; HABUCHI O, 1980, BIOCHIM BIOPHYS ACTA, V616, P208, DOI 10.1016/0005-2744(80)90139-4; HABUCHI O, 1977, J BIOL CHEM, V252, P4570; HABUCHI O, 1982, BIOCHIM BIOPHYS ACTA, V717, P414, DOI 10.1016/0304-4165(82)90282-3; HABUCHI O, 1985, J BIOL CHEM, V260, P3102; HABUCHI O, 1991, BIOCHIM BIOPHYS ACTA, V1133, P9; INOUE H, 1986, J BIOL CHEM, V261, P4470; INOUE H, 1986, J BIOL CHEM, V261, P4460; JACOBSSON I, 1980, J BIOL CHEM, V255, P5094; KELLEN L, 1991, ANNU REV BIOCHEM, V60, P443; KIM JJ, 1980, J BIOL CHEM, V255, P1586; KIM JJ, 1977, J BIOL CHEM, V252, P8292; KIM JJ, 1976, J BIOL CHEM, V251, P6210; KUSCHE M, 1988, J BIOL CHEM, V263, P15474; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MOMBURG M, 1972, H-S Z PHYSIOL CHEM, V353, P1351, DOI 10.1515/bchm2.1972.353.2.1351; NAKANISHI Y, 1981, J BIOL CHEM, V256, P5443; NAKAZAWA K, 1975, J BIOL CHEM, V250, P912; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; PRIEELS JP, 1981, J BIOL CHEM, V256, P456; RUTER ER, 1984, J BIOL CHEM, V259, P1771; SARNESTO A, 1990, J BIOL CHEM, V265, P15067; SARNESTO A, 1992, J BIOL CHEM, V267, P2737; SARNESTO A, 1992, J BIOL CHEM, V267, P2745; SHAKLEE PN, 1986, BIOCHEM J, V235, P225, DOI 10.1042/bj2350225; STROMINGER JL, 1959, J BIOL CHEM, V234, P3263; STROUS GJAM, 1982, J BIOL CHEM, V257, P7623; SUGAHARA K, 1989, J BIOCHEM-TOKYO, V106, P910, DOI 10.1093/oxfordjournals.jbchem.a122951; SUGAHARA K, 1987, ARCH BIOCHEM BIOPHYS, V258, P391, DOI 10.1016/0003-9861(87)90360-2; TANG BL, 1992, J BIOL CHEM, V267, P10122; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245	45	76	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21968	21974						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408053				2022-12-27	WOS:A1993MC80900080
J	KISTER, L; DOMENJOUD, L; GALLINARO, H; MONIQUE, J				KISTER, L; DOMENJOUD, L; GALLINARO, H; MONIQUE, J			A CIS-ACTING SELECTOR OF A 5' SPLICE-SITE - COOPERATION BETWEEN THE SEQUENCE OF THE SITE AND AN UPSTREAM EXONIC ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; OSTEOGENESIS IMPERFECTA; MAMMALIAN SPLICEOSOME; ASSEMBLY PATHWAY; GENE; MUTATION; INVITRO; BINDING; MECHANISM; INTRON	To investigate the mechanism by which a 5' splice site (D1) is selected, while a nearby potentially functional site (Dcr1) is silenced, we have studied the importance of the 9- nucleotide sequence of these 5' splice sites for their respective usage. Our model system uses a transcript derived from the early transcription unit 3 of adenovirus-2. Transcripts, harboring an exonic element previously shown to be required for the selection of Dl in the presence of Dcr1, were mutated in the Dl and Dcr1 sequences and assayed for splicing in vitro. We first show that an increased ability of Dl to pair with U1 small nuclear (sn) RNA correlates with an increased accumulation of splicing intermediates, independently of the presence of Dcr1. This variation of efficiency of the first splicing reaction does not significantly affect the overall splicing efficiency except when the potential D1-U1 snRNA hybrid is less than 6 base pairs. Equally, the selector activity of the upstream exon element requires a Dl sequence that is able to form hybrids of 6 base pairs or more with U1 snRNA. This indicates that the cis-acting selector of DI includes the exonic element (a potential stem-loop structure) and a D1 sequence of sufficient strength.	FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								ABMAYR SM, 1988, P NATL ACAD SCI USA, V85, P7216, DOI 10.1073/pnas.85.19.7216; AKLI S, 1990, J BIOL CHEM, V265, P7324; BELAGULI NS, 1992, J VIROL, V66, P2724, DOI 10.1128/JVI.66.5.2724-2730.1992; BOELENS W, 1992, NUCLEIC ACIDS RES, V12, P3165; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CAFFARELLI E, 1992, BIOCHEM BIOPH RES CO, V183, P680, DOI 10.1016/0006-291X(92)90536-T; CLADARAS C, 1985, VIROLOGY, V140, P28, DOI 10.1016/0042-6822(85)90443-X; DALESSIO M, 1991, AM J HUM GENET, V49, P400; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; Domenjoud Lionel, 1993, Gene Expression, V3, P83; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GANGULY A, 1991, J BIOL CHEM, V266, P12035; GRANT CE, 1990, NUCLEIC ACIDS RES, V18, P5457, DOI 10.1093/nar/18.18.5457; HARPER JE, 1991, MOL CELL BIOL, V11, P5945, DOI 10.1128/MCB.11.12.5945; HAYNES SR, 1992, NEW BIOL, V4, P421; HODGES D, 1992, MECH DEVELOP, V37, P127, DOI 10.1016/0925-4773(92)90075-U; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; INOUYE S, 1987, SYNTHESIS APPLICATIO, P181; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LATCHMAN D S, 1990, New Biologist, V2, P297; LEAR AL, 1990, J MOL BIOL, V211, P103, DOI 10.1016/0022-2836(90)90014-D; LEE B, 1991, J BIOL CHEM, V266, P5256; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; MATTOX W, 1992, J BIOL CHEM, V267, P19023; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; McKeown M, 1990, Genet Eng (N Y), V12, P139; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; RIO D C, 1992, Current Opinion in Cell Biology, V4, P444, DOI 10.1016/0955-0674(92)90010-A; Rio Donald C., 1992, Gene Expression, V2, P1; SAWA H, 1991, NUCLEIC ACIDS RES, V19, P3953, DOI 10.1093/nar/19.14.3953; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SPIKES D, 1992, NUCLEIC ACIDS RES, V20, P5719, DOI 10.1093/nar/20.21.5719; TACKE R, 1991, GENE DEV, V5, P1416, DOI 10.1101/gad.5.8.1416; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; UTANS U, 1990, EMBO J, V9, P4119, DOI 10.1002/j.1460-2075.1990.tb07634.x; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	44	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21955	21961						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408052				2022-12-27	WOS:A1993MC80900078
J	YANAGITA, K; MATSUMOTO, K; SEKIGUCHI, K; ISHIBASHI, H; NIHO, Y; NAKAMURA, T				YANAGITA, K; MATSUMOTO, K; SEKIGUCHI, K; ISHIBASHI, H; NIHO, Y; NAKAMURA, T			HEPATOCYTE GROWTH-FACTOR MAY ACT AS A PULMOTROPHIC FACTOR ON LUNG REGENERATION AFTER ACUTE LUNG INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MET PROTOONCOGENE; SCATTER FACTOR; MESSENGER-RNA; CELL-GROWTH; UNILATERAL NEPHRECTOMY; LIVER-REGENERATION; EPITHELIAL-CELLS; FACTOR RECEPTOR; RAT PLATELETS; DNA-SYNTHESIS	Hepatocyte growth factor (HGF) has been shown to have hepatotrophic and renotropic functions for regeneration of the liver and kidney through its mitogenic, motogenic, and morphogenic properties. To examine the involvement of HGF in lung regeneration after acute injury, we analyzed changes of HGF mRNA, HGF activity, and HGF receptors in the rat lung after lung insult and measured HGF concentration in sera of patients with various lung diseases. Following the onset of acute lung injury induced by intratracheal hydrochloride injection, a compensatory DNA synthesis occurred in the bronchial epithelium with a peak at 24 h and in the alveolar epithelium with a peak at 48 h. Expression of HGF mRNA in the rat lung remarkably increased only 3 h after the treatment and HGF activity in the lung also increased to about 3-fold at 6 h later. HGF receptors in the lung but not in the other noninjured organs were down-regulated 12 h later. These marked increases in HGF mRNA and HGF activity and the concomitant down-regulation of HGF receptor occurred before the marked compensatory DNA synthesis in bronchial and alveolar epithelial cells. HGF concentration in sera of patients with various lung diseases, as measured by radioimmunoassay, was much higher than that in healthy donors. These results suggest that HGF is newly produced in the lung after acute lung injury and may have a role in regeneration of the lung.	OSAKA UNIV,CTR BIOMED RES,SCH MED,DEPT BIOCHEM,DIV BIOCHEM,SUITA,OSAKA 565,JAPAN; DINABOT CO LTD,CTR RES & DEV,MINORIDAI,CHIBA 271,JAPAN; KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 1,FUKUOKA 812,JAPAN	Osaka University; Kyushu University								AOKI J, 1991, JPN J CLIN HEMATOL, V32, P11; ASAMI O, 1991, J BIOCHEM-TOKYO, V109, P8; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FREYCHET P, 1972, J BIOL CHEM, V247, P3953; FURLONG RA, 1991, J CELL SCI, V100, P173; GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GOLDIN GV, 1980, J EMBRYOL EXP MORPH, V60, P235; HIGASHIO K, 1990, BIOCHEM BIOPH RES CO, V170, P397, DOI 10.1016/0006-291X(90)91287-3; HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8; HIGUCHI O, 1992, FEBS LETT, V301, P282, DOI 10.1016/0014-5793(92)80257-H; IGAWA T, 1991, BIOCHEM BIOPH RES CO, V174, P831, DOI 10.1016/0006-291X(91)91493-V; IGAWA T, 1993, IN PRESS AM J PHYSL; ISHIBASHI K, 1992, BIOCHEM BIOPH RES CO, V187, P1454, DOI 10.1016/0006-291X(92)90465-W; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; JETTEN AM, 1991, AM J PHYSIOL, V260, pL361, DOI 10.1152/ajplung.1991.260.6.L361; JETTEN AM, 1986, EXP CELL RES, V147, P530; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; KONISHI T, 1991, BIOCHEM BIOPH RES CO, V180, P765, DOI 10.1016/S0006-291X(05)81131-3; KONO S, 1992, BIOCHEM BIOPH RES CO, V186, P991, DOI 10.1016/0006-291X(92)90844-B; LECHNER JF, 1981, CANCER RES, V41, P2294; MASON R M, 1992, American Review of Respiratory Disease, V145, pA122; MASON RJ, 1990, AM J RESP CELL MOL, V3, P571, DOI 10.1165/ajrcmb/3.6.571; MATSUMOTO K, 1992, Critical Reviews in Oncogenesis, V3, P27; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; NAGAIKE M, 1991, J BIOL CHEM, V266, P22781; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NAKAMURA T, 1983, J BIOL CHEM, V258, P9283; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; NALDINI L, 1991, ONCOGENE, V6, P501; OKAJIMA A, 1990, EUR J BIOCHEM, V193, P375, DOI 10.1111/j.1432-1033.1990.tb19349.x; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SEKI T, 1990, BIOCHEM BIOPH RES CO, V172, P321, DOI 10.1016/S0006-291X(05)80212-8; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; STAHLMAN MT, 1988, LAB INVEST, V59, P25; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; TAJIMA H, 1991, FEBS LETT, V291, P229, DOI 10.1016/0014-5793(91)81291-F; TAJIMA H, 1992, J BIOCHEM-TOKYO, V111, P401, DOI 10.1093/oxfordjournals.jbchem.a123769; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; VOELKER DR, 1990, LUNG CELL BIOL, P487; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; WYNNE JW, 1982, CLIN CHEST MED, V3, P25; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; ZARNEGAR R, 1989, CANCER RES, V49, P3314	48	233	236	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21212	21217						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407957				2022-12-27	WOS:A1993MA28800084
J	HUTSON, SM; HALL, TR				HUTSON, SM; HALL, TR			IDENTIFICATION OF THE MITOCHONDRIAL BRANCHED-CHAIN AMINOTRANSFERASE AS A BRANCHED-CHAIN ALPHA-KETO ACID TRANSPORT PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; HEART-MITOCHONDRIA; SKELETAL-MUSCLE; KINETIC CHARACTERIZATION; MONOCARBOXYLATE CARRIER; TRICARBOXYLATE CARRIER; PURIFICATION; RECONSTITUTION; METABOLISM; STARVATION	Conditions were developed which optimized reconstitution of branched chain alpha-keto acid transport activity, which was measured as alpha-ketoisocaproate (KIC) transport, and pyruvate transport activity. Reconstitutable KIC transport activity was about 40-fold higher in heart than in liver mitochondrial extracts and 40-fold higher than heart pyruvate transport activity but only about 7-fold higher than liver pyruvate transport activity. A purification procedure was developed for the branched chain alpha-keto acid and pyruvate transport proteins which resulted in partial purification of the proteins from rat heart mitochondria. Pyruvate transport activity appeared to be associated with a 32.5-kDa protein, whereas KIC transport activity appeared to be associated with two proteins around 41 kDa. As shown by immunoblotting and immunoaffinity chromatography, these proteins were recognized by an antiserum raised against purified rat heart mitochondrial branched chain aminotransferase (BCAT(m)). Procedures used to extract BCAT(m) from mitochondria effectively solubilized KIC transport activity, and both transaminase and transport activities in the sonicate supernatant were immunoprecipitated by BCAT(m) antiserum. The tissue distribution of reconstitutable KIC transport activity was identical with the tissue distribution of BCAT(m). On the other hand, the distribution of reconstitutable pyruvate transport activity was distinct from that of KIC transport and branched chain aminotransferase activities, and pyruvate transport activity could not be immunoprecipitated by BCAT(m) antiserum. When incorporated into phospholipid vesicles, purified BCAT(m) exhibited branched chain alpha-keto acid transport activity but did not transport pyruvate. Transport was saturable, and K(m) values for KIC and alpha-ketoisovalerate uptake were 10 and 25 muM, respectively. Substrate competition experiments indicated that KIC transport could be inhibited substantially by branched chain alpha-keto acids and their derivatives but not by substrates for the pyruvate transporter. Transport was also inhibited by several aromatic carboxylic acid derivatives and alpha-ketoglutarate, but not by N-butylmalonate and succinate. Studies with covalent protein-modifying reagents indicated that transport was inhibited by sulfhydryl reagents, the histidine reagent diethyl pyrocarbonate, and the tyrosine reagent N-acetylimidazole. When BCAT(m) was incorporated into phospholipid vesicles, pyridoxal 5-phosphate was an inhibitor of transport (75% inhibition at 10 mM) but had little effect on aminotransferase activity. The data indicate BCAT(m) is a bifunctional protein catalyzing branched chain amino acid transamination and branched chain alpha-keto acid transport. The transport properties of BCAT(m) suggest that this protein may be the branched chain alpha-keto acid transporter that was originally identified and characterized kinetically in isolated rat heart mitochondria (Hutson, S. M., and Rannels, S. L. (1985) J. Biol. Chem. 260, 14189-14193).			HUTSON, SM (corresponding author), BOWMAN GRAY SCH MED, DEPT BIOCHEM, MED CTR BLVD, WINSTON SALEM, NC 27157 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034738] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34738] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLLI R, 1989, J BIOL CHEM, V264, P18024; CAPUANO F, 1990, FEBS LETT, V261, P39, DOI 10.1016/0014-5793(90)80631-R; CLAEYS D, 1989, J BIOL CHEM, V264, P14627; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GLERUM DM, 1990, EUR J BIOCHEM, V194, P681, DOI 10.1111/j.1432-1033.1990.tb15668.x; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; HALL TR, 1993, J BIOL CHEM, V268, P3092; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; HUTSON SM, 1990, P NATL ACAD SCI USA, V87, P1028, DOI 10.1073/pnas.87.3.1028; HUTSON SM, 1992, J BIOL CHEM, V267, P15681; HUTSON SM, 1987, J BIOL CHEM, V262, P9629; HUTSON SM, 1988, J BIOL CHEM, V263, P3618; HUTSON SM, 1986, J BIOL CHEM, V261, P4420; HUTSON SM, 1978, J BIOL CHEM, V253, P8126; HUTSON SM, 1989, ANN NY ACAD SCI, V573, P230, DOI 10.1111/j.1749-6632.1989.tb15000.x; HUTSON SM, 1985, J BIOL CHEM, V260, P4189; HUTSON SM, 1988, J NUTR, V118, P1475, DOI 10.1093/jn/118.12.1475; HUTSON SM, 1980, J BIOL CHEM, V255, P2418; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KAPLAN RS, 1985, J BIOL CHEM, V260, P293; KAPLAN RS, 1990, J BIOL CHEM, V265, P13379; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANOUE KF, 1986, BIOCHEMISTRY-US, V25, P7667, DOI 10.1021/bi00371a058; NALECZ MJ, 1991, BIOCHIM BIOPHYS ACTA, V1079, P87, DOI 10.1016/0167-4838(91)90028-X; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; RIEDERER BM, 1987, J NEUROSCI, V7, P864; RUDIGER HW, 1972, BIOCHEM J, V126, P445, DOI 10.1042/bj1260445; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; WALLIN R, 1990, J BIOL CHEM, V265, P6019; WALLIN R, 1988, BIOCHEM J, V250, P557, DOI 10.1042/bj2500557; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	33	39	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3084	3091						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428987				2022-12-27	WOS:A1993KM16100014
J	HUANG, SP; TSAI, MY; TZOU, YM; WU, WG; WANG, C				HUANG, SP; TSAI, MY; TZOU, YM; WU, WG; WANG, C			ASPARTYL RESIDUE-10 IS ESSENTIAL FOR ATPASE ACTIVITY OF RAT HSC70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEIN; SHOCK COGNATE PROTEIN; HEAT-SHOCK; UNCOATING ATPASE; STRESS PROTEINS; AUTOPHOSPHORYLATION; BINDING; DNAK; PURIFICATION; HYDROLYSIS	Three mutants of rat hsc70 were constructed, over-expressed in Escherichia coli, purified, and characterized. First, site-directed mutation was utilized to substitute Asn for Asp-10. The recombinant protein, hsc70(D10N), loses not only its peptide-stimulated ATPase activity but also its basal ATPase activity. The measured dissociation constants of ATP (0.3 muM) and S-peptide (5 muM) for hsc70(D10N), however, are virtually identical to those of hsc70. The intrinsic fluorescence spectra of hsc70(D10N) also remain largely unchanged. Therefore, the overall structure of the hsc70 protein is most likely intact after mutation. Second, the entire C-terminal peptide-binding domain was deleted and the resultant mutant contains only the N-terminal ATPase domain of hsc70. This recombinant protein, Nt-hsc70, is a peptide-independent ATPase. The ATPase activity at 37-degrees-C of the Nt-hsc70, 270 pmol/h/mug of protein, is comparable to that of maximally peptide-activated hsc70. Third, the Asp-10 of Nt-hsc70 was replaced by Asn. Despite that this mutant, Nt-hsc70(D10N), is capable of binding ATP and it loses the capability to hydrolyze ATP. Taken together, these results indicate that aspartyl residue 10 of hsc70 is essential for ATP hydrolysis. Purified hsc70 and its mutants autophosphorylate in vitro at a substoichiometric level. On average, less than 1% of the hsc70 and Nt-hsc70 proteins are phosphorylated. Although the amount of phosphate incorporated into hsc70(D10N) and Nt-hsc70(D10) is reduced, a significant level of phosphorylation can still be achieved in these two site-directed mutants. Hence, autophosphorylation of hsc70 and its mutants is not correlated with their ability to hydrolyze ATP.	ACAD SINICA, INST MOL BIOL, TAIPEI 115, TAIWAN; NATL TSING HUA UNIV, INST LIFE SCI, HSINCHU 300, TAIWAN	Academia Sinica - Taiwan; National Tsing Hua University			Tzou, Yu-Min/C-6585-2008	Tzou, Yu-Min/0000-0002-3680-7303				CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; CEGIELSKA A, 1989, J BIOL CHEM, V264, P21122; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; DALIE BL, 1990, BIOCHEM BIOPH RES CO, V166, P1284, DOI 10.1016/0006-291X(90)91005-D; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LOOMIS WF, 1982, MOL CELL BIOL, V2, P484, DOI 10.1128/MCB.2.5.484; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1984, NATURE, V311, P228, DOI 10.1038/311228a0; STEITZ TA, 1976, J MOL BIOL, V104, P197, DOI 10.1016/0022-2836(76)90009-7; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; WANG C, 1986, BIOCHIM BIOPHYS ACTA, V888, P107, DOI 10.1016/0167-4889(86)90076-5; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	25	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2063	2068						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420978				2022-12-27	WOS:A1993KH62000085
J	LIU, XB; DAVIS, D; SEGALOFF, DL				LIU, XB; DAVIS, D; SEGALOFF, DL			DISRUPTION OF POTENTIAL SITES FOR N-LINKED GLYCOSYLATION DOES NOT IMPAIR HORMONE BINDING TO THE LUTROPIN CHORIOGONADOTROPIN RECEPTOR IF ASN-173 IS LEFT INTACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-ADRENERGIC-RECEPTOR; CHORIONIC-GONADOTROPIN; DIRECTED MUTAGENESIS; OVERLAP EXTENSION; STRUCTURAL BASIS; CG RECEPTOR; OLIGOSACCHARIDES; CELLS; EXPRESSION; SEQUENCE	The rat lutropin/choriogonadotropin receptor (rLHR) is a G protein-coupled receptor, the large extracellular domain of which binds human choriogonadotropin (hCG) with high affinity. Within the extracellular domain are six potential sites for N-linked glycosylation. Although several studies have attempted to determine if N-linked carbohydrates are necessary for hormone binding, the results have been in apparent disagreement. In this study we have used site-directed mutagenesis to singly and collectively alter the consensus sequences for N-linked glycosylation in the rLHR. In particular, we examined the binding activity in both intact cells as well as detergent-solubilized extracts so that the effects on trafficking to the plasma membrane could be determined. In addition, we independently examined the effects of substituting a particular Asn versus Thr or Ser residue within a given glycosylation consensus sequence. Our data suggest that substitution of Asn-173 with Gln results in both a decreased ability of the receptor to be expressed on the plasma membrane as well as a vastly decreased binding affinity of the receptor for hCG. However, if the consensus sequence for N-linked glycosylation at Asn-173 is altered by substitution of Thr-175 with Ala (instead of Asn-173 to Gln), the resulting receptor binds hCG with high affinity although it is still impaired in its ability to be expressed at the plasma membrane. Furthermore, if all consensus sequences for N-linked glycosylation are mutated collectively while maintaining Asn-173 (by substituting Thr-175 with Ala instead of Asn-173 to Gln), the resulting deglycosylated receptor, although not expressed on the plasma membrane, binds hCG with high affinity. These results resolve the apparent discrepancies in the literature on the role of N-linked carbohydrates of the rLHR on the binding of hormone by showing that they are not required for high affinity binding but that Asn-173 is involved, either directly or indirectly in the high affinity binding of hormone.	UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Iowa					NICHD NIH HHS [HD-22196, HD-00968] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD022196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000968, R01HD022196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; ASCOLI M, 1983, ENDOCRINOLOGY, V113, P2129, DOI 10.1210/endo-113-6-2129; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; FRAZIER AL, 1990, MOL ENDOCRINOL, V4, P1264, DOI 10.1210/mend-4-8-1264; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTIN G, 1980, J BIOL CHEM, V255, P8007; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JI IH, 1990, ENDOCRINOLOGY, V127, P494, DOI 10.1210/endo-127-1-494; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LEONG SR, 1992, MOL ENDOCRINOL, V6, P870, DOI 10.1210/me.6.6.870; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MINEGISHI T, 1989, P NATL ACAD SCI USA, V86, P1470, DOI 10.1073/pnas.86.5.1470; MOYLE WR, 1991, J BIOL CHEM, V266, P10807; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PETAJAREPO UE, 1991, ENDOCRINOLOGY, V128, P1209, DOI 10.1210/endo-128-3-1209; ROCHE PC, 1985, ENDOCRINOLOGY, V117, P790, DOI 10.1210/endo-117-2-790; ROSEMBLIT N, 1988, ENDOCRINOLOGY, V123, P2284, DOI 10.1210/endo-123-5-2284; RUSSO D, 1991, MOL ENDOCRINOL, V5, P29, DOI 10.1210/mend-5-1-29; SEGALOFF DL, 1993, IN PRESS ENDOCRINE R; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; TSAIMORRIS CH, 1990, J BIOL CHEM, V265, P19385; WONG SKF, 1988, J BIOL CHEM, V263, P7925; XIE YB, 1990, J BIOL CHEM, V265, P21411; ZHANG R, 1991, BIOCHEM BIOPH RES CO, V181, P804, DOI 10.1016/0006-291X(91)91261-A	30	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1513	1516						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420926				2022-12-27	WOS:A1993KH62000004
J	ERICSSON, J; RUNQUIST, M; THELIN, A; ANDERSSON, M; CHOJNACKI, T; DALLNER, G				ERICSSON, J; RUNQUIST, M; THELIN, A; ANDERSSON, M; CHOJNACKI, T; DALLNER, G			DISTRIBUTION OF PRENYLTRANSFERASES IN RAT-TISSUES - EVIDENCE FOR A CYTOSOLIC ALL-TRANS-GERANYLGERANYL DIPHOSPHATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA SUBUNITS CONTAIN; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; POSTTRANSLATIONAL MODIFICATION; PYROPHOSPHATE SYNTHETASE; DOLICHOL SYNTHESIS; MEVALONIC ACID; METHYL-ESTER; LAMIN-B	The present study describes the presence of two different geranylgeranyl diphosphate (GGPP) synthase activities, one cytosolic and one membrane-associated, in a number of rat tissues. Both enzymes utilize farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP) as substrates, but they give rise to different products. The membrane-associated activity produces trans,trans,cis-(E,E,Z)-GGPP, involved in the biosynthesis of long-chain polyprenols. The cytosolic activity produces only the all-trans-(E,E,E) isomer of GGPP, which is utilized as substrate in cytosolic protein prenylation reactions. All-trans-GGPP synthase activity was recovered in the cytosolic fraction from all tissues investigated, but the specific activities varied. The highest specific activities were found in brain, spleen, and testis, followed by kidney and liver. The enzyme activity in rat brain cytosol was further characterized and found to exhibit a narrow pH optimum around 5.0-6.0 and to be highly stimulated by Zn2+. Maximal stimulation was attained with 1 mM Zn2+, whereas Mg2+ had no effect on the enzyme activity. The all-trans-GGPP synthase activity exhibited high affinities for its substrates, i.e. the apparent K(m) values for FPP and IPP were found to be 0.6 and 3.5 muM, respectively. When rats were fed mevinolin (lovastatin), FPP and all-trans-GGPP synthase activities were affected differently in certain tissues. Mevinolin treatment resulted in an increase in FPP but a decrease in all-trans-GGPP synthase activity in rat liver and kidney. In spleen mevinolin treatment caused a greater than 70% decrease in all-trans-GGPP synthase activity, while FPP synthase was almost unaffected. The presence of two different GGPP synthase activities in the cell, together with the fact that FPP and all-trans-GGPP synthesis in the cytosol are regulated independently, may be of significance in the regulation of isoprenoid biosynthesis, as well as of protein isoprenylation.	KAROLINSKA INST,HUDDINGE HOSP,CLIN RES CTR,S-14186 HUDDINGE,SWEDEN; POLISH ACAD SCI,INST BIOCHEM & BIOPHYS,PL-02532 WARSAW,POLAND	Karolinska Institutet; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	ERICSSON, J (corresponding author), UNIV STOCKHOLM,ARRHENIUS LABS NAT SCI,DEPT BIOCHEM,S-10691 STOCKHOLM,SWEDEN.		Runquist, Marten/AAF-7613-2019; Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574				ASHBY MN, 1989, J BIOL CHEM, V264, P635; BABA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P440, DOI 10.1016/0003-9861(87)90050-6; BECK LA, 1988, J CELL BIOL, V107, P1307, DOI 10.1083/jcb.107.4.1307; BILLER SA, 1988, J MED CHEM, V31, P1869, DOI 10.1021/jm00118a001; BROWN MS, 1980, J LIPID RES, V21, P505; BUSS JE, 1991, MOL CELL BIOL, V11, P1523, DOI 10.1128/MCB.11.3.1523; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHEN Z, 1988, ARCH BIOCHEM BIOPHYS, V266, P98, DOI 10.1016/0003-9861(88)90240-8; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; CHOJNACKI T, 1984, ACTA BIOCHIM POL, V31, P115; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; ERCISSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1992, J BIOL CHEM, V267, P18708; ERICSSON J, 1991, EUR J BIOCHEM, V209, P789; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2; GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HEMMING FW, 1981, BIOCH ISOPRENOID COM, V2, P305; HOLLOWAY PW, 1967, BIOCHEM J, V104, P57, DOI 10.1042/bj1040057; JAMES MJ, 1980, J BIOL CHEM, V255, P8618; JAMES MJ, 1980, J BIOL CHEM, V255, P16; JOLY A, 1991, J BIOL CHEM, V266, P13495; JOLY A, 1991, CURR OPIN LIPIDOL, V2, P283; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; KELLER GA, 1986, J CELL BIOL, V103, P875, DOI 10.1083/jcb.103.3.875; KELLER GA, 1985, P NATL ACAD SCI USA, V82, P770, DOI 10.1073/pnas.82.3.770; KELLER RK, 1986, J BIOL CHEM, V261, P2053; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; LEONARD S, 1990, J BIOL CHEM, V265, P5157; LUTZ RJ, 1992, J BIOL CHEM, V267, P7983; LWORY OH, 1951, J BIOL CHEM, V193, P265; MALTESE WA, 1990, FASEB J, V4, P3319, DOI 10.1096/fasebj.4.15.2123808; MANNE V, 1990, P NATL ACAD SCI USA, V87, P7541, DOI 10.1073/pnas.87.19.7541; MITROPOULOS KA, 1978, EUR J BIOCHEM, V82, P419, DOI 10.1111/j.1432-1033.1978.tb12036.x; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; POTTER JER, 1981, J BIOL CHEM, V256, P2371; REISS Y, 1992, J BIOL CHEM, V267, P6403; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; REPKO EM, 1989, J BIOL CHEM, V264, P9945; RILLING HC, 1990, SCIENCE, V247, P318, DOI 10.1126/science.2296720; RUNQUIST M, 1992, BIOCHEM BIOPH RES CO, V186, P157, DOI 10.1016/S0006-291X(05)80788-0; SAGAMI H, 1991, J BIOL CHEM, V266, P3458; SAGAMI H, 1981, BIOCHEM INT, V3, P669; SCHABERMD, 1990, J BIOL CHEM, V265, P14701; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SINENSKY M, 1992, BIOESSAYS, V14, P25, DOI 10.1002/bies.950140106; SINENSKY M, 1990, J BIOL CHEM, V265, P19937; WOLDA SL, 1988, J BIOL CHEM, V263, P5997; WONG TK, 1982, J BIOL CHEM, V257, P6619; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; YAMANE HK, 1991, P NATL ACAD SCI USA, V88, P286, DOI 10.1073/pnas.88.1.286; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302	59	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					832	838						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419360				2022-12-27	WOS:A1993KG07700015
J	LEI, MG; MORRISON, DC				LEI, MG; MORRISON, DC			LIPOPOLYSACCHARIDE INTERACTION WITH S2 SUBUNIT OF PERTUSSIS TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; MURINE SPLENOCYTES; ALPHA-LACTALBUMIN; LYSOZYME; SEQUENCE; ORGANIZATION; ASSOCIATION; ENDOTOXIN; RECEPTOR; CELLS	Using radioiodinated, photoactivable, reducible cross-linker conjugated bacterial endotoxic lipopolysaccharide (I-125-ASD-LPS), we have demonstrated that LPS selectively binds to the S2 subunit of pertussis toxin (PT). Since LPS also interacts with the S2 subunit of the B-oligomer of the toxin, the binding of LPS to PT is not A-protomer (S1 subunit) dependent. The binding can be inhibited with native underivatized LPS and with purified lipid A, suggesting that the binding is mediated through the lipid A moiety of the LPS molecule. The binding of PT to LPS can be inhibited by bovine fetuin glycoprotein. Since PT has been demonstrated to interact specifically with N-linked oligosaccharide side chains of fetuin, the interaction of LPS with the S2 subunit of PT may involve carbohydrate-dependent interactions of the disaccharide back-bone of lipid A with S2. Additional studies have documented that LPS binding to PT may be competitively inhibited by lysozyme but not by polymyxin B. Sequence analysis has allowed identification of a high degree of amino acid sequence similarity between the S2 subunit of PT and hen egg white lysozyme at the N-terminal 80-residue regions. Shared N-terminal sequence similarity between lysozyme, PT-S2, and a third LPS-binding protein alpha-lactalbumin allows tentative identification of a second family of LPS binding proteins.	UNIV KANSAS, MED CTR, CTR CANC, KANSAS CITY, KS 66103 USA	University of Kansas; University of Kansas Medical Center	LEI, MG (corresponding author), UNIV KANSAS, MED CTR, DEPT MICROBIOL MOLEC GENET & IMMUNOL, KANSAS CITY, KS 66160 USA.				NATIONAL CANCER INSTITUTE [P01CA054474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023447] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA54474] Funding Source: Medline; NIAID NIH HHS [R37-AI-23447] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ARMSTRONG GD, 1988, J BIOL CHEM, V263, P8677; BREW K, 1970, J BIOL CHEM, V245, P4570; CHEN TY, 1992, MACROPHAGE MACROPHAG, P169; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; HALL L, 1987, BIOCHEM J, V242, P735, DOI 10.1042/bj2420735; HALLING JL, 1992, INFECT IMMUN, V60, P845, DOI 10.1128/IAI.60.3.845-852.1992; JUNG A, 1980, P NATL ACAD SCI-BIOL, V77, P5759, DOI 10.1073/pnas.77.10.5759; KUMBLA L, 1989, FASEB J, V3, P2075, DOI 10.1096/fasebj.3.9.2472993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRICK JW, 1991, BIOCHEM BIOPH RES CO, V179, P170, DOI 10.1016/0006-291X(91)91350-L; LEI MG, 1988, J IMMUNOL, V141, P996; LEI MG, 1988, J IMMUNOL, V141, P1006; LEI MG, 1991, J IMMUNOL, V147, P1925; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; MARRA MN, 1992, J IMMUNOL, V148, P532; MORRISON DC, 1975, J BIOL CHEM, V250, P2911; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; MORRISON DC, 1990, INT CONGR SER, V923, P183; MORRISON DC, 1991, NATURAL TOXINS CHEM, P301; MUNOZ JJ, 1988, PATHOGENESIS IMMUNIT, P173; OHNO N, 1989, EUR J BIOCHEM, V186, P629, DOI 10.1111/j.1432-1033.1989.tb15253.x; OHNO N, 1989, EUR J BIOCHEM, V186, P621, DOI 10.1111/j.1432-1033.1989.tb15252.x; OHNO N, 1989, J BIOL CHEM, V264, P4434; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; ROEDER DJ, 1989, INFECT IMMUN, V57, P1054, DOI 10.1128/IAI.57.4.1054-1058.1989; SUBBIAH MT, 1991, P SOC EXP BIOL MED, V98, P495; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Ui M, 1988, PATHOGENESIS IMMUNIT, P121; WESTPHAL O, 1954, ANGEW CHEM-GER EDIT, V66, P407, DOI 10.1002/ange.19540661312; WITVLIET MH, 1989, INFECT IMMUN, V57, P3324, DOI 10.1128/IAI.57.11.3324-3330.1989; WOLLENWEBER HW, 1985, J BIOL CHEM, V260, P5068; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	35	11	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1488	1493						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419348				2022-12-27	WOS:A1993KG07700107
J	CAPPEL, RE; GILBERT, HF				CAPPEL, RE; GILBERT, HF			OXIDATIVE INACTIVATION OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE AND SUBUNIT CROSS-LINKING INVOLVE DIFFERENT DITHIOL DISULFIDE CENTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; RAT-LIVER; GLUTATHIONE; EXCHANGE; ENZYME	Rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR) is extremely sensitive to oxidative inactivation by low concentrations (micromolar) of glutathione disulfide (GSSG) even in the presence of millimolar concentrations of glutathione (GSH). Inactivation involves the formation of an intramolecular protein-SS-protein disulfide in thiol/disulfide redox equilibrium with the reduced, active enzyme (Cappel, R. E., and Gilbert, H. F. (1988) J. Biol. Chem. 263, 12204-12212). In the absence of dithiothreitol, HMGR oxidation has been previously shown to cross-link the microsomal enzyme into a covalent dimer (Ness, G. C., McCreery, M. J., Sample, C. E., Smith, M., and Pendelton, L. C. (1985) J. Biol. Chem. 260, 12391-12393). Examination of the extent of HMGR cross-linking and residual HMGR activity in microsomes equilibrated with glutathione redox buffers establishes that inactivation and cross-linking result from oxidation of different dithiol pairs. The thiol/disulfide oxidation potential (K(ox)) for the oxidative inactivation of HMGR, E(SH)2,active + GSSG reversible E(S-S)inactive + 2 GSH, is 0.67 +/- 0.07 M. However, the equilibrium constant for HMGR cross-linking, E(SH)2,monomer + GSSG reversible E(S-S)dimer + 2 GSH, is 0.19 +/- 0.02 M, significantly lower than that for inactivation (p < 0.001). Because of the significantly different oxidation potentials and the lack of a linear relationship between cross-linking and inactivation, the two processes must involve two different sets of vicinal dithiols. HMGR becomes 5-10-fold more difficult to oxidize in the presence of saturating levels of the substrate, HMG-CoA. Both inactivation and cross-linking exhibit significantly lower oxidation potentials in the presence of this substrate, 0.072 +/- 0.01 and 0.047 +/- 0.007 M, respectively. The decrease in oxidation potential caused by substrate binding is observed for both inactivation and cross-linking, showing that both processes are affected by the binding of substrate to the enzyme. The dithiols involved in HMGR subunit cross-linking are 2-3-fold more difficult to oxidize than the dithiols that affect the enzyme activity. Thus, the observation of partial cross-linking of HMGR in vivo would imply that conditions are sufficiently oxidizing to result in significant enzyme inactivation. The extreme thermodynamic sensitivity of HMGR to oxidative inactivation and cross-linking in glutathione redox buffers that span the physiological redox state implies that thiol/disulfide redox state changes could provide a mechanism for regulating the activity and/or stability of this enzyme.			CAPPEL, RE (corresponding author), BAYLOR COLL MED, VERNA & MARRS MCLEAN DEPT BIOCHEM, HOUSTON, TX 77030 USA.				NHLBI NIH HHS [HL-28521] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028521] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALPERT AJ, 1985, ANAL BIOCHEM, V144, P553, DOI 10.1016/0003-2697(85)90153-8; Bevington P. R, 1969, DATA REDUCTION ERROR; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V57, P209; CAPPEL RE, 1990, J BIOL CHEM, V265, P15464; CAPPEL RE, 1989, J BIOL CHEM, V264, P9180; CAPPEL RE, 1988, J BIOL CHEM, V263, P12204; DOTAN I, 1987, J BIOL CHEM, V262, P17058; EDWARDS PA, 1985, J BIOL CHEM, V260, P278; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GILBERT HF, 1981, J BIOL CHEM, V256, P1782; GILBERT HF, 1982, J BIOL CHEM, V257, P2086; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GUZMANBARRON ES, 1951, ADV ENZYMOL, V11, P201; JORDANSTARCK TC, 1989, J BIOL CHEM, V264, P17919; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; NESS GC, 1985, J BIOL CHEM, V260, P2391; NESS GC, 1986, BIOCHEM J, V233, P167, DOI 10.1042/bj2330167; NESS GC, 1985, J BIOL CHEM, V260, P6395; PARKER RA, 1989, J BIOL CHEM, V264, P4877; SIES H, 1983, FUNCTIONS GLUTATHION, P231; SIES H, 1983, ADV ENZYME REGUL, V26, P175; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; VERMILION JL, 1990, J BIOL CHEM, V265, P9984; WALTERS DW, 1986, J BIOL CHEM, V261, P3135; ZAR JH, 1984, BIOSTAT ANAL, P126; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	30	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					342	348						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416941				2022-12-27	WOS:A1993KE60300053
J	CHOU, DKH; JUNGALWALA, FB				CHOU, DKH; JUNGALWALA, FB			CHARACTERIZATION AND DEVELOPMENTAL EXPRESSION OF A NOVEL SULFOTRANSFERASE FOR THE BIOSYNTHESIS OF SULFOGLUCURONYL GLYCOLIPIDS IN THE NERVOUS-SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATED GLUCURONIC-ACID; RAT-BRAIN; HNK-1 ANTIBODY; CEREBROSIDE SULFOTRANSFERASE; HNK-1-REACTIVE ANTIGENS; NEUROPATHY; IGM; GLUCURONYLTRANSFERASE; LOCALIZATION; ENZYME	Sulfoglucuronly glycolipids (SGGLs) are temporally and spatially regulated molecules in the developing nervous system. A novel sulfotransferase (ST) from rat brain which catalyzes the terminal step in the biosynthesis in vitro of SGGLs is described. The enzyme catalyzes a transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to a hydroxyl group on carbon 3 of the terminal glucuronyl residue in IV3beta-glucuronyl neolactotetraosylceramide (GlcAnLcOse4Cer) and VI3beta-glucuronyl neolactohexaosylceramide (GlcAnLcOse6Cer) to form 3-sulfated glucuronyl glycolipids. The enzyme is highly specific for glucuronylglycolipids (GGLs) and requires the free-COOH group of the terminal glucuronic acid for reactivity. GGL:ST present in the microsomal membranes requires Mn2+ ions and a nonionic detergent, Triton X-100 for activity. The optimal pH is 7.2 with Tris-HCl buffer and K(m) values were 7 muM for 3'-phosphoadenosine 5'-phosphosulfate and 29 muM for GlcAnLcOse4Cer. GGL:ST was shown to be different from previously well studied galactocerebroside:sulfotransferase for the synthesis of myelin membrane-specific lipid sulfatide. This conclusion was based upon several criteria, i.e. including different requirements of incubation conditions for maximal activity, substrate competition experiments, different effects of heat, dithiothreitol, NaCl, and pyridoxal phosphate, as well as different profiles of expression of activity during development of the nervous tissues. The two enzymes were also partially resolved on a pyridoxal phosphate-ligated agarose column. Studies on the developmental expression of the GGL:ST in the rat cerebral cortex and cerebellum showed that it is not a regulatory enzyme controlling the expression of SGGLs in these neural tissues.	HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02214	Harvard University; Harvard Medical School	CHOU, DKH (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,DEPT BIOCHEM,WALTHAM,MA 02254, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024405] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD05505] Funding Source: Medline; NINDS NIH HHS [R01-NS24405] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABO T, 1982, J IMMUNOL, V129, P1752; ANDO S, 1977, J BIOL CHEM, V252, P6247; ARIGA T, 1987, J BIOL CHEM, V262, P848; BENJAMINS JA, 1982, J NEUROCHEM, V38, P233, DOI 10.1111/j.1471-4159.1982.tb10875.x; BONNERFRASER M, 1987, DEV BIOL, V123, P321; CHOU DKH, 1987, J NEUROCHEM, V49, P865, DOI 10.1111/j.1471-4159.1987.tb00974.x; CHOU DKH, 1991, J BIOL CHEM, V266, P17941; CHOU DKH, 1990, J NEUROCHEM, V54, P1589, DOI 10.1111/j.1471-4159.1990.tb01209.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; CHOU DKH, 1991, J NEUROCHEM, V57, P852, DOI 10.1111/j.1471-4159.1991.tb08229.x; CHOU DKH, 1990, T AM SOC NEUROCHEM, V21, P120; CHOU KH, 1985, BIOCHEM BIOPH RES CO, V128, P383, DOI 10.1016/0006-291X(85)91690-0; CHURCHICH JE, 1984, EUR J BIOCHEM, V138, P327, DOI 10.1111/j.1432-1033.1984.tb07918.x; DAS KK, 1991, J BIOL CHEM, V266, P5238; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FIGLEWICZ DA, 1985, J LIPID RES, V26, P140; ILYAS AA, 1990, J NEUROCHEM, V55, P594, DOI 10.1111/j.1471-4159.1990.tb04175.x; JUNGALWALA FB, 1992, J NEUROCHEM, V53, P1045; KOHRIYAMA T, 1988, J NEUROCHEM, V51, P869, DOI 10.1111/j.1471-4159.1988.tb01823.x; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; MARGOLIS RK, 1987, BIOCHEM BIOPH RES CO, V145, P1142, DOI 10.1016/0006-291X(87)91556-7; NAIR SM, 1992, T AM SOC NEUROCHEM, V23, P137; PESHEVA P, 1988, J NEUROSCI RES, V20, P420, DOI 10.1002/jnr.490200404; PRASADARAO N, 1990, J NEUROCHEM, V55, P2024, DOI 10.1111/j.1471-4159.1990.tb05791.x; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; SHASHOUA VE, 1986, BIOCHEM BIOPH RES CO, V138, P902, DOI 10.1016/S0006-291X(86)80581-2; SIEGRIST HP, 1977, BIOCHIM BIOPHYS ACTA, V489, P58, DOI 10.1016/0005-2760(77)90231-4; SUNDARAM KS, 1990, BIOCHEM BIOPH RES CO, V169, P927, DOI 10.1016/0006-291X(90)91982-X; TENNEKOON G, 1978, J NEUROCHEM, V31, P329, DOI 10.1111/j.1471-4159.1978.tb12466.x; TENNEKOON G, 1983, J CELL BIOL, V97, P1107, DOI 10.1083/jcb.97.4.1107; VANDERPAL RHM, 1990, BIOCHIM BIOPHYS ACTA, V1043, P91, DOI 10.1016/0005-2760(90)90114-D	32	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					330	336						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416940				2022-12-27	WOS:A1993KE60300051
J	BOUDKER, O; FUTERMAN, AH				BOUDKER, O; FUTERMAN, AH			DETECTION AND CHARACTERIZATION OF CERAMIDE-1-PHOSPHATE PHOSPHATASE-ACTIVITY IN RAT-LIVER PLASMA-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA HL-60 CELLS; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; SPHINGOMYELIN TURNOVER; CULTURED FIBROBLASTS; CERAMIDE KINASE; GOLGI-APPARATUS; PHOSPHOLIPASE-D; ANIMAL-CELLS; SPHINGOSINE	A calcium-dependent ceramide (Cer) kinase was recently detected in human leukemia (HL-60) cells (Kolesnick, R. N., and Hemer, M. R. (1990) J. Biol. Chem. 265, 18803-18808) where it may function in terminating the regulatory effects of Cer, and in synaptic vesicles (Bajjalieh, S. M., Martin, T. F. J., and Floor, E. (1989) J. Biol. Chem. 264,14354-14360). We now demonstrate that the addition of both Cer-1-phosphate (Cer-1-P) and a short-acyl chain analog of Cer-1-P, N-hexanoylsphingosine-1-phosphate (C6-Cer-1-P) to cultured cells and a variety of subcellular fractions results in rapid degradation to Cer and C6-Cer, respectively. The Cer-1-P phosphatase activity is enriched in a rat liver plasma membrane fraction and appears to be distinct from the phosphatase that hydrolyzes phosphatidic acid (PA), PA phosphohydrolase, as shown by the difference in sensitivity of Cer-1-P and PA hydrolysis to propranolol, detergent, and heat treatment. Moreover, the K(m) of Cer-1-P hydrolysis is 10-fold lower than the K(m) of PA hydrolysis in plasma membrane. PA is a noncompetitive inhibitor of Cer-1-P hydrolysis, with an inhibition constant 1-1.5-fold higher than the K(m) of Cer-1-P hydrolysis. In contrast, Cer-1-P does not inhibit PA hydrolysis. Finally, we describe the synthesis of a novel analog of Cer-1-P which is not hydrolyzed in vitro and in vivo and is internalized in cultured cells by endocytosis. These results are discussed in relation to the possible roles of Cer-1-P in regulating intracellular levels of Cer.	WEIZMANN INST SCI, DEPT MEMBRANE RES & BIOPHYS, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science				Futerman, Anthony/0000-0003-0013-0115				BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; BARKER R, 1971, ORGANIC CHEM BIOL CO, P214; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DESAI NN, 1992, J BIOL CHEM, V267, P23122; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; EXTON JH, 1990, J BIOL CHEM, V265, P1; FUTERMAN AH, 1992, METHOD ENZYMOL, V209, P437; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; IWAMORI M, 1975, BIOCHIM BIOPHYS ACTA, V380, P308; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; KANOH H, 1992, J BIOL CHEM, V267, P25309; KIM MY, 1991, J BIOL CHEM, V266, P484; KISHIMOTO Y, 1974, ARCH BIOCHEM BIOPHYS, V161, P426, DOI 10.1016/0003-9861(74)90324-5; Kolesnick Richard, 1992, Trends in Cell Biology, V2, P232, DOI 10.1016/0962-8924(92)90310-J; KOLESNICK RN, 1990, J BIOL CHEM, V265, P18803; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; KOLESNICK RN, 1987, J BIOL CHEM, V262, P16759; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; LAVIE Y, 1990, FEBS LETT, V277, P7, DOI 10.1016/0014-5793(90)80796-L; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; PAGANO RE, 1989, METHOD CELL BIOL, V29, P75; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHNEIDER EG, 1973, J BIOL CHEM, V248, P3739; SCHWARZMANN G, 1987, METHOD ENZYMOL, V138, P319; YOUNES A, 1992, J BIOL CHEM, V267, P842	43	67	74	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22150	22155						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408075				2022-12-27	WOS:A1993MC80900105
J	RAMSDEN, R; SOMMER, KM; OMIECINSKI, CJ				RAMSDEN, R; SOMMER, KM; OMIECINSKI, CJ			PHENOBARBITAL INDUCTION AND TISSUE-SPECIFIC EXPRESSION OF THE RAT CYP2B2 GENE IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE CYTOCHROME-P-450; BACILLUS-MEGATERIUM; TRANSCRIPTIONAL REGULATION; MESSENGER-RNAS; LIVER; SEQUENCE; PROTEIN; BINDING	To investigate molecular events regulating the transcription of genes inducible by phenobarbital, transgenic mouse strains were developed incorporating rat cytochrome P450 2B2 (CYP2B2) genes. Expression in mouse tissues was analyzed for two series of rat CYP2B2 gene constructs, of 19 and-39 kilobase pairs total length, each containing the entire coding region, introns, and 3'-flanking sequences of CYP2B2, but differing in the respective lengths of 5'-flanking sequence. One group of mice, whose transgene included the complete 2B2 gene but only 800 base pairs of 5'-proximal sequence, were not phenobarbital-inducible in mouse liver or in any extrahepatic tissue; rather, these genes were expressed at very high levels constitutively and selectively in only kidney and liver. A second group of mice with an identical transgene, except for the presence of an additional 19 kilobase pairs of 5'-flanking sequence, expressed 2B2 only in the liver and at high levels only after phenobarbital treatment, analogous to the expression pattern observed for the endogenous CYP2B2 gene in the rat. These results demonstrate that, in vivo, phenobarbital induction and tissue-specific control requires interaction of regulatory elements far upstream of the core CYP2B2 promoter region and upstream of motifs indicated previously as determinants of phenobarbital responsiveness.	UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT ENVIRONM HLTH,SC-34,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NIGMS NIH HHS [GM32281] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032281] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEHRINGER RR, 1987, P NATL ACAD SCI USA, V84, P7056, DOI 10.1073/pnas.84.20.7056; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BRUNEL F, 1988, J BIOL CHEM, V263, P10180; BURGER HJ, 1990, ARCH BIOCHEM BIOPHYS, V281, P204, DOI 10.1016/0003-9861(90)90433-Y; FUJIIKURIYAMA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2793, DOI 10.1073/pnas.79.9.2793; GIACHELLI CM, 1989, J BIOL CHEM, V264, P7046; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; HAHN CN, 1991, J BIOL CHEM, V266, P17031; HARDWICK JP, 1983, J BIOL CHEM, V258, P8081; HAYASHI Y, 1992, J BIOL CHEM, V267, P14580; HE JS, 1991, J BIOL CHEM, V266, P7864; JAISWAL AK, 1990, NUCLEIC ACIDS RES, V18, P4237, DOI 10.1093/nar/18.14.4237; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; OMIECINSKI CJ, 1992, MOL PHARMACOL, V42, P249; OMIECINSKI CJ, 1986, NUCLEIC ACIDS RES, V14, P1525, DOI 10.1093/nar/14.3.1525; OMIECINSKI CJ, 1985, J BIOL CHEM, V260, P3247; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; RANGARAJAN PN, 1989, P NATL ACAD SCI USA, V86, P3963, DOI 10.1073/pnas.86.11.3963; SHAW GC, 1992, J BIOL CHEM, V267, P5515; SIDHU JS, 1993, ARCH BIOCHEM BIOPHYS, V301, P103, DOI 10.1006/abbi.1993.1121; SUWA Y, 1985, J BIOL CHEM, V260, P7980; WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577; WEN LP, 1989, J BIOL CHEM, V264, P10996; WEN LP, 1987, J BIOL CHEM, V262, P6676	24	90	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21722	21726						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408026				2022-12-27	WOS:A1993MC80900047
J	SHELLY, LL; LEI, KJ; PAN, CJ; SAKATA, SF; RUPPERT, S; SCHUTZ, G; CHOU, JY				SHELLY, LL; LEI, KJ; PAN, CJ; SAKATA, SF; RUPPERT, S; SCHUTZ, G; CHOU, JY			ISOLATION OF THE GENE FOR MURINE GLUCOSE-6-PHOSPHATASE, THE ENZYME-DEFICIENT IN GLYCOGEN-STORAGE-DISEASE TYPE-1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HEPATIC-MICROSOMAL GLUCOSE-6-PHOSPHATASE; MULTIFUNCTIONAL GLUCOSE-6-PHOSPHATASE; SYSTEM; LIVER; IDENTIFICATION; PROTEINS	Glycogen storage disease (GSD) type 1a (von Gierke disease) is caused by a deficiency in glucose-6-phosphatase, the key enzyme in glucose homeostasis catalyzing the terminal step in gluconeogenesis and glycogenolysis. Despite its clinical importance, this membrane-bound enzyme has eluded molecular characterization. Here we report the cloning and characterization of a murine glucose-6-phosphatase cDNA by screening a mouse liver cDNA library differentially with mRNA populations representing the normal and the albino deletion mouse known to express markedly reduced glucose-6-phosphatase activity. Additionally, we identified the gene that consists of 5 exons. Biochemical analyses indicate that the in vitro expressed enzyme is indistinguishable from mouse liver microsomal glucose-6-phosphatase exhibiting essentially identical kinetic constants, latency, thermal lability, and vanadate sensitivity. The characterization of the murine glucose-6-phosphatase gene opens the way for studying the molecular basis of GSD type 1a in humans and its etiology in an animal model.	NICHHD, HUMAN GENET BRANCH, BLDG 10, RM 95242, BETHESDA, MD 20892 USA; GERMAN CANC RES CTR, INST CELL & TUMOR BIOL, W-6900 HEIDELBERG, GERMANY	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Helmholtz Association; German Cancer Research Center (DKFZ)								ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1972, J BIOL CHEM, V247, P2558; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BEAUDET AL, 1991, HARRISONS PRINCIPLES, P1854; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUNTAWAY JL, 1988, J BIOL CHEM, V263, P2673; GLUECKSOHNWAELSCH S, 1979, CELL, V16, P225, DOI 10.1016/0092-8674(79)90001-1; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HERS H. G., 1964, ADVAN METAB DISORDERS, V1, P1; Hers HG, 1989, METABOLIC BASIS INHE, P425; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JORGENSON RA, 1980, J BIOL CHEM, V255, P5907; KRAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGE AJ, 1986, J BIOL CHEM, V261, P101; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZE HU, 1986, J BIOL CHEM, V261, P6571; SINGH J, 1981, BIOCHIM BIOPHYS ACTA, V678, P477, DOI 10.1016/0304-4165(81)90129-X; SPETH M, 1992, EUR J BIOCHEM, V208, P643, DOI 10.1111/j.1432-1033.1992.tb17230.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	29	137	142	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21482	21485						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407995				2022-12-27	WOS:A1993MC80900008
J	LEWENDON, A; SHAW, WV				LEWENDON, A; SHAW, WV			TRANSITION-STATE STABILIZATION BY CHLORAMPHENICOL ACETYLTRANSFERASE - ROLE OF A WATER MOLECULE BOUND TO THREONINE-174	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; X-RAY; MUTAGENESIS; RESOLUTION; MECHANISM; BINDING	The structure of the type III variant of chloramphenicol acetyltransferase reveals that Thr-174, a conserved residue, is hydrogen-bonded to a bound water molecule (water 252). Modeling studies (P. C. E. Moody and A. G. W. Leslie, unpublished data) suggested that water 252 could play a part in transition state stabilization via a hydrogen bond to the oxyanion of the putative tetrahedral intermediate. In addition, water 252 is one of three bound water molecules hydrogen-bonded to the 1-hydroxyl group of chloramphenicol in the chloramphenicol acetyltransferase-chloramphenicol binary complex. A combination of site-directed mutagenesis and the use of an alternative substrate has allowed the quantitation of the energetic contribution of each of the interactions made by water 252 to catalysis. Thr-174 was replaced by alanine, valine, and isoleucine, each substitution removing the hydroxyl group hydrogen-bonded to water 252. Steady-state kinetic analysis of the mutant enzymes was carried out using both chloramphenicol and 1-deoxy-chloramphenicol as acetyl acceptors. The substitutions at Thr-174 result in a fall in k(cat) and in decreased affinities for each acetyl acceptor in the binary complexes and also in the ternary complexes with acetyl-CoA. From the calculated free energies in the transition state, the hydrogen bond between water 252 and the oxyanion of the tetrahedral intermediate can be estimated to contribute 0.9 kcal mol-1 toward transition state stabilization, whereas the free energy of the hydrogen bonds between the 1-hydroxyl of chloramphenicol and three bound water molecules provides 1.6 kcal mol-1.	UNIV LEICESTER,DEPT BIOCHEM,UNIV RD,LEICESTER LE1 7RH,ENGLAND	University of Leicester					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; ELLIS J, 1991, BIOCHEMISTRY-US, V30, P10806, DOI 10.1021/bi00108a029; FINERMOORE JS, 1992, PROTEINS, V12, P203, DOI 10.1002/prot.340120302; HARDING SE, 1987, BIOCHEM SOC T, V15, P513; KLEANTHOUS C, 1985, BIOCHEMISTRY-US, V24, P5307, DOI 10.1021/bi00341a006; KLEANTHOUS C, 1984, BIOCHEM J, V223, P211, DOI 10.1042/bj2230211; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; LESLIE AGW, 1986, J MOL BIOL, V188, P283, DOI 10.1016/0022-2836(86)90310-4; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; LEWENDON A, 1988, BIOCHEMISTRY-US, V27, P7385, DOI 10.1021/bi00419a032; LEWENDON A, 1990, BIOCHEMISTRY-US, V29, P2075, DOI 10.1021/bi00460a016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURRAY IA, 1991, BIOCHEMISTRY-US, V30, P3763, DOI 10.1021/bi00229a025; MURRAY IA, 1988, BIOCHEM J, V252, P173, DOI 10.1042/bj2520173; QUICHO FA, 1989, NATURE, V340, P404; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522	21	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					20997	21001						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407936				2022-12-27	WOS:A1993MA28800056
J	RICHARDSON, JM; PESSIN, JE				RICHARDSON, JM; PESSIN, JE			IDENTIFICATION OF A SKELETAL MUSCLE-SPECIFIC REGULATORY DOMAIN IN THE RAT GLUT4 MUSCLE-FAT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE GLUCOSE TRANSPORTER; THYROID-HORMONE; MESSENGER-RNA; CARDIAC ACTIN; DIFFERENTIAL EXPRESSION; BINDING-PROTEIN; INSULIN; ELEMENTS; SEQUENCE; ENHANCER	To identify sequences responsible for the muscle-specific expression of the rat GLUT4/muscle-fat gene, we examined the transcriptional regulation of this gene in the differentiating murine C2C12 skeletal muscle cell line. Differentiated myofibers displayed a 4-5-fold increase in GLUT4 mRNA compared with undifferentiated myoblasts which paralleled the conversion from non-muscle beta-actin mRNA to muscle-specific alpha-actin mRNA expression. Transient transfection of progressive 5' and 3' deletions of the GLUT4 5'-flanking DNA identified a 281-base pair region located between -517 and -237 relative to the transcription start site which conferred myotube-specific expression. This region increased reporter activity in the context of the GLUT4 minimal promoter in an orientation-independent manner and, in addition, onto the heterologous thymidine kinase promoter. Myotube-specific expression of both GLUT4 reporter constructs and the endogenous mouse GLUT4 mRNA was also observed to be thyroid hormone-dependent. Further, cotransfection of reporter constructs containing the 281-base pair GLUT4 differentiation-specific enhancer with the thyroid hormone receptor specifically increased luciferase activity in myotubes approximately 12-fold. Thus, these data demonstrate the presence of a proximal skeletal muscle-specific activation domain that is necessary for both myotube-specific GLUT4 expression and thyroid hormone responsiveness.	UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	University of Iowa					NIDDK NIH HHS [DK01822, DK25925, DK42452] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K04DK001822, R01DK042452] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; BALDWIN TJ, 1989, NATURE, V341, P716, DOI 10.1038/341716a0; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BRODIE C, 1990, J NEUROCHEM, V55, P186, DOI 10.1111/j.1471-4159.1990.tb08837.x; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; BUSE JB, 1992, DIABETES, V41, P1436, DOI 10.2337/diabetes.41.11.1436; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; DEMDEN MC, 1992, MOL ENDOCRINOL, V6, P581, DOI 10.1210/me.6.4.581; DEVLIN RB, 1979, DEV BIOL, V69, P202, DOI 10.1016/0012-1606(79)90286-0; DIMITRIADIS G, 1985, AM J PHYSIOL, V248, pE593, DOI 10.1152/ajpendo.1985.248.5.E593; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GRAHAM F, 1973, VIROLOGY, V52, P452; GUNNING P, 1983, MOL CELL BIOL, V3, P1985, DOI 10.1128/MCB.3.11.1985; HALL CV, 1983, J MOL APPL GENET, V2, P401; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KAHN BB, 1989, J CLIN INVEST, V84, P404, DOI 10.1172/JCI114180; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEIDIG F, 1992, J BIOL CHEM, V267, P913; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; MULLER MJ, 1988, AM J PHYSIOL, V255, pE146, DOI 10.1152/ajpendo.1988.255.2.E146; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RICHARDSON JM, 1991, J BIOL CHEM, V266, P12690; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WEINSTEIN SP, 1991, ENDOCRINOLOGY, V129, P455, DOI 10.1210/endo-129-1-455; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2525, DOI 10.1073/pnas.88.6.2525; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	52	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21021	21027						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407939				2022-12-27	WOS:A1993MA28800060
J	LARMINAT, F; ZHEN, WP; BOHR, VA				LARMINAT, F; ZHEN, WP; BOHR, VA			GENE-SPECIFIC DNA-REPAIR OF INTERSTRAND CROSS-LINKS INDUCED BY CHEMOTHERAPEUTIC-AGENTS CAN BE PREFERENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; DIHYDROFOLATE-REDUCTASE GENE; DHFR GENE; CIS-DIAMMINEDICHLOROPLATINUM(II); REMOVAL; ADDUCTS; RECOMBINATION; MONOADDUCTS; CISPLATIN; MECHANISM	The gene-specific formation and repair of interstrand cross-links (ICL) were measured in the dihydrofolate reductase (DHFR) gene in hamster cells. Cells were treated with two different chemotherapeutic agents, nitrogen mustard and cisplatin, and the frequency of cross-links was quantified in the active gene and in a downstream, inactive region. About 5% of total lesions induced by these agents were ICL. Whereas the frequencies of cross-links formed were similar in the gene and in the noncoding region after cisplatin treatment, there were more nitrogen mustard-induced cross-links in the inactive region than in the active gene. At low levels of cross-linking, we found preferential DNA repair in the active gene as compared to the inactive region. At higher levels of cross-linking, there was no difference in repair rates between the gene and the noncoding region due to an increase in the repair efficiency in the inactive DNA. Implications of fine structural organization of cross-link repair are discussed.	NCI, DIV CANC TREATMENT, MOLEC PHARMACOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Bohr, Vilhelm/AAP-5931-2020					BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BOHR VA, 1986, J BIOL CHEM, V261, P6666; BOHR VA, 1991, CARCINOGENESIS, V12, P1983, DOI 10.1093/carcin/12.11.1983; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; BROOKES P, 1961, BIOCHEM J, V80, P496, DOI 10.1042/bj0800496; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; COLVIN M, 1982, PHARM PRINCIPLES CAN, P276; EASTMAN A, 1982, BIOCHEM BIOPH RES CO, V105, P869, DOI 10.1016/0006-291X(82)91050-6; FABRE F, 1977, P NATL ACAD SCI USA, V74, P1667, DOI 10.1073/pnas.74.4.1667; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; FUTSCHER WB, 1992, CELL GROWTH DIFFER, V3, P217; GALLAGHER PE, 1984, BIOCHIM BIOPHYS ACTA, V782, P394, DOI 10.1016/0167-4781(84)90045-9; GELEZIUNAS R, 1991, J NATL CANCER I, V83, P557, DOI 10.1093/jnci/83.8.557; HARTLEY JA, 1986, CANCER RES, V46, P1943; HEMMINKI K, 1984, J NATL CANCER I, V73, P1021; HICKSON ID, 1988, TRENDS GENET, V4, P101, DOI 10.1016/0168-9525(88)90097-2; ISLAS AL, 1991, CANCER RES, V51, P2867; JONES JC, 1991, J BIOL CHEM, V266, P7101; KOHN KW, 1966, J MOL BIOL, V19, P266, DOI 10.1016/S0022-2836(66)80004-9; LEFEBVRE P, 1989, NATO ADV SCI I A-LIF, V182, P141; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLENDERS LHF, 1988, NUCLEIC ACIDS RES, V16, P10607, DOI 10.1093/nar/16.22.10607; PIENTA KJ, 1984, J CELL SCI S, V1, P223; PINTO A L, 1985, Biochimica et Biophysica Acta, V780, P167, DOI 10.1016/0304-419X(85)90001-0; REARDON JT, 1991, NUCLEIC ACIDS RES, V19, P4623, DOI 10.1093/nar/19.17.4623; Roberts J J, 1979, Prog Nucleic Acid Res Mol Biol, V22, P71, DOI 10.1016/S0079-6603(08)60799-0; ROBERTS JJ, 1981, BIOCHIM BIOPHYS ACTA, V655, P146, DOI 10.1016/0005-2787(81)90004-6; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; THOMAS DC, 1989, J BIOL CHEM, V264, P18005; VANHOUTEN B, 1986, P NATL ACAD SCI USA, V83, P8077; VOS JMH, 1987, CELL, V50, P789, DOI 10.1016/0092-8674(87)90337-0; WASSERMANN K, 1990, J BIOL CHEM, V265, P13906; ZHEN WP, 1992, MOL CELL BIOL, V12, P3689, DOI 10.1128/MCB.12.9.3689	35	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2649	2654						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428941				2022-12-27	WOS:A1993KK81500059
J	VONECKARDSTEIN, A; CASTRO, G; WYBRANSKA, I; THERET, N; DUCHATEAU, P; DUVERGER, N; FRUCHART, JC; AILHAUD, G; ASSMANN, G				VONECKARDSTEIN, A; CASTRO, G; WYBRANSKA, I; THERET, N; DUCHATEAU, P; DUVERGER, N; FRUCHART, JC; AILHAUD, G; ASSMANN, G			INTERACTION OF RECONSTITUTED HIGH-DENSITY-LIPOPROTEIN DISKS CONTAINING HUMAN APOLIPOPROTEIN-A-I (APOA-I) VARIANTS WITH MURINE ADIPOCYTES AND MACROPHAGES - EVIDENCE FOR REDUCED CHOLESTEROL EFFLUX PROMOTION BY APOA-I(PRO165-]ARG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ADIPOSE-CELLS; PROTEIN-KINASE-C; STRUCTURAL-ANALYSIS; BINDING-PROTEIN; CULTURED-CELLS; HEPATOMA-CELLS; ACYLTRANSFERASE; RECEPTORS; SURFACE; FIBROBLASTS	Interaction of cells with both native and reconstituted high density lipoproteins (rHDL) containing apolipoprotein (apo) A-I mediates efflux of cellular cholesterol. To characterize structural requirements for this activity in apoA-I, six different genetic apoA-I variants and the corresponding normal allele products were isolated from heterozygous carriers, reconstituted with dimyristoylphosphatidylcholine (DMPC) into discoidal HDL and compared with regard to their ability to release intracellular cholesterol from murine adipocytes and peritoneal macrophages. In previous studies we determined the amino acid changes of these variants: Pro3 --> Arg, Pro4 --> Arg, Lys107 --> 0, Lys107 --> Met, Pro165 --> Arg, and Glu198 --> Lys (von Eckardstein, A., Funke, H., Walter, M., Altland, K., Benninghoven, A., and Assmann, G. (1990) J. Biol. Chem. 265, 8610-8617) and demonstrated that all apoA-I variants except apoA-I(Lys107 --> 0) form discoidal HDL particles with phosphatidyleholine analogues indistinguishable from normal apoA-I (Jonas, A., von Eckardstein, A., Kezdy, K. E., Steinmetz, A., and Assmann, G. (1991) J. Lipid Res. 32, 95-106). In the present study, all apoA-I-DMPC complexes except those containing apoA-I(Pro165 --> Arg) promoted cholesterol efflux as effectively as those containing normal apoA-I. Cholesterol efflux from adipocytes obtained after 180 min of incubation with apoA-I(Pro165 --> Arg)-DMPC complexes was decreased by 30% although this variant was bound to adipocytes with normal affinity. By contrast, apoA-I(Lys107 --> Met).DMPC complexes were decreased in their binding affinity compared to normal apoA-I.DMPC complexes but normally promoted cholesterol efflux. Incubation of mouse peritoneal macrophages with apoA-I(Pro165 --> Arg)-DMPC complexes did also result in a 30% decreased efflux of radiolabeled cholesterol if compared to rHDL with the normal allele product from the same donor. Together the observations suggest that the substitution of proline at residue 165 interferes with the formation of a structural domain in apoA-I that is crucial for cellular cholesterol efflux stimulation. Furthermore, our results suggest that binding of HDL to adipocytes and cholesterol efflux promotion by HDL requires different structural domains.	INST PASTEUR,SERV ETUD & RECH LIPOPROT & ATHEROSCLEROSE,F-59019 LILLE,FRANCE; FAC SCI NICE,CNRS,CTR BIOCHIM,F-06108 NICE 2,FRANCE; UNIV MUNSTER,INST ARTERIOSKLEROSEFORSCH,W-4400 MUNSTER,GERMANY	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Munster	VONECKARDSTEIN, A (corresponding author), UNIV MUNSTER,INST KLIN CHEM & LAB MED,ZENT LAB,ALBERT SCHWEITZER STR 33,W-4400 MUNSTER,GERMANY.		Theret, Nathalie/I-2871-2015; theret, nathalie/ABG-6780-2020	Theret, Nathalie/0000-0002-5857-7828; theret, nathalie/0000-0002-5857-7828; Ailhaud, Gerard/0000-0003-0596-2906; Wybranska, Iwona/0000-0002-7421-7005				ALLAN CM, 1992, J BIOL CHEM, V267, P13257; ALTLAND K, 1980, HUM GENET, V54, P221, DOI 10.1007/BF00278977; AMRI EZ, 1986, BIOCHEM J, V238, P115, DOI 10.1042/bj2380115; ANANTHARAMAIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95, DOI 10.1161/01.ATV.10.1.95; AVIRAM M, 1989, J LIPID RES, V30, P65; BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BARBARAS R, 1990, BIOCHEM J, V269, P767, DOI 10.1042/bj2690767; BERNARD DW, 1990, ARTERIOSCLEROSIS, V10, P135, DOI 10.1161/01.ATV.10.1.135; BROWN MS, 1980, J BIOL CHEM, V255, P9344; CASTRO GR, 1992, CIRCULATION S1, V86, P9; CHEN CH, 1982, J LIPID RES, V23, P680; CHEUNG MC, 1987, J LIPID RES, V28, P913; CRAIG IF, 1982, J BIOL CHEM, V257, P330; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; DELAMATRE JG, 1990, J LIPID RES, V31, P191; FIDGE NH, 1985, J BIOL CHEM, V260, P3570; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; JABS H, 1986, J LIPID RES, V27, P613; JOHNSON WJ, 1988, J BIOL CHEM, V263, P14099; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1991, J LIPID RES, V32, P95; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; LEBLOND L, 1991, J BIOL CHEM, V266, P6058; LI WH, 1988, J LIPID RES, V29, P245; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MCKNIGHT GL, 1992, J BIOL CHEM, V267, P12131; MENDEL CM, 1988, J LIPID RES, V29, P1171; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MENDEZ AJ, 1990, ARTERIOSCLEROSIS, V10, P768; MONACO L, 1987, EMBO J, V6, P3253, DOI 10.1002/j.1460-2075.1987.tb02643.x; MORRISON J, 1991, J BIOL CHEM, V266, P18780; NAZIH H, 1990, THROMB RES, V59, P913, DOI 10.1016/0049-3848(90)90115-S; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NOWICKA G, 1990, J LIPID RES, V31, P1947; ORAM JF, 1991, ARTERIOSCLER THROMB, V11, P403, DOI 10.1161/01.ATV.11.2.403; RALL SC, 1984, J BIOL CHEM, V259, P63; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; SCHMITZ G, 1985, EMBO J, V4, P613, DOI 10.1002/j.1460-2075.1985.tb03674.x; SCHMITZ G, 1985, EMBO J, V4, P2773, DOI 10.1002/j.1460-2075.1985.tb04003.x; SEGREST JP, 1992, J LIPID RES, V33, P141; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; TABAS I, 1984, J BIOL CHEM, V259, P3897; TAKATA K, 1988, J LIPID RES, V29, P1117; THERET N, 1990, BIOCHEM BIOPH RES CO, V173, P1361, DOI 10.1016/S0006-291X(05)80938-6; TOZUKA M, 1989, BIOCHEM J, V261, P239, DOI 10.1042/bj2610239; VONECKARDSTEIN A, 1989, J CLIN INVEST, V84, P1722, DOI 10.1172/JCI114355; VONECKARDSTEIN A, 1990, J BIOL CHEM, V265, P8610; [No title captured]	55	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2616	2622						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428938				2022-12-27	WOS:A1993KK81500055
J	BOUHSS, A; KRIN, E; MUNIER, H; GILLES, AM; DANCHIN, A; GLASER, P; BARZU, O				BOUHSS, A; KRIN, E; MUNIER, H; GILLES, AM; DANCHIN, A; GLASER, P; BARZU, O			COOPERATIVE PHENOMENA IN BINDING AND ACTIVATION OF BORDETELLA-PERTUSSIS ADENYLATE-CYCLASE BY CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; SKELETAL-MUSCLE; ESCHERICHIA-COLI; CONFORMATIONAL CHANGE; PHOSPHORYLASE-KINASE; DOMAIN; IDENTIFICATION; PROTEINS; SEQUENCE; CONTAINS	The catalytic domain of Bordetella pertussis adenylate cyclase located within the first 400 amino acids of the protein can be cleaved by trypsin in two subdomains (T25 and T18) corresponding to ATP-(T25) and calmodulin (CaM)-(T18) binding sites. Reassociation of subdomains by CaM is a cooperative process, which is a unique case among CaM-activated enzymes. To understand better the molecular basis of this phenomenon, we used several approaches such as partial deletions of the adenylate cyclase gene, isolation of peptides of various size, and site-directed mutagenesis experiments. We found that a stretch of 72 amino acid residues overlapping the carboxyl terminus of T25 and the amino terminus of T18 accounts for 90% of the binding energy of adenylate cyclase-CaM complex. The hydrophobic ''side'' of the helical region situated around Trp242 plays a major role in the interaction of adenylate cyclase with CaM, whereas basic residues that alternate with acidic residues in bacterial enzyme play a much less important role. The amino-terminal half of the catalytic domain of adenylate cyclase contributes only 10% to the binding energy of CaM, whereas the last 130 amino acid residues are not at all involved in binding. However, these segments of adenylate cyclase might affect protein/protein interaction and catalysis by propagating conformational changes to the CaM-binding sequence which is located in the middle of the catalytic domain of bacterial enzyme.	INST PASTEUR, UNITE BIOCHIM REGULAT CELLULAIRES, F-75724 PARIS 15, FRANCE; INST PASTEUR, UNITE REGULAT EXPRESS GENET, F-75724 PARIS 15, FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Munier-Lehmann, Helene/N-9889-2017; Munier-Lehmann, Hélène/Q-1867-2019; Glaser, Philippe/O-2641-2015	Munier-Lehmann, Helene/0000-0001-7579-8561; Munier-Lehmann, Hélène/0000-0001-7579-8561; Glaser, Philippe/0000-0003-4156-2782; Danchin, Antoine/0000-0002-6350-5001				BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; EHRMANN IE, 1992, FEBS LETT, V304, P51, DOI 10.1016/0014-5793(92)80587-7; Gibson TJ, 1984, THESIS CAMBRIDGE U; GILLES AM, 1990, BIOCHEMISTRY-US, V29, P8126, DOI 10.1021/bi00487a020; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; GLASER P, 1991, EMBO J, V10, P1683, DOI 10.1002/j.1460-2075.1991.tb07692.x; GROSS MK, 1992, P NATL ACAD SCI USA, V89, P4898, DOI 10.1073/pnas.89.11.4898; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; IKURA M, 1991, BIOCHEMISTRY-US, V30, P5498, DOI 10.1021/bi00236a024; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; JARRETT HW, 1991, J BIOL CHEM, V266, P362; KEMP BE, 1987, J BIOL CHEM, V262, P2542; LADANT D, 1992, J BIOL CHEM, V267, P2244; LADANT D, 1988, J BIOL CHEM, V263, P2612; LADANT D, 1989, J BIOL CHEM, V264, P4015; LADANT D, 1986, J BIOL CHEM, V261, P6264; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEANS AR, 1988, RECENT PROG HORM RES, V44, P223; MUNIER H, 1993, J BIOL CHEM, V268, P1695; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; MUNIER H, 1992, J BIOL CHEM, V267, P9816; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PICTON C, 1980, EUR J BIOCHEM, V111, P553, DOI 10.1111/j.1432-1033.1980.tb04971.x; PRECHEUR B, 1992, BIOCHEMISTRY-US, V31, P229, DOI 10.1021/bi00116a032; PRECHEUR B, 1991, EUR J BIOCHEM, V196, P67; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; White A A, 1974, Methods Enzymol, V38, P41; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	37	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1690	1694						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420945				2022-12-27	WOS:A1993KH62000030
J	CSERMELY, P; KAJTAR, J; HOLLOSI, M; JALSOVSZKY, G; HOLLY, S; KAHN, CR; GERGELY, P; SOTI, C; MIHALY, K; SOMOGYI, J				CSERMELY, P; KAJTAR, J; HOLLOSI, M; JALSOVSZKY, G; HOLLY, S; KAHN, CR; GERGELY, P; SOTI, C; MIHALY, K; SOMOGYI, J			ATP INDUCES A CONFORMATIONAL CHANGE OF THE 90-KDA HEAT-SHOCK PROTEIN (HSP90)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-RECEPTOR COMPLEXES; AMINO-ACID SEQUENCE; ROUS-SARCOMA VIRUS; SECONDARY STRUCTURE; DNA-REPLICATION; GLUCOCORTICOID RECEPTOR; AUTOPHOSPHORYLATING ACTIVITY; NUCLEOPROTEIN STRUCTURES; TRANSFORMING PROTEINS; DEPENDENT ACTIVATION	The 90-kDa heat shock protein (hsp90) is a well conserved, abundant cytosolic protein believed to be a ''chaperone'' of most steroid receptors. We have recently demonstrated that hsp90 has an ATP-binding site and autophosphorylating activity (Csermely, P., and Kahn, C. R. (1991) J. Biol. Chem. 266, 4943-4950). Circular dichroism analysis of highly purified hsp90 from rat liver shows that ATP induces an increase of beta-pleated sheet content of hsp90. Vanadate, molybdate, and heat treatment at 56-degrees-C induce a similar change in the circular dichroism spectrum. Fourier transformed infrared spectroscopy reveals an ATP-induced increase in the interchain interactions of the 90-kDa heat shock protein due to an increase in its beta-pleated sheet content. In further studies we found that ATP: 1) decreases the tryptophan fluorescence of hsp90 by 11.6 +/- 1.9%; 2) increases the hydrophobic character of the protein as determined by its distribution between an aqueous phase and phenyl-Sepharose; and 3) renders hsp90 less susceptible to tryptic digestion. Our results suggest that hsp90 undergoes an ''open --> closed'' conformational change after the addition of ATP, analogous in many respects to the similar changes of the DnaK protein, the immunoglobulin heavy chain binding protein (BiP/GRP78), and hsp70. The ATP-induced conformational change of hsp90 may be important in regulating its association with steroid receptors and other cellular proteins.	EOTVOS LORAND UNIV, DEPT ORGAN CHEM, H-1518 BUDAPEST, HUNGARY; HUNGARIAN ACAD SCI, CENT RES INST CHEM, H-1525 BUDAPEST, HUNGARY; BRIGHAM & WOMENS HOSP, DEPT MED, JOSLIN DIABET CTR, DIV RES, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	CSERMELY, P (corresponding author), SEMMELWEIS UNIV MED, INST BIOCHEM 1, H-1444 BUDAPEST, HUNGARY.		Sőti, Csaba/O-6070-2017; Kahn, Ronald/AAY-2435-2021; Csermely, Peter/J-2067-2017	Sőti, Csaba/0000-0002-4057-7678; Kahn, Ronald/0000-0002-7583-9228; Csermely, Peter/0000-0001-9234-0659	NIDDK NIH HHS [DK 36836, DK 33201] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033201, P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADKINS B, 1982, J VIROL, V43, P448, DOI 10.1128/JVI.43.2.448-455.1982; ALFANO C, 1989, J BIOL CHEM, V264, P10709; ALFANO C, 1989, J BIOL CHEM, V264, P10699; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BINART N, 1989, BIOCHEM BIOPH RES CO, V159, P140, DOI 10.1016/0006-291X(89)92415-7; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURDON RH, 1986, BIOCHEM J, V240, P313, DOI 10.1042/bj2400313; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CSERMELY P, 1985, BIOCHEM J, V230, P807, DOI 10.1042/bj2300807; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DORNER AJ, 1990, P NATL ACAD SCI USA, V87, P7429, DOI 10.1073/pnas.87.19.7429; DOUGHERTY JJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P74, DOI 10.1016/0167-4889(87)90067-X; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GROYER A, 1987, NATURE, V328, P624, DOI 10.1038/328624a0; HUTCHISON KA, 1992, J BIOL CHEM, V267, P13952; HWANG DS, 1990, J BIOL CHEM, V265, P19244; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LANKS KW, 1989, J CELL PHYSIOL, V140, P601, DOI 10.1002/jcp.1041400327; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIPSICH LA, 1982, MOL CELL BIOL, V2, P875, DOI 10.1128/MCB.2.7.875; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MESHINCHI S, 1990, J BIOL CHEM, V265, P11643; MOORE SK, 1989, J BIOL CHEM, V264, P5343; MOUDGIL VK, 1980, BIOCHEM J, V190, P799, DOI 10.1042/bj1900799; NECHAY BR, 1986, FASEB J, V45, P123; NIELSEN CJ, 1977, J BIOL CHEM, V252, P7568; NISHIGORI H, 1980, BIOCHEMISTRY-US, V19, P77, DOI 10.1021/bi00542a012; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; ROSE DW, 1987, BIOCHEMISTRY-US, V26, P6583, DOI 10.1021/bi00395a003; SADIS S, 1990, BIOCHEMISTRY-US, V29, P8199, DOI 10.1021/bi00488a001; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; SANDO JJ, 1979, J BIOL CHEM, V254, P4772; SCHWAB DA, 1989, P NATL ACAD SCI USA, V86, P2563, DOI 10.1073/pnas.86.8.2563; SUBJECK JR, 1986, AM J PHYSIOL, V250, pC1, DOI 10.1152/ajpcell.1986.250.1.C1; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; VANETTEN RL, 1974, J AM CHEM SOC, V96, P6782, DOI 10.1021/ja00828a053; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; Woody R. W., 1985, PEPTIDES, V7; YAMAMOTO M, 1991, J BIOCHEM-TOKYO, V110, P141, DOI 10.1093/oxfordjournals.jbchem.a123532; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; ZIEMIECKI A, 1986, BIOCHEM BIOPH RES CO, V138, P1298, DOI 10.1016/S0006-291X(86)80424-7; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	67	135	136	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1901	1907						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420964				2022-12-27	WOS:A1993KH62000062
J	KAWALLECK, P; KELLER, H; HAHLBROCK, K; SCHEEL, D; SOMSSICH, IE				KAWALLECK, P; KELLER, H; HAHLBROCK, K; SCHEEL, D; SOMSSICH, IE			A PATHOGEN-RESPONSIVE GENE OF PARSLEY ENCODES TYROSINE DECARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; GLUTATHIONE-S-TRANSFERASE; NICOTIANA-TABACUM; ESCHERICHIA-COLI; TRYPTOPHAN DECARBOXYLASE; ORNITHINE DECARBOXYLASE; 4-COUMARATE-COA LIGASE; CATHARANTHUS-ROSEUS; DOPA DECARBOXYLASE; ENZYME-ACTIVITIES	A group of recently isolated parsley (Petroselinum crispum) cDNAs representing genes that are transcriptionally activated upon fungal infection or elicitor treatment have been demonstrated to encode tyrosine decarboxylase (TyrDC). The deduced TyrDC protein sequence shares extensive similarity with two functionally related enzymes, tryptophan decarboxylase from periwinkle and dopa decarboxylase from Drosophila melanogaster. Expression of TyrDC cDNA in Escherichia coli yielded catalytically active protein with high substrate specificity for tyrosine. All four identified parsley TyrDC genes have been cloned and encode at least three TyrDC isozymes. Treatment of cultured parsley cells with fungal elicitor caused very rapid and transient increases in TyrDC mRNA and enzyme activity levels.	MAX PLANCK INST ZUCHTUNGSFORSCH,BIOCHEM ABT,W-5000 COLOGNE 30,GERMANY	Max Planck Society			Somssich, Imre/GLT-3738-2022	Somssich, Imre/0000-0003-3066-5794				AYERS AR, 1976, PLANT PHYSIOL, V57, P751, DOI 10.1104/pp.57.5.751; CHAPPLE CCS, 1984, THESIS U GUELPH GUEL; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; COHEN E, 1982, PLANT PHYSIOL, V70, P540, DOI 10.1104/pp.70.2.540; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOUGLAS C, 1987, EMBO J, V6, P1189, DOI 10.1002/j.1460-2075.1987.tb02353.x; EVELETH DD, 1986, EMBO J, V5, P2663, DOI 10.1002/j.1460-2075.1986.tb04549.x; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUGLER K, 1988, EUR J BIOCHEM, V170, P661, DOI 10.1111/j.1432-1033.1988.tb13748.x; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; HAHLBROCK K, 1987, INNOVATIVE APPROACHE, P229; JACKSON FR, 1990, J MOL EVOL, V31, P325, DOI 10.1007/BF02101126; KALNINS A, 1983, EMBO J, V2, P593, DOI 10.1002/j.1460-2075.1983.tb01468.x; KAWALLECK P, 1992, P NATL ACAD SCI USA, V89, P4713, DOI 10.1073/pnas.89.10.4713; KELLER H, 1990, THESIS U COLOGNE COL; KNOBLOCH KH, 1981, Z NATURFORSCH C, V36, P40; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; MANECKJEE R, 1983, BIOCHEMISTRY-US, V22, P6058, DOI 10.1021/bi00295a003; Maniatis T., 1982, MOL CLONING; MARQUES IA, 1988, PLANT PHYSIOL, V88, P46, DOI 10.1104/pp.88.1.46; MORGAN BA, 1986, EMBO J, V5; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P6323; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEGREL J, 1987, PHYTOCHEMISTRY, V26, P2185, DOI 10.1016/S0031-9422(00)84681-6; NEGREL J, 1984, PHYTOCHEMISTRY, V23, P2747, DOI 10.1016/0031-9422(84)83008-3; NOE W, 1984, PLANT MOL BIOL, V3, P281, DOI 10.1007/BF00017782; PALAVAN N, 1982, PHYSIOL PLANTARUM, V55, P438, DOI 10.1111/j.1399-3054.1982.tb04524.x; PERDRIZET E, 1981, PHYTOCHEMISTRY, V20, P2131, DOI 10.1016/0031-9422(81)80099-4; RAGG H, 1981, J BIOL CHEM, V256, P61; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMELZER E, 1989, PLANT CELL, V1, P993, DOI 10.1105/tpc.1.10.993; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMSSICH IE, 1989, PLANT MOL BIOL, V12, P227, DOI 10.1007/BF00020507; TOCHER RD, 1972, PHYTOCHEMISTRY, V11, P1161; ZIMMERMANN A, 1975, ARCH BIOCHEM BIOPHYS, V166, P54, DOI 10.1016/0003-9861(75)90364-1	37	90	97	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2189	2194						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420986				2022-12-27	WOS:A1993KH62000103
J	LIU, QR; LOPEZCORCUERA, B; MANDIYAN, S; NELSON, H; NELSON, N				LIU, QR; LOPEZCORCUERA, B; MANDIYAN, S; NELSON, H; NELSON, N			MOLECULAR CHARACTERIZATION OF 4 PHARMACOLOGICALLY DISTINCT ALPHA-AMINOBUTYRIC ACID TRANSPORTERS IN MOUSE-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GABA TRANSPORTER; CLONING; EXPRESSION; DNA; SYNAPTOSOMES; INHIBITORS; NEURONS	Two novel gamma-aminobutyric acid (GABA) transporters, GAT3 and GAT4. were cloned from the mouse neonatal brain cDNA library and expressed in Xenopus oocytes. Sequence analysis indicated they were members of the Na+-dependent neurotransmitter transporter family. The GABA uptake activities were measured in cRNA injected Xenopus oocytes. The K(m) for GABA uptake by GAT3 was 18 muM and by GAT4 was 0.8 muM. GAT3 also transports beta-alanine and taurine with K(m) of 28 and 540 muM, respectively. Similarly, GAT4 transports beta-alanine with K(m) of 99 muM and taurine with a K(m) of 1.4 mM. The newly cloned GABA transporters were compared with two previously cloned GABA transporters, GAT1 and GAT2, in terms of molecular and pharmacological properties. While GAT1 and GAT4 gene expression were neural specific, GAT2 and GAT3 mRNAs were detected in other tissues such as liver and kidney, in which GAT3 mRNA was especially abundant. The expression of GAT3 mRNA in mouse brain is developmentally regulated, and its mRNA is abundant in neonatal brain but not in adult brain. High affinity GABA transporters GAT1 and GAT4 were more sensitive to inhibition by nipecotic acid. Low affinity GABA transporters GAT2 and GAT3 were inhibited most effectively by betaine and beta-alanine, respectively. The differential tissue distribution and distinct pharmacological properties of those four GABA transporters suggest functional specialization in the mechanisms of GABA transmission termination.	ROCHE INST MOLEC BIOL,ROCHE RES CTR,NUTLEY,NJ 07110	Roche Holding			Liu, Qing-Rong/A-3059-2012; Corcuera, Beatriz López/D-5188-2009	Liu, Qing-Rong/0000-0001-8477-6452; Corcuera, Beatriz López/0000-0002-0383-4241; Nelson, Nathan/0000-0003-3588-7265				BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOND PA, 1973, J NEUROCHEM, V20, P511, DOI 10.1111/j.1471-4159.1973.tb12150.x; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FREMEAU RT, 1992, NEURON, V8, P9235; GAUSTELLA J, 1990, SCIENCE, V249, P1303; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; IVERSEN LL, 1971, J NEUROCHEM, V18, P1939, DOI 10.1111/j.1471-4159.1971.tb09600.x; IVERSEN LL, 1968, J NEUROCHEM, V15, P1141, DOI 10.1111/j.1471-4159.1968.tb06831.x; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Kanner BI, 1989, CURR OPIN CELL BIOL, V1, P735, DOI 10.1016/0955-0674(89)90042-2; KANNER BI, 1990, P NATL ACAD SCI USA, V87, P2550, DOI 10.1073/pnas.87.7.2550; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; LARSSON OM, 1986, J NEUROCHEM, V47, P426; LEVI G, 1973, LIFE SCI, V12, P81, DOI 10.1016/0024-3205(73)90064-7; LIU QR, 1992, P NATL ACAD SCI USA, V89, P6639, DOI 10.1073/pnas.89.14.6639; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; LIU QR, 1992, IN PRESS P NATL ACAD; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; MABJEESH NJ, 1992, FEBS LETT, V299, P99, DOI 10.1016/0014-5793(92)80109-T; MARTIN D, 1976, GABA NERVOUS SYSTEM, P357; MARTIN DL, 1973, J NEUROCHEM, V21, P345, DOI 10.1111/j.1471-4159.1973.tb04255.x; MAYSER W, 1992, FEBS LETT, V305, P31, DOI 10.1016/0014-5793(92)80649-2; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; RADIAN R, 1986, J BIOL CHEM, V261, P5437; RADIAN R, 1990, J NEUROSCI, V10, P1319; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; WOOD JD, 1986, J NEUROCHEM, V46, P739, DOI 10.1111/j.1471-4159.1986.tb13034.x; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	36	365	383	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2106	2112						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420981				2022-12-27	WOS:A1993KH62000091
J	IWASAKI, M; DARDEN, TA; PEDERSEN, LG; DAVIS, DG; JUVONEN, RO; SUEYOSHI, T; NEGISHI, M				IWASAKI, M; DARDEN, TA; PEDERSEN, LG; DAVIS, DG; JUVONEN, RO; SUEYOSHI, T; NEGISHI, M			ENGINEERING MOUSE P450COH TO A NOVEL CORTICOSTERONE 15-ALPHA-HYDROXYLASE AND MODELING STEROID-BINDING ORIENTATION IN THE SUBSTRATE POCKET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SITE-DIRECTED MUTAGENESIS; AMINO; CYTOCHROMES-P450; SPECIFICITY; MUTATION; SEQUENCE; PROTEINS; FIELD	The F209L mutation alters specificity of P450coh from coumarin 7-hydroxylation to 15alpha-hydroxylation of 11-deoxysteroids such as testosterone and 11-deoxycorticosterone. Neither the wild-type nor F209L exhibits activity toward 11beta-hydroxysteroids including corticosterone. Mutation of Phe-209 to Asn, however, confers on mutant F209N a high corticosterone 15alpha-hydroxylase activity. F209V also exhibits low corticosterone 15alpha-hydroxylase activity; K(m) and V(max) are 10-fold higher and lower, respectively, than for F209N. The results are consistent with the hypothesis that direct interaction of Asn-209 with 11OH is responsible for high corticosterone 15alpha-hydroxylase activity. To support this hypothesis, a possible steroid-binding orientation is modeled in the substrate pocket of P450cam. Our weighted homology and constrained alignments map residue 209 of P450coh to Met-184 and Met- 191 of P450cam. Energy minimization of corticosterone in the substrate pocket results in the 11 OH of the steroid directed toward Met-184 (7 angstrom) and Met-191 (16 angstrom), and in C15 located near the sixth axial position of the heme. The steroid-binding model suggests that the P450cam's substrate pocket may be conserved in the mammalian P450 and can accommodate a steroid molecule, and that residue 209 appears to be located at the critical site that determines the steroid-substrate specificity of a P450 depending on the type of group at the 11-position of steroid molecule.	NIEHS, REPRODUCT & DEV TOXICOL LAB, PHARMACOGENET SECT, RES TRIANGLE PK, NC 27709 USA; NIEHS, MOLEC TOXICOL LAB, RES TRIANGLE PK, NC 27709 USA; NIEHS, MOLEC BIOPHYS LAB, RES TRIANGLE PK, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Pedersen, Lee G/E-3405-2013; Negishi, Masahiko/F-7805-2019	Pedersen, Lee G/0000-0003-1262-9861; Negishi, Masahiko/0000-0002-2076-8928				AOYAMA T, 1989, J BIOL CHEM, V264, P21327; CAMPSTEYN H, 1973, ACTA CRYSTALLOGR B, V29, P1726, DOI 10.1107/S0567740873005364; DARDEN T, 1991, J MOL GRAPHICS, V9, P18, DOI 10.1016/0263-7855(91)80028-X; GOTOH O, 1992, J BIOL CHEM, V267, P83; GRAHAMLORENCE S, 1991, J BIOL CHEM, V266, P11939; HARADA N, 1988, BIOCHEM PHARMACOL, V37, P4778; IMAI Y, 1989, BIOCHEM BIOPH RES CO, V158, P717, DOI 10.1016/0006-291X(89)92780-0; IWASAKI M, 1991, J BIOL CHEM, V266, P3380; IWASAKI M, 1993, IN PRESS BIOCH J; JUVONEN RO, 1991, J BIOL CHEM, V266, P16431; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; KIRK DN, 1990, J CHEM SOC PERK T 2, P1567, DOI 10.1039/p29900001567; KITAMURA M, 1991, MOL ENDOCRINOL, V2, P1145; KRONBACH T, 1991, J BIOL CHEM, V266, P6215; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEGISHI M, 1992, IN PRESS J STEROID B; NELSON DR, 1989, BIOCHEMISTRY-US, V28, P656, DOI 10.1021/bi00428a036; NEUHAUS D, 1989, NUCLEAR OVERHAUSER E, P247; OEDA K, 1985, DNA-J MOLEC CELL BIO, V4, P203, DOI 10.1089/dna.1985.4.203; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1991, METHOD ENZYMOL, V206, P11; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	24	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					759	762						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419350				2022-12-27	WOS:A1993KG07700002
J	SCHROCK, RD; LLOYD, RS				SCHROCK, RD; LLOYD, RS			SITE-DIRECTED MUTAGENESIS OF THE NH2 TERMINUS OF T4-ENDONUCLEASE-V - THE POSITION OF THE ALPHA-NH2 MOIETY AFFECTS CATALYTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 ENDONUCLEASE-V; DIMER-DNA GLYCOSYLASE; ESCHERICHIA-COLI; DENV GENE; BACTERIOPHAGE-T4; SEQUENCE; REPAIR; BINDING; MECHANISMS; INHIBITION	Reductive methylation of the alphaNH2 moiety of the DNA repair enzyme T4 endonuclease V has been shown previously to eradicate both the N-glycosylase and apyrimidinic/apurinic lyase activities of the enzyme (Schrock, R. D., III, and Lloyd, R. S. (1991) J. Biol. Chem. 266, 17631-17639). The present study uses the technique of site-directed mutagenesis to investigate the important parameters involved in the cleavage mechanism. The prediction was that the addition of an amino acid in the immediate NH2-terminal region of the protein would alter the proximity of the alphaNH2 moiety of Thr2 to its target, thereby severely compromising the enzyme's catalytic activity. However, substitutions in this region generally should be tolerated. To test this hypothesis, three substitutions of the NH2-terminal amino acid were produced: Ser2 (T2S), Val2 (T2V), and Pro2 (T2P). An addition mutant was also produced by adding a glycine between the first and second amino acids of the protein (Thr2-Gly-Arg3) (+Gly). The T2P and +Gly mutants had negligible pyrimidine dimer-specific N-glycosylase activity as well as negligible pyrimidine dimer-specific nicking activity in vitro. Conversely, the T2S enzyme exhibited wild type levels of activity and the T2V exhibited intermediate levels of activity in vitro. Results from ultraviolet (UV) survival studies of the mutant enzymes indicated that the in vivo activities of these enzymes were directly correlated to the enzymes' ability to cleave at pyrimidine dimers in vitro. These results indicate that a critical parameter for the functionality of endonuclease V is the relative distance between the primary alphaNH2 group in the active site of the enzyme and those elements responsible for DNA binding and pyrimidine dimer recognition.	VANDERBILT UNIV,CTR MOLEC TOXICOL,DEPT BIOCHEM,NASHVILLE,TN 37232	Vanderbilt University				Lloyd, R. Stephen/0000-0001-7273-372X	NIEHS NIH HHS [ES07028, ES04091, ES00267] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028, R01ES004091] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BONURA T, 1982, BIOCHIMIE, V64, P643, DOI 10.1016/S0300-9084(82)80104-1; CADET J, 1990, BIOORGANIC PHOTOCHEM, V1, P1; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; DOWD DR, 1989, J MOL BIOL, V208, P701, DOI 10.1016/0022-2836(89)90160-5; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; GRUSKIN EA, 1988, J BIOL CHEM, V263, P12728; GRUSKIN EA, 1986, J BIOL CHEM, V261, P9607; HIGGINS KM, 1987, MUTAT RES, V183, P117, DOI 10.1016/0167-8817(87)90053-8; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAWRENCE CW, 1990, MOL GEN GENET, V222, P166, DOI 10.1007/BF00283040; LIUZZI M, 1987, BIOCHEMISTRY-US, V26, P3315, DOI 10.1021/bi00386a011; LLOYD RS, 1978, CANCER RES, V38, P3191; LLOYD RS, 1986, MUTAT RES, V165, P86; MANOHARAN M, 1988, J AM CHEM SOC, V110, P2690, DOI 10.1021/ja00216a074; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCMILLAN S, 1981, J VIROL, V40, P211, DOI 10.1128/JVI.40.1.211-223.1981; MORIKAWA K, 1992, SCIENCE, V256, P523, DOI 10.1126/science.1575827; NAKABEPPU Y, 1981, P NATL ACAD SCI-BIOL, V78, P2742, DOI 10.1073/pnas.78.5.2742; NICKELL C, 1991, J BIOL CHEM, V266, P5634; Patrick MH., 1976, PHOTOCHEM PHOTOBIOL, V2, P35, DOI [10.1016/B978-0-12-734602-1.50008-3, DOI 10.1016/B978-0-12-734602-1.50008-3]; PRINCE MA, 1991, J BIOL CHEM, V266, P10686; RADANY EH, 1980, NATURE, V286, P182, DOI 10.1038/286182a0; RADANY EH, 1984, J VIROL, V52, P846, DOI 10.1128/JVI.52.3.846-856.1984; RECINOS A, 1986, BIOCHEM BIOPH RES CO, V138, P945, DOI 10.1016/S0006-291X(86)80587-3; RECINOS A, 1986, J BACTERIOL, V168, P1014, DOI 10.1128/jb.168.2.1014-1018.1986; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHROCK RD, 1991, J BIOL CHEM, V266, P17631; SEAWELL PC, 1980, BIOCHEMISTRY-US, V19, P1685, DOI 10.1021/bi00549a026; VALERIE K, 1984, NUCLEIC ACIDS RES, V12, P8085, DOI 10.1093/nar/12.21.8085; VALERIE K, 1985, P NATL ACAD SCI USA, V82, P4763, DOI 10.1073/pnas.82.14.4763; WEISS B, 1987, ADV ENZYMOL RAMB, V60, P1; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	35	66	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					880	886						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419366				2022-12-27	WOS:A1993KG07700022
J	LIPPMANN, C; LINDSCHAU, C; VIJGENBOOM, E; SCHRODER, W; BOSCH, L; ERDMANN, VA				LIPPMANN, C; LINDSCHAU, C; VIJGENBOOM, E; SCHRODER, W; BOSCH, L; ERDMANN, VA			PROKARYOTIC ELONGATION FACTOR-TU IS PHOSPHORYLATED INVIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EF-TU; ESCHERICHIA-COLI; FACTOR-II; PROTEIN-KINASE; BINDING; GENES; GI; INACTIVATION; EXPRESSION; DOMAIN	Covalent modification of proteins by phosphate transfer reactions constitutes a major mechanism of regulation in higher eukaryotes. Recently, phosphorylation of eukaryotic elongation factors has been described. Analysis of Escherichia coli proteins revealed several of them to be phosphorylated. Various lines of evidence lead us to conclude that one of these proteins is identical to elongation factor (EF) Tu, which can be phosphorylated in vivo at one of its threonine residues. Structural analysis showed that one fragment of the phosphorylated EF-Tu is highly resistant to tryptic digestion. Phosphorylation of eubacterial EF-Tu is not restricted to the E. coli factor but could also be demonstrated for Thermus thermophilus HB8 EF-Tu. Overexpression of tufA did not increase the number of EF-Tu molecules to be phosphorylated. This may indicate that a constant but limited amount of EF-Tu is modified, possibly for a specific function. Phosphorylation of EF-Tu could also be demonstrated in vitro. Upon analysis of subcellular fractions the highest kinase activity was found in the ribosomal fraction of E. coli. Protein sequencing of both the in vivo and in vitro phosphorylated protein revealed position 382 as the modified threonine residue.	FREE UNIV BERLIN, INST BIOCHEM, W-1000 BERLIN 33, GERMANY; FREE UNIV BERLIN, KLINIKUM STEGLITZ, ALLGEMEINE INNERE MED & NEPHROL ABT, W-1000 BERLIN 45, GERMANY; LEIDEN UNIV, DEPT BIOCHEM, GORLAEUS LABS, 2333 AL LEIDEN, NETHERLANDS	Free University of Berlin; Free University of Berlin; Leiden University; Leiden University - Excl LUMC			Lindschau, Carsten/G-1798-2011; Lindschau, Carsten/AAE-6721-2020	Lindschau, Carsten/0000-0003-1960-099X; Vijgenboom, Erik/0000-0002-5059-069X				ARAI KI, 1976, J BIOCHEM, V79, P69, DOI 10.1093/oxfordjournals.jbchem.a131060; BOSCH L, 1983, PROG NUCLEIC ACID RE, V30, P91; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; CLARK BFC, 1990, BIOCHIM BIOPHYS ACTA, V1050, P203, DOI 10.1016/0167-4781(90)90167-Z; COOL RH, 1990, J BIOL CHEM, V265, P6744; CROUCH MF, 1988, J BIOL CHEM, V263, P3363; DONOVAN MG, 1991, FEBS LETT, V291, P303, DOI 10.1016/0014-5793(91)81307-T; ENAMI M, 1984, J BIOL CHEM, V259, P526; GAUNTKLOPFER M, 1975, BIOCHIM BIOPHYS ACTA, V390, P226, DOI 10.1016/0005-2787(75)90343-3; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GORDELADZE JO, 1989, EUR J BIOCHEM, V183, P397, DOI 10.1111/j.1432-1033.1989.tb14941.x; GUNDERSEN RE, 1990, SCIENCE, V248, P591, DOI 10.1126/science.2110382; JURNAK F, 1990, BIOCHIM BIOPHYS ACTA, V1050, P209, DOI 10.1016/0167-4781(90)90168-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERMAN R, 1980, ANAL BIOCHEM, V104, P29, DOI 10.1016/0003-2697(80)90272-9; LIPPMANN C, 1988, FEBS LETT, V240, P139, DOI 10.1016/0014-5793(88)80355-7; LIPPMANN C, 1991, CELLULAR REGULATION, P441; LITALIEN JJ, 1979, FEBS LETT, V107, P359, DOI 10.1016/0014-5793(79)80407-X; MANAI M, 1983, FEMS MICROBIOL LETT, V17, P87; Miller D L, 1974, Methods Enzymol, V30, P219; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; NAKAMURA S, 1978, EUR J BIOCHEM, V92, P533, DOI 10.1111/j.1432-1033.1978.tb12775.x; NILSSON L, 1991, J BIOL CHEM, V266, P10578; PARMEGGIANI A, 1985, ANNU REV MICROBIOL, V39, P557, DOI 10.1146/annurev.mi.39.100185.003013; PYNE NJ, 1989, FEBS LETT, V243, P77, DOI 10.1016/0014-5793(89)81221-9; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; VANDERMEIDE PH, 1983, EUR J BIOCHEM, V130, P409; VANDERMEIDE PH, 1980, P NATL ACAD SCI-BIOL, V77, P3922, DOI 10.1073/pnas.77.7.3922; VANDERMEIDE PH, 1983, EUR J BIOCHEM, V130, P397; VENEMA RC, 1991, J BIOL CHEM, V266, P11993; WANG JYJ, 1978, J BIOL CHEM, V253, P7605; WEBER K, 1969, J BIOL CHEM, V244, P4406; WITTMANN HG, 1989, BIOL CHEM H-S, V370, P87; WOOLLEY P, 1989, BIO-TECHNOL, V7, P913, DOI 10.1038/nbt0989-913; Wurmbach P, 1979, Methods Enzymol, V60, P593; YOUNG CC, 1991, J BACTERIOL, V173, P3096, DOI 10.1128/JB.173.10.3096-3100.1991	39	62	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					601	607						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416965				2022-12-27	WOS:A1993KE60300090
J	BEAN, DW; KALLAM, WE; MATSON, SW				BEAN, DW; KALLAM, WE; MATSON, SW			PURIFICATION AND CHARACTERIZATION OF A DNA HELICASE FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CALF THYMUS; UNWINDING REACTION; BINDING PROTEIN; GENE-PRODUCT; I CATALYZES; HELA-CELLS; REPLICATION; SEQUENCE; SNF2	A novel DNA helicase, scHelI, has been purified from whole cell extracts of Saccharomyces cerevisiae using biochemical assays to monitor the fractionation. The enzyme unwinds partial duplex DNA substrates, as long as 343 base pairs in length, in a reaction that is dependent on either ATP or dATP hydrolysis. scHelI also catalyzes a single-stranded DNA-dependent ATP hydrolysis reaction; the apparent K(m) for ATP is 325 muM. The unwinding reaction on circular partial duplex substrates is biphasic, with a fast component occurring within 5 min of the initiation of the reaction and a slow component continuing to 60 min. This is in contrast to the ATP hydrolysis reaction, which exhibits linear kinetics for 60 min. The direction of the unwinding reaction is 5' to 3' with respect to the strand of DNA on which the enzyme is bound. The unwinding reaction is strongly stimulated by the addition of Escherichia coli single-stranded DNA-binding protein when long partial duplex substrates are used. The enzymatic activity of scHelI copurifies with a polypeptide of 135 kDa as determined by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. The polypeptide sediments as a monomer in a glycerol gradient in the presence of 0.2 M NaCl.	UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	BEAN, DW (corresponding author), UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33476] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; CLARK MW, 1992, YEAST, V8, P133, DOI 10.1002/yea.320080208; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; FOURY F, 1987, EMBO J, V6, P1441, DOI 10.1002/j.1460-2075.1987.tb02385.x; GOETZ GS, 1988, J BIOL CHEM, V263, P383; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LAURENT BC, 1991, P NATL ACAD SCI USA, V88, P2687, DOI 10.1073/pnas.88.7.2687; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; LI XY, 1992, BIOCHEMISTRY-US, V31, P3507, DOI 10.1021/bi00128a027; LI XY, 1992, J BIOL CHEM, V267, P25321; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; MATSON SW, 1991, J BIOL CHEM, V266, P16232; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1983, J BIOL CHEM, V258, P4017; NAUMOVSKI L, 1985, MOL CELL BIOL, V5, P17, DOI 10.1128/MCB.5.1.17; RONG L, 1993, J BIOL CHEM, V268, P1252; SEO YS, 1991, J BIOL CHEM, V266, P13161; SIEGAL G, 1992, J BIOL CHEM, V267, P13629; SUGINO A, 1986, J BIOL CHEM, V261, P1744; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; THOMMES P, 1992, CHROMOSOMA, V101, P467, DOI 10.1007/BF00352468; THOMMES P, 1992, J BIOL CHEM, V267, P6063; TUTEJA N, 1990, NUCLEIC ACIDS RES, V18, P6785, DOI 10.1093/nar/18.23.6785; TUTEJA N, 1991, NUCLEIC ACIDS RES, V19, P3613, DOI 10.1093/nar/19.13.3613; YANCEYWRONA JE, 1992, EUR J BIOCHEM, V207, P479, DOI 10.1111/j.1432-1033.1992.tb17074.x; ZHANG SS, 1991, J BIOL CHEM, V266, P20483	36	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21783	21790						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408033				2022-12-27	WOS:A1993MC80900056
J	SCHMIDT, JV; CARVER, LA; BRADFIELD, CA				SCHMIDT, JV; CARVER, LA; BRADFIELD, CA			MOLECULAR CHARACTERIZATION OF THE MURINE AHR GENE - ORGANIZATION, PROMOTER ANALYSIS, AND CHROMOSOMAL ASSIGNMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON HYDROXYLASE; SINGLE-MINDED GENE; ALPHA-SUBUNIT GENE; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; MESSENGER-RNA; DNA-BINDING; EXPRESSION; RECEPTOR; DROSOPHILA	The AH receptor is a ligand-activated transcription factor that mediates the biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. The AH receptor has primary sequence homology to its dimerization partner the AH receptor nuclear translocator, and to the Drosophila proteins Sim and Per. Characterization of the gene encoding the murine AH receptor (Ahr gene) reveals that its structural organization is also conserved with respect to the sim gene, since 6 of 11 Ahr exons are spliced at homologous sites. Interestingly, little splicing homology was observed between the Ahr and per genes. The promoter of the Ahr gene is GC-rich and contains no TATA or CCAAT boxes; however, sequence analysis has shown several binding sites for the transcription factor Sp1 (GC boxes). Additionally we have identified a potential cAMP response element, AP-1 and E box sites, and two elements demonstrated in other genes to confer placenta-specific expression. Using a restriction fragment length polymorphism in exon 7 and recombinant inbred mouse lines, the Ahr gene was found to be concordant with the phenotypically defined Ahr locus, supporting the identity of these two genetic elements.	NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,303 E CHICAGO AVE,CHICAGO,IL 60611	Northwestern University					NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703, R37ES005703, R29ES005703] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09560] Funding Source: Medline; NIEHS NIH HHS [ES-05703] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSEN B, 1990, J BIOL CHEM, V265, P21874; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COBB RR, 1987, BIOCHEM GENET, V25, P401, DOI 10.1007/BF00554549; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DOLWICK KM, 1993, IN PRESS P NATL ACAD; EISEN HJ, 1983, BIOCHEM ACTION HORM, V10, P227; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; EPPIG JT, 1993, MOUSE GENOME, V91, P8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOD Y, 1992, BIOTECHNIQUES, V13, P852; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LEGRAVEREND C, 1984, GENETICS, V107, P447; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; NEBERT DW, 1969, ARCH BIOCHEM BIOPHYS, V134, P76, DOI 10.1016/0003-9861(69)90253-7; POLAND A, 1975, MOL PHARMACOL, V11, P389; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1987, MOL PHARMACOL, V32, P471; POLAND AP, 1974, J BIOL CHEM, V249, P5599; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIDA MM, 1992, P NATL ACAD SCI USA, V89, P3864, DOI 10.1073/pnas.89.9.3864; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAYLOR BA, 1976, GENETICS, V83, P373; WOOD AW, 1979, J BIOL CHEM, V254, P5647; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	46	122	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22203	22209						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408082				2022-12-27	WOS:A1993MC80900113
J	GORBEA, CM; MARCHAND, P; JIANG, WP; COPELAND, NG; GILBERT, DJ; JENKINS, NA; BOND, JS				GORBEA, CM; MARCHAND, P; JIANG, WP; COPELAND, NG; GILBERT, DJ; JENKINS, NA; BOND, JS			CLONING, EXPRESSION, AND CHROMOSOMAL LOCALIZATION OF THE MOUSE MEPRIN BETA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-LINKAGE MAP; KIDNEY; SEQUENCES; DNA; METALLOENDOPEPTIDASES; ASTACIN; REVEALS; PROTEIN; ENZYME; ALPHA	Meprins are plasma membrane homo- or hetero-oligomeric metalloendopeptidases that contain glycosylated alpha and/or beta subunits. This paper reports the cloning and sequencing of the mouse kidney beta subunit. The primary translation product is composed of 704 amino acids which includes a transient signal sequence of 20 amino acids at the NH2 terminus. The protease domain (Asn-63 to Leu-260) contains the putative zinc-binding motif characteristic of metalloendopeptidases of the ''astacin family.'' The COOH terminus contains an epidermal growth factor-like domain, a potential membrane-spanning domain, and an additional 26 amino acids. The beta subunit has an overall 42% identity to the alpha subunit, however, a 56-amino acid segment near the COOH terminus of alpha is missing in beta, and the putative transmembrane and cytoplasmic domains of the subunits share no significant sequence similarity. NH2-terminal analyses of detergent-solubilized mature forms revealed that, unlike alpha, the prosequence (Leu-21 to Lys-62) is not removed from the beta subunit. Northern blot analysis revealed a 2.5-kilobase message for the beta subunit in the kidney and intestine of C57BL/6 and C3H/He mice. The gene for the beta subunit was localized to mouse chromosome 18. These studies indicate that alpha and beta probably derived from a common ancestral gene, but have evolved so that their genes are on two different chromosomes, and their tissue-specific expression and post-translational processing differ.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT BIOL CHEM,HERSHEY,PA 17033; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ADV BIOSCI LABS INC,BASIC RES PROGRAM,FREDERICK,MD 21702	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Gorbea, Carlos/L-4406-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R37DK019691, R56DK019691] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline; NIDDK NIH HHS [DK 19691] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIROCH A, 1990, PROSITE DICT PROTEIN; BEYNON RJ, 1983, SCIENCE, V219, P1351, DOI 10.1126/science.6338590; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BUTLER PE, 1988, J BIOL CHEM, V263, P13419; BUTLER PE, 1987, BIOCHEM J, V241, P229, DOI 10.1042/bj2410229; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; CORBEIL D, 1992, FEBS LETT, V309, P203, DOI 10.1016/0014-5793(92)81095-4; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GORBEA CM, 1991, ARCH BIOCHEM BIOPHYS, V290, P549, DOI 10.1016/0003-9861(91)90580-C; Green EL, 1981, GENETICS PROBABILITY, P77; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JIANG W, 1992, FEBS LETT, V321, P110; JIANG WP, 1993, J BIOL CHEM, V268, P10380; JIANG WP, 1992, J BIOL CHEM, V267, P9185; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; JUSTICE MJ, 1992, GENOMICS, V13, P1281, DOI 10.1016/0888-7543(92)90047-V; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KENNY AJ, 1987, BIOCHEM J, V245, P525; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; MAUXION F, 1989, IMMUNOGENETICS, V29, P397, DOI 10.1007/BF00375868; MIYATANI S, 1992, P NATL ACAD SCI USA, V89, P8443, DOI 10.1073/pnas.89.18.8443; RECKELHOFF JF, 1985, IMMUNOGENETICS, V22, P617, DOI 10.1007/BF00430310; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029; YASUMASU S, 1992, DEV BIOL, V153, P250, DOI 10.1016/0012-1606(92)90110-3	34	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21035	21043						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407940				2022-12-27	WOS:A1993MA28800062
J	MIRZA, AM; SHEEHAN, JP; HARDY, LW; GLICKMAN, RL; IORIO, RM				MIRZA, AM; SHEEHAN, JP; HARDY, LW; GLICKMAN, RL; IORIO, RM			STRUCTURE AND FUNCTION OF A MEMBRANE ANCHOR-LESS FORM OF THE HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN OF NEWCASTLE-DISEASE VIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; HN GLYCOPROTEIN; ANTIGENIC SITES; SENDAI VIRUS; PROTEIN; IDENTIFICATION; PARAMYXOVIRUS; SEQUENCE; FUSION; ENVELOPE	The hemagglutinin-neuraminidase (HN) glycoprotein of paramyxoviruses is anchored in the virion membrane near its amino terminus, protruding from the virion surface to mediate attachment to cellular receptors. Solubilization of HN spikes can be achieved by treatment of virions with detergent and high salt concentrations. When the solubilized HN protein from the Australia-Victoria (AV) isolate of the virus is incubated at 37-degrees-C, a chymotrypsin-sensitive site between residues 112 and 113 is exposed. A chymotrypsin-cleaved soluble form of the protein, named CT-HN, has been prepared using this approach. It is membrane anchor-less, due to removal of a 14-kDa fragment from the NH2 terminus of HN. It retains all potential glycosylation sites and cysteines present in the ectodomain of the native protein. It migrates in nonreducing gels and sediments in sucrose gradients at the rate expected for homodimeric HN. The latter is also consistent with our demonstration by site-directed mutagenesis that cysteine residues at positions 6 and 123, respectively, mediate disulfide-linked homotetramer and homodimer formation. CT-HN retains almost total antigenicity, suggesting that it is conformationally very similar to the intact molecule, as well as receptor recognition function and, at low pH, neuraminidase activity. It should prove to be a useful tool for further studies of the structure and function of this important viral glycoprotein.	UNIV MASSACHUSETTS,SCH MED,DEPT MOLEC GENET & MICROBIOL,55 LAKE AVE N,WORCESTER,MA 01655; UNIV MASSACHUSETTS,SCH MED,PROGRAM MOLEC MED,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI024770, R01AI124770, R01AI012467, R01AI024770, R21AI024770] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-12467, AI-24770] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMINOF D, 1961, BIOCHEM J, V81, P3384; CHOPPIN PW, 1980, REV INFECT DIS, V2, P40; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; GOTOH B, 1988, VIROLOGY, V163, P174, DOI 10.1016/0042-6822(88)90244-9; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1989, VIROLOGY, V173, P196, DOI 10.1016/0042-6822(89)90235-3; IORIO RM, 1984, J IMMUNOL, V133, P2215; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; IORIO RM, 1992, J GEN VIROL, V73, P1167, DOI 10.1099/0022-1317-73-5-1167; IORIO RM, 1986, J GEN VIROL, V67, P1393, DOI 10.1099/0022-1317-67-7-1393; IORIO RM, 1992, J VIROL, V66, P6626, DOI 10.1128/JVI.66.11.6626-6633.1992; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; KINGSBURY DW, 1978, INTERVIROLOGY, V10, P137, DOI 10.1159/000148979; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1980, J VIROL, V33, P152, DOI 10.1128/JVI.33.1.152-166.1980; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCGINNES LW, 1987, VIRUS RES, V7, P187, DOI 10.1016/0168-1702(87)90027-X; MOORE NF, 1974, J GEN VIROL, V25, P275, DOI 10.1099/0022-1317-25-2-275; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; SAKAGUCHI T, 1989, VIROLOGY, V169, P260, DOI 10.1016/0042-6822(89)90151-7; SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1; SCHEID A, 1973, J VIROL, V11, P263, DOI 10.1128/JVI.11.2.263-271.1973; Scheid A., 1978, NEGATIVE STRAND VIRU, P181; SCHUY W, 1984, VIRUS RES, V1, P415, DOI 10.1016/0168-1702(84)90027-3; SHEEHAN JP, 1992, VIROLOGY, V189, P778, DOI 10.1016/0042-6822(92)90605-O; SHEEHAN JP, 1987, VIROLOGY, V161, P603, DOI 10.1016/0042-6822(87)90158-9; SMITH GW, 1981, J VIROL, V37, P256, DOI 10.1128/JVI.37.1.256-267.1981; TAKIMOTO T, 1992, J VIROL, V66, P7597, DOI 10.1128/JVI.66.12.7597-7600.1992; THOMPSON SD, 1988, J VIROL, V62, P4653, DOI 10.1128/JVI.62.12.4653-4660.1988; YUSOFF K, 1988, VIRUS RES, V11, P319, DOI 10.1016/0168-1702(88)90005-6	31	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21425	21431						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407985				2022-12-27	WOS:A1993MA28800113
J	NEDDERMANN, P; JIRICNY, J				NEDDERMANN, P; JIRICNY, J			THE PURIFICATION OF A MISMATCH-SPECIFIC THYMINE-DNA GLYCOSYLASE FROM HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXTRACTS; G.T MISPAIRS; REPAIR; PROTEIN; 5-METHYLCYTOSINE; DIFFERENTIATION; POLYMERASE; RESIDUES; ENZYMES; LINES	G/T mispairs that arise in the DNA of higher eukaryotes as a result of spontaneous hydrolytic deamination of 5-methylcytosine to thymine must be corrected to G/C pairs. We describe here the purification to apparent homogeneity of the enzyme that initiates this repair process by excising the mispaired thymine from the heteroduplex to generate an apyrimidinic site. The enzymatic activity could be attributed to a 55-kDa polypeptide, which was purified from extracts of HeLa cells by a combination of conventional and DNA-affinity chromatography. The enzyme is a mismatch-specific thymine-DNA N-glycosylase, capable of hydrolyzing the carbon-nitrogen bond between the sugar-phosphate backbone of the DNA and a mispaired thymine. In addition to the G/T, the enzyme can remove thymine also from C/T and T/T mispairs in the order G/T >> C/T > T/T. It has no detectable endonucleolytic activity on apyrimidinic sites and does not catalyze the removal of thymine from A/T pairs or from single-stranded DNA.	IST RICH BIOL MOLEC P ANGELETTI,DEPT BIOCHEM,VIA PONTINA KM 30600,I-00040 POMEZIA,ITALY									AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; BESTOR TH, 1984, MOL CELL BIOL, V4, P1800, DOI 10.1128/MCB.4.9.1800; BIRD AP, 1979, CELL, V17, P889, DOI 10.1016/0092-8674(79)90329-5; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; JIRICNY J, 1988, P NATL ACAD SCI USA, V85, P8860, DOI 10.1073/pnas.85.23.8860; JIRICNY J, 1986, NUCLEIC ACIDS RES, V14, P6579, DOI 10.1093/nar/14.16.6579; JIRICNY J, 1991, NUCLEIC ACIDS MOL BI, P72; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JOST JP, 1993, DNA METHYLATION MOL; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Sambrook J, 1989, MOL CLONING LABORATO; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; TSAIWU JJ, 1992, P NATL ACAD SCI USA, V89, P8779, DOI 10.1073/pnas.89.18.8779; Ullah Sibghat, 1993, Nucleic Acids Research, V21, P1281; WEISS B, 1987, ADV ENZYMOL, P1; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; YEH YC, 1991, J BIOL CHEM, V266, P6480	31	185	189	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21218	21224						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407958				2022-12-27	WOS:A1993MA28800085
J	HAASS, C; HUNG, AY; SCHLOSSMACHER, MG; TEPLOW, DB; SELKOE, DJ				HAASS, C; HUNG, AY; SCHLOSSMACHER, MG; TEPLOW, DB; SELKOE, DJ			BETA-AMYLOID PEPTIDE AND A 3-KDA FRAGMENT ARE DERIVED BY DISTINCT CELLULAR MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; IDENTIFICATION; LOCALIZATION; SECRETION; RECEPTOR; CLEAVAGE	We have analyzed the cellular processing pathways which produce the 4-kDa amyloid beta-peptide (Abeta) and a 3-kDa derivative (p3) of the beta-amyloid precursor protein (betaAPP) found in conditioned media of tissue culture cells and in cerebrospinal fluid. Pulse-chase experiments reveal that both peptides are secreted in parallel with soluble betaAPP (APP(s)); no precursor-product relation between Abeta and p3 was found. The protease inhibitor leupeptin did not influence the production of either peptide. In contrast, the weak base ammonium chloride (NH4Cl) showed a dose-dependent inhibition of Abeta production with less decrease in p3. A similar effect was observed using the monovalent ionophore monensin. Brefeldin A completely inhibited the generation of both peptides, indicating that proteases located in the endoplasmic reticulum or early Golgi are not sufficient for the production of the small peptides. Deletion of the betaAPP cytoplasmic domain, which removes a consensus sequence that probably mediates reinternalization, caused an increase in secretion of both APP(s) and p3 and did not abolish Abeta production. These observations suggest that completely mature betaAPP within the late Golgi and/or at the cell surface is a prerequisite for Abeta production but processing within the lysosome might not be directly required. p3 appears to derive from the 10-kDa C-terminal stub of betaAPP following secretion of APP(s).	HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	HAASS, C (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115, USA.			Schlossmacher, Michael/0000-0002-0394-0300	NATIONAL INSTITUTE ON AGING [R37AG006173, R01AG006173, R35AG007911] Funding Source: NIH RePORTER; NIA NIH HHS [AG 06173, AG 07911] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1991, J NEUROSCI, V11, P3783; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, IN PRESS NATURE; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	26	422	443	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3021	3024						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428976				2022-12-27	WOS:A1993KM16100002
J	ELTIS, LD; HOFMANN, B; HECHT, HJ; LUNSDORF, H; TIMMIS, KN				ELTIS, LD; HOFMANN, B; HECHT, HJ; LUNSDORF, H; TIMMIS, KN			PURIFICATION AND CRYSTALLIZATION OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PSEUDOALCALIGENES; DIOXYGENASE; DEGRADATION; BIPHENYL; DIBENZOFURAN; CATABOLISM; CLEAVAGE; PROTEINS; GENE	2,3-Dihydroxybiphenyl 1,2-dioxygenase, an enzyme of the biphenyl biodegradation pathway that cleaves the first of the aromatic rings, was purified to apparent homogeneity from Pseudomonas sp. strain LB400 that had been engineered to hyperexpress the bphC gene. The enzyme had a subunit molecular mass of 33.2 kDa as determined by SDS-polyacrylamide electrophoresis. Kinetic studies indicate a K(M) of 7 +/- 1 muM for 2,3-dihydroxybiphenyl. The enzyme is strongly inhibited by substrate (K(SS) = 300 +/- 10 muM). Catechol, 3-methylcatechol, and 4-methylcatechol were cleaved less efficiently and showed weaker substrate inhibition. 3,4-Dihydroxybiphenyl was not a substrate for the enzyme. Ammonium sulfate and polyethylene glycol 6000 were used as precipitants to obtain two different crystal forms. Crystals grown from ammonium sulfate and polyethylene glycol 6000 had space groups of P4(2)2(1)2 and I222, respectively. Electron microscopy indicates that the enzyme is an octamer (265 kDa) consisting of subunits arranged in two planar tetramers in a staggered conformation.			ELTIS, LD (corresponding author), NATL RES CTR BIOTECHNOL,GBF,MASCHERODER WEG 1,W-3300 BRAUNSCHWEIG,GERMANY.		Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158				ADAMS RH, 1992, APPL ENVIRON MICROB, V58, P647, DOI 10.1128/AEM.58.2.647-654.1992; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; BEDARD DL, 1990, MICROBIAL ECOL, V20, P87, DOI 10.1007/BF02543870; BRAUN M, 1990, EUR J BIOCHEM, V196, P439; DAMERVAL C, 1987, ELECTROPHORESIS, V8, P158, DOI 10.1002/elps.1150080308; DELORENZO V, 1993, IN PRESS GENE; FORTNAGEL P, 1990, APPL ENVIRON MICROB, V56, P1148, DOI 10.1128/AEM.56.4.1148-1156.1990; FURUKAWA K, 1987, J BACTERIOL, V169, P427, DOI 10.1128/jb.169.1.427-429.1987; FURUKAWA K, 1983, J BACTERIOL, V154, P1356, DOI 10.1128/JB.154.3.1356-1362.1983; FURUKAWA K, 1987, J BACTERIOL, V169, P924, DOI 10.1128/jb.169.2.924-927.1987; Harayama Shigeaki, 1992, V28, P99; KLECKA GM, 1981, APPL ENVIRON MICROB, V41, P1159, DOI 10.1128/AEM.41.5.1159-1165.1981; Kuhm A E, 1991, Biodegradation, V2, P115, DOI 10.1007/BF00114601; KUHM AE, 1991, J BACTERIOL, V173, P3795, DOI 10.1128/JB.173.12.3795-3802.1991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUNSDORF H, 1986, J MICROSC-OXFORD, V144, P211, DOI 10.1111/j.1365-2818.1986.tb02801.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1982, PREPARATION ANAL PRO, P96; MONDELLO FJ, 1989, J BACTERIOL, V171, P1725, DOI 10.1128/jb.171.3.1725-1732.1989; NADIM L, 1987, 13TH P ANN RES S LAN, P395; NOZAKI M, 1963, BIOCHEM Z, V338, P582; RAMOS JL, 1987, SCIENCE, V235, P593, DOI 10.1126/science.3468623; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; SELIFONOV S A, 1988, Biokhimiya, V53, P1040; STRUBEL V, 1991, J BACTERIOL, V173, P1932, DOI 10.1128/jb.173.6.1932-1937.1991; Unterman R., 1988, ENV BIOTECHNOLOGY RE, P253; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; WALLIS MG, 1990, BIOCHEM J, V266, P605	28	90	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2727	2732						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428946				2022-12-27	WOS:A1993KK81500070
J	KONG, HM; KUCERA, RB; JACK, WE				KONG, HM; KUCERA, RB; JACK, WE			CHARACTERIZATION OF A DNA-POLYMERASE FROM THE HYPERTHERMOPHILE ARCHAEA THERMOCOCCUS-LITORALIS - VENT DNA-POLYMERASE, STEADY-STATE KINETICS, THERMAL-STABILITY, PROCESSIVITY, STRAND DISPLACEMENT, AND EXONUCLEASE ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID POLYMERASE; ESCHERICHIA-COLI; SULFOLOBUS-ACIDOCALDARIUS; AQUATICUS; PROTEIN; SINGLE; ALPHA; BACTERIOPHAGE-T7; PURIFICATION; MUTAGENESIS	We have isolated, cloned, and characterized a DNA polymerase from the hyperthermophile archaea Thermococcus litoralis, the Tli DNA polymerase (also referred to as Vent DNA polymerase). The enzyme is extremely thermostable, having a half-life of 8 h at 95-degrees-C and about 2 h at 100-degrees-C. Pseudo-first-order kinetics at 70-degrees-C reveal an extremely low K(m) for a primed M13mp18 substrate (0.1 nM), coupled with a relatively high K(m) for dNTPs (50 muM). Accompanying extension rates are on the order of 1000 nucleotides/min. Synthesis by the polymerase is largely distributive, adding an average of 7 nucleotides/initiation event. This distributive synthesis can generate products of at least 10,000 bases. Tli DNA polymerase contains a 3' --> 5' exonuclease activity that enhances the fidelity of replication by the enzyme (Mattila, P., Korpela, J., Tenkanen, T. and Pitkanen, K. (1991) Nucleic Acids Res. 19, 4967-4973). A 2-amino acid substitution within the conserved exonuclease domain abolishes both double and single strand-dependent exonuclease activity, without altering kinetic parameters for polymerization on a primed single-stranded template. Strand displacement activity by the mutated and unmutated forms increases with increasing temperature and is enhanced in the exonuclease-deficient form of the enzyme.	NEW ENGLAND BIOLABS INC, 32 TOZER RD, BEVERLY, MA 01915 USA									ABRAMSON RD, 1990, FASEB J, V4, pA2293; ADLER S, 1979, J BIOL CHEM, V254, P1605; APOSHIAN HV, 1962, J BIOL CHEM, V237, P519; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BELKIN S, 1985, ARCH MICROBIOL, V141, P181, DOI 10.1007/BF00408055; BERNAD A, 1990, P NATL ACAD SCI USA, V87, P4610, DOI 10.1073/pnas.87.12.4610; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; CLARK JM, 1987, J MOL BIOL, V198, P123, DOI 10.1016/0022-2836(87)90462-1; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DAVEY SK, 1990, J BIOL CHEM, V265, P4098; DAVIS RP, 1961, ENZYMES, V5; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; ELIE C, 1989, EUR J BIOCHEM, V178, P619, DOI 10.1111/j.1432-1033.1989.tb14490.x; FAY PJ, 1981, J BIOL CHEM, V256, P976; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; GILLIN FD, 1975, BIOCHEM BIOPH RES CO, V64, P457, DOI 10.1016/0006-291X(75)90343-5; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAMAL A, 1990, EUR J BIOCHEM, V190, P517, DOI 10.1111/j.1432-1033.1990.tb15604.x; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; KAGUNI LS, 1982, P NATL ACAD SCI-BIOL, V79, P983, DOI 10.1073/pnas.79.4.983; KLIMCZAK LJ, 1986, BIOCHEMISTRY-US, V25, P4850, DOI 10.1021/bi00365a019; KORNBERG A, 1982, 1982 S DNA REPL; KORNBERG A, 1980, DNA REPLICATION, P1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAWYER FC, 1989, J BIOL CHEM, V264, P6427; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MATSON SW, 1980, BIOCHEMISTRY-US, V19, P2089, DOI 10.1021/bi00551a014; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; MCCLURE WR, 1975, J BIOL CHEM, V250, P4073; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PEACOCK AC, 1968, BIOCHEMISTRY-US, V7, P668, DOI 10.1021/bi00842a023; PERLER FB, 1992, P NATL ACAD SCI USA, V89, P5577, DOI 10.1073/pnas.89.12.5577; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; ROSSI M, 1986, SYST APPL MICROBIOL, V7, P337; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SALHI S, 1989, J MOL BIOL, V209, P635, DOI 10.1016/0022-2836(89)91000-0; Sambrook J, 1989, MOL CLONING LABORATO; SCHREIER PH, 1979, J MOL BIOL, V129, P169, DOI 10.1016/0022-2836(79)90068-8; SEARS LE, 1992, BIOTECHNIQUES, V13, P626; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1989, J BIOL CHEM, V264, P6447; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; 1984, HP 11C OWNERS HDB PR, P154	51	182	227	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1965	1975						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420970				2022-12-27	WOS:A1993KH62000072
J	NAKAMOTO, RK; MAEDA, M; FUTAI, M				NAKAMOTO, RK; MAEDA, M; FUTAI, M			THE GAMMA-SUBUNIT OF THE ESCHERICHIA-COLI ATP SYNTHASE - MUTATIONS IN THE CARBOXYL-TERMINAL REGION RESTORE ENERGY COUPLING TO THE AMINO-TERMINAL MUTANT GAMMA-MET-23-]LYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; FACTOR-I; ADENOSINE-TRIPHOSPHATASE; SPINACH-CHLOROPLASTS; PHOTOPHOSPHORYLATION; ACTIVATION; F1; RECONSTITUTION; MICROSCOPY; SEQUENCE	The gamma subunit mutations, gammaMet-23-->Lys or Arg, in the Escherichia coli ATP synthase were previously reported to cause dramatically inefficient energy coupling between ATPase catalysis and H+ translocation (Shin, K., Nakamoto, R. K., Maeda, M., and Futai, M. (1992) J. Biol. Chem. 267, 20835-20839). In this paper, we report that second-site mutations in the gamma subunit can suppress the effects of gammaMet-23-->Lys. By screening randomly mutagenized uncG (gammaMet-23-->Lys), eight mutations in the carboxyl-terminal region were identified; strains carrying gammaArg-242-->Cys, gammaGln-269-->Arg, gammaAla-270-->Val, gammaIle-272-->Thr, gammaThr-273-->Ser, gammaGlu-278-->Gly, gammaIle-279-->Thr, or gammaVal-280-->Ala in combination with gammaMet-23-->Lys were able to grow by oxidative phosphorylation. H+ pumping assayed in membranes prepared from double mutation strains demonstrated that efficient ATP-dependent H+ transport was restored. Interestingly, the single mutations, gammaGln-269-->Arg or gammaThr-273-->Ser, caused reduced growth by oxidative phosphorylation; however, when these mutations were in combination with gammaMet-23-->Lys, growth was substantially increased. Furthermore, strains carrying gammaMet-23-->Lys, gammaGln-269-->Arg, or gammaThr-273-->Ser as single mutations were temperature sensitive, whereas, strains with the double mutations, gammaMet-23-->Lys/gammaGln-269-->Arg or gammaMet-23-->Lys/gammaThr-273-->Ser, were thermally stable. Taken together, these results strongly suggest that gammaMet-23, gammaArg-242, and the region between gammaGln-269 to gammaVal-280 are close to each other and interact to mediate efficient energy coupling.			NAKAMOTO, RK (corresponding author), OSAKA UNIV,INST SCI & IND RES,DEPT ORGAN CHEM & BIOCHEM,IBARAKI,OSAKA 567,JAPAN.							BOEKEMA EJ, 1990, BIOCHIM BIOPHYS ACTA, V1020, P49, DOI 10.1016/0005-2728(90)90092-I; BOYER PD, 1975, FEBS LETT, V58, P1, DOI 10.1016/0014-5793(75)80212-2; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P212; DUNN SD, 1980, J BIOL CHEM, V255, P113; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FUTAI M, 1983, MICROBIOL REV, V47, P285, DOI 10.1128/MMBR.47.3.285-312.1983; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; FUTAI M, 1977, BIOCHEM BIOPH RES CO, V103, P604; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4717, DOI 10.1021/bi00437a031; HARRIS DA, 1978, BIOCHIM BIOPHYS ACTA, V463, P245, DOI 10.1016/0304-4173(78)90002-2; HUMBERT R, 1989, J BACTERIOL, V171, P1435, DOI 10.1128/jb.171.3.1435-1444.1989; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; KANAZAWA H, 1985, ARCH BIOCHEM BIOPHYS, V241, P364, DOI 10.1016/0003-9861(85)90558-2; KANAZAWA H, 1979, P NATL ACAD SCI USA, V76, P1126, DOI 10.1073/pnas.76.3.1126; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIKI J, 1986, ARCH BIOCHEM BIOPHYS, V251, P458, DOI 10.1016/0003-9861(86)90352-8; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MORONEY JV, 1980, J BIOL CHEM, V255, P6670; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; MORONEY JV, 1982, J BIOL CHEM, V257, P5915; MORONEY JV, 1979, J BIOL CHEM, V254, P8951; NALIN CM, 1984, J BIOL CHEM, V259, P7275; PAPA S, 1990, FEBS LETT, V272, P117, DOI 10.1016/0014-5793(90)80462-R; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMBROOK J, 1989, MOL CLONIN GLABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SHIN K, 1992, J BIOL CHEM, V267, P20835; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; WEISS MA, 1977, J BIOL CHEM, V252, P8007; YOSHIDA M, 1977, P NATL ACAD SCI USA, V74, P936, DOI 10.1073/pnas.74.3.936	35	69	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					867	872						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419364				2022-12-27	WOS:A1993KG07700020
J	SCARBOROUGH, RM; ROSE, JW; NAUGHTON, MA; PHILLIPS, DR; NANNIZZI, L; ARFSTEN, A; CAMPBELL, AM; CHARO, IF				SCARBOROUGH, RM; ROSE, JW; NAUGHTON, MA; PHILLIPS, DR; NANNIZZI, L; ARFSTEN, A; CAMPBELL, AM; CHARO, IF			CHARACTERIZATION OF THE INTEGRIN SPECIFICITIES OF DISINTEGRINS ISOLATED FROM AMERICAN PIT VIPER VENOMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; VONWILLEBRAND-FACTOR; PLATELET-AGGREGATION; CONTAINING PEPTIDE; FIBRINOGEN BINDING; CELL-ADHESION; SNAKE-VENOM; GPIIB-IIIA; FIBRONECTIN; INHIBITION	A new series of homologous disintegrins was isolated from the venoms of new world pit viper genus Bothrops, Crotalus, and Lachesis. The relative activities of each disintegrin in blocking adhesive protein binding activities of GPIIb-IIIa, alpha(v)beta3, and alpha5beta1 were determined and correlated with their primary amino acid sequences. Four disintegrins contained the RGDW sequence and were found to be approximately twice as effective in blocking the binding of fibrinogen to GPIIb-IIIa than inhibiting the binding of vitronectin to alpha(v)beta3 in solid-phase ligand binding assays (IC50 = 7.3 and 17.2 nM, respectively). A second group of seven disintegrins contained the RGDNP sequence and were found to be more potent inhibitors of vitronectin binding to alpha(v)beta3 than fibrinogen binding to GPIIb-IIIa (IC50 = 4.3 and 19 nM, respectively). The RGDNP containing disintegrins were also greater than 10-fold more potent than RGDW containing disintegrins in blocking the adhesion of cells mediated by alpha5beta1. These data illustrate that amino acid sequences immediately adjacent to the RGD site of disintegrins can create an extended RGD locus which coupled with conformational display of the RGD sequence may be involved in determining integrin selectivity and affinity. This information has been used in separate studies to design conformationally constrained integrin antagonists with high affinity for platelet GPIIb-IIIa.			SCARBOROUGH, RM (corresponding author), COR THERAPEUT INC, 256 E GRAND AVE, SUITE 80, S SAN FRANCISCO, CA 94080 USA.							BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BOWDITCH RD, 1990, J CELL BIOL, V111, P403; Brattstrom B. H., 1964, Transactions of the San Diego Society for Natural History, V13, P185; CHAO BH, 1989, P NATL ACAD SCI USA, V86, P8050, DOI 10.1073/pnas.86.20.8050; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHARON MH, 1990, 11TH P AM PEPT S, P82; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; GAN ZR, 1988, J BIOL CHEM, V263, P19827; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; GINSBERG MH, 1983, J CLIN INVEST, V71, P619, DOI 10.1172/JCI110808; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; HAVERSTICK DM, 1985, BLOOD, V66, P946; HUANG TF, 1989, BIOCHEMISTRY-US, V28, P661, DOI 10.1021/bi00428a037; HUANG TF, 1987, J BIOL CHEM, V262, P16157; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KLOCZEWIAK M, 1982, BIOCHEM BIOPH RES CO, V107, P181, DOI 10.1016/0006-291X(82)91686-2; KNUDSEN KA, 1988, EXP CELL RES, V179, P42, DOI 10.1016/0014-4827(88)90346-1; MOORE S, 1963, J BIOL CHEM, V238, P235; MOSHER DF, 1988, FIBRONECTIN, P48; MOULD AP, 1991, J BIOL CHEM, V266, P3579; MUSIAL J, 1990, CIRCULATION, V82, P261, DOI 10.1161/01.CIR.82.1.261; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; PYTELA R, 1986, SCIENCE, V231, P1159; RUCINSKI B, 1990, BIOCHIM BIOPHYS ACTA, V1054, P257, DOI 10.1016/0167-4889(90)90096-V; RUGGERI ZM, 1982, P NATL ACAD SCI-BIOL, V79, P6038, DOI 10.1073/pnas.79.19.6038; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAVAGE B, 1990, J BIOL CHEM, V265, P11766; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SHEBUSKI RJ, 1989, J BIOL CHEM, V264, P21550; SMITH JW, 1990, J BIOL CHEM, V265, P12267; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TRANQUI L, 1989, J CELL BIOL, V108, P2519, DOI 10.1083/jcb.108.6.2519; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILLIAMS J, 1990, BIOCHIM BIOPHYS ACTA, V1039, P81, DOI 10.1016/0167-4838(90)90229-9; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29; YAMADA KM, 1991, J BIOL CHEM, V266, P12809	43	273	295	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1058	1065						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419314				2022-12-27	WOS:A1993KG07700047
J	SEO, HC; ETTINGER, MJ				SEO, HC; ETTINGER, MJ			IDENTIFICATION AND PURIFICATION OF A SELF-ASSOCIATING COPPER-BINDING PROTEIN FROM MOUSE HEPATIC CYTOSOLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLISM; CU-67; RAT	The proteins which bind copper when it first enters cells and deliver that copper to the cellular sites where copper is incorporated into copper enzymes are unknown. When radiolabeled (Cu-64(II)) cytosol proteins were fractionated on Superose columns, two large copper-binding protein fractions were detected which together bound 63% of the total Cu-64 recovered from the column. A self-associating, 50-kDa copper-binding protein was identified whose tetramer and dimer appeared to elute in one of the major copper-binding fractions and the monomer eluted in the other. This protein was purified to homogeneity by successive Mono Q, chelating Superose, and phenyl-Superose columns. The concentrated, purified protein showed high amounts of tetramer and monomer plus some dimer, each of which bound copper. Rechromatography of the tetramer-dimer fraction on Superose gave rise to approximately equal amounts of tetramer, dimer, and monomer. Similarly, rechromatography of the monomer fraction gave rise to dimer and tetramer. Thus, the results with the purified protein confirmed that the 50-kDa protein exists as a tetramer-dimer-monomer equilibrium. The 50-kDa protein apparently makes a major contribution to the total copper-binding activity of the mouse hepatic cytosol and may play a significant role in intracellular copper metabolism.	SUNY BUFFALO,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019708] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19708] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; FREEDMAN JH, 1989, BIOCHEM BIOPH RES CO, V164, P134, DOI 10.1016/0006-291X(89)91693-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P351, DOI 10.1016/0005-2795(73)90268-7; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P338, DOI 10.1016/0005-2795(73)90267-5; PALIDA FA, 1990, BIOCHEM J, V268, P359, DOI 10.1042/bj2680359; PALIDA FA, 1991, J BIOL CHEM, V266, P4586; SEO HC, 1993, J BIOL CHEM, V268, P1160; SEO HC, 1991, THESIS STATE U NEW Y; TERAO T, 1973, AM J PHYSIOL, V224, P682, DOI 10.1152/ajplegacy.1973.224.3.682; TERAO T, 1976, TOHOKU J EXP MED, V120, P209, DOI 10.1620/tjem.120.209; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	12	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1151	1159						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419319				2022-12-27	WOS:A1993KG07700059
J	WANG, WC; ZINN, K; BJORKMAN, PJ				WANG, WC; ZINN, K; BJORKMAN, PJ			EXPRESSION AND STRUCTURAL STUDIES OF FASCICLIN-I, AN INSECT CELL-ADHESION MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; DROSOPHILA-MELANOGASTER CELLS; HUMAN CD4; PROTEINS; SUPERFAMILY; GRASSHOPPER; SEQUENCE; RECEPTOR; GLYCOPROTEINS; EFFICIENT	Fasciclin I is a lipid-linked cell-surface glycoprotein that can act as a homophilic adhesion molecule in tissue culture cells. It is thought to be involved in growth cone guidance in the embryonic insect nervous system. To facilitate structure-function studies, we have generated Chinese hamster ovary (CHO) cell lines expressing high levels of cell surface grasshopper and Drosophila fasciclin I. Grasshopper fasciclin I released by phospholipase C cleavage was purified on an immunoaffinity column and single crystals were obtained that diffracted to approximately 5-angstrom resolution. We also generated CHO and Drosophila S2 cell lines that produce a secreted form of fasciclin I. Fasciclin I expressed in S2 cells contains significantly less carbohydrate than the protein expressed in CHO cells, and may therefore be more suitable for crystallization. Biochemical characterization of purified fasciclin I indicates that the extracellular portion exists as a monomer in solution. Circular dichroism studies suggest that fasciclin I is primarily alpha-helical. Its structure is therefore different from other known cell adhesion molecules, which are predicted to be elongated beta-sheet structures. This suggests that fasciclin I may define a new structural motif used to mediate adhesive interactions between cell surfaces.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA; CALTECH, HOWARD HUGHES MED INST, PASADENA, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute				Wang, Wen-Ching/0000-0002-7422-3667	NINDS NIH HHS [NS28182] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUSUBEL FM, 1989, CURRENT PROTOCOLS MO, V1, pCH9; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CARR SA, 1989, J BIOL CHEM, V264, P21286; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURODA K, 1990, VIROLOGY, V174, P418, DOI 10.1016/0042-6822(90)90095-9; KWONG PD, 1990, P NATL ACAD SCI USA, V87, P6423, DOI 10.1073/pnas.87.16.6423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCALLISTER L, 1992, J NEUROSCI, V12, P895; RIO DC, 1985, MOL CELL BIOL, V5, P1833, DOI 10.1128/MCB.5.8.1833; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Sambrook J, 1989, MOL CLONING LABORATO; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WANG WC, 1992, THESIS CALTECH; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P398, DOI 10.1073/pnas.72.1.398; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	47	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1448	1455						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419345				2022-12-27	WOS:A1993KG07700102
J	CONCONI, A; RYAN, CA				CONCONI, A; RYAN, CA			DNASE-I AND MICROCOCCAL NUCLEASE ANALYSIS OF THE TOMATO PROTEINASE INHIBITOR-I GENE IN CHROMATIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONALLY ACTIVE CHROMATIN; RIBOSOMAL-RNA GENE; NUCLEOTIDE-SEQUENCE; PLANT-LEAVES; EXPRESSION; FRUIT; SENSITIVITY; MECHANISM; DEFENSE; INSECTS	The chromatin structure of the wound- inducible proteinase inhibitor I gene was investigated in nuclei from leaves of wounded and unwounded tomato plants. DNase I digestion of intact nuclei revealed that the inhibitor I chromatin structure was highly sensitive to the enzyme compared to the inactive ribosomal chromatin. This sensitivity was independent of wounding. Digestion of tomato nuclei with micrococcal nuclease, which produces a nucleosomal ladder from bulk chromatin in agarose gels, supported these observations. Micrococcal nuclease produced only a faint nucleosomal repeat superimposed on a smear for the coding region of the inhibitor I gene, whereas digestion of inactive ribosomal chromatin produced a well defined nucleosomal ladder. Two DNase I-hypersensitive sites were found in the promoter region of the inhibitor I gene. Both were present before and after wound induction. These two constitutive DNase I-hypersensitive sites may correspond to DNA regulatory regions of the gene. The combined results indicate the existence of an open chromatin conformation in the inhibitor I gene DNA region, present before gene induction by wounding.	WASHINGTON STATE UNIV, INST BIOL CHEM, PULLMAN, WA 99164 USA	Washington State University								BELLARD M, 1989, METHOD ENZYMOL, V170, P317; BISHOP PD, 1984, J BIOL CHEM, V259, P3172; BISHOP PD, 1981, P NATL ACAD SCI-BIOL, V78, P3536, DOI 10.1073/pnas.78.6.3536; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; CONCONI A, 1992, P NATL ACAD SCI USA, V89, P5256, DOI 10.1073/pnas.89.12.5256; DOHERTY HM, 1988, PHYSIOL MOL PLANT P, V33, P377, DOI 10.1016/0885-5765(88)90004-5; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; FLAVELL RB, 1985, MOL FORM FUNCTION PL, P1; GRAHAM JS, 1986, PLANTA, V169, P399, DOI 10.1007/BF00392137; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; GROSS DS, 1987, TRENDS BIOCHEM SCI, V12, P293, DOI 10.1016/0968-0004(87)90144-7; GRUNSTEIN M, 1990, TRENDS GENET, V6, P395, DOI 10.1016/0168-9525(90)90299-L; KAHL G, 1987, DEV GENET, V8, P405, DOI 10.1002/dvg.1020080510; KERNAN A, 1989, PLANT PHYSIOL, V91, P73, DOI 10.1104/pp.91.1.73; KISS T, 1989, NUCLEIC ACIDS RES, V17, P796, DOI 10.1093/nar/17.2.796; KISS T, 1988, NUCLEIC ACIDS RES, V16, P7179, DOI 10.1093/nar/16.14.7179; KISS T, 1989, NUCLEIC ACIDS RES, V17, P2127, DOI 10.1093/nar/17.5.2127; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; LUTHE DS, 1980, PLANT PHYSIOL, V65, P305, DOI 10.1104/pp.65.2.305; Maniatis T, 1989, MOL CLONING; MORSE RH, 1992, TRENDS BIOCHEM SCI, V17, P23, DOI 10.1016/0968-0004(92)90422-6; MURRAY MG, 1984, BIOCHEMISTRY-US, V23, P4225, DOI 10.1021/bi00313a032; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PEARCE G, 1988, PLANTA, V175, P527, DOI 10.1007/BF00393075; PEDERSON DS, 1986, ANNU REV CELL BIOL, V2, P117, DOI 10.1146/annurev.cellbio.2.1.117; PENACORTES H, 1989, P NATL ACAD SCI USA, V86, P9851, DOI 10.1073/pnas.86.24.9851; REEVES R, 1988, CHROMOSOMES CHROMATI, V1, P109; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; SPIKER S, 1983, P NATL ACAD SCI-BIOL, V80, P815, DOI 10.1073/pnas.80.3.815; STEINMULLER K, 1986, EUR J BIOCHEM, V158, P519, DOI 10.1111/j.1432-1033.1986.tb09785.x; THOMAS GH, 1984, NATO ASI SER, V101, P77; van Holde K.E., 1988, CHROMATIN; WALKERSIMMONS M, 1983, BIOCHEM BIOPH RES CO, V110, P194, DOI 10.1016/0006-291X(83)91279-2; WIDMER RM, 1984, EMBO J, V3, P1635, DOI 10.1002/j.1460-2075.1984.tb02022.x; WINGATE VPM, 1989, J BIOL CHEM, V264, P17734; WINGATE VPM, 1991, PLANT PHYSIOL, V97, P496, DOI 10.1104/pp.97.2.496; WOOD WI, 1982, J BIOL CHEM, V257, P7730	39	14	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					430	435						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416948				2022-12-27	WOS:A1993KE60300066
J	FANJUL, AN; FARIAS, RN				FANJUL, AN; FARIAS, RN			COLD-SENSITIVE CYTOSOLIC 3,5,3'-TRIIODO-L-THYRONINE-BINDING PROTEIN AND PYRUVATE-KINASE FROM HUMAN ERYTHROCYTES SHARE SIMILAR REGULATORY PROPERTIES OF HORMONE BINDING BY GLYCOLYTIC-INTERMEDIATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE; ISOZYMES; FRUCTOSE-1,6-BISPHOSPHATE; MONOMER; RAT; PURIFICATION; GENE; CELL	Similar cold-sensitive properties, values of dissociation constants (K(d) = 1 x 10(-10) M), and regulatory effectors were found for the cold-sensitive cytosolic 3,5,3'-triiodo-L-thyronine (L-T3)-binding protein (CTBP) and pyruvate kinase from human erythrocyte. Various metabolites of the blood cell were assayed for their effects on CTBP activity after heat and cold preincubation treatments. Among these compounds, five- and six-carbon phosphorylated sugars were effective in protecting the CTBP activity against cold inactivation, whereas only ATP and dATP blocked activation by heat treatments. The effects of fructose 1,6-bisphosphate, fructose 2,6-bisphosphate, and ATP were obtained at physiological concentrations. Three-carbon phosphorylated intermediates of glycolysis, ADP, AMP, cAMP, and GTP had no effect on cold and heat treatments. The monomer-tetramer interconversion of the enzyme was also regulated by fructose 1,6-bisphosphate and ATP. The association is under the control of fructose 1,6-bisphosphate, whereas the dissociation is under ATP control. This regulation may have physiological relevance since the hormone binds to the tetrameric form of the enzyme at a site other than the active site.	UNIV NACL TUCUMAN,CONICET,INSIBIO,DEPT BIOQUIM NUTR,CHACABUCO 461,RA-4000 TUCUMAN,ARGENTINA; INST QUIM BIOL DR BERNABE BLOJ,RA-4000 TUCUMAN,ARGENTINA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman								ASHIZAWA K, 1991, BIOCHEMISTRY-US, V30, P7105, DOI 10.1021/bi00243a010; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; ATAULLAKHANOV FI, 1981, EUR J BIOCHEM, V115, P359, DOI 10.1111/j.1432-1033.1981.tb05246.x; BARTLETT GR, 1958, J BIOL CHEM, V234, P449; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIN MC, 1972, HEMOGLOBIN RED CELL, V28, P145; FANJUL AN, 1991, J BIOL CHEM, V266, P16415; HARADA K, 1978, BIOCHIM BIOPHYS ACTA, V524, P327, DOI 10.1016/0005-2744(78)90169-9; HERS HG, 1982, BIOCHEM J, V206, P13; IMAMURA K, 1982, METHOD ENZYMOL, V90, P150; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; KITAGAWA S, 1987, J BIOL CHEM, V262, P3903; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARIE J, 1980, EUR J BIOCHEM, V108, P251, DOI 10.1111/j.1432-1033.1980.tb04718.x; MINAKAMI S, 1964, BIOCHEM BIOPH RES CO, V17, P748, DOI 10.1016/0006-291X(64)90425-5; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; PARKISON C, 1991, BIOCHEM BIOPH RES CO, V179, P668, DOI 10.1016/0006-291X(91)91424-B; RAPAPORT S, 1974, HUMAN RED CELL IN VI; RAPAPORT TA, 1976, BIOCHEM J, V54, P449; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; TANI K, 1988, GENE, V73, P509; VANSCHAFTINGEN E, 1981, EUR J BIOCHEM, V117, P319, DOI 10.1111/j.1432-1033.1981.tb06339.x; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	24	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					175	179						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416925				2022-12-27	WOS:A1993KE60300027
J	WEST, MG; BARLOWE, CK; APPLING, DR				WEST, MG; BARLOWE, CK; APPLING, DR			CLONING AND CHARACTERIZATION OF THE SACCHAROMYCES-CEREVISIAE GENE ENCODING NAD-DEPENDENT 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C1-TETRAHYDROFOLATE SYNTHASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; TRIFUNCTIONAL ENZYME; NUCLEOTIDE-SEQUENCE; RNA-POLYMERASE; ADE3 GENE; YEAST; PURIFICATION; EXPRESSION	Saccharomyces cerevisiae possess a monofunctional, cytoplasmic NAD-dependent 5,10-methylenetetrahydrofolate (THF) dehydrogenase that converts 5,10-methylene-THF to 5,10-methenyl-THF (Barlowe, C. K., and Appling, D. R. (1990) Biochemistry 29, 7089-7094). We have now isolated the gene encoding this enzyme from a yeast genomic library using oligonucleotide probes based on internal peptide sequences from the purified protein. Nucleotide sequence analysis reveals a 320-amino acid open reading frame that contains both of the internal peptide sequences. The predicted molecular weight (36,236) is consistent with the estimated size (33,000-38,000) of the purified protein. Disruption of the chromosomal copy of the gene resulted in loss of NAD-dependent 5,10-methylene-THF dehydrogenase activity and led to a purine requirement in certain genetic backgrounds, confirming a role for this enzyme in the oxidation of cytoplasmic one-carbon units. A single gene was mapped to chromosome XI by hybridization to a yeast chromosomal blot. We propose MTD1 as the name for this gene. Northern analysis of total yeast RNA revealed a single transcript of approximately 1,100 nucleotides. Multiple transcription initiation sites were identified between 58 and 83 base pairs upstream of the start of translation. The amino acid sequences derived from the nucleic acid sequences of seven other methylene-THF dehydrogenases cloned to date have been found to be highly homologous. Although the predicted amino acid sequence of the yeast NAD-dependent enzyme shows slight homology to the other sequences, it appears to be only distantly related to the other 5,10-methylene-THF dehydrogenases.	UNIV TEXAS, DEPT CHEM & BIOCHEM, AUSTIN, TX 78712 USA	University of Texas System; University of Texas Austin					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036913] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-36913] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVARADOURBINA G, 1981, SCIENCE, V214, P270, DOI 10.1126/science.6169150; APPLING DR, 1985, J BIOL CHEM, V260, P1248; BARLOWE CK, 1990, BIOCHEMISTRY-US, V29, P7089, DOI 10.1021/bi00482a020; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BARLOWE CK, 1989, BIOCHEMISTRY-US, V28, P2099, DOI 10.1021/bi00431a020; BELANGER C, 1989, J BIOL CHEM, V264, P4837; CHEN W, 1987, CELL, V50, P1047, DOI 10.1016/0092-8674(87)90171-1; COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94; DARI L, 1991, J BIOL CHEM, V266, P23953; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fourney R.M., 1988, FOCUS, V10, P5; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; HUM DW, 1988, J BIOL CHEM, V263, P15946; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; Ljungdahl L G, 1980, Methods Enzymol, V66, P599; Maniatis T., 1982, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; MOORE MR, 1974, J BIOL CHEM, V249, P5250; MOOS M, 1988, J BIOL CHEM, V263, P6005; OMALLEY K, 1982, J BIOL CHEM, V257, P2097; PERI KG, 1989, NUCLEIC ACIDS RES, V17, P8853, DOI 10.1093/nar/17.21.8853; RAGSDALE SW, 1984, J BIOL CHEM, V259, P3499; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SHERMAN F, 1986, METHODS YEAST GENETI, P125; STABEN C, 1986, J BIOL CHEM, V261, P4629; STRUHL K, 1986, MAXIMIZING GENE EXPR, P35; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; UYEDA K, 1967, J BIOL CHEM, V242, P4378; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WOHLFARTH G, 1991, J BACTERIOL, V173, P1411	39	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					153	160						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416923				2022-12-27	WOS:A1993KE60300024
J	CHATRENET, B; CHANG, JY				CHATRENET, B; CHANG, JY			THE DISULFIDE FOLDING PATHWAY OF HIRUDIN ELUCIDATED BY STOP GO FOLDING EXPERIMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; RIBONUCLEASE-A; PROTEIN; BPTI; MECHANISM; NMR	The folding pathway of hirudin was analyzed by structural characterization and stop/go folding experiments of acid-trapped intermediates. The results show that the folding is initiated by a near-random packing, followed by the reorganization and fine adjustment of partially compact intermediates to attain the active molecule. The process of packing is observed as the unfolded hirudin flows sequentially via three groups of equilibrated intermediates, namely one-disulfide, two-disulfide, and three-disulfide (scrambled species) isomers. Nearly all possible disulfide species were found to exist along the pathway. Specific tertiary interactions then take effect at the final stage, refining and consolidating the loosely packed intermediates, in the presence of free thiols, to form the active hirudin. The rate of packing and reorganization can be selectively regulated by a number of external factors, and conditions can be chosen to allow the completion of folding process within 10 min or 10 h.	CIBA GEIGY AG,PHARMACEUT RES LAB,K-121,104,CH-4002 BASEL,SWITZERLAND	Novartis								ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; BOERNSEN KO, 1990, CHIMIA, V44, P412; CHANG JY, 1993, J BIOL CHEM, V268, P4043; CHANG JY, 1991, ANAL BIOCHEM, V197, P52, DOI 10.1016/0003-2697(91)90354-V; CHANG JY, 1990, J BIOL CHEM, V265, P22159; CHATRENET B, 1992, J BIOL CHEM, V267, P3038; Creighton T E, 1986, Methods Enzymol, V131, P83; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1979, J MOL BIOL, V129, P411, DOI 10.1016/0022-2836(79)90504-7; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; CREIGHTON TE, 1992, SCIENCE, V256, P111, DOI 10.1126/science.1373519; CREIGHTON TE, 1988, P NATL ACAD SCI USA, V85, P5802; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DOBSON C M, 1992, Current Biology, V2, P343, DOI 10.1016/0960-9822(92)90047-E; FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038; HABER E, 1962, J BIOL CHEM, V237, P1839; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; HARUYAMA H, 1989, BIOCHEMISTRY-US, V28, P4301, DOI 10.1021/bi00436a027; Jaenicke R, 1989, PROTEIN STRUCTURE PR, P191; KARAS M, 1990, TRAC-TREND ANAL CHEM, V9, P321, DOI 10.1016/0165-9936(90)85065-F; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KONISHI Y, 1981, BIOCHEMISTRY-US, V20, P3945, DOI 10.1021/bi00517a001; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RICHARDS FM, 1991, SCI AM, P34; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; ROTHWARF DM, 1993, BIOCHEMISTRY-US, V32, P2671, DOI 10.1021/bi00061a027; SCHERAGA HA, 1987, P NATL ACAD SCI USA, V84, P5740, DOI 10.1073/pnas.84.16.5740; SECKLER R, 1992, FASEB J, V6, P2545, DOI 10.1096/fasebj.6.8.1592207; SUN XJ, 1989, J BIOL CHEM, V264, P11288; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783	38	100	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					20988	20996						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407935				2022-12-27	WOS:A1993MA28800055
J	EBERHARDT, TL; BERNARDS, MA; HE, LF; DAVIN, LB; WOOTEN, JB; LEWIS, NG				EBERHARDT, TL; BERNARDS, MA; HE, LF; DAVIN, LB; WOOTEN, JB; LEWIS, NG			LIGNIFICATION IN CELL-SUSPENSION CULTURES OF PINUS-TAEDA - IN-SITU CHARACTERIZATION OF A GYMNOSPERM LIGNIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CINNAMYL-ALCOHOL-DEHYDROGENASE; ELICITOR-MEDIATED RESPONSES; PHENYLPROPANOID METABOLISM; FORSYTHIA-INTERMEDIA; FREE-EXTRACTS; FAGUS-GRANDIFOLIA; SPRUCE LIGNIN; WHEAT STRAW; SOLID-STATE; BIOSYNTHESIS	Pinus taeda suspension cultures grown in medium containing 2,4-dichlorophenoxyacetic acid showed only primary cell wall formation and essentially no lignification, as determined by histochemical, ultrastructural, chemical, and NMR spectroscopic analyses. However, these cultures maintained a functional phenylpropanoid pathway as demonstrated by formation of the lignans (-)-matairesinol and (-)-pinoresinol. Administration of [1-C-13]Phe to these cultures, followed by solid-state carbon-13 NMR spectral analysis of their cell walls, demonstrated that the phenylalanine incorporated into the cell wall matrix was primarily as protein, rather than lignin. Successive transfer of the 2,4-dichlorophenoxyacetic acid-grown cultures to alpha-naphthaleneacetic acid-containing medium induced cell wall thickening concomitant with lignification. The presence of lignin was confirmed by histochemical, ultrastructural, chemical, biochemical, and NMR spectroscopic analyses. Specific labeling of the lignin polymer in situ with [1-C-13]-, [2-C-13]-, and [3-C-13]Phe and analysis of the cell wall preparations by solid-state carbon-13 NMR spectroscopy permitted the first direct determination of the in situ bonding patterns in a gymnosperm lignin. Several dominant interunit linkages were observed, including beta-O-aryl, furanofuran, phenylcoumarin, and phenolic-linked monolignols, consistent with those predicted but hitherto not proven. Finally, milled wood lignin derivatives prepared from these C-13-specifically enriched lignin tissues gave a relatively high fidelity copy of the native lignin.	WASHINGTON STATE UNIV, INST BIOL CHEM, PULLMAN, WA 99164 USA; PHILIP MORRIS USA RES CTR, RICHMOND, VA 23261 USA	Washington State University; Philip Morris International Inc				Davin, Laurence/0000-0002-3248-6485; Eberhardt, Thomas/0000-0002-8818-4822; Lewis, Norman/0000-0001-5742-032X				BAO WL, 1992, P NATL ACAD SCI USA, V89, P6604, DOI 10.1073/pnas.89.14.6604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CL, 1968, FOREST SCI, V14, P62; BRUNOW G, 1990, PHYTOCHEMISTRY, V29, P2535, DOI 10.1016/0031-9422(90)85183-G; CAMPBELL MM, 1992, PLANTA, V186, P409, DOI 10.1007/BF00195322; CAMPBELL MM, 1992, PHYTOCHEMISTRY, V31, P737, DOI 10.1016/0031-9422(92)80004-X; DAVIN LB, 1992, PHYTOCHEMISTRY, V31, P3869, DOI 10.1016/S0031-9422(00)97544-7; FUKUDA T, 1988, MOKUZAI GAKKAISHI, V34, P149; FUNK C, 1990, PHYTOCHEMISTRY, V29, P845, DOI 10.1016/0031-9422(90)80030-K; GAGNAIRE D, 1977, MAKROMOL CHEM, V178, P1477; GROSS GG, 1979, RECENT ADV PHYTOCHEM, V12, P177; HARTLEY RD, 1990, PHYTOCHEMISTRY, V29, P3699, DOI 10.1016/0031-9422(90)85316-8; Hayashi M., 1986, Bulletin of the Faculty of Agriculture, Kagoshima University, P1; HIGUCHI T, 1967, PHYTOCHEMISTRY, V6, P875, DOI 10.1016/S0031-9422(00)86035-5; HIGUCHI T, 1967, PHYTOCHEMISTRY, V6, P1551, DOI 10.1016/S0031-9422(00)82949-0; HIGUCHI T, 1980, LIGNIN BIODEGRADATIO, V1, P1; Hosel W., 1982, Plant Cell, Tissue and Organ Culture, V1, P137; Johnson D. B., 1961, TAPPI, V44, P793; KATAYAMA T, 1992, PHYTOCHEMISTRY, V31, P3875, DOI 10.1016/S0031-9422(00)97545-9; KNOGGE W, 1986, PLANTA, V167, P196, DOI 10.1007/BF00391415; LAPIERRE C, 1986, HOLZFORSCHUNG, V40, P47, DOI 10.1515/hfsg.1986.40.1.47; LAPIERRE C, 1988, HOLZFORSCHUNG, V42, P1, DOI 10.1515/hfsg.1988.42.1.1; LAPIERRE C, 1988, HOLZFORSCHUNG, V42, P409, DOI 10.1515/hfsg.1988.42.6.409; LEWIS NG, 1987, SCIENCE, V237, P1344, DOI 10.1126/science.237.4820.1344; LEWIS NG, 1987, MACROMOLECULES, V20, P1752, DOI 10.1021/ma00174a006; LEWIS NG, 1988, J CHEM SOC CHEM COMM, P1626, DOI 10.1039/c39880001626; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; LEWIS NG, 1989, ACS SYM SER, V399, P169; MARCINOWSKI S, 1978, EUR J BIOCHEM, V87, P37, DOI 10.1111/j.1432-1033.1978.tb12349.x; MILLER AR, 1986, CAN J BOT, V64, P2716, DOI 10.1139/b86-358; MORELLI E, 1986, PHYTOCHEMISTRY, V25, P1701, DOI 10.1016/S0031-9422(00)81239-X; MORRISON IM, 1972, J SCI FOOD AGR, V23, P455, DOI 10.1002/jsfa.2740230405; NIMZ H, 1975, Zeitschrift fuer Naturforschung Teil C Biochemie Biophysik Biologie Virologie, V30, P442; NIMZ H, 1974, MAKROMOL CHEM, V175, P2563; OZEKI Y, 1990, PHYSIOL PLANTARUM, V78, P400, DOI 10.1111/j.1399-3054.1990.tb09055.x; RAHMAN MMA, 1990, PHYTOCHEMISTRY, V29, P1841, DOI 10.1016/0031-9422(90)85025-B; RAMSDEN L, 1987, J CELL SCI, V88, P467; ROBERT D, 1989, PLANT PHYSIOL BIOCH, V27, P297; Rowell, 1986, CELLULOSE STRUCTURE, P77; SARNI F, 1984, EUR J BIOCHEM, V139, P259, DOI 10.1111/j.1432-1033.1984.tb08002.x; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Sjostrom E., 1981, WOOD CHEM FUNDAMENTA, P1; SUN HH, 1987, CARBOHYD POLYM, V7, P143, DOI 10.1016/0144-8617(87)90056-7; TALMADGE KW, 1973, PLANT PHYSIOL, V51, P158, DOI 10.1104/pp.51.1.158; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; UMEZAWA T, 1991, J BIOL CHEM, V266, P10210; WUTHRICH K, 1976, NMR BIOL RES PEPTIDE, P1; WYRAMBIK D, 1975, EUR J BIOCHEM, V59, P9, DOI 10.1111/j.1432-1033.1975.tb02418.x; YAMAMOTO E, 1989, ACS SYM SER, V399, P68; YAMAMOTO E, 1985, J PLANT PHYSIOL, V117, P441, DOI 10.1016/S0176-1617(85)80051-1; YAMAMOTO E, 1990, PLANT PHYSIOL, V94, P209, DOI 10.1104/pp.94.1.209; ZENK MH, 1975, PLANTA MED, P79, DOI 10.1055/s-0028-1104768; ZUCKER M, 1965, PLANT PHYSIOL, V40, P779, DOI 10.1104/pp.40.5.779	54	72	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21088	21096						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407945				2022-12-27	WOS:A1993MA28800069
J	KATSUSHIKA, S; KAWABE, J; HOMCY, CJ; ISHIKAWA, Y				KATSUSHIKA, S; KAWABE, J; HOMCY, CJ; ISHIKAWA, Y			INVIVO GENERATION OF AN ADENYLYLCYCLASE ISOFORM WITH A HALF-MOLECULE MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SOLUBLE GUANYLATE-CYCLASE; RAT LUNG; CLONING; SEQUENCE; DNA; IDENTIFICATION; EXPRESSION; POLYMERASE; SUBUNIT; PROTEIN	A truncated form of adenylylcyclase (type V-alpha) has been cloned from a cardiac cDNA library. It constitutes a half-molecule of type V adenylylcyclase diverging at the end of the first cytoplasmic loop. Northern blotting study has revealed the presence of such a mRNA species (approximately 3.5 kilobases in size) in the heart. Genomic sequence analysis has revealed that type V-alpha is generated via usage of a polyadenylation signal located within an intronic sequence of type V adenylylcyclase gene. When type V-alpha is co-expressed with an artificially generated half-molecule constituting the latter half of type V adenylylcyclase, the catalytic activity in transfected cell membranes is significantly higher than that of controls. However, when either alone is overexpressed, no significant increase in catalytic activity results. These results indicate that a half-molecule of adenylylcyclase, i.e. a protein containing six-transmembrane spans followed by a single cytoplasmic domain, can be generated in vivo, but catalytic activity is lacking unless heterodimerization can occur. This finding identifies another potential mechanism for generating diversity within this enzyme family.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,630 W 168TH ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; AMER CYANAMID CO,DIV MED RES,PEARL RIVER,NY 10965	Columbia University; Columbia University					NHLBI NIH HHS [HL-38070] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038070] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARNEY DF, 1991, J BIOL CHEM, V266, P18786; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GERARD RD, 1985, MOL CELL BIOL, V5, P3231, DOI 10.1128/MCB.5.11.3231; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; ISHIKAWA Y, 1990, J BIOL CHEM, V265, P8458; ISHIKAWA Y, 1992, NUCLEIC ACIDS RES, V20, P4367, DOI 10.1093/nar/20.16.4367; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KHAMBATY FM, 1990, BIOTECHNIQUES, V9, P714; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; NAKANE M, 1990, J BIOL CHEM, V265, P16841; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; TABOR S, 1987, P NATL ACAD SCI USA, V85, P9436; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716	31	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2273	2276						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428899				2022-12-27	WOS:A1993KK81500002
J	LEE, IW; LIVRELLI, V; PARK, SJ; TOTIS, PA; SUMMERS, AO				LEE, IW; LIVRELLI, V; PARK, SJ; TOTIS, PA; SUMMERS, AO			INVIVO DNA-PROTEIN INTERACTIONS AT THE DIVERGENT MERCURY RESISTANCE (MER) PROMOTERS .2. REPRESSOR ACTIVATOR (MERR)-RNA POLYMERASE INTERACTION WITH MEROP MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; REGULATORY PROTEIN; TRANSCRIPTIONAL ACTIVATION; PLASMID NR1; -35 REGIONS; BINDING; RECOGNITION; INITIATION; SPACER; OPERON	Transcription of the Tn21 mercury resistance (mer) operon is regulated by MerR which represses and activates the mer structural genes (merTPCAD) in the absence and presence of Hg(II), respectively. The promoter for the structural genes (P(TPCAD)) is divergently overlapped with the promoter for the regulatory gene (P(R)), and a dyadic operator lies between the -10 and -35 hexamers of P(TPCAD). Using in vivo dimethyl sulfate and KMnO4 footprinting of mutant mer operator-promoter (merOP) DNA to observe MerR and RNA polymerase-mediated interactions with the merOP region, we have identified three distinct domains within the palindromic mer operator. Dyad domain I consists of the outermost bases on the left arm of the operator palindrome whose alteration causes a shift, but apparently not a major loss, in occupancy by MerR, and no decrease in RNA polymerase occupancy. Mutants in dyad domain I are semiconstitutive but support additional Hg(II)-induced open complex formation at P(TPCAD). Dyad domain II consists of the four highly conserved inner bases (...GTAC....GTAC...) of the seven-base interrupted dyad, alteration of which severely modifies both MerR and RNA polymerase contacts in the promoter region. Mutants in domain II generally allow constitutive open complex formation at P(R). One unusual mutant of this group retains most of the wild-type dyad's ability to repress both promoters but is unable to support activation at P(TPCAD) in response to Hg(II), indicating that MerR undergoes a conformational change and that the required base contacts for activation are different than those for repression. Dyad domain III is tentatively defined by a mutant in the outermost base of the right palindrome arm which is unaffected in either MerR or RNA polymerase occupancy, however, a second lesion within the P(TPCAD) -10 hexamer of this mutant limits effective open complex formation. Other mutations lying solely within the -10 RNA polymerase recognition hexamer of PTPCAD are similarly competent in both MerR and RNA polymerase binding, but inadequate for open complex formation, One such mutant also affects the overlapping -10 hexamer of P(R) and results in reduced occupancy by both MerR and RNA polymerase, likely as a result of inefficient transcriptional initiation of merR mRNA. Finally, mutations affecting the -35 hexamer of P(TPCAD) bind MerR but not RNA polymerase. Dimethyl sulfate footprinting of these -35 hexamer mutants gives the first in vivo evidence for RNA polymerase contacts near the center of the interrupted dyad and also demonstrates that the Hg(II)-induced distortion in the dyad central interruption can be effected in vivo by MerR alone.	UNIV GEORGIA,DEPT MICROBIOL,ATHENS,GA 30602	University System of Georgia; University of Georgia				Summers, Anne/0000-0003-4258-9696	NIGMS NIH HHS [GM28211] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028211] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUBLE DT, 1988, J MOL BIOL, V202, P471, DOI 10.1016/0022-2836(88)90279-3; BARRINEAU P, 1984, Journal of Molecular and Applied Genetics, V2, P601; BOROWIEC JA, 1986, BIOCHEMISTRY-US, V25, P5051, DOI 10.1021/bi00366a012; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; HELMANN JD, 1990, SCIENCE, V247, P946, DOI 10.1126/science.2305262; HELTZEL A, 1987, J BACTERIOL, V169, P3379, DOI 10.1128/jb.169.7.3379-3384.1987; HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011; HUANG JZ, 1991, J BIOL CHEM, V266, P10830; LIVRELLI V, 1993, J BIOL CHEM, V268, P2623; LUND PA, 1986, J GEN MICROBIOL, V132, P465; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Miller J.H., 1972, EXPT MOL GENETICS; OHALLORAN T, 1987, SCIENCE, V235, P211, DOI 10.1126/science.3798107; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; PARK SJ, 1992, J BACTERIOL, V174, P2160, DOI 10.1128/JB.174.7.2160-2171.1992; PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157; REZNIKOFF WS, 1992, MAXIMIZING GENE EXPR, V355, P87; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P146; SHIH MC, 1983, CELL, V34, P941, DOI 10.1016/0092-8674(83)90551-2; SZOKE PA, 1987, BIOCHEMISTRY-US, V26, P6188, DOI 10.1021/bi00393a035; TRAVERS AA, 1987, CRIT REV BIOCHEM MOL, V22, P181, DOI 10.3109/10409238709101483; WULFF DL, 1987, DNA PROTEIN INTERACT	27	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2632	2639						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428940				2022-12-27	WOS:A1993KK81500057
J	SHAW, GC; FULCO, AJ				SHAW, GC; FULCO, AJ			INHIBITION BY BARBITURATES OF THE BINDING OF BM3R1 REPRESSOR TO ITS OPERATOR SITE ON THE BARBITURATE-INDUCIBLE CYTOCHROME-P450(BM-3) GENE OF BACILLUS-MEGATERIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID MONOOXYGENASE; STRUCTURAL IDENTIFICATION; VIBRIO-HARVEYI; SYSTEM; SEQUENCE; CYTOCHROME-P-450; HYDROXYLATION; INDUCTION; OMEGA-2; BIOLUMINESCENCE	In our previous publication (Shaw, G.-C., and Fulco, A. J. (1992) J. Biol. Chem. 267, 5515-5526), we reported that Bm3R1, a protein encoded in an open reading frame just upstream from the cytochrome P450BM-3 gene, is a repressor critically involved in the barbiturate-inducible expression of this gene in Bacillus megaterium. We now describe the purification of the Bm3R1 protein from an overproducing Escherichia coli strain harboring a bm3R1 gene-carrying plasmid and report the effect of barbiturate inducers on the interaction of Bm3R1 with a fragment of B. megaterium DNA containing the bicistronic operator and promoter sequences. Gel filtration analysis revealed that, under our experimental conditions, most of the Bm3R1 protein exists in highly aggregated forms. Gel mobility shift assays showed that Bm3R1 protein bound specifically to a segment of DNA containing the promoter-operator region of the bm3R1 gene while DNase I footprinting experiments established that Bm3R1 protected a region of DNA that covers and flanks the palindromic operator sequence. The interaction between Bm3R1 repressor and its operator, in vitro, was strongly inhibited by the addition of 2 mM pentobarbital or 2 mM methohexital (strong in vivo inducers of P450BM-3) but not by the same concentration of phenobarbital (a relatively weak inducer) or by mephobarbital (a non-inducer). A detailed comparison of pentobarbital and methohexital at concentrations lower than 2 mM indicated that methohexital was 5-10 times more effective as an inhibitor of Bm3R1 binding in vitro, as compared with its 7-fold greater inducer potency in vivo. The observation that the in vitro inhibition effects of barbiturates on the interaction of Bm3R1 repressor and its operator correlate strongly with their in vivo potency as inducers of cytochrome P450BM-3 suggests a mechanism for the induction process. It seems plausible that the barbiturate inducers might bear a conformational resemblance to and mimic the mode of action of an as vet unidentified endogenous inducer(s) in B. megaterium that functions by releasing the binding of Bm3R1 repressor from its operator site.	UNIV CALIF LOS ANGELES,SCH MED,BIOMED & ENVIRONM SCI LAB,900 VET AVE,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023913] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23913] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375; CAO JG, 1989, J BIOL CHEM, V264, P21670; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; FEYEREISEN R, 1989, P NATL ACAD SCI USA, V86, P1465, DOI 10.1073/pnas.86.5.1465; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; HE JS, 1991, J BIOL CHEM, V266, P7864; HO PP, 1976, BIOCHIM BIOPHYS ACTA, V431, P249, DOI 10.1016/0005-2760(76)90145-4; KIM BH, 1983, BIOCHEM BIOPH RES CO, V116, P843, DOI 10.1016/S0006-291X(83)80219-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI HY, 1991, J BIOL CHEM, V266, P11909; LUBET RA, 1992, BIOCHEM PHARMACOL, V43, P1067, DOI 10.1016/0006-2952(92)90614-O; MATSON RS, 1977, BIOCHIM BIOPHYS ACTA, V487, P487, DOI 10.1016/0005-2760(77)90218-1; MIURA Y, 1975, BIOCHIM BIOPHYS ACTA, V388, P305, DOI 10.1016/0005-2760(75)90089-2; MIURA Y, 1974, J BIOL CHEM, V249, P1880; NARHI LO, 1982, J BIOL CHEM, V257, P2147; NARHI LO, 1983, BIOCHEM BIOPH RES CO, V116, P851, DOI 10.1016/S0006-291X(83)80220-4; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1987, J BIOL CHEM, V262, P6683; RUETTINGER RT, 1984, BIOCHIM BIOPHYS ACTA, V801, P372, DOI 10.1016/0304-4165(84)90141-7; RUETTINGER RT, 1989, J BIOL CHEM, V264, P10987; RUETTINGER RT, 1981, J BIOL CHEM, V256, P5728; Sambrook J, 1989, MOL CLONING LABORATO; SHAW GC, 1992, J BIOL CHEM, V267, P5515; SHOWALTER RE, 1990, J BACTERIOL, V172, P2946, DOI 10.1128/jb.172.6.2946-2954.1990; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEN LP, 1989, J BIOL CHEM, V264, P10996; WEN LP, 1985, MOL CELL BIOCHEM, V67, P77; XU QY, 1988, ANAL BIOCHEM, V170, P19, DOI 10.1016/0003-2697(88)90084-X	32	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2997	3004						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428974				2022-12-27	WOS:A1993KK81500108
J	WONDISFORD, FE; STEINFELDER, HJ; NATIONS, M; RADOVICK, S				WONDISFORD, FE; STEINFELDER, HJ; NATIONS, M; RADOVICK, S			AP-1 ANTAGONIZES THYROID-HORMONE RECEPTOR ACTION ON THE THYROTROPIN BETA-SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; NEGATIVE REGULATION; PROTO-ONCOGENE; C-JUN; PROMOTER; ELEMENT; EXPRESSION; INHIBITION; CELLS	Thyrotropin-releasing hormone (TRH) stimulates and thyroid hormone (T3) inhibits transcription of the thyrotropin beta-subunit gene (TSH-beta). The first exon contains DNA sequences necessary for both responses and binds both AP-1 and thyroid hormone receptor (T3R). T3 did not inhibit TSH-beta gene expression in a T3R-deficient cell line. Transfection of a T3R expression vector, however, resulted in a 70% inhibition of expression by T3, which was abolished by cotransfection of c-jun and c-fos expression vectors. Mutations surrounding the transcription initiation site and DNA binding studies demonstrate both a functional and structural interaction between c-jun and T3R. Thus, TRH, acting through AP-1, may alter the set point and magnitude of thyroid hormone negative feedback of the TSH-beta gene through an interaction between AP-1 and T3R. Other regulatory pathways acting through AP-1 may alter thyroid hormone action in man.	CHARLES A DANA RES INST, BOSTON, MA USA; HARVARD UNIV, BETH ISRAEL HOSP, DEPT MED, HARVARD THORNDIKE LAB, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School					NIDDK NIH HHS [DK-43653] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043653] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BREATHNACH R, 1983, NUCLEIC ACIDS RES, V11, P7119, DOI 10.1093/nar/11.20.7119; CARR FE, 1989, MOL ENDOCRINOL, V3, P717, DOI 10.1210/mend-3-4-717; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; CARR FE, 1989, 73RD P ANN M END SOC, V265, P250; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; JONAT C, 1990, SCIENCE, V62, P1189; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SHUPNIK MA, 1986, J BIOL CHEM, V261, P2675; STEINFELDER HJ, 1992, J CLIN INVEST, V89, P409, DOI 10.1172/JCI115600; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3139; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WOOD WM, 1989, J BIOL CHEM, V264, P14840; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016	21	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2749	2754						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428949				2022-12-27	WOS:A1993KK81500073
J	ZHAO, ZZ; BOUCHARD, P; DILTZ, CD; SHEN, SH; FISCHER, EH				ZHAO, ZZ; BOUCHARD, P; DILTZ, CD; SHEN, SH; FISCHER, EH			PURIFICATION AND CHARACTERIZATION OF A PROTEIN TYROSINE PHOSPHATASE CONTAINING SH2 DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN-PLACENTA; EXPRESSION; KINASES; CLEAVAGE; HOMOLOGY; BINDING; CLONING; FAMILY	A protein tyrosine phosphatase (PTP) containing two SH2 domains (PTP1C) was purified to near homogeneity from an adenovirus expression system by a two-step chromatographic procedure with a yield of 67%. The purified enzyme behaves as a monomer of 68 kDa on gel filtration and is totally specific for phosphotyrosyl residues. Its optimal pH is around neutrality for protein substrates such as reduced, carboxamidomethylated, maleylated (RCM)-lysozyme and myelin basic protein but below 5 for low molecular weight compounds such as para-nitrophenyl phosphate (p-NPP) and phosphotyrosine. Furthermore, with the protein substrates, it displays an activity less than 1% of that obtained with other known PTPs but comparable activities toward p-NPP and phosphotyrosine. Its responsiveness toward the usual PTP activators (e.g. spermine) or inhibitors (e.g. vanadate, molybdate, heparin, or Zn2+) varied considerably with the nature of the substrates involved. Limited digestion with trypsin caused the cleavage of a C-terminal segment of the enzyme, giving rise to a 63-kDa fragment; this cleavage resulted in an approximately 20- and 10-fold activation of the enzyme toward RCM-lysozyme and myelin basic protein, respectively.	NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, MOLEC BIOL SECT, MONTREAL H4P 2R2, QUEBEC, CANADA	National Research Council Canada	ZHAO, ZZ (corresponding author), UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA.				NIDDK NIH HHS [DK0709] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK000709] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1983, METHOD ENZYMOL, V99, P243; COHEN P, 1989, J BIOL CHEM, V264, P21435; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; DAUM G, 1991, J BIOL CHEM, V266, P12211; FISCHER EH, 1955, J BIOL CHEM, V216, P121; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FISCHER EH, 1958, BIOCHEM PREPN, V6, P68; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HSU CYJ, 1990, CELL GROWTH DIFFER, V1, P191; HUNTER T, 1986, ENZYMES, V17, P191; KHANNA NC, 1987, CELL CALCIUM, V8, P217, DOI 10.1016/0143-4160(87)90020-0; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; PEPINSKY RB, 1991, METHOD ENZYMOL, V198, P260; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; PLUTZKY J, 1992, GENOMICS, V13, P869, DOI 10.1016/0888-7543(92)90172-O; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; POT DA, 1992, J BIOL CHEM, V267, P140; POT DA, 1991, J BIOL CHEM, V266, P19688; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; SAITO H, 1991, CELL GROWTH DIFFER, V2, P59; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SIMPSON RJ, 1984, BIOCHEM INT, V8, P787; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; TONKS NK, 1990, J BIOL CHEM, V265, P10674; TONKS NK, 1991, METHOD ENZYMOL, V201, P427; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; ZANDER NF, 1991, BIOCHEMISTRY-US, V30, P6964, DOI 10.1021/bi00242a022; ZHAO ZZ, 1992, ANAL BIOCHEM, V202, P361, DOI 10.1016/0003-2697(92)90119-R	40	116	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2816	2820						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428956				2022-12-27	WOS:A1993KK81500082
J	REARDEN, A; MAGNET, A; KUDO, S; FUKUDA, M				REARDEN, A; MAGNET, A; KUDO, S; FUKUDA, M			GLYCOPHORIN-B AND GLYCOPHORIN-E GENES AROSE FROM THE GLYCOPHORIN-A ANCESTRAL GENE VIA 2 DUPLICATIONS DURING PRIMATE EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HOMINOID PRIMATES; ERYTHROCYTE GLYCOPHORIN; DNA HYBRIDIZATION; POLYMORPHISMS; POLYMERASE; CHIMPANZEE; PHYLOGENY; PROTEIN; FAMILY	Human glycophorin A, B, and E genes are homologous from the 5'-flanking region to 1 kilobase downstream from the exon encoding the transmembrane region. Analysis of human Alu sequences at the transition site from the homologous to nonhomologous region suggested that the GPA gene most closely resembles the ancestral gene, whereas GPB and GPE genes arose by homologous recombination within the Alu repetitive sequence, and acquired 3' sequences from an unrelated gene (Kudo, S., and Fukuda, M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4619-4623; Kudo, S., and Fukuda, M. (1990) J. Biol. Chem. 265, 1102-1110). To understand glycophorin gene evolution in primate phylogeny, transmembrane and Alu regions of several primate genomes were amplified by the polymerase chain reaction and their sequences were analyzed. These studies revealed that the GPA gene was present in all primates studied, and the GPB gene was present in pygmy chimpanzee, chimpanzee, and gorilla, but absent from orangutan and gibbon. GPE gene was present in all species with a GPB gene, but was detected in only 7 out of 16 gorillas. The 24-base pair insertion sequence found in the transmembrane exon of the human GPE gene was shown to be derived from the ancestral GPB gene and was inserted into the ancestral GPE gene prior to gorilla divergence. The recombination site in the GPA gene was confirmed to be within an Alu repetitive sequence. We conclude that GPB and GPE genes arose from an ancestral GPA gene via two gene duplications occurring during primate evolution, prior to gorilla divergence.	UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093	University of California System; University of California San Diego					NATIONAL CANCER INSTITUTE [R01CA033000, R37CA033000] Funding Source: NIH RePORTER; NCI NIH HHS [CA33000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANSTEE DJ, 1981, SEMIN HEMATOL, V18, P13; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; DAHR W, 1986, RECENT ADV BLOOD GRO, P23; FURTHMAYR H, 1978, NATURE, V271, P519, DOI 10.1038/271519a0; GOODMAN M, 1990, J MOL EVOL, V30, P260, DOI 10.1007/BF02099995; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; HONMA K, 1980, J BIOCHEM-TOKYO, V88, P1679, DOI 10.1093/oxfordjournals.jbchem.a133143; KAWAMURA S, 1992, GENOMICS, V13, P194, DOI 10.1016/0888-7543(92)90220-M; KUDO S, 1990, J BIOL CHEM, V265, P1102; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LU WM, 1990, BIOCHEM GENET, V28, P399, DOI 10.1007/BF02401428; LU YQ, 1987, BIOCHEM GENET, V25, P477, DOI 10.1007/BF00554350; MATSUI Y, 1989, GENE, V77, P325, DOI 10.1016/0378-1119(89)90080-2; MURAYAMA JI, 1982, J MEMBRANE BIOL, V64, P205, DOI 10.1007/BF01870887; MURAYAMA JI, 1989, BIOCHIM BIOPHYS ACTA, V999, P273, DOI 10.1016/0167-4838(89)90009-5; REARDEN A, 1990, BIOCHEM GENET, V28, P223, DOI 10.1007/BF00561339; REARDEN A, 1990, BIOCHEM GENET, V28, P209, DOI 10.1007/BF00561338; REARDEN A, 1986, J IMMUNOL, V136, P2504; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; SOCHA WW, 1983, BLOOD GROUPS PRIMATE, V3; VIGNAL A, 1990, EUR J BIOCHEM, V191, P619, DOI 10.1111/j.1432-1033.1990.tb19166.x; WIENER AS, 1972, AM J PHYS ANTHROPOL, V37, P301, DOI 10.1002/ajpa.1330370216; WIENER AS, 1974, AM J HUM GENET, V26, P35; WOODING GL, 1972, J HUM EVOL, V1, P553, DOI 10.1016/0047-2484(72)90004-8	31	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2260	2267						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420995				2022-12-27	WOS:A1993KH62000114
J	ZHU, X; GUDERMANN, T; BIRNBAUMER, M; BIRNBAUMER, L				ZHU, X; GUDERMANN, T; BIRNBAUMER, M; BIRNBAUMER, L			A LUTEINIZING-HORMONE RECEPTOR WITH A SEVERELY TRUNCATED CYTOPLASMIC TAIL (LHR-CT628) DESENSITIZES TO THE SAME DEGREE AS THE FULL-LENGTH RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; ADENYLYL CYCLASE; BOVINE RHODOPSIN; ALPHA-SUBUNIT; CARBOXYL TAIL; LUTEAL CELLS; G-PROTEIN; RAT; GENE	The wild type murine luteinizing hormone (mLH) receptor, which in its mature form is predicted to be a protein of 674 amino acids (mLHR), and an artificially mutated form lacking the last 46 amino acids (mLHR-ct628) were stably expressed in murine L cells. Both forms stimulated adenylyl cyclase and underwent rapid desensitization. The mutation removed 1 tyrosine, 2 threonines, and 6 serines from the receptor. The results indicate that none of these potential phosphorylation sites participates in either adenylyl cyclase stimulation or receptor desensitization. Our results with the mLHR-ct628 (carboxyl-terminal amino acid sequence CCKHRAEL) differ from those reported recently for the essentially identically mutated rat LHR that lacks the last 43 amino acids (rLHR-ct631 with carboxyl-terminal amino acid composition CCKRRAELYRR). This 43-amino acid truncation was described to have the effect of preventing hormone-induced desensitization. While the reasons for the discrepant results are not known, our results do not support the proposal for a participatory role of the extreme carboxyl terminus of the receptor in its desensitization.	BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	ZHU, X (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041244] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45198] Funding Source: Medline; NICHD NIH HHS [HD-09581] Funding Source: Medline; NIDDK NIH HHS [DK-41244] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONELLI M, 1991, COMP BIOCHEM PHYS B, V99, P827, DOI 10.1016/0305-0491(91)90149-8; BIRNBAUMER M, 1990, MOL ENDOCRINOL, V4, P245, DOI 10.1210/mend-4-2-245; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; DAVIS JS, 1984, J BIOL CHEM, V259, P5028; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUDERMANN T, 1992, MOL ENDOCRINOL, V6, P272, DOI 10.1210/me.6.2.272; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; GUDERMANN T, 1992, BIOL REPROD S1, V46, P332; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HUNZICKERDUNN M, 1976, ENDOCRINOLOGY, V99, P211, DOI 10.1210/endo-99-1-211; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KIRCHICK HJ, 1983, ENDOCRINOLOGY, V113, P1638, DOI 10.1210/endo-113-5-1638; KOO YB, 1991, ENDOCRINOLOGY, V128, P2297, DOI 10.1210/endo-128-5-2297; LAMPRECHT SA, 1973, J ENDOCRINOL, V57, P217, DOI 10.1677/joe.0.0570217; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; Maniatis T., 1982, MOL CLONING; MARSH JM, 1970, J BIOL CHEM, V245, P1596; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; NUKADA T, 1987, FEBS LETT, V211, P5, DOI 10.1016/0014-5793(87)81263-2; OBRIEN PJ, 1984, J BIOL CHEM, V259, P5054; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; RODRIGUEZ MC, 1990, ENDOCRINOLOGY, V127, P674, DOI 10.1210/endo-127-2-674; RODRIGUEZ MC, 1991, ENDOCRINOLOGY, V128, P999; SANCHEZYAGUE J, 1992, J BIOL CHEM, V267, P7217; SANFORD J, 1991, J BIOL CHEM, V266, P9570; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THEMMEN APN, 1993, IN PRESS J REC RES; TSAIMORRIS CH, 1991, J BIOL CHEM, V266, P11355; VALIQUETTE M, 1990, P NATL ACAD SCI USA, V87, P5089, DOI 10.1073/pnas.87.13.5089; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530	34	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1723	1728						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420950				2022-12-27	WOS:A1993KH62000035
J	KREBS, JF; FIERKE, CA				KREBS, JF; FIERKE, CA			DETERMINANTS OF CATALYTIC ACTIVITY AND STABILITY OF CARBONIC ANHYDRASE-II AS REVEALED BY RANDOM MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC POCKET; MIXED OLIGODEOXYNUCLEOTIDES; EFFICIENT PROCEDURE; REFINED STRUCTURE; RNA-POLYMERASE; BINDING; SITE; EXPRESSION; MUTATIONS; CO2	The functional importance of a conserved hydrophobic face in human carbonic anhydrase II (CAII), including amino acid residues 190-210, was investigated by random mutagenesis. The catalytic activity, inhibitor binding, and level of CAII expression in Escherichia coli of 57 single amino acid variants were measured revealing that the function of amino acids correlates with their secondary structure placement. Side chains of amino acids in beta-sheet structure are required for the formation of folded, stable protein while those in the turn region determine catalytic efficiency and inhibitor specificity. The CAII active site is extremely plastic, accommodating amino acid substitutions of varied size, charge, and hydrophobicity with little effect on catalysis; only substitutions at Leu198 and Thr199 decrease the rates of CO2 hydration and ester hydrolysis more than 5-fold. These results pinpoint the hydrogen bond network, including the zinc-solvent molecule and Thr199, as crucial for high catalytic efficiency and also suggest that Leu198 forms a portion of a CO2 association site. Increased activity is observed for substitutions at Thr200 (esterase) and Leu203 (hydrase). In addition, the pK(a) of the zinc-bound water molecule varies upon substitution of amino acids which alter the overall charge of the active site. Three residues interact with sulfonamide inhibitors; substitutions at Thr199 decrease binding (up to 10(3)-fold) while mutations at Thr200) and Cys206 increase binding of dansylamide (up to 80-fold). Mutations in the beta-sheet structure (Asp190-Ser197 and Val207-Ile-210) decrease the protein expression of CAII in E. coli, causing the formation of insoluble protein aggregates in many cases. This may suggest an important role for these residues in the folding process. In addition, mutations in Trp192, cis-Pro202, and Trp209 increase thermal lability (up to 5000-fold).	DUKE UNIV,MED CTR,DEPT BIOCHEM,BOX 3711,DURHAM,NC 27710	Duke University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040602, R29GM040602] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40602] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; ARMSTRONG JM, 1966, J BIOL CHEM, V241, P5137; BEHRAVAN G, 1991, EUR J BIOCHEM, V195, P393, DOI 10.1111/j.1432-1033.1991.tb15718.x; BEHRAVAN G, 1990, EUR J BIOCHEM, V190, P351, DOI 10.1111/j.1432-1033.1990.tb15582.x; BRION LP, 1988, ANAL BIOCHEM, V175, P289, DOI 10.1016/0003-2697(88)90391-0; CARLSSON U, 1973, BIOCHIM BIOPHYS ACTA, V310, P376, DOI 10.1016/0005-2795(73)90119-0; CARUTHERS MH, 1987, METHOD ENZYMOL, V154, P287; CHEN RF, 1967, J BIOL CHEM, V242, P5813; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; COLEMAN JE, 1967, J BIOL CHEM, V242, P5212; Coleman JE., 1986, ZINC ENZYMES, P49; de Boer HA., 1986, MAXIMIZING GENE EXPR, P225; DERBYSHIRE KM, 1986, GENE, V46, P145, DOI 10.1016/0378-1119(86)90398-7; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; ERIKSSON AE, 1988, PROTEINS, V4, P283, DOI 10.1002/prot.340040407; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; FIERKE CA, 1991, CARBONIC ANHYDRASE, P22; GUILBAULT GG, 1964, ANAL CHEM, V36, P409, DOI 10.1021/ac60208a052; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANSCH C, 1985, MOL PHARMACOL, V27, P493; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; Hewett-Emmett D., 1991, CARBONIC ANHYDRASES, P15; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; JONSSON B, 1978, J AM CHEM SOC, V100, P1658, DOI 10.1021/ja00474a003; KANAMORI K, 1983, BIOCHEMISTRY-US, V22, P2658, DOI 10.1021/bi00280a011; KANNAN KK, 1977, FEBS LETT, V73, P115, DOI 10.1016/0014-5793(77)80028-8; KING RW, 1976, PROC R SOC SER B-BIO, V193, P107, DOI 10.1098/rspb.1976.0034; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; KREBS JF, 1991, BIOCHEMISTRY-US, V30, P9153, DOI 10.1021/bi00102a005; KREBS JF, 1982, INVESTIGATION ROLES, V2; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIANG JY, 1990, P NATL ACAD SCI USA, V87, P3675, DOI 10.1073/pnas.87.10.3675; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; LINDSKOG S, 1966, BIOCHEMISTRY-US, V5, P2641, DOI 10.1021/bi00872a023; MAREN TH, 1988, ANNU REV PHYSIOL, V50, P695; MERZ KM, 1990, J MOL BIOL, V214, P799, DOI 10.1016/0022-2836(90)90333-H; MERZ KM, 1991, J AM CHEM SOC, V113, P406, DOI 10.1021/ja00002a004; MURAKAMI H, 1987, Genomics, V1, P159, DOI 10.1016/0888-7543(87)90008-5; NAIR SK, 1991, J BIOL CHEM, V266, P17320; NER SS, 1988, DNA-J MOLEC CELL BIO, V7, P127, DOI 10.1089/dna.1988.7.127; POCKER Y, 1972, BIOCHEMISTRY-US, V11, P698, DOI 10.1021/bi00755a005; Pocker Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P149; POCKER Y, 1967, BIOCHEMISTRY-US, V6, P668, DOI 10.1021/bi00855a005; RIEPE ME, 1968, J BIOL CHEM, V243, P2779; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTTON JR, 1979, NEW ENGL J MED, V301, P1329, DOI 10.1056/NEJM197912133012406; TAYLOR PW, 1971, BIOCHEMISTRY-US, V10, P3859, DOI 10.1021/bi00797a010; TAYLOR PW, 1970, BIOCHEMISTRY-US, V9, P3894, DOI 10.1021/bi00822a007; THOMAS PG, 1985, NATURE, V318, P375, DOI 10.1038/318375a0; TU CK, 1982, BIOCHEMISTRY-US, V21, P6353, DOI 10.1021/bi00268a006; VEDANI A, 1984, J PHARM SCI, V73, P352, DOI 10.1002/jps.2600730316; VIDGREN J, 1990, INT J BIOL MACROMOL, V12, P342, DOI 10.1016/0141-8130(90)90040-H; WOOLLEY P, 1975, NATURE, V258, P677, DOI 10.1038/258677a0; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	61	61	69	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					948	954						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419374				2022-12-27	WOS:A1993KG07700031
J	SCARBOROUGH, RM; NAUGHTON, MA; TENG, W; ROSE, JW; PHILLIPS, DR; NANNIZZI, L; ARFSTEN, A; CAMPBELL, AM; CHARO, IF				SCARBOROUGH, RM; NAUGHTON, MA; TENG, W; ROSE, JW; PHILLIPS, DR; NANNIZZI, L; ARFSTEN, A; CAMPBELL, AM; CHARO, IF			DESIGN OF POTENT AND SPECIFIC INTEGRIN ANTAGONISTS - PEPTIDE ANTAGONISTS WITH HIGH SPECIFICITY FOR GLYCOPROTEIN-IIB-IIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION; FIBRINOGEN BINDING; CELL-ADHESION; RGD PEPTIDE; FIBRONECTIN; ANALOGS; VENOM; REQUIREMENTS; ECHISTATIN; INHIBITION	Members of the snake venon-derived, ''disintegrin'' peptide family containing the Arg-Gly-Asp (RGD) amino acid sequence are among the most potent inhibitors of the binding of adhesive proteins to platelet glycoprotein (GP) IIb-IIIa. However, GPIIb-IIIa antagonists containing the RGD sequence are not integrin specific and inhibit the adhesive functions of many other RGD-dependent integrins. The single disintegrin peptide, barbourin, containing a conservative amino acid substitution of Lys (K) for Arg (R) in the RGD sequence, is however, highly specific for GPIIb-IIIa. Using this information we have tested the hypothesis that both structural and conformational elements of barbourin are important for its high affinity and selectivity for platelet GPIIb-IIIa by synthesizing a series of conformationally constrained, disulfide-bridged peptides containing the KGD amino acid sequence. Incorporation of the KGD sequence into a cyclic peptide template, followed by systematic optimization of the cyclic ring size, optimization of secondary hydrophobic binding site interactions, and the derivatization of the lysyl side chain functionality of the KGD sequence has resulted in peptide analogs which display inhibitory potency and GPIIb-IIIa selectivity comparable to that of barbourin. This study demonstrates that the specificity and potency of the disintegrin family of antagonists, in particular barbourin, can be mimicked by small, conformationally restrained peptides.			SCARBOROUGH, RM (corresponding author), COR THERAPEUT INC, 256 E GRAND AVE, SUITE 80, S SAN FRANCISCO, CA 94080 USA.							ALDER M, 1991, Science (Washington D C), V253, P445; ALI FEF, 1990, 11TH P AM PEPT S, P94; BAJUSZ S, 1980, FEBS LETT, V110, P85, DOI 10.1016/0014-5793(80)80029-9; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHARO IF, 1991, J BIOL CHEM, V266, P1415; CHARON MH, 1990, 11TH P AM PEPT S, P82; GAN ZR, 1988, J BIOL CHEM, V263, P19827; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; HUANG TF, 1987, J BIOL CHEM, V262, P16157; KNUDSEN KA, 1988, EXP CELL RES, V179, P42, DOI 10.1016/0014-4827(88)90346-1; KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H; LUDWIG ML, 1968, METHOD ENZYMOL, V11, P585; NUTT RF, 1991, PEPTIDES 1990, P784; NUTT RF, 1992, 12TH P AM PEPT S CAM, P914; PELTON JT, 1985, P NATL ACAD SCI USA, V82, P236, DOI 10.1073/pnas.82.1.236; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; RUCINSKI B, 1990, BIOCHIM BIOPHYS ACTA, V1054, P257, DOI 10.1016/0167-4889(90)90096-V; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SCARBOROUGH RM, 1988, J BIOL CHEM, V263, P16818; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; Spatola A.F., 1983, CHEM BIOCHEM AMINO, V7, P267; TRANQUI L, 1989, J CELL BIOL, V108, P2519, DOI 10.1083/jcb.108.6.2519	26	335	357	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1066	1073						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419315				2022-12-27	WOS:A1993KG07700048
J	KARLSSON, GB; BUTTERS, TD; DWEK, RA; PLATT, FM				KARLSSON, GB; BUTTERS, TD; DWEK, RA; PLATT, FM			EFFECTS OF THE IMINO SUGAR N-BUTYLDEOXYNOJIRIMYCIN ON THE N-GLYCOSYLATION OF RECOMBINANT GP120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; HUMAN-IMMUNODEFICIENCY-VIRUS; HAMSTER OVARY CELLS; ALPHA-D-MANNOSIDASE; ENVELOPE GLYCOPROTEIN; ENDOPLASMIC-RETICULUM; RAT-LIVER; PROCESSING GLUCOSIDASES; SECRETORY GLYCOPROTEINS; INHIBITOR	The imino sugar N-butyldeoxynojirimycin (NB-DNJ) exhibits anti-HIV activity in vitro and inhibits the purified glycoprocessing enzyme alpha1,2-glucosidase I. It has been speculated that the anti-viral activity of this compound may result from inhibition of HIV envelope glycoprotein processing. However, structural evidence that glucosidase inhibition takes place in intact cells at the anti-viral concentration (0.5 mM) is lacking. In this study, N-linked glycosylation of recombinant gp120 expressed in Chinese hamster ovary cells cultured in the presence or absence of NB-DNJ has been characterized. Immunoprecipitation, in conjunction with endoglycosidase H (endo H) digestion and SDS-polyacrylamide gel electrophoresis analysis, revealed that the glycosylation of gp120 was profoundly altered in the presence of NB-DNJ. The majority of the gp120 oligosaccharides from untreated cells were resistant to endo H. However, nearly complete endo H sensitivity was observed following treatment with 0.5 mM NB-DNJ indicating that gp120 expressed in treated cells carries immature, high mannose type oligosaccharides. In addition, using metabolic labeling with [H-3]mannose, gel filtration chromatography, and digestion with highly purified glucosidases I and II, we provide the first definitive evidence that glucosidase I inhibition occurs at the anti-viral concentration of NB-DNJ. These data indicate that glucosidase inhibition is a candidate mechanism for the anti-viral activity of this compound.	UNIV OXFORD,INST GLYCOBIOL,DEPT BIOCHEM,SEARLE RES GRP,S PARKS RD,OXFORD OX1 3QU,ENGLAND	University of Oxford			Platt, Frances/G-1004-2010; Hedestam, Gunilla Karlsson/AAN-9616-2021	Platt, Frances/0000-0001-7614-0403				ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; BURKE B, 1984, EMBO J, V3, P551, DOI 10.1002/j.1460-2075.1984.tb01845.x; DATEMA R, 1982, P NATL ACAD SCI-BIOL, V79, P6787, DOI 10.1073/pnas.79.22.6787; DATEMA R, 1987, PHARMACOL THERAPEUT, V33, P221, DOI 10.1016/0163-7258(87)90066-0; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DEDERA D, 1990, AIDS RES HUM RETROV, V6, P785, DOI 10.1089/aid.1990.6.785; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FEIZI T, 1990, Glycobiology, V1, P17, DOI 10.1093/glycob/1.1.17; FLEET GWJ, 1988, FEBS LETT, V237, P128, DOI 10.1016/0014-5793(88)80185-6; FODDY L, 1988, EUR J BIOCHEM, V175, P291, DOI 10.1111/j.1432-1033.1988.tb14196.x; FUJIMOTO K, 1991, J BIOL CHEM, V266, P3571; GEYER H, 1988, J BIOL CHEM, V263, P11760; GRINNA LS, 1979, J BIOL CHEM, V254, P8814; GROSS V, 1983, J BIOL CHEM, V258, P2203; HETTKAMP H, 1984, EUR J BIOCHEM, V142, P85, DOI 10.1111/j.1432-1033.1984.tb08253.x; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HUGHES RC, 1987, BIOCHEM J, V247, P537, DOI 10.1042/bj2470537; JACOB GS, 1992, IN PRESS NATURAL PRO; KARLSSON GB, 1991, ANAL BIOCHEM, V199, P219, DOI 10.1016/0003-2697(91)90093-9; KARPAS A, 1988, P NATL ACAD SCI USA, V85, P9229, DOI 10.1073/pnas.85.23.9229; KOBATA A, 1987, METHOD ENZYMOL, V138, P779; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEE WR, 1992, J VIROL, V66, P1799, DOI 10.1128/JVI.66.3.1799-1803.1992; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; OLAFSON RW, 1990, J BIOL CHEM, V265, P12240; PEYRIERAS N, 1983, EMBO J, V2, P823, DOI 10.1002/j.1460-2075.1983.tb01509.x; PLATT FM, 1992, EUR J BIOCHEM, V208, P187, DOI 10.1111/j.1432-1033.1992.tb17173.x; RABOUILLE C, 1992, J BIOL CHEM, V267, P11573; RATNER L, 1991, VIROLOGY, V181, P180, DOI 10.1016/0042-6822(91)90483-R; REARICK JI, 1981, J BIOL CHEM, V256, P6255; ROMERO PA, 1986, J BIOL CHEM, V261, P5936; ROMERO PA, 1983, VIROLOGY, V130, P238, DOI 10.1016/0042-6822(83)90133-2; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; TAN A, 1991, J BIOL CHEM, V266, P14504; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; WILLEY RL, 1986, P NATL ACAD SCI USA, V83, P5033; WINCHESTER B, 1992, GLYCOBIOLOGY, V2, P199, DOI 10.1093/glycob/2.3.199	46	170	175	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					570	576						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416962				2022-12-27	WOS:A1993KE60300086
J	PORTER, DJT				PORTER, DJT			S-ADENOSYLHOMOCYSTEINE HYDROLASE - STEREOCHEMISTRY AND KINETICS OF HYDROGEN TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INHIBITORS; L-HOMOCYSTEINE HYDROLASE; NEPLANOCIN-A; NUCLEOSIDE ANALOGS; RAT-LIVER; INACTIVATION; 2'-DEOXYADENOSINE; CELLS; ENZYME; POTENT	The stereochemistry and kinetics for hydrogen transfer to the catalytically essential NAD+ of S-adenosylhomocysteine hydrolase (SAHase) have been determined for selected adenosine analogues. Reduced SAHase (E(NADH)), which was made by reconstituting apoSAHase with NADH, stereospecifically transferred the pro-R hydrogen of NADH to 3'-ketoadenosine, a proposed reaction intermediate. Reduction of SAHase by 5'-deoxyadenosine, alpha-L-lyxofuranosyladenine, or adenosine-5'-carboxylate quenched the intrinsic protein fluorescence and increased the absorbance of the enzyme at 330 nm. The kinetics for reduction were consistent with a two-step mechanism [GRAPHICS] where E.L was an initial complex between ligand (L) and enzyme (E), and E'.L' was a complex between reduced enzyme and oxidized ligand. Initial complex formation between SAHase and alpha-L-lyxofuranosyladenine (k-1/k1 = 22.6 muM) was too rapid to be followed by stopped-flow spectrofluorometry at 25-degrees-C. The first-order rate constants for reduction (k2) and oxidation (k-2) of the enzyme were 7.7 and 0.22 s-1, respectively. The dissociation constant for initial complex formation between 5'-deoxyadenosine and SAHase was 24 muM; k2 and k-2 were 8.4 x 10(-3) and 4.2 x 10(-3) s-1, respectively. The association rate constant for binding of adenosine-5'-carboxylate to SAHase (k1) was 2.1 x 10(5) M-1 s-1, and the dissociation rate constant (k-1) was 0.15 s-1; k2 and k-2 were 0.1 and 0.15 s-1, respectively. The association rate constant for adenine was 5.5 x 10(6) M-1 s-1, and the dissociation rate constant was 6.4 s-1.			PORTER, DJT (corresponding author), BURROUGHS WELLCOME CO,DIV EXPTL THERAPY,RES TRIANGLE PK,NC 27709, USA.							ABELES RH, 1980, BIOCHEM BIOPH RES CO, V95, P612, DOI 10.1016/0006-291X(80)90829-3; ABELES RH, 1982, BIOCHEMISTRY-US, V21, P5557, DOI 10.1021/bi00265a027; Bevington P.R., 1969, DATA REDUCTION ERROR; BORCHARDT RT, 1984, J BIOL CHEM, V259, P4353; BORCHERDING DR, 1988, J MED CHEM, V31, P1729, DOI 10.1021/jm00117a011; CHIANG PK, 1981, ARCH BIOCHEM BIOPHYS, V207, P175, DOI 10.1016/0003-9861(81)90023-0; CREWS RP, 1983, NUCLEOS NUCLEOT, V2, P275, DOI 10.1080/07328318308078861; DECLERCQ E, 1989, BIOCHEM PHARMACOL, V38, P1771, DOI 10.1016/0006-2952(89)90411-5; DELAHABA G, 1986, BIOCHEMISTRY-US, V25, P8337, DOI 10.1021/bi00373a031; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; GOMI T, 1986, J BIOL CHEM, V261, P3422; GOMI T, 1989, BIOCHIM BIOPHYS ACTA, V994, P172, DOI 10.1016/0167-4838(89)90157-X; HERSHFIELD MS, 1979, J BIOL CHEM, V254, P22; HERSHFIELD MS, 1985, BIOCHEM J, V230, P43, DOI 10.1042/bj2300043; KIM IY, 1985, BIOCHIM BIOPHYS ACTA, V829, P150, DOI 10.1016/0167-4838(85)90183-9; MADHAVAN GVB, 1988, J MED CHEM, V31, P1798, DOI 10.1021/jm00117a021; MATUSZEWSKA B, 1987, J BIOL CHEM, V262, P265; MCCARTHY JR, 1989, J AM CHEM SOC, V111, P1127, DOI 10.1021/ja00185a052; MERTA A, 1983, COLLECT CZECH CHEM C, V48, P2701, DOI 10.1135/cccc19832701; NARAYANAN SR, 1988, J MED CHEM, V31, P500, DOI 10.1021/jm00398a002; NELSESTU.GL, 1971, J BIOL CHEM, V246, P7533; PALMER JL, 1979, J BIOL CHEM, V254, P1217; PARRY RJ, 1985, J AM CHEM SOC, V107, P1417, DOI 10.1021/ja00291a055; PARRY RJ, 1991, BIOCHEMISTRY-US, V30, P9988, DOI 10.1021/bi00105a025; PORTER DJT, 1992, J BIOL CHEM, V267, P3205; PORTER DJT, 1991, J BIOL CHEM, V266, P21616; RICHARDS HH, 1978, J BIOL CHEM, V253, P4476; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P5100, DOI 10.1021/bi00642a024; STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TSENG CKH, 1989, J MED CHEM, V32, P1442, DOI 10.1021/jm00127a007; WANG SF, 1970, J BIOL CHEM, V245, P8; WOLFSON G, 1986, J BIOL CHEM, V261, P4492; YOU KS, 1982, METHOD ENZYMOL, V87, P101; 1961, OR18 PABST LAB CIRC, P2	35	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					66	73						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416969				2022-12-27	WOS:A1993KE60300012
J	TAUSSIG, R; QUARMBY, LM; GILMAN, AG				TAUSSIG, R; QUARMBY, LM; GILMAN, AG			REGULATION OF PURIFIED TYPE-I AND TYPE-II ADENYLYLCYCLASES BY G-PROTEIN BETA-GAMMA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXPRESSION VECTORS; ADENYLATE-CYCLASE; BOVINE BRAIN; PURIFICATION; AFFINITY; CHANNEL; CLONING	Type I and type II adenylylcyclases have been purified after expression in Sf9 cells, each by application of a two-step purification protocol. The specific activities of the essentially homogeneous enzymes are approximately 7 and 2 mumol.min-1.mg-1, respectively. Each purified enzyme preparation is activated by G(salpha), but they are regulated in an opposite fashion by G protein betagamma subunits. Purified betagamma inhibits G(salpha)-stimulated type I adenylylcyclase directly, while betagamma activates type II adenylylcyclase and potentiates the G(salpha)-mediated stimulation of the enzyme. This is the first demonstration of the activation of a purified effector molecule by G protein betagamma subunits.			TAUSSIG, R (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.			Quarmby, Lynne/0000-0001-6661-680X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34497] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLUMER KJ, 1991, ANNU REV PHYSIOL, V53, P37; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HOCHST H, 1988, J VAC SCI TECHNOL B, V6, P1320, DOI 10.1116/1.584257; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; PFEUFFER E, 1985, EMBO J, V4, P3675, DOI 10.1002/j.1460-2075.1985.tb04134.x; PFEUFFER T, 1982, FEBS LETT, V146, P369, DOI 10.1016/0014-5793(82)80955-1; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	25	208	213	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					9	12						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416978				2022-12-27	WOS:A1993KE60300003
J	PRICE, MG; GOMER, RH				PRICE, MG; GOMER, RH			SKELEMIN, A CYTOSKELETAL M-DISC PERIPHERY PROTEIN, CONTAINS MOTIFS OF ADHESION RECOGNITION AND INTERMEDIATE FILAMENT PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CELL-ADHESION; AMINO-ACID-SEQUENCE; LIGHT CHAIN KINASE; MOLECULE N-CAM; IMMUNOGLOBULIN-LIKE DOMAINS; SECONDARY-STRUCTURE; MESSENGER-RNA; SUPERFAMILY; MUSCLE; FIBRONECTIN	In striated muscle, myofibrils are anchored to an interconnecting cytoskeleton of desmin intermediate filaments. Skelemin (195 kDa) may be a link between myofibrils and the intermediate filament cytoskeleton. Skelemin partitions with desmin to the insoluble cytoskeleton, and increases the thickness of reconstituted intermediate filaments. Concentrated at the M-disc periphery, skelemin may also contact myosin filaments. We used immunoscreening to isolate a mouse muscle cDNA which encodes a protein with a calculated molecular mass of 185 kDa. Anti-skelemin antibodies bound to the protein products of each of three nonoverlapping regions of the open reading frame. Antibodies directed against the protein products of each one-third of the cDNA react with a 195-kDa muscle protein and stain the M-disc indistinguishably from the original anti-skelemin antibodies, suggesting that the cDNA encodes skelemin. A single skelemin mRNA is detected in muscle but not non-muscle tissues, consistent with immunostaining results. Skelemin is a member of a family of myosin-associated proteins containing fibronectin type III and immunoglobulin superfamily C2 motifs. Skelemin is unique in this family in having intermediate filament core-like motifs, one near each terminus. We hypothesize that skelemin could interact with myosin or myosin-associated proteins through its fibronectin and/or immunoglobulin motifs, and with intermediate filaments through intermediate filament-like motifs.	RICE UNIV, HOWARD HUGHES MED INST, HOUSTON, TX 77251 USA	Howard Hughes Medical Institute; Rice University	PRICE, MG (corresponding author), RICE UNIV, DEPT BIOCHEM & CELL BIOL, HOUSTON, TX 77251 USA.			Gomer, Richard/0000-0003-2361-4307				AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; BAIROCH A, 1989, PROSITE DICT PROTEIN; BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BARON M, 1992, BIOCHEMISTRY-US, V31, P2068, DOI 10.1021/bi00122a025; BAUW G, 1989, P NATL ACAD SCI USA, V86, P7701, DOI 10.1073/pnas.86.20.7701; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BRYAN J, 1989, J BIOL CHEM, V264, P13873; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; CUNNINGHAM BA, 1988, ADV CELL BIOL, V2, P25; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; EPSTEIN HF, 1991, SCIENCE, V251, P1039, DOI 10.1126/science.1998120; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FISCHMAN DA, 1991, INT CONGR SER, P211; Fraser R.D.B., 1990, CELLULAR MOL BIOL IN, P205; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; FRITZ JD, 1991, NUCLEIC ACIDS RES, V19, P3747, DOI 10.1093/nar/19.13.3747; FRYBERG CC, 1992, P ROY SOC LOND B BIO, V249, P33; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x; GOUDIE RB, 1966, LANCET, V2, P1224; GRANZIER HLM, 1993, J GEN PHYSIOL, V101, P235, DOI 10.1085/jgp.101.2.235; GRODBERG J, 1988, NUCLEIC ACIDS RES, V16, P1209, DOI 10.1093/nar/16.3.1209; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; HALL AK, 1990, J CELL BIOL, V110, P817, DOI 10.1083/jcb.110.3.817; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HAUGEN PK, 1990, J CELL BIOL, V111, P2733, DOI 10.1083/jcb.111.6.2733; HEIN J, 1990, METHOD ENZYMOL, V183, P626; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P3037, DOI 10.1073/pnas.83.9.3037; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9; HORTSCH M, 1991, ANNU REV CELL BIOL, V7, P505, DOI 10.1146/annurev.cb.07.110191.002445; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1, DOI 10.1016/S0065-2776(08)60639-2; Hynes RO, 1990, FIBRONECTINS; JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRIEG PA, 1989, NUCLEIC ACIDS RES, V17, P10321, DOI 10.1093/nar/17.24.10321; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKEY A, 1990, EMBO J, V9, P3459, DOI 10.1002/j.1460-2075.1990.tb07554.x; LAWRENCE CB, 1988, COMPUT APPL BIOSCI, V4, P25; LAZARIDES E, 1986, MOL BIOL MUSCLE DEV, P749; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; MASAKI T, 1974, J BIOCHEM, V75, P367, DOI 10.1093/oxfordjournals.jbchem.a130403; MCCORMICK MB, 1991, J CELL BIOL, V113, P1111, DOI 10.1083/jcb.113.5.1111; MCGRAW RA, 1990, BIOTECHNIQUES, V8, P674; MONROY AF, 1988, FOCUS, V10, P14; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; NOGUCHI J, 1992, J BIOL CHEM, V267, P20302; ODERMATT E, 1989, FIBRONECTIN, P25; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIEROBONBORMIOLI S, 1981, J MUSCLE RES CELL M, V2, P401, DOI 10.1007/BF00711967; Price M.G., 1983, Cell and Muscle Motility, V3, P1; PRICE MG, 1989, CELL MOTIL CYTOSKEL, V13, P274, DOI 10.1002/cm.970130406; PRICE MG, 1987, J CELL BIOL, V104, P1325, DOI 10.1083/jcb.104.5.1325; PRICE MG, 1984, AM J PHYSIOL, V246, pH566, DOI 10.1152/ajpheart.1984.246.4.H566; PRICE MG, 1991, ADV STRUCTURAL BIOL, V1, P175; PRIETO AL, 1992, J CELL BIOL, V119, P663, DOI 10.1083/jcb.119.3.663; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RAO Y, 1992, J CELL BIOL, V118, P937, DOI 10.1083/jcb.118.4.937; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Rutishauser U, 1989, CURR OPIN CELL BIOL, V1, P898, DOI 10.1016/0955-0674(89)90056-2; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMALL JV, 1992, EUR J BIOCHEM, V208, P559, DOI 10.1111/j.1432-1033.1992.tb17220.x; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STEVEN AC, 1990, CELLULAR MOL BIOL IN, P233; STREET SF, 1983, J CELL PHYSIOL, V114, P346, DOI 10.1002/jcp.1041140314; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; THORNELL LE, 1990, DEVELOPMENTAL CARDIOLOGY, P115; THORNELL LE, 1990, DYNAMIC STATE OF MUSCLE FIBERS, P369; TRINICK J, 1992, FEBS LETT, V307, P44, DOI 10.1016/0014-5793(92)80899-R; VAUGHAN KT, 1993, J BIOL CHEM, V268, P3670; WANG K, 1991, P NATL ACAD SCI USA, V88, P7101, DOI 10.1073/pnas.88.16.7101; Wang K, 1985, Cell Muscle Motil, V6, P315; WANG K, 1983, J CELL BIOL, V96, P562, DOI 10.1083/jcb.96.2.562; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; YUEN SW, 1989, BIOTECHNIQUES, V7, P74; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203	109	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21800	21810						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408035				2022-12-27	WOS:A1993MC80900058
J	ARRIBAS, J; CASTANO, JG				ARRIBAS, J; CASTANO, JG			A COMPARATIVE-STUDY OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE RAT-LIVER MULTICATALYTIC PROTEINASE AND THE CLPP FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; N-END RULE; SENSITIVE NEUTRAL ENDOPEPTIDASE; CIS-TRANS ISOMERASE; THERMOPLASMA-ACIDOPHILUM; MULTIFUNCTIONAL PROTEINASE; PROTEOLYTIC ACTIVITIES; SERINE PROTEASES; INVIVO FUNCTION; COMPLEX	A comparative study of the chymotrypsin-like activity of the purified recombinant ClpP protease and the multicatalytic proteinase from rat liver is presented. The peptidase activity of both enzymes has been analyzed with several synthetic fluorogenic peptides, containing either aromatic or nonpolar amino acids in their P1 position. The respective V(max), K(m), and V(max)/K(m) were calculated from kinetic experiments. The substrate specificity of the multicatalytic proteinase, as expressed by V(max)/K(m) values, indicate the following substrate preference: N-Suc-IIW-MCA > N-Suc-LY-MCA > N-Suc-LLVY-MCA greater-than-or-equal-to N-Suc-AAF-MCA > N-Cbz-GGL-beta-NA > Glut-GGF-beta-NA > FPAM-4-MNA. In the case of the ClpP the order of preference is: N-Suc-LY-MCA > N-Suc-IIW-MCA > N-Suc-LLVY-MCA greater-than-or-equal-to N-Suc-AAF-MCA greater-than-or-equal-to N-Cbz-GGL-beta-NA > FPAM-4-MNA (where: N-Suc, N-succinyl-; MCA, 7-amido-4-methyl coumarin; beta-NA, beta-naphthylamide; N-Cbz, N-benzyloxycarbonyl-; 4-MNA, 4-methoxy-beta-naphthylamide; Glut, glutaryl. This similar substrate specificity is further supported by the lack of activity of both enzymes against SY-MCA and N-Suc-AAPF-MCA (known substrates of chymotrypsin), by very reduced activity against N-Suc-AAA-MCA and by no significant activity against LG-beta-NA. The results of mixed substrate experiments have shown that all the peptides that are substrates seem to be hydrolyzed by a single class of chymotrypsin-like site in both enzymes. The substrate specificity studies suggest a possible evolutionary relationship between the catalytic component of the ClpP of Escherichia coli and the multicatalytic proteinase chymotrypsin-like catalytic component. This conclusion is further supported by other circumstantial evidence: the fact that affinity-purified anti-ClpP antibodies cross-react with two polypeptide components of the rat liver multicatalytic proteinase complex, presented here and also shown previously; the known resemblance of both structures at the electron microscope level; and their reported role in the degradation of NH2-end rule substrates.	UNIV AUTONOMA MADRID,FAC MED,CSIC,DEPT BIOQUIM,E-28029 MADRID,SPAIN; UNIV AUTONOMA MADRID,FAC MED,CSIC,INST INVEST BIOMED,E-28029 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)			Arribas, Joaquin/M-4482-2014	Arribas, Joaquin/0000-0002-0504-0664; G. Castano, Jose/0000-0002-6579-8442				ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; ARRIBAS J, 1991, J EXP MED, V173, P423, DOI 10.1084/jem.173.2.423; CHU-PING M, 1992, Journal of Biological Chemistry, V267, P10515; DAHLMANN B, 1992, EUR J BIOCHEM, V208, P789, DOI 10.1111/j.1432-1033.1992.tb17249.x; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; DJABALLAH H, 1992, EUR J BIOCHEM, V209, P629, DOI 10.1111/j.1432-1033.1992.tb17329.x; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANIATIS T, 1986, MOL CLONING; MASON RW, 1990, BIOCHEM J, V265, P479, DOI 10.1042/bj2650479; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; ORLOWSKI M, 1989, BIOCHEMISTRY-US, V28, P9270, DOI 10.1021/bi00450a006; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; RIVETT AJ, 1989, J BIOL CHEM, V264, P12215; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO S, 1990, BIOCHIM BIOPHYS ACTA, V1041, P269, DOI 10.1016/0167-4838(90)90283-L; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V164, P1253, DOI 10.1016/0006-291X(89)91804-4; TANAKA K, 1986, J BIOL CHEM, V261, P5204; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUKAHARA T, 1991, BIOCHIM BIOPHYS ACTA, V1079, P273, DOI 10.1016/0167-4838(91)90069-C; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; WAGNER BJ, 1991, CURR EYE RES, V10, P485, DOI 10.3109/02713689109001756; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; WO KM, 1989, J IBOL CHEM, V264, P2088; ZWICKL P, 1991, FEBS LETT, V278, P217, DOI 10.1016/0014-5793(91)80120-R; ZWICKL P, 1992, FEBS LETT, V312, P157, DOI 10.1016/0014-5793(92)80925-7	40	31	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21165	21171						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407953				2022-12-27	WOS:A1993MA28800078
J	FRANKLIN, AA; KUBIK, MF; UITTENBOGAARD, MN; BRAUWEILER, A; UTAISINCHAROEN, P; MATTHEWS, MAH; DYNAN, WS; HOEFFLER, JP; NYBORG, JK				FRANKLIN, AA; KUBIK, MF; UITTENBOGAARD, MN; BRAUWEILER, A; UTAISINCHAROEN, P; MATTHEWS, MAH; DYNAN, WS; HOEFFLER, JP; NYBORG, JK			TRANSACTIVATION BY THE HUMAN T-CELL LEUKEMIA-VIRUS TAX PROTEIN IS MEDIATED THROUGH ENHANCED BINDING OF ACTIVATING TRANSCRIPTION FACTOR-II (ATF-2) ATF-2 RESPONSE AND CAMP ELEMENT-BINDING PROTEIN (CREB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; LEUCINE ZIPPER STRUCTURE; HTLV-I; CYCLIC-AMP; 21-BASE-PAIR REPEATS; RNA-POLYMERASE; NUCLEAR FACTOR; KINASE-A; GENE; IDENTIFICATION	The human T-cell leukemia virus type I (HTLV-I)-encoded transcriptional activator protein Tax is strongly implicated in HTLV-I pathogenesis. Tax regulates HTLV-I gene expression through three 21-base pair (bp) repeat enhancer elements located in the transcriptional control region of the virus. Tax does not bind these elements directly, but mediates transactivation through the cellular transcription factors that recognize a cAMP response element (CRE)-like sequence centered within each of the 21-bp repeats. In this report, we identify activating transcription factor-2 (ATF-2) and CRE-binding protein (CREB) as the principal T-cell proteins that bind the three 21-bp repeats in vitro. Purified Tax protein augments the level of RNA synthesis induced by ATF-2 and CREB in a cell-free transcription assay, providing evidence that Tax cooperates with these cellular proteins to activate HTLV-I transcription. Furthermore, Tax dramatically increases the binding of both the T-cell-derived and recombinant forms of ATF-2 and CREB to each of the 21-bp repeats. The target sequences for this enhancement reside within the DNA binding/dimerization domains of these proteins. These data suggest that Tax transactivates HTLV-I gene expression by increasing the number of bound ATF-2 and CREB molecules at the viral promoter.	COLORADO STATE UNIV, DEPT BIOCHEM, FT COLLINS, CO 80523 USA; COLORADO STATE UNIV, DEPT MICROBIOL, FT COLLINS, CO 80523 USA; UNIV COLORADO, DEPT CHEM & BIOCHEM, BOULDER, CO 80309 USA; UNIV COLORADO, HLTH SCI CTR, DIV MED ONCOL, DENVER, CO 80262 USA	Colorado State University; Colorado State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Dynan, William/0000-0002-4045-5662	NATIONAL CANCER INSTITUTE [R55CA055035] Funding Source: NIH RePORTER; NCI NIH HHS [1 R55 CA55035] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ALTMAN R, 1988, J VIROL, V62, P1339, DOI 10.1128/JVI.62.4.1339-1346.1988; ARIAS JA, 1989, J BIOL CHEM, V264, P3223; ARMSTRONG AP, 1993, P NATL ACAD SCI USA, V90, P7303, DOI 10.1073/pnas.90.15.7303; BEIMLING P, 1992, ONCOGENE, V7, P257; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; BRADY J, 1987, J VIROL, V61, P2175, DOI 10.1128/JVI.61.7.2175-2181.1987; CANN AJ, 1985, NATURE, V318, P571, DOI 10.1038/318571a0; CHEN ISY, 1985, SCIENCE, V229, P54, DOI 10.1126/science.2990037; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FUJISAWA J, 1986, EMBO J, V5, P713, DOI 10.1002/j.1460-2075.1986.tb04272.x; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HJELLE B, 1991, ARCH PATHOL LAB MED, V115, P440; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOEFFLER JP, 1991, MOL ENDOCRINOL, V5, P256, DOI 10.1210/mend-5-2-256; JEANG KT, 1987, J VIROL, V61, P708, DOI 10.1128/JVI.61.3.708-713.1987; KADISON P, 1990, J VIROL, V64, P2141, DOI 10.1128/JVI.64.5.2141-2148.1990; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MATTHEWS MAH, 1992, MOL CELL BIOL, V12, P1986, DOI 10.1128/MCB.12.5.1986; NIKI M, 1992, J VIROL, V66, P4348, DOI 10.1128/JVI.66.7.4348-4357.1992; NYBORG JK, 1990, J BIOL CHEM, V265, P8230; NYBORG JK, 1988, P NATL ACAD SCI USA, V85, P1457, DOI 10.1073/pnas.85.5.1457; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; POTEAT HT, 1990, J VIROL, V64, P1264, DOI 10.1128/JVI.64.3.1264-1270.1990; SEIKI M, 1986, EMBO J, V5, P561, DOI 10.1002/j.1460-2075.1986.tb04247.x; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	37	160	161	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21225	21231						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407959				2022-12-27	WOS:A1993MA28800086
J	JANSEN, MAK; DEPKA, B; TREBST, A; EDELMAN, M				JANSEN, MAK; DEPKA, B; TREBST, A; EDELMAN, M			ENGAGEMENT OF SPECIFIC SITES IN THE PLASTOQUINONE NICHE REGULATES DEGRADATION OF THE D1 PROTEIN IN PHOTOSYSTEM-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIZED 32-KILODALTON PROTEIN; PHOTOSYNTHETIC REACTION CENTER; REACTION CENTER POLYPEPTIDES; CHLOROPLAST MEMBRANE; THYLAKOID MEMBRANE; D1-PROTEIN DEGRADATION; INVIVO DEGRADATION; HERBICIDE BINDING; QB SITE; PHOTOINHIBITION	Rapid degradation of the photosystem-II reaction center protein, D1, is driven by visible and ultraviolet irradiance at low photon-flux in the intact plant. We find that all inhibitors of electron flow that replace bound plastoquinone (Q(B)) from its niche on D1 inhibit UV-B-driven D1 degradation, but only some inhibit visible light-driven degradation. Stabilization of the D1 protein by nitrophenol type inhibitors in visible light depends on the dimensions of the side chain at position 6 of the phenyl ring. Likewise, resistance to trypsinization of D1 at Arg-238 and to electron flow inhibitors in D1 mutant V219I (but not A251V, F255Y, S264A, or L275F) are functions of position 6 side chain dimensions in isolated thylakoids. We conclude that the configuration of the Q(B) niche controls D1 protein degradation in intact plants under physiological photon flux. This is true irrespective of the spectral quality of radiation driving degradation. We show that UV-B-driven D1 protein degradation, but not that driven by visible light, requires plastoquinone in the Q(B) niche to proceed. D1 degradation in visible light occurs as long as specific regions at the end of helix D and in the D-de loop of the protein are not engaged. These regions, through substrate (i.e. Q(B))-mediated stabilization, are proposed to regulate rapid degradation of the D1 protein.	RUHR UNIV BOCHUM,DEPT BIOL,W-4630 BOCHUM 1,GERMANY	Ruhr University Bochum	JANSEN, MAK (corresponding author), WEIZMANN INST SCI,DEPT PLANT GENET,IL-76100 REHOVOT,ISRAEL.			Jansen, Marcel/0000-0003-2014-5859				ARO EM, 1990, BIOCHIM BIOPHYS ACTA, V1019, P269, DOI 10.1016/0005-2728(90)90204-H; BARBATO R, 1991, FEBS LETT, V290, P162, DOI 10.1016/0014-5793(91)81250-C; CRAMER WA, 1985, TRENDS BIOCHEM SCI, V10, P125, DOI 10.1016/0968-0004(85)90273-7; Crosby D G, 1976, HERBICIDES CHEM DEGR, V2, P835; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DOSTATNI R, 1988, FEBS LETT, V239, P207, DOI 10.1016/0014-5793(88)80918-9; GALLOWAY RE, 1984, PLANT PHYSIOL, V74, P469, DOI 10.1104/pp.74.3.469; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GIARDI MT, 1988, BIOCHIM BIOPHYS ACTA, V934, P64, DOI 10.1016/0005-2728(88)90120-X; GONG H, 1991, J BIOL CHEM, V266, P21293; GOUNARIS K, 1987, FEBS LETT, V211, P94, DOI 10.1016/0014-5793(87)81281-4; GREENBERG BM, 1987, EMBO J, V6, P2865, DOI 10.1002/j.1460-2075.1987.tb02588.x; GREENBERG BM, 1989, P NATL ACAD SCI USA, V86, P6617, DOI 10.1073/pnas.86.17.6617; GRESSEL J, 1985, WEED PHYSL, V2, P159; HOFFMANFALK H, 1982, J BIOL CHEM, V257, P4583; JANSEN MAK, 1990, Z NATURFORSCH C, V45, P408; JANSEN MAK, 1990, Z NATURFORSCH C, V45, P97; JANSEN MAK, 1992, REGULATION CHLOROPLA, P295; KLESS H, 1992, BIOCHEMISTRY-US, V31, P11065, DOI 10.1021/bi00160a016; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; MARDER JB, 1984, J BIOL CHEM, V259, P3900; MARDER JB, 1987, PLANT MOL BIOL, V9, P325, DOI 10.1007/BF00014907; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; OHAD N, 1990, Z NATURFORSCH C, V45, P402; ROCHAIX JD, 1988, TRENDS BIOCHEM SCI, V13, P56, DOI 10.1016/0968-0004(88)90029-1; ROCHAIX JD, 1984, PLANT MOL BIOL, V3, P363, DOI 10.1007/BF00033383; SOPORY SK, 1990, Z NATURFORSCH C, V45, P412; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; SVENSSON B, 1991, Z NATURFORSCH C, V46, P765; THOMPSON LK, 1988, BIOCHEMISTRY-US, V27, P6653, DOI 10.1021/bi00418a002; TREBST A, 1991, Z NATURFORSCH C, V46, P557; TREBST A, 1986, Z NATURFORSCH C, V41, P240; TREBST A, 1986, PHOTOSYNTH RES, V10, P381, DOI 10.1007/BF00118304; TREBST A, 1988, PHOTOSYNTH RES, V18, P163, DOI 10.1007/BF00042983; TREBST A, 1979, ADV PESTIC SCI, V2, P223; TREBST A, 1993, IN PRESS PHYTOCHEMIS; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; VIRGIN I, 1991, FEBS LETT, V287, P125, DOI 10.1016/0014-5793(91)80031-W; WETTERN M, 1984, ISRAEL J BOT, V33, P253; WILDNER GF, 1990, Z NATURFORSCH C, V45, P1142	44	70	70	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21246	21252						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407962				2022-12-27	WOS:A1993MA28800089
J	MATSUSHITA, N; SOGAWA, K; EMA, M; YOSHIDA, A; FUJIIKURIYAMA, Y				MATSUSHITA, N; SOGAWA, K; EMA, M; YOSHIDA, A; FUJIIKURIYAMA, Y			A FACTOR-BINDING TO THE XENOBIOTIC RESPONSIVE ELEMENT (XRE) OF P-4501A1 GENE CONSISTS OF AT LEAST 2 HELIX-LOOP-HELIX PROTEINS, AH RECEPTOR AND ARNT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; PLANAR AROMATIC-COMPOUNDS; DIOXIN RECEPTOR; REGULATORY ELEMENTS; INDUCIBLE EXPRESSION; LEVEL EXPRESSION; DNA INTERACTIONS; RNA-POLYMERASE; CLONING; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN	Xenobiotic responsive element (XRE) is an inducible enhancer element that drives inducible expression of P-4501A1 gene in response to xenobiotic inducers. The XRE-binding factor appears in the nuclei of Hepa-1 cells treated with 3-methylcholanthrene (3-MC). Association of the Ah receptor and Arnt (Ah receptor nuclear translocator) in an XRE-binding complex was examined by anti-Ah receptor and Arnt antibodies. Both antibodies inhibited the sequence-specific XRE-binding activity of nuclear extracts from 3-MC-treated Hepa-1 cells and of the cytosolic fraction which was prepared from the nontreated cells and treated in vitro with 3-MC. These results indicate that Ah receptor and Arnt proteins are components of the XRE-binding factor and suggest that Arnt as well as the Ah receptor are localized in the cytosol of nontreated cells. The Ah receptor present in C4 cells, a mutant of Hepa-1 cells defective in the Arnt function, showed an inducer-dependent association with Arnt synthesized in an in vitro translation system. Co-transfection of the expression plasmids of the Ah receptor and Arnt exhibited synergistically more activated transcription from a reporter gene pMC6.3k consisting of the P-4501A1 gene promoter and enhancer than transfection with either of the two plasmids alone. These findings indicate that the Ah receptor and Arnt proteins form a complex that activates transcription in an inducer-dependent manner.	TOHOKU UNIV,FAC SCI,DEPT CHEM,SENDAI,MIYAGI 980,JAPAN; NAGOYA UNIV,DEPT AGR CHEM,NAGOYA,AICHI 464,JAPAN	Tohoku University; Nagoya University				Ema, Masatsugu/0000-0003-0645-6183				ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRADFIELD CA, 1991, MOL PHARMACOL, V39, P13; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; DENISON MS, 1988, J BIOL CHEM, V263, P17221; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELFERINK CJ, 1990, J BIOL CHEM, V265, P20708; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FUJISAWASEHARA A, 1986, NUCLEIC ACIDS RES, V14, P1465; FUJISAWASEHARA A, 1988, P NATL ACAD SCI USA, V85, P5859, DOI 10.1073/pnas.85.16.5859; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANKINSON O, 1983, SOMAT CELL GENET, V9, P497, DOI 10.1007/BF01543050; HAPGOOD J, 1989, P NATL ACAD SCI USA, V86, P60, DOI 10.1073/pnas.86.1.60; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDERS JP, 1991, BIOCHEM J, V276, P273, DOI 10.1042/bj2760273; LEGRAVEREND C, 1982, J BIOL CHEM, V257, P6402; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; PROKIPCAK RD, 1988, ARCH BIOCHEM BIOPHYS, V267, P811, DOI 10.1016/0003-9861(88)90091-4; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; SOGAWA K, 1986, P NATL ACAD SCI USA, V83, P8044, DOI 10.1073/pnas.83.21.8044; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x	31	146	146	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21002	21006						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407937				2022-12-27	WOS:A1993MA28800057
J	WANG, JP; NEEDLEMAN, DH; HAMILTON, SL				WANG, JP; NEEDLEMAN, DH; HAMILTON, SL			RELATIONSHIP OF LOW-AFFINITY [H-3] RYANODINE BINDING-SITES TO HIGH-AFFINITY SITES ON THE SKELETAL-MUSCLE CA(2+) RELEASE CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; CA-2+ RELEASE; H-3 RYANODINE; FUNCTIONAL-STATE; PURIFICATION; PROBE	Both high and low affinity binding sites for [H-3]ryanodine exist in sarcoplasmic reticulum membranes derived from rabbit skeletal muscle. Negatively cooperative binding of [H-3]ryanodine at one of four initially identical sites cannot account for some of the kinetic features of the binding to high and low affinity sites. The presence of excess unlabeled ryanodine greatly slows the rate at which [H-3]ryanodine bound at the high affinity site dissociates. An examination of the rate of dissociation of [H-3]ryanodine bound at increasing [H-3]ryanodine concentrations reveals the existence of a second site, occupied only at high ligand concentrations. The occupation of this site correlates well with the conversion of the high affinity site from a site with a dissociation rate constant of approximately 0.0025 min-1 to one with a dissociation rate constant of less than 0.00025 min-1. The low affinity site itself has a dissociation rate constant of 0.013 min-1 and dissociation from this site is unaffected by the presence of 100 muM unlabeled ryanodine. These data suggest that the two binding sites are different but are either allosterically or sterically coupled. Association experiments support this interpretation. Low affinity binding sites for [H-3]ryanodine exist in transverse tubule (t-tubule) as well as sarcoplasmic reticulum membranes. High concentrations of both ryanodine and ruthenium red inhibit the binding of [H-3]PN200-110 to the dihydropyridine-binding protein in t-tubule membranes. Whether the low affinity site in t-tubule membranes is related to that found in sarcoplasmic reticulum membranes is not yet known.	BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine				Hamilton, Susan/0000-0003-0241-9369	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044, R01HL037028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR041729, R01AR041729] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-37028, HL-37044] Funding Source: Medline; NIAMS NIH HHS [AR-41729] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BUCK E, 1982, J BIOL CHEM, V267, P23560; CARROLL S, 1991, ARCH BIOCHEM BIOPHYS, V290, P239, DOI 10.1016/0003-9861(91)90615-P; CHU A, 1990, MOL PHARMACOL, V37, P735; EMMICK JT, 1993, BIOPHYS J A; HAMILTON SL, 1991, CELLULAR CALCIUM, P313; HAWKES MJ, 1989, MEMBRANE BIOCHEM, V8, P133, DOI 10.3109/09687688909025827; HAWKES MJ, 1992, J BIOL CHEM, V267, P6702; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; INUI M, 1987, J BIOL CHEM, V262, P1740; LAI FA, 1989, J BIOL CHEM, V264, P16776; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; MEISSNER G, 1992, MOL CELL BIOCHEM, V114, P119; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; ROSEMBLATT M, 1981, J BIOL CHEM, V256, P8140; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SUKHAREVA M, 1993, BIOPHYS J A; ZIMANYI I, 1991, J PHARMACOL EXP THER, V256, P938	22	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					20974	20982						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407933				2022-12-27	WOS:A1993MA28800053
J	YOSHIMURA, K; ROSENFELD, MA; SETH, P; CRYSTAL, RG				YOSHIMURA, K; ROSENFELD, MA; SETH, P; CRYSTAL, RG			ADENOVIRUS-MEDIATED AUGMENTATION OF CELL TRANSFECTION WITH UNMODIFIED PLASMID VECTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EPIDERMAL GROWTH-FACTOR; MEMBRANE-PERMEABILITY; KB-CELLS; PH; GENE; DNA; MACROMOLECULES; ENHANCEMENT; EXPRESSION; INFECTION	The present study demonstrates that the human adenovirus (Ad) can augment transfer and expression of a gene within plasmid DNA unmodified by nonspecific linkers or by linker-ligand complexes. Following the transfection of COS-7 cells with pRSVL, a luciferase expression plasmid vector directed by the Rous sarcoma virus-long terminal repeat promoter, luciferase activity in the target cells was 10(3)- to 10(4)-fold higher when the cells were also infected with Ad-CFTR, a replication-deficient recombinant Ad containing human cystic fibrosis transmembrane conductance regulator (CFTR) cDNA. The enhancement of luciferase gene expression in COS-7 cells was also observed with Ad-dl312 (a replication-deficient E1a deletion mutant Ad with no exogenous gene) and wild type Ad5. The efficiency of cell transfection with pRSVL in the presence of an Ad was achieved in a dose-dependent fashion with progressively higher luciferase activity in cells infected by increasing amounts of Ad-CFTR, Ad-dl312, or Ad5. The augmentation by Ad-CFTR of the transfer and expression of the luciferase gene in cells was similar to that of another transfection reagent, cationic liposomes. Further, when Ad-CFTR and liposomes were used in combination, 4- to 100-fold more efficient expression of the luciferase gene was achieved than with Ad-CFTR or liposomes alone. When COS-7, HeLa, and CV-1 cells were evaluated in parallel in the presence or absence of liposomes, Ad-mediated enhancement of luciferase activity was observed in all cell lines. Thus, exposure of target cells to replication-deficient or competent human Ad will markedly augment transfer and expression of the genes within plasmid DNA in mammalian cells in vitro without modifying the plasmid with linkers or linker-ligand complexes, a strategy that should be useful for in vitro and in vivo gene transfer applications.	NHLBI,PULM BRANCH,BLDG 10,RM 6D03,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARRASCO L, 1981, VIROLOGY, V113, P623, DOI 10.1016/0042-6822(81)90190-2; CARRASCO L, 1982, VIROLOGY, V117, P62, DOI 10.1016/0042-6822(82)90507-4; CURIEL DT, 1992, HUM GENE THER, V3, P147, DOI 10.1089/hum.1992.3.2-147; CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850; DEFER C, 1990, J VIROL, V64, P3661, DOI 10.1128/JVI.64.8.3661-3673.1990; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FERNANDEZPUENTES C, 1980, CELL, V20, P769, DOI 10.1016/0092-8674(80)90323-2; FITZGERALD DJP, 1983, CELL, V32, P607, DOI 10.1016/0092-8674(83)90480-4; Ginsberg HS, 1984, ADENOVIRUSES; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HORWITZ MS, 1990, VIROLOGY, P01679; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; OTERO MJ, 1987, VIROLOGY, V160, P75, DOI 10.1016/0042-6822(87)90046-8; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SETH P, 1984, J BIOL CHEM, V259, P4350; SETH P, 1984, J VIROL, V51, P650, DOI 10.1128/JVI.51.3.650-655.1984; SETH P, 1985, J BIOL CHEM, V260, P4431; SETH P, 1984, MOL CELL BIOL, V4, P1528, DOI 10.1128/MCB.4.8.1528; SETH P, 1985, J BIOL CHEM, V260, P9598; SETH P, 1987, J VIROL, V61, P883, DOI 10.1128/JVI.61.3.883-888.1987; SETH P, 1986, VIRUS ATTACHMENT ENT, P191; YAMAIZUMI M, 1979, VIROLOGY, V95, P218, DOI 10.1016/0042-6822(79)90418-5; YOSHIMURA A, 1985, CELL STRUCT FUNCT, V10, P391, DOI 10.1247/csf.10.391	30	100	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2300	2303						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428904				2022-12-27	WOS:A1993KK81500009
J	AHERN, SM; MIYATA, T; SADLER, JE				AHERN, SM; MIYATA, T; SADLER, JE			REGULATION OF HUMAN TISSUE FACTOR EXPRESSION BY MESSENGER-RNA TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; HUMAN VASCULAR ENDOTHELIUM; TUMOR NECROSIS FACTOR; C-FOS; GENE-EXPRESSION; 3T3 CELLS; PROCOAGULANT ACTIVITY; AUTO-REGULATION; PROTO-ONCOGENE; DEGRADATION	Tissue factor serves as the cellular receptor for circulating blood coagulation factor VII and s the principal physiological initiator of blood coagulation. Tissue factor is not normally expressed in cells that contact blood, such as endothelial cells and monocytes, but can be induced in these cells by tumor necrosis factor or tumor-promoting phorbol esters. Following induction, the human tissue factor mRNA is degraded with a half-life of approximately 0.75-1.5 h. The cellular mechanisms responsible for this rapid mRNA turnover were investigated with chimeric tissue factor.beta-globin constructs expressed in stably transfected mouse NIH/3T3 cells. These constructs were expressed with the transiently inducible c-fos promoter which eliminated the need to use transcriptional inhibitors to determine mRNA half-lives. Sequences capable of conferring rapid turnover to the normally stable beta-globin transcript were localized to the last 600 nucleotides of the tissue factor mRNA. The 3' end of this fragment is similar to previously described AU-rich mRNA destabilizing elements. Activity of the tissue factor element was dependent on its specific sequence and not simply a high AU nucleotide content. The degradation of unstable chimeric tissue factor.beta-globin mRNAs was prevented by inhibition of transcription with actinomycin D. Chimeric tissue factor.beta-globin mRNAs were superinduced by the protein synthesis inhibitor cycloheximide, and this superinduction may be due in part to stabilization of the mRNA.	WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,HOWARD HUGHES MED INST LABS,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)			Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X	NHLBI NIH HHS [HLBI 14147] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014147] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; BROCK ML, 1983, J BIOL CHEM, V258, P5449; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARNEIRO M, 1984, J MOL BIOL, V178, P869, DOI 10.1016/0022-2836(84)90316-4; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1988, TRENDS BIOCHEM SCI, V13, P339, DOI 10.1016/0968-0004(88)90103-X; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; DITTMAN WA, 1988, J BIOL CHEM, V263, P15815; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GAY DA, 1989, P NATL ACAD SCI USA, V86, P5763, DOI 10.1073/pnas.86.15.5763; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREGORY SA, 1989, MOL CELL BIOL, V9, P2752, DOI 10.1128/MCB.9.6.2752; HARTZELL S, 1989, MOL CELL BIOL, V9, P2567, DOI 10.1128/MCB.9.6.2567; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; MOON AM, 1991, BLOOD, V77, P2272; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; NAWORTH PP, 1986, J EXP MED, V163, P740; NAWORTH PP, 1986, P NATL ACAD SCI USA, V83, P3460; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PAEK I, 1987, MOL CELL BIOL, V7, P1496, DOI 10.1128/MCB.7.4.1496; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; RANGANATHAN G, 1991, J BIOL CHEM, V266, P496; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARPATI EM, 1989, J BIOL CHEM, V264, P20705; SCARPATI EM, 1987, BIOCHEMISTRY-US, V26, P5234, DOI 10.1021/bi00391a004; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; WELSH M, 1985, J BIOL CHEM, V260, P3590; WHITTEMORE LA, 1990, MOL CELL BIOL, V64, P1329; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	45	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2154	2159						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420984				2022-12-27	WOS:A1993KH62000098
J	FREEZE, HH; SAMPATH, D; VARKI, A				FREEZE, HH; SAMPATH, D; VARKI, A			ALPHA-XYLOSIDE AND BETA-XYLOSIDE ALTER GLYCOLIPID SYNTHESIS IN HUMAN-MELANOMA AND CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT GLUCOSYLCERAMIDE SYNTHASE; CHONDROITIN SULFATE PROTEOGLYCAN; EMBRYONIC-CHICKEN CARTILAGE; BREFELDIN-A; PROTEOCHONDROITIN SULFATE; GANGLIOSIDE BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; GOLGI-APPARATUS; D-GALACTOSIDES; UDP-GALACTOSE	Beta-D-xylosides are often used to competitively inhibit proteoglycan synthesis by serving as primers for free glycosaminoglycan (GAG) chain assembly. Quite unexpectedty, we found that when human melanoma cells and Chinese hamster ovary cells are labeled with [H-3] galactose in the presence of 4-methyl umbelliferyl beta-D-xyloside (Xylbeta4MU), a large portion of the labeled acceptor does not consist of the expected GAG chains, but of the novel G(M3) ganglioside-like structure: Sia-alpha2,3-[H-3]Galbeta1,4Xylbeta4MU. Moreover, formation of this derivative is associated with an inhibition of glycosphingolipid synthesis by up to 78% without affecting synthesis of other [H-3]Gal-labeled glycoconjugates. Inhibition occurs rapidly and equally for all glycolipid species and is partially abrogated by brefeldin A. Inhibition requires the addition of a single galactose residue to the xyloside within the lumen of the Golgi apparatus. This addition appears to be carried out by galactosyl transferase I that normally synthesizes the core region of GAG chains. Although alpha-xyloside does not inhibit proteoglycan synthesis, it is galactosylated, but not sialylated, and is nearly as effective as a beta-xyloside at inhibiting glycolipid biosynthesis. Similar results were obtained for human macrophage U937, and differentiated or undifferentiated PC12 cells. However, in neuroblastoma cell tine MR23, no low molecular weight xyloside products were made and glycolipid synthesis was not inhibited. These results suggest that some of the previously documented effects of beta-xylosides might result, in part, from their inhibition of glycolipid synthesis. The mechanism of inhibition is not a direct competition for glycolipid synthesizing enzymes; rather, it is an unexplained result of formation of Galbeta1,4Xyl-1(alpha or beta)4MU.	UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, CTR CANC, LA JOLLA, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	FREEZE, HH (corresponding author), LA JOLLA CANC RES FDN, 10901 N TORREY PINES RD, LA JOLLA, CA 92037 USA.			Freeze, Hudson/0000-0001-6316-0501	NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA38701] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHAWLA D, 1991, BIOCHEM J, V279, P159, DOI 10.1042/bj2790159; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DRZENIEK R, 1973, HISTOCHEM J, V5, P271, DOI 10.1007/BF01004994; ESKO JD, 1987, J BIOL CHEM, V262, P12189; FARACH MC, 1988, BIOL REPROD, V39, P443, DOI 10.1095/biolreprod39.2.443; FICHARD A, 1991, DEV BIOL, V148, P1, DOI 10.1016/0012-1606(91)90312-Q; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; IBER H, 1991, EUR J BIOCHEM, V195, P115, DOI 10.1111/j.1432-1033.1991.tb15683.x; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOLSET SO, 1986, BIOCHEM J, V238, P209, DOI 10.1042/bj2380209; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; MANZI AE, 1990, J BIOL CHEM, V265, P13091; MARGOLIS RK, 1991, J CELL SCI, V99, P237; MELLIS S, 1981, ANAL BIOCHEM, V114, P8398; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PLATT JL, 1987, DEV BIOL, V123, P293, DOI 10.1016/0012-1606(87)90388-5; POTTERPERIGO S, 1992, ARCH BIOCHEM BIOPHYS, V297, P101, DOI 10.1016/0003-9861(92)90646-E; ROBINSON HC, 1975, BIOCHEM J, V148, P25, DOI 10.1042/bj1480025; ROBINSON HC, 1981, BIOCHEM J, V194, P575, DOI 10.1042/bj1940575; ROBINSON JA, 1981, BIOCHEM J, V194, P839, DOI 10.1042/bj1940839; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; SCHOR AM, 1988, IN VITRO CELL DEV B, V24, P659, DOI 10.1007/BF02623603; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHAYMAN JA, 1991, AM J PHYSIOL, V260, pF291, DOI 10.1152/ajprenal.1991.260.3.F291; SHUKLA GS, 1991, J NEUROCHEM, V56, P2125, DOI 10.1111/j.1471-4159.1991.tb03475.x; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; SOBUE M, 1987, BIOCHEM J, V241, P591, DOI 10.1042/bj2410591; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; SUGUMARAN G, 1991, J BIOL CHEM, V266, P9565; TAKAGAKI K, 1991, J BIOCHEM-TOKYO, V109, P514, DOI 10.1093/oxfordjournals.jbchem.a123413; TRICHERA M, 1991, J BIOL CHEM, V266, P20907; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; VARKI A, 1991, FASEB J, V5, P226, DOI 10.1096/fasebj.5.2.2004668; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341	48	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1618	1627						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420936				2022-12-27	WOS:A1993KH62000021
J	LEBLOND, L; MARCEL, YL				LEBLOND, L; MARCEL, YL			UPTAKE OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL ESTER BY HEPG2 CELLS INVOLVES APOLIPOPROTEIN-E LOCALIZED ON THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; RAT HEPATOMA-CELLS; SELECTIVE UPTAKE; MONOCLONAL-ANTIBODIES; HUMAN-PLASMA; A-I; J774 MACROPHAGES; MEDIATED UPTAKE; LINOLEYL ETHER; ADRENAL-CELLS	High density lipoprotein (HDL) cholesterol ester (CE) is taken up by many cells without simultaneous uptake of HDL apoprotein. The studies described herein demonstrate that the selective uptake of cholesterol ester by HepG2 cells is reduced by antibody directed against the receptor-binding domain of apoE (monoclonal antibody (mAb) 1D7) but not by antibody directed against the NH2-terminal portion of the molecule. The reduction, by 1D7, of HDL cholesteryl ester uptake is not due to apoE acquisition by the labeled HDL preparation or by the transfer of [H-3]CE of HDL to apoE-containing lipoproteins and uptake by the apoB/E or apoE receptors. Rather, it appears that mAb 1D7 recognizes apoE localized at the cell surface of HepG2 cells. This conclusion is supported by the fact that: 1) reduction of HDL-CE uptake by HepG2 cells is observed within 15 min after the addition of the antibody-ligand mixture; 2) 1D7 is similarly effective in reducing the selective uptake of HDL-CE when added to the ligand or to the cells; 3) three different anti-apoE mAbs (1D7, 3B7, and 3H1) bind specifically to the surface of the cells. We have also demonstrated that heparin (5 mg/ml) does not reduce the amount of apoE-immunoreactive material bound at the cell surface when added before or after the binding period. 1D7, but not 3B7 or 3H1, binds less in the presence of heparin. The observations are consistent with a localization of apoE on the cell membrane rather than on lipoproteins bound to apoB/E or apoE receptors.	CLIN RES INST MONTREAL, LIPOPROT METAB LAB, MONTREAL H2W 1R7, QUEBEC, CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal								ALAM R, 1989, BIOCHIM BIOPHYS ACTA, V1004, P292, DOI 10.1016/0005-2760(89)90076-3; ARBEENY CM, 1987, BIOCHIM BIOPHYS ACTA, V917, P9, DOI 10.1016/0005-2760(87)90277-3; BACHORIK PS, 1982, BIOCHEMISTRY-US, V21, P5675, DOI 10.1021/bi00265a044; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; BERNARD DW, 1991, J BIOL CHEM, V266, P710; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BRANDAN E, 1989, J BIOL CHEM, V264, P10520; DASHTI N, 1984, BIOCHIM BIOPHYS ACTA, V794, P373, DOI 10.1016/0005-2760(84)90003-1; DELAMATRE JG, 1990, J LIPID RES, V31, P191; DELAMATRE JG, 1991, J CELL PHYSIOL, V146, P18, DOI 10.1002/jcp.1041460104; DORY L, 1991, J LIPID RES, V32, P783; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FAUST RA, 1987, ARTERIOSCLEROSIS, V7, P267, DOI 10.1161/01.ATV.7.3.267; FRANCIS GA, 1991, BIOCHIM BIOPHYS ACTA, V1084, P159, DOI 10.1016/0005-2760(91)90215-4; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; GRANOT E, 1987, J BIOL CHEM, V262, P3482; GWYNNE JT, 1989, J BIOL CHEM, V264, P8141; HAMILTON RL, 1990, J LIPID RES, V31, P1589; HANDLEY DA, 1981, J CELL BIOL, V90, P778, DOI 10.1083/jcb.90.3.778; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HESLER CB, 1988, J BIOL CHEM, V263, P5020; HUI DY, 1984, J BIOL CHEM, V259, P5060; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONES AL, 1984, J LIPID RES, V25, P1151; KAMBOURIS AM, 1990, ARTERIOSCLEROSIS, V10, P582, DOI 10.1161/01.ATV.10.4.582; KNECHT TP, 1989, BIOCHIM BIOPHYS ACTA, V1002, P365, DOI 10.1016/0005-2760(89)90351-2; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOO C, 1985, J BIOL CHEM, V260, P1934; KRONVALL G, 1970, J IMMUNOL, V104, P140; LEBLOND L, 1991, J BIOL CHEM, V266, P6058; LEITERSDORF E, 1986, BIOCHIM BIOPHYS ACTA, V878, P320, DOI 10.1016/0005-2760(86)90239-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON M, 1986, J BIOL CHEM, V261, P2548; MARCEL YL, 1982, J BIOL CHEM, V257, P13165; MCCALL MR, 1988, J LIPID RES, V29, P1127; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MELLMAN IS, 1980, J EXP MED, V152, P1048, DOI 10.1084/jem.152.4.1048; MILNE RW, 1981, J CLIN INVEST, V68, P111, DOI 10.1172/JCI110225; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; NICHOLS AV, 1965, J LIPID RES, V6, P206; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; RAHIM ATMA, 1991, BIOCHIM BIOPHYS ACTA, V1082, P195; RANGANATHAN S, 1990, BIOCHIM BIOPHYS ACTA, V1046, P223, DOI 10.1016/0005-2760(90)90193-2; REAVEN E, 1988, ARTERIOSCLEROSIS, V8, P298, DOI 10.1161/01.ATV.8.3.298; REAVEN E, 1990, J BIOL CHEM, V265, P19100; REYLAND ME, 1991, J BIOL CHEM, V266, P21099; RINNINGER F, 1989, J BIOL CHEM, V264, P6111; RINNINGER F, 1990, BIOCHIM BIOPHYS ACTA, V1043, P318, DOI 10.1016/0005-2760(90)90033-T; RINNINGER F, 1988, J LIPID RES, V29, P1179; RINNINGER F, 1987, J LIPID RES, V28, P1313; ROBERTS DCK, 1985, BIOCHEM J, V226, P319, DOI 10.1042/bj2260319; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHOUTEN D, 1990, ARTERIOSCLEROSIS, V10, P1127, DOI 10.1161/01.ATV.10.6.1127; SENAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1046, P81, DOI 10.1016/0005-2760(90)90097-H; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; SWENSON TL, 1989, J BIOL CHEM, V264, P14318; THRIFT RN, 1986, J LIPID RES, V27, P236; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348	64	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1670	1676						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420942				2022-12-27	WOS:A1993KH62000027
J	BERNARDI, P; VERONESE, P; PETRONILLI, V				BERNARDI, P; VERONESE, P; PETRONILLI, V			MODULATION OF THE MITOCHONDRIAL CYCLOSPORINE A-SENSITIVE PERMEABILITY TRANSITION PORE .1. EVIDENCE FOR 2 SEPARATE ME2+ BINDING-SITES WITH OPPOSING EFFECTS ON THE PORE OPEN PROBABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-INDUCED MEMBRANE TRANSITION; HEART-MITOCHONDRIA; LIVER-MITOCHONDRIA; CA-2+-DEPENDENT PORE; OXIDATIVE STRESS; INNER MEMBRANE; CA-2+ RELEASE; INHIBITION; MECHANISMS; CALCIUM	This paper reports an investigation on the regulation of the mitochondrial cyclosporin A-sensitive permeability transition pore (MTP). Energized, coupled rat liver mitochondria incubated in sucrose medium in the presence of phosphate maintain a high proton electrochemical gradient (DELTAmuH) and a low permeability to solutes. Addition of a small (10-20 muM) Ca2+ pulse leads to a transient membrane depolarization. After Ca2+ accumulation, a high DELTAmuH is recovered, and mitochondria remain coupled indefinitely. Yet, addition of fully uncoupling concentrations of carbonyl cyanide-p-trifluoromethoxyphenyl hydrazone (FCCP) brings about MTP opening within seconds. This finding confirms that MTP opening is the consequence rather than the cause of membrane depolarization, and allowed us to study the operation of the MTP in a synchronized population of mitochondria, since pore opening can be triggered by the addition of uncoupler under a series of experimental conditions. We find that three regulatory sites can be defined: (i) an internal Me2+ binding site: when this site is occupied by Ca2+, the pore ''open'' probability increases, while other Me2+ ions (Sr2+, Mn2+) have an inhibitory effect; (ii) an external Me2+ binding site: when this site is occupied by Me2+ ions, including Ca2+, the pore open probability decreases; (iii) an independent cyclosporin A binding site: when this site is occupied by cyclosporin A the pore open probability decreases. We show that at variance from the case of cyclosporin A, MTP inhibition by the phospholipase A2 inhibitors nupercaine and trifluoperazine is Ca2+-competitive and is presumably related to interference by these drugs with Ca2+ binding to the internal regulatory site.	UNIV PADUA, SCH MED, DEPT BIOMED SCI, BIOPHYS & MEMBRANE BIOL LAB, I-35121 PADUA, ITALY	University of Padua	BERNARDI, P (corresponding author), UNIV PADUA, SCH MED, CNR, STUDY PHYSIOL MITOCHONDRIA UNIT, VIA TRIESTE 75, I-35121 PADUA, ITALY.		Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404				BERNARDI P, 1992, J BIOL CHEM, V267, P8834; BERNARDI P, 1982, FEBS LETT, V139, P9, DOI 10.1016/0014-5793(82)80475-4; BERNARDI P, 1983, BIOCHIM BIOPHYS ACTA, V724, P212, DOI 10.1016/0005-2728(83)90140-8; BERNARDI P, 1992, MECHANICS SWELLING C, P357; BRIERLEY GP, 1978, MOL BIOL MEMBRANES, P295; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; BROEKEMEIER KM, 1989, BIOCHEM BIOPH RES CO, V163, P561, DOI 10.1016/0006-291X(89)92174-8; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Garlid K.D., 1988, INTEGRATION MITOCHON, P259; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HAWORTH RA, 1980, J MEMBRANE BIOL, V54, P231, DOI 10.1007/BF01870239; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; NOVGORODOV SA, 1991, BIOCHEM BIOPH RES CO, V180, P33, DOI 10.1016/S0006-291X(05)81250-1; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; SARIS NEL, 1988, J BIOENERG BIOMEMBR, V20, P749, DOI 10.1007/BF00762551; SCARPA A, 1968, BIOCHIM BIOPHYS ACTA, V150, P473, DOI 10.1016/0005-2736(68)90147-8; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537	29	177	185	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1005	1010						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419309				2022-12-27	WOS:A1993KG07700039
J	KULPA, J; DIXON, JE; PAN, GH; SADOWSKI, PD				KULPA, J; DIXON, JE; PAN, GH; SADOWSKI, PD			MUTATIONS OF THE FLP RECOMBINASE GENE THAT CAUSE A DEFICIENCY IN DNA BENDING AND STRAND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; 2-MU-M CIRCLE PLASMID; STEP-ARREST MUTANTS; SACCHAROMYCES-CEREVISIAE; SECONDARY-STRUCTURE; TARGET SEQUENCE; PROTEIN; YEAST; MECHANISM; BINDING	We have used site-directed mutagenesis to change several amino acids of the C-terminal portion of the FLP recombinase of Saccharomyces cerevisiae. These residues are absolutely conserved among the six FLP-like proteins from various yeast strains. We have examined the ability of the altered proteins to catalyze recombination in vivo and in vitro and to perform various partial steps of the reaction in vitro. Two of the mutations produced a partial defect in DNA binding but the remainder resulted in normal binding. All of these mutations caused impairment of the ability of the protein to induce the type II bend of the FRT site, and some of these proteins were also defective in DNA strand cleavage. None of the mutations affected the ability of the proteins to perform synapsis between two FRT sites, but some were defective in strand ligation. Interestingly, some mutant proteins showed impairment of the initial stages of the recombination reaction on a linear substrate and yet they maintained the ability to resolve a Holliday intermediate in the reaction. We conclude that this conserved region of the FLP protein is important for the early stage(s) of the recombination reaction.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto								ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/protein/5.1.87; AGROS P, 1986, EMBO J, V6, P433; AMIN A, 1991, MOL CELL BIOL, V11, P4497, DOI 10.1128/MCB.11.9.4497; AMIN AA, 1990, J MOL BIOL, V214, P55, DOI 10.1016/0022-2836(90)90146-D; ANDREWS BJ, 1987, J MOL BIOL, V193, P345, DOI 10.1016/0022-2836(87)90223-3; BEATTY LG, 1988, J MOL BIOL, V204, P283, DOI 10.1016/0022-2836(88)90576-1; CHEN JW, 1991, P NATL ACAD SCI USA, V88, P5944, DOI 10.1073/pnas.88.14.5944; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; EVANS BR, 1990, J BIOL CHEM, V265, P18504; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; FUTCHER AB, 1986, J THEOR BIOL, V119, P197, DOI 10.1016/S0022-5193(86)80074-1; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P2328; HOESS R, 1987, P NATL ACAD SCI USA, V84, P6840, DOI 10.1073/pnas.84.19.6840; JAYARAM M, 1988, P NATL ACAD SCI USA, V85, P7902, DOI 10.1073/pnas.85.21.7902; KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0; MEYERLEON L, 1987, NUCLEIC ACIDS RES, V15, P6469, DOI 10.1093/nar/15.16.6469; MEYERLEON L, 1988, MOL CELL BIOL, V8, P3784, DOI 10.1128/MCB.8.9.3784; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; PAN GH, 1992, J BIOL CHEM, V267, P12397; PAN H, 1991, J BIOL CHEM, V266, P11347; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; PROTEAU G, 1986, NUCLEIC ACIDS RES, V14, P4787, DOI 10.1093/nar/14.12.4787; QIAN XH, 1990, J BIOL CHEM, V265, P21779; REYNOLDS AE, 1987, MOL CELL BIOL, V7, P3566, DOI 10.1128/MCB.7.10.3566; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SCHWARTZ CJE, 1989, J MOL BIOL, V205, P647, DOI 10.1016/0022-2836(89)90310-0; SCHWARTZ CJE, 1990, J MOL BIOL, V216, P289, DOI 10.1016/S0022-2836(05)80320-1; SCHWARTZ CJE, 1990, THESIS U TORONTO; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; UTATSU I, 1987, J BACTERIOL, V169, P5537, DOI 10.1128/jb.169.12.5537-5545.1987; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2	36	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1101	1108						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419317				2022-12-27	WOS:A1993KG07700053
J	LAWSON, JH; BUTENAS, S; RIBARIK, N; MANN, KG				LAWSON, JH; BUTENAS, S; RIBARIK, N; MANN, KG			COMPLEX-DEPENDENT INHIBITION OF FACTOR-VIIA BY ANTITHROMBIN-III AND HEPARIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOLECULAR WEIGHT HEPARIN; TISSUE FACTOR; BLOOD-COAGULATION; EXTRINSIC PATHWAY; FACTOR XA; MECHANISM; THROMBIN; PLASMA; INACTIVATION; ACTIVATION	The regulation of the factor VIIa-tissue factor complex is essential for control of the hemostatic response. However, the role of the inhibitor antithrombin III in the regulation of factor VIIa has remained in question. The inhibition of factor VIIa activity by antithrombin III and heparin in the presence and absence of tissue factor was evaluated using the fluorescent substrate m-LGR-nds. Our data show that the activity of recombinant human factor VIIa is inhibited by antithrombin III in the presence of heparin at a rate of 1.7 x 10(2) M-1 s-1. In the presence of tissue factor, the rate constant for this reaction increases to 5.6 x 10(3) M-1 s-1. A 1:1 stoichiometric complex between factor VIIa and antithrombin III, with an apparent molecular weight of 110,000, was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A heterogeneous mixture of factor VIIa products with molecular weights between 50,000 and 80,000, most likely representing proteolytically degraded factor VIIa-antithrombin III complexes, was also observed.	UNIV VERMONT,DEPT BIOCHEM,BURLINGTON,VT 05405	University of Vermont					NHLBI NIH HHS [T32 HLO7594, R01 HL4697] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJAJ SP, 1981, J BIOL CHEM, V256, P253; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; BUTENAS S, 1992, BIOCHEMISTRY-US, V31, P5399, DOI 10.1021/bi00138a023; CALLANDER NS, 1992, J BIOL CHEM, V267, P876; Damus P S, 1976, Methods Enzymol, V45, P653; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67; ESMON CT, 1989, J BIOL CHEM, V264, P4743; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JESTY J, 1978, ARCH BIOCHEM BIOPHYS, V185, P165, DOI 10.1016/0003-9861(78)90156-X; JORDAN R, 1979, J BIOL CHEM, V254, P2902; JORDAN RE, 1980, J BIOL CHEM, V255, P81; KONDO S, 1987, THROMB RES, V46, P325, DOI 10.1016/0049-3848(87)90294-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JH, 1992, J BIOL CHEM, V267, P4834; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; MILETICH JP, 1978, J CLIN INVEST, V62, P824, DOI 10.1172/JCI109194; NEMERSON Y, 1988, BLOOD, V71, P1; NORDENMAN B, EUR J BIOCHEM, V78, P295; NOVOTNY WF, 1989, BLOOD S, V74, pA209; OLSON ST, 1989, THROMB HAEMOSTASIS, V62, P381; PIXLEY RA, 1985, BLOOD, V66, P198; RAPAPORT SI, 1989, BLOOD, V73, P359; RAPAPORT SI, 1991, THROMB HAEMOSTASIS, V66, P6; ROSENBERG RD, 1989, J CLIN INVEST, V74, P1; SCOTT CF, 1989, BLOOD, V73, P1373; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	31	135	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					767	770						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419351				2022-12-27	WOS:A1993KG07700004
J	MORRIS, AJ; TOLAN, DR				MORRIS, AJ; TOLAN, DR			SITE-DIRECTED MUTAGENESIS IDENTIFIES ASPARTATE-33 AS A PREVIOUSLY UNIDENTIFIED CRITICAL RESIDUE IN THE CATALYTIC MECHANISM OF RABBIT ALDOLASE-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY FRUCTOSE INTOLERANCE; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; MUSCLE ALDOLASE; MAIZE ALDOLASE; MUTATION; PROTEINS; DEFICIENCY; RESOLUTION; EXPRESSION	The expression and purification of the rabbit muscle aldolase A (D-fructose 1,6-bisphosphate:D-glyceraldehyde-3-phosphate lyase, EC 4.1.2.13) from an expression plasmid in bacteria is described. The enzyme is produced in bacteria at a level of 300 mg/liter and is indistinguishable from the enzyme isolated from muscle in assays using fructose 1,6-bisphosphate and fructose 1-phosphate. The recombinant enzyme has the same primary, secondary, and quaternary structure as the muscle enzyme. Aspartic acid 33, found near the active site lysine in the crystal structure, is changed to alanine, serine, and glutamic acid by site-directed mutagenesis, resulting in the mutant proteins, D33A, D33S, and D33E, respectively. The mutant enzymes are purified by substrate affinity elution from carboxylmethyl-Sepharose, the same method as that used for the wild-type enzyme. The secondary and quaternary structure of D33A is identical to wild-type aldolase when analyzed by light scattering, gel filtration, and circular dichroism. Moreover, the hexose substrate can be fixed in the active site by reduction of the Schiff base with sodium borohydride, indicating that the active site is not drastically altered. These single mutations in the active site have a serious effect on the activity of the enzyme. In addition, the rate of carbanion oxidation for D33A is 17-29 times slower when the substrate is fructose 1,6-bisphosphate versus dihydroxyacetone phosphate, whereas in the wild-type there is no significant difference in these rates. This evidence and the conservation of this residue in other class I aldolases indicate that aspartic acid 33 is an essential residue in the catalytic mechanism, possibly involved in abstraction of the carbon 4 hydroxyl proton.	BOSTON UNIV,DEPT BIOL,BOSTON,MA 02215	Boston University				Tolan, Dean/0000-0002-0598-7241	NIDDK NIH HHS [DK38821, DK43521] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043521, R29DK038821] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; ANAI M, 1973, ARCH BIOCHEM BIOPHYS, V156, P712, DOI 10.1016/0003-9861(73)90324-X; BALDWIN SA, 1978, BIOCHEM J, V169, P643, DOI 10.1042/bj1690643; BARR PJ, 1986, BIOTECHNIQUES, V4, P428; BEERNINK PT, 1992, PROTEIN EXPRES PURIF, V3, P332, DOI 10.1016/1046-5928(92)90009-L; BERTHIAUME L, 1991, J BIOL CHEM, V266, P17099; BERTHIAUME L, 1989, ARCH BIOCHEM BIOPHYS, V272, P281, DOI 10.1016/0003-9861(89)90221-X; BIRKENHAGER JC, 1960, BIOCHIM BIOPHYS ACTA, V40, P182, DOI 10.1016/0006-3002(60)91336-6; BLOSTEIN R, 1963, J BIOL CHEM, V238, P3280; Boyer P.D., 1990, ENZYMES, V19, P99; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS CC, 1991, AM J HUM GENET, V49, P1075; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CROSS NCP, 1990, LANCET, V335, P306, DOI 10.1016/0140-6736(90)90603-3; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; DAZZO C, 1990, AM J HUM GENET, V46, P1194; HARTMAN FC, 1974, BIOCHEM BIOPH RES CO, V57, P85, DOI 10.1016/S0006-291X(74)80360-8; HARTMAN FC, 1976, J BIOL CHEM, V251, P3057; HEALY MJ, 1973, BIOCHEMISTRY-US, V12, P35, DOI 10.1021/bi00725a006; HERS H. G., 1961, ENZYMOL BIOL ET CLIN, V1, P4; Horecker B. L, 1972, ENZYMES, P213, DOI DOI 10.1016/S1874-6047(08)60450-3; KELLY PM, 1987, PLANT PHYSIOL, V82, P1076; KISHI H, 1987, P NATL ACAD SCI USA, V84, P8623, DOI 10.1073/pnas.84.23.8623; KOBASHI K, 1967, ARCH BIOCHEM BIOPHYS, V121, P178, DOI 10.1016/0003-9861(67)90022-7; KUKITA A, 1988, EUR J BIOCHEM, V171, P471, DOI 10.1111/j.1432-1033.1988.tb13813.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI CY, 1974, SCIENCE, V183, P1204, DOI 10.1126/science.183.4130.1204; PAPPIN DJC, 1990, ANAL BIOCHEM, V187, P10, DOI 10.1016/0003-2697(90)90410-B; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; PENHOET EE, 1969, BIOCHEMISTRY-US, V8, P4391, DOI 10.1021/bi00839a025; RACKER E, 1952, J BIOL CHEM, V196, P347; ROSE IA, 1965, J BIOL CHEM, V240, P1758; ROTTMANN WH, 1984, P NATL ACAD SCI-BIOL, V81, P2738, DOI 10.1073/pnas.81.9.2738; RUTTER WJ, 1964, FED PROC, V23, P1248; SAKAKIBARA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P334, DOI 10.1016/0167-4781(89)90156-5; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; TAKAHASHI I, 1989, J BIOCHEM, V105, P281, DOI 10.1093/oxfordjournals.jbchem.a122654; TAYLOR JF, 1955, METHOD ENZYMOL, V1, P310, DOI 10.1016/0076-6879(55)01043-4; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; TOLAN DR, 1984, J BIOL CHEM, V259, P1127; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROMBETTA G, 1977, BIOCHEM BIOPH RES CO, V74, P1297, DOI 10.1016/0006-291X(77)90583-6; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VLAHOS CJ, 1990, J BIOL CHEM, V265, P20384; VOET D, 1990, BIOCHEMISTRY-US, P433	47	65	65	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1095	1100						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419316				2022-12-27	WOS:A1993KG07700052
J	STONE, CL; BOSRON, WF; DUNN, MF				STONE, CL; BOSRON, WF; DUNN, MF			AMINO-ACID SUBSTITUTIONS AT POSITION 47 OF HUMAN BETA-1-BETA-1 AND BETA-2-BETA-2 ALCOHOL DEHYDROGENASES AFFECT HYDRIDE TRANSFER AND COENZYME DISSOCIATION RATE CONSTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; ZINC-BOUND WATER; KINETIC CHARACTERIZATION; CATALYZED REDUCTION; BINDING-SITE; LIVER; PURIFICATION; ISOENZYMES; ALDEHYDE; ADH	Human liver alcohol dehydrogenase isoenzymes beta1beta1 and beta2beta2, in which position 47 in the coenzyme binding domain is an arginine or histidine, respectively, differ remarkably in steady-state kinetics. To understand which catalytic steps affect these kinetics, apparent coenzyme dissociation and association rate constants, and apparent 4-trans-(NN-dimethylamino)cinnamaldehyde (DACA) hydride transfer rate constants were obtained with stopped-flow kinetics. Enzymes containing site-specific mutations of Arg-47 in beta1beta1 (beta47R) to His (beta2beta2 or beta47H), Lys (beta47K), or Gln (beta47Q) were studied. Apparent coenzyme dissociation rate constants are greatly affected by substitutions at position 47, in which mutant enzymes with a weak base or a neutral residue at this position (beta47H and beta47Q) exhibit faster rate constants than beta47R and beta47K. Substitutions at position 47 have less effect on apparent coenzyme association rate constants. The kinetics of NADH association for beta47H and beta47Q are consistent with a two-step mechanism in which the bimolecular binding step is coupled to a unimolecular process. These findings indicate that the greater role of position 47 in coenzyme dissociation may occur after a coenzyme-induced isomerization. Substitutions at position 47 also strongly influence apparent DACA hydride transfer rate constants; hydride transfer is faster with mutant enzymes containing weak bases like histidine at this position. Steady-state kinetics, however, reveal that the rate-limiting step of both beta47R and beta47H for acetaldehyde reduction and for ethanol oxidation is coenzyme product dissociation. Thus, the different activities of beta1beta1 and beta2beta2 for ethanol oxidation and acetaldehyde reduction are caused primarily by different coenzyme dissociation rates.	INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Riverside					NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA002342, R01AA007117] Funding Source: NIH RePORTER; NIAAA NIH HHS [T32-AA07642, R01-AA07117, R01-AA02342] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDERSSON P, 1980, EUR J BIOCHEM, V108, P303, DOI 10.1111/j.1432-1033.1980.tb04724.x; ANDERSSON P, 1981, EUR J BIOCHEM, V113, P425, DOI 10.1111/j.1432-1033.1981.tb05082.x; Bosron W F, 1981, Semin Liver Dis, V1, P179, DOI 10.1055/s-2008-1041746; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BOSRON WF, 1980, P NATL ACAD SCI-BIOL, V77, P5784, DOI 10.1073/pnas.77.10.5784; BUHLER R, 1984, FEBS LETT, V173, P360, DOI 10.1016/0014-5793(84)80806-6; BURNELL JC, 1989, BIOCHEMISTRY-US, V28, P6810, DOI 10.1021/bi00443a005; Burnell JC, 1989, HUMAN METABOLISM ALC, V2, P65; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; DETRAGLIA MC, 1977, J BIOL CHEM, V252, P3493; DUNN MF, 1973, BIOCHEMISTRY-US, V12, P4882, DOI 10.1021/bi00748a012; DUNN MF, 1982, BIOCHEMISTRY-US, V21, P354, DOI 10.1021/bi00531a024; EHRIG T, 1990, ALCOHOL ALCOHOLISM, V25, P105, DOI 10.1093/oxfordjournals.alcalc.a044985; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; EKLUND H, 1984, BIOCHEMISTRY-US, V23, P5982, DOI 10.1021/bi00320a014; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; GOULD RM, 1990, BIOCHEMISTRY-US, V29, P5463, DOI 10.1021/bi00475a009; HRULEY TD, 1990, J BIOL CHEM, V265, P16366; HURLEY TD, 1991, P NATL ACAD SCI USA, V88, P8149, DOI 10.1073/pnas.88.18.8149; JORNVALL H, 1984, P NATL ACAD SCI-BIOL, V81, P3024, DOI 10.1073/pnas.81.10.3024; KVASSMAN J, 1979, EUR J BIOCHEM, V100, P115, DOI 10.1111/j.1432-1033.1979.tb02039.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCEVILY A J, 1990, Biochromatography, V5, P13; MEIERTACKMANN D, 1990, ALCOHOL, V7, P413, DOI 10.1016/0741-8329(90)90025-8; MORRIS RG, 1980, BIOCHEMISTRY-US, V19, P725, DOI 10.1021/bi00545a018; SEKHAR VC, 1988, BIOCHEMISTRY-US, V27, P5082, DOI 10.1021/bi00414a020; THEORELL H, 1963, BIOCHEM Z, V338, P537; Tipton K F, 1979, Methods Enzymol, V63, P183; WRATTEN CC, 1963, BIOCHEMISTRY-US, V2, P935, DOI 10.1021/bi00905a007; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026	31	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					892	899						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419368				2022-12-27	WOS:A1993KG07700024
J	JOHNSON, DR; DURONIO, RJ; LANGNER, CA; RUDNICK, DA; GORDON, JI				JOHNSON, DR; DURONIO, RJ; LANGNER, CA; RUDNICK, DA; GORDON, JI			GENETIC AND BIOCHEMICAL-STUDIES OF A MUTANT SACCHAROMYCES-CEREVISIAE MYRISTOYL-COA - PROTEIN N-MYRISTOYLTRANSFERASE, NMT72PLEU99-]PRO, THAT PRODUCES TEMPERATURE-SENSITIVE MYRISTIC ACID AUXOTROPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PHEROMONE RESPONSE; ADP-RIBOSYLATION FACTOR; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; 2 GENES; ACYL-COA; TRANSFERASE; ASSOCIATION; ACYLATION; SUBUNITS	Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase (Nmt1p) is an essential enzyme that transfers myristate from CoA to the amino-terminal glycine residue of at least 12 cellular proteins. Its reaction mechanism is Ordered Bi Bi with myristoyl-CoA binding occurring before binding of nascent polypeptides and release of CoA preceding release of the myristoylprotein product. nmt1-72 is a temperature-sensitive allele, identified by Stone et al. (Stone, D. E., Cole, G. M., Lopes, M. B., Goebl, M., and Reed, S. I. (1991) Genes & Dev. 5, 1969-1981) that causes arrest in the G1 phase of the cell cycle due to reduced acylation of Gpa1p. We have recovered this mutant allele and determined that it contains a single point mutation resulting in a Leu99 (CTA) to Pro (CCA) substitution. Addition of greater-than-or-equal-to 500 muM myristate but not palmitate to synthetic or rich media rescues the growth arrest caused by nmt1-72 at 37-39-degrees-C, consistent with the observation that purified nmt72p has reduced affinity for myristoyl-CoA and that exogenous myristate but not palmitate increases cellular myristoyl-CoA pools. Metabolic labeling studies in S. cerevisiae and co-expression of nmt72p with several protein substrates of Nmt1p in Escherichia coli indicate that the Leu99 --> Pro substitution causes a reduction in the acylation of some but not all protein substrates. Since formation of a myristoyl-CoA.Nmt1p complex appears to be required for synthesis/formation of a peptide binding site, these defects in acylation appear to arise either because Leu99 is a component of the enzyme's functionally distinguishable myristoyl-CoA and peptide recognition sites or because Pro99 alters the interaction between myristoyl-CoA and enzyme in a way that precludes formation of a normal peptide binding site. The reduction in affinity for myristoyl-CoA produced by Leu99 --> Pro in nmt72p is less than that produced by the Gly451 --> Asp mutation in nmt181p, which also produces temperature-sensitive myristic acid auxotrophy. Isogenic, haploid strains containing NMT1, nmt1-72, and nmt1-181 do not manifest any obvious differences in steady state levels of the acyltransferases during growth at permissive temperatures or in the biosynthesis of long chain saturated acyl-CoAs. The spectrum of cellular N-myristoylproteins whose level of acylation is affected by nmt1-72 and nmt1-181 is distinct. This is evidenced by: (i) differences in pattern of incorporation of exogenous [H-3]myristate into N-myristoylproteins, (ii) the fact that disruption of STE4 is epistatic to nmt1-72 but not to nmt1-181, (iii) the lack of effect of overexpression of Gpalp on growth of isogenic haploid nmt1-181 strains, (iv) differences in the degree of growth suppression produced by overexpression of Arf1p, and (v) differences in their abilities to acylate a panel of four substrates of Nmt1p in the E. coli co-expression system. Together, these findings suggest that nmt1-72 and nmt1-181 strains may be useful for identifying essential cellular N-myristoylproteins as well as gene products that affect myristoyl-CoA metabolism and/or the delivery of this substrate to Nmt1p.	WASHINGTON UNIV, SCH MED,DEPT MOLEC BIOL & PHARMACOL,BOX 8103, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA	Washington University (WUSTL)				Duronio, Robert/0000-0001-6469-6965	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027179, U01AI030188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27179, AI30188] Funding Source: Medline; NIGMS NIH HHS [GM07200] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALCH WE, 1992, J BIOL CHEM, V267, P13053; BESSOULE JJ, 1988, EUR J BIOCHEM, V177, P207, DOI 10.1111/j.1432-1033.1988.tb14363.x; BLINDER D, 1989, CELL, V56, P479, DOI 10.1016/0092-8674(89)90250-X; BLUMER KJ, 1991, ANNU REV PHYSIOL, V53, P37; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; CORKEY BE, 1990, PROG CLIN BIOL RES, V321, P217; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; DURONIO R J, 1990, Methods (Orlando), V1, P253, DOI 10.1016/S1046-2023(05)80325-1; DURONIO RJ, 1992, J CELL BIOL, V117, P515, DOI 10.1083/jcb.117.3.515; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; DURONIO RJ, 1992, P NATL ACAD SCI USA, V89, P4129, DOI 10.1073/pnas.89.9.4129; DURONIO RJ, 1991, J CELL BIOL, V113, P1313, DOI 10.1083/jcb.113.6.1313; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; DURONIO RJ, 1992, PROTEINS, V13, P41, DOI 10.1002/prot.340130105; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FUNABASHI H, 1989, J BIOCHEM-TOKYO, V105, P751, DOI 10.1093/oxfordjournals.jbchem.a122739; HEUCKEROTH RO, 1989, P NATL ACAD SCI USA, V86, P5262, DOI 10.1073/pnas.86.14.5262; HEUCKEROTH RO, 1988, P NATL ACAD SCI USA, V85, P8795, DOI 10.1073/pnas.85.23.8795; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KEITH AD, 1969, J BACTERIOL, V98, P415, DOI 10.1128/JB.98.2.415-420.1969; KISHORE NS, 1991, J BIOL CHEM, V266, P8835; KNOLL LJ, 1992, J BIOL CHEM, V267, P5366; KNOLL LJ, 1993, IN PRESS J BIOL CHEM; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGNER CA, 1992, J BIOL CHEM, V267, P17159; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; MEYER KH, 1974, J BACTERIOL, V117, P345, DOI 10.1128/JB.117.2.345-350.1974; MORTIMER RK, 1969, YEASTS, V1, P385; NOMOTO S, 1990, EMBO J, V9, P691, DOI 10.1002/j.1460-2075.1990.tb08161.x; OLINS PO, 1989, J BIOL CHEM, V264, P16973; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PAIGE LA, 1989, J MED CHEM, V32, P1665, DOI 10.1021/jm00128a001; REED SI, 1988, COLD SPRING HARB SYM, V53, P621, DOI 10.1101/SQB.1988.053.01.071; RESNICK MA, 1966, J BACTERIOL, V92, P597, DOI 10.1128/JB.92.3.597-600.1966; Rudnick D.A., 1992, LIPID MODIFICATION P, P37; RUDNICK DA, 1992, J BIOL CHEM, V267, P23852; RUDNICK DA, 1990, J BIOL CHEM, V265, P13370; RUDNICK DA, 1991, J BIOL CHEM, V266, P9732; RUDNICK DA, 1992, IN PRESS P NATL ACAD; RUDNICK DA, 1993, IN PRESS P NATL ACAD; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SCHWEIZER E, 1970, P NATL ACAD SCI USA, V67, P660, DOI 10.1073/pnas.67.2.660; SIKORSKI RS, 1989, GENETICS, V122, P19; SLATER MR, 1987, MOL CELL BIOL, V7, P1906, DOI 10.1128/MCB.7.5.1906; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; TOWLER D, 1986, P NATL ACAD SCI USA, V83, P2812, DOI 10.1073/pnas.83.9.2812; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; TRUEHEART J, 1987, MOL CELL BIOL, V7, P2316, DOI 10.1128/MCB.7.7.2316; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; WIEGAND RC, 1992, J BIOL CHEM, V267, P8591; WOLDEGIORGIS G, 1985, ANAL BIOCHEM, V150, P8, DOI 10.1016/0003-2697(85)90434-8	72	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					483	494						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416952				2022-12-27	WOS:A1993KE60300074
J	OZAWA, M; MURAMATSU, T				OZAWA, M; MURAMATSU, T			RETICULOCALBIN, A NOVEL ENDOPLASMIC-RETICULUM RESIDENT CA2+-BINDING PROTEIN WITH MULTIPLE EF-HAND MOTIFS AND A CARBOXYL-TERMINAL HDEL SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; MUSCLE SARCOPLASMIC-RETICULUM; GLUCOSE-REGULATED PROTEIN; LUMINAL ER PROTEINS; DISULFIDE ISOMERASE; SECRETORY PROTEINS; MOLECULAR-CLONING; GLYCOPROTEIN; CALRETICULIN; OLIGOSACCHARIDES	A novel Ca2+-binding protein, tentatively designated reticulocalbin, has been identified and characterized. Reticulocalbin is a luminal protein of the endoplasmic reticulum with an M(r) of 44,000 as revealed by biochemical analysis and immunofluorescence staining. The cDNA of reticulocalbin encodes a protein of 325 amino acids with an amino-terminal signal sequence of 20 amino acids. The protein has six repeats of a domain containing the high affinity Ca2+-binding motif, the EF-hand. Although oxygen-containing amino acids important for the positioning of Ca2+ are conserved in all six domains, the conserved glycine residues in the central portion of the EF-hand motif are absent in three of them. Calcium blots showed that recombinant reticulocalbin expressed in bacterial cells binds Ca2+. The protein has the sequence His-Asp-Glu-Leu (HDEL) at its carboxyl terminus. This is similar to the Lys-Asp-Glu-Leu sequence, which serves as a signal to retain the resident proteins in the endoplasmic reticulum of animal cells. A mutant protein lacking the HDEL sequence produced by in vitro mutagenesis has been shown to be secreted into medium in transient expression assays.			OZAWA, M (corresponding author), KAGOSHIMA UNIV,FAC MED,DEPT BIOCHEM,8-35-1 SAKURAGAOKA,KAGOSHIMA 890,JAPAN.							BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DANG CV, 1985, J BIOL CHEM, V260, P9713; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Etzler M., 1972, METHODS ENZYMOL, V28, P340; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FLIEGEL L, 1990, J BIOL CHEM, V265, P15496; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FURUKAWA T, 1990, J BIOCHEM-TOKYO, V108, P297, DOI 10.1093/oxfordjournals.jbchem.a123197; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; HUNZIKER W, 1986, P NATL ACAD SCI USA, V83, P7578, DOI 10.1073/pnas.83.20.7578; KELLY RB, 1990, NATURE, V345, P480, DOI 10.1038/345480a0; Kretsinger R H, 1980, Ann N Y Acad Sci, V356, P14, DOI 10.1111/j.1749-6632.1980.tb29594.x; MACER DRJ, 1988, J CELL SCI, V91, P61; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OZAWA M, 1988, J BIOL CHEM, V263, P3059; OZAWA M, 1982, DEV BIOL, V91, P351, DOI 10.1016/0012-1606(82)90041-0; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; ROBBI M, 1991, J BIOL CHEM, V266, P20498; ROGERS JH, 1989, NEUROSCIENCE, V31, P711, DOI 10.1016/0306-4522(89)90435-1; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SORGER PK, 1987, J MOL BIOL, V194, P341, DOI 10.1016/0022-2836(87)90380-9; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; ZAGOURAS P, 1989, J CELL BIOL, V109, P2633, DOI 10.1083/jcb.109.6.2633	38	129	134	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					699	705						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416973				2022-12-27	WOS:A1993KE60300105
J	SAKURADA, K; MASU, M; NAKANISHI, S				SAKURADA, K; MASU, M; NAKANISHI, S			ALTERATION OF CA2+ PERMEABILITY AND SENSITIVITY TO MG2+ AND CHANNEL BLOCKERS BY A SINGLE AMINO-ACID SUBSTITUTION IN THE N-METHYL-D-ASPARTATE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE RECEPTOR; NMDA RECEPTOR; ION CHANNELS; TRICYCLIC ANTIDEPRESSANTS; MOLECULAR-CLONING; DIVALENT-CATIONS; CENTRAL NEURONS; EXPRESSION; RESPONSES; SEQUENCE	The N-methyl-D-aspartate (NMDA) receptor plays an important role in glutamate-mediated neuronal plasticity and neurotoxicity in the central nervous system. This receptor is composed of a fundamental subunit (NMDAR1) and its potentiating subunits (NMDAR2A-NMDAR2D). The NMDA receptor is distinct from other glutamate receptor channels because of its high Ca2+ permeability and inhibition by selective cationic channel blockers such as Mg2+, Zn2+, and MK-801. In this study, we investigated the structural features that control Ca2+ permeation and channel blockade of the NMDA receptor by in vitro mutagenesis and expression in Xenopus oocytes. We constructed a series of mutations with single amino acid substitutions in the second transmembrane segment of NMDAR1 and examined channel properties of the resultant mutants in combined expression with the NMDAR2A subunit. Substitution of the asparagine with either glutamine or arginine altered both the Ca2+ permeability and the sensitivity to blockades by Mg2+ and MK-801. These mutations also reduced the inhibitory effects of Zn2+ and an antidepressant, desipramine. Based on these results, we concluded that an asparagine ring formed in the central part of the channel-forming second transmembrane segments plays a critical role in determining the Ca2+ permeability and the inhibition of open channel blockers.			SAKURADA, K (corresponding author), KYOTO UNIV, FAC MED, INST IMMUNOL, SAKYO KU, KYOTO 606, JAPAN.		Sakurada, Kazuhiro/AAH-2281-2021	Sakurada, Kazuhiro/0000-0002-4858-2607				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; ISHII T, 1993, IN PRESS J BIOL CHEM; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; REYNOLDS IJ, 1988, BRIT J PHARMACOL, V95, P95, DOI 10.1111/j.1476-5381.1988.tb16552.x; SERNAGOR E, 1989, NEURON, V2, P1221, DOI 10.1016/0896-6273(89)90306-1; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3	30	146	155	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					410	415						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416947				2022-12-27	WOS:A1993KE60300063
J	MARTIN, F; PRANDINI, MH; THEVENON, D; MARGUERIE, G; UZAN, G				MARTIN, F; PRANDINI, MH; THEVENON, D; MARGUERIE, G; UZAN, G			THE TRANSCRIPTION FACTOR GATA-1 REGULATES THE PROMOTER ACTIVITY OF THE PLATELET GLYCOPROTEIN-IIB GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; ERYTHROID-SPECIFIC PROTEIN; AVIAN LEUKEMIA-VIRUS; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; IMMUNOGLOBULIN GENES; HEMATOPOIETIC-CELLS; NUCLEAR FACTOR; CONTROL REGION; GLOBIN GENE	Glycoprotein IIb (GPIIb) is an early and specific marker of the megakaryocytic lineage. We have previously shown that a fragment extending 643 base pairs upstream the transcription start site of the human GPIIb promoter was able to control the tissue-specific expression of the CAT -gene in transfection experiments. Four potential GATA-binding sites, located at positions -463, -376, -243, and -54 are present within this fragment. Gel shift analysis revealed that nuclear extracts from the erythroleukemic cell line HEL contain a DNA-binding protein that recognizes these GATA sites. Using an antiserum raised to an hydrophilic region of the transcription factor GATA-1, the HEL GATA-binding protein was found to be GATA-1. Point mutations of the different GATA sites indicated that they did not equally contribute to GPIIb promoter activity. The -463 GATA motif located in an enhancer region is essential for full transcription activity and was found to be dominant upon the other GATA motifs. When this site is mutated, the -54 GATA site appears to be essential for the remaining CAT activity. These results indicate that the transcription factor GATA-1 plays an important role in the regulation of the transcription of the megakaryocyte specific GPIIb gene.			MARTIN, F (corresponding author), CEN, INSERM, DEPT BIOL MOLEC & STRUCT, HEMATOL LAB, 85X, F-38041 GRENOBLE, FRANCE.							BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; CLINTON GM, 1991, METHOD ENZYMOL, V200, P463; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; CROTTA S, 1990, NUCLEIC ACIDS RES, V18, P6863, DOI 10.1093/nar/18.23.6863; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FONG TC, 1992, GENE DEV, V6, P521, DOI 10.1101/gad.6.4.521; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HALLIGAN BD, 1987, P NATL ACAD SCI USA, V84, P7019, DOI 10.1073/pnas.84.20.7019; HEIDENREICH R, 1990, BIOCHEMISTRY-US, V29, P1232, DOI 10.1021/bi00457a020; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; INOUE A, 1989, J BIOL CHEM, V264, P14954; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; KAGEN A, 1979, METHOD HORM RADIOIMM, P328; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P1311; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MOLLA A, 1992, BRIT J HAEMATOL, V82, P635, DOI 10.1111/j.1365-2141.1992.tb06937.x; MOREAUGACHELIN F, 1990, LEUKEMIA, V4, P20; MOSCOVICI MG, 1983, VIROLOGY, V129, P65, DOI 10.1016/0042-6822(83)90396-3; ORKIN SH, 1992, BLOOD, V80, P575; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PRANDINI MH, 1988, BIOCHEM BIOPH RES CO, V156, P595, DOI 10.1016/S0006-291X(88)80884-2; PRANDINI MH, 1992, J BIOL CHEM, V267, P10370; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; RAVID K, 1991, MOL CELL BIOL, V11, P6116, DOI 10.1128/MCB.11.12.6116; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHWARTZBAUER G, 1992, NUCLEIC ACIDS RES, V20, P4429, DOI 10.1093/nar/20.17.4429; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; UZAN G, 1991, J BIOL CHEM, V266, P8932; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854	46	61	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21606	21612						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408012				2022-12-27	WOS:A1993MC80900029
J	RAMAMOORTHY, S; COOL, DR; MAHESH, VB; LEIBACH, FH; MELIKIAN, HE; BLAKELY, RD; GANAPATHY, V				RAMAMOORTHY, S; COOL, DR; MAHESH, VB; LEIBACH, FH; MELIKIAN, HE; BLAKELY, RD; GANAPATHY, V			REGULATION OF THE HUMAN SEROTONIN TRANSPORTER - CHOLERA TOXIN-INDUCED STIMULATION OF SEROTONIN UPTAKE IN HUMAN PLACENTAL CHORIOCARCINOMA CELLS IS ACCOMPANIED BY INCREASED SEROTONIN TRANSPORTER MESSENGER-RNA LEVELS AND SEROTONIN TRANSPORTER-SPECIFIC LIGAND-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BORDER MEMBRANE-VESICLES; HIGH-AFFINITY; RAT-BRAIN; IMIPRAMINE BINDING; ENDOTHELIAL-CELLS; H-3-IMIPRAMINE BINDING; ACTIVE-TRANSPORT; HUMAN-PLATELETS; I-125 RTI-55	Treatment of confluent cultures of JAR human placental choriocarcinoma cells with cholera toxin or forskolin for 16 h markedly stimulated (2.4-fold) serotonin transport activity in these cells. Cycloheximide, an inhibitor of protein synthesis or actinomycin D, an inhibitor of mRNA synthesis effectively blocked this stimulation. Northern blot analysis revealed that treatment with cholera toxin resulted in severalfold increase in the concentrations of the three mRNA species (6.8, 4.9 and 3.0 kilobases in size) which hybridized to the human placental serotonin transporter cDNA. Under similar conditions, the concentrations of the mRNA species which hybridized to the human placental taurine transporter cDNA or to the human beta-actin cDNA were not affected. Analysis of paroxetine-sensitive binding of the cocaine analog 2beta-carbomethoxy-3beta-(4-[I-125]iodophenyl)tropane to the membranes prepared from control and cholera toxin-treated cells indicated that the maximal binding capacity was increased 2.5-fold by cholera toxin, with no significant change in the binding affinity. Thus, stimulation of serotonin transporter activity in the placental choriocarcinoma cells following cholera toxin treatment is likely a result of an increase in cell surface density of the serotonin transporter protein as a consequence of increased steady state serotonin transporter mRNA levels.	MED COLL GEORGIA, DEPT BIOCHEM & MOLEC BIOL, AUGUSTA, GA 30912 USA; MED COLL GEORGIA, DEPT PHYSIOL & ENDOCRINOL, AUGUSTA, GA 30912 USA; EMORY UNIV, SCH MED, DEPT ANAT & CELL BIOL, ATLANTA, GA 30322 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University			Melikian, Haley/S-8301-2016	Melikian, Haley/0000-0002-9694-5556	NICHD NIH HHS [HD 27487] Funding Source: Medline; NIDA NIH HHS [DA 07390] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007390] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AHTEE L, 1981, LIFE SCI, V29, P2323, DOI 10.1016/0024-3205(81)90566-X; ANDERSON GM, 1992, BIOCHIM BIOPHYS ACTA, V1137, P331, DOI 10.1016/0167-4889(92)90154-4; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; BLAKELY RD, 1993, SOC GEN PHY, V48, P283; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BLOCK ER, 1987, AM J PHYSIOL, V253, pC672, DOI 10.1152/ajpcell.1987.253.5.C672; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; BOJA JW, 1991, EUR J PHARMACOL, V194, P133, DOI 10.1016/0014-2999(91)90137-F; BOSIN TR, 1989, J PHARMACOL EXP THER, V248, P67; BRILEY MS, 1980, SCIENCE, V209, P303, DOI 10.1126/science.7384806; COOL DR, 1991, J BIOL CHEM, V266, P15750; COOL DR, 1990, BIOCHEMISTRY-US, V29, P1818, DOI 10.1021/bi00459a022; COOL DR, 1990, AM J PHYSIOL, V259, pC196, DOI 10.1152/ajpcell.1990.259.2.C196; COOL DR, 1990, BIOCHEM PHARMACOL, V40, P2161, DOI 10.1016/0006-2952(90)90249-K; CORNELIUS P, 1991, J CELL PHYSIOL, V146, P298, DOI 10.1002/jcp.1041460215; FATTACCINI CM, 1990, NEUROPHARMACOLOGY, V29, P1, DOI 10.1016/0028-3908(90)90076-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GANAPATHY V, 1989, J PHARMACOL EXP THER, V251, P9; GANAPATHY V, 1993, TROPHOBLAST RES, V7, P35; GRAHAM D, 1988, NEURONAL SEROTONIN, P367; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HRDINA PD, 1987, EUR J PHARMACOL, V138, P159, DOI 10.1016/0014-2999(87)90429-8; KAMAL LA, 1984, LIFE SCI, V34, P2083, DOI 10.1016/0024-3205(84)90373-4; KELLEY LK, 1983, BIOCHIM BIOPHYS ACTA, V734, P91, DOI 10.1016/0005-2736(83)90079-2; KING SC, 1992, BIOCHEM BIOPH RES CO, V183, P487, DOI 10.1016/0006-291X(92)90508-I; KULANTHAIVEL P, 1991, BIOCHEM J, V277, P53, DOI 10.1042/bj2770053; LANGER SZ, 1980, N-S ARCH PHARMACOL, V313, P189, DOI 10.1007/BF00505732; LEE SL, 1986, AM J PHYSIOL, V250, pC766, DOI 10.1152/ajpcell.1986.250.5.C766; LESCH KP, 1993, MOL BRAIN RES, V17, P31, DOI 10.1016/0169-328X(93)90069-2; LOPEZIBOR JJ, 1988, BRIT J PSYCHIAT, V153, P26, DOI 10.1192/S0007125000297262; MARAZZITI D, 1989, N-S ARCH PHARMACOL, V340, P593; MENINI T, 1987, N-S ARCH PHARMACOL, V336, P478; MYERS CL, 1989, AM J PHYSIOL, V257, pL253, DOI 10.1152/ajplung.1989.257.4.L253; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RAMAMOORTHY S, 1992, BIOCHEM J, V286, P89, DOI 10.1042/bj2860089; RAMAMOORTHY S, 1992, AM J PHYSIOL, V262, pC1189, DOI 10.1152/ajpcell.1992.262.5.C1189; RAMAMOORTHY S, 1993, BIOCHEMISTRY-US, V32, P1346, DOI 10.1021/bi00056a021; RIFAS L, 1984, P NATL ACAD SCI-BIOL, V81, P4558, DOI 10.1073/pnas.81.14.4558; ROSS SB, 1982, BIOL SEROTONERGIC TR, P159; RUDNICK G, 1992, METHOD ENZYMOL, V215, P213; RUDNICK G, 1986, PLATELET RESPONSES M, P119; SEVERSON JA, 1985, J NEUROCHEM, V45, P1382, DOI 10.1111/j.1471-4159.1985.tb07203.x; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; WALL SC, 1993, MOL PHARMACOL, V43, P264; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	47	112	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21626	21631						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408014				2022-12-27	WOS:A1993MC80900032
J	URADE, R; TAKENAKA, Y; KITO, M				URADE, R; TAKENAKA, Y; KITO, M			PROTEIN-DEGRADATION BY ERP72 FROM RAT AND MOUSE-LIVER ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; PRE-GOLGI DEGRADATION; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; DISULFIDE-ISOMERASE; CYSTEINE PROTEASE; PHOSPHOLIPASE-C; CLONING; CALRETICULIN; INHIBITION; SEQUENCES	The endoplasmic reticulum (ER) resident protein, ER60, is a member of the protein disulfide-isomerase family and contains two copies of the internal thioredoxin motif, CGHC. Previously, ER60 was identified as a cysteine protease and named ER-60 protease (Urade, R., Nasu, M., Moriyama, T., Wada, K., and Kito, M. (1992) J. Biol. Chem. 267, 15152-15159; Urade, R., and Kito, M. (1992) FEBS Lett. 312, 83-86). Here, ERp72, the other member of the protein disulfide-isomerase family containing three CGHC motifs, was isolated from ER of rat and mouse livers through four sequential chromatographies on DEAE-Toyopearl 650, AF-heparin Toyopearl 650M, and TSK gel G3000SW twice. The purified rat protein was found to be homogeneous on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, not being contaminated by ER-60 protease, as judged on immunoblot analysis using an anti-ER-60 protease antibody. The partial amino acid sequence of rat ERp72 was 93% homologous to that of mouse ERp72. The purified rat ERp72 degraded other ER resident proteins such as protein disulfide-isomerase and calreticulin. The purified mouse ERp72 also degraded those proteins. Though rat ERp72 did not basically require Ca2+ for the reaction, the degradation of protein disulfide-isomerase was enhanced, but the degradation of calreticulin was inhibited in the presence of Ca2+. The proteolytic activity of rat ERp72 was inhibited by cysteine protease inhibitors. Its sensitivity to protease inhibitors was the same as that of ER-60 protease. In addition, the proteolytic activity of rat ERp72 was inhibited by acidic phospholipids, also similar to ER-60 protease. Therefore, we propose that ERp72 be named ER-72 protease.	KYOTO UNIV,FOOD SCI RES INST,UJI,KYOTO 611,JAPAN	Kyoto University								AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; CHANDHURI MM, 1992, BIOCHEM J, V281, P645; COHEN LW, 1986, GENE, V48, P219, DOI 10.1016/0378-1119(86)90080-6; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; HUANG SH, 1991, J BIOL CHEM, V266, P5353; INOUE S, 1992, J BIOL CHEM, V267, P9080; INOUE S, 1991, J BIOL CHEM, V266, P13311; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; MACER DRJ, 1988, J CELL SCI, V91, P61; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; OHNO S, 1987, METHOD ENZYMOL, V139, P363; PETER F, 1992, J BIOL CHEM, V267, P10631; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; TREVES S, 1990, BIOCHEM J, V271, P473, DOI 10.1042/bj2710473; URADE R, 1992, J BIOL CHEM, V267, P15152; URADE R, 1992, FEBS LETT, V312, P83, DOI 10.1016/0014-5793(92)81415-I; WAXMAN L, 1981, METHOD ENZYMOL, V80, P664; WIKSTROM L, 1991, J CELL BIOL, V113, P997, DOI 10.1083/jcb.113.5.997; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973; WILEMAN T, 1990, CELL REGUL, V2, P753	29	75	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22004	22009						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408057				2022-12-27	WOS:A1993MC80900085
J	ZACHARY, I; SINNETTSMITH, J; TURNER, CE; ROZENGURT, E				ZACHARY, I; SINNETTSMITH, J; TURNER, CE; ROZENGURT, E			BOMBESIN, VASOPRESSIN, AND ENDOTHELIN RAPIDLY STIMULATE TYROSINE PHOSPHORYLATION OF THE FOCAL ADHESION-ASSOCIATED PROTEIN PAXILLIN IN SWISS 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; BINDING-PROTEIN; PHOSPHOLIPASE-C; EXTRACELLULAR-MATRIX; MITOGENIC RESPONSE; ALPHA-SUBUNITS; GROWTH-FACTORS; EARLY EVENTS; RECEPTOR; ACTIVATION	Treatment of Swiss 3T3 cells with bombesin caused a striking increase (21-fold) in the tyrosine phosphorylation of the cytoskeleton-associated protein paxillin, as judged by anti-phosphotyrosine Western blots of anti-paxillin immunoprecipitates. Vasopressin and endothelin also stimulated paxillin tyrosine phosphorylation. Bombesin-stimulated tyrosine phosphorylation of paxillin was detectable within 1 min and was concentration-dependent (half-maximum effect at 0.09 nM). Bombesin stimulation of paxillin tyrosine phosphorylation could be dissociated from both protein kinase C (PKC) activation and the mobilization of Ca2+ from intracellular stores. Activation of PKC in quiescent Swiss 3T3 cells using the tumor promoter phorbol 12,13-dibutyrate (PDB) increased the tyrosine phosphorylation of paxillin in a time-dependent manner but was less effective than bombesin and stimulated detectable phosphorylation only within 5 min, considerably slower than bombesin-induced tyrosine phosphorylation of paxillin. Furthermore, the selective PKC inhibitor, GF109203X, or down-regulation of PKC using prolonged treatment with PDB markedly inhibited the stimulation of paxillin tyrosine phosphorylation by PDB but had little effect on the response to bombesin. In contrast, cytochalasin D, an agent that selectively disrupts the network of actin microfilaments, completely inhibited bombesin- and PDB-induced paxillin tyrosine phosphorylation. This is the first report to identify paxillin as a substrate for neuropeptide-stimulated tyrosine phosphorylation.	IMPERIAL CANC RES FUND,POB 123,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; SUNY HLTH SCI CTR,DEPT ANAT & CELL BIOL,SYRACUSE,NY 13210	Cancer Research UK; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center					NIGMS NIH HHS [R01 GM047607, GM47607] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047607, R01GM047607] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; COFFER A, 1990, FEBS LETT, V263, P80, DOI 10.1016/0014-5793(90)80710-Z; COLLINS MKL, 1983, P NATL ACAD SCI-BIOL, V80, P1924, DOI 10.1073/pnas.80.7.1924; ERUSALIMSKY JD, 1989, J CELL PHYSIOL, V141, P253, DOI 10.1002/jcp.1041410204; ERUUSALIMSKY J, 1988, J BIOL CHEM, V263, P19188; FORCE T, 1991, J BIOL CHEM, V266, P6650; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; ISSANDOU M, 1990, J BIOL CHEM, V265, P11890; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LEEBLUNDBERG LMF, 1991, J BIOL CHEM, V266, P7746; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MILLAR JBA, 1990, J BIOL CHEM, V265, P19973; MIURA Y, 1993, J BIOL CHEM, V268, P510; MOREL A, 1992, NATURE, V356, P523, DOI 10.1038/356523a0; NANBERG E, 1988, EMBO J, V7, P2741, DOI 10.1002/j.1460-2075.1988.tb03128.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; ROZENGURT E, 1991, EUR J CLIN INVEST, V21, P123, DOI 10.1111/j.1365-2362.1991.tb01801.x; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; ROZENGURT E, 1990, PHILOS T ROY SOC B, V327, P209, DOI 10.1098/rstb.1990.0055; ROZENGURT E, 1992, Current Opinion in Cell Biology, V4, P161, DOI 10.1016/0955-0674(92)90027-A; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SECKL M, 1993, J BIOL CHEM, V268, P9548; SINNETTSMITH J, 1988, J CELL BIOCHEM, V38, P237, DOI 10.1002/jcb.240380403; SINNETTSMITH J, 1990, BIOCHEM J, V265, P485, DOI 10.1042/bj2650485; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; STADDON JM, 1991, J BIOL CHEM, V266, P4840; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; THASTRUP O, 1987, BIOCHIM BIOPHYS ACTA, V927, P65, DOI 10.1016/0167-4889(87)90066-8; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1993, IN PRESS J CELL SCI; WALSH JH, 1993, IN PRESS J CELL PHYS; WU DQ, 1992, J BIOL CHEM, V267, P1811; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577; ZACHARY I, 1991, J BIOL CHEM, V266, P24126; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1987, DEV BIOL, V124, P295, DOI 10.1016/0012-1606(87)90483-0; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	55	209	209	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22060	22065						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408063				2022-12-27	WOS:A1993MC80900093
J	VOLONTE, C; ANGELASTRO, JM; GREENE, LA				VOLONTE, C; ANGELASTRO, JM; GREENE, LA			ASSOCIATION OF PROTEIN-KINASES ERK1 AND ERK2 WITH P75 NERVE GROWTH-FACTOR RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; AFFINITY NGF RECEPTOR; MYELIN BASIC-PROTEIN; STIMULATES TYROSINE PHOSPHORYLATION; TRK PROTOONCOGENE PRODUCT; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; PURINE ANALOGS; GENE-TRANSFER; INSULIN	Extracellular signal-regulated protein kinases (ERKs) constitute a family of protein serine-threonine kinases implicated in a variety of cell-signaling pathways. In cultured rat pheochromocytoma PC12 cells, ERK1 and ERK2 are activated by nerve growth factor (NGF), which also induces rapid association between ERK1 and the high affinity gp140prototrk tyrosine kinase NGF receptor. In the present work, we investigated the possible association between ERKs and the low affinity NGF receptor, p75. Extracts of PC 12 cells (before and after NGF treatment) were subjected to immunoprecipitation with anti-p75 antibodies or antiserum; the immune complexes were then assessed for the presence of ERK proteins and tyrosine phosphorylation or for ERK activity using a specific substrate peptide. ERK1 and, to a lesser extent, ERK2 were found to be constitutively associated with p75. NGF did not modulate the total amount of ERK proteins co-immunoprecipitated with p75 but did markedly stimulate the level of p75-associated ERK catalytic activity. NGF treatment also enhanced the tyrosine phosphorylation of a p75-associated species that co-migrates with ERK1 in Western blots. Finally, K-252a, a compound that specifically inhibits activation by NGF of gp140prototrk, abolished the latter effect. These findings indicate that NGF, via activation of gp140prototrk, leads to association of enzymatically active ERKs with p75 and raise the possibility that this interaction may play a role in the NGF mechanism of action.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University; Columbia University			Volonté, Cinzia/N-6474-2013	Volonté, Cinzia/0000-0001-7362-8307				AHN NG, 1991, J BIOL CHEM, V266, P4220; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERG MM, 1992, J BIOL CHEM, V267, P13; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOULTON TG, 1991, BIOCHEMISTRY-US, V30, P278, DOI 10.1021/bi00215a038; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; DRINKWATER CC, 1992, P R SOC LOND B, V246, P307; ERIKSON AK, 1990, J BIOL CHEM, V265, P19728; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HER JH, 1991, NUCLEIC ACIDS RES, V19, P3743, DOI 10.1093/nar/19.13.3743; HOSANG M, 1985, J BIOL CHEM, V260, P655; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1993, NEURON, V10, P1; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEVI A, 1991, ANNU REV PHARMACOL, V31, P205; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; OHMICHI M, 1991, CELL REGUL, V2, P691, DOI 10.1091/mbc.2.9.691; PAVNE DM, 1991, EMBO J, V10, P885; RADEKE MJ, 1991, NEURON, V7, P141, DOI 10.1016/0896-6273(91)90082-B; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROSS AH, 1991, CELL REGUL, V2, P685, DOI 10.1091/mbc.2.9.685; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SANGHERA JS, 1990, FEBS LETT, V273, P223, DOI 10.1016/0014-5793(90)81090-B; TANIUCHI M, 1986, J BIOL CHEM, V261, P3342; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAO H, 1990, J BIOL CHEM, V265, P15471; TSAO H, 1991, J BIOL CHEM, V266, P12981; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VOLONTE C, 1992, J BIOL CHEM, V267, P21663; VOLONTE C, 1993, MOL BIOL CELL, V4, P71, DOI 10.1091/mbc.4.1.71; VOLONTE C, 1989, J CELL BIOL, V109, P2395, DOI 10.1083/jcb.109.5.2395; VOLONTE C, 1992, J NEUROCHEM, V58, P700, DOI 10.1111/j.1471-4159.1992.tb09774.x; VOLONTE C, 1990, J BIOL CHEM, V265, P11050; VOLONTE C, 1993, IN PRESS J NEUROCHEM; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	63	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21410	21415						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407983				2022-12-27	WOS:A1993MA28800111
J	BOIVIN, D; GINGRAS, D; BELIVEAU, R				BOIVIN, D; GINGRAS, D; BELIVEAU, R			PURIFICATION AND CHARACTERIZATION OF A MEMBRANE-BOUND PROTEIN CARBOXYL METHYLTRANSFERASE FROM RAT-KIDNEY CORTEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ISOASPARTYL RESIDUES; ESCHERICHIA-COLI; DODECYL-SULFATE; METHYLATION; ASPARTYL; BRAIN; ISOZYMES; CARBOXYMETHYLASE; DEAMIDATION; RECOGNITION	Class II protein carboxy methyltransferases (EC 2.1.1.77) are known to exist predominantly in a soluble form in all cells studied so far. These enzymes have been purified to homogeneity from the cytosols of many mammalian tissues but not from membranes. We describe here the purification to apparent homogeneity of a membrane-associated protein carboxyl methyltransferase from the brush border membrane of rat kidney. The enzyme was purified by fast protein liquid chromatography on Superdex 75 and Mono-Q and by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and consists of a single 27,300 poly. peptide. The purified enzyme recognizes exogenous substrate proteins such as ovalbumin and gamma-globulins as well as synthetic peptides containing a L-isoaspartyl residue but not a synthetic peptide containing a farnesylated C-terminal cysteine (S-farnesyl-LARYKC). The K(m) for S-adenosyl-L-methionine with ovalbumin as the substrate is 1.5 muM and the purified enzyme is sensitive to inhibition by S-adenosyl-L-homocysteine (K(i) = 0.3 muM). Peptide map obtained after Staphylococcus aureus V8 protease digestion of brush border membrane protein carboxyl methyltransferase showed a fragmentation pattern that was identical to that obtained for a soluble protein carboxyl methyltransferase purified according to the same procedure, indicating a high degree of homology. These results support the notion that class II protein carboxyl methyltransferases are not restricted to a cytosolic localization and show that the membrane-bound form of this enzyme shares many characteristics with known cytosolic protein carboxyl methyltransferases.	UNIV QUEBEC,DEPT CHIM BIOCHIM,RECH BIOTHERAPEUT MOLEC GRP,MEMBRANOL LAB,MONTREAL H3C 3P8,QUEBEC,CANADA	University of Quebec; University of Quebec Montreal								ASWAD DW, 1987, TRENDS BIOCHEM SCI, V12, P155, DOI 10.1016/0968-0004(87)90073-9; ASWAD DW, 1984, J BIOL CHEM, V259, P714; ASWAD DW, 1983, J NEUROCHEM, V40, P1718, DOI 10.1111/j.1471-4159.1983.tb08147.x; Booth A G, 1974, Biochem J, V142, P575; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN FC, 1984, BIOCHEM PHARMACOL, V33, P2921, DOI 10.1016/0006-2952(84)90217-X; CHRISTY KG, 1989, BIOTECHNIQUES, V7, P692; CLARKE S, 1981, BIOCHIM BIOPHYS ACTA, V670, P195, DOI 10.1016/0005-2795(81)90009-X; CLARKE S, 1985, ANNU REV BIOCHEM, V54, P479, DOI 10.1146/annurev.bi.54.070185.002403; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; FU JC, 1991, J BIOL CHEM, V266, P14562; GILBERT JM, 1988, BIOCHEMISTRY-US, V27, P5227, DOI 10.1021/bi00414a042; GINGRAS D, 1991, BIOCHIM BIOPHYS ACTA, V1066, P261, DOI 10.1016/0005-2736(91)90196-F; HAKLAI R, 1987, BIOCHEMISTRY-US, V26, P4200, DOI 10.1021/bi00388a004; INGROSSO D, 1991, BIOCHEM BIOPH RES CO, V175, P351, DOI 10.1016/S0006-291X(05)81242-2; IQBAL M, 1976, J NEUROCHEM, V27, P605, DOI 10.1111/j.1471-4159.1976.tb12289.x; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1990, PROTEIN METHYLATION, P195; KELLY MH, 1970, CLIN BIOCHEM, V3, P33, DOI 10.1016/S0009-9120(70)80053-4; KIM S, 1977, J BACTERIOL, V130, P839, DOI 10.1128/JB.130.2.839-845.1977; KIM S, 1978, ANAL BIOCHEM, V84, P415, DOI 10.1016/0003-2697(78)90059-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; MURRAY ED, 1984, J BIOL CHEM, V259, P722; OCONNOR CM, 1985, BIOCHEM BIOPH RES CO, V132, P1144, DOI 10.1016/0006-291X(85)91926-6; OTA IM, 1989, J BIOL CHEM, V264, P12879; OTA IM, 1987, J BIOL CHEM, V262, P8522; OTA IM, 1990, PROTEIN METHYLATION, P179; SELLINGER OZ, 1987, NEUROCHEM INT, V10, P155, DOI 10.1016/0197-0186(87)90122-7; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; STEPHENSON RC, 1990, J BIOL CHEM, V265, P16248; VOLKER C, 1991, FEBS LETT, V295, P189, DOI 10.1016/0014-5793(91)81415-5	34	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2610	2615						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428937				2022-12-27	WOS:A1993KK81500054
J	YONEMOTO, W; MCGLONE, ML; TAYLOR, SS				YONEMOTO, W; MCGLONE, ML; TAYLOR, SS			N-MYRISTYLATION OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE CONVEYS STRUCTURAL STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; REGULATORY SUBUNIT; ACYLATED PROTEINS; ESCHERICHIA-COLI; MYRISTOYLATION; CELLS; REASSOCIATION; SPECIFICITY; EXPRESSION; MUTATION	Coexpression of the yeast N-myristyltransferase with the murine catalytic subunit of cAMP-dependent protein kinase in prokaryotic cells results in the N-myristylation of the recombinant catalytic subunit. The acylated recombinant catalytic subunit was purified following in vitro holoenzyme formation with a mutant form of the regulatory subunit and compared to the non-myristylated recombinant enzyme and to the mammalian porcine enzyme. All three enzymes are very similar in terms of their kinetic properties and their capacity to reassociate in vitro with the regulatory subunit to form holoenzyme. In contrast, the myristylated recombinant catalytic subunit is significantly more stable to thermal denaturation than the non-myristylated enzyme. Its thermal stability is now comparable to the mammalian enzyme. All three catalytic subunits are significantly more stable to thermal denaturation when they are part of the holoenzyme complex. Each shows an increase in T1/2 of 10-degrees-C. This study demonstrates that one function for the myristic acid at the NH, terminus of the catalytic subunit is to provide structural stability.	UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,DEPT CHEM,9500 GILMAN DR,LA JOLLA,CA 92093	University of California System; University of California San Diego; Scripps Institution of Oceanography					NIGMS NIH HHS [GM19301] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019301, R37GM019301] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; BRAMSON HN, 1984, CRC CR REV BIOCH MOL, V15, P93, DOI 10.3109/10409238409102298; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; CARR DW, 1991, J BIOL CHEM, V266, P14188; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; CLEGG CH, 1989, J BIOL CHEM, V264, P20140; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; GORDON JI, 1991, J BIOL CHEM, V266, P8647; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KAPLAN JM, 1988, MOL CELL BIOL, V8, P2435, DOI 10.1128/MCB.8.6.2435; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LEE YMH, 1992, VIROLOGY, V187, P814, DOI 10.1016/0042-6822(92)90485-8; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; NEITZEL JJ, 1991, BIOCHEMISTRY-US, V30, P733, DOI 10.1021/bi00217a023; NELSON NC, 1981, J BIOL CHEM, V256, P3743; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; OLSON EN, 1985, J BIOL CHEM, V260, P3784; SLICE LW, 1989, J BIOL CHEM, V264, P20940; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441	31	98	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2348	2352						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428909				2022-12-27	WOS:A1993KK81500018
J	ERICKSON, PR; HERZBERG, MC				ERICKSON, PR; HERZBERG, MC			THE STREPTOCOCCUS-SANGUIS PLATELET AGGREGATION-ASSOCIATED PROTEIN - IDENTIFICATION AND CHARACTERIZATION OF THE MINIMAL PLATELET-INTERACTIVE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; SURFACE; CHAIN; ADHESION; SEQUENCE; STRAINS; CLONING; TISSUE	Streptococcus sanguis expresses a cell wall-bound protein that induces the activation and aggregation of platelets. This platelet aggregation-associated protein (PAAP) contains a collagen-like, platelet-interactive domain within a 23-kDa protein fragment. To isolate the minimal platelet-interactive domain, p23 PAAP was digested with collagenase, and the digest chromatographed to isolate fractions with activity inhibitory to S. sanguis-induced platelet aggregation. The active fraction was then digested with cyanogen bromide, the product chromatographed, and a smaller inhibitory peptide isolated. Finally, this fraction was digested with endoproteinase Lys-C, and the digest fractionated. After each step, inhibitory activity resolved into single chromatographic peaks of 13 kDa (p13 PAAP), 2.7 kDa (p2.7 PAAP), and a minimal 7-mer peptide, respectively. These PAAP fragments showed similar ID50 (19-28 nM), suggesting that each contained a single copy of the platelet-interactive domain. The minimal 7-mer peptide was purified by immunoaffinity chromatography and reverse phase high pressure liquid chromatography. The primary structure was determined to be Pro-Gly-Glu-Gln-Gly-Pro-Lys. This sequence conforms to the predicted structural motif of the platelet-interactive domains of types I and III collagen. This 7-mer peptide is therefore the platelet-interactive domain of the PAAP from S. sanguis. Its structure explains the molecular basis for immunological cross-reactivity and functional similarity to the platelet-interactive domains of collagens.	UNIV MINNESOTA,SCH DENT,DEPT PREVENT SCI,17-164 MOOS HS TOWER,515 DELAWARE ST SE,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH DENT,GRAD PROGRAM ORAL BIOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K15DE000224, R01DE005501] Funding Source: NIH RePORTER; NIDCR NIH HHS [1 K15 DE00224, 2 R01 DE05501] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARNES MJ, 1980, THROMB RES, V18, P375, DOI 10.1016/0049-3848(80)90333-3; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; CLAWSON CC, 1980, AM J HEMATOL, V9, P43, DOI 10.1002/ajh.2830090106; CONNOLLY TM, 1992, J BIOL CHEM, V267, P6893; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; DILLON HC, 1982, DENTAL MICROBIOLOGY, P388; ERICKSON PR, 1990, J BIOL CHEM, V265, P14080; ERICKSON PR, 1987, J IMMUNOL, V138, P3360; ERICKSON PR, 1992, J BIOL CHEM, V267, P10018; FACKLAM RR, 1977, J CLIN MICROBIOL, V5, P184; FITZSIMMONS CM, 1986, THROMB HAEMOSTASIS, V56, P95; GORDON JL, 1979, NATURE, V278, P13, DOI 10.1038/278013a0; HERZBERG MC, 1983, INFECT IMMUN, V42, P394, DOI 10.1128/IAI.42.1.394-401.1983; HERZBERG MC, 1979, J BIOL CHEM, V254, P1487; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; HERZBERG MC, 1990, INFECT IMMUN, V58, P4117, DOI 10.1128/IAI.58.12.4117-4125.1990; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; HERZBERG MC, 1985, MOL BASIS ORAL MICRO, P53; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; KARNIGVIAN A, 1980, BIOCHEM BIOPH RES CO, V96, P1579; KELLER PM, 1992, J BIOL CHEM, V267, P6899; MERRIL CR, 1982, ELECTROPHORESIS, V3, P17, DOI 10.1002/elps.1150030104; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MYERS LK, 1989, J EXP MED, V170, P1999, DOI 10.1084/jem.170.6.1999; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; SANTORO SA, 1980, THROMB HAEMOSTASIS, V43, P158; SAUS J, 1989, J BIOL CHEM, V264, P6318; SCHWARZ U, 1986, EUR J BIOCHEM, V157, P49, DOI 10.1111/j.1432-1033.1986.tb09636.x; SOBERAY AH, 1987, THROMB HAEMOSTASIS, V57, P222; SOMMER P, 1992, INFECT IMMUN, V60, P360, DOI 10.1128/IAI.60.2.360-365.1992; STAATZ WD, 1991, J BIOL CHEM, V266, P7363; SULLAM PM, 1987, INFECT IMMUN, V55, P1743, DOI 10.1128/IAI.55.8.1743-1750.1987; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022	37	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1646	1649						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420939				2022-12-27	WOS:A1993KH62000024
J	LEAVITT, AD; SHIUE, L; VARMUS, HE				LEAVITT, AD; SHIUE, L; VARMUS, HE			SITE-DIRECTED MUTAGENESIS OF HIV-1 INTEGRASE DEMONSTRATES DIFFERENTIAL-EFFECTS ON INTEGRASE FUNCTIONS INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LEUKEMIA-VIRUS; RETROVIRAL INTEGRATION; PROTEIN CLEAVES; VIRAL-DNA; POL GENE; MUTATIONS; SEQUENCES; ENDS	The retroviral integrase (IN) protein is essential for integration of retroviral DNA into the host cell genome. To identify functional domains within the protein and to assess the importance of conserved residues, we performed site-directed mutagenesis of HIV-1 IN and analyzed the mutants in vitro for IN-mediated activities: 3' processing (att site-specific nuclease activity), strand transfer (the joining of att site oligonucleotides to target DNA), disintegration (the reverse of strand transfer), and integration site selection. Changing the conserved residue His-16 either to Cys or to Val in a proposed zinc-finger region had minimal effect on IN activities. Alteration of two highly conserved amino acid residues, Asp-116 --> Ile and Glu-152 --> Gly, each resulted in complete or nearly complete loss of 3' processing, strand transfer, and disintegration, whereas alteration of another conserved residue, Trp235 --> Glu, had no demonstrable effect on any of the activities in vitro. Two mutants, Asp-64 --> Val and Arg-199 --> CysDELTA, each demonstrated differential effects on IN activities. Asp-64 --> Val has no demonstrable strand transfer or disintegration activity yet maintains 3' processing activity at a diminished level. Arg199 --> CysDELTA, which lacks part of the carboxyl terminus of IN, has impaired strand transfer activity without loss of disintegration activity. Use of a target site selection assay showed that all of our mutants with strand transfer activity maintain the same integration pattern as wild type IN. We conclude that not all highly conserved IN residues are essential for IN activities in vitro, zinc coordination by the proposed zinc-finger domain may not be required for the activities assayed, alteration of single residues can yield differential effects on IN activities, and target site selection into naked DNA is not necessarily altered by changes in strand transfer activity.	UNIV CALIF SAN FRANCISCO,DEPT IMMUNOL & MICROBIOL,HSE 401,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								BARR PJ, 1991, EXPRESSION SYSTEMS P, P51; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2526; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; COLICELLI J, 1985, CELL, V42, P573, DOI 10.1016/0092-8674(85)90114-X; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; DONEHOWER LA, 1984, P NATL ACAD SCI-BIOL, V81, P6461, DOI 10.1073/pnas.81.20.6461; DONEHOWER LA, 1988, J VIROL, V62, P3958, DOI 10.1128/JVI.62.11.3958-3964.1988; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FAYET O, 1990, MOL MICROBIOL, V4, P1771, DOI 10.1111/j.1365-2958.1990.tb00555.x; FRANCHINI G, 1989, P NATL ACAD SCI USA, V86, P2433, DOI 10.1073/pnas.86.7.2433; FUJIWARA T, 1989, P NATL ACAD SCI USA, V86, P3065, DOI 10.1073/pnas.86.9.3065; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KAHN E, 1991, NUCLEIC ACIDS RES, V19, P851; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAFEMINA RL, 1991, J VIROL, V65, P5624, DOI 10.1128/JVI.65.10.5624-5630.1991; LEAVITT AD, 1992, J VIROL, V66, P2359, DOI 10.1128/JVI.66.4.2359-2368.1992; LIN TH, 1989, PROTEINS, V5, P156, DOI 10.1002/prot.340050210; MYERS G, 1991, HUMAN RETROVIRUSES A; PANGANIBAN AT, 1983, NATURE, V306, P155, DOI 10.1038/306155a0; PANGANIBAN AT, 1984, P NATL ACAD SCI-BIOL, V81, P7885, DOI 10.1073/pnas.81.24.7885; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; QUINN TP, 1988, J VIROL, V62, P2307, DOI 10.1128/JVI.62.7.2307-2312.1988; ROTH MJ, 1991, J VIROL, V65, P2141, DOI 10.1128/JVI.65.4.2141-2145.1991; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; ROTH MJ, 1990, J VIROL, V64, P4709, DOI 10.1128/JVI.64.10.4709-4717.1990; SCHWARTZBERG P, 1984, CELL, V37, P1043, DOI 10.1016/0092-8674(84)90439-2; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; WHITCOMB JM, 1991, J VIROL, V65, P3906, DOI 10.1128/JVI.65.7.3906-3910.1991; WOERNER AM, 1992, AIDS RES HUM RETROV, V8, P297, DOI 10.1089/aid.1992.8.297	35	192	201	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2113	2119						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420982				2022-12-27	WOS:A1993KH62000092
J	LOPEZCORCUERA, B; ALCANTARA, R; VAZQUEZ, J; ARAGON, C				LOPEZCORCUERA, B; ALCANTARA, R; VAZQUEZ, J; ARAGON, C			HYDRODYNAMIC PROPERTIES AND IMMUNOLOGICAL IDENTIFICATION OF THE SODIUM-COUPLED AND CHLORIDE-COUPLED GLYCINE TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SPINAL-CORD; PLASMA-MEMBRANE; EXPRESSION CLONING; BRAIN; PURIFICATION; RECONSTITUTION; GLYCOPROTEIN; PROTEINS	We have recently reported the purification of the native sodium- and chloride-coupled glycine transporter from pig brain stem (Lopez-Corcuera, B. Vazquez, J., and Aragon, C. (1991) J. Biol. Chem. 266, 24809-24814). This preparation is essentially homogeneous and contains a unique 100-kDa polypeptide based on electrophoretic migration under denaturing conditions. In this paper we report the hydrodynamic characterization of the native transporter, solubilized in two different detergents, as well as the immunological identification of the protein. On the basis of results obtained from size-exclusion chromatography, we calculated the Stokes radii of transporter 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonic acid (CHAPS) and transporter-cholate complexes to be 5.5 and 6.0 nm, respectively. In addition, from H2O/D2O sucrose density gradient sedimentation analysis, we calculated the molecular weight of protein-detergent complexes to be 115,000 and 160,000 in CHAPS and cholate, respectively, and the molecular weight of the protein moiety as 86,000. Finally, polyclonal antibodies raised against the 100-kDa polypeptide were found to immunoprecipitate specifically glycine transport activity. Taken together, the results reported herein corroborate the identity of the 100-kDa band as the sodium- and chloride-coupled glycine transporter and also suggest that in its native state the transporter is a monomeric protein.	UNIV AUTONOMA MADRID,FAC CIENCIAS,CTR BIOL MOLEC,DEPT BIOL MOLEC,E-28049 MADRID,SPAIN	Autonomous University of Madrid			Aragon, Carmen/K-9783-2014; Corcuera, Beatriz López/D-5188-2009; Vazquez, Jesus/B-7697-2015	Aragon, Carmen/0000-0001-8287-9386; Corcuera, Beatriz López/0000-0002-0383-4241; Vazquez, Jesus/0000-0003-1461-5092; Alcantara Martin, Rafael/0000-0001-5152-9922				ACKERS GK, 1967, J BIOL CHEM, V242, P3237; ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; ARAGON MC, 1987, FEBS LETT, V212, P87, DOI 10.1016/0014-5793(87)81562-4; BERGER SP, 1991, MOL PHARMACOL, V39, P429; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; CLARKE S, 1975, J BIOL CHEM, V250, P5459; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; GRIGORIADIS DE, 1989, J NEUROSCI, V9, P2664; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HIRAYAMA BA, 1991, AM J PHYSIOL, V261, pC296, DOI 10.1152/ajpcell.1991.261.2.C296; HJELMELAND LM, 1983, ANAL BIOCHEM, V130, P72, DOI 10.1016/0003-2697(83)90651-6; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KERWIN RW, 1979, EUR J PHARMACOL, V54, P93, DOI 10.1016/0014-2999(79)90411-4; Kyshe-Andersen J, 1984, J BIOCHEM BIOPH METH, V10, P203; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI XQ, 1990, J BIOL CHEM, V265, P15316; LIN QR, 1992, FEBS LETT, V305, P110; LOPEZCORCUERA B, 1991, J BIOL CHEM, V266, P24809; LOPEZCORCUERA B, 1989, BIOCHIM BIOPHYS ACTA, V983, P247, DOI 10.1016/0005-2736(89)90240-X; LOPEZCORCUERA B, 1989, EUR J BIOCHEM, V181, P519, DOI 10.1111/j.1432-1033.1989.tb14754.x; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MAYOR F, 1981, BIOCHEM J, V198, P535, DOI 10.1042/bj1980535; MCCORMICK JI, 1988, P NATL ACAD SCI USA, V85, P7877, DOI 10.1073/pnas.85.21.7877; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RADIAN R, 1986, J BIOL CHEM, V261, P5437; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Small DM, 1968, AM CHEM SOC ADV CHEM, V84, P31; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; TAMARAPPOO BK, 1992, J BIOL CHEM, V267, P2370; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; [No title captured]	35	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2239	2243						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420992				2022-12-27	WOS:A1993KH62000110
J	MAY, A; NAIRN, RS; OKUMOTO, DS; WASSERMANN, K; STEVNSNER, T; JONES, JC; BOHR, VA				MAY, A; NAIRN, RS; OKUMOTO, DS; WASSERMANN, K; STEVNSNER, T; JONES, JC; BOHR, VA			REPAIR OF INDIVIDUAL DNA STRANDS IN THE HAMSTER DIHYDROFOLATE-REDUCTASE GENE AFTER TREATMENT WITH ULTRAVIOLET-LIGHT, ALKYLATING-AGENTS, AND CISPLATIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; UV-INDUCED MUTATIONS; ESCHERICHIA-COLI; OVARY CELLS; TRANSCRIBED STRAND; PREFERENTIAL REPAIR; PYRIMIDINE DIMERS; 6-4 PHOTOPRODUCTS; HUMAN FIBROBLASTS; MAMMALIAN-CELLS	We have analyzed gene-specific and strand-specific DNA damage and repair in the dihydrofolate reductase gene in hamster cells. Cells were UV-irradiated or treated with two types of chemotherapeutics, alkylating agents or cisplatin. UV-induced pyrimidine dimers were detected using a previoulsy published technique in which the T4 endonuclease V enzyme is used to create nicks at the lesion sites. 6-4 photoproducts were detected in a similar assay using ABC excinuclease after prior reversal of the pyrimidine dimers with photolyase. Adducts formed by the alkylating agents nitrogen mustard and dimethyl sulfate were quantitated by generating strand breaks at abasic sites after neutral depurination. Cisplatin-induced intrastrand adducts were detected with ABC excinuclease, and cisplatin interstrand cross-links were detected using a denaturation-reannealing reaction before electrophoresis. In accord with previous reports by other investigators, we find distinct strand specificity of the repair of pyrimidine dimers after UV; the transcribed strand was much more efficiently repaired than the nontranscribed strand. In contrast, there was little or no strand bias in the repair of the 6-4 photoproducts. For alkylating agents, a slight bias toward repair in the transcribed strand was found after treatment with nitrogen mustard, but there appeared to be no bias in the repair after treatment with dimethyl sulfate. Cisplatin interstrand cross-links are repaired with equal efficiency from the two strands, but the more common cisplatin-induced lesion, the intrastrand adduct, is preferentially repaired from the transcribed strand. In conclusion, there is strand bias in the repair of pyrimidine dimers and cisplatin intrastrand adducts, but the strand specificity of repair may not be a general feature for all DNA lesions, as we found little or no strand bias in the repair of other lesions studied.	NCI,DIV CANC TREATMENT,MOLEC PHARMACOL LAB,BETHESDA,MD 20892; UNIV TEXAS,MD ANDERSON CANC CTR,DIV SCI PK RES,SMITHVILLE,TX 78957	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center			Bohr, Vilhelm/AAP-5931-2020					BARTLETT JD, 1991, MUTAT RES, V255, P247, DOI 10.1016/0921-8777(91)90028-N; BEECHAM EJ, 1991, MOL CELL BIOL, V11, P3095, DOI 10.1128/MCB.11.6.3095; BILL CA, 1991, J BIOL CHEM, V266, P21821; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BOHR VA, 1989, LAB INVEST, V61, P143; BOHR VA, 1986, J BIOL CHEM, V261, P6666; BOHR VA, 1991, CARCINOGENESIS, V12, P1983, DOI 10.1093/carcin/12.11.1983; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; BRASH DE, 1988, PHOTOCHEM PHOTOBIOL, V48, P59; BRASH DE, 1985, J BIOL CHEM, V260, P1438; CAROTHERS AM, 1983, NUCLEIC ACIDS RES, V11, P1997, DOI 10.1093/nar/11.7.1997; CAROTHERS AM, 1991, P NATL ACAD SCI USA, V88, P5749, DOI 10.1073/pnas.88.13.5749; CHEN RH, 1990, P NATL ACAD SCI USA, V87, P8680, DOI 10.1073/pnas.87.21.8680; CHEN RH, 1992, P NATL ACAD SCI USA, V89, P5413, DOI 10.1073/pnas.89.12.5413; CHRISTIANS F C, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P2; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; HANAWALT PC, 1989, GENOME, V31, P605, DOI 10.1139/g89-113; HUMPHREYS GO, 1975, BIOCHIM BIOPHYS ACTA, V383, P457, DOI 10.1016/0005-2787(75)90318-4; JONES JC, 1991, J BIOL CHEM, V266, P7101; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1069, DOI 10.1128/MCB.1.12.1069; LEADON SA, 1988, MOL CELL BIOL, V8, P5331, DOI 10.1128/MCB.8.12.5331; LEADON SA, 1991, MUTAT RES, V255, P67, DOI 10.1016/0921-8777(91)90019-L; LEDOUX SP, 1990, J BIOL CHEM, V265, P14875; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; OKUMOTO DS, 1987, NUCLEIC ACIDS RES, V15, P10021, DOI 10.1093/nar/15.23.10021; Patrick MH., 1976, PHOTOCHEM PHOTOBIOL, V2, P35, DOI [10.1016/B978-0-12-734602-1.50008-3, DOI 10.1016/B978-0-12-734602-1.50008-3]; PLOOY ACM, 1984, CANCER RES, V44, P2043; SADHU C, 1988, BIOTECHNIQUES, V6, P20; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SANCAR A, 1984, J MOL BIOL, V172, P223, DOI 10.1016/S0022-2836(84)80040-6; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SICCHITANO D, 1988, P NATL ACAD SCI USA, V86, P3050; Singer B, 1975, Prog Nucleic Acid Res Mol Biol, V15, P219, DOI 10.1016/S0079-6603(08)60121-X; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; THOMAS DC, 1988, P NATL ACAD SCI USA, V85, P3723, DOI 10.1073/pnas.85.11.3723; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; THOMAS DC, 1989, J BIOL CHEM, V264, P18005; VOS JMH, 1987, CELL, V50, P789, DOI 10.1016/0092-8674(87)90337-0; VRIELING H, 1989, MOL CELL BIOL, V9, P1277, DOI 10.1128/MCB.9.3.1277; VRIELING H, 1991, NUCLEIC ACIDS RES, V19, P2411, DOI 10.1093/nar/19.9.2411; VRIELING H, 1989, MOL CELL BIOL, V9, P2868; WASSERMANN K, 1990, J BIOL CHEM, V265, P13906	46	69	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1650	1657						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420940				2022-12-27	WOS:A1993KH62000025
J	RAMABHADRAN, TV; GANDY, SE; GHISO, J; CZERNIK, AJ; FERRIS, D; BHASIN, R; GOLDGABER, D; FRANGIONE, B; GREENGARD, P				RAMABHADRAN, TV; GANDY, SE; GHISO, J; CZERNIK, AJ; FERRIS, D; BHASIN, R; GOLDGABER, D; FRANGIONE, B; GREENGARD, P			PROTEOLYTIC PROCESSING OF HUMAN AMYLOID BETA-PROTEIN PRECURSOR IN INSECT CELLS - MAJOR CARBOXYL-TERMINAL FRAGMENT IS IDENTICAL TO ITS HUMAN COUNTERPART	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CLEAVAGE SITE; IDENTIFICATION; PHOSPHORYLATION; EXPRESSION; BIOGENESIS; PEPTIDE	The predominant component of amyloid plaques of Alzheimer's disease is the amyloid beta protein (Abeta), a 39-42-amino-acid peptide derived by proteolysis of a family of precursors known as amyloid precursor proteins (APP). In mammalian brain and in cultured mammalian cells, the release of APP amino-terminal fragments into the extracellular medium occurs by a proteolytic cleavage within the Abeta domain, thereby precluding amyloidogenesis. Infection of Sf9 insect cells with baculovirus vectors containing APP cDNAs results in high levels of APP expression. The concomitant release of amino-terminal fragments of APP and the production of carboxyl-terminal, cell-associated cleavage products are observed. Here we demonstrate by direct protein microsequencing that the proteolytic processing of APP in the Sf9 cells generates a prominent carboxyl-terminal species that is identical to that produced in human cells, suggesting that the major pathway for proteolytic processing of APP is conserved among metazoans.	CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021; NYU MED CTR,DEPT PATHOL,NEW YORK,NY 10016; SUNY STONY BROOK,DEPT PSYCHIAT & BEHAV SCI,STONY BROOK,NY 11794	Cornell University; NewYork-Presbyterian Hospital; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	RAMABHADRAN, TV (corresponding author), ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021, USA.				NIA NIH HHS [AG 11508, AG 10491, AG 09464] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG009464, P01AG010491, R55AG011508, R01AG011508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CZERNIK AJ, 1991, METHOD ENZYMOL, V201, P264; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GANDY SE, 1992, J NEUROCHEM, V58, P383, DOI 10.1111/j.1471-4159.1992.tb09322.x; GHISO J, 1989, BIOCHEM BIOPH RES CO, V163, P430, DOI 10.1016/0006-291X(89)92154-2; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KNOPS J, 1991, J BIOL CHEM, V266, P7285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWERY DE, 1991, J BIOL CHEM, V266, P19842; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V179, P1670, DOI 10.1016/0006-291X(91)91767-7; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; RAMAKRISHNA N, 1991, BIOCHEM BIOPH RES CO, V174, P983, DOI 10.1016/0006-291X(91)91515-E; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TOMLINSON BE, 1984, GREENFIELDS NEUROPAT, P951; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	28	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2009	2012						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420974				2022-12-27	WOS:A1993KH62000078
J	STEWART, RC				STEWART, RC			ACTIVATING AND INHIBITORY MUTATIONS IN THE REGULATORY DOMAIN OF CHEB, THE METHYLESTERASE IN BACTERIAL CHEMOTAXIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN METHYLATION REACTION; ESCHERICHIA-COLI MUTANTS; SIGNAL TRANSDUCTION; SENSORY ADAPTATION; BACILLUS-SUBTILIS; RESPONSE REGULATOR; CONSERVED ASPARTATE; PHOSPHORYLATION; IDENTIFICATION; GENES	In the chemotaxis system of Escherichia coli, CheB promotes sensory adaptation by interacting with the chemotaxis receptor-transducer proteins to catalyze removal of their gamma-glutamyl methyl ester groups. CheB is comprised of two functional domains; the C-terminal domain contains the methylesterase active site, and the N-terminal domain regulates the activity of this active site. The chemotaxis system controls CheB methylesterase activity via a mechanism involving phosphorylation of the CheB regulatory domain by the chemotaxis protein kinase CheA. To further explore the communication between the regulatory and methylesterase domains of CheB, I generated mutations in the CheB regulatory domain that affect methylesterase activity in vitro. Three of these mutations (D11K, E58K, and E91K) caused increased methylesterase activity in the absence of phosphorylation, and several other mutations (R42H, R73H, and K107R) caused decreased methylesterase activity in the purified proteins. Several of these mutations (D10N, D11K, R42H, E58K, and K107R) also affected the phosphorylation biochemistry of CheB by reducing the rate of CheA-mediated phosphorylation of CheB and/or by decreasing the autodephosphorylation rate of CheB. In addition, all of these mutations diminished the ability of excess CheA to inhibit CheB methylesterase activity. The locations of these mutations in the deduced three-dimensional structure of the CheB N-terminal domain indicate that the region of the protein surrounding the putative phosphorylation site plays important roles in its interaction with the CheB C-terminal domain as well as in its interactions with CheA.			STEWART, RC (corresponding author), MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,QUEBEC,CANADA.							ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; DAHL MK, 1991, J BACTERIOL, V173, P2539, DOI 10.1128/jb.173.8.2539-2547.1991; DAHLQUIS.FW, 1972, NATURE-NEW BIOL, V236, P120, DOI 10.1038/newbio236120a0; EGAN SM, 1991, J BACTERIOL, V173, P4424, DOI 10.1128/JB.173.14.4424-4432.1991; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOY MF, 1978, CELL, V15, P1231, DOI 10.1016/0092-8674(78)90049-1; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HEDBLOM ML, 1980, J BACTERIOL, V144, P1048, DOI 10.1128/JB.144.3.1048-1060.1980; HENNER DJ, 1988, J BACTERIOL, V170, P5102, DOI 10.1128/jb.170.11.5102-5109.1988; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1988, COLD SPRING HARB SYM, V53, P41, DOI 10.1101/SQB.1988.053.01.008; JONES GD, 1981, BIOCHEM J, V193, P1013, DOI 10.1042/bj1931013; KANAMARU K, 1992, J BIOCHEM-TOKYO, V111, P425, DOI 10.1093/oxfordjournals.jbchem.a123773; KEHRY MR, 1984, J BIOL CHEM, V259, P1828; KEHRY MR, 1982, J BIOL CHEM, V257, P378; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTNER R, 1979, BIOCHEM J, V181, P759, DOI 10.1042/bj1810759; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; LUPAS A, 1989, J BIOL CHEM, V264, P17337; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MCLEARY WR, 1990, J BACTERIOL, V172, P4877; Miller J.H., 1972, EXPT MOL GENETICS; MUTOH N, 1986, J BACTERIOL, V165, P161, DOI 10.1128/jb.165.1.161-166.1986; NARA F, 1986, MOL GEN GENET, V202, P194, DOI 10.1007/BF00331636; NINFA EG, 1991, J BIOL CHEM, V266, P9764; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; OLMEDO G, 1990, J MOL BIOL, V215, P359, DOI 10.1016/S0022-2836(05)80357-2; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PARKINSON JS, 1978, CELL, V15, P1221, DOI 10.1016/0092-8674(78)90048-X; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; PAXOUR GJ, 1992, J BACTERIOL, V174, P4169; RICE MS, 1990, THESIS U OREGON; ROLLINS C, 1981, CELL, V25, P333, DOI 10.1016/0092-8674(81)90051-9; RUSSELL CB, 1989, J BACTERIOL, V171, P3609, DOI 10.1128/jb.171.7.3609-3618.1989; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMMS SA, 1985, J BIOL CHEM, V260, P161; SPIEGELMAN G, 1990, J BACTERIOL, V172, P5011, DOI 10.1128/jb.172.9.5011-5019.1990; SPRINGER MS, 1984, P NATL ACAD SCI-BIOL, V81, P5061, DOI 10.1073/pnas.81.16.5061; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STEWART RC, 1987, CHEM REV, V87, P997, DOI 10.1021/cr00081a007; STEWART RC, 1990, J BACTERIOL, V172, P3388, DOI 10.1128/jb.172.6.3388-3399.1990; STEWART RC, 1988, J BACTERIOL, V170, P5728, DOI 10.1128/jb.170.12.5728-5738.1988; STOCK AM, 1988, COLD SPRING HARB SYM, V53, P49, DOI 10.1101/SQB.1988.053.01.009; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STOCK JB, 1991, ANNU REV BIOPHYS BIO, V20, P109, DOI 10.1146/annurev.bb.20.060191.000545; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; STOCK JB, 1981, J BIOL CHEM, V256, P826; TERWILLIGER TC, 1986, J BIOL CHEM, V261, P814; TERWILLIGER TC, 1983, J BIOL CHEM, V258, P9608; VANDERWERF P, 1977, J BIOL CHEM, V252, P2793; VOLZ K, 1991, J BIOL CHEM, V266, P15511; YONEKAWA H, 1983, J BACTERIOL, V156, P1228, DOI 10.1128/JB.156.3.1228-1235.1983	67	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1921	1930						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420965				2022-12-27	WOS:A1993KH62000065
J	JOHN, J; RENSLAND, H; SCHLICHTING, I; VETTER, I; BORASIO, GD; GOODY, RS; WITTINGHOFER, A				JOHN, J; RENSLAND, H; SCHLICHTING, I; VETTER, I; BORASIO, GD; GOODY, RS; WITTINGHOFER, A			KINETIC AND STRUCTURAL-ANALYSIS OF THE MG2+-BINDING SITE OF THE GUANINE NUCLEOTIDE-BINDING PROTEIN P21(H-RAS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACTIVATING PROTEIN; H-RAS P21; INDUCED NEURONAL DIFFERENTIATION; PC12 CELLS; ESCHERICHIA-COLI; NUCLEOSIDE PHOSPHOROTHIOATES; TRIPHOSPHATE CONFORMATION; ONCOGENIC RAS-P21; MOLECULAR SWITCH; GENE-PRODUCT	The coordination and binding of the Mg2+ ion in the nucleotide-binding site of p21 have been investigated using site-directed mutagenesis, kinetic methods, and phosphorous NMR. Mg2+ in the p21.nucleotide.Mg2+ complex appears to be in fast equilibrium with the solvent. The dissociation constant between Mg2+ and the p21.GDP complex was determined to be 2.8 muM. It decreases 30- or 16-fold on substituting Ser-17 or Asp-57 with alanine, respectively, whereas the T35A mutation has no effect. All three mutations influence the dissociation constants and the association and dissociation rate constants of the interaction between guanine nucleotides and p21, but to a different degree. We conclude that Thr-35 is only complexed to Mg2+ in the GTP conformation and both Asp-57 and Ser-17 appear to be critical for both GDP and GTP binding. P-31 NMR spectra of the GDP and Gpp(NH)p (guanosine-5'-(beta,gamma-imido)triphosphate) complexes of mutated p21 show a remarkable perturbation of the guanine nucleotide-binding site compared to wild-type protein. The mutant proteins show reduced GTPase rates, which are not stimulated by the GTPase-activating protein GAP. p21(S17A) has been reported to function just as p21(S17N) as a dominant negative inhibitor of normal p21. We find that it inhibits oncogenic p21-induced survival of primary neurons.	MAX PLANCK INST MED RES, BIOPHYS ABT, W-6900 HEIDELBERG 1, GERMANY; UNIV MUNICH, KLINIKUM GROSSHADERN, NEUROL KLIN, W-8000 MUNICH 70, GERMANY	Max Planck Society; University of Munich			Schlichting, Ilme/I-1339-2013; Goody, Roger S/J-8845-2014	Goody, Roger S/0000-0002-0772-0444; Borasio, Gian Domenico/0000-0002-2737-3662				BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BORASIO GD, 1989, NEURON, V2, P1087; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CERTA U, 1986, EMBO J, V5, P3051, DOI 10.1002/j.1460-2075.1986.tb04605.x; CLELAND WW, 1982, METHOD ENZYMOL, V87, P159; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FEUERSTEIN J, 1987, EUR J BIOCHEM, V162, P49, DOI 10.1111/j.1432-1033.1987.tb10540.x; FRECH M, 1990, J BIOL CHEM, V265, P6353; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOODY RS, 1986, TETRAHEDRON LETT, V27, P3599, DOI 10.1016/S0040-4039(00)84859-5; GRAND RJA, 1991, BIOCHEM J, V279, P609, DOI 10.1042/bj2790609; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HALL A, 1986, J BIOL CHEM, V261, P963; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HALL A, 1990, G PROTEINS MEDIATORS, P173; JAFFE EK, 1979, J BIOL CHEM, V254, P839; JOHN J, 1989, NATO ADV SCI I A-LIF, V165, P209; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1989, J BIOL CHEM, V264, P13086; JOHN J, 1988, J BIOL CHEM, V263, P11792; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KALBITZER HR, 1987, MET IONS BIOL SYST, V22, P81; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MITSOU MY, 1992, EMBO J, V11, P2391; NOWAK E, 1988, BIOCHEMISTRY-US, V27, P1785, DOI 10.1021/bi00405a060; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; QIU MS, 1991, J CELL BIOL, V115, P795, DOI 10.1083/jcb.115.3.795; RAO BDN, 1989, METHOD ENZYMOL, V176, P279; RAY BD, 1988, BIOCHEMISTRY-US, V27, P8669, DOI 10.1021/bi00423a024; Reed G., 1984, BIOL MAGN RESON, V6, P73; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; Sambrook J, 1989, MOL CLONING LABORATO; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHLICHTING I, 1990, BIOCHEMISTRY-US, V29, P504, DOI 10.1021/bi00454a026; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; SMITHERS GW, 1990, ARCH BIOCHEM BIOPHYS, V280, P416, DOI 10.1016/0003-9861(90)90351-X; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THOMSON TM, 1990, MOL CELL BIOL, V10, P1556, DOI 10.1128/MCB.10.4.1556; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAECHTER F, 1975, EUR J BIOCHEM, V57, P453, DOI 10.1111/j.1432-1033.1975.tb02320.x; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P	58	218	220	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					923	929						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419371				2022-12-27	WOS:A1993KG07700028
J	CANTORAL, JM; GUTIERREZ, S; FIERRO, F; GILESPINOSA, S; VANLIEMPT, H; MARTIN, JF				CANTORAL, JM; GUTIERREZ, S; FIERRO, F; GILESPINOSA, S; VANLIEMPT, H; MARTIN, JF			BIOCHEMICAL-CHARACTERIZATION AND MOLECULAR-GENETICS OF 9 MUTANTS OF PENICILLIUM-CHRYSOGENUM IMPAIRED IN PENICILLIN BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N-SYNTHASE; COENZYME-A-6-AMINOPENICILLANIC ACID ACYLTRANSFERASE; AMINOADIPYL-CYSTEINYL-VALINE; ASPERGILLUS-NIDULANS; DELTA-(L-ALPHA-AMINOADIPYL)-L-CYSTEINYL-D-VALINE SYNTHETASE; PEPTIDE SYNTHETASE; 1ST ENZYME; GENES; CLONING; AMPLIFICATION	Nine mutants of Penicillium chrysogenum (npe1 to npe8 and npe10) impaired in penicillin biosynthesis were screened after nitrosoguanidine mutation. Mutants npe1, npe4, npe5, npe6, npe7, npe8, and npe10 failed to synthesize significant levels of penicillin, whereas strains npe2 and npe3 synthesized about 20% of the penicillin level produced by the parental strain. Mutants npe5 and npe10 did not show alpha-aminoadipyl-cysteinyl-valine cysteinyl-valine (ACV) synthetase activity in vitro and did not form ACV in vivo. Immunoblotting analysis of the different mutants using antibodies raised against Aspergillus nidulans ACV synthetase showed that mutants npe5 and npe10 lacked this multienzyme protein, which in the parental strain had a molecular mass of about 420 kDa, and mutants npe2 and npe3 formed reduced level of this protein. All mutants showed normal levels of isopenicillin N synthase, as shown by Western blot analysis and enzyme assays (except npe10 that lacked this enzyme and npe2 and npe3 that formed reduced levels); npe1, npe4, npe6, npe7, npe8, and npe10 lacked isopenicillin N acyltransferase. Southern hybridizations of total DNA of the parental strain and mutants npe5, npe6, npe8, and npe10 with probes internal to the pcbAB, pcbC, and penDE genes showed that mutants npe5, npe6, and npe8 had the same arrangement of the penicillin gene cluster carrying probably point mutations, but mutant npe10 lacked the three penicillin biosynthetic genes, suggesting that it had suffered a deletion of the entire penicillin cluster. Southern hybridization with a pyrG probe as control and fingerprinting analysis of total DNA of npe10 as compared to several P. chrysogenum strains and other Penicillium and Aspergillus species, confirmed that npe10 is a deletion mutant of P. chrysogenum that had lost the penicillin biosynthetic genes.	UNIV LEON,FAC BIOL,DEPT ECOL GENET & MICROBIOL,MICROBIOL SECT,E-24071 LEON,SPAIN; TECH UNIV BERLIN,TU BIOCHEM,W-1000 BERLIN 10,GERMANY	Universidad de Leon; Technical University of Berlin			Gutiérrez, Santiago/H-6456-2015; Cantoral, Jesus Manuel/N-1161-2014	Gutiérrez, Santiago/0000-0001-6659-1390; Cantoral, Jesus Manuel/0000-0003-3019-4144; Fierro, Francisco/0000-0002-2582-5362				ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; BALDWIN JE, 1988, NAT PROD REP, V5, P129, DOI 10.1039/np9880500129; BANKO G, 1987, J AM CHEM SOC, V109, P2858, DOI 10.1021/ja00243a068; BARREDO JL, 1989, MOL GEN GENET, V216, P91, DOI 10.1007/BF00332235; BARREDO JL, 1989, CURR GENET, V16, P453, DOI 10.1007/BF00340725; BARREDO JL, 1989, GENE, V83, P291, DOI 10.1016/0378-1119(89)90115-7; CANTORAL JM, 1988, NUCLEIC ACIDS RES, V16, P8177, DOI 10.1093/nar/16.16.8177; CANTORAL JM, 1988, THESIS U LEON SPAIN; COQUE JJR, 1991, MOL MICROBIOL, V5, P1125, DOI 10.1111/j.1365-2958.1991.tb01885.x; Demain AL, 1983, ANTIBIOTICS CONTAINI, P189; DIEZ B, 1989, MOL GEN GENET, V218, P572, DOI 10.1007/BF00332426; DIEZ B, 1990, J BIOL CHEM, V265, P16358; EDWARDS GFS, 1974, J GEN MICROBIOL, V84, P420, DOI 10.1099/00221287-84-2-420; GUTIERREZ S, 1992, J BACTERIOL, V174, P3056; GUTIERREZ S, 1991, MOL GEN GENET, V225, P56; GUTIERREZ S, 1991, MOL GEN GENET, V173, P2354; HOPWOOD DA, 1982, GENETIC ENG, V4, P119; Lee S G, 1975, Methods Enzymol, V43, P585; LOPEZNIETO MJ, 1985, APPL MICROBIOL BIOT, V22, P343, DOI 10.1007/BF00582418; MACCABE AP, 1991, J BIOL CHEM, V266, P12646; Martin J F, 1989, Adv Biochem Eng Biotechnol, V39, P153; MARTIN JF, 1984, BIO-TECHNOL, V2, P63, DOI 10.1038/nbt0184-63; MARTINEZ J L JR, 1991, P149; MEYER W, 1991, CURR GENET, V19, P239, DOI 10.1007/BF00336493; MONTENEGRO E, 1990, MOL GEN GENET, V221, P322, DOI 10.1007/BF00259395; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; NORMANSELL PJM, 1979, J GEN MICROBIOL, V112, P113, DOI 10.1099/00221287-112-1-113; PALISSA H, 1989, J BACTERIOL, V171, P5720, DOI 10.1128/jb.171.10.5720-5728.1989; Queener S W, 1978, Annu Rev Microbiol, V32, P593, DOI 10.1146/annurev.mi.32.100178.003113; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; REVILLA G, 1984, J ANTIBIOT, V37, P781, DOI 10.7164/antibiotics.37.781; REVILLA G, 1986, J BACTERIOL, V168, P947, DOI 10.1128/jb.168.2.947-952.1986; SMITH DJ, 1989, MOL GEN GENET, V216, P492, DOI 10.1007/BF00334395; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; VANLIEMPT H, 1989, J BIOL CHEM, V264, P3680; WHITEMAN PA, 1990, FEBS LETT, V262, P342, DOI 10.1016/0014-5793(90)80224-7	36	48	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					737	744						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416976				2022-12-27	WOS:A1993KE60300111
J	BOWMAN, EP; UHLINGER, DJ; LAMBETH, JD				BOWMAN, EP; UHLINGER, DJ; LAMBETH, JD			NEUTROPHIL PHOSPHOLIPASE-D IS ACTIVATED BY A MEMBRANE-ASSOCIATED RHO FAMILY SMALL MOLECULAR-WEIGHT GTP-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GDP/GTP EXCHANGE PROTEINS; BETA-GAMMA-SUBUNITS; GUANINE-NUCLEOTIDES; NADPH OXIDASE; REGULATORY COMPONENT; CHEMOTACTIC PEPTIDE; HL-60 GRANULOCYTES; ADENYLYL CYCLASE; PHOSPHATIDYLCHOLINE; IDENTIFICATION	Phospholipase D in human neutrophil lysates is activated by GTPgammaS (guanosine 5'-O-(3-thiotriphosphate)), implying the participation of a GTP-binding protein. Reconstitution of GTPgammaS-dependent activity requires protein factors in both the plasma membrane and the cytosol (Olson, S. C., Bowman, E. P., and Lambeth, J. D. (1991) J. Biol. Chem. 266,17236-17242). The location of the GTP-binding protein was investigated by preincubating either cytosol or plasma membrane with GTPgammaS, followed by removal of all but tightly bound nucleotide and reconstituting activity with the complementing untreated subcellular fraction. This approach indicated that the GTP-binding protein was membrane-associated. A low magnesium requirement for GTPgammaS prebinding, as well as a failure of aluminum fluoride to activate, suggested a Ras-like small M(r) GTP-binding protein. smg GDP dissociation stimulator, which stimulates the exchange of GDP for GTP on a variety of small GTP-binding proteins, stimulated GTP-dependent phospholipase D activity. Rho GDP dissociation inhibitor, a regulatory protein that binds specifically to and inhibits the functions of Rho family small GTP-binding proteins, inhibited GTPgammaS-dependent activity. Thus, neutrophil phospholipase D is regulated by a membrane-associated small molecular weight GTP-binding protein, likely to be a member of the Rho family.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University					NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NCI NIH HHS [CA46508] Funding Source: Medline; NIAID NIH HHS [AI22809] Funding Source: Medline; NIGMS NIH HHS [T32 GM08367] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDO S, 1992, J BIOL CHEM, V267, P25709; ANTHES JC, 1991, BIOCHEM BIOPH RES CO, V175, P236, DOI 10.1016/S0006-291X(05)81225-2; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BLANK JL, 1991, J BIOL CHEM, V266, P18206; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BOSNER RW, 1989, BIOCHEM J, V264, P617; BOURMEYSTER N, 1992, BIOCHEMISTRY-US, V31, P12863, DOI 10.1021/bi00166a022; BURSTEIN ES, 1992, BIOCHEM J, V282, P387, DOI 10.1042/bj2820387; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CHUANG TH, 1993, J BIOL CHEM, V268, P775; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HURST KM, 1990, BIOCHEM J, V272, P749, DOI 10.1042/bj2720749; IYENGAR R, 1982, P NATL ACAD SCI-BIOL, V79, P5179, DOI 10.1073/pnas.79.17.5179; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; KURODA S, 1989, BIOCHEM BIOPH RES CO, V163, P674, DOI 10.1016/0006-291X(89)92276-6; LAMBETH JD, 1993, PROTEIN KINASE; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MISTOU MY, 1992, EUR J BIOCHEM, V204, P179, DOI 10.1111/j.1432-1033.1992.tb16621.x; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PAI JK, 1988, BIOCHEM BIOPH RES CO, V150, P355, DOI 10.1016/0006-291X(88)90528-1; PEMBER SO, 1983, ARCH BIOCHEM BIOPHYS, V221, P391, DOI 10.1016/0003-9861(83)90158-3; QIAN Z, 1989, J BIOL CHEM, V264, P21720; QUILLIAM LA, 1990, SEC MESS PHOSPHOPROT, V13, P59; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; TAMIR A, 1990, BIOCHEMISTRY-US, V29, P6947, DOI 10.1021/bi00482a002; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; WANG P, 1991, J BIOL CHEM, V266, P14877; XIE MS, 1991, BIOCHEM J, V278, P81, DOI 10.1042/bj2780081	39	244	246	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21509	21512						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408000				2022-12-27	WOS:A1993MC80900015
J	ROSORIUS, O; ISSINGER, OG; BRAULKE, T				ROSORIUS, O; ISSINGER, OG; BRAULKE, T			PHOSPHORYLATION OF THE CYTOPLASMIC TAIL OF THE 300-KDA MANNOSE 6-PHOSPHATE RECEPTOR IS REQUIRED FOR THE INTERACTION WITH A CYTOSOLIC PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR-II RECEPTOR; GOLGI	The cytoplasmic tail of the human 300-kDa mannose 6-phosphate receptor (MPR 300-CT) is an excellent substrate for casein kinase II in vitro. The phosphorylated MPR 300-CT was cross-linked by means of bis(sulfosuccinimidyl) suberate mainly to a cytosolic protein of 35 kDa (referred to as TIP 35) and to 35- and 91-kDa proteins salt-washed from bovine brain membranes. Gel filtration suggested that TIP 35 is part of a higher molecular mass complex of approximately 130-150 kDa. Inhibition studies, using non-phosphorylated and phosphorylated MPR 300-CT and cross-linking, indicate that the interaction with TIP 35 is phosphorylation-specific. Furthermore, TIP 35 was only cross-linked to the MPR 300-CT phosphorylated by casein kinase II whereas the MPR 300-CT phosphorylated by protein kinase A failed to cross-link to TIP 35. These results indicate that the cytoplasmic tail of the MPR 300 interacts with a cytosolic protein depending on the phosphorylation by a casein kinase II-like kinase. The cross-linking with salt-washed membrane proteins, however, is inhibited by non-phosphorylated MPR 300-CT, suggesting that different structural determinants in the MPR 300-CT interact with cytosol- and membrane-derived proteins.	UNIV GOTTINGEN,INST BIOCHEM 2,GOSSLERSTR 12D,D-37073 GOTTINGEN,GERMANY; UNIV SAARLAND,INST HUMAN GENET,D-66421 HOMBURG,GERMANY	University of Gottingen; Saarland University			Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; DAMKE H, 1991, J BIOL CHEM, V266, P24829; GRANKOWSKI N, 1991, EUR J BIOCHEM, V198, P25, DOI 10.1111/j.1432-1033.1991.tb15982.x; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MERESSE S, 1993, J CELL BIOL, V120, P67, DOI 10.1083/jcb.120.1.67; MERESSE S, 1990, J BIOL CHEM, V265, P18833; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; ROSORIUS O, 1993, BIOCHEM J, V292, P833, DOI 10.1042/bj2920833; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONFIGURA K, 1985, BIOCHEM J, V225, P543, DOI 10.1042/bj2250543	14	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21470	21473						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407994				2022-12-27	WOS:A1993MC80900005
J	WANG, GL; SEMENZA, GL				WANG, GL; SEMENZA, GL			CHARACTERIZATION OF HYPOXIA-INDUCIBLE FACTOR-I AND REGULATION OF DNA-BINDING ACTIVITY BY HYPOXIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROPOIETIN GENE; MESSENGER-RNA LEVELS; RHIZOBIUM-MELILOTI; PROTEIN-SYNTHESIS; TRANSGENIC MICE; ENHANCER ELEMENT; HEPATOMA-CELLS; OXYGEN SENSOR; PHORBOL ESTER; TRANSCRIPTION	Hypoxia-inducible factor 1 (HIF-1) is a DNA binding activity detected in nuclear extracts from Hep3B cells cultured in 1% O2 but not in extracts from cells cultured in 20% O2. HIF-1 binds to a sequence within the human erythropoietin gene enhancer that is required for hypoxic activation of transcription. Induction of HIF-1 is inhibited by cycloheximide, which also inhibits induction of erythropoietin RNA. We now demonstrate that induction of both HIF-1 and erythropoietin RNA is inhibited by the protein kinase inhibitor 2-aminopurine. HIF-1 binding to DNA was eliminated by phosphatase treatment of nuclear extracts. Actinomycin D also inhibited HIF-1 induction, suggesting that de novo transcription is required. The kinetics of HIF-1 induction by hypoxia paralleled the kinetics of erythropoietin gene transcriptional induction. HIF-1 DNA binding activity decayed rapidly when hypoxic cells were exposed to increased oxygen tension. In vitro, the kinetics of HIF-1 association with, and dissociation from, its binding site were extremely rapid, with a t1/2 for both processes of <1 min. These findings are consistent with the proposed function of HIF-1 as a physiologic regulator of gene expression that responds to changes in cellular oxygen tension. Methylation interference analysis indicated that HIF-1 makes specific contacts with DNA in the major groove.	JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT PEDIAT, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21287 USA	Johns Hopkins University; Johns Hopkins University								BECK I, 1991, J BIOL CHEM, V266, P15563; BERU N, 1990, J BIOL CHEM, V265, P14100; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; BONDURANT MC, 1986, MOL CELL BIOL, V6, P2731, DOI 10.1128/MCB.6.7.2731; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; DEBENEDETTI A, 1983, J BIOL CHEM, V258, P4556; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; GOLDBERG MA, 1991, BLOOD, V77, P271; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMAGAWA S, 1991, BLOOD, V77, P278; JELKMANN W, 1991, BIOCHEM BIOPH RES CO, V179, P1441, DOI 10.1016/0006-291X(91)91734-T; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; KOURY MJ, 1988, J CLIN INVEST, V82, P154, DOI 10.1172/JCI113564; KOURY ST, 1989, BLOOD, V74, P645; KRANTZ SB, 1991, BLOOD, V77, P419; KURTZ A, 1992, AM J PHYSIOL, V262, pC1204, DOI 10.1152/ajpcell.1992.262.5.C1204; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Maxam A M, 1980, Methods Enzymol, V65, P499; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; MONSON EK, 1992, P NATL ACAD SCI USA, V89, P4280, DOI 10.1073/pnas.89.10.4280; NEBERT DW, 1989, INT J BIOCHEM, V21, P243, DOI 10.1016/0020-711X(89)90182-1; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1990, MOL CELL BIOL, V10, P930, DOI 10.1128/MCB.10.3.930; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1989, P NATL ACAD SCI USA, V86, P2301, DOI 10.1073/pnas.86.7.2301; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P8725, DOI 10.1073/pnas.88.19.8725; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562	37	707	770	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21513	21518						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408001				2022-12-27	WOS:A1993MC80900016
J	MOTTRAM, JC; KINNAIRD, JH; SHIELS, BR; TAIT, A; BARRY, JD				MOTTRAM, JC; KINNAIRD, JH; SHIELS, BR; TAIT, A; BARRY, JD			A NOVEL CDC2-RELATED PROTEIN-KINASE FROM LEISHMANIA-MEXICANA, LMMCRK1, IS POSTTRANSLATIONALLY REGULATED DURING THE LIFE-CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION-PROMOTING FACTOR; CONTROL GENE CDC2+; CELL DIVISION CYCLE; FISSION YEAST; M-PHASE; TYROSINE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; CRITHIDIA-FASCICULATA; TRYPANOSOMA-BRUCEI; HISTONE-H1 KINASE	The p34CDC2 protein kinase is a key component in the regulation of the eukaryotic cell cycle. We have isolated from the protozoan parasite Leishmania mexicana mexicana a CDC2-related kinase gene (Lmmcrk1) encoding a 34-kDa protein kinase (lmmCRK1) which has 56% amino acid identity with the human CDC2 and contains a PCTAIR motif in place of the highly conserved PSTAIR box. lmmCRK1 was detected in all life cycle stages at comparable levels, yet its histone H1 kinase activity was detected in only the promastigote form, indicating that its activity is stage-regulated at a post-translational level. lmmCRK1 did not bind p13suc1 beads and Lmmcrk1 was unable to complement a fission yeast temperature-sensitive cdc2 mutant. These data suggest that Lmmcrk1 is unlikely to be the functional L. mexicana cdc2 homologue. A distinct histone H1 kinase activity that binds p13suc1 beads (SBCRK) was also detected, with activity that correlated with the division status of the developmental forms of the parasite, being present in the dividing stages of the parasite and absent in nondividing metacyclic forms. SBCRK is a candidate for the functional CDC2 homologue, but it does not react with an anti-PSTAIR monoclonal antibody on Western blots when eluted from p13suc1 beads, indicating a divergent PSTAIR box. These data suggest that a family of CDC2-related protein kinases are present in Leishmania. Some share sequence and biochemical properties with CDC2, but significant differences also exist, possibly reflecting the evolutionary distance between Leishmania and higher eukaryotes.	UNIV GLASGOW, DEPT VET PARASITOL, GLASGOW G11 5JS, SCOTLAND	University of Glasgow	MOTTRAM, JC (corresponding author), UNIV GLASGOW, INST GENET, WELLCOME UNIT MOLEC PARASITOL, CHURCH ST, GLASGOW G11 5JS, SCOTLAND.			Mottram, Jeremy/0000-0001-5574-3766; Shiels, Brian/0000-0001-7595-2514	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BERGER SL, 1987, METHOD ENZYMOL, V152, P215; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; BROWN L, 1992, NUCLEIC ACIDS RES, V20, P5451, DOI 10.1093/nar/20.20.5451; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; COLASANTI J, 1991, P NATL ACAD SCI USA, V88, P3377, DOI 10.1073/pnas.88.8.3377; Cox F. E., 1982, MODERN PARASITOLOGY; DRAETTA G, 1989, J CELL SCI, P21; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; DURKACZ B, 1985, MOL GEN GENET, V201, P543, DOI 10.1007/BF00331353; ELION EA, 1990, CELL, V60, P649, DOI 10.1016/0092-8674(90)90668-5; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FEILER HS, 1990, P NATL ACAD SCI USA, V87, P5397, DOI 10.1073/pnas.87.14.5397; GABRIELLI BG, 1992, J BIOL CHEM, V267, P1969; GABRIELLI BG, 1992, J BIOL CHEM, V267, P18040; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARLOW E, 1988, ANTIBODIES LABORATOR; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HINDLEY J, 1984, GENE, V31, P129, DOI 10.1016/0378-1119(84)90203-8; HINZE E, 1992, DEV GROWTH DIFFER, V34, P363; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; JIMENEZ J, 1990, EMBO J, V9, P3565, DOI 10.1002/j.1460-2075.1990.tb07567.x; JOHN PCL, 1989, PLANT CELL, V1, P1185; JOHN PCL, 1991, PROTOPLASMA, V161, P70, DOI 10.1007/BF01328899; JONES RH, 1988, CELL, V53, P659, DOI 10.1016/0092-8674(88)90581-8; Killick-Kendrick R., 1986, Journal of the Royal Army Medical Corps, V132, P134; KREK W, 1992, NEW BIOL, V4, P323; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1989, EMBO J, V8, P3071, DOI 10.1002/j.1460-2075.1989.tb08458.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LABBE JC, 1988, NATURE, V335, P251, DOI 10.1038/335251a0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; LEW J, 1992, J BIOL CHEM, V267, P25922; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; MALLINSON DJ, 1989, PARASITOLOGY, V98, P7, DOI 10.1017/S0031182000059631; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MOTTRAM JC, 1985, EXP PARASITOL, V59, P151, DOI 10.1016/0014-4894(85)90067-0; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NORBURY CJ, 1989, BIOCHIM BIOPHYS ACTA, V989, P85, DOI 10.1016/0304-419X(89)90036-X; NORTH MJ, 1983, MOL BIOCHEM PARASIT, V9, P161, DOI 10.1016/0166-6851(83)90107-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PARIS J, 1991, P NATL ACAD SCI USA, V88, P1039, DOI 10.1073/pnas.88.3.1039; PINES J, 1990, New Biologist, V2, P389; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; SACKS DL, 1985, J IMMUNOL, V135, P564; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sambrook J, 1989, MOL CLONING LABORATO; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOGIN ML, 1986, P NATL ACAD SCI USA, V83, P1383, DOI 10.1073/pnas.83.5.1383; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; TOHE A, 1988, MOL GEN GENET, V214, P162, DOI 10.1007/BF00340196; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; TURNER CMR, 1992, PARASITOL TODAY, V8, P3, DOI 10.1016/0169-4758(92)90295-D; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; YAMAGUCHI A, 1991, DEV GROWTH DIFFER, V33, P625; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; [No title captured]	79	58	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21044	21052						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407941				2022-12-27	WOS:A1993MA28800063
J	ROSING, J; BAKKER, HM; THOMASSEN, MCLGD; HEMKER, HC; TANS, G				ROSING, J; BAKKER, HM; THOMASSEN, MCLGD; HEMKER, HC; TANS, G			CHARACTERIZATION OF 2 FORMS OF HUMAN FACTOR-VA WITH DIFFERENT COFACTOR ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-V; BOVINE FACTOR-V; THROMBIN-CATALYZED ACTIVATION; PHOSPHOLIPID-VESICLES; FACTOR-XA; BINDING-SITE; PROTHROMBINASE COMPLEX; VARYING COMPOSITION; MEMBRANE-BINDING; PROTEIN-C	Factor Va is an essential cofactor in factor Xa-catalyzed prothrombin activation. Purified human factor Va appears to consist of a heavy chain (M(r) almost-equal-to 105,000) and a light chain doublet with M(r) almost-equal-to 74,000 and almost-equal-to 71,000. We separated factor Va by chromatography on a Mono-S column into two fractions, designated factors Va1 and Va2. Factor Va1 contains the light chain with M(r) almost-equal-to 74,000, and factor Va2 exclusively contains the light chain with M(r) almost-equal-to 71,000. The two forms of factor Va express different cofactor activities when prothrombin is activated at low phospholipid concentrations or on membranes containing low amounts of phosphatidylserine in phosphatidylcholine. Compared with factor Va2, much higher amounts of factor Va1 are required for factor Xa.Va complex formation at the membrane surface. Once incorporated into the prothrombinase complex, factors Va1 and Va2 are equally active in prothrombin activation. This indicates that the two forms of factor Va do not differ in their ability to promote the catalytic activity of factor Xa or to interact with prothrombin. Direct binding experiments show that the different cofactor activities are explained by a greatly impaired ability of factor Va1 to bind to negatively charged membranes. Factor V is also separated into two protein peaks after chromatography on a Mono-S column. Upon incubation with thrombin, the first peak yields factor Va1 and the second peak factor Va2. The same two forms of factor Va were generated when freshly prepared plasma samples or platelet suspensions were treated with thrombin. This shows that the heterogeneity of the light chain domain is an intrinsic property of both plasma and platelet factor V. It is hypothesized that the heterogeneity is caused by small differences in the carboxyl-terminal C2 domain of factor V that are introduced as the result of post-ribosomal processing.			ROSING, J (corresponding author), UNIV LIMBURG,INST CARDIOVASC RES,DEPT BIOCHEM,POB 616,6200 MD MAASTRICHT,NETHERLANDS.			Thomassen, Stella/0000-0002-9686-6364; Hemker, Coen/0000-0003-1669-2358				BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; CUYPERS PA, 1983, J BIOL CHEM, V258, P2426; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; ESMON CT, 1979, J BIOL CHEM, V254, P964; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; GUINTO ER, 1982, J BIOL CHEM, V257, P38; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; KALAFATIS M, 1990, J BIOL CHEM, V265, P21580; KANE WH, 1981, J BIOL CHEM, V256, P1002; KRIEG UC, 1987, BIOCHEMISTRY-US, V26, P103, DOI 10.1021/bi00375a015; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P5714; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECOMPTE MF, 1987, J BIOL CHEM, V262, P1935; LINDHOUT T, 1982, BIOCHEMISTRY-US, V21, P5494, DOI 10.1021/bi00265a018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; ODEGAARD B, 1987, J BIOL CHEM, V262, P11233; ORTEL TL, 1992, J BIOL CHEM, V267, P4189; PLETCHER CH, 1982, J BIOL CHEM, V257, P5342; PUSEY ML, 1982, BIOCHEMISTRY-US, V21, P5262, DOI 10.1021/bi00264a022; PUSEY ML, 1984, BIOCHEMISTRY-US, V23, P6202, DOI 10.1021/bi00320a048; ROSING J, 1980, J BIOL CHEM, V255, P274; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIFFMAN S, 1969, BIOCHEMISTRY-US, V8, P1397, DOI 10.1021/bi00832a014; SMITH RL, 1973, J BIOL CHEM, V248, P2418; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1991, BLOOD, V77, P2641; TANS G, 1991, J BIOL CHEM, V266, P21864; VANDEWAART P, 1983, BIOCHEMISTRY-US, V22, P2427, DOI 10.1021/bi00279a019; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008	37	93	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21130	21136						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407949				2022-12-27	WOS:A1993MA28800074
J	SUMBILLA, C; LU, L; LEWIS, DE; INESI, G; ISHII, T; TAKEYASU, K; FENG, Y; FAMBROUGH, DM				SUMBILLA, C; LU, L; LEWIS, DE; INESI, G; ISHII, T; TAKEYASU, K; FENG, Y; FAMBROUGH, DM			CA(2+)-DEPENDENT AND THAPSIGARGIN-INHIBITED PHOSPHORYLATION OF NA+,K+-ATPASE CATALYTIC DOMAIN FOLLOWING CHIMERIC RECOMBINATION WITH CA(2+)-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA-2+-ATPASE; CA2+ TRANSPORT ATPASE; FUNCTIONAL CONSEQUENCES; AMINO-ACIDS; ADENOSINE-TRIPHOSPHATASE; LYSYL RESIDUE; HIGH-AFFINITY; BINDING SITE; CALCIUM; EXPRESSION	Two chimeric proteins comprising the Na,K-ATPase catalytic domain (large cytosolic loop) and the two flanking regions of the Ca-ATPase were obtained by transient or stable expression in mammalian cells transfected with recombinant DNA. In the first chimera (CpNC), a large portion (containing the nucleotide-binding site) of the cytosolic loop between putative membrane spans M4 and M5 of the sarcoendoplasmic reticulum Ca2+ (SERCA) 1 (fast muscle) ATPase was replaced by the corresponding portion of the Na,K-ATPase al subunit. In the second chimera (CNpC), an even larger portion (containing the nucleotide-binding site and the phosphorylation site) of the analogous cytosolic loop of the SERCA2 (cardiac muscle) ATPase was replaced by the corresponding portion of the Na,K-ATPase alpha1 subunit. Steady state Ca2+ transport and coupled ATP hydrolysis by the chimeric proteins were negligible as compared to those obtained with SERCA enzymes. Nevertheless, the chimeric proteins were able to utilize ATP to form phosphoenzyme levels equal to those formed by SERCA ATPases. Chimeric and SERCA enzymes exhibited an identical Ca2+ requirement for ATP utilization and sensitivity to thapsigargin (TG) which is a specific inhibitor of SERCA ATPase and not of Na,K-ATPase. Furthermore, both SERCA and chimeric enzymes could be phosphorylated with P(i), and this reaction required removal of Ca2+. In comparative experiments, the functional pattern of seemingly unaffected phosphoenzyme formation and inhibited Ca2+ transport was produced in the SERCA ATPase even by single mutation of Pro337 to Ala, evidently due to defective protein conformation. Retention of Ca2+ and TG sensitivity by the chimeric proteins demonstrates that the Ca2+- and TG-binding domains do not reside within the cytosolic loop replaced by chimeric substitution and strongly support previous studies suggesting that binding of calcium required for enzyme activation occurs within the membrane-bound region of the SERCA ATPases (Clarke et al., 1989a; Sumbilla et al., 1991).	OHIO STATE UNIV, DEPT MED BIOCHEM, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA; JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA	Ohio State University; Ohio State University; Johns Hopkins University	SUMBILLA, C (corresponding author), UNIV MARYLAND, DEPT BIOL CHEM, BALTIMORE, MD 21201 USA.							ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; BASTIDE F, 1973, Journal of Biological Chemistry, V248, P8385; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; BLASIE JK, 1992, ANN NY ACAD SCI, V671, P11, DOI 10.1111/j.1749-6632.1992.tb43780.x; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; CHADWICK CC, 1983, BIOCHIM BIOPHYS ACTA, V730, P201, DOI 10.1016/0005-2736(83)90334-6; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; DEGANI C, 1973, J BIOL CHEM, V248, P8222; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; HERRMANN T, 1986, EUR J BIOCHEM, V158, P550; HORGAN DJ, 1972, ANAL BIOCHEM, V48, P147, DOI 10.1016/0003-2697(72)90178-9; INESI G, 1973, J MOL BIOL, V81, P483, DOI 10.1016/0022-2836(73)90518-4; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; INESI G, 1992, ANN NY ACAD SCI, V671, P32, DOI 10.1111/j.1749-6632.1992.tb43782.x; INESI G, 1992, ADV ENZYMOL RAMB, V65, P185; KAPRIELIAN Z, 1987, DEV BIOL, V124, P490, DOI 10.1016/0012-1606(87)90502-1; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; KLEMENS MR, 1988, FEBS LETT, V237, P4, DOI 10.1016/0014-5793(88)80160-1; KLEMENS MR, 1988, BIOCHEM BIOPH RES CO, V155, P236, DOI 10.1016/S0006-291X(88)81074-X; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; LEMAS MV, 1992, J BIOL CHEM, V267, P20987; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LUCKIE DB, 1992, BIOPHYS J, V62, P220, DOI 10.1016/S0006-3495(92)81807-6; LUCKIE DB, 1991, FEBS LETT, V281, P231, DOI 10.1016/0014-5793(91)80400-W; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MCINTOSH DB, 1992, J BIOL CHEM, V267, P5301; MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2; MURPHY AJ, 1977, ARCH BIOCHEM BIOPHYS, V180, P114, DOI 10.1016/0003-9861(77)90014-5; RASMUSSEN U, 1978, ACTA PHARM SUEC, V15, P133; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SQUIER TC, 1990, J BIOL CHEM, V265, P13713; SUMBILLA C, 1991, J BIOL CHEM, V266, P12682; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; YAMAMOTO H, 1988, J BIOCHEM-TOKYO, V103, P452, DOI 10.1093/oxfordjournals.jbchem.a122291; YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706	50	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21185	21192						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407954				2022-12-27	WOS:A1993MA28800080
J	RHOADS, RE				RHOADS, RE			REGULATION OF EUKARYOTIC PROTEIN-SYNTHESIS BY INITIATION-FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CAP-BINDING-PROTEIN; MESSENGER-RNA CAP; INTERNAL TRANSLATION INITIATION; POLYPEPTIDE-CHAIN INITIATION; NUCLEOTIDE-EXCHANGE FACTOR; AMINO-ACID SEQUENCE; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; RABBIT RETICULOCYTES; KINASE-C				RHOADS, RE (corresponding author), LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM & MOLEC BIOL, SHREVEPORT, LA 71130 USA.				NIGMS NIH HHS [GM20818] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; AKKARAJU GR, 1991, J BIOL CHEM, V266, P24451; ALLEN ML, 1992, J BIOL CHEM, V267, P23232; ALTMANN M, 1989, MOL CELL BIOL, V9, P4467, DOI 10.1128/MCB.9.10.4467; ALTMANN M, 1989, J BIOL CHEM, V264, P12145; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; AMICK GD, 1992, BIOCHEM BIOPH RES CO, V183, P431, DOI 10.1016/0006-291X(92)90499-B; ANTHONY DD, 1991, J BIOL CHEM, V266, P10218; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BOROVJAGIN AV, 1991, NUCLEIC ACIDS RES, V19, P4999, DOI 10.1093/nar/19.18.4999; BU X, 1991, FEBS LETT, V283, P219, DOI 10.1016/0014-5793(91)80592-Q; CHAMOT D, 1992, NUCLEIC ACIDS RES, V20, P665, DOI 10.1093/nar/20.4.665; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; CHOI SY, 1992, J BIOL CHEM, V267, P286; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; COHEN RB, 1990, EMBO J, V9, P3831, DOI 10.1002/j.1460-2075.1990.tb07601.x; CONROY SC, 1990, ARCH BIOCHEM BIOPHYS, V282, P363, DOI 10.1016/0003-9861(90)90130-Q; DAVIES MV, 1989, P NATL ACAD SCI USA, V86, P9163, DOI 10.1073/pnas.86.23.9163; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DHOLAKIA JN, 1988, P NATL ACAD SCI USA, V85, P51, DOI 10.1073/pnas.85.1.51; DOLPH PJ, 1990, J VIROL, V64, P2669, DOI 10.1128/JVI.64.6.2669-2677.1990; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; DONALDSON RW, 1991, J BIOL CHEM, V266, P3162; DUBOIS MF, 1989, J BIOL CHEM, V264, P12165; DUNCAN R, 1987, J BIOL CHEM, V262, P380; EMST H, 1987, J BIOL CHEM, V262, P1206; FAGAN RJ, 1991, J BIOL CHEM, V266, P16518; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; GROSS M, 1989, J BIOL CHEM, V264, P21879; GUY GR, 1992, J BIOL CHEM, V267, P1846; HAAS DW, 1992, SEC MESS PHOSPHOPROT, V14, P55; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HINNEBUSCH AG, 1991, TRANSLATION EUKARYOT, P243; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; Jackson RJ, 1991, TRANSLATION EUKARYOT, P193; JAGUS R, 1992, J BIOL CHEM, V267, P15530; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KATZE MG, 1992, J INTERFERON RES, V12, P241, DOI 10.1089/jir.1992.12.241; KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAMPHEAR BJ, 1991, J BIOL CHEM, V266, P2789; LANKER S, 1992, CELL, V70, P647, DOI 10.1016/0092-8674(92)90433-D; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; LINDER P, 1988, NUCLEIC ACIDS RES, V16, P10359, DOI 10.1093/nar/16.21.10359; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MARINO MW, 1991, J BIOL CHEM, V266, P2685; MATTS RL, 1992, J BIOL CHEM, V267, P18160; MATTS RL, 1992, J BIOL CHEM, V267, P18168; MATTS RL, 1991, J BIOL CHEM, V266, P12695; MCMULLIN EL, 1988, BIOCHEM BIOPH RES CO, V153, P340, DOI 10.1016/S0006-291X(88)81228-2; MCMULLIN EL, 1988, BIOCHEM BIOPH RES CO, V153, P925; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; MENDEZ R, 1992, J BIOL CHEM, V267, P11500; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MILBURN SC, 1990, EMBO J, V9, P2783, DOI 10.1002/j.1460-2075.1990.tb07466.x; MORLEY SJ, 1991, J BIOL CHEM, V266, P4669; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; PAIN VM, 1991, TRANSLATION EUKARYOT, P293; PATHAK VK, 1988, CELL, V54, P633, DOI 10.1016/S0092-8674(88)80007-2; PAY A, 1991, PLANT MOL BIOL, V17, P927, DOI 10.1007/BF00037075; PEREZ L, 1992, J VIROL, V189, P178; POLLARD JW, 1989, EUR J BIOCHEM, V182, P1, DOI 10.1111/j.1432-1033.1989.tb14793.x; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; RHOADS RE, 1993, IN PRESS PROG NUCLEI; Rhoads RE, 1991, CURR OPIN CELL BIOL, V3, P1019, DOI 10.1016/0955-0674(91)90123-G; RINKERSCHAEFFER CW, 1992, J BIOL CHEM, V267, P10659; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; RYCHLIK W, 1987, P NATL ACAD SCI USA, V84, P945, DOI 10.1073/pnas.84.4.945; RYCHLIK W, 1992, NUCLEIC ACIDS RES, V20, P6415, DOI 10.1093/nar/20.23.6415; RYCHLIK W, 1990, J BIOL CHEM, V265, P19467; SANDHOLZER U, 1989, FEBS LETT, V246, P94, DOI 10.1016/0014-5793(89)80260-1; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SMITMCBRIDE Z, 1989, J BIOL CHEM, V264, P1578; TAHARA SM, 1991, J BIOL CHEM, V266, P3594; THOMAS AAM, 1991, J VIROL, V65, P2953, DOI 10.1128/JVI.65.6.2953-2959.1991; Trachsel H., 1991, TRANSLATION EUKARYOT; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; TUAZON PT, 1990, J BIOL CHEM, V265, P10617; WEK RC, 1992, MOL CELL BIOL, V12, P5700, DOI 10.1128/MCB.12.12.5700; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; WELSH GI, 1992, BIOCHEM J, V284, P19, DOI 10.1042/bj2840019; YAN RQ, 1992, J BIOL CHEM, V267, P23226; YANG JM, 1992, J BIOL CHEM, V267, P20519; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZAPATA JM, 1991, J BIOL CHEM, V266, P16007	101	285	296	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3017	3020						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428975				2022-12-27	WOS:A1993KM16100001
J	HATTORI, A; TANAKA, E; MURASE, K; ISHIDA, N; CHATANI, Y; TSUJIMOTO, M; HAYASHI, K; KOHNO, M				HATTORI, A; TANAKA, E; MURASE, K; ISHIDA, N; CHATANI, Y; TSUJIMOTO, M; HAYASHI, K; KOHNO, M			TUMOR-NECROSIS-FACTOR STIMULATES THE SYNTHESIS AND SECRETION OF BIOLOGICALLY-ACTIVE NERVE GROWTH-FACTOR IN NONNEURONAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE ENZYME-IMMUNOASSAY; RAT SCIATIC-NERVE; MOLECULAR-CLONING; FACTOR RECEPTOR; EXPRESSION; NGF; ANTIBODIES; PROTEINS; INTERLEUKIN-1; REGENERATION	Tumor necrosis factor-alpha (TNF) markedly stimulates the synthesis and secretion of immunoreactive nerve growth factor (NGF) in quiescent mouse fibroblasts, which is a result of increase in the NGF mRNA level. NGF produced by TNF-treated fibroblasts has a molecular mass of 13 kDa on SDS-polyacrylamide gel electrophoresis, which is consistent in size with the subunit of mouse beta-NGF, and induces neurite outgrowth in paravertebral sympathetic neurons. Several peptide growth factors such as basic fibroblast growth factor (bFGF) and epidermal growth factor also stimulate NGF production in the cells, but not platelet-derived growth factor. The dose responses of TNF and bFGF to stimulate NGF production in the cells are, respectively, similar to those to induce cell proliferation. However, no correlation is observed between the ability of these growth factors to stimulate NGF production and that to induce cell proliferation. Thus, the stimulation of NGF production in the cells seems to be a specific activity of TNF and some other growth factors. TNF stimulates the synthesis and secretion of NGF also in other cells such as human glioblastoma cells. These findings suggest that TNF plays a role in regulating neuronal cell function through an indirect mechanism by which it stimulates NGF production in glial cells and fibroblasts.	GIFU PHARMACEUT UNIV, DEPT BIOL, 5-6-1 MITAHORA HIGASHI, GIFU 502, JAPAN; GIFU PHARMACEUT UNIV, DEPT MOLEC BIOL, GIFU 502, JAPAN; SUNTORY INST BIOMED RES, OSAKA 618, JAPAN	Gifu Pharmaceutical University; Gifu Pharmaceutical University; Suntory Holdings Ltd								ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; DIMARCO E, 1991, J BIOL CHEM, V266, P21718; EDWARDS RH, 1986, NATURE, V319, P784, DOI 10.1038/319784a0; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; FURUKAWA Y, 1984, J BIOL CHEM, V259, P1259; GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020, DOI 10.1128/MCB.11.6.3020; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KOHNO M, 1990, BIOCHEM J, V267, P91, DOI 10.1042/bj2670091; LE JM, 1987, LAB INVEST, V56, P234; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; MURASE K, 1991, BIOCHEM INT, V25, P29; MURASE K, 1990, BIOCHEM INT, V22, P807; NISHIZAWA N, 1990, CELL REGUL, V1, P747, DOI 10.1091/mbc.1.10.747; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHAFFER HE, 1981, ANAL BIOCHEM, V115, P113, DOI 10.1016/0003-2697(81)90533-9; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; TSUJIMOTO M, 1987, J BIOCHEM-TOKYO, V102, P1571, DOI 10.1093/oxfordjournals.jbchem.a122206; ULLRICH A, 1983, COLD SPRING HARB SYM, V48, P435, DOI 10.1101/SQB.1983.048.01.048; VARON S, 1972, METHODS NEUROCHEMIST, V3, P203; VILCEK J, 1991, J BIOL CHEM, V266, P7313; VILCEK J, 1992, TUMOR NECROSIS FACTO, P269; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012	40	154	155	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2577	2582						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428934				2022-12-27	WOS:A1993KK81500049
J	HOROWITZ, PM; BUTLER, M				HOROWITZ, PM; BUTLER, M			INTERACTIVE INTERMEDIATES ARE FORMED DURING THE UREA UNFOLDING OF RHODANESE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANIDINIUM CHLORIDE; DENATURED RHODANESE; STATE	Structural transitions have been studied on the pathway for urea denaturation of rhodanese. Unlike guanidinium hydrochloride, urea gives no visible precipitation. Increasing urea concentrations cause a transit ion in which the enzyme activity is completely lost by 4.5 M urea, and there is a shift of the intrinsic fluorescence maximum from 335 nm for the native enzyme to 350 nm. There is a maximum exposure of organized hydrophobic surfaces at 4.5 M urea as reported by the fluorescence of 1,1'-bi(4-anilino)naphthalene-5,5'-disulfonic acid. Above 4.5 M urea, this probe reports the progressive loss of organized hydrophobic surfaces. The polarization of the intrinsic fluorescence falls with increasing urea concentrations in a complex transition showing that rhodanese flexibility increases in at least two phases. Rhodanese becomes increasingly susceptible to digestion by subtilisin between 3.5 and 4.5 M urea, giving rise to large fragments. At urea concentrations >5 M, rhodanese is completely digested. There is a small increase in the rate of sulfhydryl accessibility between 3.5 and 4.5 M urea, but there is a large increase in the sulfhydryl accessibility above 4.5 M urea. Dimethyl suberimidate cross-linking shows the presence of associated species in 3-5 M urea, but there are few cross-linkable species at lower or higher urea concentrations. These results are consistent with a model i n which urea unfolding of rhodanese is associated with the initial production of a species having organized regions of structure with exposed hydrophobic surfaces separated by flexible elements.			HOROWITZ, PM (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHOW SF, 1986, J BIOL CHEM, V261, P7264; DOLGIKH DA, 1985, EUR BIOPHYS J BIOPHY, V13, P109, DOI 10.1007/BF00256531; HOROWITZ P, 1986, J BIOL CHEM, V261, P5652; HOROWITZ PM, 1986, J BIOL CHEM, V261, P13887; HOROWITZ PM, 1978, ANAL BIOCHEM, V86, P751, DOI 10.1016/0003-2697(78)90803-5; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; MCCLURE WO, 1966, BIOCHEMISTRY-US, V5, P1908, DOI 10.1021/bi00870a018; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1992, J BIOL CHEM, V267, P17631; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; PENSA B, 1977, BIOCHIM BIOPHYS ACTA, V484, P368, DOI 10.1016/0005-2744(77)90092-4; Ploegman J.H., 1978, NATURE, V273, P1245; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TANDON S, 1989, J BIOL CHEM, V264, P9859; TANDON S, 1986, J BIOL CHEM, V261, P5615; TANDON S, 1987, J BIOL CHEM, V262, P4486; TURNER DC, 1968, BIOCHEMISTRY-US, V7, P3381, DOI 10.1021/bi00850a011; ZARDENETA G, 1992, J BIOL CHEM, V267, P5811; ZARDENETA G, 1993, IN PRESS EUR J BIOCH	24	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2500	2504						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428927				2022-12-27	WOS:A1993KK81500040
J	WESTAWAY, SK; BELFORD, HG; APOSTOL, BL; ABELSON, J; GREER, CL				WESTAWAY, SK; BELFORD, HG; APOSTOL, BL; ABELSON, J; GREER, CL			NOVEL ACTIVITY OF A YEAST LIGASE DELETION POLYPEPTIDE - EVIDENCE FOR GTP-DEPENDENT TRANSFER-RNA SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PURIFICATION; ENDONUCLEASE; PRECURSORS; PROTEIN; GENE	Yeast tRNA ligase possesses multiple activities which are required for the joining of tRNA halves during the tRNA splicing process: cyclic phosphodiesterase, kinase, adenylylate synthetase, and ligase. A deletion polypeptide of a dihydrofolate reductase-ligase fusion protein, designated DAC, was previously shown to join tRNA halves although ATP-dependent kinase activity was not measurable in the assay used. We describe here a characterization of the mechanism of joining used by DAC and the structure of the tRNA product. DAC produces a joined tRNA and a splice junction with a structure identical to that produced by DAKC, the full-length dihydrofolate reductase-ligase fusion. Furthermore, DAC can use GTP as the sole cofactor in the joining reaction, in contrast to DAKC, which can only complete splicing in the presence of ATP. Both enzymes exhibit GTP-dependent kinase activity at 100-fold greater efficiency than with ATP. These results suggest that a potential function for the center domain of tRNA ligase (missing in DAC) is to provide structural integrity and aid in substrate interactions and specificity. They also support the hypothesis that ligase may prefer to use two different cofactors during tRNA splicing.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; CALTECH,DIV BIOL,PASADENA,CA 91125	University of California System; University of California Irvine; California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035955] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35955] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELSON J, 1991, HARVEY LECT, V85, P1; ABELSON JN, 1986, CHEM SCRIPTA, V26B, P127; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; BACCANARI D, 1975, BIOCHEMISTRY-US, V14, P5267, DOI 10.1021/bi00695a006; BELFORD HG, 1993, J BIOL CHEM, V268, P2444; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; KNAPP G, 1979, CELL, V18, P37, DOI 10.1016/0092-8674(79)90351-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCCAITH SM, 1991, J BIOL CHEM, V266, P11986; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; OGDEN RC, 1984, NUCLEIC ACIDS RES, V12, P9367, DOI 10.1093/nar/12.24.9367; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PEEBLES CL, 1979, CELL, V18, P27, DOI 10.1016/0092-8674(79)90350-7; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; Richardson C.C., 1981, ENZYMES A, V14, P299, DOI DOI 10.1016/S1874-6047(08)60342-X; RUBY SW, 1990, METHOD ENZYMOL, V181, P97; Uhlenbeck O.C., 1982, ENZYMES, V15, P31, DOI [10.1016/s1874-6047(08)60274-7, DOI 10.1016/S1874-6047(08)60274-7]; VOLCKAERT G, 1976, ANAL BIOCHEM, V72, P433, DOI 10.1016/0003-2697(76)90551-0; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; XU Q, 1990, BIOCHEMISTRY-US, V29, P6132, DOI 10.1021/bi00478a004	23	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2435	2443						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428918				2022-12-27	WOS:A1993KK81500031
J	WISSELAAR, HA; KROOS, MA; HERMANS, MMP; VANBEEUMEN, J; REUSER, AJJ				WISSELAAR, HA; KROOS, MA; HERMANS, MMP; VANBEEUMEN, J; REUSER, AJJ			STRUCTURAL AND FUNCTIONAL-CHANGES OF LYSOSOMAL ACID ALPHA-GLUCOSIDASE DURING INTRACELLULAR-TRANSPORT AND MATURATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; SUCRASE-ISOMALTASE COMPLEX; HUMAN BETA-HEXOSAMINIDASE; GLYCOGENOSIS TYPE-II; BRUSH-BORDER; HUMAN-FIBROBLASTS; MEMBRANE-PROTEIN; PRECURSOR FORM; PHOSPHATASE; ENZYMES	The synthesis and posttranslational modification of lysosomal acid alpha-glucosidase were studied in a cell-free translation system and in mammalian cells transfected with acid alpha-glucosidase cDNA constructs. The newly synthesized precursor, sequestered in the endoplasmic reticulum, was demonstrated to be membrane-bound by lack of signal peptide cleavage, and to be catalytically inactive. Sugar chain modification was shown to occur in the Golgi complex and to be dependent on the rate of transport. From the trans-Golgi network different routes were found to be followed by acid alpha-glucosidase. A fraction of precursor molecules, proteolytically released from the membrane anchor, appeared to enter the secretory pathway and was recovered from the cell culture medium in a catalytically active form. A second fraction was transported to the lysosomes and was trimmed in a stepwise process at both the amino- and carboxyl-terminal ends. The intramolecular cleavage sites were determined. Involvement of thiol proteinases was demonstrated. Specificity for the natural substrate glycogen was gained during the maturation process. The phosphomannosyl receptor is assumed to be instrumental in the lysosomal targeting of acid alpha-glucosidase, but a phosphomannosyl receptor-independent transport of membrane-bound precursor molecules to the lysosomes, either directly or via the plasma membrane, cannot be excluded.	ERASMUS UNIV,DEPT CELL BIOL & GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS; STATE UNIV GHENT,MICROBIOL LAB,B-9000 GHENT,BELGIUM	Erasmus University Rotterdam; Ghent University								AN GH, 1982, MOL CELL BIOL, V2, P1628, DOI 10.1128/MCB.2.12.1628; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; CREEK KE, 1984, LYSOSOM BIOL PATHOL, V7, P63; ELFERINK RPJO, 1984, EUR J BIOCHEM, V139, P497, DOI 10.1111/j.1432-1033.1984.tb08033.x; ELFERINK RPJO, 1984, EUR J BIOCHEM, V139, P489, DOI 10.1111/j.1432-1033.1984.tb08032.x; ELFERINK RPJO, 1989, EUR J CELL BIOL, V50, P299; FRANSEN JAM, 1988, EUR J CELL BIOL, V47, P72; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; HERMANS MMP, 1993, IN PRESS BIOCH J; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; HOEFSLOOT LH, 1990, BIOCHEM J, V272, P485, DOI 10.1042/bj2720485; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; JEZEQUEL AM, 1965, LAB INVEST, V14, P1894; JONAS AJ, 1990, BIOCHEM J, V272, P323, DOI 10.1042/bj2720323; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; KLUMPERMAN J, 1991, J CELL SCI, V100, P339; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KOSTER JF, 1972, EUR J CLIN INVEST, V2, P467, DOI 10.1111/j.1365-2362.1972.tb00678.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANCINI GMS, 1990, J BIOL CHEM, V265, P12380; MARTINIUK F, 1990, AM J HUM GENET, V47, P440; MATTER K, 1990, J BIOL CHEM, V265, P3503; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; PHILLIPS MJ, 1967, J ULTRA MOL STRUCT R, V18, P142, DOI 10.1016/S0022-5320(67)80236-3; QUON DVK, 1989, J BIOL CHEM, V264, P3380; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; ROSENFELD EL, 1975, PATHOL BIOL, V25, P71; SCHONHOLZER F, 1985, EUR J BIOCHEM, V147, P273, DOI 10.1111/j.1432-1033.1985.tb08747.x; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SONDERFELDFRESKO S, 1988, J BIOL CHEM, V263, P13463; STIRLING J, 1988, FEBS LETT, V231, P47, DOI 10.1016/0014-5793(88)80699-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJI A, 1987, BIOCHEM INT, V15, P945; TSUJI A, 1988, J BIOCHEM-TOKYO, V104, P276, DOI 10.1093/oxfordjournals.jbchem.a122457; TSUJI A, 1988, BIOCHEM BIOPH RES CO, V151, P1358, DOI 10.1016/S0006-291X(88)80512-6; VANDONGEN JM, 1985, EUR J CELL BIOL, V39, P179; VANDONGEN JM, 1984, HISTOCHEM J, V16, P941, DOI 10.1007/BF01003850; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WILLEMSEN R, 1991, HISTOCHEM J, V23, P467, DOI 10.1007/BF01041377	57	133	154	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2223	2231						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420990				2022-12-27	WOS:A1993KH62000108
J	UNEMORI, EN; AMENTO, EP; BAUER, EA; HORUK, R				UNEMORI, EN; AMENTO, EP; BAUER, EA; HORUK, R			MELANOMA GROWTH-STIMULATORY ACTIVITY GRO DECREASES COLLAGEN EXPRESSION BY HUMAN FIBROBLASTS - REGULATION BY C-X-C BUT NOT C-C CYTOKINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; NECROSIS-FACTOR-ALPHA; MOLECULAR CHARACTERIZATION; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; I COLLAGEN; CLONING; GENE; SECRETION; PROTEINS	Melanoma growth-stimulatory activity (MGSA)/GRO is well characterized as a potent neutrophil chemoattractant. In the present study, we have demonstrated that MGSA induced a dose-dependent decrease in the expression of interstitial collagens by rheumatoid synovial fibroblasts. The decrease was observed over a dose range of 0.6-6.0 nM MGSA. This effect was specific, as MGSA had no demonstrable effect on the expression of collagen-degrading metalloproteinases, nor did it affect the collagenase inhibitor, tissue inhibitor of metalloproteinases. It also had no effect on the proliferation rate of these fibroblasts, unlike its mitogenic effect on melanoma cells. The ability to inhibit collagen expression was also demonstrated by another member of the C-X-C branch of the platelet factor 4 superfamily, interleukin-8 (IL-8), but not by RANTES, MIP-1alpha, or MIP-1beta, which belong to the C-C branch. Steady-state levels of expression of MGSA and IL-8 transcripts in normal adult tissues were dissimilar, suggesting that expression may be an important level at which the activity of these cytokines is regulated. Direct binding experiments with I-125-MGSA on synovial fibroblasts have allowed us to identify an MGSA receptor with a K(D) of 10.1 nM and approximately 75,000 binding sites/fibroblast. I-125-MGSA binding was specific and could not be displaced by unlabeled IL-8. These results suggest that MGSA, as well as IL-8, may play a role other than that of neutrophil chemo-attractant and more specifically, may be important in the regulation of collagen turnover.	GENENTECH INC,DEPT PROT CHEM,S SAN FRANCISCO,CA 94080; STANFORD UNIV,MED CTR,DEPT DERMATOL,STANFORD,CA 94305	Roche Holding; Genentech; Stanford University	UNEMORI, EN (corresponding author), GENENTECH INC,DEPT IMMUNOL,460 PT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.				NIAMS NIH HHS [AR 41045-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041045] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; CARRE PC, 1991, J CLIN INVEST, V88, P1802, DOI 10.1172/JCI115501; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOLDS EE, 1989, BIOCHEM J, V259, P585, DOI 10.1042/bj2590585; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HEBERT CA, 1990, J IMMUNOL, V145, P3033; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; HERRON GS, 1986, J BIOL CHEM, V261, P2810; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1993, J BIOL CHEM, V268, P541; IIDA N, 1990, MOL CELL BIOL, V10, P5596, DOI 10.1128/MCB.10.10.5596; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; LEE J, 1992, J BIOL CHEM, V267, P16283; LOIDL HR, 1984, NUCLEIC ACIDS RES, V12, P9383, DOI 10.1093/nar/12.24.9383; MARTINSGREEN M, 1990, J CELL BIOL, V110, P581, DOI 10.1083/jcb.110.3.581; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; MYERS JC, 1981, P NATL ACAD SCI-BIOL, V78, P3516, DOI 10.1073/pnas.78.6.3516; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHRODER JM, 1990, J IMMUNOL, V144, P2223; SHERRY B, 1991, CURR OPIN IMMUNOL, V3, P56, DOI 10.1016/0952-7915(91)90077-E; TOKUNAGA K, 1987, CANCER RES, V47, P5616; UNEMORI EN, 1992, J INVEST DERMATOL, V99, P337, DOI 10.1111/1523-1747.ep12616665; UNEMORI EN, 1991, J CLIN INVEST, V88, P1656, DOI 10.1172/JCI115480; UNEMORI EN, 1990, J BIOL CHEM, V265, P445; Werb Z., 1989, TXB RHEUMATOLOGY, P300	35	74	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1338	1342						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419336				2022-12-27	WOS:A1993KG07700086
J	DIPERSIO, LP; HUI, DY				DIPERSIO, LP; HUI, DY			ASPARTIC-ACID 320 IS REQUIRED FOR OPTIMAL ACTIVITY OF RAT PANCREATIC CHOLESTEROL ESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; TORPEDO-CALIFORNICA; CATALYTIC SITE; AMINO-ACIDS; ACETYLCHOLINESTERASE; HYDROLASE; SEQUENCE; LIPASE; HYDROLYSIS; RESIDUES	The acidic amino acid residue required for the catalytic activity of rat pancreatic cholesterol esterase has been identified in this study by sequence comparison with other serine esterases and by site-directed mutagenesis experiments. The sequence comparison studies identified 3 acidic residues in homologous domains between cholesterol esterase, acetylcholinesterase, cholinesterase, and Geotrichum candida lipase that may potentially be the catalytic acidic residue in these proteins. The role of Glu78, Asp79, and Asp320 in the catalytic activity of rat cholesterol esterase was then addressed by mutagenesis and expression of the cDNA. Results showed that replacement of Glu78 or Asp79 with alanine has no effect on the ability of the cholesterol esterase to hydrolyze the artificial water-soluble substrate p-nitrophenyl butyrate. In contrast, the Asp320 --> Ala320 substitution abolished the enzyme activity of the cholesterol esterase. The specific requirement of Asp320 for optimal enzyme activity was demonstrated by substitution of the aspartic acid with glutamic acid, thus retaining the charge unit at this position. The Asp320 --> Glu320 substitution resulted in an enzyme that displayed normal interaction with bile salt. However, catalytic activity of this mutagenized protein was reduced by approximately 50%. These results strongly suggested that aspartic acid 320 is an important component of the catalytic triad of pancreatic cholesterol esterase. The specific requirement of aspartic acid, instead of glutamic acid, for optimal activity is different from that of other members of the serine esterase gene family.	UNIV CINCINNATI,COLL MED,DEPT PATHOL & LAB MED,231 BETHESDA AVE,CINCINNATI,OH 45267	University of Cincinnati					NIDDK NIH HHS [DK40917] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040917] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUAKIL N, 1989, BIOCHIM BIOPHYS ACTA, V1002, P225, DOI 10.1016/0005-2760(89)90291-9; BHAT SG, 1982, BIOCHEM BIOPH RES CO, V109, P486, DOI 10.1016/0006-291X(82)91747-8; BORJA CR, 1964, AM J PHYSIOL, V206, P223, DOI 10.1152/ajplegacy.1964.206.1.223; DIPERSIO LP, 1990, J BIOL CHEM, V265, P16801; DIPERSIO LP, 1991, J BIOL CHEM, V266, P4033; FONTAINE RN, 1991, BIOCHEMISTRY-US, V30, P7008, DOI 10.1021/bi00242a028; GALLO LL, 1984, J LIPID RES, V25, P604; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; HUI DY, 1990, FEBS LETT, V276, P131, DOI 10.1016/0014-5793(90)80525-N; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; JACOBSON PW, 1990, J BIOL CHEM, V265, P515; KISSEL JA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P227, DOI 10.1016/0005-2760(89)90201-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOMBARDO D, 1982, BIOCHIM BIOPHYS ACTA, V700, P67, DOI 10.1016/0167-4838(82)90293-X; LOMBARDO D, 1982, BIOCHIM BIOPHYS ACTA, V700, P75, DOI 10.1016/0167-4838(82)90294-1; LOMBARDO D, 1981, BIOCHIM BIOPHYS ACTA, V659, P401, DOI 10.1016/0005-2744(81)90066-8; Rudd E.A., 1984, P185; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; STOUT JS, 1985, BIOCHIM BIOPHYS ACTA, V837, P6, DOI 10.1016/0005-2760(85)90079-7; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	23	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					300	304						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416937				2022-12-27	WOS:A1993KE60300046
J	LATCHINIANSADEK, L; THOMAS, DY				LATCHINIANSADEK, L; THOMAS, DY			EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF THE YEAST KEX1 GENE-PRODUCT, A POLYPEPTIDE PRECURSOR PROCESSING CARBOXYPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE PROTEIN; ALPHA-FACTOR; ENKEPHALIN CONVERTASE; KILLER TOXIN; ENZYMES; QUANTITIES; INHIBITORS; PROTEASES; MEMBRANES; SEQUENCE	The Saccharomyces cerevisiae KEX1 gene encodes a protease with carboxypeptidase B-like activity involved in K1 and K2 killer toxins and alpha-factor (mating pheromone) precursors processing. The gene has been expressed using the baculovirus/insect cell system, and the KEX1 encoded protein (Kex1p) was purified to apparent homogeneity from detergent-solubilized membrane preparations of insect cells infected with the recombinant virus. The specific activity of the enzyme was enriched 126-fold as compared with the cell lysate, with a recovery of 29%. The NH2-terminal sequence of the purified active enzyme was identical to the predicted sequence after the removal of the signal peptide. This provides evidence that Kex1p, at least in insect cells, is not made as a proenzyme. The optimum pH for activity was 6.0, and the apparent pI value of the protein was below pH 3.0. The enzyme cleaves arginine or lysine from the COOH terminus of synthetic peptides: benzoyl-Phe-Ala-Arg (K(m) = 284 muM), furylacryloyl (fa)-Ala-Arg (K(m) = 516 muM), and fa-Ala-Lys (K(m) = 962 muM). The kinetic data obtained reveals that Kex1p preferentially cleaves the COOH-terminal arginine of peptides over the COOH-terminal lysine. Insect-derived Kex1p processes alpha-factor-Lys-Arg, its known natural substrate, to mature active alpha-factor, and this maturation event takes place in a sequential manner. Furthermore, the enzyme expresses very high affinity for the 15-amino acid-long peptide, alpha-factor-Lys-Arg (K(i) = 22 muM), and somewhat lower affinity for the heptapeptides [Leu]enkephalin-Arg-Arg, -Arg-Lys, and [Met]enkephalin-Lys-Lys (K(i) = 45, 57, and 81 muM, respectively). The data demonstrate that processing at the COOH terminus of the peptides tested stops after the cleavage of the Arg and/or Lys residues. The specificity of the enzyme for COOH-terminal basic amino acid residues of the peptides used in this study and its high affinity for alpha-factor-Lys-Arg confirms the role that Kex1p plays in polypeptide precursor processing in yeast.	MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA	McGill University	LATCHINIANSADEK, L (corresponding author), NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,EUKARYOT GENET GRP,6100 AVE ROYALMOUNT,MONTREAL H4P 2R2,PQ,CANADA.		Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				ACHSTETTER T, 1985, EMBO J, V4, P173, DOI 10.1002/j.1460-2075.1985.tb02333.x; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BOURBONNAIS Y, 1992, IN PRESS ENZYME; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDDAM K, 1986, CARLSBERG RES COMMUN, V51, P83, DOI 10.1007/BF02907561; BUSSEY H, 1988, YEAST, V4, P17, DOI 10.1002/yea.320040103; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; COOPER A, 1989, MOL CELL BIOL, V9, P2706, DOI 10.1128/MCB.9.6.2706; DIGNARD D, 1991, MOL GEN GENET, V227, P127, DOI 10.1007/BF00260717; DMOCHOWSKA A, 1987, CELL, V50, P573, DOI 10.1016/0092-8674(87)90030-4; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1983, BIOCHEM BIOPH RES CO, V111, P994, DOI 10.1016/0006-291X(83)91398-0; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; GALJART NJ, 1990, J BIOL CHEM, V265, P4678; HEMMINGS BA, 1981, P NATL ACAD SCI-BIOL, V78, P435, DOI 10.1073/pnas.78.1.435; Hutton JC, 1990, CURR OPIN CELL BIOL, V2, P1131, DOI 10.1016/0955-0674(90)90167-D; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO DI, 1990, J BIOL CHEM, V265, P6528; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; LYNCH DR, 1986, ANNU REV BIOCHEM, V55, P773, DOI 10.1146/annurev.bi.55.070186.004013; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; PARKINSON D, 1990, J BIOL CHEM, V265, P17101; PLUMMER TH, 1980, ANAL BIOCHEM, V108, P348, DOI 10.1016/0003-2697(80)90598-9; ROSSIER J, 1989, ANAL BIOCHEM, V178, P27, DOI 10.1016/0003-2697(89)90350-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; Summers MD, 1987, TEXAS AGR EXPT STATI; THOMAS L, 1990, J BIOL CHEM, V265, P10821; WAGNER JC, 1987, FEBS LETT, V221, P423, DOI 10.1016/0014-5793(87)80967-5; WALKER JM, 1992, IN PRESS BACULOVIRUS; [No title captured]	35	19	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					534	540						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416959				2022-12-27	WOS:A1993KE60300081
J	CHOU, DKH; JUNGALWALA, FB				CHOU, DKH; JUNGALWALA, FB			N-ACETYLGLUCOSAMINYLTRANSFERASE REGULATES THE EXPRESSION OF NEOLACTOGLYCOLIPIDS INCLUDING SULFOGLUCURONYLGLYCOLIPIDS IN THE DEVELOPING NERVOUS-SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATED GLUCURONIC-ACID; HUMAN COLONIC ADENOCARCINOMA; PURKINJE-CELL ABNORMALITY; L2/HNK-1 CARBOHYDRATE; DEVELOPMENTAL EXPRESSION; HNK-1-REACTIVE ANTIGENS; BIOSYNTHESIS INVITRO; ADHESION MOLECULE; HNK-1 ANTIBODY; MURINE MUTANTS	Lactosylceramide N-acetylglucosaminyltransferase (GlcNAc-Tr) in the synthesis of lactotriosylceramide (LcOse3Cer) was characterized in the nervous system. The microsomal membrane GlcNAc-Tr required a divalent metal ion, preferably Mn2+, and a nonionic detergent. The pH optimum was around 7.0. The enzyme also transferred GlcNAc to neoactotetraosylceramide (nLcOse4Cer), G(M1), and asialo-G(M1), but not to other glycolipids. The K(m) value for lactosylceramide was 21 muM (V(max) = 91 pmol/mg/h), and that for nLcOse4Cer was 35 muM (V(max) = 112 pmol/mg/h). The GlcNAc-Tr for the glycolipids appears to be separate from that for oligosaccharides. The developmental expression of GlcNAc-Tr, both in the cerebral cortex and cerebellum, correlated well with the tissue levels of LcOse3Cer, nLcOse4Cer, sulfoglucuronylglycolipids (SGGLs), and other neolacto series glycolipids (nLSGs). In the cerebral cortex, the specific activity of GlcNAc-Tr decreased sharply from a maximum level at embryonic day 15, and by postnatal day 10 onward, it was undetectable. In the adult cerebral cortex, although significant activities of other glycosyltransferases involved in the subsequent steps of the synthesis of SGGLs were present, the absence of GlcNAc-Tr stymied the formation of LcOse3Cer and therefore the synthesis of nLSGs, including SGGLs. In the cerebellum, the GlcNAc-Tr specific activity declined from the day of birth to postnatal day 3, but later, the activity increased and reached a maximum at postnatal day 15, which correlated with the increasing synthesis of nLSGs. The results indicate that lactosylceramide GlcNAc-Tr is the key regulatory enzyme controlling the differential expression of all nLSGs in the developing nervous system.	EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DEPT BIOMED SCI, 200 TRAPELO RD, WALTHAM, MA 02254 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024405] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD05505] Funding Source: Medline; NINDS NIH HHS [R01-NS24405] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABO T, 1982, J IMMUNOL, V129, P1752; ANDERSEN BB, 1992, J COMP NEUROL, V326, P549, DOI 10.1002/cne.903260405; ARIGA T, 1987, J BIOL CHEM, V262, P848; ASA D, 1992, GLYCOBIOLOGY, V2, P395, DOI 10.1093/glycob/2.5.395; BASU M, 1987, METHOD ENZYMOL, V138, P575; BASU M, 1991, CARBOHYD RES, V209, P261, DOI 10.1016/0008-6215(91)80162-G; BASU M, 1984, J BIOL CHEM, V259, P2557; BONNERFRASER M, 1987, DEV BIOL, V123, P321; CHOU DKH, 1991, J BIOL CHEM, V266, P17941; CHOU DKH, 1988, J NEUROCHEM, V50, P1655, DOI 10.1111/j.1471-4159.1988.tb03056.x; CHOU DKH, 1990, J NEUROCHEM, V54, P1589, DOI 10.1111/j.1471-4159.1990.tb01209.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; CHOU DKH, 1993, J BIOL CHEM, V268, P330; CHOU DKH, 1991, J NEUROCHEM, V57, P852, DOI 10.1111/j.1471-4159.1991.tb08229.x; CHOU DKH, 1992, T AM SOC NEUROCHEM, V23, P139; CHOU DKH, 1993, T AM SOC NEUROCHEM, V24, P264; CHOU DKH, 1993, IN PRESS J NEUROCHEM; CHOU KH, 1985, BIOCHEM BIOPH RES CO, V128, P383, DOI 10.1016/0006-291X(85)91690-0; DIXON M, 1964, ENZYMES, P72; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FIGLEWICZ DA, 1985, J LIPID RES, V26, P140; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; HOLMES EH, 1991, ARCH BIOCHEM BIOPHYS, V288, P87, DOI 10.1016/0003-9861(91)90168-I; HOLMES EH, 1987, J BIOL CHEM, V262, P15649; HOLMES EH, 1988, ARCH BIOCHEM BIOPHYS, V260, P461, DOI 10.1016/0003-9861(88)90470-5; KOHRIYAMA T, 1988, J NEUROCHEM, V51, P869, DOI 10.1111/j.1471-4159.1988.tb01823.x; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; MARGOLIS RK, 1987, BIOCHEM BIOPH RES CO, V145, P1142, DOI 10.1016/0006-291X(87)91556-7; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; MOHAN PS, 1992, BIOCHEM BIOPH RES CO, V182, P689, DOI 10.1016/0006-291X(92)91787-Q; MOHAN PS, 1990, J NEUROCHEM, V54, P2024, DOI 10.1111/j.1471-4159.1990.tb04907.x; NAIR SM, 1993, J COMP NEUROL, V332, P282, DOI 10.1002/cne.903320303; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; PESHEVA P, 1988, J NEUROSCI RES, V20, P420, DOI 10.1002/jnr.490200404; PILLER F, 1984, J BIOL CHEM, V259, P3385; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P7044, DOI 10.1073/pnas.85.19.7044; PRASADARAO N, 1990, J NEUROCHEM, V55, P2024, DOI 10.1111/j.1471-4159.1990.tb05791.x; SCHACHTER H, 1989, METHOD ENZYMOL, V179, P351; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; SHASHOUA VE, 1986, BIOCHEM BIOPH RES CO, V138, P902, DOI 10.1016/S0006-291X(86)80581-2; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P1763, DOI 10.1111/j.1471-4159.1991.tb02078.x; VANDENEIJNDEN DH, 1983, J BIOL CHEM, V258, P3435; 1977, LIPIDS, V12, P455	47	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21727	21733						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408027				2022-12-27	WOS:A1993MC80900048
J	CREEMERS, JWM; SIEZEN, RJ; ROEBROEK, AJM; AYOUBI, TAY; HUYLEBROECK, D; VANDEVEN, WJM				CREEMERS, JWM; SIEZEN, RJ; ROEBROEK, AJM; AYOUBI, TAY; HUYLEBROECK, D; VANDEVEN, WJM			MODULATION OF FURIN-MEDIATED PROPROTEIN PROCESSING ACTIVITY BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE; VONWILLEBRAND-FACTOR VWF; SUBSTRATE-SPECIFICITY; KEX2-LIKE ENDOPROTEASE; GENE-EXPRESSION; PROTO-ONCOGENE; YEAST KEX2; ENZYME; CLEAVAGE; CDNA	The proprotein processing activity of mutants of the subtilisin-like enzyme furin was studied in transfected mammalian cells. Our studies indicate that the three residues of the catalytic triad of furin, Asp46, His87, and Ser261, are critical not only for substrate processing but also, for maturation of furin. Furthermore, evidence is provided that maturation of furin occurs through an intramolecular autocatalytic process. Substitution of the asparagine residue (Asn188) of the oxyanion hole by an alanine residue appears to block substrate processing but not furin maturation. Analysis of carboxyl-terminal deletion mutants revealed that the segment encompassing residues Glu449 to Glu469 of the ''middle'' domain, which is more than 100 residues downstream of the predicted catalytic domain, contains residues that seem to be critical for processing activity but that the more carboxyl-terminal cysteine-rich region, the transmembrane region, and the cytosolic tail are dispensable. Finally, we made mutants in the substrate binding region of human furin and, studied their ability to process von Willebrand factor (pro-vWF) substrates, including wild-type pro-vWF as well as pro-vWF mutants in which the P1 (vWFR-1G), P2 (vWFK-2A), or P4 (vWFR-4A) basic residue with respect to the pro region cleavage site had been mutated. It is demonstrated that particular negatively charged residues in or near the substrate binding region of furin are critical for cleavage activity and specificity of the enzyme for multiple basic residues in the substrate. Furthermore, substrate binding region mutants of furin were obtained, which cleaved either the pro-vWFK-2A or pro-vWFR-4A mutant of pro-vWF more efficiently than wild-type pro-vWF.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOLEC ONCOL LAB,HERESTR 49,B-3000 LOUVAIN,BELGIUM; NEDERLANDS INST ZUIVELONDERZOEK,DEPT BIOPHYS CHEM,6710 BA EDE,NETHERLANDS; CATHOLIC UNIV LEUVEN,CELGEN,MOLEC BIOL LAB,B-3000 LOUVAIN,BELGIUM	KU Leuven; KU Leuven			Siezen, Roland J/P-5745-2015	Huylebroeck, Danny/0000-0003-4862-1079				ANDREASSON KI, 1989, FEBS LETT, V248, P43, DOI 10.1016/0014-5793(89)80428-4; BARR PJ, 1991, DNA CELL BIOL, V10, P319, DOI 10.1089/dna.1991.10.319; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; CHRETIEN M, 1967, CAN J BIOCHEM CELL B, V45, P1163, DOI 10.1139/o67-133; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; EVNIN LB, 1990, P NATL ACAD SCI USA, V87, P6659, DOI 10.1073/pnas.87.17.6659; FEURST TO, 1986, P NATL ACAD SCI USA, V83, P8122; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutton JC, 1990, CURR OPIN CELL BIOL, V2, P1131, DOI 10.1016/0955-0674(90)90167-D; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KORNER J, 1991, P NATL ACAD SCI USA, V88, P6834, DOI 10.1073/pnas.88.15.6834; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; MARYNEN P, 1990, FEBS LETT, V262, P349, DOI 10.1016/0014-5793(90)80226-9; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; REHEMTULLA A, 1992, BLOOD, V79, P2349; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROEBROEK AJM, 1986, MOL BIOL REP, V11, P117, DOI 10.1007/BF00364823; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; SIEZEN RJ, 1993, IN PRESS SUBTILISIN; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; VANDEVEN WJM, 1992, ENZYME, V45, P257; VANDUIJNHOVEN HLP, 1992, HYBRIDOMA, V11, P71, DOI 10.1089/hyb.1992.11.71; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; VOS P, 1991, PROTEIN ENG, V4, P479, DOI 10.1093/protein/4.4.479; WELLS JA, 1987, P NATL ACAD SCI USA, V84, P5167, DOI 10.1073/pnas.84.15.5167; WELLS JA, 1987, P NATL ACAD SCI USA, V84, P1219, DOI 10.1073/pnas.84.5.1219; WELLS JA, 1988, TRENDS BIOCHEM SCI, V13, P291, DOI 10.1016/0968-0004(88)90121-1	52	122	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21826	21834						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408037				2022-12-27	WOS:A1993MC80900061
J	KIM, JS; LOWE, KE; SHANE, B				KIM, JS; LOWE, KE; SHANE, B			REGULATION OF FOLATE AND ONE-CARBON METABOLISM IN MAMMALIAN-CELLS .4. ROLE OF FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE IN METHOTREXATE METABOLISM AND CYTOTOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L1210 LEUKEMIA-CELLS; RAT-LIVER; TETRAHYDROFOLATE COFACTORS; FACILITATED TRANSPORT; HEPATOMA-CELLS; CYTO-TOXICITY; TUMOR-CELLS; S180 CELLS; POLYGLUTAMATES; INVITRO	Chinese hamster ovary (CHO) cells expressing human and Escherichia coli folylpoly-gamma-glutamate synthetase (FPGS) activities were used as models to study factors regulating the cytotoxicity and metabolism of methotrexate (MTX). CHO cells expressing human FPGS metabolized MTX to polyglutamates characteristic of human cells. Cellular MTX accumulation and metabolism to polyglutamates were dependent on the level of FPGS activity and were unaffected by putative gamma-glutamyl hydrolase inhibitors. The sensitivity of cells continuously exposed to MTX was not influenced by FPGS activity. After short term exposure to MTX, cells expressing higher levels of FPGS were more sensitive to the drug. MTX was not transported into the mitochondria and MTX treatment had no effect on preexisting mitochondrial folates while cytosolic folates were converted to oxidized forms. Mitochondrial folate accumulation was significantly impaired by MTX treatment, suggesting that the mitochondrial folate transport system is specific for reduced folates.	UNIV CALIF BERKELEY,DEPT NUTR SCI,BERKELEY,CA 94720	University of California System; University of California Berkeley					NCI NIH HHS [CA-41991] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRUECO JR, 1992, J BIOL CHEM, V267, P19986; BARRUECO JR, 1991, J BIOL CHEM, V266, P11732; BEARDSLEY GP, 1989, J BIOL CHEM, V264, P328; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P504, DOI 10.1021/bi00376a024; COLL RJ, 1991, BIOCHEM PHARMACOL, V42, P833, DOI 10.1016/0006-2952(91)90043-5; COOK JD, 1987, BIOCHEMISTRY-US, V26, P530, DOI 10.1021/bi00376a027; CYBULSKI RL, 1981, BIOCHIM BIOPHYS ACTA, V646, P329, DOI 10.1016/0005-2736(81)90339-4; FABRE I, 1984, CANCER RES, V44, P3190; FREISHEIM JH, 1984, FOLATE ANTAGONISTS T, V1, P69; GEORGE S, 1987, BIOCHEMISTRY-US, V26, P522, DOI 10.1021/bi00376a026; HAGAN RL, 1991, BIOCHEM PHARMACOL, V41, P781, DOI 10.1016/0006-2952(91)90081-F; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Jackson R, 1984, FOLATE ANTAGONISTS T, V1, P289; JOHNSON TB, 1988, CANCER RES, V48, P2426; KALMAN T I, 1986, P583; KELLEY JL, 1990, J MED CHEM, V33, P561, DOI 10.1021/jm00164a014; Lenz H.-J., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P504; LI WW, 1992, CANCER RES, V52, P1434; LI WW, 1992, CANCER RES, V52, P3908; LIN BF, 1993, J BIOL CHEM, V268, P21674; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MCGUIRE JJ, 1985, CANCER RES, V45, P6395; MORAN RG, 1985, MOL PHARMACOL, V27, P156; NIMEC Z, 1983, ARCH BIOCHEM BIOPHYS, V226, P671, DOI 10.1016/0003-9861(83)90337-5; OCONNOR BM, 1991, CANCER RES, V51, P3874; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; PIZZORNO G, 1988, CANCER RES, V48, P2149; PIZZORNO G, 1989, CANCER RES, V49, P5275; SAMUELS LL, 1986, CANCER RES, V46, P2230; SAMUELS LL, 1985, CANCER RES, V45, P1488; SEITHER RL, 1989, J BIOL CHEM, V264, P17016; SEITHER RL, 1991, J BIOL CHEM, V266, P4112; SHANE B, 1990, CHEMISTRY AND BIOLOGY OF PTERIDINES 1989, P891; SHANE B, 1983, J BACTERIOL, V153, P316, DOI 10.1128/JB.153.1.316-325.1983; SIROTNAK FM, 1988, BIOCHEM PHARMACOL, V37, P4239, DOI 10.1016/0006-2952(88)90122-0; SIROTNAK FM, 1985, CANCER RES, V45, P3992; SOKOLOSKI JA, 1989, CANCER RES, V49, P4824; TRENT DF, 1991, BIOCHEM PHARMACOL, V42, P1015, DOI 10.1016/0006-2952(91)90283-B; WHITEHEAD VM, 1987, BIOCHEM BIOPH RES CO, V144, P292, DOI 10.1016/S0006-291X(87)80509-0; WHITEHEAD VM, 1990, BLOOD, V76, P44; WHITEHEAD VM, 1975, CANCER RES, V35, P2985; WILSON SD, 1984, ANAL BIOCHEM, V142, P529, DOI 10.1016/0003-2697(84)90502-5	44	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21680	21685						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408021				2022-12-27	WOS:A1993MC80900040
J	LIN, J; PAN, LP; CHAN, SI				LIN, J; PAN, LP; CHAN, SI			THE SUBUNIT LOCATION OF MAGNESIUM IN CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART; IDENTIFICATION; COPPER; YEAST; HEME	The magnesium ion in bovine heart cytochrome c oxidase can be depleted up to 75% by heat treatment of the enzyme at 43-degrees-C followed by dialysis against EDTA buffer solution. The magnesium-depleted enzyme so obtained retains 40% of the activity of the native enzyme. This is the first attempt to deplete magnesium ion from bovine heart cytochrome c oxidase without denaturation of the protein. Magnesium depletion exposes at least one carboxyl group on subunit IV for labeling by N-cyclohexyl-N'-(4-dimethylaminonaphthyl)carbodiimide (NCD-4). The NCD-4 labeling of subunit IV of the magnesium-depleted enzyme is significantly enhanced relative to what is observed for the native and heat-treated oxidase, suggesting that the magnesium ion is located in subunit IV with at least one carboxyl ligand. By comparing the activity of the magnesium-depleted enzyme with that of a control sample of heat-treated oxidase, the influence of divalent magnesium on the activity of the enzyme is assessed.	CALTECH, ARTHUR AMOS NOYES LAB CHEM PHYS, 127-72, PASADENA, CA 91125 USA	California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022432, R37GM022432] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 22432] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CASEY RP, 1980, J BIOL CHEM, V255, P3994; CHADWICK CC, 1983, BIOCHIM BIOPHYS ACTA, V730, P201, DOI 10.1016/0005-2736(83)90334-6; DARLEYUSMAR VM, 1984, FEBS LETT, V166, P131, DOI 10.1016/0014-5793(84)80058-7; DOWNER NW, 1976, BIOCHEMISTRY-US, V15, P2930, DOI 10.1021/bi00658a036; HALL J, 1988, J BIOL CHEM, V263, P8142; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; LUDWIG B, 1980, BIOCHIM BIOPHYS ACTA, V594, P177, DOI 10.1016/0304-4173(80)90008-7; MARTIN CT, 1988, J BIOL CHEM, V263, P8420; MONTECUCCO C, 1986, BIOCHEM J, V234, P241, DOI 10.1042/bj2340241; PAN LP, 1991, J BIOL CHEM, V266, P1367; POWER SD, 1984, J BIOL CHEM, V259, P6575; PROCHASKA LJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P360, DOI 10.1016/0005-2728(81)90175-4; RIZZUTO R, 1991, BIOCHIM BIOPHYS ACTA, V1089, P386, DOI 10.1016/0167-4781(91)90180-T; STEFFENS GCM, 1987, EUR J BIOCHEM, V164, P295, DOI 10.1111/j.1432-1033.1987.tb11057.x; VANGELDER BF, 1966, BIOCHIM BIOPHYS ACTA, V118, P36, DOI 10.1016/S0926-6593(66)80142-X; WIKSTROM M, 1981, CYTOCHROME OXIDASE S, P2; WINTER DB, 1980, J BIOL CHEM, V255, P1408; YEWEY GL, 1987, BIOCHEM BIOPH RES CO, V148, P1520, DOI 10.1016/S0006-291X(87)80304-2; ZHANG YZ, 1988, ANN NY ACAD SCI, V550, P3	20	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22210	22214						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408083				2022-12-27	WOS:A1993MC80900114
J	MASUOKA, J; HEGENAUER, J; VANDYKE, BR; SALTMAN, P				MASUOKA, J; HEGENAUER, J; VANDYKE, BR; SALTMAN, P			INTRINSIC STOICHIOMETRIC EQUILIBRIUM-CONSTANTS FOR THE BINDING OF ZINC(II) AND COPPER(II) TO THE HIGH-AFFINITY SITE OF SERUM-ALBUMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PLASMA; REGRESSION; IONS	Intrinsic stoichiometric equilibrium constants were determined for zinc(II) and copper(II) binding to bovine and human serum albumin. Data were obtained from equilibrium dialysis experiments. Metals were presented to apoprotein as metal chelates in order to avoid metal hydrolysis and to minimize nonspecific metal-protein interactions. Scatchard analysis of the binding data indicated that the high affinity class for both zinc and copper was comprised of one site. Results of binding experiments done at several pH values suggested that while both histidyl and carboxyl groups appear to be involved in copper binding, histidyl residues alone were sufficient for zinc binding. These amino acid residues were used in combination to model several binding sites used in the formulation of equilibria expressions from which stoichiometric constants were calculated. The log10K for bovine serum albumin were calculated to be 7.28 for Zn(II) and 11.12 for Cu(II). Those for human serum albumin were determined to be 7.53 and 11.18 for Zn(II) and Cu(II), respectively. These constants were used in equilibria to simulate speciation of metal-albumin and metal-chelator and to illustrate relative binding affinities. This comparison of binding strengths was possible only through the calculation of an intrinsic stoichiometric binding constant.			MASUOKA, J (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NIDDK NIH HHS [DK 12386-25] Funding Source: Medline; NIGMS NIH HHS [GM 07313] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012386] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERTHON G, 1978, J CHEM SOC DALTON, P1433, DOI 10.1039/dt9780001433; BLONDEAU JP, 1975, EUR J BIOCHEM, V55, P375, DOI 10.1111/j.1432-1033.1975.tb02172.x; DIXON JW, 1972, BIOCHEM BIOPH RES CO, V48, P197, DOI 10.1016/0006-291X(72)90362-2; DYKE B, 1987, BIOCHEMISTRY-US, V26, P3228, DOI 10.1021/bi00385a044; FELDMAN HA, 1972, ANAL BIOCHEM, V48, P317, DOI 10.1016/0003-2697(72)90084-X; GIROUX E, 1981, J INORG BIOCHEM, V14, P359, DOI 10.1016/S0162-0134(00)80292-5; HARRIS WR, 1989, J NUTR, V119, P1677, DOI 10.1093/jn/119.11.1677; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HEGENAUER J, 1979, BIOCHEMISTRY-US, V18, P3865, DOI 10.1021/bi00585a006; KAMIKUBO K, 1986, JPN J PHARMACOL, V40, P342, DOI 10.1254/jjp.40.342; KLOTZ IM, 1971, BIOCHEMISTRY-US, V10, P3065, DOI 10.1021/bi00792a013; KLOTZ IM, 1948, J AM CHEM SOC, V70, P939, DOI 10.1021/ja01183a015; KRUCK TPA, 1973, CAN J CHEM, V51, P3549, DOI 10.1139/v73-529; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALMSTROM BG, 1953, ARCH BIOCHEM BIOPHYS, V46, P345, DOI 10.1016/0003-9861(53)90207-0; MAY PM, 1976, EXPERIENTIA, V32, P1492, DOI 10.1007/BF01924411; OSTERBERG R, 1971, ACTA CHEM SCAND, V25, P3827, DOI 10.3891/acta.chem.scand.25-3827; PETTIT LD, 1976, J CHEM SOC DALTON, P588, DOI 10.1039/dt9760000588; RAO MSN, 1958, J AM CHEM SOC, V80, P3222, DOI 10.1021/ja01546a013; RAO MSN, 1958, J AM CHEM SOC, V80, P3226, DOI 10.1021/ja01546a014; REILMAN MA, 1986, J QUAL TECHNOL, V18, P162, DOI 10.1080/00224065.1986.11979004; RYALL X, 1974, THESIS AUSTR NATIONA; SAROFF HA, 1953, J AM CHEM SOC, V75, P1420, DOI 10.1021/ja01102a044; SASSKORTSAK A, 1967, CAN MED ASSOC J, V96, P361; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Spiro T.G., 1969, STRUCTURE BONDING, V6; TAKAHASHI N, 1987, P NATL ACAD SCI USA, V84, P7403, DOI 10.1073/pnas.84.21.7403; TANFORD C, 1952, J AM CHEM SOC, V74, P211, DOI 10.1021/ja01121a054; TANFORD C, 1955, J AM CHEM SOC, V77, P6414, DOI 10.1021/ja01629a002	30	197	205	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21533	21537						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408004				2022-12-27	WOS:A1993MC80900019
J	RACHIE, NA; SEGER, R; VALENTINE, MA; OSTROWSKI, J; BOMSZTYK, K				RACHIE, NA; SEGER, R; VALENTINE, MA; OSTROWSKI, J; BOMSZTYK, K			IDENTIFICATION OF AN INDUCIBLE 85-KDA NUCLEAR-PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE-POLYACRYLAMIDE GELS; SODIUM DODECYL-SULFATE; S6 KINASE; T-CELLS; CYTOPLASMIC ALKALINIZATION; RIBOSOMAL PROTEIN-S6; INTERFERON-GAMMA; EPITHELIAL-CELLS; SWISS 3T3-CELLS; GENE-EXPRESSION	To identify inducible protein kinases localized exclusively in the nucleus, nuclear and cytosolic extracts were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroblotted to an Immobilon-P membrane. After denaturation-renaturation, the membranes were incubated in phosphorylation buffer containing [gamma-P-32]ATP. Autoradiographs of the membranes revealed an 85-kDa P-32-labeled band; the intensity of this band was transiently increased in nuclear but not in cytosolic extracts from interleukin-1alpha-treated cells. Incorporation of P-32 label into a blotted protein band suggested the presence of an interleukin-1alpha-responsive 85-kDa nuclear protein kinase. Fractionation of nuclear extracts by Mono Q failed to separate the kinase activity from the substrate, indicating that the 85-kDa band identified on the Immobilon-P membrane represents a protein kinase that undergoes autophosphorylation. Phosphoamino acid analysis of the 85-kDa band showed that this enzyme is a serine/threonine kinase. Purified pp90RSK could not be identified by the denaturation-renaturation method, indicating that the 85-kDa kinase identified here is not pp90RSK. This observation, nuclear but not cytoplasmic localization, and the fact that antibodies to known protein kinases kinase failed to recognize it suggest that the enzyme identified here is a novel protein kinase.	UNIV WASHINGTON, DEPT MED, RM-11, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MICROBIOL, SEATTLE, WA 98195 USA; MED CTR POSTGRAD EDUC, DEPT GASTROENTEROL & METAB, WARSAW, POLAND	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre of Postgraduate Medical Education - Poland				Ostrowski, Jerzy/0000-0003-1363-3766	NIGMS NIH HHS [P01 GM42508, R01 GM45134] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508, R01GM045134] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; AHN NG, 1990, J BIOL CHEM, V265, P11495; AKAGI S, J HISTOCHEM CYTOCHEM, V36, P1533; ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BACHER N, 1991, MOL CELL BIOL, V11, P126, DOI 10.1128/MCB.11.1.126; BIRD TA, 1989, J IMMUNOL, V142, P126; BIRD TA, 1991, J BIOL CHEM, V266, P22661; BLENIS J, 1987, J BIOL CHEM, V262, P14373; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COTO JA, 1992, P NATL ACAD SCI USA, V89, P7752, DOI 10.1073/pnas.89.16.7752; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINARELLO CA, 1991, BLOOD, V77, P1627; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; GREIF H, 1992, MOL CELL BIOL, V12, P1304, DOI 10.1128/MCB.12.3.1304; GUESDON F, 1991, J IMMUNOL, V147, P3402; GUY GR, 1991, J BIOL CHEM, V266, P14343; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAO QL, 1991, MOL CELL BIOL, V11, P1180, DOI 10.1128/MCB.11.2.1180; HARLOW E, 1988, ANTIBODIES LABORATOR; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; IWASAKI T, 1992, FEBS LETT, V298, P240, DOI 10.1016/0014-5793(92)80067-Q; KAETZEL CS, 1987, BIOCHEM J, V241, P39, DOI 10.1042/bj2410039; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVETT DH, 1988, J CLIN INVEST, V82, P115, DOI 10.1172/JCI113558; LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MUNOZ E, 1991, J IMMUNOL, V146, P136; MUNOZ E, 1992, EUR J IMMUNOL, V22, P1391, DOI 10.1002/eji.1830220610; MUNOZ E, 1990, BIOCHIM BIOPHYS ACTA, V1052, P173; OPPENHEIMER MN, 1990, EXP HEMATOL, V18, P888; OSTROWSKI J, 1988, J BIOL CHEM, V263, P13786; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PESONEN M, 1984, J CELL BIOL, V99, P803, DOI 10.1083/jcb.99.3.803; QUIGG RJ, 1989, AM J PATHOL, V134, P1125; SEGER R, 1992, J BIOL CHEM, V267, P25628; SEGER R, 1992, J BIOL CHEM, V267, P14373; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH LL, 1988, J BIOL CHEM, V263, P7359; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; VIK TA, 1990, P NATL ACAD SCI USA, V87, P2685, DOI 10.1073/pnas.87.7.2685; WEEKS RS, 1988, J IMMUNOL, V140, P1312; WEIEL JE, 1990, ADV SEC MESS PHOSPH, V24, P182	60	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22143	22149						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408074				2022-12-27	WOS:A1993MC80900104
J	SIROIS, J; RICHARDS, JS				SIROIS, J; RICHARDS, JS			TRANSCRIPTIONAL REGULATION OF THE RAT PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 GENE IN GRANULOSA-CELLS - EVIDENCE FOR THE ROLE OF A CIS-ACTING C/EBP-BETA PROMOTER ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; ENHANCER-BINDING-PROTEIN; PREOVULATORY FOLLICLES; H SYNTHASE; LUTEINIZING-HORMONE; G/H SYNTHASE; COMPLEMENTARY-DNA; INDUCTION; CYCLOOXYGENASE; EXPRESSION	The promoter of the rat prostaglandin endoperoxide synthase 2 (PGS-2) gene has recently been shown to confer gonadotropic hormone (follicle-stimulating hormone (FSH), luteinizing hormone (LH), cAMP) inducibility when ligated to a CAT (chloramphenicol acetyltransferase) reporter gene and transfected into primary cultures of differentiated granulosa cells. To delineate cis-acting elements and trans-activating factors mediating this response, deletions of the active promoter region (-192/-53 base pairs upstream of the transcriptional start site) were tested for their ability to bind protein of granulosa cell nuclear extracts and activate reporter gene activity. Electrophoretic mobility shift assays revealed that the DNA subregion -142/-120 inhibited protein/DNA binding observed between granulosa cell nuclear extracts and the labeled PGS-2 fragment -192/-53. The subregion -142/-120 was shown to contain a consensus sequence for the cis-acting element C/EBPbeta, 5'-TTATGCAAT-3'. Point mutations within the C/EBPbeta element abolished protein/DNA binding and resulted in a 50% loss of forskolin/LH/FSH inducibility of reporter gene activity. C/EBPbeta mRNA and protein were induced rapidly in granulosa cells in vivo by an ovulatory dose of human chorionic gonadotropin (hCG). Collectively, these results indicate that C/EBPbeta appears to play a key role in regulating induction of the PGS-2 gene in granulosa cells prior to ovulation.	BAYLOR COLL MED,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030	Baylor College of Medicine					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD016229] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016229] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-16229] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CLARK MR, 1978, J BIOL CHEM, V253, P7757; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; ESPEY LL, 1980, BIOL REPROD, V22, P73, DOI 10.1095/biolreprod22.1.73; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FITZPATRICK SL, 1991, ENDOCRINOLOGY, V129, P1452, DOI 10.1210/endo-129-3-1452; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; FU JY, 1990, J BIOL CHEM, V265, P16737; FUNK CD, 1991, FASEB J, V5, P2304, DOI 10.1096/fasebj.5.9.1907252; GADDYKURTEN D, 1991, MOL ENDOCRINOL, V5, P1280, DOI 10.1210/mend-5-9-1280; GARLATTI M, 1993, J BIOL CHEM, V268, P6567; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; HEDIN L, 1987, ENDOCRINOLOGY, V121, P722, DOI 10.1210/endo-121-2-722; HEDIN L, 1987, ENDOCRINOLOGY, V120, P1928, DOI 10.1210/endo-120-5-1928; HEMLER M, 1976, J BIOL CHEM, V251, P5575; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; JONES DA, 1993, J BIOL CHEM, V268, P9049; KRAEMER SA, 1992, ARCH BIOCHEM BIOPHYS, V293, P391, DOI 10.1016/0003-9861(92)90411-O; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; KULMACZ RJ, 1987, CRC HDB EICOSANOID A, V1, P163; KURTEN RC, 1992, MOL ENDOCRINOL, V6, P536, DOI 10.1210/me.6.4.536; LEE SH, 1992, J BIOL CHEM, V267, P25934; LIN AH, 1989, J BIOL CHEM, V264, P17379; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MORRIS JK, 1993, IN PRESS ENDOCRINOLO; OBANION MK, 1991, J BIOL CHEM, V266, P23261; OONK RB, 1989, J BIOL CHEM, V264, P21934; PARK EA, 1993, J BIOL CHEM, V268, P613; PELHAM HRB, 1976, ANAL BIOCHEM, V72, P248; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; RAZ A, 1989, P NATL ACAD SCI USA, V86, P1657, DOI 10.1073/pnas.86.5.1657; ROESLER WJ, 1993, J BIOL CHEM, V268, P3791; Sambrook J, 1989, MOL CLONING LABORATO; SIGAL E, 1991, AM J PHYSIOL, V260, pL13, DOI 10.1152/ajplung.1991.260.2.L13; SIMONSON MS, 1991, MOL ENDOCRINOL, V5, P441, DOI 10.1210/mend-5-3-441; SIROIS J, 1992, J BIOL CHEM, V267, P11586; SIROIS J, 1992, J BIOL CHEM, V267, P6382; SIROIS J, 1993, J BIOL CHEM, V268, P12199; SMITH WL, 1992, AM J PHYSIOL, V263, pF181; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WONG WYL, 1992, ENDOCRINOLOGY, V130, P3512, DOI 10.1210/en.130.6.3512; WONG WYL, 1989, MOL ENDOCRINOL, V3, P1714, DOI 10.1210/mend-3-11-1714; WONG WYL, 1991, MOL ENDOCRINOL, V5, P1269, DOI 10.1210/mend-5-9-1269; XIE WL, 1993, ARCH BIOCHEM BIOPHYS, V300, P247, DOI 10.1006/abbi.1993.1034; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0	59	219	219	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21931	21938						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408049				2022-12-27	WOS:A1993MC80900075
J	SOLER, C; BEGUINOT, L; SORKIN, A; CARPENTER, G				SOLER, C; BEGUINOT, L; SORKIN, A; CARPENTER, G			TYROSINE PHOSPHORYLATION OF RAS GTPASE-ACTIVATING PROTEIN DOES NOT REQUIRE ASSOCIATION WITH THE EPIDERMAL GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-GAMMA; PDGF BETA-RECEPTOR; NIH 3T3 CELLS; AUTOPHOSPHORYLATION SITES; SIGNAL TRANSDUCTION; EGF RECEPTOR; KINASE-ACTIVITY; SELF-PHOSPHORYLATION; INSULIN STIMULATION; MOLECULAR-CLONING	The importance of the carboxyl-terminal domain of the epidermal growth factor (EGF) receptor and its five autophosphorylation sites in the in vivo interaction and tyrosine phosphorylation of the ras GTPase-activating protein (rasGAP) has been investigated, using NIH 3T3 cells transfected with mutant EGF receptors. Phosphorylation of rasGAP by EGF receptor mutants, in which one to four autophosphorylation sites (Tyr-1173, -1148, -1086, and -1068) were mutated to phenylalanine, was reduced by 50-60% compared to the wild-type receptor. Elimination of these four autophosphorylation sites by truncation of 123 carboxyl-terminal residues of the EGF receptor paralleled results obtained with point mutants. Substantial inhibition (about 90%) of rasGAP tyrosine phosphorylation by the EGF receptor occurred only when the remaining autophosphorylation site (Tyr-1992) was mutated, in the context of this truncated receptor or in the full-length receptor mutated at all four other autophosphorylation sites. However, a point mutation of only Tyr-992 in the full-length receptor suppressed tyrosine phosphorylation of rasGAP only by 50%. In contrast, an EGF receptor lacking the last 214 amino acid residues (Dc214), which emcompasses all five autophosphorylation sites, phosphorylated rasGAP to the same extent as the wild-type receptor. However, this truncated receptor was significantly impaired in its capacity to phosphorylate phospholipase C-gamma1. Interestingly, while EGF receptor autophosphorylation sites are required for EGF-induced rasGAP association with the receptor, maximal phosphorylation of rasGAP by the truncated receptor Dc214 occurred without detectable formation of receptor.rasGAP complexes. Furthermore, the capacity of mutated EGF receptors to bring about focal transformation was correlated with their capacity to phosphorylate rasGAP.	VANDERBILT UNIV, MED CTR, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; DIBIT HS RAFFAELE, ONCOL MOLEC LAB, MILAN, ITALY	Vanderbilt University; Vanderbilt University			Soler, Concepció/L-1185-2014	Soler, Concepció/0000-0001-6502-5012; Sorkin, Alexander/0000-0002-4446-1920	NCI NIH HHS [CA24071] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA024071] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BOUTON AH, 1991, MOL CELL BIOL, V11, P945, DOI 10.1128/MCB.11.2.945; BROTT BK, 1991, P NATL ACAD SCI USA, V88, P755, DOI 10.1073/pnas.88.3.755; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CARPENTER G, 1992, FASEB J, V6, P3283, DOI 10.1096/fasebj.6.14.1385243; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CICHOWSKI K, 1992, J BIOL CHEM, V267, P5025; DECKER SJ, 1992, J BIOL CHEM, V267, P1104; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ELLIS C, 1991, ONCOGENE, V6, P895; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HELIN K, 1991, ONCOGENE, V6, P825; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KUMJIAN DA, 1991, J BIOL CHEM, V266, P3973; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU XQ, 1991, MOL CELL BIOL, V11, P2511, DOI 10.1128/MCB.11.5.2511; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; MOLLOY CJ, 1992, MOL CELL BIOL, V12, P3903, DOI 10.1128/MCB.12.9.3903; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHWEIGHOFFER F, 1992, SCIENCE, V256, P825, DOI 10.1126/science.1317056; SERTH J, 1992, BIOCHEMISTRY-US, V31, P6361, DOI 10.1021/bi00143a001; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1991, J BIOL CHEM, V266, P8355; STOSCHECK CM, 1983, ARCH BIOCHEM BIOPHYS, V227, P457, DOI 10.1016/0003-9861(83)90476-9; SUH PG, 1988, J BIOL CHEM, V263, P14497; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VEGA QC, 1992, MOL CELL BIOL, V12, P128, DOI 10.1128/MCB.12.1.128; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WALTON GM, 1990, J BIOL CHEM, V265, P1750; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; WOOD ER, 1992, J BIOL CHEM, V267, P14138; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; ZHU GC, 1992, P NATL ACAD SCI USA, V89, P9559, DOI 10.1073/pnas.89.20.9559	71	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22010	22019						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408058				2022-12-27	WOS:A1993MC80900086
J	FRITZ, G; DOSCH, J; THIELMANN, HW; KAINA, B				FRITZ, G; DOSCH, J; THIELMANN, HW; KAINA, B			MOLECULAR AND CELLULAR CHARACTERIZATION OF MEX- METHYLATION-RESISTANT PHENOTYPE - GENE AND CDNA CLONING, SERUM DEPENDENCE, AND TUMOR SUPPRESSION OF TRANSFECTANT STRAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; DNA-REPAIR GENE; ALKYLATING-AGENTS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; METHYLTRANSFERASE ACTIVITY; O6-METHYLGUANINE-DNA METHYLTRANSFERASE; LYMPHOBLASTOID LINES; HUMAN FIBROBLAST	Methylating agents are widely distributed environmental mutagens. To identify mechanisms that protect cells against the toxic effects of methylating compounds Chinese hamster ovary (CHO) cells were transfected with human DNA and selected for resistance to methylating agents. From methylation-resistant transfectants, human DNA was cloned that conferred methylation resistance to CHO cells. A human cDNA was isolated (designated c81) encoding a protein of 410 amino acids which is partially identical to human lamp-2 encoding a lysosomal membrane glycoprotein. Transfection of c81, but not of the neo gene or a c81 antisense construct, into CHO cells gave rise to significant increases of survivors after methylating treatments. c81 mRNA is expressed both in human, CHO parental, and transfected cells, albeit in different amounts. The methylation-resistant transfectants lacked alkyltransferase activity (Mex- phenotype), did not repair O6-methylguanine in vivo, and neither showed reduced initial DNA methylation level nor increase of removal of 3-methyladenine and 7-methylguanine from DNA. They are therefore representatives of the ''tolerance'' phenotype. The transfectants also showed a higher serum requirement, flat growth, and a reduced tumor forming ability. The data suggest a link between altered regulation of cell proliferation and acquired resistance to methylating DNA damaging agents.	FORSCHUNGSZENTRUM JULICH, DEPT GENET, D-76021 KARLSRUHE, GERMANY; GERMAN CANC RES CTR, D-69120 HEIDELBERG, GERMANY	Helmholtz Association; Research Center Julich; Helmholtz Association; German Cancer Research Center (DKFZ)			Kaina, Bernd/AAE-4692-2020					ANGEL P, 1986, MOL CELL BIOL, V6, P1760, DOI 10.1128/MCB.6.5.1760; [Anonymous], 1985, DNA REPAIR; AQUILINA G, 1989, CARCINOGENESIS, V10, P1219, DOI 10.1093/carcin/10.7.1219; BAKER RM, 1979, P NATL ACAD SCI USA, V76, P5249, DOI 10.1073/pnas.76.10.5249; BATES PF, 1983, GENE, V26, P137, DOI 10.1016/0378-1119(83)90183-X; BELT PBGM, 1989, GENE, V84, P407, DOI 10.1016/0378-1119(89)90515-5; BIANCHI R, 1992, CANCER CHEMOTH PHARM, V29, P277, DOI 10.1007/BF00685945; BOON T, 1977, P NATL ACAD SCI USA, V74, P272, DOI 10.1073/pnas.74.1.272; BRENNAND J, 1986, P NATL ACAD SCI USA, V83, P6292, DOI 10.1073/pnas.83.17.6292; BURGLIN TR, 1987, EMBO J, V6, P2617, DOI 10.1002/j.1460-2075.1987.tb02552.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLVIN M, 1982, PHARM PRINCIPLES CAN, P276; DAY RS, 1980, CARCINOGENESIS, V1, P21, DOI 10.1093/carcin/1.1.21; DAY RS, 1979, NATURE, V279, P797, DOI 10.1038/279797a0; DAY RS, 1980, NATURE, V288, P724, DOI 10.1038/288724a0; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GEBARA MM, 1987, MOL CELL BIOL, V7, P1459, DOI 10.1128/MCB.7.4.1459; GIAMPIETRI A, 1980, J NATL CANCER I, V64, P297, DOI 10.1093/jnci/64.2.297; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; GOTHGOLDSTEIN R, 1987, CARCINOGENESIS, V8, P1449, DOI 10.1093/carcin/8.10.1449; GREEN MHL, 1989, CARCINOGENESIS, V10, P893, DOI 10.1093/carcin/10.5.893; HALL J, 1988, CARCINOGENESIS, V9, P1587, DOI 10.1093/carcin/9.9.1587; IBEANU G, 1992, CARCINOGENESIS, V13, P1989, DOI 10.1093/carcin/13.11.1989; IKENAGA M, 1987, MUTAT RES, V184, P161, DOI 10.1016/0167-8817(87)90073-3; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; ISHIZAKI K, 1986, MUTAT RES, V166, P135, DOI 10.1016/0167-8817(86)90011-8; KAINA B, 1987, CARCINOGENESIS, V8, P1935, DOI 10.1093/carcin/8.12.1935; KAINA B, 1990, P NATL ACAD SCI USA, V87, P2710, DOI 10.1073/pnas.87.7.2710; KAINA B, 1991, CARCINOGENESIS, V12, P1857; KAINA B, 1990, MUTAT RES, V243, P219, DOI 10.1016/0165-7992(90)90094-Z; KAINA B, 1987, MOL CELL BIOL, V7, P2024, DOI 10.1128/MCB.7.5.2024; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KARRAN P, 1982, NATURE, V296, P770, DOI 10.1038/296770a0; KARRAN P, 1985, CANCER SURV, V4, P583; KATAOKA H, 1986, EMBO J, V5, P3195, DOI 10.1002/j.1460-2075.1986.tb04629.x; KLINGER HP, 1983, J NATL CANCER I, V3, P559; KLUNGLAND A, 1992, EMBO J, V11, P4439, DOI 10.1002/j.1460-2075.1992.tb05544.x; KYRTOPOULOS SA, 1989, CANCER SURV, V8, P423; Maniatis T., 1982, MOL CLONING; MITANI H, 1987, MUTAT RES, V191, P201, DOI 10.1016/0165-7992(87)90154-0; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; PEGG AE, 1990, CANCER RES, V50, P6119; Peto R., 1984, IARC SCI PUBL, V57, P627; PUCCETTI P, 1987, CANCER METAST REV, V6, P93, DOI 10.1007/BF00052845; SAMSON L, 1986, P NATL ACAD SCI USA, V83, P5607, DOI 10.1073/pnas.83.15.5607; SCUDIERO DA, 1984, CANCER RES, V44, P961; SHILOH Y, 1981, CANCER RES, V41, P5114; Singer B., 1983, MOL BIOL MUTAGENS CA; SKLAR R, 1981, NATURE, V289, P417, DOI 10.1038/289417a0; SKLAR RM, 1983, CANCER RES, V43, P3316; THIELMANN HW, 1991, CANCER RES, V51, P3456; WOOD RD, 1982, MUTAT RES, V95, P505, DOI 10.1016/0027-5107(82)90281-0; YAROSH DB, 1983, CARCINOGENESIS, V4, P199, DOI 10.1093/carcin/4.2.199	55	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21102	21112						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407947				2022-12-27	WOS:A1993MA28800071
J	KRACHT, M; HEINER, A; RESCH, K; SZAMEL, M				KRACHT, M; HEINER, A; RESCH, K; SZAMEL, M			INTERLEUKIN-1-INDUCED SIGNALING IN T-CELLS - EVIDENCE FOR THE INVOLVEMENT OF PHOSPHATASES PP1 AND PP2A IN REGULATING PROTEIN-KINASE C-MEDIATED PROTEIN-PHOSPHORYLATION AND INTERLEUKIN-2 SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; OKADAIC ACID; LYMPHOCYTES-T; GROWTH-FACTOR; CYCLIC-AMP; ACTIVATION; TRANSDUCTION; IL-1; EXPRESSION; MECHANISM	Binding of human recombinant interleukin-1beta (IL-1beta) to the cell surface receptors of EL-4 6.1 murine T-cells results in enhanced phosphorylation of several cellular proteins. Staurosporine abolished the enhanced phosphorylation in response to IL-1 for some of these proteins, suggesting that protein kinase C (PKC) was at least partially responsible. PKC-beta was translocated from the cytosol to the plasma membrane between 2 and 15 min after IL-1 binding. Activation of PKC-beta was enhanced by the protein phosphatase inhibitor okadaic acid. In fact, okadaic acid inhibited dephosphorylation of the PKC-specific peptide GS (Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys). On the other hand, okadaic acid also led to elevation of IL-1-induced trans/autophosphorylation of PKC-beta. Accordingly, IL-1 induction of interleukin-2 synthesis was markedly enhanced by okadaic acid in EL-4 cells. These data suggest that activation of PKC-beta contributes to enhanced phosphorylation of cellular proteins in IL-1-treated cells and support the importance of protein phosphorylation and dephosphorylation in the regulation of IL-1-induced IL-2 synthesis in EL-4 6.1 T-cells.			KRACHT, M (corresponding author), MED SCH HANNOVER,INST MOLEC PHARMACOL,KONSTANTY GUTSCHOW STR 8,D-30623 HANNOVER,GERMANY.			Kracht, Michael/0000-0002-8501-043X				ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; ALEXANDER DR, 1990, BIOCHEM J, V268, P303, DOI 10.1042/bj2680303; ALEXANDER DR, 1989, IMMUNOL TODAY, V10, P200, DOI 10.1016/0167-5699(89)90325-3; BERRY N, 1990, P NATL ACAD SCI USA, V87, P2294, DOI 10.1073/pnas.87.6.2294; BIANCHINI L, 1991, J BIOL CHEM, V266, P15406; BIRD TA, 1989, J IMMUNOL, V142, P126; BIRD TA, 1990, J BIOL CHEM, V265, P235; BIRD TA, 1990, J BIOL CHEM, V265, P13578; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEDID M, 1991, J IMMUNOL, V147, P867; CSERMELY P, 1988, J BIOL CHEM, V263, P6487; DINARELLO CA, 1991, BLOOD, V77, P1627; GILLIS S, 1978, J IMMUNOL, V120, P2027; GUESDON F, 1991, J IMMUNOL, V147, P3402; GUY GR, 1992, J BIOL CHEM, V267, P1846; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; KILEY SC, 1991, J BIOL CHEM, V266, P23761; LUCAS S, 1990, FEBS LETT, V260, P53, DOI 10.1016/0014-5793(90)80064-P; MARTIN M, 1989, EUR J BIOCHEM, V148, P1; MILLS GB, 1990, J CELL PHYSIOL, V142, P539, DOI 10.1002/jcp.1041420313; MIZEL SB, 1990, IMMUNOL TODAY, V11, P390, DOI 10.1016/0167-5699(90)90154-2; MODIANO JF, 1991, J BIOL CHEM, V266, P10552; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; MUNOZ E, 1990, J IMMUNOL, V144, P964; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ONEILL LAJ, 1990, J BIOL CHEM, V265, P3146; ONEILL LAJ, 1990, IMMUNOL TODAY, V11, P392, DOI 10.1016/0167-5699(90)90155-3; OSTROWSKI J, 1988, J BIOL CHEM, V263, P13786; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SAWAMURA S, 1989, FEBS LETT, V247, P353, DOI 10.1016/0014-5793(89)81369-9; SHEARMAN MS, 1988, FEBS LETT, V234, P387, DOI 10.1016/0014-5793(88)80122-4; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SZAMEL M, 1989, J IMMUNOL, V143, P2806; TAFFS RE, 1991, J IMMUNOL, V147, P722; THEVENIN C, 1991, J BIOL CHEM, V266, P9363; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	37	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21066	21072						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407943				2022-12-27	WOS:A1993MA28800066
J	SLACK, BE; NITSCH, RM; LIVNEH, E; KUNZ, GM; BREU, J; ELDAR, H; WURTMAN, RJ				SLACK, BE; NITSCH, RM; LIVNEH, E; KUNZ, GM; BREU, J; ELDAR, H; WURTMAN, RJ			REGULATION BY PHORBOL ESTERS OF AMYLOID PRECURSOR PROTEIN RELEASE FROM SWISS 3T3 FIBROBLASTS OVEREXPRESSING PROTEIN KINASE-C-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BETA-PROTEIN; PHOSPHORYLATION; CELLS; IDENTIFICATION; PEPTIDE; BIOGENESIS; EXPRESSION; ACTIVATION; SECRETION	Release of large soluble NH2-terminal fragments of the amyloid precursor protein (APP) of Alzheimer's disease was measured in two Swiss 3T3 fibroblast cell lines (designated SF1.4 and SF3.2), overexpressing the alpha subtype of protein kinase C, and in two control cell lines (SC1 and SC2) (Eldar, H., Zisman, Y., Ullrich, A., and Livneh, E. (1990) J. Biol. Chem. 265, 13290-13296). Basal release of APP was significantly increased in SF1.4 cells, but not in SF3.2 cells, relative to controls. Phorbol 12-myristate 13-acetate, an activator of protein kinase C, elicited a concentration-dependent increase in APP release in all four cell lines. However, the estimated EC50 for this effect was lower in the two cell lines overexpressing protein kinase C-alpha (7 and 6 nM, in SF1.4 and SF3.2 cells, respectively) than in control SC1 and SC2 cells (56 and 22 nM, respectively). The absolute amount of APP released by maximal concentrations of phorbol ester was not altered by overexpression of protein kinase Calpha. The protein kinase C inhibitor H-7 (1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride) significantly reduced the response to phorbol esters in control (SC1) cells but not in cells (SF1.4) that overexpress protein kinase Calpha. Levels of cell-associated APP were slightly elevated, and rates of APP turnover were unchanged, in SF1.4 cells relative to controls. However, cell-associated APP levels were lower in SF3.2 cells than in controls. The results demonstrate that protein kinase Calpha regulates APP release in Swiss 3T3 fibroblasts, and perhaps in other tissues, including brain, and may be the isozyme that mediates receptor-evoked release of APP.	MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02114 USA; WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Weizmann Institute of Science	SLACK, BE (corresponding author), MIT, DEPT BRAIN & COGNIT SCI, CAMBRIDGE, MA 02139 USA.		Eldar-Finkelman, Hagit/AAF-8329-2019; Slack, Barbara/AAU-9917-2021	Eldar-Finkelman, Hagit/0000-0002-8460-9686; Slack, Barbara/0000-0002-7619-410X	NIMH NIH HHS [MH-28783] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH028783, R01MH028783] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BRUEL A, 1991, NEUROSCI LETT, V133, P89, DOI 10.1016/0304-3940(91)90064-Z; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ELDAR H, 1993, J BIOL CHEM, V268, P12560; ELDAR H, 1990, J BIOL CHEM, V265, P13290; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GILLESPIE SL, 1992, BIOCHEM BIOPH RES CO, V187, P1285, DOI 10.1016/0006-291X(92)90442-N; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LOWERY DE, 1991, J BIOL CHEM, V266, P19842; MASLIAH E, 1990, J NEUROSCI, V10, P2113; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SHASPIRO IP, 1992, SOC NEUR ABSTR, V18, P1442; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLACK BE, 1991, J BIOL CHEM, V266, P24503; SUZUKI T, 1992, NEUROSCIENCE, V48, P755, DOI 10.1016/0306-4522(92)90264-3; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	33	98	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21097	21101						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407946				2022-12-27	WOS:A1993MA28800070
J	TAKIMOTO, CH; VOELLER, DB; STRONG, JM; ANDERSON, L; CHU, E; ALLEGRA, CJ				TAKIMOTO, CH; VOELLER, DB; STRONG, JM; ANDERSON, L; CHU, E; ALLEGRA, CJ			EFFECTS OF 5-FLUOROURACIL SUBSTITUTION ON THE RNA CONFORMATION AND IN-VITRO TRANSLATION OF THYMIDYLATE SYNTHASE MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT KB CELLS; DIHYDROFOLATE-REDUCTASE; CARCINOMA-CELLS; CYTO-TOXICITY; RIBOSOMAL-RNA; HUMAN-BREAST; INHIBITION; COMBINATION; ACID	In vitro transcribed thymidylate synthase (TS) mRNA which is 100% substituted with 5-fluorouracil (FUra) was analyzed for changes in mRNA secondary structure, for alterations in translational efficiency, and for evidence of translational miscoding in vitro. FUra substitution in TS mRNA results in an altered migration pattern in non-denaturing RNA gels and in decreased hyperchromicity in RNA melting temperature studies, consistent with a change in mRNA secondary structure. However, no change in the translational efficiency of FUra-substituted TS mRNA is seen compared to control TS mRNA in either rabbit reticulocyte lysate or wheat germ extract in vitro translation systems. Analysis of the in vitro translation product of FUra-substituted TS mRNA by Western immunoblotting, isoelectric focusing, 5-fluoro-2'-deoxyuridine 5'-monophosphate binding, and TS catalytic activity experiments shows no difference compared to control TS mRNA. We conclude that the in vitro translation products of FUra-substituted and control TS mRNA are identical. Our findings do not support the hypothesis that changes in the mRNA template are responsible for the RNA-directed cytotoxicity of FUra.	US FDA, CTR DRUG EVALUAT & RES, DIV CLIN PHARMACOL, OFF RES RESOURCES, ROCKVILLE, MD 20850 USA	US Food & Drug Administration (FDA)	TAKIMOTO, CH (corresponding author), NATL NAVAL MED CTR, NCI,DIV CANC TREATMENT,MED ONCOL BRANCH,BLDG 8, RM 5101, BETHESDA, MD 20814 USA.							ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720; ARMSTRONG RD, 1986, J BIOL CHEM, V261, P21; CADMAN E, 1979, SCIENCE, V205, P1135, DOI 10.1126/science.472732; CHU E, 1990, CANCER RES, V50, P5834; CHU E, 1991, MOL PHARMACOL, V39, P136; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; DANENBERG PV, 1990, CANCER RES, V50, P1757; DAVISSON VJ, 1989, J BIOL CHEM, V264, P9145; DOLNICK BJ, 1985, J BIOL CHEM, V260, P3006; DOONG SL, 1988, J BIOL CHEM, V263, P4467; GLAZER RI, 1983, MOL PHARMACOL, V23, P540; GLAZER RI, 1981, MOL PHARMACOL, V19, P117; GLEASON MK, 1976, P NATL ACAD SCI USA, V73, P1528, DOI 10.1073/pnas.73.5.1528; GREENHALGH DA, 1990, BRIT J CANCER, V61, P415, DOI 10.1038/bjc.1990.91; GREM JL, 1990, CANC CHEMOTHERAPY PR, P180; GRUNBERG M, 1964, BIOCHIM BIOPHYS ACTA, V87, P593, DOI 10.1016/0926-6550(64)90277-4; KUFE DW, 1981, J BIOL CHEM, V256, P9802; MARTIN DS, 1983, CANCER RES, V43, P2317; NAKADA D, 1964, J MOL BIOL, V8, P105, DOI 10.1016/S0022-2836(64)80153-4; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; ROSEN B, 1969, J MOL BIOL, V44, P363, DOI 10.1016/0022-2836(69)90181-8; SIERAKOWSKA H, 1989, J BIOL CHEM, V264, P19185; SOWERS LC, 1987, J BIOL CHEM, V262, P15436; SPIEGELMAN S, 1980, P NATL ACAD SCI-BIOL, V77, P4966, DOI 10.1073/pnas.77.8.4966; TAKIMOTO CH, 1987, BIOCHEM PHARMACOL, V36, P3243, DOI 10.1016/0006-2952(87)90640-X; TSENG WC, 1978, CANCER RES, V38, P1250; Uchida J, 1992, Gan To Kagaku Ryoho, V19, P677; WILKINSON DS, 1973, J BIOL CHEM, V248, P63; WILL CL, 1987, J BIOL CHEM, V262, P5433; WILL CL, 1989, J BIOL CHEM, V264, P21413	31	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21438	21442						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407987				2022-12-27	WOS:A1993MA28800115
J	ANNWEILER, A; ZWILLING, S; HIPSKIND, RA; WIRTH, T				ANNWEILER, A; ZWILLING, S; HIPSKIND, RA; WIRTH, T			ANALYSIS OF TRANSCRIPTIONAL STIMULATION BY RECOMBINANT OCT PROTEINS IN A CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN PROMOTER; RNA POLYMERASE-II; IMMUNOGLOBULIN GENES; ACTIVATION DOMAINS; SEQUENCE ELEMENTS; GAL4 DERIVATIVES; HELA-CELLS; B-CELLS; BINDING; INVITRO	The transactivation potential of several isoforms of the lymphoid-specific transcription factor Oct2 has been analyzed using in vitro transcription. Oct2 can stimulate transcription in B-cell nuclear extracts and in HeLa nuclear extracts depleted of the ubiquitous factor Oct1 by wheat germ lectin affinity chromatography. Activity is observed from both natural and synthetic promoters containing single or multiple copies of the octamer motif ATGCAAAT. Multimerization of this motif does not result in a synergistic transcriptional stimulation, but rather leads to a linear increase in activity. To analyze the various Oct2 isoforms, they were overexpressed in HeLa cells using recombinant vaccinia virus. Although all the isoforms bind similarly to the octamer sequence, they show clear differences in their ability to transactivate transcription. This ranges from a 2-fold stimulation for Oct2.3 to the almost 20-fold effect of the most potent variant Oct2.5. In general the relative activity of the isoforms in vitro reflects that observed in vivo in cotransfection experiments. Interestingly the ubiquitous factor Oct1 is also an efficient activator of transcription in vitro, but only from promoters with multiple octamer motifs. Sarkosyl inhibition studies suggest that both Oct1 and Oct2 function in vitro by stabilizing preinitiation complexes without affecting the reinitiation rate of RNA polymerase II.	ZENTRUM MOLEK BIOL,NEUENHEIMER FELD 282,W-6900 HEIDELBERG,GERMANY; HANNOVER MED SCH,INST MOLEK BIOL,W-3000 HANNOVER 61,GERMANY	Ruprecht Karls University Heidelberg; Hannover Medical School			Wirth, Thomas/X-7172-2019					ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; Ausubel FM, 1988, MOL REPROD DEV; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CURRIE RA, 1990, NUCLEIC ACIDS RES, V18, P2987, DOI 10.1093/nar/18.10.2987; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; HARLOW E, 1988, ANTIBODIES LABORATOR; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HERMANSON GG, 1989, P NATL ACAD SCI USA, V86, P7341, DOI 10.1073/pnas.86.19.7341; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19572; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; JOHNSON DG, 1990, MOL CELL BIOL, V10, P982, DOI 10.1128/MCB.10.3.982; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; MIZUSHIMASUGANO J, 1986, P NATL ACAD SCI USA, V83, P8511, DOI 10.1073/pnas.83.22.8511; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; POELLINGER L, 1989, MOL CELL BIOL, V9, P747, DOI 10.1128/MCB.9.2.747; ROSNER MH, 1991, CELL, V64, P1103, DOI 10.1016/0092-8674(91)90265-Z; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SEN R, 1987, MOL CELL BIOL, V7, P1989, DOI 10.1128/MCB.7.5.1989; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; YOZA BK, 1990, MOL CELL BIOL, V10, P2145, DOI 10.1128/MCB.10.5.2145; ZELZNIKLE NJ, 1992, J BIOL CHEM, V267, P7677	44	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2525	2534						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428930				2022-12-27	WOS:A1993KK81500043
J	SVITIL, AL; CASHEL, M; ZYSKIND, JW				SVITIL, AL; CASHEL, M; ZYSKIND, JW			GUANOSINE TETRAPHOSPHATE INHIBITS PROTEIN-SYNTHESIS INVIVO - A POSSIBLE PROTECTIVE MECHANISM FOR STARVATION STRESS IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCHARGED TRANSFER RNATRP; RIBOSOMAL-RNA; PPGPP; EXPRESSION; METHIONINE; TRANSPORT; MUTANTS	Guanosine 3',5'-bispyrophosphate (ppGpp) accumulates in bacteria in response to either amino acid or energy source starvation. Here we demonstrate that levels of ppGpp similar to those induced by amino acid starvation inhibit the rate of protein synthesis by 84-91%. The intracellular concentration of ppGpp is manipulated in our studies by increasing the expression of a truncated relA gene encoding a smaller but catalytically active peptide with ppGpp synthetase activity. We find that the intracellular activity of the truncated RelA peptide is insensitive to chloramphenicol, unlike the product of the wild-type relA gene, ppGpp synthetase I. Previously, this same ppGpp expression system was used (Schreiber, G., Metzger, S., Aizenman, E., Roza, S., Cashel, M., and Glaser, G. (1991) J. Biol. Chem. 226, 3760-3767) to demonstrate that increasing the ppGpp concentration inhibits growth and ribosomal RNA transcription, and they found suggestive evidence for ppGpp inhibition of protein synthesis. We further investigated the effect of ppGpp on protein synthesis and find that ppGpp is a potent inhibitor of protein synthesis as well as glycerol accumulation but has no effect on transport of methionine, the amino acid used in measuring protein synthesis rates, or on uptake of alpha-methylglucoside, a non-metabolizable analogue of glucose.	SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; NICHHD, MOLEC GENET LAB, BETHESDA, MD 20892 USA	California State University System; San Diego State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; CASHEL M, 1969, J BIOL CHEM, V244, P3133; CASHEL M, 1987, ESCHERICHIA COLI SAL, V2, P1410; DIX DB, 1986, P NATL ACAD SCI USA, V83, P2027, DOI 10.1073/pnas.83.7.2027; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GENTRY D, 1991, J BACTERIOL, V173, P3901, DOI 10.1128/JB.173.12.3901-3903.1991; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HAMEL E, 1974, ARCH BIOCHEM BIOPHYS, V162, P293, DOI 10.1016/0003-9861(74)90128-3; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; HAYASHI SI, 1965, J MOL BIOL, V14, P515, DOI 10.1016/S0022-2836(65)80200-5; KADNER RJ, 1975, J BACTERIOL, V123, P985, DOI 10.1128/JB.123.3.985-991.1975; KADNER RJ, 1974, J BACTERIOL, V117, P232, DOI 10.1128/JB.117.1.232-241.1974; LAFFLER T, 1974, CELL, V3, P47, DOI 10.1016/0092-8674(74)90036-1; LARK KG, 1963, BIOCHIM BIOPHYS ACTA, V76, P9; LEGAULT L, 1972, FEBS LETT, V27, P71, DOI 10.1016/0014-5793(72)80412-5; LINDAHL L, 1982, ADV GENET, V21, P53, DOI 10.1016/S0065-2660(08)60297-7; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; PEDERSEN FS, 1973, NATURE-NEW BIOL, V243, P13; ROJAS AM, 1984, MOL GEN GENET, V197, P36, DOI 10.1007/BF00327920; ROJIANI MV, 1990, P NATL ACAD SCI USA, V87, P1511, DOI 10.1073/pnas.87.4.1511; ROJIANI MV, 1989, J BACTERIOL, V171, P6493, DOI 10.1128/jb.171.12.6493-6502.1989; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; SOKAWA Y, 1969, BIOCHEM BIOPH RES CO, V34, P99, DOI 10.1016/0006-291X(69)90534-8; TEDIN K, 1992, J BIOL CHEM, V267, P2337; XIAO H, 1991, J BIOL CHEM, V266, P5980; YOSHIDA M, 1972, FEBS LETT, V23, P163, DOI 10.1016/0014-5793(72)80331-4	29	153	153	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2307	2311						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428905				2022-12-27	WOS:A1993KK81500011
J	WAHLE, E; LUSTIG, A; JENO, P; MAURER, P				WAHLE, E; LUSTIG, A; JENO, P; MAURER, P			MAMMALIAN POLY(A)-BINDING PROTEIN-II - PHYSICAL-PROPERTIES AND BINDING TO POLYNUCLEOTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA PRECURSORS; POLY(A) POLYMERASE; CYTOPLASMIC POLY(A)-RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN-PARTICLES; TRANSLATION INITIATION; REPEATING STRUCTURE; POLYADENYLATION; CLEAVAGE; EXPRESSION; PURIFICATION	The 49-kDa poly(A)-binding protein II (PAB II) was purified to homogeneity from calf thymus. The 70-kDa poly(A)-binding protein I (PAB I) was obtained in different fractions of the same preparation. Whereas PAB II stimulated poly(A) polymerase, PAB I was an inhibitor. In analytical ultracentrifugation, the predominant form of PAB II was a monomer of 50.3 kDa. A sedimentation constant of only 2.2 S indicated a distinctly non-spherical shape. Binding was specific for single-stranded purine polyribonucleotides. The dependence of the dissociation constant on the length of oligoriboadenylate indicated a binding site size of 12 nucleotides. A single site was bound with a K(D) of 2 x 10(-9) M, as determined by nitrocellulose filter binding assays. From fluorescence quenching and gel retardation experiments, the packing ratio on poly(A) was estimated as 23 nucleotides/protein monomer.	UNIV BASEL,BIOCTR,DEPT CELL BIOL,CH-4056 BASEL,SWITZERLAND; UNIV BASEL,BIOCTR,DEPT BIOCHEM,CH-4056 BASEL,SWITZERLAND	University of Basel; University of Basel	WAHLE, E (corresponding author), UNIV BASEL,BIOCTR,DEPT CELL BIOL,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND.			Wahle, Elmar/0000-0003-2504-0677				ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; BAER BW, 1980, P NATL ACAD SCI-BIOL, V77, P1890, DOI 10.1073/pnas.77.4.1890; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BLOBEL G, 1973, P NATL ACAD SCI USA, V70, P924, DOI 10.1073/pnas.70.3.924; Bock R. M., 1967, METHODS ENZYMOLOGY A, V12, P218; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P549; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KNECHT R, 1986, ANAL CHEM, V58, P2375, DOI 10.1021/ac00125a006; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFRERE V, 1990, GENE, V96, P219, DOI 10.1016/0378-1119(90)90256-Q; LINGNER J, 1991, J BIOL CHEM, V266, P8741; PEATTIE DA, 1983, METHODS DNA RNA SEQU, P261; PINGOUD A, 1975, EUR J BIOCHEM, V56, P617, DOI 10.1111/j.1432-1033.1975.tb02269.x; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Sambrook J, 1989, MOL CLONING LABORATO; Schachman H.K., 1959, ULTRACENTRIFUGATION; SETYONO B, 1981, CELL, V24, P775, DOI 10.1016/0092-8674(81)90103-3; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; Stone K. L., 1988, MACROMOLECULAR SEQUE, P7; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1992, BIOESSAYS, V14, P113, DOI 10.1002/bies.950140208; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WERNER M, 1991, BIOCHEMISTRY-US, V30, P5832, DOI 10.1021/bi00238a004; ZELUS BD, 1989, MOL CELL BIOL, V9, P2756, DOI 10.1128/MCB.9.6.2756	45	82	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2937	2945						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428968				2022-12-27	WOS:A1993KK81500100
J	WAND, GS; DIEHL, AM; LEVINE, MA; WOLFGANG, D; SAMY, S				WAND, GS; DIEHL, AM; LEVINE, MA; WOLFGANG, D; SAMY, S			CHRONIC ETHANOL TREATMENT INCREASES EXPRESSION OF INHIBITORY G-PROTEINS AND REDUCES ADENYLYLCYCLASE ACTIVITY IN THE CENTRAL-NERVOUS-SYSTEM OF 2 LINES OF ETHANOL-SENSITIVE MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE ACTIVITY; INDUCED HETEROLOGOUS DESENSITIZATION; MOUSE CEREBRAL-CORTEX; REGULATES G-PROTEINS; BINDING-PROTEINS; ENZYME-ACTIVITY; MESSENGER-RNA; NEURAL CELLS; ADENOSINE	The possibility that a 7-day period of ethanol exposure could regulate expression of specific GTP-binding regulatory proteins was investigated in two distinct brain regions from two different lines of ethanol-sensitive mice. Following ethanol treatment, plasma membranes were prepared from cerebellum and pons of short and long sleep mice. Studies of membranes were performed to assess hormone-sensitive adenylylcyclase activity and to quantify expression of G-protein subunits. Immunoblot analysis showed that levels of G(i)alpha(1) and G(i)alpha(2) were markedly increased in cerebellar and pons membranes from ethanol-exposed mice compared to controls. Treatment of short sleep mice with ethanol enhanced ADP-ribosylation of both a 41- and a 39-40 kDa protein catalyzed by pertussis toxin. Ethanol did not alter expression of G(s)alpha as assessed by immunoblot analysis, cholera toxin-dependent ADP-ribosylation, or by the ability of detergent extracted G(s)alpha to reconstitute a functional adenylylcyclase in membranes from S49 cyc- murine lymphoma cells, a cell line which genetically lacks G(s)alpha. Moreover, ethanol exposure did not influence levels of G(o)alpha or Gbeta35-36 in either cerebellar or pons membranes. Cerebellar and pons membranes from ethanol-exposed short sleep mice demonstrated significantly less adenylylcyclase activity following stimulation with GTP, GTPgammaS, AlF, forskolin, and stimulatory ligands for three distinct receptors which couple to G(s)alpha. Pretreatment of membranes with pertussis toxin reversed the ethanol-induced inhibition in adenylylcyclase activity. These observations were not limited to one line of mice but were also documented in a second line of ethanol-sensitive mice (e.g. long sleep). We conclude that ethanol exposure enhances expression of G(i)alpha(1) and G(i)alpha(2) in ethanol-sensitive mice, and is associated with decreased adenylylcyclase activity. Enhanced expression of G(i)alpha(1) and G(i)alpha(2) may contribute to impaired signal transduction in the central nervous system, and reduce the efficacy of neurotransmitters which signal through the adenylylcyclase system.	JOHNS HOPKINS UNIV,SCH MED,DIV GASTROENTEROL,BALTIMORE,MD 21205	Johns Hopkins University	WAND, GS (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DIV ENDOCRINOL,720 RUTLAND AVE,ROSS BLDG,ROOM 1032,BALTIMORE,MD 21205, USA.			Levine, Michael/0000-0003-0036-7809	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009000, R29AA007384] Funding Source: NIH RePORTER; NIAAA NIH HHS [R29AA07384, R29AA-01260, R01-AA09000] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BODE DC, 1988, J PHARMACOL EXP THER, V246, P1040; CHARNESS ME, 1986, J BIOL CHEM, V261, P3164; CHARNESS ME, 1988, BIOCHEM BIOPH RES CO, V155, P138, DOI 10.1016/S0006-291X(88)81060-X; CHUNG CT, 1989, J PHARMACOL EXP THER, V249, P16; DIAMOND I, 1987, P NATL ACAD SCI USA, V84, P1413, DOI 10.1073/pnas.84.5.1413; DOWNS RW, 1985, J CLIN ENDOCR METAB, V61, P351, DOI 10.1210/jcem-61-2-351; FOSTER KA, 1990, AM J PHYSIOL, V259, pH432, DOI 10.1152/ajpheart.1990.259.2.H432; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; GOWLER D, 1987, NATURE, V327, P229; HOFFMAN PL, 1990, FASEB J, V4, P2612, DOI 10.1096/fasebj.4.9.2161371; HYNIE S, 1980, ACTA PHARMACOL TOX, V47, P58; JAFFEY K, 1988, NEUROSCI LETT, V84, P317; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE MA, 1983, J CLIN INVEST, V72, P316, DOI 10.1172/JCI110971; LEVINE MA, 1990, J BIOL CHEM, V265, P3553; LI PP, 1991, EUR J PHARM-MOLEC PH, V206, P165, DOI 10.1016/0922-4106(91)90027-F; LUCCHI L, 1983, NEUROSCI LETT, V40, P187, DOI 10.1016/0304-3940(83)90300-2; MILLER BA, 1991, BLOOD, V77, P486; MOCHLYROSEN D, 1988, NATURE, V33, P848; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1988, P NATL ACAD SCI USA, V85, P6973, DOI 10.1073/pnas.85.18.6973; RABE CS, 1990, BIOCHEM PHARMACOL, V40, P565, DOI 10.1016/0006-2952(90)90557-2; RABIN RA, 1990, J PHARMACOL EXP THER, V252, P1021; RABIN RA, 1983, J PHARMACOL EXP THER, V227, P551; ROS M, 1988, J BIOL CHEM, V263, P4362; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SAITO N, 1989, P NATL ACAD SCI USA, V86, P3906, DOI 10.1073/pnas.86.10.3906; SAITO T, 1987, J NEUROCHEM, V48, P1817, DOI 10.1111/j.1471-4159.1987.tb05741.x; SAITO T, 1985, J NEUROCHEM, V44, P1037, DOI 10.1111/j.1471-4159.1985.tb08722.x; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STENSTROM S, 1982, J PHARMACOL EXP THER, V221, P334; TABAKOFF B, 1988, NEW ENGL J MED, V318, P134, DOI 10.1056/NEJM198801213180302; TABAKOFF B, 1979, J PHARMACOL EXP THER, V208, P216; TABAKOFF B, 1988, T AM SOC NEUROCHEM, V19, P144; VALVERIUS P, 1987, MOL PHARMACOL, V32, P217; VALVERIUS P, 1989, J NEUROCHEM, V52, P492, DOI 10.1111/j.1471-4159.1989.tb09147.x; WALTMAN C, IN PRESS ALCOHOL CLI; WAND GS, 1989, ENDOCRINOLOGY, V124, P518, DOI 10.1210/endo-124-1-518; WAND GS, 1991, ALCOHOL CLIN EXP RES, V15, P705, DOI 10.1111/j.1530-0277.1991.tb00583.x; WHELAND J P, 1991, Alcoholism Clinical and Experimental Research, V15, P333	42	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2595	2601						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428935				2022-12-27	WOS:A1993KK81500052
J	PAPINI, E; RAPPUOLI, R; MURGIA, M; MONTECUCCO, C				PAPINI, E; RAPPUOLI, R; MURGIA, M; MONTECUCCO, C			CELL PENETRATION OF DIPHTHERIA-TOXIN - REDUCTION OF THE INTERCHAIN DISULFIDE BRIDGE IS THE RATE-LIMITING STEP OF TRANSLOCATION IN THE CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERO CELLS; MEMBRANE TRANSLOCATION; LIPID INTERACTION; FRAGMENT-B; LOW PH; RECEPTOR; PROTEIN; ENTRY; PURIFICATION; TRANSPORT	The pathway of cell penetration of diphtheria toxin (DT) was studied in Vero cells by following the kinetics of uptake, reduction, degradation, and sub-cellular distribution of I-125-DT in the absence or presence of bafilomycin A1 (baf-A1), a powerful inhibitor of the endosomal H+-ATPase. After a lag phase of 4 min, DT, bound to Vero cells, reached an acidic intracellular compartment, where about one-third of it underwent a transition to a state competent for subsequent reduction and membrane translocation. After further 4 min, this DT fraction was reduced in a baf-A1-insensitive reaction and DT-A, the intracellularly active protomer of DT, was immediately released in the cytosol. The present data indicate that cell-mediated reduction of the toxin is the rate-determining step of the DT cell intoxication process. Subcellular fractionation showed that DT underwent the low pH-driven conformational change in an early endosome, distinct from the subsequent endosomal compartment where reduction took place. DT-B remained endosome-bound and was proteolyzed at low pH as well as the portion of DT which was not reduced after the exposure to low pH in early endosomes.	IST RIC IMMUNOBIOL, I-53100 SIENA, ITALY; UNIV PADUA, DIPARTIMENTO SCI BIOMED, I-35121 PADUA, ITALY	University of Padua	PAPINI, E (corresponding author), UNIV PADUA, CNR, CTR BIOMEMBRANE, VIA TRIESTE 75, I-35121 PADUA, ITALY.		Papini, Emanuele/AAE-6961-2022	Papini, Emanuele/0000-0001-6033-4473				BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BEAUMELLE B, 1992, J BIOL CHEM, V267, P11525; BISSON R, 1987, TRENDS BIOCHEM SCI, V12, P181, DOI 10.1016/0968-0004(87)90087-9; BLEWITT MG, 1985, BIOCHEMISTRY-US, V24, P5458, DOI 10.1021/bi00341a027; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLI AW, 1988, J BIOL CHEM, V263, P16283; CABIAUX V, 1989, J BIOL CHEM, V264, P4928; CARROLL SF, 1988, METHOD ENZYMOL, V165, P68; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1990, ADP RIBOSYLATING TOX, P3, DOI DOI 10.1126/SCIENCE.250.4982.841-A; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; DEMEL R, 1991, EUR J BIOCHEM, V197, P481, DOI 10.1111/j.1432-1033.1991.tb15935.x; DRAPER RK, 1980, J CELL BIOL, V87, P849, DOI 10.1083/jcb.87.3.849; FALNES PO, 1992, J BIOL CHEM, V267, P12284; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HU VW, 1984, J BIOL CHEM, V259, P2226; HUDSON TH, 1988, J BIOL CHEM, V263, P4773; HUDSON TH, 1985, J BIOL CHEM, V260, P2675; HUDSON TH, 1987, J BIOL CHEM, V262, P16484; IMATA T, 1990, J BIOL CHEM, V265, P21940; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LONDON E, 1992, BIOCHIM BIOPHYS ACTA, V1113, P25, DOI 10.1016/0304-4157(92)90033-7; MARKWELL MA, 1978, METHOD ENZYMOL, V72, P297; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; MEKADA E, 1991, J BIOL CHEM, V266, P20457; MIDDLEBROOK JL, 1978, J BIOL CHEM, V253, P7325; MONTECUCCO C, 1985, BIOCHEM J, V231, P123, DOI 10.1042/bj2310123; MONTECUCCO C, 1992, FEMS MICROBIOL IMMUN, V105, P101; MORRIS RE, 1985, INFECT IMMUN, V50, P721, DOI 10.1128/IAI.50.3.721-727.1985; MOSKAUG JO, 1987, J BIOL CHEM, V262, P10339; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NEVILLE DM, 1986, ANNU REV BIOCHEM, V55, P195, DOI 10.1146/annurev.biochem.55.1.195; OLSNES S, 1985, BIOCHIM BIOPHYS ACTA, V846, P334, DOI 10.1016/0167-4889(85)90003-5; PAPINI E, 1988, EMBO J, V7, P3353, DOI 10.1002/j.1460-2075.1988.tb03207.x; PAPINI E, 1987, EUR J BIOCHEM, V169, P637, DOI 10.1111/j.1432-1033.1987.tb13655.x; PAPINI E, 1987, FEBS LETT, V215, P73, DOI 10.1016/0014-5793(87)80116-3; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; RAPPUOLI R, 1983, J CHROMATOGR, V268, P543, DOI 10.1016/S0021-9673(01)95457-3; RONNBERG BJ, 1989, TOXICON, V27, P1377, DOI 10.1016/0041-0101(89)90069-X; RYSER HJP, 1991, J BIOL CHEM, V266, P18439; SANDVIG K, 1986, J BIOL CHEM, V261, P1570; SANDVIG K, 1988, J BIOL CHEM, V263, P12352; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; SANDVIG K, 1991, SOURCEBOOK BACTERIAL, P57; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; YAMAMOTO Y, 1978, IEEE J QUANTUM ELECT, V14, P245, DOI 10.1109/JQE.1978.1069769; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; [No title captured]	52	102	104	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1567	1574						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420931				2022-12-27	WOS:A1993KH62000013
J	SVOBODA, DL; TAYLOR, JS; HEARST, JE; SANCAR, A				SVOBODA, DL; TAYLOR, JS; HEARST, JE; SANCAR, A			DNA-REPAIR BY EUKARYOTIC NUCLEOTIDE EXCISION NUCLEASE - REMOVAL OF THYMINE DIMER AND PSORALEN MONOADDUCT BY HELA CELL-FREE-EXTRACT AND OF THYMINE DIMER BY XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-PHASE SYNTHESIS; PYRIMIDINE DIMER; BUILDING BLOCK; LESIONS; OLIGONUCLEOTIDES; EXONUCLEASE; STRAND; ENZYME; SITE	Using a human cell-free extract, we have recently shown that thymine dimers are removed from DNA in oligonucleotides 27-29 nucleotides in length (Huang, J. C., Svoboda, D. L., Reardon, J. T., and Sancar, A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3664-3668). In this study we find that the excision reaction is dependent on ATP, the excised fragments range in length from 27-32 nucleotides, and have 5'-P and 3'-OH termini. We also found that a thymine-psoralen furan side monoadduct is excised from the DNA with a similar incision pattern, indicating that in humans bulky adducts are removed from DNA by the same enzyme system which hydrolyzes mainly the 22-24th and the 5th phosphodiester bonds 5' and 3', respectively, to the lesion. This incision pattern might be common to eukaryotic excision nucleases as thymine dimers were removed from DNA by the same dual incision pattern by Xenopus laevis oocytes.	WASHINGTON UNIV, DEPT CHEM, ST LOUIS, MO 63130 USA; LAWRENCE BERKELEY LAB, DIV CHEM BIODYNAM, BERKELEY, CA 94720 USA	Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	SVOBODA, DL (corresponding author), UNIV N CAROLINA, SCH MED, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA.			Taylor, John-Stephen/0000-0002-8615-7257	NIGMS NIH HHS [GM32833] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; CHENG S, 1988, J BIOL CHEM, V263, P15110; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; CLEAVER JE, 1991, PHOTOCHEM PHOTOBIOL, V54, P393, DOI 10.1111/j.1751-1097.1991.tb02033.x; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; EDENBERG H, 1972, BIOCHIM BIOPHYS ACTA, V272, P361, DOI 10.1016/0005-2787(72)90389-9; FRIEDBERG EC, 1985, DNA REPAIR, P213; FUCHS RPP, 1984, J MOL BIOL, V177, P173, DOI 10.1016/0022-2836(84)90063-9; HAYS JB, 1990, MOL CELL BIOL, V10, P3505, DOI 10.1128/MCB.10.7.3505; HOEIJMAKERS JHJ, 1991, J CELL SCI, V100, P687; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; KORNBERG A, 1991, DNA REPLICATION, P187; LEGERSKI RJ, 1987, MOL CELL BIOL, V7, P4317, DOI 10.1128/MCB.7.12.4317; LIN JJ, 1992, MOL MICROBIOL, V6, P2219, DOI 10.1111/j.1365-2958.1992.tb01398.x; MATSUMOTO Y, 1991, MOL CELL BIOL, V11, P4441, DOI 10.1128/MCB.11.9.4441; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; REARDON JT, 1991, NUCLEIC ACIDS RES, V19, P4623, DOI 10.1093/nar/19.17.4623; ROYERPOKORA B, 1981, NUCLEIC ACIDS RES, V9, P4595, DOI 10.1093/nar/9.18.4595; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SAXENA JK, 1990, NUCLEIC ACIDS RES, V18, P7425, DOI 10.1093/nar/18.24.7425; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; SIBGHATULLAH, 1989, NUCLEIC ACIDS RES, V17, P4471, DOI 10.1093/nar/17.12.4471; TAYLOR JS, 1987, J AM CHEM SOC, V109, P6735, DOI 10.1021/ja00256a030; TAYLOR JS, 1988, NUCLEIC ACIDS RES, V16, P5123, DOI 10.1093/nar/16.11.5123; VARLET I, 1990, P NATL ACAD SCI USA, V87, P7883, DOI 10.1073/pnas.87.20.7883; WOOD RD, 1989, BIOCHEMISTRY-US, V28, P8287, DOI 10.1021/bi00447a005; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6	30	122	124	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1931	1936						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420966				2022-12-27	WOS:A1993KH62000066
J	GUSTAFSSON, C; BJORK, GR				GUSTAFSSON, C; BJORK, GR			THE TRANSFER RNA-(M(5)U54)-METHYLTRANSFERASE OF ESCHERICHIA-COLI IS PRESENT IN 2 FORMS INVIVO, ONE OF WHICH IS PRESENT AS BOUND TO TRANSFER-RNA AND TO A 3'-END FRAGMENT OF 16-S RIBOSOMAL-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; SALMONELLA-TYPHIMURIUM; CATALYTIC MECHANISM; (M5U54)-METHYLTRANSFERASE; SEQUENCE; IDENTIFICATION; EXPRESSION; BINDING; GENES; ACID	The enzyme tRNA-(m5U54)-methyltransferase (EC 2.1.1.35) of Escherichia coli catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to uridine in position 54 of the TPSI-loop of all E. coli tRNA species, forming 5-methyluridine (m5U). In vivo, this enzyme is present both as a native polypeptide of 42 kDa and as a TrmA.RNA complex. The TrmA.RNA complex is not dissociated during strong denaturing conditions such as boiling in 8 M urea or 6 m guanidine HCl, consisting with that the RNA is covalently bound to the protein. After sequencing and Southern blot analyses, the RNA was identified to be a subset of undermodified tRNA species as well as the 3' terminus of 16 S rRNA. However, the complex is not associated with the ribosome and the covalently bound RNA does not affect the tRNA methylating activity of the enzyme.			GUSTAFSSON, C (corresponding author), UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN.		Björk, Glenn/AAE-8219-2022	Gustafsson, Claes/0000-0003-2181-3126				BELLISARIO RL, 1976, P NATL ACAD SCI USA, V73, P1848, DOI 10.1073/pnas.73.6.1848; BERESTEN S, 1992, NUCLEIC ACIDS RES, V20, P1523, DOI 10.1093/nar/20.7.1523; BJORK GR, 1975, J BACTERIOL, V124, P99; BJORK GR, 1975, J BACTERIOL, V124, P92; BJORK GR, 1973, VIROLOGY, V52, P507, DOI 10.1016/0042-6822(73)90346-2; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; BUCK M, 1983, ANAL BIOCHEM, V129, P1, DOI 10.1016/0003-2697(83)90044-1; DAVANLOO P, 1979, NUCLEIC ACIDS RES, V6, P1571, DOI 10.1093/nar/6.4.1571; DURWALD H, 1968, J MOL BIOL, V34, P331, DOI 10.1016/0022-2836(68)90257-X; GOURSE RL, 1985, P NATL ACAD SCI USA, V82, P1069, DOI 10.1073/pnas.82.4.1069; GREENBERG R, 1980, J BIOL CHEM, V255, P8296; GU X, 1992, IN PRESS BIOCHEMISTR; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; GU XR, 1990, DNA CELL BIOL, V9, P273, DOI 10.1089/dna.1990.9.273; GUSTAFSSON C, 1991, J BACTERIOL, V173, P1757, DOI 10.1128/jb.173.5.1757-1764.1991; KEALEY JT, 1991, BIOCHEMISTRY-US, V30, P9724, DOI 10.1021/bi00104a022; KERSTEN H, 1981, EUR J BIOCHEM, V114, P451, DOI 10.1111/j.1432-1033.1981.tb05166.x; KUNITANI MG, 1980, BIOCHEMISTRY-US, V19, P1271, DOI 10.1021/bi00548a001; LEHNER AF, 1984, J BACTERIOL, V160, P682, DOI 10.1128/JB.160.2.682-686.1984; MARCU KB, 1976, NATURE, V261, P159, DOI 10.1038/261159a0; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; Nishimura S., 1979, TRANSFER RNA STRUCTU, P551; NY T, 1980, J BACTERIOL, V141, P67, DOI 10.1128/JB.141.1.67-73.1980; NY T, 1977, J BACTERIOL, V130, P635, DOI 10.1128/JB.130.2.635-641.1977; NY T, 1980, J BACTERIOL, V142, P371, DOI 10.1128/JB.142.2.371-379.1980; NY T, 1988, EUR J BIOCHEM, V177, P467, DOI 10.1111/j.1432-1033.1988.tb14396.x; PERSSON BC, 1992, P NATL ACAD SCI USA, V89, P3995, DOI 10.1073/pnas.89.9.3995; ROE BA, 1976, P NATL ACAD SCI USA, V74, P3696; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; SPRINGER RA, 1991, CURRENT PROTOCOLS MO; SPRINZL M, 1991, NUCLEIC ACIDS RES, V19, P2127, DOI 10.1093/nar/19.suppl.2127; TAKATA R, 1978, MOL GEN GENET, V161, P15, DOI 10.1007/BF00266610; WIKSTROM PM, 1988, J MOL BIOL, V203, P141, DOI 10.1016/0022-2836(88)90098-8; WU JC, 1987, J BIOL CHEM, V262, P4778; YEH YC, 1967, J BIOL CHEM, V242, P1307	36	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1326	1331						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419334				2022-12-27	WOS:A1993KG07700084
J	POYNER, DR; COOKE, F; HANLEY, MR; REYNOLDS, DJM; HAWKINS, PT				POYNER, DR; COOKE, F; HANLEY, MR; REYNOLDS, DJM; HAWKINS, PT			CHARACTERIZATION OF METAL ION-INDUCED [H-3] INOSITOL HEXAKISPHOSPHATE BINDING TO RAT CEREBELLAR MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTIC ACID; MYOINOSITOL HEXAKISPHOSPHATE; INOSITOL TETRAKISPHOSPHATE; BRAIN; CELLS; PENTAKISPHOSPHATE; PHOSPHATES; INOSITOLHEXAKISPHOSPHATE; PHOSPHORYLATION; CA-2+	The binding of [H-3]inositol hexakisphosphate ([H-3]InsP6) to rat cerebellar membranes has been characterized with the objective of establishing the role, if any, of a membrane protein receptor. In the presence of EDTA, we have previously identified an InsP6-binding site with a capacity of approximately 20 pmol/mg protein (Hawkins, P. T., Reynolds, D. J. M., Poyner, D. R., and Hanley, M. R. (1990) Biochem. Biophys. Res. Commun. 167, 819-827). However, in the presence of 1 mm Mg2+, the capacity of [H-3]InsP6 binding to membranes was increased approximately 9-fold. This enhancing effect of Mg2+ was reversed by addition of 10 muM of several cation chelators, suggesting that the increased binding required trace quantities of other metal cations. This is supported by experiments where it was possible to saturate binding by addition of excess membranes, despite not significantly depleting radioligand, pointing to removal of some other factor. Removal of endogenous cations from the binding assay by pretreatment with chelex resin also prevents the Mg2+-induced potentiation. Consideration of the specificity of the chelators able to abolish this potentiation suggested involvement of Fe3+ or Al3+. Both these ions (but not several others) were able to increase [H-3]InsP6 binding to chelex-pretreated membranes at concentrations of 1 muM. It is possible to demonstrate synergy between Fe3+ and Mg2+ under these conditions. We propose that [H-3] InsP6 may interact with membranes through non-protein recognition, possibly via phospholipids, in a manner dependent upon trace metals. The implications of this for InsP6 biology are considered.	INST ANIM PHYSIOL & GENET RES,CAMBRIDGE RES STN,CAMBRIDGE CB2 4AT,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE INFIRM,DEPT CLIN PHARMACOL,OXFORD OX2 6HE,ENGLAND; MRC,CAMBRIDGE CB2 2QH,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Oxford				Hawkins, Phillip/0000-0002-6979-0464; Poyner, David R/0000-0003-1590-112X				ACEVES J, 1985, BRIT J PHARMACOL, V84, P417, DOI 10.1111/j.1476-5381.1985.tb12925.x; BARRACO RA, 1989, EUR J PHARMACOL, V173, P75, DOI 10.1016/0014-2999(89)90010-1; CHADWICK CC, 1992, J BIOL CHEM, V267, P3473; Cosgrove D., 1980, INOSITOL PHOSPHATES; COSGROVE DJ, 1969, ANN NY ACAD SCI, V165, P677; CRICHTON RR, 1979, CIBA F S, V65, P57; EGGLETON P, 1991, BIOCHIM BIOPHYS ACTA, V1094, P309, DOI 10.1016/0167-4889(91)90091-B; FRENCH PJ, 1988, BIOCHEM SOC T, V16, P985, DOI 10.1042/bst0160985; GRAF E, 1984, J BIOL CHEM, V259, P3620; GRAF E, 1987, J BIOL CHEM, V262, P11647; GROHLIC D, 1979, INT J BIOCHEM, V10, P803; HANLEY MR, 1988, PHILOS T R SOC B, V320, P381, DOI 10.1098/rstb.1988.0083; HAWKINS PT, 1990, BIOCHEM BIOPH RES CO, V167, P819, DOI 10.1016/0006-291X(90)92099-L; HESLOP JP, 1985, J EXP BIOL, V119, P395; HUGHES PJ, 1990, J BIOL CHEM, V265, P9869; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; Jacobs A., 1977, CIBA F S, V51, P91; MADDAIAH VT, 1964, P SOC EXP BIOL MED, V115, P391, DOI 10.3181/00379727-115-28922; Martell A. E., 1982, CRITICAL STABILITY C, V5, P340; MITCHELL R, 1991, BIOCHEM SOC T, V19, pS116, DOI 10.1042/bst019116s; NICOLETTI F, 1990, MOL PHARMACOL, V37, P689; NICOLETTI F, 1989, J NEUROCHEM, V53, P1026, DOI 10.1111/j.1471-4159.1989.tb07390.x; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PITTET D, 1989, J BIOL CHEM, V264, P18489; REGUNATHAN S, 1992, BIOCHEM PHARMACOL, V43, P1331, DOI 10.1016/0006-2952(92)90510-P; SMITH SE, 1990, EUR J PHARMACOL, V191, P337, DOI 10.1016/0014-2999(90)94166-U; STEPHENS LR, 1990, NATURE, V346, P580, DOI 10.1038/346580a0; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; THEIBERT AB, 1991, P NATL ACAD SCI USA, V88, P3165, DOI 10.1073/pnas.88.8.3165; TUFANO TP, 1981, J AM CHEM SOC, V103, P6617, DOI 10.1021/ja00412a015; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; VOHRA P, 1965, J POULTRY SCI, V43, P1164; WILLIAMS SG, 1970, PLANT PHYSIOL, V45, P376, DOI 10.1104/pp.45.4.376; WISE A, 1982, TOXICOL LETT, V11, P49, DOI 10.1016/0378-4274(82)90104-7; WORLEY PF, 1989, J NEUROSCI, V9, P339; 1989, BIOCHEM J, V258, P1	38	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1032	1038						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419311				2022-12-27	WOS:A1993KG07700043
J	SHIVANNA, BD; MEJILLANO, MR; WILLIAMS, TD; HIMES, RH				SHIVANNA, BD; MEJILLANO, MR; WILLIAMS, TD; HIMES, RH			EXCHANGEABLE GTP BINDING-SITE OF BETA-TUBULIN - IDENTIFICATION OF CYSTEINE-12 AS THE MAJOR SITE OF CROSS-LINKING BY DIRECT PHOTOAFFINITY-LABELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE; PEPTIDE; ALPHA; GENE; LOCALIZATION; ANTIBODIES; MECHANISM; DOMAIN; YEAST	After direct photoaffinity cross-linking of [H-3]GTP to the beta-subunit of tubulin, followed by tryptic digestion and alkaline phosphatase treatment, we employed cis-diol-specific boronate gel chromatography and reversed-phase high-pressure liquid chromatography to purify a peptide containing most of the covalently bound radioactivity. The sequence of this peptide corresponded to that of residues 3-19 of beta-tubulin. Residue 10 of the peptide, which is Cys-12 in beta-tubulin, could not be identified. The fast atom bombardment mass spectrum of this peptide showed the presence of a predominant species with a molecular mass of 2022 kDa (2021 kDa for the C-12 variant), which is 255 Da greater than the molecular mass of the peptide. Fast atom bombardment collision-activated decomposition mass spectrometry analysis produced fragments which are consistent with the beta(3-19) peptide but having a unit of mass of 358 at position 12. Thermolysin digestion of the tryptic peptide restricted the cross-linking site to the 9-amino acid sequence, I(L)QAGQXGNQ. The molecular mass of this peptide was 1174 kDa, which is equal to the mass of the beta(7-15) peptide containing an extra group of mass 255. To explain the molecular masses of the two labeled peptides, which are 26 atomic mass units less than expected, a mechanism of photolabeling is proposed that involves opening of the guanine ring and loss of the C-6 carbonyl function as CO2.	UNIV KANSAS, DEPT BIOCHEM, LAWRENCE, KS 66045 USA; UNIV KANSAS, MASS SPECTROMETRY LAB, LAWRENCE, KS 66045 USA	University of Kansas; University of Kansas					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036953] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36953] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGAIER J, 1988, BIOCHIM BIOPHYS ACTA, V954, P235, DOI 10.1016/0167-4838(88)90078-7; ALVAREZGONZALEZ R, 1983, ANAL BIOCHEM, V135, P69, DOI 10.1016/0003-2697(83)90732-7; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BOGLE GS, 1962, PHOTOCHEM PHOTOBIOL, V1, P277, DOI 10.1111/j.1751-1097.1962.tb08103.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURNS RG, 1991, CELL MOTIL CYTOSKEL, V20, P181, DOI 10.1002/cm.970200302; CARLIER MF, 1989, INT REV CYTOL, V115, P139; Chavan AJ, 1990, BIOCONJUGATE CHEM, V1, P337, DOI 10.1021/bc00005a007; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; FARR GW, 1992, J MOL BIOL, V227, P307, DOI 10.1016/0022-2836(92)90700-T; GEAHLEN RL, 1979, J BIOL CHEM, V254, P1982; GEAHLEN RL, 1977, P NATL ACAD SCI USA, V74, P4375, DOI 10.1073/pnas.74.10.4375; HESSE J, 1985, FEBS LETT, V179, P91, DOI 10.1016/0014-5793(85)80198-8; HESSE J, 1987, J BIOL CHEM, V262, P15472; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; HUYSER ES, 1970, FREE RADICAL CHAIN R, P77; JELLINEK T, 1970, PHOTOCHEM PHOTOBIOL, V11, P349, DOI 10.1111/j.1751-1097.1970.tb06007.x; KIM H, 1987, FASEB J, V46, P2229; KIMMEL BE, 1985, GENE, V35, P237, DOI 10.1016/0378-1119(85)90002-2; KIRCHNER K, 1985, EMBO J, V4, P2397, DOI 10.1002/j.1460-2075.1985.tb03945.x; LINSE K, 1988, J BIOL CHEM, V263, P15205; LITTLE M, 1987, BIOCHIM BIOPHYS ACTA, V912, P28, DOI 10.1016/0167-4838(87)90243-3; LITTLE M, 1981, BIOSYSTEMS, V14, P239, DOI 10.1016/0303-2647(81)90031-9; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; NATH JP, 1985, BIOCHEMISTRY-US, V24, P1555, DOI 10.1021/bi00327a040; NATH JP, 1986, BIOCHEM BIOPH RES CO, V135, P1135, DOI 10.1016/0006-291X(86)91046-6; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; PONSTINGL H, 1990, LABORATORY METHODOLO, P151; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; STEINMAUS H, 1971, J ORG CHEM, V36, P3594; STERNLICHT H, 1987, FEBS LETT, V214, P226, DOI 10.1016/0014-5793(87)80061-3; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001	36	69	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					127	132						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416920				2022-12-27	WOS:A1993KE60300020
J	YESLAND, KD; NELSON, AW; FEATHERS, DMS; JOHNSON, JD				YESLAND, KD; NELSON, AW; FEATHERS, DMS; JOHNSON, JD			IDENTITY OF SACCHAROMYCES-CEREVISIAE TRANSFER RNA(TRP) IS NOT CHANGED BY AN ANTICODON MUTATION THAT CREATES AN AMBER SUPPRESSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; TYROSINE TRANSFER-RNA; AMINOACYLATION; NUCLEOTIDES; CODONS; RECOGNITION; ELEMENTS; VALINE	A C35-->T mutation in an Escherichia coli tRNA(Trp) gene creates an amber suppressor which efficiently inserts glutamine in response to UAG codons in vivo (Soll, L., and Berg, P. (1969) Nature 223, 1340-1342). We have introduced the same change in a yeast tRNA(Trp) gene and demonstrated that the tRNA acts as an efficient amber suppressor in vivo. Amino acid sequence analyses were performed on chitinase produced by cells carrying the corresponding gene with a UAG codon at position 8 of the mature protein plus the mutant tRNA(Trp) gene. In contrast to comparable experiments with E. coli, tryptophan is inserted at a frequency greater-than-or-equal-to 80% by the yeast suppressor tRNA(Trp). Furthermore, in vitro charging experiments with the mutant tRNA(Trp) reveal no detectable increase in glutamine acceptor activity results from the C35-->T transition. The identity elements in E. coli tRNA(Gln) are well characterized (Jahn, M., Rogers, J., and Soll, D. (1991) Nature 352, 258-260). Sequence comparisons of the tRNA(Trp) and tRNA(Gln) molecules from E. coli reveal that the amber suppressor tRNA(Trp) has four of five identity elements required for glutaminyl-tRNA synthetase recognition. A similar comparison in the yeast system shows only two of the five potential identity elements are present. We conclude that, in spite of substantial structural similarities between yeast and E. coli aminoacyl-tRNA synthetases, fundamental differences can exist with regard to tRNA recognition.	UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071	University of Wyoming								BARE L, 1986, BIOCHEMISTRY-US, V25, P58925; BONNET J, 1972, EUR J BIOCHEM, V31, P335, DOI 10.1111/j.1432-1033.1972.tb02538.x; CELIS JE, 1976, J MOL BIOL, V104, P729, DOI 10.1016/0022-2836(76)90132-7; EDWARDS H, 1991, P NATL ACAD SCI USA, V88, P1153, DOI 10.1073/pnas.88.4.1153; ENGLISCHPETERS S, 1991, BIOCHIMIE, V73, P1501; GHYSEN A, 1974, J MOL BIOL, V73, P333; HASEGAWA T, 1992, BIOCHEM BIOPH RES CO, V184, P478, DOI 10.1016/0006-291X(92)91219-G; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIMENO H, 1991, NUCLEIC ACIDS RES, V19, P6379, DOI 10.1093/nar/19.23.6379; HIRSH D, 1970, NATURE, V228, P57, DOI 10.1038/228057a0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; KEITH G, 1971, FEBS LETT, V17, P306, DOI 10.1016/0014-5793(71)80171-0; KIM D, 1990, NUCLEIC ACIDS RES, V18, P4215, DOI 10.1093/nar/18.14.4215; KIM DY, 1988, J BIOL CHEM, V263, P7316; KNOWLTON RG, 1980, J MOL BIOL, V139, P705, DOI 10.1016/0022-2836(80)90056-X; KURANDA M, 1991, J BIOL CHEM, V26, P19758; LEE CP, 1991, P NATL ACAD SCI USA, V88, P11378, DOI 10.1073/pnas.88.24.11378; MCCLAIN W, 1988, SCIENCE, V242, P1682; MCCLAIN WH, 1990, P NATL ACAD SCI USA, V87, P9260, DOI 10.1073/pnas.87.23.9260; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P6147, DOI 10.1073/pnas.88.14.6147; MONIER R, 1960, BIOCHIM BIOPHYS ACTA, V43, P1, DOI 10.1016/0006-3002(60)90399-1; NAGEL G, 1991, P NATL ACAD SCI USA, V88, P8221; NAZARENKO IA, 1992, NUCLEIC ACIDS RES, V20, P475, DOI 10.1093/nar/20.3.475; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; PALLANCK L, 1992, J BIOL CHEM, V267, P7221; PALLANCK L, 1991, P NATL ACAD SCI USA, V88, P3872, DOI 10.1073/pnas.88.9.3872; PUTZ J, 1991, SCIENCE, V252, P1696, DOI 10.1126/science.2047878; RAFTERY LA, 1985, J MOL BIOL, V184, P343, DOI 10.1016/0022-2836(85)90385-7; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P3463; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SARIN PS, 1964, BIOCHIM BIOPHYS ACTA, V91, P653, DOI 10.1016/0926-6550(64)90018-0; SCHIMMEL P, 1989, BIOCHEMISTRY-US, V28, P2747, DOI 10.1021/bi00433a001; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SHERMAN F, 1982, MOL BIOL YEAST SACCH, P463; SOLL L, 1969, NATURE, V223, P1340, DOI 10.1038/2231340a0; TREZEGUET V, 1991, MOL CELL BIOL, V11, P2744, DOI 10.1128/MCB.11.5.2744; TSCHUMPER G, 1982, J MOL BIOL, V156, P293, DOI 10.1016/0022-2836(82)90330-8; WEISS WA, 1986, J MOL BIOL, V192, P725, DOI 10.1016/0022-2836(86)90024-0; YANIV M, 1974, J MOL BIOL, V86, P245, DOI 10.1016/0022-2836(74)90016-3	42	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					217	220						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416930				2022-12-27	WOS:A1993KE60300034
J	YU, FX; LIN, SC; MORRISONBOGORAD, M; ATKINSON, MAL; YIN, HL				YU, FX; LIN, SC; MORRISONBOGORAD, M; ATKINSON, MAL; YIN, HL			THYMOSIN BETA-10 AND THYMOSIN BETA-4 ARE BOTH ACTIN MONOMER SEQUESTERING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; F-ACTIN; ACANTHAMOEBA ACTOBINDIN; DEPOLYMERIZING FACTOR; CAPPING PROTEIN; SKELETAL-MUSCLE; BINDING PROTEIN; PLASMA GELSOLIN; RETINOIC ACID; PROFILIN	The beta-thymosins are a family of related peptides. Recently, thymosin beta4 was identified as a significant actin monomer sequestering protein in cells. To determine if other beta-thymosins also bind actin, and how they may participate in the regulation of actin polymerization, we expressed thymosin beta4 and its major homolog, thymosin beta10, in bacteria and characterized their interactions with actin. Equilibrium sedimentation studies showed that thymosin beta4 behaved as a monomeric protein in solution. Both beta-thymosins bound skeletal muscle actin and inhibited actin polymerization with similar K(d) values (between 0.7-1 muM). They were not inhibited by polyphosphoinositides. Kinetic measurements showed that at high ratios of beta-thymosin to actin, beta-thymosin decreased the rate of barbed end filament growth. However, in spite of a close agreement between the kinetic and steady state K(d) values, the rate of barbed end filament growth was slightly, but reproducibly, larger than expected, and this deviation was particularly noticeable at lower ratios of beta-thymosin to actin. We conclude that unlike profilin, beta-thymosins are primarily actin monomer sequestering proteins, although some aspects of their interactions with actin are still not completely understood.	UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT NEUROL & BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,CTR HLTH,DEPT BIOCHEM,TYLER,TX 75710	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD014886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029113] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL29113] Funding Source: Medline; NICHD NIH HHS [HD14886] Funding Source: Medline; NIGMS NIH HHS [GM40423] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE H, 1990, BIOCHEMISTRY-US, V29, P7420, DOI 10.1021/bi00484a010; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUBB MR, 1991, J BIOL CHEM, V266, P3820; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CASELLA JF, 1986, J BIOL CHEM, V261, P915; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; COOPER JA, 1986, J BIOL CHEM, V261, P477; ERICKSONVIITANE.S, 1983, ARCH BIOCHEM BIOPHYS, V222, P407; GOLDSCHMIDTCLER.PJ, 1991, J CELL BIOL, V115, P3; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; GOODALL GJ, 1987, ARCH BIOCHEM BIOPHYS, V256, P402, DOI 10.1016/0003-9861(87)90461-9; HALL AK, 1991, J NEUROCHEM, V56, P462, DOI 10.1111/j.1471-4159.1991.tb08173.x; HALL AK, 1990, MOL BRAIN RES, V8, P129, DOI 10.1016/0169-328X(90)90057-K; HANNAPPEL E, 1989, ARCH BIOCHEM BIOPHYS, V273, P396, DOI 10.1016/0003-9861(89)90498-0; HANNAPPEL E, 1982, P NATL ACAD SCI-BIOL, V79, P1708, DOI 10.1073/pnas.79.6.1708; HARITOS AA, 1987, FEBS LETT, V218, P107, DOI 10.1016/0014-5793(87)81028-1; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBOOY PK, 1988, J BIOL CHEM, V263, P12836; LAMBOOY PK, 1986, J BIOL CHEM, V261, P7150; LIN SC, 1990, J MOL NEUROSCI, V2, P35, DOI 10.1007/BF02896924; LIN SC, 1991, J BIOL CHEM, V266, P23347; LIND SE, 1987, J CELL BIOL, V105, P833, DOI 10.1083/jcb.105.2.833; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; LOW TLK, 1985, METHOD ENZYMOL, V116, P248; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2336; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; SOUTHWICK FS, 1986, J BIOL CHEM, V261, P14191; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOBACMAN LS, 1983, J BIOL CHEM, V258, P8806; VANCOMPERNOLLE K, 1991, J BIOL CHEM, V266, P15427; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; WODNARFILIPOWICZ A, 1984, P NATL ACAD SCI-BIOL, V81, P2295, DOI 10.1073/pnas.81.8.2295; YAMAMOTO H, 1990, J BIOCHEM-TOKYO, V108, P505, DOI 10.1093/oxfordjournals.jbchem.a123229; YIN HL, 1981, J BIOL CHEM, V256, P9693; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912; YU FX, 1991, J BIOL CHEM, V266, P19269; YU FX, 1992, J BIOL CHEM, V267, P14616; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; ZARBOCK J, 1990, BIOCHEMISTRY-US, V29, P7814, DOI 10.1021/bi00486a006	56	165	171	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					502	509						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416954				2022-12-27	WOS:A1993KE60300076
J	ZIOBER, BL; WILLSON, JKV; HYMPHREY, LE; CHILDRESSFIELDS, K; BRATTAIN, MG				ZIOBER, BL; WILLSON, JKV; HYMPHREY, LE; CHILDRESSFIELDS, K; BRATTAIN, MG			AUTOCRINE TRANSFORMING GROWTH FACTOR-ALPHA IS ASSOCIATED WITH PROGRESSION OF TRANSFORMED PROPERTIES IN HUMAN COLON CANCER-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER RIBONUCLEIC-ACID; FACTOR RECEPTOR ANTIBODIES; HUMAN-BREAST CANCER; TGF-ALPHA; CARCINOMA-CELLS; TRANSGENIC MICE; MONOCLONAL-ANTIBODY; HUMAN-FIBROBLASTS; EPITHELIAL-CELLS; SARCOMA-VIRUS	The GEO colon carcinoma cell line is weakly tumorigenic in athymic mice and shows differentiated properties both in tissue culture and in xenografts. Proliferating monolayer cultures of GEO cells which normally require exogenous epidermal growth factor (EGF) for optimal growth displayed a marked inhibition in growth upon addition of antibodies that block binding to the EGF receptor or neutralize TGF-alpha. These results indicated that GEO cells utilize TGF-alpha in a weak autocrine loop. The availability of a weakly malignant model system in which TGF-alpha had demonstrable, but low level autocrine activity, permitted the investigation of the role of TGF-alpha in tumorigenesis by generating a stronger autocrine loop through the overexpression of the polypeptide. GEO cells were electroporated with an expression vector containing the human TGF-alpha cDNA, and stable clones were isolated that constitutively expressed the TGF-alpha cDNA in a strong autocrine loop. However, the growth rate of the parental cells in EGF-supplemented medium was the same as that of transfected cells with or without growth factor-supplemented medium. Thus, any biological changes generated by the overexpression of TGF-alpha were due to the autocrine nature of the growth mechanism rather than due to any decrease in doubling time leading to a faster growth rate. Transfected GEO cells showed an increase in anchorage-independent growth and formed tumors more readily in athymic nude mice indicating that TGF-alpha plays a role in progression of transformed properties.	BAYLOR COLL MED, DEPT PHARMACOL, HOUSTON, TX 77030 USA; CASE WESTERN RESERVE UNIV, DEPT MED, CLEVELAND, OH 44106 USA	Baylor College of Medicine; Case Western Reserve University					NCI NIH HHS [CA45967, CA50457, CA54807] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054807, R01CA050457, U01CA045967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANKELESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289; BATES SE, 1990, ENDOCRINOLOGY, V126, P596, DOI 10.1210/endo-126-1-596; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BOYD DD, 1988, CANCER RES, V48, P2469; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHANTRET I, 1988, CANCER RES, V48, P1936; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEMMONS DR, 1985, J CLIN INVEST, V75, P1914, DOI 10.1172/JCI111906; COFFEY RJ, 1987, CANCER RES, V47, P4590; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DERYNCK R, 1989, CANCER CEL, V7, P297; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DERYNCK R, 1987, CANCER RES, V47, P707; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; ENNIS BW, 1989, MOL ENDOCRINOL, V3, P1830, DOI 10.1210/mend-3-11-1830; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINZI E, 1987, P NATL ACAD SCI USA, V84, P3733, DOI 10.1073/pnas.84.11.3733; GILL GN, 1984, J BIOL CHEM, V259, P7755; HEMAR A, 1991, J IMMUNOL, V146, P2409; IWAMOTO M, 1990, CELL IMMUNOL, V125, P151, DOI 10.1016/0008-8749(90)90070-8; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; JOHNSSON A, 1985, NATURE, V317, P438, DOI 10.1038/317438a0; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; LEE JC, 1982, J IMMUNOL, V128, P2393; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MALDEN LT, 1989, INT J CANCER, V43, P380, DOI 10.1002/ijc.2910430305; Maniatis T., 1982, MOL CLONING; MARKOWITZ SD, 1990, J CLIN INVEST, V86, P356, DOI 10.1172/JCI114709; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; MCPHERSON GA, 1983, COMPUT PROG BIOMED, V17, P107, DOI 10.1016/0010-468X(83)90031-4; MUELLER SG, 1990, MOL CELL BIOL, V10, P4596, DOI 10.1128/MCB.10.9.4596; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; MULDER KM, 1991, CANCER RES, V51, P2256; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; RAYMOND VW, 1989, CANCER RES, V49, P3608; RODECK U, 1990, J CELL BIOCHEM, V44, P69, DOI 10.1002/jcb.240440202; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; ROSENTHAL SM, 1991, J CLIN INVEST, V87, P1212, DOI 10.1172/JCI115121; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sato J D, 1983, Mol Biol Med, V1, P511; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SIZELAND AM, 1991, MOL CELL BIOL, V11, P4005, DOI 10.1128/MCB.11.8.4005; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	56	83	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					691	698						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416972				2022-12-27	WOS:A1993KE60300104
J	COLLAWN, JF; LAI, A; DOMINGO, D; FITCH, M; HATTON, S; TROWBRIDGE, IS				COLLAWN, JF; LAI, A; DOMINGO, D; FITCH, M; HATTON, S; TROWBRIDGE, IS			YTRF IS THE CONSERVED INTERNALIZATION SIGNAL OF THE TRANSFERRIN RECEPTOR, AND A 2ND YTRF SIGNAL AT POSITION-31-34 ENHANCES ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID-PHOSPHATASE; FACTOR-II RECEPTOR; CYTOPLASMIC DOMAIN; AMINO-ACID; RAPID INTERNALIZATION; INSULIN-RECEPTOR; CDNA SEQUENCE; DNA; TAIL; SITE	By functional analysis of mutant human transferrin receptors (TR) expressed in chicken embryo fibroblasts, we previously identified a tetrapeptide sequence, Y20TRF23, within the 61-residue cytoplasmic tail as the signal for high-efficiency endocytosis (Collawn, J. F., Stangel, M., Kuhn, L. A., Esekogwu, V., Jing, S., Trowbridge, I. S., and Tainer, J. A. (1990) Cell 63, 1061-1072). It has been inferred from other studies, however, that the TR internalization signal was localized to a much larger region, residues 7 through 26 (Girones, N., Alvarez, E., Seth, A., Lin, I-M., Latour, D. A., and Davis, R. J. (1991) J. Biol. Chem. 266,19006-19012). Additionally, Tyr20 was reported to not be conserved in the Chinese hamster cytoplasmic tail sequence (Alvarez, E., Girones, N., and Davis, R. J. (1990) Biochem. J. 267, 31-35). In the studies reported here, we examined the effect of insertion of an extra copy of a YTRF sequence at three different locations within the human TR cytoplasmic domain and show that the insertion of another YTRF signal at position 31-34 in the wild-type TR, but not the other two locations, increases the rate of endocytosis 2-fold. Furthermore, introduction of YTRF at position 31-34 in an internalization-defective mutant receptor restores endocytosis to wild-type levels, indicating that YTRF signals at either positions 20-23 or 31-34 are necessary and sufficient to promote TR internalization and function in an independent and additive manner. We also report the complete primary structure of the Chinese hamster TR deduced from its cDNA sequence and show that the Tyr20 as well as the complete YTRF motif is conserved.	SALK INST BIOL STUDIES, DEPT CANC BIOL, SAN DIEGO, CA 92138 USA	Salk Institute					NATIONAL CANCER INSTITUTE [R01CA034787] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA34787] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALVAREZ E, 1990, BIOCHEM J, V267, P31, DOI 10.1042/bj2670031; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BATES GW, 1973, J BIOL CHEM, V248, P3228; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COLLAWN JF, 1991, EMBO J, V10, P3247, DOI 10.1002/j.1460-2075.1991.tb04888.x; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; GERHARDT EM, 1991, GENE, V102, P249, DOI 10.1016/0378-1119(91)90085-P; GIRONES N, 1991, J BIOL CHEM, V266, P19006; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; JADOT M, 1992, J BIOL CHEM, V267, P11069; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; MCCLELLAND A, 1984, CELL, V39, P267, DOI 10.1016/0092-8674(84)90004-7; MCGRAW TE, 1991, J CELL BIOL, V112, P853, DOI 10.1083/jcb.112.5.853; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; SCHNEIDER C, 1982, J BIOL CHEM, V257, P8516; STEARNE PA, 1985, J IMMUNOL, V134, P3474; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; TROWBRIDGE IS, 1988, EXCERPTA MED INT C S, V775, P441	37	97	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21686	21692						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408022				2022-12-27	WOS:A1993MC80900041
J	QUINN, MT; EVANS, T; LOETTERLE, LR; JESAITIS, AJ; BOKOCH, GM				QUINN, MT; EVANS, T; LOETTERLE, LR; JESAITIS, AJ; BOKOCH, GM			TRANSLOCATION OF RAC CORRELATES WITH NADPH OXIDASE ACTIVATION - EVIDENCE FOR EQUIMOLAR TRANSLOCATION OF OXIDASE COMPONENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; GTP-BINDING PROTEIN; CELL-FREE SYSTEM; CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL CYTOCHROME-B; PLASMA-MEMBRANE; SUPEROXIDE GENERATION; CYTOSOLIC COMPONENTS; GUANINE-NUCLEOTIDES; HUMAN-GRANULOCYTES	Activation of the superoxide-generating NADPH oxidase system of human neutrophils involves the assembly of several neutrophil components, some located on the plasma membrane and others in the cytosol. It has recently been established that one of the required components for NADPH oxidase activity is the GTP-binding protein Rac. To further investigate the role of Rac in the NADPH oxidase system, studies were carried out to determine its subcellular distribution in resting and activated human neutrophils. In resting cells, Rac and an associated guanine nucleotide regulatory factor, GDP dissociation inhibitor (GDI), were located only in the cytosol, along with other known oxidase factors, p47-phox and p67-phox. After activation of neutrophils with phorbol 12-myristate 13-acetate or formyl-methionyl-leucyl-phenylalanine, Rac was translocated from the cytosol to the plasma membrane, and this translocation corresponded temporally with the translocation of p47-phox and p67-phox and with the generation of superoxide. GDI remained localized to the cytosol, suggesting activation of the oxidase involved dissociation of the Rac-GDI complex prior to Rac translocation. Determination of the quantities of cytosolic factors associated with the plasma membrane indicated that Rac, p47-phox, and p67-phox are translocated to the plasma membrane simultaneously in equimolar amounts, but that the membrane-associated cytochrome b was present at 3-4-fold molar excess. These findings suggest that Rac may play a role in assembly of the active NADPH oxidase complex.	ONYX PHARMACEUT, RICHMOND, CA 94806 USA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	QUINN, MT (corresponding author), MONTANA STATE UNIV, DEPT MICROBIOL, BOZEMAN, MT 59717 USA.			Jesaitis, Algirdas/0000-0001-9001-5617	NIAID NIH HHS [AI26711] Funding Source: Medline; NIAMS NIH HHS [AR40929-01] Funding Source: Medline; NIGMS NIH HHS [GM44428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044428] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BABIOR BM, 1977, BLOOD, V50, P517; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BOKOCH GM, 1988, J CELL BIOL, V106, P1927, DOI 10.1083/jcb.106.6.1927; CHUANG T, 1993, FASEB J, V7, P1141; CHUANG TH, 1993, J BIOL CHEM, V268, P775; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; DUSI S, 1993, BIOCHEM J, V290, P173, DOI 10.1042/bj2900173; GABIG TG, 1987, J BIOL CHEM, V262, P1685; GABIG TG, 1990, J IMMUNOL, V145, P945; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1990, BLOOD, V76, pA183; JESAITIS AJ, 1983, J BIOL CHEM, V258, P1968; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LETO TL, 1991, J BIOL CHEM, V266, P19812; LIGETI E, 1988, BIOCHEMISTRY-US, V27, P193, DOI 10.1021/bi00401a029; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; PARK JW, 1992, J BIOL CHEM, V267, P19901; PARK JW, 1992, J BIOL CHEM, V267, P17327; PARKOS CA, 1985, J BIOL CHEM, V260, P6541; QUINN MT, 1992, BLOOD, V79, P2438; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; QUINN MT, 1989, BIOCHIM BIOPHYS ACTA, V987, P83, DOI 10.1016/0005-2736(89)90458-6; QUINN MT, 1992, J BIOL CHEM, V267, P7303; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; SEGAL AW, 1992, BIOCHEM J, V284, P7881; TAMURA M, 1992, J BIOL CHEM, V267, P7529; TEAHAN CG, 1990, BIOCHEM J, V267, P485, DOI 10.1042/bj2670485; UHLINGER DJ, 1991, J BIOL CHEM, V266, P20990; UHLINGER DJ, 1992, BIOCHEM BIOPH RES CO, V186, P509, DOI 10.1016/S0006-291X(05)80837-X; UHLINGER DJ, 1993, J BIOL CHEM, V268, P19901; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; WOODMAN RC, 1991, J CLIN INVEST, V87, P1345, DOI 10.1172/JCI115138; YEA CM, 1990, BIOCHEM J, V265, P95, DOI 10.1042/bj2650095	46	293	296	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					20983	20987						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407934				2022-12-27	WOS:A1993MA28800054
J	TROTTER, PJ; PEDRETTI, J; VOELKER, DR				TROTTER, PJ; PEDRETTI, J; VOELKER, DR			PHOSPHATIDYLSERINE DECARBOXYLASE FROM SACCHAROMYCES-CEREVISIAE - ISOLATION OF MUTANTS, CLONING OF THE GENE, AND CREATION OF A NULL ALLELE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILIZED ANIMAL-CELLS; ESCHERICHIA-COLI; RAT-LIVER; PHOSPHOLIPID-SYNTHESIS; SUBCELLULAR MEMBRANES; NEUROSPORA-CRASSA; LIPID-SYNTHESIS; YEAST; MITOCHONDRIA; TRANSLOCATION	Phosphatidylserine decarboxylase plays a pivotal role in the synthesis of phospholipid by the mitochondria. The substrate phosphatidylserine is synthesized extramitochondrially and must be translocated to the mitochondria prior to decarboxylation. To understand the properties of the decarboxylase and exploit its unique topology to address basic questions of interorganelle cooperation in membrane assembly, we have begun to examine this enzyme in Saccharomyces cerevisiae. Strains of the yeast defective in enzyme activity were isolated by modified brute force using 1-acyl-2[N-(6-[7-nitrobenz-2-oxa- 1,3-diazo-4-yl)]aminocaproyl] (NBD)-phosphatidyl[1'-C-14]serine as substrate for permeabilized cells. Mutant strains with less than 5% wild type activity exhibited no defective growth phenotype. The gene for the phosphatidylserine decarboxylase (PSD) was cloned using an oligonucleotide probe degenerate for the sequence VGAT(I)/(N)VGSI, which is the longest stretch of sequence identity between the Escherichia coli sequence (I at position 5) and the putative CHO cell sequence (N at position 5). The gene encodes a 500 amino acid protein with 28-43% identity to the bacterial and mammalian sequences. The yeast PSD gene maps to the long arm of chromosome 14 between the kex 2 and RAS 2 loci. Null mutations created by disrupting the PSD gene with TRP1 demonstrate that the gene is not essential for cell growth even when the engineered strains are deprived of choline and ethanolamine. Analysis of lipid synthesis and enzyme activity in null mutants indicates that there are two PSD genes.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, 1400 JACKSON ST, DENVER, CO 80206 USA	National Jewish Health								AGRANOFF BW, 1963, BIOCHEM PREP, V10, P46; ARDAIL D, 1991, J BIOL CHEM, V266, P7978; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1984, GENETICS, V108, P533; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BJERVE KS, 1973, BIOCHIM BIOPHYS ACTA, V296, P549, DOI 10.1016/0005-2760(73)90115-X; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; DENNIS EA, 1972, J LIPID RES, V13, P263; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; GARDINER K, 1989, ELECTROPHORESIS, V10, P296, DOI 10.1002/elps.1150100505; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; GNAMUSCH E, 1992, BIOCHIM BIOPHYS ACTA, V1111, P120, DOI 10.1016/0005-2736(92)90281-P; HANSON BA, 1980, J LIPID RES, V21, P309; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HJELMSTAD RH, 1988, J BIOL CHEM, V263, P19748; HOVIUS R, 1992, J BIOL CHEM, V267, P16790; HUBSCHER G, 1962, BIOCHIM BIOPHYS ACTA, V56, P555; JONG SC, 1990, CATALOGUE YEASTS, P106; KANFER J, 1964, J BIOL CHEM, V239, P1720; KANFER JN, 1972, J LIPID RES, V13, P468; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; KUGE O, 1991, J BIOL CHEM, V266, P6370; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; OHTA A, 1981, J BIOL CHEM, V256, P2219; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 1989, MOL CLONING LABORATO; SATRE M, 1978, J BIOL CHEM, V253, P479; SEGUIREAL B, 1992, FEBS LETT, V313, P2, DOI 10.1016/0014-5793(92)81171-H; SHERMAN F, 1983, METHODS YEAST GENETI, P112; SHERMAN F, 1992, METHOD ENZYMOL, V194, P3; SIMBENI R, 1990, J BIOL CHEM, V265, P281; STOFFEL W, 1972, H-S Z PHYSIOL CHEM, V353, P965, DOI 10.1515/bchm2.1972.353.1.965; STOFFEL W, 1968, H-S Z PHYSIOL CHEM, V349, P1745, DOI 10.1515/bchm2.1968.349.2.1745; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VIEBROCK A, 1982, EMBO J, V1, P565, DOI 10.1002/j.1460-2075.1982.tb01209.x; VOELKER DR, 1991, J BIOL CHEM, V266, P12185; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; VOELKER DR, 1993, J BIOL CHEM, V268, P7069; VOELKER DR, 1985, J BIOL CHEM, V260, P4671; VOELKER DR, 1990, J BIOL CHEM, V265, P14340; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	55	187	189	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21416	21424						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407984				2022-12-27	WOS:A1993MA28800112
J	SCHAFFER, L; KJELDSEN, T; ANDERSEN, AS; WIBERG, FC; LARSEN, UD; CARA, JF; MIRMIRA, RG; NAKAGAWA, SH; TAGER, HS				SCHAFFER, L; KJELDSEN, T; ANDERSEN, AS; WIBERG, FC; LARSEN, UD; CARA, JF; MIRMIRA, RG; NAKAGAWA, SH; TAGER, HS			INTERACTIONS OF A HYBRID INSULIN INSULIN-LIKE GROWTH FACTOR-I ANALOG WITH CHIMERIC INSULIN TYPE-I INSULIN-LIKE GROWTH-FACTOR RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BINDING-SPECIFICITY; STRUCTURAL ANALOGS; REDUCED AFFINITY; FACTOR (IGF)-I; DETERMINANTS; REGIONS; CELLS	We have examined, by use of a hybrid insulin/insulin-like growth factor-I analog and chimeric insulin/type I insulin-like growth factor receptors, the interplay between ligand and receptor structure in determining the affinity and specificity of hormone-receptor interactions in the insulin and insulin-like growth factor-I systems. Our findings, obtained through the study of radiolabeled peptide binding to detergent-solubilized full-length receptors and to soluble truncated receptors, show that (a) the two-chain hybrid analog exhibits significant cross-reactivity with both receptor systems, (b) the exchange of appropriate domains in chimeric receptors enhances the receptor binding affinity of the analog by 3.5-21-fold, and (c) the affinity of the hybrid analog for the chimeric receptors actually exceeds that of either natural insulin or natural insulin-like growth factor-I. We conclude that the specificity-conferring domains of the insulin and type I insulin-like growth factor receptors reside in different regions of a common binding site, and that the exchange of domains between pairs of related hormones and between pairs of related receptors can yield new ligand-receptor systems with significantly altered affinities and selectivities.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637; NOVO NORDISK AS,DEPT DIABET RES,DK-2880 BAGSVAERD,DENMARK; NOVO NORDISK AS,DEPT PHARMACEUT RES,DK-2880 BAGSVAERD,DENMARK	University of Chicago; University of Chicago; Novo Nordisk; Novo Nordisk			Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Kjeldsen, Thomas/0000-0003-0094-9286	NIDDK NIH HHS [DK 43702, DK 20595] Funding Source: Medline; NIGMS NIH HHS [GM 07281] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK043702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1988, J BIOL CHEM, V263, P6233; CARA JF, 1990, J BIOL CHEM, V265, P17820; CARA JF, 1988, ENDOCRINOLOGY, V122, P2881, DOI 10.1210/endo-122-6-2881; CASCIERI MA, 1988, BIOCHEMISTRY-US, V27, P3229, DOI 10.1021/bi00409a016; CASCIERI MA, 1989, J BIOL CHEM, V264, P2199; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; MARKUSSEN J, 1991, J BIOL CHEM, V266, P18814; MCCLAIN DA, 1990, J BIOL CHEM, V265, P1678; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SINHA MK, 1989, DIABETES, V38, P1217, DOI 10.2337/diabetes.38.10.1217	17	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3044	3047						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428981				2022-12-27	WOS:A1993KM16100008
J	ESTEBAN, JA; SALAS, M; BLANCO, L				ESTEBAN, JA; SALAS, M; BLANCO, L			FIDELITY OF PHI-29 DNA-POLYMERASE - COMPARISON BETWEEN PROTEIN-PRIMED INITIATION AND DNA POLYMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MANGANESE MUTAGENESIS; REPLICATION FIDELITY; KINETIC MECHANISM; TERMINAL PROTEIN; INVITRO; ENZYME; ALPHA; FRAGMENT; MUTANTS	Phi29 DNA polymerase is able to catalyze two different synthetic reactions: protein-primed initiation and DNA polymerization. We have studied the fidelity of phi29 DNA polymerase when carrying out these two reactions. Global fidelity was dissected into three steps: insertion discrimination, mismatch elongation, and proofreading. The insertion discrimination of phi29 DNA polymerase in DNA polymerization ranged from 10(4) to 10(6). The efficiency of mismatch elongation was 10(5)-10(6)-fold lower than that of a properly paired primer terminus. These factors indicate that DNA polymerization catalyzed by phi29 DNA polymerase is a highly accurate process. Conversely, the insertion fidelity of protein-primed initiation was quite low, the insertion discrimination factor being about 10(2). Mismatch elongation discrimination was also rather low: mismatched terminal protein (TP).dNMP complexes were elongated from 2- to 6-fold more slowly than the correct TP.dNMP complex. Even more, the 3' --> 5' exonuclease activity of phi29 DNA polymerase was unable to act on the TP.dNMP initiation complex, precluding the possibility that a wrong dNMP covalently linked to TP could be excised and corrected. Therefore, protein-primed initiation can be predicted as a quite inaccurate reaction. The problem of maintaining the sequence at the DNA ends is discussed in the context of a recently described model for protein-primed initiation.	UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC,CANTOBLANCO,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Esteban, Jose/L-4944-2014; Salas, Margarita/J-9873-2014; Blanco, Luis/I-1848-2015	Esteban, Jose/0000-0002-3759-3300; Salas, Margarita/0000-0001-5939-3441; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER; NIGMS NIH HHS [5R01 GM27242-13] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; BERNAD A, 1987, EMBO J, V6, P4219, DOI 10.1002/j.1460-2075.1987.tb02770.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BERNAD A, 1990, P NATL ACAD SCI USA, V87, P4610, DOI 10.1073/pnas.87.12.4610; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; BLANCO L, 1992, J BIOL CHEM, V267, P1225; BLASCO MA, 1990, NUCLEIC ACIDS RES, V18, P4763; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; CLAYTON LK, 1979, J BIOL CHEM, V254, P1902; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; ELDEIRY WS, 1988, BIOCHEMISTRY-US, V27, P546, DOI 10.1021/bi00402a007; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; ESTEBAN JA, 1992, BIOCHEMISTRY-US, V31, P350, DOI 10.1021/bi00117a006; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; HIBNER U, 1980, NATURE, V285, P300, DOI 10.1038/285300a0; JOYCE CM, 1987, TRENDS BIOCHEM SCI, V12, P288, DOI 10.1016/0968-0004(87)90143-5; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; MAKI H, 1991, J BIOL CHEM, V266, P5055; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; MURRAY MJ, 1976, BIOCHIM BIOPHYS ACTA, V425, P256, DOI 10.1016/0005-2787(76)90032-0; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; RICCHETTI M, 1990, EMBO J, V9, P1583, DOI 10.1002/j.1460-2075.1990.tb08278.x; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; STRAUSS EC, 1986, ANAL BIOCHEM, V154, P353, DOI 10.1016/0003-2697(86)90536-1; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; YU H, 1992, J BIOL CHEM, V267, P10888; ZABALLOS A, 1989, NUCLEIC ACIDS RES, V17, P10353, DOI 10.1093/nar/17.24.10353	39	206	232	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2719	2726						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428945				2022-12-27	WOS:A1993KK81500069
J	KATOH, T; MORITA, F				KATOH, T; MORITA, F			ACTIN-BINDING PEPTIDES OBTAINED FROM THE C-TERMINAL 24-KDA FRAGMENT OF PORCINE AORTA SMOOTH-MUSCLE MYOSIN SUBFRAGMENT-1 HEAVY-CHAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; CHICKEN GIZZARD MYOSIN; RABBIT SKELETAL-MUSCLE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; LIGHT-CHAIN; F-ACTIN; ADENOSINE-TRIPHOSPHATASE; PROTEOLYTIC FRAGMENTS; ELECTRON-MICROSCOPY; COMPLETE NUCLEOTIDE	The C-terminal 24-kDa fragment of myosin subfragment-1 (S-1) heavy chain was isolated by papain digestion of porcine aorta myosin followed by ethanol fractionation. The isolated 24-kDa fragment was digested by lysylendopeptidase. When the digest was ultracentrifuged with F-actin, 7- and 2-kDa peptides coprecipitated with the actin. These two peptides were isolated by high performance liquid chromatography, and their amino acid sequences were determined. The 7- and 2-kDa peptides correspond to residues 692-744 and 835-846, respectively, of the chicken gizzard myosin heavy chain (Yanagisawa, M., Hamada, Y., Katsuragawa, Y., Imamura, M., Mikawa, T., and Masaki, r. (1987) J. Mol. Biol. 198,143-157). The 7-kDa peptide contains the reactive cysteine residues, SH1 and SH2. The isolated 7- and 2-kDa peptides also bound to F-actin with dissociation constants of 0.6 and 12 muM, respectively. The 2-kDa peptide was found to compete with rabbit skeletal S-1 for the binding to F-actin by examining the binding of S-1 to actin in the presence of various concentrations of the 2-kDa peptide. The 2-kDa peptide was also shown to interact with the regulatory light chain of aorta myosin by difference UV absorption spectroscopy. The 2-kDa peptide inhibited the actin-activated ATPase activity of skeletal S-1, and the inhibition was canceled by the addition of the isolated regulatory light chain. These results suggest that the newly found 2-kDa peptide region may be related to the regulation of smooth muscle actomyosin ATPase activity by phosphorylation of the regulatory light chain.			KATOH, T (corresponding author), HOKKAIDO UNIV,FAC SCI,DEPT CHEM,SAPPORO,HOKKAIDO 060,JAPAN.							BABIJ P, 1991, P NATL ACAD SCI USA, V88, P10676, DOI 10.1073/pnas.88.23.10676; BETTACHE N, 1992, BIOCHEMISTRY-US, V31, P389, DOI 10.1021/bi00117a012; BURKE M, 1990, FEBS LETT, V262, P185, DOI 10.1016/0014-5793(90)80185-L; BURKE M, 1976, BIOCHEMISTRY-US, V15, P1923, DOI 10.1021/bi00654a020; CAPONY JP, 1981, BIOPHYS J, V33, pA148; CHASE PB, 1991, BIOPHYS J, V60, P352, DOI 10.1016/S0006-3495(91)82060-4; CHAUSSEPIED P, 1989, BIOCHEMISTRY-US, V28, P9123, DOI 10.1021/bi00449a025; CHAUSSEPIED P, 1988, P NATL ACAD SCI USA, V85, P7471, DOI 10.1073/pnas.85.20.7471; ELZINGA M, 1977, P NATL ACAD SCI USA, V74, P4281, DOI 10.1073/pnas.74.10.4281; ETO M, 1990, J BIOCHEM-TOKYO, V108, P499, DOI 10.1093/oxfordjournals.jbchem.a123228; FLICKER PF, 1983, J MOL BIOL, V169, P723, DOI 10.1016/S0022-2836(83)80167-3; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRAND RJA, 1983, BIOCHEM J, V211, P267, DOI 10.1042/bj2110267; HASEGAWA Y, 1990, J BIOCHEM-TOKYO, V108, P909, DOI 10.1093/oxfordjournals.jbchem.a123313; HIRATSUKA T, 1987, BIOCHEMISTRY-US, V26, P3168, DOI 10.1021/bi00385a034; IKEBE M, 1984, J BIOL CHEM, V259, P1639; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KATOH T, 1985, J BIOL CHEM, V260, P6723; KATOH T, 1984, J BIOCHEM-TOKYO, V95, P447, DOI 10.1093/oxfordjournals.jbchem.a134626; KATOH T, 1984, J BIOCHEM-TOKYO, V96, P1223, DOI 10.1093/oxfordjournals.jbchem.a134940; KATOH T, 1989, J CELL BIOL, V109, P1549, DOI 10.1083/jcb.109.4.1549; KAVINSKY CJ, 1984, J BIOL CHEM, V259, P2775; KEANE AM, 1990, NATURE, V344, P265, DOI 10.1038/344265a0; MAITA T, 1991, J BIOCHEM, V110, P75, DOI 10.1093/oxfordjournals.jbchem.a123546; MAITA T, 1991, J BIOCHEM-TOKYO, V110, P68, DOI 10.1093/oxfordjournals.jbchem.a123545; MARIANNEPEPIN T, 1985, BIOCHEMISTRY-US, V24, P3024, DOI 10.1021/bi00333a033; MARUTA S, 1989, EUR J BIOCHEM, V184, P213, DOI 10.1111/j.1432-1033.1989.tb15009.x; MINOWA O, 1983, J BIOCHEM-TOKYO, V94, P25, DOI 10.1093/oxfordjournals.jbchem.a134337; MITCHELL EJ, 1986, EUR J BIOCHEM, V161, P25, DOI 10.1111/j.1432-1033.1986.tb10120.x; MORITA F, 1967, J BIOL CHEM, V242, P4501; MORNET D, 1981, NATURE, V292, P301, DOI 10.1038/292301a0; MUHLRAD A, 1984, P NATL ACAD SCI-BIOL, V81, P1003, DOI 10.1073/pnas.81.4.1003; NYITRAY L, 1991, J BIOL CHEM, V266, P18469; OKAGAKI T, 1991, J BIOCHEM, V109, P858, DOI 10.1093/oxfordjournals.jbchem.a123471; ONISHI H, 1986, J BIOCHEM, V100, P1433, DOI 10.1093/oxfordjournals.jbchem.a121849; ONISHI H, 1985, J BIOCHEM, V98, P81, DOI 10.1093/oxfordjournals.jbchem.a135276; ONISHI H, 1992, BIOCHEMISTRY-US, V31, P1201, DOI 10.1021/bi00119a033; ONODERA M, 1971, J BIOCHEM-TOKYO, V69, P145, DOI 10.1093/oxfordjournals.jbchem.a129443; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; PLAPP BV, 1971, J BIOL CHEM, V246, P939; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; REISLER E, 1974, BIOCHEMISTRY-US, V13, P2014, DOI 10.1021/bi00707a003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELLERS JR, 1985, J CELL BIOL, V101, P1897, DOI 10.1083/jcb.101.5.1897; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; SHERRY JMF, 1978, BIOCHEMISTRY-US, V17, P4411, DOI 10.1021/bi00614a009; SOBIESZEK A, 1977, J MOL BIOL, V112, P559, DOI 10.1016/S0022-2836(77)80164-2; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stark GR., 1967, METHOD ENZYMOL, V25, P590; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; SUTOH K, 1988, BIOCHEMISTRY-US, V27, P2964, DOI 10.1021/bi00408a045; SUZUKI H, 1978, J BIOCHEM, V84, P1529, DOI 10.1093/oxfordjournals.jbchem.a132278; SUZUKI H, 1985, J BIOL CHEM, V260, P4810; SUZUKI R, 1987, J BIOL CHEM, V262, P11410; SUZUKI R, 1990, J BIOL CHEM, V265, P4939; TOKUNAGA M, 1987, J MOL BIOL, V194, P245, DOI 10.1016/0022-2836(87)90372-X; TONG SW, 1990, J BIOL CHEM, V265, P4893; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; VIBERT P, 1982, J MOL BIOL, V157, P299, DOI 10.1016/0022-2836(82)90236-4; WAGNER PD, 1986, J BIOL CHEM, V261, P7778; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; YAMAMOTO K, 1989, BIOCHEMISTRY-US, V28, P5573, DOI 10.1021/bi00439a035; YANAGISAWA M, 1987, J MOL BIOL, V198, P143, DOI 10.1016/0022-2836(87)90302-0; YANARI S, 1960, J BIOL CHEM, V235, P2818; YAZAWA M, 1980, J BIOCHEM, V87, P1313, DOI 10.1093/oxfordjournals.jbchem.a132869; YOSHIDA M, 1983, J BIOCHEM-TOKYO, V94, P1925, DOI 10.1093/oxfordjournals.jbchem.a134546; YOSHIDA M, 1986, J BIOCHEM-TOKYO, V99, P1027, DOI 10.1093/oxfordjournals.jbchem.a135566; YOSHIDA M, 1988, J BIOCHEM-TOKYO, V103, P380, DOI 10.1093/oxfordjournals.jbchem.a122278	73	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2380	2388						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428912				2022-12-27	WOS:A1993KK81500023
J	GEORGEL, P; DEMELER, B; TERPENING, C; PAULE, MR; VANHOLDE, KE				GEORGEL, P; DEMELER, B; TERPENING, C; PAULE, MR; VANHOLDE, KE			BINDING OF THE RNA POLYMERASE-I TRANSCRIPTION COMPLEX TO ITS PROMOTER CAN MODIFY POSITIONING OF DOWNSTREAM NUCLEOSOMES ASSEMBLED INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PARTICLES; DNA; HISTONES; ELONGATION; INITIATION; SEQUENCES; INHIBIT; SYSTEM; GENE	We have studied the reconstitution of chromatin-like structures in vitro, using purified RNA polymerase I transcription complexes and histone octamers. The plasmid construct used in these studies is a pUC8 derivative in which we have inserted an RNA polymerase I core promoter region of Acanthamoeba castellanii upstream of four repeats of the 5 S rDNA nucleosome positioning sequence (208 base pairs) from Lytechinus variegatus. When histone octamers were reconstituted onto the naked DNA template, the expected nucleosome positioning previously observed using tandem repeats of the same 208-base pair fragment was not obtained (as assayed by restriction enzyme digestion mapping of the inserted region of the plasmid). We show that the location of the RNA polymerase I core promoter region with regard to the tandemly repeated 208-base pair positioning sequence is a major determinant in the positioning of the histone octamers. Reconstituting first with the stalled transcription complex excluded octamers from the promoter region and recovered the expected nucleosome positioning downstream on the four repeats of the 5 S positioning sequence. The observed competition between histone octamers and the transcription complex for the promoter region suggests a great similarity with what has been reported from in vitro studies of RNA polymerase II and III transcription systems. We may be looking at a mechanism of regulation of transcription for the RNA polymerase I.	OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; COLORADO STATE UNIV,DEPT BIOCHEM,FT COLLINS,CO 80523; COLORADO STATE UNIV,PROGRAM CELL & MOLEC BIOL,FT COLLINS,CO 80523	Oregon State University; Colorado State University; Colorado State University				Demeler, Borries/0000-0002-2414-9518	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES004766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022580] Funding Source: NIH RePORTER; NIEHS NIH HHS [5 PO-1 ES 04766] Funding Source: Medline; NIGMS NIH HHS [GM-12296, GM-22580] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; CONSTANZO G, 1990, J MOL BIOL, V216, P363; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; FREEMAN L A, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P165; GRUNSTEIN M, 1990, TRENDS GENET, V6, P395, DOI 10.1016/0168-9525(90)90299-L; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; IIDA CT, 1992, IN PRESS NUCLEIC ACI; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; KOWNIN P, 1985, NUCLEIC ACIDS RES, V13, P6237, DOI 10.1093/nar/13.17.6237; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LORCH Y, 1988, CELL, V55, P5839; LOSA R, 1987, CELL, V50, P501; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; MORSE RH, 1989, EMBO J, V8, P2343, DOI 10.1002/j.1460-2075.1989.tb08362.x; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; PENNINGS S, 1989, BIOCHEMISTRY-US, V25, P5043; PENNINGS S, 1991, BIOCHEMISTRY-US, V220, P101; PFAFFLE P, 1990, J BIOL CHEM, V265, P16830; RETIEF JD, 1984, FEBS LETT, V167, P170, DOI 10.1016/0014-5793(84)80855-8; SCHROTH GP, 1992, J BIOL CHEM, V267, P9958; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; SIMPSON RT, 1986, BIOESSAYS, V4, P172, DOI 10.1002/bies.950040408; STEIN A, 1979, J MOL BIOL, V130, P103, DOI 10.1016/0022-2836(79)90421-2; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; WASYLYK B, 1979, EUR J BIOCHEM, V98, P317, DOI 10.1111/j.1432-1033.1979.tb13191.x; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; ZWICK MG, 1991, NUCLEIC ACIDS RES, V19, P1681, DOI 10.1093/nar/19.7.1681	33	41	41	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1947	1954						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420969				2022-12-27	WOS:A1993KH62000069
J	SHENOY, BC; KUMAR, GK; SAMOLS, D				SHENOY, BC; KUMAR, GK; SAMOLS, D			DISSECTION OF THE BIOTINYL SUBUNIT OF TRANSCARBOXYLASE INTO REGIONS ESSENTIAL FOR ACTIVITY AND ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENATOR; ENZYMES	Transcarboxylase, a multisubunit enzyme containing 12 S, 5 S, and 1.3 S subunits, catalyzes the transfer of a carboxyl group from methylmalonyl-CoA to pyruvate (overall reaction) via two partial reactions. In the first partial reaction, a carboxyl group from methylmalonyl-CoA bound to the 12 S subunit is transferred to the biotin of the 1.3 S subunit, and, in the second partial reaction, the carboxylated biotin transfers its carboxyl group from biotin to pyruvate, bound to the 5 S subunit. Previously we have shown that the region around the biotinyl lysine of the 1.3 S subunit is critical for catalysis, that peptides in the amino-terminal region of 1.3 S are capable of forming complexes with 12 S and 5 S, and that amino acids in the carboxyl terminus of the 1.3 S subunit form part of the recognition site for holocarboxylase synthetase. In order to further examine the role of the sequences in this subunit, we generated 8 shortened forms of the 1.3 S biotinyl subunits missing either one or both termini. Truncated 1.3 S subunits were active in both partial reactions until deletion reached amino acid 59. None of the truncated subunits was able to support stable complex formation with the 12 S and 5 S subunits or catalyze the overall reaction. The results suggest that the region between 59 and 78 is required for activity and the sequence 1-18 is required for enzyme assembly. Activity in the partial reactions correlated with intrinsic fluorescence enhancement of tryptophan residues in either the 12 S or 5 S subunit. Fluorescence enhancement was observed with the shortened 1.3 S subunits until truncation reached amino acid 59 implying either 1) that the internal sequence, 59-78, transiently associates with the other subunits to properly orient the biotin for catalysis or 2) that the sequence 59-78 contributes to the folded conformation of the 1.3 S subunit so that subunit interactions can take place.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,10900 EUCLID AVE,CLEVELAND,OH 44106	Case Western Reserve University					NIGMS NIH HHS [GM 40786] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040786] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN SHG, 1963, J BIOL CHEM, V238, P1637; BAHLER C, 1981, BIOCHEM INT, V3, P349; CHUANG M, 1975, BIOCHEMISTRY-US, V14, P1611, DOI 10.1021/bi00679a011; CRAFT DV, 1985, BIOCHEMISTRY-US, V24, P2471, DOI 10.1021/bi00331a012; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; ERICSSON LH, 1977, SOLID PHASE METHODS, P137; GLAJCH JL, 1985, J CHROMATOGR, V318, P23, DOI 10.1016/S0021-9673(01)90661-2; HENNESSEY JP, 1982, BIOCHEMISTRY-US, V21, P642, DOI 10.1021/bi00533a007; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; KUMAR GK, 1982, J BIOL CHEM, V257, P13828; KUMAR GK, 1986, ANN NY ACAD SCI, V447, P403; KUMAR KG, 1982, BIOCH INT, V4, P605; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; LOCHMULLER H, 1966, J BIOL CHEM, V241, P5678; MACHLEIDT W, 1981, HIGH PERFORMANCE CHR, P245; MALOY WL, 1979, J BIOL CHEM, V254, P1615; MURTIF VL, 1985, P NATL ACAD SCI USA, V82, P5617, DOI 10.1073/pnas.82.17.5617; MURTIF VL, 1987, J BIOL CHEM, V262, P11813; PHILLIPS NFB, 1986, BIOCHEMISTRY-US, V25, P1644, DOI 10.1021/bi00355a030; RYLATT DB, 1977, ARCH BIOCHEM BIOPHYS, V183, P113, DOI 10.1016/0003-9861(77)90425-8; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; SHENOY BC, 1988, FASEB J, V2, P2396, DOI 10.1096/fasebj.2.8.3360240; SHENOY BC, 1988, FASEB J, V2, P2505, DOI 10.1096/fasebj.2.9.3131174; SHENOY BC, 1992, IN PRESS J BIOL CHEM, V267; SMITHIES O, 1971, BIOCHEMISTRY-US, V10, P4912, DOI 10.1021/bi00802a013; WARBURG O, 1941, BIOCHEM Z, V310, P394; Wood H G, 1976, CRC Crit Rev Biochem, V4, P47, DOI 10.3109/10409237609102558; Wood H. G., 1969, METHOD ENZYMOL, V8, P215; WOOD HG, 1977, ANNU REV BIOCHEM, V46, P385, DOI 10.1146/annurev.bi.46.070177.002125; WOOD HG, 1976, TRENDS BIOCHEM SCI, V1, P4, DOI 10.1016/0968-0004(76)90253-X; WOOD HG, 1963, BIOCHEM Z, V337, P247; WOOD HG, 1968, METHOD ENZYMOL, V13, P297; WRIGLEY NG, 1977, J BIOL CHEM, V252, P1500	33	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2232	2238						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420991				2022-12-27	WOS:A1993KH62000109
J	STAGSTED, J; ZIEBE, S; SATOH, S; HOLMAN, GD; CUSHMAN, SW; OLSSON, L				STAGSTED, J; ZIEBE, S; SATOH, S; HOLMAN, GD; CUSHMAN, SW; OLSSON, L			INSULINOMIMETIC EFFECT ON GLUCOSE-TRANSPORT BY EPIDERMAL GROWTH-FACTOR WHEN COMBINED WITH A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-DERIVED PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; PLASMA-MEMBRANE; TYROSINE KINASE; RAT ADIPOCYTES; FAT-CELLS; STIMULATION; DEGRADATION; ANTIGENS; BINDING; TRANSLOCATION	Peptides derived from the alpha1-region of the murine H-2D(k) molecule enhance glucose uptake in rat adipose cells above the maximum obtained with insulin stimulation alone (Stagsted, J., Reaven, G. M., Hansen, T., Goldstein, A., and Olsson, L. (1990) Cell 62, 297-307). We now describe that epidermal growth factor (EGF) in combination with the same peptides, D(k)-61-85) and D(k)-(62-85), stimulates cellular glucose uptake 5-7 times over the basal level, i.e. to 30-50% of the maximal insulin effect. EGF alone increased glucose uptake by only approximately 50% above basal and the peptide alone by 100% above basal. Maximal effect of EGF and peptide was reached in 10-20 min with 30 muM peptide (EC50 10-15 muM) and 50 nM EGF (EC50 1-2 nM). The effect of EGF and peptide on glucose uptake was additive to that of insulin and peptide until the maximal level attained with insulin and peptide was reached. The combined effect of EGF plus peptide on glucose transport was associated with a recruitment of GLUT4 molecules to the plasma membrane. However, the phosphatidylinositol (PI) kinase which is activated by insulin was not activated by EGF plus peptide. Thus, the effect of EGF plus peptide on glucose uptake seems independent of the activity status of the insulin receptor. I-125-Labeled EGF bound specifically to rat adipose cells with an apparent affinity of approximately 2 nM and B(max) approximately 5 x 10(3). However, the major histocompatibility complex (MHC) peptides did not affect EGF-stimulated internalization of EGF receptor, in contrast to their effect on the insulin receptors. Transforming growth factor(alpha) had an effect similar to EGF on glucose uptake. Three other peptides derived from other parts of murine MHC class I had no effect on glucose uptake in combination with EGF. Thus, EGF in combination with certain MHC class I-derived peptides is insulinomimetic concerning glucose transport and this effect is independent of the insulin receptor activity.	NIDDKD, DIABET BRANCH, EXPTL DIABET METAB & NUTR SECT, BETHESDA, MD 20892 USA; UNIV BATH, DEPT BIOCHEM, BATH BA2 7AY, AVON, ENGLAND	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Bath	STAGSTED, J (corresponding author), RECEPTRON INC, CONCORD, CA 94520 USA.			Holman, Geoffrey/0000-0001-7045-1358				BARNES D, 1976, J CELL PHYSIOL, V89, P633, DOI 10.1002/jcp.1040890420; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; CARPENTER G, 1985, J CELL SCI, P1; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CONRADKESSEL WJ, 1988, MOL CELL ENDOCRINOL, V57, P25, DOI 10.1016/0303-7207(88)90028-7; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DUE C, 1986, P NATL ACAD SCI USA, V83, P6007, DOI 10.1073/pnas.83.16.6007; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; GAMMELTOFT S, 1973, BIOCHIM BIOPHYS ACTA, V320, P16, DOI 10.1016/0304-4165(73)90161-X; HAYSTEAD TAJ, 1986, BIOCHEM J, V234, P279, DOI 10.1042/bj2340279; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KONO T, 1971, J BIOL CHEM, V246, P6210; OKA Y, 1988, J BIOL CHEM, V263, P13432; PESSIN JE, 1983, J BIOL CHEM, V258, P7386; PHILLIPS ML, 1986, P NATL ACAD SCI USA, V83, P3474, DOI 10.1073/pnas.83.10.3474; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHREIBER AB, 1984, J CELL BIOL, V98, P725, DOI 10.1083/jcb.98.2.725; SIMONSEN M, 1983, ANN INST PASTEUR IMM, VD134, P85, DOI 10.1016/S0769-2625(83)80059-2; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WHITMAN M, 1989, ANNU REV CELL BIOL, V5, P93; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	28	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1770	1774						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420953				2022-12-27	WOS:A1993KH62000042
J	ZHENG, MZ; FANG, H; TSURUOKA, T; TSUJI, T; SASAKI, T; HAKOMORI, S				ZHENG, MZ; FANG, H; TSURUOKA, T; TSUJI, T; SASAKI, T; HAKOMORI, S			REGULATORY ROLE OF GM3 GANGLIOSIDE IN ALPHA-5-BETA-1 INTEGRIN RECEPTOR FOR FIBRONECTIN-MEDIATED ADHESION OF FUA169 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE PROTEINS GLYCOSIDASES; MELANOMA-CELLS; SURFACE; RECOGNITION; COLLAGEN; GLYCOPROTEIN; SPECIFICITY; LECTINS; COMPLEX; FAMILY	Mouse mammary carcinoma mutant cell line FUA169, characterized by high G(M3) ganglioside content, was established from parent cell line FM3A/F28-7, which has high lactosyl ceramide (LacCer) content but no G(M3). FUA169 displays no changes in protein glycosylation, and is a typical glycolipid mutant differing from its parent in that it contains high quantities of G(M3) and GlcCer, but no LacCer (see accompanying paper; Tsuruoka, T., Tsuji, T., Nojiri, H., Holmes, E. H., Hakomori, S. (1993) J. Biol. Chem. 268, 2211-2216). In contrast to parent F28-7 cells, FUA169 cells showed clear adhesion to fibronectin (FN). Several lines of evidence indicate that adhesion of FUA169 cells to FN requires the presence of G(M3), which supports the function of integrin receptor. (i) Both FUA 169 and F28-7 cells express the same quantity of FN integrin receptor, which consists of alpha5beta1 (sensitive to RGDS peptide) and alpha4beta1 (sensitive to CS1 peptide). However, adhesion to FN-coated plates, regardless of type of FN, was much higher for FUA169 than for F28-7 cells. (ii) F28-7 cells, which normally lack G(M3) and adhere only weakly to FN, acquired G(M3) during incubation in G(M3)-containing medium, and subsequently adhered strongly to FN. (iii) Cholesterol-lecithin liposomes (cholesterol was C-14-labeled) incorporating alpha5beta1 receptor isolated from human placenta showed clear adhesion to FN-coated plates, and this adhesion was completely inhibited by RGDS peptide and by anti-beta1 mAb ZH1. When liposomes included a moderate quantity of G(M3) (0.22-0.44 mug (0.2-0.4 nmol)/55 mug of phosphatidylcholine, 33 mug of cholesterol, 5 mug of alpha5beta1 in liposome), adhesion was enhanced significantly. In contrast, adhesion was greatly reduced below control level for alpha5beta1 liposomes containing a higher quantity (2.2 mug; >2 nm) of G(M3). Adhesion to FN was also inhibited, but never enhanced, for alpha5beta1 liposomes with similar composition but containing 0.4 nmol (or other quantities) of LacCer or GlcCer instead of G(M3). These findings suggest that the greater adhesion to FN by FUA169 cells, relative to parent F28-7 cells, is due to functional support by G(M3) of alpha5beta1 integrin receptor.	UNIV WASHINGTON,DEPT PATHOBIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT CHEM,SEATTLE,WA 98195; MEIJI SEIKA KAISHA LTD,KOHOKU KU,YOKOHAMA,KANAGAWA 222,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Meiji Holdings Co., Ltd.; University of Tokyo	ZHENG, MZ (corresponding author), BIOMEMBRANE INST,SEATTLE,WA 98119, USA.				NCI NIH HHS [CA42505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042505] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; CARTER WG, 1981, J CELL BIOL, V88, P138, DOI 10.1083/jcb.88.1.138; CHERESH DA, 1987, J CELL BIOL, V105, P1163, DOI 10.1083/jcb.105.3.1163; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; KLEINMAN HK, 1979, P NATL ACAD SCI USA, V76, P3367, DOI 10.1073/pnas.76.7.3367; KOJIMA N, 1989, J BIOL CHEM, V264, P20159; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; OKADA Y, 1984, EXP CELL RES, V155, P448, DOI 10.1016/0014-4827(84)90205-2; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RAUVALA H, 1981, J CELL BIOL, V88, P127, DOI 10.1083/jcb.88.1.127; RAUVALA H, 1981, J CELL BIOL, V88, P149, DOI 10.1083/jcb.88.1.149; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SCHWARZMANN G, 1978, BIOCHIM BIOPHYS ACTA, V529, P106, DOI 10.1016/0005-2760(78)90108-X; SEKIGUCHI K, 1985, J BIOL CHEM, V260, P5105; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; TSURUOKA T, 1993, J BIOL CHEM, V268, P2211; Yamada KM, 1989, FIBRONECTIN, P47	25	120	123	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2217	2222						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420989				2022-12-27	WOS:A1993KH62000107
J	BRINI, AT; LEE, GM; KINET, JP				BRINI, AT; LEE, GM; KINET, JP			INVOLVEMENT OF ALU SEQUENCES IN THE CELL-SPECIFIC REGULATION OF TRANSCRIPTION OF THE GAMMA-CHAIN OF FC AND T-CELL RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; ZETA-CHAIN; MOLECULAR-CLONING; ANTIGEN RECEPTOR; BINDING PROTEIN; MAMMALIAN-CELLS; NUCLEAR-PROTEIN; IGE; GENE; EXPRESSION	The FcepsilonRI-gamma chains are expressed in a variety of hematopoietic cells where they play a critical role in signal transduction. They are part of the high affinity IgE receptor in mast cells, basophils, Langerhans cells, and possibly other cells; a component of the low affinity receptor for IgG (FcgammaRIIIA or CD16) in natural killer cells and macrophages; and part of the T cell antigen receptor in subsets of T cells. Here we have investigated the transcriptional regulation of the gamma chain gene by analyzing the 2.5-kilobase sequence upstream of the transcription start site. This sequence contains a promoter specific to cells of hematopoietic lineage. However, the tissue specificity of this promoter is only partial because it is active in all of the hematopoietic cells tested here, regardless of whether they constitutively express FcepsilonI- gamma chain transcripts. We have identified two adjacent cis-acting regulatory elements, both of which are part of an Alu repeat. The first (-445/-366) is a positive element active in both basophils and T cells. The second (-365/-264) binds to nuclear factors, which appear to be different in basophils and T cells, and acts as a negative element in basophils and as a positive one in T cells. Thus, this Alu repeat (90% identical to Alu consensus sequences) has evolved to become both a positive and negative regulator.	NIAID,MOLEC ALLERGY & IMMUNOL SECT,ROCKVILLE,MD 20852	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Brini, Anna Teresa/C-2610-2017	Brini, Anna Teresa/0000-0002-7848-8099				ANDERSON P, 1990, P NATL ACAD SCI USA, V87, P2274, DOI 10.1073/pnas.87.6.2274; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BANIYASH M, 1989, J BIOL CHEM, V264, P13252; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; HSU VW, 1992, NEW BIOL, V4, P166; HUPP K, 1989, J IMMUNOL, V143, P3787; JIN YJ, 1990, P NATL ACAD SCI USA, V87, P3319, DOI 10.1073/pnas.87.9.3319; KINET JP, 1992, CURR OPIN IMMUNOL, V4, P43, DOI 10.1016/0952-7915(92)90122-U; KINET JP, 1990, CURR OPIN IMMUNOL, V2, P499, DOI 10.1016/0952-7915(90)90002-X; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; KLAGES S, 1992, NUCLEIC ACIDS RES, V20, P1925, DOI 10.1093/nar/20.8.1925; KORNBLUTH J, 1982, J IMMUNOL, V129, P2831; KORNER M, 1990, BIOCHEM J, V265, P547, DOI 10.1042/bj2650547; KOYASU S, 1992, J EXP MED, V175, P203, DOI 10.1084/jem.175.1.203; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; KUSTER H, 1990, J BIOL CHEM, V265, P6448; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; LECONIAT M, 1990, IMMUNOGENETICS, V32, P183, DOI 10.1007/BF02114971; LETOURNEUR F, 1989, IMMUNOGENETICS, V29, P265, DOI 10.1007/BF00717911; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MCDONAGH KT, 1991, J BIOL CHEM, V266, P11965; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; SAFFER JD, 1989, MOL CELL BIOL, V9, P355, DOI 10.1128/MCB.9.2.355; Sambrook J, 1989, MOL CLONING LABORATO; SELBY MJ, 1990, CELL, V62, P769, DOI 10.1016/0092-8674(90)90121-T; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHEN MR, 1991, J MOL EVOL, V33, P311; TECHUNG L, 1982, NUCLEIC ACIDS RES, V20, P140; TOMILIN NV, 1990, FEBS LETT, V263, P69, DOI 10.1016/0014-5793(90)80707-P; VIVIER E, 1991, J IMMUNOL, V147, P4263; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709	43	77	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1355	1361						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419337				2022-12-27	WOS:A1993KG07700089
J	MCCOOL, BA; PLONK, SG; MARTIN, PR; SINGLETON, CK				MCCOOL, BA; PLONK, SG; MARTIN, PR; SINGLETON, CK			CLONING OF HUMAN TRANSKETOLASE CDNAS AND COMPARISON OF THE NUCLEOTIDE-SEQUENCE OF THE CODING REGION IN WERNICKE-KORSAKOFF AND NON-WERNICKE-KORSAKOFF INDIVIDUALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; RHODOBACTER-CAPSULATUS; GENE; BRAIN; SUBUNIT; IDENTIFICATION; OPERON; YEAST; DNA; DECARBOXYLASE	Variants of the enzyme transketolase which possess reduced affinity for its cofactor thiamine pyrophosphate (high apparent K(m)) have been described in chronic alcoholic patients with Wernicke-Korsakoff syndrome. Since the syndrome has been shown to be directly related to thiamine deficiency, it has been hypothesized that such transketolase variants may represent a genetic predisposition to the development of this syndrome. To test this hypothesis, human transketolase cDNA clones were isolated, and their nucleotide and predicted amino acid sequence were determined. Transketolase was found to be a single copy gene which produces a single mRNA of approximately 2100 nucleotides. Additionally, the nucleotide sequence of the transketolase coding region in fibroblasts derived from two Wernicke-Korsakoff (WK) patients was compared to that of two nonalcoholic controls. Although nucleotide and predicted amino acid differences were detected between fibroblast cultures and the original cDNAs and among the cultures themselves, no specific nucleotide variations, which would encode a variant amino acid sequence, were associated exclusively with the coding region from WK patients. Thus, allelic variants of the transketolase gene cannot account for the biochemically distinct forms of the enzyme found in these patients nor be considered as a mechanism for genetic predisposition to the development of Wernicke-Korsakoff syndrome. Instead, the underlying mechanism must be extragenic and may be a result of differences in post-translational processing/modification of the transketolase polypeptide.	VANDERBILT UNIV,DEPT MOLEC BIOL,NASHVILLE,TN 37235; VANDERBILT UNIV,DEPT PSYCHIAT,NASHVILLE,TN 37235; VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37235	Vanderbilt University; Vanderbilt University; Vanderbilt University			McCool, Brian A/C-9710-2009; Martin, Peter R/A-7738-2008	McCool, Brian/0000-0002-1002-9435	NIAAA NIH HHS [AA08492] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008492] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABEDINIA M, 1992, BIOCHEM BIOPH RES CO, V183, P1159, DOI 10.1016/S0006-291X(05)80312-2; AUSUBEL FM, 1989, CURRENT PROTOCOLS MO, P481; BAUER CE, 1988, J BIOL CHEM, V263, P4820; BEHAL RH, 1989, BIOCHEM BIOPH RES CO, V164, P941, DOI 10.1016/0006-291X(89)91549-0; BLASS JP, 1977, NEW ENGL J MED, V297, P1367, DOI 10.1056/NEJM197712222972503; BLASS JP, 1979, ALCOHOL CLIN EXP RES, V3, P126, DOI 10.1111/j.1530-0277.1979.tb05286.x; BUELL MV, 1958, J BIOL CHEM, V232, P979; BUTTERS N, 1980, ALCOHOLIC KORSAKOFFS; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHEN JH, 1991, J BIOL CHEM, V266, P20447; CHERNAK JM, 1989, NUCLEIC ACIDS RES, V17, P1933, DOI 10.1093/nar/17.5.1933; CRESPI F, 1982, BRAIN RES, V248, P275, DOI 10.1016/0006-8993(82)90585-6; DEMEIRLEIR L, 1988, J BIOL CHEM, V263, P1991; FLETCHER TS, 1992, BIOCHEMISTRY-US, V31, P1892, DOI 10.1021/bi00121a044; GOBLET C, 1989, NUCLEIC ACIDS RES, V17, P2144, DOI 10.1093/nar/17.5.2144; GREEN JBA, 1989, FEBS LETT, V246, P1, DOI 10.1016/0014-5793(89)80241-8; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; HEMILA H, 1990, J BACTERIOL, V172, P5052, DOI 10.1128/jb.172.9.5052-5063.1990; HEROUX M, 1988, J NEUROCHEM, V51, P1221, DOI 10.1111/j.1471-4159.1988.tb03090.x; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOFFMANN A, 1990, GENE DEV, V4, P1141, DOI 10.1101/gad.4.7.1141; HUH TL, 1990, J BIOL CHEM, V265, P13320; JANOWICZ ZA, 1985, NUCLEIC ACIDS RES, V13, P3043, DOI 10.1093/nar/13.9.3043; JOSEPHSON BL, 1969, J BACTERIOL, V100, P1289, DOI 10.1128/JB.100.3.1289-1295.1969; LANGLAIS PJ, 1988, NEUROCHEM RES, V13, P1199, DOI 10.1007/BF00971639; LIN CT, 1991, PLANT PHYSIOL, V95, P1250, DOI 10.1104/pp.95.4.1250; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LISHMAN WA, 1981, BRAIN, V104, P1, DOI 10.1093/brain/104.1.1; MAHLER HR, 1971, BIOL CHEM, P530; Maniatis T., 1982, MOL CLONING; MARTIN PR, 1986, PROG NEURO-PSYCHOPH, V10, P147, DOI 10.1016/0278-5846(86)90069-2; MARTIN PR, 1992, IN PRESS ALCOHOL CLI; MAYERHOFER R, 1991, EMBO J, V10, P697, DOI 10.1002/j.1460-2075.1991.tb07999.x; McIlwain H., 1985, BIOCH CENTRAL NERVOU, V5th ed.; MINSHULL J, 1986, NUCLEIC ACIDS RES, V14, P6433, DOI 10.1093/nar/14.16.6433; MORGAN MY, 1982, BRIT MED BULL, V38, P21, DOI 10.1093/oxfordjournals.bmb.a071727; MORI H, 1991, J BIOL CHEM, V266, P18446; MUKHERJEE AB, 1987, J CLIN INVEST, V79, P1039, DOI 10.1172/JCI112916; NIXON PF, 1984, EUR J CLIN INVEST, V14, P278, DOI 10.1111/j.1365-2362.1984.tb01181.x; PERHAM RN, 1991, EUR J BIOCHEM, V194, P95; PRIEFERT H, 1991, J BACTERIOL, V173, P4056, DOI 10.1128/jb.173.13.4056-4071.1991; SCHNEIDER G, 1989, J BIOL CHEM, V264, P21619; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; STRYER L, 1988, BIOCHEMISTRY-US, P427; TAKEUCHI T, 1986, BIOCHIM BIOPHYS ACTA, V872, P24, DOI 10.1016/0167-4838(86)90143-3; TAKEUCHI T, 1984, CLIN CHEM, V30, P658; THOMPSON SG, 1985, NEUROCHEM RES, V10, P1653, DOI 10.1007/BF00988607; THOMSON AD, 1983, ALCOHOL ALCOHOLISM, V18, P27; TORVIK A, 1982, J NEUROL SCI, V56, P233, DOI 10.1016/0022-510X(82)90145-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WELLINGTON CL, 1989, GENE, V83, P251, DOI 10.1016/0378-1119(89)90111-X; Woo S L, 1979, Methods Enzymol, V68, P389; YOUVAN DC, 1984, P NATL ACAD SCI-BIOL, V81, P189, DOI 10.1073/pnas.81.1.189; ZIMMERN D, 1978, P NATL ACAD SCI USA, V75, P4257, DOI 10.1073/pnas.75.9.4257	56	70	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1397	1404						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419340				2022-12-27	WOS:A1993KG07700095
J	MURAKAMI, M; KUDO, I; INOUE, K				MURAKAMI, M; KUDO, I; INOUE, K			MOLECULAR NATURE OF PHOSPHOLIPASES-A2 INVOLVED IN PROSTAGLANDIN-I2 SYNTHESIS IN HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - POSSIBLE PARTICIPATION OF CYTOSOLIC AND EXTRACELLULAR TYPE-II PHOSPHOLIPASES-A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PLATELET PHOSPHOLIPASE-A2; TUMOR-NECROSIS-FACTOR; CULTURED HUMAN; MESSENGER-RNA; PANCREATIC PHOSPHOLIPASE-A2; PROSTACYCLIN PRODUCTION; SERUM PHOSPHOLIPASE-A2; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; INFLAMMATORY EXUDATE	A lysate of unstimulated human umbilical vein endothelial cells (HUVEC) exhibited phospholipase A2 (PLA2) activity, which hydrolyzed phospholipids bearing arachidonate more preferentially than those bearing linoleate at the sn-2 position. An anti-rabbit cytosolic PLA2 monoclonal antibody absorbed the activity, whereas an anti-human type II PLA2 monoclonal antibody did not. HUVEC treated with thrombin generated prostaglandin I2 (PGI2), and the PLA2 activity of the thrombin-stimulated cells was absorbed almost completely by the anti-cytosolic PLA2 antibody. HUVEC treated with tumor necrosis factor (TNF) also generated PGI2. PGI2 generation by TNF-treated cells was suppressed partially by extracellular addition of the anti-type II PLA2 antibody. PLA2 activity in a lysate of TNF-stimulated cells was increased about 2-3-fold, and about half of the increased activity was suppressed by the anti-type II PLA2 antibody. Addition of heparin together with TNF resulted in release of type II PLA2 in the medium. Thus, both cytosolic and type II PLA2s may be involved in agonist-stimulated PGI2 synthesis in HUVEC. Furthermore, exogenously added type II PLA2 was bound to the cell surface and synergistically enhanced PGI2 generation in TNF-stimulated HUVEC. This binding was blocked by either heparin or a monoclonal antibody recognizing the heparin-binding domain of type II PLA2. Taken together, type II PLA2 generated endogenously as well as added exogenously may be captured on the HUVEC surface via heparan sulfate proteoglycan and may contribute to cellular arachidonate metabolism.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo								AARSMAN AJ, 1989, J BIOL CHEM, V264, P10008; ALLIKMETS EY, 1986, TISSUE CELL, V18, P481, DOI 10.1016/0040-8166(86)90014-5; BAENZIGER NL, 1980, BIOCHEM BIOPH RES CO, V92, P1435, DOI 10.1016/0006-291X(80)90447-7; BICKNELL R, 1989, P NATL ACAD SCI USA, V86, P1573, DOI 10.1073/pnas.86.5.1573; BUONASSISI V, 1975, BIOCHIM BIOPHYS ACTA, V385, P1, DOI 10.1016/0304-4165(75)90067-7; CHANG HW, 1987, J BIOCHEM, V102, P147, DOI 10.1093/oxfordjournals.jbchem.a122026; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CROWL RM, 1991, J BIOL CHEM, V266, P2647; DOLE VP, 1960, J BIOL CHEM, V235, P2595; FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466; FORST S, 1986, BIOCHEMISTRY-US, V25, P8381, DOI 10.1021/bi00374a008; FUJIMORI Y, 1992, J BIOCHEM-TOKYO, V111, P54, DOI 10.1093/oxfordjournals.jbchem.a123718; Gerritsen M E, 1990, Adv Exp Med Biol, V275, P115; GOODMAN R, 1991, AGENTS ACTIONS, V34, P113, DOI 10.1007/BF01993253; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; HARA S, 1991, J BIOCHEM, V110, P163, DOI 10.1093/oxfordjournals.jbchem.a123550; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; HAYAKAWA M, 1988, J BIOCHEM-TOKYO, V104, P767, DOI 10.1093/oxfordjournals.jbchem.a122547; KAWAKAMI M, 1986, BIOCHEM BIOPH RES CO, V141, P482, DOI 10.1016/S0006-291X(86)80198-X; KERR JS, 1989, BIOCHEM BIOPH RES CO, V165, P1079, DOI 10.1016/0006-291X(89)92712-5; KIM DK, 1991, BIOCHIM BIOPHYS ACTA, V1083, P80; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MARCUS AJ, 1980, J CLIN INVEST, V66, P979, DOI 10.1172/JCI109967; McLean L R, 1986, Methods Enzymol, V129, P738; MIZUSHIMA H, 1989, J BIOCHEM-TOKYO, V105, P520, DOI 10.1093/oxfordjournals.jbchem.a122699; MURAKAMI M, 1989, BIOCHIM BIOPHYS ACTA, V1005, P270; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; MURAKAMI M, 1988, J BIOCHEM-TOKYO, V104, P884, DOI 10.1093/oxfordjournals.jbchem.a122577; MURAKAMI M, 1990, BIOCHIM BIOPHYS ACTA, V1043, P34, DOI 10.1016/0005-2760(90)90107-9; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NAKANO T, 1990, FEBS LETT, V273, P23, DOI 10.1016/0014-5793(90)81042-M; OKA S, 1991, J BIOL CHEM, V266, P9956; ONO T, 1988, J BIOL CHEM, V263, P5732; ONO T, 1984, J BIOCHEM-TOKYO, V96, P785, DOI 10.1093/oxfordjournals.jbchem.a134896; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; ROSENTHANL MD, 1989, ARCH BIOCHEM BIOPHYS, V273, P590; SAKATA T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P124, DOI 10.1016/0167-4781(89)90141-3; SCHALKWIJK C, 1991, BIOCHEM BIOPH RES CO, V174, P268, DOI 10.1016/0006-291X(91)90515-9; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; SHARP JD, 1991, J BIOL CHEM, V266, P14850; STONER CR, 1991, J IMMUNOL METHODS, V145, P127, DOI 10.1016/0022-1759(91)90318-A; TAKAYAMA K, 1991, FEBS LETT, V282, P326, DOI 10.1016/0014-5793(91)80506-X; TAKAYAMA K, 1990, BIOCHEM BIOPH RES CO, V167, P1309, DOI 10.1016/0006-291X(90)90666-B; TOJO H, 1988, J BIOL CHEM, V263, P5724; VADAS P, 1983, CAN J PHYSIOL PHARM, V61, P561, DOI 10.1139/y83-086; VERGER R, 1982, BIOCHEMISTRY-US, V21, P6883, DOI 10.1021/bi00269a040; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; WEKSLER BB, 1978, J CLIN INVEST, V62, P923, DOI 10.1172/JCI109220; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515	55	237	238	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					839	844						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419361				2022-12-27	WOS:A1993KG07700016
J	SLEPAK, VZ; WILKIE, TM; SIMON, MI				SLEPAK, VZ; WILKIE, TM; SIMON, MI			MUTATIONAL ANALYSIS OF G-PROTEIN ALPHA-SUBUNIT GO-ALPHA EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; BETA-ADRENERGIC-RECEPTOR; ROD OUTER SEGMENTS; REGULATORY PROTEINS; BOVINE BRAIN; ADENYLYL CYCLASE; ADP-RIBOSYLATION; GAMMA-SUBUNITS; GTP; IDENTIFICATION	G protein-mediated signal transduction is dependent on alpha subunit interactions with betagamma subunits, receptors, effectors, magnesium ions, and guanine nucleotides. The interdependence of these interactions can be probed by mutational analysis. We developed large scale screening procedures in recombinant Escherichia coli to identify and characterize novel mutations in G(o)alpha. Random mutations were generated by polymerase chain reaction in the amino-terminal 56 amino acids of G(o)alpha. Guanine nucleotide binding properties of the mutants were assayed in situ and in crude extracts of recombinant E. coli. Betagamma interactions were assayed by pertussis toxin mediated ADP-ribosylation. Efficacy of the screening procedures was evaluated by studying properties of wild-type G(o)alpha and site-directed mutations that were characterized previously in other G proteins. Several novel mutants with altered GTP binding characteristics and reduced ability to interact with betagamma had been isolated from the randomly generated mutant library. ADP-ribosylation of mutants R10G, K21N, and K35E was significantly reduced, whereas two of the mutants bearing multiple amino acid substitutions were refractory to modification. Mutant K35E also exhibited reduced affinity to guanosine 5'-(3-O-thio)triphosphate at submicromolar concentrations of magnesium. These experiments demonstrate the feasibility of using large scale random mutagenesis in the studies of G protein function.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034236, R37GM034236] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34236] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BERTIN B, 1992, J BIOL CHEM, V267, P8200; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT DR, 1986, J BIOL CHEM, V261, P1656; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; DENKER BM, 1992, J BIOL CHEM, V267, P9998; DENKER BM, 1992, J BIOL CHEM, V267, P6272; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; DURONIO R J, 1990, Methods (Orlando), V1, P253, DOI 10.1016/S1046-2023(05)80325-1; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; FEIG LA, 1986, P NATL ACAD SCI USA, V83, P4607, DOI 10.1073/pnas.83.13.4607; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FREISSMUTH M, 1991, J BIOL CHEM, V266, P17778; FUNG BKK, 1983, J BIOL CHEM, V258, P503; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HAGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HIRSCH JP, 1991, GENE DEV, V5, P467, DOI 10.1101/gad.5.3.467; HOLBROOK SR, 1989, P NATL ACAD SCI USA, V86, P1751, DOI 10.1073/pnas.86.6.1751; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; ITOH H, 1991, J BIOL CHEM, V266, P16226; JOHNSON GL, 1991, J CELL BIOCHEM, V47, P136, DOI 10.1002/jcb.240470207; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE E, 1992, J BIOL CHEM, V267, P1212; Leung DW, 1989, TECHNIQUE, V1, P11; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LINDER ME, 1990, J BIOL CHEM, V265, P8243; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MUMBY S, 1988, J BIOL CHEM, V263, P2020; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEER EJ, 1984, J BIOL CHEM, V259, P4222; OSAWA S, 1991, J BIOL CHEM, V266, P4673; PANG IH, 1989, P NATL ACAD SCI USA, V86, P7814, DOI 10.1073/pnas.86.20.7814; RUBENSTEIN RC, 1991, BIOCHEMISTRY-US, V30, P10769, DOI 10.1021/bi00108a023; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUNIER T, 1984, J BIOL CHEM, V259, P15447; TABOR S, 1987, J BIOL CHEM, V262, P16212; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; WU DQ, 1992, J BIOL CHEM, V267, P1811	62	36	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1414	1423						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419342				2022-12-27	WOS:A1993KG07700097
J	MABLY, JD; SOLE, MJ; LIEW, CC				MABLY, JD; SOLE, MJ; LIEW, CC			CHARACTERIZATION OF THE GARC MOTIF - A NOVEL CIS-ACTING ELEMENT OF THE HUMAN CARDIAC MYOSIN HEAVY-CHAIN GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MUSCLE-SPECIFIC TRANSCRIPTION; PROTEIN-BINDING SITE; RNA POLYMERASE-II; ALPHA-ACTIN; THYROID-HORMONE; C-FOS; REGULATORY FACTORS; COMPLETE SEQUENCE	A positive element between positions -924 and -851 and a negative element between -851 and -762 of the 5'-upstream region of the alpha-myosin heavy chain gene were identified through transient transfection assays in primary cultures of neonatal rat heart cells. Subsequent DNase I protection analysis revealed almost identical footprints at two positions (GAAAAATCT at -904 to -896 and GAAAATCT at -823 to -816). We have designated this sequence the GArC motif (for G,AT-rich,C). Gel mobility shift assays demonstrated the formation of specific complexes with GArC oligomers when either rat heart, rat liver, or HeLa cell nuclear extracts were used. Competition studies with unlabeled GArC oligomers resulted in a loss of binding. Oligomers were also made to the Xenopus cytoskeletal actin serum response element and to a segment of the alpha-MyHC gene (AT-core), each with a similar AT-rich core sequence. No detectable loss of binding resulted from the addition of an excess of either of these unlabeled oligomers. Southwestern blot analysis identified several proteins which interacted with the GArC element, suggesting the presence of a group of related trans-acting factors. Analysis of a sequence in the beta-MyHC gene with the same AT-rich core was negative, suggesting a role for the bases surrounding the protected area in binding. We propose that the GArC motif, together with its associated trans-acting factor(s), provides a novel mechanism of transcriptional control in addition to those previously reported for the cardiac myosin heavy chain genes.	UNIV TORONTO,TORONTO HOSP,INST BANTING,CTR CARDIOVASC RES,MOLEC CARDIOL LAB,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto								BOUVAGNET PF, 1987, MOL CELL BIOL, V7, P4377, DOI 10.1128/MCB.7.12.4377; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1989, MOL CELL BIOL, V9, P2513, DOI 10.1128/MCB.9.6.2513; BRENOWITZ M, 1989, CURRENT PROTOCOLS MO, P1241; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHODOSH LA, 1989, CURRENT PROTOCOLS MO, P1221; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94; COWAN DB, 1991, BIOCHEM J, V274, P687, DOI 10.1042/bj2740687; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FLINK IL, 1992, J BIOL CHEM, V267, P9917; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GUSTAFSON TA, 1986, CIRC RES, V59, P194, DOI 10.1161/01.RES.59.2.194; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KARIYA K, 1991, J BIOL CHEM, V266, P10023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; LIEW CC, 1990, NUCLEIC ACIDS RES, V18, P3647, DOI 10.1093/nar/18.12.3647; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MIWA T, 1987, P NATL ACAD SCI USA, V84, P6702, DOI 10.1073/pnas.84.19.6702; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; PHANDINHTUY F, 1988, EUR J BIOCHEM, V173, P507, DOI 10.1111/j.1432-1033.1988.tb14027.x; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P707; SAEZ LJ, 1987, NUCLEIC ACIDS RES, V15, P5443, DOI 10.1093/nar/15.13.5443; Sambrook J, 1989, MOL CLONING LABORATO; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SINGH H, 1989, CURRENT PROTOCOLS MO, P1271; SWYNGHEDAUW B, 1986, PHYSIOL REV, V66, P710, DOI 10.1152/physrev.1986.66.3.710; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TSIKA RW, 1990, P NATL ACAD SCI USA, V87, P379, DOI 10.1073/pnas.87.1.379; WANG DL, 1992, BIOCHEM BIOPH RES CO, V183, P1260, DOI 10.1016/S0006-291X(05)80326-2; YAMAUCHITAKIHARA K, 1989, P NATL ACAD SCI USA, V86, P3504, DOI 10.1073/pnas.86.10.3504; YU YT, 1989, MOL CELL BIOL, V9, P1839, DOI 10.1128/MCB.9.5.1839	51	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					476	482						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416951				2022-12-27	WOS:A1993KE60300073
J	MIURA, Y; KIKUCHI, A; MUSHA, T; KURODA, S; YAKU, H; SASAKI, T; TAKAI, Y				MIURA, Y; KIKUCHI, A; MUSHA, T; KURODA, S; YAKU, H; SASAKI, T; TAKAI, Y			REGULATION OF MORPHOLOGY BY RHO P21 AND ITS INHIBITORY GDP/GTP EXCHANGE PROTEIN (RHO GDI) IN SWISS 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; BOTULINUM ADP-RIBOSYLTRANSFERASE; BOVINE BRAIN CYTOSOL; CLOSTRIDIUM-BOTULINUM; SMOOTH-MUSCLE; MOLECULAR-CLONING; GENE-PRODUCT; SMG P21S; PURIFICATION; RIBOSYLATION	rho GDP dissociation inhibitor (GDI) is an inhibitory GDP/GTP exchange protein for a group of small GTP-binding proteins including at least rhoA p21, rhoB p21, rac1 p21, rac2 p21, and G25K. Microinjection of rho GDI into Swiss 3T3 cells made the cells round and refractile. This morphological change was accompanied by the disappearance of stress fibers. The rho GDI action was prevented by comicroinjection of rho GDI with the guanosine 5'-(3-O-thio)triphosphate (GTPgammaS)-bound form of rhoA p21, but not with the GTPgammaS-bound form of rhoA p21 lacking the C-terminal three amino acids, which was not post-translationally modified with lipids. The GTPgammaS-bound form of rac1 p21, the same form of G25K, the same form of smg p21B, or Ki-ras(val12) p21 was ineffective. Microinjection of the bacterial ADP-ribosyltransferase C3 specific for rho p21 into Swiss 3T3 cells induced the similar changes of morphology and stress fibers. This C3 action was not prevented by comicroinjection Of C3 with the GTPgammaS-bound form of rhoA p21, but was prevented by comicroinjection with the same form of a rhoA p21 mutant which was not ADP-ribosylated by C3. These results indicate that the rho GDI-rho p21 system regulates cell morphology presumably through the actomyosin system in Swiss 3T3 cells.	KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN	Kobe University			KURODA, SHINYA/G-4961-2014					ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BRAUN U, 1989, FEBS LETT, V243, P70, DOI 10.1016/0014-5793(89)81220-7; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; FUJIWARA T, 1989, J PHYSIOL-LONDON, V408, P535, DOI 10.1113/jphysiol.1989.sp017474; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HIRATA K, 1992, J BIOL CHEM, V267, P8719; HORI Y, 1991, ONCOGENE, V6, P515; ISOMURA M, 1990, BIOCHEM BIOPH RES CO, V169, P652, DOI 10.1016/0006-291X(90)90380-6; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; KIKUCHI A, 1988, J BIOL CHEM, V263, P16303; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KURODA S, 1992, BIOCHEM BIOPH RES CO, V185, P473, DOI 10.1016/S0006-291X(05)81009-5; MARUMIYA S, 1988, J BIOL CHEM, V263, P17255; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MOHR C, 1990, FEBS LETT, V275, P168, DOI 10.1016/0014-5793(90)81464-Y; MORIISHI K, 1991, J BACTERIOL, V173, P6025, DOI 10.1128/jb.173.19.6025-6029.1991; MOSS J, 1990, ADP RIBOSYLATING TOX, P567; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; NISHIKI T, 1990, BIOCHEM BIOPH RES CO, V167, P265, DOI 10.1016/0006-291X(90)91760-P; NISHIMURA J, 1988, BIOCHEM BIOPH RES CO, V157, P677, DOI 10.1016/S0006-291X(88)80303-6; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Sambrook J, 1989, MOL CLONING LABORATO; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STASIA MJ, 1991, BIOCHEM BIOPH RES CO, V180, P615, DOI 10.1016/S0006-291X(05)81110-6; SUGAI M, 1990, BIOCHEM BIOPH RES CO, V173, P92, DOI 10.1016/S0006-291X(05)81026-5; SUGAI M, 1992, J BIOL CHEM, V267, P2600; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; UEDA T, 1990, J BIOL CHEM, V265, P9373; Weber K, 1972, Methods Enzymol, V26, P3; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; YOSHIDA Y, 1991, BIOCHEM BIOPH RES CO, V175, P720, DOI 10.1016/0006-291X(91)91625-M	50	125	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					510	515						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416955				2022-12-27	WOS:A1993KE60300077
J	TAKUWA, N; WEI, Z; KUMADA, M; TAKUWA, Y				TAKUWA, N; WEI, Z; KUMADA, M; TAKUWA, Y			CA2+-DEPENDENT STIMULATION OF RETINOBLASTOMA GENE-PRODUCT PHOSPHORYLATION AND P34CDC2 KINASE ACTIVATION IN SERUM-STIMULATED HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; CHICKEN-EMBRYO FIBROBLASTS; EPIDERMAL GROWTH-FACTOR; SWISS 3T3 FIBROBLASTS; RAT-LIVER CELLS; SUSCEPTIBILITY GENE; HISTONE-H1 KINASE; DNA-REPLICATION; CALCIUM REQUIREMENTS; TUMOR SUPPRESSOR	In serum-deprived human fibroblasts IMR-90 and WI-38 cells, the addition of fetal calf serum or basic fibroblast growth factor stimulates DNA synthesis in an extracellular Ca2+-dependent manner; the effect of serum on [H-3]thymidine incorporation into DNA is 4-16-fold greater at 2.0 mM CaCl2 as compared with that at 0.03 mM CaCl2. By contrast, in SV40 virus-transformed WI-38 (SV-WI-38) cells DNA synthesis is essentially independent of the extracellular calcium concentration ([Ca]out) and serum growth factors. To explore the role of Ca2+ in mitogenic signal transduction through G1 to S phase cell cycle progression, we studied and compared the effect of [Ca]out on phosphorylation of RB protein, the product of a tumor suppressor retinoblastoma gene. In IMR-90 and WI-38 cells, serum or basic fibroblast growth factor induces an increase in the amount of hyperphosphorylated forms of RB protein in a manner strictly dependent on [Ca]out. In sharp contrast, in SV-WI-38 cells, the extent of RB phosphorylation is little affected by [Ca]out or the presence or absence of serum growth factors. In addition, potent calmodulin antagonists W-7 and calmidazolium, but not an inactive analogue W-12 or W-5, strongly inhibit serum-induced increases in DNA synthesis and RB phosphorylation in IMR-90 and WI-38 cells, whereas in SV-WI-38 cells, the inhibitory effect is much more limited. Under the same treatment conditions, we measured histone H1 kinase activity associated with anti-p34cdc2 immunoprecipitate and found that the serum-induced increase in p34cdc2 kinase activity is strongly dependent on [Ca]out and is potently inhibited by the active calmodulin antagonists in IMR-90 and WI-38 cells, but not in SV-WI-38 cells. In IMR-90 cells that have been incubated with serum in 0.03 mM [Ca]out for 24 h, restoration of [Ca]out to 2.0 mM results in initiation of DNA synthesis after 13 h and concomitant increases in RB phosphorylation and p34cdc2 histone H1 kinase activity. These results suggest that in human fibroblasts, Ca2+/calmodulin regulates the signaling cascade leading to cdc2 kinase activation, RB protein phosphorylation, and DNA synthesis and that this Ca2+-dependent regulation is abrogated in SV40-transformed cells.	UNIV TOKYO,FAC MED,DEPT CARDIOVASC BIOL,TOKYO 113,JAPAN	University of Tokyo	TAKUWA, N (corresponding author), UNIV TOKYO,FAC MED,DEPT PHYSIOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.			TAKUWA, Noriko/0000-0002-4278-2704				ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BALK SD, 1971, P NATL ACAD SCI USA, V68, P271, DOI 10.1073/pnas.68.2.271; BLOW JJ, 1990, CELL, V62, P855, DOI 10.1016/0092-8674(90)90261-C; BOYNTON AL, 1977, CANCER RES, V37, P2657; BOYNTON AL, 1976, P NATL ACAD SCI USA, V73, P1651, DOI 10.1073/pnas.73.5.1651; BOYNTON AL, 1980, BIOCHEM BIOPH RES CO, V95, P745, DOI 10.1016/0006-291X(80)90849-9; BOYNTON AL, 1977, J CELL PHYSIOL, V92, P241, DOI 10.1002/jcp.1040920212; BRIZUELA L, 1989, P NATL ACAD SCI USA, V86, P4362, DOI 10.1073/pnas.86.12.4362; CHAFOULEAS JG, 1981, P NATL ACAD SCI-BIOL, V78, P996, DOI 10.1073/pnas.78.2.996; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; CHAFOULEAS JG, 1984, CELL, V36, P73, DOI 10.1016/0092-8674(84)90075-8; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CRISS WE, 1982, FED PROC, V41, P2289; CUTRY AF, 1989, J BIOL CHEM, V264, P19700; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DICICCOBLOOM E, 1989, BRAIN RES, V491, P403, DOI 10.1016/0006-8993(89)90080-2; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DULBECCO R, 1975, P NATL ACAD SCI USA, V72, P1584, DOI 10.1073/pnas.72.4.1584; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FURUKAWA Y, 1990, P NATL ACAD SCI USA, V87, P2770, DOI 10.1073/pnas.87.7.2770; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GIORDANO A, 1991, SCIENCE, V253, P1271, DOI 10.1126/science.1653969; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HOWE PH, 1991, MOL CELL BIOL, V11, P1185, DOI 10.1128/MCB.11.3.1185; HUPE DJ, 1991, J BIOL CHEM, V266, P10136; LABBE JC, 1989, CELL, V57, P253, DOI 10.1016/0092-8674(89)90963-X; LEE MG, 1988, NATURE, V333, P676, DOI 10.1038/333676a0; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MAGNI M, 1991, J BIOL CHEM, V266, P6329; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; NICHOLSON NB, 1984, J CELL BIOL, V99, P2314, DOI 10.1083/jcb.99.6.2314; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1980, GENETICS, V96, P627; PAUL D, 1979, J CELL PHYSIOL, V98, P31, DOI 10.1002/jcp.1040980105; PUJOL MJ, 1989, J BIOL CHEM, V264, P18863; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; RASMUSSEN CD, 1987, EMBO J, V6, P3961, DOI 10.1002/j.1460-2075.1987.tb02738.x; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; RIXON RH, 1976, J CELL PHYSIOL, V87, P147, DOI 10.1002/jcp.1040870203; SASAKI Y, 1982, BIOCHEM BIOPH RES CO, V104, P451, DOI 10.1016/0006-291X(82)90658-1; SERRATOSA J, 1988, BIOCHEM BIOPH RES CO, V150, P1162, DOI 10.1016/0006-291X(88)90751-6; SORIANO M, 1985, CELL TISSUE KINET, V18, P475, DOI 10.1111/j.1365-2184.1985.tb00689.x; TAKAHASHI R, 1991, P NATL ACAD SCI USA, V88, P5257, DOI 10.1073/pnas.88.12.5257; TAKUWA N, 1988, J BIOL CHEM, V263, P9738; TAKUWA N, 1991, J BIOL CHEM, V266, P1403; TAKUWA N, 1987, J BIOL CHEM, V262, P182; TAYA Y, 1989, BIOCHEM BIOPH RES CO, V164, P580, DOI 10.1016/0006-291X(89)91759-2; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; TUPPER JT, 1980, J CELL PHYSIOL, V104, P97, DOI 10.1002/jcp.1041040113; VEIGL ML, 1982, FED PROC, V41, P2282; WATTERSON DM, 1976, P NATL ACAD SCI USA, V73, P2711, DOI 10.1073/pnas.73.8.2711; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; ZENDEGUI JG, 1984, MOL CELL BIOL, V4, P883, DOI 10.1128/MCB.4.5.883	64	98	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					138	145						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416921				2022-12-27	WOS:A1993KE60300022
J	DUMAS, C; CAMONIS, J				DUMAS, C; CAMONIS, J			CLONING AND SEQUENCE-ANALYSIS OF THE CDNA FOR ARGININE KINASE OF LOBSTER MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MITOCHONDRIAL CREATINE-KINASE; AMINO-ACID SEQUENCES; MESSENGER-RNA; PROTEIN; SHUTTLE; CHICKEN; ENZYME; CLONES; BRAIN	Arginine kinase belongs to an evolutionary conserved family of ATP:guanidino phosphotransferases, whose members play an important role in energy metabolism. In this work, a lambdagt11 lobster muscle library was constructed and screened by using both polyclonal antibodies and two synthetic oligonucleotides. The complete amino acid sequence of arginine kinase (ATP:L-arginine N-phosphotransferase, EC 2.7.3.3) from lobster muscle was determined by cloning and sequencing the DNA complementary to its mRNA. The identity of the clone was confirmed by comparing the amino acid sequence deduced by nucleotide sequence analysis with previously published partial sequences of amino- and carboxyl-terminal regions of the enzyme and some of its fragments (Regnouf, F., Kassab, R., Debuire, B., Richard, C., and Han K. K. (1981) Int. J. Peptide Protein Res. 17, 143-155). The nucleotide sequence of the cDNA was found to contain an open reading frame encoding 355 amino acid residues with a calculated molecular mass of 39,830 daltons. This enzyme exhibits a significant sequence identity to those of representative members of the guanidino kinase family, including creatine kinase. This report represents the first molecular cloning and sequencing of an ATP-guanidino phosphotransferase which is not a creatine kinase isoform.	UNIV PARIS 11,CNRS,UMR 9920,BIOL STRUCT LAB,F-91405 ORSAY,FRANCE; UNIV PARIS 11,CNRS,URA 1122,INFORMAT GENET & DEV GRP,F-91405 ORSAY,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BENFIELD PA, 1984, J BIOL CHEM, V259, P4979; BENFIELD PA, 1985, GENE, V39, P263, DOI 10.1016/0378-1119(85)90321-X; BERTHOU A, 1975, J MOL BIOL, V95, P331; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BILLADELLO JJ, 1986, BIOCHEM BIOPH RES CO, V138, P392, DOI 10.1016/0006-291X(86)90294-9; BLETHEN SL, 1967, BIOCHEMISTRY-US, V6, P1413, DOI 10.1021/bi00857a025; BREVET A, 1975, BIOCHIM BIOPHYS ACTA, V393, P1, DOI 10.1016/0005-2795(75)90209-3; BUECHTER DD, 1992, J BIOL CHEM, V267, P2173; BUSKIN JN, 1985, J MOL EVOL, V22, P334, DOI 10.1007/BF02115689; BUTTLAIRE DH, 1974, J BIOL CHEM, V249, P5733; DEBUIRE B, 1977, J BIOCHEM, V81, P611, DOI 10.1093/oxfordjournals.jbchem.a131496; DERTERROSSIAN E, 1969, EUR J BIOCHEM, V11, P482; DESSEN P, 1990, COMPUT APPL BIOSCI, V6, P355; GIRAUDAT J, 1984, P NATL ACAD SCI-BIOL, V81, P7313, DOI 10.1073/pnas.81.23.7313; HAAS RC, 1990, J BIOL CHEM, V265, P6921; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOSSLE JP, 1986, NUCLEIC ACIDS RES, V14, P1449, DOI 10.1093/nar/14.3.1449; HOSSLE JP, 1988, BIOCHEM BIOPH RES CO, V151, P408, DOI 10.1016/0006-291X(88)90608-0; JARORI GK, 1989, BIOCHEMISTRY-US, V28, P9343, DOI 10.1021/bi00450a015; KENYON GL, 1983, ADV ENZYMOL RAMB, V54, P367; KWIATKOWSKI RW, 1984, NUCLEIC ACIDS RES, V12, P6925, DOI 10.1093/nar/12.18.6925; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Morrison J. F., 1973, ENZYMES, V8, P457, DOI 10.1016/S1874-6047; MUNNEKE LR, 1988, BIOCHEM GENET, V26, P131, DOI 10.1007/BF00555494; NICHOLS R, 1988, ANAL BIOCHEM, V170, P110, DOI 10.1016/0003-2697(88)90096-6; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERRYMAN MB, 1986, BIOCHEM BIOPH RES CO, V140, P981, DOI 10.1016/0006-291X(86)90732-1; PICKERING L, 1985, P NATL ACAD SCI USA, V82, P2310, DOI 10.1073/pnas.82.8.2310; PRADEL LA, 1973, CR ACAD SCI D NAT, V276, P2843; PUTNEY S, 1984, J BIOL CHEM, V259, P14317; RAO BDN, 1981, J BIOL CHEM, V256, P1716; RATTO A, 1988, EUR J BIOCHEM, V173, P667, DOI 10.1111/j.1432-1033.1988.tb14050.x; REGNOUF F, 1981, INT J PEPT PROT RES, V17, P143; REGNOUF F, 1974, EUR J BIOCHEM, V44, P67, DOI 10.1111/j.1432-1033.1974.tb03458.x; RICHARD C, 1984, INT J BIOCHEM, V16, P727, DOI 10.1016/0020-711X(84)90182-4; ROMAN D, 1985, P NATL ACAD SCI USA, V82, P8394, DOI 10.1073/pnas.82.24.8394; ROUSTAN C, 1970, BIOCHIM BIOPHYS ACTA, V206, P369, DOI 10.1016/0005-2744(70)90153-1; ROUXFROMY M, 1988, EUR J BIOCHEM, V176, P343, DOI 10.1111/j.1432-1033.1988.tb14287.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHNYDER T, 1991, J BIOL CHEM, V266, P5318; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; STEIN LD, 1990, J BIOL CHEM, V265, P6582; TERROSSIAN ED, 1971, EUR J BIOCHEM, V22, P585; THOAI NV, 1970, METHODS ENZYMOLOGY A, V17, P1002; THOMSON AR, 1964, NATURE, V203, P267, DOI 10.1038/203267a0; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; VILLARREALLEVY G, 1987, BIOCHEM BIOPH RES CO, V144, P1116, DOI 10.1016/0006-291X(87)91427-6; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALLIMAN.T, 1973, EUR J BIOCHEM, V38, P180, DOI 10.1111/j.1432-1033.1973.tb03048.x; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WATTS DC, 1973, ENZYMES, V8, P383; WEST BL, 1984, P NATL ACAD SCI-BIOL, V81, P7007, DOI 10.1073/pnas.81.22.7007; WOTHE DD, 1990, P NATL ACAD SCI USA, V87, P5203, DOI 10.1073/pnas.87.13.5203; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0167-4838(92)90506-9; [No title captured]	58	45	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21599	21605						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408011				2022-12-27	WOS:A1993MC80900028
J	KOSAKI, A; WEBSTER, NJG				KOSAKI, A; WEBSTER, NJG			EFFECT OF DEXAMETHASONE ON THE ALTERNATIVE SPLICING OF THE INSULIN-RECEPTOR MESSENGER-RNA AND INSULIN ACTION IN HEPG2 HEPATOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOCYTES; LIVER; GENE; RESPONSIVENESS; HORMONE; SUBUNIT; DIFFERENTIATION; TRANSCRIPTION; SENSITIVITY; EXPRESSION	We have shown that culturing HepG2 cells in Ham's F-12 medium supplemented with calf serum, dexamethasone, and triiodothyronine causes an increase in the insulin sensitivity and responsiveness for glucose incorporation into glycogen. This correlates with increased expression of the mRNA encoding the B isoform of the insulin receptor. Of all the components in the medium, we found that dexamethasone exerted the greatest effect. Dexamethasone alone could cause both a switch in expression from the A to the B isoform of the insulin receptor and also an increase in insulin sensitivity for both glucose incorporation into glycogen and 2-deoxyglucose transport. In addition, we found that expression of the B isoform of the insulin receptor is developmentally regulated in the 3T3-L1 adipocyte leading to the suggestion that the alternatively spliced B isoform of the insulin receptor may play an important role in signal transduction in insulin target tissues such as liver, fat, and muscle.	VET ADM MED CTR,MED RES SERV,SAN DIEGO,CA 92161	US Department of Veterans Affairs; Veterans Health Administration (VHA)			Webster, Nick/AAI-8410-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R01DK044643, R37DK033651] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33651, DK44643] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON CM, 1991, J BIOL CHEM, V266, P21760; ANDERSON CM, 1993, J CLIN ENDOCR METAB, V76, P1380, DOI 10.1210/jc.76.5.1380; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; CZECH MP, 1985, ANNU REV PHYSIOL, V47, P357, DOI 10.1146/annurev.ph.47.030185.002041; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FLEIG WE, 1985, BIOCHIM BIOPHYS ACTA, V847, P352, DOI 10.1016/0167-4889(85)90041-2; FROST SC, 1985, J BIOL CHEM, V260, P2646; GOLDSTEIN BJ, 1990, MOL ENDOCRINOL, V4, P235, DOI 10.1210/mend-4-2-235; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HERREROS A, 1989, J BIOL CHEM, V264, P19994; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; KAHN CR, 1985, ANNU REV MED, V36, P429; KARLSSON FA, 1979, ENDOCRINOLOGY, V104, P1383, DOI 10.1210/endo-104-5-1383; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KELLY JH, 1989, IN VITRO CELL DEV B, V25, P217; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; MCDONALD AR, 1988, J CLIN INVEST, V81, P499, DOI 10.1172/JCI113347; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NAKANISHI O, 1985, GENE, V35, P289; OLEFSKY JM, 1990, DIABETES, V39, P1009, DOI 10.2337/diabetes.39.9.1009; PODSKALNY JM, 1985, EUR J BIOCHEM, V150, P401, DOI 10.1111/j.1432-1033.1985.tb09034.x; RESH MD, 1982, J BIOL CHEM, V257, P6978; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SALHANICK AI, 1989, BIOCHEM J, V261, P985, DOI 10.1042/bj2610985; SCHMID E, 1987, EUR J BIOCHEM, V165, P499, DOI 10.1111/j.1432-1033.1987.tb11467.x; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SESTI G, 1992, DIABETES, V41, P6, DOI 10.2337/diabetes.41.1.6; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VOGT B, 1991, BIOCHEM BIOPH RES CO, V177, P1013, DOI 10.1016/0006-291X(91)90639-O; WHITE MF, 1989, J CELL BIOCHEM, V39, P429, DOI 10.1002/jcb.240390409; WILLIAMS JF, 1990, ENDOCRINOLOGY, V127, P1706, DOI 10.1210/endo-127-4-1706; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058	35	97	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21990	21996						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408055				2022-12-27	WOS:A1993MC80900083
J	MALILA, LH; SIIVARI, KM; MAKELA, MJ; JALONEN, JE; LATIPAA, PM; KUNAU, WH; HILTUNEN, JK				MALILA, LH; SIIVARI, KM; MAKELA, MJ; JALONEN, JE; LATIPAA, PM; KUNAU, WH; HILTUNEN, JK			ENZYMES CONVERTING D-3-HYDROXYACYL-COA TO TRANS-2-ENOYL-COA - MICROSOMAL AND PEROXISOMAL ISOENZYMES IN RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; ION-TRAP DETECTOR; BETA-OXIDATION; 3-HYDROXYACYL-COA EPIMERASE; DELTA-3,DELTA-2-ENOYL-COA ISOMERASE; 2,4-DIENOYL-COA REDUCTASE; SUBCELLULAR-DISTRIBUTION; ESCHERICHIA-COLI; CHAIN; MITOCHONDRIA	Epimerization of 3-hydroxyacyl-CoA, which has been shown to occur as a two-step dehydration-hydration reaction (Hiltunen, J. K., Palosaari, P. M., and Kunau, W.-H. (1989) J. Biol. Chem. 264, 13536-13540; Smeland, E., Jianxun, L., Chu, C., Cuebas, D., and Schulz, H. (1989) Biochem. Biophys. Res. Commun. 160, 988-992) was studied in rat liver. Subcellular fractionations of rat liver on different density gradients revealed a dual distribution of activity, catalyzing dehydration of D-3-hydroxydecanoyl-CoA to trans-2-decenoyl-CoA (hydratase 2) in both peroxisomal and microsomal compartments. Both hydratase 2 activity peaks were separated by dye ligand chromatography from the extract of the combined heavy and light mitochondrial fractions. The activity eluted at low salt was identified as the microsomal isoform and was purified to apparent homogeneity. The M(r) of the native protein (subunit) was found to be 60,000 (31,500), indicating that it is homodimeric. The enzyme activity was inhibited by IgGs isolated from antisera raised against the denatured subunit. The activity eluted at high salt was tentatively identified to be peroxisomal of origin, and the M(r) of the native protein (subunit) was determined to be 62,000 (33,500). The peroxisomal enzyme was not recognized by the antibody to its microsomal counterpart. Analysis of the reaction products of microsomal enzyme activity by gas chromatography-mass spectrometry showed that the enzyme catalyzed reversibly hydration/dehydration between trans-2-enoyl-CoA and D-3-hydroxyacyl-CoA, but L-3-hydroxydecanoyl-CoA was not dehydrated to DELTA2-enoyl-CoA compounds. Similar reaction characteristics were also determined for the peroxisomal hydratase by using stereospecific auxiliary enzymes. The present data demonstrate that rat liver contains microsomal and peroxisomal proteins possessing hydratase 2 activities. Although their kinetic properties are similar, immunological data, subunit sizes, and chromatographic evidence clearly indicate that they are different enzymes. Comparisons with other hydratases revealed that the microsomal and peroxisomal hydratase 2 described in the present work are proteins that have not been previously purified.	UNIV OULU, BIOCTR OULU, DEPT MED BIOCHEM, KAJAANINTIE 52 A, SF-90220 OULU, FINLAND; UNIV OULU, DEPT CHEM, SF-90570 OULU, FINLAND; RUHR UNIV BOCHUM, FAK MED, INST PHYSIOL CHEM, ZELLBIOCHEM ABT, W-4630 BOCHUM, GERMANY	University of Oulu; University of Oulu; Ruhr University Bochum								BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BEHRENDS W, 1988, ARCH BIOCHEM BIOPHYS, V263, P161, DOI 10.1016/0003-9861(88)90624-8; BERGMEYER HU, 1970, METHODEN ENZYMATISCH, P533; BERNERT JT, 1977, J BIOL CHEM, V252, P6736; BOCK P, 1980, PEROXISOMES RELATED; BREMER J, 1982, J LIPID RES, V23, P243; CHU CH, 1985, FEBS LETT, V185, P129, DOI 10.1016/0014-5793(85)80755-9; CHU CH, 1984, BIOCHEM BIOPH RES CO, V118, P162, DOI 10.1016/0006-291X(84)91081-7; COOK L, 1992, BIOCHEM J, V287, P91, DOI 10.1042/bj2870091; DICZFALUSY U, 1988, J LIPID RES, V29, P1629; DOMMES V, 1981, J BIOL CHEM, V256, P8259; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; GHOOS Y, 1991, ANAL CHIM ACTA, V247, P223, DOI 10.1016/S0003-2670(00)83816-7; GHOSH MK, 1986, ANAL BIOCHEM, V159, P169, DOI 10.1016/0003-2697(86)90323-4; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; GRESSNER AM, 1982, CLIN CHIM ACTA, V124, P315, DOI 10.1016/0009-8981(82)90425-9; GRONN M, 1990, BIOCHIM BIOPHYS ACTA, V1044, P249, DOI 10.1016/0005-2760(90)90310-T; HAGVE TA, 1986, BIOCHIM BIOPHYS ACTA, V875, P165, DOI 10.1016/0005-2760(86)90165-7; HAKKOLA EH, 1989, J HISTOCHEM CYTOCHEM, V37, P1863, DOI 10.1177/37.12.2584694; HILTUNEN JK, 1990, PROG CLIN BIOL RES, V321, P265; HILTUNEN JK, 1986, J BIOL CHEM, V261, P6484; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; HILTUNEN JK, 1989, J BIOL CHEM, V264, P13536; HORMAN I, 1989, BIOMED ENVIRON MASS, V18, P1016, DOI 10.1002/bms.1200181111; KARKI T, 1987, FEBS LETT, V215, P228, DOI 10.1016/0014-5793(87)80151-5; KILPONEN JM, 1990, BIOCHEM J, V269, P223, DOI 10.1042/bj2690223; KIMURA C, 1984, J BIOCH, V36, P1463; KUNAU WH, 1978, EUR J BIOCHEM, V91, P533, DOI 10.1111/j.1432-1033.1978.tb12707.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JX, 1990, J BIOL CHEM, V265, P13629; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; OSMUNDSEN H, 1983, IODINATED DENSITY GR, P139; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; PULLMAN ME, 1973, ANAL BIOCHEM, V54, P188, DOI 10.1016/0003-2697(73)90262-5; RAATIKAINEN MJP, 1992, BIOCHIM BIOPHYS ACTA, V1099, P238; RATHKE MW, 1970, J ORG CHEM, V35, P3966, DOI 10.1021/jo00836a087; RUPPERT JF, 1974, J ORG CHEM, V39, P269, DOI 10.1021/jo00916a043; SCHEPERS L, 1989, BIOCHEM J, V257, P221, DOI 10.1042/bj2570221; SCHEPERS L, 1988, J BIOL CHEM, V263, P2724; SMELAND TE, 1992, P NATL ACAD SCI USA, V89, P6673, DOI 10.1073/pnas.89.15.6673; SMELAND TE, 1989, BIOCHEM BIOPH RES CO, V160, P988, DOI 10.1016/S0006-291X(89)80098-1; SMIDT E, 1983, METHOD ENZYMAT AN, V3, P216; STOFFEL W, 1965, H-S Z PHYSIOL CHEM, V339, P167; SYMONS LJ, 1987, ANAL BIOCHEM, V164, P382, DOI 10.1016/0003-2697(87)90508-2; THEILACKER WHW, 1955, METHOD ORGAN CHEM, V4, P518; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSERNG KY, 1991, J BIOL CHEM, V266, P11614; WAKABAYASHI K, 1963, BIOCHIM BIOPHYS ACTA, V70, P132, DOI 10.1016/0006-3002(63)90733-9; WHITEHEAD TP, 1983, NATURE, V305, P158, DOI 10.1038/305158a0; YANG SY, 1983, J BIOL CHEM, V258, P9780; YANG SY, 1986, J BIOL CHEM, V261, P2238; YOKOTA S, 1988, HISTOCHEM J, V20, P679, DOI 10.1007/BF01002748	53	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21578	21585						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408009				2022-12-27	WOS:A1993MC80900025
J	MASON, SA; HOUSLEY, PR				MASON, SA; HOUSLEY, PR			SITE-DIRECTED MUTAGENESIS OF THE PHOSPHORYLATION SITES IN THE MOUSE GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CHLORAMPHENICOL ACETYLTRANSFERASE; TRANSCRIPTIONAL ENHANCEMENT; MAMMALIAN-CELLS; CULTURED-CELLS; INTACT-CELLS; PROTEIN; EXPRESSION; HORMONE; BINDING; DNA	The functional significance of receptor phosphorylation in mediating the actions of glucocorticoids remains undefined. The identification of seven phosphorylation sites in the mouse glucocorticoid receptor (Bodwell, J. E., Orti, E., Coull, J. M., Pappin, D. J. C., Smith, L. I., and Swift, F. (1991) J. Biol. Chem. 266, 7549-7555) permits a direct examination of the potential regulatory role of glucocorticoid receptor phosphorylation in transactivation. Using oligonucleotide-directed mutagenesis of the mouse glucocorticoid receptor cDNA, we have substituted alanine or aspartate for the residues phosphorylated in this ligand-dependent transcription factor. COS-1 cells were cotransfected with mutant receptor cDNA expression vectors and a reporter plasmid containing the glucocorticoid-inducible mouse mammary tumor virus promoter linked to chloramphenicol acetyltransferase in order to characterize the effect of these substitutions on receptor-mediated gene expression. Substitution of alanine or aspartate at single phosphorylation sites does not prevent receptor transactivation. Receptors containing multiple substitutions of alanine or aspartate at the major phosphorylation sites in the acidic domain elicit levels of hormone-induced reporter gene expression that are comparable to wild-type receptors. Mutant receptors substituted with alanine at the five phosphorylation sites conserved among the rat, human, and mouse receptors exhibit a 22% decrease in transcriptional activity. Receptors mutated at all seven sites display a similar modest reduction. These results demonstrate that receptor phosphorylation at these seven identified residues is not a major determinant in glucocorticoid receptor transcriptional activity at the mouse mammary tumor virus promoter.	UNIV S CAROLINA,SCH MED,DEPT PHARMACOL,COLUMBIA,SC 29208	University of South Carolina; University of South Carolina System; University of South Carolina Columbia					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036905] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK36905] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CRABB DW, 1987, ANAL BIOCHEM, V163, P88, DOI 10.1016/0003-2697(87)90096-0; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DENNER LA, 1990, J BIOL CHEM, V265, P16548; DENNER LA, 1991, 73RD ANN M END SOC W, P32; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HOECK W, 1989, J BIOL CHEM, V264, P14396; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HOUSLEY PR, 1989, BIOCHEM BIOPH RES CO, V164, P480, DOI 10.1016/0006-291X(89)91745-2; HOUSLEY PR, 1982, J BIOL CHEM, V257, P8615; HOUSLEY PR, 1983, J BIOL CHEM, V258, P4630; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; ORTI E, 1992, ENDOCR REV, V13, P105, DOI 10.1210/er.13.1.105; ORTI E, 1989, J BIOL CHEM, V264, P9728; ORTI E, 1989, J STEROID BIOCHEM, V34, P85, DOI 10.1016/0022-4731(89)90069-1; ORTI E, 1993, J BIOL CHEM, V268, P7779; PRATT WB, 1992, TRENDS ENDOCRIN MET, V3, P326, DOI 10.1016/1043-2760(92)90111-D; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; ROCHETTEEGLY C, 1991, J CELL BIOL, V115, P535, DOI 10.1083/jcb.115.2.535; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575	42	77	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21501	21504						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407999				2022-12-27	WOS:A1993MC80900013
J	PRATT, WB				PRATT, WB			THE ROLE OF HEAT-SHOCK PROTEINS IN REGULATING THE FUNCTION, FOLDING, AND TRAFFICKING OF THE GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ROUS-SARCOMA VIRUS; STEROID-BINDING DOMAIN; NON-DNA-BINDING; PROGESTERONE-RECEPTOR; 59-KILODALTON PROTEIN; POLYCLONAL ANTIBODY; 90-KDA; HSP90; COMPLEX; HORMONE				PRATT, WB (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NATIONAL CANCER INSTITUTE [R01CA028010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031573, R01DK031573] Funding Source: NIH RePORTER; NCI NIH HHS [CA28010] Funding Source: Medline; NIDDK NIH HHS [DK31573] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARSONY J, 1992, J BIOL CHEM, V267, P24457; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; CALLEBAUT I, 1992, P NATL ACAD SCI USA, V89, P6270, DOI 10.1073/pnas.89.14.6270; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686; CHANDRAN UR, 1992, MOL ENDOCRINOL, V6, P837, DOI 10.1210/me.6.5.837; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; DENIS M, 1988, J BIOL CHEM, V263, P18520; DENIS M, 1989, J BIOL CHEM, V264, P6005; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIBBONS IR, 1988, J BIOL CHEM, V263, P15837; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; HUTCHISON KA, 1992, J BIOL CHEM, V267, P13952; HUTCHISON KA, 1992, J BIOL CHEM, V267, P2902; HUTCHISON KA, 1993, BIOCHEMISTRY-US, V32, P3953, DOI 10.1021/bi00066a015; JOAB I, 1984, NATURE, V308, P850, DOI 10.1038/308850a0; KIEFFER LJ, 1993, J BIOL CHEM, V268, P12303; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LEACH KL, 1979, J BIOL CHEM, V254, P1884; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MARTINS VR, 1991, MOL ENDOCRINOL, V5, P217, DOI 10.1210/mend-5-2-217; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; NADEAU K, 1993, J BIOL CHEM, V268, P1479; NING YM, 1993, J BIOL CHEM, V268, P6073; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PICARD D, 1988, NATURE, V54, P73; Picard Didier, 1993, Trends in Cell Biology, V3, P278, DOI 10.1016/0962-8924(93)90057-8; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, pC69, DOI 10.1016/0303-7207(90)90198-H; PRATT WB, 1988, J BIOL CHEM, V263, P267; PRATT WB, 1992, TRENDS ENDOCRIN MET, V3, P326, DOI 10.1016/1043-2760(92)90111-D; PRATT WB, 1993, IN PRESS J STEROID B; RADANYI C, 1983, P NATL ACAD SCI-BIOL, V80, P2854, DOI 10.1073/pnas.80.10.2854; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; REXIN M, 1992, J BIOL CHEM, V267, P9619; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; RUFF VA, 1992, J BIOL CHEM, V267, P21285; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6086; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P7325, DOI 10.1021/bi00147a017; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHOWALTER DB, 1991, J BIOL CHEM, V266, P21165; SCHUH S, 1985, J BIOL CHEM, V260, P4292; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH DF, 1990, J BIOL CHEM, V265, P3996; SMITH DF, 1993, MOL ENDOCRINOL, V7, P4, DOI 10.1210/me.7.1.4; SMITH DF, 1993, J BIOL CHEM, V268, P18365; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SMITH DF, 1993, IN PRESS J BIOL CHEM, V268; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; TOFT D, 1966, P NATL ACAD SCI USA, V55, P1574, DOI 10.1073/pnas.55.6.1574; WALSH CT, 1992, J BIOL CHEM, V267; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YEM AW, 1992, J BIOL CHEM, V267, P2868	77	551	562	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21455	21458						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407992				2022-12-27	WOS:A1993MC80900001
J	RESNICOFF, M; SELL, C; AMBROSE, D; BASERGA, R; RUBIN, R				RESNICOFF, M; SELL, C; AMBROSE, D; BASERGA, R; RUBIN, R			ETHANOL INHIBITS THE AUTOPHOSPHORYLATION OF THE INSULIN-LIKE GROWTH FACTOR-I (IGF-1) RECEPTOR AND THE IGF-1-MEDIATED PROLIFERATION OF 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL ALCOHOL SYNDROME; FACTOR-I; HEPATIC REGENERATION; SIGNAL TRANSDUCTION; LIVER-REGENERATION; BINDING-PROTEINS; TYROSINE KINASE; PHOSPHOLIPASE-C; INVITRO; EXPOSURE	The effect of ethanol on cell proliferation was studied in Balb/c 3T3 cells and in stably transfected 3T3 cells constitutively overexpressing the human insulin-like growth factor 1 (IGF-1) receptor (p6 cells). Ethanol inhibited growth of both cell lines when they were cultured in serum-free medium supplemented with individual growth factors, i. e. platelet-derived growth factor and IGF-1 for 3T3 cells, and IGF-1 only for p6 cells. Increases in cell number were prevented in both cell lines even when ethanol was present exclusively during the period of IGF-1 stimulation. The inhibitory effect of ethanol was concentration-dependent, with a 30% inhibition observed at 10 mM ethanol. IGF-1 receptor tyrosine autophosphorylation was completely prevented by ethanol both in intact cells and in immunopurified IGF-1 receptor preparations. The binding of IGF-1 to its receptor on intact cells was unaffected by ethanol. Ethanol also inhibited the stimulation of IGF-1 receptor autophosphorylation and the corresponding growth of p6 cells induced by IGF-2. Transcription of c-myc, c-fos, and c-jun in response to IGF-1 was inhibited by ethanol. These findings demonstrate that ethanol at low concentrations markedly inhibits IGF-1 receptor autophosphorylation and IGF-1-mediated cell growth.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT PATHOL & CELL BIOL, 606 LIFE SCI BLDG, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, JEFFERSON CANC INST, PHILADELPHIA, PA 19107 USA	Jefferson University; Jefferson University					NCI NIH HHS [CA-56309] Funding Source: Medline; NIAAA NIH HHS [AA-7309, AA-07186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA056309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA007186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1; [Anonymous], 1991, INSULIN LIKE GROWTH; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Baserga Renato, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P47; CARTER EA, 1988, ALCOHOL CLIN EXP RES, V12, P555, DOI 10.1111/j.1530-0277.1988.tb00241.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLES CD, 1992, DEV CENTRAL NERVOUS; COOK RT, 1990, ALCOHOL ALCOHOLISM, V25, P33; COOK RT, 1990, ALCOHOL CLIN EXP RES, V14, P695, DOI 10.1111/j.1530-0277.1990.tb01229.x; CURRAN T, 1987, ONCOGENE, V2, P79; DATTA R, 1990, BLOOD, V76, P298; DAVIES DL, 1991, BRAIN RES, V547, P53; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DUGUAY L, 1982, GUT, V23, P8, DOI 10.1136/gut.23.1.8; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FRANK WO, 1979, J LAB CLIN MED, V93, P402; FRIDAY KE, 1991, METABOLISM, V40, P562, DOI 10.1016/0026-0495(91)90044-W; GOLDRING M B, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P301; HENDERSON GI, 1989, J CLIN INVEST, V84, P1287, DOI 10.1172/JCI114296; HIGASHI K, 1991, J BIOL CHEM, V266, P2178; HIGGINS PJ, 1986, BIOCHEM PHARMACOL, V35, P3857, DOI 10.1016/0006-2952(86)90676-3; HIGGINS PJ, 1987, ALCOHOL CLIN EXP RES, V11, P550, DOI 10.1111/j.1530-0277.1987.tb00172.x; HOEK JB, 1990, ALCOHOL ALCOHOLISM, V25, P143, DOI 10.1093/oxfordjournals.alcalc.a044989; HOFFMAN PL, 1990, FASEB J, V4, P2612, DOI 10.1096/fasebj.4.9.2161371; HUANG S, 1992, NATURE, V360, P745, DOI 10.1038/360745a0; IMPERIA PS, 1984, P SOC EXP BIOL MED, V175, P219; ISENBERG K, 1992, ALCOHOL CLIN EXP RES, V16, P695, DOI 10.1111/j.1530-0277.1992.tb00663.x; JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102; KATO H, 1993, J BIOL CHEM, V268, P2655; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; MICHALOPOULOS G, 1992, LAB INVEST, V67, P413; PANTAZIS NJ, 1992, ALCOHOL, V9, P171, DOI 10.1016/0741-8329(92)90048-F; PHILLIPS PD, 1987, J CELL PHYSIOL, V133, P135, DOI 10.1002/jcp.1041330117; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; POSO H, 1980, MED BIOL, V58, P329; ROONEY TA, 1989, J BIOL CHEM, V264, P6817; RUBIN R, 1989, ARCH BIOCHEM BIOPHYS, V270, P99, DOI 10.1016/0003-9861(89)90012-X; RUBIN R, 1988, BIOCHEM J, V254, P147, DOI 10.1042/bj2540147; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; SARA VR, 1990, KAR INS NCS, P179; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SCHENKER S, 1990, ALCOHOL CLIN EXP RES, V14, P635, DOI 10.1111/j.1530-0277.1990.tb01220.x; SLATER SJ, 1993, NATURE, V364, P82, DOI 10.1038/364082a0; SURMACZ E, 1992, EXP CELL RES, V199, P275, DOI 10.1016/0014-4827(92)90435-B; SVRZIC D, 1990, BIOCHEM BIOPH RES CO, V172, P54, DOI 10.1016/S0006-291X(05)80172-X; TARASCHI TF, 1985, LAB INVEST, V52, P120; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; THURSTON AW, 1992, BIOCHEM BIOPH RES CO, V185, P1062, DOI 10.1016/0006-291X(92)91734-8; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Wands J R, 1980, Adv Exp Med Biol, V132, P663; WANDS JR, 1979, GASTROENTEROLOGY, V77, P528; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; WERNER H, 1992, RECEPTORS DEV NERVOU, P109; YOSHINOUCHI M, 1993, CELL PROLIFERAT, V26, P139, DOI 10.1111/j.1365-2184.1993.tb00014.x	56	94	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21777	21782						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408032				2022-12-27	WOS:A1993MC80900055
J	CAPPS, GG; ZUNIGA, MC				CAPPS, GG; ZUNIGA, MC			THE CYTOPLASMIC DOMAIN OF THE H-2L(D) CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE IS DIFFERENTIALLY ACCESSIBLE TO IMMUNOLOGICAL AND BIOCHEMICAL PROBES DURING TRANSPORT TO THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; INTRACELLULAR-TRANSPORT; TRANSPLANTATION ANTIGENS; PEPTIDE LIGAND; VIRAL PEPTIDES; G-PROTEIN; T-CELLS; HLA-A; LD; HEMAGGLUTININ	An antiserum was generated against a synthetic peptide corresponding to a portion of the cytoplasmic domains of the H-2L(d) and H-2D(b) class I major histocompatibility complex molecules of the mouse. This antibody preparation, R4, binds exclusively to endoglycosidase H-resistant H-2L(d)/D(b) molecules which are not associated with beta2-microglobulin. Interestingly, acquisition of resistance to endoglycosidase H precedes acquisition of R4 reactivity by 30 min. R4-reactive H-2L(d) and H-2D(b) molecules occur on the cell surface and are phosphorylated in vivo. Other studies show that the tyrosine in the cytoplasmic domain is accessible to radioiodination on only a subset of H-2L(d) molecules, and that the two-dimensional electrophoretic profiles of phosphorylated H-2L(d)/D(b) molecules, of R4-reactive molecules, and of H-2L(d) molecules radiolabeled on this cytoplasmic domain tyrosine are virtually identical. R4-reactive H-2L(d) molecules do not undergo the peptide- and beta2-microglobulin-induced conformational changes characteristic of free class I major histocompatibility complex heavy chains. The accessibility of the H-2L(d) cytoplasmic domain to R4 and to radioiodination late in biosynthesis and its biological significance are discussed.	UNIV CALIF SANTA CRUZ,DEPT BIOL,SINSHEIMER LABS,SANTA CRUZ,CA 95064	University of California System; University of California Santa Cruz								BJORKMAN PJ, 1985, J MOL BIOL, V186, P205, DOI 10.1016/0022-2836(85)90271-2; CAPPS GG, 1990, BIOTECHNIQUES, V8, P62; CAPPS GG, 1993, J IMMUNOL, V151, P159; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; DOYLE C, 1985, J CELL BIOL, V100, P704, DOI 10.1083/jcb.100.3.704; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; EVANS GA, 1982, NATURE, V300, P755, DOI 10.1038/300755a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; JONES PP, 1980, SELECTED METHODS CEL, P398; KESKIOJA J, 1977, BIOCHEM BIOPH RES CO, V74, P699, DOI 10.1016/0006-291X(77)90359-X; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; LIPPE R, 1991, J EXP MED, V174, P1159, DOI 10.1084/jem.174.5.1159; MACK D, 1989, J CELL BIOL, V109, P2057, DOI 10.1083/jcb.109.5.2057; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MYERS NB, 1989, J IMMUNOL, V142, P2751; OWEN MJ, 1980, J BIOL CHEM, V255, P9678; PARKS GD, 1990, J VIROL, V64, P3605, DOI 10.1128/JVI.64.8.3605-3616.1990; PLOEGH HL, 1981, CELL, V24, P287, DOI 10.1016/0092-8674(81)90318-4; PULLEN JK, 1992, J IMMUNOL, V148, P953; RAVIPRAKASH K, 1990, J BIOL CHEM, V265, P1777; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; SHIROISHI T, 1985, J IMMUNOL, V134, P623; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; SMITH MH, 1990, MOL IMMUNOL, V27, P169, DOI 10.1016/0161-5890(90)90112-D; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, COLD SPRING HARB SYM, V1, P299; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; WALLNY HJ, 1990, NATURE, V343, P275, DOI 10.1038/343275a0; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X; ZUNIGA MC, 1983, CELL, V34, P535, DOI 10.1016/0092-8674(83)90386-0; ZUNIGA MC, 1986, J CELL BIOL, V102, P1, DOI 10.1083/jcb.102.1.1	37	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21263	21270						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407964				2022-12-27	WOS:A1993MA28800091
J	HARRINGTON, MA; KONICEK, B; SONG, A; XIA, XL; FREDERICKS, WJ; RAUSCHER, FJ				HARRINGTON, MA; KONICEK, B; SONG, A; XIA, XL; FREDERICKS, WJ; RAUSCHER, FJ			INHIBITION OF COLONY-STIMULATING FACTOR-I PROMOTER ACTIVITY BY THE PRODUCT OF THE WILMS-TUMOR LOCUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-A-CHAIN; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; MAMMALIAN-CELLS; SUPPRESSOR WT1; MESSENGER-RNA; BINDING; CSF-1; TRANSCRIPTION; PROTEIN	Colony-stimulating factor-1 (CSF-1) is a member of the immediate early gene family, which is expressed in mitogen-stimulated quiescent fibroblasts. The biological effects of CSF-1 are multifaceted and include stimulation of the proliferation and differentiation of myeloid progenitors and activity of circulating monocytes and tissue-specific macrophages. Ablation of circulating levels of biologically active CSF-1 in mice leads to osteopetrosis and sterility, thus implicating a role for CSF-1 in bone remodeling and implantation. Identification of regulatory elements and cognate transcription factors that bind the csf-1 promoter and mediate such diverse expression patterns is of great interest. We identified a sequence element at -273 to -265 (relative to the transcription initiation site) in the murine csf-1 promoter, which contains overlapping consensus sequences for the Wilms' tumor protein (WT1), EGR-1, SP1, and SP3 proteins. WT1 and EGR-1 proteins produced in vitro bound to this sequence, and co-transfection of wt1 with a csf-1-cat reporter plasmid resulted in repression of promoter activity. Interestingly, nuclear extracts prepared from serum-stimulated C3H10T1/2 cells contained predominantly SP1 and SP3 binding activities, which recognized the -273 to -265 site. Thus repression of the csf-1 promoter by WT1 at this site may involve competition between SP1 family transcriptional activators and the WT1 repressor. Colony-stimulating factor-1 may be a physiologically relevant target gene for regulation by the WT1 transcription factor.	INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; The Wistar Institute	HARRINGTON, MA (corresponding author), INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,IB 549,975 W WALNUT ST,INDIANAPOLIS,IN 46202, USA.				NCI NIH HHS [CA 52009] Funding Source: Medline; NIDDK NIH HHS [1-P50-DK45191] Funding Source: Medline; NIGMS NIH HHS [GM43972] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA052009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK045191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043972, R29GM043972] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBOUD SL, 1991, BLOOD, V78, P103; ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; BARTOCCI A, 1986, J EXP MED, V164, P956, DOI 10.1084/jem.164.3.956; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BOWENPOPE DF, 1991, TRENDS GENET, V7, P413, DOI 10.1016/0168-9525(91)90222-C; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROXMEYER HE, 1988, CRC CR REV ONCOL-HEM, V8, P173, DOI 10.1016/S1040-8428(88)80016-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Daiter E, 1992, REPROD MED REV, V1, P83; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; FALKENBURG JHF, 1990, J IMMUNOL, V144, P4657; FALKENBURG JHF, 1991, BLOOD, V78, P658; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GILBERT HS, 1989, BLOOD, V74, P1231; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HABER DA, 1992, ADV CANCER RES, V59, P41, DOI 10.1016/S0065-230X(08)60302-4; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HARRINGTON MA, 1990, MOL CELL BIOL, V10, P4948, DOI 10.1128/MCB.10.9.4948; HARRINGTON MA, 1991, GENE, V102, P165, DOI 10.1016/0378-1119(91)90074-L; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HORIGUCHI J, 1988, MOL CELL BIOL, V8, P3951, DOI 10.1128/MCB.8.9.3951; KACINSKI BM, 1991, ONCOGENE, V6, P941; KACINSKI BM, 1990, AM J PATHOL, V137, P135; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; LEIBOVITCH SA, 1989, ONCOGENE RES, V4, P157; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; PAIK S, 1989, LAB INVEST, V61, P522; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Roth P, 1992, Curr Top Microbiol Immunol, V181, P141; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; WANG JM, 1988, J IMMUNOL, V141, P575; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	40	170	176	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21271	21275						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407965				2022-12-27	WOS:A1993MA28800092
J	TAN, JC; INDELICATO, SR; NARULA, SK; ZAVODNY, PJ; CHOU, CC				TAN, JC; INDELICATO, SR; NARULA, SK; ZAVODNY, PJ; CHOU, CC			CHARACTERIZATION OF INTERLEUKIN-10 RECEPTORS ON HUMAN AND MOUSE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS CYTOKINE PRODUCTION; HIGH-AFFINITY; MOLECULAR-CLONING; B-CELLS; GM-CSF; COLORIMETRIC ASSAY; EXPRESSION CLONING; T-CELLS; IL-10; GROWTH	Human interleukin (IL)-10 is a pleiotropic cytokine acting on a variety of immune cells. Here we show that the protein can be enzymatically iodinated to high specific radioactivity with retention of biological activity. The radiolabeled ligand binds specifically to its receptor in several mouse and human cell lines, notably human B-lymphoma line JY and mouse mast cell line MC/9. Human IL-10 apparently binds as a dimer to a single class of receptor in both the JY and MC/9 cell lines with a K(d) in the 50-200 pM range. Interestingly, mouse IL-10 was capable of blocking binding of human IL-10 to mouse but not human cells. There appears to be at most only a few hundred IL-10 receptors/cell for both mouse and human cell lines examined. Chemical cross-linking of the radioiodinated hIL-10 to JY and MC/9 cells revealed a common protein complex with an apparent molecular mass of about 97 kDa. Additional high molecular weight complexes were detected with JY but not MC/9 cells.	SCHERING PLOUGH RES INST,DEPT BIOTECHNOL MOLEC BIOL,KENILWORTH,NJ 07033	Merck & Company; Schering-Plough Research Institute								ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; ARIMA N, 1992, J EXP MED, V176, P1265, DOI 10.1084/jem.176.5.1265; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CHEN WF, 1991, J IMMUNOL, V147, P528; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HOWARD M, 1992, J CLIN IMMUNOL, V12, P239, DOI 10.1007/BF00918147; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEV S, 1992, J BIOL CHEM, V267, P15970; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P915; MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; RAZIN E, 1991, J IMMUNOL, V146, P981; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SUDA T, 1990, CELL IMMUNOL, V129, P228, DOI 10.1016/0008-8749(90)90200-B; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; ZLOTNIK A, 1991, CYTOKINE, V3, P366, DOI 10.1016/1043-4666(91)90039-G	40	130	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21053	21059						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407942				2022-12-27	WOS:A1993MA28800064
J	CHEN, GG; JAGENDORF, AT				CHEN, GG; JAGENDORF, AT			IMPORT AND ASSEMBLY OF THE BETA-SUBUNIT OF CHLOROPLAST COUPLING FACTOR-I (CF(1)) INTO ISOLATED INTACT CHLOROPLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; ATP SYNTHASE; FACTOR-I; POLYPHENOL OXIDASE; MEMBRANE-PROTEINS; INVITRO SYNTHESIS; FOREIGN PROTEIN; TRANSIT PEPTIDE; TRANSPORT; TENTOXIN	The transit peptide gene of the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase from Nicotiana plumbaginifolia was fused to the tentoxin-resistant beta-subunit gene of chloroplast coupling factor 1 (CF1) from Nicotiana tabacum via a linker sequence. The consequent fusion gene encodes the entire gene sequences of both the transit peptide and the beta-subunit of CF1 without a single change of amino acid residues. The fusion gene was in vitro expressed in a coupled transcription-translation system as a 62-kDa precursor and was imported into isolated intact chloroplasts of Nicotiana longiflora. The imported precursor was found to be processed to the expected mature beta-subunit size. Evidence is presented that radioactively labeled beta-subunit was incorporated into mature CF1 and not just nonspecifically associated with the thylakoid membranes. Since the fusion protein containing only the transit peptide sequence was imported and apparently correctly processed, it may not be necessary to include N-terminal amino acids of the mature small subunit for correct proteolytic cleavage in the chloroplast stroma.	CORNELL UNIV, PLANT BIOL SECT, PLANT SCI BLDG, ITHACA, NY 14853 USA	Cornell University								AVNI A, 1991, J BIOL CHEM, V266, P7317; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; BHAYA D, 1985, ARCH BIOCHEM BIOPHYS, V237, P217, DOI 10.1016/0003-9861(85)90272-3; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; CASHMORE A, 1985, BIO-TECHNOL, V3, P803, DOI 10.1038/nbt0985-803; CHEN GG, 1989, THESIS CORNELL U; CLINE K, 1986, J BIOL CHEM, V261, P4804; DANIELL H, 1990, P NATL ACAD SCI USA, V87, P88, DOI 10.1073/pnas.87.1.88; DEBOER AD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P221, DOI 10.1016/0304-4157(91)90015-O; DOBBERSTEIN B, 1977, P NATL ACAD SCI USA, V74, P1082, DOI 10.1073/pnas.74.3.1082; DURBIN RD, 1977, PHYTOPATHOLOGY, V67, P602, DOI 10.1094/Phyto-67-602; GATENBY AA, 1988, EMBO J, V7, P1307, DOI 10.1002/j.1460-2075.1988.tb02945.x; HERRIN D, 1985, ARCH BIOCHEM BIOPHYS, V237, P224, DOI 10.1016/0003-9861(85)90273-5; HUDSON GS, 1988, PHOTOSYNTH RES, V18, P205, DOI 10.1007/BF00042985; JAGENDORF AT, 1991, CELL CULTURE SOMATIC, P225; JOSHI RL, 1991, FEBS LETT, V281, P1, DOI 10.1016/0014-5793(91)80346-5; KASAMO K, 1989, PLANT CELL PHYSIOL, V30, P729; KEEGSTRA K, 1989, CELL, V56, P247, DOI 10.1016/0092-8674(89)90898-2; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KINDLE KL, 1991, P NATL ACAD SCI USA, V88, P1721, DOI 10.1073/pnas.88.5.1721; KLOTZ MG, 1988, PHYSIOL PLANTARUM, V74, P575, DOI 10.1111/j.1399-3054.1988.tb02021.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEU S, 1990, FEBS LETT, V269, P41, DOI 10.1016/0014-5793(90)81114-4; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MARGULIES MM, 1983, EUR J BIOCHEM, V137, P241, DOI 10.1111/j.1432-1033.1983.tb07821.x; MEYER WL, 1975, J AM CHEM SOC, V97, P3802, DOI 10.1021/ja00846a041; NAGLEY P, 1989, TRENDS BIOCHEM SCI, V14, P31, DOI 10.1016/0968-0004(89)90087-X; PEACOCK J, 1992, NATURE, V357, P358, DOI 10.1038/357358a0; PERRY SE, 1991, METHOD CELL BIOL, V34, P327; POULSEN C, 1986, MOL GEN GENET, V205, P193, DOI 10.1007/BF00430426; RICHTER ML, 1986, J BIOL CHEM, V261, P2109; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT GW, 1986, ANNU REV BIOCHEM, V55, P879; SCHREIER PH, 1985, EMBO J, V4, P25, DOI 10.1002/j.1460-2075.1985.tb02312.x; SHINOHARA K, 1988, ARCH BIOCHEM BIOPHYS, V260, P452, DOI 10.1016/0003-9861(88)90469-9; Shinozaki K., 1986, PLANT MOL BIOL REP, V4, P111, DOI DOI 10.1007/BF02669253; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; VANDENBROECK G, 1985, NATURE, V313, P358, DOI 10.1038/313358a0; VAUGHN KC, 1984, PHYSIOL PLANTARUM, V60, P257, DOI 10.1111/j.1399-3054.1984.tb04574.x; VAUGHN KC, 1981, PHYSIOL PLANTARUM, V53, P421, DOI 10.1111/j.1399-3054.1981.tb02725.x; VAUGHN KC, 1982, PHYSIOL PLANTARUM, V11, P48; WALDEN R, 1990, EUR J BIOCHEM, V192, P563, DOI 10.1111/j.1432-1033.1990.tb19262.x; WASMANN CC, 1986, MOL GEN GENET, V205, P446, DOI 10.1007/BF00338081; YE GN, 1990, PLANT MOL BIOL, V15, P808	45	4	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2363	2367						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428910				2022-12-27	WOS:A1993KK81500020
J	FERNANDEZCHECA, JC; YI, JR; GARCIARUIZ, C; KNEZIC, Z; TAHARA, SM; KAPLOWITZ, N				FERNANDEZCHECA, JC; YI, JR; GARCIARUIZ, C; KNEZIC, Z; TAHARA, SM; KAPLOWITZ, N			EXPRESSION OF RAT-LIVER REDUCED GLUTATHIONE TRANSPORT IN XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFLUX; HEPATOCYTES; INHIBITION; SYSTEM; METHIONINE; KINETICS; MEMBRANE; CLONING	We have studied the expression of the hepatic GSH transport system in Xenopus laevis oocytes. Injection of rat liver poly(A)+ RNA resulted in the functional expression of the GSH transport system determined as GSH efflux from GSH loaded oocytes. Expression required 3-5 days to process the liver mRNA. Methionine, cystathionine, and sulfobromophthalein (BSP)-GSH inhibited the efflux of GSH from liver mRNA-injected oocytes according to their known cis or transactions on hepatocytes, namely BSP-GSH from inside and methionine and cystathionine from outside. The expressed hepatic GSH transport system also mediated the uptake of intact GSH into the oocyte, consistent with the bidirectional operation of this facilitative transporter. The uptake of GSH into mRNA-injected oocytes was inhibited by BSP-GSH in chloride-free conditions. Finally, two different mRNA size fractions encoded for hepatic GSH transport activity (uptake or efflux): a 2.0-2.5-kilobase size class, which expressed GSH transport (uptake or efflux) completely inhibited by BSP-GSH (compatible with sinusoidal GSH transport), and a 3.5-4.0-kilobase size class, which expressed GSH transport (uptake or efflux) not inhibited by BSP-GSH. These results demonstrate that hepatic GSH transport can be expressed in Xenopus oocytes and mRNA of two distinct sizes encode for GSH transporters.	UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT MED,DIV GASTROINTESTINAL & LIVER DIS,LOS ANGELES,CA 90033	University of Southern California; University of Southern California			Fernández-Checa, José Carlos/L-8342-2014	Fernández-Checa, José Carlos/0000-0003-3422-2990; Tahara, Stanley/0000-0001-5097-0927	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030312, R37DK030312] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30312] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AW TY, 1986, AM J PHYSIOL, V250, pG236, DOI 10.1152/ajpgi.1986.250.2.G236; AW TY, 1987, BIOCHEM BIOPH RES CO, V143, P377, DOI 10.1016/0006-291X(87)90676-0; AW TY, 1984, J BIOL CHEM, V259, P9355; BOORER KJ, 1992, FEBS LETT, V302, P166, DOI 10.1016/0014-5793(92)80431-F; COLMAN A, 1986, TRANSCRIPTION TRANSL, P271; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; FERNANDEZCHECA JC, 1990, AM J PHYSIOL, V258, pG967, DOI 10.1152/ajpgi.1990.258.6.G967; FERNANDEZCHECA JC, 1989, J CLIN INVEST, V83, P1247, DOI 10.1172/JCI114008; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; JACQUEMIN E, 1991, J CLIN INVEST, V88, P2146, DOI 10.1172/JCI115546; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; MANIATIS T, 1982, MOL CLONING LABORATO, P461; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; OOKHTENS M, 1988, J CLIN INVEST, V82, P608, DOI 10.1172/JCI113639; OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682; WEBER WM, 1989, J MEMBRANE BIOL, V111, P93, DOI 10.1007/BF01869212; WHELAN G, 1970, J LAB CLIN MED, V75, P542; WOLKOFF AW, 1987, J CLIN INVEST, V79, P1259, DOI 10.1172/JCI112946	24	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2324	2328						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428906				2022-12-27	WOS:A1993KK81500014
J	MOLKENTIN, JD; BROGAN, RS; JOBE, SM; MARKHAM, BE				MOLKENTIN, JD; BROGAN, RS; JOBE, SM; MARKHAM, BE			EXPRESSION OF THE ALPHA-MYOSIN HEAVY-CHAIN GENE IN THE HEART IS REGULATED IN PART BY AN E-BOX-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-HEART; BINDING-FACTOR; MUSCLE-CELLS; FUSION GENE; TRANSCRIPTION; PROMOTER; FIBROBLASTS; MYOBLASTS; MYOD; IDENTIFICATION	Proximal regulatory element B (PRE-B), located from positions -318 to -284 in the a-myosin heavy chain (MHC) promoter, stimulated expression from an otherwise weak alpha-MHC promoter fragment in primary rat neonatal cardiomyocytes but not in the C2C12 myogenic cell line. PRE-B interacted with alpha-MHC binding factor 2 (BF-2), a protein found in nuclear extracts from several neonatal rat tissues and cell types including cardiomyocytes. BF-2 DNA binding activity was greatly reduced in adult versus neonatal tissues. Methylation interference footprints indicated that BF-2 bound to an element that included an E-box consensus sequence. Site-directed mutations in the BF-2-binding site, that abolish BF-2 binding, reduced expression from the full-length alpha-MHC promoter by 70%. A BF-2-like protein interacts within the HF-1a element of the myosin light chain-2 (MLC-2) promoter suggesting that one of the proteins that regulates the alpha-MHC and MLC-2 genes is identical or closely related. Analysis of binding by competition gel shift experiments indicated that both BF-2 and HF-1a are E-box-binding proteins. The alpha-MHC and MLC-2 genes encode contractile proteins which are precursors of myosin. Regulation by the same transcription factor might indicate that the expression of alpha-MHC and MLC-2 is coordinately controlled.	MED COLL WISCONSIN, CARDIOVASC RES CTR, DEPT PHYSIOL, 8701 WATERTOWN PLANK RD, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, MOLEC & CELLULAR BIOL TRAINING PROGRAM, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, MED SCIENTIST TRAINING PROGRAM, MILWAUKEE, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin				Molkentin, Jeffery/0000-0002-3558-6529	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043662] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43662] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BURT JM, 1982, J MEMBRANE BIOL, V68, P227, DOI 10.1007/BF01872267; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUSTAFSON TA, 1987, P NATL ACAD SCI USA, V84, P3122, DOI 10.1073/pnas.84.10.3122; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JACKOWSKI G, 1980, BIOCHEM J, V188, P363, DOI 10.1042/bj1880363; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LEE KJ, 1992, J BIOL CHEM, V267, P15875; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MARKHAM BE, 1990, J BIOL CHEM, V265, P6489; MARKHAM BE, 1987, J BIOL CHEM, V262, P12856; Maxam A M, 1980, Methods Enzymol, V65, P499; MORKIN E, 1989, CELLULAR MOL BIOL MU, P381; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; OJAMAA K, 1991, BIOCHEM BIOPH RES CO, V179, P1269, DOI 10.1016/0006-291X(91)91710-T; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PINNEY DF, 1988, CELL, V53, P781, DOI 10.1016/0092-8674(88)90095-5; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TSIKA RW, 1990, P NATL ACAD SCI USA, V87, P379, DOI 10.1073/pnas.87.1.379; UMEDA PK, 1986, MOL BIOL MUSCLE DEV, P808; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	40	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2602	2609						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428936				2022-12-27	WOS:A1993KK81500053
J	PEREZ, HD; HOLMES, R; VILANDER, LR; ADAMS, RR; MANZANA, W; JOLLEY, D; ANDREWS, WH				PEREZ, HD; HOLMES, R; VILANDER, LR; ADAMS, RR; MANZANA, W; JOLLEY, D; ANDREWS, WH			FORMYL PEPTIDE RECEPTOR CHIMERAS DEFINE DOMAINS INVOLVED IN LIGAND-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN	We have begun to study the structural requirements for the binding of formyl peptides to their specific receptors. As an initial approach, we constructed C5a-formyl peptide receptor chimeras. Unique (and identical) restriction sites were introduced within the transmembrane domains of these receptors that allowed for the exchange of specific areas. Four types of chimeric receptors were generated. 1) The C5a receptor was progressively substituted by the formyl peptide receptor. 2) The formyl peptide receptor was progressively substituted by the C5a receptor. 3) Specific domains of the C5a receptor were substituted by the corresponding domain of the formyl peptide receptor. 4) Specific domains of the formyl peptide receptor were replaced by the same corresponding domain of the C5a receptor. Wild type and chimeric receptors were transfected into COS 7 cells and their ability to bind formyl peptide determined, taking into account efficiency of transfection and expression of chimeric protein. Based on these results, a ligand binding model is presented in which the second, third, and fourth extracellular (and/or their transmembrane) domains together with the first transmembrane domain form a ligand binding pocket for formyl peptides. It is proposed that the amino-terminal domain plays a role by presumably providing a ''lid'' to the pocket. The carboxyl-terminal cytoplasmic tail appears to modulate ligand binding by regulating receptor affinity.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	PEREZ, HD (corresponding author), BERLEX BIOSCI INC,213 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM028566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028290] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-28566] Funding Source: Medline; NIAID NIH HHS [AI-28290] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOMMAKANTI RK, 1992, CLIN RES, V40, pA352; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; KUNZ D, 1992, J BIOL CHEM, V267, P9101; PEREZ HD, 1992, J BIOL CHEM, V267, P358; PEREZ HD, 1992, BIOCHEMISTRY-US, V31, P11595, DOI 10.1021/bi00161a044; PEREZ HD, 1992, GENE, V118, P303, DOI 10.1016/0378-1119(92)90208-7; PEREZ HD, 1991, J CLIN INVEST, V87, P971, DOI 10.1172/JCI115105; PROSSNITZ E, 1992, FASEB J, V6, pA2058; QUEHENBERGER O, 1992, FASEB J, V6, pA2056; RADEL SJ, 1991, BIOCHEM INT, V25, P745; SCHREIBER RE, 1992, FASEB J, V6, pA2056	13	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2292	2295						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428903				2022-12-27	WOS:A1993KK81500007
J	BAUER, JW; KIRCHMAIR, R; EGGER, C; FISCHERCOLBRIE, R				BAUER, JW; KIRCHMAIR, R; EGGER, C; FISCHERCOLBRIE, R			HISTAMINE INDUCES A GENE-SPECIFIC SYNTHESIS REGULATION OF SECRETOGRANIN-II BUT NOT OF CHROMOGRANIN-A AND CHROMOGRANIN-B IN CHROMAFFIN CELLS IN A CALCIUM-DEPENDENT MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADRENAL-MEDULLA; MESSENGER-RNA LEVELS; INOSITOL PHOSPHATES; SECRETORY PROTEINS; PRIMARY CULTURES; OPIOID-PEPTIDES; NEUROPEPTIDE-Y; ANGIOTENSIN-II; CYCLIC-AMP; GRANULES	The effect of histamine on steady-state mRNA levels of three soluble secretory proteins from chromaffin granules was investigated in cultured bovine adrenal medullary cells. Histamine stimulated secretogranin II mRNA 4-fold, with no or only slight effects on chromogranin A and B transcription. After an initial lag phase, secretogranin II mRNA increased markedly between 4 and 12 h followed by a plateau phase up to 48 h. The effect of histamine on secretogranin II gene-expression was abolished by the H-1 receptor antagonist promethazine but not by the H-2 blocker cimetidine. The histamine-induced elevation of secretogranin II mRNA was partially reduced by the L-type calcium channel blocker nifedipine, indicating a contribution of extracellular calcium in the second messenger signaling pathway involved. At present, the H-1 histaminergic receptor is the first membrane receptor found regulating secretogranin II biosynthesis in chromaffin cells. The selective up-regulation of secretogranin II mRNA but not of chromogranin A and B by histamine is another example illustrating that the synthesis regulation of secretory components co-stored in large vesicles of neuroendocrine cells is specific to the individual gene. Together with results obtained earlier, our data demonstrate a marked variation in the relative composition of peptides secreted from adrenal medulla into circulation following different physiologic conditions.	UNIV INNSBRUCK, DEPT PHARMACOL, PETER MAYR STR 1A, A-6020 INNSBRUCK, AUSTRIA	University of Innsbruck								ANOUAR Y, 1991, ENDOCRINOLOGY, V129, P2393, DOI 10.1210/endo-129-5-2393; BARBOSA JA, 1991, ENDOCRINOLOGY, V128, P174, DOI 10.1210/endo-128-1-174; BAUER JW, 1991, BIOCHIM BIOPHYS ACTA, V1089, P124, DOI 10.1016/0167-4781(91)90094-3; BENEDUM UM, 1986, EMBO J, V5, P1495, DOI 10.1002/j.1460-2075.1986.tb04388.x; BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; BOMMER M, 1987, J NEUROCHEM, V49, P1688, DOI 10.1111/j.1471-4159.1987.tb02426.x; BUNN SJ, 1990, NEUROPEPTIDES, V15, P187, DOI 10.1016/0143-4179(90)90012-N; CHANG RSL, 1979, J PHARMACOL EXP THER, V209, P437; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DREES BM, 1991, ENDOCRINOLOGY, V129, P3381, DOI 10.1210/endo-129-6-3381; EIDEN LE, 1987, NEUROSCIENCE, V21, P1019, DOI 10.1016/0306-4522(87)90056-X; EIDEN LE, 1984, P NATL ACAD SCI-BIOL, V81, P3949, DOI 10.1073/pnas.81.13.3949; EIDEN LE, 1983, LIFE SCI, V33, P687, DOI 10.1016/0024-3205(83)90772-5; FARIN CJ, 1990, J BIOL CHEM, V265, P19116; FASCIOTTO BH, 1990, ENDOCRINOLOGY, V127, P1329, DOI 10.1210/endo-127-3-1329; FISCHERCOLBRIE R, 1990, J BIOL CHEM, V265, P9208; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1992, J NEUROENDOCRINOL, V4, P125, DOI 10.1111/j.1365-2826.1992.tb00355.x; FISCHERCOLBRIE R, 1986, J NEUROCHEM, V47, P318; FISCHERCOLBRIE R, 1985, J NEUROCHEM, V44, P1854, DOI 10.1111/j.1471-4159.1985.tb07179.x; FISCHERCOLBRIE R, 1988, P NATL ACAD SCI USA, V85, P3240, DOI 10.1073/pnas.85.9.3240; FISCHERCOLBRIE R, 1989, J ENDOCRINOL, V121, P487, DOI 10.1677/joe.0.1210487; GALINDO E, 1991, P NATL ACAD SCI USA, V88, P1426, DOI 10.1073/pnas.88.4.1426; GERDES HH, 1989, J BIOL CHEM, V264, P12009; HOFLE G, 1991, REGUL PEPTIDES, V32, P321, DOI 10.1016/0167-0115(91)90025-C; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; IACANGELO A, 1986, NATURE, V323, P82, DOI 10.1038/323082a0; KANAMATSU T, 1986, P NATL ACAD SCI USA, V83, P9245, DOI 10.1073/pnas.83.23.9245; KLEY N, 1987, NEUROENDOCRINOLOGY, V46, P89, DOI 10.1159/000124801; KLEY N, 1986, EMBO J, V5, P967, DOI 10.1002/j.1460-2075.1986.tb04310.x; LASLOP A, 1990, BIOCHIM BIOPHYS ACTA, V1033, P65, DOI 10.1016/0304-4165(90)90195-3; LASLOP A, 1992, NEUROSCIENCE, V49, P443, DOI 10.1016/0306-4522(92)90109-F; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; LIVETT BG, 1986, BRIT J PHARMACOL, V89, P327, DOI 10.1111/j.1476-5381.1986.tb10264.x; MAHATA SK, 1992, NEUROSCIENCE, V48, P669, DOI 10.1016/0306-4522(92)90410-4; MAHATA SK, 1991, EUR J NEUROSCI, V3, P895, DOI 10.1111/j.1460-9568.1991.tb00101.x; MARLEY PD, 1991, BRIT J PHARMACOL, V104, P839, DOI 10.1111/j.1476-5381.1991.tb12515.x; MOULAND AJ, 1991, ENDOCRINOLOGY, V128, P441, DOI 10.1210/endo-128-1-441; NOBLE EP, 1986, BIOCHEM BIOPH RES CO, V135, P566, DOI 10.1016/0006-291X(86)90031-8; NOBLE EP, 1988, BIOCHEM PHARMACOL, V37, P221, DOI 10.1016/0006-2952(88)90721-6; NOLAN JA, 1985, J HISTOCHEM CYTOCHEM, V33, P791, DOI 10.1177/33.8.3894497; PLEVIN R, 1988, J NEUROCHEM, V51, P634, DOI 10.1111/j.1471-4159.1988.tb01085.x; RUSSELL J, 1990, MOL ENDOCRINOL, V4, P505, DOI 10.1210/mend-4-3-505; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SIETZEN M, 1987, NEUROSCIENCE, V22, P131, DOI 10.1016/0306-4522(87)90203-X; SIMON JP, 1989, BIOCHEM J, V262, P1; SOMOGYI P, 1984, BRAIN RES REV, V8, P193, DOI 10.1016/0165-0173(84)90007-9; STAUDERMAN KA, 1990, J NEUROCHEM, V54, P946, DOI 10.1111/j.1471-4159.1990.tb02342.x; STEINER HJ, 1989, HISTOCHEMISTRY, V91, P473, DOI 10.1007/BF00492518; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; THOENEN H, 1972, PHARMACOL REV, V24, P255; WAN DCC, 1989, EUR J PHARM-MOLEC PH, V172, P117, DOI 10.1016/0922-4106(89)90003-5; WILSON SP, 1991, J NEUROCHEM, V56, P945, DOI 10.1111/j.1471-4159.1991.tb02013.x; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WOHLFARTER T, 1988, FEBS LETT, V231, P67, DOI 10.1016/0014-5793(88)80704-X; YAMASHITA M, 1991, BIOCHEM BIOPH RES CO, V177, P1233, DOI 10.1016/0006-291X(91)90673-U	57	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1586	1589						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420933				2022-12-27	WOS:A1993KH62000016
J	LUTTRELL, BM				LUTTRELL, BM			THE BIOLOGICAL RELEVANCE OF THE BINDING OF CALCIUM-IONS BY INOSITOL PHOSPHATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RECEPTOR-BINDING; XENOPUS OOCYTES; 1,4,5-TRISPHOSPHATE; RELEASE; CA-2+; 1,3,4,5-TETRAKISPHOSPHATE; PROTEIN; INTACT; BRAIN	The binding of Ca2+ (chelation) by myo-inositol polyphosphates at pH 7.0 was studied using a Ca2+-sensitive electrode. Glucose 6-phosphate (used as a model for a monophosphate) bound Ca2+ with an affinity of 152 +/- 31 liters/mol and a molar ratio of 0.94 +/- 0.02. Inositol 3,4-bisphosphate, inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, and inositol hexakisphosphate showed affinities of 9.0 +/- 2.1 x 10(3), 6.3 +/- 1.5 x 10(3), 6.2 x 10(4), and 1.92 +/- 0.47 x 10(5) liters/mol, respectively, and molar ratios of 0.92 +/- 0.49, 0.95 +/- 0.10, 0.75, and 2.5 +/- 0.5. In general, the affinity increased with the number of phosphate substituents on the inositol ring, although the stereochemistry is also expected to be important. This suggests that for the physiologically relevant inositol phosphates (tris-, tetrakis-, pentakis-, and hexakis-) half-maximal Ca2+ binding will occur in the Ca2+ concentration range of approximately 5 x 10(-6) to 2 x 10(-4) M. This range lies between the basal intracellular and the free extracellular Ca2+ levels (10(-7) and 10(-3) M), respectively, and may therefore be of physiological importance. Chelation provides a possible simple explanation for the inhibition by Ca2+ of inositol 1,4,5-trisphosphate binding to its receptor in rat cerebellum and other tissues. It may also have a role in limiting inositol phosphate-mediated increases in intracellular Ca2+.			LUTTRELL, BM (corresponding author), ROYAL N SHORE HOSP, DEPT ENDOCRINOL, ST LEONARDS, NSW 2065, AUSTRALIA.							AHREN B, 1992, NEUROPEPTIDES, V21, P163, DOI 10.1016/0143-4179(92)90040-4; BENESCH R, 1969, NATURE, V221, P618, DOI 10.1038/221618a0; BEVERIDGE MJ, 1984, NATURE, V312, P315; BIDEN TJ, 1986, J BIOL CHEM, V261, P1931; COHN M, 1962, J BIOL CHEM, V237, P176; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; EGGLETON P, 1991, BIOCHIM BIOPHYS ACTA, V1094, P309, DOI 10.1016/0167-4889(91)90091-B; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; GOSSELIN RE, 1953, ARCH BIOCHEM BIOPHYS, V45, P301, DOI 10.1016/S0003-9861(53)80007-X; GRAF E, 1987, J BIOL CHEM, V262, P11647; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; HEILIG M, 1991, EUR J PHARMACOL, V209, P27, DOI 10.1016/0014-2999(91)90006-C; HENDRICKSON HS, 1969, BIOCHEMISTRY-US, V8, P4855, DOI 10.1021/bi00840a031; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; INHORN RC, 1987, J BIOL CHEM, V262, P15946; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; IVORRA I, 1991, BIOCHEM J, V273, P317, DOI 10.1042/bj2730317; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LUTTRELL BM, 1991, J BIOL CHEM, V266, P21626; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MUALLEM S, 1989, J BIOL CHEM, V264, P205; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; STITH BJ, 1989, J CELL BIOCHEM, V40, P321, DOI 10.1002/jcb.240400308; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; WILSON DB, 1981, J BIOL CHEM, V256, P11718; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	28	71	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1521	1524						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420927				2022-12-27	WOS:A1993KH62000006
J	RYAN, RO; OIKAWA, K; KAY, CM				RYAN, RO; OIKAWA, K; KAY, CM			CONFORMATIONAL, THERMODYNAMIC, AND STABILITY PROPERTIES OF MANDUCA-SEXTA APOLIPOPHORIN-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEINS; APOLIPOPROTEIN-A-IV; INSECT APOLIPOPROTEIN; LOCUSTA-MIGRATORIA; AQUEOUS-SOLUTIONS; SELF-ASSOCIATION; APOA-I; C-II; PLASMA; BEHAVIOR	Apolipophorin III (apoLp-III) is a major protein in hemolymph of adult Manduca sexta. Although it normally exists in a lipid-free state, during sustained flight, apoLp-III functions as an apolipoprotein, reversibly associating with the surface of lipoprotein particles. In an effort to gain a fuller understanding of this dual existence, we have investigated its solution properties using spectroscopic methods. The UV absorption spectrum of apoLp-III is distinctive owing to the absence of tryptophan and the presence of a single tyrosine residue. Circular dichroism experiments revealed an enhancement of apoLp-III alpha-helical content when spectra were obtained in 50% trifluoroethanol versus aqueous buffer. The helical content in buffer was unaffected by protein concentration, suggesting that apoLp-III exists in solution as a monomeric species. At pH values >10 and <4, there was a marked loss of helical content. Increasing the temperature of apoLp-III solutions also caused a loss of secondary structure, with a temperature-induced denaturation midpoint of 52-degrees-C. Upon recooling of heat-denatured apoLp-III, approximately 95% of the secondary structure was restored. In guanidine HCl denaturation studies monitored by CD, a 50% transition midpoint of 0.355 M was determined, corresponding to a DELTAG(D)H2O of 1.29 kcal/mol. Fluorescence studies indicated that guanidine HCl induced an enhancement of tyrosine fluorescence emission at 300 nm when excited at 277 nm. In native apoLp-III, we propose that tyrosine fluorescence is quenched to a large extent due to a hydrophobic stacking interaction of its side chain with that of a neighboring phenylalanine residue. DELTAG(D)H2O was determined from the fluorescence data to be 2.1 kcal/mol, with a transition midpoint occurring at 0.25 M guanidine HCl. The lower concentration of guanidine HCl required to induce half-maximal tyrosine fluorescence enhancement versus the transition midpoint detected by CD may be a reflection of the fact that this residue is located near the COOH-terminal end of the protein and as such may be more susceptible to denaturation. The results presented indicate that apoLp-III assumes a relatively labile conformation in solution that' appears to be partially stabilized by side chain charge-charge interactions within predicted alpha-helical segments.	UNIV ALBERTA,UPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA; UNIV ALBERTA,MRC,PROT STRUCT & FUNCT,EDMONTON T6G 2S2,AB,CANADA	University of Alberta; University of Alberta	RYAN, RO (corresponding author), UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034786] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 34786] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BABUL J, 1969, ANAL BIOCHEM, V28, P216, DOI 10.1016/0003-2697(69)90172-9; BIERZYNSKI A, 1982, P NATL ACAD SCI-BIOL, V79, P2470, DOI 10.1073/pnas.79.8.2470; BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; COLE KD, 1987, J BIOL CHEM, V262, P11794; DELAMATRE JG, 1983, J LIPID RES, V24, P1578; EDELSTEIN C, 1980, J BIOL CHEM, V255, P5747; GWYNNE J, 1975, J BIOL CHEM, V250, P2269; GWYNNE J, 1974, J BIOL CHEM, V249, P2411; GWYNNE J, 1975, J BIOL CHEM, V170, P204; HOLDEN HM, 1988, J BIOL CHEM, V263, P3960; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KANOST MR, 1988, J BIOL CHEM, V263, P10568; KAWOOYA JK, 1984, J BIOL CHEM, V259, P733; LEFEVRE M, 1986, J LIPID RES, V27, P1163; LIU H, 1991, BIOCHEM BIOPH RES CO, V179, P734, DOI 10.1016/0006-291X(91)91878-G; MAKINO S, 1974, J BIOL CHEM, V249, P7379; MANTULIN WW, 1980, J BIOL CHEM, V255, P8185; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; NAKAE Y, 1973, J BIOCHEM, V73, P1249, DOI 10.1093/oxfordjournals.jbchem.a130198; Pace C N, 1986, Methods Enzymol, V131, P266; PRASAD SV, 1986, J BIOL CHEM, V261, P558; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; REIJNGOULD DJ, 1982, BIOCHEMISTRY-US, V21, P2069; REYNOLDS JA, 1976, J BIOL CHEM, V251, P6013; ROSSENEU M, 1976, EUR J BIOCHEM, V70, P285, DOI 10.1111/j.1432-1033.1976.tb10980.x; RYAN RO, 1990, J LIPID RES, V31, P1725; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SHORTLE D, 1989, J BIOL CHEM, V264, P5315; SINGH TKA, 1992, J BIOL CHEM, V267, P9275; STONE WL, 1975, J BIOL CHEM, V250, P8045; TAJIMA S, 1982, J BIOCHEM-TOKYO, V91, P1273, DOI 10.1093/oxfordjournals.jbchem.a133812; TALL AR, 1976, J BIOL CHEM, V251, P3749; VANDERHORST DJ, 1988, J BIOL CHEM, V263, P2027; VANDERHORST DJ, 1990, BIOCHIM BIOPHYS ACTA, V1047, P195, DOI 10.1016/0005-2760(90)90518-3; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; WEINBERG RB, 1985, J LIPID RES, V26, P26; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; WEINBERG RB, 1990, J BIOL CHEM, V265, P8081; WELLS MA, 1987, J BIOL CHEM, V262, P4172; WELLS MA, 1985, INSECT BIOCHEM, V15, P565, DOI 10.1016/0020-1790(85)90116-7; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375	45	69	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1525	1530						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420928				2022-12-27	WOS:A1993KH62000007
J	ALONSO, JC; STIEGE, AC; DOBRINSKI, B; LURZ, R				ALONSO, JC; STIEGE, AC; DOBRINSKI, B; LURZ, R			PURIFICATION AND PROPERTIES OF THE RECR PROTEIN FROM BACILLUS-SUBTILIS 168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DNA-REPAIR; GENETIC-RECOMBINATION; XERODERMA-PIGMENTOSUM; MOLECULAR-CLONING; EXCISION REPAIR; EXPRESSION; BINDING; MUTATIONS; STRAINS	Genetic evidence suggests that the Bacillus subtilis recR gene product is involved in DNA repair and recombination. To assign a biochemical function to the recR gene product, the RecR protein was labeled and purified by monitoring the radioactive label. NH2-terminal protein sequence analysis of RecR was consistent with the deduced amino acid sequence of the recR gene. The RecR protein (molecular mass of 25 kDa, isoelectric point 5.4) bound single- and double-stranded DNA in a filter binding assay. RecR-DNA complex formation is enhanced by the presence of a damage in the DNA substrate. The RecR-DNA complex formation proceeds in the absence of divalent cations and nucleotide cofactors, but is markedly stimulated by ATP and divalent cations. In our experimental conditions the apparent equilibrium constants of the optimized RecR-DNA complexes are 3 x 10(-7) M and 9 x 10(-7) M for damaged and undamaged DNA, respectively. The binding reaction is cooperative. Electron microscopy studies show that the presence of divalent cations increases the rate of RecR protein self-assembly. Addition of ATP or dATP promotes the organization of discrete series of quaternary structures on DNA, but ATPgammaS inhibits the DNA binding activity. A possible mechanism for the RecR function in DNA repair is discussed.			ALONSO, JC (corresponding author), MAX PLANCK INST MOLEC GENET,IHNESTR 73,W-1000 BERLIN 33,GERMANY.		Alonso, Juan C./D-2595-2009	Alonso, Juan C./0000-0002-5178-7179				ALONSO JC, 1990, NUCLEIC ACIDS RES, V18, P6771, DOI 10.1093/nar/18.23.6771; ALONSO JC, 1991, BIOCHIMIE, V73, P277, DOI 10.1016/0300-9084(91)90213-K; ALONSO JC, 1991, J BACTERIOL, V173, P3977, DOI 10.1128/JB.173.13.3977-3980.1991; ALONSO JC, 1987, GENE AMST, V65, P325; BERG JM, 1990, J BIOL CHEM, V265, P6513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKARDT H, 1988, ADV MOL GENETICS, P281; CEGLOWSKI P, 1990, MOL GEN GENET, V222, P441, DOI 10.1007/BF00633853; CLARK AJ, 1991, BIOCHIMIE, V73, P523, DOI 10.1016/0300-9084(91)90124-J; GASSEL M, 1989, MOL MICROBIOL, V3, P1269, DOI 10.1111/j.1365-2958.1989.tb00277.x; GRIFFIN TJ, 1990, J BACTERIOL, V172, P6291, DOI 10.1128/jb.172.11.6291-6299.1990; Iordanescu S, 1976, Arch Roum Pathol Exp Microbiol, V35, P111; KOLODNER R, 1985, J BACTERIOL, V163, P1060, DOI 10.1128/JB.163.3.1060-1066.1985; KOOISTRA J, 1991, J BACTERIOL, V173, P3644, DOI 10.1128/JB.173.12.3644-3655.1991; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLOYD RG, 1988, MOL GEN GENET, V212, P317, DOI 10.1007/BF00334702; LLOYD RG, 1991, BIOCHIMIE, V73, P313, DOI 10.1016/0300-9084(91)90218-P; MADIRAJU MVVS, 1991, NUCLEIC ACIDS RES, V19, P6295, DOI 10.1093/nar/19.22.6295; MAHDI AA, 1989, NUCLEIC ACIDS RES, V17, P6781, DOI 10.1093/nar/17.17.6781; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; MCPARTLAND A, 1980, CELL, V20, P731, DOI 10.1016/0092-8674(80)90319-0; MORRISON PT, 1989, J BACTERIOL, V171, P3641, DOI 10.1128/jb.171.7.3641-3649.1989; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; Sambrook J, 1989, MOL CLONING LABORATO; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SANDLER SJ, 1992, NUCLEIC ACIDS RES, V20, P839, DOI 10.1093/nar/20.4.839; SAWITZKE JA, 1992, GENETICS, V130, P7; SHEMYAKIN MF, 1979, EUR J BIOCHEM, V98, P417, DOI 10.1111/j.1432-1033.1979.tb13201.x; SMITH GR, 1990, NUCLEIC ACIDS MOL BI, V4, P78; SPIESS E, 1988, METHOD MICROBIOL, V20, P293, DOI 10.1016/S0580-9517(08)70057-6; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; TELANDERMUSKAVI.KM, 1981, ENZYMES, V14, P234; THOMAS DC, 1986, J BIOL CHEM, V261, P4496; THOMS B, 1987, J BACTERIOL, V169, P498; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; VISSE R, 1992, J BIOL CHEM, V267, P6736; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	40	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1424	1429						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419343				2022-12-27	WOS:A1993KG07700098
J	KAGIWADA, S; MURATA, M; HISHIDA, R; TAGAYA, M; YAMASHINA, S; OHNISHI, S				KAGIWADA, S; MURATA, M; HISHIDA, R; TAGAYA, M; YAMASHINA, S; OHNISHI, S			INVITRO FUSION OF RABBIT LIVER GOLGI MEMBRANES WITH LIPOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; VESICULAR TRANSPORT; RAT-LIVER; PROTEIN; PHOSPHOLIPIDS; APPARATUS; VESICLES; REQUIRES	Fusion of Golgi membranes isolated from rabbit liver with liposomes was studied by lipid mixing of fluorescent lipid analogues and internal content mixing and by electron microscopic observation of transfer of horseradish peroxidase from liposomes into Golgi membranes. A monoclonal antibody was used to confirm fusion of Golgi membranes but not other contaminating vesicles. Fusion was rapid and efficient, reaching about 20% of the maximum after a 5-min incubation using small or large unilamellar dioleoylphosphatidylcholine vesicles. The fusion was dependent on temperature, decreasing at lower temperatures, and becoming nearly zero below 10-degrees-C. The addition of ATP, GTP, cytosolic factors, or N-ethylmaleimide did not affect fusion. Treatments of Golgi membranes with 0.1 M Na2CO3 or 1 M KCl did not cause any changes in fusion. However, treatment with proteases inhibited fusion. These results suggest that Golgi integral membrane protein(s) are involved in fusion. Changing the medium to an isoosmotic substance, sucrose, in place of KCl or NaCl inhibited fusion. The binding assay of fluorescent liposomes to Golgi membranes showed that lowering the temperature or replacing salts with sucrose did not affect binding. However, treatment of Golgi membranes with proteases inhibited binding. Addition of phosphatidylserine or phosphatidylethanolamine to dioleoylphosphatidylcholine liposomes caused a 2-fold increase in binding and fusion. Fusion between Golgi membranes by themselves did not occur. These results provide some information on the mechanism of intracellular vesicular transport.	OSAKA UNIV,INST SCI & IND RES,IBARAKI,OSAKA 567,JAPAN; KITASATO UNIV,SCH MED,DEPT ANAT,SAGAMIHARA,KANAGAWA 228,JAPAN	Osaka University; Kitasato University	KAGIWADA, S (corresponding author), KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN.							ALKAISSI E, 1983, J IMMUNOL METHODS, V58, P127, DOI 10.1016/0022-1759(83)90269-7; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1989, J BIOL CHEM, V264, P16965; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BECKERS CJM, 1990, J BIOL CHEM, V265, P18298; BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BREW K, 1975, J BIOL CHEM, V250, P1434; CHLAPOWSKI FJ, 1971, J CELL BIOL, V50, P634, DOI 10.1083/jcb.50.3.634; DECURTIS I, 1989, CELL, V58, P719, DOI 10.1016/0092-8674(89)90106-2; DESILVA NS, 1981, J BIOL CHEM, V256, P5845; DEWALD B, 1973, J BIOL CHEM, V248, P7223; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; FREISCHER S, 1974, METHOD ENZYMOL, V31, P6; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZBAZENET C, 1988, BIOCHIM BIOPHYS ACTA, V943, P35, DOI 10.1016/0005-2736(88)90344-6; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MILLS JT, 1984, P NATL ACAD SCI-BIOL, V81, P1385, DOI 10.1073/pnas.81.5.1385; MOREAU P, 1991, J BIOL CHEM, V266, P4322; Ohnishi Shun-Ichi, 1988, Curr Top Membr Transp, V32, P257, DOI 10.1016/S0070-2161(08)60137-9; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROTHMAN JE, 1987, J BIOL CHEM, V262, P12502; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SHEN DF, 1982, BIOCHIM BIOPHYS ACTA, V689, P31, DOI 10.1016/0005-2736(82)90185-7; SINGLETON WS, 1965, J AM OIL CHEM SOC, V42, P53, DOI 10.1007/BF02558256; SLEIGHT RG, 1984, J CELL BIOL, V99, P742, DOI 10.1083/jcb.99.2.742; SLEIGHT RG, 1985, J BIOL CHEM, V260, P1146; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; STUTZIN A, 1986, FEBS LETT, V197, P274, DOI 10.1016/0014-5793(86)80341-6; SWANSON MA, 1955, METHOD ENZYMOL, V2, P541, DOI 10.1016/S0076-6879(55)02247-7; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TABAS I, 1979, J BIOL CHEM, V254, P1655; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; WATERS M G, 1991, Current Opinion in Cell Biology, V3, P615, DOI 10.1016/0955-0674(91)90031-S; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1430	1435						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419344				2022-12-27	WOS:A1993KG07700099
J	MURAO, S; OHKUNI, K; NAGAO, M; HIRAYAMA, K; FUKUHARA, K; ODA, K; OYAMA, H; SHIN, T				MURAO, S; OHKUNI, K; NAGAO, M; HIRAYAMA, K; FUKUHARA, K; ODA, K; OYAMA, H; SHIN, T			PURIFICATION AND CHARACTERIZATION OF KUMAMOLYSIN, A NOVEL THERMOSTABLE PEPSTATIN-INSENSITIVE CARBOXYL PROTEINASE FROM BACILLUS NOVOSP MN-32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCYTALIDIUM-LIGNICOLUM M-133; INHIBITORS S-PI; ACID PROTEASES; STREPTOMYCES EF-44-201; PEPSIN; ACIDOCALDARIUS; BACTERIUM; TEMPERATURE; COMPLEX; GROWTH	We have found a novel type of thermostable, pepstatinin-sensitive carboxyl proteinase in the culture filtrate of Bacillus novosp. MN-32. The carboxyl proteinase, which was named kumamolysin, was purified about 8,300-fold by column chromatography including DEAE-Sepharose CL-6B, Sephadex G-100, and TSKgel DEAE-5PW. The purified kumamolysin gave a single band corresponding to 41 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The molecular mass of kumamolysin was estimated to be 40 kDa by gel filtration. The isoelectric point of kumamolysin was estimated to be pH 3.5 by isoelectric focusing. Kumamolysin has maximum proteolytic activity at 70-degrees-C and at pH 3.0. Kumamolysin specifically hydrolyzed the Leu15-Tyr16 peptide bond in oxidized insulin B-chain (K(m) = 9.0 x 10(-5) M, K(cat) = 71 s-1; at pH 3.0, 30-degrees-C), and additional cleavage at Phe25-Tyr26 was detected at a considerably lower rate. Kumamolysin is insensitive to the known carboxyl proteinase inhibitors pepstatin, diazoacetyl-DL-norleucine methyl ester, and 1,2-epoxy-3-(p-nitrophenoxy)propane. Kumamolysin has no similarity to the thermostable acid protease thermopsin from Sulfolobus acidocaldarius (Lin, X.-L., and Tang, J. (1990) J. Biol. Chem. 265, 1490-1495). Thus, the substrate specificity, the inhibitor sensitivity, the molecular mass, and the thermostability all suggest that kumamolysin is a novel type of carboxyl proteinase.	UNIV OSAKA PREFECTURE,DEPT AGR CHEM,SAKAI,OSAKA 591,JAPAN	Osaka Metropolitan University	MURAO, S (corresponding author), KUMAMOTO INST TECHNOL,DEPT APPL MICROBIAL TECHNOL,IKEDA 4-22-1,KUMAMOTO 860,JAPAN.							ANTONOV VK, 1985, ASPARTIC PROTEINASES, P129; AOYAGI T, 1971, J ANTIBIOT, V24, P687, DOI 10.7164/antibiotics.24.687; BOTT R, 1982, BIOCHEMISTRY-US, V21, P6956, DOI 10.1021/bi00269a052; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; DARLAND G, 1970, SCIENCE, V170, P1416, DOI 10.1126/science.170.3965.1416; DUNN BM, 1985, ASPARTIC PROTEINASES, P221; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EMI S, 1976, BIOCHEMISTRY-US, V15, P842, DOI 10.1021/bi00649a018; FARRAND SG, 1983, ARCH MICROBIOL, V135, P272, DOI 10.1007/BF00413480; FARRAND SG, 1983, ARCH MICROBIOL, V135, P276, DOI 10.1007/BF00413481; Freeman H.C., 1973, INORGANIC BIOCHEMIST, P121; FUKUHARA K, 1982, AGR BIOL CHEM TOKYO, V46, P1707, DOI 10.1080/00021369.1982.10865316; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; KLOTZ IM, 1961, ARCH BIOCHEM BIOPHYS, V95, P540, DOI 10.1016/0003-9861(61)90188-6; KOLTZ IM, 1954, J AM CHEM SOC, V76, P805; LIN XL, 1990, J BIOL CHEM, V265, P1490; MOORE S, 1963, J BIOL CHEM, V238, P235; MURAO S, 1985, AGR BIOL CHEM TOKYO, V49, P895, DOI 10.1080/00021369.1985.10866825; MURAO S, 1970, AGR BIOL CHEM TOKYO, V34, P1265, DOI 10.1080/00021369.1970.10859764; MURAO S, 1972, AGR BIOL CHEM TOKYO, V36, P1327, DOI 10.1080/00021369.1972.10860407; MURAO S, 1972, AGR BIOL CHEM TOKYO, V36, P1647, DOI 10.1080/00021369.1972.10860454; Murao S., 1985, ASPARTIC PROTEINASES, P379; NAKATANI H, 1975, BIOCHIM BIOPHYS ACTA, V391, P415, DOI 10.1016/0005-2744(75)90266-1; ODA K, 1974, AGR BIOL CHEM TOKYO, V38, P2435, DOI 10.1080/00021369.1974.10861522; ODA K, 1987, AGR BIOL CHEM TOKYO, V51, P3073; ODA K, 1987, BIOCHIM BIOPHYS ACTA, V923, P463, DOI 10.1016/0304-4165(87)90055-9; ODA K, 1986, AGR BIOL CHEM TOKYO, V50, P1995, DOI 10.1080/00021369.1986.10867684; ODA K, 1986, AGR BIOL CHEM TOKYO, V50, P659, DOI 10.1080/00021369.1986.10867442; OSHIMA T, 1977, J BIOCHEM-TOKYO, V81, P1107, DOI 10.1093/oxfordjournals.jbchem.a131535; RAJAGOPALAN TG, 1966, J BIOL CHEM, V241, P4295; RYLE AP, 1968, BIOCHEM J, V110, pP4; TANAKA N, 1977, BIOCHIM BIOPHYS ACTA, V485, P406, DOI 10.1016/0005-2744(77)90176-0; TANG J, 1971, J BIOL CHEM, V246, P4510; TERASHITA T, 1981, AGR BIOL CHEM TOKYO, V45, P1937, DOI 10.1080/00021369.1981.10864821; TERASHITA T, 1984, AGR BIOL CHEM TOKYO, V48, P1029, DOI 10.1080/00021369.1984.10866245; TERASHITA T, 1981, AGR BIOL CHEM TOKYO, V45, P1037; UCHINO F, 1967, AGR BIOL CHEM TOKYO, V31, P817, DOI 10.1080/00021369.1967.10858890; Weber K, 1972, Methods Enzymol, V26, P3	38	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					349	355						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416942				2022-12-27	WOS:A1993KE60300054
J	NORDSTEDT, C; CAPORASO, GL; THYBERG, J; GANDY, SE; GREENGARD, P				NORDSTEDT, C; CAPORASO, GL; THYBERG, J; GANDY, SE; GREENGARD, P			IDENTIFICATION OF THE ALZHEIMER BETA/A4 AMYLOID PRECURSOR PROTEIN IN CLATHRIN-COATED VESICLES PURIFIED FROM PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; NEXIN-II; DISEASE; RECEPTOR; CDNA; LOCALIZATION; ENDOCYTOSIS; BIOGENESIS; LYSOSOMES	The Alzheimer beta/A4 amyloid precursor protein (APP) can be proteolytically processed by at least two separate pathways in PC12 cells: chloroquine-insensitive secretory cleavage and chloroquine-sensitive intracellular degradation, presumably in the endosomal/lysosomal system. To further investigate the possibility of APP processing in the endosomal/lysosomal system, we have examined whether APP is present in clathrin-coated vesicles (CCVs), which mediate the transport of many proteins to the endosomal compartment. Using a procedure derived from established protocols for the purification of CCVs from mammalian organs, we obtained from PC12 cells highly purified CCVs that displayed the same morphological features as described for CCVs purified from other sources. The CCVs were enriched in full-length mature (fully post-translationally modified) forms of APP, as well as in the carboxyl-terminal APP fragment produced by the secretory cleavage pathway. As CCVs are known to be involved in only two intracellular pathways (trafficking from the plasma membrane to early endosomes, and from the trans-Golgi network to late endosomes/prelysosomes), these findings provide direct evidence that APP is transported to the endosomal/lysosomal system. Furthermore, the presence in CCVs of the carboxyl-terminal fragment resulting from APP secretory cleavage suggests that APP secretory processing occurs in a pre-CCV compartment.	ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021; KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT GERIATR MED,S-14186 HUDDINGE,SWEDEN; KAROLINSKA INST,INST MED NOBEL,DEPT CELL BIOL,S-10401 STOCKHOLM 60,SWEDEN; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021	Rockefeller University; Karolinska Institutet; Karolinska Institutet; Cornell University; NewYork-Presbyterian Hospital					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NIA NIH HHS [AG-09464] Funding Source: Medline; NIGMS NIH HHS [GM-07739] Funding Source: Medline; NINDS NIH HHS [NS-01095] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BENOWITZ LI, 1989, EXP NEUROL, V106, P237, DOI 10.1016/0014-4886(89)90156-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLE GM, 1989, NEUROCHEM RES, V14, P933, DOI 10.1007/BF00965926; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GANDY SE, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P155; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; NANDI PK, 1982, P NATL ACAD SCI-BIOL, V79, P5881, DOI 10.1073/pnas.79.19.5881; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURKEWITZ AP, 1989, J CELL BIOL, V108, P2127, DOI 10.1083/jcb.108.6.2127; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	38	181	183	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					608	612						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416966				2022-12-27	WOS:A1993KE60300091
J	GAYLE, RB; POINDEXTER, K; COSMAN, D; DOWER, SK; GILLIS, S; HOPP, T; JERZY, R; KRONHEIM, S; LUM, V; LEWIS, A; GOODGAME, MM; MARCH, CJ; SMITH, DL; SRINIVASAN, S				GAYLE, RB; POINDEXTER, K; COSMAN, D; DOWER, SK; GILLIS, S; HOPP, T; JERZY, R; KRONHEIM, S; LUM, V; LEWIS, A; GOODGAME, MM; MARCH, CJ; SMITH, DL; SRINIVASAN, S			IDENTIFICATION OF REGIONS IN INTERLEUKIN-1-ALPHA IMPORTANT FOR ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; FIBROBLAST GROWTH-FACTOR; RECEPTOR ANTAGONIST; 3-DIMENSIONAL STRUCTURE; KEY RESIDUES; EXPRESSION; RESOLUTION; SEQUENCE; BINDING; 1-ALPHA	Saturation mutagenesis of the mature human interleukin-1alpha (IL-1alpha) gene has been performed. Following expression in Escherichia coli, the biological and receptor binding activities of the mutant proteins were examined. Most of the molecule could be altered with little effect on either function. More than 3,500 mutants were examined, and only 23 unique amino acid sequences were identified which resulted in an altered ratio of biological to binding activity when compared with wild-type IL-1alpha. These proteins possessed mutations at 38 of the 159 amino acid residues in IL-1alpha. Random mutagenesis at several of these positions identified further substitutions that affected activity. Examination of a model for IL-1alpha localized most of the residues which altered activity along one face of the molecule. This region appears to be distinct from areas of IL-1 which have been postulated to make contact with IL-1 receptor.	EASTMAN KODAK CO,LIFE SCI RES LABS,ROCHESTER,NY 14650	Eastman Kodak	GAYLE, RB (corresponding author), IMMUNEX RES & DEV CORP,51 UNIV ST,SEATTLE,WA 98101, USA.			dower, steve/0000-0002-4675-4225				AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; AURON PE, 1987, J IMMUNOL, V138, P1447; Ausubel FM., 1988, CURRENT PROTOCOLS MO; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; CRAIG S, 1989, INT J PEPT PROT RES, V33, P256; DOWER S K, 1990, P137; DOWER SK, 1990, PROG CLIN BIOL RES, V349, P241; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; DURUM SK, 1985, ANNU REV IMMUNOL, V3, P263; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; GEHRKE L, 1990, J BIOL CHEM, V265, P5922; GILLILAND GL, 1987, J BIOL CHEM, V262, P12323; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GRENFELL S, 1991, BIOCHEM J, V280, P111, DOI 10.1042/bj2800111; GRONENBORN AM, 1988, FEBS LETT, V231, P135, DOI 10.1016/0014-5793(88)80717-8; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; KAMOGASHIRA T, 1988, J BIOCHEM-TOKYO, V104, P837, DOI 10.1093/oxfordjournals.jbchem.a122559; KAMOGASHIRA T, 1988, BIOCHEM BIOPH RES CO, V150, P1106, DOI 10.1016/0006-291X(88)90743-7; KAWASHIMA H, 1992, PROTEIN ENG, V5, P171, DOI 10.1093/protein/5.2.171; LABRIOLATOMPKINS E, 1991, P NATL ACAD SCI USA, V88, P11182, DOI 10.1073/pnas.88.24.11182; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MOSLEY B, 1987, P NATL ACAD SCI USA, V84, P4572, DOI 10.1073/pnas.84.13.4572; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; PEEPLES WJ, 1989, CYTOBIOS, V58, P109; POINDEXTER K, 1991, NUCLEIC ACIDS RES, V19, P1899, DOI 10.1093/nar/19.8.1899; PRIESTLE JP, 1990, PROG CLIN BIOL RES, V349, P297; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMS JE, 1993, IL 1 SIGNAL TRANSDUC; VEERAPANDIAN B, 1992, PROTEINS, V12, P10, DOI 10.1002/prot.340120103; YAMAYOSHI M, 1990, LYMPHOKINE RES, V9, P405; YANOFSKY SD, 1990, J BIOL CHEM, V265, P13000; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556; ZURAWSKI G, 1991, TRENDS BIOTECHNOL, V9, P250, DOI 10.1016/0167-7799(91)90079-W	42	8	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22105	22111						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408069				2022-12-27	WOS:A1993MC80900099
J	LOWE, KE; OSBORNE, CB; LIN, BF; KIM, JS; HSU, JC; SHANE, B				LOWE, KE; OSBORNE, CB; LIN, BF; KIM, JS; HSU, JC; SHANE, B			REGULATION OF FOLATE AND ONE-CARBON METABOLISM IN MAMMALIAN-CELLS .2. EFFECT OF FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE SUBSTRATE-SPECIFICITY AND LEVEL ON FOLATE METABOLISM AND FOLYLPOLY-GAMMA-GLUTAMATE SPECIFICITY OF METABOLIC CYCLES OF ONE-CARBON METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; POLYGLUTAMATE CHAIN-LENGTH; DEPENDENT ENZYMES; PIG-LIVER; FOLYLPOLYGLUTAMATES; INVITRO; METHOTREXATE; TRANSPORT; MUTANT; EXPRESSION	The effect of folylpoly-gamma-glutamate synthetase (FPGS) levels on folate accumulation was investigated in Chinese hamster ovary cells expressing various levels of human and Escherichia coli FPGS activity. At low medium folate concentrations, folate accumulation was limited by influx and was independent of FPGS activity except in cells expressing extremely low levels of FPGS. Essentially all transported folate was metabolized to retained polyglutamate derivatives, the chain length of which varied with the level of FPGS activity. As medium folate concentration increased through the physiological to the pharmacological range, cellular folate accumulation became proportional to FPGS activity and the chain length of intracellular folates decreased. At high folate concentrations, competition between substrates for FPGS limited the extent of polyglutamylation and less than 5% of transported folate was retained by the cell. Pteroyltriglutainates functioned as effectively as the longer chain length polyglutamates normally found in mammalian cells in the metabolic cycles of de novo purine and thymidylate biosynthesis but were unable to support glycine and methionine synthesis. Transfectants expressing human FPGS and containing folates of glutamate chain length ranging from four to eight were equally effective at supporting glycine synthesis, and transfectants expressing higher levels of FPGS were able to grow in the absence of methionine. Growth in the absence of methionine required high (nonphysiological) intracellular folate levels and longer chain length polyglutamates.	UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				LIN, BI-FONG/0000-0003-2260-6081	NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER; NCI NIH HHS [CA-41991] Funding Source: Medline; NIGMS NIH HHS [GM073079] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARRUECO JR, 1991, J BIOL CHEM, V266, P11732; BOARMAN DM, 1992, CANCER RES, V52, P36; BOGNAR AL, 1985, J BIOL CHEM, V260, P5625; BOGNAR AL, 1986, METHOD ENZYMOL, V122, P349; CASSADY IA, 1980, BIOCHIM BIOPHYS ACTA, V633, P258, DOI 10.1016/0304-4165(80)90411-0; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P513, DOI 10.1021/bi00376a025; COLL RJ, 1991, BIOCHEM PHARMACOL, V42, P833, DOI 10.1016/0006-2952(91)90043-5; COOK JD, 1987, BIOCHEMISTRY-US, V26, P530, DOI 10.1021/bi00376a027; ETO I, 1982, LIFE SCI, V30, P183, DOI 10.1016/0024-3205(82)90651-8; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; FOO SK, 1982, J BIOL CHEM, V257, P13587; GREEN JM, 1988, BIOCHEMISTRY-US, V27, P8014, DOI 10.1021/bi00421a007; HOFFMAN RM, 1982, IN VITRO CELL DEV B, V18, P421; Houghton J A, 1989, Cancer Commun, V1, P167; HOUGHTON JA, 1990, CANCER RES, V50, P3940; HOUGHTON JA, 1990, CANCER RES, V50, P3493; KALMAN T I, 1986, P763; KIM JS, 1993, J BIOL CHEM, V268, P21680; KRUMDIECK CL, 1983, VITAM HORM, V40, P45, DOI 10.1016/S0083-6729(08)60432-X; LU YZ, 1984, BIOCHEMISTRY-US, V23, P6870, DOI 10.1021/bi00321a091; MacKenzie R E, 1984, FOLATES PTERINS CHEM, V1, P255; MATTHEWS RG, 1987, ADV ENZYME REGUL, V26, P157, DOI 10.1016/0065-2571(87)90012-4; MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCGUIRE JJ, 1980, J BIOL CHEM, V255, P5776; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; OCONNOR BM, 1991, CANCER RES, V51, P3874; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; PRIEST DG, 1983, BIOCHIM BIOPHYS ACTA, V756, P253, DOI 10.1016/0304-4165(83)90332-X; SAMUELS LL, 1986, CANCER RES, V46, P2230; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; SHANE B, 1989, VITAM HORM, V45, P263; SIN BF, 1983, J BIOL CHEM, V268, P21674; SIROTNAK FM, 1985, CANCER RES, V45, P3992; TAYLOR RT, 1975, ARCH BIOCHEM BIOPHYS, V171, P507, DOI 10.1016/0003-9861(75)90060-0; TAYLOR RT, 1979, ARCH BIOCHEM BIOPHYS, V197, P36, DOI 10.1016/0003-9861(79)90215-7; WEITMAN SD, 1992, CANCER RES, V52, P3396; WHITEHEAD VM, 1987, BIOCHEM BIOPH RES CO, V144, P292, DOI 10.1016/S0006-291X(87)80509-0; ZHANG ZG, 1991, CANCER RES, V51, P3476	41	65	68	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21665	21673						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408019				2022-12-27	WOS:A1993MC80900038
J	OSHIRO, S; NAKAJIMA, H; MARKELLO, T; KRASNEWICH, D; BERNARDINI, I; GAHL, WA				OSHIRO, S; NAKAJIMA, H; MARKELLO, T; KRASNEWICH, D; BERNARDINI, I; GAHL, WA			REDOX, TRANSFERRIN-INDEPENDENT, AND RECEPTOR-MEDIATED ENDOCYTOSIS IRON UPTAKE SYSTEMS IN CULTURED HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; PLASMA-MEMBRANE; DIFERRIC TRANSFERRIN; K562 CELLS; BOUND IRON; REDUCTASE; LIVER; MECHANISM; RETICULOCYTES; LYSOSOMES	Sepharose beads bound to Fe-55-transferrin (Tf) were used to evaluate Tf-dependent iron uptake not employing receptor-mediated endocytosis (RME). The iron of Fe-55(2)-Tf-Sepharose was reduced and taken up by cultured human fibroblasts in a time- and concentration-dependent fashion (K(m) 7 muM; V(max) 128 pmol/mg/min). This redox system resembled that for Tf-independent iron uptake (Tf-IU, evaluated using Fe-55-citrate) in several ways. 1) NH4Cl did not inhibit iron uptake from Fe-55-citrate and Fe-55(2)-Tf-Sepharose but did inhibit uptake from Fe-55(2)-Tf (RME system). 2) Iron uptake and reduction from Fe-55(2)-Tf-Sepharose and Fe-55-citrate increased with temperature hyperbolically, differing from the sigmoidal curve for RME uptake. 3) The subcellular distributions of iron from Fe-55-citrate and Fe-55(2)-Tf-Sepharose resembled each other and differed from that for Fe-55(2)-Tf. 4) The optimal pH for iron reduction and uptake using Fe-55(2)-Tf-Sepharose or Fe-55-citrate was less than pH 5.5, while that for iron uptake from Fe-55(2)-Tf was pH 7.4. 5) The uptake and reduction of iron from Fe-55(2)-Tf-Sepharose was inhibited by ferric citrate and by transition metals. We conclude that both Tf-independent and non-RME, Tf-dependent iron uptake proceed via a common redox system for iron. The mechanisms of cellular iron uptake can be separately evaluated in fibroblasts using Fe-55-citrate, Fe-55(2)-Tf, and Fe-55(2)-Tf-Sepharose beads.	NICHHD,HUMAN GENET BRANCH,HUMAN BIOCHEM GENET SECT,BLDG 10,RM 95242,BETHESDA,MD 20892; TOKYO MED & DENT UNIV,MED RES INST,DEPT BIOCHEM GENET,TOKYO 113,JAPAN	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tokyo Medical & Dental University (TMDU)								BATES GW, 1971, J BIOL CHEM, V246, P3679; BATES GW, 1973, J BIOL CHEM, V248, P3228; BERCZI A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P562, DOI 10.1016/0304-4165(91)90231-5; BOTHWELL TH, 1989, METABOLIC BASIS INHE, P1433; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; DUNN WA, 1980, J BIOL CHEM, V255, P5971; GABER BP, 1970, BIOCHIM BIOPHYS ACTA, V221, P228, DOI 10.1016/0005-2795(70)90262-X; GOLDENBERG H, 1990, EUR J BIOCHEM, V192, P475, DOI 10.1111/j.1432-1033.1990.tb19250.x; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; HUEBERS H, 1981, P NATL ACAD SCI-BIOL, V78, P621, DOI 10.1073/pnas.78.1.621; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; KNISELY AS, 1989, AM J PATHOL, V134, P439; KOJIMA N, 1979, J BIOL CHEM, V254, P8847; LOH TT, 1977, BIOCHIM BIOPHYS ACTA, V471, P118, DOI 10.1016/0005-2736(77)90399-6; MORAND JN, 1986, ANAL BIOCHEM, V159, P157, DOI 10.1016/0003-2697(86)90321-0; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; MORLEY CGD, 1985, INT J BIOCHEM, V17, P553, DOI 10.1016/0020-711X(85)90286-1; MORRE DJ, 1969, BIOCHEM BIOPH RES CO, V37, P813; MORRE JD, 1971, METHOD ENZYMOL, V22, P138; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; NUNEZ MT, 1983, J BIOL CHEM, V258, P1146; OSHIRO S, 1988, J BIOL CHEM, V263, P16032; RAY TK, 1970, BIOCHIM BIOPHYS ACTA, V196, P1, DOI 10.1016/0005-2736(70)90159-8; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; ROME LH, 1981, J BIOL CHEM, V256, P763; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SPIRO TG, 1967, J AM CHEM SOC, V89, P5555, DOI 10.1021/ja00998a008; SPIRO TG, 1967, J AM CHEM SOC, V89, P5559, DOI 10.1021/ja00998a009; STURROCK A, 1990, J BIOL CHEM, V265, P3139; SUN IL, 1987, BIOCHEM INT, V14, P119; SUN IL, 1988, BIOCHIM BIOPHYS ACTA, V938, P17, DOI 10.1016/0005-2736(88)90117-4; SUN IL, 1987, J BIOL CHEM, V262, P15915; THORSTENSEN K, 1990, BIOCHEM J, V271, P1; THORSTENSEN K, 1988, J BIOL CHEM, V263, P8844; THORSTENSEN K, 1990, BIOCHIM BIOPHYS ACTA, V1052, P29, DOI 10.1016/0167-4889(90)90053-G; THORSTENSEN K, 1988, J BIOL CHEM, V263, P16837; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; WORWOOD M, 1973, BIOCHEM J, V134, P183, DOI 10.1042/bj1340183; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; YOUNG SP, 1984, BIOCHEM J, V219, P505, DOI 10.1042/bj2190505	43	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21586	21591						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408010				2022-12-27	WOS:A1993MC80900026
J	PATANKAR, MS; OEHNINGER, S; BARNETT, T; WILLIAMS, RL; CLARK, GF				PATANKAR, MS; OEHNINGER, S; BARNETT, T; WILLIAMS, RL; CLARK, GF			A REVISED STRUCTURE FOR FUCOIDAN MAY EXPLAIN SOME OF ITS BIOLOGICAL-ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN SPERM; ZONA-PELLUCIDA; LINKED OLIGOSACCHARIDES; METHYLATION ANALYSIS; SACCHARIDE MOIETIES; MASS-SPECTROMETRY; HUMAN SPERMATOZOA; SULFATED GLYCANS; CELL-ADHESION; BINDING	Fucoidan from Fucus vesiculosus inhibits human sperm-zona pellucida binding and blocks the zona pellucida-induced acrosome reaction in human sperm. Fucoidan also potently inhibits selectin-mediated adhesion of leukocytes to vascular endothelium. To understand the molecular basis for fucoidan's inhibition of specific cell adhesion events, we have investigated the structure of this fucan using definitive methods of carbohydrate structural analysis. We report the revised average structure for fucoidan. [GRAPHICS] This average structure differs from the previous model for fucoidan in two respects. First, the core region of the fucan is composed primarily of a polymer of alpha1-3-linked fucose with sulfate groups substituted at the 4 position on some of the fucose residues. Secondly, fucose is also attached to this polymer to form branch points, one for every 2-3 fucose residues within the chain. This revised average structure is consistent with previous studies suggesting a branched random coil as the best model for this polysaccharide. The proposed model is also a closer structural analogue of the sulfated carbohydrate ligands that bind to selectins. This information should be useful for determining whether a relationship exists between selectin-mediated adhesion of leukocytes and human sperm-egg binding.	EASTERN VIRGINIA MED SCH, DEPT BIOCHEM, POB 1980, NORFOLK, VA 23501 USA; EASTERN VIRGINIA MED SCH, DEPT OBSTET & GYNECOL, NORFOLK, VA 23501 USA; OLD DOMINION UNIV, DEPT CHEM & BIOCHEM, NORFOLK, VA 23529 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Old Dominion University			Oehninger, Sergio/AAZ-8443-2020					AHUJA KK, 1982, EXP CELL RES, V140, P353, DOI 10.1016/0014-4827(82)90124-0; ANNO K, 1970, CARBOHYD RES, V13, P167, DOI 10.1016/S0008-6215(00)84905-8; BABA M, 1988, ANTIVIR RES, V9, P335, DOI 10.1016/0166-3542(88)90035-6; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; BERNARDI G, 1962, J BIOL CHEM, V237, P75; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BJORNDAL H, 1970, ANGEW CHEM INT EDIT, V9, P610, DOI 10.1002/anie.197006101; BJORNDAL HAKAN, 1967, CAR BOHYD RES, V5, P433, DOI 10.1016/S0008-6215(00)81115-5; BLACK WAP, 1952, J SCI FOOD AGR, V3, P122, DOI 10.1002/jsfa.2740030305; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BOLWELL GP, 1979, J CELL SCI, V36, P19; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARK GF, 1992, FASEB J, V6, pA233; CONCHIE J, 1950, J CHEM SOC, P827, DOI 10.1039/jr9500000827; COTE RH, 1959, J CHEM SOC, P2248, DOI 10.1039/jr9590002248; DABROWSKI J, 1989, METHOD ENZYMOL, V179, P122; DEANGELIS PL, 1987, J BIOL CHEM, V262, P13946; DODGSON KS, 1961, BIOCHEM J, V78, P312, DOI 10.1042/bj0780312; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; GLABE CG, 1982, J CELL BIOL, V94, P123, DOI 10.1083/jcb.94.1.123; GREEN PJ, 1992, BIOCHEM BIOPH RES CO, V188, P244, DOI 10.1016/0006-291X(92)92376-9; GUNNARSSON A, 1987, GLYCOCONJUGATE J, V4, P239, DOI 10.1007/BF01048429; HANDA K, 1991, BIOCHEM BIOPH RES CO, V181, P1223, DOI 10.1016/0006-291X(91)92069-V; HUANG TTF, 1982, GAMETE RES, V5, P355, DOI 10.1002/mrd.1120050406; JONES R, 1991, DEVELOPMENT, V111, P1155; Klenk E, 1941, H-S Z PHYSIOL CHEM, V270, P185, DOI 10.1515/bchm2.1941.270.3-4.185; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LEVERY SB, 1987, METHOD ENZYMOL, V138, P13, DOI 10.1016/0076-6879(87)38004-8; MAHONY MC, 1991, CONTRACEPTION, V44, P657, DOI 10.1016/0010-7824(91)90085-T; OEHNINGER S, 1990, FERTIL STERIL, V53, P143; OEHNINGER S, 1991, FERTIL STERIL, V55, P165; Percival E., 1967, CHEM ENZYMOLOGY MARI, P157; PERCIVAL EGV, 1949, Q REV CHEM SOC, V3, P369, DOI 10.1039/qr9490300369; PETERSON RN, 1984, J EXP ZOOL, V231, P137, DOI 10.1002/jez.1402310118; SHALGI R, 1986, BIOL REPROD, V34, P446, DOI 10.1095/biolreprod34.3.446; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; STELLNER K, 1973, ARCH BIOCHEM BIOPHYS, V155, P464, DOI 10.1016/0003-9861(73)90138-0; STOFFYN P, 1971, J LIPID RES, V12, P318; THOMASOATES JE, 1989, BIOCHEM SOC T, V17, P243, DOI 10.1042/bst0170243; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; URCH UA, 1991, DEVELOPMENT, V111, P1165; VARKI A, 1980, J BIOL CHEM, V255, P847; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; WILLIAMS RM, 1993, J EXP ZOOL, V266, P65, DOI 10.1002/jez.1402660110; YEDNOCK TA, 1989, ADV IMMUNOL, V44, P313; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003; ZEHAVI U, 1972, J ORG CHEM, V37, P2141, DOI 10.1021/jo00978a017	49	426	452	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21770	21776						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408031				2022-12-27	WOS:A1993MC80900054
J	WESSENDORF, JHM; GARFINKEL, S; ZHAN, X; BROWN, S; MACIAG, T				WESSENDORF, JHM; GARFINKEL, S; ZHAN, X; BROWN, S; MACIAG, T			IDENTIFICATION OF A NUCLEAR-LOCALIZATION SEQUENCE WITHIN THE STRUCTURE OF THE HUMAN INTERLEUKIN-1-ALPHA PRECURSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; HUMAN ENDOTHELIAL-CELLS; NIH 3T3 CELLS; LEUKOCYTE INTERLEUKINS; RECEPTOR ANTAGONIST; INTERNALIZATION; EXPRESSION; PROTEINS; BINDING; CDNA	Recent studies have suggested that the signal peptide-less cytokine, interleukin (IL)-1alpha, may play a role as an intracellular regulator of human endothelial cell proliferation in vitro (Garfinkel, S., Haines, D. S., Brown, S., Wessendorf, J., Gillespie, D. H., and Maciag, T. (1992) J. Biol. Chem. 267, 24375-24378). In order to determine the intracellular locale of the IL-1alpha precursor, we fused the open reading frame of the IL-1alpha precursor to the reporter gene beta-galactosidase (Gal) and studied the cellular distribution of the chimera in NIH 3T3 cells after transfection. Immunological and enzymatic analysis demonstrated that the IL-1alpha:beta-Gal fusion protein was associated with the nucleus. To further define the region responsible for this activity, we ligated the mature form of IL-1alpha (IL-1alpha113-271) and the IL-1alpha precursor domain (IL-1alpha1-112) to beta-Gal. Analysis of the intracellular distribution of these chimeric polypeptides following transfection demonstrated a differential distribution of IL-1alpha1-112:beta-Gal in the nucleus and IL-1alpha113-271:beta-Gal in the cytosol. Because the IL-1alpha precursor domain contains a sequence that resembles a nuclear translocation signal (KVLKKRRL, residues 79-86), we prepared an IL-1alpha precursor point mutant in which Lys82 was replaced by Glu. Transfection of NIH 3T3 cells with the IL-1alpha precursor point mutant (IL-1alpha1-271 Glu82:beta-Gal) resulted in a significant reduction in the ability of the IL-1alpha precursor to associate with the nucleus and similar data were obtained as a result of Lys82 mutagenesis in the IL-1alpha precursor domain (IL-1alpha1-112 Glu82:beta-Gal). These data suggest that the IL-1alpha precursor contains a functional nuclear localization sequence within the structure of the precursor domain and Lys82 is critical for its function.	AMER RED CROSS,HOLLAND LAB,DEPT MOLEC BIOL,ROCKVILLE,MD 20855	American Red Cross					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007450] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35627] Funding Source: Medline; NIA NIH HHS [AG07450] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CURTIS BM, 1990, J IMMUNOL, V144, P1295; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FOROUGH R, 1993, J BIOL CHEM, V268, P2960; GARFINKEL S, 1992, J BIOL CHEM, V267, P24375; GRENFELL S, 1989, BIOCHEM J, V264, P813, DOI 10.1042/bj2640813; GRENFELL S, 1991, BIOCHEM J, V280, P111, DOI 10.1042/bj2800111; GUBLER U, 1986, J IMMUNOL, V136, P2492; HASKILL S, 1991, P NATL ACAD SCI USA, V88, P3681, DOI 10.1073/pnas.88.9.3681; HEGUY A, 1991, CELL GROWTH DIFFER, V2, P311; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MONTESANO R, 1985, J CELL PHYSIOL, V122, P424, DOI 10.1002/jcp.1041220313; MONTESANO R, 1984, J CELL BIOL, V99, P1706, DOI 10.1083/jcb.99.5.1706; MOSLEY B, 1987, P NATL ACAD SCI USA, V84, P4572, DOI 10.1073/pnas.84.13.4572; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; QUARTO N, 1991, CELL REGUL, V2, P699, DOI 10.1091/mbc.2.9.699; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114; SAEGUSA Y, 1990, J CELL PHYSIOL, V142, P488, DOI 10.1002/jcp.1041420307; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; STEVENSON FT, 1992, J CELL PHYSIOL, V152, P223, DOI 10.1002/jcp.1041520202; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P81, DOI 10.1016/0968-0004(86)90271-9; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WEITZMANN MN, 1992, BIOCHEM BIOPH RES CO, V187, P1166, DOI 10.1016/0006-291X(92)91319-L; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447; ZHAN X, 1992, BIOCHEM BIOPH RES CO, V188, P982, DOI 10.1016/0006-291X(92)91328-N; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	42	159	163	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22100	22104						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408068				2022-12-27	WOS:A1993MC80900098
J	WILHELM, SM; SHAO, ZH; HOUSLEY, TJ; SEPERACK, PK; BAUMANN, AP; GUNJASMITH, Z; WOESSNER, JF				WILHELM, SM; SHAO, ZH; HOUSLEY, TJ; SEPERACK, PK; BAUMANN, AP; GUNJASMITH, Z; WOESSNER, JF			MATRIX METALLOPROTEINASE-3 (STROMELYSIN-1) - IDENTIFICATION AS THE CARTILAGE ACID METALLOPROTEASE AND EFFECT OF PH ON CATALYTIC PROPERTIES AND CALCIUM AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; RHEUMATOID SYNOVIAL FIBROBLASTS; HUMAN-SKIN; PURIFICATION; PROTEOGLYCAN; TISSUE; COLLAGENASE; COMPONENTS; CELLS; DEGRADATION	Human pro-MMP-3 (pro-matrix metalloproteinase-3) was purified from three sources: articular cartilage and conditioned media from synovial fibroblasts and Chinese hamster ovary cells expressing recombinant pro-MMP-3. All three preparations reacted with two monoclonal antibodies specific for human fibroblast pro-MMP-3. Each preparation of active MMP-3 possessed properties identical to those previously reported for the cartilage acid metalloproteinase (MMP-6; Azzo and Woessner, J. F., Jr. (1986) J. Biol. Chem. 261, 5434-5441): an acid pH optimum of 5.3-5.5 for digestion of cartilage aggrecan; digestion of oxidized insulin B-chain at Ala14-Leu15 and Tyr16-Leu17 in a ratio of 3:1; and heat stability at neutral pH. Further characterization of MMP-3 establishes that the acid pH optimum for cartilage aggrecan is not due to substrate denaturation since the same optimum is found by viscosity assay, by SDS-polyacrylamide gel electrophoresis assay of G1 domain, and by digestion of aggrecan in fresh cartilage fragments in vitro. Fibronectin was also digested optimally at pH 5.5 and NH2-terminal sequence analysis revealed no pH change in a major proteolytic site of cleavage at the Pro689-Leu690 bond. The specificity constant k(cat)/K(m) is maximal at pH 5.5 as determined in a quenched fluorescence peptide assay. This is due to an increase in k(cat) at pH 5.5 without any substantial effect on K(m). The affinity of MMP-3 for calcium is decreased about 10-fold at pH 5.3 compared to neutral pH. Finally, the neutral cartilage metalloproteinase is identified as 72-kDa pro-MMP-2 based on M(r), specificity of insulin B-chain cleavage, and reactivity with a specific polyconal antibody to human MMP-2.	UNIV MIAMI,SCH MED,DEPT MED,MIAMI,FL 33101	University of Miami	WILHELM, SM (corresponding author), MILES INC,MILES RES CTR,INST BONE & JOINT DISORDERS,400 MORGAN LANE,W HAVEN,CT 06516, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR016940, R01AR016940] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-16940] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AZZO W, 1986, J BIOL CHEM, V261, P5434; CAMPBELL IK, 1986, J RHEUMATOL, V13, P20; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; EECKHOUT Y, 1990, BIOCHEM J, V272, P529, DOI 10.1042/bj2720529; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FLANNERY CR, 1992, J BIOL CHEM, V267, P1008; FOSANG AJ, 1991, MATRIX, V11, P17, DOI 10.1016/S0934-8832(11)80223-4; GALLOWAY WA, 1983, BIOCHEM J, V209, P741, DOI 10.1042/bj2090741; GUNJASMITH Z, 1989, BIOCHEM J, V258, P115, DOI 10.1042/bj2580115; HARRISON R, 1989, ANAL BIOCHEM, V180, P110, DOI 10.1016/0003-2697(89)90096-1; HARRISON RK, 1992, BIOCHEMISTRY-US, V31, P10757, DOI 10.1021/bi00159a016; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; HOUSLEY TJ, 1903, J BIOL CHEM, V268, P4481; HUGHES C, 1991, BIOCHEM J, V279, P733, DOI 10.1042/bj2790733; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KUNUGI S, 1982, EUR J BIOCHEM, V124, P157, DOI 10.1111/j.1432-1033.1982.tb05919.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P41, DOI 10.1038/newbio238041a0; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; NAGASE H, 1980, ANAL BIOCHEM, V107, P385, DOI 10.1016/0003-2697(80)90400-5; OKADA Y, 1988, BIOCHEM J, V254, P731, DOI 10.1042/bj2540731; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; OKADA Y, 1986, J BIOL CHEM, V261, P14245; SAPOLSKY AI, 1976, J CLIN INVEST, V58, P1030, DOI 10.1172/JCI108526; SELTZER JL, 1981, J BIOL CHEM, V256, P4662; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; Wilhelm S M, 1992, Matrix Suppl, V1, P37; WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725; WOESSNER JF, 1973, FED PROC, V32, P1485; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918; WOESSNER JF, 1984, J BIOL CHEM, V259, P3633	36	72	73	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21906	21913						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408046				2022-12-27	WOS:A1993MC80900072
J	FLORESROZAS, H; HURWITZ, J				FLORESROZAS, H; HURWITZ, J			CHARACTERIZATION OF A NEW RNA HELICASE FROM NUCLEAR EXTRACTS OF HELA-CELLS WHICH TRANSLOCATES IN THE 5' TO 3' DIRECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; MESSENGER-RNA; TRANSLATION INITIATION; DEPENDENT ATPASE; DNA HELICASE; PROTEIN; COMPLEX; GENE; DROSOPHILA; FRACTIONS	RNA helicase II, isolated from nuclear extracts of HeLa cells, was purified 1,300-fold and contained a single protein band of 100 kDa when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The enzyme displaced partial duplex RNA exclusively in a 5' to 3' direction. This reaction was supported only by ATP and deoxy-ATP at relatively high concentrations (the K(m) was estimated as 1 mM). The enzyme displayed only ATPase and deoxy-ATPase activity that was stimulated preferentially by poly(C). RNA helicase catalyzed the unwinding of duplex RNA and RNA . DNA hybrids provided that single-stranded (ss) RNA was available for the helicase to bind. In the presence of MgCl2 and ATP or adenosine 5'-O-3-thiotriphosphate) RNA helicase II interacted with ssRNA and yielded a protein-RNA complex only when reaction mixtures were treated with glutaraldehyde after incubation. When the reactions contained non-hydrolyzable ATP analogs or GTP, ssRNA was converted into an electrophoretically slower migrating form by the helicase. The slower migrating RNA form was shown to be an RNA species containing secondary structure that resided within a putative hairpin loop. These observations indicate that RNA helicase II can introduce intramolecular secondary structure in ssRNA.	MEM SLOAN KETTERING CANC CTR, SLOAN KETTERING INST, GRAD PROGRAM MOLEC BIOL, 1275 YORK AVE, NEW YORK, NY 10021 USA	Memorial Sloan Kettering Cancer Center								BARRIJAL S, 1992, NUCLEIC ACIDS RES, V20, P5053, DOI 10.1093/nar/20.19.5053; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; CLAUDE A, 1991, J BIOL CHEM, V266, P10358; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; DALBADIEMCFARLAND G, 1990, P NATL ACAD SCI USA, V87, P4236, DOI 10.1073/pnas.87.11.4236; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOVAL BC, 1991, SCIENCE, V252, P1823; FURNEAUX HM, 1985, P NATL ACAD SCI USA, V82, P4351, DOI 10.1073/pnas.82.13.4351; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LAIN S, 1990, NUCLEIC ACIDS RES, V18, P7003, DOI 10.1093/nar/18.23.7003; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEE CG, 1992, J BIOL CHEM, V267, P4398; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; LINDER P, 1988, NUCLEIC ACIDS RES, V16, P10359, DOI 10.1093/nar/16.21.10359; NISHI K, 1988, NATURE, V336, P496, DOI 10.1038/336496a0; PRUZAN R, 1990, J BIOL CHEM, V265, P2804; RAY BK, 1985, J BIOL CHEM, V260, P7651; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; SEO YS, 1991, J BIOL CHEM, V266, P13161; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SHUMAN S, 1992, P NATL ACAD SCI USA, V89, P10935, DOI 10.1073/pnas.89.22.10935; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STRAUSS EJ, 1991, GENE DEV, V5, P629, DOI 10.1101/gad.5.4.629; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0	35	68	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21372	21383						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407977				2022-12-27	WOS:A1993MA28800105
J	LEWIS, CT; SEYER, JM; CASSELL, RG; CARLSON, GM				LEWIS, CT; SEYER, JM; CASSELL, RG; CARLSON, GM			IDENTIFICATION OF VICINAL THIOLS OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CYTOSOL; GUANOSINE TRIPHOSPHATE; MESSENGER-RNA; INACTIVATION; CHICKEN; PROTEIN; 5'-TRIPHOSPHATE; DISULFIDE; CYSTEINE; DITHIOL	Phosphoenolpyruvate carboxykinase (PEPCK) from the cytosol of rat liver has 13 cysteines, at least one of which (Cys288) is known to be very reactive and critical for catalytic activity (Lewis, C. T., Seyer, J. M., and Carlson, G. M. (1989) J. Biol. Chem. 264, 27-33). Previous results provided evidence for the existence of at least 1 pair of vicinal cysteines within or near the active site of PEPCK (Lewis, C. T., Haley, B. E., and Carlson, G. M. (1989) Biochemistry 28, 9248-9255). An intramolecular cystine disulfide is induced to form upon treatment of PEPCK with equimolar 5,5'-dithiobis(2-nitrobenzoate) (Nbs2) or upon irradiation of the enzyme in the presence of the photoaffinity probe 8-azidoGTP. In each case, modification is accompanied by a substantial loss in catalytic activity, and substrates protect against inactivation and modification. We now report the identification of these modified thiols by differential alkylation of cysteines and half-cystines with radioactive iodoacetate, followed by isolation and sequencing of the modified tryptic peptides. The results indicate that the disulfide formed by equimolar NbS2 lies within a 15-residue region of the PEPCK sequence that includes Cys399, Cys407, and Cys413. In addition, Cys407 and/or Cys413 also appear to participate in formation of the disulfide induced by 8-azidoGTP. These thiols lie very near a consensus sequence that has been suggested to represent the binding site for the guanine ring of GTP.	UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT BIOCHEM,800 MADISON AVE,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center								ALVEAR M, 1989, BIOCHIM BIOPHYS ACTA, V994, P7, DOI 10.1016/0167-4838(89)90055-1; ANNAMALAI AE, 1981, J BIOL CHEM, V256, P276; BALLARD FJ, 1976, BIOCHEM J, V154, P717, DOI 10.1042/bj1540717; BALLARD FJ, 1969, J BIOL CHEM, V244, P5625; BEALE EG, 1985, J BIOL CHEM, V260, P748; BRINKWORTH RI, 1981, J BIOL CHEM, V256, P795; CARDEMIL E, 1990, BIOCHIM BIOPHYS ACTA, V1040, P71, DOI 10.1016/0167-4838(90)90147-8; CARLSON GM, 1978, BIOCHEMISTRY-US, V17, P5329, DOI 10.1021/bi00618a002; COLOMBO G, 1981, BIOCHEMISTRY-US, V20, P2758, DOI 10.1021/bi00513a009; COLOMBO G, 1978, BIOCHEMISTRY-US, V17, P5321, DOI 10.1021/bi00618a001; COLOMBO G, 1981, BIOCHEMISTRY-US, V20, P2749, DOI 10.1021/bi00513a008; COOK JS, 1986, P NATL ACAD SCI USA, V83, P7583, DOI 10.1073/pnas.83.20.7583; CREIGHTON TE, 1984, METHOD ENZYMOL, V107, P305; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; HANNINK M, 1985, P NATL ACAD SCI USA, V82, P7894, DOI 10.1073/pnas.82.23.7894; HEBDA CA, 1982, J BIOL CHEM, V257, P5503; LEWIS CT, 1989, J BIOL CHEM, V264, P27; LEWIS CT, 1989, BIOCHEMISTRY-US, V28, P9248, DOI 10.1021/bi00450a003; MILLER RS, 1968, J BIOL CHEM, V243, P6030; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RIPPA M, 1981, J BIOL CHEM, V256, P451; UTTER MF, 1954, J BIOL CHEM, V207, P803	22	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1628	1636						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420937				2022-12-27	WOS:A1993KH62000022
J	YRUELA, I; ALFONSO, M; DEZARATE, IO; MONTOYA, G; PICOREL, R				YRUELA, I; ALFONSO, M; DEZARATE, IO; MONTOYA, G; PICOREL, R			PRECISE LOCATION OF THE CU(II)-INHIBITORY BINDING-SITE IN HIGHER-PLANT AND BACTERIAL PHOTOSYNTHETIC REACTION CENTERS AS PROBED BY LIGHT-INDUCED ABSORPTION CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II REACTION CENTER; ELECTRON-TRANSPORT PROPERTIES; PHOTOSYSTEM-II; RHODOPSEUDOMONAS-VIRIDIS; PHOTOREACTION CENTER; PROTEIN SUBUNITS; B559 COMPLEX; COPPER; QA; CHLOROPLASTS	Light-dependent absorption change at 325 nm, ascribed to Q(A) activity, was strongly reduced in the presence of Cu(II) in oxygen-evolving core complex. This change was much less affected in the presence of the herbicide 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), indicating that the Cu(II)-binding site is different from that of the DCMU and that Cu(II) blocks Q(A) reduction. Cu(II) did not eliminate the absorption change at 545 nm, ascribed to pheophytin reduction, in Na2S2O4-treated oxygen-evolving core and D1-D2-cytochrome b559 complexes. This indicates that Cu(II) does not affect the electron transport between P680 and pheophytin. Moreover, the activity of the bacterial reaction center probed by the absorption change at 790 nm was inhibited by Cu(II), but the signal at 530 nm, associated to the reduction of bacteriopheophytin in Na2S2O4-treated reaction center, was not inhibited. We conclude that Cu(II) impaired the photosynthetic electron transport between pheophytin and Q(A) in both higher plants and photosynthetic bacteria. Cu(II) would bind to an amino acid(s) highly conserved in non-oxygenic and oxygenic reaction centers, which is(are) necessary for the electron transfer between pheophytin and Q(A). Based on the atomic structure of the bacterial reaction center several schemes of possible Cu(II) binding are shown.	CSIC,ESTAC EXPTL AULA DEI,APARTADO 202,E-50080 ZARAGOZA,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)			PICOREL, RAFAEL/K-7930-2014; Yruela, Inmaculada/A-9330-2015; Alfonso, Miguel/L-6970-2014; Yruela, Inmaculada/T-1239-2019	PICOREL, RAFAEL/0000-0003-3791-129X; Yruela, Inmaculada/0000-0003-3608-4720; Alfonso, Miguel/0000-0002-8190-5156; Yruela, Inmaculada/0000-0003-3608-4720				ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; BARBER J, 1987, FEBS LETT, V220, P67, DOI 10.1016/0014-5793(87)80877-3; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BOWLBY NR, 1988, LIGHT ENERGY TRANSDU, P215; BRAUN P, 1990, BIOCHEMISTRY-US, V29, P10376, DOI 10.1021/bi00497a012; CHAPMAN DJ, 1988, BIOCHIM BIOPHYS ACTA, V933, P423, DOI 10.1016/0005-2728(88)90077-1; CLIJSTERS H, 1985, PHOTOSYNTH RES, V7, P731; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; COLEMAN W, 1990, CURRENT RES PHOTOSYN, P149; COLEMAN WJ, 1990, ANNU REV BIOPHYS BIO, V19, P333; Cramer W. A., 1982, PHOTOSYNTHESIS, V1, P387; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; DINER BA, 1991, PHYSIOL PLANTARUM, V81, P423; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; HANSSON O, 1990, PHOTOSYNTH RES, V23, P131, DOI 10.1007/BF00035006; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; HSU BD, 1988, PLANT PHYSIOL, V87, P116, DOI 10.1104/pp.87.1.116; MAR T, 1991, BIOCHIM BIOPHYS ACTA, V1056, P190, DOI 10.1016/S0005-2728(05)80286-5; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P17; MOHANTY N, 1989, PLANT PHYSIOL, V90, P175, DOI 10.1104/pp.90.1.175; MONTOYA G, 1991, FEBS LETT, V283, P255, DOI 10.1016/0014-5793(91)80601-X; NAGATSUKA T, 1991, BIOCHIM BIOPHYS ACTA, V1057, P223, DOI 10.1016/S0005-2728(05)80105-7; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; PICOREL R, 1980, BIOCHIM BIOPHYS ACTA, V593, P76, DOI 10.1016/0005-2728(80)90009-2; PLATO M, 1989, FEBS LETT, V249, P70, DOI 10.1016/0014-5793(89)80018-3; SAMSON G, 1988, PHOTOCHEM PHOTOBIOL, V48, P329, DOI 10.1111/j.1751-1097.1988.tb02829.x; SCHATZ GH, 1985, BIOCHIM BIOPHYS ACTA, V810, P283, DOI 10.1016/0005-2728(85)90212-9; SEIBERT M, 1988, PLANT PHYSIOL, V87, P303, DOI 10.1104/pp.87.2.303; SINGH DP, 1987, PLANT PHYSIOL, V83, P12, DOI 10.1104/pp.83.1.12; SULKOWSKI E, 1985, TRENDS BIOTECHNOL, V3, P1, DOI 10.1016/0167-7799(85)90068-X; TANAKAKITATANI Y, 1990, PLANT CELL PHYSIOL, V31, P1039; THORNBER JP, 1987, PHOTOSYNTHETIC BACTE, P133; TREBST A, 1987, Z NATURFORSCH C, V42, P742; VADEBONCOEUR C, 1979, BIOCHEMISTRY-US, V18, P4301, DOI 10.1021/bi00587a007; VANGORKOM HJ, 1982, FUNCTION QUINONES EN, P213; YRUELA I, 1992, PHOTOSYNTH RES, V33, P227, DOI 10.1007/BF00030033; YRUELA I, 1991, J BIOL CHEM, V266, P22847	39	44	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1684	1689						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420944				2022-12-27	WOS:A1993KH62000029
J	HINEK, A; RABINOVITCH, M				HINEK, A; RABINOVITCH, M			THE DUCTUS-ARTERIOSUS MIGRATORY SMOOTH-MUSCLE CELL PHENOTYPE PROCESSES TROPOELASTIN TO A 52-KDA PRODUCT ASSOCIATED WITH IMPAIRED ASSEMBLY OF ELASTIC LAMINAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER RIBONUCLEIC-ACID; BOVINE ELASTIN; BINDING-PROTEIN; MONOCLONAL-ANTIBODY; SOLUBLE ELASTIN; NUCHAL LIGAMENT; CHICK AORTA; GENE; RNA; SEQUENCE	We established the identity of a 52-kDa protein secreted by fetal lamb ductus arteriosus (DA) smooth muscle cells (SMC) and suggest how it might be related to structural changes unique to DA development, i.e. reduced assembly of elastic laminae and associated formation of intimal cushions. We produced a monoclonal antibody (HI-20) to the 52-kDa protein and observed, by electron microscopy, immunogold labeling of elastin in both DA and aorta vessel walls. Western immunoblotting showed that HI-20, as well as antibodies to tropoelastin, reacted with the 52-kDa protein secreted by DA SMC, as well as with 68-kDa tropoelastin. The highly specific antibody to the carboxyl-terminal sequence of tropoelastin failed, however, to recognize the 52-kDa protein, although it reacted well with the 68-kDa tropoelastin. Amino acid analysis and sequencing data confirmed the identity of the affinity-purified 52-kDa protein as truncated tropoelastin with an intact amino terminus. Cell-free translation of mRNA extracted from DA and aorta SMC produced a 68-kDa, but not a 52-kDa, immunoprecipitated tropoelastin. When DA and aorta SMC were pulsed with [C-14]valine, we immunoprecipitated, after only a 15-min chase, both 68-kDa and 52-kDa tropoelastin from cell extracts of DA SMC, but only the 68-kDa tropoelastin was present in aorta SMC. There was no evidence of proteolytic degradation of radiolabeled aorta 68-kDa tropoelastin to a 52-kDa species when mixed with DA SMC conditioned medium. This suggests that the 52-kDa tropoelastin is the result of cell-associated processing or degradation of an original 68-kDa product of translation. Furthermore, pulse-chase experiments showed initial secretion of equivalent amounts of 68-kDa and 52-kDa tropoelastins by cultured DA SMC with increasing accumulation of the 52-kDa species, suggesting its impaired insolubilization. The production, in high concentration, of a 52-kDa tropoelastin product that lacks the carboxyl terminus, may prevent its alignment on the microfibrillar scaffold, resulting in abnormal assembly of elastic laminae in the DA. The accumulation of this soluble tropoelastin may be associated with the previously described property of chemotaxis resulting in the increased SMC migration into the subendothelium associated with DA intimal thickening.	HOSP SICK CHILDREN,RES INST,DIV CARDIOVASC RES,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT PATHOL,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto			Hinek, Aleksander/V-8790-2019					BOUDREAU N, 1991, DEV BIOL, V143, P235, DOI 10.1016/0012-1606(91)90074-D; BOUDREAU N, 1991, LAB INVEST, V64, P187; BUCHNAN JW, 1978, BIRTH DEFECTS, V124, P349; BURNETT W, 1980, BIOCHEMISTRY-US, V19, P1106, DOI 10.1021/bi00547a010; CHIPMAN SD, 1985, J BIOL CHEM, V260, P2780; CICILA G, 1985, BIOCHEMISTRY-US, V24, P3075, DOI 10.1021/bi00334a001; DAVIDSON JM, 1984, BIOCHEM J, V220, P643, DOI 10.1042/bj2200643; DAVIDSON JM, 1982, J BIOL CHEM, V257, P747; DAVIDSON JM, 1982, ARCH BIOCHEM BIOPHYS, V218, P31, DOI 10.1016/0003-9861(82)90317-4; DEREEDER EG, 1990, ANAT EMBRYOL, V182, P473; DEREEDER EG, 1988, AM J PATHOL, V132, P574; EMANUEL BS, 1985, AM J HUM GENET, V37, P873; FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591; FOSTER JA, 1980, BIOCHEMISTRY-US, V19, P857, DOI 10.1021/bi00546a005; FOSTER JA, 1981, BIOCHEMISTRY-US, V20, P3528, DOI 10.1021/bi00515a035; FOSTER JA, 1986, COLLAGEN REL RES, V6, P387; FRANZBLAU C, 1989, J BIOL CHEM, V264, P15115; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; GITTENBERGERDEGROOT AC, 1985, J AM COLL CARDIOL, V6, P394, DOI 10.1016/S0735-1097(85)80178-9; Hineck A, 1990, ELASTIN CHEM BIOL AS, P369; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; INDIK Z, 1989, AM J MED GENET, V34, P81, DOI 10.1002/ajmg.1320340115; INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MECHAM RP, 1984, J CELL BIOL, V98, P1813, DOI 10.1083/jcb.98.5.1813; MECHAM RP, 1977, BIOCHEMISTRY-US, V16, P3825, DOI 10.1021/bi00636a017; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; OLLIVER L, 1987, COLLAGEN REL RES, V7, P77; PARKS WC, 1988, J BIOL CHEM, V263, P4416; PATTERSON DF, 1979, PEDIATR CARDIOL, V2, P45; PROSSER IW, 1991, CONNECT TISSUE RES, V25, P265, DOI 10.3109/03008209109029162; RABINOVITCH M, 1988, DEV BIOL, V130, P250, DOI 10.1016/0012-1606(88)90431-9; RAJU K, 1987, J BIOL CHEM, V262, P5755; ROMERO N, 1986, ARCH BIOCHEM BIOPHYS, V244, P161, DOI 10.1016/0003-9861(86)90105-0; ROSENBLOOM J, 1986, COLLAGEN REL RES, V6, P423; ROSENBLOOM J, 1984, LAB INVEST, V51, P605; Sandberg L B, 1976, Int Rev Connect Tissue Res, V7, P159; SANDBERG LB, 1982, METHOD ENZYMOL, V82, P657; SANDBERG LB, 1985, PATHOL BIOL, V33, P266; SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; TODOROVICHHUNTER L, 1988, LAB INVEST, V58, P184; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUKADA T, 1987, AM J PATHOL, V126, P51; WRENN DS, 1986, BIOCHEMISTRY-US, V25, P5172, DOI 10.1021/bi00366a028; WRENN DS, 1987, J BIOL CHEM, V262, P2244; WRENN DS, 1986, METHOD ENZYMOL, V144, P246; YEH H, 1987, COLLAGEN REL RES, V7, P235; YEH H, 1989, BIOCHEMISTRY-US, V28, P2365, DOI 10.1021/bi00432a003; YODER MJ, 1978, ANAT REC, V192, P19, DOI 10.1002/ar.1091920103; YOON K, 1985, ARCH BIOCHEM BIOPHYS, V241, P684, DOI 10.1016/0003-9861(85)90595-8; YOON K, 1984, BIOCHEM BIOPH RES CO, V118, P261, DOI 10.1016/0006-291X(84)91095-7; ZHU L, 1993, IN PRESS LAB INVEST	58	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1405	1413						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419341				2022-12-27	WOS:A1993KG07700096
J	JONES, G; MANCZAK, M; HORN, M				JONES, G; MANCZAK, M; HORN, M			HORMONAL-REGULATION AND PROPERTIES OF A NEW GROUP OF BASIC HEMOLYMPH-PROTEINS EXPRESSED DURING INSECT METAMORPHOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; MANDUCA-SEXTA; JUVENILE-HORMONE; BOMBYX-MORI; TOBACCO HORNWORM; STORAGE PROTEIN; STRUCTURAL PROTEINS; GENE-EXPRESSION; TRICHOPLUSIA-NI; FAT-BODY	Two abundant basic proteins, and arylphorin, that are expressed during metamorphosis of Trichoplusia ni were isolated, their cDNAs cloned, and regulation of their expression assessed. According to the criteria of encoded protein sequence, positions of sequence coinitiation and cotermination, amino acid compositions, nonsex-specificity, and immunological analyses, the related yet distinct basic proteins do not correspond to any previously established group of insect proteins, each of which can be distinguished on the basis of such criteria, although they appear to be within the arthropod hemocyanin superfamily. The basic proteins can be separated under native isoelectric focusing conditions, indicating that they do not preferentially form heteromeric complexes under such conditions. While the transcripts for both basic proteins and a coexpressed acidic protein (Jones, G., Brown, N., Manczak, M., Hiremath, S., and Kafatos, F. (1990) J. Biol. Chem. 265, 8596-8602) appeared in both sexes on the day prior to ecdysteroid-driven metamorphic commitment, and persisted at high abundance for the next 24 h, the arylphorin mRNA appeared 1 day earlier and declined immediately after metamorphic commitment. The dynamics of suppression of the appearance and abundance of transcripts in response to maintenance of a high juvenile hormone titer was different for the acidic versus the two basic proteins. Another regulatory difference in response to juvenile hormone was shown by a decreased translatability of the mRNAs for the two basic proteins, but not for the acidic protein. In contrast, the abundance and translatability of arylphorin mRNA was insensitive to a high juvenile hormone level. A further difference in regulation was shown by the maintenance of a high level of both arylphorin and the acidic protein in the hemolymph after disappearance of their transcripts, while the basic proteins instead disappeared from the hemolymph and persisted in the fat body. These results establish at least three qualitatively different effects of juvenile hormone on the abundance of transcripts for these representatives of three groups in the hemocyanin superfamily, and also establish mRNA translatability as another differential level of regulation among them. Given these differences in mechanisms of regulation of evolutionarily related proteins, this system of metamorphosis-associated proteins in T. ni should prove to be a valuable tool in studies of mechanisms of hormonal regulation of gene expression during the metamorphic transformation of larval tissues.			JONES, G (corresponding author), UNIV KENTUCKY, SCH BIOL SCI, LEXINGTON, KY 40506 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039197] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK39197] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOSQUET G, 1985, J INSECT PHYSIOL, V31, P603, DOI 10.1016/0022-1910(85)90058-7; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COLE KD, 1990, INSECT BIOCHEM, V20, P381, DOI 10.1016/0020-1790(90)90058-3; DELANEY SJ, 1986, J MOL BIOL, V189, P1, DOI 10.1016/0022-2836(86)90376-1; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJII T, 1989, J BIOL CHEM, V264, P11020; GOODMAN WG, 1985, BIOCHEMISTRY-US, V24, P1168, DOI 10.1021/bi00326a017; HAUNERLAND NH, 1986, BIOCHEM BIOPH RES CO, V24, P1168; HELLMANN GM, 1983, VIROLOGY, V124, P434, DOI 10.1016/0042-6822(83)90359-8; HUEBERS HA, 1988, J COMP PHYSIOL B, V158, P291, DOI 10.1007/BF00695327; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JONES D, 1981, J INSECT PHYSIOL, V27, P779, DOI 10.1016/0022-1910(81)90068-8; JONES G, 1985, ENTOMOL EXP APPL, V39, P171, DOI 10.1007/BF00414505; JONES G, 1989, BIOCHEM BIOPH RES CO, V162, P1382, DOI 10.1016/0006-291X(89)90827-9; JONES G, 1988, J BIOL CHEM, V263, P1089; JONES G, 1987, BIOCHEM BIOPH RES CO, V146, P265, DOI 10.1016/0006-291X(87)90720-0; JONES G, 1990, J INSECT PHYSIOL, V36, P77, DOI 10.1016/0022-1910(90)90177-H; JONES G, 1990, J BIOL CHEM, V265, P8596; Jones G., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V49, P295; KRAMER SJ, 1980, INSECT BIOCHEM, V10, P279, DOI 10.1016/0020-1790(80)90023-2; KUMARAN AK, 1987, INSECT BIOCHEM, V17, P1053; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMEUR M, 1981, CELL, V23, P561, DOI 10.1016/0092-8674(81)90152-5; Levenbook L., 1985, P307; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MINTZAS AC, 1983, DEV BIOL, V95, P492, DOI 10.1016/0012-1606(83)90051-9; RYAN RO, 1985, J BIOL CHEM, V260, P782; SAKURAI H, 1988, NUCLEIC ACIDS RES, V16, P7717, DOI 10.1093/nar/16.15.7717; SANGER F, 1977, P NATL ACAD SCI USA, V80, P3963; SCHENKEL H, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P290; Telfer W.H., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V49, P305; TOJO S, 1980, INSECT BIOCHEM, V10, P289, DOI 10.1016/0020-1790(80)90024-4; WEBB BA, 1988, DEV BIOL, V130, P671, DOI 10.1016/0012-1606(88)90359-4; WILLOTT E, 1989, J BIOL CHEM, V264, P19052	34	65	68	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1284	1291						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419330				2022-12-27	WOS:A1993KG07700078
J	WILBANKS, SM; GLAZER, AN				WILBANKS, SM; GLAZER, AN			ROD STRUCTURE OF A PHYCOERYTHRIN-II-CONTAINING PHYCOBILISOME .1. ORGANIZATION AND SEQUENCE OF THE GENE-CLUSTER ENCODING THE MAJOR PHYCOBILIPROTEIN ROD COMPONENTS IN THE GENOME OF MARINE SYNECHOCOCCUS-SP-WH8020	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM FREMYELLA-DIPLOSIPHON; CYTOSOLIC ACID-PHOSPHATASE; UNICELLULAR CYANOBACTERIA; PORPHYRIDIUM-CRUENTUM; B-PHYCOERYTHRIN; ENERGY-TRANSFER; PHYCOCYANIN; EXPRESSION; CLONING; OPERON	Phycobilisomes of the unicellular marine cyanobacteria are unique in having rod substructures with two distinct phycoerythrins, PE I and PE II, with five and six bilins, respectively (Ong, L. J., and Glazer, A. N. (1991) J. Biol. Chem. 266, 9515-9527). The genes for the alpha and beta subunits of PE I, PE II, and phycocyanin, and that for the PE II-associated linker polypeptide, are clustered on a single 15-kilobase region of the genome of Synechococcus sp. WH8020. Complete sequencing of this region allowed definitive assignment of the positions of all bilin attachment sites in these phycobiliproteins. Twelve other open reading frames are closely associated with the structural genes specified above. Six are homologous to open reading frames adjacent to phycobiliprotein genes in other cyanobacteria and inferred to be involved in bilin addition. This is the largest number of open reading frames of this class known in any cyanobacterium. Another of the open reading frames has a short region of striking similarity to the active site sequence of a bovine protein-phosphotyrosine phosphatase.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Wilbanks, Sigurd/0000-0001-7565-8913	NIGMS NIH HHS [GM28994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028994] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JF, 1985, FEBS LETT, V193, P271, DOI 10.1016/0014-5793(85)80167-8; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ANDERSON LK, 1990, J BACTERIOL, V172, P1297, DOI 10.1128/jb.172.3.1297-1305.1990; [Anonymous], [No title captured]; BELKNAP WR, 1987, EMBO J, V6, P871, DOI 10.1002/j.1460-2075.1987.tb04833.x; BRITSCHGI TB, 1991, APPL ENVIRON MICROB, V57, P1707, DOI 10.1128/AEM.57.6.1707-1713.1991; Bryant D.A., 1988, LIGHT ENERGY TRANSDU, P62; Bryant D.A., 1991, CELL CULTURE SOMATIC, V1st ed., P255; CAMICI G, 1989, J BIOL CHEM, V264, P2560; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; DELORIMIER R, 1992, PLANT MOL BIOL, V20, P353, DOI 10.1007/BF00014507; DELORIMIER R, 1992, IN PRESS PLANT MOL B; DEMARSAC NT, 1990, FEMS SYMP, V53, P143; DEMARSAC NT, 1988, PHOTOSYNTH RES, V18, P99, DOI 10.1007/BF00042981; DEMARSAC NT, 1991, CELL CULTURE SOMAT B, V7, P417; DUBBS JM, 1991, MOL MICROBIOL, V5, P3073, DOI 10.1111/j.1365-2958.1991.tb01867.x; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FEDERSPIEL NA, 1990, J BACTERIOL, V172, P4072, DOI 10.1128/jb.172.7.4072-4081.1990; FICNER R, 1992, PHTOSYNTHETIC LIGHT, V2; FRANCHE C, 1988, METHOD ENZYMOL, V167, P803; GLAZER AN, 1977, J BIOL CHEM, V252, P32; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1988, METHOD ENZYMOL, V167, P304; Glover HE., 1985, ADV AQUATIC MICROB, V3, P49; GROSSMAN AR, 1990, PLANT CELL ENVIRON, V13, P651, DOI 10.1111/j.1365-3040.1990.tb01081.x; HENIKOFF S, 1984, GENE, V28, P51; HOUMARD J, 1988, METHOD ENZYMOL, V167, P808; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LAGARIAS JC, 1988, J BIOL CHEM, V263, P12977; LIND LK, 1988, THESIS U UMEA; MAZEL D, 1988, MOL GEN GENET, V211, P296, DOI 10.1007/BF00330607; MAZEL D, 1986, NUCLEIC ACIDS RES, V14, P8279, DOI 10.1093/nar/14.21.8279; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; ONG LJ, 1988, THESIS U CALIFORNIA; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; RAMPONI G, 1989, FEBS LETT, V250, P469, DOI 10.1016/0014-5793(89)80778-1; ROELL M, 1992, IN PRESS PLANT MOL B; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; SIDLER W, 1989, BIOL CHEM H-S, V370, P115, DOI 10.1515/bchm3.1989.370.1.115; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; SWANSON RV, 1992, J BACTERIOL, V174, P2640, DOI 10.1128/jb.174.8.2640-2647.1992; Tarsac N. T. de, 1987, The Cyanobacteria., P251; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; WILBANKS SM, 1991, J BIOL CHEM, V266, P9535; WILBANKS SM, 1993, J BIOL CHEM, V268, P1236; ZHOU JH, 1992, J BIOL CHEM, V267, P16138; Zuber H, 1987, LIGHT REACTIONS, P197	55	57	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1226	1235						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419325				2022-12-27	WOS:A1993KG07700070
J	KEREM, A; KRONMAN, C; BARNUN, S; SHAFFERMAN, A; VELAN, B				KEREM, A; KRONMAN, C; BARNUN, S; SHAFFERMAN, A; VELAN, B			INTERRELATIONS BETWEEN ASSEMBLY AND SECRETION OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYBRID CELL-LINE; MOLECULAR-FORMS; ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; EXPRESSION; GOLGI; IGM; BUTYRYLCHOLINESTERASE; CHOLINESTERASE; DEGRADATION	Transport and secretion of recombinant human acetylcholinesterase (HuAChE) were studied in transfected human 293 cells expressing either the oligomerized soluble enzyme or a monomeric mutant derivative in which Cys-580 was substituted by alanine (C580A). In cells expressing the wild-type enzyme, the gradual assembly of newly synthesized intracellular rHuAChE monomers into oligomers occurs within the endoplasmic reticulum. Secretion of mature wild-type enzyme into the medium is efficient and appears to be exclusive to multimeric forms. Consistently, intracellular oligomers, but not monomers, are endoglycosidase H-resistant, indicating that only oligomers undergo terminal glycosylation in the wild-type enzyme. In contrast, in cells expressing the dimerization-defective C580A mutant, newly synthesized rHuAChE monomers undergo terminal glycosylation and are secreted into the medium as efficiently as wild-type multimers. No significant difference between the intracellular transport rates of wild-type rHuAChE oligomers and mutant C580A monomers was revealed by probing with specific lectins. In both systems, transport and processing prior to the trans-Golgi galactosylation compartment appear to be rate-limiting, whereas the following passage to the cell surface is rapid. In conclusion, we suggest that in the presence of a free cysteine at the COOH terminus of the rHuAChE polypeptide, secretion of monomers is not effectuated, whereas in its absence, monomers are exported from the endoplasmic reticulum and are capable of traversing the entire secretory pathway.	ISRAEL INST BIOL RES,DEPT BIOCHEM,POB 19,IL-70450 NESS ZIONA,ISRAEL; TEL AVIV UNIV,SCH LIFE SCI,DEPT BIOCHEM,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University								ALLMAND P, 1981, J NEUROCHEM, V36, P860; AMITAY R, 1991, J BIOL CHEM, V266, P12568; ATACK JR, 1987, J NEUROCHEM, V48, P1845, DOI 10.1111/j.1471-4159.1987.tb05746.x; BROCKMAN SK, 1986, J BIOL CHEM, V261, P1201; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; DAVIS AC, 1988, EUR J IMMUNOL, V18, P1001, DOI 10.1002/eji.1830180705; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HEIDER H, 1992, BIOCHEM J, V281, P279, DOI 10.1042/bj2810279; HURTLEY SM, 1989, ANN REV CELL BIOL, V5, P227; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KLAUSNER RD, 1989, CELL, V57, P703, DOI 10.1016/0092-8674(89)90783-6; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; KRONMAN C, 1992, IN PRESS GENE AMST; LAZAR M, 1980, J NEUROCHEM, V35, P1067, DOI 10.1111/j.1471-4159.1980.tb07860.x; LAZAR M, 1984, J BIOL CHEM, V259, P3703; LI Y, 1991, J BIOL CHEM, V266, P23083; LOCKRIDGE O, 1979, J BIOL CHEM, V254, P8324; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; RIEGER F, 1980, DEV BIOL, V76, P238, DOI 10.1016/0012-1606(80)90376-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1979, J BIOL CHEM, V254, P4790; SCHUMACHER M, 1988, J BIOL CHEM, V263, P18979; SHACHAR I, 1992, J BIOL CHEM, V267, P24241; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VELAN B, 1991, J BIOL CHEM, V266, P23977; VELAN B, 1991, CELL MOL NEUROBIOL, V11, P143, DOI 10.1007/BF00712806; WILCHEK M, 1982, BIOCHEM INT, V4, P629	42	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					180	184						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416926				2022-12-27	WOS:A1993KE60300028
J	KWONG, FYP; WU, JSR; SHI, MM; FINCHAM, HE; DAVIES, A; HENDERSON, PJF; BALDWIN, SA; YOUNG, JD				KWONG, FYP; WU, JSR; SHI, MM; FINCHAM, HE; DAVIES, A; HENDERSON, PJF; BALDWIN, SA; YOUNG, JD			ENZYMATIC CLEAVAGE AS A PROBE OF THE MOLECULAR-STRUCTURES OF MAMMALIAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE GLUCOSE TRANSPORTER; PARA-CHLOROMERCURIPHENYL SULFONATE; ENDO-BETA-GALACTOSIDASE; GUINEA-PIG; NITROBENZYLTHIOINOSINE-BINDING; SPECIES-DIFFERENCES; LEUKEMIA-CELLS; ADENOSINE; SITES; RAT	We have used enzymic cleavage by trypsin in conjunction with glycosidase digestion to probe the transmembrane topologies and molecular structures of mammalian equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive, nucleoside transport systems. Transporters from four species (human, pig, guinea pig, and rat) and three tissues (erythrocyte, liver, and lung), which differ from each other in size and in their sensitivity to inhibition by the vasodilator dipyridamole, were investigated. Broadly equivalent sites of [H-3]NBMPR photolabeling, carbohydrate attachment, and trypsin cleavage were observed for all systems. Results from these experiments demonstrate that molecular weight differences between rat transporters and those from two other species (human and guinea pig) are due largely to oligosaccharide heterogeneity and that the low dipyridamole sensitivity of rat nucleoside transporters is probably a consequence of relatively minor differences in molecular structure. In marked contrast, carbohydrate removal increases the molecular weight difference between the pig erythrocyte transporter and, for example, that in human erythrocytes. This polypeptide difference is limited largely, if not completely, to one tryptic fragment of the protein. In the case of the human erythrocyte transporter, the site of N-linked glycosylation has been located very close to one end of the protein, and the site of NBMPR photolabeling to within 16 kDa of that site. Trypsin cleavage occurs endofacially. Our results provide evidence of substantial structural conservation among mammalian NBMPR-sensitive nucleoside transporters.	UNIV LONDON,ROYAL FREE HOSP,SCH MED,DEPT PROT & MOLEC BIOL,LONDON NW3 2PF,ENGLAND; UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND; CHINESE UNIV HONG KONG,DEPT BIOCHEM,SHA TIN,HONG KONG; UNIV ALBERTA,DEPT PATHOL,EDMONTON T6G 2H7,ALBERTA,CANADA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Cambridge; Chinese University of Hong Kong; University of Alberta	KWONG, FYP (corresponding author), UNIV LONDON,ROYAL FREE HOSP,SCH MED,DEPT BIOCHEM & CHEM,ROWLAND HILLS ST,LONDON NW3 2PF,ENGLAND.		Henderson, Peter JF/Q-1907-2018	Henderson, Peter/0000-0002-9187-0938				ALVAREZ J, 1987, J BIOL CHEM, V262, P3502; ASANO T, 1991, J BIOL CHEM, V266, P24632; BELT JA, 1985, BIOCHEM J, V232, P681, DOI 10.1042/bj2320681; CAIRNS MT, 1987, BIOCHIM BIOPHYS ACTA, V905, P295, DOI 10.1016/0005-2736(87)90458-5; CAIRNS MT, 1984, BIOCHEM J, V221, P179, DOI 10.1042/bj2210179; CASS CE, 1974, BIOCHIM BIOPHYS ACTA, V345, P1, DOI 10.1016/0005-2736(74)90239-9; CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; DAGNINO L, 1990, CANCER RES, V50, P6549; DAVIES A, 1987, J BIOL CHEM, V262, P9347; FEUGEAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P60, DOI 10.1016/0005-2736(90)90238-J; FEUGEAS JP, 1991, BIOCHIM BIOPHYS ACTA, V1066, P59, DOI 10.1016/0005-2736(91)90250-C; GATI WP, 1986, BIOCHEM J, V236, P665, DOI 10.1042/bj2360665; HOGUE DL, 1990, BIOCHEM CELL BIOL, V68, P199, DOI 10.1139/o90-026; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; HOPKINS SV, 1971, BIOCHEM PHARMACOL, V20, P3359, DOI 10.1016/0006-2952(71)90440-0; JANMOHAMED NS, 1985, BIOCHEM J, V230, P777, DOI 10.1042/bj2300777; JARVIS SM, 1980, BIOCHIM BIOPHYS ACTA, V597, P183, DOI 10.1016/0005-2736(80)90162-5; JARVIS SM, 1982, BIOCHEM J, V208, P83, DOI 10.1042/bj2080083; JARVIS SM, 1986, J MEMBRANE BIOL, V93, P1, DOI 10.1007/BF01871013; JARVIS SM, 1980, BIOCHEM J, V190, P377, DOI 10.1042/bj1900377; JARVIS SM, 1985, J NEUROCHEM, V44, P183, DOI 10.1111/j.1471-4159.1985.tb07129.x; JARVIS SM, 1986, J BIOL CHEM, V261, P1077; KOLASSA N, 1971, EUR J PHARMACOL, V13, P320, DOI 10.1016/0014-2999(71)90221-4; KWAN KF, 1984, AM J PHYSIOL, V246, pH710, DOI 10.1152/ajpheart.1984.246.5.H710; KWONG FYP, 1988, BIOCHEM J, V255, P243; KWONG FYP, 1987, BIOCHIM BIOPHYS ACTA, V904, P105, DOI 10.1016/0005-2736(87)90091-5; KWONG FYP, 1986, BIOCHEM J, V240, P349, DOI 10.1042/bj2400349; KWONG FYP, 1992, J BIOL CHEM, V267, P21954; LIENHARD GE, 1984, BIOCHIM BIOPHYS ACTA, V769, P404, DOI 10.1016/0005-2736(84)90324-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SAKAI K, 1981, J CARDIOVASC PHARM, V3, P420, DOI 10.1097/00005344-198105000-00002; SCUDDER P, 1983, BIOCHEM J, V213, P485, DOI 10.1042/bj2130485; SHANAHAN MF, 1987, J BIOL CHEM, V262, P5978; SHI MM, 1984, BIOCHEM BIOPH RES CO, V118, P594, DOI 10.1016/0006-291X(84)91344-5; SHI MM, 1986, BIOCHEM J, V240, P879, DOI 10.1042/bj2400879; Steck T.L., 1974, METHODS MEMBRANE BIO, P245; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; TSE CM, 1985, BIOCHIM BIOPHYS ACTA, V818, P316, DOI 10.1016/0005-2736(85)90005-7; WU JSR, 1983, J BIOL CHEM, V258, P3745; WU JSR, 1984, BIOCHEM J, V220, P499, DOI 10.1042/bj2200499; YOUNG JD, 1983, BIOSCIENCE REP, V3, P309, DOI 10.1007/BF01122895; YOUNG JD, 1989, BIOCHEM SOC T, V17, P444, DOI 10.1042/bst0170444	42	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22127	22134						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408072				2022-12-27	WOS:A1993MC80900102
J	SOTO, M; REQUENA, JM; GARCIA, M; GOMEZ, LC; NAVARRETE, I; ALONSO, C				SOTO, M; REQUENA, JM; GARCIA, M; GOMEZ, LC; NAVARRETE, I; ALONSO, C			GENOMIC ORGANIZATION AND EXPRESSION OF 2 INDEPENDENT GENE ARRAYS CODING FOR 2 ANTIGENIC ACIDIC RIBOSOMAL-PROTEINS OF LEISHMANIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI; ESCHERICHIA-COLI; HEAT-SHOCK; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; SULFOLOBUS-SOLFATARICUS; NUCLEOTIDE-SEQUENCE; DONOVANI-CHAGASI; FAMILY; CDNA	In the present paper we describe the isolation and characterization of four novel genes of the parasitic protozoan Leishmania infantum. These genes are organized as two independent gene clusters, and they are related by nucleotide sequence to eukaryotic genes encoding acidic ribosomal proteins. Each gene cluster contains two tandemly linked genes coding for identical proteins. Each of the proteins coded by the gene clusters (called LiP and LiP') are highly divergent in sequence, showing the characteristic features of eukaryotic P-proteins from the P2 group. In spite of the sequence conservation of the coding regions of each of the genes in the cluster, the 5'- and 3'-untranslated regions are heterogeneous in sequence. The analysis of the expression of these genes indicates that logarithmic phase promastigotes show increased levels of LiP- and LiP'-specific transcripts compared with stationary phase promastigotes. The steady state RNA levels of the LiP and LiP' genes show a similar dependence of the growth phase of the parasite. Using specific probes for the divergent 3'-untranslated regions of each of the genes, it was found that the abundance of the mature transcripts is different even when the transcripts are derived from the same gene cluster. These findings probably indicate that the 3'-untranslated regions may influence the stability or turnover of the transcripts derived from both LiP and LiP' gene clusters.	UNIV AUTONOMA MADRID,FAC CIENCIAS,CSIC,CTR BIOL MOLEC SEVERO OCHOA,CANTOBLANCO,E-28049 MADRID,SPAIN; UNIV EXTREMADURA,FAC VET,DEPT MED & SANIDAD ANIM,E-10071 CACERES,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Extremadura			Álvarez, Manuel Soto/Q-5234-2018; Requena, Jose M/I-2022-2019	Álvarez, Manuel Soto/0000-0001-6825-841X; Requena, Jose M/0000-0001-7550-0198; GOMEZ FERNANDEZ, LUIS/0000-0002-4346-4820; GARCIA ALONSO, MERCEDES/0000-0003-3416-1075				AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; BELTRAME M, 1990, MOL CELL BIOL, V10, P2341, DOI 10.1128/MCB.10.5.2341; CASIANO C, 1991, J BIOL CHEM, V266, P21578; CASIANO C, 1990, J BIOL CHEM, V265, P18757; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELAFAILLE MAC, 1992, P NATL ACAD SCI USA, V89, P2703, DOI 10.1073/pnas.89.7.2703; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; GENSKE JE, 1991, MOL CELL BIOL, V11, P240, DOI 10.1128/MCB.11.1.240; GONZALEZ A, 1985, NUCLEIC ACIDS RES, V12, P3777; Higgins CF, 1992, CURR OPIN GENET DEV, V2, P739, DOI 10.1016/S0959-437X(05)80134-0; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; HYUNH TV, 1985, DNA CLONING TECHNIQU, V1, P49; JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1; KAISER K, 1985, DNA CLONING PRACTICA, V1, P1; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; LAIRD PW, 1989, TRENDS GENET, V5, P204, DOI 10.1016/0168-9525(89)90082-6; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; MACFARLANE J, 1990, EUR J BIOCHEM, V190, P377, DOI 10.1111/j.1432-1033.1990.tb15586.x; Maniatis T., 1982, MOL CLONING; MESRI EA, 1990, J CLIN MICROBIOL, V28, P1219, DOI 10.1128/JCM.28.6.1219-1224.1990; MITSUI K, 1988, NUCLEIC ACIDS RES, V16, P3575, DOI 10.1093/nar/16.8.3575; MOLLER W, 1983, J MOL BIOL, V163, P553, DOI 10.1016/0022-2836(83)90112-2; Molyneux D.H., 1983, BIOL TRYPANOSOMA LEI; MOWATT MR, 1988, MOL CELL BIOL, V8, P4055, DOI 10.1128/MCB.8.10.4055; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; NAFZIGER DA, 1991, MOL BIOCHEM PARASIT, V49, P325, DOI 10.1016/0166-6851(91)90076-I; NARANDA T, 1991, P NATL ACAD SCI USA, V88, P10563, DOI 10.1073/pnas.88.23.10563; NEWPORT G, 1988, PARASITOL TODAY, V4, P306, DOI 10.1016/0169-4758(88)90111-1; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; PATERAKI E, 1983, INFECT IMMUN, V42, P496, DOI 10.1128/IAI.42.2.496-500.1983; QIAN S, 1987, NUCLEIC ACIDS RES, V15, P987, DOI 10.1093/nar/15.3.987; RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888; REMACHA M, 1988, J BIOL CHEM, V263, P9094; REQUENA JM, 1988, NUCLEIC ACIDS RES, V16, P1393, DOI 10.1093/nar/16.4.1393; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRA M, 1988, EMBO J, V7, P2895, DOI 10.1002/j.1460-2075.1988.tb03147.x; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SOGIN ML, 1986, P NATL ACAD SCI USA, V83, P1383, DOI 10.1073/pnas.83.5.1383; SOTO M, 1992, EUR J BIOCHEM, V205, P211, DOI 10.1111/j.1432-1033.1992.tb16770.x; SOTO M, 1991, NUCLEIC ACIDS RES, V19, P4554, DOI 10.1093/nar/19.16.4554; STEIN DA, 1990, NUCLEIC ACIDS RES, V18, P1549, DOI 10.1093/nar/18.6.1549; TERHORST C, 1972, EUR J BIOCHEM, V25, P13, DOI 10.1111/j.1432-1033.1972.tb01661.x; TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998; VAZQUEZ MP, 1992, NUCLEIC ACIDS RES, V20, P2893, DOI 10.1093/nar/20.11.2893; VAZQUEZ MP, 1992, NUCLEIC ACIDS RES, V20, P2599, DOI 10.1093/nar/20.10.2599; WIGBOLDUS JD, 1987, NUCLEIC ACIDS RES, V15, P10064, DOI 10.1093/nar/15.23.10064; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443	54	47	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21835	21843						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408038				2022-12-27	WOS:A1993MC80900062
J	STANCATO, LF; CHOW, YH; HUTCHISON, KA; PERDEW, GH; JOVE, R; PRATT, WB				STANCATO, LF; CHOW, YH; HUTCHISON, KA; PERDEW, GH; JOVE, R; PRATT, WB			RAF EXISTS IN A NATIVE HETEROCOMPLEX WITH HSP90 AND P50 THAT CAN BE RECONSTITUTED IN A CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; ROUS-SARCOMA VIRUS; STEROID-RECEPTOR COMPLEXES; MOUSE GLUCOCORTICOID RECEPTORS; HAMSTER OVARY CELLS; PROGESTERONE-RECEPTOR; TRANSFORMING PROTEIN; POLYCLONAL ANTIBODY; BINDING DOMAIN; 90-KDA	Recently, we have demonstrated that the tyrosine kinase pp60v-src can undergo cell-free assembly into a heterocomplex with rabbit hsp90 and p50 when the immunoadsorbed protein is incubated with rabbit reticulocyte lysate (Hutchison, K. A., Brott, B. K., De Leon, J. H., Perdew, G. H., Jove, R., and Pratt, W. B. (1992) J. Biol. Chem. 267, 2902-2908). Using a baculovirus system to express a high level of human c-Raf serine/threonine kinase in Sf9 insect cells, we show here that immunoadsorbed c-Raf undergoes similar lysate-mediated assembly into a heterocomplex with hsp90 and p50. As with pp60v-src and steroid receptors, binding of c-Raf to hsp90 occurs in an ATP-dependent and K+-dependent manner and the resulting heterocomplex is stabilized by molybdate. With a very rapid and gentle procedure of Sf9 cell cytosol preparation and c-Raf immunoadsorption, we show coimmunoadsorption of the insect homologue of hsp90. The same procedures permit detection of a native complex of v-Raf with rat hsp90 and p50 in stably transfected rat 3Y1 fibroblasts, and v-Raf is also assembled into a heterocomplex with rabbit hsp90 and p50 by reticulocyte lysate. Using the 22W mutant of c-Raf in which the NH2-terminal half has been deleted, we show that the catalytic domain of the kinase is sufficient for both formation of the native heterocomplex in mouse NIH 3T3 cells and cell-free reconstitution of the heterocomplex by rabbit reticulocyte lysate. Although the native Raf-heat shock protein heterocomplex is less stable than native pp60v-src and glucocorticoid receptor heterocomplexes, by analogy with these proteins its detection may have important implications regarding the mechanism of Raf trafficking through the cytoplasm.	UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,6322 MED SCI BLDG 1,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT MICROBIOL & IMMUNOL,ANN ARBOR,MI 48109; PURDUE UNIV,DEPT FOODS & NUTR,W LAFAYETTE,IN 47907	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NCI NIH HHS [CA28010, CA55652] Funding Source: Medline; NIEHS NIH HHS [ESO4869] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028010, R01CA055652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004869, R01ES004869] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANG D, 1991, J BIOL CHEM, V266, P24233; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686; COURTNEIDGE SA, 1982, P NATL ACAD SCI-BIOL, V79, P7117, DOI 10.1073/pnas.79.23.7117; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; ERHART JC, 1988, ONCOGENE, V3, P595; FREZ H, 1991, J AM CHEM SOC, V113, P1409; HIRST MA, 1990, MOL ENDOCRINOL, V4, P162, DOI 10.1210/mend-4-1-162; HUTCHISON KA, 1992, J BIOL CHEM, V267, P13952; HUTCHISON KA, 1992, J BIOL CHEM, V267, P2902; HUTCHISON KA, 1993, BIOCHEMISTRY-US, V32, P3953, DOI 10.1021/bi00066a015; HUTCHISON KA, 1992, J BIOL CHEM, V267, P1407; JOVE R, 1986, J VIROL, V60, P849, DOI 10.1128/JVI.60.3.849-857.1986; LEBEAU MC, 1992, J BIOL CHEM, V267, P4281; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; NAKAO K, 1985, CAN J BIOCHEM CELL B, V63, P33, DOI 10.1139/o85-005; PARK S, 1992, J BIOL CHEM, V267, P11612; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; PRATT WB, 1990, MOL CELL ENDOCRINOL, V74, pC69, DOI 10.1016/0303-7207(90)90198-H; PRATT WB, 1988, J BIOL CHEM, V263, P267; RUFF VA, 1992, J BIOL CHEM, V267, P21285; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P7325, DOI 10.1021/bi00147a017; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SCHOWALTER DB, 1991, J BIOL CHEM, V266, P21165; SEFTON BM, 1982, J VIROL, V44, P467, DOI 10.1128/JVI.44.2.467-474.1982; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; TAMURA T, 1983, CELL, V34, P587, DOI 10.1016/0092-8674(83)90391-4; WALSH CT, 1992, J BIOL CHEM, V267, P13115; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; WIEDERRECHT G, 1992, J BIOL CHEM, V267, P21753; YEM AW, 1992, J BIOL CHEM, V267, P2868	46	289	298	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21711	21716						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408024				2022-12-27	WOS:A1993MC80900045
J	GUDI, T; GUPTA, CM				GUDI, T; GUPTA, CM			HSP 70-LIKE PROTEIN IN RHESUS ERYTHROCYTE CYTOSOL AND ITS INTERACTIONS WITH MEMBRANE SKELETON UNDER HEAT AND PATHOLOGICAL STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK PROTEINS; PHOSPHOLIPID ORGANIZATION; STRUCTURAL TRANSITIONS; POLYACRYLAMIDE GELS; PLASMA-MEMBRANE; SPECTRIN; CELLS; INVOLVEMENT; BINDING	The rhesus erythrocytes were examined for the presence of protein(s) similar to the 70-kDa class of heat shock proteins (hsp 70). Also, interactions of these proteins with the erythrocyte membrane were studied under heat stress. These cells in their cytosol contained at least two proteins of about 70 kDa molecular mass; one of which closely resembled the hsp 70 family of proteins. This protein under normal conditions localized mainly in the cytosol, but it had a strong tendency to bind the membrane under heat stress. The binding was almost exclusively restricted to the membrane skeleton and seemed to involve primarily the hydrophobic interactions. A 70-kDa protein immunologically similar to the above protein(s) was detected also in the membranes of rhesus erythrocytes harboring the schizont stage of the simian malarial parasite Plasmodium knowlesi. From these results, we conclude that hsp 70-like proteins in the mature mammalian erythrocytes could perhaps play an important role in protecting the cells under stress by stabilizing the membrane skeleton through their interactions with skeletal proteins.	INST MICROBIAL TECHNOL,CHANDIGARH 160014,INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)				Gupta, Dr.Chhitar M/0000-0002-7290-627X				AUJAME L, 1988, BIOCHEM CELL BIOL, V66, P691, DOI 10.1139/o88-079; BANERJI SS, 1987, GENE DEV, V1, P946, DOI 10.1101/gad.1.9.946; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BRANDTS JF, 1977, BIOCHEMISTRY-US, V16, P3450, DOI 10.1021/bi00634a024; BURDON RH, 1988, ENDEAVOUR, V12, P133, DOI 10.1016/0160-9327(88)90134-2; COLLIER NC, 1986, J CELL BIOL, V103, P1495, DOI 10.1083/jcb.103.4.1495; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; DAVIS JQ, 1986, J BIOL CHEM, V261, P5368; DAVIS JQ, 1985, J BIOL CHEM, V260, P4850; DI YP, 1992, J CELL BIOL, V115, pA350; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GUDI SRP, 1990, BIOCHIM BIOPHYS ACTA, V1023, P63, DOI 10.1016/0005-2736(90)90010-L; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HUBBARD BD, 1979, J CELL BIOL, V80, P166, DOI 10.1083/jcb.80.1.166; JOSHI P, 1987, BIOCHEM J, V246, P103, DOI 10.1042/bj2460103; KUMAR A, 1990, BIOCHIM BIOPHYS ACTA, V1030, P269, DOI 10.1016/0005-2736(90)90303-6; LEE WC, 1992, BRIT J CANCER, V66, P653, DOI 10.1038/bjc.1992.332; LIEM RK, 1989, J BIOL CHEM, V264, P15210; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LYSKO KA, 1981, BIOCHEMISTRY-US, V20, P5570, DOI 10.1021/bi00522a034; MARCHESI VT, 1985, ANNU REV CELL BIOL, V1, P531, DOI 10.1146/annurev.cellbio.1.1.531; MELBY EC, 1976, HDB LABORATORY ANIMA, V3, P23; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHANIAN V, 1984, EUR J BIOCHEM, V144, P375, DOI 10.1111/j.1432-1033.1984.tb08474.x; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SINGH MK, 1984, NATURE, V309, P631, DOI 10.1038/309631a0; TOMASOVIC SP, 1989, INT J HYPERTHER, V5, P173, DOI 10.3109/02656738909140446; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Welch WJ, 1990, STRESS PROTEINS BIOL, P223; WELLER NK, 1988, BIOL CELL, V63, P307, DOI 10.1016/0248-4900(88)90121-9; YOSHINO H, 1987, BIOCHIM BIOPHYS ACTA, V905, P100, DOI 10.1016/0005-2736(87)90013-7	34	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21344	21350						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407973				2022-12-27	WOS:A1993MA28800101
J	PANG, JH; CHEN, KY				PANG, JH; CHEN, KY			A SPECIFIC CCAAT-BINDING PROTEIN, CBP/TK, MAY BE INVOLVED IN THE REGULATION OF THYMIDINE KINASE GENE-EXPRESSION IN HUMAN IMR-90 DIPLOID FIBROBLASTS DURING SENESCENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE-DEPENDENT GENES; CELL-CYCLE; MESSENGER-RNA; TRANSCRIPTION INITIATION; MOUSE FIBROBLASTS; FACTORS INTERACT; PROMOTER; SEQUENCE; AGE; BOX	The aging of IMR-90 human diploid fibroblasts in culture is accompanied by a 5-7-fold decrease in the level of thymidine kinase (TK) mRNA and TK activity (Chang, Z. F., and Chen, K. Y. (1988) J. Biol. Chem. 263, 11431-11435). We have employed a gel mobility shift analysis to investigate the molecular basis of the age-dependent attenuation of TK gene expression. Several cis-elements including two inverted CCAAT boxes, located at base pairs (bp) -36 and -67, and GC-rich Sp1 binding sites have been identified in the TK promoter. A 28-bp (-91 to -64) fragment containing the distal inverted CCAAT element was excised from the TK promoter to examine possible differences in nuclear protein binding between young and old IMR-90 cells. A prominent DNA-protein complex was identified in serum-stimulated young cells by a gel mobility shift assay. Competition analysis indicated that the binding was highly specific. The nuclear protein responsible for the complex formation was named CBP/tk (CCAAT Binding Protein for TK gene) since methylation interference assay showed that the inverted CCAAT box was involved in binding. The appearance of the CBP/tk-28-bp complex in IMR-90 cells was (i) serum-dependent, becoming prominent 12-24 h after serum stimulation, and (ii) age-dependent, prominent only in young but not in old IMR-90 cells. Similar serum- and age-dependent complex formations were also observed using a 67-bp fragment (-63 to +4) containing the proximal CCAAT element and a TATA box. In contrast, the binding activities for the Sp1 sequence were the same in young and old cells and appeared to be serum-independent. CBP/tk binding activity in nuclear extracts was abolished by heat (60-degrees-C, 5 min) or treatment with proteinase K (0.1 mug/ml) and sodium dodecyl sulfate (0.005%), but not by Nonidet P-40 or Triton X-100. Treatment of nuclear extracts with alkaline phosphatase or lectins (concanavalin A and wheat germ agglutinin) did not affect the binding activity. Metal chelators such as 1,10-orthophenanthroline (0.5 mM) inhibited the CBP/tk binding activity. Cycloheximide added to the serum-stimulated cultures at an early or mid-G, phase inhibited the CBP/tk binding activity. The half-life of the serum-induced CBP/tk binding activity was estimated to be less than 1 h. These data suggested that CBP/tk is a unique CCAAT-binding protein and that it may play a key role in the cell cycle- and age-dependent regulation of TK gene expression in human IMR-90 cells.	RUTGERS STATE UNIV,DEPT CHEM,WRIGHT CHEM LAB,POB 939,PISCATAWAY,NJ 08855; RUTGERS STATE UNIV,GRAD PROGRAM BIOCHEM,PISCATAWAY,NJ 08855	Rutgers State University New Brunswick; Rutgers State University New Brunswick				Chen, Kuang Yu/0000-0002-5629-7785	NATIONAL INSTITUTE ON AGING [R01AG003578] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG03578] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARCOT SS, 1989, J BIOL CHEM, V264, P2343; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPISI J, 1982, P NATL ACAD SCI-BIOL, V79, P436, DOI 10.1073/pnas.79.2.436; CHANG CD, 1991, J BIOL CHEM, V266, P8663; CHANG ZF, 1988, J BIOL CHEM, V263, P11431; CHEN KY, 1989, EXP GERONTOL, V24, P523; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHOI HS, 1990, J BIOL CHEM, V265, P18005; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DOU QP, 1991, P NATL ACAD SCI USA, V88, P1157, DOI 10.1073/pnas.88.4.1157; FARNHAM PJ, 1990, MOL CELL BIOL, V10, P1390, DOI 10.1128/MCB.10.4.1390; FLEMINGTON E, 1987, GENE, V52, P267, DOI 10.1016/0378-1119(87)90053-9; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GROSS MK, 1988, NUCLEIC ACIDS RES, V16, P11625, DOI 10.1093/nar/16.24.11625; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; HENDRICKSON SL, 1980, P NATL ACAD SCI-BIOL, V77, P5140, DOI 10.1073/pnas.77.9.5140; HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331; HJORTH AL, 1989, GENE DEV, V3, P747, DOI 10.1101/gad.3.6.747; JOHNSON LF, 1982, EXP CELL RES, V138, P76; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KIM YK, 1992, J BIOL CHEM, V267, P2723; KNIGHT GB, 1987, P NATL ACAD SCI USA, V84, P8350, DOI 10.1073/pnas.84.23.8350; KREIDBERG JA, 1986, MOL CELL BIOL, V6, P2903, DOI 10.1128/MCB.6.8.2903; LIEBERMAN HB, 1988, MOL CELL BIOL, V8, P1551; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P6848, DOI 10.1073/pnas.86.18.6848; LIU HT, 1985, J BIOL CHEM, V260, P3269; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MARTIN GM, 1977, AM J PATHOL, V89, P484; MARTIN GM, 1970, LAB INVEST, V23, P86; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; PANG JH, 1992, FASEB J, V6, pA4894; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157; RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316; ROEHL HH, 1990, MOL CELL BIOL, V10, P3834, DOI 10.1128/MCB.10.7.3834; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; STEWART CJ, 1987, MOL CELL BIOL, V7, P1156, DOI 10.1128/MCB.7.3.1156; TRAVALI S, 1988, MOL CELL BIOL, V8, P1551, DOI 10.1128/MCB.8.4.1551; VANHUIJSDUIJNEN RAMH, 1987, NUCLEIC ACIDS RES, V15, P7265, DOI 10.1093/nar/15.18.7265	55	50	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2909	2916						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428965				2022-12-27	WOS:A1993KK81500096
J	SKERKA, C; KUHN, S; GUNTHER, K; LINGELBACH, K; ZIPFEL, PF				SKERKA, C; KUHN, S; GUNTHER, K; LINGELBACH, K; ZIPFEL, PF			A NOVEL SHORT CONSENSUS REPEAT-CONTAINING MOLECULE IS RELATED TO HUMAN-COMPLEMENT FACTOR-H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SEQUENCE; GENE; TRANSLOCATION; RECOGNITION; TRANSCRIPTS; COMPONENTS; CLEAVAGE; CLONING; ACID	We have identified a novel factor H-related cDNA, which was isolated from a human liver cDNA library. The DOWN16 clone is 1269 base pairs in size and hybridized to a mRNA of 1.4 kilobases. Similar to the previously described factor H-related proteins, the predicted translation product of 331 amino acids contains a hydrophobic signal sequence followed by a stretch of five short consensus repeats (SCRs). These five SCRs display homology to SCRs of factor H: SCRs1-3 (DOWN16) are homologous to SCRs6-8 of factor H, while SCRs4 and -5 are related to SCRs19 and -20. In vitro translation demonstrated that the DOWN16 cDNA encodes a primary translation product of an apparent molecular mass of 37,500 Da which is directed to the secretory pathway and is glycosylated. Thus, we propose that the protein will be present in human serum. The relatedness of structural elements between this novel gene and factor H may suggest common functions of these proteins not yet determined.	BERNHARD NOCHT INST TROP MED,BERNHARD NOCHT STR 74,W-2000 HAMBURG 36,GERMANY	Bernhard Nocht Institut fur Tropenmedizin								ALSENZ J, 1985, BIOCHEM J, V232, P841, DOI 10.1042/bj2320841; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BORA NS, 1989, J EXP MED, V169, P597, DOI 10.1084/jem.169.2.597; CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; ESTALLER C, 1991, EUR J IMMUNOL, V21, P799, DOI 10.1002/eji.1830210337; ESTALLER C, 1991, J IMMUNOL, V146, P3190; FARRIES TC, 1991, IMMUNOL TODAY, V12, P295, DOI 10.1016/0167-5699(91)90002-B; FONTAINE M, 1989, BIOCHEM J, V258, P927, DOI 10.1042/bj2580927; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRISTENSEN T, 1986, J IMMUNOL, V136, P3407; LAU JTY, 1983, J BIOL CHEM, V258, P5255; MISASI R, 1989, EUR J IMMUNOL, V19, P1765, DOI 10.1002/eji.1830190936; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; RAGGE K, 1990, MOL BIOCHEM PARASIT, V42, P93, DOI 10.1016/0166-6851(90)90116-4; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; REYCAMPOS J, 1988, J EXP MED, V167, P664, DOI 10.1084/jem.167.2.664; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SKERKA C, 1992, J IMMUNOL, V148, P3313; TIMMANN C, 1991, J IMMUNOL, V4146, P1265; VIK DP, 1988, J BIOL CHEM, V263, P16720; VIK DP, 1990, J BIOL CHEM, V265, P3193; VIK DP, 1989, CURR TOP MICROBIOL I, V153, P148; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALTER P, 1983, METHOD ENZYMOL, V96, P682	28	37	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2904	2908						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428964				2022-12-27	WOS:A1993KK81500095
J	TOHKIN, M; KISHINO, J; ISHIZAKI, J; ARITA, H				TOHKIN, M; KISHINO, J; ISHIZAKI, J; ARITA, H			PANCREATIC-TYPE PHOSPHOLIPASE-A(2) STIMULATES PROSTAGLANDIN SYNTHESIS IN MOUSE OSTEOBLASTIC CELLS (MC3T3-E1) VIA A SPECIFIC BINDING-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II PHOSPHOLIPASE-A2; EPIDERMAL GROWTH-FACTOR; FATTY-ACID CYCLOOXYGENASE; BONE-RESORPTION INVITRO; MESSENGER-RNA SYNTHESIS; SMOOTH-MUSCLE CELLS; PARATHYROID-HORMONE; PORCINE PANCREAS; RAT; LINE	Previously, we have reported a novel proliferative action of pancreatic group I phospholipase A2 (PLA2-I) via a specific binding site in Swiss 3T3 fibroblasts, vascular smooth muscle cells, and chondrocytes. In this study, we characterized the PLA2-I specific binding site in osteoblastic cell line (MC3T3-E1 cells) with an equilibrium binding constant (K(d)) value of 1.13 nM and maximum binding capacity of 40.1 fmol/10(6) cells. PLA2-I stimulated prostaglandin E2 (PGE2) production in a concentration-dependent manner in MC3T3-E1 cells, and its EC50 value was similar to the K(d) value for PLA2-I binding. This effect of PLA2-I was type-specific and did not depend on its hydrolytic activity. PLA2-I increased the activity of prostaglandin endoperoxide synthase (PES), and PLA2-I-stimulated PGE2 synthesis was inhibited by cycloheximide. Northern blot analysis showed the increase in both type-1 and type-2 PES mRNAs. These findings indicated that PLA2-I Stimulated PGE2 synthesis by induction of PES via a specific binding site in osteoblastic cells.	SHIONOGI & CO LTD,SHIONOGI RES LAB,12-4 SAGISU 5-CHOME,FUKUSHIMA KU,OSAKA 553,JAPAN	Shionogi & Company Limited								ARITA H, 1989, PROG LIPID RES, V28, P273, DOI 10.1016/0163-7827(89)90002-7; ARITA H, 1991, J BIOL CHEM, V266, P19139; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CHYUN YS, 1984, PROSTAGLANDINS, V27, P97, DOI 10.1016/0090-6980(84)90223-5; DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P118, DOI 10.1016/0005-2744(68)90249-0; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DIETRICH JW, 1975, PROSTAG OTH LIPID M, V10, P231; FORREST SM, 1985, CALCIFIED TISSUE INT, V37, P51, DOI 10.1007/BF02557679; HAKEDA Y, 1985, BIOCHEM BIOPH RES CO, V126, P340, DOI 10.1016/0006-291X(85)90611-4; HANASAKI K, 1992, J BIOL CHEM, V267, P6414; HANASAKI K, 1992, BIOCHIM BIOPHYS ACTA, V1127, P233, DOI 10.1016/0005-2760(92)90226-L; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HORIGOME K, 1987, J BIOCHEM-TOKYO, V101, P625, DOI 10.1093/jb/101.3.625; HULKOWER KI, 1992, BIOCHEM BIOPH RES CO, V184, P712, DOI 10.1016/0006-291X(92)90648-5; IKEDA E, 1988, CALCIFIED TISSUE INT, V43, P162, DOI 10.1007/BF02571314; IRVINE RF, 1982, BIOCHEM J, V204, P153; KAMEMASA T, 1992, BIOCHIM BIOPHYS ACTA, V1125, P210; KISHINO J, 1992, BIOCHEM BIOPH RES CO, V186, P1025, DOI 10.1016/0006-291X(92)90849-G; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KUMEGAWA M, 1983, CALCIFIED TISSUE INT, V35, P542, DOI 10.1007/BF02405091; KUMEGAWA M, 1984, CALCIFIED TISSUE INT, V36, P72, DOI 10.1007/BF02405296; KURIHARA H, 1991, BIOCHIM BIOPHYS ACTA, V1082, P285, DOI 10.1016/0005-2760(91)90204-U; KUSAKA M, 1988, BIOCHIM BIOPHYS ACTA, V972, P339, DOI 10.1016/0167-4889(88)90210-8; LORENZO JA, 1988, ENDOCRINOLOGY, V123, P2194, DOI 10.1210/endo-123-5-2194; LORENZO JA, 1986, J CLIN INVEST, V77, P1897, DOI 10.1172/JCI112517; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NAKANO T, 1990, J BIOL CHEM, V265, P12745; NEFUSSI JR, 1985, ANAT REC, V211, P9, DOI 10.1002/ar.1092110103; NISHIJIMA J, 1983, J BIOCHEM, V94, P137, DOI 10.1093/oxfordjournals.jbchem.a134322; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OHARA O, 1990, NUCLEIC ACIDS RES, V18, P6997, DOI 10.1093/nar/18.23.6997; OKA S, 1991, J BIOL CHEM, V266, P9956; ONO T, 1984, J BIOCHEM-TOKYO, V101, P625; OSHIMA T, 1991, J BIOL CHEM, V266, P13621; PUIJK WC, 1979, BIOCHIM BIOPHYS ACTA, V580, P411, DOI 10.1016/0005-2795(79)90153-3; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1076, DOI 10.1210/endo-126-2-1076; RAISZ LG, 1977, NATURE, V267, P532, DOI 10.1038/267532a0; RAPUANO BE, 1991, BIOCHIM BIOPHYS ACTA, V1091, P374, DOI 10.1016/0167-4889(91)90203-A; RAZ A, 1988, J BIOL CHEM, V263, P3022; SAKATA T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P124, DOI 10.1016/0167-4781(89)90141-3; SEILHAMER JJ, 1986, DNA-J MOLEC CELL BIO, V5, P519, DOI 10.1089/dna.1.1986.5.519; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; TOJO H, 1988, J BIOL CHEM, V263, P5724; VADAS P, 1986, LAB INVEST, V55, P391; WU KK, 1988, J BIOL CHEM, V263, P19043; YANAGA F, 1992, J BIOL CHEM, V267, P5114; YANAGA F, 1991, BIOCHIM BIOPHYS ACTA, V1094, P139; YASUDA T, 1990, BIOCHIM BIOPHYS ACTA, V1046, P189, DOI 10.1016/0005-2760(90)90188-4; YOKOTA K, 1986, J BIOL CHEM, V261, P5410	53	76	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2865	2871						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428961				2022-12-27	WOS:A1993KK81500089
J	KU, DH; WEN, SC; ENGELHARD, A; NICOLAIDES, NC; LIPSON, KE; MARINO, TA; CALABRETTA, B				KU, DH; WEN, SC; ENGELHARD, A; NICOLAIDES, NC; LIPSON, KE; MARINO, TA; CALABRETTA, B			C-MYB TRANSACTIVATES CDC2 EXPRESSION VIA MYB BINDING-SITES IN THE 5'-FLANKING REGION OF THE HUMAN CDC2 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; AVIAN-MYELOBLASTOSIS VIRUS; HUMAN LYMPHOCYTES-T; ONCOGENE PRODUCT; DNA-REPLICATION; PROTEIN; SEQUENCE; RNA; DIFFERENTIATION; PROTOONCOGENE	The c-myb protooncogene is preferentially expressed in hematopoietic cells and is required for cell cycle progression at the G1/S boundary. Because c-myb encodes a transcriptional activator that functions via DNA binding, it is likely that c-myb exerts its biological activity by regulating the transcription of genes required for DNA synthesis and cell cycle progression. One such gene, cdc2, encodes a 34-kDa serine-threonine kinase that appears to be required for G1/S transition in normal human T-lymphocytes. To determine whether c-myb is a transcriptional regulator of cdc2 expression, we subcloned a segment of a cdc2 human genomic clone containing extensive 5'-flanking sequences and part of the first exon. Sequence analysis revealed the presence of two closely spaced Myb binding sites that interact with bacterially synthesized Myb protein within a region extending from nucleotides -410 to -392 upstream of the transcription initiation site. A 465-base pair segment of 5'-flanking sequence containing these sites was linked to the CAT gene and had promoter activity in rodent fibroblasts. Cotransfection of this construct with a full-length human c-myb cDNA driven by the early simian virus 40 promoter resulted in a 6-8-fold enhancement of CAT activity that was abrogated by mutations in the Myb binding sites. These data suggest that c-myb participates in the regulation of cell cycle progression by activating the expression of the cdc2 gene.	THOMAS JEFFERSON UNIV,DEPT MICROBIOL,BLUEMLE LIFE SCI BLDG,233 S 10TH ST,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107; CONNECT TISSUE RES INST,PHILADELPHIA,PA; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT ANAT & CELL BIOL,PHILADELPHIA,PA 19140	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University				Lipson, Kenneth/0000-0001-8847-6051	NATIONAL CANCER INSTITUTE [T32CA009678, T32CA009644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044836] Funding Source: NIH RePORTER; NCI NIH HHS [1T32CA09678, CA 09644] Funding Source: Medline; NIDDK NIH HHS [DK44836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BLOW JJ, 1990, CELL, V62, P855, DOI 10.1016/0092-8674(90)90261-C; BOYLE WJ, 1984, P NATL ACAD SCI-BIOL, V81, P4265, DOI 10.1073/pnas.81.14.4265; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DASGUPTA P, 1990, P NATL ACAD SCI USA, V87, P8090, DOI 10.1073/pnas.87.20.8090; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GRIFFIN CA, 1985, CANCER RES, V45, P272; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HUTTNER KM, 1981, J CELL BIOL, V91, P153, DOI 10.1083/jcb.91.1.153; KENNEY SC, 1992, MOL CELL BIOL, V12, P136, DOI 10.1128/MCB.12.1.136; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; Moscovici C, 1975, Curr Top Microbiol Immunol, V71, P79; Moscovici C., 1982, ADV VIRAL ONCOL, V1, P83; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; NICOLAIDES NC, 1992, J BIOL CHEM, V267, P19665; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1985, TRENDS GENET, V1, P51, DOI 10.1016/0168-9525(85)90023-X; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sambrook J, 1989, MOL CLONING LABORATO; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; TALAVERA A, 1977, J CELL PHYSIOL, V92, P425, DOI 10.1002/jcp.1040920310; THIELE CJ, 1988, MOL CELL BIOL, V8, P1677, DOI 10.1128/MCB.8.4.1677; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TORELLI G, 1987, CANCER RES, V47, P5266; VENTURELLI D, 1990, P NATL ACAD SCI USA, V87, P5963, DOI 10.1073/pnas.87.15.5963; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	43	126	127	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2255	2259						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420994				2022-12-27	WOS:A1993KH62000113
J	LUIS, AM; IZQUIERDO, JM; OSTRONOFF, LK; SALINAS, M; SANTAREN, JF; CUEZVA, JM				LUIS, AM; IZQUIERDO, JM; OSTRONOFF, LK; SALINAS, M; SANTAREN, JF; CUEZVA, JM			TRANSLATIONAL REGULATION OF MITOCHONDRIAL DIFFERENTIATION IN NEONATAL RAT-LIVER - SPECIFIC INCREASE IN THE TRANSLATIONAL EFFICIENCY OF THE NUCLEAR-ENCODED MITOCHONDRIAL BETA-F1-ATPASE MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION FACTOR-II; PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; BETA-SUBUNIT; POSTNATAL-DEVELOPMENT; COORDINATE INDUCTION; ADENINE-NUCLEOTIDES; GENE-EXPRESSION; PHOSPHORYLATION; INHIBITION	Postnatal (1-h) mitochondrial differentiation in normal neonatal rat liver is regulated at the translational level (Izquierdo, J. M., Luis, A. M., and Cuezva, J. M. (1990) J. Biol. Chem. 265, 9090-9097). The rapid postnatal increase in liver global rate of protein synthesis preferentially affects mitochondrial proteins (Valcarce, C., Navarrete, R. M., Encabo, P., Loeches, E., Satrustegui, J., and Cuezva, J. M. (1988) J. Biol. Chem. 263, 7767-7775). Analysis of polysome profiles and determination of both eukaryotic initiation factor 2 (eIF-2) activity and amount of eIF-2beta protein in the liver of fetal and 1-h-old neonatal rats, indicate a rapid activation of translation initiation without changes in the amount of the translational machinery available between both stages of liver development. Appearance of a more acidic eIF-2 beta-subunit form in two-dimensional Western blots from 1-h-old rat livers suggests that covalently regulated modifications of the initiation factor phosphoproteins might be responsible for increased translation in the neonatal liver. On the other hand, preferential cytosolic translation of the mitochondrial nuclear-encoded beta-F1-ATPase mRNA at this stage of liver development is accomplished by (i) the antenatal accumulation of this mRNA in the fetal liver in 5-6-fold excess than that found in adults, although fetal liver beta-F1-ATPase mRNA shows negligible translational efficiency when compared to the adult counterpart; (ii) a 2-fold increase of the stored beta-F1-ATPase mRNA being rapidly mobilized into cytosolic polyribosomes, and (iii) a 3-fold increase in the in vitro determined translational efficiency of beta-F1-ATPase mRNA. Increased translational efficiency of beta-F1-ATPase mRNA at 1-h postnatal is specific for the nuclear-encoded template since beta-tubulin mRNA did not show any postnatal alteration in its translational efficiency. The results presented suggest that developmental changes in the poly(A)+ RNA fraction or in the reporter template itself are responsible for the increased and preferential translation of the nuclear-encoded mitochondrial mRNAs needed for mitochondrial differentiation and, thus, for mammalian adaptation to the extrauterine environment.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC, DEPT BIOL MOLEC, E-28049 MADRID, SPAIN; HOSP RAMON Y CAJAL, DEPT INVEST, E-28034 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Ramon y Cajal			Cuezva, Jose M/F-8381-2011; Cuezva, Jose M/AAR-5392-2020	Cuezva Marcos, Jose Manuel/0000-0003-1118-248X				ALONI R, 1992, MOL CELL BIOL, V12, P2203, DOI 10.1128/MCB.12.5.2203; APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9; AREVALO MA, 1990, J MOL BIOL, V214, P105, DOI 10.1016/0022-2836(90)90150-K; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BAILLY A, 1991, BIOL CELL, V73, P121, DOI 10.1016/0248-4900(91)90094-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALES C, 1985, J NEUROCHEM, V45, P1298, DOI 10.1111/j.1471-4159.1985.tb05557.x; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; COLOT HV, 1982, DEV BIOL, V94, P79, DOI 10.1016/0012-1606(82)90070-7; CUEZVA JM, 1990, REPROD BIOL, P113; CUEZVA JM, 1982, PEDIATR RES, V16, P632, DOI 10.1203/00006450-198208000-00009; DEHERDT E, 1979, NUCLEIC ACIDS RES, V7, P1363; DIONNE CA, 1982, J BIOL CHEM, V257, P2373; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; FRANKEL AD, 1991, CELL, V67, P1041, DOI 10.1016/0092-8674(91)90282-4; GARBOCZI DN, 1988, BIOCHEMISTRY-US, V27, P553, DOI 10.1021/bi00402a008; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HOUSTEK J, 1991, FEBS LETT, V294, P191, DOI 10.1016/0014-5793(91)80666-Q; IZQUIERDO JM, 1990, J BIOL CHEM, V265, P9090; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KELLY DP, 1989, J BIOL CHEM, V264, P18921; KLEENE KC, 1989, DEVELOPMENT, V106, P367; KLEENE KC, 1987, DEV BIOL, V123, P125, DOI 10.1016/0012-1606(87)90434-9; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LLOYD MA, 1980, J BIOL CHEM, V255, P1189; MARTIN ME, 1991, NEUROCHEM RES, V16, P749, DOI 10.1007/BF00965683; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MUSCHEL R, 1986, MOL CELL BIOL, V6, P337, DOI 10.1128/MCB.6.1.337; NAGLEY P, 1991, TRENDS GENET, V7, P1, DOI 10.1016/0168-9525(91)90002-8; NATHANSON MA, 1986, J BIOL CHEM, V261, P1477; PALATNIK CM, 1981, J MOL BIOL, V150, P389, DOI 10.1016/0022-2836(81)90554-4; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PROUD CG, 1982, FEBS LETT, V143, P55, DOI 10.1016/0014-5793(82)80273-1; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; SANTAREN JF, 1990, ELECTROPHORESIS, V11, P254, DOI 10.1002/elps.1150110309; SARKAR S, 1984, PROG NUCLEIC ACID RE, V31, P267, DOI 10.1016/S0079-6603(08)60380-3; SARRE TF, 1989, BIOSYSTEMS, V22, P311, DOI 10.1016/0303-2647(89)90053-1; SCARPULLA RC, 1986, J BIOL CHEM, V261, P4660; SCHMID HP, 1984, EMBO J, V3, P29, DOI 10.1002/j.1460-2075.1984.tb01757.x; SERRANO E, 1989, ANN NY ACAD SCI, V573, P412, DOI 10.1111/j.1749-6632.1989.tb15023.x; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; TORRONI A, 1990, J BIOL CHEM, V265, P20589; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; VALCARCE C, 1991, FEBS LETT, V294, P225, DOI 10.1016/0014-5793(91)81435-B; VALCARCE C, 1990, J BIOCHEM, V108, P642; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; VANDERBURG CR, 1988, J CELL BIOL, V107, P1085, DOI 10.1083/jcb.107.3.1085; VINCENT A, 1981, EUR J BIOCHEM, V114, P179, DOI 10.1111/j.1432-1033.1981.tb05135.x; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P320, DOI 10.1016/0968-0004(90)90022-4; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; [No title captured]	61	66	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1868	1875						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420961				2022-12-27	WOS:A1993KH62000058
J	OZAWA, K; SZALLASI, Z; KAZANIETZ, MG; BLUMBERG, PM; MISCHAK, H; MUSHINSKI, JF; BEAVEN, MA				OZAWA, K; SZALLASI, Z; KAZANIETZ, MG; BLUMBERG, PM; MISCHAK, H; MUSHINSKI, JF; BEAVEN, MA			CA2+-DEPENDENT AND CA2+-INDEPENDENT ISOZYMES OF PROTEIN-KINASE-C MEDIATE EXOCYTOSIS IN ANTIGEN-STIMULATED RAT BASOPHILIC RBL-2H3 CELLS - RECONSTITUTION OF SECRETORY RESPONSES WITH CA2+ AND PURIFIED ISOZYMES IN WASHED PERMEABILIZED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; DIFFERENTIAL DOWN-REGULATION; 2H3 CELLS; HISTAMINE-RELEASE; LEUKEMIA-CELLS; CALCIUM SIGNAL; IGE RECEPTORS; CALPHOSTIN-C; MAST-CELLS; FAMILY	Rat basophilic RBL-2H3 cells, which exhibit Ca2+-dependent secretion of granules when stimulated with antigen, contained the Ca2+-dependent alpha and beta and the Ca2+-independent delta, epsilon, and zeta isoforms of protein kinase C. These isoforms associated, to variable extents (i.e. delta the most and zeta the least), with the membrane fraction upon antigen stimulation but without external Ca2+; only the Ca2+-independent isoforms did so. Both types of isozymes were probably necessary for optimal responses to antigen as indicated by the following observations. All Ca2+-dependent isozymes were degraded in cells treated with 20 nM phorbol 12-myristate 13-acetate for 6 h, whereas the Ca2+-independent isozymes were not degraded and were retained when the cells were subsequently permeabilized and washed. Cells so treated still exhibited antigen-induced secretion (25-33% of normal) which was suppressed by selective inhibitors of protein kinase C (Ro31-7549 and calphostin C) thereby indicating a possible contribution of the Ca2+-independent isozymes in secretion. Normally, washed permeabilized cells lost all isozymes of protein kinase C and failed to secrete in response to antigen. A full secretory response to antigen could be reconstituted by the subsequent addition of nanomolar concentrations of either beta or delta isozymes of protein kinase C (other isozymes were much less effective) but only in the presence of 1 muM free Ca2+ to indicate distinct roles for Ca2+ and protein kinase C in exocytosis.	NHLBI, CHEM PHARMACOL LAB, BETHESDA, MD 20892 USA; NCI, CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB, BETHESDA, MD 20892 USA; NCI, GENET LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Mischak, Harald/E-8685-2011	Szallasi, Zoltan/0000-0001-5395-7509; Mischak, Harald/0000-0003-0323-0306				ASE K, 1988, FEBS LETT, V236, P396, DOI 10.1016/0014-5793(88)80064-4; BEAVEN MA, 1987, J CELL BIOL, V105, P1129, DOI 10.1083/jcb.105.3.1129; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; BEAVEN MA, 1988, PROG ALLERGY, V42, P123; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; BLUMBERG PM, 1991, MOL CARCINOGEN, V4, P339, DOI 10.1002/mc.2940040502; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CHIDA K, 1990, BIOCHEM BIOPH RES CO, V173, P351, DOI 10.1016/S0006-291X(05)81064-2; CUNHAMELO JR, 1989, J IMMUNOL, V143, P2617; EISEMAN E, 1992, NATURE, V355, P78; ELLIOTT LH, 1990, BIOCHEM BIOPH RES CO, V171, P148, DOI 10.1016/0006-291X(90)91369-4; HUANG FL, 1989, J BIOL CHEM, V264, P4238; HUANG K-P, 1990, Biofactors, V2, P171; HUANG KP, 1991, METHOD ENZYMOL, V200, P241; ISHIZUKA T, 1992, BIOCHEM BIOPH RES CO, V183, P814, DOI 10.1016/0006-291X(92)90556-Z; Jaken S, 1990, CURR OPIN CELL BIOL, V2, P192, DOI 10.1016/0955-0674(90)90006-Z; JONES SVP, 1991, FEBS LETT, V289, P47, DOI 10.1016/0014-5793(91)80905-I; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KILEY SC, 1991, J BIOL CHEM, V266, P23761; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MAEYAMA K, 1986, J BIOL CHEM, V261, P2583; MILLARD PJ, 1989, J BIOL CHEM, V264, P19730; NAKADATE T, 1987, J BIOL CHEM, V262, P11507; NAOR Z, 1989, P NATL ACAD SCI USA, V86, P4501, DOI 10.1073/pnas.86.12.4501; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; OSADA S, 1990, J BIOL CHEM, V265, P22434; PFEFFER LM, 1991, P NATL ACAD SCI USA, V88, P7988, DOI 10.1073/pnas.88.18.7988; SAGIEISENBERG R, 1985, NATURE, V313, P59, DOI 10.1038/313059a0; SAHARA S, 1992, BIOCHEM BIOPH RES CO, V182, P105, DOI 10.1016/S0006-291X(05)80118-4; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; Summers M.D., 1987, B TEXAS AGR EXPT STA, V1555; WHITE KN, 1988, J IMMUNOL, V141, P942; YAMADA K, 1992, J IMMUNOL, V149, P1031	36	395	398	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1749	1756						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420951				2022-12-27	WOS:A1993KH62000039
J	AVVAKUMOV, GV; WARMELSRODENHISER, S; HAMMOND, GL				AVVAKUMOV, GV; WARMELSRODENHISER, S; HAMMOND, GL			GLYCOSYLATION OF HUMAN CORTICOSTEROID-BINDING GLOBULIN AT ASPARGINE-238 IS NECESSARY FOR STEROID BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRANSCORTIN; CARBOHYDRATE MOIETY; PROTEINS; GLYCOPROTEIN; VARIANTS; CORTISOL; GLYCOPEPTIDES; INHIBITORS; EXPRESSION; MEMBRANES	Human corticosteroid binding-globulin (CBG) is a plasma glycoprotein that binds and regulates the biological activity of glucocorticoids and progesterone. Carbohydrates comprise approximately 25% of its molecular mass being represented by bi- and triantennary N-linked oligosaccharides of the N-acetyllactosamine type. To assess the impact of these carbohydrate chains on CBG production and steroid binding, we mutated a human CBG cDNA so that the six consensus sites for N-glycosylation in the CBG polypeptide were eliminated individually and in various combinations. Expression of the mutant cDNAs in Chinese hamster ovary cells showed that all consensus sites may be utilized during the CBG biosynthesis and that the immunochemical properties of the recombinant glycoproteins are similar to those of CBG isolated from human serum. Removal of sugar chains generally led to a reduction in the secretion of recombinant CBG, but complete removal of N-glycosylation sites did not prevent production or secretion of the protein. Our data indicate that an oligosaccharide linked to Asn238 is essential for steroid binding, and we suggest that an interaction between this sugar chain and the polypeptide may be essential for the creation of a high affinity steroid-binding site. In addition, concanavalin A chromatography of mutants containing only one N-glycosylation site at either Asn74 or Asn238 indicated that processing of the oligosaccharides at these positions is site-specific.	UNIV WESTERN ONTARIO,DEPT OBSTET & GYNECOL,LONDON N6A 4L6,ON,CANADA; UNIV WESTERN ONTARIO,MRC,FETAL & NEONATAL HLTH & DEV GRP,LONDON N6A 4L6,ON,CANADA; UNIV WESTERN ONTARIO,DEPT BIOCHEM,LONDON N6A 4L6,ON,CANADA; UNIV WESTERN ONTARIO,DEPT ONCOL,LONDON N6A 4L6,ON,CANADA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)				Hammond, Geoffrey/0000-0002-4639-7336				AKHREM AA, 1981, BIOORG KHIM+, V7, P662; AKHREM AA, 1982, BIOCHIM BIOPHYS ACTA, V714, P177, DOI 10.1016/0304-4165(82)90142-8; AVVAKUMOV GV, 1988, BIOCHIM BIOPHYS ACTA, V938, P1, DOI 10.1016/0005-2736(88)90115-0; AVVAKUMOV GV, 1991, LECTINS CANCER, P263; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BOCCHINFUSO WP, 1991, MOL ENDOCRINOL, V5, P1723, DOI 10.1210/mend-5-11-1723; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOLTON NJ, 1981, J ENDOCRINOL, V90, P125, DOI 10.1677/joe.0.0900125; CARVER JP, 1987, PURE APPL CHEM, V59, P1465, DOI 10.1351/pac198759111465; CHEN WY, 1991, J BIOL CHEM, V266, P8192; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GHOSEDASTIDAR J, 1991, P NATL ACAD SCI USA, V88, P6408, DOI 10.1073/pnas.88.15.6408; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; HOSSNER KL, 1981, ENDOCRINOLOGY, V108, P1780, DOI 10.1210/endo-108-5-1780; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MICKELSON KE, 1982, BIOCHEMISTRY-US, V21, P654, DOI 10.1021/bi00533a010; NARASIMHAN S, 1979, CAN J BIOCHEM CELL B, V57, P83, DOI 10.1139/o79-011; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; ROBINSON PA, 1985, J ENDOCRINOL, V104, P269, DOI 10.1677/joe.0.1040269; ROSNER W, 1990, ENDOCR REV, V11, P80, DOI 10.1210/edrv-11-1-80; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SMITH CL, 1992, J STEROID BIOCHEM, V42, P671, DOI 10.1016/0960-0760(92)90107-T; STRELCHYONOK OA, 1984, CARBOHYD RES, V134, P133, DOI 10.1016/0008-6215(84)85028-4; STRELCHYONOK OA, 1982, BIOCHIM BIOPHYS ACTA, V705, P167, DOI 10.1016/0167-4838(82)90175-3; STRELCHYONOK OA, 1983, BIOCHIM BIOPHYS ACTA, V755, P514, DOI 10.1016/0304-4165(83)90257-X; STRELCHYONOK OA, 1991, J STEROID BIOCHEM, V40, P795, DOI 10.1016/0960-0760(91)90305-O; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; TREUHEIT MJ, 1992, BIOCHEM J, V283, P105, DOI 10.1042/bj2830105; WINTERBURN PJ, 1972, NATURE, V236, P147, DOI 10.1038/236147a0	36	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					862	866						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419363				2022-12-27	WOS:A1993KG07700019
J	REHRAUER, WM; KOWALCZYKOWSKI, SC				REHRAUER, WM; KOWALCZYKOWSKI, SC			ALTERATION OF THE NUCLEOSIDE TRIPHOSPHATE (NTP) CATALYTIC DOMAIN WITHIN ESCHERICHIA-COLI RECA PROTEIN ATTENUATES NTP HYDROLYSIS BUT NOT JOINT MOLECULE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; SITE-SPECIFIC MUTAGENESIS; ATP HYDROLYSIS; ADENYLATE KINASE; EXCISION REPAIR; BINDING DOMAIN; SSB PROTEIN; HUMAN-CELLS; PURIFICATION; ABSENCE	The hydrolysis of the nucleoside triphosphates, such as ATP or GTP, plays a central role in a variety of biochemical processes; but, in most cases, the specific mechanism of energy transduction is unclear. DNA strand exchange promoted by the Escherichia coli recA protein is normally associated with ATP hydrolysis. However, we advanced the idea that the observed ATP hydrolysis is not obligatorily linked to the exchange of DNA strands (Menetski, J. P., Bear, D. G., and Kowalczykowski, S. C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 21-25); instead, ATP binding resulting in an allosteric transition to an active form of the recA protein is sufficient. In this paper, we extend this conclusion by introducing a mutation within a highly conserved region of the recA protein that, on the basis of sequence similarity, is proposed to interact with the pyrophosphate moiety of a bound NTP molecule. The conservative substitution of an arginine for the invariant lysine at position 72 reduces NTP hydrolysis by almost-equal-to 600-850-fold. This mutation does not significantly alter the capacity of the mutant recA(K72R) protein either to bind nucleotide cofactors and single-stranded DNA or to respond allosterically to nucleotide cofactor binding. Despite the dramatic attenuation in NTP hydrolysis, the recA(K72R) protein retains the ability to promote homologous pairing and extensive exchange of DNA strands (up to 1.5 kilobase pairs). These results both identify a component of the catalytic domain for NTP hydrolysis and demonstrate that the recA protein-promoted pairing and exchange of DNA strands mechanistically require the allosteric transition induced by NTP cofactor binding, but not the energy educed from NTP hydrolysis.	NORTHWESTERN UNIV,SCH MED,DEPT CELL MOLEC & STRUCT BIOL,CHICAGO,IL 60611; UNIV CALIF DAVIS,DIV BIOL SCI,MICROBIOL & MOLEC BIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,CELL BIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,BIOCHEM SECT,DAVIS,CA 95616	Northwestern University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018987] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-18987] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; DREUSICKE D, 1988, J MOL BIOL, V199, P359, DOI 10.1016/0022-2836(88)90319-1; EGGLESTON AK, 1991, BIOCHIMIE, V73, P163, DOI 10.1016/0300-9084(91)90199-B; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; HSIEH P, 1986, CELL, V44, P885, DOI 10.1016/0092-8674(86)90011-5; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KOLODNER R, 1987, P NATL ACAD SCI USA, V84, P5560, DOI 10.1073/pnas.84.16.5560; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P5872, DOI 10.1021/bi00368a006; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LEBOWITZ JH, 1985, THESIS J HOPKINS U; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; LOWENHAUPT K, 1989, J BIOL CHEM, V264, P20568; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENETSKI JP, 1987, J BIOL CHEM, V262, P2085; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MOORE SP, 1990, J BIOL CHEM, V265, P11108; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PUGH BF, 1988, J BIOL CHEM, V263, P76; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSELLI W, 1990, J MOL BIOL, V216, P335; RUYECHAN WT, 1975, BIOCHEMISTRY-US, V14, P5529, DOI 10.1021/bi00696a023; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; SILVER MS, 1982, BIOCHEMISTRY-US, V21, P6066, DOI 10.1021/bi00267a007; Stasiak A, 1988, GENETIC RECOMBINATIO, P265; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STORY RM, 1991, THESIS YALE U; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; TONG L, 1989, SCIENCE, V245, P244, DOI 10.1126/science.2665078; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8845; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126	42	146	153	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1292	1297						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419331				2022-12-27	WOS:A1993KG07700079
J	ROGALSKA, E; RANSAC, S; VERGER, R				ROGALSKA, E; RANSAC, S; VERGER, R			CONTROLLING LIPASE STEREOSELECTIVITY VIA THE SURFACE PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC LIPASES; MONOLAYERS; OPTIMIZATION; HYDROLYSIS	In the present study, the stereoselectivity of Rhizomucor miehei lipase, lipoprotein lipase, Candida antarctica B lipase, and human gastric lipase towards racemic dicaprin spread as a monolayer at the air-water interface was investigated. For this purpose we have developed a method with which the enantiomeric excess of the residual substrate can be measured in monomolecular films. The stereoselectivity, which is one of the main aspects of enzymic catalysis, was found to depend on the surface pressure of the substrate. With all four lipases tested, low surface pressures enhanced the stereoselectivity while decreasing the enzymes' catalytic activity.	CTR BIOCHIM & BIOL MOLEC,CNRS,31 CH J AIGUIER,BP 71,F-13402 MARSEILLE 9,FRANCE	Centre National de la Recherche Scientifique (CNRS)			Bilewicz, Renata/AAF-4738-2021; ROGALSKA, Ewa/AFL-9986-2022; ROGALSKA, Ewa/AAH-2259-2022	Bilewicz, Renata/0000-0003-0058-3691; ROGALSKA, Ewa/0000-0001-6068-7746; ROGALSKA, Ewa/0000-0001-6068-7746				ANDELMAN D, 1989, J AM CHEM SOC, V111, P6536, DOI 10.1021/ja00199a009; Brockerhoff H., 1974, LIPOLYTIC ENZYMES; BROGSTROM B, 1984, LIPASES; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; CHEN CS, 1989, ANGEW CHEM INT EDIT, V28, P695, DOI 10.1002/anie.198906951; DEVEER AMTJ, 1992, BIOCHIM BIOPHYS ACTA, V1125, P73, DOI 10.1016/0005-2760(92)90158-R; DEVEER AMTJ, 1991, BIOCHEMISTRY-US, V30, P10034, DOI 10.1021/bi00105a031; GUBERNATOR K, 1991, GBF MONOGRAPHS, V16, P9; HARVEY NG, 1989, LANGMUIR, V5, P998, DOI 10.1021/la00088a020; HOLMBERG E, 1991, BIOTECHNOL LETT, V13, P323, DOI 10.1007/BF01027676; LAM LKP, 1986, J ORG CHEM, V51, P2047, DOI 10.1021/jo00361a021; LUTHIPENG Q, 1992, EUR J BIOCHEM, V205, P383, DOI 10.1111/j.1432-1033.1992.tb16791.x; PARIDA S, 1991, J AM CHEM SOC, V113, P2253, DOI 10.1021/ja00006a051; PETERS AR, 1992, BIOCHEMISTRY-US, V31, P10024, DOI 10.1021/bi00156a023; PIERONI G, 1990, ADV COLLOID INTERFAC, V32, P341, DOI 10.1016/0001-8686(90)80023-S; RANSAC S, 1990, J BIOL CHEM, V265, P20263; RETEY J, 1982, STEREOSPECIFICITY OR; ROGALSKA E, 1990, J BIOL CHEM, V265, P20271; SLOTBOOM AJ, 1976, CHEM PHYS LIPIDS, V17, P128, DOI 10.1016/0009-3084(76)90057-8; VERGER R, 1980, METHOD ENZYMOL, V64, P341	20	58	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					792	794						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419355				2022-12-27	WOS:A1993KG07700009
J	SMITH, PL; BOUSFIELD, GR; KUMAR, S; FIETE, D; BAENZIGER, JU				SMITH, PL; BOUSFIELD, GR; KUMAR, S; FIETE, D; BAENZIGER, JU			EQUINE LUTROPIN AND CHORIONIC-GONADOTROPIN BEAR OLIGOSACCHARIDES TERMINATING WITH SO4-4-GALNAC AND SIA-ALPHA-2,3GAL, RESPECTIVELY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; AMINO-ACID-SEQUENCE; GLYCANASE-RELEASED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; PITUITARY GLYCOPROTEIN HORMONES; MARE SERUM GONADOTROPIN; BETA-SUBUNIT; SIALYLATED OLIGOSACCHARIDES; ANIONIC OLIGOSACCHARIDES; STRUCTURAL ELUCIDATION	Equine chorionic gonadotropin (eCG) and lutropin (eLH) are heterodimeric glycoprotein hormones which are synthesized in the placenta and pituitary, respectively. The beta subunits of eCG and eLH, like their alpha subunits, arise from a single gene and have identical amino acid sequences. In contrast, the beta subunits of CG and LH in primates arise from different genes and differ in sequence. We have examined the structures of the Asn-linked oligosaccharides on eCG and eLH. eCG bears di- and tri-branched Asn-linked oligosaccharides terminating with Siaalpha2,3 or 6Galbeta1,4GlcNAc. In contrast, >72% of the Asn-linked oligosaccharides on eLH have 1 or 2 branches terminating with the sequence SO4-4-GalNAcbeta1,4GlcNAc. The nonsulfated oligosaccharides on eLH are neutral (6% of the total) or have branches terminating with sialic acid-Gal (22% of the total). Since the alpha and beta subunits of eCG and eLH both contain the tripeptide motif, Pro-Xaa-Arg/Lys, recognized by the glycoprotein hormone-specific GalNAc-transferase found in pituitary, expression of the GalNAc- and sulfotransferases must differ in the placenta and pituitary. eLH, but not eCG, is bound by the hepatic endothelial cell receptor specific for the sequence SO4-4-GalNAcbeta1,4GlcNAc. As a result, eLH is removed from the circulation 5.7-fold more rapidly than eCG and is selectively localized to the liver. Since the major structural difference between eCG and eLH is in the terminal glycosylation of their Asn-linked oligosaccharides and this has a major impact on circulatory half-life, it is likely that the difference in circulatory half-life defines the functional difference between eCG and eLH.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; WICHITA STATE UNIV,DEPT BIOL SCI,WICHITA,KS 67208	Washington University (WUSTL); Wichita State University			Baenziger, Jacques U/E-9430-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41738] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BAENZIGER JU, 1991, BIOL CARBOHYDRATES, V3, P1; BOUSFIELD GR, 1985, J BIOL CHEM, V260, P9531; BOUSFIELD GR, 1987, J BIOL CHEM, V262, P8610; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHRISTAKOS S, 1979, J BIOL CHEM, V254, P4253; CROWLEY WF, 1985, EPISODIC SECRETION H, P121; DAMM JBL, 1989, EUR J BIOCHEM, V189, P175; ENDO Y, 1979, J BIOCHEM-TOKYO, V85, P669; FIDDES JC, 1984, RECENT PROG HORM RES, V40, P43; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; GREEN ED, 1987, J BIOL CHEM, V262, P12018; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1987, ANAL BIOCHEM, V167, P62, DOI 10.1016/0003-2697(87)90134-5; GREEN ED, 1988, J BIOL CHEM, V263, P18253; GREEN ED, 1985, P NATL ACAD SCI USA, V82, P7850, DOI 10.1073/pnas.82.23.7850; GREEN ED, 1986, ANAL BIOCHEM, V158, P42, DOI 10.1016/0003-2697(86)90585-3; Hussa R O, 1980, Endocr Rev, V1, P268; KESSLER MJ, 1979, J BIOL CHEM, V254, P7901; KEUTMANN HT, 1979, BIOCHEM BIOPH RES CO, V90, P842, DOI 10.1016/0006-291X(79)91904-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHT P, 1979, J ENDOCRINOL, V83, P311, DOI 10.1677/joe.0.0830311; LINCOLN DW, 1985, RECENT PROG HORM RES, V41, P364; MATSUI T, 1991, BIOCHEM BIOPH RES CO, V174, P940, DOI 10.1016/0006-291X(91)91509-B; MATZUK MM, 1990, ENDOCRINOLOGY, V126, P376, DOI 10.1210/endo-126-1-376; MELLIS SJ, 1983, ANAL BIOCHEM, V134, P442, DOI 10.1016/0003-2697(83)90320-2; MIZUOCHI T, 1980, BIOCHEM BIOPH RES CO, V97, P772, DOI 10.1016/0006-291X(80)90331-9; MOORE WT, 1980, J BIOL CHEM, V255, P6930; MOORE WT, 1980, CHORIONIC GONADOTROP, P89; MORGAN FJ, 1975, J BIOL CHEM, V250, P5247; MURPHY BD, 1991, ENDOCR REV, V12, P27, DOI 10.1210/edrv-12-1-27; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; POLICASTRO P, 1983, J BIOL CHEM, V258, P1492; Rennels E G, 1980, Int Rev Physiol, V22, P1; SHRMAN GB, 1992, MOL ENDOCRINOL, V6, P951; SKELTON TP, 1991, J BIOL CHEM, V266, P17142; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1990, J BIOL CHEM, V265, P874; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; SMITHPL, 1992, P NATL ACAD SCI USA, V89, P329; STEWART F, 1979, J REPROD FERTIL    S, V27, P431; SUGINO H, 1987, J BIOL CHEM, V262, P8603; TALMADGE K, 1984, NATURE, V307, P37, DOI 10.1038/307037a0; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; VELDHUIS JD, 1988, AM J PHYSIOL, V255, pE749, DOI 10.1152/ajpendo.1988.255.6.E749; WANG H, 1991, J BIOL CHEM, V266, P780; WEISSHAAR G, 1991, EUR J BIOCHEM, V195, P257, DOI 10.1111/j.1432-1033.1991.tb15702.x; WEISSHAAR G, 1990, EUR J BIOCHEM, V192, P741, DOI 10.1111/j.1432-1033.1990.tb19285.x; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688	55	83	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					795	802						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419356				2022-12-27	WOS:A1993KG07700010
J	SALIH, E; HOWARD, S; CHISHTI, SB; COHEN, SG; LIU, WS; COHEN, JB				SALIH, E; HOWARD, S; CHISHTI, SB; COHEN, SG; LIU, WS; COHEN, JB			LABELING OF CYSTEINE-231 IN ACETYLCHOLINESTERASE FROM TORPEDO-NOBILIANA BY THE ACTIVE-SITE DIRECTED REAGENT, 1-BROMO-2-[C-14] PINACOLONE - EFFECTS OF 2,2'-DIPYRIDYL DISULFIDE AND OTHER SULFHYDRYL-REAGENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM CHOLINESTERASE; AMINO-ACID SEQUENCE; REVERSIBLE INHIBITORS; ANIONIC SUBSITES; TRIMETHYL; CALIFORNICA; HYDROLYSIS; PROTEIN; BINDING; PURIFICATION	Acetylcholinesterase (AcChE, EC 3.1.1.7) was isolated from the electric organ of T. nobiliana and treated with the active-site- directed alkylating agent 1-bromo-2-[C-14]pinacolone ([C-14]BrPin), or with BrPin, which acts initially as a competitive inhibitor, K(i) = 0.18 mm, and then inactivates the enzyme, k2 = 1.8 x 10(-4) s-1. AcChE aliquots were digested with trypsin and fractionated by reversed phase high performance liquid chromatography. Inactivation caused a decrease in one absorption peak and an increase in another, identified as the peptide beginning at Ala-222 and extending to Arg-242. 5-Trimethylammonio-2-pentanone, a competitive inhibitor, isosteric with acetylcholine, retarded the inactivation and decreased the quantity of labeled peptide. On sequencing, the C-14 label was found associated with Cys-231. This was confirmed by comparison with synthesized S-pinacolonylcysteine, by study of effects of blocking the sequencing by o-phthalaldehyde, and by inactivation by 2,2'-dipyridyl disulfide (2-PDS), a thiol-specific reagent that acts initially as a competitive inhibitor, K(i) = 0.042 mM, and then inactivates the enzyme, k2 = 5.0 x 10(-4) s-1. This is retarded by 5-trimethylammonio-2-pentanone, and prior inactivation by 2-PDS prevents subsequent reaction of [C-14]BrPin in the active site. BrPin inactivates AcChEs from Electrophorus electricus and from human erythrocyte, but 2-PDS does not. Neither reagent inactivates butyrylcholinesterases from human and horse serum.	BRANDEIS UNIV, DEPT CHEM, WALTHAM, MA 02254 USA; WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA	Brandeis University; Washington University (WUSTL)				Salih, Erdjan/0000-0003-3322-2323	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS022828, R01NS019522] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 22828, NS 19522] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], ENZYMES 3E; BERMAN HA, 1986, BIOCHIM BIOPHYS ACTA, V872, P125, DOI 10.1016/0167-4838(86)90155-X; BILO J, 1990, NUCLEIC ACIDS RES, V18, P3990; BON S, 1986, FEBS LETT, V209, P206, DOI 10.1016/0014-5793(86)81112-7; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CARR C, 1987, BIOCHEMISTRY-US, V26, P7090, DOI 10.1021/bi00396a034; CHHAJLANI V, 1989, FEBS LETT, V247, P279, DOI 10.1016/0014-5793(89)81352-3; COHEN SG, 1987, BIOORG CHEM, V15, P237, DOI 10.1016/0045-2068(87)90022-8; COHEN SG, 1989, BIOCHIM BIOPHYS ACTA, V997, P167, DOI 10.1016/0167-4838(89)90182-9; COHEN SG, 1984, J MED CHEM, V27, P1643, DOI 10.1021/jm00378a020; COHEN SG, 1982, J BIOL CHEM, V257, P4087; COHEN SG, 1991, BIOCHIM BIOPHYS ACTA, V1076, P112, DOI 10.1016/0167-4838(91)90227-Q; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; HASAN FB, 1981, J BIOL CHEM, V256, P7781; HASAN FB, 1980, J BIOL CHEM, V255, P3898; KREIENKAMP HJ, 1991, P NATL ACAD SCI USA, V88, P6117, DOI 10.1073/pnas.88.14.6117; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P12945; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; ROSENBERRY TL, 1971, BIOCHEMISTRY-US, V10, P4114, DOI 10.1021/bi00798a016; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; STEINBERG N, 1990, BIOCHEM INT, V21, P1043; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1974, MOL PHARMACOL, V10, P78; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x	36	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					245	251						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416933				2022-12-27	WOS:A1993KE60300039
J	SHORNICK, LP; HOLTZMAN, MJ				SHORNICK, LP; HOLTZMAN, MJ			A CRYPTIC, MICROSOMAL-TYPE ARACHIDONATE 12-LIPOXYGENASE IS TONICALLY INACTIVATED BY OXIDATION-REDUCTION CONDITIONS IN CULTURED EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE LEUKOCYTES; GLUTATHIONE; ACID; LIPOXYGENASE; OXYGENATION; IDENTIFICATION; METABOLITES; INHIBITION; PLATELETS; DISTINCT	Cultured ovine tracheal epithelial cells converted arachidonic acid to prostaglandin E2 (PGE2), but microsome-containing subcellular fractions prepared from these cells under calcium-free conditions converted arachidonic acid to PGE2 and to 12-hydroxyeicosatetraenoic acid (12-HETE) at a high rate (2-4 nmol/mg of protein/15 min). Identification of the membrane-bound 12-HETE-forming activity as a 12-lipoxygenase included 12S-stereospecificity of product formation and trapping of 12-hydroperoxyeicosatetraenoic acid as a reaction product. The 12-lipoxygenase activity was extracted from cell membranes only with detergent (1% Triton X-100), and the activity (membrane-bound or detergent-solubilized) was completely inactivated by mixing with the cytosol-containing subcellular fraction. The inhibitory effect of the cytosolic fraction was reversed by treating the cytosol with GSH-depleting agents (2-cyclohexene-1-one or N-ethylmaleimide) or by mixing it with lipid hydroperoxide (13-hydroperoxyoctadecadienoic acid) at a concentration that had little direct effect on enzyme activity. Inhibition of 12-lipoxygenase activity could also be achieved by treatment of enzyme preparations with GSH at levels (0.1-10 mM) found in epithelial cell cytosol. In addition, treatment of cultured epithelial cells with a GSH-depleting agent (buthionine sulfoximine) and lipid hydroperoxide restored cellular 12-lipoxygenase activity. Little or no detectable 12-lipoxygenase activity was found in freshly isolated ovine tracheal epithelial cells, but the cytosolic 12-lipoxygenase found in freshly isolated bovine tracheal epithelial cells was relatively insensitive to regulation by GSH or lipid hydroperoxide. These observations indicate that a 12-lipoxygenase is expressed in a cryptic, microsomal-type form in primary-culture epithelial cells and that this form of the enzyme may be selectively regulated by changes in cellular oxidation-reduction conditions dependent on cytosolic levels of GSH versus lipid hydroperoxide.	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV PULM & CRIT CARE MED,660 S EUCLID AVE,BOX 8052,ST LOUIS,MO 63110	Washington University (WUSTL)				Shornick, Laurie/0000-0001-6652-1878	NHLBI NIH HHS [HL-40078] Funding Source: Medline; NIDDK NIH HHS [DK-38111] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038111] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BABA A, 1989, J BIOL CHEM, V264, P15790; BROWN LAS, 1992, AM J PHYSIOL, V262, pL305, DOI 10.1152/ajplung.1992.262.3.L305; CHANG WC, 1992, J BIOL CHEM, V267, P3657; DEMARZO N, 1992, AM J PHYSIOL, V262, pL198; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; FLEMING J, 1989, GENE, V79, P181, DOI 10.1016/0378-1119(89)90103-0; FUNK CD, 1990, P NATL ACAD SCI USA, V87, P5638, DOI 10.1073/pnas.87.15.5638; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HAMBERG M, 1980, BIOCHEM BIOPH RES CO, V95, P1090, DOI 10.1016/0006-291X(80)91584-3; HANSBROUGH JR, 1989, AM J RESP CELL MOL, V1, P237, DOI 10.1165/ajrcmb/1.3.237; HANSBROUGH JR, 1990, J BIOL CHEM, V265, P1771; HOLTZMAN MJ, 1992, ANNU REV PHYSIOL, V54, P303; HOLTZMAN MJ, 1988, BIOCHIM BIOPHYS ACTA, V963, P401, DOI 10.1016/0005-2760(88)90308-6; HOLTZMAN MJ, 1989, J CLIN INVEST, V84, P1446, DOI 10.1172/JCI114319; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; HOLTZMAN MJ, 1991, AIRWAY EPITHELIUM PH, P55; HUNTER JA, 1985, P NATL ACAD SCI USA, V82, P4633, DOI 10.1073/pnas.82.14.4633; ISHII Y, 1992, J CLIN INVEST, V89, P794, DOI 10.1172/JCI115658; JONES GS, 1982, J APPL PHYSIOL, V53, P258, DOI 10.1152/jappl.1982.53.1.258; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; LIANG CM, 1989, J BIOL CHEM, V264, P13519; MEISTER A, 1988, J BIOL CHEM, V263, P17205; NADLER JL, 1987, J CLIN INVEST, V80, P1763, DOI 10.1172/JCI113269; PENTLAND AP, 1990, J CLIN INVEST; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; ROSEN GD, 1989, BIOCHEM BIOPH RES CO, V164, P1358, DOI 10.1016/0006-291X(89)91819-6; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SHANNON VR, 1991, AM J PHYSIOL, V261, pL399, DOI 10.1152/ajplung.1991.261.6.L399; SHANNON VR, 1992, IN PRESS AM J PHYSL, V263; SHANNON VR, 1993, IN PRESS AM REV RESP, V147; SHANNON VR, 1993, IN PRESS AM J PHYSL, V264; STENSON WF, 1983, AM J PHYSIOL, V244, pG273, DOI 10.1152/ajpgi.1983.244.3.G273; TAKAHASHI Y, 1988, ARCH BIOCHEM BIOPHYS, V266, P613, DOI 10.1016/0003-9861(88)90294-9; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; UEDA N, 1990, J BIOL CHEM, V265, P2311; WEDNER HJ, 1981, J CLIN INVEST, V68, P535, DOI 10.1172/JCI110285; WU R, 1986, IN VITRO MODELS RESP, P1; YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714; YOSHIMOTO T, 1990, P NATL ACAD SCI USA, V87, P2142, DOI 10.1073/pnas.87.6.2142	39	47	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					371	376						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416945				2022-12-27	WOS:A1993KE60300057
J	LEE, SK; NESHEIM, JC; LIPSCOMB, JD				LEE, SK; NESHEIM, JC; LIPSCOMB, JD			TRANSIENT INTERMEDIATES OF THE METHANE MONOOXYGENASE CATALYTIC CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; METHYLOCOCCUS-CAPSULATUS BATH; HYDROXYLASE COMPONENT; RIBONUCLEOTIDE REDUCTASE; RADICAL INTERMEDIATE; IRON CLUSTER; OXO; OXIDATION; CYTOCHROME-P-450; HYDROCARBONS	Three new intermediates of the catalytic cycle of the soluble form of methane monooxygenase (MMO) isolated from Methylosinus trichosporium OB3b have been detected using transient kinetic techniques. MMO consists of hydroxylase (MMOH), reductase, and ''B'' (MMOB) components. MMOH contains an oxygen-bridged [Fe(III).Fe(III)] cluster that catalyzes O2 activation and insertion chemistry. At 4-degrees-C, rapid mixing of O2 with diferrous MMOH ([Fe(II).Fe(II)]) in the presence of a 2-fold excess of MMOB resulted in loss of the g = 16 EPR signal characteristic of the diferrous cluster at an apparent first order rate of 22 +/- 5 s-1 (O2 almost-equal-to 700 muM). Subsequently, an EPR silent, chromophoric (lambda(max) = 330 and 430 nm, epsilon almost-equal-to 7500 M-1 cm-1 at each wavelength) intermediate (compound Q) formed with an average first order rate constant of 1 +/- 0.1 s-1 and then decayed at 0.05 +/- 0.01 s-1. Since compound Q formed much more slowly than diferrous MMOH disappeared, at least one other undetected intermediate (compound P) must have formed before compound Q. MMO substrates had little or no effect on the formation rate of compound Q, but they caused the decay rate to increase linearly with the concentration added. The substrates methane, furan, and nitrobenzene caused compound Q decay to occur with second order rate constants of 19,000 M-1 s-1, 9000 M-1 s-1, and 200 M-1 s-1 (+/- 5%), respectively. When nitrobenzene was used as a substrate, a second chromophoric intermediate (compound T, lambda(max) = 325 nm, with a shoulder at 395 nm, epsilon395 almost-equal-to 6000 M-1 cm-1) formed at the same rate as compound Q decay. Chemical quench studies showed that compound T is an enzyme-product complex that decays with a rate constant of 0.02 +/- 0.005 s-1. This rate is approximately the same as k(cat) for nitrobenzene turnover at 4-degrees-C catalyzed by the reconstituted MMO system, suggesting that product release is the rate-limiting step in catalysis. The characteristics of compound Q suggest that it may be the activated form of the enzyme that directly catalyzes substrate oxidation.	UNIV MINNESOTA,SCH MED,DEPT BIOCHEM,4-225 MILLARD HALL,435 DELAWARE ST SE,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities				Lipscomb, John/0000-0002-8158-5594	NIGMS NIH HHS [R01 GM040466] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040466] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALCOCK NW, 1970, T FARADAY SOC, V66, P2210, DOI 10.1039/tf9706602210; ANDERSSON KK, 1991, NEW J CHEM, V15, P411; Anthony C., 1982, BIOCH METHYLOTROPHS; BOLLINGER JM, 1991, J AM CHEM SOC, V113, P6289, DOI 10.1021/ja00016a066; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; Dalton H., 1993, P65; DALTON H, 1980, ADV APPL MICROBIOL, V26, P71; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; DONG YH, 1993, J AM CHEM SOC, V115, P1851, DOI 10.1021/ja00058a033; FOX BG, 1988, J BIOL CHEM, V263, P10553; FOX BG, 1990, BIOCHEMISTRY-US, V29, P6419, DOI 10.1021/bi00479a013; FOX BG, 1989, J BIOL CHEM, V264, P10023; FOX BG, 1991, J BIOL CHEM, V266, P540; FOX BG, 1993, J AM CHEM SOC, V115, P3688, DOI 10.1021/ja00062a039; FOX BG, 1990, METHOD ENZYMOL, V188, P191; FROLAND WA, 1992, J BIOL CHEM, V267, P17588; GREEN J, 1989, BIOCHEM J, V259, P167, DOI 10.1042/bj2590167; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; HENDRICH MP, 1990, J AM CHEM SOC, V112, P5861, DOI 10.1021/ja00171a029; HRYCAY EG, 1976, EUR J BIOCHEM, V61, P43, DOI 10.1111/j.1432-1033.1976.tb09995.x; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; LEISING RA, 1990, INORG CHEM, V29, P2553, DOI 10.1021/ic00339a003; McMurry T. J., 1986, CYTOCHROME P450 STRU, P1; MENAGE S, 1990, J AM CHEM SOC, V112, P6423, DOI 10.1021/ja00173a055; PRIESTLEY ND, 1992, J AM CHEM SOC, V114, P7561, DOI 10.1021/ja00045a037; RATAJ MJ, 1991, J BIOL CHEM, V266, P18684; REEM RC, 1989, J AM CHEM SOC, V111, P4688, DOI 10.1021/ja00195a024; RUZICKA F, 1990, BIOCHEMISTRY-US, V29, P1696, DOI 10.1021/bi00459a005; SANDERSLOEHR J, 1989, J AM CHEM SOC, V111, P8084, DOI 10.1021/ja00203a003; SEGEL IH, 1975, ENZYME KINETICS, P544; SWINBOURNE ES, 1971, ANAL KINETIC DATA, P90; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4476; WOODLAND MP, 1986, BIOCHIM BIOPHYS ACTA, V873, P237, DOI 10.1016/0167-4838(86)90050-6	34	322	324	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21569	21577						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408008				2022-12-27	WOS:A1993MC80900024
J	MORII, M; TAKEGUCHI, N				MORII, M; TAKEGUCHI, N			DIFFERENT BIOCHEMICAL-MODES OF ACTION OF 2 IRREVERSIBLE H+,K+-ATPASE INHIBITORS, OMEPRAZOLE AND E3810	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED GASTRIC VESICLES; AMINO-ACID-SEQUENCE; (H+ + K+)-ATPASE; ADENOSINE-TRIPHOSPHATASE; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; CATALYTIC CYCLE; FLUORESCEIN ISOTHIOCYANATE; LABELED PEPTIDE; K+-SITE	Omeprazole and E3810 were found to inhibit gastric H+,K+-ATPase following different biochemical mechanisms. Effects of the specific binding of the inhibitors on the conformational state of the enzyme were studied by measuring the fluorescence of the enzyme labeled with fluorescein 5'-isothiocyanate. The absolute fluorescence level of the omeprazole-bound enzyme was lower than that of the control enzyme, and reduction of S-S cross-linking between the enzyme and omeprazole increased the fluorescence. Addition of K+ into the control vesicle solution quenched the fluorescence (E1 --> E2K+). The quench was inhibited in the omeprazole-bound enzyme but not in the E3810-bound enzyme. These results suggest that the omeprazole-bound enzyme has a low fluorescence conformation (E2 form). On the other hand, the conformation of the E3810-bound enzyme was the same as that of the control enzyme (E1 form). Phosphoenzyme formation in the absence of K+ was inhibited in both the E3810- and omeprazole-bound enzymes. Binding of 2',3'-o-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate to the enzyme was equally inhibited by E3810 and omeprazole. K+-dependent dephosphorylation from the phosphoenzyme was inhibited in the E3810-bound enzyme but not in the omeprazole-bound enzyme. These experimental results have shown that the inhibition mechanism of H+,K+-ATPase by omeprazole was different from that by E3810; the partial reaction that was the most differently affected by the inhibitors was the conformational change from the E2 to E1 form for omeprazole and the luminal K+-dependent dephosphorylation for E3810.			MORII, M (corresponding author), TOYAMA MED & PHARMACEUT UNIV,FAC PHARMACEUT SCI,2630 SUGITANI,TOYAMA 93001,JAPAN.							ASANO S, 1990, J BIOL CHEM, V265, P22167; ASANO S, 1987, J BIOL CHEM, V262, P13263; ASANO S, 1992, J BIOL CHEM, V267, P6590; BEIL W, 1986, BRIT J PHARMACOL, V88, P19, DOI 10.1111/j.1476-5381.1986.tb09466.x; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; BUXBAUM E, 1991, EUR J BIOCHEM, V195, P407, DOI 10.1111/j.1432-1033.1991.tb15720.x; FALLER LD, 1990, BIOCHEMISTRY-US, V29, P3179, DOI 10.1021/bi00465a004; FALLER LD, 1991, BIOCHEMISTRY-US, V30, P3503, DOI 10.1021/bi00228a022; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; FARLEY RA, 1985, J BIOL CHEM, V260, P3899; FRYKLUND J, 1988, BIOCHEM PHARMACOL, V37, P254; FUJISAKI H, 1991, BIOCHEM PHARMACOL, V42, P321, DOI 10.1016/0006-2952(91)90719-L; JACKSON RJ, 1983, BIOCHIM BIOPHYS ACTA, V731, P9, DOI 10.1016/0005-2736(83)90391-7; KEELING DJ, 1987, BIOCHEM PHARMACOL, V36, P339, DOI 10.1016/0006-2952(87)90291-7; KEELING DJ, 1989, J BIOL CHEM, V264, P5552; KEELING DJ, 1989, J BIOL CHEM, V264, P5545; KEELING DJ, 1991, BIOCHEM PHARMACOL, V42, P123, DOI 10.1016/0006-2952(91)90690-7; KEELING DJ, 1988, BIOCHEM PHARMACOL, V37, P2231, DOI 10.1016/0006-2952(88)90586-2; LORENTZON P, 1987, BIOCHIM BIOPHYS ACTA, V897, P41, DOI 10.1016/0005-2736(87)90313-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENDLEIN J, 1989, J BIOL CHEM, V264, P18512; MENDLEIN J, 1990, J BIOL CHEM, V265, P15590; MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2346; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2357; MORII M, 1989, GASTROENTEROLOGY, V96, P1453, DOI 10.1016/0016-5085(89)90512-X; MORII M, 1990, BIOCHEM PHARMACOL, V39, P661, DOI 10.1016/0006-2952(90)90143-9; MORII M, 1984, BIOCHEMISTRY-US, V23, P6816, DOI 10.1021/bi00321a083; MORII M, 1990, BIOCHEM BIOPH RES CO, V167, P754, DOI 10.1016/0006-291X(90)92089-I; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1982, J BIOL CHEM, V257, P6111; RABON E, 1991, J BIOL CHEM, V266, P12395; RABON E, 1978, BIOCHEMISTRY-US, V17, P3345, DOI 10.1021/bi00609a027; RABON EC, 1990, J BIOL CHEM, V265, P19594; REPHAELI A, 1986, J BIOL CHEM, V261, P2437; REPHAELI A, 1986, J BIOL CHEM, V261, P6248; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SCHRIJEN JJ, 1980, BIOCHIM BIOPHYS ACTA, V597, P331, DOI 10.1016/0005-2736(80)90110-8; TAKEGUCHI N, 1983, J BIOL CHEM, V258, P3094; WALLMARK B, 1980, J BIOL CHEM, V255, P5313; WALLMARK B, 1979, J BIOL CHEM, V254, P1899; WALLMARK B, 1985, J BIOL CHEM, V260, P3681; WALLMARK B, 1987, J BIOL CHEM, V262, P2077	43	29	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21553	21559						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408006				2022-12-27	WOS:A1993MC80900022
J	SIRAWARAPORN, W; PRAPUNWATTANA, P; SIRAWARAPORN, R; YUTHAVONG, Y; SANTI, DV				SIRAWARAPORN, W; PRAPUNWATTANA, P; SIRAWARAPORN, R; YUTHAVONG, Y; SANTI, DV			THE DIHYDROFOLATE-REDUCTASE DOMAIN OF PLASMODIUM-FALCIPARUM THYMIDYLATE SYNTHASE-DIHYDROFOLATE REDUCTASE - GENE SYNTHESIS, EXPRESSION, AND ANTI-FOLATE-RESISTANT MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PYRIMETHAMINE; PROTEINS; MALARIA; PURIFICATION; CYCLOGUANIL; SEQUENCE; PROTOZOA	A 693-base pair gene coding for the 27,132-dalton dihydrofolate reductase (DHFR) domain of the thymidylate synthase-dihydrofolate reductase (TS-DHFR) bifunctional protein of Plasmodium falciparum was designed to have Escherichia coli codon preference and multiple unique restriction sites and was chemically synthesized. The gene was overexpressed (>50% total cellular protein) in E. coli as insoluble inclusion bodies which could be unfolded and refolded to recover soluble enzyme activity. The refolded DHFR was purified by methotrexate-Sepharose affinity chromatography to give the homogeneous enzyme. Active site titration with methotrexate revealed that the purified protein was fully active. The purified DHFR migrates as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with apparent mass of approximately 30 kDa, and gel filtration showed that the protein is a monomer. The yield of purified enzyme was about 5-6 mg/liter of bacterial culture. Kinetic properties of the purified recombinant DHFR were similar to those reported for wild type bifunctional TS-DHFR. Cassette mutagenesis of the synthetic gene was performed to give the S108N and the N51I+S108N mutants which provided DHFRs analogous to pyrimethamine-resistant mutants found in nature.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; MAHIDOL UNIV,FAC SCI,DEPT BIOCHEM,BANGKOK 10400,THAILAND	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mahidol University			Yuthavong, Yongyuth/E-7392-2010	Yuthavong, Yongyuth/0000-0002-3582-8401	NIAID NIH HHS [AI 19358] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019358] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1; Blakley R.L., 1984, FOLATES PTERINS, V1, P191; BRODIN P, 1986, BIOCHEMISTRY-US, V25, P5371, DOI 10.1021/bi00367a004; BRUCECHWATT LJ, 1986, CHEMOTHERAPY MALARIA, P110; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; CLIMIE S, 1990, P NATL ACAD SCI USA, V87, P633, DOI 10.1073/pnas.87.2.633; de Boer HA., 1986, MAXIMIZING GENE EXPR, P225; FERONE R, 1980, P NATL ACAD SCI-BIOL, V77, P5802, DOI 10.1073/pnas.77.10.5802; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; FRIEDKIN M, 1962, FED PROC, V21, P176; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; HALL SJ, 1991, MOL BIOCHEM PARASIT, V45, P317, DOI 10.1016/0166-6851(91)90100-K; HILLCOAT BL, 1967, ANAL BIOCHEM, V21, P178, DOI 10.1016/0003-2697(67)90179-0; IVANETICH KM, 1990, FASEB J, V4, P1591, DOI 10.1096/fasebj.4.6.2180768; IVANETICH KM, 1991, BIOTECHNIQUES, V10, P704; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN KH, 1991, BIOTECHNOLOGY, V11, P750; MARTINEZ HM, 1985, SEQUENCE AAL PROGRAM; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PINTER K, 1988, DNA-J MOLEC CELL BIO, V7, P235, DOI 10.1089/dna.1988.7.235; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEGER DR, 1949, J AM CHEM SOC, V71, P1753, DOI 10.1021/ja01173a061; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; SIRAWARAPORN W, 1990, BIOCHEMISTRY-US, V29, P10779, DOI 10.1021/bi00500a009; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WILLIAMS JW, 1981, BIOCHEMISTRY-US, V20, P6024, DOI 10.1021/bi00524a016; YOUNG RA, 1979, J BIOL CHEM, V254, P2725	33	99	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21637	21644						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408015				2022-12-27	WOS:A1993MC80900034
J	CRENSHAW, DG; HSIEH, TS				CRENSHAW, DG; HSIEH, TS			FUNCTION OF THE HYDROPHILIC CARBOXYL-TERMINUS OF TYPE-II DNA TOPOISOMERASE FROM DROSOPHILA-MELANOGASTER .1. IN-VITRO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; NUCLEOTIDE-SEQUENCE; ANTITUMOR DRUGS; YEAST; PHOSPHORYLATION; BINDING; INVIVO; PROTEIN; GYRASE; GENE	The function of the hydrophilic carboxyl-terminal region of Drosophila DNA topoisomerase II was examined by constructing a series of deletion mutants at the 3'-end of the Drosophila Top2 cDNA. The truncated enzymes were then expressed in Saccharomyces cerevisiae. Deletion of up to 240 out of 1447 total amino acids had no apparent effect on the enzyme's ability to catalyze topisomerization reactions. When 273, or more, amino acids were deleted, the enzyme was no longer active. Examples were found where deletion of less than 240 amino acids inactivated the enzyme. Based on the hydrodynamic properties determined for one of these mutants, the lack of activity was most likely due to misfolding of the polypeptides. The active mutants have similar hydrodynamic properties and heat inactivation profiles as the intact enzyme, suggesting that they are dimeric and stably folded. The carboxyl-terminal 240 amino acids also were not required for interaction with the drug VM26. The only difference noted between the shortest, active mutant and the full-length enzyme was a decrease in the stability of the interaction of the truncated enzyme with DNA as evidenced by a decrease in the ionic strength at which catalysis was optimal and at which the transition between a processive and distributive mode of supercoil relaxation occurred.	DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University			Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012		NIGMS NIH HHS [5T32 GM07184, GM29006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006, T32GM007184] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARON PR, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P1; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21335; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; HECK MMS, 1989, J BIOL CHEM, V264, P15161; HSIEH TS, 1983, METHOD ENZYMOL, V100, P161; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE MP, 1989, J BIOL CHEM, V264, P13510; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LIU LF, 1981, NUCLEIC ACIDS RES, V9, P3979, DOI 10.1093/nar/9.16.3979; LYNN R, 1986, SCIENCE, V233, P647, DOI 10.1126/science.3014661; Maniatis T., 1982, MOL CLONING; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MAXWELL A, 1986, ADV PROTEIN CHEM, V38, P69, DOI 10.1016/S0065-3233(08)60526-4; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROTTMANN M, 1987, EMBO J, V6, P3939, DOI 10.1002/j.1460-2075.1987.tb02735.x; SAHYOUN N, 1986, P NATL ACAD SCI USA, V83, P1604; SANDER M, 1987, J MOL BIOL, V194, P219, DOI 10.1016/0022-2836(87)90370-6; SANDER M, 1983, J BIOL CHEM, V258, P8421; SANDER M, 1984, P NATL ACAD SCI-BIOL, V81, P6938, DOI 10.1073/pnas.81.22.6938; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; SHERMAN F, 1986, LABORATORY COURSE MA; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SHIOZAKI K, 1991, MOL CELL BIOL, V11, P6093, DOI 10.1128/MCB.11.12.6093; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; UEMURA T, 1986, EMBO J, V5, P2355, DOI 10.1002/j.1460-2075.1986.tb04504.x; VOSBERG HP, 1985, CURR TOP MICROBIOL, V114, P19; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; WYCKOFF E, 1988, P NATL ACAD SCI USA, V85, P6272, DOI 10.1073/pnas.85.17.6272; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985	40	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21328	21334						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407971				2022-12-27	WOS:A1993MA28800099
J	HOWE, PH; DOBROWOLSKI, SF; REDDY, KB; STACEY, DW				HOWE, PH; DOBROWOLSKI, SF; REDDY, KB; STACEY, DW			RELEASE FROM G(1) GROWTH ARREST BY TRANSFORMING GROWTH-FACTOR-BETA-1 REQUIRES CELLULAR RAS ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SIGNAL TRANSDUCTION; EPITHELIAL-CELLS; PROTEIN-KINASE; EXPRESSION CLONING; TYROSINE KINASE; MAP KINASE; INHIBITION; RECEPTOR; PHOSPHORYLATION	Transforming growth factor beta1 (TGFbeta1) is a potent inhibitor of epithelial cell growth, although the mechanism of growth inhibition remains unknown. We report here a critical relationship between cellular p21ras activity and TGFbeta1 action. Microinjection of oncogenic Ha-ras protein into TGFbeta1-arrested mink lung epithelial cells overcomes TGFbeta1 growth inhibition and allows progression into S phase. Cells released from TGFbeta1 inhibition following microinjection with anti-p21ras antibody, on the other hand, remain TGFbeta1-arrested and do not enter S phase, indicating a requirement for p21ras activity. These biological data are substantiated biochemically in that TGFbeta1 is shown to decrease the activation state of endogenous p21ras as measured by the level of GTP-bound p21ras. In addition, the phosphorylation and kinase activity of mitogen-activated protein kinase, which depends upon cellular ras activity, is elevated in cells which have been released from growth arrest by TGFbeta1. Together these data demonstrate the involvement of p21ras activity in TGFbeta1-induced growth inhibition and suggest that the inhibitor controls proliferation by modulating the activity of p21ras.	CLEVELAND CLIN,RES INST,DEPT MOLEC BIOL,CLEVELAND,OH 44195	Cleveland Clinic Foundation	HOWE, PH (corresponding author), CLEVELAND CLIN,RES INST,DEPT CELL BIOL,CLEVELAND,OH 44195, USA.				NCI NIH HHS [CA53496, CA 55536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA053496, R29CA055536] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Downward J, 1992, CURR OPIN GENET DEV, V2, P13, DOI 10.1016/S0959-437X(05)80315-6; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FILMUS J, 1992, ONCOGENE, V7, P521; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; HOUCK KA, 1989, ONCOGENE, V4, P19; HOWE PH, 1991, MOL CELL BIOL, V11, P1185, DOI 10.1128/MCB.11.3.1185; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LONGSTREET M, 1992, ONCOGENE, V7, P1549; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULDER KM, 1992, J BIOL CHEM, V267, P5029; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; RAPP UR, 1991, ONCOGENE, V6, P495; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; VRIESSMITS AMM, 1992, NATURE, V357, P602; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZENTELLA A, 1991, MOL CELL BIOL, V11, P4952, DOI 10.1128/MCB.11.10.4952	33	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21448	21452						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407989				2022-12-27	WOS:A1993MA28800117
J	KEENEY, S; CHANG, GJ; LINN, S				KEENEY, S; CHANG, GJ; LINN, S			CHARACTERIZATION OF A HUMAN DNA-DAMAGE BINDING-PROTEIN IMPLICATED IN XERODERMA-PIGMENTOSUM-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTICANCER DRUG CISPLATIN; COMPLEMENTATION GROUP-E; REPAIR GENE; GROUP-A; POLYACRYLAMIDE GELS; EXCISION REPAIR; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; RECOGNITION PROTEIN; HUMAN-PLACENTA	A human DNA damage binding protein implicated in the DNA excision repair disorder xeroderma pigmentosum E was purified to near homogeneity from HeLa cells. The protein is abundant (approximately 10(5) copies/cell) and has a native molecular weight of 154,000-163,000 as estimated by gel filtration and glycerol gradient sedimentation. DNA damage binding activity copurified with polypeptides of 124 and 41 kDa. Based on the native molecular weight, cosedimentation of both polypeptides with DNA damage binding activity on glycerol gradients, and a molar ratio of approximately 1:1 for the two polypeptides, it appears that p124 and p41 are subunits of a heterodimeric protein. Binding to damaged DNA was resistant to K+ concentrations approaching 1 M, but showed anion-specific sensitivity to Cl- concentrations above 0.5 M, suggesting that the majority of the binding energy is contributed by nonionic interactions. In contrast to previous reports, the DNA damage binding protein was shown to recognize cyclobutane pyrimidine dimers in addition to a nonphotoreactivable lesion(s), most likely the pyrimidine-pyrimidone (6-4) photoproduct.	UNIV CALIF BERKELEY,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley			Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417	NIEHS NIH HHS [P30ES011896] Funding Source: Medline; NIGMS NIH HHS [GM07232-15, GM30415] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES011896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R01GM030415] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMIC M, 1991, J BIOL CHEM, V266, P22493; CHAO CCK, 1991, CANCER RES, V51, P601; CHAO CCK, 1992, BIOCHEM J, V282, P203, DOI 10.1042/bj2820203; CHAO CCK, 1991, MOL CELL BIOL, V11, P2075, DOI 10.1128/MCB.11.4.2075; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; CHU G, 1990, P NATL ACAD SCI USA, V87, P3324, DOI 10.1073/pnas.87.9.3324; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; de Weerd-Kastelein E A, 1974, Mutat Res, V22, P87, DOI 10.1016/0165-1218(74)90056-1; DONAHUE BA, 1990, BIOCHEMISTRY-US, V29, P5872, DOI 10.1021/bi00476a032; EKER APM, 1992, MUTAT RES, V274, P211, DOI 10.1016/0921-8777(92)90067-D; FELDBERG RS, 1980, NUCLEIC ACIDS RES, V8, P1133, DOI 10.1093/nar/8.5.1133; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; FELDBERG RS, 1982, J BIOL CHEM, V257, P6394; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HIRSCHFELD S, 1990, MOL CELL BIOL, V10, P2041, DOI 10.1128/MCB.10.5.2041; HOEIJMAKERS JHJ, 1990, MUTAT RES, V236, P223, DOI 10.1016/0921-8777(90)90007-R; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; Johns E.W., 1982, HMG CHROMOSOMAL PROT, P1; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KATAOKA H, 1991, BIOCHEM BIOPH RES CO, V175, P1139, DOI 10.1016/0006-291X(91)91684-5; KEENEY S, 1992, MUTAT RES, V273, P49, DOI 10.1016/0921-8777(92)90049-9; KONDO S, 1989, PHOTODERMATOLOGY, V6, P89; KUHNLEIN U, 1976, P NATL ACAD SCI USA, V73, P1169, DOI 10.1073/pnas.73.4.1169; LEE J C, 1974, Biochemistry, V13, P257, DOI 10.1021/bi00699a005; LIN JJ, 1992, MOL MICROBIOL, V6, P2219, DOI 10.1111/j.1365-2958.1992.tb01398.x; MITCHELL DL, 1990, NUCLEIC ACIDS RES, V18, P963, DOI 10.1093/nar/18.4.963; MOUNKES LC, 1992, CELL, V71, P925, DOI 10.1016/0092-8674(92)90389-T; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NISHIDA C, 1988, J BIOL CHEM, V263, P501; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; REARDON JT, 1993, J BIOL CHEM, V268, P21301; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; RINE J, 1987, GENETICS, V116, P9; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; ROSS M, 1990, BIOTECHNIQUES, V9, P532; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5512, DOI 10.1073/pnas.86.14.5512; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZELLE B, 1979, MUTAT RES, V62, P363, DOI 10.1016/0027-5107(79)90091-5	45	184	190	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21293	21300						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407967				2022-12-27	WOS:A1993MA28800095
J	LUO, Y; SHUMAN, S				LUO, Y; SHUMAN, S			RNA-BINDING PROPERTIES OF VACCINIA VIRUS CAPPING ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSCRIPTION TERMINATION; ESCHERICHIA-COLI; (GUANINE-7-)METHYLTRANSFERASE COMPLEX; GUANYLATE INTERMEDIATE; EARLY GENES; GUANYLYLTRANSFERASE; VIRIONS; ASSOCIATION; SUBUNITS	Vaccinia virus capping enzyme, a heterodimer of 95-kDa and 33-kDa subunits, modifies the 5' RNA end and also acts as a transcription termination factor during synthesis of viral early mRNAs. Termination occurs in response to a specific signal, UUUUUNU, in the nascent RNA chain. We now report that purified capping enzyme binds to defined RNAs in solution to form complexes that are stable during native gel electrophoresis. Multiple enzyme molecules can bind to a single RNA. No particular 5' end structure is required for RNA binding, suggesting that the observed protein-RNA interaction is unrelated to the triphosphatase, guanylyltransferase, or methyltransferase functions of capping enzyme. Although binding does not require a UUUUUNU element in the RNA, complex formation is competed preferentially by poly(U) compared to poly(C). Capping enzyme binds to the synthetic 30-mer homopolymers to form a single protein-RNA complex; affinity for U-30 is 10-fold higher than for A-30. The sites of protein-RNA contact, as detected by UV cross-linking, are located predominantly within the 95-kDa capping enzyme subunit, which is itself sufficient to bind and cross-link to RNA in the absence of the small subunit.			LUO, Y (corresponding author), SLOAN KETTERING INST CANC RES,MOLEC BIOL PROGRAM,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042498] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 42498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CONG PJ, 1993, J BIOL CHEM, V268, P7256; CONG PJ, 1992, J BIOL CHEM, V267, P16424; GUO PX, 1990, P NATL ACAD SCI USA, V87, P4023, DOI 10.1073/pnas.87.11.4023; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; HIGMAN MA, 1992, J BIOL CHEM, V267, P16430; LUO Y, 1991, J BIOL CHEM, V266, P13303; LUO Y, 1991, VIROLOGY, V185, P432, DOI 10.1016/0042-6822(91)90793-B; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; MOSS B, 1976, VIROLOGY, V72, P341, DOI 10.1016/0042-6822(76)90163-X; NILES EG, 1989, VIROLOGY, V172, P513, DOI 10.1016/0042-6822(89)90194-3; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROTH MJ, 1984, J BIOL CHEM, V259, P3488; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1990, J BIOL CHEM, V265, P11967; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; SHUMAN S, 1989, J BIOL CHEM, V264, P9690; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; TOYAMA R, 1983, EMBO J, V2, P2195, DOI 10.1002/j.1460-2075.1983.tb01723.x; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VOS JC, 1991, EMBO J, V10, P2553, DOI 10.1002/j.1460-2075.1991.tb07795.x; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	26	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21253	21262						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407963				2022-12-27	WOS:A1993MA28800090
J	MAHAFFEY, D; YOO, Y; RECHSTEINER, M				MAHAFFEY, D; YOO, Y; RECHSTEINER, M			UBIQUITIN METABOLISM IN CYCLING XENOPUS EGG EXTRACTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT RETICULOCYTE LYSATE; ACTIVATING ENZYME; CELL-CYCLE; PROTEIN; DEGRADATION; PURIFICATION; RESOLUTION; MECHANISM; PROTEASES; RECEPTOR	Xenopus egg extract is capable of supporting mitosis in vitro, which makes it ideal for biochemical analysis of the cell cycle. Since several studies have implicated the ubiquitin system in cell cycle progression, we have measured ubiquitin conjugation rates, proteolysis of ubiquitin-lysozyme conjugates, and rates of isopeptidase activity in cycling Xenopus egg extracts. Although ubiquitin conjugation in cytostatic factor arrested extract was half that in activated extract, there were no changes in rates of ubiquitin conjugation during the cell cycle. Ubiquitin conjugates are degraded by a 26 S ATP-stimulated protease. The ability of the 26 S protease to degrade ubiquitin-lysozyme conjugates and a fluorigenic peptide also remained constant across the cell cycle. In contrast to previously characterized systems, isopeptidase activity in Xenopus egg extract is energy-dependent. Glycerol gradient fractionation of Xenopus egg extract separated two ATP-dependent isopeptidases. One co-sedimented with the 26 S protease; the other sedimented slower and was not associated with any additional proteolytic activity. As found for rates of Ub conjugation and conjugate proteolysis, there was little or no variation in isopeptidase activity during the cell cycle.	UNIV UTAH,SCH MED,DEPT BIOCHEM,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah					NATIONAL CANCER INSTITUTE [T32CA009602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027159] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA09602] Funding Source: Medline; NIGMS NIH HHS [GM 27159] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1992, CURRENT PROTOCOLS MO; BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; DEVERAUX Q, 1990, J BIOL CHEM, V265, P6323; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GONDA DK, 1989, J BIOL CHEM, V264, P16700; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HADARI T, 1992, J BIOL CHEM, V267, P719; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HOUGH R, 1986, J BIOL CHEM, V261, P2391; KANADA F, 1986, BIOCHIM BIOPHYS ACTA, V870, P64; KAWAHARA H, 1992, FEBS LETT, V310, P119, DOI 10.1016/0014-5793(92)81310-I; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; MORI S, 1992, J BIOL CHEM, V267, P6429; MUELLER RD, 1985, J BIOL CHEM, V260, P5147; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1992, J BIOL CHEM, V267, P14418; RECHSTEINER MC, 1971, J IMMUNOL, V107, P985; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6	32	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21205	21211						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407956				2022-12-27	WOS:A1993MA28800083
J	ROHER, AE; LOWENSON, JD; CLARKE, S; WOLKOW, C; WANG, R; COTTER, RJ; REARDON, IM; ZURCHERNEELY, HA; HEINRIKSON, RL; BALL, MJ; GREENBERG, BD				ROHER, AE; LOWENSON, JD; CLARKE, S; WOLKOW, C; WANG, R; COTTER, RJ; REARDON, IM; ZURCHERNEELY, HA; HEINRIKSON, RL; BALL, MJ; GREENBERG, BD			STRUCTURAL ALTERATIONS IN THE PEPTIDE BACKBONE OF BETA-AMYLOID CORE PROTEIN MAY ACCOUNT FOR ITS DEPOSITION AND STABILITY IN ALZHEIMERS-DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ISOASPARTYL METHYLTRANSFERASE; PRECURSOR PROTEIN; SENILE PLAQUES; ASPARTYL RESIDUES; CARBOXYL METHYLTRANSFERASES; NEUROFIBRILLARY TANGLES; HUMAN-ERYTHROCYTES; NEURONAL ORIGIN; CLEAVAGE SITE; ACID	The structure of beta-amyloid (betaA) from Alzheimer disease brains was examined to determine if post-translational modifications might be linked to the abnormal deposition of this peptide in the diseased tissue. The betaA peptides were isolated from the compact amyloid cores of neuritic plaques and separated from minor glycoprotein components by size-exclusion high-pressure liquid chromatography (HPLC). This parenchymal betaA has a maximal length of 42 residues, but shorter forms with ''ragged'' NH2 termini are also present. Tryptic peptide analysis revealed heterogeneity in the betaA1-5 and betaA6-16 peptides, each of which eluted as four peaks on reverse phase HPLC. Amino acid composition and sequence analyses, mass spectrometry, enzymatic methylation, and stereoisomer determinations revealed that these multiple peptide forms resulted from structural rearrangements of the aspartyl residues at betaA positions 1 and 7. The L-isoaspartyl form predominates at each of these positions, whereas the D-isoaspartyl, L-aspartyl, and D-aspartyl forms are present in lesser amounts. BetaA purified from the leptomeningeal microvasculature contains the same structural alterations as parenchymal, betaA, but is 2 residues shorter at its COOH terminus. Using two different purification protocols, and using a synthetic betaA1-42 peptide as a control, we show that these modifications arose endogenously and were not caused by the experimental manipulations. The abundance of structurally altered aspartyl residues may profoundly affect the conformation of the betaA protein within plaque cores and thus significantly impact normal catabolic processes designed to limit its deposition. These alterations may therefore contribute to the production and stability of beta-amyloid deposits in Alzheimer brain tissue.	UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PHARMACOL & MOLEC SCI, MIDDLE ATLANTIC MASS SPECTROMETRY LAB, BALTIMORE, MD 21205 USA; UPJOHN CO, LABS, CNS RES, KALAMAZOO, MI 49001 USA; OREGON HLTH SCI UNIV, DEPT PATHOL, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT NEUROL, PORTLAND, OR 97201 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; Pfizer; Oregon Health & Science University; Oregon Health & Science University	ROHER, AE (corresponding author), WAYNE STATE UNIV, SCH MED, DEPT ANAT & CELL BIOL, 540 E CANFIELD AVE, DETROIT, MI 48201 USA.		Lowenson, Jonathan/AAN-6768-2020; Wang, Rong/A-8721-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER; NIA NIH HHS [P30-AG08017] Funding Source: Medline; NIGMS NIH HHS [GM-26020] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; ARAI H, 1990, P NATL ACAD SCI USA, V87, P2249, DOI 10.1073/pnas.87.6.2249; ASWAD DW, 1987, TRENDS BIOCHEM SCI, V12, P155, DOI 10.1016/0968-0004(87)90073-9; ASWAD DW, 1984, ANAL BIOCHEM, V137, P405, DOI 10.1016/0003-2697(84)90106-4; Ball M J, 1988, Alzheimer Dis Assoc Disord, V2, P29, DOI 10.1097/00002093-198802010-00004; BRUNAUER LS, 1986, J BIOL CHEM, V261, P2538; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CATALDO AM, 1990, BRAIN RES, V513, P181, DOI 10.1016/0006-8993(90)90456-L; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CHEVRIER MR, 1991, RAPID COMMUN MASS SP, V5, P611, DOI 10.1002/rcm.1290051209; CLARKE S, 1985, ANNU REV BIOCHEM, V54, P479, DOI 10.1146/annurev.bi.54.070185.002403; COTTER RJ, 1988, ANAL CHEM, V60, pA781, DOI 10.1021/ac00164a002; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; CRAS P, 1990, AM J PATHOL, V137, P241; CUMMINGS BJ, 1992, NEUROSCIENCE, V48, P763, DOI 10.1016/0306-4522(92)90265-4; DEWJI NN, 1990, J MOL NEUROSCI, V2, P19, DOI 10.1007/BF02896922; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FISHER GH, 1992, BRAIN RES BULL, V28, P127, DOI 10.1016/0361-9230(92)90239-T; GALLETTI P, 1989, INT J PEPT PROT RES, V33, P397; GEIGER T, 1987, J BIOL CHEM, V262, P785; GILBERT JM, 1988, BIOCHEMISTRY-US, V27, P5227, DOI 10.1021/bi00414a042; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GREENBERG BD, 1991, ANNU REP MED CHEM, V26, P229; GUIROY DC, 1987, P NATL ACAD SCI USA, V84, P2073, DOI 10.1073/pnas.84.7.2073; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; JOACHIM C, 1991, AM J PATHOL, V138, P373; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KAWAI M, 1992, AM J PATHOL, V140, P947; KLIER FG, 1990, BRAIN RES, V515, P336, DOI 10.1016/0006-8993(90)90619-M; KLUNK WE, 1990, J NEUROCHEM, V54, P2050, DOI 10.1111/j.1471-4159.1990.tb04910.x; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357; MACLAREN DC, 1992, IN PRESS GENOMICS; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCFADDEN PN, 1982, P NATL ACAD SCI-BIOL, V79, P2460, DOI 10.1073/pnas.79.8.2460; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; MCGEER PL, 1991, BRAIN RES, V544, P315, DOI 10.1016/0006-8993(91)90071-3; MEINWALD YC, 1986, INT J PEPT PROT RES, V28, P79; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; MORI H, 1992, J BIOL CHEM, V267, P17082; MURPHY GM, 1991, NEUROSCI LETT, V131, P100, DOI 10.1016/0304-3940(91)90346-U; MURRAY ED, 1984, J BIOL CHEM, V259, P722; MURTOMAKI S, 1992, J NEUROSCI RES, V32, P261, DOI 10.1002/jnr.490320216; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; ORLANDO R, 1992, BIOCHEM BIOPH RES CO, V184, P686, DOI 10.1016/0006-291X(92)90644-Z; OTA IM, 1988, BIOCHEM BIOPH RES CO, V151, P1136, DOI 10.1016/S0006-291X(88)80484-4; PARDRIDGE WM, 1987, J NEUROCHEM, V49, P1394, DOI 10.1111/j.1471-4159.1987.tb01005.x; PAYAN IL, 1992, NEUROCHEM RES, V17, P187, DOI 10.1007/BF00966798; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PETSKO GA, 1992, SCIENCE, V256, P1403, DOI 10.1126/science.1604313; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; ROHER A, 1986, P NATL ACAD SCI USA, V83, P2662, DOI 10.1073/pnas.83.8.2662; SEKOE DJ, 1988, J NEUROCHEM, V46, P1820; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; SHAPIRA R, 1988, J NEUROCHEM, V50, P69, DOI 10.1111/j.1471-4159.1988.tb13231.x; SHOJI M, 1990, BRAIN RES, V512, P164, DOI 10.1016/0006-8993(90)91187-L; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMYTH DG, 1962, J BIOL CHEM, V237, P1845; SNOW AD, 1988, AM J PATHOL, V133, P456; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TORGERSON DF, 1974, BIOCHEM BIOPH RES CO, V60, P616, DOI 10.1016/0006-291X(74)90285-X; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; WANG R, 1991, J BIOL CHEM, V266, P16960; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	81	713	732	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3072	3083						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428986				2022-12-27	WOS:A1993KM16100013
J	LORENZ, P; PEPPERKOK, R; ANSORGE, W; PYERIN, W				LORENZ, P; PEPPERKOK, R; ANSORGE, W; PYERIN, W			CELL BIOLOGICAL STUDIES WITH MONOCLONAL AND POLYCLONAL ANTIBODIES AGAINST HUMAN CASEIN KINASE-II SUBUNIT-BETA DEMONSTRATE PARTICIPATION OF THE KINASE IN MITOGENIC SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; SERUM RESPONSE FACTOR; DNA-BINDING ACTIVITY; PROTEIN-KINASE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; ALPHA; MICROINJECTION; TRANSCRIPTION	Casein kinase II (CKII) is a highly conserved ubiquitous serine/threonine kinase composed of two catalytically active (alpha and/or alpha') and two regulatory (beta) subunits. It has been suspected that, among numerous other cellular functions, CKII might play a role in the control of mitogenic signaling. To test for such a role and its mechanism in intact cells, monoclonal antibodies (mAbs) were generated against CKIIbeta using a recombinant protein containing amino acids 20-200 of human CKIIbeta. The CKIIbeta-specific mAb with the highest reactivity, mAb IVG6 (classified as IgG1 with kappa light chains), was purified to homogeneity. It recognized a CKIIbeta epitope comprising the amino acids 140-156, a basic and highly conserved region. In addition, polyclonal antibodies (pAbs) were raised and made monospecific by affinity purification. pAbs-mediated quantitative immunofluorescence microscopy of human IMR-90 fibroblasts and/or Western blots of cell fractions revealed (i) CKIIbeta was present in exponentially growing cells at a 2-3-fold higher level than in quiescent cells, (ii) CKIIbeta was localized predominantly in the nucleus of cells (3-15-fold cytoplasmic level depending on cellular state and assay used), and (iii) the nuclear/cytoplasmic ratio of CKIIbeta was higher by a factor of 2 in exponentially growing cells. Consequently, mitogenic stimulation of quiescent cells by fetal calf serum doubled the nuclear/cytoplasmic ratio of CKIIbeta. The increase occurred within the 1st h of stimulation. The translocation of CKIIbeta into the nucleus was inhibited when mAb IVG6 was injected into the cytoplasm at the time of mitogenic stimulation. This microinjection also significantly inhibited the cell proliferation. The data imply that cytoplasmic CKII participates in the transmission of mitogenic signals by translocation into the nucleus.	GERMAN CANC RES CTR, W-6900 HEIDELBERG, GERMANY; EUROPEAN MOLEC BIOL LAB, W-6900 HEIDELBERG, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)			Ansorge, Wilhelm/AAN-8780-2020	Lorenz, Peter A./0000-0001-7925-1002				ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; ANSORGE W, 1988, J BIOCHEM BIOPH METH, V16, P283, DOI 10.1016/0165-022X(88)90062-0; BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARROLL D, 1989, J BIOL CHEM, V264, P7345; COCHET C, 1983, J BIOL CHEM, V258, P1403; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P5367; FILHOL O, 1991, BIOCHEMISTRY-US, V30, P11133, DOI 10.1021/bi00110a016; FILHOL O, 1990, BIOCHEMISTRY-US, V29, P9928, DOI 10.1021/bi00494a025; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GAUTHIERROUVIERE C, 1991, EMBO J, V10, P2921, DOI 10.1002/j.1460-2075.1991.tb07842.x; GRANKOWSKI N, 1991, EUR J BIOCHEM, V198, P25, DOI 10.1111/j.1432-1033.1991.tb15982.x; HELLERHARRISON RA, 1991, J BIOL CHEM, V266, P14435; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x; JAKOBI R, 1989, EUR J BIOCHEM, V183, P227, DOI 10.1111/j.1432-1033.1989.tb14917.x; KATNIK I, 1987, J IMMUNOL METHODS, V102, P279, DOI 10.1016/0022-1759(87)90087-1; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefkovits I, 1979, IMMUNOLOGICAL METHOD, V1, P355; LIN WJ, 1991, J BIOL CHEM, V266, P5664; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; Maniatis T., 1982, MOL CLONING; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; MOLINA E, 1991, BIOCHEM J, V277, P811, DOI 10.1042/bj2770811; MULNERLORILLON O, 1990, EUR J BIOCHEM, V193, P529, DOI 10.1111/j.1432-1033.1990.tb19368.x; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; PEPPERKOK R, 1991, EXP CELL RES, V197, P245, DOI 10.1016/0014-4827(91)90429-X; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PYERIN W, 1987, BIOL CHEM H-S, V368, P215, DOI 10.1515/bchm3.1987.368.1.215; PYERIN W, 1988, BIOL CHEM H-S, V369, P896; PYERIN W, 1992, RECENT ADV CELL MOL, V4, P86; PYERIN W, 1992, IN PRESS ANN NY ACAD; REMAUT E, 1983, GENE, V22, P103, DOI 10.1016/0378-1119(83)90069-0; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; SCHNEPPENHEIM R, 1987, EUR J CLIN MICROBIOL, V6, P49, DOI 10.1007/BF02097190; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SONDERGARDANDERSEN J, 1990, J IMMUNOL METHODS, V131, P99, DOI 10.1016/0022-1759(90)90238-Q; STREBEL K, 1986, J VIROL, V57, P983, DOI 10.1128/JVI.57.3.983-991.1986; TUAZON PT, 1991, ADV 2ND MESSENGER PH, V23, P123; WESTERWOUDT RJ, 1986, METHOD ENZYMOL, V121, P3; YU IJ, 1991, J CELL BIOL, V114, P1217, DOI 10.1083/jcb.114.6.1217	56	132	132	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2733	2739						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428947				2022-12-27	WOS:A1993KK81500071
J	STROUS, GJ; VAN KERKHOF, P; VAN MEER, G; RIJNBOUTT, S; STOORVOGEL, W				STROUS, GJ; VAN KERKHOF, P; VAN MEER, G; RIJNBOUTT, S; STOORVOGEL, W			DIFFERENTIAL-EFFECTS OF BREFELDIN-A ON TRANSPORT OF SECRETORY AND LYSOSOMAL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUGH ENDOPLASMIC-RETICULUM; GOLGI-COMPLEX; CELL-SURFACE; NETWORK; OLIGOMERIZATION; SPHINGOMYELIN; ACCUMULATION; CISTERNAE; APPARATUS; ENDOSOMES	Brefeldin A (BFA) rapidly blocks anterograde exocytotic transport through the Golgi complex. Sustained retrograde traffic induced by brefeldin A causes redistribution of constituents of the Golgi, but not the trans-Golgi network (TGN), to the endoplasmic reticulum (ER). In the present study on HepG2 cells, we have observed a differential effect of BFA on transport from the TGN of two soluble proteins: alpha1-antitrypsin as a representative of secretory proteins and cathepsin D as a prototype of lysosomal enzymes. The Golgi complex of HepG2 cells is sensitive to BFA, as within minutes after its addition nearly all activity of three resident Golgi enzymes was recovered in the ER as monitored by cell fractionation on sucrose density gradients. In accordance with this, ''high mannose''-glycosylated alpha1-antitrypsin was retained in or transported back to the ER. ''Complex''-glycosylated al-antitrypsin was neither secreted into the medium nor transported back to the ER. Most of it was retained in vesicles with the buoyant density of Golgi. These vesicles contained the fluid phase endocytotic marker horseradish peroxidase when this was added to the culture medium prior to the BFA, suggesting that the vesicles derived from the TGN. After BFA addition, the compartment became inaccessible to endocytosed horseradish peroxidase. In contrast to blocking transport of complex alpha1-antitrypsin, BFA did not affect processing of newly synthesized complex-glycosylated procathepsin D (53 kDa) to the mature 31-kDa form. Neither did it interfere with processing of endocytosed procathepsin D. That the mature cathepsin D had indeed reached the lysosomes was verified by Percoll density gradient fractionation. In conclusion, in HepG2 cells, BFA induces two blocks in the secretory pathway: one at the level of the ER-Golgi juncture and the other in the TGN. In contrast, transport from the Golgi complex to the lysosomes and from the plasma membrane to the lysosomes continued.			STROUS, GJ (corresponding author), UNIV UTRECHT, AZU,DEPT CELL BIOL,CELL BIOL LAB, HEIDELBERGLAAN 100, ROOM H02314, 3584 CX UTRECHT, NETHERLANDS.		van Meer, Gerrit/AAH-1560-2021	van Kerkhof, Peter/0000-0002-8954-2230; van Meer, Gerrit/0000-0002-5976-6436				BRAULKE T, 1988, BIOL CHEM H-S, V369, P441, DOI 10.1515/bchm3.1988.369.1.441; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; DEKKER J, 1990, J BIOL CHEM, V265, P18116; DEMKE H, 1991, J BIOL CHEM, V266, P24829; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LODISH HF, 1987, J CELL BIOL, V104, P221, DOI 10.1083/jcb.104.2.221; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; MISUMI Y, 1990, J BIOL CHEM, V265, P2178; NILSSON B, 1979, J BIOL CHEM, V254, P4545; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; RIJNBOUTT S, 1992, J BIOL CHEM, V267, P15665; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; STOORVOGEL W, 1991, J BIOL CHEM, V266, P5438; STOORVOGEL W, 1988, J CELL BIOL, V106, P1821, DOI 10.1083/jcb.106.6.1821; STROUS GJ, 1991, BIOL CELL, V71, P25, DOI 10.1016/0248-4900(91)90048-R; STROUS GJAM, 1982, J BIOL CHEM, V257, P7623; TAKATSUKI A, 1985, AGR BIOL CHEM TOKYO, V49, P899, DOI 10.1080/00021369.1985.10866826; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	35	73	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2341	2347						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428908				2022-12-27	WOS:A1993KK81500017
J	GUARNIERI, FG; ARTERBURN, LM; PENNO, MB; CHA, Y; AUGUST, JT				GUARNIERI, FG; ARTERBURN, LM; PENNO, MB; CHA, Y; AUGUST, JT			THE MOTIF TYR-X-X-HYDROPHOBIC RESIDUE MEDIATES LYSOSOMAL MEMBRANE TARGETING OF LYSOSOME-ASSOCIATED MEMBRANE PROTEIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS; CELL-SURFACE GLYCOPROTEINS; CYTOPLASMIC DOMAIN; ACID-PHOSPHATASE; PLASMA-MEMBRANE; CDNA SEQUENCE; RECEPTOR; ANTIGEN; INTERNALIZATION; PURIFICATION	We have investigated the mechanism by which LAMP-1, a principal protein of the lysosomal membrane, is targeted to lysosomes. Mutagenesis and transfection experiments indicate that the motif Tyr-X-X-hydrophobic residue at the carboxyl terminus of the 11-amino acid cytoplasmic tail of the protein constitutes the lysosomal targeting signal for LAMP-1. This motif directs CD44, a cell surface hyaluronate receptor, to the lysosomal membrane, but only when the signal is placed at the the carboxyl-terminus of a truncated cytoplasmic tail. The signal did not confer lysosomal targeting when it was situated internally or at the carboxyl terminus of the normal CD44 cytoplasmic tail. An apparent paradox is that similar Tyr-containing sequences mediate internalization, but not lysosomal targeting, of several receptors. Of possible relevance is the additional finding that purified LAMP-1 protein lacks the two carboxyl-terminal residues predicted by cDNA, both of which are essential for proper trafficking. A model is proposed in which lysosomal targeting is distinguished from receptor internalization through proteolytic modification of the internalization signal.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOLEC SCI,725 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007626] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA4618] Funding Source: Medline; NICHD NIH HHS [N01-HD-6-2915] Funding Source: Medline; NIGMS NIH HHS [5.T32.GM07626] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTERBURN LM, 1990, J BIOL CHEM, V265, P7419; AZORSA DO, 1991, BLOOD, V78, P280; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHA Y, 1990, J BIOL CHEM, V265, P5008; CHEN JW, 1988, J BIOL CHEM, V263, P8754; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DSOUZA MP, 1986, ARCH BIOCHEM BIOPHYS, V249, P522, DOI 10.1016/0003-9861(86)90030-5; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; GOTTSCHALK S, 1989, EMBO J, V8, P3215, DOI 10.1002/j.1460-2075.1989.tb08480.x; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HOTTA H, 1988, CANCER RES, V48, P2955; HUGHES EN, 1981, J BIOL CHEM, V256, P664; HUGHES EN, 1983, J BIOL CHEM, V258, P1014; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIPPICOTTSCHWAR.J, 1987, CELL, V49, P699; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; MENGOD G, 1981, ARCH BIOCHEM BIOPHYS, V209, P718, DOI 10.1016/0003-9861(81)90335-0; METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8749, DOI 10.1093/nar/13.24.8749; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WOLFFE EJ, 1990, J BIOL CHEM, V265, P341	37	154	157	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1941	1946						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420968				2022-12-27	WOS:A1993KH62000068
J	OHTSU, T; KATAGIRI, C; KIMURA, MT; HORI, SH				OHTSU, T; KATAGIRI, C; KIMURA, MT; HORI, SH			COLD ADAPTATIONS IN DROSOPHILA - QUALITATIVE CHANGES OF TRIACYLGLYCEROLS WITH RELATION TO OVERWINTERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; DIAPAUSE	Triacylglycerols are the major fuel for basal metabolism during the winter in temperate species of the Drosophila melanogaster species group. Differential scanning calorimetry analysis revealed that the transition temperatures of triacylglycerols were lower in diapausing adults than in reproducing ones, and also lower in species or strains adapted to cooler climates than those adapted to warmer climates. These phenomena were correlated to the fatty acid compositions of the triacylglycerols; the proportion of unsaturated fatty acids in the triacylglycerols was higher in the diapausing individuals, and in the species or strains adapted to cooler climates. Furthermore, in the temperate species of the montium species subgroup (D. subauraria, D. biauraria, D. triauraria, and D. rufa), the amount of saturated triacylglycerols was smaller than the value expected on the assumption that fatty acids are randomly distributed in the triacylglycerols, suggesting the nonrandom distribution of unsaturated fatty acids among triacylglycerols. This may facilitate the lowering of the transition temperature of triacylglycerols, and hence may be related to the ability of Drosophila to cope with temperate climates.	HOKKAIDO UNIV,FAC SCI,DEPT ZOOL,SAPPORO,HOKKAIDO 060,JAPAN; HOKKAIDO UNIV,INST LOW TEMP SCI,BIOCHEM LAB,SAPPORO,HOKKAIDO 060,JAPAN	Hokkaido University; Hokkaido University								ADEDOKUN TA, 1985, J INSECT PHYSIOL, V31, P229, DOI 10.1016/0022-1910(85)90124-6; ALFORD JA, 1961, J FOOD SCI, V26, P518, DOI 10.1111/j.1365-2621.1961.tb00399.x; GOLDSON SL, 1981, NEW ZEAL J ZOOL, V8, P79, DOI 10.1080/03014223.1981.10427943; Harwood R. F., 1965, Journal of Insect Physiology, V11, P711, DOI 10.1016/0022-1910(65)90153-8; HIRSCH J, 1958, J BIOL CHEM, V233, P311; IWAO Y, 1980, Kontyu, V48, P160; KATAGIRI C, 1985, J BIOL CHEM, V260, P3490; Kimura MT, 1988, FUNCT ECOL, V2, P177, DOI 10.2307/2389693; KIMURA MT, 1992, J INSECT PHYSIOL, V38, P871, DOI 10.1016/0022-1910(92)90098-X; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; KIMURA MT, 1984, PHYSIOL ENTOMOL, V9, P425, DOI 10.1111/j.1365-3032.1984.tb00784.x; KISHIMOTO Y, 1972, METHODS NEUROCHEMIST, V3, P75; KUTHIALA A, 1989, ARCH INSECT BIOCHEM, V12, P123, DOI 10.1002/arch.940120206; LAMBREMONT EDWARD N., 1964, ANN ENTOMOL SOC AMER, V57, P526; Lemeunier F., 1986, P147; OHTSU T, 1992, J COMP PHYSIOL B, V162, P203, DOI 10.1007/BF00357524; PULLIN AS, 1987, J ZOOL, V211, P631, DOI 10.1111/j.1469-7998.1987.tb04476.x; SCHAEFER CH, 1969, J INSECT PHYSIOL, V15, P395, DOI 10.1016/0022-1910(69)90287-X; SEBEDIO JL, 1985, LIPIDS, V20, P555, DOI 10.1007/BF02534899; STANLEYSAMUELSON DW, 1985, COMP BIOCHEM PHYS B, V81, P749, DOI 10.1016/0305-0491(85)90399-2; SUGIURA M, 1975, CHEM PHARM BULL, V23, P1226; SUIGIURA M, 1984, LIPASES, P505; VALDER SM, 1969, J INSECT PHYSIOL, V15, P1199, DOI 10.1016/0022-1910(69)90230-3	23	71	72	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1830	1834						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420958				2022-12-27	WOS:A1993KH62000052
J	SZTUL, E; COLOMBO, M; STAHL, P; SAMANTA, R				SZTUL, E; COLOMBO, M; STAHL, P; SAMANTA, R			CONTROL OF PROTEIN TRAFFIC BETWEEN DISTINCT PLASMA-MEMBRANE DOMAINS - REQUIREMENT FOR A NOVEL 108,000 PROTEIN IN THE FUSION OF TRANSCYTOTIC VESICLES WITH THE APICAL PLASMA-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; GTP-BINDING PROTEIN; CANINE KIDNEY-CELLS; TRANS-CELLULAR TRANSPORT; RAT-LIVER; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; SECRETORY COMPONENT; IGA RECEPTOR; MORPHOLOGICAL CHARACTERIZATION	We have developed a cell-free system that reconstitutes the last step in transcytosis, i.e. the fusion of transcytotic transport vesicles with the apical plasma membrane (PM). Subcellular fractions containing transcytotic vesicles (the donor) or apical PM (the acceptor) were prepared from rat liver by sucrose density centrifugation. Fusion between the donor and acceptor fractions was measured by the conversion of the 120,000 transmembrane form of the polymeric IgA receptor (pIgA-R), an endogenous protein of transcytotic vesicles, to a processed fragment by a protease endogenous to the apical PM. Fusion occurred only at 37-degrees-C and was critically dependent on the presence of ATP and cytosol. Fusion was inhibited by treating the in vitro fusion reaction with N-ethylmaleimide or by adding antibodies against N-ethylmaleimide-sensitive factor (NSF). We have previously identified a specific transcytotic vesicle-associated protein (TAP) and here show that TAP exists in both cytosolic and membrane-associated pools. Because of its exclusive interaction with transcytotic vesicles, we tested the involvement of TAP in distinct fusion processes. Removal of TAP inhibited fusion in an in vitro transcytotic fusion reaction but had no inhibitory effect in an in vitro endosome-endosome fusion system or in an in vitro intra-Golgi transport reaction. We propose that TAP represents part of the molecular machinery specifically involved in targeting and/or fusion of transcytotic vesicles with the apical PM.	WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	SZTUL, E (corresponding author), PRINCETON UNIV, DEPT MOLEC BIOL, PRINCETON, NJ 08544 USA.							ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DAVEY J, 1985, CELL, V43, P643, DOI 10.1016/0092-8674(85)90236-3; DECURTIS I, 1988, P NATL ACAD SCI USA, V85, P8052, DOI 10.1073/pnas.85.21.8052; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; DIAZ R, 1988, J BIOL CHEM, V263, P6093; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRUENBERG J, 1987, P NATL ACAD SCI USA, V84, P5758, DOI 10.1073/pnas.84.16.5758; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; HOPPE CA, 1985, J CELL BIOL, V101, P2113, DOI 10.1083/jcb.101.6.2113; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; JACKSON GDF, 1978, EUR J IMMUNOL, V8, P123, DOI 10.1002/eji.1830080210; LARKIN JM, 1986, P NATL ACAD SCI USA, V83, P4759, DOI 10.1073/pnas.83.13.4759; MATLIN K, 1983, J CELL BIOL, V97, P627, DOI 10.1083/jcb.97.3.627; MAYORGA LS, 1989, J BIOL CHEM, V264, P5392; MAYORGA LS, 1989, CELL REGUL, V1, P113, DOI 10.1091/mbc.1.1.113; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; MULLOCK BM, 1980, FEBS LETT, V120, P278, DOI 10.1016/0014-5793(80)80316-4; MUSIL LS, 1987, J CELL BIOL, V104, P1725, DOI 10.1083/jcb.104.6.1725; MUSIL LS, 1988, J BIOL CHEM, V263, P15799; NAIR J, 1990, J CELL BIOL, V110, P1897, DOI 10.1083/jcb.110.6.1897; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; PESONEN M, 1983, J CELL BIOL, V97, P638, DOI 10.1083/jcb.97.3.638; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROMAN LM, 1984, J CELL BIOL, V98, P1497, DOI 10.1083/jcb.98.4.1497; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; SCHAERER E, 1990, J CELL BIOL, V110, P987, DOI 10.1083/jcb.110.4.987; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SZTUL E, 1991, CELL, V64, P81, DOI 10.1016/0092-8674(91)90210-P; SZTUL ES, 1985, J CELL BIOL, V100, P1248, DOI 10.1083/jcb.100.4.1248; SZTUL ES, 1985, J CELL BIOL, V100, P1255, DOI 10.1083/jcb.100.4.1255; SZTUL ES, 1983, J CELL BIOL, V97, P1582, DOI 10.1083/jcb.97.5.1582; TOOZE SA, 1990, NATURE, V347, P207, DOI 10.1038/347207a0; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WATTENBERG B W, 1990, New Biologist, V2, P505; WILSON DW, 1992, METHOD ENZYMOL, V219, P309; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531	60	74	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1876	1885						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420962				2022-12-27	WOS:A1993KH62000059
J	THORBURN, A; THORBURN, J; CHEN, SY; POWERS, S; SHUBEITA, HE; FERAMISCO, JR; CHIEN, KR				THORBURN, A; THORBURN, J; CHEN, SY; POWERS, S; SHUBEITA, HE; FERAMISCO, JR; CHIEN, KR			HRAS-DEPENDENT PATHWAYS CAN ACTIVATE MORPHOLOGICAL AND GENETIC-MARKERS OF CARDIAC-MUSCLE CELL HYPERTROPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MYOCARDIAL-CELLS; ATRIAL-NATRIURETIC-FACTOR; PC12 CELLS; ADRENERGIC STIMULATION; INDUCIBLE EXPRESSION; GROWTH-FACTOR; T-ANTIGEN; DIFFERENTIATION; MICROINJECTION; TRANSFORMATION	We have investigated the role of the proto-oncogene HRas in cardiac cell growth and hypertrophy. By direct needle microinjection of activated Ras protein into primary neonatal rat ventricular cardiac myocytes, we find that, unlike many other cell types Ras does not induce DNA synthesis in these cells. However, injection of activated Ras does induce expression of both the c-Fos and atrial natriuretic factor (ANF) genes. Expression of both these genes is associated with the hypertrophic response in ventricular myocytes suggesting that Ras is involved in the hypertrophic signalling pathway. Ras injection also causes morphological changes in the cells so that they increase in profile and show changes in the organization of the contractile apparatus. Further support for a role for Ras in the hypertrophic response was obtained from studies showing that activated Ras stimulates ANF promoter activity in transient transfection assays. We also show that a dominant interfering Ras mutant inhibits the hypertrophic stimulation of the ANF promoter by phenylephrine, indicating a role for Ras in the hypertrophic effect of an alpha-adrenergic agonist.	UNIV CALIF SAN DIEGO, DEPT MED, 0613-C, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR CANC, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, AMER HEART ASSOC, BUGHER FDN CTR MOLEC BIOL, LA JOLLA, CA 92093 USA; UNIV MED & DENT NEW JERSEY, DEPT BIOCHEM, PISCATAWAY, NJ 08854 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rutgers State University New Brunswick; Rutgers State University Medical Center				Powers, Scott/0000-0003-2769-1932				BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FIELD LJ, 1988, SCIENCE, V239, P1029, DOI 10.1126/science.2964082; GROSS M, 1985, MOL CELL BIOL, V5, P1015, DOI 10.1128/MCB.5.5.1015; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LEE HR, 1988, J BIOL CHEM, V263, P7352; LONG CS, 1991, CELL REGUL, V2, P1081, DOI 10.1091/mbc.2.12.1081; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PAYNE PA, 1987, P NATL ACAD SCI USA, V84, P8956, DOI 10.1073/pnas.84.24.8956; POWERS S, 1989, MOL CELL BIOL, V9, P390, DOI 10.1128/MCB.9.2.390; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; SEN A, 1988, J BIOL CHEM, V263, P19132; SEREMETIS S, 1989, SCIENCE, V243, P660, DOI 10.1126/science.2536954; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SHUBEITA HE, 1992, CIRCULATION, V85, P2236, DOI 10.1161/01.CIR.85.6.2236; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J	26	204	207	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2244	2249						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420993				2022-12-27	WOS:A1993KH62000111
J	RAO, SI; WILKS, A; DEMONTELLANO, PRO				RAO, SI; WILKS, A; DEMONTELLANO, PRO			THE ROLES OF HIS-64, TYR-103, TYR-146, AND TYR-151 IN THE EPOXIDATION OF STYRENE AND BETA-METHYLSTYRENE BY RECOMBINANT SPERM WHALE MYOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; FERRYL MYOGLOBIN; LIGAND-BINDING; COMPOUND-I; HEME; SPECTROSCOPY; METMYOGLOBIN; ACID	Previous studies demonstrated that at least two mechanisms are involved in the epoxidation of styrene and stilbene by myoglobin and H2O2 (Ortiz de Montellano, P. R., and Catalano, C. E. (1985) J. Biol. Chem. 260, 9265-9271). One mechanism, reaction of the olefin with the ferryl oxygen, preserves the olefin stereochemistry and incorporates an oxygen from H2O2 into the epoxide. The second mechanism, proposed to be a protein-mediated co-oxidation process, results in loss of stereochemistry and incorporation of an atom of molecular oxygen. To examine the role of individual residues in olefin epoxidation, we have examined the catalytic activities of the possible Tyr --> Phe mutants, the His-64 --> Val mutant, and a protein combining all the tyrosine and histidine mutations. The latter protein is less stable than the other mutants and is the only one for which a protein radical is not detected in the reaction with H2O2. The K(m) and V(max) for styrene epoxidation range, respectively, from 0.3-8 mM and 12-35 pmol/min/nmol of protein. Incubation with (H2O2)-O-18 results in 20-30% incorporation of labeled oxygen into the epoxide with all the mutants except Y103F/Y151F, Y146F/Y151F, H64V, and H64V/Y103F/Y146F/Y151F, for which 52, 58, 89, and 96% of the epoxide oxygen, respectively, is labeled. Oxidation of cis-beta-methylstyrene by wild-type myoglobin yielded a 54:46 ratio of cis- and trans-beta-methylstyrene oxides. The cis-isomer accounts for 47-100% of the epoxide produced by the mutant hemoproteins, with the two H64V mutants yielding almost exclusively the cis-epoxide. The oxygen in the cis-epoxide derives primarily or exclusively from H2O2 and that in the trans-epoxide from an alternative source. These results indicate that tyrosine residues may participate in, but are not essential for, protein-mediated epoxidation. In contrast, His-64 appears to be essential for co-oxidative epoxidation because in its absence olefin epoxidation is mediated almost exclusively by ferryl oxygen transfer.	UNIV CALIF SAN FRANCISCO, SCH PHARM, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco					NCRR NIH HHS [RR01614] Funding Source: Medline; NIDDK NIH HHS [DK30297, P-50 DK26743] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297, P30DK026743] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLENTOFF AJ, 1993, IN PRESS J AM CHEM S; BOSSHARD HR, 1991, PEROXIDASES CHEM BIO, V2, P51; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CATALANO CE, 1987, BIOCHEMISTRY-US, V26, P8373, DOI 10.1021/bi00399a052; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1259, DOI 10.1021/bi00354a010; DAUTREVAUX M, 1969, EUR J BIOCHEM, V11, P267, DOI 10.1111/j.1432-1033.1969.tb00769.x; DAVIES MJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P86, DOI 10.1016/0167-4838(91)90529-9; DEMONTELLANO PRO, 1987, BIOCHEMISTRY-US, V26, P5310, DOI 10.1021/bi00391a014; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; EDMUNDSO.AB, 1965, NATURE, V205, P883, DOI 10.1038/205883a0; FOX JB, 1974, BIOCHEMISTRY-US, V13, P5178, DOI 10.1021/bi00722a020; FRUETEL JA, 1992, J AM CHEM SOC, V114, P6987, DOI 10.1021/ja00044a006; GALARIS D, 1989, BIOCHEM BIOPH RES CO, V160, P1162, DOI 10.1016/S0006-291X(89)80125-1; GARRISON JM, 1989, J AM CHEM SOC, V111, P4960, DOI 10.1021/ja00195a060; GIBSON JF, 1958, NATURE, V181, P1398, DOI 10.1038/1811398a0; HE GX, 1991, J AM CHEM SOC, V113, P5644, DOI 10.1021/ja00015a018; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KIMURA S, 1979, ARCH BIOCHEM BIOPHYS, V198, P580, DOI 10.1016/0003-9861(79)90534-4; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; KING NK, 1963, J BIOL CHEM, V238, P1520; Klebanoff S.J., 1991, PEROXIDASES CHEM BIO, P1; LABEQUE R, 1987, J AM CHEM SOC, V109, P2828, DOI 10.1021/ja00243a048; LAMAR GN, 1983, J AM CHEM SOC, V105, P782, DOI 10.1021/ja00342a022; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; MILLER VP, 1992, J BIOL CHEM, V267, P8936; MODI S, 1991, J CHEM SOC CHEM COMM, P830, DOI 10.1039/c39910000830; PHILLIPS GN, 1990, PROTEINS, V7, P358, DOI 10.1002/prot.340070407; RAJARATHNAM K, 1991, J AM CHEM SOC, V113, P7886, DOI 10.1021/ja00021a010; RICE RH, 1983, ARCH BIOCHEM BIOPHYS, V221, P417, DOI 10.1016/0003-9861(83)90160-1; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SITTER AJ, 1985, BIOCHIM BIOPHYS ACTA, V828, P229, DOI 10.1016/0167-4838(85)90301-2; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; TEW D, 1988, J BIOL CHEM, V263, P17880; TURNER JJO, 1991, BIOCHEM J, V277, P833, DOI 10.1042/bj2770833; UCHIDA K, 1989, BIOORG CHEM, V17, P330, DOI 10.1016/0045-2068(89)90035-7; UYEDA M, 1981, BIOCHEMISTRY-US, V20, P2028, DOI 10.1021/bi00510a045; WILBUR DJ, 1976, J BIOL CHEM, V251, P5187; WILKS A, 1992, J BIOL CHEM, V267, P8827; YONETANI T, 1967, J BIOL CHEM, V242, P1974	41	72	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					803	809						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419357				2022-12-27	WOS:A1993KG07700011
J	SCHODEL, F; PETERSON, D; ZHENG, J; JONES, JE; HUGHES, JL; MILICH, DR				SCHODEL, F; PETERSON, D; ZHENG, J; JONES, JE; HUGHES, JL; MILICH, DR			STRUCTURE OF HEPATITIS-B VIRUS CORE AND E-ANTIGEN - A SINGLE PRECORE AMINO-ACID PREVENTS NUCLEOCAPSID ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SIGNAL SEQUENCE; EXPRESSION; REGION; GENE; IMMUNOGENICITY; SECRETION; PROTEIN; DETERMINANTS; PARTICLES	The hepatitis B virus core gene codes for two polypeptides: the core protein, which assembles to form particles (HBcAg), and the secreted precore protein (HBeAg). Expression vectors directing the synthesis in Escherichia coli of a recombinant HBeAg corresponding in sequence to serum-derived HBeAg encompassing the 10 precore amino acids remaining after cleavage of the precursor and residues 1-149 of HBcAg (PC-HBeAg) were constructed. Recombinant PC-HBeAg, HBcAg, and C-terminally truncated HBcAg were isolated from E. coli and analyzed by sucrose velocity sedimentation, electron microscopy, anti-HBc/e specific monoclonal antibody analysis, and for immunogenicity. HBcAg and truncated HBcAg formed 27-nm particles and displayed HBc antigenicity. In contrast, PC-HBeAg was nonparticulate and did not band in sucrose gradients. PC-HBeAg was recognized efficiently by HBeAg-specific antibodies and displayed little HBc antigenicity. Immunogenicity studies including T and B cell recognition confirmed that PC-HBeAg demonstrates HBe antigenicity. The presence of the 10 precore amino acids therefore prevented particle formation. To analyze which precore amino acids might be responsible for the prevention of particle formation a cysteine to glutamine substitution at amino acid position -7 was introduced into PC-HBeAg (-7C-->Q)PC-HBeAg. This single amino acid change at position -7 restored particle formation and HBc antigenicity. The evolutionarily conserved cysteine at position -7 thus appears responsible for the prevention of particle assembly in the HBeAg biosynthesis pathway.	MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY; VIRGINIA COMMONWEALTH UNIV, DEPT BIOCHEM, RICHMOND, VA 23298 USA; SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	Max Planck Society; Virginia Commonwealth University; Scripps Research Institute			milich, david/W-6493-2019		NIAID NIH HHS [AI20720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020720] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BORISOVA GP, 1989, FEBS LETT, V259, P121, DOI 10.1016/0014-5793(89)81509-1; BRUSS V, 1988, VIROLOGY, V163, P268, DOI 10.1016/0042-6822(88)90266-8; CHANG C, 1987, J VIROL, V61, P3322, DOI 10.1128/JVI.61.10.3322-3325.1987; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; CLICK RE, 1972, CELL IMMUNOL, V3, P264, DOI 10.1016/0008-8749(72)90165-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; IMAI M, 1982, J IMMUNOL, V128, P69; JEANJEAN O, 1989, VIROLOGY, V170, P99, DOI 10.1016/0042-6822(89)90356-5; MACKAY P, 1981, J MED VIROL, V8, P237, DOI 10.1002/jmv.1890080404; MCLACHLAN A, 1987, J VIROL, V61, P683, DOI 10.1128/JVI.61.3.683-692.1987; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; MILICH DR, 1988, J IMMUNOL, V141, P3617; MILICH DR, 1987, J IMMUNOL, V139, P1223; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; MIMMS L, 1988, VIRAL HEPATITIS LIVE, P248; MIYANOHARA A, 1986, J VIROL, V59, P176, DOI 10.1128/JVI.59.1.176-180.1986; NASSAL M, 1992, J MOL BIOL, V225, P1013, DOI 10.1016/0022-2836(92)90101-O; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; ROOSSINCK MJ, 1986, MOL CELL BIOL, V6, P1393, DOI 10.1128/MCB.6.5.1393; Sambrook J, 1989, MOL CLONING LABORATO; SCHLICHT HJ, 1987, J VIROL, V61, P3701, DOI 10.1128/JVI.61.12.3701-3709.1987; SCHLICHT HJ, 1991, J VIROL, V65, P6817, DOI 10.1128/JVI.65.12.6817-6825.1991; SCHODEL F, 1992, J VIROL, V66, P106; SCHODEL F, 1989, INFECT IMMUN, V57, P1347; SCHODEL F, 1991, VACCINES, V91, P319; SCHODEL F, 1990, VACCINES, V90, P193; SCHODEL F, 1989, ADV VIRAL ONCOL, V8, P73; STAHL S, 1982, P NATL ACAD SCI-BIOL, V79, P1606, DOI 10.1073/pnas.79.5.1606; STAHL SJ, 1989, P NATL ACAD SCI USA, V86, P6283, DOI 10.1073/pnas.86.16.6283; STANDRING DN, 1988, P NATL ACAD SCI USA, V85, P8405, DOI 10.1073/pnas.85.22.8405; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; WEIMER T, 1987, J VIROL, V61, P3109, DOI 10.1128/JVI.61.10.3109-3113.1987; ZHENG J, 1992, J BIOL CHEM, V267, P9422	37	80	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1332	1337						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419335				2022-12-27	WOS:A1993KG07700085
J	DEPAMPHILIS, ML				DEPAMPHILIS, ML			ORIGINS OF DNA-REPLICATION IN METAZOAN CHROMOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIHYDROFOLATE-REDUCTASE DOMAIN; C-MYC GENE; DROSOPHILA-MELANOGASTER; AUTONOMOUS REPLICATION; MAMMALIAN-CELLS; NUCLEAR MATRIX; POLYOMA-VIRUS; CHO CELLS; CHROMATIN; INITIATION				DEPAMPHILIS, ML (corresponding author), ROCHE INST MOLEC BIOL, ROCHE RES CTR, NUTLEY, NJ 07110 USA.							ANACHKOVA B, 1989, MOL CELL BIOL, V9, P532, DOI 10.1128/MCB.9.2.532; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; BLOW JJ, 1990, J CELL SCI, V95, P383; BURHANS WC, 1986, BIOCHEMISTRY-US, V25, P441, DOI 10.1021/bi00350a025; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; BURHANS WC, 1986, P NATL ACAD SCI USA, V83, P7790, DOI 10.1073/pnas.83.20.7790; CARRI MT, 1986, EXP CELL RES, V164, P426, DOI 10.1016/0014-4827(86)90041-8; CARROLL SM, 1992, IN PRESS MOL CELL BI; COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; CUSICK ME, 1989, METHOD ENZYMOL, V170, P290; DELIDAKIS C, 1989, EMBO J, V8, P891, DOI 10.1002/j.1460-2075.1989.tb03450.x; DEPAMPHILIS ML, 1988, CANCER CELL, V6, P165; DEPAMPHILIS ML, 1992, IN PRESS C GES BIOL, V43; DEPAMPHILIS ML, 1993, IN PRESS ANN REV BIO; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; DIJKWEL PA, 1992, MOL CELL BIOL, V12, P3715, DOI 10.1128/MCB.12.9.3715; ECKDAHL TT, 1990, NUCLEIC ACIDS RES, V18, P1609, DOI 10.1093/nar/18.6.1609; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GILBERT D, 1989, CELL, V56, P143, DOI 10.1016/0092-8674(89)90885-4; GUO ZS, 1991, NUCLEIC ACIDS RES, V19, P7081, DOI 10.1093/nar/19.25.7081; HANDELI S, 1989, CELL, V57, P909, DOI 10.1016/0092-8674(89)90329-2; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; HECK MMS, 1990, J CELL BIOL, V110, P903, DOI 10.1083/jcb.110.4.903; HEINTZ NH, 1982, P NATL ACAD SCI-BIOL, V79, P4083, DOI 10.1073/pnas.79.13.4083; HEINTZ NH, 1988, MOL CELL BIOL, V8, P1923, DOI 10.1128/MCB.8.5.1923; HEINZEL SS, 1991, MOL CELL BIOL, V11, P2263, DOI 10.1128/MCB.11.4.2263; HELD PG, 1992, BIOCHIM BIOPHYS ACTA, V1130, P235, DOI 10.1016/0167-4781(92)90435-3; HENDRICKSON EA, 1987, EMBO J, V6, P2011, DOI 10.1002/j.1460-2075.1987.tb02465.x; HENDRICKSON EA, 1987, NUCLEIC ACIDS RES, V15, P6369, DOI 10.1093/nar/15.16.6369; HOFMANN JFX, 1991, CELL, V64, P951, DOI 10.1016/0092-8674(91)90319-T; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; KARPEN GH, 1990, CELL, V63, P97; KRUDE T, 1991, MOL CELL BIOL, V11, P6257, DOI 10.1128/MCB.11.12.6257; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; LANDRY S, 1991, BIOCHIM BIOPHYS ACTA, V1088, P234, DOI 10.1016/0167-4781(91)90059-U; LENO GH, 1992, CELL, V69, P151, DOI 10.1016/0092-8674(92)90126-W; LEU TH, 1989, MOL CELL BIOL, V9, P523, DOI 10.1128/MCB.9.2.523; LEU TH, 1992, MOL CELL BIOL, V12, P2804, DOI 10.1128/MCB.12.6.2804; LINSKENS MHK, 1990, CELL, V62, P845, DOI 10.1016/0092-8674(90)90258-G; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; MALKI A, 1992, NUCLEIC ACIDS RES, V20, P105, DOI 10.1093/nar/20.1.105; MCARTHUR JG, 1991, NUCLEIC ACIDS RES, V19, P2477, DOI 10.1093/nar/19.9.2477; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; MCWHINNEY C, 1990, NUCLEIC ACIDS RES, V18, P1233, DOI 10.1093/nar/18.5.1233; MEIER J, 1991, J CELL SCI, V98, P271; ORRWEAVER TL, 1991, BIOESSAYS, V13, P97, DOI 10.1002/bies.950130302; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; RIVIER DH, 1992, SCIENCE, V256, P659, DOI 10.1126/science.1585179; SANCHEZ JA, 1992, IN PRESS J CELL SCI; SHINOMIYA T, 1991, NUCLEIC ACIDS RES, V19, P3935, DOI 10.1093/nar/19.14.3935; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; SUGASAWA K, 1992, P NATL ACAD SCI USA, V89, P1055, DOI 10.1073/pnas.89.3.1055; UMEK RM, 1989, BIOCHIM BIOPHYS ACTA, V1007, P1, DOI 10.1016/0167-4781(89)90123-1; VASSILEV L, 1990, MOL CELL BIOL, V10, P4899, DOI 10.1128/MCB.10.9.4899; VASSILEV LT, 1992, CRIT REV BIOCHEM MOL, V27, P445, DOI 10.3109/10409239209082569; VASSILEV LT, 1990, MOL CELL BIOL, V10, P4685, DOI 10.1128/MCB.10.9.4685; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	61	100	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					1	4						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416916				2022-12-27	WOS:A1993KE60300001
J	HONG, L; SCHROTH, GP; MATTHEWS, HR; YAU, P; BRADBURY, EM				HONG, L; SCHROTH, GP; MATTHEWS, HR; YAU, P; BRADBURY, EM			STUDIES OF THE DNA-BINDING PROPERTIES OF HISTONE H4 AMINO TERMINUS - THERMAL-DENATURATION STUDIES REVEAL THAT ACETYLATION MARKEDLY REDUCES THE BINDING CONSTANT OF THE H4 TAIL TO DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONALLY ACTIVE CHROMATIN; LINKING NUMBER CHANGE; SILENT MATING LOCI; NUCLEOSOME; H-4; HYPERACETYLATION; ACTIVATION; REPRESSION; PEPTIDES; NEUTRON	The effect of acetylation on the DNA binding properties of the rigidly conserved histone H4 amino-terminal tail has been studied in detail using the technique of thermal denaturation. The quantitative DNA-binding parameters for both the non- and fully acetylated H4 amino terminus have been determined from thermal denaturation data for complexes of the peptides bound to mixed sequence 146-base pair DNA. We find that under dilute buffer conditions (5 mM Tris-HCl) the binding constant for the non-acetylated peptide to double-stranded DNA is 5 x 10(11) M-1 and that acetylation of lysine residues in the peptide reduces the binding constant to 1 x 10(5) M-1. The dramatic differences observed in the binding constants for the non- and fully acetylated peptides are probably due to the effect of acetylation on the even distribution of positively charged residues in the H4 amino terminus. In other experiments, the binding of both peptides to a 30-base pair oligonucleotide has been studied in solution with varying concentrations of sodium, magnesium, and phosphate ions. These experiments demonstrate that both magnesium and phosphate ions have strong effects on the binding of the H4 tail to DNA, especially weakening the binding of the acetylated peptide. For instance, the dissociation of the non-acetylated peptide from DNA requires 6 mM magnesium, yet the binding of the acetylated peptide is abolished in only 30 muM magnesium. The modulation of the DNA binding interactions of the H4 amino terminus by physiologically relevant ionic conditions, in addition to the effect of acetylation, can be important in the regulation of chromatin structure and function.	UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616; OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; LOS ALAMOS NATL LAB,DIV LIFE SCI,LOS ALAMOS,NM 87545	University of California System; University of California Davis; Oregon State University; United States Department of Energy (DOE); Los Alamos National Laboratory				Yau, Peter/0000-0002-1984-185X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026901] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEGRA P, 1987, J MOL BIOL, V196, P379, DOI 10.1016/0022-2836(87)90698-X; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BOHM L, 1981, EUR J BIOCHEM, V119, P67, DOI 10.1111/j.1432-1033.1981.tb05577.x; BRADBURY EM, 1981, DNA CHROMATIN CHROMO; CARY PD, 1982, EUR J BIOCHEM, V127, P137, DOI 10.1111/j.1432-1033.1982.tb06847.x; CHAHAL SS, 1980, NATURE, V287, P76, DOI 10.1038/287076a0; CHEN TA, 1987, P NATL ACAD SCI USA, V84, P5252, DOI 10.1073/pnas.84.15.5252; CHRISTENSEN ME, 1984, NUCLEIC ACIDS RES, V12, P4575, DOI 10.1093/nar/12.11.4575; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; DOVE WF, 1962, J MOL BIOL, V5, P467, DOI 10.1016/S0022-2836(62)80119-3; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; EBRALIDSE KK, 1988, NATURE, V331, P365, DOI 10.1038/331365a0; GATEWOOD JM, 1987, SCIENCE, V236, P962, DOI 10.1126/science.3576213; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HELENE C, 1981, CRC CR REV BIOCH MOL, V10, P213, DOI 10.3109/10409238109113600; IMAI BS, 1986, J BIOL CHEM, V261, P8784; JOHNS EW, 1967, BIOCHEM J, V105, P611, DOI 10.1042/bj1050611; JOHNSON EM, 1987, J BIOL CHEM, V262, P6943; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; MARVIN KW, 1990, J BIOL CHEM, V265, P19839; MCGHEE JD, 1976, BIOPOLYMERS, V15, P1345, DOI 10.1002/bip.1976.360150710; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MORGAN BA, 1991, MOL CELL BIOL, V11, P4111, DOI 10.1128/MCB.11.8.4111; MORGAN JE, 1986, ARCH BIOCHEM BIOPHYS, V246, P225, DOI 10.1016/0003-9861(86)90467-4; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; PERRY M, 1982, J BIOL CHEM, V257, P7336; REEVES R, 1984, BIOCHIM BIOPHYS ACTA, V782, P343, DOI 10.1016/0167-4781(84)90044-7; SCHROTH GP, 1990, FEBS LETT, V268, P117, DOI 10.1016/0014-5793(90)80987-T; SMITH RM, 1989, J BIOL CHEM, V264, P10574; WATERBORG JH, 1984, EUR J BIOCHEM, V142, P329, DOI 10.1111/j.1432-1033.1984.tb08290.x; WHITLOCK JP, 1977, J BIOL CHEM, V252, P6516; WOOD MJ, 1991, J BIOL CHEM, V266, P5696; YAU P, 1982, EUR J BIOCHEM, V129, P281, DOI 10.1111/j.1432-1033.1982.tb07050.x; ZHANG DE, 1988, BIOCHEM J, V250, P233, DOI 10.1042/bj2500233	37	308	314	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					305	314						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416938				2022-12-27	WOS:A1993KE60300047
J	NAGIEC, MM; WELLS, GB; LESTER, RL; DICKSON, RC				NAGIEC, MM; WELLS, GB; LESTER, RL; DICKSON, RC			A SUPPRESSOR GENE THAT ENABLES SACCHAROMYCES-CEREVISIAE TO GROW WITHOUT MAKING SPHINGOLIPIDS ENCODES A PROTEIN THAT RESEMBLES AN ESCHERICHIA-COLI FATTY ACYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; SHUTTLE VECTORS; YEAST; MEMBRANE; STRAINS; SEQUENCE; DNA; TRANSCRIPTION; MANIPULATION; ACTIVATION	Saccharomyces cerevisiae normally requires sphingolipid biosynthesis for growth; however, mutant strains lacking sphingolipids have been isolated by suppression of a genetic defect in sphingolipid long chain base biosynthesis. To begin to understand the nature of the suppressor(s) we isolated and characterized a suppressor gene, SLC1 (sphingolipid compensation). DNA sequence analysis showed that the wild type SLC1 allele differs from the suppressor allele by a single nucleotide which changes Gln-44 in the predicted wild type protein to Leu4-4 in the predicted SLC1-1 suppressor protein. The predicted SLC1 protein sequence is homologous to the 1-acyl-sn-glycerol-3-phosphate acyltransferase of Escherichia coli encoded by the plsC gene. The homology extends to function as well since the SLC1 gene complements the growth defect in an E. coli strain mutated in plsC. These results suggest that the SLC1 protein has a fatty acyltransferase activity. SLC1 thus may be the first eucaryotic sn2-acylglyceride fatty acyltransferase gene to be cloned. SLC strains grown in the absence of long chain base make novel phosphatidylinositol derivatives (Lester, R. L., Wells, G. B., Oxford, G., and Dickson, R. C. (1993) J. Biol. Chem. 268, 845-856) having a C26 fatty acid at the sn-2 position and the same polar head groups as normal sphingolipids. We postulate that the SLC1 suppressor allele encodes a variant enzyme with an altered substrate specificity that enables it to use a C26 in place of a C-16/18 fatty acid precursor to acylate the sn-2 position of inositol-containing. glycerolipids.	UNIV KENTUCKY, MED CTR, DEPT BIOCHEM, 800 ROSE ST, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, LUCILLE P MARKEY CANC CTR, LEXINGTON, KY 40536 USA	University of Kentucky; University of Kentucky					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043102] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43102] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNES DA, 1986, MOL CELL BIOL, V6, P2828, DOI 10.1128/MCB.6.8.2828; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; DICKSON RC, 1990, MOL CELL BIOL, V10, P2176, DOI 10.1128/MCB.10.5.2176; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DORSMAN JC, 1989, NUCLEIC ACIDS RES, V17, P4917, DOI 10.1093/nar/17.13.4917; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; HAKOMORI S, 1983, HDB LIPID RES, V3, P1; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HALFTER H, 1989, EMBO J, V8, P3029, DOI 10.1002/j.1460-2075.1989.tb08453.x; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JOHNSTON SA, 1982, P NATL ACAD SCI USA, V79, P6871; KAWAGUCHI A, 1981, J BIOCHEM-TOKYO, V89, P337, DOI 10.1093/oxfordjournals.jbchem.a133207; KUZHANDAIVELU N, 1992, MOL CELL BIOL, V12, P1924, DOI 10.1128/MCB.12.5.1924; LESTER RL, 1993, J BIOL CHEM, V268, P845; LUTTINGER AL, 1991, NEW BIOL, V3, P687; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; NIKOLOFF DM, 1991, ANNU REV GENET, V25, P559; OLSEN MV, 1986, P NATL ACAD SCI USA, V83, P7826; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; STEINER S, 1969, P NATL ACAD SCI USA, V64, P1042, DOI 10.1073/pnas.64.3.1042; STILES JI, 1981, CELL, V25, P277, DOI 10.1016/0092-8674(81)90253-1; STRATHERN JN, 1991, METHOD ENZYMOL, V194, P319; WELLS GB, 1983, J BIOL CHEM, V258, P200	40	146	164	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22156	22163						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408076				2022-12-27	WOS:A1993MC80900106
J	PETRONILLI, V; COLA, C; MASSARI, S; COLONNA, R; BERNARDI, P				PETRONILLI, V; COLA, C; MASSARI, S; COLONNA, R; BERNARDI, P			PHYSIOLOGICAL EFFECTORS MODIFY VOLTAGE SENSING BY THE CYCLOSPORINE A-SENSITIVE PERMEABILITY TRANSITION PORE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-INDUCED MEMBRANE TRANSITION; HEART-MITOCHONDRIA; CA-2+-DEPENDENT PORE; LIVER-MITOCHONDRIA; OXIDATIVE STRESS; DIVALENT-CATIONS; CA-2+ RELEASE; RUTHENIUM RED; CALCIUM; CHANNELS	This paper reports an investigation on the modulation of the mitochondrial permeability transition pore (MTP) by the membrane potential. Energized rat liver mitochondria loaded with a small Ca2+ pulse in sucrose medium supplemented with phosphate favor a high MTP ''closed'' probability because of the high membrane potential and therefore maintain a low permeability to sucrose. Upon depolarization by the addition of fully uncoupling concentrations of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) mitochondria favor a high MTP ''open'' probability and rapidly undergo a process of osmotic swelling following sucrose diffusion toward the matrix. A titration with FCCP reveals that discrete subpopulations of mitochondria with different gating potentials for MTP opening may exist, since increasing concentrations of FCCP increase the fraction of mitochondria undergoing osmotic swelling. We show that physiological effectors (Ca2+, Mg2+, ADP, palmitate) modify pore opening in a mitochondrial population by shifting the fraction of mitochondria with a functionally open pore at any given membrane potential. Many inducers and inhibitors may therefore affect the pore directly through an effect on the MTP voltage sensing rather than indirectly through an effect on the membrane potential. Thus, many effectors may induce pore opening by shifting the MTP gating potential to higher levels, whereas many inhibitors may induce pore closure by shifting the MTP gating potential to lower levels.	UNIV PADUA, SCH MED,DEPT BIOMED SCI, BIOPHYS & MEMBRANE BIOL LAB,VIA TRIESTE 75, I-35121 PADUA, ITALY; CNR, STUDY PHYSIOL MITOCHONDRIA UNIT, I-35121 PADUA, ITALY	University of Padua; Consiglio Nazionale delle Ricerche (CNR)			Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404				BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEATRICE MC, 1982, J BIOL CHEM, V257, P7161; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; BEAVIS AD, 1985, J BIOL CHEM, V260, P3424; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; BERNARDI P, 1983, BIOCHIM BIOPHYS ACTA, V724, P212, DOI 10.1016/0005-2728(83)90140-8; BERNARDI P, 1992, MECHANICS SWELLING C, P357; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; KAMISHIMA T, 1992, AM J PHYSIOL, V263, pC69, DOI 10.1152/ajpcell.1992.263.1.C69; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; LUVISETTO S, 1990, J BIOENERG BIOMEMBR, V22, P635, DOI 10.1007/BF00809068; MASSARI S, 1972, J MEMBRANE BIOL, V9, P57, DOI 10.1007/BF01868043; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1991, ANNU REV BIOPHYS BIO, V20, P65, DOI 10.1146/annurev.biophys.20.1.65; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; TEDESCHI H, 1955, ARCH BIOCHEM BIOPHYS, V58, P52, DOI 10.1016/0003-9861(55)90092-8; ZORATTI M, 1986, BIOCHEMISTRY-US, V25, P760, DOI 10.1021/bi00352a004	37	294	306	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21939	21945						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408050				2022-12-27	WOS:A1993MC80900076
J	LITVINOV, SV; HILKENS, J				LITVINOV, SV; HILKENS, J			THE EPITHELIAL SIALOMUCIN, EPISIALIN, IS SIALYLATED DURING RECYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MANNOSE 6-PHOSPHATE RECEPTOR; CARCINOMA-ASSOCIATED MUCIN; TRANS-GOLGI NETWORK; CELL-SURFACE; ASIALOGLYCOPROTEIN RECEPTOR; INTRACELLULAR MOVEMENT; PROTEINS; APPARATUS; CDNA	Episialin, the sialomucin encoded by the MUC1 gene is abundantly present at the surface of various epithelial cells. it is a transmembrane molecule that matures through several intermediate forms generated by proteolysis and sequential addition and processing of numerous O-linked glycans. Here we demonstrate that one of the biosynthetic intermediates, the premature form, which is incompletely glycosylated appears at the cell surface. By neuraminidase protection assays we show that cell surface-associated forms of episialin are constitutively internalized (0.9% of surface fraction/min) and recycled, with the intracellular residence time and total cycle time being approximately 66 and 143 min, respectively. During recycling, sialic acid residues are added to the premature form of episialin resulting in complete maturation of the molecule. Complete sialylation of episialin requires several rounds of recycling which continues after sialylation is apparently completed. The recycling of episialin may serve to achieve and maintain a high degree of sialylation.	ANTONI VAN LEEUWENHOEK HOSP,NETHERLANDS CANC INST,DIV TUMOR BIOL,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute				Hilkens, John/0000-0002-0932-7793				BRANDLI AW, 1989, EMBO J, V8, P3207, DOI 10.1002/j.1460-2075.1989.tb08479.x; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; BREITFELD PP, 1985, INT REV CYTOL, V97, P47, DOI 10.1016/S0074-7696(08)62348-7; BUSCH G, 1989, EUR J CELL BIOL, V50, P257; CALAFAT J, 1988, CANCER RES, V48, P3822; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; ECKHARDT AE, 1991, J BIOL CHEM, V266, P9678; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GREEN SA, 1992, J CELL BIOL, V117, P47, DOI 10.1083/jcb.117.1.47; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GUM JR, 1992, J BIOL CHEM, V267, P21375; HILKENS J, 1988, J BIOL CHEM, V263, P4215; HILKENS J, 1988, Cancer Reviews, V11-12, P25; HILKENS J, 1989, CANCER RES, V49, P786; HULL SR, 1991, J BIOL CHEM, V266, P13580; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; JIN M, 1989, J BIOL CHEM, V264, P7675; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAN MS, 1990, J BIOL CHEM, V265, P15294; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; LIGTENBERG MJL, 1992, CANCER RES, V52, P2318; LINSLEY PS, 1988, J BIOL CHEM, V263, P8390; NEEFJES JJ, 1988, J CELL BIOL, V107, P79, DOI 10.1083/jcb.107.1.79; REICHNER JS, 1988, J BIOL CHEM, V263, P16316; ROTH J, 1986, J BIOL CHEM, V261, P14307; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SCHWARTZ AL, 1984, J CELL BIOL, V98, P732, DOI 10.1083/jcb.98.2.732; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; WINDELL CC, 1982, CELL, V28, P61; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; XU G, 1992, BIOCHEM BIOPH RES CO, V183, P821, DOI 10.1016/0006-291X(92)90557-2	38	124	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21364	21371						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407976				2022-12-27	WOS:A1993MA28800104
J	BHAMIDIPATI, SP; HAMILTON, JA				BHAMIDIPATI, SP; HAMILTON, JA			NMR-STUDIES OF PHOSPHOLIPASE-C HYDROLYSIS OF PHOSPHATIDYLCHOLINE IN MODEL MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN-PLASMA LECITHIN; APOLIPOPROTEIN-A-I; CHOLESTEROL ACYLTRANSFERASE; C-13 NMR; SIGNAL TRANSDUCTION; SPECIFICITY; BILAYERS; DIACYLGLYCEROLS; SOLUBILIZATION	Hydrolysis of phospholipids in biological membranes by phospholipase C (PLC) produces an important second messenger molecule, 1,2-diacylglycerol (DAG), that is essential for the activation of protein kinase C (PKC). While the effects of DAG on model membranes have been investigated earlier, studies on physical properties of DAG introduced into phospholipid bilayers by PLC have been lacking. We present an NMR approach for studying structural and kinetic aspects of PLC-mediated hydrolysis of 13 carbonyl-enriched phospholipids in model membranes (small unilamellar vesicles). The product DAG is readily detected by C-13 NMR, and its structural properties as well as those of the model membrane can be monitored continuously. PLC hydrolysis was limited to a low proportion of the model membrane by incorporating a small amount of ester phospholipid into a nonhydrolyzable ether-linked phospholipid matrix. Under these conditions, PLC (Bacillus cereus) hydrolyzed only the monolayer of phosphatidylcholine to which it was exposed (the outer monolayer). The 1,2-DAG product remained associated with the membrane bilayer and did not alter bilayer structure in any detectable way. From the chemical shift data, it is inferred that the DAG has an interfacial conformation similar to that of phosphatidylcholine. These results show that DAG could activate PKC by direct interaction with the enzyme rather than by perturbation of the membrane bilayer.	BOSTON UNIV,SCH MED,HOUSMAN MED RES CTR,DEPT BIOPHYS,80 E CONCORD ST,BOSTON,MA 02118	Boston University				Hamilton, James/0000-0002-4747-7071	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER; NHLBI NIH HHS [1PO1 HL26335] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BELL RM, 1991, J BIOL CHEM, V266, P4661; BERDEN JA, 1974, FEBS LETT, V46, P55, DOI 10.1016/0014-5793(74)80333-9; BHAMIDIPATI SP, 1989, BIOCHEMISTRY-US, V28, P6667, DOI 10.1021/bi00442a020; BURNS RA, 1981, BIOCHEMISTRY-US, V20, P5945, DOI 10.1021/bi00524a004; DEBOECK H, 1989, BIOCHEMISTRY-US, V28, P7439, DOI 10.1021/bi00444a043; DEMANT EJF, 1979, EUR J BIOCHEM, V95, P613, DOI 10.1111/j.1432-1033.1979.tb13002.x; ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V837, P325, DOI 10.1016/0005-2760(85)90056-6; EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y; EXTON JH, 1990, J BIOL CHEM, V265, P1; GEORGE R, 1990, BIOCHEM CELL BIOL, V68, P161, DOI 10.1139/o90-022; GOLDFINE H, 1982, BIOCHEM BIOPH RES CO, V108, P1502, DOI 10.1016/S0006-291X(82)80077-6; HAMILTON JA, 1991, BIOCHEMISTRY-US, V30, P2894, DOI 10.1021/bi00225a024; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; HAMILTON JA, 1974, J BIOL CHEM, V249, P4872; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; KODALI DR, 1990, CHEM PHYS LIPIDS, V52, P163, DOI 10.1016/0009-3084(90)90111-4; MASSEY JB, 1985, J BIOL CHEM, V260, P1719; MCKEONE BJ, 1986, BIOCHEMISTRY-US, V25, P7711, DOI 10.1021/bi00371a064; Merrill AH, 1991, CURR OPIN STRUC BIOL, V1, P516, DOI 10.1016/S0959-440X(05)80071-5; NEWTON AC, 1990, BIOCHEMISTRY-US, V29, P6656, DOI 10.1021/bi00480a015; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; POWNALL HJ, 1985, BIOCHIM BIOPHYS ACTA, V833, P456, DOI 10.1016/0005-2760(85)90103-1; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P5010, DOI 10.1021/bi00438a016; SMITH SO, 1992, BIOCHEMISTRY-US, V31, P11660, DOI 10.1021/bi00161a054; SUNDLER R, 1978, J BIOL CHEM, V253, P5299; ZIDOVETZKI R, 1992, BIOCHIM BIOPHYS ACTA, V1134, P261, DOI 10.1016/0167-4889(92)90185-E	29	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2431	2434						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428917				2022-12-27	WOS:A1993KK81500030
J	DALESSANDRO, F; COLAMONICI, OR; NORDAN, RP				DALESSANDRO, F; COLAMONICI, OR; NORDAN, RP			DIRECT ASSOCIATION OF INTERLEUKIN-6 WITH A 130-KDA COMPONENT OF THE INTERLEUKIN-6 RECEPTOR SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY FACTOR-II; PLASMACYTOMA GROWTH-FACTOR; CROSS-LINKING; SIGNAL TRANSDUCER; CELLS; PROTEIN; DIFFERENTIATION; EXPRESSION; IL-6; INTERFERON-BETA-2	Affinity cross-linking of membrane bound I-125-interleukin-6 (IL-6) on several cell lines revealed a three-band pattern of IL-6-containing cross-linked complexes with molecular masses of 100, 120, and 150 kDa. To identify the membrane components that were associated with IL-6 in the three complexes, we employed the Denny-Jaffe reagent, a heterobifunctional, cleavable cross-linker that allows the transfer of I-125 from the ligand to its receptor. Samples cross-linked with Denny-Jaffe reagent were analyzed by two-dimensional SDS-polyacrylamide gel electrophoresis in which the cross-linker was cleaved prior to the second dimension. This analysis revealed that IL-6 directly associates with a 130-kDa membrane protein thus allowing the formation of the 150-kDa complex. In addition, both the 100- and 120-kDa cross-linked complexes were shown to include an 80-kDa membrane glycoprotein associated with one and two IL-6 molecules, respectively.	NCI,CLIN PHARMACOL BRANCH,BLDG 10,RM 13N268,BETHESDA,MD 20892; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago								AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; CALVO JC, 1983, BIOCHEM J, V212, P259, DOI 10.1042/bj2120259; COULIE PG, 1987, EUR J IMMUNOL, V17, P1435, DOI 10.1002/eji.1830171008; DENNY JB, 1984, P NATL ACAD SCI-BIOL, V81, P5286, DOI 10.1073/pnas.81.17.5286; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GAZDAR AF, 1986, BLOOD, V67, P1542; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; HIRATA Y, 1989, J IMMUNOL, V143, P2900; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; JAFFE CL, 1980, BIOCHEMISTRY-US, V19, P4423, DOI 10.1021/bi00560a007; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; ROSEJOHN S, 1991, J BIOL CHEM, V266, P3841; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; SCHWAB G, 1991, BLOOD, V77, P587; SHABO Y, 1989, MOL CELL BIOL, V9, P4109, DOI 10.1128/MCB.9.9.4109; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; SIEGALL CB, 1990, MOL CELL BIOL, V10, P2443, DOI 10.1128/MCB.10.6.2443; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1987, J EXP MED, V166, P967, DOI 10.1084/jem.166.4.967; VANCURA S, 1987, P NATL ACAD SCI USA, V84, P3575, DOI 10.1073/pnas.84.11.3575; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	32	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2149	2153						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420983				2022-12-27	WOS:A1993KH62000097
J	OLEINIKOV, AV; PERROUD, B; WANG, B; TRAUT, RR				OLEINIKOV, AV; PERROUD, B; WANG, B; TRAUT, RR			STRUCTURAL AND FUNCTIONAL DOMAINS OF ESCHERICHIA-COLI RIBOSOMAL-PROTEIN L7/L12 - THE HINGE REGION IS REQUIRED FOR ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; C-TERMINAL DOMAIN; MONOCLONAL-ANTIBODIES; LOCALIZATION; SUBUNIT; L7-L12; EPITOPES	Variant forms of Escherichia coli ribosomal protein L7/L12 were constructed, overexpressed, and purified. These included proteins that deleted residues 35-52 (DELTA35-52) and 42 to 52 (DELTA42-52), others that contained single cysteine substitutions at residues 63 and 89, and combinations of the deletions and cysteine substitutions. Chemical modification of the introduced cysteine residues with [C-14]iodoacetamide was used to radiolabel the protein variants in order to quantify their binding to the ribosome. Neither of the deletions in the hinge domain, DELTA35-52 and DELTA42-52, had any effect on L7/L12 dimer formation as detected by cross-linking by dimethyl suberimidate. Perpendicular urea gradient gel electrophoresis showed that both deletion variants retained a compact structural element attributable to the globular C-terminal domain. Reconstitution of core particles depleted of wild type L7/L12 with the deletion proteins showed that DELTA42-52 bound normally in 4 copies per particle, whereas DELTA35-52 bound in only 2.5 copies following isolation of the particles by high speed centrifugation or gel filtration. Ribosomes mixed with an excess of the deletion variants and assayed directly for polyphenylalanine synthesis were completely inactive. The results suggest that the flexibility conferred by the hinge is required for activity, perhaps by allowing the C-terminal domain to occupy a location near the base of the L7/L12 stalk.			OLEINIKOV, AV (corresponding author), UNIV CALIF DAVIS, SCH MED, DEPT BIOL CHEM, DAVIS, CA 95616 USA.				NIGMS NIH HHS [GM17924] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017924, R01GM017924] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUSHUEV VN, 1989, J BIOL CHEM, V264, P4498; CASIANO C, 1990, J BIOL CHEM, V265, P18757; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; CREIGHTON TE, 1979, J MOL BIOL, V129, P235, DOI 10.1016/0022-2836(79)90279-1; CREIGHTON TE, 1980, NATURE, V284, P487, DOI 10.1038/284487a0; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; GEORGALIS Y, 1989, J BIOL CHEM, V264, P9210; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; GUDKOV AT, 1991, BIOCHIMIE, V73, P1387, DOI 10.1016/0300-9084(91)90168-Z; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P309, DOI 10.1111/j.1432-1033.1978.tb12605.x; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P313, DOI 10.1111/j.1432-1033.1978.tb12606.x; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; HAMEL E, 1972, J BIOL CHEM, V247, P805; KOTELIANSKY VE, 1978, EUR J BIOCHEM, V90, P319, DOI 10.1111/j.1432-1033.1978.tb12607.x; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; LEIJONMARCK M, 1981, STRUCTURAL ASPECTS R, P761; LI K, 1975, ANAL BIOCHEM, V64, P121, DOI 10.1016/0003-2697(75)90413-3; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; LILJAS A, 1982, PROG BIOPHYS MOL BIO, V40, P161, DOI 10.1016/0079-6107(82)90013-X; Maniatis T., 1982, MOL CLONING; MOLLER W, 1983, J MOL BIOL, V163, P553, DOI 10.1016/0022-2836(83)90112-2; OLSON HM, 1986, J BIOL CHEM, V261, P6924; SCHOP EN, 1982, EUR J BIOCHEM, V128, P371; SOMMER A, 1985, J BIOL CHEM, V260, P6522; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THIELEN APGM, 1984, BIOCHEMISTRY-US, V23, P3317; TOKIMATSU H, 1981, J MOL BIOL, V152, P397, DOI 10.1016/0022-2836(81)90250-3; VANAGTHOVEN AJ, 1975, BIOCHEM BIOPH RES CO, V64, P1184, DOI 10.1016/0006-291X(75)90818-9; VERSCHOOR A, 1985, J ULTRA MOL STRUCT R, V92, P180, DOI 10.1016/0889-1605(85)90045-X; ZECHERLE GN, 1992, J BIOL CHEM, V267, P5889; ZECHERLE GN, 1992, BIOCHEMISTRY-US, V31, P9526, DOI 10.1021/bi00155a003	31	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					917	922						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419370				2022-12-27	WOS:A1993KG07700027
J	SCOTT, CW; SPREEN, RC; HERMAN, JL; CHOW, FP; DAVISON, MD; YOUNG, J; CAPUTO, CB				SCOTT, CW; SPREEN, RC; HERMAN, JL; CHOW, FP; DAVISON, MD; YOUNG, J; CAPUTO, CB			PHOSPHORYLATION OF RECOMBINANT TAU BY CAMP-DEPENDENT PROTEIN-KINASE - IDENTIFICATION OF PHOSPHORYLATION SITES AND EFFECT ON MICROTUBULE ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; BRAIN; TUBULIN; PURIFICATION; EPITOPE; ALZ-50; DEPHOSPHORYLATION	Tau protein is an integral component of paired helical filaments, a pathological feature of Alzheimer's disease. tau extracted from these filaments displays decreased electrophoretic mobility due to aberrant phosphorylation. Here we show that recombinant human tau can be phosphorylated by cAMP-dependent protein kinase resulting in decreased electrophoretic mobility. Phosphorylation of tau by cAMP-dependent protein kinase caused a 92% decrease in the maximum rate of tau-induced microtubule assembly. The sites of phosphorylation were identified by digesting phosphorylated tau with proteases, separating the peptides by reversed-phase HPLC, and analyzing the isolated peptides by liquid-secondary ion mass spectrometry and solid-phase N-terminal sequencing. Five phosphorylation sites were identified, two of which were located within microtubule binding domains. One site was previously shown to be the sole phosphorylation site for CaM kinase II; phosphorylation at this site by CaM kinase II was sufficient to cause decreased electrophoretic mobility (Steiner, B., Mandelkow, E. M., Biernat, J., Gustke, N., Meyer, H. E., Schmidt, B., Mieskes, G., Soling, H. D., Drechsel, D., Kirschner, M. W., Goedert, M., and Mandelkow, E. (1990) EMBO J. 9, 3539-3544). Thus two different second messenger-dependent protein kinases can phosphorylate tau at the same site and induce a shift in tau mobility like that seen in Alzheimer's disease.	ICI PHARMACEUT DIV, DEPT BIOTECHNOL, MACCLESFIELD, CHESHIRE, ENGLAND		SCOTT, CW (corresponding author), ICI AMER INC, DEPT PHARMACOL, ICI PHARMACEUT GRP, WILMINGTON, DE 19897 USA.							BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; BUTLER M, 1986, J NEUROCHEM, V47, P1517, DOI 10.1111/j.1471-4159.1986.tb00788.x; CAPUTO CB, 1989, BIOCHIM BIOPHYS ACTA, V1012, P299, DOI 10.1016/0167-4889(89)90112-2; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; FLAMENT S, 1989, J NEUROL SCI, V92, P133, DOI 10.1016/0022-510X(89)90131-7; GASESTEL M, 1991, J BIOL CHEM, V266, P14721; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; GIBSON BW, 1990, METHOD ENZYMOL, V193, P480, DOI 10.1016/0076-6879(90)93434-M; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; HOSHI M, 1987, FEBS LETT, V217, P237, DOI 10.1016/0014-5793(87)80670-1; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; ISHIGURO K, 1991, NEUROSCI LETT, V128, P195, DOI 10.1016/0304-3940(91)90259-V; ISHIGURO K, 1988, J BIOCHEM-TOKYO, V104, P319, DOI 10.1093/oxfordjournals.jbchem.a122465; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7948; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7943; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; MURPHY DB, 1982, METHOD CELL BIOL, V24, P31; PERRY G, 1991, J NEUROSCI, V11, P1748; PIERRE M, 1983, BIOCHEM BIOPH RES CO, V115, P212, DOI 10.1016/0006-291X(83)90991-9; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; RICKENBERG HV, 1987, ENZYMES, V18, P419; RODER HM, 1991, J NEUROSCI, V11, P3325; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; UEDA K, 1990, J NEUROSCI, V10, P3295; WICHE G, 1991, INT REV CYTOL, V124, P217; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YAMAMOTO H, 1988, J NEUROCHEM, V50, P1614, DOI 10.1111/j.1471-4159.1988.tb03051.x; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YANG SD, 1991, J PROTEIN CHEM, V10, P171, DOI 10.1007/BF01024781	52	198	200	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1166	1173						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419321				2022-12-27	WOS:A1993KG07700061
J	SWIEZEWSKA, E; DALLNER, G; ANDERSSON, B; ERNSTER, L				SWIEZEWSKA, E; DALLNER, G; ANDERSSON, B; ERNSTER, L			BIOSYNTHESIS OF UBIQUINONE AND PLASTOQUINONE IN THE ENDOPLASMIC RETICULUM-GOLGI MEMBRANES OF SPINACH LEAVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; PLANT-MITOCHONDRIA; DOLICHOL; COMPARTMENTATION; PRENYLQUINONES; LOCALIZATION; CHLOROPLASTS; ENVELOPE; SYSTEM; CELLS	The localization of ubiquinone (UQ) and plastoquinone (PQ) biosynthesis in subfractions isolated from spinach leaves has been studied. UQ-9 and UQ-10 were found mainly in mitochondria, whereas PQ was enriched in chloroplasts, but also found in Golgi membranes. Alpha-unsaturated polyprenol-11 was also present at a low concentration in chloroplasts. Autoradiography revealed the presence of nonaprenyl-4-hydroxy-benzoate (NPHB) and nonaprenyl-2-methylquinol (NPMQ) transferase activities involved in quinone biosynthesis in all subfractions, but the specific activities involved in quinone biosynthesis in the total microsomal fraction were 20 times higher than those in mitochondria and chloroplasts. The isolated Golgi vesicles were particularly enriched in both activities. When the incubation medium containing total microsomes or Golgi membranes was supplemented with NADH, NADPH, S-adenosylmethionine, and an ATP-generating system, NPHB and NPMQ were transferred to UQ-9 and PQ, respectively. trans-Prenyltransferase, which synthesizes the side chain of UQ and PQ, was present in the total microsomal fraction. With farnesyl-PP as substrate, no product was formed, but with geranyl-PP, solanesyl-PP was synthesized and transferred to 4-hydroxybenzoate present in the total microsomal fraction. The results show that these membranes from spinach contain farnesyl-PP synthetase. It is concluded that the plant leaf Golgi membranes contain the enzymes for both UQ and PQ biosynthesis and that a specific transport and targeting system is required for selective transfer of UQ to the mitochondria and of PQ to the chloroplast.	KAROLINSKA INST, HUDDINGE HOSP, CLIN RES CTR, S-14186 HUDDINGE, SWEDEN	Karolinska Institutet	SWIEZEWSKA, E (corresponding author), UNIV STOCKHOLM, DEPT BIOCHEM, ARRHENIUS LABS NAT SCI, S-10691 STOCKHOLM, SWEDEN.		Andersson, Bertil/C-9328-2009	Swiezewska, Ewa/0000-0002-3439-8948				ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BACH TJ, 1990, RECENT ADV PHYTOCHEM, V24, P1; BACH TJ, 1983, Z NATURFORSCH C, V38, P212; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; CHOJNACKI T, 1975, ANAL BIOCHEM, V69, P114, DOI 10.1016/0003-2697(75)90572-2; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535; ERNSTER L, 1991, BIOMED CLIN, V6, P45; ERNSTER L, 1992, BIOFACTORS, V3, P241; ERNSTER L, 1962, J CELL BIOL, V15, P563, DOI 10.1083/jcb.15.3.563; FERON G, 1990, FEBS LETT, V271, P236, DOI 10.1016/0014-5793(90)80414-E; Goodwin T. W., 1977, Lipids and lipid polymers in higher plants., P29; HACHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659; HAMASUR B, 1990, PHYSIOL PLANTARUM, V78, P367, DOI 10.1111/j.1399-3054.1990.tb09050.x; HUNDAL T, 1991, 1ST NORD C PHOT COP; KALEN A, 1990, J BIOL CHEM, V265, P1158; KALEN A, 1987, BIOCHIM BIOPHYS ACTA, V926, P70, DOI 10.1016/0304-4165(87)90183-8; KEENAN RW, 1975, ANAL BIOCHEM, V69, P504, DOI 10.1016/0003-2697(75)90153-0; KREUZ K, 1984, EUR J BIOCHEM, V141, P531, DOI 10.1111/j.1432-1033.1984.tb08225.x; LICHTENTHALER HK, 1981, BIOCHIM BIOPHYS ACTA, V641, P99, DOI 10.1016/0005-2736(81)90572-1; LOW P, 1992, LIPIDS, V27, P1, DOI 10.1007/BF02537050; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTKEBRINKHAUS F, 1984, EUR J BIOCHEM, V141, P537, DOI 10.1111/j.1432-1033.1984.tb08226.x; LUTKEBRINKHAUS F, 1987, METHOD ENZYMOL, V148, P486; MITCHELL P, 1991, BIOMEDICAL CLIN ASPE, P3; MOORE DJ, 1979, EUR J CELL BIOL, V20, P195; PENNOCK JF, 1985, METHOD ENZYMOL, V110, P313; SCHINDLER S, 1982, BIOCH METABOLISM PLA, P545; SIEGENTHALER PA, 1976, EUR J BIOCHEM, V61, P575; SOLL J, 1985, ARCH BIOCHEM BIOPHYS, V238, P290, DOI 10.1016/0003-9861(85)90167-5; SOLL J, 1987, METHOD ENZYMOL, V148, P383; TOLLBOM O, 1988, J BIOL CHEM, V263, P1347	34	91	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1494	1499						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419349				2022-12-27	WOS:A1993KG07700108
J	RAMACHANDRA, M; NAKANO, R; MOHAN, PM; RAWITCH, AB; PADMANABHAN, R				RAMACHANDRA, M; NAKANO, R; MOHAN, PM; RAWITCH, AB; PADMANABHAN, R			ADENOVIRUS DNA-POLYMERASE IS A PHOSPHOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; SV40 T-ANTIGEN; NUCLEAR FACTOR-III; ANIMAL VIRUS-DNA; CELL-CYCLE; REPLICATION INVITRO; EXPRESSION VECTORS; BINDING PROTEIN; PRETERMINAL PROTEIN; VACCINIA VIRUS	Biological activities of many of the eukaryotic DNA replication proteins are modulated by protein phosphorylation. Investigations of the phosphorylation of adenovirus DNA polymerase (AdPol) have been difficult mainly because of its low level of synthesis in adenovirus-infected HeLa cells. However, when AdPol was overproduced using the recombinant vaccinia virus (RV-AdPol) and the baculovirus expression systems, or by a large scale metabolic labeling of adenovirus 2-infected HeLa cells (native AdPol), in vivo phosphorylation of AdPol could be demonstrated. Phosphoamino acid analysis of [P-32]AdPol indicated the presence of phosphoserine independent of the source of AdPol. Comparison of tryptic peptide maps of native AdPol and RV-AdPol revealed that the majority of phosphopeptides were common. Fractionation by high performance liquid chromatography and sequencing of one of the major phosphopeptides revealed serine 67 as a site of phosphorylation. Interestingly, this site is located close to the nuclear localization signal of AdPol and has a consensus substrate recognition sequence for histone H1 (cdc2-related) kinases and mitogen-activated protein kinases. Dephosphorylation of AdPol with calf intestinal alkaline phosphatase resulted in significant decrease in its activity in the in vitro DNA replication initiation assay, suggesting that phosphorylation is important for its biological activity.	UNIV KANSAS, MED CTR, DEPT BIOCHEM MOLEC BIOL, 3901 RAINBOW BLVD, KANSAS CITY, KS 66160 USA	University of Kansas; University of Kansas Medical Center			Mohan, PM/C-9594-2018	Mohan, PM/0000-0001-6194-3772; Ramachandra, Murali/0000-0003-4039-1491	NATIONAL CANCER INSTITUTE [R01CA033099] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; ADDISON C, 1990, ONCOGENE, V5, P423; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS RR, 1991, METHOD ENZYMOL, V208, P3; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; CHEN M, 1990, J BIOL CHEM, V265, P18634; CRIPPSWOLFMAN J, 1989, J BIOL CHEM, V264, P19478; DANSE JM, 1981, FEBS LETT, V124, P84, DOI 10.1016/0014-5793(81)80059-2; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DOBBS L, 1990, VIROLOGY, V178, P43, DOI 10.1016/0042-6822(90)90377-4; DONALDSON RW, 1987, P NATL ACAD SCI USA, V84, P759, DOI 10.1073/pnas.84.3.759; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DUCEMAN BW, 1980, BIOCHEM J, V190, P781, DOI 10.1042/bj1900781; DURBAN E, 1985, EMBO J, V4, P2921, DOI 10.1002/j.1460-2075.1985.tb04024.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GRASSER FA, 1987, J VIROL, V61, P3373; Green M, 1979, Methods Enzymol, V58, P425; HAY RT, 1989, BIOCHEM J, V258, P3, DOI 10.1042/bj2580003; HOSS A, 1990, J VIROL, V64, P4799; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JENDRISAK JJ, 1975, BIOCHEMISTRY-US, V14, P4639, DOI 10.1021/bi00692a012; JENG YH, 1977, J VIROL, V22, P402, DOI 10.1128/JVI.22.2.402-411.1977; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; KLEIN H, 1979, J BIOL CHEM, V254, P1051; KRANIAS EG, 1977, J BIOL CHEM, V252, P6750; KRAUSS SW, 1987, J BIOL CHEM, V262, P3432; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN IR, 1989, J BIOL CHEM, V264, P4265; LINNE T, 1980, EUR J BIOCHEM, V103, P259, DOI 10.1111/j.1432-1033.1980.tb04310.x; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MALLER JL, 1990, BIOCHEMISTRY-US, V29, P3157, DOI 10.1021/bi00465a001; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; MOHR IJ, 1987, EMBO J, V6, P153, DOI 10.1002/j.1460-2075.1987.tb04733.x; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; MOSS B, 1987, ANNU REV IMMUNOL, V5, P305, DOI 10.1146/annurev.iy.05.040187.001513; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P4266, DOI 10.1073/pnas.80.14.4266; NAKANO R, 1991, GENE, V105, P173, DOI 10.1016/0378-1119(91)90148-5; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; PRUIJN GJM, 1986, NATURE, V322, P656, DOI 10.1038/322656a0; PRUIJN GJM, 1987, EMBO J, V6, P3771, DOI 10.1002/j.1460-2075.1987.tb02712.x; RAWLINS DR, 1984, CELL, V37, P309, DOI 10.1016/0092-8674(84)90327-1; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROACH PJ, 1991, METHOD ENZYMOL, V201, P200; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROSE KM, 1979, J BIOL CHEM, V254, P256; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SAMIEI M, 1991, J BIOL CHEM, V266, P14889; SASAGURI Y, 1987, VIROLOGY, V160, P389, DOI 10.1016/0042-6822(87)90010-9; SCHEIDTMANN KH, 1991, J VIROL, V65, P1479, DOI 10.1128/JVI.65.3.1479-1490.1991; SCHNEIDER J, 1988, J VIROL, V62, P1598, DOI 10.1128/JVI.62.5.1598-1605.1988; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STURZBECHER HW, 1990, ONCOGENE, V5, P795; TEMPERLEY SM, 1991, NUCLEIC ACIDS RES, V19, P3243, DOI 10.1093/nar/19.12.3243; TEMPLETON DJ, 1992, MOL CELL BIOL, V12, P435, DOI 10.1128/MCB.12.2.435; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TOKUI T, 1991, J BIOL CHEM, V266, P10820; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Vishwanatha J K, 1989, Cancer Commun, V1, P345; WIDES RJ, 1987, MOL CELL BIOL, V7, P864, DOI 10.1128/MCB.7.2.864; WONG SW, 1986, J BIOL CHEM, V261, P7958; ZHAO LJ, 1991, NEW BIOL, V3, P1074; ZHAO LJ, 1988, CELL, V55, P1005, DOI 10.1016/0092-8674(88)90245-0; ZHAO LJ, 1991, GENE, V100, P147, DOI 10.1016/0378-1119(91)90360-N	79	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					442	448						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416949				2022-12-27	WOS:A1993KE60300068
J	SIDERS, WM; KLIMOVITZ, JC; MIZEL, SB				SIDERS, WM; KLIMOVITZ, JC; MIZEL, SB			CHARACTERIZATION OF THE STRUCTURAL REQUIREMENTS AND CELL-TYPE SPECIFICITY OF IL-1-ALPHA AND IL-1-BETA SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCYTE INTERLEUKIN-1; ACTIVATED NEUTRAL PROTEASE; ESCHERICHIA-COLI; IL-1 SECRETION; PRECURSOR; PROTEINS; 1-BETA; CDNA; IDENTIFICATION; EXPRESSION	The murine macrophage cell line, P388D1, was transfected with expression plasmids containing a cDNA for the precursor or mature form of human interleukin (IL)-1alpha or -1beta, and the extent of IL-1 protein secretion was analyzed. The secretion of IL-1beta from cells transfected with a cDNA encoding the mature IL-1beta was approximately 15-fold greater than from cells transfected with a precursor IL-1beta cDNA. Although P388D1 cells transfected with precursor and mature IL-1alpha cDNAs exhibited similar levels of secretion, the precursor IL-1alpha cDNA-transfected cells secreted only the mature form of IL-1alpha. Relatively high levels of IL-1 secretion were also observed in cultures of HeLa cells and the murine EL 4 and human Jurkat T cell lines that were transfected with a mature IL-1alpha or -beta expression plasmid. Secretion was not observed when these cell lines were transfected with precursor IL-1alpha or -beta expression plasmids. Secretion was also minimal when P388D1 cells were transfected with cDNAs encoding mature IL-1beta proteins lacking the NH2- or COOH-terminal 20 amino acids. These results indicate that the mature forms of IL-1 proteins are the preferred substrates for secretion and that the maintenance of a specific conformation of these proteins may be required for optimal secretion.	WAKE FOREST UNIV, MED CTR, DEPT MICROBIOL & IMMUNOL, WINSTON SALEM, NC 27157 USA	Wake Forest University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025836] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25836] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BAKOUCHE O, 1987, J IMMUNOL, V138, P4249; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BLACK RA, 1989, J BIOL CHEM, V264, P5323; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DAVIES WA, 1977, J CELL BIOL, V75, P941, DOI 10.1083/jcb.75.3.941; DINARELLO CA, 1992, CHEM IMMUNOL, V51, P1; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; GIRI JG, 1985, J IMMUNOL, V134, P343; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HOSOKAWA R, 1988, J BIOL CHEM, V263, P10045; HOWARD AD, 1991, J IMMUNOL, V147, P2964; KAMOGASHIRA T, 1988, J BIOCHEM-TOKYO, V104, P837, DOI 10.1093/oxfordjournals.jbchem.a122559; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; LANGER T, 1991, CURR TOP MICROBIOL, V167, P3; LILLQUIST JS, 1988, J IMMUNOL, V141, P1975; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; LORD PCW, 1991, J CLIN INVEST, V87, P1312, DOI 10.1172/JCI115134; MIGNATTI P, 1991, J CELL BIOCHEM, V47, P201, DOI 10.1002/jcb.240470303; MOSLEY B, 1987, P NATL ACAD SCI USA, V84, P4572, DOI 10.1073/pnas.84.13.4572; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; SINGER II, 1988, J EXP MED, V167, P389, DOI 10.1084/jem.167.2.389; SUTTLES J, 1990, J IMMUNOL, V144, P175; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	37	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22170	22174						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408078				2022-12-27	WOS:A1993MC80900108
J	JENKINS, AL; BOOTMAN, MD; TAYLOR, CW; MACKIE, EJ; STONE, SR				JENKINS, AL; BOOTMAN, MD; TAYLOR, CW; MACKIE, EJ; STONE, SR			CHARACTERIZATION OF THE RECEPTOR RESPONSIBLE FOR THROMBIN-INDUCED INTRACELLULAR CALCIUM RESPONSES IN OSTEOBLAST-LIKE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOSARCOMA CELLS; CA2+ MOBILIZATION; AGONIST PEPTIDES; BONE-RESORPTION; ACTIVATION; MECHANISM; EXPRESSION; PATHWAYS; CLONING; HIRUDIN	The receptor responsible for the increase in intracellular calcium concentration ([Ca2+]i) after the addition of thrombin to the human osteoblast-like cell line Saos-2 has been characterized. Thrombin caused a dose-dependent increase in [Ca2+]i; a half-maximal stimulation was observed with 3.2 +/- 1.1 nM thrombin. The human platelet thrombin receptor is activated by thrombin cleavage to create a new NH2 terminus that acts as a tethered ligand, and peptides based on the tethered ligand can activate the receptor independently of thrombin. Northern analysis indicated the presence of mRNA encoding the platelet receptor in Saos-2 cells, and surface expression of the receptor was demonstrated by immunocytochemistry. A tethered ligand peptide (SFLLRNPNDKYEPF, single-letter amino acid code) was found to increase [Ca2+]i. The maximal response to the peptide was similar to that observed with thrombin, and a half-maximal response was observed with 22 +/- 6 muM peptide. The time course of the increase in [Ca2+]i with the peptide was different than that observed with thrombin; a pronounced shoulder was observed after an initial sharp rise. The phenylalanine in the second position of the agonist peptide and the arginine in the fifth position were shown to be essential for its activity. The requirement for proteolysis of the receptor for the thrombin-dependent increase in [Ca2+]i was demonstrated by two methods. Antibodies that reacted with the cleavage site of the receptor abolished the effect of thrombin on [Ca2+]i. In addition, a mutant of thrombin without catalytic activity as well as chemically inactivated thrombin failed to cause an increase in [Ca2+]i. Similar results were obtained with the rat osteoblast-like cell line UMR-106; a tethered ligand peptide based on the rat sequence induced an increase in [Ca2+]i, and antibodies to the cleavage site of the rat receptor inhibited the effect of thrombin.	UNIV CAMBRIDGE,MRC CTR,DEPT HAEMATOL,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND; UNIV CAMBRIDGE,DEPT ZOOL,AFRC,MOLEC SIGNALLING LAB,CAMBRIDGE CB2 3EJ,ENGLAND; UNIV CAMBRIDGE,DEPT PHARMACOL,CAMBRIDGE CB2 1QJ,ENGLAND; ADDENBROOKES HOSP,RHEUMATOL RES UNIT,CAMBRIDGE CB2 2QQ,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge			Bootman, Martin/AAB-3330-2019; Taylor, Colin/G-2447-2010	Bootman, Martin/0000-0002-6447-3451; Mackie, Eleanor/0000-0002-8057-5407; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BABICH M, 1990, ENDOCRINOLOGY, V126, P948, DOI 10.1210/endo-126-2-948; BABICH M, 1991, ENDOCRINOLOGY, V129, P1463, DOI 10.1210/endo-129-3-1463; BARSHAVIT R, 1983, J CELL BIOL, V96, P282, DOI 10.1083/jcb.96.1.282; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; CHAO BH, 1992, BIOCHEMISTRY-US, V31, P6175, DOI 10.1021/bi00142a001; DOOLITTLE RF, 1986, URFS ORFS, P91; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUSTAFSON GT, 1983, BIOSCIENCE REP, V3, P255, DOI 10.1007/BF01122457; HOFFMANN O, 1986, PROSTAGLANDINS, V31, P601, DOI 10.1016/0090-6980(86)90168-1; HOWELLS GL, 1993, BRIT J HAEMATOL, V84, P156, DOI 10.1111/j.1365-2141.1993.tb03039.x; HUNG DT, 1992, J CLIN INVEST, V89, P444, DOI 10.1172/JCI115604; MACKIE EJ, 1992, J CELL SCI, V103, P765; OFORIDARKO E, 1993, AM J PHYSIOL, V264, pC1266; PARTRIDGE NC, 1983, CANCER RES, V43, P4308; PARTRIDGE NC, 1985, PROSTAGLANDINS, V30, P527; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; RODAN SB, 1987, CANCER RES, V47, P4961; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; STERN PH, 1990, J BONE MINER RES, V5, P443, DOI 10.1002/jbmr.5650050505; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; STONE SR, 1987, BIOCHEMISTRY-US, V26, P4617, DOI 10.1021/bi00389a004; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; TATAKIS DN, 1991, BIOCHEM BIOPH RES CO, V174, P181, DOI 10.1016/0006-291X(91)90503-Y; TATAKIS DN, 1989, BIOCHEM BIOPH RES CO, V164, P119, DOI 10.1016/0006-291X(89)91691-4; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VOURETCRAVIARI V, 1992, MOL BIOL CELL, V3, P95, DOI 10.1091/mbc.3.1.95; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; ZHONG CZ, 1992, J BIOL CHEM, V267, P16975	29	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21433	21437						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407986				2022-12-27	WOS:A1993MA28800114
J	MAZZORANA, M; GRUFFAT, H; SERGEANT, A; VANDERREST, M				MAZZORANA, M; GRUFFAT, H; SERGEANT, A; VANDERREST, M			MECHANISMS OF COLLAGEN TRIMER FORMATION - CONSTRUCTION AND EXPRESSION OF A RECOMBINANT MINIGENE IN HELA-CELLS REVEALS A DIRECT EFFECT OF PROLYL HYDROXYLATION ON CHAIN ASSEMBLY OF TYPE-XII COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROCOLLAGEN-MESSENGER-RNA; TRIPLE-HELIX; TRANS ISOMERIZATION; ASCORBIC-ACID; PEPTIDE-BONDS; II COLLAGEN; IX COLLAGEN; CARTILAGE; STIMULATION; INCELLULO	Collagen types IX, XII, and XIV are characterized by the presence of a highly conserved region comprising the most C-terminal triple helical domain (COL1, approximately 100 residues/chain) and 2 cysteines separated by 4 amino acid residues at the junction between this COL1 domain and the C-terminal non-triple helical domain (NC1). In order to better understand the functions of this conserved domain, we have constructed a recombinant minigene, comprising the sequence coding for an unrelated signal peptide and for the COL1 and NC1 domains of type XII collagen. This construct was placed under the control of the cytomegalovirus promoter and transfected into HeLa cells. The cells expressed the transfected minigene and the secreted chain, called alpha1(mini XII), could be detected by immunotransfer with an anti-peptide antibody recognizing an epitope found in the NC 1 domain. Under conditions preventing the hydroxylation of prolyl residues (absence of ascorbate or presence of alphaalpha'-dipyridyl), interchain disulfide bridges did not form, while in the presence of ascorbate, disulfide-bonded (alpha1(mini XII))3 molecules were secreted. The collagenous nature and triple helical conformation of the trimeric molecule were ascertained by the differential resistances of the COL1 and NC1 domains to trypsin and collagenase digestions, respectively. Our data demonstrate that the NC1 and COL1 domains of type XII collagen contain the information necessary for trimer formation and that, contrary to the fibrillar collagen types, posttranslational modification of the triple helical domain is essential for assembly and disulfide bonding of the chains.	ECOLE NORMAL SUPER LYON,F-69364 LYON 07,FRANCE	Ecole Normale Superieure de Lyon (ENS de LYON)	MAZZORANA, M (corresponding author), INST BIOL & CHIM PROT,PASSAGE DU VERCORS,F-69367 LYON 07,FRANCE.		Gruffat, Henri/I-2407-2016	Gruffat, Henri/0000-0002-4735-6894; MAZZORANA, Marlene/0000-0002-3956-4319				BACHINGER HP, 1981, J BIOL CHEM, V256, P3193; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; CHOJKIER M, 1989, J BIOL CHEM, V264, P16957; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; DUBLET B, 1987, J BIOL CHEM, V262, P17724; DUBLET B, 1988, FEBS LETT, V233, P177, DOI 10.1016/0014-5793(88)81379-6; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FESSLER LI, 1974, J BIOL CHEM, V249, P7637; FURTH JJ, 1991, EXP CELL RES, V192, P118, DOI 10.1016/0014-4827(91)90165-Q; GORDON MK, 1991, EUR J BIOCHEM, V201, P333, DOI 10.1111/j.1432-1033.1991.tb16290.x; GORDON MK, 1987, P NATL ACAD SCI USA, V84, P6040, DOI 10.1073/pnas.84.17.6040; GORDON MK, 1990, ANN NY ACAD SCI, V508, P8; GORDON MK, 1989, J BIOL CHEM, V264; KRIEGLER M, 1990, GENE TRANSFER EXPRES, P96; LUNSTRUM GP, 1992, J BIOL CHEM, V267, P20087; LYONS BL, 1984, NUCLEIC ACIDS RES, V12, P2569, DOI 10.1093/nar/12.5.2569; MURAD S, 1981, P NATL ACAD SCI-BIOL, V78, P2879, DOI 10.1073/pnas.78.5.2879; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; OLSEN BR, 1989, COLLAGEN BIOCH BIOTE, P1; SCHWARZ RI, 1978, J CELL BIOL, V79, P672, DOI 10.1083/jcb.79.3.672; SUGRUE SP, 1989, J CELL BIOL, V109, P939, DOI 10.1083/jcb.109.2.939; SUGRUE SP, 1989, INVEST OPHTH VIS SCI, V32, P1876; TAJIMA S, 1982, BIOCHEM BIOPH RES CO, V106, P632, DOI 10.1016/0006-291X(82)91157-3; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VANDERREST M, 1990, BIOCHIMIE, V72, P473, DOI 10.1016/0300-9084(90)90071-N; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; YAMAGATA M, 1991, J CELL BIOL, V115, P209, DOI 10.1083/jcb.115.1.209	30	49	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3029	3032						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428977				2022-12-27	WOS:A1993KM16100004
J	SINHA, U; WOLF, DL				SINHA, U; WOLF, DL			CARBOHYDRATE RESIDUES MODULATE THE ACTIVATION OF COAGULATION FACTOR-X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BOVINE FACTOR-X; BLOOD-COAGULATION	Factor X is a plasma protein involved in both the intrinsic and extrinsic pathways of blood coagulation. Post-translational modifications of the protein involve gamna-carboxylation of specific glutamic acid residues, beta-hydroxylation of one aspartic acid residue, and N- and O-linked glycosylation. Even though it is known that gamma-carboxylation is instrumental in regulating biological activity, the role of glycosylation in the function and properties of factor X has not been previously investigated. We utilized lectin binding and glycosidase treatment to investigate the functional role of carbohydrates on the activation peptide of factor X. Sambucus nigra agglutinin, a lectin that binds to sialic acid terminally linked alpha(2-6) to galactose or N-acetyl-galactosamine inhibits activation of human factor X in a dose-dependent manner. Inhibition of activation was observed for both intrinsic (factor IXa/VIIIa) and extrinsic (factor VIIa/tissue factor) pathway complexes. In accordance with this, selective removal of sialic acid residues on the activation peptide of factor X by neuraminidase also results in a drastic reduction of activation of the zymogen by these complexes. Corresponding reduction of activity in classical clotting assays (activated partial thromboplastin time and prothrombin time) also agrees with this observation. These results suggest a possible role of N-linked carbohydrates in the activation of factor X.			SINHA, U (corresponding author), COR THERAPEUT INC,256 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.							BAJAJ SP, 1983, BIOCHEMISTRY-US, V22, P4047, DOI 10.1021/bi00286a009; DAVIE EW, 1987, HEMOSTASIS THROMBOSI, P250; HILLEUBANKS DC, 1990, J BIOL CHEM, V265, P17854; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; MIZUOCHI T, 1980, J BIOL CHEM, V255, P3526; MORITA T, 1986, J BIOL CHEM, V261, P4015; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; STENFLO J, 1972, J BIOL CHEM, V247, P8160; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; WOLF DL, 1991, J BIOL CHEM, V266, P13726	13	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3048	3051						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428982				2022-12-27	WOS:A1993KM16100009
J	RON, D; BOTTARO, DP; FINCH, PW; MORRIS, D; RUBIN, JS; AARONSON, SA				RON, D; BOTTARO, DP; FINCH, PW; MORRIS, D; RUBIN, JS; AARONSON, SA			EXPRESSION OF BIOLOGICALLY-ACTIVE RECOMBINANT KERATINOCYTE GROWTH-FACTOR - STRUCTURE-FUNCTION ANALYSIS OF AMINO-TERMINAL TRUNCATION MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HEPARIN-BINDING; ENZYMATIC AMPLIFICATION; 3-DIMENSIONAL STRUCTURE; RECEPTOR-BINDING; FACTOR-I; FIBROBLAST; POLYMERASE; PROTEINS; AFFINITY	Keratinocyte growth factor (KGF) is a newly identified member of the fibroblast growth factor (FGF) family (FGF-7). KGF is expressed by stromal fibroblasts and acts on epithelial cells in a paracrine mode. To facilitate structure/function studies, we utilized the T7 prokaryotic expression system to synthesize this growth factor. Recombinant KGF (rKGF) was mitogenic with a specific activity around 10-fold higher than native KGF. By in vitro mutagenesis, we generated a series of KGF mutants with sequential deletions of the amino-terminal domain, the most divergent region among different FGF members. Mutant proteins, produced in bacteria, were tested for their ability to bind heparin, bind and activate the KGF receptor, and induce DNA synthesis. Heparin binding properties were preserved with deletion of up to 28 amino-terminal residues of the mature KGF but lost by the deletion of an additional 10 residues. Biological activity of mutants with deletions of up to 10 residues was comparable to that of rKGF. However, deletion of 29 residues resulted in significantly reduced ability to stimulate KGF receptor tyrosine-kinase activity and DNA synthesis, although this mutant bound the receptor at high affinity. These characteristics of a partial agonist may be useful in the development of competitive antagonists of KGF action.	NCI,CELLULAR & MOLEC BIOL LAB,BLDG 37,RM 1E24,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Bottaro, Donald P/F-8550-2010; Bottaro, Donald P/AAF-3853-2020	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334				BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BOTTARO DP, 1990, J BIOL CHEM, V265, P12767; BURGESS WH, 1991, J CELL BIOCHEM, V45, P131, DOI 10.1002/jcb.240450203; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GIULIAN GG, 1983, ANAL BIOCHEM, V129, P277, DOI 10.1016/0003-2697(83)90551-1; GOSPODAROWICZ D, 1990, J CELL PHYSIOL, V142, P325, DOI 10.1002/jcp.1041420215; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOOMAN AC, 1987, EMBO J, V6, P2489, DOI 10.1002/j.1460-2075.1987.tb02530.x; MANIATIS T, 1982, MOL CLONING LABORATO, pA2; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PASQUALE DB, 1988, MOL CELL BIOL, V8, P2933; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; SHIPLEY GD, 1989, J CELL PHYSIOL, V138, P511, DOI 10.1002/jcp.1041380310; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	31	102	130	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2984	2988						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428972				2022-12-27	WOS:A1993KK81500106
J	YEPIZPLASCENCIA, GM; HO, CM; MARTEL, RR; LAW, JH				YEPIZPLASCENCIA, GM; HO, CM; MARTEL, RR; LAW, JH			MOLECULAR-CLONING AND SEQUENCE OF A NOVEL OMMOCHROME-BINDING PROTEIN CDNA FROM AN INSECT, MANDUCA-SEXTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO HORNWORM; DNA; SIMILARITY; PROGRAMS; ACID	An ommochrome-binding protein (OBP) from the hemolymph of Manduca sexta has recently been purified and characterized. A cDNA clone was isolated from a fifth instar larval cDNA expression library utilizing antiserum against OBP. Northern blot analysis of total fat body RNA detected a transcript of approximately 1.2 kilobases in fifth instar wandering larvae RNA. The complete nucleotide sequence of the 905-base pair cDNA insert was determined by the dideoxy chain termination method. The OBP cDNA encodes a polypeptide of 274 residues with a predicted molecular weight of 30,580 and with one consensus N-linked glycosylation site. Comparison of the NH2-terminal sequence of the mature protein and the cDNA sequence revealed a typical signal peptide of 18 amino acids. In wandering stage larvae, the OBP transcript appeared to be at least 250-fold less abundant than ribosomal RNA.	UNIV ARIZONA,CTR INSECT SCI,TUCSON,AZ 85721; UNIV ARIZONA,DEPT BIOCHEM,TUCSON,AZ 85721; NATL YANG MING MED COLL,DEPT PARASITOL,TAIPEI 11221,TAIWAN	University of Arizona; University of Arizona; National Yang Ming Chiao Tung University			Yepiz, Gloria/ABE-1101-2020	Yepiz-Plascencia, Gloria/0000-0001-5730-4011	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029238] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29238] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTFELD NS, 1990, J BIOL CHEM, V265, P21684; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FOURNEY RM, 1987, FOCUS, V10, P5; GALE K, 1989, EUR J BIOCHEM, V185, P311, DOI 10.1111/j.1432-1033.1989.tb15117.x; HALLICK RB, 1977, NUCLEIC ACIDS RES, V4, P3055, DOI 10.1093/nar/4.9.3055; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Kayser H., 1985, P367; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Maniatis T., 1982, MOL CLONING; MARTEL RR, 1992, INSECT BIOCHEM MOLEC, V22, P561, DOI 10.1016/0965-1748(92)90033-B; MARTEL RR, 1991, J BIOL CHEM, V266, P21392; MARTEL RR, 1991, THESIS U ARIZONA; MOUNT DW, 1986, NUCLEIC ACIDS RES, V14, P443, DOI 10.1093/nar/14.1.443; PRASAD SV, 1986, J BIOL CHEM, V261, P7174; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; VIERA J, 1987, METHOD ENZYMOL, V153, P3; WANG X, 1988, J BIOL CHEM, V263, P8851	21	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2337	2340						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428907				2022-12-27	WOS:A1993KK81500016
J	ERIKSSON, S; NORDEN, B; TAKAHASHI, M				ERIKSSON, S; NORDEN, B; TAKAHASHI, M			BINDING OF DNA QUENCHES TYROSINE FLUORESCENCE OF RECA WITHOUT ENERGY-TRANSFER TO DNA BASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR DICHROISM SPECTROSCOPY; ANGLE NEUTRON-SCATTERING; FLOW-ORIENTED SOLUTION; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; GENERAL RECOMBINATION; ELECTRON-MICROSCOPY; NUCLEOTIDE COFACTOR; SELF-ASSOCIATION; LAMBDA-REPRESSOR	The binding of single- as well as double-stranded DNA to RecA, in the presence of the cofactor analog ATPgammaS (adenosine 5'-O-(3-thiotriphosphate)), leads to about 20% quenching of the tyrosine fluorescence of the protein but to no essential change of the tryptophan fluorescence. The excitation spectrum of the fluorescent DNA analog poly(depsilonA), complexed with RecA, shows no sign of energy transfer from the tyrosine residues of RecA to the etheno-modified adenine bases of the polynucleotide. From this observation we reject stacking interaction between tyrosine residues and DNA bases. The RecA filament may bind up to three molecules of single-stranded DNA; however, the observed fluorescence change occurs only upon the binding of the first DNA strand, indicating that the binding mode of this first strand is different from those of the others. The fluorescence change is interpreted in terms of a conformational change of the RecA protein promoted by cooperative binding to DNA. A larger quenching (40%) upon the binding of single-stranded DNA is observed in the absence of cofactor. At high salt condition, which induces ATPase activity in RecA just as DNA binding does, the tyrosine fluorescence is more pronounced than at low salt conditions, indicating that the effect induced by high salt is different from the conformational change induced by DNA binding.	CNRS,INST BIOL MOLEC & CELLULAIRE,CANCEROGENESE & MUTAGENESE MOLEC & STRUCT GRP,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	ERIKSSON, S (corresponding author), CHALMERS UNIV TECHNOL,DEPT PHYS CHEM,S-41296 GOTHENBURG,SWEDEN.		Norden, Bengt/ABE-3675-2020	Norden, Bengt/0000-0002-7946-200X				BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CHABBERT M, 1987, BIOCHEMISTRY-US, V26, P2218, DOI 10.1021/bi00382a022; CHABBERT M, 1991, J BIOL CHEM, V266, P5395; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; COTTERILL SM, 1982, BIOCHEMISTRY-US, V21, P4332, DOI 10.1021/bi00261a023; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; CRAIG NL, 1980, NATURE, V283, P26, DOI 10.1038/283026a0; DICAPUA E, 1990, J MOL BIOL, V214, P557, DOI 10.1016/0022-2836(90)90198-U; DICAPUA E, 1990, J STRUCT BIOL, V104, P91, DOI 10.1016/1047-8477(90)90062-H; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; DICAPUA E, 1980, NUCLEIC ACIDS MOL BI, V283, P26; ERIKSSON S, 1993, J BIOL CHEM, V268, P1811; GRIFFITH JD, 1988, CRC CR REV BIOCH MOL, V23, pS43, DOI 10.3109/10409238809083375; HELENE C, 1981, CRC CR REV BIOCH MOL, V10, P213, DOI 10.3109/10409238109113600; HORII T, 1991, BIOCHIMIE, V73, P177, DOI 10.1016/0300-9084(91)90200-K; HORII T, 1980, P NATL ACAD SCI-BIOL, V77, P313, DOI 10.1073/pnas.77.1.313; ISHIDA T, 1988, NUCLEIC ACIDS RES, V16, P6175, DOI 10.1093/nar/16.13.6175; KHAMIS MI, 1988, BIOCHIM BIOPHYS ACTA, V950, P132, DOI 10.1016/0167-4781(88)90005-X; KIM SK, 1993, IN PRESS CARCINOGENE; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P5872, DOI 10.1021/bi00368a006; KUBISTA M, 1988, NUCLEOS NUCLEOT, V7, P783, DOI 10.1080/07328318808056330; KUBISTA M, 1990, J BIOL CHEM, V265, P18891; KURAMITSU S, 1981, J BIOCHEM-TOKYO, V90, P1033, DOI 10.1093/oxfordjournals.jbchem.a133555; LEDNEVA RK, 1978, NUCLEIC ACIDS RES, V5, P4225, DOI 10.1093/nar/5.11.4225; LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Longworth J, 1971, EXCITED STATES PROTE, P319; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MUENCH KA, 1991, J BIOL CHEM, V266, P844; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; NORDEN B, 1990, J MOL BIOL, V216, P223, DOI 10.1016/S0022-2836(05)80311-0; NORDEN B, 1992, J MOL BIOL, V226, P1175, DOI 10.1016/0022-2836(92)91060-3; NORDEN B, 1992, STRUCTURE FUNCTION, V2, P61; PUGH BF, 1988, J BIOL CHEM, V263, P76; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; Sasada Y, 1988, Adv Biophys, V24, P57, DOI 10.1016/0065-227X(88)90004-4; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; SMITH GR, 1989, CELL, V58, P807, DOI 10.1016/0092-8674(89)90929-X; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; TAKAHASHI M, 1989, J BIOL CHEM, V264, P8568; TAKAHASHI M, 1991, FEBS LETT, V279, P270, DOI 10.1016/0014-5793(91)80165-Y; TAKAHASHI M, 1987, J BIOL CHEM, V262, P8109; TAKAHASHI M, 1989, EUR J BIOCHEM, V183, P617, DOI 10.1111/j.1432-1033.1989.tb21091.x; TAKAHASHI M, 1989, J MOL BIOL, V205, P137, DOI 10.1016/0022-2836(89)90371-9; TAKAHASHI M, 1991, BIOCHIMIE, V73, P219, DOI 10.1016/0300-9084(91)90205-F; TAKAHASHI M, 1989, J BIOL CHEM, V264, P288; TOULME JJ, 1980, BIOCHIM BIOPHYS ACTA, V606, P95, DOI 10.1016/0005-2787(80)90101-X; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WEINSTOCK GM, 1982, BIOCHIMIE, V64, P611, DOI 10.1016/S0300-9084(82)80098-9; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P883; WILLIAMS RC, 1986, J MOL BIOL, V187, P109, DOI 10.1016/0022-2836(86)90410-9; ZLOTNICK A, 1990, J BIOL CHEM, V265, P17050	58	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1805	1810						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420955				2022-12-27	WOS:A1993KH62000048
J	HARRIS, RZ; NEWMYER, SL; DEMONTELLANO, PRO				HARRIS, RZ; NEWMYER, SL; DEMONTELLANO, PRO			HORSERADISH PEROXIDASE-CATALYZED 2-ELECTRON OXIDATIONS - OXIDATION OF IODIDE, THIOANISOLES, AND PHENOLS AT DISTINCT SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; AROMATIC DONOR MOLECULES; COMPOUND-I; OXYGEN-TRANSFER; IRON COMPLEXES; MECHANISM; HEME; LACTOPEROXIDASE; SULFIDES; CHLOROPEROXIDASE	The atypical two-electron oxidation of thioanisole and its p-methyl, p-methoxy, and p-nitro analogues by horseradish peroxidase, contrary to earlier reports, stereoselectively produces the (S) sulfoxides in 60-70% enantiomeric excess. Horseradish peroxidase reconstituted with delta-meso-ethylheme has little peroxidase (guaiacol oxidizing) activity, as previously reported, but exhibits increased sulfoxidation activity. Difference spectroscopy shows that guaiacol binds to delta-meso-ethylheme-reconstituted horseradish peroxidase even though it is essentially not oxidized. In contrast, horseradish peroxidase reconstituted with delta-meso-methylheme is active in both reactions. Studies with (H2O2)-O-18 show that the oxygen in the sulfoxide produced by delta-meso-ethylheme-reconstituted horseradish peroxidase derives, as it does in the reaction catalyzed by the native enzyme, primarily from the peroxide. Preincubation of horseradish peroxidase with phenylhydrazine, which modifies the protein, suppresses peroxidase activity but does not inhibit thioanisole sulfoxidation. On the other hand, the oxidation of iodide is blocked by reconstitution of horseradish peroxidase with delta-meso-ethylheme or preincubation with phenylhydrazine. Noncompetitive kinetics are observed for the inhibition of guaiacol and iodide oxidation by thioanisole and of guaiacol oxidation by iodide. The kinetic data and the differential inhibitory effects of delta-meso-ethylheme reconstitution and phenylhydrazine preincubation indicate that thioanisole and iodide, both of which undergo net two-electron oxidations, are oxidized at sites distinct from each other and from that involved in the oxidation of guaiacol. Spectroscopic substrate binding studies provide support for distinct thioanisole, guaiacol, and iodide-binding sites. An active site model is proposed to rationalize the results.	UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco				Newmyer, Sherri/0000-0003-1039-5416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032488] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32488] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATOR MA, 1987, J BIOL CHEM, V262, P14954; ATOR MA, 1989, J BIOL CHEM, V264, P9250; ATOR MA, 1987, J BIOL CHEM, V262, P1542; BJORKSTEN F, 1970, BIOCHIM BIOPHYS ACTA, V212, P396, DOI 10.1016/0005-2744(70)90245-7; COLONNA S, 1992, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39920000357; COLONNA S, 1990, BIOCHEMISTRY-US, V29, P10465, DOI 10.1021/bi00498a006; DEMONTELLANO PRO, 1983, J BIOL CHEM, V258, P558; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; DEMONTELLANO PRO, 1987, J BIOL CHEM, V262, P11641; DEMONTELLANO PRO, 1988, BIOCHEMISTRY-US, V27, P5470, DOI 10.1021/bi00415a013; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; DOERGE DR, 1986, ARCH BIOCHEM BIOPHYS, V244, P678, DOI 10.1016/0003-9861(86)90636-3; DOERGE DR, 1991, BIOCHEMISTRY-US, V30, P8960, DOI 10.1021/bi00101a007; DUNFORD HB, 1986, ARCH BIOCHEM BIOPHYS, V251, P536, DOI 10.1016/0003-9861(86)90361-9; DUNFORD HB, 1976, COORDIN CHEM REV, V19, P187, DOI 10.1016/S0010-8545(00)80316-1; ELFARRA AA, 1991, ARCH BIOCHEM BIOPHYS, V286, P244, DOI 10.1016/0003-9861(91)90036-I; FERNANDEZ M, 1991, BIOCHEM BIOPH RES CO, V180, P360, DOI 10.1016/S0006-291X(05)81301-4; GROVES JT, 1986, CYTOCHROME P 450 STR, P1; HARRIS RZ, 1992, BIOCHEMISTRY-US, V31, P2193; HASHIMOTO S, 1986, P NATL ACAD SCI USA, V83, P2417, DOI 10.1073/pnas.83.8.2417; HOSOYA T, 1989, BIOCHEMISTRY-US, V28, P2639, DOI 10.1021/bi00432a042; JOB D, 1976, EUR J BIOCHEM, V66, P607, DOI 10.1111/j.1432-1033.1976.tb10588.x; KEDDERIS GL, 1986, J BIOL CHEM, V261, P5910; Klebanoff S.J., 1991, PEROXIDASES CHEM BIO, P1; KOBAYASHI S, 1987, BIOCHEMISTRY-US, V26, P5019, DOI 10.1021/bi00390a020; KOBAYASHI S, 1986, BIOCHEM BIOPH RES CO, V135, P166, DOI 10.1016/0006-291X(86)90957-5; LEIGH JS, 1975, FEBS LETT, V51, P304, DOI 10.1016/0014-5793(75)80913-6; LEMAR GN, 1992, BIOCHEMISTRY-US, V31, P9158; MAGNUSSON RP, 1984, J BIOL CHEM, V259, P3783; Marnett L.J., 1986, CYTOCHROME P 450 STR, P29; MEUNIER G, 1985, J BIOL CHEM, V260, P576, DOI 10.1016/S0021-9258(19)85124-4; MILLER VP, 1992, J BIOL CHEM, V267, P8936; MODI S, 1989, J BIOL CHEM, V264, P19677; NARUTA Y, 1990, J CHEM SOC CHEM COMM, P1378, DOI 10.1039/c39900001378; NEWMYER SL, 1992, BIOCHEMISTRY-US, V31, P2195; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; PAUL KG, 1978, ACTA CHEM SCAND B, V32, P395, DOI 10.3891/acta.chem.scand.32b-0395; PEREZ U, 1990, BIOCHIM BIOPHYS ACTA, V1038, P98, DOI 10.1016/0167-4838(90)90016-9; PEREZ U, 1990, BIOCHEMISTRY-US, V29, P2757, DOI 10.1021/bi00463a019; RAAG R, 1990, BIOCHEMISTRY-US, V29, P8119, DOI 10.1021/bi00487a019; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; ROMAN R, 1972, BIOCHEMISTRY-US, V11, P2076, DOI 10.1021/bi00761a013; SAKURADA J, 1987, J BIOL CHEM, V262, P4007; SAKURADA J, 1986, J BIOL CHEM, V261, P9657; SAXENA A, 1990, BIOCHIM BIOPHYS ACTA, V1041, P83, DOI 10.1016/0167-4838(90)90126-Z; SCHEJTER A, 1976, ARCH BIOCHEM BIOPHYS, V174, P36, DOI 10.1016/0003-9861(76)90321-0; SWANSON BA, 1991, J BIOL CHEM, V266, P19258; THANABAL V, 1987, J AM CHEM SOC, V109, P7516, DOI 10.1021/ja00258a043	48	97	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1637	1645						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420938				2022-12-27	WOS:A1993KH62000023
J	JACKSON, DG; SMITH, DK; LUO, CL; ELLIOTT, JF				JACKSON, DG; SMITH, DK; LUO, CL; ELLIOTT, JF			CLONING OF A NOVEL SURFACE-ANTIGEN FROM THE INSECT STAGES OF TRYPANOSOMA-BRUCEI BY EXPRESSION IN COS CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFRICAN TRYPANOSOMES; GENE-EXPRESSION; REPETITIVE PROTEIN; MOLECULAR-CLONING; CULTURE FORMS; AMINO-ACIDS; T-BRUCEI; GLYCOPROTEIN; PROCYCLIN; SEQUENCE	Trypanosoma brucei cDNA libraries constructed in the vector pCDM8 were screened selectively for insect (procyclic) stage surface antigen cDNAs by transient expression in mammalian COS-7 fibroblasts and ''panning'' with a rabbit polyclonal antiserum. This strategy yielded two surface antigen cDNAs termed PSSA-1 and PSSA-2. The PSSA-1 cDNA encoded an isotype of procyclin, the major phosphatidylinositol-linked stage-specific glycoprotein antigen of the tsetse fly infective forms of T. brucei. The PSSA-2 cDNA encoded a new and previously unidentified stage-specific surface antigen with the features of a typical transmembrane glycoprotein but with an unusual cytoplasmic tail composed of a proline-rich tandem repeat. Fluorescent antibody staining of PSSA-1 transfected COS cells with a panel of procyclin-specific monoclonal antibodies confirmed that the protein was located on the outer surface of the plasma membrane. Furthermore, the antigen on COS cells was insensitive to treatment with phosphatidylinositol-specific phospholipase C suggesting that the inositol of the glycosylinositol phospholipid-lipid anchor contained the same fatty acyl modification reported recently for the procyclin molecule in cultured procyclic trypanosomes. In contrast the PSSA-2 antigen on COS cells was stained very weakly by whole parasite antisera. Northern blot hybridization revealed that the PSSA-2 antigen was encoded by a single 1.7-kilobase transcript which was present in parasites from the insect procyclic stage of the life cycle but not from the animal bloodstream stage. Southern blot hybridization analysis of DNA from procyclic stage trypanosomes indicated that the gene for PSSA-2 may be present in more than one copy in procyclic trypanosomes.	UNIV ALBERTA, DEPT IMMUNOL, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV ALBERTA, DEPT MED MICROBIOL & INFECT DIS, EDMONTON T6G 2H7, ALBERTA, CANADA	University of Alberta; University of Alberta	JACKSON, DG (corresponding author), UNIV OXFORD, JOHN RADCLIFFE HOSP, INST MOLEC MED, MOLEC IMMUNOL GRP, OXFORD OX3 9DU, ENGLAND.			, david/0000-0002-4133-9364	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELOPOULOS E, 1970, J PROTOZOOL, V17, P39, DOI 10.1111/j.1550-7408.1970.tb05157.x; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BOOTHROYD JC, 1982, J MOL BIOL, V157, P547, DOI 10.1016/0022-2836(82)90475-2; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BRUN R, 1979, ACTA TROP, V36, P289; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; CULLY DF, 1985, CELL, V42, P173, DOI 10.1016/S0092-8674(85)80113-6; DORN PL, 1991, MOL BIOCHEM PARASIT, V44, P133, DOI 10.1016/0166-6851(91)90229-Y; DUNCAN LR, 1991, MOL BIOCHEM PARASIT, V48, P11, DOI 10.1016/0166-6851(91)90159-4; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIELD MC, 1992, J BIOL CHEM, V267, P5324; FISCHER GF, 1990, J IMMUNOL, V144, P638; GARDINER PR, 1983, J IMMUNOL, V131, P454; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; JACKSON DG, 1992, J BIOL CHEM, V267, P4732; JACKSON DG, 1985, BIOCHEM J, V230, P195, DOI 10.1042/bj2300195; JACKSON DG, 1990, BIOCHEM SOC T, V18, P1032, DOI 10.1042/bst0181032; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Maniatis T., 1982, MOL CLONING; MOWATT MR, 1987, MOL CELL BIOL, V7, P2838, DOI 10.1128/MCB.7.8.2838; MOWATT MR, 1988, MOL CELL BIOL, V8, P4055, DOI 10.1128/MCB.8.10.4055; OZAKI LS, 1983, NATURE, V305, P29; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; RICHARDSON JP, 1986, J IMMUNOL, V136, P2259; RICHARDSON JP, 1988, MOL BIOCHEM PARASIT, V31, P203, DOI 10.1016/0166-6851(88)90150-8; RODITI I, 1987, NATURE, V325, P272, DOI 10.1038/325272a0; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; RODITI I, 1990, PARASITOL TODAY, V6, P79, DOI 10.1016/0169-4758(90)90216-Q; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHELL D, 1991, EMBO J, V10, P1061, DOI 10.1002/j.1460-2075.1991.tb08045.x; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SIMMONS D, 1988, J IMMUNOL, V141, P2797; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; VICKERMAN K, 1969, NATURE, V224, P1125, DOI 10.1038/2241125a0; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WONG RSC, 1980, J BIOL CHEM, V255, P5943; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10797	46	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1894	1900						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420963				2022-12-27	WOS:A1993KH62000061
J	MUNIER, H; BLANCO, FJ; PRECHEUR, B; DIESIS, E; NIETO, JL; CRAESCU, CT; BARZU, O				MUNIER, H; BLANCO, FJ; PRECHEUR, B; DIESIS, E; NIETO, JL; CRAESCU, CT; BARZU, O			CHARACTERIZATION OF A SYNTHETIC CALMODULIN-BINDING PEPTIDE DERIVED FROM BACILLUS-ANTHRACIS ADENYLATE-CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BORDETELLA-PERTUSSIS; SECONDARY STRUCTURE; ALPHA-HELICES; CATALYTIC ACTIVITY; CHEMICAL-SHIFTS; TRUNCATED FORM; PROTEINS; IDENTIFICATION; DOMAIN	A 34-amino acid peptide corresponding to residues 532-565 of Bacillus anthracis adenylate cyclase (P532-565), a calmodulin (CaM)-activated enzyme, was synthesized by solid phase method. Although not homologous to any known CaM binding sequence, P532-565 exhibits molecular features characteristic of this class of peptides: a higher proportion of basic and hydrophobic residues, segregated onto the two faces of the alpha-helical structure. Fluorescence measurements and gel retardation analysis showed that P532-565 binds CaM in a Ca2+-dependent manner, with a binding energy that represents 80% of the binding energy of the adenylate cyclase-CaM complex. Circular dichroism analysis showed that P532-565 exists in solution as a mixture of random-coil and alpha-helical structures and that trifluoroethanol increases the relative proportion of alpha-helical population. Analysis of proton NMR spectrum in H2O allowed identification of the different amino acid spin systems and complete spectral assignment. The pattern of nuclear Overhauser effect connectivities, intense NN(i,i + 1) and medium range alphaN(i,i + 3) and alphabeta(i,i + 3) indicate the presence of an alpha-helix in the carboxyl-terminal end (between residues 551 and 563) in fast exchange with extended structures. These data, together with CaM-binding properties of Bordetella pertussis adenylate cyclase, show that despite rather divergent primary structures, the two bacterial enzymes possess similar structural organization of their binding sites for activator protein.	INST PASTEUR,UNITE BIOCHIM REGULAT CELLULAIRES,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE; CSTC,INST ESTRUCT MAT,E-28006 MADRID,SPAIN; HOP HENRI MONDOR,INSERM,U91,F-94010 CRETEIL,FRANCE; INST PASTEUR,SERV CHIM BIOMOLEC,F-59019 LILLE,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille			Blanco, Francisco J/D-4401-2009; Munier-Lehmann, Hélène/Q-1867-2019; Munier-Lehmann, Helene/N-9889-2017	Blanco, Francisco J/0000-0003-2545-4319; Munier-Lehmann, Hélène/0000-0001-7579-8561; Munier-Lehmann, Helene/0000-0001-7579-8561				AU DC, 1989, BIOCHEMISTRY-US, V28, P2772, DOI 10.1021/bi00433a005; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; BOUHSS A, 1993, J BIOL CHEM, V268, P1690; BRUIX M, 1990, BIOCHEM BIOPH RES CO, V167, P1009, DOI 10.1016/0006-291X(90)90623-U; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; ESCUYER V, 1988, GENE, V71, P293, DOI 10.1016/0378-1119(88)90045-5; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; JAMES P, 1988, J BIOL CHEM, V263, P2905; JIMENEZ MA, 1987, FEBS LETT, V221, P320, DOI 10.1016/0014-5793(87)80948-1; JIMENEZ MA, 1986, J MOL STRUCT, V143, P435, DOI 10.1016/0022-2860(86)85294-2; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KUNTZ ID, 1991, J AM CHEM SOC, V113, P1406, DOI 10.1021/ja00004a050; LABRUYERE E, 1990, BIOCHEMISTRY-US, V29, P4922, DOI 10.1021/bi00472a024; LABRUYERE E, 1991, BIOCHEMISTRY-US, V30, P2619, DOI 10.1021/bi00224a008; LADANT D, 1992, J BIOL CHEM, V267, P2244; LADANT D, 1988, J BIOL CHEM, V263, P2612; LADANT D, 1989, J BIOL CHEM, V264, P4015; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PRECHEUR B, 1992, BIOCHEMISTRY-US, V31, P229, DOI 10.1021/bi00116a032; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; SARFATI RS, 1990, J BIOL CHEM, V265, P18902; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; SZILAGYI L, 1989, J MAGN RESON, V83, P441, DOI 10.1016/0022-2364(89)90341-7; TIPPETTS MT, 1988, J BACTERIOL, V170, P2263, DOI 10.1128/jb.170.5.2263-2266.1988; WILLIAMSON M P, 1990, Biopolymers, V29, P1423, DOI 10.1002/bip.360291009; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; XIA ZG, 1990, J BIOL CHEM, V265, P6517	34	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1695	1701						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420946				2022-12-27	WOS:A1993KH62000031
J	PETRENKO, AG; LAZARYEVA, VD; GEPPERT, M; TARASYUK, TA; MOOMAW, C; KHOKHLATCHEV, AV; USHKARYOV, YA; SLAUGHTER, C; NASIMOV, IV; SUDHOF, TC				PETRENKO, AG; LAZARYEVA, VD; GEPPERT, M; TARASYUK, TA; MOOMAW, C; KHOKHLATCHEV, AV; USHKARYOV, YA; SLAUGHTER, C; NASIMOV, IV; SUDHOF, TC			POLYPEPTIDE COMPOSITION OF THE ALPHA-LATROTOXIN RECEPTOR - HIGH-AFFINITY BINDING-PROTEIN CONSISTS OF A FAMILY OF RELATED HIGH-MOLECULAR-WEIGHT POLYPEPTIDES COMPLEXED TO A LOW-MOLECULAR-WEIGHT PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WIDOW SPIDER VENOM; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; BRAIN SYNAPTOSOMES; SYNAPTIC VESICLES; PLASMA-MEMBRANE; PURIFICATION; EXOCYTOSIS	Alpha-latrotoxin is a vertebrate neurotoxin from black widow spider venom that causes massive neurotransmitter release. In order to gain insight into the mechanism of action of alpha-latrotoxin, we have studied alpha-latrotoxin-binding proteins from bovine and rat brain. Proteins purified by affinity chromatography on immobilized alpha-latrotoxin were investigated. Two sets of proteins were isolated: 1) three polypeptides of M(r) 79,000, 65,000, and 43,000 that were eluted from immobilized alpha-latrotoxin by increasing KCl concentrations in the presence of Ca2+, and 2) a family of related proteins ranging in molecular weight from 160,000 to 220,000 and a low molecular weight component of M(r) 29,000 that were eluted from immobilized alpha-latrotoxin only after removal of Ca2+. Amino acid sequences of these proteins demonstrated that all of these proteins represent novel proteins except for the M(r) 65,000 polypeptide, which is identical with synaptotagmin (Petrenko, A. G., Perin, M. S., Davletov, B. A., Ushkaryov, Y. A., Geppert, M., and Sudhof, T. C. (1991) Nature 353, 65-68). Surprisingly, the M(r) 79,000 and 43,000 proteins were also found in tissues insensitive to alpha-latrotoxin action. Since these proteins do not bind I-125-alpha-latrotoxin with high affinity, their purification probably is not physiologically significant. On the other hand, the fractions containing the M(r) 160,000-220,000 and 29,000 polypeptides bound alpha-latrotoxin with high affinity. Sucrose gradient centrifugations and anion exchange chromatography suggested that most of the M(r) 160,000-220,000 proteins were complexed with the M(r) 29,000 protein. Alpha-latrotoxin binding correlated with the presence of the M(r) 160,000220, 000 proteins and M(r) 29,000 polypeptide, and alpha-latrotoxin formed stable complexes with the M(r) 160,000-220,000 proteins. Accordingly, the alpha-latrotoxin receptor consists of a high molecular weight protein (M(r) 160,000-220,000) that is complexed with one or several copies of an M(r) 29,000 polypeptide. In addition, the receptor is found in a less tight association with synaptotagmin but not with other polypeptides.	UNIV TEXAS,SW MED SCH,HOWARD HUGHES MED INST,DALLAS,TX 75235; SHEMYAKIN BIOORGAN CHEM INST,MOSCOW 117871,RUSSIA; UNIV TEXAS,DEPT MOLEC GENET,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Texas System; University of Texas Dallas			Ushkaryov, Yuri/AAQ-2985-2020	Ushkaryov, Yuri/0000-0002-5712-8297; Petrenko, Alexander/0000-0002-6689-6546				CLARK AW, 1970, NATURE, V225, P703, DOI 10.1038/225703a0; COCHET C, 1988, J BIOL CHEM, V263, P3290; FESCE R, 1986, J GEN PHYSIOL, V88, P59, DOI 10.1085/jgp.88.1.59; FINKELSTEIN A, 1976, SCIENCE, V193, P1009, DOI 10.1126/science.948756; FRITZ LC, 1980, NATURE, V283, P486, DOI 10.1038/283486a0; FRONTALI N, 1976, J CELL BIOL, V68, P462, DOI 10.1083/jcb.68.3.462; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MATUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCMAHON HT, 1990, J NEUROCHEM, V55, P2039, DOI 10.1111/j.1471-4159.1990.tb05793.x; MELDOLESI J, 1982, J NEUROCHEM, V38, P1559, DOI 10.1111/j.1471-4159.1982.tb06633.x; MORRISEY JH, 1988, ANAL BIOCHEM, V117, P307; NICHOLLS DG, 1982, P NATL ACAD SCI-BIOL, V79, P7924, DOI 10.1073/pnas.79.24.7924; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; PETRENKO AG, 1990, EMBO J, V9, P2023, DOI 10.1002/j.1460-2075.1990.tb08331.x; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; QUEIROZ LS, 1982, PROC R SOC SER B-BIO, V216, P103, DOI 10.1098/rspb.1982.0063; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; SCHEER H, 1985, EMBO J, V4, P323, DOI 10.1002/j.1460-2075.1985.tb03632.x; TZENG MC, 1979, J NEUROCHEM, V33, P263, DOI 10.1111/j.1471-4159.1979.tb11728.x; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1986, BIOORG KHIM+, V12, P71; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124	25	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1860	1867						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420960				2022-12-27	WOS:A1993KH62000057
J	SUN, JD; ODDOUX, C; LAZARUS, A; GILBERT, MT; CATANZARO, DF				SUN, JD; ODDOUX, C; LAZARUS, A; GILBERT, MT; CATANZARO, DF			PROMOTER ACTIVITY OF HUMAN RENIN 5'-FLANKING DNA-SEQUENCES IS ACTIVATED BY THE PITUITARY-SPECIFIC TRANSCRIPTION FACTOR PIT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GROWTH-HORMONE; PROLACTIN GENE; MESSENGER-RNA; EXPRESSION; RAT; BINDING; CELLS; PROTEIN; SYSTEM; ASSAY	Although the renal juxtaglomerular cell is the source of circulating renin, the renin gene is also expressed at a number of extrarenal sites including lactotrope cells of human and ovine pituitaries. In the present study, we demonstrate that GC cells, a pituitary lactotrope precursor cell line, efficiently express transiently transfected hybrid genes containing human renin 5'-flanking DNA sequences -148/+11. Gel mobility shift competition analyses show that a highly conserved sequence in human and rodent renin 5'-flanking DNAs (human coordinates: -80/-58) binds a nuclear factor from GC cells, most likely the pituitary-specific factor Pit-1. Deletional and mutational analyses demonstrate that this site is a major determinant of renin promoter activity in GC cells. Transfection of a Pit-1 expression construct into HeLa cells, where activity of the human renin promoter is low, stimulates expression of cotransfected renin-luciferase constructs. Moreover, activation of the human renin promoter by co-expression of Pit-1 is dependent on an intact Pit-1 site. Taken together, these data strongly suggest that Pit-1 activates pituitary renin gene expression. This finding raises the possibility that member(s) of the POU family of transcription factors, of which Pit-1 is an archetypal member, may direct renin expression in other tissues, including the kidney.	CORNELL UNIV, MED CTR, COLL MED, CTR CARDIOVASC, 525 E 68TH ST, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT MED, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT PHYSIOL, NEW YORK, NY 10021 USA	Cornell University; Cornell University; Cornell University								BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BURNHAM CE, 1987, P NATL ACAD SCI USA, V84, P5605, DOI 10.1073/pnas.84.16.5605; BURT DW, 1989, GENE, V84, P91, DOI 10.1016/0378-1119(89)90143-1; DESCHEPPER CF, 1986, P NATL ACAD SCI USA, V83, P7552, DOI 10.1073/pnas.83.19.7552; ELSHOLTZ HP, 1990, GENE DEV, V4, P43, DOI 10.1101/gad.4.1.43; FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069; HARDMAN JA, 1984, DNA-J MOLEC CELL BIO, V3, P457, DOI 10.1089/dna.1.1984.3.457; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES CA, 1990, MOL ENDOCRINOL, V4, P375, DOI 10.1210/mend-4-3-375; JONES GJ, 1991, MOL ENDOCRINOL, V5, P1836, DOI 10.1210/mend-5-12-1836; KETTANI S, 1991, HISTOCHEMISTRY, V95, P561, DOI 10.1007/BF00266742; KINGSTON RE, 1991, CURRENT PROTOCOLS MO; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; NARUSE K, 1981, P NATL ACAD SCI-BIOL, V78, P7579, DOI 10.1073/pnas.78.12.7579; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SAINTANDRE JP, 1989, HISTOCHEMISTRY, V91, P291, DOI 10.1007/BF00493003; SCHADLOW VC, 1992, MOL BIOL CELL, V3, P941, DOI 10.1091/mbc.3.8.941; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SEALEY JE, 1986, AM J MED, V81, P1041, DOI 10.1016/0002-9343(86)90402-X; SEALEY JE, 1990, FRONT NEUROENDOCRIN, V11, P213; Sealey JE, 1990, HYPERTENSION PATHOPH, P1287; SHARP ZD, 1989, NUCLEIC ACIDS RES, V17, P2705, DOI 10.1093/nar/17.7.2705; SIGMUND CD, 1991, HYPERTENSION, V18, P446, DOI 10.1161/01.HYP.18.4.446; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P3617, DOI 10.1093/nar/20.14.3617; TANSEY WP, 1991, J BIOL CHEM, V266, P9805; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	28	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1505	1508						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420924				2022-12-27	WOS:A1993KH62000002
J	CAWLEY, KC; AKITA, CG; ANGELOS, KL; WALSH, DA				CAWLEY, KC; AKITA, CG; ANGELOS, KL; WALSH, DA			CHARACTERIZATION OF THE GENE FOR RAT PHOSPHORYLASE-KINASE CATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS; ENHANCER BINDING; BETA-SUBUNITS; DNA-BINDING; EXPRESSION; SEQUENCE; MYOD; IDENTIFICATION	Phosphorylase kinase, a key enzyme in glycogen metabolism, has a subunit composition of (alphabetagammadelta)4, in which the alpha and beta subunits are regulatory, delta is calmodulin, and the gamma subunit is catalytic. As one segment of our studies on the regulation of the expression of phosphorylase kinase subunits, we present in this report the structure of the gene for the catalytic gamma subunit. The gene extends over 16 kilobase pairs (kb) of DNA, and contains eight introns within the coding region plus one 3.3-kb intron upstream in the 5'-untranslated region. Within this first intron, and also upstream of the transcription start site, are sequences homologous to defined regulatory elements, including some found in other muscle-specific genes. The positions of intron splice junctions for this gene have been compared with similar data for other protein kinase genes. A somewhat unexpected finding for the gamma subunit is that two of the splice junctions fall in the midst of highly conserved strings of amino acids, both of which have been nominally defined as functional domains for the protein kinases and appear to make key contributions to substrate binding and phosphotransferase catalysis.			CAWLEY, KC (corresponding author), UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013613] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK13613] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BALDWIN TJ, 1989, NATURE, V341, P716, DOI 10.1038/341716a0; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BUSHKIN JN, 1989, MOL CELL BIOL, V9, P2627; CAWLEY KC, 1992, J BIOL CHEM, V267, P17287; CAWLEY KC, 1988, NUCLEIC ACIDS RES, V16, P2355, DOI 10.1093/nar/16.5.2355; CAWLEY KC, 1989, BIOCHEM J, V263, P223, DOI 10.1042/bj2630223; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GORIN F, 1989, AM J PHYSIOL, V257, pC495, DOI 10.1152/ajpcell.1989.257.3.C495; GROSS RE, 1990, J BIOL CHEM, V265, P6896; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARMANN B, 1991, J BIOL CHEM, V266, P15631; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HU ED, 1990, J BIOL CHEM, V265, P5072; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KALDERON D, 1989, J BIOL CHEM, V264, P10738; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LAWRENCE JC, 1986, AM J PHYSIOL, V250, pC84, DOI 10.1152/ajpcell.1986.250.1.C84; LAWRENCE JC, 1986, J BIOL CHEM, V261, P8556; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; LOCKYER JM, 1991, J BIOL CHEM, V266, P20262; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEWSHOLME P, 1992, J BIOL CHEM, V267, P810; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PAUDEL HK, 1991, P NATL ACAD SCI USA, V87, P7285; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pickett-Gies CA., 1986, ENZYMES, V17, P395; PICKETTGIES CA, 1987, J BIOL CHEM, V262, P3227; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Rosenthal N, 1989, CURR OPIN CELL BIOL, V1, P1094, DOI 10.1016/S0955-0674(89)80056-0; SALSGIVER WJ, 1986, AM J PHYSIOL, V250, pC365, DOI 10.1152/ajpcell.1986.250.3.C365; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104	44	13	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1194	1200						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419323				2022-12-27	WOS:A1993KG07700065
J	NATARAJAN, V; TAHER, MM; ROEHM, B; PARINANDI, NL; SCHMID, HHO; KISS, Z; GARCIA, JGN				NATARAJAN, V; TAHER, MM; ROEHM, B; PARINANDI, NL; SCHMID, HHO; KISS, Z; GARCIA, JGN			ACTIVATION OF ENDOTHELIAL-CELL PHOSPHOLIPASE-D BY HYDROGEN-PEROXIDE AND FATTY-ACID HYDROPEROXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERT-BUTYL-HYDROPEROXIDE; GLUTATHIONE REDOX CYCLE; OXYGEN RADICALS; PHORBOL ESTER; ADENOSINE-TRIPHOSPHATE; LIPID-PEROXIDATION; OXIDANT INJURY; LUNG INJURY; MECHANISMS; METABOLISM	We have investigated oxidant-mediated stimulation of phospholipase D (PLD) activity in bovine pulmonary artery endothelial cells (BPAEC), prelabeled with [P-32] orthophosphate or [P-32]lysophospholipids. Treatment of cells incubated in Hanks' balanced salt solution (HBSS) containing 0.5% ethanol with hydrogen peroxide (H2O2) or linoleic acid hydroperoxide (18:2-OOH) enhanced the formation of P-32-labeled phosphatidylethanol (PEt) and phosphatidic acid (PA) in a dose- and time-dependent manner. indicating the activation of PLD. The H2O2- and 18:2-OOH-mediated PLD activation was not associated with cytotoxicity as determined by [H-3]deoxyglucose release. The addition of ferrous chloride (50 muM) augmented H2O2-induced formation of [P-32]PEt and [P-32]PA about 2-fold, whereas the addition of the iron chelator desferoxamine blocked the potentiating effect of ferrous chloride. Replacement of the HBSS medium with Medium 199 containing 20% calf serum also potentiated the effect of H2O2-induced PLD activation. In addition to phosphatidyl-choline (PC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI) were readily hydrolyzed by PLD in response to H2O2 and 18:2-OOH treatment. The substrate specificity for oxidant-stimulated PLD activity differed from that observed in the presence of bradykinin or exhibited by agonist stimulation with 12-O-tetradecanoylphorbol 13-acetate (TPA) where PC was the major phospholipid hydrolyzed by PLD. The formation of PEt in the presence of H2O2 and 18:2-OOH was not abolished by chelation of either extracellular Ca2+ with EGTA (5 mM) or intracellular Ca2+ with 1,2-bis-(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid-acetoxymethyl ester (BAPTA-AM) (25 muM, 30 min). Furthermore, pretreatment of BPAEC with the protein kinase C (PKC) inhibitor staurosporine and down-regulation of PKC by chronic TPA treatment (100 nM, 18 hr) had no effect on H2O2-induced PLD activation, suggesting that PLD activation by H2O2 is independent of PKC activity. It is possible that H2O2- and 18:2-OOH-induced activation of PLD represents an important mechanism to produce PA and diacylglycerol in endothelial cells.	UNIV MINNESOTA,HORMEL INST,AUSTIN,MN 55912	University of Minnesota System	NATARAJAN, V (corresponding author), INDIANA UNIV,SCH MED,DEPT MED,DIV PULM,1001 W 10TH ST,OPW 425,INDIANAPOLIS,IN 46202, USA.		Garcia, Joe GN/E-8862-2010		NCRR NIH HHS [PHS507 RR5371L] Funding Source: Medline; NHLBI NIH HHS [HL02312, HL 47671] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047671, R55HL047671, K08HL002312] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREOLI SP, 1985, J LAB CLIN MED, V106, P253; ANDREOLI SP, 1990, J LAB CLIN MED, V115, P304; BALSINDE J, 1988, BIOCHEM BIOPH RES CO, V154, P502, DOI 10.1016/0006-291X(88)90168-4; BARCHOWSKY A, 1987, BIOCHIM BIOPHYS ACTA, V927, P372, DOI 10.1016/0167-4889(87)90102-9; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Buege J A, 1978, Methods Enzymol, V52, P302; CAO YZ, 1990, BIOCHEM BIOPH RES CO, V171, P955, DOI 10.1016/0006-291X(90)90777-K; CHAKRABORTI S, 1989, AM J PHYSIOL, V257, pL430, DOI 10.1152/ajplung.1989.257.6.L430; COOK SJ, 1991, BIOCHEM SOC T, V19, P108; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; DUANE PG, 1991, AM J RESP CELL MOL, V4, P408, DOI 10.1165/ajrcmb/4.5.408; ELLIOTT SJ, 1989, J BIOL CHEM, V264, P3806; EXTON JH, 1990, J BIOL CHEM, V265, P1; FARRUKH IS, 1988, AM REV RESPIR DIS, V137, P1343, DOI 10.1164/ajrccm/137.6.1343; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GARCIA JGN, 1992, BLOOD, V79, P2056; GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115; GARCIA JGN, 1992, LUNG VASCULAR INJURY, P1; GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; HARLAN JM, 1981, J CLIN INVEST, V68, P1394, DOI 10.1172/JCI110390; HARLAN JM, 1984, J CLIN INVEST, V73, P706, DOI 10.1172/JCI111263; HARLAN JM, 1984, J CLIN INVEST, V74, P442, DOI 10.1172/JCI111440; HARLAN JM, 1985, BLOOD, V65, P5136; JANERO DR, 1988, LIPIDS, V23, P452, DOI 10.1007/BF02535519; JOHNSON A, 1989, AM J PHYSIOL, V256, pH1012, DOI 10.1152/ajpheart.1989.256.4.H1012; KAPPUS H, 1992, LIPID PEROXIDATION M, P273; KISS Z, 1990, PROG LIPID RES, V29, P141, DOI 10.1016/0163-7827(90)90001-2; KISS Z, 1989, J BIOL CHEM, V264, P1483; LEWIS MS, 1988, J CLIN INVEST, V82, P2045, DOI 10.1172/JCI113825; MARTIN TW, 1989, BIOCHEM BIOPH RES CO, V165, P319, DOI 10.1016/0006-291X(89)91072-3; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; MICCADEI S, 1988, ARCH BIOCHEM BIOPHYS, V265, P311, DOI 10.1016/0003-9861(88)90133-6; NATARAJAN V, 1992, IN PRESS J LAB CLIN; PARINANDI NL, 1990, ARCH BIOCHEM BIOPHYS, V280, P45, DOI 10.1016/0003-9861(90)90516-2; PATEL JM, 1991, AM J RESP CELL MOL, V5, P321, DOI 10.1165/ajrcmb/5.4.321; PHILLIPS FC, 1979, LIPIDS, V14, P949, DOI 10.1007/BF02533511; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SARAN M, 1989, FREE RADICAL RES COM, V7, P213, DOI 10.3109/10715768909087944; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; SHASBY DM, 1985, BLOOD, V65, P605; SHASBY DM, 1988, BLOOD, V72, P491; SPRAGG RG, 1985, J CLIN INVEST, V76, P1471, DOI 10.1172/JCI112126; SUTTORP N, 1986, AM J PHYSIOL, V251, pC671, DOI 10.1152/ajpcell.1986.251.5.C671; TROTTA RJ, 1981, BIOCHIM BIOPHYS ACTA, V678, P230, DOI 10.1016/0304-4165(81)90211-7; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VERCELLOTTI GM, 1991, J LAB CLIN MED, V117, P15; WANG P, 1991, J BIOL CHEM, V266, P14877; WARD PA, 1991, J LAB CLIN MED, V118, P421; WHORTON AR, 1985, J CLIN INVEST, V76, P295, DOI 10.1172/JCI111960	55	212	219	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					930	937						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419372				2022-12-27	WOS:A1993KG07700029
J	LOMAS, DA; EVANS, DL; UPTON, C; MCFADDEN, G; CARRELL, RW				LOMAS, DA; EVANS, DL; UPTON, C; MCFADDEN, G; CARRELL, RW			INHIBITION OF PLASMIN, UROKINASE, TISSUE PLASMINOGEN-ACTIVATOR, AND C1S BY A MYXOMA VIRUS SERINE PROTEINASE-INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; CRYSTAL-STRUCTURE; FIBROMA VIRUS; COWPOX VIRUS; ALPHA-1-ANTITRYPSIN; RECOMBINANT; OVALBUMIN; SERPINS; FAMILY; GENES	The myxoma and malignant rabbit fibroma poxviruses are lethal tumorigenic viruses of rabbits whose virulence is modulated by the production of a virus-encoded secreted serine proteinase inhibitor, SERP-1. This viral protein was detected in medium harvested from myxoma and malignant rabbit fibroma virus-infected cells, and its inhibitory profile has been characterized by gel and kinetic analysis. SERP-1 forms complexes with and inhibits the human fibrinolytic enzymes plasmin, urokinase, and two-chain tissue-type plasminogen activator (association rate constants 3.4 X 10(4), 4.3 x 10(4), and 3.6 x 10(4) M-1 s-1 respectively). It is also able to inhibit C1S, the first enzyme in the complement cascade with an association rate constant which was unaffected by the addition of heparin (1.3 X 10(3) M-1 s-1). SERP-1 acts as a substrate for and is cleaved by thrombin, porcine trypsin, human neutrophil elastase, porcine pancreatic elastase, thermolysin, subtilisin, bovine alpha-chymotrypsin, and factor Xa. Incubation with kallikrein and cathepsin G had no effect. The structure of SERP-1 has been modeled on other members of the serpin family which revealed the characteristic serpin architecture apart from the absence of the D-helix. Structural analysis and kinetic assays demonstrate that the absence of this region does not prevent inhibitory activity and furthermore allow the identification of cysteine residues involved in internal and intermolecular disulfide bonding.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,ALBERTA,CANADA	University of Alberta	LOMAS, DA (corresponding author), UNIV CAMBRIDGE,MRC CTR,DEPT HAEMATOL,CAMBRIDGE CB2 2QH,ENGLAND.		Upton, Chris/A-4670-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BLOCK W, 1985, VIROLOGY, V140, P113, DOI 10.1016/0042-6822(85)90450-7; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BOURSNELL MEG, 1988, J GEN VIROL, V69, P2995, DOI 10.1099/0022-1317-69-12-2995; BOYLE MDP, 1987, J IMMUNOL, V139, P169; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHUA TP, 1990, IMMUNOLOGY, V69, P202; CREIGHTON TE, 1988, BIOESSAYS, V8, P57, DOI 10.1002/bies.950080204; DOOLITTLE RF, 1983, SCIENCE, V222, P417, DOI 10.1126/science.6604942; ELLIS V, 1986, BIOCHEM J, V238, P329, DOI 10.1042/bj2380329; EVANS DL, 1991, J BIOL CHEM, V266, P22307; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; HARRISON RA, 1983, BIOCHEMISTRY-US, V22, P5001, DOI 10.1021/bi00290a019; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/S0042-6822(88)90115-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAW KM, 1992, J GEN VIROL, V73, P549, DOI 10.1099/0022-1317-73-3-549; LENNICK M, 1986, BIOCHEMISTRY-US, V25, P3890, DOI 10.1021/bi00361a023; LESK AM, 1986, PROTEIN ENG, V1, P77, DOI 10.1093/protein/1.1.77; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LUNDGARD R, 1989, CARLSBERG RES COMMUN, V54, P173, DOI 10.1007/BF02904471; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; PALUMBO GJ, 1989, VIROLOGY, V172, P262, DOI 10.1016/0042-6822(89)90128-1; PATSTON PA, 1990, J BIOL CHEM, V265, P10786; PEMBERTON PA, 1989, THESIS U CAMBRIDGE; PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; PRATT CW, 1989, THROMB RES, V53, P595, DOI 10.1016/0049-3848(89)90149-7; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT CF, 1986, J CLIN INVEST, V77, P631, DOI 10.1172/JCI112346; SMITH GL, 1989, J GEN VIROL, V70, P2333, DOI 10.1099/0022-1317-70-9-2333; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; STRAYER DS, 1983, J IMMUNOL, V130, P399; TOMLEY F, 1988, J GEN VIROL, V69, P1025, DOI 10.1099/0022-1317-69-5-1025; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAVIS J, 1985, J BIOL CHEM, V260, P4384; TURNER PC, 1992, J VIROL, V66, P2076, DOI 10.1128/JVI.66.4.2076-2085.1992; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F	46	78	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					516	521						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416956				2022-12-27	WOS:A1993KE60300078
J	MIAO, F; ABELSON, J				MIAO, F; ABELSON, J			YEAST TRANSFER RNA-SPLICING ENDONUCLEASE CLEAVES PRECURSOR TRANSFER-RNA IN A RANDOM PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; LIGASE; IDENTIFICATION; EXCISION; INVITRO	Introns interrupt many of the tRNA genes of Saccharomyces cerevisiae at a constant position in the anti-codon loop. Pre-tRNA transcripts must be accurately cleaved at 3' and 5' splice sites by tRNA endonuclease to release these introns. In order to study splice site cleavage order, substrates were prepared in which the ribose 2'-OH at each of the splice sites was phosphorylated. This modification blocked cleavage by the endonuclease. We found that whichever splice site was blocked the endonuclease can cleave the other site, indicating that the two splice sites were cleaved independently. The endonuclease also cleaved both 3'- and 5'-nicked pre-tRNA(Phe). In addition, both kinds of ''2/3 molecules'' (exon+intron) were observed in kinetic studies, indicating that they were true biochemical intermediates. The rates of cleavage at the 3' and 5' splice sites of pre-tRNA were compared in several ways. The results showed that the endonuclease cleaves 3' and 5' sites at almost the same rate in the first cleavage, whereas in the second cleavage the 3' site was cleaved faster, indicating that the rates of the two routes for cleavage were unequal. These results demonstrated that the endonuclease cleaved pre-tRNA in a random order, creating two routes for removal of introns from pre-tRNA.	CALTECH,DIV BIOL 14775,PASADENA,CA 91125	California Institute of Technology								ABELSON JN, 1986, MOL EVOLUTION LIFE, P127; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; BALTZINGER M, 1982, BIOCHEMISTRY-US, V21, P2467, DOI 10.1021/bi00539a028; CULBERTSON MR, 1989, YEAST, V5, P405, DOI 10.1002/yea.320050602; GEGENHEIMER P, 1983, J BIOL CHEM, V258, P8365; GREER CL, 1986, MOL CELL BIOL, V6, P635, DOI 10.1128/MCB.6.2.635; GREER CL, 1987, MOL CELL BIOL, V7, P76, DOI 10.1128/MCB.7.1.76; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; HO CK, 1990, EMBO J, P1245; HOPPER AK, 1984, PROCESSING RNA, P91; LIN SX, 1984, BIOCHEMISTRY-US, V23, P4109, DOI 10.1021/bi00313a015; Maniatis T., 1982, MOL CLONING; MATHISON L, 1989, MOL CELL BIOL, V9, P4220, DOI 10.1128/MCB.9.10.4220; MCCRAITH SM, 1991, J BIOL CHEM, V266, P11986; MCCRAITH SM, 1990, MOL CELL BIOL, V10, P1049, DOI 10.1128/MCB.10.3.1049; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; OCONNOR JP, 1990, THESIS U PITTSBURGH; OGDEN RC, 1984, NUCLEIC ACIDS RES, V12, P9367, DOI 10.1093/nar/12.24.9367; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; SANGER F, 1977, P NATL ACAD SCI USA, V75, P190; SZEKELY E, 1988, J BIOL CHEM, V263, P13839; TANNER NK, 1988, BIOCHEMISTRY-US, V27, P8852, DOI 10.1021/bi00424a025; Uhlenbeck O.C., 1982, ENZYMES, V15, P31, DOI [10.1016/s1874-6047(08)60274-7, DOI 10.1016/S1874-6047(08)60274-7]; VOLCKAERT G, 1976, ANAL BIOCHEM, V72, P433, DOI 10.1016/0003-2697(76)90551-0; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; XU Q, 1990, BIOCHEMISTRY-US, V29, P6132, DOI 10.1021/bi00478a004	30	10	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					672	677						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416971				2022-12-27	WOS:A1993KE60300101
J	PISTOCCHI, R; KASHIWAGI, K; MIYAMOTO, S; NUKUI, E; SADAKATA, Y; KOBAYASHI, H; IGARASHI, K				PISTOCCHI, R; KASHIWAGI, K; MIYAMOTO, S; NUKUI, E; SADAKATA, Y; KOBAYASHI, H; IGARASHI, K			CHARACTERISTICS OF THE OPERON FOR A PUTRESCINE TRANSPORT-SYSTEM THAT MAPS AT 19 MINUTES ON THE ESCHERICHIA-COLI CHROMOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; ORNITHINE DECARBOXYLASE; POLYAMINE TRANSPORT; NUCLEIC-ACIDS; PROTEINS; GENE; IDENTIFICATION; POLYMERASE; CLONING; COMPONENTS	The nucleotide sequence of the operon for the putrescine transport system that maps at 19 min on the Escherichia coli chromosome was determined. It contained four open reading frames encoding potF, -G, -H, and -I proteins. The potF protein (M(r) = 38,000) was inferred to be a putrescine-specific binding protein existing in a periplasmic fraction from the results of Western blot analysis of the cell fractions and from measurements of polyamine binding to the protein. The potG protein (M(r) = 45,000) had consensus amino acid sequences for the nucleotide-binding site. The potH (M(r) = 35,000) and potI (M(r) = 31,000) proteins consisted of six putative transmembrane-spanning segments linked by hydrophilic segments of variable length as shown by hydropathy profiles. The spermidine-putrescine transport system, which is mainly involved in spermidine transport, consisted of potA, -B, -C, and -D proteins (Furuchi, T., Kashiwagi, K., Kobayashi, H., and Igarashi, K. (1991) J. Biol. Chem. 266, 20928-20933). The homologies of the corresponding two proteins between those two systems, F and D, G and A, H and B, and I and C, were 35, 42, 37, and 36%, respectively. The initiation point of the transcription of the operon for the putrescine transport system was determined by primer extension and S1 nuclease mapping. Transcription started from the T residue located either 149 or 150 nucleotides upstream from the initiator AUG codon of potF protein mRNA. By making several subclones and a mutant lacking the potF gene, we showed that the expression of all four proteins was necessary for maximal putrescine transport activity. These results indicate that the putrescine transport system can also be defined as a bacterial periplasmic transport system.	CHIBA UNIV, FAC PHARMACEUT SCI, 1-33 YAYOI CHO, INAGE KU, CHIBA 263, JAPAN	Chiba University				Igarashi, Kazuei/0000-0003-3751-3187; PISTOCCHI, ROSSELLA/0000-0003-1304-6270				AMEMURA M, 1985, J MOL BIOL, V184, P241, DOI 10.1016/0022-2836(85)90377-8; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANRAKU Y, 1968, J BIOL CHEM, V243, P3116; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; FRIEDRICH MJ, 1987, J BACTERIOL, V169, P3556, DOI 10.1128/jb.169.8.3556-3563.1987; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; GILSON E, 1982, NUCLEIC ACIDS RES, V10, P7449, DOI 10.1093/nar/10.22.7449; HIGGINS CF, 1982, NATURE, V298, P723, DOI 10.1038/298723a0; IGARASHI K, 1982, ARCH BIOCHEM BIOPHYS, V219, P438, DOI 10.1016/0003-9861(82)90175-8; IGARASHI K, 1975, J BIOCHEM-TOKYO, V77, P383, DOI 10.1093/oxfordjournals.jbchem.a130736; ITO K, 1990, ARCH BIOCHEM BIOPHYS, V278, P277, DOI 10.1016/0003-9861(90)90260-6; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KASHIWAGI K, 1990, J BIOL CHEM, V265, P8387; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING LAB MANU, P250; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MUNRO GF, 1974, J BACTERIOL, V118, P952, DOI 10.1128/JB.118.3.952-963.1974; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; OLIVER DB, 1982, CELL, V30, P311, DOI 10.1016/0092-8674(82)90037-X; PEGG AE, 1988, CANCER RES, V48, P759; PLATT T, 1981, CELL, V24, P10, DOI 10.1016/0092-8674(81)90496-7; SANCAR A, 1981, J MOL BIOL, V148, P45, DOI 10.1016/0022-2836(81)90234-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1966, J BIOL CHEM, V241, P3714; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATANABE Y, 1981, BIOCHIM BIOPHYS ACTA, V656, P134, DOI 10.1016/0005-2787(81)90078-2; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	49	100	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					146	152						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416922				2022-12-27	WOS:A1993KE60300023
J	CAPIEAUX, E; RAPIN, C; THINES, D; DUPONT, Y; GOFFEAU, A				CAPIEAUX, E; RAPIN, C; THINES, D; DUPONT, Y; GOFFEAU, A			OVEREXPRESSION IN ESCHERICHIA-COLI AND PURIFICATION OF AN ATP-BINDING PEPTIDE FROM THE YEAST PLASMA-MEMBRANE H+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; NUCLEOTIDE-BINDING; SCHIZOSACCHAROMYCES-POMBE; TRANSPORT; FUNGI	The two major hydrophilic domains from the Saccharomyces cerevisiae plasma membrane H+-ATPase fused to glutathione S-transferase have been expressed in Escherichia coli. The GST-L peptide contained the hydrophilic region from Ala340 to Ser660. The GST-SL peptide contained in addition the hydrophilic region Glu162 to Val276. After solubilization of the inclusion bodies with urea, renaturation, and affinity chromatography, 3 mg of highly purified peptides were recovered per liter of E. coli culture. The purified peptides interacted with 2'(3')-O-(2,4,6-trinitrophenyl)adenosine-5'-triphosphate (TNP-ATP), the fluorescence of which was enhanced identically upon binding of either GST-L or GST-SL. ATP competitively displaced the TNP-ATP binding. The observed dissociation constants for TNP-ATP (6.5 muM) and ATP (3 mM) are close to those found for the complete native H+-ATPase protein. The fluorescence of TNP-ATP was sensitive to Mg2+ indicating the existence of a Mg2+-binding site on the peptide. Apparent affinity for this Mg2+ site was found to vary from 50 muM at pH 7.5 to 400 muM at pH 5.5.	UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, B-1348 LOUVAIN, BELGIUM; CEN GRENOBLE, DEPT BIOL MOLEC & STRUCT, BIOPHYS MOLEC & CELLULAIRE, F-3804 GRENOBLE, FRANCE	Universite Catholique Louvain; CEA								AMANN EJ, 1983, GENE, V40, P183; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; BOWDEN GA, 1990, J BIOL CHEM, V265, P16760; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; CLELAND JL, 1990, BIO-TECHNOL, V8, P1274, DOI 10.1038/nbt1290-1274; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DUFOUR JP, 1988, METHOD ENZYMOL, V157, P513; DUPONT Y, 1983, FEBS LETT, V256, P2346; ERASO P, 1990, TRENDS BIOMEMBR BIOE, V1, P1; GHISLAIN M, 1992, EUR J BIOCHEM, V209, P275, DOI 10.1111/j.1432-1033.1992.tb17286.x; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; GOFFEAU A, 1990, MONOVALENT CATIONS B, P155; HOLZER KP, 1989, J BIOL CHEM, V264, P14389; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; Maniatis T., 1982, MOL CLONING; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MCLENNAN DH, 1985, NATURE, V316, P696; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2346; NAKAMOTO RK, 1989, J BIOENERG BIOMEMBR, V21, P621, DOI 10.1007/BF00808117; PORTILLO F, 1988, EMBO J, V7, P1793, DOI 10.1002/j.1460-2075.1988.tb03010.x; RAO US, 1991, J BIOL CHEM, V266, P14740; RONJAT M, 1986, THESIS U GRENOBLE; SCARBOROUGH GA, 1993, IN PRESS MOL ASPECTS; SERRANO R, 1989, ANNU REV PLANT PHYS, V40, P61; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TAYLOR WR, 1989, EUR J BIOCHEM, V179, P241, DOI 10.1111/j.1432-1033.1989.tb14547.x; THOMAS PJ, 1991, SCIENCE, V251, P555, DOI 10.1126/science.1703660; VANDIJKCK L, 1990, EUR J BIOCHEM, V189, P675; VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482; WACH A, 1992, J BIOENERG BIOMEMBR, V24, P309	33	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21895	21900						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408044				2022-12-27	WOS:A1993MC80900070
J	RAO, SM; HOWELLS, RD				RAO, SM; HOWELLS, RD			CIS-ACTING ELEMENTS IN THE 5'-UNTRANSLATED REGION OF RAT TESTIS PROENKEPHALIN MESSENGER-RNA REGULATE TRANSLATION OF THE PRECURSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL PYROPHOSPHATE SYNTHETASE; HAPLOID GERM-CELLS; SPERMATOGENIC CELLS; MOLECULAR-CLONING; GENE-EXPRESSION; TRANSGENIC MICE; SOMATIC-CELLS; SERTOLI CELLS; TRANSCRIPTION; PEPTIDE	We found that a rat testis cDNA library contained two types of proenkephalin cDNA, corresponding to somatic and germ cell-specific transcripts. The somatic form is identical in primary sequence to previously characterized transcripts from rat brain and heart. The longer germ cell-specific cDNA contains a novel 5' terminus derived from the somatic intron A. We found that germ cell-specific transcripts translate in vitro with significantly lower efficiency than do somatic-type transcripts. Deletion analysis indicated that translational inefficiency is mediated primarily by the presence of four upstream AUG codons followed by short open reading frames within the leader sequence. Secondary structure in the form of a stem-and-loop upstream of the initiator codon for proenkephalin was found to have a slightly inhibitory effect on translation. These results, coupled with the very low abundance of the somatic transcript, provide a possible explanation for the low levels of opioid peptides found in adult rat testis in spite of the abundant quantity of germ cell-specific proenkephalin transcript.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT BIOCHEM & MOLEC BIOL,185 S ORANGE AVE,NEWARK,NJ 07103; UNIV MED & DENT NEW JERSEY GRAD SCH BIOMED SCI,NEWARK,NJ 07103	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center					NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005819] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 05819] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; ARRICK BA, 1991, MOL CELL BIOL, V11, P4306, DOI 10.1128/MCB.11.9.4306; CRAIN SM, 1990, TRENDS PHARMACOL SCI, V11, P77, DOI 10.1016/0165-6147(90)90322-Y; DONOVAN DM, 1992, P NATL ACAD SCI USA, V89, P2345, DOI 10.1073/pnas.89.6.2345; FOO NC, 1991, ENDOCRINOLOGY, V128, P2118, DOI 10.1210/endo-128-4-2118; GARRETT JE, 1989, MOL CELL BIOL, V9, P4381, DOI 10.1128/MCB.9.10.4381; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; HOWELLS RD, 1984, P NATL ACAD SCI-BIOL, V81, P7651, DOI 10.1073/pnas.81.23.7651; HOWELLS RD, 1986, P NATL ACAD SCI USA, V83, P1960, DOI 10.1073/pnas.83.6.1960; HOWELLS RD, 1991, NATL I DRUG ABUSE RE, V105, P116; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JEANNOTTE L, 1987, MOL ENDOCRINOL, V1, P749, DOI 10.1210/mend-1-10-749; KEW D, 1989, MOL ENDOCRINOL, V3, P179, DOI 10.1210/mend-3-1-179; KEW D, 1989, MOL ENDOCRINOL, V3, P1191, DOI 10.1210/mend-3-8-1191; KEW D, 1990, P NATL ACAD SCI USA, V87, P1943; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KILPATRICK DL, 1987, P NATL ACAD SCI USA, V84, P5695, DOI 10.1073/pnas.84.16.5695; KILPATRICK DL, 1984, P NATL ACAD SCI-BIOL, V81, P7221, DOI 10.1073/pnas.81.22.7221; KILPATRICK DL, 1985, P NATL ACAD SCI USA, V82, P7467, DOI 10.1073/pnas.82.21.7467; KILPATRICK DL, 1986, ENDOCRINOLOGY, V119, P370, DOI 10.1210/endo-119-1-370; KILPATRICK DL, 1986, P NATL ACAD SCI USA, V83, P5015, DOI 10.1073/pnas.83.14.5015; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LACAZEMASMONTEIL T, 1987, P NATL ACAD SCI USA, V84, P7261, DOI 10.1073/pnas.84.20.7261; LOW KG, 1990, MOL ENDOCRINOL, V4, P1408, DOI 10.1210/mend-4-9-1408; MANSOUR A, 1987, J NEUROSCI, V7, P2445; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; PERSSON H, 1990, MOL CELL BIOL, V10, P4701, DOI 10.1128/MCB.10.9.4701; PERSSON H, 1989, P NATL ACAD SCI USA, V86, P6166, DOI 10.1073/pnas.86.16.6166; POLAKIEWICZ RD, 1990, MOL CELL BIOL, V10, P736, DOI 10.1128/MCB.10.2.736; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; RAO SM, 1992, REGUL PEPTIDES, V40, P397, DOI 10.1016/0167-0115(92)90526-Z; RATTNER A, 1991, MOL CELL BIOL, V11, P1017, DOI 10.1128/MCB.11.2.1017; ROSEN H, 1984, J BIOL CHEM, V259, P4309; SCHALLING M, 1990, J CLIN INVEST, V86, P660, DOI 10.1172/JCI114758; TERUYA JH, 1991, BIOL REPROD, V44, P663, DOI 10.1095/biolreprod44.4.663; TERUYA JH, 1990, MOL CELL BIOL, V10, P2315, DOI 10.1128/MCB.10.5.2315; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907; YOSHIKAWA K, 1989, BIOCHEM BIOPH RES CO, V161, P568, DOI 10.1016/0006-291X(89)92637-5; YOSHIKAWA K, 1989, FEBS LETT, V246, P193, DOI 10.1016/0014-5793(89)80281-9; YOSHIKAWA K, 1988, FEBS LETT, V237, P183, DOI 10.1016/0014-5793(88)80197-2; ZINN SA, 1991, J BIOL CHEM, V266, P23850	45	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22164	22169						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408077				2022-12-27	WOS:A1993MC80900107
J	REARDON, JT; NICHOLS, AF; KEENEY, S; SMITH, CA; TAYLOR, JS; LINN, S; SANCAR, A				REARDON, JT; NICHOLS, AF; KEENEY, S; SMITH, CA; TAYLOR, JS; LINN, S; SANCAR, A			COMPARATIVE-ANALYSIS OF BINDING OF HUMAN DAMAGED DNA-BINDING PROTEIN (XPE) AND ESCHERICHIA-COLI DAMAGE RECOGNITION PROTEIN (UVRA) TO THE MAJOR ULTRAVIOLET PHOTOPRODUCTS - T[C,S]T, T[T,S]T, T[6-4]T, AND T[DEWAR]T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION GROUP-E; SOLID-PHASE SYNTHESIS; CELL-FREE-EXTRACTS; (A)BC EXCINUCLEASE; EXCISION NUCLEASE; THYMINE DIMERS; BUILDING BLOCK; HUMAN-PLACENTA; PRIMATE CELLS; REPAIR	Human cells contain a protein that binds to UV-irradiated DNA with high affinity. This protein, the damaged DNA-binding protein (DDB), is absent from some xeroderma pigmentosum complementation group E cell strains; therefore, it has been suggested that it may be the damage recognition subunit of a human excision nuclease complex. However, the identity of the UV photoproduct bound by DDB and the role of this protein in nucleotide excision repair have been controversial. In this study, we used several synthetic DNA substrates, each of which contains one of the major UV photoproducts, and DDB purified to apparent homogeneity to quantify the specific binding of DDB to various photoproducts. For comparison, the binding of the same photoproducts by the Escherichia coli damage recognition protein UvrA, which is known to be a subunit of the E. coli excision nuclease, was also measured. UvrA and DDB each bound with high affinity to T[t,s]T, T[6-4]T, and T[Dewar]T, but only marginally discriminated between an undamaged oligomer and an oligomer with a T[c,s]T. In contrast to these similarities with regard to the binding to UV photoproducts, UvrA bound to another excision repair substrate, the psoralen-thymine monoadduct, with high specificity, whereas DDB was unable to distinguish between psoralen-adducted DNA and undamaged DNA. We conclude that DDB may play a special role in the repair of UV damage, but it cannot be the sole damage recognition subunit of human excision nuclease.	UNIV CALIF BERKELEY, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA; WASHINGTON UNIV, DEPT CHEM, ST LOUIS, MO 63130 USA	University of California System; University of California Berkeley; Washington University (WUSTL)	REARDON, JT (corresponding author), UNIV N CAROLINA, SCH MED, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA.		Taylor, John-Stephen/AAA-3218-2020; Keeney, Scott/GVR-8515-2022	Taylor, John-Stephen/0000-0002-8615-7257; Smith, Colin/0000-0001-5652-0855; Keeney, Scott/0000-0002-1283-6417	NIEHS NIH HHS [P30 ES01896, ES011896] Funding Source: Medline; NIGMS NIH HHS [GM32833] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896, R43ES011896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMIC M, 1991, J BIOL CHEM, V266, P22493; BERTRANDBURGGRAF E, 1991, J MOL BIOL, V219, P27, DOI 10.1016/0022-2836(91)90854-Y; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; CAREW JA, 1985, NUCLEIC ACIDS RES, V13, P303, DOI 10.1093/nar/13.1.303; CHAO CCK, 1991, MOL CELL BIOL, V11, P2075, DOI 10.1128/MCB.11.4.2075; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; CHU G, 1990, P NATL ACAD SCI USA, V87, P3324, DOI 10.1073/pnas.87.9.3324; EKER APM, 1992, MUTAT RES, V274, P211, DOI 10.1016/0921-8777(92)90067-D; FELDBERG RS, 1980, NUCLEIC ACIDS RES, V8, P1133, DOI 10.1093/nar/8.5.1133; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; FELDBERG RS, 1982, J BIOL CHEM, V257, P6394; FRIEDBERG EC, 1985, DNA REPAIR, P505; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P4915, DOI 10.1093/nar/19.18.4915; HIRSCHFELD S, 1990, MOL CELL BIOL, V10, P2041, DOI 10.1128/MCB.10.5.2041; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; KATAOKA H, 1991, BIOCHEM BIOPH RES CO, V175, P1139, DOI 10.1016/0006-291X(91)91684-5; KEENEY S, 1993, J BIOL CHEM, V268, P21293; KEENEY S, 1992, MUTAT RES, V273, P49, DOI 10.1016/0921-8777(92)90049-9; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; PATTERSON M, 1989, MOL CELL BIOL, V9, P5105, DOI 10.1128/MCB.9.11.5105; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; REARDON JT, 1991, NUCLEIC ACIDS RES, V19, P4623, DOI 10.1093/nar/19.17.4623; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; SANCAR A, 1984, J MOL BIOL, V172, P223, DOI 10.1016/S0022-2836(84)80040-6; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SANCAR GB, 1985, BIOCHEMISTRY-US, V24, P1849, DOI 10.1021/bi00329a007; SEEBERG E, 1982, P NATL ACAD SCI-BIOL, V79, P988, DOI 10.1073/pnas.79.4.988; SEGEL IH, 1975, ENZYME KINETICS, P109; SIBGHATULLAH, 1989, NUCLEIC ACIDS RES, V17, P4471, DOI 10.1093/nar/17.12.4471; SMITH CA, 1993, J BIOL CHEM, V268, P11143; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; SVOBODA DL, 1993, J BIOL CHEM, V268, P10694; TAYLOR JS, 1987, J AM CHEM SOC, V109, P6735, DOI 10.1021/ja00256a030; TAYLOR JS, 1988, NUCLEIC ACIDS RES, V16, P5123, DOI 10.1093/nar/16.11.5123; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; TONEY JH, 1989, P NATL ACAD SCI USA, V86, P8328, DOI 10.1073/pnas.86.21.8328; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; VANHOUTEN B, 1988, J BIOL CHEM, V263, P16553; WOLFENDEN R, 1987, ENZYME MECHANISMS, P97; WOOD RD, 1989, BIOCHEMISTRY-US, V28, P8287, DOI 10.1021/bi00447a005; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; YEUNG AT, 1986, NUCLEIC ACIDS RES, V14, P2567, DOI 10.1093/nar/14.6.2567	45	187	189	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21301	21308						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407968				2022-12-27	WOS:A1993MA28800096
J	TASKEN, K; SKALHEGG, BS; SOLBERG, R; ANDERSSON, KB; TAYLOR, SS; LEA, T; BLOMHOFF, HK; JAHNSEN, T; HANSSON, V				TASKEN, K; SKALHEGG, BS; SOLBERG, R; ANDERSSON, KB; TAYLOR, SS; LEA, T; BLOMHOFF, HK; JAHNSEN, T; HANSSON, V			NOVEL ISOZYMES OF CAMP-DEPENDENT PROTEIN-KINASE EXIST IN HUMAN-CELLS DUE TO FORMATION OF RI-ALPHA-RI-BETA HETERODIMERIC COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; GLUTATHIONE-S-TRANSFERASE; AMINO-ACID SEQUENCE; CYCLIC-AMP; HUMAN TESTIS; ADENOSINE-MONOPHOSPHATE; MOLECULAR-CLONING; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; CDNA STRUCTURE	We report that a human neoplastic B cell line (Reh) contains cAMP-dependent protein kinase (cAK) type I (cAKI), but is practically devoid of cAK type II (cAKII). However, these cells contain a novel cAKI isozyme consisting of an RIalpha-RIbeta heterodimer in association with phosphotransferase activity (RIalphaRIbetaC2) eluting from DEAE-cellulose columns at a salt concentration characteristic of a cAKII. Immunoprecipitation of 8-azido-[P-32]cAMP-labeled extracts and DEAE fractions employing specific antibodies directed against RIalpha and RIbeta clearly demonstrated the presence of RIalpha-RIbeta heterodimers. RIalpha was precipitated with RIbeta antiserum and vice versa. Furthermore, disruption of disulfide bridges by reduction-alkylation abolished this coimmunoprecipitation. In addition, formation of heterodimeric complexes of RIalpha and RIbeta could be demonstrated in vitro using recombinant RI proteins. Finally, the presence of low levels of RIalpha-RIbeta heterodimers could also be demonstrated in human peripheral blood T lymphocytes. RIalpha-RIbeta heterodimers complexed with the catalytic subunit represent a novel isozyme of cAKI (RIalphaRIbetaC2), which enhances the possibilities for diversification of cAMP-mediated effects.	NATL HOSP,INST GEN & RHEUMATOL IMMUNOL,N-0027 OSLO,NORWAY; NORWEGIAN RADIUM HOSP,INST CANC RES,N-0310 OSLO,NORWAY; NORWEGIAN RADIUM HOSP,DEPT IMMUNOL,N-0310 OSLO,NORWAY; UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of California System; University of California San Diego	TASKEN, K (corresponding author), UNIV OSLO,INST MED BIOCHEM,POB 1112,BLINDERN,N-0317 OSLO,NORWAY.		Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Tasken, Kjetil/0000-0003-2841-4697	NIGMS NIH HHS [GM34921] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; BEEBE SJ, 1986, ENZYMES, V17, P43; BLOMHOFF HK, 1987, J CELL PHYSIOL, V131, P426, DOI 10.1002/jcp.1041310315; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; BUBIS J, 1987, J BIOL CHEM, V262, P14961; CADD GG, 1990, J BIOL CHEM, V265, P19502; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; COBB CE, 1988, METHOD ENZYMOL, V159, P202; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; CORBIN JD, 1975, J BIOL CHEM, V250, P218; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DOSKELAND SO, 1978, BIOCHEM BIOPH RES CO, V83, P542, DOI 10.1016/0006-291X(78)91024-0; FANTOZZI DA, 1992, J BIOL CHEM, V267, P16824; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALBRUGGE M, 1990, J BIOL CHEM, V265, P3088; HUNZICKERDUNN M, 1991, J BIOL CHEM, V266, P7166; JAHNSEN T, 1985, J BIOL CHEM, V260, P5980; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KERYER G, 1993, EXP CELL RES, V204, P230, DOI 10.1006/excr.1993.1029; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1990, J BIOL CHEM, V265, P7814; LANOTTE M, 1991, J CELL PHYSIOL, V146, P73, DOI 10.1002/jcp.1041460110; LEON DA, 1991, BIOCHEMISTRY-US, V30, P3035, DOI 10.1021/bi00226a008; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; LIU AYC, 1982, J BIOL CHEM, V257, P298; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MOGER WH, 1991, ENDOCRINOLOGY, V128, P1414, DOI 10.1210/endo-128-3-1414; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; OTTEN AD, 1991, J BIOL CHEM, V266, P23074; OYEN O, 1988, ENDOCRINOLOGY, V122, P2658; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROGERS KV, 1992, MOL ENDOCRINOL, V6, P1756, DOI 10.1210/me.6.10.1756; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SANDBERG M, 1987, BIOCHEM BIOPH RES CO, V149, P939, DOI 10.1016/0006-291X(87)90499-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASWAT LD, 1986, J BIOL CHEM, V261, P1091; SCHWARTZ DA, 1983, J BIOL CHEM, V258, P777; SCOTT JD, 1992, NEWS PHYSIOL SCI, V7, P143; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SKALHEGG BS, 1992, J BIOL CHEM, V267, P5374; SKALHEGG BS, 1992, J BIOL CHEM, V267, P15707; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLBERG R, 1991, BIOCHEM BIOPH RES CO, V176, P166, DOI 10.1016/0006-291X(91)90904-L; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TASKEN K, 1990, BIOCHEM BIOPH RES CO, V172, P409, DOI 10.1016/0006-291X(90)90688-J; THOMIS DC, 1992, J BIOL CHEM, V267, P10723; WALTER U, 1983, METHOD ENZYMOL, V99, P154; WIEMANN S, 1991, J BIOL CHEM, V266, P5140; ZICK SK, 1982, J BIOL CHEM, V257, P2287	55	90	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21276	21283						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407966				2022-12-27	WOS:A1993MA28800093
J	CERNEUS, DP; UEFFING, E; POSTHUMA, G; STROUS, GJ; VANDERENDE, A				CERNEUS, DP; UEFFING, E; POSTHUMA, G; STROUS, GJ; VANDERENDE, A			DETERGENT INSOLUBILITY OF ALKALINE-PHOSPHATASE DURING BIOSYNTHETIC TRANSPORT AND ENDOCYTOSIS - ROLE OF CHOLESTEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-GLYCAN; HUMAN-FIBROBLASTS; PLASMA-MEMBRANES; CANCER-CELLS; COATED PITS; PROTEINS; 5'-NUCLEOTIDASE; SPHINGOMYELIN; LOCALIZATION; ANTIBODIES	Alkaline phosphatase is anchored to the outer leaflet of the plasma membrane by a covalently attached glycosyl-phosphatidylinositol anchor. We have studied the biosynthetic. transport and endocytosis of alkaline phosphatase in the choriocarcinoma cell line BeWo, which endogenously expresses this protein. It was demonstrated that the protein was synthesized as a Triton X-100-soluble precursor. During transport to the cell surface the enzyme was converted in a mature form, which was insoluble in Triton X-100 at 0-degrees-C. Once at the cell surface 85% of alkaline phosphatase remained in the detergent-insoluble form. Under steady state conditions 15% of alkaline phosphatase was endocytosed. Most interestingly, this fraction of internalized alkaline phosphatase was completely soluble in Triton X-100 at 0-degrees-C. After depletion of membrane cholesterol by saponin, alkaline phosphatase became completely soluble in Triton X-100 at 0-degrees-C, suggesting that cholesterol plays a critical role in the formation and maintenance of Triton X-100-resistant membrane domains.	UNIV UTRECHT,SCH MED,DEPT CELL BIOL,HEIDELBERGLAAN 100,H02314,3584 CX UTRECHT,NETHERLANDS	Utrecht University			van der Ende, Arie/A-4346-2012					ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CERNEUS DP, 1991, J CELL BIOL, V114, P1149, DOI 10.1083/jcb.114.6.1149; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; Ferguson MAJ, 1991, CURR OPIN STRUC BIOL, V1, P522, DOI 10.1016/S0959-440X(05)80072-7; HOOPER NM, 1991, BIOCHEM J, V280, P745, DOI 10.1042/bj2800745; HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865; HOPKINS CR, 1992, TRENDS BIOCHEM SCI, V17, P27, DOI 10.1016/0968-0004(92)90423-7; JEMMERSON R, 1985, FEBS LETT, V179, P316, DOI 10.1016/0014-5793(85)80542-1; JEMMERSON R, 1985, J HISTOCHEM CYTOCHEM, V33, P1227, DOI 10.1177/33.12.4067276; KELLER GA, 1992, EMBO J, V11, P863, DOI 10.1002/j.1460-2075.1992.tb05124.x; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGE Y, 1991, J LIPID RES, V32, P329; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LEMANSKY P, 1990, J CELL BIOL, V110, P1525, DOI 10.1083/jcb.110.5.1525; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; LOWE ME, 1990, CANCER RES, V50, P3956; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; MATSUURA S, 1984, J CELL BIOL, V99, P166, DOI 10.1083/jcb.99.1.166; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MILLAN JL, 1990, ISOZYMES STRUCTURE F, P453; OGATA S, 1988, J BIOL CHEM, V263, P10489; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SCHLOSSER E, 1969, Z NATURFORSCH PT B, VB 24, P1284; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P251, DOI 10.1016/0005-2736(90)90301-4; TAKAMI N, 1988, J BIOL CHEM, V263, P3016; TOKUYASU KT, 1976, J CELL BIOL, V71, P894, DOI 10.1083/jcb.71.3.894; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VANDENBOSCH RA, 1988, EMBO J, V7, P3345, DOI 10.1002/j.1460-2075.1988.tb03206.x; VANDERENDE A, 1987, J BIOL CHEM, V262, P8910; WATANABE S, 1989, J BIOL CHEM, V264, P12611; WATANABE T, 1991, J BIOL CHEM, V266, P21174; WEBB PD, 1988, EUR J BIOCHEM, V172, P647, DOI 10.1111/j.1432-1033.1988.tb13938.x; YANDOUZI EHE, 1992, BIOCHEMISTRY-US, V31, P547; YEAGLE PL, 1986, J BIOL CHEM, V261, P8175; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5	48	152	153	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3150	3155						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428991				2022-12-27	WOS:A1993KM16100023
J	PELANDA, R; VANONI, MA; PEREGO, M; PIUBELLI, L; GALIZZI, A; CURTI, B; ZANETTI, G				PELANDA, R; VANONI, MA; PEREGO, M; PIUBELLI, L; GALIZZI, A; CURTI, B; ZANETTI, G			GLUTAMATE SYNTHASE GENES OF THE DIAZOTROPH AZOSPIRILLUM-BRASILENSE - CLONING, SEQUENCING, AND ANALYSIS OF FUNCTIONAL DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; KINETIC MECHANISM; 3FE-4S CLUSTER; GLT-LOCUS; PROTEINS; BINDING; AMIDOTRANSFERASES; ELECTROPHORESIS; IDENTIFICATION; DEHYDROGENASE	A 10-kilobase EcoRI fragment of Azospirillum brasilense genomic DNA was cloned in Escherichia coli. Two open reading frames of 4548 and 1446 base pairs (bp) were identified within the fragment as the structural genes for the alpha and beta subunits (gltB and gltD, respectively) of A. brasilense GltS. The organization of the gltBD region of A. brasilense differs from that of the corresponding region in E. coli: in A. brasilense, gltD is upstream relative to gltB, and its stop codon is separated by 141 bp from the first ATG of gltB. The deduced amino acid sequences reveal a high similarity with GltS from E. coli and with the ferredoxin-dependent GltS from maize. Binding domains for flavin cofactors and NADPH, a domain for glutamine binding and activation, and cysteine clusters for iron-sulfur centers formation were tentatively identified on the basis of sequence comparison with flavoproteins, pyridine nucleotide-dependent enzymes, amidotransferases, and iron-sulfur proteins.	UNIV MILAN, DIPARTIMENTO FISIOL & BIOCHIM GEN, VIA CELORIA 26, I-20133 MILAN, ITALY; UNIV PAVIA, DIPARTIMENTO GENET & MICROBIOL, I-27100 PAVIA, ITALY; UNIV MILAN, CTR INTERUNIV STUDIO MACROMOLEC INFORMAZ, I-20133 MILAN, ITALY	University of Milan; University of Pavia; University of Milan			Vanoni, Maria/AAP-2089-2021	Vanoni, Maria/0000-0001-7213-732X; PIUBELLI, LUCIANO/0000-0003-0805-5121				Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; Ausubel FM, 1988, MOL REPROD DEV; BERBERICH MA, 1972, BIOCHEM BIOPH RES CO, V47, P1498, DOI 10.1016/0006-291X(72)90242-2; BOWER S, 1983, BIOCHEMISTRY-US, V22, P1613, DOI 10.1021/bi00276a014; BOZOUKLIAN H, 1986, BIOCHIMIE, V68, P1181, DOI 10.1016/S0300-9084(86)80062-1; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEZAMAROCZY M, 1990, MOL GEN GENET, V224, P421, DOI 10.1007/BF00262437; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; FANI R, 1989, MOL GEN GENET, V220, P81, DOI 10.1007/BF00260860; GOSSET G, 1989, Protein Sequences and Data Analysis, V2, P9; HILGERT U, 1987, MOL GEN GENET, V210, P195, DOI 10.1007/BF00325684; JOHNSON MK, 1988, J BIOL CHEM, V263, P14732; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KISSINGER CR, 1988, J AM CHEM SOC, V110, P8721, DOI 10.1021/ja00234a038; KNAFF DB, 1991, J BIOL CHEM, V266, P15080; LEWIS TA, 1990, J BACTERIOL, V172, P2413, DOI 10.1128/jb.172.5.2413-2420.1990; Lindqvist Y, 1992, CHEM BIOCH FLAVOENZY, V3, P367; MANODORI A, 1992, BIOCHEMISTRY-US, V31, P2703, DOI 10.1021/bi00125a010; Mathews FS, 1991, CURR OPIN STRUC BIOL, V1, P954, DOI 10.1016/0959-440X(91)90091-7; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTAJ IW, 1982, FEBS LETT, V147, P21, DOI 10.1016/0014-5793(82)81003-X; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; MCKIE JH, 1991, FEBS LETT, V279, P5, DOI 10.1016/0014-5793(91)80236-V; MEI B, 1989, J BIOL CHEM, V264, P16613; MEI BG, 1990, J BACTERIOL, V172, P3512, DOI 10.1128/jb.172.6.3512-3514.1990; MONTEIRO MJ, 1984, J GEN MICROBIOL, V130, P2403; MOOS M, 1988, J BIOL CHEM, V263, P6005; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OLIVER G, 1987, GENE, V60, P1, DOI 10.1016/0378-1119(87)90207-1; QUIVIGER B, 1982, BIOCHIMIE, V64, P495, DOI 10.1016/S0300-9084(82)80165-X; RATTI S, 1985, J BACTERIOL, V163, P724, DOI 10.1128/JB.163.2.724-729.1985; RENDINA A, 1980, THESIS U WISCONSIN M; RENDINA AR, 1978, BIOCHEMISTRY-US, V17, P5388, DOI 10.1021/bi00618a011; SAKAKIBARA H, 1991, J BIOL CHEM, V266, P2028; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; TARRAND JJ, 1978, CAN J MICROBIOL, V24, P967, DOI 10.1139/m78-160; VANONI MA, 1992, BIOCHEMISTRY-US, V31, P4613, DOI 10.1021/bi00134a011; VANONI MA, 1990, BIOCHIM BIOPHYS ACTA, V1039, P374, DOI 10.1016/0167-4838(90)90273-I; VANONI MA, 1991, EUR J BIOCHEM, V202, P181, DOI 10.1111/j.1432-1033.1991.tb16361.x; VANONI MA, 1991, BIOCHEMISTRY-US, V30, P11478, DOI 10.1021/bi00112a016; VANONI MA, 1991, CHEM BIOCH FLAVOENZY, V3, P309; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; ZIMMER W, 1991, MOL GEN GENET, V229, P41, DOI 10.1007/BF00264211; [No title captured]	48	46	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3099	3106						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428988				2022-12-27	WOS:A1993KM16100016
J	CHU, FF; DOROSHOW, JH; ESWORTHY, RS				CHU, FF; DOROSHOW, JH; ESWORTHY, RS			EXPRESSION, CHARACTERIZATION, AND TISSUE DISTRIBUTION OF A NEW CELLULAR SELENIUM-DEPENDENT GLUTATHIONE-PEROXIDASE, GSHPX-GI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HUMAN-PLASMA; EUKARYOTIC CELLS; ACTIVE-SITE; GENE; CDNA; PROTEINS; ENZYME; SELENOCYSTEINE; DISTINCT	We have characterized a new selenium-dependent glutathione peroxidase, GSHPx-GI, by expressing a GSHPx-GI cDNA isolated from human hepatoma HepG2 cells in human mammary carcinoma MCF-7 cells, which have virtually undetectable expression of either the classical cellular enzyme, GSHPx-1, or GSHPx-GI at the protein level. One of the G418-resistant clones, neo-D1, expresses the transfected GSHPx-GI cDNA. This is based on 1) the presence of an additional GSHPx-GI DNA restriction fragment detected by Southern analysis; 2) the presence of a 1.9-kilobase (kb) GSHPx-GI mRNA in addition to the 1.0-kb endogenous mRNA by Northern analysis; and 3) the appearance of a 22-kDa Se-75-labeled protein which is absent in parental MCF-7 cells revealed by SDS-polyacrylamide gel electrophoresis. GSHPx-GI expressed in neo-D1 is a tetrameric protein localized in cytosol. GSHPx-GI does not cross-react with antisera against human GSHPx-1 or human plasma glutathione peroxidase (GSHPx-P). Similar substrate specificities are found for GSHPx-1 and GSHPx-GI; they both catalyze the reduction of H2O2, tert-butyl hydroperoxide, cumene hydroperoxide, and linoleic acid hydroperoxide with glutathione, but not of phosphatidylcholine hydroperoxide. GSHPx-GI mRNA was readily detected in human liver and colon, and occasionally in human breast samples, but not other human tissues including kidney, heart, lung, placenta, or uterus. In rodent tissues, GSHPx-GI mRNA is only detected in the gastrointestinal tract, and not in other tissues including liver. In fact, GSHPx-GI appears to be the major glutathione-dependent peroxidase activity in rodent GI tract. This finding suggests that GSHPx-GI could play a major role in protecting mammals from the toxicity of ingested lipid hydroperoxides. In conclusion, we have demonstrated that GSHPx-GI is the fourth member in the selenium-dependent glutathione peroxidase family, in addition to GSHPx-1, GSHPx-P, and phospholipid hydroperoxide glutathione peroxidase (PHGPX).	CITY HOPE NATL MED CTR,DEPT MED ONCOL & THERAPEUT RES,DUARTE,CA 91010	City of Hope				Esworthy, Steve/0000-0002-4111-3349	NCI NIH HHS [CA 33572] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKASAKA M, 1990, NUCLEIC ACIDS RES, V18, P4619, DOI 10.1093/nar/18.15.4619; AVISSAR N, 1991, J NUTR, V121, P1243, DOI 10.1093/jn/121.8.1243; BURK RF, 1991, FASEB J, V5, P2274, DOI 10.1096/fasebj.5.9.1830557; CHADA S, 1990, GENOMICS, V6, P268, DOI 10.1016/0888-7543(90)90566-D; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHAMBERS I, 1988, OXYRADICALS MOL BIOL, P289; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU FF, 1992, BLOOD, V79, P3233; CHU FF, 1990, NUCLEIC ACIDS RES, V18, P1531, DOI 10.1093/nar/18.6.1531; CHU FF, 1988, P AM ASSOC CANC RES, V29, P440; ESWORTHY RS, 1991, ARCH BIOCHEM BIOPHYS, V286, P330, DOI 10.1016/0003-9861(91)90048-N; FAURE J, 1991, BIOL REPROD, V44, P13, DOI 10.1095/biolreprod44.1.13; GHYSELINCK NB, 1990, NUCLEIC ACIDS RES, V18, P7144, DOI 10.1093/nar/18.23.7144; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HILL RE, 1985, MOL CELL BIOL, V5, P2144; KANE SE, 1989, GENE, V84, P439, DOI 10.1016/0378-1119(89)90518-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MADDIPATI KR, 1987, ARCH BIOCHEM BIOPHYS, V254, P9, DOI 10.1016/0003-9861(87)90075-0; MAIORINO M, 1991, J BIOL CHEM, V266, P7728; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MCBRIDE O W, 1988, Biofactors, V1, P285; MILLS GC, 1957, J BIOL CHEM, V229, P189; MULLENBACH GT, 1987, NUCLEIC ACIDS RES, V15, P5484, DOI 10.1093/nar/15.13.5484; MULLIGAN RC, 1979, NATURE, V277, P108, DOI 10.1038/277108a0; NIELSEN DA, 1983, P NATL ACAD SCI-BIOL, V80, P5198, DOI 10.1073/pnas.80.17.5198; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; ROVERI A, 1992, J BIOL CHEM, V267, P6142; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCKELT R, 1991, FREE RADICAL RES COM, V14, P343, DOI 10.3109/10715769109093424; SINET P M, 1975, Biochemical and Biophysical Research Communications, V67, P910, DOI 10.1016/0006-291X(75)90763-9; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145, DOI 10.1093/oxfordjournals.jbchem.a123172; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; THOMAS JP, 1990, J BIOL CHEM, V265, P454; VILAS NN, 1976, J NUTR, V106, P589, DOI 10.1093/jn/106.5.589; YOSHIMURA S, 1991, J BIOCHEM-TOKYO, V109, P918, DOI 10.1093/oxfordjournals.jbchem.a123480	37	453	479	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2571	2576						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428933				2022-12-27	WOS:A1993KK81500048
J	DARRIGO, A; MANERA, E; LONGHI, R; BORGESE, N				DARRIGO, A; MANERA, E; LONGHI, R; BORGESE, N			THE SPECIFIC SUBCELLULAR-LOCALIZATION OF 2 ISOFORMS OF CYTOCHROME-B5 SUGGESTS NOVEL TARGETING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; RAT-LIVER CELLS; ENDOPLASMIC-RETICULUM; REDUCTASE-ACTIVITY; C REDUCTASE; BINDING; HEMOPROTEIN; MICROSOMES; PROTEINS; B5	Two forms of cytochrome b5 are present in rat tissues, with a sequence identity of almost-equal-to 60% in the cytoplasmically exposed, tryptic fragments (Lederer, F., Ghrir, R., Guiard, B., Cortial, S., and Ito, A. (1983) Eur. J. Biochem. 132, 95-102). It has been suggested that the two isoforms have partially overlapping subcellular distributions, with each form localized to some extent on both endoplasmic reticulum and outer mitochondrial membranes (Ito, A. (1980) J. Biochem. (Tokyo) 87, 73-80). To investigate the degree of specificity of the localization of cytochrome b5 isoforms, we studied their subcellular distributions with antipeptide antibodies, one specific for microsomal cytochrome b5, one specific for outer membrane cytochrome b, and one against a sequence common to the two cytochromes. We first identified outer membrane Cyt b as a tightly bound, Triton X-114-extractable, 23-kDa polypeptide. We then analyzed biochemically characterized rat liver subcellular fractions by Western blotting and found that outer mitochondrial membrane cytochrome b was not present on endoplasmic reticulum membranes. Conversely, microsomal cytochrome b5 was present on outer mitochondrial membranes in extremely low concentration, at a level <5% of that on endoplasmic reticulum membranes. Thus, the subcellular distribution of microsomal cytochrome b5 is more restricted than previously thought, suggesting that novel posttranslational targeting mechanisms direct it to the endoplasmic reticulum.	UNIV MILAN,DEPT MED PHARMACOL,I-20122 MILAN,ITALY; CNR,IST CHIM ORMONI,I-20133 MILAN,ITALY	University of Milan; Consiglio Nazionale delle Ricerche (CNR)	DARRIGO, A (corresponding author), CNR,CTR CYTOPHARMACOL,VIA VANVITELLI 32,I-20129 MILAN,ITALY.		Borgese, Nica/GWZ-8895-2022	Borgese, Nica/0000-0002-7537-3974				ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; BENAZKO P, 1982, EUR J BIOCHEM, V123, P121; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; BORGESE N, 1980, J CELL BIOL, V85, P501, DOI 10.1083/jcb.85.3.501; BRIAND JP, 1985, J IMMUNOL METHODS, V78, P59, DOI 10.1016/0022-1759(85)90329-1; BRUDER G, 1980, BIOCHIM BIOPHYS ACTA, V600, P739, DOI 10.1016/0005-2736(80)90477-0; COLLOT M, 1982, EUR J CELL BIOL, V29, P34; DAILEY HA, 1981, J BIOL CHEM, V256, P3951; ENOCH HG, 1979, J BIOL CHEM, V254, P6483; ENOMOTO KI, 1977, BIOCHIM BIOPHYS ACTA, V466, P136, DOI 10.1016/0005-2736(77)90214-0; FLEISCHER S, 1971, BIOCHIM BIOPHYS ACTA, V225, P194, DOI 10.1016/0005-2736(71)90212-4; FOWLER S, 1976, J CELL BIOL, V71, P535, DOI 10.1083/jcb.71.2.535; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUKUSHIMA L, 1972, J BIOCHEM-TOKYO, V71, P447; GARFINKEL D, 1958, ARCH BIOCHEM BIOPHYS, V77, P493, DOI 10.1016/0003-9861(58)90095-X; ICHIKAWA Y, 1970, BIOCHEM BIOPH RES CO, V40, P297, DOI 10.1016/0006-291X(70)91009-0; ITO A, 1981, BIOCHEM BIOPH RES CO, V101, P591, DOI 10.1016/0006-291X(81)91300-0; ITO A, 1980, J BIOCHEM, V87, P73, DOI 10.1093/oxfordjournals.jbchem.a132754; ITO A, 1980, J BIOCHEM, V87, P63, DOI 10.1093/oxfordjournals.jbchem.a132753; JARASCH ED, 1979, J CELL BIOL, V80, P37, DOI 10.1083/jcb.80.1.37; LADOKHIN AS, 1991, BIOCHEMISTRY-US, V30, P10200, DOI 10.1021/bi00106a018; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; LIU FT, 1979, BIOCHEMISTRY-US, V18, P690, DOI 10.1021/bi00571a022; Maizel JV, 1971, METHOD VIROL, V5, P179; Merrifield RB, 1976, SCIENCE, V232, P341, DOI DOI 10.1126/SCIENCE.3961484; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; OZOLS J, 1982, BIOCHIM BIOPHYS ACTA, V704, P163, DOI 10.1016/0167-4838(82)90143-1; PARSONS DF, 1968, MITOCHONDRIAL STRUCT, P29; POENSGEN J, 1980, BIOCHIM BIOPHYS ACTA, V596, P248, DOI 10.1016/0005-2736(80)90359-4; RACHUBINSKI RA, 1980, J CELL BIOL, V84, P705, DOI 10.1083/jcb.84.3.705; REMACLE J, 1978, J CELL BIOL, V79, P291, DOI 10.1083/jcb.79.2.291; REMACLE J, 1980, BIOCHIM BIOPHYS ACTA, V597, P564, DOI 10.1016/0005-2736(80)90228-X; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; SOELLNER T, 1990, Cell, V62, P107; SOELLNER T, 1989, Cell, V59, P1061; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Stewart JM, 1984, SOLID PHASE PEPTIDE; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; VEBER DF, 1972, J AM CHEM SOC, V94, P5456, DOI 10.1021/ja00770a600; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499	43	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2802	2808						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428954				2022-12-27	WOS:A1993KK81500080
J	ISHII, T; MORIYOSHI, K; SUGIHARA, H; SAKURADA, K; KADOTANI, H; YOKOI, M; AKAZAWA, C; SHIGEMOTO, R; MIZUNO, N; MASU, M; NAKANISHI, S				ISHII, T; MORIYOSHI, K; SUGIHARA, H; SAKURADA, K; KADOTANI, H; YOKOI, M; AKAZAWA, C; SHIGEMOTO, R; MIZUNO, N; MASU, M; NAKANISHI, S			MOLECULAR CHARACTERIZATION OF THE FAMILY OF THE N-METHYL-D-ASPARTATE RECEPTOR SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID RECEPTORS; GLUTAMATE RECEPTOR; NMDA RECEPTOR; CHANNELS; BRAIN; IDENTIFICATION; PERMEABILITY; ANTAGONISTS; EXPRESSION; RESPONSES	cDNA clones for four different N-methyl-D-aspartate (NMDA) receptor subunits (NMDAR2A-NMDAR2D) were isolated through polymerase chain reactions followed by molecular screening of a rat brain cDNA library. These subunits are only about 15% identical with the key subunit of the NMDA receptor (NMDAR1) but are highly homologous (approximately 50% homology) with one another. They also commonly possess large hydrophilic domains at both amino- and carboxyl-terminal sides of the four putative transmembrane segments. NMDAR2A and NMDAR2C expressed individually in Xenopus oocytes showed no electrophysiological response to agonists. However, these subunits in combined expression with NMDAR1 markedly potentiated the NMDAR1 activity and produced functional variability in the affinity of agonists, the effectiveness of antagonists, and the sensitivity to Mg2+ blockade. Thus, NMDAR1 is essential for the function of the NMDA receptor, and multiple NMDAR2 subunits potentiate and differentiate the function of the NMDA receptor by forming different heteromeric configurations with NMDAR1. Northern blotting and in situ hybridization analyses revealed that the expressions of individual mRNAs for the NMDAR2 subunits overlap in some brain regions but are also specialized in many other regions. This investigation demonstrates the anatomical and functional differences of the NMDAR2 subunits, which provide the molecular basis for the functional diversity of the NMDA receptor.	KYOTO UNIV, FAC MED, INST IMMUNOL, SAKYO KU, KYOTO 606, JAPAN; KYOTO UNIV, FAC MED, DEPT MORPHOL BRAIN SCI, KYOTO 606, JAPAN	Kyoto University; Kyoto University			Kadotani, Hiroshi/A-7908-2015; Shigemoto, Ryuichi/E-3628-2013	Kadotani, Hiroshi/0000-0001-7474-3315; Shigemoto, Ryuichi/0000-0001-8761-9444; Sakurada, Kazuhiro/0000-0002-4858-2607				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEATON JA, 1992, J NEUROCHEM, V59, P754, DOI 10.1111/j.1471-4159.1992.tb09433.x; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; EBERT B, 1991, EUR J PHARM-MOLEC PH, V208, P49, DOI 10.1016/0922-4106(91)90050-R; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONAGHAN DT, 1991, EXCITATORY AMINO ACI, P33; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; QUARUM ML, 1990, J NEUROCHEM, V54, P1163, DOI 10.1111/j.1471-4159.1990.tb01944.x; SAKURADA K, 1993, IN PRESS J BIOL CHEM, V268; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERNAGOR E, 1989, NEURON, V2, P1221, DOI 10.1016/0896-6273(89)90306-1; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VIGNON J, 1986, BRAIN RES, V378, P133, DOI 10.1016/0006-8993(86)90294-5; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A	33	919	948	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2836	2843						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428958				2022-12-27	WOS:A1993KK81500085
J	BOURSIER, JP; ALCOVER, A; HERVE, F; LAISNEY, I; ACUTO, O				BOURSIER, JP; ALCOVER, A; HERVE, F; LAISNEY, I; ACUTO, O			EVIDENCE FOR AN EXTENDED STRUCTURE OF THE T-CELL CORECEPTOR CD8-ALPHA AS DEDUCED FROM THE HYDRODYNAMIC PROPERTIES OF SOLUBLE FORMS OF THE EXTRACELLULAR REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MHC; PERIPHERAL-BLOOD LYMPHOCYTES; HLA CLASS-I; ALPHA-3 DOMAIN; HUMAN CD4; MONOCLONAL-ANTIBODIES; SURFACE-ANTIGENS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; 2ND CHAIN	We expressed soluble forms of the human T-cell coreceptor CD8alpha extracellular region, CD8alpha161, and the amino-terminal immunoglobulin-like domain, CD8alpha114, in Chinese hamster ovary cells and Escherichia coli, respectively. Both molecules were readily purified to homogeneity in milligram amounts and were recognized by a large panel of monoclonal antibodies. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis indicated that approximately 70% of CD8alpha161 was secreted as a disulfide-linked dimer, but CD8alpha114 was not disulfide-linked. To investigate the structural features of CD8alpha161 and CD8alpha114 under native conditions, we performed gel filtration and sucrose gradient sedimentation analysis. In spite of being partially or totally noncovalently bound, both recombinant molecules were stably associated homodimers, as no monomers could be detected at a fairly low protein concentration (approximately 1 muM). This suggests that the CD8alpha amino-terminal domain alone strongly contributes to chain association. Determination of the Stokes radius (R(s)) and sedimentation coefficient (s20,w) gave results consistent with CD8alpha114 having a globular shape and CD8alpha161 being an asymmetric molecule. Taking into account the contribution of hydration to the frictional coefficient, we obtained for CD8alpha161 an axial ratio of approximately 5, when modeled as a prolate ellipsoid. These results indicate that the elongated structure of CD8alpha161 is essentially contributed by the hinge region and help to explain how the CD8alpha is able to bridge the distance between the T-cell surface and its binding site in the alpha3 domain of major histocompatibility complex class I molecules on the target cell.	INST PASTEUR,DEPT IMMUNOL,MOLEC IMMUNOL LAB,28 RUE DR ROUX,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				Alcover, Andres/0000-0002-9507-3450				ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ALCOVER A, 1992, IN PRESS MOL IMMUNOL; BARTHOLMES P, 1979, EUR J BIOCHEM, V95, P323, DOI 10.1111/j.1432-1033.1979.tb12968.x; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BOULOT G, 1990, J MOL BIOL, V213, P617, DOI 10.1016/S0022-2836(05)80248-7; Buttin G, 1978, Curr Top Microbiol Immunol, V81, P27; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; CHARMOT D, 1984, LEUKOCYTE TYPING, V2, P45; CLASSON BJ, 1992, INT IMMUNOL, V4, P215, DOI 10.1093/intimm/4.2.215; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; CONNOLLY JM, 1988, J EXP MED, V168, P325, DOI 10.1084/jem.168.1.325; CONNOLLY JM, 1990, P NATL ACAD SCI USA, V87, P2137, DOI 10.1073/pnas.87.6.2137; CRON RQ, 1989, J IMMUNOL, V142, P3754; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FLEURY S, 1991, CELL, V66, P1037, DOI 10.1016/0092-8674(91)90447-7; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON P, 1986, NATURE, V323, P74, DOI 10.1038/323074a0; KAUFMAN RJ, 1987, EMBO J, V6, P187, DOI 10.1002/j.1460-2075.1987.tb04737.x; KAVATHAS P, 1984, P NATL ACAD SCI-BIOL, V81, P7688, DOI 10.1073/pnas.81.24.7688; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; KWONG PD, 1990, P NATL ACAD SCI USA, V87, P6423, DOI 10.1073/pnas.87.16.6423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LETOURNEUR F, 1990, P NATL ACAD SCI USA, V87, P2339, DOI 10.1073/pnas.87.6.2339; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; MACDONALD HR, 1982, IMMUNOL REV, V68, P88; MALISSEN B, 1982, EUR J IMMUNOL, V12, P739, DOI 10.1002/eji.1830120908; MARSHALL AG, 1978, BIOPHYSICAL CHEM, P181; MEUER SC, 1982, P NATL ACAD SCI-BIOL, V79, P4395, DOI 10.1073/pnas.79.14.4395; MEUNIER JC, 1972, FEBS LETT, V24, P63, DOI 10.1016/0014-5793(72)80827-5; NAKAUCHI H, 1985, P NATL ACAD SCI USA, V82, P5126, DOI 10.1073/pnas.82.15.5126; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PARNES JR, 1989, ADV IMMUNOL, V44, P265; ROSENSTEIN Y, 1989, J EXP MED, V169, P149, DOI 10.1084/jem.169.1.149; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SANDERS SK, 1991, J EXP MED, V174, P371, DOI 10.1084/jem.174.2.371; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHIUE L, 1988, J EXP MED, V168, P1993, DOI 10.1084/jem.168.6.1993; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SNOW PM, 1985, J BIOL CHEM, V260, P2700; SNOW PM, 1983, J BIOL CHEM, V258, P4675; Sober H. H., 1968, HDB BIOCH; SWAIN SL, 1981, P NATL ACAD SCI-BIOL, V78, P7101, DOI 10.1073/pnas.78.11.7101; SZMELCMAN S, 1990, J ACQ IMMUN DEF SYND, V3, P859; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; VANDEKERCKHOVE J, 1985, EUR J BIOCHEM, V152, P9, DOI 10.1111/j.1432-1033.1985.tb09157.x; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WANG J, 1992, NATURE, V348, P411; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	66	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2013	2020						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420975				2022-12-27	WOS:A1993KH62000079
J	ERIKSSON, S; NORDEN, B; MORIMATSU, K; HORII, T; TAKAHASHI, M				ERIKSSON, S; NORDEN, B; MORIMATSU, K; HORII, T; TAKAHASHI, M			ROLE OF TYROSINE RESIDUE-264 OF RECA FOR THE BINDING OF COFACTOR AND DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; LINEAR DICHROISM; GENERAL RECOMBINATION; ELECTRON-MICROSCOPY; NUCLEOTIDE COFACTOR; LAMBDA-REPRESSOR; ATP HYDROLYSIS; PROTEIN; COMPLEXES	The tyrosine fluorescence of the RecA protein is quenched by about 15% upon binding of the cofactor analog adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS). This quenching is not observed with a modified RecA in which the tyrosine residue at position 264 (Tyr-264) is replaced for alanine by site-directed mutagenesis, a modification which also results in a decrease of binding affinity of cofactor. This indicates that Tyr-264 is responsible for the fluorescence change and that the residue is close to or within the cofactor binding site. Upon DNA binding, a change of tyrosine fluorescence is observed both with the modified protein and with wild type RecA, indicating that DNA binding affects the environment of other tyrosine residues than Tyr-264. However, the change is significantly smaller in the modified protein, suggesting that both Tyr-264 as well as other residue(s) may be affected by the DNA binding. Changed fluorescence properties of the remaining tyrosine residues as a result of a slightly different DNA binding mode of the modified protein are also possible. Tyr-264 may be an important residue for the allosteric effect induced by the cofactor for the binding of DNA to RecA. In the recent crystal structure of RecA-ADP published by Story and Steitz (Story, R. M., and Steitz, T. A. (1992) Nature 355, 374-376), ADP is stacked with Tyr-103 and does not interact with Tyr-264. The fact that we observe no interaction of ATPgammaS with Tyr-103 (as evidenced from absence of fluorescence change) but instead with Tyr-264 may suggest an important conformational difference between the RecA complexes with, respectively, ADP and ATP.	OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN; CNRS,INST BIOL MOLEC & CELLULAIRE,CANCEROGENESE & MUTAGENESE MOLEC & STRUCT LAB,F-67084 STRASBOURG,FRANCE	Osaka University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	ERIKSSON, S (corresponding author), CHALMERS UNIV TECHNOL,DEPT PHYS CHEM,S-41296 GOTHENBURG,SWEDEN.		Morimatsu, Katsumi/G-5029-2013; Norden, Bengt/ABE-3675-2020	Norden, Bengt/0000-0002-7946-200X; Horii, Toshihiro/0000-0002-3000-2045				BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CHABBERT M, 1991, J BIOL CHEM, V266, P5395; COTTERIL SM, 1982, BIOCHEMISTRY-US, V1, P4332; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; CRAIG NL, 1980, NATURE, V283, P26, DOI 10.1038/283026a0; DICAPUA E, 1990, J STRUCT BIOL, V104, P91, DOI 10.1016/1047-8477(90)90062-H; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; ERIKSSON S, 1993, J BIOL CHEM, V268, P1805; FREITAG NE, 1991, J BIOL CHEM, V266, P7058; GRIFFITH JD, 1988, CRC CR REV BIOCH MOL, V23, pS43, DOI 10.3109/10409238809083375; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; IKAWA S, 1989, J BIOL CHEM, V264, P21167; KAWASHIMA H, 1984, MOL GEN GENET, V193, P288, DOI 10.1007/BF00330682; KNIGHT KL, 1985, J BIOL CHEM, V260, P185; KOBAYASHI N, 1987, BIOCHEMISTRY-US, V26, P6801, DOI 10.1021/bi00395a033; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P5872, DOI 10.1021/bi00368a006; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; KURAMITSU S, 1981, J BIOCHEM-TOKYO, V90, P1033, DOI 10.1093/oxfordjournals.jbchem.a133555; LEAHY MC, 1986, J BIOL CHEM, V261, P6954; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MULLER B, 1990, J MOL BIOL, V212, P97, DOI 10.1016/0022-2836(90)90307-8; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; NORDEN B, 1990, J MOL BIOL, V216, P223, DOI 10.1016/S0022-2836(05)80311-0; Ogawa H, 1986, Adv Biophys, V21, P135, DOI 10.1016/0065-227X(86)90019-5; PRASAD BVV, 1987, J MOL BIOL, V193, P579; PUGH BF, 1988, J BIOL CHEM, V263, P76; RADDING CM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P131, DOI 10.1016/0167-4781(80)90001-9; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; TAKAHASHI M, 1991, FEBS LETT, V279, P270, DOI 10.1016/0014-5793(91)80165-Y; TAKAHASHI M, 1987, J BIOL CHEM, V262, P8109; TAKAHASHI M, 1989, J MOL BIOL, V205, P137, DOI 10.1016/0022-2836(89)90371-9; TAKAHASHI M, 1991, BIOCHIMIE, V73, P219, DOI 10.1016/0300-9084(91)90205-F; TONG L, 1989, SCIENCE, V245, P244, DOI 10.1126/science.2665078; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEINSTOCK GM, 1982, BIOCHIMIE, V64, P611, DOI 10.1016/S0300-9084(82)80098-9; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P883; WILLIAMS RC, 1986, J MOL BIOL, V187, P109, DOI 10.1016/0022-2836(86)90410-9; ZLOTNICK A, 1990, J BIOL CHEM, V265, P17050	45	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1811	1816						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420956				2022-12-27	WOS:A1993KH62000049
J	LIND, LK; SHUKLA, VK; NYHUS, KJ; PAKRASI, HB				LIND, LK; SHUKLA, VK; NYHUS, KJ; PAKRASI, HB			GENETIC AND IMMUNOLOGICAL ANALYSES OF THE CYANOBACTERIUM SYNECHOCYSTTIS SP PCC-6803 SHOW THAT THE PROTEIN ENCODED BY THE PSBJ GENE REGULATES THE NUMBER OF PHOTOSYSTEM-II CENTERS IN THYLAKOID MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLOROPLAST GENOME; DELETION MUTAGENESIS; NUCLEOTIDE-SEQUENCE; CYTOCHROME-B559; DNA; CONSTRUCTION; ORGANIZATION; INHIBITION; EVOLUTION	The psbJ gene is a member of the psbEFLJ gene cluster in the cyanobacterium Synechocystis sp. PCC 6803 as well as in the chloroplasts of green plants. The putative product of the psbJ gene is a 4-kDa protein with one membrane-spanning domain. We have raised rabbit antibodies against a T7 gene 10-psbJ fusion protein, overexpressed in Escherichia coli. These antibodies recognized a polypeptide of expected size in the thylakoid membrane from wild type Synechocystis cells. We have also created a targeted mutant of Synechocystis 6803 in which the fourth codon of the psbJ open reading frame was modified to a translational stop codon. Thylakoid membranes from these mutant cells lacked the protein recognized by the antibodies. In the mutant cells, the partial electron transfer reaction mediated by the photosystem I complex was unaffected, whereas the rate of the photosystem II (PSII)-mediated reaction was 46% of that in wild type cells. Herbicide binding assays indicated that the PSII to chlorophyll ratio in the mutant cells was 49% of that in wild type cells. These results indicate that while the PsbJ protein is not essential for the photochemical activity it controls the amount of functionally assembled PSII complex in the thylakoid membrane.	WASHINGTON UNIV, DEPT BIOL, ST LOUIS, MO 63130 USA	Washington University (WUSTL)					NIGMS NIH HHS [GM45797] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; CANTRELL A, 1988, PHOTOSYNTH RES, V16, P65, DOI 10.1007/BF00039486; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CUSHMAN JC, 1988, CURR GENET, V13, P173, DOI 10.1007/BF00365652; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; FONG SE, 1992, CURR GENET, V21, P527, DOI 10.1007/BF00351664; Hallick RB, 1989, PLANT MOL BIOL REP, V7, P266, DOI [10.1007/BF02668635, DOI 10.1007/BF02668635]; HARLOW E, 1988, ANTIBODIES LABORATOR; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; IKEUCHI M, 1992, BOT MAG TOKYO, V105, P327, DOI 10.1007/BF02489425; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MacKinney G, 1941, J BIOL CHEM, V140, P315; NYHUS KJ, 1992, J BIOL CHEM, V267, P12489; NYHUS KJ, 1989, TECHNIQUES NEW DEV P, P469; PAKRASI HB, 1991, EMBO J, V10, P1619, DOI 10.1002/j.1460-2075.1991.tb07684.x; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PAKRASI HB, 1990, Z NATURFORSCH C, V45, P423; PAKRASI HB, 1992, CURRENT TOPICS PHOTO, V11, P231; ROGNER M, 1990, J BIOL CHEM, V265, P6189; Sambrook J, 1989, MOL CLONING LABORATO; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; SHUKLA VK, 1992, MOL MICROBIOL, V6, P947, DOI 10.1111/j.1365-2958.1992.tb01544.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAE GS, 1992, BIOCHEMISTRY-US, V31, P4066, DOI 10.1021/bi00131a024; TISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V460, P113, DOI 10.1016/0005-2728(77)90157-8; VANRENSEN JJS, 1978, Z NATURFORSCH C, V33, P413, DOI 10.1515/znc-1978-5-617; VERMAAS W, 1990, BIOCHEMISTRY-US, V29, P5325, DOI 10.1021/bi00474a017; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	34	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1575	1579						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420932				2022-12-27	WOS:A1993KH62000014
J	LESTER, RL; WELLS, GB; OXFORD, G; DICKSON, RC				LESTER, RL; WELLS, GB; OXFORD, G; DICKSON, RC			MUTANT STRAINS OF SACCHAROMYCES-CEREVISIAE LACKING SPHINGOLIPIDS SYNTHESIZE NOVEL INOSITOL GLYCEROPHOSPHOLIPIDS THAT MIMIC SPHINGOLIPID STRUCTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHOSPHOLIPIDS	Mutant strains of Saccharomyces cerevisiae, termed SLC, make no detectable sphingolipids when cultured without a sphingolipid long chain base such as phytosphingosine (Dickson, R. C., Wells, G. B., Schmidt, A., and Lester, R. L. (1990) Mol. Cell. Biol. 10, 2176-2181). When grown with phytosphingosine they make sphingolipids in normal amounts. SLC strains carry a secondary suppressor mutation that bypasses the need to synthesize a long chain base. Hypothetically, the suppressor mutation could function by mutating a gene whose protein product required a sphingolipid for function, by increasing the level of one or more endogenous lipids, or by making new lipid(s). Here we demonstrate that SLC strains make novel inositol glycerophospholipids when cultured without a long chain base. The novel lipids are phosphatidylinositol (PI), mannosyl-PI, and inositol-P-(mannosyl-PI), containing 1 mol of C26 fatty acid, ordinarily found in yeast sphingolipids but not usually found in glycerophospholipids; the C26 fatty acid appears to be located at the SN-2 position of the glycerol. In addition, mono-fattyacyl versions of these three compounds were also identified. The polar head groups and hydrophobic portions of these novel lipids are strikingly similar to S. cerevisiae sphingolipids found in wild-type cells. We speculate that the novel lipids structurally mimic sphingolipids and thereby compensate for some sphingolipid function(s) necessary for growth.			LESTER, RL (corresponding author), UNIV KENTUCKY,COLL MED,DEPT BIOCHEM,LEXINGTON,KY 40536, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043102] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43102] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BRENNAN PJ, 1988, MICROBIAL LIPIDS, V1, P204; DICKSON RC, 1990, MOL CELL BIOL, V10, P2176, DOI 10.1128/MCB.10.5.2176; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HAKOMORI SI, 1983, SPHINGOLIPID BIOCH, P1; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANSON BA, 1980, J LIPID RES, V21, P309; LESTER RL, 1968, J BIOL CHEM, V243, P4889; LESTER RL, 1992, IN PRESS ADV LIPID R, V25; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; PATTON GM, 1982, J LIPID RES, V23, P190; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; Rattray J. B. M., 1988, MICROBIAL LIPIDS, P555; SKIPSKI VP, 1969, METHOD ENZYMOL, V14, P545; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; TREVELYAN WE, 1968, J I BREWING, V74, P365, DOI 10.1002/j.2050-0416.1968.tb03142.x; WELLS GB, 1983, J BIOL CHEM, V258, P200; WILEY MG, 1992, LIPIDS, V27, P295, DOI 10.1007/BF02536479; WOOD R, 1983, J CHROMATOGR, V254, P237, DOI 10.1016/S0021-9673(01)88338-2	23	105	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					845	856						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419362				2022-12-27	WOS:A1993KG07700017
J	LING, MH; QI, HY; CHI, CW				LING, MH; QI, HY; CHI, CW			PROTEIN, CDNA, AND GENOMIC DNA-SEQUENCES OF THE TOWEL GOURD TRYPSIN-INHIBITOR - A SQUASH FAMILY INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; SEEDS CUCURBITA-MAXIMA; SOLID-PHASE SYNTHESIS; ECBALLIUM-ELATERIUM; SERINE PROTEINASE; CMTI-I; PLANTS; SPECIFICITY; ELASTASE; TOBACCO	Two trypsin inhibitor components of the squash family were isolated and purified from the juice of the towel gourd (Luffa cylindrica) using anhydrotrypsin affinity chromatography followed by high pressure liquid chromatography. The inhibitors were sequenced and found to consist of 28 and 29 amino acid residues. The determined sequences show high similarity to other inhibitors of the squash family, especially in the location of disulfide bonds and the reactive site and also in the COOH-terminal region. A cDNA library of towel gourd was constructed and used as a template for polymerase chain reaction amplification of two cDNA fragments of the inhibitor with an overlapping sequence. A full-length cDNA sequence coding for the inhibitor was then completed. The open reading frame codes for a prepro-inhibitor protein with the pre- and pro-peptides consisting of 21 and 13 residues, respectively. The deduced amino acid sequence of 29 residues for the inhibitor is consistent with that determined by primary structure analysis. The genomic sequence of the mature inhibitor was also ascertained using the total DNA of the towel gourd as a polymerase chain reaction template. The genomic sequence is completely identical with that of the cDNA, showing no intervening sequence.	ACAD SINICA,SHANGHAI INST BIOCHEM,320 YUE YANG RD,SHANGHAI 200031,PEOPLES R CHINA; FOURTH MED UNIV XIAN,DEPT BIOCHEM,XIAN 710032,PEOPLES R CHINA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS								AXEN R, 1971, EUR J BIOCHEM, V18, P351; BENDICK AL, 1976, PLANT PHYSIOL, V42, P959; BODE W, 1989, FEBS LETT, V242, P285, DOI 10.1016/0014-5793(89)80486-7; CHEN XM, 1992, J BIOCHEM-TOKYO, V112, P45, DOI 10.1093/oxfordjournals.jbchem.a123863; DRYJANSKI M, 1990, BIOL CHEM H-S, V371, P889, DOI 10.1515/bchm3.1990.371.2.889; FAVEL A, 1989, BIOCHEM BIOPH RES CO, V162, P79, DOI 10.1016/0006-291X(89)91964-5; GERARD GF, 1986, FOCUS, V8, P3; GUSTAFSON G, 1976, J BIOL CHEM, V251, P7004; HARA S, 1989, J BIOCHEM-TOKYO, V105, P88, DOI 10.1093/oxfordjournals.jbchem.a122625; HEIJNE GV, 1983, EUR J BIOCHEM, V133, P17; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; HILDER VA, 1987, NATURE, V330, P160, DOI 10.1038/330160a0; HUANG QC, 1992, FEBS LETT, V297, P143, DOI 10.1016/0014-5793(92)80346-I; HUANG ZF, 1990, SCI CHINA SER B, V33, P1192; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; KNIGHTS RJ, 1974, ARCH BIOCHEM BIOPHYS, V160, P377, DOI 10.1016/0003-9861(74)90411-1; KUPRYSZEWSKI G, 1986, INT J PEPT PROT RES, V27, P245; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LENGUYEN D, 1989, INT J PEPT PROT RES, V34, P492; LIENER IE, 1979, INT REV BIOCHEM, V27, P97; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MATATHIAS AS, 1989, FOCUS, V11, P79; MCWHERTER CA, 1989, BIOCHEMISTRY-US, V28, P5708, DOI 10.1021/bi00440a002; OTLEWSKI J, 1987, BIOL CHEM H-S, V368, P1505; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; QIAN YW, 1990, SCI CHINA SER B, V33, P599; RICHARDSON M, 1977, PHYTOCHEMISTRY, V16, P159, DOI 10.1016/S0031-9422(00)86777-1; RYAN CA, 1978, TRENDS BIOCHEM SCI, V5, P148; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WIECZOREK M, 1985, BIOCHEM BIOPH RES CO, V126, P646, DOI 10.1016/0006-291X(85)90233-5	31	35	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					810	814						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419358				2022-12-27	WOS:A1993KG07700012
J	PILLET, L; TREMEAU, O; DUCANCEL, F; DREVET, P; ZINNJUSTIN, S; PINKASFELD, S; BOULAIN, JC; MENEZ, A				PILLET, L; TREMEAU, O; DUCANCEL, F; DREVET, P; ZINNJUSTIN, S; PINKASFELD, S; BOULAIN, JC; MENEZ, A			GENETIC-ENGINEERING OF SNAKE TOXINS - ROLE OF INVARIANT RESIDUES IN THE STRUCTURAL AND FUNCTIONAL-PROPERTIES OF A CURAREMIMETIC TOXIN, AS PROBED BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ALPHA-BUNGAROTOXIN BINDING; AMINO-ACID-SEQUENCE; INITIAL PROTEIN REFINEMENT; RABIES VIRUS GLYCOPROTEIN; CRYSTAL-STRUCTURE; SYNTHETIC PEPTIDES; ERABUTOXIN-B; 3-DIMENSIONAL STRUCTURE; 0.140-NM RESOLUTION	To study the site by which erabutoxin a (Ea) from Laticauda semifasciata binds to the nicotinic acetylcholine receptor, we mutated most residues that are shared with other curaremimetic toxins and studied the structural and biological consequences of introduced mutations. By site-directed mutagenesis, we changed Ser-8 into Gly (EaS8G), Lys-27 into Glu (EaK27E), Trp-29 into Phe (EaW29F) and His (EaW29H), Asp-31 into His (EaD31H), Phe-32 into Leu (EaF32L), Arg-33 into Lys (EaR33K) and Glu (EaR33E), Gly-34 into Ser (EaG34S), Glu-38 into Gln (EaE38Q) and Lys (EaE38K), Gly-49 into Val (EaG49V), and Leu-52 into Ala (EaL52A). All mutants were homogeneous as judged by various analytical procedures. EaE38Q, EaG49V, and EaL52A bound the nicotinic acetylcholine receptor with apparent K(d) values close to 10(-10) M, virtually identical to wild Ea. Therefore, Glu-38, Gly-49, and Leu-52 are not important elements in the expression of curaremimetic function in Ea. Mutations of Phe-32 and Gly-34 provoked a 7-fold affinity decrease, suggesting that these residues moderately contribute to function. The 176-fold affinity decrease due to mutation of Ser-8 may reflect some structural change that operates in the polypeptide chain of the mutant, as detected by circular dichroism. Decreases in affinity by a factor of 175, 67, 46, and 318 were seen upon mutations of Lys-27 into Glu, Trp-29 into Phe, Asp-31 into His, and Arg-33 into Glu, with no concomitant change in secondary structure. These residues appear to be important elements of the curaremimetic function of Ea. Thus, a picture of the contribution of conserved residues to the function of a curaremimetic toxin is proposed on the basis of experimental evidence.	CEA, CTR ETUD SACLAY, DEPT INGN & ETUD PROT, F-91190 GIF SUR YVETTE, FRANCE	CEA; UDICE-French Research Universities; Universite Paris Saclay								ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; BOQUET P, 1979, HDB EXP PHARM, V52, P751; BOURNE PE, 1985, EUR J BIOCHEM, V153, P521, DOI 10.1111/j.1432-1033.1985.tb09333.x; BOYOT P, 1990, FEBS LETT, V266, P87, DOI 10.1016/0014-5793(90)81513-N; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG CC, 1971, BIOCHIM BIOPHYS ACTA, V251, P334, DOI 10.1016/0005-2795(71)90120-6; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; Chiappinelli V., 1991, SNAKE TOXINS, P223; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CONTITRONCONI BM, 1990, BIOCHEMISTRY-US, V29, P6221, DOI 10.1021/bi00478a016; CORFIELD PWR, 1989, J BIOL CHEM, V264, P9239; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DONNELLYROBERTS DL, 1991, MOL BRAIN RES, V11, P107; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; DUCANCEL F, 1991, TOXICON, V29, P516, DOI 10.1016/0041-0101(91)90026-N; DUCANCEL F, 1989, PROTEIN ENG, V3, P139, DOI 10.1093/protein/3.2.139; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Endo T., 1991, P165; FAURE G, 1983, BIOCHEMISTRY-US, V22, P2068, DOI 10.1021/bi00278a006; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GREENSTEIN JP, 1961, CHEM AMINO ACIDS, P1687; HARVEY AL, 1984, BRIT J PHARMACOL, V82, P709, DOI 10.1111/j.1476-5381.1984.tb10810.x; HERVE M, 1992, EUR J BIOCHEM, V208, P125, DOI 10.1111/j.1432-1033.1992.tb17165.x; HORI H, 1976, BIOCHEM J, V153, P217, DOI 10.1042/bj1530217; ISHIKAWA Y, 1977, TOXICON, V15, P477, DOI 10.1016/0041-0101(77)90098-8; JANIN J, 1990, J BIOL CHEM, V265, P16027; JOUBERT FJ, 1975, H-S Z PHYSIOL CHEM, V356, P53, DOI 10.1515/bchm2.1975.356.1.53; KARLIN A, 1973, P NATL ACAD SCI USA, V70, P3636, DOI 10.1073/pnas.70.12.3636; KARLSSON E, 1991, TOXICON, V29, P521, DOI 10.1016/0041-0101(91)90027-O; KIM HS, 1982, BIOCHEM J, V207, P215, DOI 10.1042/bj2070215; LABHARDT AM, 1988, EUR J BIOCHEM, V149, P5; LAPLANTE SR, 1990, INT J PEPT PROT RES, V36, P227; LEGOAS R, 1992, BIOCHEMISTRY-US, V31, P4867, DOI 10.1021/bi00135a018; LENTZ TL, 1991, BIOCHEMISTRY-US, V30, P10949, DOI 10.1021/bi00109a020; LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37; LOW BW, 1986, EUR J BIOCHEM, V161, P579, DOI 10.1111/j.1432-1033.1986.tb10481.x; LOW BW, 1976, P NATL ACAD SCI USA, V73, P2991, DOI 10.1073/pnas.73.9.2991; LOW BW, 1987, ASIA PAC J PHARMACOL, V2, P115; LOW BW, 1979, HDB EXPT PHARMACOLOG, V52, P213; MARTIN BM, 1983, J BIOL CHEM, V258, P8714; MCLANE KE, 1991, BIOCHEMISTRY-US, V30, P4925, DOI 10.1021/bi00234a013; MENEZ A, 1982, TOXICON, V20, P95, DOI 10.1016/0041-0101(82)90172-6; MENEZ A, 1976, BIOCHIM BIOPHYS ACTA, V453, P121, DOI 10.1016/0005-2795(76)90256-7; MENEZ A, 1971, FEBS LETT, V17, P333, DOI 10.1016/0014-5793(71)80180-1; MENEZ A, 1978, BIOCHIMIE, V60, P505; MENEZ A, 1984, J PHYSIOLOGY PARIS, V79, P196; MENEZ A, 1992, SNAKE TOXINS ANTIGEN, P293; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MORI N, 1991, J PHARM PHARMACOL, V43, P785, DOI 10.1111/j.2042-7158.1991.tb03482.x; MULACJERICEVIC B, 1986, FEBS LETT, V199, P68, DOI 10.1016/0014-5793(86)81225-X; NEGRERIE M, 1990, BIOCHEMISTRY-US, V29, P8258, DOI 10.1021/bi00488a009; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; OSWALD RE, 1982, FEBS LETT, V139, P225, DOI 10.1016/0014-5793(82)80857-0; RALSTON S, 1987, BIOCHEMISTRY-US, V26, P3261, DOI 10.1021/bi00386a004; REES B, 1987, P NATL ACAD SCI USA, V84, P3132, DOI 10.1073/pnas.84.10.3132; RUAN KH, 1990, P NATL ACAD SCI USA, V87, P6156, DOI 10.1073/pnas.87.16.6156; RYDEN L, 1973, INT J PEPT PROT RES, V5, P261; SAITOH T, 1980, FEBS LETT, V116, P30, DOI 10.1016/0014-5793(80)80522-9; SATO S, 1971, BIOCHEM J, V122, P453, DOI 10.1042/bj1220453; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; TAMIYA T, 1985, BIOCHIMIE, V67, P185, DOI 10.1016/S0300-9084(85)80046-8; TSERNOGLOU D, 1978, MOL PHARMACOL, V14, P710; TSERNOGLOU D, 1976, FEBS LETT, V68, P1, DOI 10.1016/0014-5793(76)80390-0; WALKINSHAW MD, 1980, P NATL ACAD SCI-BIOL, V77, P2400, DOI 10.1073/pnas.77.5.2400; WEBER M, 1974, MOL PHARMACOL, V10, P1; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; WILSON PT, 1988, MOL PHARMACOL, V34, P643; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; WOODY RW, 1978, BIOPOLYMERS, V17, P1451, DOI 10.1002/bip.1978.360170606; YANG CC, 1974, BIOCHIM BIOPHYS ACTA, V365, P1, DOI 10.1016/0005-2795(74)90245-1; YU C, 1990, EUR J BIOCHEM, V193, P789, DOI 10.1111/j.1432-1033.1990.tb19401.x; ZINNJUSTIN S, 1992, IN PRESS BIOCHEMISTR; [No title captured]	75	153	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					909	916						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419369				2022-12-27	WOS:A1993KG07700026
J	HILL, JR; MORRIS, DR				HILL, JR; MORRIS, DR			CELL-SPECIFIC TRANSLATIONAL REGULATION OF S-ADENOSYLMETHIONINE DECARBOXYLASE MESSENGER-RNA - DEPENDENCE ON TRANSLATION AND CODING CAPACITY OF THE CIS-ACTING UPSTREAM OPEN READING FRAME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOGEN-ACTIVATED LYMPHOCYTES; EUKARYOTIC RIBOSOMES; INITIATION; EXPRESSION; SEQUENCES; GENE; EFFICIENCY; MODEL; SITE	The mRNA encoding S-adenosylmethionine decarboxylase (AdoMetDC) has a 330-nucleotide 5'-transcript leader containing an open reading frame (uORF) that codes for the hexapeptide MAGDIS. The uORF restricts the intracellular distribution of AdoMetDC mRNA primarily to monosomes in normal T-lymphocytes and in T-cell lines. In contrast, non-lymphoid cells normally carry an average of seven to nine ribosomes per AdoMetDC mRNA molecule (Hill, J. R., and Morris, D. R. (1992) J. Biol. Chem. 267, 21886-21893). Several alterations abolish the negative regulatory effect of the uORF in T-cells. These include removing the site of translational initiation; weakening the context of the translational initiation site; changing the coding capacity of the fourth, fifth, and sixth codons; increasing the length of the uORF at either the 5' or 3' end; or changing the primary order of the codons. In contrast, altering the nucleic acid sequence of the uORF at degenerative positions without changing the amino acid coding capacity did not cause deregulation. The uORF does not regulate translation in the trans-configuration. Our results support a model in which translation of the uORF generates a nascent hexapeptide that interacts with its translating ribosome to suppress translation of AdoMetDC mRNA in a cell-specific manner. Structural features of the carboxyl-terminal 3 amino acids of the putative hexapeptide govern the interaction of the peptide with a component of the translation machinery.	UNIV WASHINGTON,DEPT BIOCHEM,SJ-70,SEATTLE,WA 98195	University of Washington; University of Washington Seattle			Morris, David/G-4503-2011		NATIONAL CANCER INSTITUTE [R01CA039053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, P01GM042508] Funding Source: NIH RePORTER; NCI NIH HHS [CA39053] Funding Source: Medline; NIGMS NIH HHS [GM42508, GM07266-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABASTADO JP, 1991, NEW BIOL, V3, P511; DEGEN JL, 1983, J BIOL CHEM, V258, P2153; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HILL JR, 1992, J BIOL CHEM, V267, P21886; KANDROR K V, 1988, Molekulyarnaya Biologiya (Moscow), V22, P31; KASPAR RL, 1992, J BIOL CHEM, V267, P508; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MACH M, 1986, J BIOL CHEM, V261, P1697; Maniatis T., 1982, MOL CLONING; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEISS MR, 1991, J VIROL, V65, P6782, DOI 10.1128/JVI.65.12.6782-6789.1991; SHIRAHATA A, 1986, J BIOL CHEM, V261, P3833; STANLEY BA, 1989, J BIOL CHEM, V264, P21073; THEIL EC, 1990, J BIOL CHEM, V265, P4771; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; WHITE MW, 1990, BIOCHEM J, V268, P657, DOI 10.1042/bj2680657; WHITE MW, 1987, EUR J BIOCHEM, V170, P87, DOI 10.1111/j.1432-1033.1987.tb13670.x; WHITE MW, 1988, PHYSL POLYAMINES, P331; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; [No title captured]	30	108	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					726	731						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416975				2022-12-27	WOS:A1993KE60300109
J	SIMONS, M; MORGAN, KG; PARKER, C; COLLINS, E; ROSENBERG, RD				SIMONS, M; MORGAN, KG; PARKER, C; COLLINS, E; ROSENBERG, RD			THE PROTOONCOGENE C-MYB MEDIATES AN INTRACELLULAR CALCIUM RISE DURING THE LATE G1-PHASE OF THE CELL-CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSION; EXPRESSION; MUSCLE; CA-2+; G1; PROLIFERATION; CALMODULIN; MITOSIS; HEPARIN; LINES	The intracellular concentration of ionized calcium is involved in regulating mitosis. However, little is known about intracellular levels of calcium during G1. We have demonstrated in vascular smooth muscle cells a mid-G, decrease in ionized calcium concentration followed by a 2-fold rise at the G1/S interface (44 nM +/- 0.6 nM versus 98 nM +/- 1.1 nM, p < 0.01). The elevation of intracellular calcium is preceded by an increase in c-myb mRNA levels and is abolished with antisense but not mirsense c-myb oligonucleotides. Furthermore, cells stably transfected with c-myb show a similar 2-fold augmentation in intracellular calcium concentrations, as compared with untransfected cells, which is also abolished by antisense c-myb oligonucleotides. The c-myb-induced rise in intracellular calcium is dependent upon the presence of extracellular calcium and is not suppressed by L type calcium channel blockers. We conclude that c-myb induces an elevation in intracellular calcium levels of vascular smooth muscle cells at the G1/S interface which provides a novel role for this proto-oncogene as well as a potentially important control point for cell cycle regulation.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BETH ISRAEL HOSP,PROGRAM SMOOTH MUSCLE RES,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	SIMONS, M (corresponding author), MIT,DEPT BIOL,77 MASSACHUSETTS AVE,BLDG E25-229,CAMBRIDGE,MA 02139, USA.		Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734; Morgan, Kathleen/0000-0003-3300-3630	NHLBI NIH HHS [HL41484, HL31704, HL33014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014, R01HL031704, P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; BROWN KE, 1992, J BIOL CHEM, V267, P4625; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DEAGOSTINI AL, 1990, P NATL ACAD SCI USA, V87, P9784, DOI 10.1073/pnas.87.24.9784; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; IIDA H, 1990, J BIOL CHEM, V265, P21216; KEITH CH, 1985, NATURE, V316, P848, DOI 10.1038/316848a0; LIPSICK JS, 1987, MOL CELL BIOL, V7, P3358, DOI 10.1128/MCB.7.9.3358; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; LUSCHER B, 1990, GENE DEV, V4, P2235, DOI 10.1101/gad.4.12b.2235; MCINTOSH JR, 1989, SCIENCE, V246, P622; MOORE EDW, 1990, CELL CALCIUM, V11, P157, DOI 10.1016/0143-4160(90)90068-6; PAPAGEORGIOU P, 1991, AM J PHYSIOL, V260, pH507, DOI 10.1152/ajpheart.1991.260.2.H507; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; PAUL D, 1979, J CELL PHYSIOL, V98, P31, DOI 10.1002/jcp.1040980105; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; REILLY CF, 1989, J BIOL CHEM, V264, P6990; REILLY CF, 1990, J CELL PHYSIOL, V142, P342, DOI 10.1002/jcp.1041420217; Sambrook J, 1989, MOL CLONING LABORATO; SIMONS M, 1992, CIRC RES, V70, P835, DOI 10.1161/01.RES.70.4.835; SISKEN JE, 1985, ADV MICROSCOPY, P73; SMITH IL, 1991, 7TH ANN M ONC F ADV, P6; STEINHARDT RA, 1988, NATURE, V332, P364, DOI 10.1038/332364a0; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; TWIGG J, 1988, NATURE, V332, P366, DOI 10.1038/332366a0	32	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					627	632						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416967				2022-12-27	WOS:A1993KE60300094
J	DO, KY; CUMMINGS, RD				DO, KY; CUMMINGS, RD			2,6-BRANCHED MANNOSE AND THE REGULATION OF POLY-N-ACETYLLACTOSAMINE BIOSYNTHESIS IN N-LINKED OLIGOSACCHARIDES OF CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; CONCANAVALIN-A-SEPHAROSE; STRUCTURAL DETERMINANTS; HUMAN-GRANULOCYTES; SUGAR CHAINS; CARBOHYDRATE MOIETY; HUMAN-ERYTHROCYTES; PLASMA-MEMBRANE; HIGH-AFFINITY; SIALIC-ACID	Poly-N-acetyllactosamine (PL) sequences (repeating (3Galbeta1-4GlcNAcbeta1)n) in complex-type N-linked oligosaccharides often occur in branched tri- and tetraantennary chains containing alpha-linked mannosyl residues disubstituted by N-acetyllactosaminyl units at C-2 and C-6 (2,6-branched mannose). We report here our studies on the factors affecting PL biosynthesis and the branching of N-linked oligosaccharides in glycoproteins from Chinese hamster ovary (CHO) cells. For our studies, we utilized a mutant CHO cell line designated Lec8 CHO, which lacks the ability to galactosylate its glycoproteins and consequently synthesizes glycoproteins containing terminal GlcNAc residues and lacking poly-N-acetyl-lactosamine and sialic acid. Glycoproteins in extracts of [H-3]glucosamine- or [H-3]mannose-labeled Lec8 CHO cells were galactosylated by exogenous beta1-4-galactosyltransferase and analyzed by chromatography on leukoagglutinating phytohemagglutinin-Sepharose, a lectin reactive with glycoproteins containing 2,6-branched mannosyl residues. Approximately 10% of the radiolabeled glycoproteins were bound, and these were primarily of high molecular mass. Structural analyses of the bound glycoproteins demonstrated that they quantitatively contained 296-branched mannose. We then determined whether the ''small i'' N-acetylglucosaminyltransferase (iGNT), which initiates PL biosynthesis, could specifically recognize glycoproteins in vitro and whether recognition was dependent on the presence of 2,6-branched mannose. When the galactosylated glycoproteins in extracts of Lec8 CHO cells were incubated with UDP-[H-3]GlcNAc, the endogenous iGNT quantitatively added GlcNAc in beta1-3-linkage to terminal galactosyl residues in the leukoagglutinating phytohemagglutinin-bound glycoproteins. These results demonstrate for the first time that 2,6-branched mannosyl residues are restricted to a subset of CHO glycoproteins and that the iGNT in vitro preferentially recognizes glycoproteins containing the 2,6-branched mannose determinant.	UNIV OKLAHOMA HLTH SCI CTR, HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,POB 26901, BSEB-325, OKLAHOMA CITY, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center					NCI NIH HHS [CA-37626] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037626] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BERGER EG, 1985, P NATL ACAD SCI USA, V82, P4736, DOI 10.1073/pnas.82.14.4736; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BRILES EB, 1977, J BIOL CHEM, V252, P1107; BUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; CHILDS RA, 1983, BIOCHEM BIOPH RES CO, V110, P424, DOI 10.1016/0006-291X(83)91166-X; CRAWLEY SC, 1990, ANAL BIOCHEM, V185, P112, DOI 10.1016/0003-2697(90)90264-A; CUMMINGS RD, 1992, BIOESSAYS, V14, P849, DOI 10.1002/bies.950141210; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; CUMMINGS RD, 1993, IN PRESS GUIDE TECHN; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DO KY, 1990, BIOCHEM BIOPH RES CO, V173, P1123, DOI 10.1016/S0006-291X(05)80902-7; EASTON EW, 1991, J BIOL CHEM, V266, P21674; EGGE H, 1985, J BIOL CHEM, V260, P4927; ENDO T, 1990, BIOCHEMISTRY-US, V29, P9126, DOI 10.1021/bi00491a005; FUKUDA M, 1988, J BIOL CHEM, V263, P5314; FUKUDA M, 1984, J BIOL CHEM, V259, P8260; FUKUDA M, 1984, J BIOL CHEM, V259, P4782; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUDA M, 1984, BIOCHIM BIOPHYS ACTA, V780, P119, DOI 10.1016/0304-419X(84)90002-7; FUKUDA MN, 1978, J BIOL CHEM, V253, P6814; FUKUDA MN, 1985, J BIOL CHEM, V260, P1067; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; JARNEFELT J, 1978, J BIOL CHEM, V253, P8006; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; KNIBBS RN, 1989, BIOCHEMISTRY-US, V28, P6379, DOI 10.1021/bi00441a034; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRUSIUS T, 1976, FEBS LETT, V71, P117, DOI 10.1016/0014-5793(76)80911-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFERTE S, 1989, BIOCHEM J, V259, P569, DOI 10.1042/bj2590569; LI E, 1978, J BIOL CHEM, V253, P7762; LI E, 1980, ARCH BIOCHEM BIOPHYS, V199, P393, DOI 10.1016/0003-9861(80)90295-7; Li Y.-T., 1972, METHOD ENZYMOL, V28, P702; MATSUMOTO A, 1982, ARCH BIOCHEM BIOPHYS, V217, P682, DOI 10.1016/0003-9861(82)90550-1; McEver Rodger P., 1992, Current Opinion in Cell Biology, V4, P840, DOI 10.1016/0955-0674(92)90109-P; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; MORI E, 1991, BIOCHEMISTRY-US, V30, P2078, DOI 10.1021/bi00222a012; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; ORBERGER G, 1992, EUR J BIOCHEM, V205, P257, DOI 10.1111/j.1432-1033.1992.tb16776.x; PIERCE M, 1986, J BIOL CHEM, V261, P772; PILLER F, 1983, J BIOL CHEM, V258, P2293; PLAAS AHK, 1992, TRENDS GLYCOSCI GLYC, V4, P445; QUN Z, 1993, ARCH BIOCHEM BIOPHYS, V300, P6, DOI 10.1006/abbi.1993.1002; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SEGUCHI T, 1991, ARCH BIOCHEM BIOPHYS, V284, P245, DOI 10.1016/0003-9861(91)90292-Q; SMITH DF, 1990, J BIOL CHEM, V265, P6225; SPOONCER E, 1984, J BIOL CHEM, V259, P4792; SRIVATSAN J, 1992, J BIOL CHEM, V267, P20196; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; SZILAGYI PJ, 1985, ANAL BIOCHEM, V148, P260, DOI 10.1016/0003-2697(85)90655-4; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; VANDENEIJNDEN DH, 1988, J BIOL CHEM, V263, P12461; WANG WC, 1991, J BIOL CHEM, V266, P23185; YAMAMOTO K, 1984, EUR J BIOCHEM, V143, P133, DOI 10.1111/j.1432-1033.1984.tb08352.x; YAMASHITA K, 1989, J BIOL CHEM, V264, P2415; YOSHIMA H, 1980, J BIOL CHEM, V255, P793; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244; ZHU BCR, 1984, J BIOL CHEM, V259, P3962	70	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22028	22035						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408060				2022-12-27	WOS:A1993MC80900088
J	NOMURA, T; SAKAI, N; SARAI, A; SUDO, T; KANEIISHII, C; RAMSAY, RG; FAVIER, D; GONDA, TJ; ISHII, S				NOMURA, T; SAKAI, N; SARAI, A; SUDO, T; KANEIISHII, C; RAMSAY, RG; FAVIER, D; GONDA, TJ; ISHII, S			NEGATIVE AUTOREGULATION OF C-MYB ACTIVITY BY HOMODIMER FORMATION THROUGH THE LEUCINE-ZIPPER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; PROTO-ONCOGENE PRODUCT; B-CELL LYMPHOMAS; V-MYB; MYELOMONOCYTIC CELLS; GLUCOCORTICOID RECEPTOR; CONSTITUTIVE EXPRESSION; NUCLEOTIDE-SEQUENCE; MYELOID-LEUKEMIA; GENE	The trans-activating and transforming capacities of the c-myb proto-oncogene product (c-Myb) are negatively regulated through a leucine zipper structure in its negative regulatory domain. We show here that in contransfection assays, maximal Myb-induced trans-activation occurs with relatively low amounts of wild-type c-Myb, while higher levels of c-Myb result in reduced Myb-induced trans-activation. By contrast, this apparent negative autoregulation is not observed with a c-Myb mutant containing an impaired leucine zipper. Data presented here suggest that this negative autoregulation of trans-activation by wild-type c-Myb is a consequence of homodimer formation by c-Myb through its leucine zipper and of the inability of c-Myb dimers to bind DNA. These findings point to a novel mechanism of regulation of a transcription factor.	ROYAL MELBOURNE HOSP,LUDWIG INST CANC RES,MELBOURNE TUMOUR BIOL BRANCH,PARKVILLE,VIC 3050,AUSTRALIA; INST MED & VET SCI,HANSON CTR CANC RES,ADELAIDE,SA 5000,AUSTRALIA	Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Institute Medical & Veterinary Science Australia	NOMURA, T (corresponding author), RIKEN,TSUKUBA LIFE SCI CTR,TSUKUBA,IBARAKI 305,JAPAN.		Ishii, Shunsuke/A-5271-2016; Ramsay, Robert G/C-3291-2015	Ishii, Shunsuke/0000-0002-6530-2478; Ramsay, Robert G/0000-0001-5003-0433				ABEL T, 1989, NATURE, V341, P24, DOI 10.1038/341024a0; ANTON IA, 1988, NATURE, V336, P719, DOI 10.1038/336719a0; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOULUKOS KE, 1988, EMBO J, V7, P697, DOI 10.1002/j.1460-2075.1988.tb02865.x; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FRAMPTON J, 1989, NATURE, V342, P134, DOI 10.1038/342134a0; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987; GONDA TJ, 1989, EMBO J, V8, P1767, DOI 10.1002/j.1460-2075.1989.tb03570.x; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRASSER FA, 1991, MOL CELL BIOL, V11, P3987; HIGUCHI R, 1990, PCR TECHNOLOGY PRINC, P61; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; HU YL, 1991, ONCOGENE, V6, P1549; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KANEIISHII C, 1990, J BIOL CHEM, V265, P19990; KANEIISHII C, 1992, P NATL ACAD SCI USA, V89, P3088, DOI 10.1073/pnas.89.7.3088; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEWIN B, 1990, CELL, V61, P1161, DOI 10.1016/0092-8674(90)90675-5; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MACGREGOR PF, 1990, ONCOGENE, V5, P451; METZ T, 1991, GENE DEV, V5, P369, DOI 10.1101/gad.5.3.369; Moscovici C., 1982, ADV VIRAL ONCOL, V1, P83; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKAGOSHI H, 1989, NUCLEIC ACIDS RES, V17, P7315, DOI 10.1093/nar/17.18.7315; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1987, CELL, V51, P41, DOI 10.1016/0092-8674(87)90008-0; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; PIZER E, 1989, J VIROL, V63, P1630, DOI 10.1128/JVI.63.4.1630-1640.1989; RAMSAY RG, 1992, J BIOL CHEM, V267, P5656; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; RAMSAY RG, 1991, ONCOGENE, V6, P1875; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SAIKUMAR P, 1990, P NATL ACAD SCI USA, V87, P8452, DOI 10.1073/pnas.87.21.8452; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TANIKAWA J, 1993, IN PRESS P NATL ACAD; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; YANAGISAWA H, 1991, BIOCHIM BIOPHYS ACTA, V1088, P380, DOI 10.1016/0167-4781(91)90128-9; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	66	73	74	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21914	21923						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408047				2022-12-27	WOS:A1993MC80900073
J	CRENSHAW, DG; HSIEH, TS				CRENSHAW, DG; HSIEH, TS			FUNCTION OF THE HYDROPHILIC CARBOXYL-TERMINUS OF TYPE-II DNA TOPOISOMERASE FROM DROSOPHILA-MELANOGASTER .2. IN-VIVO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERTWINED CATENATED DIMERS; CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; MITOTIC CHROMOSOMES; YEAST; REPLICATION; SEGREGATION; TRANSCRIPTION; CONDENSATION; COMPONENT	Genetic complementation, protein distribution, and in vivo enzymatic activity by carboxyl-terminal truncation mutations of the Drosophila enzyme were examined. Removal of more than 273 of the 1447 amino acids composing the full-length topoisomerase inactivates the enzyme in vivo and in vitro; removal of 227 amino acids or less has no apparent effect on the ability of the enzyme to substitute for a conditional lethal, or null mutation, of the Saccharomyces cerevisiae top2 gene. Four catalytically active mutants, from which 227 or 240 amino acids are deleted, define an intervening, critical region. Each mutant in this critical region displays different in vivo complementation activity ranging from complete complementation to non-complementation. Deletion analysis revealed a potent nuclear localization signal within the most distal 60 amino acids, although this is apparently not the only functional signal sequence encoded in the enzyme. Subcellular fractionation and indirect immunofluorescence demonstrate that the truncated enzymes localize to the nucleus, albeit with reduced efficiency compared to wild type. The ability of these mutants, including a mutant in the critical region which does not complement, to catalyze the decatenation of replicated plasmids and the segregation of replicated chromosomes was also examined.	DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University			Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012		NIGMS NIH HHS [5T32 GM07184, GM29006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184, R01GM029006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CARON PR, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P1; CHARRON M, 1991, CHROMOSOMA, V100, P97, DOI 10.1007/BF00418242; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; DAVIS LI, 1990, CELL, V61, P965, DOI 10.1016/0092-8674(90)90062-J; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; HIRANO T, 1991, J CELL BIOL, V115, P1479, DOI 10.1083/jcb.115.6.1479; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HSIEH T, 1983, J BIOL CHEM, V258, P8413; IDE GJ, 1981, CURR GENET, V4, P85, DOI 10.1007/BF00365686; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS CW, 1988, J CELL BIOL, V107, P1401; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOHR D, 1988, YEAST PRACTICAL APPR, P125; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; ROSE D, 1990, CELL, V60, P1009, DOI 10.1016/0092-8674(90)90349-J; SHERMAN F, 1986, LABORATORY COURSE MA; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SHIOZAKI K, 1991, MOL CELL BIOL, V11, P6093, DOI 10.1128/MCB.11.12.6093; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; WANG JC, 1987, BIOCHIM BIOPHYS ACTA, V909, P1, DOI 10.1016/0167-4781(87)90040-6; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; WYCKOFF E, 1988, P NATL ACAD SCI USA, V85, P6272, DOI 10.1073/pnas.85.17.6272; YANAGIDA M, 1987, NUCLEIC ACIDS MOL BI, V1, P196; ZAKIAN VA, 1979, CELL, V17, P923, DOI 10.1016/0092-8674(79)90332-5	46	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21335	21343						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407972				2022-12-27	WOS:A1993MA28800100
J	REEVES, R; NISSEN, MS				REEVES, R; NISSEN, MS			INTERACTION OF HIGH-MOBILITY GROUP-I(Y) NONHISTONE PROTEINS WITH NUCLEOSOME CORE PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GROUP-I PROTEIN; HMG-I; CHROMOSOMAL-PROTEINS; THERMAL-DENATURATION; GENE-REGULATION; SATELLITE DNA; CDC2 KINASE; BETA GENE; SEQUENCE	Mammalian high mobility group (HMG)-I(Y) chromosomal proteins bind with high affinity to the minor groove of A.T-rich sequences of DNA both in vitro and in vivo. Electrophoretic mobility shift assays demonstrate that in vitro both native and recombinant human HMG-I proteins also bind, but with lower affinity, to preferred regions on isolated avian nucleosome core particles containing approximately 146 base pairs of random sequence DNA. Up to four discrete HMG-I . core particle complexes can be detected by electrophoretic mobility shift assays when increasing molar ratios of protein are associated with cores. Both protein-DNA and protein-protein interactions are involved in HMG-I binding to cores. The interaction of HMG-I with core DNA is demonstrated by both thermal denaturation and DNase I footprinting experiments. Chemical cross-linking studies employing reversible photoactivatable cross-linkers, combined with one- and two-dimensional electrophoretic analyses, indicate that in vitro HMG-I binds to cores in close proximity to histones H2A and H2B and H3. In situ cross-linking of K562 human erythroleukemia cell nuclei demonstrate that native HMG-I(Y) binds in a similar manner to nucleosomal histones in vivo. Proteolytic removal of the positively charged amino-terminal tails of the octamer histones abolishes binding of HMG-I to core particles. However, core binding is not mediated by the negatively charged carboxyl-terminal tail of the HMG-I protein since an in vitro produced mutant protein lacking this region binds to core particles in a manner similar to full-length HMG-I. Together these results demonstrate that HMG-I, both in vitro and in vivo, binds to preferred regions on the front face of core nucleosomes.	WASHINGTON STATE UNIV, DEPT GENET & CELL BIOL, PULLMAN, WA 99164 USA	Washington State University	REEVES, R (corresponding author), WASHINGTON STATE UNIV, DEPT BIOCHEM & BIOPHYS, PULLMAN, WA 99164 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026356] Funding Source: NIH RePORTER; NIAID NIH HHS [5-R01-AI26356] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBRIGHT SC, 1980, J BIOL CHEM, V255, P3673; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BRAWLEY JV, 1992, BIOCHEMISTRY-US, V31, P364, DOI 10.1021/bi00117a008; BUSSEMAKERS MJG, 1991, CANCER RES, V51, P606; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CORTADAS J, 1979, EUR J BIOCHEM, V99, P179, DOI 10.1111/j.1432-1033.1979.tb13244.x; COWMAN MK, 1980, BIOCHEMISTRY-US, V19, P532, DOI 10.1021/bi00544a022; CRIPPA MP, 1992, J MOL BIOL, V228, P442, DOI 10.1016/0022-2836(92)90833-6; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; DREW HR, 1993, J MOL BIOL, V230, P824, DOI 10.1006/jmbi.1993.1204; EDEN FC, 1978, BIOCHEMISTRY-US, V17, P5838, DOI 10.1021/bi00619a035; ELTON TS, 1986, ANAL BIOCHEM, V157, P53, DOI 10.1016/0003-2697(86)90195-8; ELTON TS, 1987, BIOCHEM BIOPH RES CO, V143, P260, DOI 10.1016/0006-291X(87)90659-0; EVANS JNS, 1992, B MAG RESON, V14, P171; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; FULMER AW, 1979, BIOCHEMISTRY-US, V18, P659, DOI 10.1021/bi00571a017; GIANCOTTI V, 1989, EXP CELL RES, V184, P538, DOI 10.1016/0014-4827(89)90352-2; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HUANG SY, 1989, METHOD ENZYMOL, V170, P116; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; LEVINGER L, 1982, P NATL ACAD SCI-BIOL, V79, P7152, DOI 10.1073/pnas.79.23.7152; LIBERTINI LJ, 1980, NUCLEIC ACIDS RES, V8, P3517, DOI 10.1093/nar/8.16.3517; LUND T, 1990, BIOCHEM BIOPH RES CO, V171, P342, DOI 10.1016/0006-291X(90)91399-D; LUND T, 1983, FEBS LETT, V152, P163, DOI 10.1016/0014-5793(83)80370-6; LUTTER LC, 1989, METHOD ENZYMOL, V170, P264; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; MCGHEE JD, 1980, NUCLEIC ACIDS RES, V8, P2751, DOI 10.1093/nar/8.12.2751; MEANS GE, 1971, CHEM MODIFICATION PR, P219; MEIJER L, 1991, EUR J BIOCHEM, V196, P557, DOI 10.1111/j.1432-1033.1991.tb15850.x; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; OLIVA R, 1986, BIOCHEMISTRY-US, V25, P6508, DOI 10.1021/bi00369a025; PATON AE, 1983, J BIOL CHEM, V258, P3221; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; RAM TG, 1993, CANCER RES, V53, P2655; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; REEVES R, 1992, Current Opinion in Cell Biology, V4, P413, DOI 10.1016/0955-0674(92)90006-X; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; SANDEEN G, 1980, NUCLEIC ACIDS RES, V8, P3757, DOI 10.1093/nar/8.17.3757; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SHEEN JY, 1988, BIOTECHNIQUES, V6, P942; SHICK VV, 1985, J MOL BIOL, V185, P329, DOI 10.1016/0022-2836(85)90407-3; SIMPSON RT, 1979, J BIOL CHEM, V254, P123; SKALNIK DG, 1992, BIOCHEM BIOPH RES CO, V187, P563, DOI 10.1016/0006-291X(92)91231-E; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; STERNER R, 1982, J BIOL CHEM, V257, P13872; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; SWERDLOW PS, 1983, NUCLEIC ACIDS RES, V11, P387, DOI 10.1093/nar/11.2.387; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMAS JO, 1989, METHOD ENZYMOL, V170, P549; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1980, BIOPHYS J, V32, P271, DOI 10.1016/S0006-3495(80)84956-3; WEISCHET WO, 1978, NUCLEIC ACIDS RES, V5, P139, DOI 10.1093/nar/5.1.139; WOLFFE A, 1992, CRHOMATIN STRUCTURE; WU KC, 1983, J MOL BIOL, V170, P93, DOI 10.1016/S0022-2836(83)80228-9	68	75	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21137	21146						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407950				2022-12-27	WOS:A1993MA28800075
J	BELFORD, HG; WESTAWAY, SK; ABELSON, J; GREER, CL				BELFORD, HG; WESTAWAY, SK; ABELSON, J; GREER, CL			MULTIPLE NUCLEOTIDE COFACTOR USE BY YEAST LIGASE IN TRANSFER-RNA SPLICING - EVIDENCE FOR INDEPENDENT ATP-BINDING AND GTP-BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDONUCLEASE; ENZYME; GENE	We have examined multiple cofactor usage by yeast tRNA ligase in splicing in vitro. The ligase mechanism of action requires expenditure of two molar equivalents of nucleotide cofactor per mole of tRNA product. Recent evidence (Westaway, S. K., Belford, H. G., Apostol, B. L., Abelson, J., and Greer, C. L. (1993) J. Biol. Chem. 268, 2435-2443) demonstrated that the ligase-associated kinase activity is more efficient with GTP as cofactor than with ATP. Employing a ligase fusion construct with dihydrofolate reductase (Apostol, B. L., Westaway, S. K., Abelson, J., and Greer, C. L. (1991) J. Biol. Chem. 266, 7445-7455) for purposes of enzyme purification, we performed joining assays demonstrating that ATP and GTP are the most effective combination of cofactors. ATP was essential to the joining reaction, while UTP, CTP, or ATP replaced GTP inefficiently.,Specific and functionally independent binding sites were confirmed for ATP and GTP by direct binding measurement. A third site was implicated in UTP- and CTP-ligase interactions. Comparison of binding constants with K(app) values determined for nucleotide-dependent joining suggested both that nucleotide triphosphate binding may be limiting in tRNA joining and that tRNA ligation occurs most efficiently using GTP for the kinase reaction and ATP as the adenylylate synthetase cofactor.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; CALTECH,DIV BIOL,PASADENA,CA 91125	University of California System; University of California Irvine; California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035955] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35955] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELSON J, 1991, HARVEY LECT, V85, P1; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; APOSTOL BL, 1991, NUCLEIC ACIDS RES, V19, P1853, DOI 10.1093/nar/19.8.1853; BURRIDGE PW, 1977, CAN J BIOCHEM CELL B, V55, P935, DOI 10.1139/o77-140; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; MCCRAITH SM, 1991, J BIOL CHEM, V266, P11986; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PERLMAN PS, 1990, INTERVENING SEQUENCE, P112; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; RUBY SW, 1990, METHOD ENZYMOL, V181, P97; VOLCKAERT G, 1976, ANAL BIOCHEM, V72, P433, DOI 10.1016/0003-2697(76)90551-0; WESTAWAY SK, 1993, J BIOL CHEM, V268, P2435; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; XU Q, 1990, BIOCHEMISTRY-US, V29, P6132, DOI 10.1021/bi00478a004	18	20	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2444	2450						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428919				2022-12-27	WOS:A1993KK81500032
J	CALA, SE; ULBRIGHT, C; KELLEY, JS; JONES, LR				CALA, SE; ULBRIGHT, C; KELLEY, JS; JONES, LR			PURIFICATION OF A 90-KDA PROTEIN (BAND-VII) FROM CARDIAC SARCOPLASMIC-RETICULUM - IDENTIFICATION AS CALNEXIN AND LOCALIZATION OF CASEIN KINASE-II PHOSPHORYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; MOLECULAR-CLONING; CDNA CLONING; RAT-LIVER; CALSEQUESTRIN; VESICLES; GLYCOPROTEIN; 53,000-DALTON; SPECIFICITY; EXPRESSION	Purification and sequencing of proteins from cardiac sarcoplasmic reticulum (SR) vesicles have provided a framework for the study of SR function. Included among the SR proteins so far investigated are a collection of intralumenal proteins that stain blue with the protein dye Stains-All in sodium dodecyl sulfate-polyacrylamide gels. A single prominent blue staining SR protein of apparent M(r) = 90,000 (Band VII), however, has remained uncharacterized. In the work described here, purification of Band VII from dog cardiac SR vesicles, along with amino acid sequencing and cDNA cloning, identified this protein as calnexin, a homologue of calreticulin recently described in dog pancreatic microsomes. Using ryanodine-mediated calcium oxalate loading of SR vesicles followed by density gradient centrifugation, we have shown that calnexin is a bona fide SR protein and an integral constituent of both junctional and free SR vesicles. Calnexin was found to be a substrate for casein kinase II and was phosphorylated at two distinct sites localized to the carboxyl- and amino-terminal ends of the molecule. Enrichment of calnexin in cardiac SR vesicles indicates a role for calnexin involving the specialized function of the SR membrane.	INDIANA UNIV,SCH MED,DEPT BIOCHEM,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,KRANNERT INST CARDIOL,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	CALA, SE (corresponding author), INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028556] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28556, HL06308] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; ALLEN G, 1989, SEQUENCING PROTEINS; Cala S E, 1990, Semin Cell Biol, V1, P265; CALA S E, 1991, Biophysical Journal, V59, p249A; CALA SE, 1983, J BIOL CHEM, V258, P1932; CALA SE, 1992, BIOCHIM BIOPHYS ACTA, V1118, P277, DOI 10.1016/0167-4838(92)90285-L; CALA SE, 1991, J BIOL CHEM, V266, P391; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FUZIKI Y, 1982, J CELL BIOL, V93, P97; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HOFMANN SL, 1989, J BIOL CHEM, V264, P8260; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; JONES LR, 1979, J BIOL CHEM, V254, P530; JONES LR, 1981, J BIOL CHEM, V256, P1809; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1989, J BIOL CHEM, V264, P3484; LEBERER E, 1989, P NATL ACAD SCI USA, V86, P6047, DOI 10.1073/pnas.86.16.6047; LEBERER E, 1990, J BIOL CHEM, V265, P10118; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1992, HEART CARDIOVASCULAR, P1203; Maniatis T., 1982, MOL CLONING; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SEILER S, 1984, J BIOL CHEM, V259, P8550; SLUPSKY JR, 1987, BIOCHEMISTRY-US, V26, P6539, DOI 10.1021/bi00394a038; VAN PN, 1989, J BIOL CHEM, V264, P17494; WADA I, 1991, J BIOL CHEM, V266, P19599; WITCHER DR, 1991, J BIOL CHEM, V266, P11144	37	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2969	2975						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428970				2022-12-27	WOS:A1993KK81500104
J	MCGUIRE, MJ; LIPSKY, PE; THIELE, DL				MCGUIRE, MJ; LIPSKY, PE; THIELE, DL			GENERATION OF ACTIVE MYELOID AND LYMPHOID GRANULE SERINE PROTEASES REQUIRES PROCESSING BY THE GRANULE THIOL PROTEASE DIPEPTIDYL PEPTIDASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE METHYL-ESTER; CYTO-TOXIC LYMPHOCYTES; NATURAL-KILLER CELLS; MAST-CELL; CYTOTOXIC LYMPHOCYTES; NEUTROPHIL ELASTASE; MONOCLONAL-ANTIBODY; DIAZOMETHYL KETONES; ZYMOGEN ACTIVATION; MOLECULAR-CLONING	The proenzyme activation peptides predicted from cDNAs encoding each of the granule serine proteases synthesized by cytotoxic lymphocytes and myeloid and mast cells are composed of 2 residues. The mechanism by which these amino-terminal dipeptides are cleaved to generate the active enzymes has not been elucidated. The comparable distribution of dipeptidyl peptidase I (DPPI) and serine proteases and the ability of DPPI to hydrolyze relevant dipeptide sequences suggested a role for DPPI in the processing and activation of granule serine proteases. This study demonstrates that inhibition of DPPI activity is associated with impairment of the generation of granule serine protease activity in CD8(+) T cells, lymphokine-activated killer cells, P815 mastocytoma cells, and U-937 myeloid cells. Inhibition of DPPI resulted in impairment of the generation of cathepsin G enzymatic activity without reduction in the amount of immunoreactive cathepsin G produced. In U-937 cells pulsed with [H-3]isoleucine, inhibition of DPPI activity was associated with the accumulation of the inactive proenzyme form of cathepsin G bearing an amino-terminal dipeptide extension to the isoleucine residue that normally occupies the amino terminus of the enzymatically active protein. These results indicate that DPPI plays a requisite role in the post-translational processing and activation of members of the family of granule serine proteases expressed in bone marrow-derived effector cells.			MCGUIRE, MJ (corresponding author), UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI024639, R01AI024639] Funding Source: NIH RePORTER; NIAID NIH HHS [AI24639] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BAUGH RJ, 1976, BIOCHEMISTRY-US, V15, P836, DOI 10.1021/bi00649a017; BLEACKLEY RC, 1989, CURR TOP MICROBIOL, V140, P67; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; FRUTON JS, 1960, ENZYMES, V4, P233; GOLDSTEIN SM, 1992, J IMMUNOL, V148, P2475; GREEN GDJ, 1979, ANAL BIOCHEM, V93, P223, DOI 10.1016/S0003-2697(79)80070-6; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; HENKART PA, 1987, J IMMUNOL, V139, P2398; HSIUNG HM, 1987, METHOD ENZYMOL, V153, P390; HUBER R, 1977, REGULATORY PROTEOLYT, P15; JENNE D, 1988, P NATL ACAD SCI USA, V85, P4814, DOI 10.1073/pnas.85.13.4814; JENNE DE, 1989, BIOCHEMISTRY-US, V28, P7953, DOI 10.1021/bi00445a060; KIRSCHKE H, 1987, LYSOSOMES THEIR ROLE, P193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOGDBERG L, 1985, CELL IMMUNOL, V94, P299, DOI 10.1016/0008-8749(85)90254-0; MAGNUSSON S, 1971, ENZYMES, V3, P277; MCDONALD JK, 1969, J BIOL CHEM, V244, P6199; MCDONALD JK, 1969, J BIOL CHEM, V244, P2693; MCDONALD JK, 1970, TISSUE PROTEINASES, P69; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MURPHY MEP, 1988, PROTEINS, V4, P190, DOI 10.1002/prot.340040306; OKANO K, 1990, BIOCHEM BIOPH RES CO, V167, P1326, DOI 10.1016/0006-291X(90)90668-D; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; PRENDERGAST JA, 1992, J BIOL CHEM, V267, P5090; PURCELL GM, 1963, BIOCHIM BIOPHYS ACTA, V78, P800, DOI 10.1016/0006-3002(63)91067-9; RAFF RF, 1988, TRANSPLANTATION, V46, P655, DOI 10.1097/00007890-198811000-00005; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; ROBINSON NC, 1973, BIOCHEMISTRY-US, V12, P420, DOI 10.1021/bi00727a010; SALVESEN G, 1987, BIOCHEMISTRY-US, V26, P2289, DOI 10.1021/bi00382a032; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SCHICK B, 1990, IMMUNOLOGY, V69, P423; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SENIOR RM, 1982, J CLIN INVEST, V69, P384, DOI 10.1172/JCI110462; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; SHAW E, 1981, METHOD ENZYMOL, V80, P820; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEVENS RL, 1989, CURR TOP MICROBIOL, V140, P93; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; STROUD RM, 1975, PROTEASES BIOL CONTR, P13; TAKAHASHI T, 1981, METHOD ENZYMOL, V80, P565; TAKAYAMA H, 1987, J IMMUNOL, V138, P566; THIELE DL, 1987, J IMMUNOL, V138, P51; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; THIELE DL, 1985, P NATL ACAD SCI USA, V82, P2468, DOI 10.1073/pnas.82.8.2468; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; THIELE DL, 1986, J IMMUNOL, V136, P1038; THIELE DL, 1992, TRANSPLANTATION, V53, P1334, DOI 10.1097/00007890-199206000-00030; Tubbs P.K., 1969, METHODS ENZYMOL, V13, P535, DOI [10.1016/0076-6879(69)13079-7, DOI 10.1016/0076-6879(69)13079-7]; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; VIVIER I, 1991, J IMMUNOL, V147, P447; WATANABE T, 1982, BIOCHIM BIOPHYS ACTA, V717, P439, DOI 10.1016/0304-4165(82)90285-9; WILDE CG, 1990, J BIOL CHEM, V265, P2038; Worthington C.C, 1988, WORTHINGTON ENZYME M, P199; YOUNG JDE, 1986, CELL, V47, P183, DOI 10.1016/0092-8674(86)90441-1; ZUNINO SJ, 1990, J IMMUNOL, V144, P2001	64	189	197	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2458	2467						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428921				2022-12-27	WOS:A1993KK81500034
J	NELSON, JE; KRAWETZ, SA				NELSON, JE; KRAWETZ, SA			LINKAGE OF HUMAN SPERMATID-SPECIFIC BASIC NUCLEAR-PROTEIN GENES - DEFINITION AND EVOLUTION OF THE P1-]P2-]TP2 LOCUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION PROTEIN-1; PROTAMINE GENES; CHROMOSOMAL LOCALIZATION; NUCLEOTIDE-SEQUENCE; PRM1; HYBRIDIZATION; ASSIGNMENT; CHAIN; TNP2; TP1	Protamines and transition proteins are highly basic sperm-specific nuclear proteins that serve to compact the DNA within the condensing spermatid nucleus. It has been proposed that the genes for protamine P1 and P2 and transition protein 2 may be clustered at a single loci. This may have marked implications for their evolution and coordinate developmental regulation. The cloning of a contiguous segment encompassing this region would directly address these issues. We have utilized a cloned segment of the human protamine P1 gene to isolate a human cosmid clone which contains the genes for protamines P1 and P2 and transition protein TP2. Sequence and hybridization analysis of this cosmid showed that the TP2 gene resided 3' of the P2 gene at a distance of approximately 7 kilobases (kb). This establishes the order of this gene cluster within a 13-kb region of 16pl3.13-16pl3.2 to be P1-->P2-->TP2. Similar to their spatial order, comparative computer-assisted sequence analysis predicts an identical relative rank order of emergence. Accordingly we propose that this gene cluster may have arisen from the P1 gene through a series of gene duplication events.	WAYNE STATE UNIV,SCH MED,CS MOTT CTR HUMAN GROWTH & DEV 253,DEPT OBSTET & GYNECOL,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,CS MOTT CTR HUMAN GROWTH & DEV,DEPT MOLEC BIOL & GENET,DETROIT,MI 48201	Wayne State University; Wayne State University			krawetz, stephen/GQQ-3308-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028504] Funding Source: NIH RePORTER; NICHD NIH HHS [1RO1HD2850401A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADHAM IM, 1991, CYTOGENET CELL GENET, V57, P47, DOI 10.1159/000133113; AKAMA K, 1990, BIOCHIM BIOPHYS ACTA, V1041, P264, DOI 10.1016/0167-4838(90)90282-K; Balhorn R., 1989, P366; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; BELLVE AR, 1988, BIOCHEMISTRY-US, V27, P2890, DOI 10.1021/bi00408a034; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BRUTLAG DL, 1990, COMPUT APPL BIOSCI, V6, P237; Dickerson R E., 1971, Journal Molec Evol, V1, P26, DOI 10.1007/BF01659392; DIXON GH, 1986, CHROMOSOMAL PROTEINS, P287; DOMENJOUD L, 1990, GENOMICS, V8, P127, DOI 10.1016/0888-7543(90)90234-L; DUPRESSOIR T, 1985, EXP CELL RES, V161, P63, DOI 10.1016/0014-4827(85)90490-2; Goldberg ML, 1979, SEQUENCE ANAL DROSOP; HARLOW P, 1988, J MOL EVOL, V27, P56, DOI 10.1007/BF02099730; Hecht N.B., 1989, P396; Hecht NB, 1989, HISTONES OTHER BASIC, P347; HEIDARAN MA, 1988, J CELL BIOL, V106, P1427, DOI 10.1083/jcb.106.5.1427; HEIDARAN MA, 1989, GENE, V75, P39, DOI 10.1016/0378-1119(89)90381-8; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; KEIME S, 1992, BIOL CHEM H-S, V373, P261, DOI 10.1515/bchm3.1992.373.1.261; KLEENE KC, 1990, GENE, V95, P301, DOI 10.1016/0378-1119(90)90376-3; KRAWETZ SA, 1989, GENOMICS, V5, P639, DOI 10.1016/0888-7543(89)90036-0; KRAWETZ SA, 1988, J MOL EVOL, V27, P291, DOI 10.1007/BF02101190; KRAWETZ SA, 1988, J BIOL CHEM, V263, P321; KRAWETZ SA, 1988, BIOTECHNIQUES, V5, P620; LUERSSEN H, 1990, GENOMICS, V8, P324, DOI 10.1016/0888-7543(90)90289-7; Meistrich M., 1989, HISTONES OTHER BASIC, P165; MEISTRICH ML, 1981, BIOREGULATORS REPROD, P151; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NELSON JE, 1992, IN PRESS ANAL BIOCH, V207; Oliva R., 1991, PROGR NUCL ACID RES, P26; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; REINHART N, 1991, BIOL CHEM H-S, V372, P431, DOI 10.1515/bchm3.1991.372.1.431; RICHARDS RI, 1991, GENOMICS, V10, P1047, DOI 10.1016/0888-7543(91)90197-M; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCHLUTER G, 1992, GENOMICS, V14, P377, DOI 10.1016/S0888-7543(05)80229-0; SVINARICH DM, 1992, J BIOL CHEM, V267, P14382; VIGUIE F, 1990, HUM GENET, V85, P171; YELICK PC, 1991, GENOMICS, V11, P687, DOI 10.1016/0888-7543(91)90076-Q	39	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2932	2936						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428967				2022-12-27	WOS:A1993KK81500099
J	OSAWA, Y; DARBYSHIRE, JF; STEINBACH, PJ; BROOKS, BR				OSAWA, Y; DARBYSHIRE, JF; STEINBACH, PJ; BROOKS, BR			METABOLISM-BASED TRANSFORMATION OF MYOGLOBIN TO AN OXIDASE BY BRCCL3 AND MOLECULAR MODELING OF THE OXIDASE FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; CYTOCHROME-P-450 HEME; CRYSTAL-STRUCTURE; PROSTHETIC HEME; PROTEIN ADDUCTS; IRON RELEASE; DEGRADATION; HEMOGLOBIN; DYNAMICS; INACTIVATION	The stoichiometric reductive debromination of BrCCl3 to a trichloromethyl radical by myoglobin caused the prosthetic heme to become covalently cross-linked to the protein moiety and transformed myoglobin from an oxygen storage protein to an oxidase. This was shown in experiments in which oxygen consumption was measured during redox cycling of the altered myoglobin in the presence of ascorbate or an enzymatic reducing system containing diaphorase and NADH. Redox cycling eventually led to loss of the protein-bound heme adduct and oxidase activity of myoglobin. We have used molecular modeling and the known structure of the protein-bound heme adduct to identify probable mechanisms for transformation of myoglobin to an oxidase. Based on these modeling studies, the most likely structure of the experimentally observed adduct involves ligation to the heme iron of the epsilon-nitrogen atom of histidine 97 and/or that of histidine 64. The model structures revealed access of solvent to the heme active site, which could facilitate oxygen reduction. The transformation of myoglobins and perhaps other hemoproteins to oxidases may have toxicological importance in causing the tissue damage resulting from exposure to various xenobiotics and endogenous chemicals as well as explaining how hemoproteins are inactivated during catalysis.	NIH, DIV COMP RES & TECHNOL, MOLEC GRAPH & SIMULAT LAB, BETHESDA, MD 20892 USA		OSAWA, Y (corresponding author), NHLBI, CHEM PATHOL LAB, BLDG 10, RM 8N110, BETHESDA, MD 20892 USA.							ANTONINI E, 1964, BIOCHIM BIOPHYS ACTA, V79, P284; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; DAVIES HW, 1986, CHEM-BIOL INTERACT, V58, P345, DOI 10.1016/S0009-2797(86)80108-9; DEMONTELLANO PRO, 1990, PHARMACOL THERAPEUT, V48, P95, DOI 10.1016/0163-7258(90)90020-3; DEMONTELLANO PRO, 1983, ANNU REV PHARMACOL, V23, P481; EDMUNDSO.AB, 1965, NATURE, V205, P883, DOI 10.1038/205883a0; FERRALI M, 1989, BIOCHEM PHARMACOL, V38, P1819, DOI 10.1016/0006-2952(89)90417-6; GUENGERICH FP, 1986, BIOCHEM BIOPH RES CO, V138, P193, DOI 10.1016/0006-291X(86)90265-2; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; LONCHARICH RJ, 1990, J MOL BIOL, V215, P439, DOI 10.1016/S0022-2836(05)80363-8; OSAWA Y, 1990, J BIOL CHEM, V265, P10340; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; OSAWA Y, 1991, J BIOL CHEM, V266, P3208; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1989, J AM CHEM SOC, V111, P4462, DOI 10.1021/ja00194a048; OSAWA Y, 1992, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1991, P415; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; PHILLIPS GN, 1990, PROTEINS, V7, P358, DOI 10.1002/prot.340070407; PRASAD MR, 1989, BIOCHEM J, V263, P731, DOI 10.1042/bj2630731; PUPPO A, 1988, FREE RADICAL RES COM, V4, P415, DOI 10.3109/10715768809066910; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; REDDY BR, 1989, FREE RADICAL BIO MED, V7, P45; SAKAIDA I, 1990, MOL PHARMACOL, V37, P435; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; STEINBACH PJ, 1991, CHEM PHYS, V158, P383, DOI 10.1016/0301-0104(91)87078-A; SULLIVAN JL, 1989, AM HEART J, V117, P1177, DOI 10.1016/0002-8703(89)90887-9; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; TROTTA RJ, 1983, BIOCHEM J, V212, P759, DOI 10.1042/bj2120759; WALLACE WJ, 1982, J BIOL CHEM, V257, P4966	33	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2953	2959						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428969				2022-12-27	WOS:A1993KK81500102
J	ZHANG, YY; LIND, B; RADMARK, O; SAMUELSSON, B				ZHANG, YY; LIND, B; RADMARK, O; SAMUELSSON, B			IRON CONTENT OF HUMAN 5-LIPOXYGENASE, EFFECTS OF MUTATIONS REGARDING CONSERVED HISTIDINE-RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN 5-LIPOXYGENASE; SOYBEAN LIPOXYGENASE; ARACHIDONATE 12-LIPOXYGENASE; PORCINE LEUKOCYTES; LEUKOTRIENES; ENVIRONMENT; PATHWAY; ENZYME; ACIDS; PROBE	Recombinant human 5-lipoxygenase was expressed in Escherichia coli and purified to more than 95% homogeneity by ammonium sulfate precipitation and agarose-ATP column chromatography. The specific activity of the purified enzyme was 21-28 mumol/mg, as assessed by the generation of 5-hydro(pero)xyeicosatetraenoic acid. The iron content was analyzed by graphite furnace atomic absorption spectrophotometry for six preparations of the enzyme. The average value of the iron content was 0.86 mol/mol (iron/protein) with a range of 0.74-1.15 mol/mol. All lipoxygenases that have been sequenced contain 6 conserved histidine residues. Mutants of 5-lipoxygenase, with substitutions of these 6 conserved histidines, were purified and analyzed. Mutants H372Q and H550Q had no detectable enzyme activity and were also practically devoid of iron. Three mutants regarding His367 (H367Q, H367N, and H367S) were all inactive but had partial iron contents (0.5, 0.2, and 0.5 mol/mol, respectively). Finally, the mutated proteins H362Q, H390Q, and H399Q displayed reduced enzyme activity but contained similar amounts of iron as non-mutated 5-lipoxygenase. We conclude that histidines 372 and 550 constitute two of the iron ligands in 5-lipoxygenase. Also His367 is necessary for the enzyme activity, but this residue is not crucial for binding of iron.	KAROLINSKA INST, INST ENVIRONM MED, S-10401 STOCKHOLM 60, SWEDEN	Karolinska Institutet	ZHANG, YY (corresponding author), KAROLINSKA INST, DEPT PHYSIOL CHEM 2, S-10401 STOCKHOLM 60, SWEDEN.							CHAN HWS, 1973, BIOCHIM BIOPHYS ACTA, V327, P32, DOI 10.1016/0005-2744(73)90100-9; COOKE ST, 1991, LIPOXYGENASES THEIR; COREY EJ, 1987, J AM CHEM SOC, V109, P8107, DOI 10.1021/ja00260a038; DEMARZO N, 1992, LUNG CELL MOL PHYSL, V6, pL198; DENIS D, 1991, J BIOL CHEM, V266, P5072; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; DUNHAM WR, 1990, EUR J BIOCHEM, V190, P611, DOI 10.1111/j.1432-1033.1990.tb15616.x; FEITERS MC, 1990, RECL TRAV CHIM PAY B, V109, P133; FURUKAWA M, 1984, BIOCHIM BIOPHYS ACTA, V795, P458; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; GEORGE DG, 1990, METHOD ENZYMOL, V183, P333; ISHII S, 1992, BIOCHEM BIOPH RES CO, V182, P1482, DOI 10.1016/0006-291X(92)91901-2; KRONECK PMH, 1991, FEBS LETT, V287, P105, DOI 10.1016/0014-5793(91)80026-Y; MATSUDA S, 1991, BIOCHIM BIOPHYS ACTA, V1084, P202; MATSUMOTO T, 1991, 27 P YAM C INT S OXY, P51; NAVARATNAM S, 1988, BIOCHIM BIOPHYS ACTA, V956, P70, DOI 10.1016/0167-4838(88)90299-3; NGUYEN T, 1991, J BIOL CHEM, V266, P22057; OHTA H, 1992, EUR J BIOCHEM, V206, P331, DOI 10.1111/j.1432-1033.1992.tb16931.x; PERCIVAL MD, 1991, J BIOL CHEM, V266, P10058; PISTORIUS EK, 1974, J BIOL CHEM, V249, P3183; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; ROZA M, 1973, BIOCHIM BIOPHYS ACTA, V327, P24, DOI 10.1016/0005-2744(73)90099-5; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SHIBATA D, 1991, PLANT MOL BIOL, V16, P353, DOI 10.1007/BF00020569; STECZKO J, 1992, BIOCHEMISTRY-US, V31, P4053, DOI 10.1021/bi00131a022; Veldink G A, 1984, Adv Inorg Biochem, V6, P139; WHITTAKER JW, 1986, J AM CHEM SOC, V108, P835, DOI 10.1021/ja00264a045; WIESNER R, 1983, BIOMED BIOCHIM ACTA, V42, P431; WISEMAN JS, 1989, BIOCHEMISTRY-US, V28, P2106, DOI 10.1021/bi00431a021; YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714; YOSHIMOTO T, 1990, BIOCHEM BIOPH RES CO, V172, P1230, DOI 10.1016/0006-291X(90)91580-L; ZHANG Y, 1991, J AM CHEM SOC, V113, P5162, DOI 10.1021/ja00014a004; ZHANG YY, 1992, P NATL ACAD SCI USA, V89, P485, DOI 10.1073/pnas.89.2.485	34	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2535	2541						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428931				2022-12-27	WOS:A1993KK81500044
J	DACOSTA, KA; COCHARY, EF; BLUSZTAJN, JK; GARNER, SC; ZEISEL, SH				DACOSTA, KA; COCHARY, EF; BLUSZTAJN, JK; GARNER, SC; ZEISEL, SH			ACCUMULATION OF 1,2-SN-DIRADYLGLYCEROL WITH INCREASED MEMBRANE-ASSOCIATED PROTEIN-KINASE-C MAY BE THE MECHANISM FOR SPONTANEOUS HEPATOCARCINOGENESIS IN CHOLINE-DEFICIENT RATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-GLYCOGEN SYNTHASE; FED METHYL-DEFICIENT; DEVOID DIET; HUMAN-NEUTROPHILS; PHOSPHOLIPASE-C; FATTY-ACIDS; TRANSFORMED FIBROBLASTS; METHOTREXATE TREATMENT; LINKED DIGLYCERIDES; SIGNAL TRANSDUCTION	Choline deficiency, via deprivation of labile methyl groups, is associated with a greatly increased incidence of hepatocarcinoma in experimental animals. This dietary deficiency also causes fatty liver, because choline is needed for hepatic secretion of lipoproteins. We hypothesized that fatty liver might be associated with the accumulation of 1,2-sn-diradylglycerol and subsequent activation of protein kinase C. Several lines of evidence indicate that cancers might develop secondary to abnormalities in protein kinase C-mediated signal transduction. We observed that rats fed a choline-deficient diet for 1, 6, or 27 weeks had increased hepatic concentrations of 1,2-diradylglycerol. At 1 and 6 weeks, hepatic plasma membrane from choline-deficient rats had increased concentrations of 1,2-sn-diacylglycerol and 1-alkyl, 2-acylglycerol, with the latter accounting for 20-26% of membrane 1,2-sn-diradylglycerol (as compared with only 2-5% in controls). Protein kinase C activity was increased in hepatic plasma membrane at 1 week of choline deficiency. By Western blotting there was an increase in the amount of protein kinase C zeta and a decrease in the amount of protein kinase C delta in liver at 1 week. By 6 weeks of choline deficiency, hepatic plasma membrane and cytosolic protein kinase C (PKC) activities were increased significantly, with increased amounts of hepatic plasma membrane protein kinase C alpha, and delta detected by Western blotting. Glycogen synthase activity in liver was diminished after 1 week of choline deficiency; this enzyme is inhibited by PKC-mediated phosphorylation. We suggest that choline deficiency perturbed PKC-mediated transmembrane signaling within liver and that this contributed to the development of hepatic cancer in these animals.	UNIV N CAROLINA, SCH PUBL HLTH, DEPT NUTR, CHAPEL HILL, NC 27599 USA; TUFTS UNIV, USDA, HUMAN NUTR RES CTR AGING, BOSTON, MA 02111 USA; BOSTON UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02118 USA; UNIV N CAROLINA, SCH MED, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Tufts University; United States Department of Agriculture (USDA); Boston University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine				/0000-0001-8438-3122	NICHD NIH HHS [HD16727] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016727] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHMAD Z, 1984, J BIOL CHEM, V259, P8743; ANDERSCH MA, 1947, AM J CLIN PATHOL, V17, P571, DOI 10.1093/ajcp/17.7_ts.571; Aronson N N Jr, 1974, Methods Enzymol, V31, P90; BANNI S, 1990, CARCINOGENESIS, V11, P2053, DOI 10.1093/carcin/11.11.2053; BASS DA, 1988, J BIOL CHEM, V263, P19610; BAULDRY SA, 1988, J BIOL CHEM, V263, P16787; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BLANK ML, 1984, J CHROMATOGR, V298, P473, DOI 10.1016/S0021-9673(01)92744-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUSZTAJN JK, 1989, FEBS LETT, V243, P267, DOI 10.1016/0014-5793(89)80142-5; BOCCKINO SB, 1985, J BIOL CHEM, V260, P4201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS G, 1991, CANCER RES, V51, P3281; CABAUD PG, 1958, AM J CLIN PATHOL, V30, P234, DOI 10.1093/ajcp/30.3.234; CABOT MC, 1984, BIOCHEM BIOPH RES CO, V125, P163, DOI 10.1016/S0006-291X(84)80349-6; CAMICI M, 1984, J BIOL CHEM, V259, P3429; CAMICI M, 1984, J BIOL CHEM, V259, P2466; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHANDAR N, 1987, CARCINOGENESIS, V8, P669, DOI 10.1093/carcin/8.5.669; CHANDAR N, 1988, CARCINOGENESIS, V9, P259, DOI 10.1093/carcin/9.2.259; CHANDAR N, 1989, P NATL ACAD SCI USA, V86, P2703, DOI 10.1073/pnas.86.8.2703; COOPER RH, 1985, J BIOL CHEM, V260, P3281; DANIEL LW, 1988, BIOCHEM BIOPH RES CO, V151, P291, DOI 10.1016/0006-291X(88)90592-X; DAWSON WD, 1987, J CELL PHYSIOL, V132, P104, DOI 10.1002/jcp.1041320114; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; DIXON TF, 1954, J CLIN PATHOL, V7, P341, DOI 10.1136/jcp.7.4.341; DIZIK M, 1991, CARCINOGENESIS, V12, P1307, DOI 10.1093/carcin/12.7.1307; EXTON JH, 1988, HEPATOLOGY, V8, P152, DOI 10.1002/hep.1840080129; FORD DA, 1989, J BIOL CHEM, V264, P13818; GHOSHAL AK, 1983, AM J PATHOL, V113, P309; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANNUN YA, 1989, SCIENCE, V246, P1050; HATA A, 1989, FEBS LETT, V252, P144, DOI 10.1016/0014-5793(89)80907-X; HEYMANS F, 1987, FEBS LETT, V218, P35, DOI 10.1016/0014-5793(87)81013-X; HSIEH LL, 1989, CANCER RES, V49, P3795; HSIEH LL, 1989, J CELL BIOCHEM, V41, P179, DOI 10.1002/jcb.240410403; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; KAIBUCHI K, 1986, J BIOL CHEM, V261, P1187; KATO M, 1989, FEBS LETT, V247, P247, DOI 10.1016/0014-5793(89)81345-6; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; KRAUSS RS, 1989, ONCOGENE, V4, P991; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPETINA EG, 1985, J BIOL CHEM, V260, P1358; LAVIE Y, 1990, FEBS LETT, V277, P7, DOI 10.1016/0014-5793(90)80796-L; LI DH, 1990, CANCER RES, V50, P3991; LOCKER J, 1986, CARCINOGENESIS, V7, P1309, DOI 10.1093/carcin/7.8.1309; LOMBARDI B, 1971, FED PROC, V30, P139; LOMBARDI B, 1968, J LIPID RES, V9, P437; MAVIS RD, 1972, J BIOL CHEM, V247, P2835; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MIKOL YB, 1983, CARCINOGENESIS, V4, P1619, DOI 10.1093/carcin/4.12.1619; NEWBERNE PM, 1986, ANNU REV NUTR, V6, P407, DOI 10.1146/annurev.nu.06.070186.002203; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; PESSIN MS, 1990, J BIOL CHEM, V265, P7959; POMFRET EA, 1989, ANAL BIOCHEM, V180, P85, DOI 10.1016/0003-2697(89)90091-2; POMFRET EA, 1990, J NUTR BIOCHEM, V1, P533, DOI 10.1016/0955-2863(90)90039-N; PREISS J, 1986, J BIOL CHEM, V261, P8597; PRICE BD, 1989, J BIOL CHEM, V264, P16638; RIDER LG, 1988, J IMMUNOL, V140, P200; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROGUE P, 1990, J BIOL CHEM, V265, P4161; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SELHUB J, 1991, CANCER RES, V51, P16; SHINOZUKA H, 1980, CANCER RES, V40, P3846; SINGH U, 1990, J NUTR BIOCHEM, V1, P434, DOI 10.1016/0955-2863(90)90120-A; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Snyder F, 1975, Prog Biochem Pharmacol, V10, P1; TACCONI M, 1985, J NEUROCHEM, V45, P805, DOI 10.1111/j.1471-4159.1985.tb04064.x; TAKAHASHI S, 1979, CANCER LETT, V7, P265, DOI 10.1016/S0304-3835(79)80053-1; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TURINSKY J, 1990, J BIOL CHEM, V265, P7933; TYAGI SR, 1989, J BIOL CHEM, V264, P12977; WEINSTEIN IB, 1990, ADV SEC MESS PHOSPH, V24, P307; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; WILKISON WO, 1989, ONCOGENE, V4, P625; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; Zeisel S.H., 1988, MODERN NUTR HLTH DIS, P440; ZEISEL SH, 1989, BIOCHEM J, V259, P725, DOI 10.1042/bj2590725	85	80	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2100	2105						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420980				2022-12-27	WOS:A1993KH62000090
J	JAULT, JM; ALLISON, WS				JAULT, JM; ALLISON, WS			SLOW BINDING OF ATP TO NONCATALYTIC NUCLEOTIDE BINDING-SITES WHICH ACCELERATES CATALYSIS IS RESPONSIBLE FOR APPARENT NEGATIVE COOPERATIVITY EXHIBITED BY THE BOVINE MITOCHONDRIAL F1-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEEF-HEART F1-ATPASE; ADENOSINE-TRIPHOSPHATASE; BETA-SUBUNIT; THERMOPHILIC BACTERIUM; CHEMICAL MODIFICATION; HYSTERETIC BEHAVIOR; ANION ACTIVATION; ENZYME-ACTIVITY; RAT-LIVER; MECHANISM	The bovine heart mitochondrial F1-ATPase depleted of nucleotides (nd-MF1) hydrolyzes 50 muM ATP in three kinetic phases at 30-degrees-C. An initial ''burst'' rapidly transforms into an intermediate, slower rate, which slowly accelerates to the final, steady-state rate. The intermediate phase disappears progressively as the concentration of ATP in the assay medium is increased and is absent at 2 mM. Activation in the intermediate phase is lost when nd-MF1 is inactivated by 5'-p-fluorosulfonylbenzoyladenosine, which modifies three noncatalytic sites. Correlation of [H-3]ATP binding to nd-MF1, after treatment either with 50 muM Mg[H-3]ATP plus a regenerating system or 10 mM free [H-3]ATP, with stimulation of the intermediate phase suggests that this phase is abolished when at least two noncatalytic sites are filled with ATP. Prior incubation of nd-MF1 with MgPP(i) stimulates hydrolysis of 30 muM to 2 mM ATP and abolishes the intermediate phase. Following incubation with Mg[P-32]PP(i), 3.3 mol of [P-32]PP(i)/mol of enzyme are bound, 1 and 0.5 mol of which are released by cold chases with MgATP and MgITP, respectively. Since the cold chases diminish activation only slightly, the stimulatory effect is not caused by PP(i) binding to catalytic sites. A Lineweaver-Burk plot of initial rates of the intermediate phase for hydrolysis of 30 muM to 2 mm ATP by nd-MF1 is biphasic, extrapolating to apparent K(m) values of 120 and 440 muM. The latter value is the same as the apparent K(d) determined from dependence of the rate of activation of the intermediate phase on ATP concentration in the assay medium. After prior incubation of nd-MF1 with MgPP(i) or free ATP, Lineweaver-Burk plots are linear with the highest K(m) disappearing. Thus, this K(m) reflects rate acceleration when ATP binds to noncatalytic sites. From these results it is concluded that slow binding of ATP to noncatalytic sites during hydrolysis of low concentrations of substrate, which accelerates catalysis, is responsible for apparent negative cooperativity exhibited by MF1.	UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego			jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777	NIGMS NIH HHS [GM-16974] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON WS, 1986, METHOD ENZYMOL, V126, P741; BULLOUGH DA, 1986, J BIOL CHEM, V261, P5722; BULLOUGH DA, 1988, J BIOL CHEM, V263, P14053; BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171; CHERNYAK BV, 1992, ARCH BIOCHEM BIOPHYS, V295, P247, DOI 10.1016/0003-9861(92)90514-W; CROSS RL, 1987, P NATL ACAD SCI USA, V84, P5715, DOI 10.1073/pnas.84.16.5715; CROSS RL, 1982, J BIOL CHEM, V257, P2101; CROSS RL, 1982, J BIOL CHEM, V257, P2874; CROSS RL, 1988, J BIOENERG BIOMEMBR, V20, P395, DOI 10.1007/BF00762200; DIPIETRO A, 1980, BIOCHEMISTRY-US, V19, P5671, DOI 10.1021/bi00566a002; DIPIETRO A, 1981, BIOCHEMISTRY-US, V20, P6312, DOI 10.1021/bi00525a005; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; EBEL RE, 1975, J BIOL CHEM, V250, P191; ESCH FS, 1978, J BIOL CHEM, V253, P6100; FALSON P, 1986, J BIOL CHEM, V261, P7151; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; HARRIS DA, 1989, BIOCHIM BIOPHYS ACTA, V974, P156, DOI 10.1016/S0005-2728(89)80368-8; ISSARTEL JP, 1987, J BIOL CHEM, V262, P13538; JAULT JM, 1991, J BIOL CHEM, V266, P8073; KALASHNIKOVA TY, 1988, EUR J BIOCHEM, V177, P213, DOI 10.1111/j.1432-1033.1988.tb14364.x; KIRONDE FAS, 1987, J BIOL CHEM, V262, P3488; KNOWLES AF, 1972, J BIOL CHEM, V247, P6617; MILGROM YM, 1990, J BIOL CHEM, V265, P18725; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; MILGROM YM, 1989, BIOCHIM BIOPHYS ACTA, V975, P50, DOI 10.1016/S0005-2728(89)80200-2; MILGROM YM, 1991, J BIOL CHEM, V266, P11551; PEDERSEN PL, 1976, J BIOL CHEM, V251, P934; PEINNEQUIN A, 1992, BIOCHEMISTRY-US, V31, P2088, DOI 10.1021/bi00122a028; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RECKTENWALD D, 1977, FEBS LETT, V76, P25, DOI 10.1016/0014-5793(77)80113-0; ROVERI OA, 1985, FEBS LETT, V192, P123, DOI 10.1016/0014-5793(85)80056-9; SCHUSTER SM, 1975, J BIOL CHEM, V250, P7848; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; WONG SY, 1984, BIOCHEMISTRY-US, V23, P5004, DOI 10.1021/bi00316a027; YOHDA M, 1988, BIOCHIM BIOPHYS ACTA, V933, P156, DOI 10.1016/0005-2728(88)90065-5; YOSHIDA M, 1986, J BIOL CHEM, V261, P5714; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910; YSERN X, 1988, J BIOENERG BIOMEMBR, V20, P423, DOI 10.1007/BF00762202; ZHUO SQ, 1992, J BIOL CHEM, V267, P12916	43	122	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1558	1566						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420930				2022-12-27	WOS:A1993KH62000012
J	YU, B; PEREIRA, ME; WILK, S				YU, B; PEREIRA, ME; WILK, S			CHANGES IN THE STRUCTURE AND CATALYTIC ACTIVITIES OF THE BOVINE PITUITARY MULTICATALYTIC PROTEINASE COMPLEX FOLLOWING DIALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NEUTRAL ENDOPEPTIDASE; CHEMICAL MODIFICATION; MACROPAIN PROTEASOME; RAT-LIVER; PURIFICATION; SPECIFICITY; SUBUNITS; COMPONENTS; UBIQUITIN; MHC	The multicatalytic proteinase complex (proteasome) contains at least four distinct active sites catalyzing the degradation of selected chromogenic substrates (trypsin-like, chymotrypsin-like, and peptidylglutamyl peptide hydrolyzing activities) and proteins such as beta-casein. Oxidized insulin B chain was recently proposed as a model substrate for protein degradation by the multicatalytic proteinase complex (Dick, L. R., Moomaw, C. R., DeMartino, G. N., and Slaughter, C. A. (1991) Biochemistry 30, 2725-2734). We studied the dialysis-induced activation of the hydrolysis of oxidized insulin B chain by this enzyme. Removal of EDTA from purified preparations of bovine pituitary multicatalytic proteinase complex by dialysis against Tris-HCl buffers led to marked changes in the catalytic properties and structure of the enzyme. Dialysis produced a time-dependent activation of oxidized insulin B chain hydrolysis with predominant cleavage at the Glu13-Ala14 bond. A new chromogenic assay was developed for measurement of this activity. Activation was accompanied by a virtually total inactivation of the chymotrypsin-like, trypsin-like, and peptidylglutamyl peptide hydrolyzing activities. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a loss of the 24-kDa subunit and the appearance of a new band at 21 kDa. Amino-terminal amino acid analysis established that the 21-kDa band was autolytically derived from the 24-kDa subunit. Evidence for partial dissociation and/or aggregation indicated that autolysis destabilizes the complex. By altering the profile of catalytic activities of the multicatalytic proteinase complex, autolysis may serve as a mechanism for regulation of this macromolecule.	CUNY MT SINAI SCH MED,DEPT PHARMACOL,1 GUSTAVE L LEVY PL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Pereira, Maria/GZA-9681-2022		NIMH NIH HHS [MH 00350] Funding Source: Medline; NINDS NIH HHS [NS-17392] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH000350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017392] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKI M, 1992, FEBS LETT, V301, P65, DOI 10.1016/0014-5793(92)80211-X; BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; DICK LR, 1991, BIOCHEMISTRY-US, V30, P2725, DOI 10.1021/bi00224a022; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FRENTZEL S, 1992, FEBS LETT, V302, P121, DOI 10.1016/0014-5793(92)80420-L; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; HOUGH R, 1987, J BIOL CHEM, V262, P8303; KUEHN L, 1992, ARCH BIOCHEM BIOPHYS, V295, P55, DOI 10.1016/0003-9861(92)90487-H; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE LW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P178, DOI 10.1016/0167-4838(90)90165-C; LILLEY KS, 1990, FEBS LETT, V262, P327, DOI 10.1016/0014-5793(90)80220-D; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORLOWSKI M, 1989, BIOCHEMISTRY-US, V28, P9270, DOI 10.1021/bi00450a006; ORLOWSKI M, 1981, BIOCHEM BIOPH RES CO, V101, P814; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; PEREIRA ME, 1992, J BIOL CHEM, V267, P7949; PEREIRA ME, 1992, ARCH BIOCHEM BIOPHYS, V294, P1, DOI 10.1016/0003-9861(92)90128-J; PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; RIVETT AJ, 1991, BIOCHEM J, V278, P171, DOI 10.1042/bj2780171; SATO S, 1990, BIOCHIM BIOPHYS ACTA, V1041, P269, DOI 10.1016/0167-4838(90)90283-L; SHIVANANDAPPA T, 1991, CURR EYE RES, V10, P871, DOI 10.3109/02713689109013883; SUZUKI K, 1981, J BIOCHEM-TOKYO, V90, P275, DOI 10.1093/oxfordjournals.jbchem.a133463; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V158, P548, DOI 10.1016/S0006-291X(89)80084-1; TANAKA K, 1986, J BIOL CHEM, V261, P5197; WAGNER BJ, 1991, CURR EYE RES, V10, P485, DOI 10.3109/02713689109001756; WEITMAN D, 1992, J BIOL CHEM, V267, P6977; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WILK S, 1979, LIFE SCI, V24, P457, DOI 10.1016/0024-3205(79)90218-2; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; WILK S, 1990, NEUROPEPTIDES, V16, P163, DOI 10.1016/0143-4179(90)90129-M; WILK S, 1991, BIOMED BIOCHIM ACTA, V50, P471; YU B, 1991, J BIOL CHEM, V266, P17396; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	39	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2029	2036						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420977				2022-12-27	WOS:A1993KH62000081
J	ANDRES, DA; GOLDSTEIN, JL; HO, YK; BROWN, MS				ANDRES, DA; GOLDSTEIN, JL; HO, YK; BROWN, MS			MUTATIONAL ANALYSIS OF ALPHA-SUBUNIT OF PROTEIN FARNESYLTRANSFERASE - EVIDENCE FOR A CATALYTIC ROLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS PROTEINS; PEPTIDE-BINDING; A-FACTOR; EXPRESSION; YEAST; SEQUENCE; CLONING; GENE; FARNESYL	Protein farnesyltransferase from rat brain is composed of tightly associated alpha- and beta-subunits of 377 and 437 amino acids that migrate on SDS-polyacrylamide gels with apparent molecular masses of 49 and 46 kDa, respectively. The enzyme attaches farnesyl groups to cysteines in p21ras and other proteins that contain cysteine residues at the fourth position from the COOH terminus. Production of stable enzyme in animal cells requires the simultaneous synthesis of both subunits, and all activity is lost when the subunits are dissociated chemically. The beta-subunit functions in the Zn2+-dependent binding of the protein substrate. The role of the alpha-subunit is unknown. In the current studies we used in vitro mutagenesis and transfection of cloned cDNAs to define the parts of the alpha-subunit that are necessary to stabilize the beta-subunit and to support farnesyl transfer. Deletion of 51 amino acids at the NH2 terminus of the alpha-subunit allowed normal stabilization of the beta-subunit and production of normal enzyme activity, but deletion of 106 amino acids abolished both of these properties. A proline-rich region at residues 12-34 of the alpha-subunit is not required for activity, but its presence explains the anomalously slow migration of the polypeptide on SDS-polyacrylamide gels. Deletion of only 5 amino acids at the COOH terminus of the alpha-subunit reduced activity appreciably. Substitution of asparagine for a conserved lysine at position 164 produced an alpha-subunit that stabilized the beta-subunit normally and permitted normal binding of the two substrates, farnesyl pyrophosphate and p21H-ras. Nevertheless, the rate of transfer of the bound farnesyl group to p21Hras was markedly reduced. The latter finding suggests that the alpha-subunit plays a direct role in the catalytic reaction in addition to its role in the stabilization of the beta-subunit.			ANDRES, DA (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.				NHLBI NIH HHS [HL 20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKUSJARVI G, 1987, MOL CELL BIOL, V7, P549, DOI 10.1128/MCB.7.1.549; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BOGUSKI MS, 1992, NEW BIOL, V4, P408; BOYD LF, 1992, P NATL ACAD SCI USA, V89, P2242, DOI 10.1073/pnas.89.6.2242; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Glomset J. A., 1991, CURR OPIN LIPIDOL, V2, P118; GOODMAN LE, 1990, P NATL ACAD SCI USA, V87, P9665, DOI 10.1073/pnas.87.24.9665; GOODMAN LE, 1988, YEAST, V4, P271, DOI 10.1002/yea.320040405; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; INGLESE J, 1992, J BIOL CHEM, V267, P1422; KOHL NE, 1991, J BIOL CHEM, V266, P18884; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; MOORES SL, 1991, J BIOL CHEM, V266, P14603; POMPLIANO DL, 1992, BIOCHEMISTRY-US, V31, P3800, DOI 10.1021/bi00130a010; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; REISS Y, 1990, Methods (Orlando), V1, P241, DOI 10.1016/S1046-2023(05)80323-8; REISS Y, 1992, J BIOL CHEM, V267, P6403; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER WR, 1990, SCIENCE, V249, P1133, DOI 10.1126/science.2204115; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6	27	82	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1383	1390						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419339				2022-12-27	WOS:A1993KG07700093
J	GIROD, PA; VIERSTRA, RD				GIROD, PA; VIERSTRA, RD			A MAJOR UBIQUITIN CONJUGATION SYSTEM IN WHEAT-GERM EXTRACTS INVOLVES A 15-KDA UBIQUITIN-CONJUGATING ENZYME (E2) HOMOLOGOUS TO THE YEAST UBC4/UBC5 GENE-PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; CARRIER PROTEIN; MULTIUBIQUITIN CHAIN; BINDING-SITES; DEGRADATION; PATHWAY; PURIFICATION; CLONING; LIGASE; RAD6	In eukaryotes, conjugation of ubiquitin to proteins serves as a committed step for intracellular protein degradation. Formation of ubiquitin-protein conjugates involves the transfer of ubiquitin-conjugating enzyme (E2)-bound ubiquitin to the target proteins with or without the assistance of ubiquitin-protein ligase (E3). We report the isolation and characterization of an E2 purified from wheat germ that accounts for the majority of ubiquitin conjugation activity observed in vitro. This E2 is basic, has an apparent molecular mass of 15 kDa, and forms oligomers that dissociate upon treatment with sulfhydryl reducing agents. E2(15 kDa) will not work alone in vitro but requires an additional factor putatively identified as an E3 for substrate recognition. This E3 is distinct from E3alpha previously described to be required for N-terminal recognition of target proteins. Partial amino acid sequence analysis of E2(15 kDa) revealed a substantial identity (approximately 80% in two peptide regions) with yeast E2s encoded by UBC4/UBC5 genes. This homology was confirmed by immunodetection of a 16-kDa yeast protein corresponding to the molecular mass of the UBC4/UBC5 proteins with E2(15kDa) antisera. The products of yeast UBC4 and UBC5 genes along with that of UBC1 gene constitute a subfamily of functionally overlapping E2s that mediate the selective degradation of short-lived and abnormal proteins in vivo. Considering the high degree of functional and structural similarity of wheat E2(15 kDa) with that of yeast UBC4/UBC5, it is likely that yeast UBC4/UBC5 and their homologs from other eukaryotes exhibit the same E3 dependence in performing their roles in protein degradation.	UNIV WISCONSIN,DEPT HORT,1575 LINDEN DR,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GONEN H, 1991, J BIOL CHEM, V266, P19221; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HATFIELD PM, 1989, BIOCHEMISTRY-US, V28, P735, DOI 10.1021/bi00428a048; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; PICKART CM, 1985, J BIOL CHEM, V260, P1573; QIN S, 1991, J BIOL CHEM, V266, P15549; REISS Y, 1988, J BIOL CHEM, V263, P2693; REISS Y, 1990, J BIOL CHEM, V265, P3685; Rose MD., 1990, METHODS YEAST GENETI; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SHANKLIN J, 1987, P NATL ACAD SCI USA, V84, P359, DOI 10.1073/pnas.84.2.359; SULLIVAN ML, 1989, P NATL ACAD SCI USA, V86, P9861, DOI 10.1073/pnas.86.24.9861; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; SULLIVAN ML, 1990, PLANT PHYSIOL, V94, P710, DOI 10.1104/pp.94.2.710; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; VANNOCKER S, 1991, P NATL ACAD SCI USA, V88, P10297, DOI 10.1073/pnas.88.22.10297; WING SS, 1992, J BIOL CHEM, V267, P6495	37	45	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					955	960						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419375				2022-12-27	WOS:A1993KG07700032
J	FERREIRA, GC; DAILEY, HA				FERREIRA, GC; DAILEY, HA			EXPRESSION OF MAMMALIAN 5-AMINOLEVULINATE SYNTHASE IN ESCHERICHIA-COLI - OVERPRODUCTION, PURIFICATION, AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; IRON-RESPONSIVE ELEMENT; SIGNAL SEQUENCE; MESSENGER-RNA; ACID SYNTHASE; NUCLEOTIDE-SEQUENCE; X-CHROMOSOME; RAT-LIVER; GENE; IDENTIFICATION	5-Aminolevulinate synthase catalyzes the first step of the heme biosynthetic pathway in nonplant higher eukaryotes. A cDNA encoding for the mouse erythroid 5-aminolevulinate synthase (Schoenhaut, D. S., and Curtis, P. J. (1986) Gene (Amst.) 48, 55-63) has been expressed in Escherichia coli, using the alkaline phosphatase promoter, to a level of 50-60% of the total bacterial protein. Aminolevulinate synthase was overexpressed in an active form and, therefore, was able to rescue hemA mutants, which are unable to grow in the absence of 5-aminolevulinate. A simple purification from the aminolevulinate synthase-overproducing bacterial strain yielded approximately 50 mg of protein, in a high state of purity, per liter of bacterial culture. Moreover, the expressed aminolevulinate synthase could be easily concentrated up to 6-8 mg/ml. Significantly, recombinant aminolevulinate synthase retained physical and catalytic properties identical to those of natural sources. These include the dimeric structure, subunit molecular mass, and pyridoxal 5'-phosphate as an essential cofactor. Removal of the pyridoxal 5'-phosphate led to complete loss of activity. However, the apoenzyme could be readily reconstituted by incubation with 20 muM 5'-pyridoxal phosphate. The K(m) values are 51 mM for glycine and 55 muM for succinyl-CoA, in the same range of the K(m) values determined for the nonrecombinant enzyme. This report describes the overexpression of a mammalian 5-aminolevulinate synthase in E. coli and its purification from an overproducing strain. The ready availability of the pure, cloned, sequenced erythroid 5-aminolevulinate synthase makes it possible now for questions pertinent to the enzyme's structure, mechanism, and regulation to be addressed.	UNIV S FLORIDA,INST BIOMOLEC SCI,TAMPA,FL 33612; UNIV GEORGIA,DEPT MICROBIOL,ATHENS,GA 30602; UNIV GEORGIA,CTR MET ENZYME STUDIES,ATHENS,GA 30602	State University System of Florida; University of South Florida; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	FERREIRA, GC (corresponding author), UNIV S FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,BOX 7,12901 BRUCE B DOWNS BLVD,TAMPA,FL 33612, USA.		Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NIDDK NIH HHS [DK 35898, R56 DK032303] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035898] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams E, 1979, Methods Enzymol, V62, P407; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BORTHWICK IA, 1986, METHOD ENZYMOL, V123, P395; BOTTOMLE.SS, 1969, BLOOD-J HEMATOL, V34, P857; CORNISHBOWDEN A, 1981, FUUNDAMENTALS ENZYME, P99; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; COX TC, 1990, AM J HUM GENET, V46, P107; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Dierks P, 1990, BIOSYNTHESIS HEME CH, P201; ELFERINK CJ, 1988, J BIOL CHEM, V263, P13012; FANICAGA.M, 1973, EUR J BIOCHEM, V40, P19, DOI 10.1111/j.1432-1033.1973.tb03164.x; FERREIRA GC, 1987, J BIOL CHEM, V262, P4407; FERREIRA GC, 1992, J BIOL CHEM, V267, P5460; FERREIRA GC, 1988, BIOCHEM J, V250, P597, DOI 10.1042/bj2500597; FERREIRA GC, 1991, FASEB J, V5, pA1544; FUJITA H, 1991, J BIOL CHEM, V266, P17494; GARBOCZI DN, 1988, J BIOL CHEM, V263, P15694; INOUYE H, 1982, J BACTERIOL, V149, P434, DOI 10.1128/JB.149.2.434-439.1982; JORDAN PM, 1986, METHOD ENZYMOL, V123, P435; JORDAN PM, 1972, ENZYMES, P339; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; Karpeisky M., 1986, VITAMIN B6 PYRIDOXAL, P76; KENDALL DA, 1988, J BIOL CHEM, V263, P7261; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; KOLLEN RG, 1985, TRANSAMINASES, P545; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFORET GA, 1991, J BIOL CHEM, V266, P1326; LI JM, 1989, J BACTERIOL, V171, P2547, DOI 10.1128/jb.171.5.2547-2552.1989; LIEN LF, 1982, ENZYME, V28, P120; MARCEAU M, 1988, J BIOL CHEM, V263, P16934; NANDI AL, 1978, ARCH BIOCHEM BIOPHYS, V188, P266; OHASHI A, 1979, J BIOCHEM-TOKYO, V85, P239, DOI 10.1093/oxfordjournals.jbchem.a132317; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOENHAUT DS, 1986, GENE, V48, P55, DOI 10.1016/0378-1119(86)90351-3; SHORTLE D, 1986, J CELL BIOCHEM, V30, P281, DOI 10.1002/jcb.240300402; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; URBANGRIMAL D, 1986, EUR J BIOCHEM, V156, P511, DOI 10.1111/j.1432-1033.1986.tb09610.x; WHITING MJ, 1976, J BIOL CHEM, V251, P1340; YAMAUCHI K, 1980, J BIOL CHEM, V255, P1746	43	57	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					584	590						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416963				2022-12-27	WOS:A1993KE60300088
J	ZANETTI, M; DELSAL, G; STORICI, P; SCHNEIDER, C; ROMEO, D				ZANETTI, M; DELSAL, G; STORICI, P; SCHNEIDER, C; ROMEO, D			THE CDNA OF THE NEUTROPHIL ANTIBIOTIC BAC5 PREDICTS A PRO-SEQUENCE HOMOLOGOUS TO A CYSTEINE PROTEINASE-INHIBITOR THAT IS COMMON TO OTHER NEUTROPHIL ANTIBIOTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTARY-DNA SEQUENCE; BOVINE NEUTROPHILS; ANTIMICROBIAL POLYPEPTIDES; PIG LEUKOCYTES; PEPTIDES; BACTENECINS; TRANSLATION; DEFENSE; CLONING	Bac5 is a 5-kDa proline- and arginine-rich antibiotic, stored as inactive precursor (proBac5) in the large granules of bovine neutrophils. A full-length cDNA encoding the precursor form of Bac5 has been cloned. The encoded protein (pre-proBac5) has a calculated mass of 20,031 Da and a pI of 9.21. This comprises a putative signal peptide of 29 amino acid residues and a 101-residue pro-sequence that precede the mature antibiotic. The pro-sequence is acidic and may neutralize the highly cationic Bac5, thus accounting for the inactivation of the antibiotic activity observed in in vitro experiments. The structure of mature Bac5 agrees closely with the amino acid sequence previously determined, with an additional tripeptide tail predicting carboxyl-terminal amidation. A valyl residue is deduced at the cleavage site for the proteolytic maturation of proBac5, consistent with a previous observation showing elastase as the enzyme involved in this processing step. The region upstream of Bac5 reveals high identity to corresponding regions of two neutrophil antimicrobial polypeptides, CAP18 from rabbit and bovine indolicidin. The COOH-terminal sequences of these antibiotics are completely unrelated. The pro-region also exhibits remarkable similarity to pig cathelin, an inhibitor of cathepsin L, indicating a common evolutionary origin.	LAB NAZL CONSORZIO INTERUNIV BIOTECHNOL,AREA SCI PK,I-34012 TRIESTE,ITALY		ZANETTI, M (corresponding author), UNIV TRIESTE,DIPARTIMENTO BIOCHIM BIOFIS & CHIM MACROMOLEC,VIA A VALERIO 38,I-34127 TRIESTE,ITALY.			storici, paola/0000-0002-2590-3332; DEL SAL, GIANNINO/0000-0003-2185-6003				AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; ALMEIDA RP, 1991, BIOCHEM BIOPH RES CO, V177, P688, DOI 10.1016/0006-291X(91)91843-2; BARKER RL, 1988, J EXP MED, V168, P1493, DOI 10.1084/jem.168.4.1493; BOMAN HG, 1989, J BIOL CHEM, V264, P5852; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; DASSO MC, 1989, NUCLEIC ACIDS RES, V17, P3129, DOI 10.1093/nar/17.8.3129; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DELSAL G, 1992, BIOCHEM BIOPH RES CO, V187, P467, DOI 10.1016/S0006-291X(05)81517-7; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; ELSBACH P, 1990, TRENDS BIOTECHNOL, V8, P26, DOI 10.1016/0167-7799(90)90127-J; Elsbach P., 1988, INFLAMMATION BASIC P, P445; FRANK RW, 1990, J BIOL CHEM, V265, P18871; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GANZ T, 1989, J IMMUNOL, V143, P1358; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; GENNARO R, 1991, BLOOD CELL BIOCH, V3, P335; GIBSON BW, 1991, J BIOL CHEM, V266, P23103; GRAY PW, 1989, J BIOL CHEM, V264, P9505; GRIMALDI G, 1987, NUCLEIC ACIDS RES, V15, P9608, DOI 10.1093/nar/15.22.9608; JOINER KA, 1989, J CELL BIOL, V109, P2771, DOI 10.1083/jcb.109.6.2771; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; KOPITAR M, 1989, BIOL CHEM H-S, V370, P1145, DOI 10.1515/bchm3.1989.370.2.1145; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARRICK JW, 1991, BIOCHEM BIOPH RES CO, V179, P170, DOI 10.1016/0006-291X(91)91350-L; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEHRER RI, 1990, BLOOD, V76, P2169; LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127; MAINS RE, 1983, TRENDS NEUROSCI, V6, P229, DOI 10.1016/0166-2236(83)90100-5; MASON RW, 1986, BIOCHEM J, V233, P925, DOI 10.1042/bj2330925; RITONJA A, 1989, FEBS LETT, V255, P211, DOI 10.1016/0014-5793(89)81093-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOCCHI M, 1992, IN PRESS EUR J BIOCH; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; SPITZNAGEL JK, 1990, J CLIN INVEST, V86, P1381, DOI 10.1172/JCI114851; ZANETTI M, 1991, J IMMUNOL, V146, P4295; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	40	109	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					522	526						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416958				2022-12-27	WOS:A1993KE60300079
J	CHEN, HW; CHAN, WY; CHEN, CL; MANSFIELD, BC; CHOU, JY				CHEN, HW; CHAN, WY; CHEN, CL; MANSFIELD, BC; CHOU, JY			THE CARBOXYL-TERMINAL DOMAIN OF THE HUMAN PREGNANCY-SPECIFIC GLYCOPROTEIN SPECIFIES INTRACELLULAR RETENTION AND STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARCINOEMBRYONIC ANTIGEN; INTERCELLULAR-ADHESION MOLECULE; ENDOPLASMIC-RETICULUM; GENE FAMILY; MESSENGER-RNAS; CDNA SEQUENCE; CELL-ADHESION; BREFELDIN-A; BETA-1-GLYCOPROTEIN; PROTEINS	The pregnancy-specific glycoproteins (PSGs), which are members of the immunoglobulin superfamily, are the major pregnancy-associated proteins synthesized by the human placenta. Thirty or more PSG members have been identified which are encoded by at least 11 linked genes. The PSG proteins share 85-95% sequence homology in the coding region, but show variability at the carboxyl-terminal (COOH) domains. In the present study, we examined the effects of PSG COOH domains on protein secretion and stability. Using PSGs containing short (11-12 residues) hydrophilic (PSG1e, PSG11s, and PSG16a), short (22 residues) hydrophobic (PSG6r), and long (81 residues) hydrophobic (PSG11w) COOH domains, we showed that most PSG members were secretory proteins except PSG11w which was largely retained in cells. When the PSG11w COOH domain was replaced with a short COOH domain of PSG1e, the resulting PSG-N11w/C1e chimera became secreted into the medium. On the other hand, chimeras that harbored the PSG11w COOH domain, PSG-N1e/C11w and PSG-N16a/C11w, remained in cells, demonstrating that the COOH domain of PSG11w confers intracellular retention. Deletion analysis showed that mutant (PSG11w-C2) that contained the first 21 amino acids of PSG11w COOH domain or mutant (PSG11w-C3) that contained a deletion of hydrophobic residues 372-392 in the PSG11w COOH domain remained largely in cells. In contrast, the PSG11w-C1 mutant which contained the first 12 residues of the PSG11w COOH domain became a secretory protein. Studies of PSG synthesis and processing in the presence of Brefeldin A, a drug that impedes protein transport from endoplasmic reticulum to the Golgi system, showed that PSG11w resided and degraded in the endoplasmic reticulum. The endoplasmic reticulum localization of PSG11w and the cell-associated mutant PSGs was further demonstrated by their sensitivity to endoglycosidase H and indirect immunofluorescence analysis.	NICHHD,HUMAN GENET BRANCH,BLDG 10,RM 95242,BETHESDA,MD 20892; UNIV FLORIDA,COLL VET MED,DEPT LARGE ANIM CLIN SCI,GAINESVILLE,FL 32611; GEORGETOWN UNIV,MED CTR,DEPT PEDIAT,WASHINGTON,DC 20007; MASSEY UNIV,DEPT MICROBIOL & GENET,PALMERSTON NORTH,NEW ZEALAND	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University System of Florida; University of Florida; Georgetown University; Massey University			Chan, Wai Yee/R-7442-2018	Chan, Wai Yee/0000-0002-9714-0936; Mansfield, Brian/0000-0002-8533-2789				ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BOHN H, 1971, ARCH GYNAKOL, V210, P440, DOI 10.1007/BF01628222; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BROPHY BK, 1992, BIOCHIM BIOPHYS ACTA, V1131, P119, DOI 10.1016/0167-4781(92)90110-L; CHAN WY, 1988, DNA-J MOLEC CELL BIO, V7, P545, DOI 10.1089/dna.1.1988.7.545; CHAN WY, 1991, MOL CELL BIOCHEM, V106, P61; CHOU JY, 1992, SEMIN REPROD ENDOCR, V10, P116, DOI 10.1055/s-2007-1018867; CHOU JY, 1990, ENDOCRINOLOGY, V127, P2127, DOI 10.1210/endo-127-5-2127; GHODA L, 1990, J BIOL CHEM, V265, P11823; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; GUSSOW D, 1987, IMMUNOL TODAY, V8, P220, DOI 10.1016/0167-5699(87)90170-8; HEFTA SA, 1988, P NATL ACAD SCI USA, V85, P4648, DOI 10.1073/pnas.85.13.4648; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HSU VW, 1992, CELL, V69, P625, DOI 10.1016/0092-8674(92)90226-3; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE JN, 1979, BRIT J OBSTET GYNAEC, V86, P888, DOI 10.1111/j.1471-0528.1979.tb10717.x; LESLIE KK, 1990, P NATL ACAD SCI USA, V87, P5822, DOI 10.1073/pnas.87.15.5822; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; LIN TM, 1974, J CLIN INVEST, V54, P576, DOI 10.1172/JCI107794; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MACDONALD DJ, 1983, AM J OBSTET GYNECOL, V147, P430, DOI 10.1016/S0002-9378(16)32239-6; MASSON GM, 1983, BRIT J OBSTET GYNAEC, V90, P146, DOI 10.1111/j.1471-0528.1983.tb08899.x; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; PLOUZEK CA, 1991, BIOCHEM BIOPH RES CO, V176, P1532, DOI 10.1016/0006-291X(91)90461-F; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; ROONEY BC, 1988, GENE, V71, P439, DOI 10.1016/0378-1119(88)90061-3; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SORENSEN S, 1984, TUMOUR BIOL, V5, P275; STREYDIO C, 1988, BIOCHEM BIOPH RES CO, V154, P130, DOI 10.1016/0006-291X(88)90660-2; TAKAMI N, 1988, J BIOL CHEM, V263, P12716; TAMSEN L, 1983, J PERINAT MED, V11, P19, DOI 10.1515/jpme.1983.11.1.19; TATARINOV Y S, 1970, Byulleten' Eksperimental'noi Biologii i Meditsiny, V69, P66; TATARINOV YS, 1978, GYNECOL OBSTET INVES, V9, P65, DOI 10.1159/000300972; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; THOMPSON J, 1992, GENOMICS, V12, P761, DOI 10.1016/0888-7543(92)90307-E; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; WATANABE S, 1988, BIOCHEM BIOPH RES CO, V152, P762, DOI 10.1016/S0006-291X(88)80103-7; WATANABE S, 1988, J BIOL CHEM, V263, P2049; WATANABE T, 1992, BIOCHEMISTRY-US, V31, P3051, DOI 10.1021/bi00127a004; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; WURZ H, 1981, J PERINAT MED, V9, P67, DOI 10.1515/jpme.1981.9.2.67; ZIMMERMANN W, 1989, BIOCHEM BIOPH RES CO, V163, P1197, DOI 10.1016/0006-291X(89)91105-4	59	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22066	22075						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408064				2022-12-27	WOS:A1993MC80900094
J	KAJI, EH; LODISH, HF				KAJI, EH; LODISH, HF			IN-VITRO UNFOLDING OF RETINOL-BINDING PROTEIN BY DITHIOTHREITOL - ENDOPLASMIC RETICULUM-ASSOCIATED FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; DISULFIDE-ISOMERASE; SACCHAROMYCES-CEREVISIAE; TRANSPORT; GOLGI; BONDS; HEMAGGLUTININ; PURIFICATION; MATURATION; CATALYSTS	HepG2 cells in the presence of DTT synthesize fully reduced serum retinol-binding protein (RBP) within the endoplasmic reticulum (ER). Upon removal of DTT, RBP forms disulfide bonds and a folding intermediate, compact II, accumulates within the ER. Compact II RBP co-migrates on nonreducing gel electrophoresis with the secreted form of RBP but is differentiated from secreted RBP by its sensitivity to DTT-induced unfolding (see accompanying article; Kaji, E. H., and Lodish, H. F. (1993) J. Biol. Chem. 268, 22188-22194). Here, we have reconstituted DTT-induced unfolding of compact II RBP in a broken cell system and demonstrate that ER-associated factors enhance the unfolding of RBP by DTT. Protein disulfide isomerase is likely to be one such factor since it enhances the rate of RBP unfolding by DTT in vitro; protein disulfide isomerase-induced unfolding requires the absence of retinoids, similar to the DTT-induced unfolding in vivo. ATP enhances the unfolding of RBP in the absence but not in the presence of retinol, both in intact and broken cells. Thus, protein disulfide isomerase and other ATP-dependent factors can unfold partly folded (or misfolded) RBP in the ER, suggesting how improperly folded proteins might be correctly refolded in vivo.	WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)								BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CREIGHTON TE, 1977, J MOL BIOL, V113, P275, DOI 10.1016/0022-2836(77)90142-5; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FREEDMAN RB, 1989, BIOCHEM SOC SYMP, V55, P167; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GUNTHER R, 1991, J BIOL CHEM, V266, P24557; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOJI EH, 1993, J BIOL CHEM, V268, P22188; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; LODISH HF, 1988, J BIOL CHEM, V263, P2107; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RAZ A, 1970, J BIOL CHEM, V245, P1903; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTHBLAT GH, 1976, IN VITRO CELL DEV B, V12, P554; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; ROTHMAN JE, 1986, NATURE, V322, P209, DOI 10.1038/322209a0; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SMITH JE, 1978, CELL, V15, P865, DOI 10.1016/0092-8674(78)90271-4; STATES DJ, 1984, J MOL BIOL, V174, P411, DOI 10.1016/0022-2836(84)90345-0; TOKUNAGA M, 1992, J BIOL CHEM, V267, P17553; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	40	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22195	22202						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408081				2022-12-27	WOS:A1993MC80900112
J	MURPHY, JE; XU, X; KANTROWITZ, ER				MURPHY, JE; XU, X; KANTROWITZ, ER			CONVERSION OF A MAGNESIUM BINDING-SITE INTO A ZINC-BINDING SITE BY A SINGLE AMINO-ACID SUBSTITUTION IN ESCHERICHIA-COLI ALKALINE-PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MULTIWIRE AREA DETECTOR; MECHANISM	The replacement of aspartic acid by histidine at position 153 in Escherichia coli alkaline phosphatase results in a mutant enzyme that is remarkably similar to certain mammalian alkaline phosphatases that are activated by magnesium in a time-dependent fashion. These mammalian alkaline phosphatases have histidine at the position corresponding to 153 of the E. coli sequence. Here we report the three-dimensional structure of the mutant E. coli alkaline phosphatase with histidine at position 153. The structure reveals that the octahedral magnesium binding site has been converted to a tetrahedral zinc binding site with an imidazole ring nitrogen of His-153 as one of the ligands to the zinc. The alteration in metal binding caused by the mutation could explain the origin of the magnesium activation observed with the mammalian alkaline phosphatases. The structure also reveals differences in the mode of phosphate binding, explaining the enhanced phosphate affinity and the reduced activity of the mutant enzyme in the presence of zinc.	BOSTON COLL,MERKERT CHEM CTR,DEPT CHEM,CHESTNUT HILL,MA 02167	Boston College					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RA, 1976, BIOCHEMISTRY-US, V15, P3710, DOI 10.1021/bi00662a011; ANDERSON RA, 1975, P NATL ACAD SCI USA, V72, P2989, DOI 10.1073/pnas.72.8.2989; BRUNEL C, 1973, BIOCHIM BIOPHYS ACTA, V309, P104, DOI 10.1016/0005-2744(73)90322-7; BUTTERWORTH PJ, 1968, BIOCHEM J, V107, P467, DOI 10.1042/bj1070467; CATHALA G, 1975, J BIOL CHEM, V250, P6046; HAMLIN R, 1981, J APPL CRYSTALLOGR, V14, P85, DOI 10.1107/S0021889881008856; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; JANEWAY CML, 1993, BIOCHEMISTRY-US, V32, P1601, DOI 10.1021/bi00057a026; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KIM EE, 1989, CLIN CHIM ACTA, V186, P175; SCHWARTZ JH, 1961, P NATL ACAD SCI USA, V47, P1996, DOI 10.1073/pnas.47.12.1996; SOWADSKI J M, 1983, Journal of Molecular Biology, V170, P575, DOI 10.1016/S0022-2836(83)80162-4; SOWADSKI JM, 1985, J MOL BIOL, V186, P417, DOI 10.1016/0022-2836(85)90115-9	13	53	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21497	21500						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407998				2022-12-27	WOS:A1993MC80900012
J	HOFFMAN, GG; LEE, S; CHRISTIANO, AM; CHUNGHONET, LC; CHENG, W; KATCHMAN, S; UITTO, J; GREENSPAN, DS				HOFFMAN, GG; LEE, S; CHRISTIANO, AM; CHUNGHONET, LC; CHENG, W; KATCHMAN, S; UITTO, J; GREENSPAN, DS			COMPLETE CODING SEQUENCE, INTRON-EXON ORGANIZATION, AND CHROMOSOMAL LOCATION OF THE GENE FOR THE CORE-I PROTEIN OF HUMAN UBIQUINOL-CYTOCHROME-C REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VII COLLAGEN; PROCESSING PEPTIDASE; BC1 COMPLEX; 1ST INTRON; MITOCHONDRIAL; DNA; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; SUBUNIT	Core I protein is a nuclear-encoded component of the ubiquinol-cytochrome c reductase complex of the mitochondrial respiratory chain. We have located the gene for the human core I protein in the p21 region of chromosome 3, just upstream of the COL7A1 gene which encodes type VII collagen. The core I gene, which has been sequenced in its entirety, is comprised of 10,417 base pairs, from the major transcription start site to the polyadenylation signal, and contains 13 exons. The predicted polypeptide contains 480 amino acids, of which the first 34 are predicted to constitute a typical mitochondrial leader peptide containing 6 positively charged arginine residues. The predicted human protein shows significant homology with core I protein from Saccharomyces cerevisiae, rather high homology (64% similarity, 46% identity) with the processing enhancing protein, which functions as core I protein in Neurospora crassa, and, surprisingly, highest homology with the small subunit of the mitochondrial processing peptidase of rat (74% similarity, 55% identity). The predicted human sequence is 87% identical to the reported bovine core I sequence predicted from cDNA cloning, up to residue 298, but the two predicted sequences are widely divergent after that point.	UNIV WISCONSIN,DEPT PATHOL & LAB MED,1300 UNIV AVE,MADISON,WI 53706; UNIV WISCONSIN,PROGRAM CELL & MOLEC BIOL,MADISON,WI 53706; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Jefferson University; Jefferson University			Lee, Seungbok/AAS-1529-2021	Lee, Seungbok/0000-0002-6620-6269; Greenspan, Daniel/0000-0001-8096-7446	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007561, P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923, T32-AR07561] Funding Source: Medline; NIGMS NIH HHS [GM46846] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARRETZ M, 1991, BIOMED BIOCHIM ACTA, V50, P403; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; CAPALDI RA, 1988, J BIOENERG BIOMEMBR, V20, P291, DOI 10.1007/BF00769634; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; DYNAN W, 1986, TRENDS GENET, V6, P196; EAGLE H, 1955, P SOC EXP BIOL MED, V89, P362; GENCIC S, 1991, EUR J BIOCHEM, V199, P123, DOI 10.1111/j.1432-1033.1991.tb16099.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GONZALEZHALPHEN D, 1988, BIOCHEMISTRY-US, V27, P7021, DOI 10.1021/bi00418a053; GREENSPAN DS, 1993, CYTOGENET CELL GENET, V62, P35, DOI 10.1159/000133440; GREENSPAN DS, 1993, HUM MOL GENET, V2, P273, DOI 10.1093/hmg/2.3.273; GREENSPAN DS, 1991, GENE EXPRESSION, V1, P29; GREENSPAN DS, 1989, J BIOL CHEM, V264, P20683; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; HOSOKAWA Y, 1989, J BIOL CHEM, V264, P13483; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KENNAWAY N G, 1988, Journal of Bioenergetics and Biomembranes, V20, P325, DOI 10.1007/BF00769636; KITADA S, 1993, BIOCHEM BIOPH RES CO, V190, P289, DOI 10.1006/bbrc.1993.1044; KLEIBER J, 1990, P NATL ACAD SCI USA, V87, P7978, DOI 10.1073/pnas.87.20.7978; LAHERTY CD, 1989, J BIOL CHEM, V264, P11222; LEE ST, 1988, J BIOL CHEM, V263, P13414; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; OUDSHOORN P, 1987, EUR J BIOCHEM, V163, P97, DOI 10.1111/j.1432-1033.1987.tb10741.x; PACES V, 1993, P NATL ACAD SCI USA, V90, P5355, DOI 10.1073/pnas.90.11.5355; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RAWLINGS ND, 1991, BIOCHEM J, V275, P389, DOI 10.1042/bj2750389; RYYNANEN J, 1992, J CLIN INVEST, V89, P163, DOI 10.1172/JCI115557; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; SCHNEIDER H, 1990, J BIOL CHEM, V265, P9881; SCHULTE U, 1989, NATURE, V339, P147, DOI 10.1038/339147a0; SHORT JM, 1986, J BIOL CHEM, V261, P9721; TZAGOLOFF A, 1986, J BIOL CHEM, V261, P7163; Uitto J, 1992, Exp Dermatol, V1, P2, DOI 10.1111/j.1600-0625.1992.tb00065.x; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x	41	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21113	21119						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407948				2022-12-27	WOS:A1993MA28800072
J	SIERON, AL; FERTALA, A; ALAKOKKO, L; PROCKOP, DJ				SIERON, AL; FERTALA, A; ALAKOKKO, L; PROCKOP, DJ			DELETION OF A LARGE DOMAIN IN RECOMBINANT HUMAN PROCOLLAGEN-II DOES NOT ALTER THE THERMAL-STABILITY OF THE TRIPLE-HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-IV; OSTEOGENESIS IMPERFECTA; COLLAGEN; GENE; MUTATIONS; FIBROBLASTS; DISEASES; PATIENT; COL2A1; CHAINS	A construct of the human gene for procollagen II (COL2A1) was prepared with an internal deletion of 5 kilobases that removed 12 exons coding for 291 amino acids from near the NH2 terminus of the triple helix. The construct was then used to transfect stably a human tumor cell line (HT-1080), and clones secreting internally deleted proalpha1(II) chain of procollagen II were isolated. The protein was purified, and the thermal stability of the triple-helical domain was assayed by brief protease digestion. The thermal stability of the internally deleted protein was the same as that of intact collagen II even though the triple helix was 39% shorter. Additionally, the thermal stability of the collagenase A fragment was the same as that of the collagenase A fragment of normal collagen II even though it was 38% shorter. Analysis of the results suggested that the thermal stabilities of large fragments of collagen II depended primarily on their contents of -Gly-Pro-Hyp-triplets corrected for length.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, JEFFERSON INST MOLEC MED, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA	Jefferson University			Sieron, Aleksander L/G-1700-2013	Sieron, Aleksander L./0000-0002-3894-9508	NIAMS NIH HHS [AR 39740, AR 38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188, P01AR039740] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1991, J BIOL CHEM, V266, P14175; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.med.43.1.269; CONSTANTINOU CD, 1987, EUR J BIOCHEM, V263, P247; DEAK SB, 1985, COLLAGEN REL RES, V5, P305; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Fertala Andrzej, 1993, Matrix, V13, P15; FIEDLERNAGY C, 1982, J BIOL CHEM, V257, P9181; GERMANN HP, 1988, BIOPOLYMERS, V27, P157, DOI 10.1002/bip.360270112; HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143; KADLER KE, 1988, J BIOL CHEM, V263, P10517; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LAW MF, 1983, MOL CELL BIOL, V3, P2110, DOI 10.1128/MCB.3.11.2110; LEE B, 1991, AM J HUM GENET, V48, P511; PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162; PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Ramachandran G.N., 1967, TREATISE COLLAGEN, P103; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; RIGBY BJ, 1975, COMP BIOCHEM PHYS B, V52, P89, DOI 10.1016/0305-0491(75)90120-0; RIGBY BJ, 1967, BIOCHIM BIOPHYS ACTA, V133, P272, DOI 10.1016/0005-2795(67)90067-0; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; Sambrook J, 1989, MOL CLONING LABORATO; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; SOKOLOV B P, 1989, Medical Science Research, V17, P911; SOKOLOV BP, 1987, BIOKHIMIYA, V53, P1828; SUNADA H, 1981, COLLAGEN REL RES, V1, P177; VISSING H, 1991, J BIOL CHEM, V266, P5244; VONHIPPEL PH, 1967, TREATISE COLLAGEN CH, V1, P316; WEISS JB, 1976, INT REV CONNECT TISS, V7, P102; WESTERHAUSEN A, 1990, J BIOL CHEM, V265, P13995; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	40	34	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21232	21237						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407960				2022-12-27	WOS:A1993MA28800087
J	TAKAHASHI, M; MATSUSHITA, Y; IIJIMA, Y; TANZAWA, K				TAKAHASHI, M; MATSUSHITA, Y; IIJIMA, Y; TANZAWA, K			PURIFICATION AND CHARACTERIZATION OF ENDOTHELIN-CONVERTING ENZYME FROM RAT LUNG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIG ENDOTHELIN-1; VASOCONSTRICTOR ACTIVITY; CELLS; PHOSPHORAMIDON; CONVERSION; EXPRESSION; PROTEINS; RECEPTOR; INVITRO; CLONING	Endothelin-converting enzyme, a key enzyme in the production of a potent vasoconstricting peptide, endothelin, was purified to homogeneity from rat lung microsomes. A sensitive and convenient assay method using the I-125-endothelin-1 receptor binding assay was developed for purification studies. The enzyme was solubilized with Triton X-100 and was purified at high yield by sequential column chromatography on wheat germ agglutinin-agarose, zinc-chelating Sepharose, and Blue B-agarose. Electrophoretic analysis of the purified enzyme revealed one protein band with M(r) 130,000. High performance liquid chromatographic analysis of the enzyme reaction revealed that purified enzyme quantitatively converted big endothelin-1 to endothelin-1, indicating that the enzyme specifically cleaved the bond between Trp21 and Val22. The enzyme was inhibited by metal chelators and phosphoramidon, but not by thiorphan and captopril. Lung endothelin-converting enzyme preferred big endothelin-1 to big endothelin-2 or -3 as a substrate, and kinetic analysis revealed that the Michaelis constant and a maximal velocity for big endothelin-1 were 0.20 muM and 3.1 nmol/min.mg protein, respectively. Lung endothelin-converting enzyme is a typical neutral metalloproteinase and is similar to the enzyme from endothelial cells.	SANKYO CO LTD,NEW LEAD RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN	Daiichi Sankyo Company Limited	TAKAHASHI, M (corresponding author), SANKYO CO LTD,FERMENTAT RES LABS,1-2-58 HIROMACHI,SHINAGAWA KU,TOKYO 140,JAPAN.							ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KASHIWABARA T, 1989, FEBS LETT, V247, P73, DOI 10.1016/0014-5793(89)81243-8; KIMURA S, 1989, J CARDIOVASC PHARM, V13, pS5, DOI 10.1097/00005344-198900135-00003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUMURA Y, 1990, FEBS LETT, V272, P166, DOI 10.1016/0014-5793(90)80475-X; MATSUMURA Y, 1990, EUR J PHARMACOL, V185, P103, DOI 10.1016/0014-2999(90)90216-S; MATSUMURA Y, 1992, FEBS LETT, V305, P86, DOI 10.1016/0014-5793(92)80870-M; MATSUMURA Y, 1991, BIOCHEM BIOPH RES CO, V178, P531, DOI 10.1016/0006-291X(91)90140-3; MCMAHON EG, 1991, P NATL ACAD SCI USA, V88, P703, DOI 10.1073/pnas.88.3.703; OHNAKA K, 1991, BIOCHEM INT, V23, P499; OHNAKA K, 1992, BIOCHEM BIOPH RES CO, V185, P611, DOI 10.1016/0006-291X(92)91668-G; OKADA K, 1991, BIOCHEM BIOPH RES CO, V180, P1019, DOI 10.1016/S0006-291X(05)81167-2; OKADA K, 1990, BIOCHEM BIOPH RES CO, V171, P1192, DOI 10.1016/0006-291X(90)90811-Z; OPGENORTH TJ, 1992, FASEB J, V6, P2653, DOI 10.1096/fasebj.6.9.1612289; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SUZUKI N, 1989, J IMMUNOL METHODS, V118, P245, DOI 10.1016/0022-1759(89)90012-4; TAKADA J, 1991, BIOCHEM BIOPH RES CO, V176, P860, DOI 10.1016/S0006-291X(05)80265-7; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	22	136	142	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21394	21398						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407980				2022-12-27	WOS:A1993MA28800108
J	SLACK, J; MCMAHAN, CJ; WAUGH, S; SCHOOLEY, K; SPRIGGS, MK; SIMS, JE; DOWER, SK				SLACK, J; MCMAHAN, CJ; WAUGH, S; SCHOOLEY, K; SPRIGGS, MK; SIMS, JE; DOWER, SK			INDEPENDENT BINDING OF INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA TO TYPE-I AND TYPE-II INTERLEUKIN-1 RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; MULTIVALENT IMMUNE-COMPLEXES; GROWTH-FACTOR-RECEPTOR; MURINE B-CELL; IL-1 RECEPTOR; HIGH-AFFINITY; T-CELLS; SIGNAL TRANSDUCTION; EXPRESSION CLONING; ESCHERICHIA-COLI	Interleukin (IL)-1 refers to a group of three polypeptide hormones with a wide range of cellular targets. Two types of IL-1 receptor have been identified and characterized by cDNA cloning. Both human type I and type II IL-1 receptors contain extracellular domains of approximately 310 residues and a single membrane-spanning region. The type I receptor contains a cytoplasmic domain of 213 residues. The cytoplasmic region of the type II receptor is 29 residues in length. It has been found recently that a number of cells express both forms of receptor. By analogy with other cytokine receptor systems, the two IL-1 receptors might be expected to form a heterodimeric complex, the type II receptor being an alpha-chain-like structure, functioning only to bind ligand, and associating with the type I receptor (a beta-chain-like structure) which would transduce signals. In this report we show that this is not the case, but rather that IL-1, when complexed to type II receptor, cannot bind type I receptors, and vice versa. These data show that the complex patterns often observed for IL-1 binding to cells cannot be accounted for by the same type of mechanism that underlies the behavior of, for example, the IL-2 system.	IMMUNEX RES & DEV CORP,DEPT BIOCHEM,IMMUNEX BLDG,51 UNIV ST,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,DEPT PROC DEV,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,HYBRIDOMA LAB,SEATTLE,WA 98101					Sims, John/0000-0002-5667-9185; dower, steve/0000-0002-4675-4225				Arend W P, 1991, Br J Rheumatol, V30 Suppl 2, P49; AREND WP, 1989, J IMMUNOL, V143, P1851; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BENJAMIN D, 1990, BLOOD, V75, P2017; BENJAMIN D, 1990, J BIOL CHEM, V265, P9943; BENSIMON C, 1989, J IMMUNOL, V143, P1168; BIRD TA, 1991, J BIOL CHEM, V266, P22661; BOMSZTYK K, 1989, P NATL ACAD SCI USA, V86, P8034, DOI 10.1073/pnas.86.20.8034; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; CHIN J, 1987, J EXP MED, V165, P70, DOI 10.1084/jem.165.1.70; CHIZZONITE R, 1989, P NATL ACAD SCI USA, V86, P8029, DOI 10.1073/pnas.86.20.8029; COCHET C, 1988, J BIOL CHEM, V263, P3290; CONCA W, 1991, J BIOL CHEM, V266, P16265; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; DELISI C, 1981, P NATL ACAD SCI-BIOL, V78, P5569, DOI 10.1073/pnas.78.9.5569; DELISI C, 1981, NATURE, V289, P322, DOI 10.1038/289322a0; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DINARELLO CA, 1991, BLOOD, V77, P1627; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; DOWER SK, 1981, BIOCHEMISTRY-US, V20, P6326, DOI 10.1021/bi00525a007; DOWER SK, 1989, J IMMUNOL, V142, P4314; DOWER SK, 1987, IMMUNOL TODAY, V8, P46, DOI 10.1016/0167-5699(87)90238-6; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; DOWER SK, 1981, BIOCHEMISTRY-US, V20, P6335, DOI 10.1021/bi00525a008; DOWER SK, 1989, INTERLEUKIN 1 INFLAM, P63; DOWER SK, 1991, INTERLEUKINS MOL BIO, P33; DOWER SK, 1989, LYMPHOKINE RECEPTOR, P17; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; EISENBERG SP, 1991, P NATL ACAD SCI USA, V88, P5232, DOI 10.1073/pnas.88.12.5232; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; KILIAN PL, 1990, PROG CLIN BIOL RES, V349, P251; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KRONHEIM SR, 1986, BIO-TECHNOL, V4, P1078, DOI 10.1038/nbt1286-1078; KUPPER TS, 1988, J CLIN INVEST, V82, P1787, DOI 10.1172/JCI113792; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060; MALISZEWSKI CR, 1990, J IMMUNOL, V144, P3028; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MATSUSHIMA K, 1986, J IMMUNOL, V136, P4496; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MELTON LB, 1989, CLIN IMMUNOL IMMUNOP, V50, P171, DOI 10.1016/0090-1229(89)90126-8; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; Orencole S F, 1989, Cytokine, V1, P14, DOI 10.1016/1043-4666(89)91044-2; PARK LS, 1989, J BIOL CHEM, V264, P5420; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SHALABY MR, 1990, J EXP MED, V172, P1517, DOI 10.1084/jem.172.5.1517; SIMS JE, 1989, P NATL ACAD SCI USA, V86, P8946, DOI 10.1073/pnas.86.22.8946; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SLACK J, 1989, BIOTECHNIQUES, V7, P1132; SPRIGGS MK, 1990, J BIOL CHEM, V265, P22499; URDAL DL, 1988, J BIOL CHEM, V263, P2870; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	62	107	110	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2513	2524						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428929				2022-12-27	WOS:A1993KK81500042
J	TAGAYA, M; WILSON, DW; BRUNNER, M; ARANGO, N; ROTHMAN, JE				TAGAYA, M; WILSON, DW; BRUNNER, M; ARANGO, N; ROTHMAN, JE			DOMAIN-STRUCTURE OF AN N-ETHYLMALEIMIDE-SENSITIVE FUSION PROTEIN INVOLVED IN VESICULAR TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI STACK; YEAST; GENE; REQUIRES; FAMILY; NSF; PURIFICATION; ENDOCYTOSIS; EXPRESSION; COMPONENT	N-Ethylmaleimide-sensitive fusion protein (NSF) is an essential component for protein transport between Golgi cisternae. Sequence analysis and proteolytic dissection reveal that NSF contains two tandem ''ATP domains,'' each containing the consensus sequence for the binding of nucleotide. When Escherichia coli-produced Chinese hamster ovary NSF is purified, it exhibits a low, but significant, ATPase activity. The ATPase activity of NSF is sensitive to N-ethylmaleimide and influenced by monoclonal antibodies against recombinant NSF.	SLOAN KETTERING INST CANC RES,ROCKEFELLER RES LAB,PROGRAM CELLULAR BIOCHEM & BIOPHYS,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center				Brunner, Michael/0000-0001-9798-3047	NIDDK NIH HHS [DK 27044] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027044, R01DK027044] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; SIGNOR G, 1990, EUR J BIOCHEM, V189, P221, DOI 10.1111/j.1432-1033.1990.tb15480.x; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0	27	169	169	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2662	2666						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428942				2022-12-27	WOS:A1993KK81500061
J	PIROLA, CJ; WANG, HM; KAMYAR, A; WU, SX; ENOMOTO, H; SHARIFI, B; FORRESTER, JS; CLEMENS, TL; FAGIN, JA				PIROLA, CJ; WANG, HM; KAMYAR, A; WU, SX; ENOMOTO, H; SHARIFI, B; FORRESTER, JS; CLEMENS, TL; FAGIN, JA			ANGIOTENSIN-II REGULATES PARATHYROID HORMONE-RELATED PROTEIN EXPRESSION IN CULTURED RAT AORTIC SMOOTH-MUSCLE CELLS THROUGH TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE GENE-EXPRESSION; KINASE-C ACTIVATION; GROWTH-FACTOR-BETA; MESSENGER-RNA; SYNTHETIC PEPTIDE; HUMAN HOMOLOG; HUMAN-TUMOR; FOS GENE; GM-CSF; INDUCTION	Parathyroid hormone-related protein (PTHrP), a tumor product responsible for malignancy-associated hypercalcemia, is also produced in many normal tissues, including vascular smooth muscle cells (SMC). As PTHrP exhibits vasodilatory properties, we postulated that other vasoactive agents may control PTHrP gene expression in SMC. Addition of angiotensin II to serum-deprived SMC resulted in a marked induction of PTHrP mRNA by 2 h, with a peak (6-10-fold) at 4-6 h. Angiotensin II effects on PTHrP gene expression were inhibited by saralasin, an angiotensin II receptor antagonist, and blocked by actinomycin D and cycloheximide, suggesting a requirement for gene transcription and protein synthesis. Nuclear run-off assays revealed a 3-fold increase in PTHrP gene transcription 1 h after angiotensin II treatment. Angiotensin II also prolonged PTHrP mRNA half-life by 2-3-fold. Angiotensin-induced PTHrP mRNA is partially dependent on cyclooxygenase products and protein kinase C activation. Other vasoconstrictor substances, including serotonin and bradykinin, also stimulated PTHrP expression, whereas the vasodilator atrial natriuretic peptide did not. Addition of recombinant PTHrP-(1-141) significantly inhibited angiotensin II-induced SMC DNA synthesis. PTHrP expression is increased by angiotensin II through transcriptional and post-transcriptional mechanisms. In addition, PTHrP modulates the effect of angiotensin II on SMC proliferation. This suggests that PTHrP acts locally in SMC, possibly to oppose the vasoactive and/or growth-promoting effects of vasoconstrictor agents such as angiotensin II.	UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,CEDARS SINAI RES INST,DEPT MED,DIV CARDIOL,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,CEDARS SINAI RES INST,DEPT ENDOCRINOL,LOS ANGELES,CA 90048	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				Pirola, Carlos/0000-0001-8234-4058	NATIONAL CANCER INSTITUTE [R29CA050706, R01CA050906, R01CA050706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042792] Funding Source: NIH RePORTER; NCI NIH HHS [CA 50706, CA 50906] Funding Source: Medline; NIDDK NIH HHS [DK 42792] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; ADACHI N, 1990, BIOCHEM BIOPH RES CO, V166, P1088, DOI 10.1016/0006-291X(90)90978-V; ALLINSON ET, 1992, CANCER RES, V52, P3103; BELL L, 1990, AM J PATHOL, V137, P7; BENJAMIN N, 1991, CLIN SCI, V80, P183, DOI 10.1042/cs0800183; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CARE AD, 1990, EXP PHYSIOL, V75, P605, DOI 10.1113/expphysiol.1990.sp003437; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P199, DOI 10.1210/endo-125-1-199; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; DAIFOTIS AG, 1991, J BONE MINER RES, V6, P3195; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DZAU VG, 1988, CIRCULATION, V55, P14; FAGIN JA, 1989, DIABETES, V38, P428, DOI 10.2337/diabetes.38.4.428; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIANNELLANETO D, 1992, CIRC RES, V71, P646, DOI 10.1161/01.RES.71.3.646; GIBBONS GH, 1990, CLIN RES, V38, pA287; HONGO T, 1991, J CLIN INVEST, V88, P1841, DOI 10.1172/JCI115505; HORIUCHI N, 1987, SCIENCE, V238, P1566, DOI 10.1126/science.3685994; IKEDA K, 1990, J BIOL CHEM, V265, P5398; KARAPLIS AC, 1990, MOL ENDOCRINOL, V4, P441, DOI 10.1210/mend-4-3-441; KAWAHARA Y, 1988, BIOCHEM BIOPH RES CO, V150, P52, DOI 10.1016/0006-291X(88)90485-8; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; MACISAAC RJ, 1991, ENDOCRINOLOGY, V129, P757, DOI 10.1210/endo-129-2-757; MANGIN M, 1988, P NATL ACAD SCI USA, V85, P597, DOI 10.1073/pnas.85.2.597; MANGIN M, 1989, P NATL ACAD SCI USA, V86, P2408, DOI 10.1073/pnas.86.7.2408; MARLUFF WF, 1984, TRANSCRIPTION TRANSL, P89; MATSUMOTO T, 1990, CALCIUM REGULATION B, P60; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOK LLS, 1989, ENDOCR REV, V10, P420, DOI 10.1210/edrv-10-4-420; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NAFTILAN AJ, 1990, MOL CELL BIOL, V10, P5536, DOI 10.1128/MCB.10.10.5536; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; NICKOLS GA, 1990, ENDOCRINOLOGY, V126, P721, DOI 10.1210/endo-126-2-721; RODAN SB, 1989, J ENDOCRINOL, V122, P219, DOI 10.1677/joe.0.1220219; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHARIFI BG, 1992, J BIOL CHEM, V267, P23910; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STREUTKER C, 1991, MOL ENDOCRINOL, V5, P703, DOI 10.1210/mend-5-5-703; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; THIEDE MA, 1990, P NATL ACAD SCI USA, V87, P6969, DOI 10.1073/pnas.87.18.6969; THIEDE MA, 1988, P NATL ACAD SCI USA, V85, P4605, DOI 10.1073/pnas.85.13.4605; THIEDE MA, 1991, ENDOCRINOLOGY, V129, P1958, DOI 10.1210/endo-129-4-1958; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; YASUDA T, 1989, J BIOL CHEM, V264, P7720; YASUDA T, 1989, MOL ENDOCRINOL, V3, P518, DOI 10.1210/mend-3-3-518; YATES AJP, 1988, J CLIN INVEST, V81, P932, DOI 10.1172/JCI113406	52	121	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1987	1994						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420973				2022-12-27	WOS:A1993KH62000075
J	ZHANG, YH; SNELL, WJ				ZHANG, YH; SNELL, WJ			DIFFERENTIAL REGULATION OF ADENYLYLCYCLASES IN VEGETATIVE AND GAMETIC FLAGELLA OF CHLAMYDOMONAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-DEPENDENT PHOSPHORYLATION; ADENYLATE-CYCLASE ACTIVITY; CYCLIC-AMP; INTRACELLULAR SIGNALS; PLASMA-MEMBRANE; CALCIUM; REINHARDTII; FERTILIZATION; INHIBITION; MOTILITY	To learn more about the mechanism of regulation of cAMP during fertilization in Chlamydomonas, we have begun to study the flagellar adenylylcyclase. Recently (Zhang, Y., Ross, E. M., and Snell, W. J. (1991) J. Biol. Chem. 266, 22954-22959) we reported that the adenylylcyclase in gametic flagella is inhibited by ATP and activated by pretreatment at 45-degrees-C or by incubation with the protein kinase inhibitor staurosporine. Here we present evidence that this novel regulatory mechanism is unique to gametes and may be required for sexual signaling between mt+ and mt- gametes during fertilization. The vegetative form of the enzyme, which has a specific activity 3-5-fold less than the gametic form, was neither inhibited by ATP nor activated at 45-degrees-C. 5'-Adenylylimidodiphosphate, staurosporine, and Mn2+, which activated the gametic enzyme, had no effect on the vegetative adenylylcyclase. In addition the gametic enzyme was inhibited by low (0.1-1 muM) Ca2+ concentrations, whereas the vegetative form was unaffected by 10 muM Ca2+. During gametogenesis acquisition of the ability to undergo sexual signaling was coincident with the appearance of the gametic flagellar adenylylcyclase. Our results suggest that gametogenesis is accompanied by appearance of a new adenylylcyclase that may play a central role in signal transduction during fertilization in Chlamydomonas.	UNIV TEXAS, SW MED SCH, DEPT CELL BIOL & NEUROSCI, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Zhang, Yuhua/0000-0003-0901-935X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM025661, GM-25661] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BONINI NM, 1991, ADV SEC MESS PHOSPH, V23, P227; BOOKBINDER LH, 1990, J CELL BIOL, V111, P1859, DOI 10.1083/jcb.111.5.1859; BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; BUCHANAN MJ, 1989, J CELL BIOL, V108, P199, DOI 10.1083/jcb.108.1.199; BUCHANAN MJ, 1988, EXP CELL RES, V179, P181, DOI 10.1016/0014-4827(88)90357-6; COLVIN RA, 1991, CELL CALCIUM, V12, P19, DOI 10.1016/0143-4160(91)90081-O; DEBERNARDI MA, 1991, P NATL ACAD SCI USA, V88, P9257, DOI 10.1073/pnas.88.20.9257; DETMERS PA, 1983, J CELL BIOL, V97, P522, DOI 10.1083/jcb.97.2.522; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FISCHER U, 1974, BIOCHIM BIOPHYS ACTA, V341, P412, DOI 10.1016/0005-2744(74)90234-4; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; Garbers D L, 1980, Adv Cyclic Nucleotide Res, V13, P251; GARBERS DL, 1989, MOL BIOL FERTILIZATI, P3; GIANNATTASIO G, 1987, ENDOCRINOLOGY, V120, P2611, DOI 10.1210/endo-120-6-2611; GOODENOUGH UW, 1989, J CELL BIOL, V109, P247, DOI 10.1083/jcb.109.1.247; GOODENOUGH UW, 1975, J CELL BIOL, V67, P623, DOI 10.1083/jcb.67.3.623; GUSTIN MC, 1987, BIOCHEM J, V246, P337, DOI 10.1042/bj2460337; HAMASAKI T, 1991, P NATL ACAD SCI USA, V88, P7918, DOI 10.1073/pnas.88.18.7918; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HASEGAWA E, 1987, CELL MOTIL CYTOSKEL, V8, P302, DOI 10.1002/cm.970080403; HINTERMANN R, 1979, PLANTA, V146, P459, DOI 10.1007/BF00380860; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; HUNNICUTT GR, 1991, DEV BIOL, V147, P216, DOI 10.1016/S0012-1606(05)80019-3; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; KOOIJMAN R, 1990, PLANTA, V181, P529, DOI 10.1007/BF00193006; KRUPINSKI J, 1991, MOL CELL BIOCHEM, V104, P73; LINDEMANN CB, 1991, CELL MOTIL CYTOSKEL, V20, P316, DOI 10.1002/cm.970200407; MATSUDA Y, 1985, J BIOL CHEM, V260, P6303; MINOCHERHOMJEE AM, 1988, CALMODULIN, P249; NARAYANAN N, 1989, ENDOCRINOLOGY, V124, P484, DOI 10.1210/endo-124-1-484; NEER EJ, 1979, J BIOL CHEM, V254, P2089; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PASQUALE SM, 1988, BOT ACTA, V101, P118, DOI 10.1111/j.1438-8677.1988.tb00021.x; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; PIJST HLA, 1984, FEBS LETT, V174, P132, DOI 10.1016/0014-5793(84)81091-1; ROLIN S, 1990, EXP PARASITOL, V71, P350, DOI 10.1016/0014-4894(90)90041-A; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SAGER R, 1954, J GEN PHYSIOL, V37, P729, DOI 10.1085/jgp.37.6.729; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; SNELL WJ, 1989, J CELL BIOL, V109, P1689, DOI 10.1083/jcb.109.4.1689; SNELL WJ, 1976, J CELL BIOL, V68, P48, DOI 10.1083/jcb.68.1.48; SNELL WJ, 1993, IN PRESS MOL MECHANI; TAMAOKI J, 1989, J APPL PHYSIOL, V66, P1035, DOI 10.1152/jappl.1989.66.3.1035; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TASH JS, 1989, CELL MOTIL CYTOSKEL, V14, P332, DOI 10.1002/cm.970140303; TOMSON AM, 1990, PROTOPLASMA, V155, P200, DOI 10.1007/BF01322629; TOOWICHARANONT P, 1988, J BIOL CHEM, V263, P6877; WADMAN IA, 1991, BIOCHEM J, V276, P621, DOI 10.1042/bj2760621; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; ZHANG YH, 1991, J BIOL CHEM, V266, P22954	53	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1786	1791						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420954				2022-12-27	WOS:A1993KH62000045
J	CHANG, ZF; HUANG, DY				CHANG, ZF; HUANG, DY			THE REGULATION OF THYMIDINE KINASE IN HL-60 HUMAN PROMYELOLEUKEMIA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CYCLE REGULATION; GENE; PURIFICATION; PROTEINS; ENZYME; DNA; ACID; NITROCELLULOSE; FRAGMENTS	It has been well established that the regulation of thymidine kinase (TK) expression is highly growth-dependent. In this report, we present evidence that TK expression in undifferentiated HL-60 cells is not stringently controlled in a growth-dependent manner, except for a very moderate activation of TK in response to growth stimulation. Moreover, we have demonstrated for the first time that TK becomes phosphorylated, and the fluctuation of TK activity in these cells is related to the extent of phosphorylation of seryl residues of the TK polypeptide. This is further reinforced by the observation that the presence of Ser/Thr phosphatases inhibitor in the crude extract increases TK activity. Our data suggest that post-translational modification by phosphorylation is implicated in TK regulation in HL-60 cells.			CHANG, ZF (corresponding author), CHANG GUNG MED COLL,DEPT BIOCHEM,TAOYUAN,TAIWAN.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRADSHAW HD, 1984, MOL CELL BIOL, V4, P2316, DOI 10.1128/MCB.4.11.2316; CHANG ZF, 1990, BIOCHEM BIOPH RES CO, V169, P780, DOI 10.1016/0006-291X(90)90399-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; CYERT MS, 1989, CELL, V57, P891, DOI 10.1016/0092-8674(89)90325-5; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GROSS MK, 1989, P NATL ACAD SCI USA, V86, P4987, DOI 10.1073/pnas.86.13.4987; GROUDINE M, 1984, NUCLEIC ACIDS RES, V12, P1427, DOI 10.1093/nar/12.3.1427; GUDAS JM, 1988, P NATL ACAD SCI USA, V85, P4705, DOI 10.1073/pnas.85.13.4705; ITO M, 1990, J BIOL CHEM, V265, P6954; JOHNSON LF, 1982, EXP CELL RES, V138, P79, DOI 10.1016/0014-4827(82)90093-3; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE LS, 1976, J BIOL CHEM, V251, P2600; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P6848, DOI 10.1073/pnas.86.18.6848; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; ROEHL HH, 1990, MOL CELL BIOL, V10, P3834, DOI 10.1128/MCB.10.7.3834; SCHLOSSER CA, 1981, P NATL ACAD SCI-BIOL, V78, P1119, DOI 10.1073/pnas.78.2.1119; SHERLEY JL, 1988, J BIOL CHEM, V263, P375; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; SHIOTANI T, 1989, CANCER RES, V49, P1090; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUART P, 1985, MOL CELL BIOL, V5, P1490, DOI 10.1128/MCB.5.6.1490; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	33	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1266	1271						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419329				2022-12-27	WOS:A1993KG07700075
J	HO, MN; HILL, KJ; LINDORFER, MA; STEVENS, TH				HO, MN; HILL, KJ; LINDORFER, MA; STEVENS, TH			ISOLATION OF VACUOLAR MEMBRANE H+-ATPASE-DEFICIENT YEAST MUTANTS - THE VMA5 AND VMA4 GENES ARE ESSENTIAL FOR ASSEMBLY AND ACTIVITY OF THE VACUOLAR H+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRIFLUOPERAZINE RESISTANCE; ADENOSINE-TRIPHOSPHATASE; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; CELL-CYCLE; SUBUNIT; DNA; ACIDIFICATION; IDENTIFICATION	The vacuolar membrane H+-ATPase of the yeast Saccharomyces cerevisiae is a multisubunit enzyme complex composed of an integral membrane V0 sector, and a peripherally associated V1 sector. Deletion of one of several structural genes for vacuolar H+-ATPase subunits was previously demonstrated to prevent proper assembly of the remaining V1 subunits onto the vacuolar membrane (Kane, P. M., Kuehn, M. C., Howald-Stevenson, I., and Stevens, T. H. (1992) J. Biol. Chem. 267, 447-454). A genetic screen was designed to identify new genes whose products were essential for the synthesis, assembly, and/or function of the yeast vacuolar H+-ATPase. Mutants were identified based on phenotypes associated with vacuolar membrane H+-ATPase loss of function (vma), including an inability to grow on media buffered at neutral pH. Representatives in five complementation groups were identified, including four novel mutants vma5, vma21, vma22, and vma23, all of which were defective in vacuolar ATPase enzyme activity. We report here the characterization of two genes, VMA4 and VMA5, that encode peripheral subunits of the vacuolar H+-ATPase. We determined that VMA5 encodes the 42-kDa subunit of the vacuolar H+-ATPase. The VMA4 gene, originally described by Foury (Foury, F. (1990) J. Biol. Chem. 265, 18554-18560), was determined to encode the 27-kDa subunit of the purified yeast vacuolar H+-ATPase. Characterization of the vma5 and vma4 mutants revealed that the 42- and 27-kDa subunits are essential for the assembly of the peripheral membrane portion of the H+-ATPase onto the vacuolar membrane.	UNIV OREGON, INST MOLEC BIOL, EUGENE, OR 97403 USA	University of Oregon				Stevens, Tom/0000-0001-6427-6848	NIGMS NIH HHS [GM38006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BELTRAN C, 1992, J BIOL CHEM, V267, P774; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; FOURY F, 1990, J BIOL CHEM, V265, P18554; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HIRATA R, 1990, J BIOL CHEM, V265, P6726; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1992, J BIOL CHEM, V267, P447; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119; NELSON H, 1989, J BIOL CHEM, V264, P1775; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; NELSON H, 1990, J BIOL CHEM, V265, P20390; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; RINE J, 1979, GENETICS, V93, P877; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherman F., 1982, METHODS YEAST GENETI; SHIH CK, 1990, MOL CELL BIOL, V10, P3397, DOI 10.1128/MCB.10.7.3397; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737	42	115	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					221	227						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416931				2022-12-27	WOS:A1993KE60300035
J	KHANANSHVILI, D; PRICE, DC; GREENBERG, MJ; SARNE, Y				KHANANSHVILI, D; PRICE, DC; GREENBERG, MJ; SARNE, Y			PHE-MET-ARG-PHE-NH2 (FMRFA)-RELATED PEPTIDES INHIBIT NA+-CA2+ EXCHANGE IN CARDIAC SARCOLEMMA VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; MEMBRANE-VESICLES; ENDOGENOUS NEUROPEPTIDE; FMRFAMIDE; MUSCLE; TRANSLOCATION; MODULATION; TRANSPORT; MECHANISM; CURRENTS	The molluscan cardioexcitatory tetrapeptide FMRF-amide (Phe-Met-Arg-Phe-NH2) and related peptides inhibit Na+-Ca2+ exchange in calf cardiac sarcolemma vesicles. FMRFa itself has a low inhibitory potency (IC50 = 750 muM) which completely resides in its COOH-terminal RFa portion. The physiologically active analog FLRFa is 10-fold more potent (IC50 = 60 muM). Two other substitutions of the Met2 in FMRFa, by either Ile or Lys increase inhibitory potency 7- and 50-fold, respectively. The inhibitory potency increases 300-500-fold if the NH2-terminal Phe1 in FMRFa is substituted by either Val or His (IC50 = 1-2 muM). The inhibitory activity of W(n)LRFa (IC50 = 40 muM) is lost when either the NH2-terminal amino group is acylated or the NH2-terminal Trp1 is deleted. These data suggest that the COOH-terminal portion is essential for the basic low potency inhibition of Na+-Ca2+ exchange, whereas the NH2-terminal portion is important for the potentiation of the inhibitory activity. Although the IC50 values of various peptides range widely (10(-6)-10(-3) M), all of them induce a complete inhibition. The dose-response pattern of the peptide-induced inhibition is identical for the Na+-Ca2+ exchange and its partial reaction, the Ca2+-Ca2+ exchange. The inhibitory effect is reversible and affects both Na(i)(or Ca(i))-dependent Ca-45 uptake and Na(o)-dependent Ca-45 efflux, suggesting that the bidirectional movements of ions are altered. A mild pretreatment of vesicles with trypsin augments the Na+-Ca2+ exchange 1.5-fold but diminishes the inhibitory potency 3-4-fold, suggesting that the inhibition is mediated by an extravesicular membrane protein. The characteristics of the peptide-induced inhibition resemble the effect of opiates on Na+-Ca2+ exchange. FLRFa and dextrorphan (a non-opioid stereoisomer of an opiate agonist) are mutually exclusive inhibitors, suggesting that they may bind to the same site. This putative site lacks the pharmacological properties of opiate receptors and may be located either on the Na+-Ca2+ exchanger or at its vicinity. Endogenous analogs of FMRFa may regulate intracellular calcium via Na+-Ca2+ exchange.	UNIV FLORIDA, WHITNEY LAB, ST AUGUSTINE, FL 32086 USA	State University System of Florida; University of Florida	KHANANSHVILI, D (corresponding author), TEL AVIV UNIV, SACKLER SCH MED, DEPT PHYSIOL & PHARMACOL, IL-69978 TEL AVIV, ISRAEL.			Khananshvili, Daniel/0000-0002-4202-9966				BAUER PJ, 1981, ANAL BIOCHEM, V110, P61, DOI 10.1016/0003-2697(81)90112-3; BLAUSTEIN MP, 1991, ANN NY ACAD SCI, V639, P254, DOI 10.1111/j.1749-6632.1991.tb17315.x; BREZDEN BL, 1991, J PHYSIOL-LONDON, V443, P727, DOI 10.1113/jphysiol.1991.sp018860; BREZINA V, 1987, J PHYSIOL-LONDON, V382, P267, DOI 10.1113/jphysiol.1987.sp016367; BRIDGE JHB, 1990, SCIENCE, V248, P376, DOI 10.1126/science.2158147; CARVALHO AP, 1991, ANN NY ACAD SCI, V639, P300, DOI 10.1111/j.1749-6632.1991.tb17318.x; COTTRELL GA, 1982, NATURE, V296, P87, DOI 10.1038/296087a0; DORKEY GJ, 1981, NATURE, V293, P656; EGAN TM, 1989, J PHYSIOL-LONDON, V411, P639, DOI 10.1113/jphysiol.1989.sp017596; GARCIA ML, 1988, BIOCHEMISTRY-US, V27, P2410, DOI 10.1021/bi00407a024; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; JACOBY MB, 1987, NEUROSCI LETT, V83, P128, DOI 10.1016/0304-3940(87)90228-X; KACZOROWSKI GJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P287, DOI 10.1016/0304-4157(89)90022-1; KAVALIERS M, 1985, NEUROPEPTIDES, V6, P485, DOI 10.1016/0143-4179(85)90110-6; KAVALIERS M, 1985, PEPTIDES, V6, P847, DOI 10.1016/0196-9781(85)90312-2; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; KHANANSHVILI D, 1991, J BIOL CHEM, V266, P13764; KHANANSHVILI D, 1991, ANN NY ACAD SCI, V639, P85, DOI 10.1111/j.1749-6632.1991.tb17291.x; Khananshvili D, 1990, CURR OPIN CELL BIOL, V2, P731, DOI 10.1016/0955-0674(90)90117-W; KHANANSHVILI D, 1992, LIFE SCI, V52, P275; LI Z, 1990, J BIOL CHEM, V266, P1014; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; NOBLE D, 1991, ANN NY ACAD SCI, V639, P334, DOI 10.1111/j.1749-6632.1991.tb17323.x; PAINTER SD, 1982, J COMP PHYSIOL, V148, P491, DOI 10.1007/BF00619787; PHILIPSON KD, 1990, CALCIUM HEART, P85; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; PRICE DA, 1989, BIOL BULL, V177, P198, DOI 10.2307/1541933; RAFFA RB, 1988, PEPTIDES, V9, P915, DOI 10.1016/0196-9781(88)90141-6; REEVES JP, 1988, METHOD ENZYMOL, V157, P505; REEVES JP, 1989, SODIUM CALCIUM EXCHA, P27; SAGY M, 1987, J CARDIOVASC PHARM, V9, P682, DOI 10.1097/00005344-198706000-00007; SEGEL IH, 1975, ENZYME KINETICS, P479; SLAUGHTER RS, 1988, BIOCHEMISTRY-US, V27, P2403, DOI 10.1021/bi00407a023; Stein W., 2012, TRANSPORT DIFFUSION; TANG J, 1984, P NATL ACAD SCI-BIOL, V81, P5002, DOI 10.1073/pnas.81.15.5002; THOMPSON KJ, 1992, J NEUROPHYSIOL, V67, P280, DOI 10.1152/jn.1992.67.2.280	38	34	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					200	205						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416928				2022-12-27	WOS:A1993KE60300031
J	LEE, HC				LEE, HC			POTENTIATION OF CALCIUM-INDUCED AND CAFFEINE-INDUCED CALCIUM RELEASE BY CYCLIC ADP-RIBOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; TUMOR PROMOTER; METABOLITE; NAD+; THAPSIGARGIN; MICROSOMES; TISSUES; ENZYME; CELLS	Cyclic ADP-ribose (cADPR) is a naturally occurring metabolite of NAD+ that is as potent as inositol 1,4,5-trisphosphate (IP3) in mobilizing Ca2+ in sea urchin eggs. Previous pharmacological evidence suggests that cADPR acts through a system similar to the Ca2+-induced Ca2+ release (CICR). Here I showed that in the presence of low concentrations of cADPR addition of Ca2+ to egg homogenates stimulated further release of Ca2+ in a concentration-dependent manner. In the absence of cADPR, no induced release was seen, and the added Ca2+ was, instead, sequestered by a thapsigargin-sensitive transport system. High concentrations of strontium (>50 muM) could also induce Ca2+ release. The effective concentrations of Sr2+, however, were reduced 10-20-fold in the presence of low concentrations of cADPR. Barium, at up to 0.4 mM, did not stimulate Ca2+ release with or without cADPR. The potentiation between divalent cations and cADPR was mutual since the Ca2+ releasing activity of cADPR was also increased in the presence of strontium. Ionomycin and thapsigargin both released Ca2+ but neither potentiated Ca2+ release induced by divalent cations. Caffeine also released Ca2+ in a concentration-dependent manner, and its potency was greatly increased by low concentrations of cADPR, while no such simulation was seen with IP3. Conversely, low concentrations of caffeine that were not sufficient to release Ca2+ increased the effectiveness of cADPR 10-fold. Isocaffeine, an isomer of caffeine, was four to five times less effective, demonstrating the specificity of the caffeine effect. These results suggest that cADPR can function as an endogenous regulator of CICR in eggs.			LEE, HC (corresponding author), UNIV MINNESOTA,DEPT PHYSIOL,MINNEAPOLIS,MN 55455, USA.		Lee, Hon Cheung/C-4329-2009		NICHD NIH HHS [HD17484] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017484] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; DELISLE S, 1992, J BIOL CHEM, V267, P7963; DUPONT G, 1990, CELL REGUL, V1, P853, DOI 10.1091/mbc.1.11.853; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1991, J BIOL CHEM, V266, P2276; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; RUSINKO N, 1989, J BIOL CHEM, V264, P11725; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WALSETH TF, 1991, BIOCHIM BIOPHYS ACTA, V1094, P113, DOI 10.1016/0167-4889(91)90032-S	20	233	237	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					293	299						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416936				2022-12-27	WOS:A1993KE60300045
J	LYONS, CE; PAYETTE, KL; PRICE, JL; HUANG, RCC				LYONS, CE; PAYETTE, KL; PRICE, JL; HUANG, RCC			EXPRESSION AND STRUCTURAL-ANALYSIS OF A TELEOST HOMOLOG OF A MAMMALIAN ZONA-PELLUCIDA GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITELLINE ENVELOPE PROTEINS; ESTROGEN-RESPONSIVE ELEMENT; TROUT SALMO-GAIRDNERI; WINTER FLOUNDER; RAINBOW-TROUT; MESSENGER-RNA; ONCORHYNCHUS-MYKISS; SPLICE JUNCTIONS; SPERM RECEPTOR; EGG MEMBRANE	Gene expression in oviparous vertebrates during vitellogenesis is hormonally regulated. Our laboratory has characterized a unique gene (wf female), which is seasonally expressed in the liver of the female winter flounder Pseudopleuronectes americanus. The wf female mRNA is coexpressed with vitellogenin mRNA and reaches a high level during vitellogenesis. The wf female gene is 2554 base pairs in length and encodes a putative protein of 509 amino acids. The gene consists of eight exons separated by seven introns of different sizes. Within exon 1, there are six PQQ-rich repeats. Four of them encode a putative (PQQ)4PKY polypeptide, similar to the repeats found in the extracellular domains of other proteins. Exons 2-7 share homology with the zona pellucida protein genes rc55 of rabbit and zp-2 of mouse, and the positions of intron boundaries are conserved in the wf female and mouse zp-2 genes. In addition, the transcriptional regulatory cis elements (estrogen response element, CCAAT and TATAAA boxes), as found in vertebrate genes, are also conserved for the wf female promoter and mapped upstream from the initiation site of the wf female primary transcript.	JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA	Johns Hopkins University					NIGMS NIH HHS [5T 33 GM07231] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGLER JJ, 1987, 3RD P INT S REPR PHY, P209; AMANZE D, 1990, DEVELOPMENT, V109, P495; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BEGOVAC PC, 1989, J EXP ZOOL, V251, P56, DOI 10.1002/jez.1402510108; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BRIVIO MF, 1991, MOL REPROD DEV, V28, P85, DOI 10.1002/mrd.1080280114; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; BURTON MP, 1984, CAN J ZOOL, V62, P2563, DOI 10.1139/z84-374; CALLARD IP, 1990, PROG CLIN BIOL RES, V342, P343; CALLARD IP, 1987, FUNDAMENTALS COMP VE, V1, P257; CHEN TT, 1983, CAN J BIOCHEM CELL B, V61, P802, DOI 10.1139/o83-102; CHEN TT, 1989, PHYSIOL ZOOL, V62, P25, DOI 10.1086/physzool.62.1.30159996; COTELLI F, 1988, J ULTRA MOL STRUCT R, V99, P70, DOI 10.1016/0889-1605(88)90034-1; CRAIK CS, 1983, SCIENCE, V220, P1125, DOI 10.1126/science.6344214; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOURLIE B, 1984, J BIOL CHEM, V259, P4960; GROOT EP, 1985, CAN J ZOOL, V63, P552, DOI 10.1139/z85-082; HAGENMAIER HE, 1976, H-S Z PHYSIOL CHEM, V357, P1435, DOI 10.1515/bchm2.1976.357.2.1435; HAMAZAKI TS, 1989, DEV BIOL, V133, P101, DOI 10.1016/0012-1606(89)90301-1; HAMODRAKAS SJ, 1992, STRUCTURE CELLULAR S, P115; HOLLAND LJ, 1992, J BIOL CHEM, V267, P7053; HUANG RCC, 1990, UCLA SYM BI, V116, P109; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; HYLLNER SJ, 1991, J ENDOCRINOL, V131, P229, DOI 10.1677/joe.0.1310229; HYLLNER SJ, 1992, J ENDOCRINOL, V135, P303, DOI 10.1677/joe.0.1350303; IUCHI I, 1976, BIOCHIM BIOPHYS ACTA, V453, P240, DOI 10.1016/0005-2795(76)90269-5; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; KAIGHN ME, 1964, DEV BIOL, V9, P56, DOI 10.1016/0012-1606(64)90014-4; KAO SM, 1991, J BACTERIOL, V173, P7650, DOI 10.1128/jb.173.23.7650-7664.1991; KINLOCH RA, 1990, DEV BIOL, V142, P414, DOI 10.1016/0012-1606(90)90363-N; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAL AA, 1987, J BIOL CHEM, V262, P2937; LAURSEN RA, 1992, STRUCTURE CELLULAR S, P55; LIANG LF, 1990, MOL CELL BIOL, V10, P1507, DOI 10.1128/MCB.10.4.1507; LIN Y, 1981, P NATL ACAD SCI-BIOL, V78, P2825, DOI 10.1073/pnas.78.5.2825; LYONS CE, 1993, THESIS J HOPKINS U; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MILLAR SE, 1991, MOL CELL BIOL, V11, P6197, DOI 10.1128/MCB.11.12.6197; MOLLER CC, 1989, DEV BIOL, V132, P103, DOI 10.1016/0012-1606(89)90209-1; Mommsen T.P., 1988, P347; OHZU E, 1981, ANNOT ZOOL JAPON, V54, P241; OPPENBERNTSEN DO, 1990, DEV BIOL, V137, P258, DOI 10.1016/0012-1606(90)90252-E; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEREZ LE, 1991, COMP BIOCHEM PHYS B, V100, P821, DOI 10.1016/0305-0491(91)90297-Q; PRICE JL, 1990, FISH PHYSIOL BIOCHEM, V8, P187, DOI 10.1007/BF00004457; PRICE JL, 1986, PHYSIOL ZOOL, V59, P679, DOI 10.1086/physzool.59.6.30158614; Sambrook J, 1989, MOL CLONING LABORATO; SCHWOEBEL E, 1991, J BIOL CHEM, V266, P7214; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; WISKOCIL R, 1980, P NATL ACAD SCI-BIOL, V77, P4474, DOI 10.1073/pnas.77.8.4474; YOUNG EG, 1956, J BIOL CHEM, V219, P161; YUREWICZ EC, 1987, J BIOL CHEM, V262, P564	61	98	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21351	21358						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407974				2022-12-27	WOS:A1993MA28800102
J	PONSIN, G; PULCINI, T; SPARROW, JT; GOTTO, AM; POWNALL, HJ				PONSIN, G; PULCINI, T; SPARROW, JT; GOTTO, AM; POWNALL, HJ			HIGH-DENSITY-LIPOPROTEIN INTERCONVERSIONS IN RAT AND MAN AS ASSESSED WITH A NOVEL NONTRANSFERABLE APOLIPOPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; LIPID TRANSFER PROTEINS; ESTER TRANSFER PROTEIN; PLASMA-LIPOPROTEINS; CHOLESTEROL ACYLTRANSFERASE; POSTPRANDIAL LIPEMIA; HEPATIC LIPASE; METABOLISM; KINETICS; PHOSPHATIDYLCHOLINES	A nontransferable peptide analog of a plasma apolipoprotein diacyl lipid-associating peptide (diLAP) incorporates into model reassembled high density lipoproteins (R-HDL). In whole plasma in vitro, diLAP irreversibly transfers to native rat HDL2 and human HDL3, but not to rat HDL1 or human HDL2. The rate of transfer is dependent on the physical state of the lipid in the R-HDL. Exogenous cholesterol promotes the formation of larger HDL. When diLAP-labeled R-HDL were injected into rats, the diLAP that initially associated with HDL2 transferred to HDL1 over a period of 48 h. The rate of clearance of diLAP-labeled HDL was slower than that of apoA-I. The liver was the preferred site for diLAP-labeled HDL1 uptake. In contrast, diLAP-labeled HDL2 were associated with liver, ovaries, and adrenal glands, with the adrenal grands exhibiting the highest specific association. DiLAP was not found in the kidneys. These data show that 1) rat HDL is cleared more slowly than rat apoA-I; 2) HDL is removed from the plasma compartment as a particle; 3) there are tissue-specific differences in the removal of rat HDL1 and HDL2; 4) HDL2 is a precursor to HDL1; and 5) cholesterol and the activity of lecithin:cholesterol acyltransferase are essential to HDL remodeling.	METHODIST HOSP,MAIL STN A601,6565 FANNIN ST,HOUSTON,TX 77030; HOP ANTIQUAILLE,METAB LIPIDES LAB,F-69321 LYON 5,FRANCE; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	The Methodist Hospital System; The Methodist Hospital - Houston; CHU Lyon; Baylor College of Medicine				Pownall, Henry/0000-0001-8412-506X				BARTER PJ, 1987, AM HEART J, V113, P538, DOI 10.1016/0002-8703(87)90628-4; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; EDELSTEIN C, 1979, J LIPID RES, V20, P143; EISENBERG S, 1984, J LIPID RES, V25, P121; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GAVISH D, 1987, J LIPID RES, V28, P257; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GORDON V, 1983, J BIOL CHEM, V258, P6202; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HAMILTON RL, 1976, J CLIN INVEST, V58, P667, DOI 10.1172/JCI108513; HICKSONBICK D, 1988, BIOCHEMISTRY-US, V27, P7881, DOI 10.1021/bi00420a045; HINZ H, 1972, J BIOL CHEM, V247, P6071; JARNAGIN AS, 1987, P NATL ACAD SCI USA, V84, P1854, DOI 10.1073/pnas.84.7.1854; KOO C, 1985, J BIOL CHEM, V260, P1934; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MCKEONE BJ, 1988, BIOCHEMISTRY-US, V27, P4500, DOI 10.1021/bi00412a042; ORAM JF, 1983, J CLIN INVEST, V72, P1611, DOI 10.1172/JCI111120; OSCHRY Y, 1982, J LIPID RES, V23, P1099; Patsch J R, 1986, Methods Enzymol, V129, P3; PATSCH JR, 1987, J CLIN INVEST, V80, P341, DOI 10.1172/JCI113078; PATSCH JR, 1984, J CLIN INVEST, V74, P2017, DOI 10.1172/JCI111624; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; PONSIN G, 1986, J CLIN INVEST, V77, P559, DOI 10.1172/JCI112337; PONSIN G, 1985, J THEOR BIOL, V112, P183, DOI 10.1016/S0022-5193(85)80123-5; PONSIN G, 1984, BIOCHEMISTRY-US, V23, P5337, DOI 10.1021/bi00317a036; PONSIN G, 1985, BIOCHEM BIOPH RES CO, V133, P856, DOI 10.1016/0006-291X(85)91213-6; POWNALL HJ, 1980, P NATL ACAD SCI-BIOL, V77, P3154, DOI 10.1073/pnas.77.6.3154; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; RALL SC, 1986, METHOD ENZYMOL, V128, P273; RETZINGER GS, 1985, ANAL BIOCHEM, V150, P131, DOI 10.1016/0003-2697(85)90451-8; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SCHWARTZ CC, 1982, J CLIN INVEST, V70, P105, DOI 10.1172/JCI110582; SHEN BW, 1977, P NATL ACAD SCI USA, V74, P837, DOI 10.1073/pnas.74.3.837; SHEPHERD J, 1978, EUR J CLIN INVEST, V8, P115, DOI 10.1111/j.1365-2362.1978.tb00823.x; STEIN Y, 1966, BIOCHIM BIOPHYS ACTA, V116, P95, DOI 10.1016/0005-2760(66)90095-6; TALL AR, 1986, J LIPID RES, V27, P361	39	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3114	3119						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428990				2022-12-27	WOS:A1993KM16100018
J	EICHHOLTZ, T; DEBONT, DBA; DEWIDT, J; LISKAMP, RMJ; PLOEGH, HL				EICHHOLTZ, T; DEBONT, DBA; DEWIDT, J; LISKAMP, RMJ; PLOEGH, HL			A MYRISTOYLATED PSEUDOSUBSTRATE PEPTIDE, A NOVEL PROTEIN-KINASE-C INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-PHASE; POTENT INHIBITORS; PHOSPHOLIPASE-C; PHORBOL ESTERS; PHOSPHORYLATION; ACTIVATION; EXPRESSION; CELLS; INDUCTION; SUBSTRATE	Synthetic peptides corresponding to the pseudosubstrate domains of protein kinase C (PKC) have been used as specific inhibitors of PKC in in vitro assays and permeabilized cell systems. However, their use in vivo was hampered by the impermeability of the plasma membrane for such peptides. Here, we show that N-myristoylation of the PKC pseudosubstrate nonapeptide Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln permits its use as an inhibitor of PKC in intact cells. The myristoylated peptide, myr-psiPKC, inhibits phosphorylation of the myristoylated alanine-rich C kinase substrate protein, as induced by 12-O-tetradecanoylphorbol-13-acetate, and the activation of phospholipase D by bradykinin, which strictly depends on PKC. Half-maximal inhibition is obtained at concentrations of 8 and 20 muM, respectively. An N-myristoylated peptide derived from an inhibitor protein of the cAMP-dependent protein kinases, Myr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-Ile, was ineffective. These results show that myr-psiPKC is a selective and cell-permeable inhibitor of PKC.	NETHERLANDS CANC INST, DEPT CELLULAR BIOCHEM, PLESMANLAAN 121, 1066 CX AMSTERDAM, NETHERLANDS; LEIDEN UNIV, GORLAEUS LABS, DEPT ORGAN CHEM, 2300 RA LEIDEN, NETHERLANDS	Netherlands Cancer Institute; Leiden University; Leiden University - Excl LUMC			Liskamp, Rob M/I-5889-2012	Liskamp, Rob M/0000-0001-8897-8975				ALEXANDER DR, 1989, BIOCHEM J, V260, P893, DOI 10.1042/bj2600893; ALEXANDER DR, 1990, BIOCHEM J, V268, P303, DOI 10.1042/bj2680303; ATHERTON E, 1983, J CHEM SOC CHEM COMM, P1060, DOI 10.1039/c39830001060; Atherton E., 1990, SOLID PHASE PEPTIDE; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BUCHLER W, 1988, FEBS LETT, V228, P27, DOI 10.1016/0014-5793(88)80577-5; CASTRO B, 1975, TETRAHEDRON LETT, P1219; COSTE J, 1990, PEPTIDES CHEM STRUCT, P885; DEBONT HBA, 1989, INT J PEPT PROT RES, V33, P115; DEBONT HBA, 1990, TETRAHEDRON LETT, V31, P2497, DOI 10.1016/S0040-4039(00)97399-4; EICHHOLTZ T, 1990, FEBS LETT, V261, P147, DOI 10.1016/0014-5793(90)80657-5; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOUSE C, 1990, CELL SIGNAL, V2, P187, DOI 10.1016/0898-6568(90)90022-3; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; IOANNIDES CG, 1990, CELL IMMUNOL, V131, P242, DOI 10.1016/0008-8749(90)90250-U; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1991, METHOD ENZYMOL, V201, P287; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBRIAN CA, 1990, BIOCHEM PHARMACOL, V39, P49, DOI 10.1016/0006-2952(90)90647-4; OBRIAN CA, 1991, INVEST NEW DRUG, V9, P169, DOI 10.1007/BF00175084; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; RAMAGE R, 1987, TETRAHEDRON LETT, V28, P2287, DOI 10.1016/S0040-4039(00)96103-3; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P5732, DOI 10.1073/pnas.82.17.5732; SMITH MK, 1990, J BIOL CHEM, V265, P1837; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; VANBLITTERSWIJK WJ, 1991, J BIOL CHEM, V266, P10344; VANNISPEN JW, 1985, RECL TRAV CHIM PAY B, V104, P99; WANG SS, 1973, J AM CHEM SOC, V95, P1328, DOI 10.1021/ja00785a602	41	262	298	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1982	1986						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420972				2022-12-27	WOS:A1993KH62000074
J	ZHOU, JM; BOYER, PD				ZHOU, JM; BOYER, PD			EVIDENCE THAT ENERGIZATION OF THE CHLOROPLAST ATP SYNTHASE FAVORS ATP FORMATION AT THE TIGHT-BINDING CATALYTIC SITE AND INCREASES THE AFFINITY FOR ADP AT ANOTHER CATALYTIC SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; CHANGE MECHANISM; COUPLING FACTOR; PHOTOPHOSPHORYLATION; COOPERATIVITY; ACTIVATION; HYDROLYSIS; KINETICS	Previous results have not established whether the attainment of a rapid photophosphorylation rate as ADP concentration is increased in the micromolar range (apparent K(m) = approximately 30 muM) results from the filling of a second or a third catalytic site. Measurements reported here show that the ATP synthase of chloroplast thylakoids, with 2-4 muM medium ADP present during steady-state photophosphorylation, has one catalytic site filled with tightly bound nucleotides, but other catalytic sites are largely empty. Thus, the rapid increase in the photophosphorylation rate with higher ADP concentrations results from the filling of a second catalytic site. Even with 30 muM added ADP in the dark, the binding of more than one ADP per synthase was not detectable. The sensitivity of the assay was such that the K(d) for binding of ADP at a second catalytic site of the de-energized synthase is >150 muM, considerably above the apparent K(m) for rapid photophosphorylation. This result can be explained by an increase in the affinity of a second catalytic site for ADP upon energization. Other experiments assessed the effect of ADP binding at a second catalytic site on the equilibrium between bound ATP and ADP and P(i) at the tight catalytic site. When the rate of photophosphorylation is limited by a low ADP concentration, about equal amounts of ATP and ADP are bound at one catalytic site on the synthase. In contrast, when the rate is limited by a low P(i) concentration with 100 muM ADP present, the equilibrium of bound reactants is shifted so that close to one ATP per synthase is present. This is as expected if the binding of ADP at a second catalytic site allows the protonmotive force to promote ATP formation from ADP and P(i) at a tight binding catalytic site. A scheme for the binding change mechanism incorporating these results is presented.	UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NIGMS NIH HHS [GM-11094] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM011094] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFLALO C, 1982, EUR J BIOCHEM, V126, P61, DOI 10.1111/j.1432-1033.1982.tb06746.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BOYER PD, 1977, ANN REV BIOCH, V46, P97; CROSS RL, 1981, ANNU REV BIOCHEM, V50, P681, DOI 10.1146/annurev.bi.50.070181.003341; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; CZARNECKI JJ, 1985, BIOCHIM BIOPHYS ACTA, V809, P51, DOI 10.1016/0005-2728(85)90166-5; DU ZY, 1990, BIOCHEMISTRY-US, V29, P402, DOI 10.1021/bi00454a014; DU ZY, 1989, BIOCHEMISTRY-US, V28, P873, DOI 10.1021/bi00428a070; FELDMAN RI, 1983, J BIOL CHEM, V258, P2178; FROMME P, 1990, BIOCHIM BIOPHYS ACTA, V1016, P29, DOI 10.1016/0005-2728(90)90003-M; GRABER P, 1990, BIOELECTROCHEMISTRY, V3, P277; KOHLBRENNER WE, 1982, J BIOL CHEM, V257, P3441; KOMATSUTAKAKI M, 1992, J BIOL CHEM, V267, P2360; LECKBAND D, 1988, BIOCHEMISTRY-US, V27, P3629, DOI 10.1021/bi00410a016; MAGNUSSON RP, 1976, BIOCHEM BIOPH RES CO, V70, P1283, DOI 10.1016/0006-291X(76)91041-X; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; PEREZ JA, 1990, BIOCHEMISTRY-US, V29, P10503, DOI 10.1021/bi00498a013; ROSEN G, 1979, J BIOL CHEM, V254, P654; SELMAN BR, 1981, J BIOL CHEM, V256, P1722; SHAVIT N, 1980, METHOD ENZYMOL, V69, P323; SMITH DJ, 1976, P NATL ACAD SCI USA, V73, P4314, DOI 10.1073/pnas.73.12.4314; SMITH LT, 1983, J BIOL CHEM, V258, P887; STROOP SD, 1985, BIOCHEMISTRY-US, V24, P2304, DOI 10.1021/bi00330a027; SUGINO Y, 1964, J BIOL CHEM, V239, P2360; ZHOU JM, 1992, BIOCHEMISTRY-US, V31, P3166, DOI 10.1021/bi00127a017	26	29	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1531	1538						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420929				2022-12-27	WOS:A1993KH62000008
J	HEFFERNAN, M; LOTAN, R; AMOS, B; PALCIC, M; TAKANO, R; DENNIS, JW				HEFFERNAN, M; LOTAN, R; AMOS, B; PALCIC, M; TAKANO, R; DENNIS, JW			BRANCHING BETA-1-6N-ACETYLGLUCOSAMINETRANSFERASES AND POLYLACTOSAMINE EXPRESSION IN MOUSE F9 TERATOCARCINOMA CELLS AND DIFFERENTIATED COUNTERPARTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; ACID-INDUCED DIFFERENTIATION; ASN-LINKED OLIGOSACCHARIDES; MOLECULAR-WEIGHT GLYCOPROTEINS; BLOOD-GROUP-I; RETINOIC-ACID; MEMBRANE-GLYCOPROTEINS; GENE-EXPRESSION; HUMAN-BREAST; TUMOR	Beta-all-trans-retinoic acid (RA)-induced endodermal differentiation of mouse F9 teratocarcinoma cells is accompanied by changes in glycoprotein glycosylation, including expression of i antigen (i.e. polylactosamine) and leukophytohemagglutinin-reactive oligosaccharides (i.e.-GlcNAcbeta1-6Manalpha1-6-branched N-linked). We have used the F9 teratocarcinoma cells as a model to study developmental regulation of glycosyltransferase activities which are responsible for the biosynthesis of beta1-6GlcNAc-branched N- and O-linked oligosaccharides and polylactosamine. Growth of F9 cells in the presence of 10(-6) M RA for 4 days increased core 2 GlcNAc transferase and GlcNAc transferase V activities by 13- and 6-fold, respectively, whereas the activities of GlcNAc transferase I, beta1-3GlcNAc transferase (i), beta1-4Gal transferase, and beta1-3Gal transferase increased 2-4-fold. Induction of glycosyltransferase activities by RA was dose-dependent and showed a biphasic response with approximately half of the increase observed 3 days after RA treatment and the remainder occurred by day 4. PYS-2, a parietal endoderm cell line, showed levels of glycosyltransferase activities similar to those of RA-treated F9 cells. Glycosyltransferase activities in the RA-resistant F9 cell line (RA-3-10) were low and showed only a small induction by RA. These observations suggest that differentiation of F9 cells is closely associated with induction of multiple glycosyltransferase activities, with most pronounced increases in GlcNAc transferase V and 2', 5'-tetradenylate (core 2) GlcNAc transferase. The increase in GlcNAc transferase V was also reflected by the 4-6-fold increase in the binding of I-125-leukophytohemagglutinin to several cellular glycoproteins, which occurred after 3 days of RA treatment. The endo-beta-galactosidase-sensitive polylactosamine content of membrane glycoproteins and, in particular, the LAMP-1 glycoprotein was markedly increased after RA treatment of F9 cells. Consistent with these observations, fucosylated polylactosamine (i.e. dimeric Le(x))) was also increased in RA-treated cells. Analysis of the aryl oligosaccharides produced by F9 cells cultured in the presence of aryl alpha-D-GalNAc showed that RA treatment enhanced the synthesis of disialyl core 2 O-linked oligosaccharides and increased the polylactosamine content of the aryl oligosaccharides by >20-fold. The results suggest that differentiation of F9 cells into endoderm is closely associated with increased GlcNAc transferase V and core 2 GlcNAc transferase activities, enzymes which control the level of beta1-6GlcNAc-branched N- and O-linked oligosaccharides, the preferred substrates for polylactosamine addition.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,600 UNIV AVE,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5G 1X5,ON,CANADA; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030; UNIV ALBERTA,DEPT FOOD SCI,EDMONTON T6G 2P5,ALBERTA,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Alberta			Dennis, James/E-7268-2013					AMOS B, 1990, J BIOL CHEM, V265, P19192; AMOS B, 1990, INT J CANCER, V46, P86, DOI 10.1002/ijc.2910460117; BIRD JM, 1984, DEV BIOL, V104, P449, DOI 10.1016/0012-1606(84)90101-5; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; CHEN C, 1989, BIOCHEMISTRY-US, V28, P2229, DOI 10.1021/bi00431a039; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P547; CHILDS RA, 1983, BIOCHEM J, V215, P491, DOI 10.1042/bj2150491; COSSU G, 1985, DIFFERENTIATION, V29, P63, DOI 10.1111/j.1432-0436.1985.tb00293.x; CRAWLEY SC, 1990, ANAL BIOCHEM, V185, P1; CUMMINGS RD, 1988, J BIOL CHEM, V263, P511; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DE LUCA LM, 1991, FASEB J, V5, P2924; DENNIS JW, 1989, ONCOGENE, V4, P853; DENNIS JW, 1989, CANCER RES, V49, P945; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DEUTSCH V, 1983, EXP CELL RES, V149, P237, DOI 10.1016/0014-4827(83)90395-6; FENDERSON BA, 1986, DEV BIOL, V114, P12, DOI 10.1016/0012-1606(86)90379-9; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; FERNANDES B, 1991, CANCER RES, V51, P718; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1984, BIOL GLYCOPROTEINS, P183; GLASS CK, 1991, DNA CELL BIOL, V10, P623, DOI 10.1089/dna.1991.10.623; GRIPPO JF, 1987, J BIOL CHEM, V262, P4492; HEFFERNAN M, 1989, CANCER RES, V49, P6077; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Hogan B. L. M, 1983, CANCER SURV, V2, P115; KAPADIA A, 1981, EXP CELL RES, V131, P185, DOI 10.1016/0014-4827(81)90418-3; KERBEL RS, 1980, J NATL CANCER I, V64, P1221; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LAFERTE S, 1989, BIOCHEM J, V259, P569, DOI 10.1042/bj2590569; LEHMAN JM, 1974, J CELL PHYSIOL, V84, P13, DOI 10.1002/jcp.1040840103; LOPEZ LC, 1989, MOL CELL BIOL, V9, P2370, DOI 10.1128/MCB.9.6.2370; LOTAN R, 1991, BIOMED PHARMACOTHER, V45, P145, DOI 10.1016/0753-3322(91)90102-Y; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; PALCIC MM, 1990, J BIOL CHEM, V265, P6759; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; PENNINGTON JE, 1985, J EMBRYOL EXP MORPH, V90, P335; ROGERS MB, 1990, J CELL BIOL, V110, P1767, DOI 10.1083/jcb.110.5.1767; ROSENMAN SJ, 1989, EXP CELL RES, V180, P326, DOI 10.1016/0014-4827(89)90061-X; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SINGHAL AK, 1990, CANCER RES, V50, P1375; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRIKLAND S, 1980, CELL, V21, P393; TORRES CR, 1984, J BIOL CHEM, V259, P3308; VANDENEIJNDEN DH, 1988, J BIOL CHEM, V263, P12461; VARKI A, 1991, CELL, V65, P65, DOI 10.1016/0092-8674(91)90408-Q; WANG SY, 1984, J BIOL CHEM, V259, P5899; WARREN L, 1978, BIOCHIM BIOPHYS ACTA, V516, P97, DOI 10.1016/0304-419X(78)90005-7; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; ZHUANG D, 1991, Glycobiology, V1, P425, DOI 10.1093/glycob/1.4.425	51	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1242	1251						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419327				2022-12-27	WOS:A1993KG07700072
J	NADEAU, K; DAS, A; WALSH, CT				NADEAU, K; DAS, A; WALSH, CT			HSP90 CHAPERONINS POSSESS ATPASE ACTIVITY AND BIND HEAT-SHOCK TRANSCRIPTION FACTORS AND PEPTIDYL PROLYL ISOMERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN; PURIFICATION; DNAK; SITE; DISSOCIATION; CYCLOPHILIN; HYDROLYSIS; RECEPTORS; COMPLEXES	Heat shock proteins of the 82-90 kDa class (hsp82 and hsp90) are abundant, conserved, and ubiquitous from prokaryotes to eukaryotes. Although proposed to be chaperones, they had not been reported to possess enzymatic activity until our recent observation that pure trypanosomatid hsp83 had potent ATPase activity (Nadeau, K., Sullivan, M., Engman, D., and Walsh, C. T. (1992) Protein Sci. 1, 970-979). We have now purified the hsp90 homolog from Escherichia coli (HtpG) and from Saccharomyces cerevisiae (hsp82) to homogeneity and observe ATPase activity with k(cat) values of 3 min-1 and 140 min-1. In addition, examinations of purified rat hsp90 and human hsp90 detect ATPase activity with a k(cat) of 0.6 min-1 and 10 min-1. Each of these hsp90s undergoes autophosphorylation on serine or threonine residues. In prokaryotes and eukaryotes, the induction of hsps during heat shock is controlled, respectively, by the binding of an alternate sigma32 or a transcriptional activator (heat shock factor or HSF) at heat shock promoter elements. Here we show that E. coli HtpG immobilized to Affi-Gel beads selectively retains sigma32 while the yeast hsp90 and rat hsp90 retain HSF. The peptidyl prolyl isomerase hsp59 of the FK506 binding class is known to bind to hsp90. We also detect binding of the other family of PPIases, the cyclophilins, to immobilized hsp90, consistent with a functional convergence of protein foldases.			NADEAU, K (corresponding author), HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM 20011] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R37GM020011] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; AUSEBEL FM, 1989, CURRENT PROTOCOLS MO; BARDWELL JCA, 1987, P NATL ACAD SCI USA, V84, P5177, DOI 10.1073/pnas.84.15.5177; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; CALLEBAUT I, 1992, P NATL ACAD SCI USA, V89, P6270, DOI 10.1073/pnas.89.14.6270; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CHAPPELL TG, 1987, CELL, V45, P3; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DUNCAN K, 1988, BIOCHEMISTRY-US, V27, P3709, DOI 10.1021/bi00410a028; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GROSS C, 1991, TRENDS BIOCHEM SCI, V16, P135; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LARSON J, 1990, NATURE, V355, P372; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; MATTS RL, 1989, J BIOL CHEM, V264, P15542; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Morimoto RI, 1990, STRESS PROTEINS BIOL; NADEAU K, 1992, PROTEIN SCI, V1, P970, DOI 10.1002/pro.5560010802; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6907; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SPENCE J, 1989, J BIOL CHEM, V264, P4398; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; WALSH CT, 1992, J BIOL CHEM, V267, P13115; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P961, DOI 10.1002/pro.5560010801	47	224	235	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1479	1487						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419347				2022-12-27	WOS:A1993KG07700106
J	PIZZORNO, G; CASHMORE, AR; MOROSON, BA; CROSS, AD; SMITH, AK; MARLINGCASON, M; KAMEN, BA; BEARDSLEY, GP				PIZZORNO, G; CASHMORE, AR; MOROSON, BA; CROSS, AD; SMITH, AK; MARLINGCASON, M; KAMEN, BA; BEARDSLEY, GP			5,10-DIDEAZATETRAHYDROFOLIC ACID (DDATHF) TRANSPORT IN CCRF-CEM AND MA104 CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE ACTIVITY; CARRIER-MEDIATED TRANSPORT; HUMAN LYMPHOBLASTOID CELLS; FOLATE ANALOG TRANSPORT; DENOVO PURINE SYNTHESIS; LEUKEMIA HL-60 CELLS; METHOTREXATE TRANSPORT; L1210 CELLS; MEMBRANE-TRANSPORT; RESISTANT	5,10-Dideazatetrahydrolic acid (DDATHF) is representative of a new class of antifolates acting through inhibition of de novo purine synthesis. We report here the transport characteristics of the diastereomers of DDATHF, which differ in configuration at C6, and comparison studies with other folate and antifolate analogs. (6R)-DDATHF showed high affinity for the influx system of CCRF-CEM cells with a K(m) of 1.07 muM and an influx V(max) of 4.04 pmol/min/10(7) cells. Comparative studies with methotrexate yielded an influx K(m) of 4.98 muM and a V(max) of 6.64 pmol/min/10(7) cells, and with 5-formyltetrahydrofolate an influx K(m) of 2.18 muM and a V(max) of 6.84 pmol/min/10(7) cells. Uptake of (6R)-DDATHF was competitively inhibited by (6S)-DDATHF, methotrexate (MTX), and 5-formyltetrahydrofolate, all with K(i) values similar to their influx K(m). The (6S)-DDATHF diastereomer had an influx K(m) of 1.04 muM, similar to that of (6R)-DDATHF; however, the V(max) of 1.72 pmol/min/10(7) cells was 2.3-fold lower than for (6R)-DDATHF. The transport properties of DDATHF were also studied in a mutant cell line (CEM/MTX), resistant to MTX based on impaired drug transport. In this system (6R)-DDATHF showed an influx K(m) of 1.49 muM and a decreased influx V(max) of 0.60 pmol/min/10(7) cells. A similar effect was shown for MTX (K(m) of 7.48 muM, V(max) of 1.02 pmol/min/10(7) cells). The number of binding sites in CCRF-CEM cells was similar for (6R)-DDATHF, (6S)-DDATHF, and MTX, 0.74, 0.71, and 0.76 pmol/10(7) cells, respectively. These values were slightly higher in the CEM/MTX cell line (1.07 and 1.09 pmol/10(7) cells for (6R)-DDATHF and MTX, respectively). Treatment of CCRF-CEM cells with either the N-hydroxysuccinimide ester of MTX or the corresponding N-hydroxysuccinimide ester of (6R)-DDATHF caused substantial inhibition (>90%) of the influx of (6R)-[H-3]DDATHF and [H-3]MTX, respectively. These results suggest strongly that DDATHF and MTX share a common influx mechanism through the reduced folate transport system. The internalization of DDATHF by monkey kidney epithelial MA104 cells, which express a high affinity folate receptor, was also studied. Competitive binding studies using purified folate receptor and radiolabeled 5-methyltetrahydrofolate showed that (6S)- and (6R)-DDATHF both had I50 values lower than 5-methyltetrahydrofolate (12 nM). Further studies indicate that both DDATHF isomers are actively intracellularly concentrated through this route and are also rapidly converted to high chain length polyglutamates. Transport via this system was inhibited in folate-depleted cells by 10 nM folic acid. At a concentration of 10 nM, receptor-mediated uptake results in greater drug accumulation in receptor-positive cells compared to receptor-negative cells.	YALE UNIV,SCH MED,DEPT PEDIAT,DEPT PEDIAT & PHARMACOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510; UNIV TEXAS,SW MED CTR,DALLAS,TX 75235	Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NCI NIH HHS [CA57320, CA42367] Funding Source: Medline; NCRR NIH HHS [RR01237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042367] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALT FW, 1978, J BIOL CHEM, V253, P1357; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BARNETT CJ, 1989, CHEM BIOL PTERIDINES, P102; BEARDSLEY G P, 1986, P953; BEARDSLEY GP, 1989, J BIOL CHEM, V264, P328; BEARDSLEY GP, 1989, CHEM BIOL PTERIDINES, P1001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHELLO PL, 1982, BIOCHEM PHARMACOL, V31, P1527, DOI 10.1016/0006-2952(82)90376-8; COWAN KH, 1984, J BIOL CHEM, V289, P10789; DEDHAR S, 1985, BIOCHEM J, V225, P609, DOI 10.1042/bj2250609; DEMBO M, 1984, J MEMBRANE BIOL, V78, P9, DOI 10.1007/BF01872527; DEMBO M, 1976, BIOCHIM BIOPHYS ACTA, V448, P505, DOI 10.1016/0005-2736(76)90303-5; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; DOLNICK BJ, 1979, J CELL BIOL, V83, P394, DOI 10.1083/jcb.83.2.394; FISCHER GA, 1962, BIOCHEM PHARMACOL, V11, P1233, DOI 10.1016/0006-2952(62)90200-9; FLINTOFF WF, 1980, BIOCHEMISTRY-US, V19, P4321, DOI 10.1021/bi00559a027; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FREI E, 1984, P NATL ACAD SCI-BIOL, V81, P2873, DOI 10.1073/pnas.81.9.2873; FRY DW, 1982, J BIOL CHEM, V257, P1890; HABER DA, 1981, J BIOL CHEM, V256, P9501; HAKALA MT, 1965, BIOCHIM BIOPHYS ACTA, V102, P198, DOI 10.1016/0926-6585(65)90213-X; HENDERSON GB, 1987, BIOCHEM PHARMACOL, V36, P3007, DOI 10.1016/0006-2952(87)90216-4; HENDERSON GB, 1984, J BIOL CHEM, V259, P4558; HENDERSON GB, 1980, ARCH BIOCHEM BIOPHYS, V202, P144, DOI 10.1016/0003-9861(80)90416-6; HENDERSON GB, 1986, CANCER RES, V46, P1633; HILLCOAT BL, 1967, P NATL ACAD SCI USA, V58, P1632, DOI 10.1073/pnas.58.4.1632; JACKSON RC, 1975, CANCER BIOCHEM BIOPH, V1, P151; KAMEN BA, 1989, J CLIN INVEST, V84, P1379, DOI 10.1172/JCI114310; KAMEN BA, 1986, P NATL ACAD SCI USA, V83, P5983, DOI 10.1073/pnas.83.16.5983; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MELARA PW, 1980, J BIOL CHEM, V255, P7024; MINI E, 1985, CANCER RES, V45, P325; MORAN RG, 1989, J BIOL CHEM, V264, P21047; NIETHAMMER D, 1975, EUR J CANCER, V11, P845, DOI 10.1016/0014-2964(75)90083-3; PIZZORNO G, 1988, CANCER RES, V48, P2149; PIZZORNO G, 1989, CANCER RES, V49, P5275; PIZZORNO G, 1991, MOL PHARMACOL, V39, P85; PRIEST DG, 1980, ANAL BIOCHEM, V103, P51, DOI 10.1016/0003-2697(80)90234-1; ROSOWSKY A, 1980, BIOCHEM PHARMACOL, V29, P648, DOI 10.1016/0006-2952(80)90391-3; SCHUETZ JD, 1988, J BIOL CHEM, V263, P9840; SIROTNAK FM, 1976, CANCER RES, V36, P1151; SIROTNAK FM, 1981, CANCER RES, V41, P4447; SIROTNAK FM, 1979, BIOCHEM PHARMACOL, V28, P2993, DOI 10.1016/0006-2952(79)90599-9; SIROTNAK FM, 1980, PHARMACOL THERAPEUT, V8, P71, DOI 10.1016/0163-7258(80)90060-1; SIROTNAK FM, 1984, J BIOL CHEM, V259, P3139; SIROTNAK FM, 1987, BIOCHEM PHARMACOL, V36, P1659, DOI 10.1016/0006-2952(87)90051-7; SRIMATKANDADA S, 1983, BIOCHEMISTRY-US, V22, P5774, DOI 10.1021/bi00294a015; WARREN RD, 1978, CANCER RES, V38, P668; WEIMAN SD, 1992, CANCER RES, V52, P3396; WHITE JC, 1978, J BIOL CHEM, V253, P242; ZWIENER RJ, 1993, IN PRESS CANCER CHEM	53	39	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1017	1023						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419310				2022-12-27	WOS:A1993KG07700041
J	WESTENBERG, DJ; GUNSALUS, RP; ACKRELL, BAC; SICES, H; CECCHINI, G				WESTENBERG, DJ; GUNSALUS, RP; ACKRELL, BAC; SICES, H; CECCHINI, G			ESCHERICHIA-COLI FUMARATE REDUCTASE FRDC AND FRDD MUTANTS - IDENTIFICATION OF AMINO-ACID-RESIDUES INVOLVED IN CATALYTIC ACTIVITY WITH QUINONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-SPHAEROIDES R-26; BACTERIAL REACTION CENTERS; SUCCINATE-DEHYDROGENASE; ELECTRON-TRANSPORT; PROTON-TRANSFER; REPLACEMENT; COMPLEX; PATHWAY; COMPONENT; ACCEPTOR	Escherichia coli fumarate reductase (FRD) is a four-subunit enzyme that catalyzes the terminal step in anaerobic respiration to fumarate. The hydrophobic FrdC and FrdD subunits anchor the FrdA and FrdB catalytic subunits to the inner surface of the cytoplasmic membrane and are required for the enzyme to interact with quinones. Thirty-five single-site mutations were constructed in the FrdC and FrdD polypeptides by site-directed mutagenesis. Each mutant enzyme was characterized for its ability to catalyze quinone oxidation and reduction and to support growth of E. coli DW35 (DELTAfrdABCD sdhC=kan) under selective conditions requiring functional enzyme. Replacement of FrdC(E29) with Asp, Leu, Lys, or Phe had a deleterious effect both on quinol oxidase and quinone reductase activities. Substitution of FrdC(H82) with Arg, Leu, Tyr, or Glu also decreased menaquinol oxidase activity, but had variable effects on the reverse reaction, the reduction of ubiquinone. Data are presented to support the hypothesis that the positive charge at FrdC(H82) is required for stabilization of the quinone radical intermediate and the negative charge at FrdC(E29) for deprotonation of menaquinol. Other critical amino acids identified in FrdC included Ala-32, Phe-38, Trp-86, Phe-87, and in FrdD residues Phe-57, Gln-59, Ser-60, and His-80. The established roles of such residues in the Q(A) and Q(B) sites of the photosynthetic reaction center would suggest a similar type of structure operative in the FRD complex. In such a model, Glu-29, Ala-32, His-82, Trp-86 of FrdC and His-80 of FrdD are considered participants in a Q(B)-type site, and FrdD Phe-57, Gln-59, and Ser-60 components in an apolar Q(A)-type site.	DVA MED CTR,DIV MOLEC BIOL,4150 CLEMENT ST,SAN FRANCISCO,CA 94121; UNIV CALIF LOS ANGELES,DEPT MICROBIOL & MOLEC GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco			Westenberg, David J/I-2211-2016	Westenberg, David J/0000-0003-3510-0311	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016251] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 16251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; ALLEN JP, 1988, P NATL ACAD SCI USA, V85, P8487, DOI 10.1073/pnas.85.22.8487; BLUM P, 1989, J BACTERIOL, V171, P538, DOI 10.1128/jb.171.1.538-546.1989; CAMMACK R, 1986, BIOCHEM SOC T, V14, P1207, DOI 10.1042/bst0141207; CECCHINI G, 1986, P NATL ACAD SCI USA, V83, P8898, DOI 10.1073/pnas.83.23.8898; CECCHINI G, 1986, J BIOL CHEM, V261, P1808; CECCHINI G, 1984, FLAVINS FLAVOPROTEIN, P555; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; COLEMAN WJ, 1990, CURRENT RES PHOTOSYN, V1; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GIRDLESTONE J, 1981, BIOCHEMISTRY-US, V20, P152, DOI 10.1021/bi00504a025; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; JOHNSONMK, 1988, J BIOL CHEM, V263, P14732; JONES HM, 1987, J BACTERIOL, V169, P3340, DOI 10.1128/jb.169.7.3340-3349.1987; KOMIYA H, 1988, P NATL ACAD SCI USA, V85, P9012, DOI 10.1073/pnas.85.23.9012; KROGER A, 1978, BIOCHIM BIOPHYS ACTA, V505, P129, DOI 10.1016/0304-4173(78)90010-1; LATOUR DJ, 1987, J GEN MICROBIOL, V97, P597; LEMIRE BD, 1982, J BACTERIOL, V152, P1126; MCLENDON G, 1991, MET IONS BIOL SYST, V27, P183; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; PADDOCK ML, 1990, P NATL ACAD SCI USA, V87, P6803, DOI 10.1073/pnas.87.17.6803; PADDOCK ML, 1989, P NATL ACAD SCI USA, V86, P6602, DOI 10.1073/pnas.86.17.6602; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; SALACH J, 1972, EUR J BIOCHEM, V26, P267, DOI 10.1111/j.1432-1033.1972.tb01765.x; SALERNO JC, 1977, FEBS LETT, V82, P179, DOI 10.1016/0014-5793(77)80579-6; Silhavy T. J., 1984, EXPT GENE FUSIONS; TAKAHASHI E, 1990, CURRENT RES PHOTOSYN, V1; UNDEN G, 1983, FEMS MICROBIOL LETT, V20, P181; WEINER JH, 1986, P NATL ACAD SCI USA, V83, P2056, DOI 10.1073/pnas.83.7.2056; WEINER JH, 1979, J BIOL CHEM, V254, P8590; WESTENBERG DJ, 1990, J BIOL CHEM, V265, P19560; ZAGURSKY RJ, 1985, FOCUS, V7, P4	34	87	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					815	822						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419359				2022-12-27	WOS:A1993KG07700013
J	CARLOS, S; HUNT, DF; ROCCHINI, C; ARNOTT, DP; AUSIO, J				CARLOS, S; HUNT, DF; ROCCHINI, C; ARNOTT, DP; AUSIO, J			POSTTRANSLATIONAL CLEAVAGE OF A HISTONE H1-LIKE PROTEIN IN THE SPERM OF MYTILUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASIC-PROTEINS; MICROHETEROGENEITY; VARIABILITY; MOLLUSKS	Starting with total RNA from spermatogenic cells of Mytilus trossulus and using random priming, we have cloned and sequenced the c-DNAs corresponding to two variants of the sperm-specific protein PLII* (phi2B). DNA sequencing in conjunction with mass spectrometry and protein sequence data have allowed us to establish that of the three sperm-specific proteins present in the sperm of Mytilus (PL-II*(phi2B), PL-III (phi1), PL-IV (phi3)), the first and the last one are the result of post-translational cleavage of a common precursor. This common precursor is a member of the histone H1 family, and it exhibits inter- and intraspecific microheterogeneity.	UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,VICTORIA V8W 3P6,BC,CANADA; UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22901	University of Victoria; University of Virginia			Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368				AUSIO J, 1989, EUR J BIOCHEM, V182, P569, DOI 10.1111/j.1432-1033.1989.tb14865.x; AUSIO J, 1982, BIOCHEMISTRY-US, V21, P5910, DOI 10.1021/bi00266a028; AUSIO J, 1982, EXP CELL RES, V141, P39, DOI 10.1016/0014-4827(82)90065-9; AUSIO J, 1986, COMP BIOCHEM PHYS B, V85, P439, DOI 10.1016/0305-0491(86)90025-8; AUSIO J, 1992, BIOL BULL, V182, P31, DOI 10.2307/1542178; AUSUBEL MF, 1987, CURRENT PROTOCOLS MO, V1; BLOCH DP, 1966, PROTOPLASMATOLOGIA, V5, P1; CARLOS S, 1993, J BIOL CHEM, V268, P185; COLE RD, 1987, INT J PEPT PROT RES, V30, P433; DIXON GH, 1986, CHROMOSOMAL PROTEINS, P287; HUNT DF, 1991, TECHNIQUES PROTEIN C, V2, P441; IATROU K, 1977, CELL, V10, P433, DOI 10.1016/0092-8674(77)90030-7; JUTGLAR L, 1991, J BIOL CHEM, V266, P8184; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; MOGENSEN C, 1991, FEBS LETT, V282, P273, DOI 10.1016/0014-5793(91)80493-M; PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3; PHELAN JJ, 1974, J BIOL CHEM, V249, P1099; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5643; SUBIRANA JA, 1973, BIOCHIM BIOPHYS ACTA, V317, P364, DOI 10.1016/0005-2795(73)90231-6; SUBIRANA JA, 1983, SPERM CELL, P197; ZALENSKII AO, 1986, MOL BIOL+, V20, P677	22	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					195	199						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416927				2022-12-27	WOS:A1993KE60300030
J	BLACHE, P; KERVRAN, A; LENGUYEN, D; DUFOUR, M; COHENSOLAL, A; DUCKWORTH, W; BATAILLE, D				BLACHE, P; KERVRAN, A; LENGUYEN, D; DUFOUR, M; COHENSOLAL, A; DUCKWORTH, W; BATAILLE, D			ENDOPEPTIDASE FROM RAT-LIVER MEMBRANES, WHICH GENERATES MINIGLUCAGON FROM GLUCAGON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; THIOL-DEPENDENT METALLOENDOPEPTIDASE; PARTIAL-PURIFICATION; PLASMA-MEMBRANE; CA-2+ PUMP; PROTEASE; PROTEINS; HORMONE; SEQUENCE; CDNA	An endopeptidase activity that cleaves glucagon, producing miniglucagon or glucagon (19-29), a Ca2+ pump inhibitory peptide, was isolated from rat liver membranes. The purified enzyme has a molecular mass of approximately 100 kDa and a pH optimum of approximately 8. It is inhibited by, both sulfhydryl-blocking reagents and metal-chelating reagents and activated by thiol compounds. The partial N-terminal amino acid sequence of the 100-kDa protein does not correspond to any known protein. An antiserum was raised against a synthetic octapeptide corresponding to the N-terminal sequence. Immunoblot analysis of crude liver membranes revealed a single band at 100 kDa. Immunoreactivity was found in liver, pancreas, and heart, which are glucagon and miniglucagon target tissues, and in gastric mucosa and kidney. Low levels were detected in spleen, whereas immunoreactivity was undetectable in skeletal muscle and intestinal mucosa. The endopeptidase activity was inhibited by insulin, glucagon-like peptide-1, and glucagon-like peptide-1 (7-36) amide, whereas other peptides that contain dibasic sites had no effect on its activity, indicating that the endopeptidase does not display strict selectivity toward basic doublets.	UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, OMAHA, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	BLACHE, P (corresponding author), CCIPE, INSERM, U264, RUE CARDONILLE, F-34094 MONTPELLIER 5, FRANCE.		blache, philippe/C-2009-2008					AFFHOLTER JA, 1988, SCIENCE, V242, P1415, DOI 10.1126/science.3059494; BARRETT AJ, 1990, BIOCHEM J, V271, P701, DOI 10.1042/bj2710701; BATAILLE D, 1992, BIOMED RES-TOKYO, V13, P137; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; BLACHE P, 1989, CR ACAD SCI III-VIE, V308, P467; BLACHE P, 1990, J BIOL CHEM, V265, P21514; BLACHE P, 1992, BIOMED RES-TOKYO, V13, P51; BLACHE P, 1985, REGUL PEPTIDES, V53, P20; BLACHE P, 1988, BIOMED RES S3, V9, P19; DESSEN P, 1990, COMPUT APPL BIOSCI, V6, P355; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; DUCKWORTH WC, 1990, J BIOL CHEM, V265, P2984; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; HAGOPIAN WA, 1987, J CLIN INVEST, V79, P409, DOI 10.1172/JCI112827; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KOLE HK, 1992, ARCH BIOCHEM BIOPHYS, V297, P199, DOI 10.1016/0003-9861(92)90662-G; KUO WL, 1990, MOL ENDOCRINOL, V4, P1580, DOI 10.1210/mend-4-10-1580; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENGUYEN D, 1988, PEPTIDE CHEM 1987, P391; MALLAT A, 1987, NATURE, V325, P620, DOI 10.1038/325620a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MISBIN RI, 1984, METHODS DIABETIC R A, V1, P389; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; NEVILLE DM, 1968, BIOCHIM BIOPHYS ACTA, V154, P540, DOI 10.1016/0005-2795(68)90014-7; PAVOINE C, 1991, AM J PHYSIOL, V260, pC993, DOI 10.1152/ajpcell.1991.260.5.C993; RAWLINGS ND, 1991, BIOCHEM J, V275, P389, DOI 10.1042/bj2750389; RESNICK NM, 1991, CELL, V66, P541, DOI 10.1016/0092-8674(81)90017-9; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHEETZ MJ, 1988, J BIOL CHEM, V263, P19210; SHII K, 1986, DIABETES, V35, P675, DOI 10.2337/diabetes.35.6.675; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; TAO Z, 1991, NEUROPEPTIDES, V20, P125, DOI 10.1016/0143-4179(91)90062-N; THOMAS TC, 1990, METHOD ENZYMOL, V182, P499	33	21	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21748	21753						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408029				2022-12-27	WOS:A1993MC80900051
J	DANIEL, LW; HUANG, CF; STRUM, JC; SMITHERMAN, PK; GREENE, D; WYKLE, RL				DANIEL, LW; HUANG, CF; STRUM, JC; SMITHERMAN, PK; GREENE, D; WYKLE, RL			PHOSPHOLIPASE-D HYDROLYSIS OF CHOLINE PHOSPHOGLYCERIDES IS SELECTIVE FOR THE ALKYL-LINKED SUBCLASS OF MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; STIMULATED HUMAN FIBROBLASTS; MOLECULAR-SPECIES ANALYSIS; HUMAN-NEUTROPHILS; PHOSPHATIDYLCHOLINE HYDROLYSIS; SIGNAL TRANSDUCTION; HL-60 GRANULOCYTES; PHOSPHATIDIC-ACID; ALPHA-THROMBIN; MAST-CELLS	Madin-Darby canine kidney (MDCK) cells were used to study the synthesis of diglycerides from choline phospholipids (PC) in response to 12-O-tetradecanoylphorbol-13-acetate (TPA). In this system, diglyceride formation was blocked in the presence of ethanol (0.5%), and a corresponding amount of phosphatidylethanol (PEt) was formed, indicating that phospholipase D is responsible for the diglyceride production. Analysis of the subclasses of phosphatidylethanol revealed 1-O-alkyl-(alkyl), 1-O-alk-1'-enyl-(alkenyl), and 1-acyl species of PEt (38.0,8.3, and 53.7%, respectively). The molecular species of the alkyl-PEt most closely matched the alkyl-PC. No change in the relative amounts of alkyl- versus acyl-PEt was observed with time after stimulation. Comparison of the alkyl content of PEt (38.0%) and the parent PC (15.2%) indicated a marked selectivity for the alkyl subclass of PC. A cell-free assay (Huang, C., Wykle, R. L., Daniel, L. W., and Cabot, M. C. (1992) J. Biol. Chem. 267, 16859-16865) for phospholipase D was also used to confirm the selectivity of the enzyme for alkyl-PC versus acyl-PC. The predominant molecular species of PEt contained saturated acyl or alkyl chains in position-1 and monounsaturated residues in position-2 accounting for approximately 50% of the total PEt. 1-O-Octadecyl-2-oleoyl-sn-glycerol, a representative alkyl molecular species, was synthesized and tested for its effect upon protein kinase C derived from MDCK cells. This alkyl-diglyceride (DG) neither stimulated protein kinase C nor inhibited its activation by diacylglycerol. In summary, TPA-stimulated phospholipase D is selective for the alkyl-PC subclass in MDCK cells. The alkyl-DG subsequently formed does not appear to function as a second-messenger in activating protein kinase C.			DANIEL, LW (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,MED CTR BLVD,WINSTON SALEM,NC 27157, USA.				NCI NIH HHS [CA43297, CA48995] Funding Source: Medline; NHLBI NIH HHS [HL26818] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043297, R01CA048995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGWU DE, 1991, J IMMUNOL, V146, P3895; AGWU DE, 1989, J BIOL CHEM, V264, P1405; BASS DA, 1989, J BIOL CHEM, V264, P19610; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLANK ML, 1984, J CHROMATOGR, V298, P473, DOI 10.1016/S0021-9673(01)92744-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; CABOT MC, 1984, BIOCHEM BIOPH RES CO, V125, P163, DOI 10.1016/S0006-291X(84)80349-6; CHABOT MC, 1989, CANCER RES, V49, P4441; DANIEL LW, 1988, BIOCHEM BIOPH RES CO, V151, P291, DOI 10.1016/0006-291X(88)90592-X; DANIEL LW, 1986, J BIOL CHEM, V261, P9128; DANIEL LW, 1987, LIPIDS, V22, P851, DOI 10.1007/BF02535543; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; DOUGHERTY RW, 1989, J BIOL CHEM, V264, P11263; EXTON JH, 1990, J BIOL CHEM, V265, P1; FORD DA, 1989, J BIOL CHEM, V264, P13818; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; HEYMANS F, 1987, FEBS LETT, V218, P35, DOI 10.1016/0014-5793(87)81013-X; HUANG CF, 1992, J BIOL CHEM, V267, P16859; HUANG CF, 1990, J BIOL CHEM, V265, P14858; IRVING HR, 1987, J BIOL CHEM, V262, P3440; KENNERLY DA, 1990, J IMMUNOL, V144, P3912; KENNERLY DA, 1987, J BIOL CHEM, V262, P16305; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LEACH KL, 1991, J BIOL CHEM, V266, P3215; LOFFELHOLZ K, 1989, BIOCHEM PHARMACOL, V38, P1543, DOI 10.1016/0006-2952(89)90299-2; MARASCO CJ, 1990, J MED CHEM, V33, P985, DOI 10.1021/jm00165a016; MARX MH, 1988, J MED CHEM, V31, P858, DOI 10.1021/jm00399a029; MUELLER HW, 1984, J LIPID RES, V25, P383; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; OFLAHERTY JT, 1984, BIOCHEM BIOPH RES CO, V123, P64, DOI 10.1016/0006-291X(84)90380-2; OLSON SC, 1990, FEBS LETT, V272, P19, DOI 10.1016/0014-5793(90)80439-P; PAI JK, 1988, J BIOL CHEM, V263, P12472; PAI JK, 1987, CARCINOGENESIS, V8, P173, DOI 10.1093/carcin/8.1.173; PARKER J, 1987, J BIOL CHEM, V262, P5385; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; PREISS JE, 1987, J IMMUNOL, V138, P1542; PRICE BD, 1989, J BIOL CHEM, V264, P16638; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; STRUM JC, 1992, J BIOL CHEM, V267, P1576; Sugiura T., 1987, PLATELET ACTIVATING, P55; SURLES JR, 1985, J MED CHEM, V28, P73, DOI 10.1021/jm00379a015; TETTENBORN CS, 1988, BIOCHEM BIOPH RES CO, V155, P249, DOI 10.1016/S0006-291X(88)81076-3; TYAGI SR, 1989, J BIOL CHEM, V264, P12977; VANBLITTERSWIJK WJ, 1991, J BIOL CHEM, V266, P10344; VANBLITTERSWIJK WJ, 1991, J BIOL CHEM, V266, P10337	53	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21519	21526						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408002				2022-12-27	WOS:A1993MC80900017
J	DRIGGERS, WJ; LEDOUX, SP; WILSON, GL				DRIGGERS, WJ; LEDOUX, SP; WILSON, GL			REPAIR OF OXIDATIVE DAMAGE WITHIN THE MITOCHONDRIAL-DNA OF RINR-38 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APURINIC APYRIMIDINIC SITES; DEGENERATIVE DISEASES; MUTATIONS; OXYGEN; BIOCHEMISTRY; MUTAGENESIS; DIAGNOSIS; DELETION; INCREASE	A growing body of evidence suggests that a variety of chronic diseases, including cancer and diabetes, are associated with damage to mitochondrial DNA. Since mitochondria are constantly exposed to high levels of reactive oxygen species, it is likely that oxidative damage to mitochondrial DNA may be responsible for some of these maladies. To determine whether mitochondria can repair this damage, a quantitative Southern blot technique was utilized to identify repair in specific DNA fragments. A 10.8-kilobase mitochondrial restriction fragment was studied employing a probe containing the entire mouse mitochondrial genome. Alloxan was employed to generate oxygen radicals. Insulinoma cells were exposed to alloxan for 1 h, and total cellular DNA was isolated immediately or after intervals of up to 8 h. Alkali treatment was used to identify abasic sites and sugar lesions, endonuclease III was used to identify lesions associated with thymine and cytosine damage, and formamidopyrimidine-DNA glycosylase was employed to recognize formamidopyrimidines and 8-oxoguanines in DNA. The results showed that all forms of damage studied were repaired by 4 h, indicating that mitochondria are able to efficiently repair damage to their DNA caused by reactive oxygen species.	UNIV SO ALABAMA,DEPT STRUCT & CELLULAR BIOL,MSB 2042,MOBILE,AL 36688	University of South Alabama					NATIONAL CANCER INSTITUTE [P01CA047995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003456] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47995] Funding Source: Medline; NIEHS NIH HHS [ES 03456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; DEMPLE B, 1991, OXIDATIVE STRESS OXI, P127; FREI B, 1985, J BIOL CHEM, V260, P7394; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; FRENKEL K, 1992, PHARMACOL THERAPEUT, V53, P127, DOI 10.1016/0163-7258(92)90047-4; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GERBITZ KD, 1990, J CLIN CHEM CLIN BIO, V28, P241; GERBITZ KD, 1992, DIABETOLOGIA, V35, P1181, DOI 10.1007/BF00401375; HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MEYERS KA, 1988, CARCINOGENESIS, V9, P285; MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I; MIQUEL J, 1977, FREE RADICALS BIOL, V3, P133; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; PACKER L, 1974, P NATL ACAD SCI USA, V71, P4763, DOI 10.1073/pnas.71.12.4763; PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113; REID RA, 1983, TRENDS BIOCHEM SCI, V8, P190, DOI 10.1016/0968-0004(83)90205-0; RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O; RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SATOH MS, 1988, J BIOL CHEM, V263, P6854; SIES H, 1989, NATURWISSENSCHAFTEN, V76, P57, DOI 10.1007/BF00396705; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929; WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X; WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WRIGHT PH, 1971, DIABETES, V20, P33, DOI 10.2337/diab.20.1.33; YEN TC, 1992, BIOCHEM INT, V26, P457	39	164	169	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22042	22045						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408062				2022-12-27	WOS:A1993MC80900090
J	MORGENSTERN, KA; HENZEL, WJ; BAKER, JB; WONG, S; PASTUSZYN, A; KISIEL, W				MORGENSTERN, KA; HENZEL, WJ; BAKER, JB; WONG, S; PASTUSZYN, A; KISIEL, W			ISOLATION AND CHARACTERIZATION OF AN INTRACELLULAR SERINE PROTEINASE-INHIBITOR FROM A MONKEY KIDNEY EPITHELIAL-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; HUMAN PROTEASE NEXIN; ELASTASE INHIBITOR; ALPHA-1-PROTEINASE INHIBITOR; PROTEOLYTIC ACTIVATION; ANTIGEN PRESENTATION; ENDOTHELIAL-CELLS; ANTITHROMBIN-III; CDNA CLONING; THROMBIN	A recent report described a thrombin inhibitory activity in the soluble fraction of human placenta and the cytosolic fraction of K562 cells. Isolation and characterization of the functionally inactive 35-38-kDa placental form of this protein revealed that it was a novel serine proteinase inhibitor (Coughlin, P. B., Tetaz, T., and Salem, H. H. (1993) J. Biol. Chem. 268, 9541-9547). In the present study, we observed a 67-kDa sodium dodecyl sulfate (SDS)-stable complex when I-125-thrombin was incubated with the cytosolic fraction of a monkey kidney epithelial cell line, BSC-1. This complex was not observed in either the particulate cell fraction extracted with 0.2% Triton X-100 or medium conditioned by cells, suggesting that the thrombin-complexing factor is confined to the cytoplasm. The cytoplasmic antithrombin activity was purified to apparent homogeneity from the cytosol of BSC-1 cells previously pulsed with [S-35]methionine by a combination of heparin-agarose chromatography, Mono Q fast protein liquid chromatography, and anhydrotrypsin-Affi-Gel 10 affinity chromatography. Analysis of the affinity-purified preparation by SDS-polyacrylamide gel electrophoresis and fluorography revealed a single protein with an apparent molecular mass of 38 kDa. The purified 38-kDa protein inhibited the amidolytic activities of thrombin, trypsin, urokinase, and factor Xa but not that of elastase. Incubation of the 38-kDa protein with excess thrombin identified approximately 60% of the labeled 38-kDa protein in an SDS-stable 67-kDa complex. The purified 38-kDa inhibitor was cleaved with cyanogen bromide and the isolated peptides subjected to microsequencing. Amino acid sequence obtained for a region within this protein exhibited significant homology with human antithrombin III and plasminogen activator inhibitors 1 and 2. This homologous peptide contained the full complement of residues designated as highly conserved in helix F of the greater serine proteinase inhibitor superfamily. In addition, an internal sequence of GGGGDIHQGF was found in the monkey cytoplasmic inhibitor, which is identical to that reported for an internal sequence of the human placental inhibitor. These findings confirm the existence of a novel cytoplasmic serine proteinase inhibitor in mammalian cells and provide additional details of its molecular properties. The physiological function of this novel serine proteinase inhibitor in cytoplasm is unknown.	UNIV NEW MEXICO, SCH MED, DEPT PATHOL, BLOOD SYST RES FDN LAB, ALBUQUERQUE, NM 87131 USA; UNIV NEW MEXICO, SCH MED, DEPT BIOCHEM, ALBUQUERQUE, NM 87131 USA; GENENTECH INC, PROT CHEM, S SAN FRANCISCO, CA 94080 USA; GENENTECH INC, CARDIOVASC RES, S SAN FRANCISCO, CA 94080 USA	University of New Mexico; University of New Mexico; Roche Holding; Genentech; Roche Holding; Genentech				Henzel, William/0000-0003-2940-3797				AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; ASTRUP T, 1978, PROGR CHEM FIBRINOLY, V3, P1; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BAKER JB, 1986, RECEPTORS, V3, P153; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSON T, 1991, PRINCIPLES TRANSFUSI, P307; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; COUGHLIN PB, 1993, J BIOL CHEM, V268, P9541; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DESA MFG, 1988, J CELL BIOL, V107, P1517, DOI 10.1083/jcb.107.4.1517; DJONDJUROV LP, 1984, EXP CELL RES, V152, P134, DOI 10.1016/0014-4827(84)90237-4; DUBIN A, 1992, J BIOL CHEM, V267, P6576; EATON DL, 1983, J CELL PHYSIOL, V117, P175, DOI 10.1002/jcp.1041170207; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRONKE RS, 1989, BLOOD, V73, P472; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; ISHII SI, 1983, METHOD ENZYMOL, V91, P378; JOSLIN G, 1993, J BIOL CHEM, V268, P1886; KAZAMA Y, 1993, BLOOD, V81, P676; KIRSCHNER RJ, 1980, J BIOL CHEM, V255, P5468; KISIEL W, 1985, BLOOD, V66, P1302; KOPITAR M, 1985, THROMB HAEMOSTASIS, V54, P750; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODERMANN H, 1984, J MOL BIOL, V177, P531; LONGAS MO, 1980, BIOCHEM J, V189, P481, DOI 10.1042/bj1890481; MAST AE, 1991, BIOCHEMISTRY-US, V30, P1723, DOI 10.1021/bi00220a039; MATHEWS CK, 1990, BIOCHEMISTRY-US, P16; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCGROGAN M, 1988, BIO-TECHNOL, V6, P172, DOI 10.1038/nbt0288-172; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; MOTIZUKI M, 1986, EUR J BIOCHEM, V158, P345, DOI 10.1111/j.1432-1033.1986.tb09757.x; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; NY T, 1984, P NATL ACAD SCI-BIOL, V81, P5355, DOI 10.1073/pnas.81.17.5355; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OWEN WG, 1975, BIOCHIM BIOPHYS ACTA, V405, P380, DOI 10.1016/0005-2795(75)90103-8; PARHAM P, 1991, NATURE, V351, P271, DOI 10.1038/351271a0; PONTREMOLI S, 1990, P NATL ACAD SCI USA, V87, P3705, DOI 10.1073/pnas.87.10.3705; POTEMPA J, 1990, NATO ADV SCI I A-LIF, V191, P163; POTEMPA J, 1988, J BIOL CHEM, V263, P7364; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; REMOLDODONNELL E, 1985, J EXP MED, V162, P2142, DOI 10.1084/jem.162.6.2142; REMOLDODONNELL E, 1989, J EXP MED, V169, P1071, DOI 10.1084/jem.169.3.1071; ROBERTSON M, 1991, NATURE, V353, P300, DOI 10.1038/353300a0; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SCHACHTER M, 1979, PHARMACOL REV, V31, P1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHLEEF RR, 1991, J CELL BIOL, V113, P1413, DOI 10.1083/jcb.113.6.1413; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; SCOTT RW, 1983, J BIOL CHEM, V258, P439; SHARIFI BG, 1986, J NEUROCHEM, V46, P461, DOI 10.1111/j.1471-4159.1986.tb12990.x; STEINER DF, 1992, J BIOL CHEM, V267, P23435; TRACY PB, 1986, BIOCH PLATELETS, P296; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VANDENAKKER WMR, 1990, FEBS LETT, V276, P123, DOI 10.1016/0014-5793(90)80523-L; WAGNER SL, 1988, BIOCHEMISTRY-US, V27, P2173, DOI 10.1021/bi00406a053; WAGNER SL, 1989, J BIOL CHEM, V264, P611; WING LR, 1991, FEBS LETT, V278, P95, DOI 10.1016/0014-5793(91)80092-H; YE RD, 1988, J BIOL CHEM, V263, P4869; YE RD, 1987, J BIOL CHEM, V262, P3718; YE RD, 1989, J BIOL CHEM, V264, P5495	73	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21560	21568						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408007				2022-12-27	WOS:A1993MC80900023
J	OSBORNE, CB; LOWE, KE; SHANE, B				OSBORNE, CB; LOWE, KE; SHANE, B			REGULATION OF FOLATE AND ONE-CARBON METABOLISM IN MAMMALIAN-CELLS .1. FOLATE METABOLISM IN CHINESE-HAMSTER OVARY CELLS EXPRESSING ESCHERICHIA-COLI OR HUMAN FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE SYNTHETASE; DEPENDENT ENZYMES; INVITRO SYNTHESIS; FOLC GENE; PROTEINS; ANALOGS; ACID; FOLYLPOLYGLUTAMATES; IDENTIFICATION; METHOTREXATE	Chinese hamster ovary (CHO) cell transfectants expressing various levels of human and Escherichia coli folylpoly-gamma-glutamate synthetase (FPGS) activity and possessing different folylpolyglutamate chain length distributions have been developed as models for folate and antifolate metabolism. The synthesis of pteroyltriglutamate was sufficient for normal cellular retention of folate and also overcame the phenotypic requirement for purines and thymidine of AUXB1, a CHO cell mutant lacking FPGS activity and lacking folylpolyglutamates. Only low levels of FPGS are required to enable cellular metabolism of folates to forms that are retained by mammalian cells. The higher levels found in mammalian cells are required for the synthesis of the long chain polyglutamate derivatives characteristic of mammalian cells. At low medium folate concentrations, folate accumulation by transfectants expressing human FPGS was not responsive to FPGS levels as the limiting step in metabolism was beyond the triglutamate, the chain length required for retention. The rate-limiting step in folate metabolism in cells expressing the E. coli enzyme was the conversion of diglutamate to triglutamate, and, at low FPGS levels, the E. coli enzyme was about 50-fold less effective than the human FPGS in enabling cellular folate accumulation. These data suggest that cellular accumulation of any folate analog whose mono- or diglutamate derivative is a poor substrate for FPGS would be very responsive to the level of FPGS activity.	UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley					NCI NIH HHS [CA-41991] Funding Source: Medline; NIGMS NIH HHS [GM073079] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOGNAR AL, 1987, J BIOL CHEM, V262, P12337; BOGNAR AL, 1985, J BIOL CHEM, V260, P5625; BOGNAR AL, 1986, METHOD ENZYMOL, V122, P349; BORMAN LS, 1989, J CELL PHYSIOL, V140, P335, DOI 10.1002/jcp.1041400220; BRODY T, 1989, PTERIDINS, V1, P159; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P504, DOI 10.1021/bi00376a024; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P513, DOI 10.1021/bi00376a025; COLL RJ, 1991, BIOCHEM PHARMACOL, V42, P833, DOI 10.1016/0006-2952(91)90043-5; COOK JD, 1987, BIOCHEMISTRY-US, V26, P530, DOI 10.1021/bi00376a027; FERNANDES DJ, 1983, CANCER RES, V43, P1117; FERONE R, 1986, J BIOL CHEM, V261, P6363; FERONE R, 1986, J BIOL CHEM, V261, P6356; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; FOO SK, 1982, J BIOL CHEM, V257, P13587; GARROW TA, 1992, P NATL ACAD SCI USA, V89, P9151, DOI 10.1073/pnas.89.19.9151; GEORGE S, 1987, BIOCHEMISTRY-US, V26, P522, DOI 10.1021/bi00376a026; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGAN RL, 1991, BIOCHEM PHARMACOL, V41, P781, DOI 10.1016/0006-2952(91)90081-F; KIM JS, 1993, J BIOL CHEM, V268, P21680; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN BF, 1993, J BIOL CHEM, V268, P21674; LOWE KE, 1993, J BIOL CHEM, V268, P21665; Maniatis T., 1982, MOL CLONING; MATHERLY LH, 1990, CANCER RES, V50, P3262; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCGUIRE JJ, 1987, CANCER RES, V47, P5975; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; OCONNOR BM, 1991, CANCER RES, V51, P3874; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SAMUELS LL, 1985, CANCER RES, V45, P1488; SHANE B, 1986, METHOD ENZYMOL, V122, P323; SHANE B, 1989, VITAM HORM, V45, P263; SHANE B, 1982, AM J CLIN NUTR, V35, P599, DOI 10.1093/ajcn/35.3.599; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUSSMAN DJ, 1986, SOMAT CELL MOLEC GEN, V12, P531, DOI 10.1007/BF01671939; SUSSMAN DJ, 1986, ANAL BIOCHEM, V158, P371, DOI 10.1016/0003-2697(86)90563-4; TAYLOR RT, 1985, MUTAT RES, V151, P293, DOI 10.1016/0027-5107(85)90082-X; TAYLOR RT, 1977, ARCH BIOCHEM BIOPHYS, V181, P331, DOI 10.1016/0003-9861(77)90512-4; TAYLOR RT, 1979, ARCH BIOCHEM BIOPHYS, V197, P36, DOI 10.1016/0003-9861(79)90215-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER C, 1986, FOLATES PTERINS, V3, P251; WEITMAN SD, 1992, CANCER RES, V52, P3396	44	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21657	21664						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408018				2022-12-27	WOS:A1993MC80900037
J	SHIH, DM; WALL, RJ; SHAPIRO, SG				SHIH, DM; WALL, RJ; SHAPIRO, SG			A 5' CONTROL REGION OF THE HUMAN EPSILON-GLOBIN GENE IS SUFFICIENT FOR EMBRYONIC SPECIFICITY IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-GAMMA-GLOBIN; GREEK HEREDITARY PERSISTENCE; LOCUS ACTIVATION REGION; ERYTHROID-SPECIFIC EXPRESSION; STAGE-SPECIFIC EXPRESSION; BETA-GLOBIN; FETAL HEMOGLOBIN; DEVELOPMENTAL REGULATION; HYPERSENSITIVE SITE; 5'-FLANKING REGION	When introduced as part of DNA constructions containing the human beta-globin locus control region (LCR), the human embryonic beta-globin gene, epsilon, is expressed in primitive but not definitive erythroid cells of recipient transgenic mice. In contrast to this pattern, the hu an fetal, beta-globin gene, gamma, has been shown to be expressed in both primitive and definitive erythroid cells of transgenic mice when introduced in similar LCR-containing constructions. To begin to identify the minimal sequence(s) necessary for the epsilon expression pattern, we have fused a DNA fragment that contains the human epsilon-globin gene promoter region, and 13.7-kilobase (kb) of contiguous upstream flanking sequence containing super-hypersensitive (HS) sites 5'HS-2 and 5'HS-1 of the globin LCR, to the structural portion and near 3'-flanking region of the human gamma-globin gene. This construction, and one containing an intact human gamma-globin gene with the same 3'-flanking sequence and 383 base pairs of 5'-flanking sequence linked to LCR DNA from -0.86 to -13.7 kb upstream of epsilon, were each microinjected to produce transgenic mice. While the construction containing the intact gamma-globin gene is transcriptionally active in primitive and definitive erythroid cells of the transgenic mice, the fusion construction, in which the gamma-globin gene promoter and promoter proximal region is essentially replaced by that of epsilon, is not active in definitive erythroid cells and expresses with the same pattern as an intact epsilon gene. These results indicate that the promoter and near 5'-flanking region of epsilon, when linked to the LCR, is sufficient for embryonic-specific expression in transgenic mice. The level of expression of the fusion construction in primitive erythroid cells of transgenic mice is similar to that previously observed for the intact epsilon gene when identically cloned. This suggests that the epsilon 5'-region of the fusion construction also contains all the sequence necessary for the LCR-dependent activation of epsilon in transgenic mice.	UNIV MARYLAND,DEPT ZOOL,COLLEGE PK,MD 20742; UNIV MARYLAND,PROGRAM MOLEC & CELL BIOL,COLLEGE PK,MD 20742; USDA ARS,BELTSVILLE AGR RES CTR,GENE EVALUAT & MAPPING LAB,BELTSVILLE,MD 20705	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)								BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P4894, DOI 10.1073/pnas.81.15.4894; CURTIN PT, 1989, P NATL ACAD SCI USA, V86, P7082, DOI 10.1073/pnas.86.18.7082; DILLON N, 1991, NATURE, V350, P252, DOI 10.1038/350252a0; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; ENVER T, 1989, P NATL ACAD SCI USA, V86, P7033, DOI 10.1073/pnas.86.18.7033; FANTONI A, 1967, SCIENCE, V157, P1327, DOI 10.1126/science.157.3794.1327; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; GELINAS R, 1985, NATURE, V313, P323, DOI 10.1038/313323a0; GIGLIONI B, 1984, EMBO J, V3, P2641, DOI 10.1002/j.1460-2075.1984.tb02187.x; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUTMAN PD, 1992, GENE, V110, P197, DOI 10.1016/0378-1119(92)90648-9; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; HANSEN JN, 1982, J BIOL CHEM, V257, P1048; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; KARLSSON S, 1985, ANNU REV BIOCHEM, V54, P1071; KIOUSSIS D, 1985, EMBO J, V4, P927, DOI 10.1002/j.1460-2075.1985.tb03720.x; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; LIN HJ, 1987, J CLIN INVEST, V80, P374, DOI 10.1172/JCI113082; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; LUSE DS, 1981, NUCLEIC ACIDS RES, V9, P4339, DOI 10.1093/nar/9.17.4339; MAGRAM J, 1985, NATURE, V315, P338, DOI 10.1038/315338a0; OTTOLENGHI S, 1988, BLOOD, V71, P815; PEREZSTABLE C, 1990, MOL CELL BIOL, V10, P1116, DOI 10.1128/MCB.10.3.1116; RAICH N, 1990, SCIENCE, V250, P1147, DOI 10.1126/science.2251502; RAICH N, 1992, BLOOD, V79, P861; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SHIH DM, 1990, NUCLEIC ACIDS RES, V18, P5465, DOI 10.1093/nar/18.18.5465; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SURREY S, 1988, BLOOD, V71, P807; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; TRUDEL M, 1987, MOL CELL BIOL, V7, P4024, DOI 10.1128/MCB.7.11.4024; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; YU CY, 1991, J BIOL CHEM, V266, P8907	43	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3066	3071						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428985				2022-12-27	WOS:A1993KM16100012
J	HAMILTON, JA; STEINRAUF, LK; BRADEN, BC; LIEPNIEKS, J; BENSON, MD; HOLMGREN, G; SANDGREN, O; STEEN, L				HAMILTON, JA; STEINRAUF, LK; BRADEN, BC; LIEPNIEKS, J; BENSON, MD; HOLMGREN, G; SANDGREN, O; STEEN, L			THE X-RAY CRYSTAL-STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL-30-]MET VARIANT TO 1.7-A RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLASMA PREALBUMIN; AMINO-ACID-SEQUENCE; PRE-ALBUMIN; THYROXINE-BINDING; MACROMOLECULAR STRUCTURES; CHOROID-PLEXUS; PROTEIN; POLYNEUROPATHY; BRAIN; GENE	The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-angstrom resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (F(obs) > 2.0sigma). Standard deviations for stereochemical parameters are 0.018 and 0.022 angstrom for bond distances, 0.030 and 0.038 angstrom for angle distances, and 0.035 and 0.070 A for planar 14 distances. The newly refined normal structure shows improvement over the original structure of Blake and Swan (Blake, C. C. F., and Swan, I. D. A. (1971) J. Mol. Biol. 61, 217-224) in stereochemistry and in the conformation of the loop regions. Residues Arg-103, Thr-123, Asn-124, and Pro-125 have now been resolved, and residues 1-9 and 126-127 have been modeled with the aid of simulated annealing refinement. The functional form of transthyretin is a tetramer, having a cylindrical cavity which will bind thyroxine and an exterior binding site for the complex of retinol with retinol-binding protein. The monomer is a beta barrel flattened to become more like a sandwich with residue 30 in the interior. The methionyl for valyl substitution forces the beta sheets of the monomer as much as 1 angstrom apart, resulting in a distortion of the thyroxine-binding cavity, in agreement with the independent observations that the Met-30 variant has low affinity for thyroxine.	INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202; UMEA UNIV,DEPT CLIN GENET,S-90187 UMEA,SWEDEN; UMEA UNIV,DEPT OPHTHALMOL,S-90187 UMEA,SWEDEN; UMEA UNIV,DEPT CLIN MED,S-90187 UMEA,SWEDEN	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Umea University; Umea University; Umea University	HAMILTON, JA (corresponding author), INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202, USA.			Hamilton, James/0000-0002-4747-7071	NCRR NIH HHS [RR-00750] Funding Source: Medline; NIDDK NIH HHS [NIDDK-34881, NIDDK-42111] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034881, R01DK042111] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENSON MD, 1981, J CLIN INVEST, V67, P1035, DOI 10.1172/JCI110114; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; CHAMBERS JL, 1979, ACTA CRYSTALLOGR B, V35, P1861, DOI 10.1107/S0567740879007925; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; COSTA PP, 1978, P NATL ACAD SCI USA, V75, P4499, DOI 10.1073/pnas.75.9.4499; CRUICKSHANK DWJ, 1949, ACTA CRYSTALLOGR, V2, P65, DOI 10.1107/S0365110X49000175; DICKSON PW, 1985, BIOCHEM BIOPH RES CO, V127, P890, DOI 10.1016/S0006-291X(85)80027-9; DICKSON PW, 1985, J BIOL CHEM, V260, P8214; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; FELDING P, 1982, BIOCHIM BIOPHYS ACTA, V716, P446, DOI 10.1016/0304-4165(82)90040-X; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; HAMILTON JA, 1992, BIOCHIM BIOPHYS ACTA, V1139, P9, DOI 10.1016/0925-4439(92)90075-X; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JONES AL, 1992, 2ND P INT S FAM AM P, P61; JONES TA, 1982, COMPUTATIONAL CRYSTA, P3303; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; KANDA Y, 1974, J BIOL CHEM, V249, P6796; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MITA S, 1986, NEUROLOGY, V36, P298, DOI 10.1212/WNL.36.2.298; MITA S, 1986, J BIOCHEM-TOKYO, V100, P1215, DOI 10.1093/oxfordjournals.jbchem.a121826; REFETOFF S, 1986, J CLIN ENDOCR METAB, V63, P1432, DOI 10.1210/jcem-63-6-1432; ROBBINS J, 1960, PHYSIOL REV, V40, P415, DOI 10.1152/physrev.1960.40.3.415; SARAIVA MJM, 1991, AMYLOID AND AMYLOIDOSIS 1990, P569; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; STEINRAUF LK, 1993, J BIOL CHEM, V268, P2425; STEINRAUF LK, 1991, BIOCHEM BIOPH RES CO, V179, P804, DOI 10.1016/0006-291X(91)91888-J; SUNDELIN J, 1985, J BIOL CHEM, V260, P6481; TSUZUKI T, 1985, J BIOL CHEM, V260, P2224; WAKASUGI S, 1985, J BIOCHEM-TOKYO, V98, P1707, DOI 10.1093/oxfordjournals.jbchem.a135442; WAKASUGI S, 1986, J BIOCHEM-TOKYO, V100, P49, DOI 10.1093/oxfordjournals.jbchem.a121705	38	221	224	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2416	2424						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428915				2022-12-27	WOS:A1993KK81500028
J	HEEB, MJ; MESTERS, RM; TANS, G; ROSING, J; GRIFFIN, JH				HEEB, MJ; MESTERS, RM; TANS, G; ROSING, J; GRIFFIN, JH			BINDING OF PROTEIN-S TO FACTOR VA ASSOCIATED WITH INHIBITION OF PROTHROMBINASE THAT IS INDEPENDENT OF ACTIVATED PROTEIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-XA; VENOUS THROMBOEMBOLISM; ANTICOAGULANT ACTIVITY; MONOCLONAL-ANTIBODIES; C4B-BINDING PROTEIN; DEFICIENCY; INACTIVATION; PLASMA; PLATELETS; IDENTIFICATION	Since plasma protein S serves an anticoagulant function by mechanisms which are not completely understood, its possible interaction with Factor Va was investigated. Human protein S bound to immobilized human Factor Va in a calcium-dependent, saturable, and reversible manner and Factor Va bound similarly to immobilized protein S. Binding of protein S to immobilized Factor V was greatly enhanced by pretreatment of the surface-bound Factor V with increasing doses of thrombin up to 1 unit/ml. Binding of protein S to Factor Va was also demonstrated in fluid phase with a K(d) of 33 +/- 9 nM. Biotin-labeled heavy chain of Factor Va bound to immobilized protein S, and this binding was reversed by a 17-fold molar excess of intact unlabeled Factor Va. Protein S competed efficiently with prothrombin for binding to immobilized Factor Va. The prothrombinase activity in a reaction mixture of purified clotting factors was inhibited by protein S and exhibited a pattern of mixed inhibition. The concentration of protein S needed for 50% inhibition of the prothrombinase activity of a mixture containing 1 nm Factor Xa, 20 pm Factor Va, and 50 muM phospholipids was about 16 nM. Since not all protein S preparations exhibited this degree of prothrombinase inhibitory activity, extensive control experiments were performed to verify that the inhibitory activity was associated with protein S during immunoaffinity chromatography and was not caused by traces of activated protein C in the protein S preparations. These data show that protein S has an anticoagulant function which is independent of activated protein C and, at least in part, that this is because of its competition with prothrombin for direct binding to Factor Va.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, BCR-5, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA; UNIV LIMBURG, DEPT BIOCHEM, 6229 MAASTRICHT, NETHERLANDS	Scripps Research Institute; Scripps Research Institute; Maastricht University				Griffin, John/0000-0002-4302-2547	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-21544] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERTINA RM, 1985, HAEMOSTASIS, V15, P241; BROEKMANS AW, 1985, THROMB HAEMOSTASIS, V53, P273; CLEZARDIN P, 1985, J CHROMATOGR, V319, P67, DOI 10.1016/S0021-9673(01)90540-0; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GARDINER JE, 1984, CIRCULATION, V70, P205; GLADSON CL, 1988, THROMB HAEMOSTASIS, V59, P18; GRIFFIN JH, 1992, BLOOD, V79, P3203; GRUBER A, 1989, BLOOD, V73, P639; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; HARRIS KW, 1985, J BIOL CHEM, V260, P2007; HEEB MJ, 1988, THROMB RES, V52, P33, DOI 10.1016/0049-3848(88)90038-2; HILLARP A, 1991, THROMB HAEMOSTASIS, V65, P710; JANE SM, 1991, BLOOD COAGUL FIBRIN, V2, P723, DOI 10.1097/00001721-199112000-00005; LUNDWALL A, 1986, P NATL ACAD SCI USA, V83, P6716, DOI 10.1073/pnas.83.18.6716; MANNUCCI PM, 1986, THROMB HAEMOSTASIS, V55, P440; MESTERS RM, 1991, J BIOL CHEM, V266, P24514; MITCHELL CA, 1988, J CLIN INVEST, V82, P2142, DOI 10.1172/JCI113836; MITCHELL CA, 1988, THROMB HAEMOSTASIS, V60, P298; NELSON RM, 1991, BIOCHEMISTRY-US, V30, P2384, DOI 10.1021/bi00223a013; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21794; SCHWARZ HP, 1984, BLOOD, V64, P1297; SCHWARZ HP, 1985, BLOOD, V66, P1452; SCHWARZ HP, 1986, THROMB HAEMOSTASIS, V56, P382; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; STENFLO J, 1979, FEBS LETT, V101, P377, DOI 10.1016/0014-5793(79)81048-0; STERN DM, 1986, J BIOL CHEM, V261, P713; SUZUKI K, 1984, J BIOCHEM-TOKYO, V96, P455, DOI 10.1093/oxfordjournals.jbchem.a134857; TANS G, 1991, BLOOD, V77, P2641; UPDYKE TV, 1984, J IMMUNOL METHODS, V73, P83, DOI 10.1016/0022-1759(84)90034-6; WALKER FJ, 1986, J BIOL CHEM, V261, P941; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1980, J BIOL CHEM, V255, P5521	37	214	218	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2872	2877						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428962				2022-12-27	WOS:A1993KK81500090
J	LIVRELLI, V; LEE, IW; SUMMERS, AO				LIVRELLI, V; LEE, IW; SUMMERS, AO			INVIVO DNA-PROTEIN INTERACTIONS AT THE DIVERGENT MERCURY RESISTANCE (MER) PROMOTERS .1. METALLOREGULATORY PROTEIN MERR MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; TRANSCRIPTIONAL ACTIVATION; REGULATORY PROTEIN; RNA-POLYMERASE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RECEPTOR-SITE; BINDING; COMPLEX; REPRESSION	Regulation of transcriptional initiation of the Tn21 mercury resistance (mer) operon occurs at the diver gent promoter region lying between the structural genes (merTPCAD) and a regulatory gene (merR). During repression, both promoters are negatively regulated by MerR bound to a dyadic operator located between the -10 and -35 hexamers of P(TPCAD). Upon Hg(II) induction, MerR activates transcription only from P(TPCAD) and continues to repress transcription from P(R). Using in vivo dimethyl sulfate and KMnO4 footprinting of the merOP region of strains carrying wild-type MerR or MerR mutants, we have dissected the steps in MerR-mediated positive and negative regulation of the divergent mer promoters. The greater sensitivity of primer extension footprinting allowed the resolution of details previously undetectable in vivo. Two MerR mutants unable to bind merOP DNA allow RNA polymerase to form an open complex preferentially at P(R). The intensity of the P(R) open complex is considerably less than that which occurs upon MerR-Hg(II) activation of P(TPCAD) and considerably greater than that which occurs at P(TPCAD) when MerR is deleted; this is the first in vivo estimate of the relative strengths of these two promoters. Although retaining the wild-type capacity to sequester RNA polymerase in the closed complex, the four MerR mutants defective in Hg(II) binding do not distort the dyad DNA or foster open complex formation when the inducer is added. Two activation-defective MerR mutants foster closed complex formation as well as wild-type, but they do not distort the dyad DNA or foster open complex formation when the inducer is added, although they are also able to bind Hg(II). Two semiconstitutive inducible MerR mutants differ from each other in that one (which lies nearer the COOH terminus) does distort the dyad center upon Hg(II) induction, whereas the other (which lies in near the center of merR) exhibits no dyad distortion upon induction. Paradoxically, despite their relatively strong semiconstitutive expression of mer-lac transcriptional fusions, neither of these mutants has a detectable open complex in the absence of added Hg(II).	UNIV GEORGIA, DEPT MICROBIOL, ATHENS, GA 30602 USA	University System of Georgia; University of Georgia				Summers, Anne/0000-0003-4258-9696	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028211] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28211] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0; AUSTIN S, 1991, NUCLEIC ACIDS RES, V19, P2281, DOI 10.1093/nar/19.9.2281; BHRIAIN NNN, 1983, J BACTERIOL, V155, P690, DOI 10.1128/JB.155.2.690-703.1983; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; CROSA JH, 1981, MANUAL METHODS GENER; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HELMANN JD, 1990, SCIENCE, V247, P946, DOI 10.1126/science.2305262; HELMANN JD, 1989, J BACTERIOL, V171, P222, DOI 10.1128/jb.171.1.222-229.1989; HELTZEL A, 1987, J BACTERIOL, V169, P3379, DOI 10.1128/jb.169.7.3379-3384.1987; HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011; IRWIN N, 1987, P NATL ACAD SCI USA, V84, P8315, DOI 10.1073/pnas.84.23.8315; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LADDAGA RA, 1987, P NATL ACAD SCI USA, V84, P5106, DOI 10.1073/pnas.84.15.5106; LEE IW, 1989, J BACTERIOL, V171, P2222, DOI 10.1128/jb.171.4.2222-2225.1989; LEE IW, 1993, J BIOL CHEM, V268, P2632; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; LUND P, 1989, NUCLEIC ACIDS RES, V17, P5517, DOI 10.1093/nar/17.14.5517; LUND PA, 1986, J GEN MICROBIOL, V132, P465; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MINCHIN SD, 1989, EMBO J, V8, P3491, DOI 10.1002/j.1460-2075.1989.tb08514.x; MISRA TK, 1992, PLASMID, V27, P4, DOI 10.1016/0147-619X(92)90002-R; MORETT E, 1989, J MOL BIOL, V210, P65, DOI 10.1016/0022-2836(89)90291-X; MUKHOPADHYAY D, 1991, J BIOL CHEM, V266, P18538; OHALLORAN T, 1987, SCIENCE, V235, P211, DOI 10.1126/science.3798107; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; PARK SJ, 1992, J BACTERIOL, V174, P2160, DOI 10.1128/JB.174.7.2160-2171.1992; PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; Sambrook J, 1989, MOL CLONING LABORATO; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P146; SHEWCHUK LM, 1989, BIOCHEMISTRY-US, V28, P2331, DOI 10.1021/bi00431a052; SHEWCHUK LM, 1989, BIOCHEMISTRY-US, V28, P2340, DOI 10.1021/bi00431a053; STRANEY DC, 1989, J MOL BIOL, V206, P41, DOI 10.1016/0022-2836(89)90522-6; SUMEMRS AO, 1992, J BACTERIOL, V174, P3097; WATTON SP, 1990, J AM CHEM SOC, V112, P2824, DOI 10.1021/ja00163a067; WRIGHT JG, 1990, J AM CHEM SOC, V112, P2434, DOI 10.1021/ja00162a062	40	29	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2623	2631						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428939				2022-12-27	WOS:A1993KK81500056
J	WILKISON, WO; SPIEGELMAN, BM				WILKISON, WO; SPIEGELMAN, BM			BIOSYNTHESIS OF THE VASOACTIVE LIPID MONOBUTYRIN - CENTRAL ROLE OF DIACYLGLYCEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; RAT ADIPOSE-TISSUE; PROTEIN KINASE-C; 3T3 ADIPOCYTES; CELLS; ANGIOGENESIS; STIMULATION; SPECIFICITY; METABOLISM; MECHANISM	Monobutyrin (1-butyrylglycerol) is a simple lipid secreted by adipocytes that stimulates both angiogenesis and vasodilation of microvascular beds. While monobutyrin production is increased during lipolysis, little is known about the biosynthetic pathway of this short chain monoacylglycerol. We show here that diacylglycerol, an intermediate in the lipolytic pathway, can stimulate monobutyrin synthesis from an adipocyte particulate fraction and does so by acting as a substrate. The biosynthetic route involves the acylation of diacylglycerol with butyryl-CoA to form a transient triacylglycerol intermediate. This intermediate is then hydrolyzed by a lipase(s) with specificity for long chain fatty acyl groups to form monobutyrin. Based on this information, a novel pathway for the synthesis of monobutyrin is proposed. Preliminary characterization of these enzymatic activities with respect to their cell-type specificity indicates that the acyltransferase activity is found in several cell types, albeit at lower levels than in adipocytes. The lipase activity appears to be two distinct steps, with both steps being adipocyte differentiation-dependent. These results indicate the likely biochemical basis for the restriction of monobutyrin synthesis to fat cells and also suggests a molecular basis for the close linkage between lipolysis, monobutyrin synthesis, and vasodilation.	HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	WILKISON, WO (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042420, F32DK008277] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42420, DK08277] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDINEJAD A, 1981, ARCH BIOCHEM BIOPHYS, V208, P135, DOI 10.1016/0003-9861(81)90132-6; BISHOP WR, 1986, J BIOL CHEM, V261, P2513; BOWERY B, 1973, BRIT J PHARMACOL, V47, P305, DOI 10.1111/j.1476-5381.1973.tb08328.x; BUGAUT M, 1989, LIPIDS, V24, P193, DOI 10.1007/BF02535234; CASTELLOT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P5597, DOI 10.1073/pnas.79.18.5597; CASTELLOT JJ, 1986, J CELL PHYSIOL, V127, P323, DOI 10.1002/jcp.1041270221; CASTELLOT JJ, 1980, P NATL ACAD SCI-BIOL, V77, P6007, DOI 10.1073/pnas.77.10.6007; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; DALTON C, 1974, PROSTAG OTH LIPID M, V6, P227, DOI 10.1016/S0090-6980(74)80050-X; DOBSON DE, 1990, CELL, V61, P223, DOI 10.1016/0092-8674(90)90803-M; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fleischer S, 1974, Methods Enzymol, V31, P6; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; FREDRIKSON G, 1983, J BIOL CHEM, V258, P4253; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; GANONG BR, 1986, CELL MEMBRANES METHO; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; HANSEN JK, 1980, BIOCHEM J, V186, P287, DOI 10.1042/bj1860287; KRAEMER FB, 1991, J LIPID RES, V32, P1303; MARSHALL MO, 1979, EUR J BIOCHEM, V94, P93, DOI 10.1111/j.1432-1033.1979.tb12875.x; MARSHALL MO, 1977, EUR J BIOCHEM, V81, P259, DOI 10.1111/j.1432-1033.1977.tb11947.x; MICHELL RH, 1988, PHILOS T ROY SOC B, V320, P239, DOI 10.1098/rstb.1988.0074; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RIZACK MA, 1961, J BIOL CHEM, V236, P657; ROSELL S, 1979, PHYSIOL REV, V59, P1078, DOI 10.1152/physrev.1979.59.4.1078; SCHUTE HR, 1975, BIOCHIM BIOPHYS ACTA, V409, P283; SHULZ H, 1990, FATTY ACID OXIDATION, P23; THIDINH KLK, 1990, LIPIDS, V25, P278, DOI 10.1007/BF02544388; WASSERMANN F., 1965, HANDBOOK PHYSIOL, V5, P87; WILKISON WO, 1991, J BIOL CHEM, V266, P16886; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N; ZINDER O, 1973, J BIOL CHEM, V248, P7673	35	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2844	2849						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428959				2022-12-27	WOS:A1993KK81500086
J	COX, DA; MATLIB, MA				COX, DA; MATLIB, MA			A ROLE FOR THE MITOCHONDRIAL NA+-CA2+ EXCHANGER IN THE REGULATION OF OXIDATIVE-PHOSPHORYLATION IN ISOLATED HEART-MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMITOCHONDRIAL CA-2+-SENSITIVE ENZYMES; SODIUM-CALCIUM EXCHANGE; RAT-HEART; 2-OXOGLUTARATE DEHYDROGENASE; PYRUVATE-DEHYDROGENASE; CARDIAC MITOCHONDRIA; MYOCARDIAL ISCHEMIA; ADENINE-NUCLEOTIDES; LIVER-MITOCHONDRIA; INHIBITORY-ACTION	The role of the Na+-Ca2+ exchanger of heart mitochondria in cellular functioning is not yet clear. The objectives of this study were to investigate the effects of stimulation and inhibition of the Na+-Ca2+ exchanger on the matrix free Ca2+ concentration in isolated heart mitochondria and to determine the consequences of these changes on the rate of NADH production via Krebs cycle turnover and the oxidative phosphorylation rate (OPR) supported by alpha-ketoglutarate dehydrogenase, a Ca2+-regulated matrix enzyme. Activation of Na+-Ca2+ exchange by increasing extramitochondrial Na+ concentration was found to decrease the matrix free [Ca2+] in a concentration-dependent manner. Inhibitors of mitochondrial Na+-Ca2+ exchange activity inhibited the decrease in matrix free [Ca2+] mediated by Na+. Increasing concentrations of Na+ were also found to inhibit both the rate of NADH production and OPR. Inhibitors of mitochondrial Na+-Ca2+ exchange also blocked the effects of Na+ on the rate of NADH production and OPR in a similar concentration range. The results indicate that alterations in matrix free [Ca2+] induced by changes in mitochondrial Na+-Ca2+ exchange activity are translated into changes in the rate of NADH production and the overall rate of oxidative phosphorylation.	UNIV CINCINNATI, DEPT PHARMACOL & CELL BIOPHYS, 231 BETHESDA AVE, CINCINNATI, OH 45267 USA	University of Cincinnati					NHLBI NIH HHS [R01-HL34664] Funding Source: Medline; PHS HHS [TO7382] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034664] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAYSAL K, 1991, ARCH BIOCHEM BIOPHYS, V291, P383, DOI 10.1016/0003-9861(91)90150-H; Carafoli E., 1978, CURR TOP MEMBR TRANS, V10, P151; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; CHIESI M, 1988, BIOCHEM PHARMACOL, V37, P4399, DOI 10.1016/0006-2952(88)90623-5; COX DA, 1983, IN PRESS J CARDIOVAS; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; CROMPTON M, 1978, EUR J BIOCHEM, V91, P599, DOI 10.1111/j.1432-1033.1978.tb12713.x; DAS AM, 1990, CARDIOVASC RES, V24, P411, DOI 10.1093/cvr/24.5.411; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; EDOUTE Y, 1979, J MOL CELL CARDIOL, V11, P831, DOI 10.1016/0022-2828(79)90408-5; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; GOSHIMA K, 1981, J MOL CELL CARDIOL, V13, P489, DOI 10.1016/0022-2828(81)90265-0; GROVER GJ, 1989, J CARDIOVASC PHARM, V14, P331, DOI 10.1097/00005344-198908000-00022; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALESTRAP AP, 1987, BIOCHEM J, V244, P159, DOI 10.1042/bj2440159; HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004; HAYAT LH, 1982, BIOCHEM J, V202, P509, DOI 10.1042/bj2020509; KATZ AM, 1988, AM J CARDIOL, V62, pA3, DOI 10.1016/S0002-9149(88)80077-8; LEE CO, 1975, J GEN PHYSIOL, V65, P695, DOI 10.1085/jgp.65.6.695; LOTSCHER HR, 1980, EUR J BIOCHEM, V110, P211, DOI 10.1111/j.1432-1033.1980.tb04857.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATLIB MA, 1985, BIOCHEM BIOPH RES CO, V128, P290, DOI 10.1016/0006-291X(85)91677-8; MATLIB MA, 1983, EUR J PHARMACOL, V89, P327, DOI 10.1016/0014-2999(83)90518-6; MATLIB MA, 1991, AM J HYPERTENS, V4, pS435, DOI 10.1093/ajh/4.7.435S; MATLIB MA, 1984, METHOD PHARMACOL, V5, P25; MCCORMACK JG, 1984, BIOCHEM J, V218, P235, DOI 10.1042/bj2180235; MCCORMACK JG, 1980, BIOCHEM J, V190, P95, DOI 10.1042/bj1900095; MCCORMACK JG, 1985, BIOCHEM J, V231, P581, DOI 10.1042/bj2310581; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; MCCORMACK JG, 1989, BIOCHIM BIOPHYS ACTA, V973, P420, DOI 10.1016/S0005-2728(89)80384-6; MCCORMACK JG, 1985, BIOCHEM SOC T, V13, P664, DOI 10.1042/bst0130664; MELA L, 1977, CURR TOP MEMBR TRANS, V9, P321; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; NAGAO T, 1980, J MOL CELL CARDIOL, V12, P29, DOI 10.1016/0022-2828(80)90109-1; PUSKIN JS, 1976, BIOCHEMISTRY-US, V15, P3834, DOI 10.1021/bi00662a029; RIZZUTO R, 1987, BIOCHEM J, V246, P271, DOI 10.1042/bj2460271; RUTTER GA, 1989, ANN NY ACAD SCI, V573, P206, DOI 10.1111/j.1749-6632.1989.tb14998.x; RUTTER GA, 1988, BIOCHEM J, V252, P181, DOI 10.1042/bj2520181; SOMLYO AP, 1986, J CARDIOVASC PHARM, V8, pS42, DOI 10.1097/00005344-198600088-00009; TAGAMI M, 1985, JPN HEART J, V26, P823; TANZ RD, 1982, J MOL CELL CARDIOL, V14, P655, DOI 10.1016/0022-2828(82)90163-8; THORN MB, 1953, BIOCHEM J, V54, P540, DOI 10.1042/bj0540540; VAGHY PL, 1982, J BIOL CHEM, V257, P6000; VANECHTELD CJA, 1991, J MOL CELL CARDIOL, V23, P297, DOI 10.1016/0022-2828(91)90066-U; WAN B, 1989, J BIOL CHEM, V264, P13430; WATTS J, 1987, EUR J PHARMACOL, V138, P335, DOI 10.1016/0014-2999(87)90471-7; WEISHAAR R, 1979, AM J CARDIOL, V43, P1137, DOI 10.1016/0002-9149(79)90144-9; WILLIAMSON JR, 1979, ANNU REV PHYSIOL, V41, P485, DOI 10.1146/annurev.ph.41.030179.002413; WOLSKA BM, 1991, J MOL CELL CARDIOL, V23, P217, DOI 10.1016/0022-2828(91)90108-X; YAMADA EW, 1981, J BIOL CHEM, V256, P203	54	139	140	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					938	947						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419373				2022-12-27	WOS:A1993KG07700030
J	SUGISAKI, H; TAKANAMI, M				SUGISAKI, H; TAKANAMI, M			THE 5'-TERMINAL REGION OF THE APOCYTOCHROME-B TRANSCRIPT IN CRITHIDIA-FASCICULATA IS SUCCESSIVELY EDITED BY 2 GUIDE RNAS IN THE 3' TO 5' DIRECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDASE SUBUNIT-III; MESSENGER-RNA; KINETOPLASTID MITOCHONDRIA; TRYPANOSOMA-BRUCEI; CYTOCHROME-OXIDASE; MAXICIRCLE DNA; MINICIRCLES; MOLECULES; SEQUENCE; DOMAINS	We analyzed the chimeric guide RNA (gRNA-mRNA molecules in Crithidia fasciculata that are predicted to transiently exist in editing of the 5'-terminal domain of apocytochrome b (CYb) mRNA, by polymerase chain reaction amplification and DNA sequencing, and obtained evidence suggesting that among the 14 editing sites numbered from 3' to 5', the sequence in the 3'-half of the sites (3' block) was specified by one guide RNA species (gRNA-I) and that in the remaining half of the sites (5' block) by the other guide RNA species (gRNA-II) and that the direction of editing in each block was 3' to 5'. The predicted transition site of editing by two gRNAs was between the first and second U residues from the 3' end within editing site 7. We found that a stretch of the edited sequence in the 3' block of mRNA could form a stable duplex with a stretch immediately upstream of the guide sequence in gRNA-II. The result leads to a successive editing model that the 3' block of pre-edited mRNA is first edited by gRNA-I, and after completion of editing, the 5' portion of gRNA-II pairs with the edited mRNA for editing of the 5' block.			SUGISAKI, H (corresponding author), KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN.							BENNE R, 1990, TRENDS GENET, V6, P177, DOI 10.1016/0168-9525(90)90173-4; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; BIRKENMEYER L, 1986, J BIOL CHEM, V261, P2362; BLUM B, 1991, CELL, V65, P543, DOI 10.1016/0092-8674(91)90087-F; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; CECH TR, 1991, CELL, V64, P667, DOI 10.1016/0092-8674(91)90494-J; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; FEAGIN JE, 1990, J BIOL CHEM, V265, P19373; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; POLLARD VW, 1991, MOL CELL BIOL, V11, P1668, DOI 10.1128/MCB.11.3.1668; POLLARD VW, 1990, CELL, V63, P783, DOI 10.1016/0092-8674(90)90144-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SLOOF P, 1987, NUCLEIC ACIDS RES, V15, P51, DOI 10.1093/nar/15.1.51; STUART K, 1991, TRENDS BIOCHEM SCI, V16, P68, DOI 10.1016/0968-0004(91)90027-S; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; STURM NR, 1991, NUCLEIC ACIDS RES, V19, P6277, DOI 10.1093/nar/19.22.6277; VANDERSPEK H, 1991, EMBO J, V10, P1217, DOI 10.1002/j.1460-2075.1991.tb08063.x; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3	24	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					887	891						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419367				2022-12-27	WOS:A1993KG07700023
J	DEWAARD, P; VANDERWAL, H; HUIJBERTS, GNM; EGGINK, G				DEWAARD, P; VANDERWAL, H; HUIJBERTS, GNM; EGGINK, G			HETERONUCLEAR NMR ANALYSIS OF UNSATURATED FATTY-ACIDS IN POLY(3-HYDROXYALKANOATES) - STUDY OF BETA-OXIDATION IN PSEUDOMONAS-PUTIDA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER PEROXISOMES; ESCHERICHIA-COLI; FLUORESCENT PSEUDOMONADS; REVISED PATHWAY; OLEOVORANS; POLYESTERS; C-13; SENSITIVITY; PROTEINS; COMPLEX	Poly(3-hydroxyalkanoates) (PHAs) were isolated from Pseudomonas putida KT2442 cultivated on petroselenic acid, oleic acid, and linoleic acid to study beta-oxidation of unsaturated fatty acids. Both saturated and unsaturated medium chain length 3-hydroxy fatty acids were found to be constituents of these polymers. With the aid of proton-detected multiple quantum coherence and proton-detected multiple bond coherence NMR spectra the structures of the unsaturated monomers were identified as 3-hydroxy-5-cis-tetradecanoate for PHA produced on oleic acid, and 3-hydroxy-6-cis-dodecanoate and 3-hydroxy-5-cis-8-cis-tetradecadienoate for PHA produced on linoleic acid. The identified structures, which are derived from fatty acid degradation intermediates, indicate a degradation of oleic acid via the enoyl-CoA isomerase-dependent route and a degradation of linoleic acid via the dienoyl-CoA reductase-dependent route.	AGROTECHNOL RES INST,POB 17,6700 AA WAGENINGEN,NETHERLANDS									BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BAX A, 1988, J AM CHEM SOC, V110, P7926, DOI 10.1021/ja00231a081; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BREMSER W, 1985, MAGN RESON CHEM, V23, P271, DOI 10.1002/mrc.1260230413; BRUHWILER D, 1986, J MAGN RESON, V69, P546, DOI 10.1016/0022-2364(86)90174-5; Doi Y., 1990, MICROBIAL POLYESTERS; Eggink G, 1990, NATO ASI SERIES; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; HUJIBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536; IMAMURA S, 1990, J BIOCHEM, V107, P184, DOI 10.1093/oxfordjournals.jbchem.a123023; JIN SJ, 1990, BIOCHEMISTRY-US, V29, P8540, DOI 10.1021/bi00489a006; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; PREUSTING H, 1990, MACROMOLECULES, V23, P4220, DOI 10.1021/ma00221a007; SCHULZ H, 1987, TRENDS BIOCHEM SCI, V12, P403, DOI 10.1016/0968-0004(87)90196-4; STOFFEL W, 1965, H-S Z PHYSIOL CHEM, V341, P76, DOI 10.1515/bchm2.1965.341.1.76; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; TSERNG KY, 1991, J BIOL CHEM, V266, P11614; WITHOLT B, 1972, J BACTERIOL, V109, P350, DOI 10.1128/JB.109.1.350-364.1972; YANG SY, 1986, J BIOL CHEM, V261, P2238; YANG SY, 1986, J BIOL CHEM, V261, P5390; YOU SY, 1989, J BIOL CHEM, V264, P16489; ZUIDERWEG ERP, 1990, J MAGN RESON, V86, P346, DOI 10.1016/0022-2364(90)90265-B	25	74	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					315	319						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416939				2022-12-27	WOS:A1993KE60300048
J	SIMBULAN, CMG; SUZUKI, M; IZUTA, S; SAKURAI, T; SAVOYSKY, E; KOJIMA, K; MIYAHARA, K; SHIZUTA, Y; YOSHIDA, S				SIMBULAN, CMG; SUZUKI, M; IZUTA, S; SAKURAI, T; SAVOYSKY, E; KOJIMA, K; MIYAHARA, K; SHIZUTA, Y; YOSHIDA, S			POLY(ADP-RIBOSE) POLYMERASE STIMULATES DNA POLYMERASE-ALPHA BY PHYSICAL ASSOCIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADENOSINE DIPHOSPHATE RIBOSE); ADENOSINE DIPHOSPHORIBOSYL TRANSFERASE; MESSENGER-RNA LEVELS; CALF THYMUS; ADP-RIBOSYLATION; TOPOISOMERASE-I; BINDING DOMAIN; PROTEIN FACTOR; STRAND BREAKS; RAT-LIVER	The direct effect of the eukaryotic nuclear DNA-binding protein poly(ADP-ribose) polymerase on the activity of DNA polymerase alpha was investigated. Homogenously purified poly(ADP-ribose) polymerase (5 to 10 mug/ml) stimulated the activity of immunoaffinity-purified calf or human DNA polymerase alpha by about 6 to 60-fold in a dose-dependent manner. It had no effect on the activities of DNA polymerase beta, DNA polymerase gamma, and primase, indicating that its effect is specific for DNA polymerase alpha. Apparently, poly(ADP-ribosyl)ation of DNA polymerase alpha was not necessary for the stimulation. The stimulatory activity is due to poly(ADP-ribose) polymerase itself since it was immunoprecipitated with a monoclonal antibody directed against poly(ADP-ribose) polymerase. Kinetic analysis showed that, in the presence of poly(ADP-ribose) polymerase, the saturation curve for DNA template primer became sigmoidal; at very low concentrations of DNA, it rather inhibited the reaction in competition with template DNA, while, at higher DNA doses, it greatly stimulated the reaction by increasing the V(max) of the reaction. By the automodification of poly(ADP-ribose) polymerase, however, both the inhibition at low DNA concentration and the stimulation at high DNA doses were largely lost. Furthermore, stimulation by poly(ADP-ribose) polymerase could not be attributed to its DNA-binding function alone since its fragment, containing only the DNA-binding domain, could not exert full stimulatory effect on DNA polymerase, as of the intact enzyme. Poly(ADP-ribose) polymerase is coimmunoprecipitated with DNA polymerase alpha, using anti-DNA polymerase alpha antibody, clearly showing that poly(ADP-ribose) polymerase may be physically associated with DNA polymerase alpha. In a crude extract of calf thymus, a part of poly(ADP-ribose) polymerase activity existed in a 400-kDa, as well as, a larger 700-kDa complex containing DNA polymerase alpha, suggesting the existence in vivo of a complex of these two enzymes.	NAGOYA UNIV,SCH MED,DIS MECHANISM & CONTROL RES INST,CANC CELL BIOL LAB,SHOWA KU,NAGOYA,AICHI 466,JAPAN; KOCHI MED SCH,DEPT MED CHEM,NANKOKU,KOCHI 78151,JAPAN	Nagoya University; Kochi University			Suzuki, Motoshi/I-7246-2014	Suzuki, Motoshi/0000-0003-0682-5006; Simbulan-Rosenthal, Ph.D, Cynthia M./0000-0002-5070-0342				Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; ANACHKOVA B, 1989, CYTOBIOS, V59, P19; BAKSI K, 1987, EXP CELL RES, V172, P110, DOI 10.1016/0014-4827(87)90098-X; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; BOULIKAS T, 1988, EMBO J, V7, P57, DOI 10.1002/j.1460-2075.1988.tb02783.x; BOULIKAS T, 1990, J BIOL CHEM, V265, P14638; BUKI KG, 1991, BIOCHEM BIOPH RES CO, V180, P496, DOI 10.1016/S0006-291X(05)81092-7; BURZIO L, 1972, FEBS LETT, V20, P29, DOI 10.1016/0014-5793(72)80009-7; CESARONE CF, 1990, BIOCHIM BIOPHYS ACTA, V1087, P241, DOI 10.1016/0167-4781(90)90211-J; CESARONE CF, 1990, BIOCHEM BIOPH RES CO, V171, P1037, DOI 10.1016/0006-291X(90)90788-O; COHEN JJ, 1982, BIOCHEMISTRY-US, V21, P4931, DOI 10.1021/bi00263a016; CREISSEN D, 1982, NATURE, V296, P271, DOI 10.1038/296271a0; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; EKI T, 1991, J BIOL CHEM, V266, P3087; FERRO AM, 1984, J BIOL CHEM, V259, P547; FRY M, 1987, J BIOL CHEM, V262, P8861; GILL DM, 1972, J BIOL CHEM, V247, P5964; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; ITAYA A, 1988, EUR J BIOCHEM, V174, P261, DOI 10.1111/j.1432-1033.1988.tb14092.x; ITOH S, 1979, J BIOL CHEM, V254, P3647; JACOBSON EL, 1983, J BIOL CHEM, V258, P103; JUMP DB, 1980, BIOCHEMISTRY-US, V19, P1024, DOI 10.1021/bi00546a030; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KASID UN, 1986, CARCINOGENESIS, V7, P327, DOI 10.1093/carcin/7.2.327; KASID UN, 1989, J BIOL CHEM, V264, P18687; KAWASAKI K, 1986, BIOCHEMISTRY-US, V25, P3044, DOI 10.1021/bi00358a046; LEHMANN AR, 1974, EXP CELL RES, V83, P63, DOI 10.1016/0014-4827(74)90688-0; OHASHI Y, 1986, BIOCHEM BIOPH RES CO, V140, P666, DOI 10.1016/0006-291X(86)90783-7; OHTSUKI M, 1984, FEBS LETT, V168, P275, DOI 10.1016/0014-5793(84)80261-6; PRITCHARD CG, 1983, J BIOL CHEM, V258, P9810; SAPP M, 1985, J BIOL CHEM, V260, P1550; SASTRY SS, 1990, BIOCHEM BIOPH RES CO, V167, P842, DOI 10.1016/0006-291X(90)92102-6; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; STONE PR, 1975, EXP CELL RES, V91, P95, DOI 10.1016/0014-4827(75)90145-7; TAMAI K, 1988, BIOCHIM BIOPHYS ACTA, V950, P263, DOI 10.1016/0167-4781(88)90122-4; TANAKA Y, 1984, J BIOL CHEM, V259, P6579; TANAKA Y, 1986, EUR J BIOCHEM, V155, P19, DOI 10.1111/j.1432-1033.1986.tb09453.x; THIBODEAU J, 1989, BIOCHEM CELL BIOL, V67, P653, DOI 10.1139/o89-097; TUBO RA, 1987, J BIOL CHEM, V262, P5857; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; USHIRO H, 1987, J BIOL CHEM, V262, P2352; YAGURA T, 1983, NUCLEIC ACIDS RES, V11, P6369, DOI 10.1093/nar/11.18.6369; YAMANAKA H, 1988, J BIOL CHEM, V263, P3879; YOSHIDA S, 1974, BIOCHIM BIOPHYS ACTA, V353, P463, DOI 10.1016/0005-2787(74)90052-5; YOSHIDA S, 1979, J BIOCHEM-TOKYO, V85, P1387, DOI 10.1093/oxfordjournals.jbchem.a132465; YOSHIDA S, 1989, J BIOCHEM-TOKYO, V106, P389, DOI 10.1093/oxfordjournals.jbchem.a122863; YOSHIDA S, 1983, BIOCHIM BIOPHYS ACTA, V741, P348, DOI 10.1016/0167-4781(83)90155-0	49	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					93	99						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416979				2022-12-27	WOS:A1993KE60300016
J	VOIGT, J; NAGEL, K				VOIGT, J; NAGEL, K			REGULATION OF ELONGATION FACTOR-G GTPASE ACTIVITY BY THE RIBOSOMAL STATE - THE EFFECTS OF INITIATION-FACTORS AND DIFFERENTIALLY BOUND TRANSFER-RNA, AMINOACYL-TRANSFER RNA, AND PEPTIDYL-TRANSFER RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC 3-SITE MODEL; ESCHERICHIA-COLI; MESSENGER-RNA; TRANSLATION; CYCLE	The elongation factor G (EF-G) is responsible for the translocation of the ribosome along the mRNA chain. Under in vitro conditions, EF-G exhibits a very active uncoupled GTPase activity which is dependent on the presence of ribosomes and is modulated by mRNA-dependent binding of tRNA. In the absence of tRNA, uncoupled EF-G GTPase is inhibited by initiation factors IF1 and IF3, but not by initiation factor IF2. In the presence of N-fMet-tRNA(fMet) and poly(A,U,G) or in the presence of N-acetyl-Phe-tRNA(Phe) and poly(U), initiation factor IF2 causes an additional decrease of the uncoupled EF-G GTPase activity. This effect, however, is dependent on the presence of IF1 and IF3 and is obviously due to the mRNA- and initiation factor-dependent binding of N-fMet-tRNA(fMet) and N-acetyl-Phe-tRNA(Phe), respectively, to the ribosomal P-site. Non-enzymatic binding of N-fMet-tRNA(fMet) and N-acetyl-Phe-tRNA(Phe), however, causes a stimulation of uncoupled EF-G GTPase activity. The same effects are observed for Met-tRNA, Phe-tRNA(Phe) and uncharged tRNA. These findings are discussed in the light of the three-site model of the ribosome and the mechanism of translocation.			VOIGT, J (corresponding author), TECH UNIV BRAUNSCHWEIG,INST BOT,MENDELSSOHNSTR 4,W-3300 BRAUNSCHWEIG,GERMANY.		Voigt, Juergen/H-2163-2011	Voigt, Juergen/0000-0002-8104-6443				CABRER B, 1976, J BIOL CHEM, V251, P1718; CHINALI G, 1980, J BIOL CHEM, V255, P7455; CHINALI G, 1982, EUR J BIOCHEM, V125, P415, DOI 10.1111/j.1432-1033.1982.tb06699.x; CHINALI G, 1973, EUR J BIOCHEM, V32, P463, DOI 10.1111/j.1432-1033.1973.tb02629.x; CHINALI G, 1973, BIOCHEM BIOPH RES CO, V54, P33, DOI 10.1016/0006-291X(73)90884-X; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; DAHLFORS AAR, 1990, J MOL BIOL, V216, P311; DUBNOFF JS, 1971, P NATL ACAD SCI USA, V68, P318, DOI 10.1073/pnas.68.2.318; DUBNOFF JS, 1971, METHOD ENZYMOL, V20, P248; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; GUPTA SL, 1971, BIOCHEMISTRY-US, V10, P4410, DOI 10.1021/bi00800a010; HAENNI AL, 1966, BIOCHIM BIOPHYS ACTA, V114, P135, DOI 10.1016/0005-2787(66)90261-9; HASELKORN R, 1973, ANN REV BIOCH, V41, P397; HAUSNER TP, 1988, J BIOL CHEM, V263, P13103; KAJI A, 1969, COLD SPRING HARB SYM, V34, P167, DOI 10.1101/SQB.1969.034.01.024; KAZIRO Y, 1969, COLD SPRING HARB SYM, V34, P385, DOI 10.1101/SQB.1969.034.01.045; KAZIROY, 1968, J BIOCHEM-TOKYO, V64, P423; KURIKI Y, 1974, J BIOL CHEM, V249, P7166; KURIKI Y, 1972, BIOCHEM BIOPH RES CO, V48, P700, DOI 10.1016/0006-291X(72)90405-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCASLENARD J, 1967, P NATL ACAD SCI USA, V57, P1050, DOI 10.1073/pnas.57.4.1050; MIALL SH, 1972, BIOCHEMISTRY-US, V11, P4826, DOI 10.1021/bi00775a028; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MODOLELL J, 1973, J BIOL CHEM, V248, P488; NAAKTGEBOREN N, 1977, EUR J BIOCHEM, V72, P49, DOI 10.1111/j.1432-1033.1977.tb11223.x; NAGEL K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P145, DOI 10.1016/0167-4781(92)90478-I; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; NOLL M, 1972, NATURE-NEW BIOL, V238, P225, DOI 10.1038/newbio238225a0; RHEINBERGER HJ, 1986, J BIOL CHEM, V261, P9133; SABOL S, 1970, NATURE, V228, P1269, DOI 10.1038/2281269a0; SANDER G, 1975, BIOCHEMISTRY-US, V14, P1805, DOI 10.1021/bi00680a001; SUBRAMAN.AR, 1968, P NATL ACAD SCI USA, V61, P761, DOI 10.1073/pnas.61.2.761; SUBRAMANIAN AR, 1970, NATURE, V228, P1273, DOI 10.1038/2281273a0; SUTTLE DP, 1973, BIOCHEM BIOPH RES CO, V51, P376, DOI 10.1016/0006-291X(73)91268-0; THACH SS, 1971, P NATL ACAD SCI USA, V68, P1791, DOI 10.1073/pnas.68.8.1791; VOIGT J, 1990, EUR J BIOCHEM, V194, P579, DOI 10.1111/j.1432-1033.1990.tb15655.x; Wahba A J, 1974, Methods Enzymol, V30, P3	37	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					100	106						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416917				2022-12-27	WOS:A1993KE60300017
J	FIORELLA, PD; GIGUERE, V; NAPOLI, JL				FIORELLA, PD; GIGUERE, V; NAPOLI, JL			EXPRESSION OF CELLULAR RETINOIC ACID-BINDING PROTEIN (TYPE-II) IN ESCHERICHIA-COLI - CHARACTERIZATION AND COMPARISON TO CELLULAR RETINOIC ACID-BINDING PROTEIN (TYPE-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SMALL-INTESTINE; T7 RNA-POLYMERASE; MOLECULAR-CLONING; PROMYELOCYTIC LEUKEMIA; NUCLEAR RECEPTOR; DIFFERENTIATION; PURIFICATION; SKIN; ESTERIFICATION; FLUORESCENCE	Cellular retinoic acid-binding protein type II, CRABP(II), has been expressed efficiently in Escherichia coli from the mouse cDNA and compared to E. coli-expressed cellular retinoic acid-binding protein type I, CRABP(I). CRABP(II) had a molecular weight approximately 15,700, a pl of 5.46, an A(max) of 350 nm with A350/A280 of 1.8, a fluorescence excitation maximum at 347 nm, and a fluorescence emission maximum at 465 nm (holoprotein). All-trans-retinoic acid and 3,4-didehydro-, 4-hydroxy-, 4-oxo-, 16-hydroxy-4-oxo-, and 18-hydroxy-retinoic acids bind CRABP(II) and CRABP(I) stoichiometrically (K(d) values no greater than approximately 10-20 nM). 9-cis-Retinoic acid exhibited saturation binding to both CRABP(II) and CRABP(I) with similar affinities, K(d) = approximately 50-70, as did 13-cis-retinoic acid, K(d) = approximately 160-240 nM, demonstrating that CRABP(II) and CRABP(I) have similar orders of selectivity for known retinoids. HoloCRABP(II) transferred approximately 70% of its all-trans-retinoic acid to CRABP(I), however, indicating that CRABP(II) has approximately a 3-fold lower affinity for stoichiometrically binding retinoids than CRABP(I). Stern-Volmer plots of both native and denatured CRABP(II) and CRABP(I) were consistent with comparable loci for the tryptophan residues and similar three-dimensional structures. These results suggest that CRABP(II) and CRABP(I), when expressed in vivo in excess of total retinoids, bind several ligands, and functional dissimilarities between the two proteins would not be related to unique preferences for known endogenous retinoids. Rather, CRABP(I) and CRABP(II) may modulate the steady-state concentrations of retinoids to different set points.	SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOCHEM,140 FARBER HALL,BUFFALO,NY 14214; HOSP SICK CHILDREN,RES INST,DIV ENDOCRINOL,TORONTO M5G 1X8,ONTARIO,CANADA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Giguere, Vincent/0000-0001-9567-3694	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK36870] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; ASTROM A, 1991, J BIOL CHEM, V266, P17662; BAILEY JS, 1988, J BIOL CHEM, V263, P9326; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BERMAN E, 1992, J CLIN PHARMACOL, V32, P296, DOI 10.1002/j.1552-4604.1992.tb03840.x; BLANCHETBARDON C, 1991, J AM ACAD DERMATOL, V24, P982, DOI 10.1016/0190-9622(91)70158-X; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; CROW JA, 1985, P NATL ACAD SCI USA, V82, P4707, DOI 10.1073/pnas.82.14.4707; DE LUCA LM, 1991, FASEB J, V5, P2924; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; ERIKSSON U, 1987, J CELL PHYSIOL, V133, P482, DOI 10.1002/jcp.1041330308; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; GIGUERE V, 1990, P NATL ACAD SCI USA, V87, P6233, DOI 10.1073/pnas.87.16.6233; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; KAKKAD BP, 1988, J BIOL CHEM, V263, P12916; KITAMOTO T, 1988, BIOCHEM BIOPH RES CO, V157, P1302, DOI 10.1016/S0006-291X(88)81016-7; LACKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P258; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; LI E, 1991, J BIOL CHEM, V266, P3622; Lotan R, 1988, Prog Clin Biol Res, V259, P261; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; MADEN M, 1988, NATURE, V335, P733, DOI 10.1038/335733a0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MORRISSKAY G, 1992, CANCER SURV, V14, P181; OLSEN EA, 1992, J AM ACAD DERMATOL, V26, P215, DOI 10.1016/0190-9622(92)70030-J; ONG DE, 1982, J BIOL CHEM, V257, P13385; ONG DE, 1987, J BIOL CHEM, V262, P2729; ONG DE, 1978, J BIOL CHEM, V253, P4551; ONG DE, 1988, J BIOL CHEM, V263, P5789; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PILKINGTON T, 1992, DRUGS, V43, P597, DOI 10.2165/00003495-199243040-00010; POSCH KC, 1992, J BIOL CHEM, V267, P19676; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANI BP, 1978, BIOCHEM J, V173, P643, DOI 10.1042/bj1730643; STONER CM, 1989, CANCER RES, V49, P1497; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; SUBEITA HE, 1987, P NATL ACAD SCI USA, V84, P5645; TORMA H, 1991, SKIN PHARMACOL, V4, P246; VANHOLDE KE, 1985, PHYSICAL BIOCH, P58; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WEI LN, 1990, DNA CELL BIOL, V9, P471, DOI 10.1089/dna.1990.9.471; WINSTON MH, 1991, PEDIATR CLIN N AM, V38, P889; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; WOLF G, 1984, PHYSIOL REV, V64, P873, DOI 10.1152/physrev.1984.64.3.873; YOST RW, 1988, J BIOL CHEM, V263, P18693; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG JH, 1992, PROTEINS, V13, P87, DOI 10.1002/prot.340130202	58	88	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21545	21552						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408005				2022-12-27	WOS:A1993MC80900021
J	GIMBLE, FS; THORNER, J				GIMBLE, FS; THORNER, J			PURIFICATION AND CHARACTERIZATION OF VDE, A SITE-SPECIFIC ENDONUCLEASE FROM THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-I INTRON; UPSTREAM ACTIVATION SITE; MESSENGER-RNA MATURASE; FLANKING EXONS; MITOCHONDRIAL INTRON; DNA ENDONUCLEASE; ADENOSINE-TRIPHOSPHATASE; ENCODED PROTEINS; READING FRAME; S-CEREVISIAE	The 119-kDa primary translation product of the VMA1 gene of Saccharomyces cerevisiae undergoes a self-catalyzed rearrangement (''protein splicing'') that excises an internal 50-kDa segment of the polypeptide and joins the amino-terminal and carboxyl-terminal segments to generate the 69-kDa subunit of the vacuolar membrane-associated H+-ATPase. We have shown previously that the internal segment is a site-specific endonuclease (Gimble, F. S., and Thorner, J. (1992) Nature 357, 301-306). Here we describe methods for the high level expression and purification to near homogeneity of both the authentic VMA1-derived endonuclease (or VDE) from yeast (yield 18%) and a recombinant form of VDE made in bacteria (yield 29%). Detailed characterization of these preparations demonstrated that the yeast-derived and bacterially produced enzymes were indistinguishable, as judged by: (a) behavior during purification; (b) apparent native molecular mass (50 kDa); (c) immunological reactivity; and (d) catalytic properties (specific activity; cleavage site recognition; and optima for pH, temperature, divalent cation and ionic strength). The minimal site required for VDE cleavage was delimited to a 30-base pair sequence within its specific substrate (the VMA1DELTAvde allele).	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL, RM 401,BARKER HALL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley			THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841, R37GM021841] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANZIANO PQ, 1982, CELL, V30, P925, DOI 10.1016/0092-8674(82)90297-5; BELFORT M, 1990, ANNU REV GENET, V24, P363; BELLPEDERSEN D, 1990, NUCLEIC ACIDS RES, V18, P3763, DOI 10.1093/nar/18.13.3763; BELLPEDERSEN D, 1989, GENE, V82, P119, DOI 10.1016/0378-1119(89)90036-X; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMER MCD, 1992, NUCLEIC ACIDS RES, V20, P5484, DOI 10.1093/nar/20.20.5484; BURGER G, 1985, J MOL BIOL, V186, P231, DOI 10.1016/0022-2836(85)90100-7; CARIGNANI G, 1983, CELL, V35, P733, DOI 10.1016/0092-8674(83)90106-X; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; COOPER AA, 1993, EMBO J, V12, P2575, DOI 10.1002/j.1460-2075.1993.tb05913.x; CUMMINGS DJ, 1989, CURR GENET, V16, P407, DOI 10.1007/BF00340720; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415; DUJARDIN G, 1982, NATURE, V298, P628, DOI 10.1038/298628a0; DUJON B, 1980, CELL, V20, P185, DOI 10.1016/0092-8674(80)90246-9; EDDY SR, 1991, GENE DEV, V5, P1032, DOI 10.1101/gad.5.6.1032; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; HARLOW E, 1988, ANTIBODIES LABORATOR; HENSGENS LAM, 1983, CELL, V32, P379, DOI 10.1016/0092-8674(83)90457-9; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; HIRATA R, 1990, J BIOL CHEM, V265, P6726; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; KOSTRIKEN R, 1984, COLD SPRING HARB SYM, V49, P89, DOI 10.1101/SQB.1984.049.01.012; KOSTRIKEN R, 1983, CELL, V35, P167, DOI 10.1016/0092-8674(83)90219-2; KRONSTAD JW, 1987, CELL, V50, P369, DOI 10.1016/0092-8674(87)90491-0; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; LEMIEUX B, 1988, MOL GEN GENET, V212, P48, DOI 10.1007/BF00322443; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1986, CELL, V46, P323, DOI 10.1016/0092-8674(86)90651-3; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; MORAN JV, 1992, NUCLEIC ACIDS RES, V20, P4069, DOI 10.1093/nar/20.15.4069; MUSCARELLA DE, 1989, CELL, V56, P443, DOI 10.1016/0092-8674(89)90247-X; PERLMAN PS, 1989, SCIENCE, V246, P1106, DOI 10.1126/science.2479980; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; QUIRK SM, 1989, CELL, V56, P455, DOI 10.1016/0092-8674(89)90248-1; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGUEIL B, 1991, MOL GEN GENET, V225, P340, DOI 10.1007/BF00269867; SERAPHIN B, 1992, GENE, V113, P1, DOI 10.1016/0378-1119(92)90663-A; Sherman F., 1986, METHODS YEAST GENETI; SHIBATA T, 1984, J BIOL CHEM, V259, P499; SHIH CK, 1988, MOL CELL BIOL, V8, P3094, DOI 10.1128/MCB.8.8.3094; SIKORSKI RS, 1989, GENETICS, V122, P19; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VANARSDELL SW, 1987, TRANSCRIPTIONAL CONT, P325; WARING RB, 1982, P NATL ACAD SCI-BIOL, V79, P6332, DOI 10.1073/pnas.79.20.6332; WATABE H, 1983, J BIOL CHEM, V258, P4663; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; WERNETTE CM, 1990, J BIOL CHEM, V265, P18976; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315	60	61	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21844	21853						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408039				2022-12-27	WOS:A1993MC80900063
J	LEVINE, A; YEIVIN, A; BENASHER, E; ALONI, Y; RAZIN, A				LEVINE, A; YEIVIN, A; BENASHER, E; ALONI, Y; RAZIN, A			HISTONE-H1-MEDIATED INHIBITION OF TRANSCRIPTION INITIATION OF METHYLATED TEMPLATES IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; CPG BINDING-PROTEIN; DNA METHYLATION; CHROMATIN STRUCTURE; ACTIVE CHROMATIN; HISTONE BINDING; PROMOTER; GENE; INVOLVEMENT; EXPRESSION	The detailed mechanism underlying the inhibition of transcription by DNA methylation is still obscure. Chromatin structure has frequently been proposed as a role player in this mechanism. Histone H1 is a known key element in the formation and stabilization of chromatin fibers. We describe here experiments designed to examine the effect of DNA methylation on the binding of histone H1 to DNA and the consequent inhibitory effect of the bound histone H1 on in vitro transcription. The results of these experiments showed a clear preferential binding of histone H1 to methylated DNA as compared with unmethylated DNA. The in vitro transcription assay indicated that transcription of methylated templates was inhibited at a lower histone H1/DNA ratio than of unmethylated templates, and that the extent of inhibition depends on the density of methyl groups in the promoter region. This inhibition of in vitro transcription was alleviated efficiently by methylated competitor DNA, whereas, under similar conditions, almost no effect was observed with unmethylated competitor. Experiments designed to pinpoint the stage in the transcription process that was suppressed by the preferred binding of histone H1 to methylated template revealed that inhibition occurred at the initiation and not at the elongation level.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT CELLULAR BIOCHEM,IL-91010 JERUSALEM,ISRAEL; WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL	Hebrew University of Jerusalem; Weizmann Institute of Science			Levine, Alex/A-6867-2008		NCI NIH HHS [CA 14995] Funding Source: Medline; NIGMS NIH HHS [GM 20483] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014995] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALL DJ, 1983, P NATL ACAD SCI-BIOL, V80, P5490, DOI 10.1073/pnas.80.18.5490; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; BUSHLAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177; CLARK DJ, 1988, EUR J BIOCHEM, V178, P225, DOI 10.1111/j.1432-1033.1988.tb14447.x; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; CONKLIN K, 1984, DNA METHYLATION BIOC, P243; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; FALZON M, 1991, MOL CELL BIOL, V11, P117, DOI 10.1128/MCB.11.1.117; GARRARD WT, 1991, BIOESSAYS, V13, P87, DOI 10.1002/bies.950130208; HIGURASHI M, 1991, J BIOL CHEM, V266, P8619; HOLLER M, 1991, GENE DEV, V5, P1127; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; KAMAKAKA RT, 1990, EMBO J, V9, P3997, DOI 10.1002/j.1460-2075.1990.tb07621.x; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LEVINE A, 1991, P NATL ACAD SCI USA, V88, P6515, DOI 10.1073/pnas.88.15.6515; LEVINE A, 1992, P NATL ACAD SCI USA, V89, P10119, DOI 10.1073/pnas.89.21.10119; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MURRAY EJ, 1987, EMBO J, V6, P2329, DOI 10.1002/j.1460-2075.1987.tb02508.x; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; RENZ M, 1975, P NATL ACAD SCI USA, V72, P733, DOI 10.1073/pnas.72.2.733; RESNEKOV O, 1989, P NATL ACAD SCI USA, V86, P12, DOI 10.1073/pnas.86.1.12; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; WOLFFE AP, 1989, EMBO J, V8, P527, DOI 10.1002/j.1460-2075.1989.tb03407.x; ZLATANOVA J, 1991, DNA CELL BIOL, V10, P239, DOI 10.1089/dna.1991.10.239	35	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21754	21759						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408030				2022-12-27	WOS:A1993MC80900052
J	KOHNO, H; FURUKAWA, T; YOSHINAGA, T; TOKUNAGA, R; TAKETANI, S				KOHNO, H; FURUKAWA, T; YOSHINAGA, T; TOKUNAGA, R; TAKETANI, S			COPROPORPHYRINOGEN OXIDASE - PURIFICATION, MOLECULAR-CLONING, AND INDUCTION OF MESSENGER-RNA DURING ERYTHROID-DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME PATHWAY ENZYMES; III OXIDASE; UROPORPHYRINOGEN DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; RHODOBACTER-SPHAEROIDES; ERYTHROLEUKEMIA-CELLS; FERROCHELATASE; SEQUENCE; GENE; ACTIVATION	Coproporphyrinogen oxidase (EC 1.3.3.3), the enzyme involved in the sixth step of heme biosynthesis, was purified to apparent homogeneity from bovine liver; it has a molecular mass of 37,000 daltons. Partial amino acid sequences were determined. Two degenerate oligonucleotides based on the sequences of trypsin-digested peptides were used in a polymerase chain reaction to amplify a 198-base pair fragment of coproporphyrinogen oxidase DNA, using bovine kidney cells cDNA as a starting template. This fragment was used as a hybridization probe to isolate full-length coproporphyrinogen oxidase clones from a mouse erythroleukemia (MEL) cell cDNA library. Sequence analysis revealed that coproporphyrinogen oxidase comprises 354 amino acid residues (M(r) 40,647), with a putative leader sequence of 31 amino acid residues, the result being a mature protein of 323 amino acid residues (M(r) 37,255). RNA blot analysis revealed a 3.0-kilobase coproporphyrinogen oxidase mRNA in mouse liver and in MEL cells. Treatment of MEL cells with dimethyl sulfoxide led to an increase in coproporphyrinogen oxidase mRNA within 10 h, the induction reached a maximum at 24 h, and was in parallel with the induction of ferrochelatase mRNA. The cDNA allows for the expression of active coproporphyrinogen oxidase, the activity of which is mainly present in mitochondria of transfected cultured cells, thereby indicating that mammalian coproporphyrinogen oxidase is mitochondrial enzyme.	KANSAI MED UNIV,DEPT HYG,MORIGUCHI,OSAKA 570,JAPAN; KYOTO UNIV,FAC MED,DEPT PUBL HLTH,KYOTO 606,JAPAN	Kansai Medical University; Kyoto University								ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; BATLLE AMD, 1965, BIOCHEM J, V97, P731, DOI 10.1042/bj0970731; CAMADRO JM, 1986, EUR J BIOCHEM, V156, P579, DOI 10.1111/j.1432-1033.1986.tb09617.x; CONDER LH, 1991, BIOCHEM J, V275, P321, DOI 10.1042/bj2750321; COOMBER SA, 1992, MOL MICROBIOL, V6, P3159, DOI 10.1111/j.1365-2958.1992.tb01772.x; DEVERNEUIL H, 1983, J BIOL CHEM, V258, P2454; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; FUJITA H, 1991, BIOCHIM BIOPHYS ACTA, V1090, P311, DOI 10.1016/0167-4781(91)90195-R; GIBSON LCD, 1992, MOL MICROBIOL, V6, P3171, DOI 10.1111/j.1365-2958.1992.tb01773.x; GRANDCHAMP B, 1985, J BIOL CHEM, V260, P9630; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NAKAHASHI Y, 1990, BIOCHIM BIOPHYS ACTA, V1037, P321, DOI 10.1016/0167-4838(90)90032-B; POULSON R, 1974, J BIOL CHEM, V249, P6367; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO S, 1961, J BIOL CHEM, V236, P1173; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; SASSA S, 1983, REGULATION HEMOGLOBI, P359; TAIT GH, 1969, BIOCHEM BIOPH RES CO, V37, P116, DOI 10.1016/0006-291X(69)90888-2; TAKETANI S, 1992, EUR J BIOCHEM, V205, P217, DOI 10.1111/j.1432-1033.1992.tb16771.x; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; YOSHINAGA T, 1980, J BIOL CHEM, V255, P4722; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718	29	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21359	21363						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407975				2022-12-27	WOS:A1993MA28800103
J	SANTELL, L; RUBIN, RL; LEVIN, EG				SANTELL, L; RUBIN, RL; LEVIN, EG			ENHANCED PHOSPHORYLATION AND DEPHOSPHORYLATION OF A HISTONE-LIKE PROTEIN IN RESPONSE TO HYPEROSMOTIC AND HYPOOSMOTIC CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL-CELLS; HEAT-SHOCK PROTEIN; PLASMINOGEN-ACTIVATOR RELEASE; KINASE-C; VOLUME REGULATION; ADRENERGIC-RECEPTOR; AGONIST OCCUPANCY; STRESS PROTEINS; MESSENGER-RNA; HUMAN HSP27	Placement of endothelial cells under hypoosmotic or hyperosmotic conditions results in the reduction and increase, respectively, in the phosphorylation of a M(r) = 16,500 protein (P17). The changes were dose-dependent with a 3.3 +/- 0.3-fold increase occurring at 485 mosm/kg H2O and negligible phosphorylation observed at 202 mosm/kg H2O. The phosphorylation and dephosphorylation were rapid and prolonged; modified phosphorylation levels were maintained as long as the anisotonic conditions were present. However, return to isotonic medium reversed the phosphorylation back to normal within 1 h. Cellular fractionation studies showed that P17 was associated only with the nuclear compartment under isotonic, hypertonic, or hypotonic conditions. Two forms of P17 with pI values of 9.2 and 9.6 were resolved by isoelectric focusing; both forms showed enhanced phosphorylation by hyperosmotic treatment. Phosphorylation occurred on serines exclusively. These studies demonstrate that a nuclear protein with characteristics similar to histones is affected by cell shrinkage or swelling through changes in its phosphorylation state.	SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute	SANTELL, L (corresponding author), SCRIPPS RES INST, ROON RES CTR ARTERIOSCLEROSIS & THROMBOSIS, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040435] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40435] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; BURG MB, 1992, J AM SOC NEPHROL, V3, P121; BUXBAUM JD, 1989, J BIOL CHEM, V264, P9344; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; COHEN P, 1989, J BIOL CHEM, V264, P21435; EVELOFF JL, 1987, AM J PHYSIOL, V252, pF1; EXTON JH, 1985, J CLIN INVEST, V75, P1753, DOI 10.1172/JCI111886; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; GECK P, 1992, ANN NY ACAD SCI, V652, P166; GUESDON F, 1991, J IMMUNOL, V147, P3402; KWIATKOWSKI AP, 1989, BIOCHEMISTRY-US, V28, P5380, DOI 10.1021/bi00439a010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LEVIN EG, 1989, J BIOL CHEM, V264, P16030; LEVIN EG, 1983, P NATL ACAD SCI-BIOL, V80, P6804, DOI 10.1073/pnas.80.22.6804; LEVIN EG, 1987, J CELL BIOL, V105, P2543, DOI 10.1083/jcb.105.6.2543; LEVIN EG, 1991, J BIOL CHEM, V266, P174; LEVIN EG, 1991, J IMMUNOL, V146, P3772; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; LEWIS SA, 1990, NEWS PHYSIOL SCI, V5, P112; LUNDGREN DW, 1992, J BIOL CHEM, V267, P6841; MANDELSOHN ME, 1991, P NATL ACAD SCI USA, V88, P11212; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; REGAZZI R, 1988, BIOCHEM BIOPH RES CO, V152, P62, DOI 10.1016/S0006-291X(88)80680-6; SANTELL L, 1992, BIOCHEM J, V284, P705, DOI 10.1042/bj2840705; UCHIDA S, 1989, AM J PHYSIOL, V256, pC614, DOI 10.1152/ajpcell.1989.256.3.C614; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	36	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21443	21447						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407988				2022-12-27	WOS:A1993MA28800116
J	NGUYEN, TT; MUENCH, KA; BRYANT, FR				NGUYEN, TT; MUENCH, KA; BRYANT, FR			INACTIVATION OF THE RECA-PROTEIN BY MUTATION OF HISTIDINE-97 OR LYSINE-248 AT THE SUBUNIT INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; EXCHANGE; RENATURATION; PURIFICATION; COMPLEXES; SEQUENCES; VECTORS; CLONING	We have used site-directed mutagenesis to prepare two new mutant recA proteins, one in which histidine 97 has been replaced by alanine, and another in which lysine 248 has been replaced by alanine. Although these mutant proteins were originally designed from different considerations, they turned out to have remarkably similar properties. Both the [H97A]recA protein and the [K248A]recA protein bind poorly to single-stranded DNA, have no single-stranded DNA-dependent ATP hydrolysis activity, and do not promote renaturation of complementary single-stranded DNA molecules or the ATP-dependent three-strand exchange reaction. Furthermore, both mutant proteins are defective in Mg2+-induced helical filament formation. To account for these results, we propose that the mutation of either histidine 97 or lysine 248 alters subunit interactions between recA monomers and that this leads to the loss of cooperative single-stranded DNA binding and DNA pairing activities. This proposal is consistent with the recently determined x-ray structure of the recA protein, which shows that although histidine 97 and lysine 248 are distant from one another in the monomer structure, these two residues are on the opposing complementary faces of the recA subunit and pack against each other at the interface between adjacent recA monomers in the helical filament (Story, R. M., Weber, 1. T., and Steitz, T. A. (1992) Nature 355, 318-325).	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOCHEM,615 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University					NIGMS NIH HHS [GM 36516] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036516] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; BRYANT FR, 1988, J BIOL CHEM, V263, P8716; BRYANT FR, 1986, J BIOL CHEM, V261, P2988; BRYANT FR, 1985, J BIOL CHEM, V260, P1196; BRYANT FR, 1989, BIOCHEMISTRY-US, V28, P1062, DOI 10.1021/bi00429a021; COX MM, 1981, J BIOL CHEM, V256, P4676; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; GRIFFITH JD, 1988, CRC CRIT REV BIOC S1, V23, P43; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; HORII T, 1980, P NATL ACAD SCI-BIOL, V77, P313, DOI 10.1073/pnas.77.1.313; KOBAYASHI N, 1987, BIOCHEMISTRY-US, V26, P6801, DOI 10.1021/bi00395a033; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURAMITSU S, 1981, J BIOCHEM-TOKYO, V90, P1033, DOI 10.1093/oxfordjournals.jbchem.a133555; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LEGENDRE N, 1990, Biotechniques, V9, P788; MENGE KL, 1988, BIOCHEMISTRY-US, V27, P2635, DOI 10.1021/bi00407a055; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MUENCH KA, 1991, J BIOL CHEM, V266, P844; PRASAD BVV, 1987, J MOL BIOL, V193, P579; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SANCAR A, 1980, P NATL ACAD SCI-BIOL, V77, P2611, DOI 10.1073/pnas.77.5.2611; SCOTT JF, 1978, J BIOL CHEM, V253, P3292; STASIAK A, 1986, BIOPHYS J, V49, P5, DOI 10.1016/S0006-3495(86)83569-X; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	29	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3107	3113						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428989				2022-12-27	WOS:A1993KM16100017
J	CASTLE, VP; OU, XL; OROURKE, K; DIXIT, VM				CASTLE, VP; OU, XL; OROURKE, K; DIXIT, VM			HIGH-LEVEL THROMBOSPONDIN-1 EXPRESSION IN 2 NIH 3T3 CLONED LINES CONFERS SERUM-INDEPENDENT AND ANCHORAGE-INDEPENDENT GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISTEP CARCINOGENESIS; PLATELET THROMBOSPONDIN; MONOCLONAL-ANTIBODIES; EXTRACELLULAR-MATRIX; CELLS; ONCOGENES; CDNA; TRANSFORMATION; TUMORIGENESIS; PROLIFERATION	Thrombospondin (TSP) is a trimeric molecule synthesized by a variety of normal and transformed cells and secreted into the extracellular matrix. A number of studies have shown TSP to be intimately involved in the regulation of cellular proliferation. These include the findings that TSP is a mitogen-inducible immediate-early response gene; it localizes to areas of cellular proliferation in the developing mouse embryo; it augments the proliferative response to epidermal growth factor; anti-TSP monoclonal antibodies block cell proliferation; and TSP levels correlate directly with the growth and invasive phenotype and inversely with the degree of differentiation of squamous carcinoma cells. To determine whether TSP could behave as an oncogene, conferring serum and anchorage independence, NIH 3T3 cells were stably transfected with a TSP expression vector. Clones producing high levels of TSP displayed enhanced viability and a proliferative advantage in serum-reduced media. Moreover, this growth advantage could be specifically negated by treatment of the transfected cells with anti-TSP monoclonal antibodies. While the TSP overexpressing clones were capable of anchorage-independent growth in soft agar, surprisingly, they were incapable of forming tumors in nude mice, possibly due to the in vivo antiangiogenic activity of TSP. Regardless, these studies demonstrate that overexpression of thrombospondin, a constituent of the extracellular matrix, results in serum and anchorage independent growth, attributes normally associated with the transformed phenotype.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,1301 CATHERINE ST,BOX 0602,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,COMM CELL & MOLEC BIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	NATIONAL CANCER INSTITUTE [R01CA058182] Funding Source: NIH RePORTER; NCI NIH HHS [CAO 1599-01, CA 58182] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BOYD JA, 1990, PHARMACOL THERAPEUT, V46, P469, DOI 10.1016/0163-7258(90)90028-Z; CASTLE V, 1991, J CLIN INVEST, V87, P1883, DOI 10.1172/JCI115212; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; COOPER GM, 1980, NATURE, V284, P418, DOI 10.1038/284418a0; DIXIT VM, 1986, J BIOL CHEM, V261, P1962; DIXIT VM, 1986, P NATL ACAD SCI USA, V83, P5449, DOI 10.1073/pnas.83.15.5449; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; HARPEL PC, 1990, J BIOL CHEM, V265, P11289; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIOTTA LA, 1984, AM J PATHOL, V117, P339; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; MAJACK RA, 1987, J BIOL CHEM, V262, P8821; MCPHERSON J, 1981, J BIOL CHEM, V256, P1330; MILLER AD, 1984, CELL, V36, P51; MUMBY SM, 1984, J CELL PHYSIOL, V120, P280, DOI 10.1002/jcp.1041200304; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PHAN SH, 1989, BIOCHEM BIOPH RES CO, V163, P56, DOI 10.1016/0006-291X(89)92098-6; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; VARANI J, 1989, CLIN EXP METASTAS, V7, P265, DOI 10.1007/BF01753679; ZHAN X, 1986, MOL CELL BIOL, V6, P3541, DOI 10.1128/MCB.6.10.3541	32	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2899	2903						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428963				2022-12-27	WOS:A1993KK81500094
J	KHAN, SH; CRAWLEY, SC; KANIE, O; HINDSGAUL, O				KHAN, SH; CRAWLEY, SC; KANIE, O; HINDSGAUL, O			A TRISACCHARIDE ACCEPTOR ANALOG FOR N-ACETYLGLUCOSAMINYLTRANSFERASE-V WHICH BINDS TO THE ENZYME BUT STERICALLY PRECLUDES THE TRANSFER-REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOSACCHARIDE; GLYCOSYLTRANSFERASES; GLYCOSYLATION; RECOGNITION; INHIBITORS	Development of inhibitors specific for the glycosyltransferases involved in the biosynthesis of asparagine-linked sugar chains has been undertaken in the hopes that these compounds may serve as tools to elucidate the roles of complex carbohydrates in biological recognition events. We report here the first example of a glycosyltransferase acceptor analog in which strategic replacement of a nonreacting hydroxyl group with a larger substituent produces a molecule which is recognized by the enzyme but does not react because of a steric block to the glycosyl transfer reaction. N-Acetylglucosaminyltransferase V catalyzes the transfer of GlcNAc from the sugar nucleotide donor UDP-GlcNAc to the 6-OH group of mannose in the synthetic trisaccharide acceptor betaGlcNAc(1 --> 2)alphaMan(1 --> 6)betaGlc-O(CH2)7CH3 (K(m) = 23 +/- 2 muM; V(max) = 116 +/- 3 pmol/h) to form the tetrasaccharide betaGlcNAc(1 --> 2)(betaGlcNAc(1 --> 6))alphaMan(1 --> 6)betaGlc-O(CH2)7CH3. The acceptor analog produced by replacement of the adjacent nonreacting 4-OH group of the mannose residue with an O-methyl group was not a substrate for the enzyme but was found to be a good competitive inhibitor of GlcNAc transferase V with K(i) = 14 +/- 2 muM. To test the theory that it was the presence of the large methyl group which prevented the glycosyl transfer reaction the 4'-deoxygenated analog was synthesized. It was found to be a good substrate with K(m) = 74 +/- 6 muM and an almost 5-fold higher k(cat) (V(max) = 535 +/- 13 pmol/h). NMR data show no evidence of important conformational differences between the trisaccharide analogs, and kinetic experiments detected no differences for the binding of UDP-GIcNAc in their presence. The conclusion was therefore reached that the large methyl group introduced on O-4' sterically prevented the formation of product even though both potential substrates were bound by the enzyme. This ''steric exclusion'' strategy offers potential for the design of inhibitors for that class of glycosyltransferases in which the reactive hydroxyl group is also an essential recognition element.	UNIV ALBERTA, DEPT CHEM, EDMONTON T6G 2G2, ALBERTA, CANADA; UNIV ALBERTA, DEPT FOOD SCI, EDMONTON T6G 2G2, ALBERTA, CANADA	University of Alberta; University of Alberta			Kanie, Osamu/D-1741-2010	Kanie, Osamu/0000-0003-4147-6868				BEYER TA, 1981, ADV ENZYMOL, V52, P24; BOCK K, 1992, CARBOHYD RES, V228, P1, DOI 10.1016/S0008-6215(00)90544-5; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; DENNIS JW, 1989, CANCER RES, V49, P945; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; Feizi T, 1991, CURR OPIN STRUC BIOL, V1, P766, DOI 10.1016/0959-440X(91)90176-T; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; KAUR KJ, 1992, CARBOHYD RES, V226, P219, DOI 10.1016/0008-6215(92)84069-5; Khan S.H., 1992, GLYCOCONJUGATES COMP, P361; KHAN SH, 1990, CARBOHYD RES, V205, P385, DOI 10.1016/0008-6215(90)80156-W; PALCIC MM, 1989, J BIOL CHEM, V264, P17174; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PRITCHETT TJ, 1987, VIROLOGY, V160, P502, DOI 10.1016/0042-6822(87)90026-2; ROSEVEAR PR, 1982, BIOCHEMISTRY-US, V21, P1421, DOI 10.1021/bi00535a049; SEGEL IH, 1975, ENZYME KINETICS, P46; SRIVASTAVA OP, 1988, CARBOHYD RES, V179, P137, DOI 10.1016/0008-6215(88)84115-6	20	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2468	2473						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428922				2022-12-27	WOS:A1993KK81500035
J	ROY, P; CHATELLARD, C; LEMAY, G; CRINE, P; BOILEAU, G				ROY, P; CHATELLARD, C; LEMAY, G; CRINE, P; BOILEAU, G			TRANSFORMATION OF THE SIGNAL PEPTIDE MEMBRANE ANCHOR DOMAIN OF A TYPE-II TRANSMEMBRANE PROTEIN INTO A CLEAVABLE SIGNAL PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTION; SACCHAROMYCES-CEREVISIAE; HUMAN LYSOZYME; COS-1 CELLS; SEQUENCE; SECRETION; SITE; DNA; RESIDUES; ENKEPHALINASE	Rabbit neutral endopeptidase-24.11 is a type II transmembrane protein with a 27-amino acid residue positively charged NH2-terminal cytoplasmic domain, a 23-amino acid residue hydrophobic signal peptide/membrane anchor domain, and a large catalytic COOH-terminal domain exposed on the exoplasmic side of the membrane. In order to study the mechanism of membrane anchoring of neutral endopeptidase-24.11, we created mutants in which the cytoplasmic tail was deleted. Expression of these mutants in COS-1 cells resulted in the secretion of approximately 10-20% of the protein into the culture medium, due possibly to the cleavage of part or all of the signal peptide/membrane anchor domain by the rough endoplasmic reticulum signal peptidase. In a second set of mutants, a hydrophilic sequence (GSQNS) was inserted midway in the signal peptide/membrane anchor domain of neutral endopeptidase-24.11. When this hydrophilic sequence was introduced into the full-length neutral endopeptidase-24.11, approximately 20% of the enzyme activity was recovered in the culture medium. This proportion increased to 93% when the cytosolic tail was deleted. Sequencing of the [H-3]tyrosine- or [H-3]isoleucine-labeled secreted protein indicated that proteolysis, possibly by signal peptidase, occurred on the COOH-terminal side of the signal peptide/membrane anchor domain. We conclude that the efficient cleavage of the signal peptide/membrane anchor domain and secretion of the protein require both the deletion of the cytosolic domain and the presence of a hydrophilic sequence.	UNIV MONTREAL,FAC MED,DEPT BIOCHIM,CP 6128,SUCC A,MONTREAL H3C 3J7,QUEBEC,CANADA	Universite de Montreal			Lemay, Guy/B-2165-2008	Lemay, Guy/0000-0002-0402-1285				Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BIRD P, 1990, J BIOL CHEM, V265, P8420; BOYD D, 1989, P NATL ACAD SCI USA, V86, P9446, DOI 10.1073/pnas.86.23.9446; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CRINE P, 1985, BIOCHEM BIOPH RES CO, V131, P255, DOI 10.1016/0006-291X(85)91796-6; DEJONG WW, 1978, BIOCHEM BIOPH RES CO, V82, P532, DOI 10.1016/0006-291X(78)90907-5; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOMEZ S, 1989, EMBO J, V8, P2911, DOI 10.1002/j.1460-2075.1989.tb08440.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; JABBAR MA, 1987, MOL CELL BIOL, V7, P1476, DOI 10.1128/MCB.7.4.1476; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAY G, 1989, J BIOL CHEM, V264, P15620; LIPP J, 1986, CELL, V46, P1103, DOI 10.1016/0092-8674(86)90710-5; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MUELLER M, 1982, Journal of Biological Chemistry, V257, P11860; MURAKAMI H, 1982, P NATL ACAD SCI-BIOL, V79, P1158, DOI 10.1073/pnas.79.4.1158; NAGAHORA H, 1988, FEBS LETT, V238, P329, DOI 10.1016/0014-5793(88)80506-4; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P21797; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID SR, 1988, J BIOL CHEM, V263, P16886; SINGER SJ, 1990, ANN REV CELL BIOL, V6, P287; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; STRAUSS AW, 1979, P NATL ACAD SCI USA, V76, P4225, DOI 10.1073/pnas.76.9.4225; SUMMERS RG, 1989, J BIOL CHEM, V264, P20082; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; SZCZESNASKORUPA E, 1989, J CELL BIOL, V108, P1237, DOI 10.1083/jcb.108.4.1237; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIRELLA G, 1974, IMMUNOCHEMISTRY, V11, P157, DOI 10.1016/0019-2791(74)90213-4; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; YAMAMOTO Y, 1989, BIOCHEMISTRY-US, V28, P2728, DOI 10.1021/bi00432a054; YOST CS, 1983, CELL, V34, P759	47	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2699	2704						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428944				2022-12-27	WOS:A1993KK81500066
J	TANIGUCHI, T; KITAGAWA, H; YASUE, S; YANAGI, S; SAKAI, K; ASAHI, M; OHTA, S; TAKEUCHI, F; NAKAMURA, S; YAMAMURA, H				TANIGUCHI, T; KITAGAWA, H; YASUE, S; YANAGI, S; SAKAI, K; ASAHI, M; OHTA, S; TAKEUCHI, F; NAKAMURA, S; YAMAMURA, H			PROTEIN-TYROSINE KINASE P72(SYK) IS ACTIVATED BY THROMBIN AND IS NEGATIVELY REGULATED THROUGH CA2+ MOBILIZATION IN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RABBIT PLATELETS; YES PROTEIN; PHOSPHORYLATION; SECRETION; PURIFICATION; AGGREGATION; MECHANISMS; EXPRESSION; MEMBRANE; VANADATE	Activation of platelets by thrombin results in a dramatic increase in tyrosine phosphorylation on multiple cellular proteins (Ferrell, J. E., and Martin, G. S. (1988) Mol. Cell. Biol. 8, 3603-3610; Golden, A., and Brugge, J. S. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 901-905; Nakamura, S., and Yamamura, H. (1989) J. Biol. Chem. 264, 7089-7091). However, none of the responsible protein-tyrosine kinase has been reported so far. We report here that p72syk, one of the non-receptor-type protein-tyrosine kinases, is activated following thrombin stimulation in blood platelets. Washed porcine platelets were stimulated by thrombin, and the activation of p72syk was assessed in an immunoprecipitation kinase assay. The activity of p72syk increased within 5 s, reached a maximum at 10 s, and decreased to a basal level within 60 s after 0.5 unit/ml thrombin stimulation. The amount of immunoprecipitated p72syk was not altered throughout the time course. This activation was greatly enhanced in a dose-dependent manner and was completely canceled by the pretreatment of platelet suspension with hirudin, a specific antagonist of thrombin. In the Ca2+-depleted condition both extra- and intracellularly, the activation of p72syk was still persistent; in contrast, the deactivation process was completely abrogated even at 120 s after thrombin stimulation. In addition, the replenishment of Ca2+ resulted in a similar deactivation pattern as seen in the Ca2+-rich condition. Furthermore, this deactivation was also canceled by the pretreatment of platelets with W7, a calmodulin antagonist, as well as ML9, a myosin-light-chain kinase inhibitor. These results indicate that p72syk can be a responsible enzyme to the protein-tyrosine phosphorylation events following the platelet activation by thrombin and may be negatively regulated by Ca2+ in a calmodulin-dependent manner, inter alia myosin light-chain kinase, in thrombin-stimulated platelets.	FUKUI MED SCH,DEPT BIOCHEM,FUKUI 91011,JAPAN	University of Fukui								APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ASAHI M, 1992, FEBS LETT, V309, P10, DOI 10.1016/0014-5793(92)80728-Y; DHAR A, 1990, MOL PHARMACOL, V37, P519; FERRELL JE, 1988, MOL CELL BIOL, V8, P3603, DOI 10.1128/MCB.8.9.3603; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GUADETTE DC, 1990, BIOCHEM BIOPH RES CO, V170, P238; HORAK ID, 1990, ONCOGENE, V5, P597; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; INAZU T, 1990, BIOCHEM BIOPH RES CO, V170, P259, DOI 10.1016/0006-291X(90)91268-W; KOBAYASHI T, 1990, EUR J BIOCHEM, V188, P535, DOI 10.1111/j.1432-1033.1990.tb15433.x; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KROLL MH, 1989, BLOOD, V74, P1181; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; NAKAMURA S, 1989, J BIOL CHEM, V264, P7089; NAKAMURA S, 1988, EUR J BIOCHEM, V174, P471, DOI 10.1111/j.1432-1033.1988.tb14122.x; NISHIKAWA M, 1980, NATURE, V287, P863, DOI 10.1038/287863a0; OHTA S, 1992, BIOCHEM BIOPH RES CO, V185, P1128, DOI 10.1016/0006-291X(92)91743-A; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SALARI H, 1990, FEBS LETT, V263, P104, DOI 10.1016/0014-5793(90)80715-U; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; YAMADA T, 1991, BIOCHEM BIOPH RES CO, V180, P1325, DOI 10.1016/S0006-291X(05)81340-3; ZHAO YH, 1990, ONCOGENE, V5, P1629; ZSCHAUER A, 1988, NATURE, V334, P703, DOI 10.1038/334703a0	28	141	141	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2277	2279						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428900				2022-12-27	WOS:A1993KK81500003
J	GERSHON, PD; MOSS, B				GERSHON, PD; MOSS, B			STIMULATION OF POLY(A) TAIL ELONGATION BY THE VP39 SUBUNIT OF THE VACCINIA VIRUS-ENCODED POLY(A) POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; EARLY GENES; TRANSCRIPTION; POLYADENYLATION; SPECIFICITY; TERMINATION; DOWNSTREAM; SEQUENCE; VIRIONS; PROTEIN	The VP55 subunit of the vaccinia virus-encoded poly(A) polymerase can add a maximum of 35 adenylates to the 3'-end of an RNA primer in a rapid and highly processive manner, whereas the VP55-VP39 heterodimer catalyzes the formation of poly(A) tails several hundred nucleotides in length. Here, we describe the overexpression of the VP39 subunit, its purification to near homogeneity, and its ability to associate physically with VP55 and to stimulate polyadenylation. Although VP39 possessed no independent poly(A) polymerase activity, RNA primers with oligo(A) tails greater than 30 adenylates in length could be extended nearly 40-fold more rapidly in the presence of VP39. VP39 enhanced the polyadenylation rate by converting the slow, nonprocessive polyadenylation occurring after the rapid burst in the presence of monomeric VP55, to a rapid, semiprocessive reaction. The effect of VP39 was dramatic when poly(A) primers were used as, 60 mm NaCl, VP39 enhanced the polyadenylation rate 500-fold, and at 90 mm NaCl VP39 was absolutely required. Nevertheless, the VP39-containing polymerase remained selective for polyadenylation of an mRNA 3'-end in the presence of excess poly(A). These data suggest that the role of VP39 in polyadenylation is to increase the affinity of the polymerase for the growing poly(A) tail.	NIAID,VIRAL DIS LAB,BLDG 4,RM 229,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)				Moss, Bernard/0000-0002-2154-8564				BOYLE A, 1987, CURRENT PROTOCOLS MO; BROYLES SS, 1987, MOL CELL BIOL, V7, P7, DOI 10.1128/MCB.7.1.7; CHELEY S, 1991, BIOTECHNIQUES, V10, P730; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GERSHON PD, 1991, CELL, V66, P1269, DOI 10.1016/0092-8674(91)90048-4; GERSHON PD, 1992, GENE DEV, V6, P1575, DOI 10.1101/gad.6.8.1575; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1975, J BIOL CHEM, V250, P4722; Moss B, 1991, CURRENT PROTOCOLS MO; NEVINS JR, 1977, J BIOL CHEM, V252, P6939; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; SHEETS MD, 1989, GENE DEV, V3, P1401, DOI 10.1101/gad.3.9.1401; SHUMAN S, 1988, J BIOL CHEM, V263, P8405; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P320, DOI 10.1016/0968-0004(90)90022-4; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	22	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2203	2210						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420988				2022-12-27	WOS:A1993KH62000105
J	DOWD, TL; GUPTA, RK				DOWD, TL; GUPTA, RK			NMR-STUDIES OF THE EFFECT OF HYPERGLYCEMIA ON INTRACELLULAR CATIONS IN RAT-KIDNEY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SPONTANEOUSLY HYPERTENSIVE RAT; CYTOSOLIC FREE CALCIUM; MAGNETIC-RESONANCE; PROXIMAL TUBULES; GLUCOSE; SODIUM; ION; CELLS; SPECTROSCOPY	Alterations in intracellular cation concentrations in the kidney during hyperglycemia may play a role in a number of complications associated with diabetes mellitus such as renal hypertrophy and hypertension. In this study, we have investigated the effect of 25 mM glucose on intracellular pH and free Mg2+, free Ca2+, and Na+ concentrations in the perfused kidneys of Sprague-Dawley rats using P-31, F-19, and Na-23 triple-quantum filtered NMR. No significant alteration occurred in the intracellular free Mg2+ concentration, pH, or ATP concentration during hyperglycemia. However, a sizable (approximately 50%) increase in the intracellular Na+ concentration was inferred from Na-23 triple-quatum filtered NMR after 30-45 min of perfusion with 25 mM glucose. Intracellular free Ca2+, measured to be 390 +/- 15 nM at 5 mM glucose, increased significantly (95%; p < 0.001) to a value of 765 +/- 28 nm after 30 min of perfusion with 25 mM glucose. This effect of glucose was reversible. Only small increases (less-than-or-equal-to 20%) in free Ca2+ were found with addition of comparable concentrations of a nontransportable sugar (20 mM mannitol), indicating that glucose entry into the cell (through the Na+/glucose cotransporter) plays a role in causing the free Ca2+ increase. No effect on free Ca2+ was, however, seen with 1 mM ouabain, which caused a sizable increase in intracellular Na+, indicating that Na+/Ca2+ exchange does not play a significant role in the maintenance of low intracellular free Ca2+ in the kidney and that the observed increase in free Ca2+ is probably due to a decrease in the Ca2+/Mg2+-ATPase activity during hyperglycemia. Increased concentrations of Na+ and free Ca2+ during hyperglycemia may be involved in the mechanism of renal hypertrophy and hypertension, frequently associated with diabetes mellitus.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	DOWD, TL (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT PHYSIOL & BIOPHYS, BRONX, NY 10461 USA.				NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032030] Funding Source: NIH RePORTER; NCI NIH HHS [CA13330] Funding Source: Medline; NIDDK NIH HHS [DK32030] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLIS JL, 1991, J MAGN RESON, V93, P71, DOI 10.1016/0022-2364(91)90032-O; AYO SH, 1991, AM J PHYSIOL, V261, pF571, DOI 10.1152/ajprenal.1991.261.4.F571; BADARGOFFER RS, 1990, J NEUROCHEM, V55, P878, DOI 10.1111/j.1471-4159.1990.tb04573.x; BERRIDGE MJ, 1986, CANCER SURV, V5, P413; BODENHAUSEN G, 1977, J MAGN RESON, V27, P511, DOI 10.1016/0022-2364(77)90016-6; BRAUNSCHWEILER L, 1983, MOL PHYS, V48, P535, DOI 10.1080/00268978300100381; DAVIS FB, 1985, DIABETES, V34, P639, DOI 10.2337/diabetes.34.7.639; DOWD T, 1989, RENAL PHYSIOL BIOCH, V12, P161; DOWD TL, 1992, J BIOL CHEM, V267, P3637; DRAZNIN B, 1987, J BIOL CHEM, V262, P14385; EGGERS PW, 1988, NEW ENGL J MED, V318, P223, DOI 10.1056/NEJM198801283180406; ENDRE ZH, 1989, MAGNET RESON MED, V11, P267, DOI 10.1002/mrm.1910110215; FINE LG, 1985, P NATL ACAD SCI USA, V82, P1736, DOI 10.1073/pnas.82.6.1736; GUPTA RK, 1980, P NATL ACAD SCI-BIOL, V77, P2487, DOI 10.1073/pnas.77.5.2487; HISE MK, 1988, ENDOCRINOLOGY, V123, P1553, DOI 10.1210/endo-123-3-1553; JELICKS LA, 1990, J BIOL CHEM, V265, P1394; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; KOCH KS, 1979, CELL, V18, P153, DOI 10.1016/0092-8674(79)90364-7; KUMAR AM, 1988, KIDNEY INT, V33, P792, DOI 10.1038/ki.1988.69; LEE CO, 1980, NATURE, V287, P859, DOI 10.1038/287859a0; LEVY J, 1989, AM J MED S6A, V87, pA7; LIEBLING MS, 1987, ANN NY ACAD SCI, V508, P149, DOI 10.1111/j.1749-6632.1987.tb32901.x; LLIBRE J, 1988, HYPERTENSION, V12, P399, DOI 10.1161/01.HYP.12.4.399; MORGENSEN CE, 1973, DIABETES, V22, P706; MORRILL GA, 1985, BIOCHIM BIOPHYS ACTA, V844, P377, DOI 10.1016/0167-4889(85)90140-5; NISHIITS.JM, 1967, BIOCHEM J, V103, P852, DOI 10.1042/bj1030852; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; REAVEN GM, 1991, AM J HYPERTENS, V4, P610, DOI 10.1093/ajh/4.7.610; ROSS BD, 1973, AM J PHYSIOL, V225, P1165, DOI 10.1152/ajplegacy.1973.225.5.1165; SACERDOTI D, 1989, SCIENCE, V243, P388, DOI 10.1126/science.2492116; SEYERHANSEN K, 1977, DIABETOLOGIA, V13, P141, DOI 10.1007/BF00745142; SHINE N, 1987, ANN NY ACAD SCI, V508, P99, DOI 10.1111/j.1749-6632.1987.tb32898.x; SMITH GA, 1983, P NATL ACAD SCI-BIOL, V80, P7178, DOI 10.1073/pnas.80.23.7178; TUTTLE KR, 1991, SEMIN NEPHROL, V11, P220; WEINMAN EJ, 1975, KIDNEY INT, V8, P493	35	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					991	996						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419377				2022-12-27	WOS:A1993KG07700037
J	SEO, HC; ETTINGER, MJ				SEO, HC; ETTINGER, MJ			PURIFICATION AND PROPERTIES OF A SELF-ASSOCIATING, 50-KDA COPPER-BINDING PROTEIN FROM BRINDLED MOUSE LIVERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENKES-DISEASE; SKIN FIBROBLASTS; PRIMARY DEFECT; METABOLISM; MICE; ACCUMULATION; MODEL; HEPATOCYTES; MUTANTS; ALBUMIN	The brindled mouse is an animal model of Menkes disease, a fatal, X-linked disease of copper metabolism. A self-associating, 50-kDa copper-binding protein (CuBP) was purified from brindled mouse hepatic cytosols, and some of its properties were determined. When Cu-64-labeled whole hepatic cytosols were fractionated on Superose, statistically significantly less than normal Cu-64 binding was detected in both the fraction which contained the tetramer plus dimer (almost-equal-to 26% less) and the fraction containing the monomer of CuBP (almost-equal-to 37% less). CuBP was purified from brindled mouse hepatic cytosols by successive Mono Q, chelating Superose, and phenyl-Superose columns using the same methods used to purify the protein from normal mice. However, CuBP from the brindled mice was somewhat unstable during the purification. Also, CuBP from the brindled mouse eluted abnormally from the phenyl-Superose column. Thus, while the protein from normal mice eluted at almost-equal-to 20 min after starting the final water elution step, the brindled mouse protein eluted by almost-equal-to 5 min. This seemed to be due to abnormal self-association in the column buffers. Consistent with the results using whole cytosols, the purified CuBP from the brindled mouse showed decreased copper binding in both the tetramer and monomer fractions from Superose. Moreover, under the same conditions, CuBP from the brindled mice seemed to have relatively less tetramer and more dimer than normal. The results are consistent with a significant role for CuBP in intracellular copper metabolism, and an abnormal structure of CuBP may be the basic defect in the brindled mice and, by inference, Menkes disease.	SUNY BUFFALO,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019708] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19708] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERATIS NG, 1978, PEDIATR RES, V12, P699, DOI 10.1203/00006450-197806000-00004; CASTILLO RO, 1990, PEDIATR RES, V27, P492, DOI 10.1203/00006450-199005000-00015; DANKS DM, 1977, INORG PERSPECT BIOL, V1, P73; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DARWISH HM, 1983, J BIOL CHEM, V258, P3621; ETTINGER MJ, 1987, LIFE CHEM REPORTS, V5, P169; HERD SM, 1987, BIOCHEM J, V247, P341, DOI 10.1042/bj2470341; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU SJ, 1971, J BIOL CHEM, V246, P5938; MANN JR, 1979, BIOCHEM J, V180, P605, DOI 10.1042/bj1800605; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P351, DOI 10.1016/0005-2795(73)90268-7; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P338, DOI 10.1016/0005-2795(73)90267-5; MENKES JH, 1962, PEDIATRICS, V29, P764; PALIDA FA, 1990, BIOCHEM J, V268, P359, DOI 10.1042/bj2680359; PALIDA FA, 1991, J BIOL CHEM, V266, P4586; PHILLIPS M, 1986, BIOCHEM J, V238, P177, DOI 10.1042/bj2380177; PORT AE, 1979, BIOCHEM J, V183, P721, DOI 10.1042/bj1830721; PRINS HW, 1979, J INORG BIOCHEM, V10, P19, DOI 10.1016/S0162-0134(00)81002-8; RIORDAN JR, 1982, J BIOL CHEM, V257, P4639; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; SEO HC, 1993, J BIOL CHEM, V268, P1151; SEO HC, 1991, THESIS U NEW YORK BU; TERAO T, 1973, AM J PHYSIOL, V224, P682, DOI 10.1152/ajplegacy.1973.224.3.682; TERAO T, 1976, TOHOKU J EXP MED, V120, P209, DOI 10.1620/tjem.120.209; WALDROP GL, 1990, BIOCHEM J, V267, P417, DOI 10.1042/bj2670417; WALDROP GL, 1990, AM J PHYSIOL, V259, pG219, DOI 10.1152/ajpgi.1990.259.2.G219; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	28	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1160	1165						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419320				2022-12-27	WOS:A1993KG07700060
J	ENGELBORGHS, Y; DUMORTIER, C; DHOORE, A; VANDECANDELAERE, A; FITZGERALD, TJ				ENGELBORGHS, Y; DUMORTIER, C; DHOORE, A; VANDECANDELAERE, A; FITZGERALD, TJ			EVIDENCE FOR AN ALTERNATIVE PATHWAY FOR COLCHICINE BINDING TO TUBULIN, BASED ON THE BINDING-KINETICS OF THE CONSTITUENT RINGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE STOPPED FLOW; ANALOG 2-METHOXY-5-(2'; PODOPHYLLOTOXIN; DISSOCIATION; MECHANISM; COMPLEX; TROPONE; BRAIN	The kinetics of tropolone methyl ether binding to tubulin were measured by following the loss of colchicine binding capacity upon preincubation of tubulin with tropolone methyl ether. At 25-degrees-C a bimolecular association rate constant of 2.7 (+/-0.2) m-1 min-1 was determined, and from the temperature dependence an activation energy of 37 (+/- 8) kJ.mol-1 was calculated. By displacement experiments a dissociation rate constant of 2.9 (+/- 0.6) x 10(-2) min-1 was determined at 25-degrees-C. The effect of 3',4',5'-trimethoxyacetophenone (TMA) is 2-fold. TMA reduces the apparent association rate constant of colchicine, indicating that it equilibrates very rapidly and reversibly with the colchicine binding site. From this reduction the binding constant for TMA can be obtained. At 25-degrees-C a value of 112 (+/- 13) M-1 is estimated. The binding of TMA is practically thermoneutral. Preincubation of tubulin with TMA over 30 min not only reduces the subsequent binding rate constant of colchicine but also the amplitude. This indicates that TMA also binds slowly in a second mode or site. Stopped-flow kinetic studies reveal that fast TMA binding competes for the initial binding of colchicine. From these results it is concluded that colchicine binds initially with its trimethoxybenzene ring and in a subsequent step with the tropolone ring.	FLORIDA A&M UNIV,COLL PHARM,TALLAHASSEE,FL 32307	State University System of Florida; Florida A&M University	ENGELBORGHS, Y (corresponding author), KATHOLIEKE UNIV LEUVEN,CHEM & BIOL DYNAM LAB,CELESTIJNENLAAN 200D,B-3001 LOUVAIN,BELGIUM.							ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P6465, DOI 10.1021/bi00268a023; ANDREU JM, 1991, BIOCHEMISTRY-US, V30, P3777, DOI 10.1021/bi00229a027; ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P534, DOI 10.1021/bi00532a019; BANE S, 1984, J BIOL CHEM, V259, P7391; BANERJEE A, 1987, FEBS LETT, V219, P103, DOI 10.1016/0014-5793(87)81199-7; BANERJEE A, 1991, J BIOL CHEM, V266, P1689; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIAZ JF, 1991, J BIOL CHEM, V266, P2890; ENGELBORGHS Y, 1987, J BIOL CHEM, V262, P5204; ENGELBORGHS Y, 1986, ANN NY ACAD SCI, V466, P709, DOI 10.1111/j.1749-6632.1986.tb38453.x; ENGELBORGHS Y, 1977, FEBS LETT, V80, P81, DOI 10.1016/0014-5793(77)80411-0; FITZGERALD TJ, 1976, BIOCHEM PHARMACOL, V25, P1383; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; HARRISSON CMH, 1976, NATURE, V260, P470; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; LAMBEIR A, 1981, J BIOL CHEM, V256, P3279; MACGREGOR RB, 1987, BIOCHEMISTRY-US, V26, P4008, DOI 10.1021/bi00387a040; MEDRANO FJ, 1989, BIOCHEMISTRY-US, V28, P5598; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SILENCE K, 1992, BIOCHEMISTRY-US, V31, P11133, DOI 10.1021/bi00160a025; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	24	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					107	112						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416918				2022-12-27	WOS:A1993KE60300018
J	KING, IN; DESOYZA, T; CATANZARO, DF; LAVIN, TN				KING, IN; DESOYZA, T; CATANZARO, DF; LAVIN, TN			THYROID-HORMONE RECEPTOR-INDUCED BENDING OF SPECIFIC DNA-SEQUENCES IS MODIFIED BY AN ACCESSORY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE ELEMENTS; RAT-LIVER; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; ESCHERICHIA-COLI; GENE-REGULATION; RETINOIC ACID; MALIC ENZYME; BINDING; PROTEIN	Transcriptional regulation by thyroid and steroid hormone receptors requires their recognition and binding of specific DNA sequences. However, little is known about the mechanisms whereby DNA bound receptors regulate transcription. In the present study, we examined the effects of thyroid hormone receptor (TR) binding on DNA conformation using various TR recognition sites contained within sets of circularly permuted flanking sequences. We show that under conditions where TR binds predominantly as monomer, the conformation of a number of binding sites is changed in a manner consistent with receptor induced bending. Despite similar affinities for receptor binding, not all binding sites tested showed evidence for receptor-induced bending. Notably, the conformation of a sequence from the frog vitellogenin 2 gene, which confers a positive transcriptional response when bound by estrogen receptor (ER), but a negative response when bound by TR, appeared to be unaffected by binding of either TR or ER. The observations suggest that the ability of the receptor to alter DNA architecture is strongly dependent on sequence characteristics other than those required for receptor binding. While both partly purified TR from rat liver and TR translated in vitro were able to induce DNA bending, the bend centers and bend angles produced by these different sources of receptor differed. However, addition of a receptor-depleted fraction from the rat liver TR preparation to in vitro translated receptor stimulated TR binding and appeared to form heterodimers with TR. This resulted in changes in both bend centers and bend angles to resemble more closely those produced by native receptor. Together, these results suggest that receptor-induced DNA bending may be specific to TRs and that the position and degree of bending is further modulated by the formation of heterodimers between TRs and accessory protein(s).	CORNELL UNIV,MED CTR,COLL MED,CTR CARDIOVASC,DEPT MED,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,CTR CARDIOVASC,DEPT PHYSIOL & BIOPHYS,NEW YORK,NY 10021	Cornell University; Cornell University					NIDDK NIH HHS [DK39998] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039998] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APRILETTI JW, 1988, J BIOL CHEM, V263, P9409; BEEBE JS, 1991, MOL ENDOCRINOL, V5, P85, DOI 10.1210/mend-5-1-85; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CALLADINE CR, 1988, J MOL BIOL, V201, P127, DOI 10.1016/0022-2836(88)90444-5; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DOZIN B, 1985, BIOCHEMISTRY-US, V24, P5581, DOI 10.1021/bi00341a044; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GRIFFITH J, 1986, NATURE, V322, P750, DOI 10.1038/322750a0; GUSTAFSON TA, 1989, P NATL ACAD SCI USA, V86, P2162, DOI 10.1073/pnas.86.7.2162; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; KOUDELKA GB, 1988, P NATL ACAD SCI USA, V85, P4633, DOI 10.1073/pnas.85.13.4633; LAVIN TN, 1988, J BIOL CHEM, V263, P9418; LAVIN TN, 1981, MOL PHARMACOL, V20, P28; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; LIUJOHNSON HN, 1986, CELL, V47, P995, DOI 10.1016/0092-8674(86)90814-7; MAGNUSON MA, 1983, J BIOL CHEM, V258, P2712; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NORMAN MF, 1989, J BIOL CHEM, V264, P12063; PEREZMARTIN J, 1989, J BIOL CHEM, V264, P21334; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; ROBERTSON M, 1987, NATURE, V327, P464, DOI 10.1038/327464a0; SAMUELS HH, 1989, ANNU REV PHYSIOL, V51, P623, DOI 10.1146/annurev.ph.51.030189.003203; SHEY DJ, 1986, NATURE, V323, P459; SILVA ES, 1977, J BIOL CHEM, V252, P6799; SNYDER UK, 1989, NATURE, V341, P255, DOI 10.1038/341255a0; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YEN PM, 1992, J BIOL CHEM, V267, P3565; ZHANG X, 1991, MOL ENDOCRINOL, V5, P1909, DOI 10.1210/mend-5-12-1909; ZWIEB C, 1989, GENE DEV, V3, P606, DOI 10.1101/gad.3.5.606	44	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					495	501						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416953				2022-12-27	WOS:A1993KE60300075
J	WU, JH; ROSEN, BP				WU, JH; ROSEN, BP			METALLOREGULATED EXPRESSION OF THE ARS OPERON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; ARSENICAL RESISTANCE OPERON; ESCHERICHIA-COLI; ANION PUMP; PROTEIN; DNA; REPRESSOR; BINDING; PROMOTER; CONTACTS	The plasmid-borne arsenical resistance (ars) operon encodes an arsenical-translocating ATPase and confers resistance to antimonials and arsenicals in Escherichia coli by extrusion of the toxic compounds from the cytosol. The trans-acting regulatory ArsR protein was shown to bind to a fragment of DNA containing the ars promoter. Hybrid formation of the ArsR protein with a ArsR-beta-lactamase chimeric protein suggested that the active form of the ArsR repressor is a dimer. From footprinting analysis the binding site was defined as a region of imperfect dyad symmetry just upstream of the -35 site. In vivo the operon was derepressed by oxyions of +III oxidation state of arsenic, antimony, and bismuth, as well as arsenate (As(V)), whereas in vitro ArsR protein-operator interaction was reduced by each of those compounds except arsenate, as determined by gel retardation and DNase I and hydroxyl radical footprinting experiments. This indicates that arsenate is not a true inducer and must be reduced to arsenite in vivo to induce. An operator mutant obtained by deletion of the in vitro ArsR-protected DNA sequence exhibited constitutive ars promoter activity, demonstrating that the binding site is the functional target for the ArsR repressor in vivo.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,540 E CANFIELD AVE,DETROIT,MI 48201	Wayne State University				Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019793] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19793] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHURCHILL MEA, 1991, TRENDS BIOCHEM SCI, V16, P92, DOI 10.1016/0968-0004(91)90040-3; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GICQUELSANZEY B, 1982, EMBO J, V1, P591, DOI 10.1002/j.1460-2075.1982.tb01213.x; GRALLA JD, 1990, METHOD ENZYMOL, V185, P37; HEDGES RW, 1973, J BACTERIOL, V115, P459, DOI 10.1128/JB.115.1.459-460.1973; HSU CM, 1989, J BIOL CHEM, V264, P17349; JI G, 1992, IN PRESS P NATL ACAD; KAUR P, 1992, PLASMID, V27, P29, DOI 10.1016/0147-619X(92)90004-T; KIM SH, 1992, SCIENCE, V255, P1217, DOI 10.1126/science.1546321; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Miller J.H., 1972, EXPT MOL GENETICS; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; OWOLABI JB, 1990, J BACTERIOL, V172, P2367, DOI 10.1128/jb.172.5.2367-2371.1990; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; REIDL J, 1989, J BACTERIOL, V171, P4888, DOI 10.1128/jb.171.9.4888-4899.1989; Sambrook J, 1989, MOL CLONING LABORATO; SANFRANCISCO MJD, 1990, NUCLEIC ACIDS RES, V18, P619; SILVER S, 1981, J BACTERIOL, V146, P983, DOI 10.1128/JB.146.3.983-996.1981; SMITH JD, 1973, COMPREHENSIVE INORGA, V2, P547; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TISA LS, 1990, J BIOL CHEM, V265, P190; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x	29	151	156	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					52	58						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416957				2022-12-27	WOS:A1993KE60300010
J	CHEN, AJ; ZHANG, DL; POULTER, CD				CHEN, AJ; ZHANG, DL; POULTER, CD			(S)-GERANYLGERANYLGLYCERYL PHOSPHATE SYNTHASE - PURIFICATION AND CHARACTERIZATION OF THE 1ST PATHWAY-SPECIFIC ENZYME IN ARCHAEBACTERIAL MEMBRANE LIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1'-4 COUPLING REACTION; QUANTITATION; SYNTHETASE; GENE	The first pathway-specific step in the biosynthesis of the core membrane diether lipids in archaebacteria is the alkylation of the primary hydroxyl group in (S)-glyceryl phosphate by geranylgeranyl diphosphate. The reaction is catalyzed by (S)-3-O-geranylgeranylglyceryl phosphate ((S)-GGGP) synthase. The cytosolic enzyme was purified to homogeneity from the moderately thermophilic archaebacterium Methanobacterium thermoautotrophicum by a combination of ammonium sulfate precipitation, four chromatographic steps (DE52, Q-Sepharose, phenyl-Superose, and Protein Pak), and native polyacrylamide gel electrophoresis. SDS-polyacrylamide gel electrophoresis of gel-purified GGGP synthase gave a single band at 29 kDa. The enzyme requires Mg2+ for optimal activity, although prenyltransfer is also seen in buffers containing Mn2+ or Zn2+. A well defined pH optimum occurs between 6.0 and 7.5. Maximal activity is seen at 50-65-degrees-C. The Michaelis constants for GGGP synthase are V(max) = 4.1 +/- 0.5 mumol min-1 mg-1, K(M)GGPP = 4.1 +/- 1.1 muM, and K(M)GP = 41 +/- 5 muM.	UNIV UTAH, DEPT CHEM, SALT LAKE CITY, UT 84112 USA	Utah System of Higher Education; University of Utah					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021328, R01GM021328] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-21328] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMICO V, 1977, EXPERIENTIA, V33, P989, DOI 10.1007/BF01945922; ANDERSON MS, 1989, J BIOL CHEM, V264, P19176; BEVERIDGE TJ, 1993, J BACTERIOL, V175, P1191, DOI 10.1128/JB.175.4.1191-1197.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN AJ, 1993, J BIOL CHEM, V268, P11002; DEROSA M, 1982, PHYTOCHEMISTRY, V21, P595, DOI 10.1016/0031-9422(82)83147-6; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DEROSA M, 1986, MICROBIOL REV, V50, P70, DOI 10.1128/MMBR.50.1.70-80.1986; DEROSA M, 1976, PHYTOCHEMISTRY, V15, P1995, DOI 10.1016/S0031-9422(00)88872-X; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; GEBLER JC, 1992, ARCH BIOCHEM BIOPHYS, V296, P308, DOI 10.1016/0003-9861(92)90577-J; HEATHCOCK CH, 1985, SCIENCE, V229, P862, DOI 10.1126/science.3927485; KAKINUMA K, 1990, J AM CHEM SOC, V112, P2740, DOI 10.1021/ja00163a041; LAM WL, 1992, J BIOL CHEM, V267, P5829; LASKOVICS FM, 1979, J BIOL CHEM, V254, P9458; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; MAYER MP, 1993, IN PRESS GENE AMST; Poulter C. D., 1981, BIOSYNTHESIS ISOPREN, V1, P161; POULTER CD, 1990, ACCOUNTS CHEM RES, V23, P70, DOI 10.1021/ar00171a003; POULTER CD, 1978, ACCOUNTS CHEM RES, V11, P307, DOI 10.1021/ar50128a004; SAGAMI H, 1984, BIOCHEM INT, V8, P661; TORNABENE TG, 1979, J MOL EVOL, V13, P73, DOI 10.1007/BF01732755; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1981, SCI AM, V244, P98, DOI 10.1038/scientificamerican0681-98; ZHANG DL, 1993, J ORG CHEM, V58, P3919, DOI 10.1021/jo00067a025; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331	28	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21701	21705						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408023				2022-12-27	WOS:A1993MC80900043
J	KAJI, EH; LODISH, HF				KAJI, EH; LODISH, HF			UNFOLDING OF NEWLY MADE RETINOL-BINDING PROTEIN BY DITHIOTHREITOL - SENSITIVITY TO RETINOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ROUGH ENDOPLASMIC-RETICULUM; DISULFIDE BOND FORMATION; SECRETION; GOLGI; TRANSPORT; CELLS; BIOSYNTHESIS; ISOMERASE; PATHWAY	In cultured hepatoma HepG2 cells, serum retinol-binding protein (RBP) is secreted more rapidly in the presence of retinol than in its absence (Tosetti, F., Ferrari, N., Pfeffer, U., Brigati, C., and Vidali, G. (1992) Exp. Cell Res. 200, 467-472). In the presence of millimolar concentration of DTT, HepG2 cells synthesize fully reduced RBP within the endoplasmic reticulum (ER) which, upon removal of DTT, forms disulfide bonds post-translationally. Secretion of this post-translationally folded RBP is also dependent on the presence of retinol. Using nonreducing gel electrophoresis, we resolved disulfide-bonded RBP folding intermediates. In addition, two other intracellular folding intermediates, compact I and II, which co-migrate with mature RBP were resolved by their different sensitivity to DTT-induced unfolding. Retinol, as well as retinoic acid, stabilized both compact I and II RBP intermediates to DTT-induced unfolding, suggesting that RBP assumes different conformations in the ER in the presence and absence of a ligand. However, only RBP synthesized in the presence of retinol is rapidly secreted, indicating that the ER export quality control system recognizes RBP containing retinol, but not retinoic acid, as fully folded and competent for export. Folding of RBP so that it is stabilized to DTT reduction is not a sufficient condition for ER exit.	WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)								BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BYCHKOVA VE, 1992, BIOCHEMISTRY-US, V31, P7566, DOI 10.1021/bi00148a018; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; CREIGHTON TE, 1977, J MOL BIOL, V113, P275, DOI 10.1016/0022-2836(77)90142-5; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1989, PROTEINS STRUCTURES; FREEDMAN RB, 1989, BIOCHEM SOC SYMP, V55, P167; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HUTH JR, 1992, J BIOL CHEM, V267, P8870; LODISH HF, 1988, J BIOL CHEM, V263, P2107; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; MELHUS H, 1992, J BIOL CHEM, V267, P12036; MORGAN EH, 1985, J BIOL CHEM, V260, P4793; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PETERS T, 1982, J BIOL CHEM, V257, P8847; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RONNE H, 1983, J CELL BIOL, V96, P907, DOI 10.1083/jcb.96.3.907; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROTHBLAT GH, 1976, IN VITRO CELL DEV B, V12, P554; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SMITH JE, 1978, CELL, V15, P865, DOI 10.1016/0092-8674(78)90271-4; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TOSETTI F, 1992, EXP CELL RES, V200, P467, DOI 10.1016/0014-4827(92)90197-G; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783	32	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22188	22194						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408080				2022-12-27	WOS:A1993MC80900111
J	ROSEJOHN, S; SCHOOLTINK, H; SCHMITZVANDELEUR, H; MULLBERG, J; HEINRICH, PC; GRAEVE, L				ROSEJOHN, S; SCHOOLTINK, H; SCHMITZVANDELEUR, H; MULLBERG, J; HEINRICH, PC; GRAEVE, L			INTRACELLULAR RETENTION OF INTERLEUKIN-6 ABROGATES SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY FACTOR-II; LEUKEMIA-INHIBITORY FACTOR; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; HUMAN-MONOCYTES; UP-REGULATION; HEPG2 CELLS; RECEPTOR; PROTEIN; GP130	Three forms of interleukin-6 (IL-6) have been constructed and stably transfected into human hepatoma cells (HepG2). Wild type IL-6 containing a signal peptide was rapidly secreted as a biologically active protein. IL-6 lacking the signal peptide accumulated within the cytoplasm of transfected cells. Surprisingly, IL-6 carrying a COOH-terminal extension of the amino acids Lys-Asp-Glu-Leu (KDEL) was not completely retained in the endoplasmic reticulum (ER). Complete retention in the ER was achieved when the 14 COOH-terminal amino acids of protein disulfide isomerase which include the KDEL signal were added to the COOH terminus of IL-6. This finding clearly demonstrates that the addition of the protein sorting signal KDEL alone is not sufficient for full retention of IL-6 in the ER. IL-6 accumulated in the cytoplasm and IL-6 retained in the ER failed to induce liver-specific acute-phase protein synthesis in the host cells, indicating that there is no intracellular role for IL-6 in signal transduction. Retention of IL-6 in the ER led to the prevention of surface expression of the IL-6 receptor protein gp80, making these cells unresponsive to IL-6. This phenomenon can be exploited in the future to generate transgenic animals which will become completely cytokine unresponsive in the tissues in which they express an ER retained cytokine.			ROSEJOHN, S (corresponding author), RHEIN WESTFAL TH AACHEN, DEPT BIOCHEM, PAUWELSSTR 30, W-5100 AACHEN, GERMANY.		Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279				AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; ANDRES DA, 1990, J BIOL CHEM, V265, P5952; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; BAUMANN H, 1989, J IMMUNOL, V143, P1163; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; BUONOCORE L, 1990, NATURE, V345, P625, DOI 10.1038/345625a0; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; DUNBAR CE, 1989, SCIENCE, V245, P1493, DOI 10.1126/science.2789432; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; GARMAN RD, 1987, P NATL ACAD SCI USA, V84, P7629, DOI 10.1073/pnas.84.21.7629; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GRAEVE L, 1990, J BIOL CHEM, V265, P1216; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HEINRICH PC, 1991, MOL ASPECTS INFLAMMA, P129; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KELLY RB, 1990, NATURE, V345, P480, DOI 10.1038/345480a0; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BA, 1992, J CELL BIOL, V118, P1057, DOI 10.1083/jcb.118.5.1057; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; MIYAURA C, 1988, FEBS LETT, V234, P17, DOI 10.1016/0014-5793(88)81293-6; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1992, BIOCHEM BIOPH RES CO, V189, P794, DOI 10.1016/0006-291X(92)92272-Y; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NESBITT JE, 1992, MOL BIOL CELL, V3, P103, DOI 10.1091/mbc.3.1.103; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Roberts A. B., 1990, PEPTIDE GROWTH FACTO, P633; ROSEJOHN S, 1987, BIOCHEM BIOPH RES CO, V147, P219, DOI 10.1016/S0006-291X(87)80109-2; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; ROSEJOHN S, 1991, J BIOL CHEM, V266, P3841; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE J, 1991, J CELL SCI, V100, P415; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; SCHIEL X, 1990, EUR J IMMUNOL, V20, P883, DOI 10.1002/eji.1830200425; SCHOOLTINK H, 1992, FEBS LETT, V297, P263, DOI 10.1016/0014-5793(92)80552-R; SCHOOLTINK H, 1991, BIOCHEM J, V277, P659, DOI 10.1042/bj2770659; SNYERS L, 1990, P NATL ACAD SCI USA, V87, P2838, DOI 10.1073/pnas.87.7.2838; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1992, P NATL ACAD SCI USA, V89, P10998, DOI 10.1073/pnas.89.22.10998; TAGAYA Y, 1988, J IMMUNOL, V140, P2614; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YANG FM, 1983, P NATL ACAD SCI-BIOL, V80, P5875, DOI 10.1073/pnas.80.19.5875; ZAGOURAS P, 1989, J CELL BIOL, V109, P2633, DOI 10.1083/jcb.109.6.2633; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	64	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22084	22091						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408066				2022-12-27	WOS:A1993MC80900096
J	CHEN, XL; SPARKS, JD; YAO, Z; FISHER, EA				CHEN, XL; SPARKS, JD; YAO, Z; FISHER, EA			HEPATIC POLYSOMES THAT CONTAIN APOPROTEIN-B MESSENGER-RNA HAVE UNUSUAL PHYSICAL-PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEP G2 CELLS; APOLIPOPROTEIN-B; GENE-EXPRESSION; STOP CODON; THYROID-HORMONE; DIABETIC RATS; EDITING SITE; LIVER; LIPOPROTEINS; TISSUE	To characterize the association of the mRNA for apoprotein B (apoB) with ribosomes, rat hepatic cytoplasmic extracts were fractionated by density gradient centrifugation. On linear sucrose gradients, the sedimentation velocity of the 14.4-kilobase apoB mRNA was retarded compared to the mRNAs for other hepatic proteins, which were concentrated in fractions containing the bulk of the polysomes. This unusual distribution of apoB mRNA could not be explained by co-translational association of nascent apoB peptides with lipids, based on experiments using either detergents to delipidate proteins or puromycin to release nascent peptides from polysomes. The results were also not the result of the editing of apoB mRNA, since the sucrose gradient distributions of both edited and nonedited forms were similar. In contrast, the distribution of a 3'-truncated apoB mRNA (apoB-42, 5.8 kilobases) expressed in rat hepatoma cells resembled that of mRNA of a typical hepatic protein. As opposed to the sedimentation velocity results, on equilibrium density gradients most hepatic apoB mRNA was found in the fraction that contained polysomes. Based on these data, the elongation rate of nascent apoB, and the calculated translational yield of apoB mRNA, we conclude that the majority of rat hepatic apoB mRNA must be part of polysomal complexes with unusual physical properties related to the presence of sequence(s) in the 3'-region of the message. These sequences may either be primary determinants of structural features or binding sites for protein factors that effect conformational changes.	MED COLL PENN,DEPT BIOCHEM,2900 QUEEN LANE,PHILADELPHIA,PA 19129; UNIV ROCHESTER,SCH MED & DENT,DEPT PATHOL & LAB MED,ROCHESTER,NY 14642; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA	Drexel University; University of Rochester; University of Alberta				Sparks, Janet/0000-0002-0072-766X; Fisher, Edward/0000-0001-9802-143X	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005418] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NCRR NIH HHS [SO7RR05418] Funding Source: Medline; NHLBI NIH HHS [HL22633] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; AZIZ N, 1986, NUCLEIC ACIDS RES, V14, P915, DOI 10.1093/nar/14.2.915; BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BACKUS JW, 1991, NUCLEIC ACIDS RES, V19, P6781, DOI 10.1093/nar/19.24.6781; BACKUS JW, 1990, BIOCHEM BIOPH RES CO, V170, P513, DOI 10.1016/0006-291X(90)92121-F; BALIGA BS, 1968, J MOL BIOL, V34, P199, DOI 10.1016/0022-2836(68)90247-7; BALLINGER DG, 1983, CELL, V33, P103, DOI 10.1016/0092-8674(83)90339-2; BENNETT VD, 1987, J BIOL CHEM, V262, P14806; BIRNIE GD, 1973, BIOCHIM BIOPHYS ACTA, V331, P283, DOI 10.1016/0005-2787(73)90441-3; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; BLOBEL G, 1967, J MOL BIOL, V26, P293, DOI 10.1016/0022-2836(67)90298-7; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; BRACEY LT, 1987, P NATL ACAD SCI USA, V84, P9020, DOI 10.1073/pnas.84.24.9020; BUCKINGHAM ME, 1975, FEBS LETT, V53, P355, DOI 10.1016/0014-5793(75)80054-8; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CHEN X, 1992, 65TH SCI SESS AM HEA; CHEN XL, 1993, FASEB J, V7, pA796; DAVIDSON NO, 1988, J LIPID RES, V29, P1511; DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482; DAWSON PA, 1989, J LIPID RES, V30, P403; ELOVSON J, 1981, P NATL ACAD SCI USA, V78, P156; FAN H, 1970, J MOL BIOL, V50, P665; FRANKEL AD, 1991, CELL, V67, P1041, DOI 10.1016/0092-8674(91)90282-4; GEHRKE L, 1981, J BIOL CHEM, V256, P2514; GEHRKE L, 1981, J BIOL CHEM, V258, P2522; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GLICKMAN RM, 1972, J CLIN INVEST, V51, P356, DOI 10.1172/JCI106821; HARRIS SG, 1993, J BIOL CHEM, V268, P7382; HERBERT PN, 1983, METABOLIC BASIS INHE, P597; HIGUCHI K, 1988, P NATL ACAD SCI USA, V85, P1772, DOI 10.1073/pnas.85.6.1772; HILL JR, 1992, J BIOL CHEM, V267, P21886; HODGES P, 1992, TRENDS BIOCHEM SCI, V17, P77, DOI 10.1016/0968-0004(92)90506-5; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; LAU PP, 1990, NUCLEIC ACIDS RES, V18, P5817, DOI 10.1093/nar/18.19.5817; MATSUSHIMA T, 1989, J LIPID RES, V30, P841; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; PEAVY DE, 1985, AM J PHYSIOL, V248, pE656, DOI 10.1152/ajpendo.1985.248.6.E656; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT J, 1990, CURRENT OPINION LIPI, V1, P96; SHAH RR, 1991, J BIOL CHEM, V266, P16301; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; SPARKS CE, 1981, J LIPID RES, V22, P519; SPARKS JD, 1986, ATHEROSCLEROSIS, V61, P205, DOI 10.1016/0021-9150(86)90139-5; SPARKS JD, 1992, J CLIN INVEST, V89, P1418, DOI 10.1172/JCI115731; WU JH, 1990, J BIOL CHEM, V265, P12312; YAO ZM, 1991, J BIOL CHEM, V266, P3300; ZOLFAGHARI R, 1992, ARTERIOSCLER THROMB, V12, P295, DOI 10.1161/01.ATV.12.3.295	53	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21007	21013						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407938				2022-12-27	WOS:A1993MA28800058
J	CRUZ, MA; HANDIN, RI; WISE, RJ				CRUZ, MA; HANDIN, RI; WISE, RJ			THE INTERACTION OF THE VON-WILLEBRAND FACTOR-A1 DOMAIN WITH PLATELET GLYCOPROTEIN-IB-IX - THE ROLE OF GLYCOSYLATION AND DISULFIDE BONDING IN A MONOMERIC RECOMBINANT A1 DOMAIN PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON WILLEBRAND FACTOR; FACTOR-VIII; FACTOR VWF; MULTIMERIC STRUCTURE; MONOCLONAL-ANTIBODY; FIBRINOGEN BINDING; IIB/IIIA COMPLEX; ESCHERICHIA-COLI; COLLAGEN; CARBOHYDRATE	The interaction of von Willebrand factor (vWF) with platelet glycoprotein Ib/IX plays an important role in primary hemostasis. Previous studies have localized the GpIbalpha binding domain of vWF to amino acid residues 449-728, a region containing the vWF-A1 domain. In order to assess the role of A1 domain structure in vWF binding functions, a cDNA encoding residues 475-709 of vWF was expressed in Escherichia coli (non-glycosylated) and in Chinese hamster ovary (CHO) cells (glycosylated). These recombinant proteins contain a single intrachain disulfide bond between C509 and C695 and were purified as monomers with apparent molecular weights of 36,000 (E. coli) and 39,000 (CHO). S-35-Labeled-vWF-A1 proteins bound directly to GpIb/IX receptors on platelets. The non-glycosylated form had a slightly higher affinity (K(d) = 1.4 +/- 0.4 muM) than the glycosylated vWF-A1 protein (K(d) = 4.5 +/- 0.9 muM) but had similar binding capacity of 28,000 GpIb/IX-specific binding sites per platelet. Additionally, both recombinant vWF-A1 proteins bound to heparin but neither bound to immobilized type I and III collagen. Both E. coli- and CHO-derived vWF-A1 proteins inhibited ristocetin-induced platelet agglutination with IC50 values of 300 and 700 nM, respectively. Reduction of the only disulfide bond between C509 and C695 abolished platelet binding activity at concentration up to 2 muM of protein. Confirmation of the importance of the 509-695 disulfide bond was obtained from a full-length vWF mutant containing substitutions at C509 and C695 (C509/695S) which failed to bind to the platelet GpIb/IX receptor. These studies document that vWF-A1 domain can bind to GpIb/IX and heparin but not collagen, and that binding to GpIb/IX requires an intact disulfide bond between C509 and C695. Furthermore, glycosylation increases the solubility but reduces binding affinity of recombinant vWF A1.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV HEMATOL ONCOL,LMRC-610,75 FRANCIS ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NHLBI NIH HHS [P01-HL33014, R37-HL34787] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014, R37HL034787] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN JP, 1975, J LAB CLIN MED, V85, P318; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; AZUMA H, 1991, J BIOL CHEM, V266, P12342; BEACHAM DA, 1992, J BIOL CHEM, V267, P3409; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BONTHRON D, 1986, NUCLEIC ACIDS RES, V14, P7125, DOI 10.1093/nar/14.17.7125; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; CAREW JA, 1992, J CLIN INVEST, V90, P2258, DOI 10.1172/JCI116112; CHRISTOPHE O, 1991, BLOOD, V78, P2310; COLLER BS, 1983, BLOOD, V61, P99; CRUZ MA, 1992, J BIOL CHEM, V267, P1303; CRUZ MA, 1993, THROMB HAEMOSTASIS, V69, P980; DEMARCO L, 1985, P NATL ACAD SCI USA, V82, P7424; DEMARCO L, 1985, J CLIN INVEST, V75, P1198, DOI 10.1172/JCI111816; DEMARCO L, 1990, J CLIN INVEST, V86, P785, DOI 10.1172/JCI114775; FEDERICI AB, 1988, BLOOD, V71, P947; FUJIMURA Y, 1991, BLOOD, V77, P113; FUJIMURA Y, 1987, J BIOL CHEM, V262, P1743; GINSBURG D, 1992, BLOOD, V79, P2507; GIRMA JP, 1987, BLOOD, V70, P605; GRALNICK HR, 1992, P NATL ACAD SCI USA, V89, P7880, DOI 10.1073/pnas.89.17.7880; GRALNICK HR, 1981, BLOOD, V58, P387; GRALNICK HR, 1983, P NATL ACAD SCI-BIOL, V80, P2771, DOI 10.1073/pnas.80.9.2771; GRANILK HR, 1985, J CLIN INVEST, V75, P19; KAO KJ, 1980, J BIOL CHEM, V255, P134; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MILLER JL, 1990, BRIT J HAEMATOL, V74, P313, DOI 10.1111/j.1365-2141.1990.tb02589.x; MOHRI H, 1989, J BIOL CHEM, V264, P17361; MOHRI H, 1988, J BIOL CHEM, V263, P17901; PARETI FI, 1987, J BIOL CHEM, V262, P13835; PIETU G, 1989, BIOCHEM BIOPH RES CO, V164, P1339; PRIOR C, 1992, BIO-TECHNOL, V10, P66, DOI 10.1038/nbt0192-66; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; SIXMA JJ, 1991, EUR J BIOCHEM, V688, P1; SODETZ JM, 1979, J BIOL CHEM, V254, P754; SUGIMOTO M, 1991, BIOCHEMISTRY-US, V30, P5202, DOI 10.1021/bi00235a013; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; TURITTO VT, 1984, J CLIN INVEST, V74, P1730, DOI 10.1172/JCI111591; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; WEISS HJ, 1978, J LAB CLIN MED, V92, P750; WISE RJ, 1991, J BIOL CHEM, V266, P21948; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; WISE RJ, 1993, HUM GENET, V91, P367	47	112	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21238	21245						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407961				2022-12-27	WOS:A1993MA28800088
J	FERNANDEZPOL, JA; KLOS, DJ; HAMILTON, PD				FERNANDEZPOL, JA; KLOS, DJ; HAMILTON, PD			A GROWTH FACTOR-INDUCIBLE GENE ENCODES A NOVEL NUCLEAR-PROTEIN WITH ZINC-FINGER STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING DOMAINS; FACTOR RECEPTOR GENE; CARCINOMA CELL-LINE; FACTOR-BETA; DNA-BINDING; ONCOGENE EXPRESSION; ACID-BINDING; TRIIODOTHYRONINE; IDENTIFICATION; MODULATION	Growth factors rapidly induce numerous genes that encode regulatory proteins, many of which have been identified by cDNA cloning. In this study, differential hybridization was used to screen a cDNA library constructed from human mammary carcinoma MDA-468 cells that were stimulated with transforming growth factor beta-1 (TGF-beta1) in the presence of cycloheximide. One of the cDNA clones that was induced by TGF-beta1 was found to have a nucleotide sequence that predicts a 9,450-Da protein with homology to regulatory DNA-binding proteins. This clone was designated metallopan-stimulin-1 (MPS-1) because it encodes a metalloprotein whose mRNA is expressed in a wide variety of actively proliferating cells and tumor tissues. MPS-1 protein contains one ''zinc finger'' domain of the C4 type, similar to those present in proteins of the steroid/thyroid hormone receptor superfamily and other DNA-binding proteins. The mRNA for MPS-1 was induced in MDA-468 cells by fetal calf serum, TGF-beta1, TGF-beta2, and cAMP analogues. The MPS-1 gene is expressed at relatively high levels in several human carcinoma cell lines, particularly those derived from ectodermal layers, and at higher levels in melanomas (ontogenically of neural origin). In contrast, the MPS-1 mRNA is expressed at low levels in normal WI-38 human lung diploid fibroblasts in culture. We hypothesize that MPS-1 protein may play a role as a potentially important mediator of cellular proliferative responses to various growth factors and other environmental signals.	ST LOUIS UNIV, DEPT MED, DIV NUCL MED, ST LOUIS, MO 63106 USA	Saint Louis University	FERNANDEZPOL, JA (corresponding author), DVA MED CTR, MOLEC ONCOL LAB 115JC, 915 N GRAND BLVD, ST LOUIS, MO 63106 USA.							ARCHER TK, 1990, P NATL ACAD SCI USA, V87, P7560, DOI 10.1073/pnas.87.19.7560; BERG JM, 1990, J BIOL CHEM, V265, P6513; BERG JM, 1989, PROG INORG CHEM, V37, P143; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; Erlich H.A., 1989, PCR TECHNOLOGY PRINC; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FERNANDEZ-POL J A, 1991, Critical Reviews in Oncogenesis, V2, P173; FERNANDEZPOL JA, 1987, CANCER RES, V47, P4260; FERNANDEZPOL JA, 1989, J BIOL CHEM, V264, P4151; FERNANDEZPOL JA, 1989, J CELL BIOCHEM, V41, P159, DOI 10.1002/jcb.240410306; FERNANDEZPOL JA, 1987, BIOCHEM BIOPH RES CO, V144, P1197, DOI 10.1016/0006-291X(87)91438-0; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Gribskov M., 1991, SEQUENCE ANAL PRIMER; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; JANSEN R, 1989, GENE ANAL TECH, V6, P79, DOI 10.1016/0735-0651(89)90020-4; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; MATSUGI T, 1990, MOL CELL BIOL, V10, P1259, DOI 10.1128/MCB.10.3.1259; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELTON RW, 1989, DEVELOPMENT, V106, P759; RYCHLIK W, 1990, OLIGOTM PRIMER ANAL; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; TAGAWA M, 1990, J BIOL CHEM, V265, P20021; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684	37	55	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21198	21204						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407955				2022-12-27	WOS:A1993MA28800082
J	MUTA, T; ODA, T; IWANAGA, S				MUTA, T; ODA, T; IWANAGA, S			HORSESHOE-CRAB COAGULATION FACTOR-B - A UNIQUE SERINE-PROTEASE ZYMOGEN ACTIVATED BY CLEAVAGE OF AN ILE-ILE BOND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYPLEUS-TRIDENTATUS HEMOCYTES; AMINO-ACID-SEQUENCE; LIMULUS-POLYPHEMUS HEMOCYTES; DORSAL-VENTRAL PATTERN; 4 TANDEM REPEATS; HUMAN FACTOR-XI; FACTOR-C; PLASMA PREKALLIKREIN; PROCLOTTING ENZYME; PROTEINS	Horseshoe crab factor B is an intracellular serine protease zymogen involved in the bacterial endotoxin-responsive hemolymph coagulation cascade. cDNAs for factor B were isolated utilizing a polymerase chain reaction product using two primers derived from the partial amino acid sequence. The cloned cDNA of 1928 base pairs encoded 400 amino acid residues of factor B precursor. The first 23 amino acid residues constitute a presumed prepropeptide that may be processed by both a signal peptidase and a processing protease, similar to mammalian vitamin K-dependent protease precursors. The mature protein consists of 377 amino acids with a calculated molecular mass of 40,570 Da. The overall structure is highly homologous to that of limulus proclotting enzyme (35.9% identity), the substrate for active factor B in the cascade. Like the proclotting enzyme, mature factor B is composed of an amino-terminal ''clip''-like domain and a carboxyl-terminal serine protease domain homologous to that of human plasma prekallikrein (36.5%). Internal sequences encode a unique activation peptide. Surprisingly, the cleavage sites of the zymogen factor B for activation by limulus active factor C were found to be an Arg-Ser and an Ile-Ile bond, the latter of which has not been found in any other protease zymogens. These cleavages result in the release of the activation peptide, which consists of 21 residues with a carboxyl-terminal isoleucine. These results indicate that the intracellular clotting system of the limulus hemocyte, like mammalian plasma clotting cascade, proceeds with the sequential activation of three serine protease zymogens: factor C, factor B, and proclotting enzyme.	KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN	Kyushu University								AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ARMSTRONG PB, 1991, LIMULUS POLYPHEMUS I, P3; ASAKAI R, 1987, BIOCHEMISTRY-US, V26, P7221, DOI 10.1021/bi00397a004; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DAVIE EW, 1987, HEMOSTASIS THROMBOSI, P242; DELOTTO R, 1986, NATURE, V323, P688, DOI 10.1038/323688a0; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; Halkier T, 1991, MECH BLOOD COAGULATI, P302; HERMODSON MA, 1973, BIOCHEMISTRY-US, V12, P3146, DOI 10.1021/bi00741a002; IWANAGA S, 1986, J PROTEIN CHEM, V5, P255, DOI 10.1007/BF01025424; KURIBAYASHI K, 1988, NUCLEIC ACIDS RES S, V19, P61; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN J, 1964, B JOHNS HOPKINS HOSP, V115, P265; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Maniatis T., 1982, MOL CLONING; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIYATA T, 1986, J BIOCHEM-TOKYO, V100, P213, DOI 10.1093/oxfordjournals.jbchem.a121696; MIYATA T, 1984, J BIOL CHEM, V259, P8924; MIYATA T, 1989, J BIOCHEM-TOKYO, V101, P1321; MORITA T, 1981, FEBS LETT, V129, P318, DOI 10.1016/0014-5793(81)80192-5; Morita T, 1985, Prog Clin Biol Res, V189, P53; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MURER EH, 1975, J CELL PHYSIOL, V86, P533, DOI 10.1002/jcp.1040860310; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1986, J BIOCHEM, V99, P847, DOI 10.1093/oxfordjournals.jbchem.a135545; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Ornberg R.L., 1979, Progress in Clinical and Biological Research, V29, P125; SCULLY MF, 1991, BRIT J HAEMATOL, V79, P537, DOI 10.1111/j.1365-2141.1991.tb08078.x; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SODERHALL K, 1992, ANN REV FISH DISEASE, V1, P3; TOH Y, 1991, CELL TISSUE RES, V266, P137, DOI 10.1007/BF00678720; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337; TOKUNAGA F, 1987, EUR J BIOCHEM, V167, P405, DOI 10.1111/j.1432-1033.1987.tb13352.x; TULINSKY A, 1991, THROMB HAEMOSTASIS, V66, P16; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17	43	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21384	21388						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407978				2022-12-27	WOS:A1993MA28800106
J	BRIESEWITZ, R; EPSTEIN, MR; MARCANTONIO, EE				BRIESEWITZ, R; EPSTEIN, MR; MARCANTONIO, EE			EXPRESSION OF NATIVE AND TRUNCATED FORMS OF THE HUMAN INTEGRIN ALPHA(1)-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; COMPLEMENT RECEPTOR TYPE-3; CELL ANTIGEN RECEPTOR; ALPHA-SUBUNIT; VONWILLEBRAND-FACTOR; CYTOPLASMIC DOMAIN; FIBRONECTIN RECEPTOR; MAMMALIAN-CELLS; BETA-SUBUNITS; IV COLLAGEN	We report here the molecular cloning of cDNAs encoding for the human integrin alpha1 subunit. The sequence is characteristic of an I domain containing integrin a subunit, with a high degree of homology to the rat integrin alpha1 subunit, including complete identity of the transmembrane and cytoplasmic domains between the two species. The human cDNA directs the expression in mouse NIH 3T3 cells of authentic human alpha1 protein as demonstrated by the reactivity of this subunit with two human-specific anti-alpha1 monoclonal antibodies. This exogenous integrin specifically binds to type IV collagen in a Mg2+-dependent fashion. We have expressed in both transient systems and in stable cell lines truncated, soluble forms of the human alpha1 subunit combined with truncated, soluble forms of beta1 subunits. Although soluble beta1 subunit was found in the media when the corresponding cDNA was used, the secretion of the soluble alpha1 subunit was found to be dependent on dimerization with soluble beta1. Co-transfection of truncated human alpha1 cDNA with truncated forms of either the human or avian beta1 cDNA led to efficient secretion of alpha1.beta1 heterodimers. These soluble heterodimers specifically bind to collagen IV in a manner similar to their full-length counterparts. Biosynthetic studies using stably expressing cell lines demonstrate that the soluble heterodimers and the native heterodimers are formed independently, strongly suggesting that the transmembrane or cytoplasmic domains of alpha and beta subunits are involved in the assembly of native heterodimers.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,630 W 168TH ST,BLACK BLDG 1427,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032	Columbia University; Columbia University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044585] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 44585] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; ARNAOUT MA, 1988, J CELL BIOL, V106, P2153, DOI 10.1083/jcb.106.6.2153; Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; DESIMONE DW, 1988, J BIOL CHEM, V263, P5333; DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0; DUPERRAY A, 1989, BLOOD, V74, P1603; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GRZESIAK JJ, 1992, J CELL BIOL, V117, P1109, DOI 10.1083/jcb.117.5.1109; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; HEMLER ME, 1986, J CLIN INVEST, V78, P696, DOI 10.1172/JCI112629; HEMLER ME, 1985, J BIOL CHEM, V260, P5246; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HO MK, 1983, J BIOL CHEM, V258, P2766; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1989, J CELL BIOL, V109, P409, DOI 10.1083/jcb.109.1.409; IGNATIUS MJ, 1990, J CELL BIOL, V111, P709, DOI 10.1083/jcb.111.2.709; KARGER BD, 1990, FOCUS, V12, P25; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; KRAMER RH, 1989, J BIOL CHEM, V264, P4684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MARCANTONIO EE, 1990, CELL REGUL, V1, P597, DOI 10.1091/mbc.1.8.597; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; ROSA JP, 1989, J BIOL CHEM, V264, P12596; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TAKADA Y, 1987, P NATL ACAD SCI USA, V84, P3239, DOI 10.1073/pnas.84.10.3239; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; TOMASELLI KJ, 1988, J CELL BIOL, V107, P1241, DOI 10.1083/jcb.107.3.1241; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; TURNER DC, 1989, J NEUROSCI, V9, P3287; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699	55	106	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2989	2996						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428973				2022-12-27	WOS:A1993KK81500107
J	COOK, RK; ROOT, D; MILLER, C; REISLER, E; RUBENSTEIN, PA				COOK, RK; ROOT, D; MILLER, C; REISLER, E; RUBENSTEIN, PA			ENHANCED STIMULATION OF MYOSIN SUBFRAGMENT-1 ATPASE ACTIVITY BY ADDITION OF NEGATIVELY CHARGED RESIDUES TO THE YEAST ACTIN NH2 TERMINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALI LIGHT-CHAINS; NON-MUSCLE CELLS; SACCHAROMYCES-CEREVISIAE; SLIDING MOVEMENT; DICTYOSTELIUM-DISCOIDEUM; CYTOPLASMIC MYOSINS; IONIC-STRENGTH; AMINO TERMINUS; BINDING SITES; CROSS-LINKING	We examined the effects of yeast actin NH2-terminal mutations on actomyosin interactions and the function of actin in vivo through measurements of actin-activated ATPase activity, cosedimentation with rabbit muscle myosin subfragment 1 (S-1), in vitro motility, and invertase secretion assays. As reported earlier (Cook, R. K., Blake, W., and Rubenstein, P. A. (1992) J. Biol. Chem. 267, 9430-9436), elimination of NH2-terminal acidic residues from yeast actin results in an increased actin bundling, decreased actin-activated S1 ATPase, and complete inhibition of actin filament sliding over myosin. Here we show that the addition of 2 new acidic residues to the NH2 terminus of yeast actin increased the V(max) value and the catalytic efficiency of the actin-activated ATPase activity of S-1. However, the binding of actin to S-1 in the presence of ATP and the velocities of actin sliding over myosin in the in vitro motility assays were not affected by this mutation. Thus, the number of actin NH2-terminal negative charges is important for actin activation of myosin S-1 ATPase activity, while only a minimum number of acidic residues is required for actin sliding over myosin in vitro. The number of actin NH2-terminal negative charges therefore appears to determine the efficiency with which the energy from ATP hydrolysis is converted to filament sliding.	UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	COOK, RK (corresponding author), UNIV IOWA, COLL MED, DEPT BIOCHEM, IOWA CITY, IA 52242 USA.			Rubenstein, Peter/0000-0003-1225-4414	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR022031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 22031, R01 AR022031] Funding Source: Medline; NIGMS NIH HHS [GM-33689] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASPENSTROM P, 1992, FEBS LETT, V303, P59, DOI 10.1016/0014-5793(92)80477-X; ASPENSTROM P, 1991, EUR J BIOCHEM, V200, P35, DOI 10.1111/j.1432-1033.1991.tb21045.x; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BERTRAND R, 1989, EUR J BIOCHEM, V181, P747, DOI 10.1111/j.1432-1033.1989.tb14787.x; Cantor C., 1980, BIOPHYSICAL CHEM 3, P892; CHALOVICH JM, 1984, BIOCHEMISTRY-US, V23, P4885, DOI 10.1021/bi00316a011; CHAUSSEPIED P, 1988, P NATL ACAD SCI USA, V85, P7471, DOI 10.1073/pnas.85.20.7471; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; DASGUPTA G, 1989, J MOL BIOL, V207, P833, DOI 10.1016/0022-2836(89)90249-0; DASGUPTA G, 1991, BIOCHEMISTRY-US, V30, P9961, DOI 10.1021/bi00105a021; DASGUPTA G, 1992, BIOCHEMISTRY-US, V31, P1836, DOI 10.1021/bi00121a036; DOI Y, 1987, EUR J BIOCHEM, V164, P89, DOI 10.1111/j.1432-1033.1987.tb10997.x; GALLWITZ D, 1980, P NATL ACAD SCI-BIOL, V77, P2546, DOI 10.1073/pnas.77.5.2546; GODFREY JE, 1970, BIOCHEMISTRY-US, V9, P886, DOI 10.1021/bi00806a025; Goldstein A, 1975, Methods Enzymol, V42, P504; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KORN ED, 1982, PHYSIOL REV, V62, P672, DOI 10.1152/physrev.1982.62.2.672; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MEJEAN C, 1987, BIOCHEM J, V244, P571, DOI 10.1042/bj2440571; MILLER L, 1987, BIOCHEMISTRY-US, V26, P6064, DOI 10.1021/bi00393a018; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POPE B, 1981, EUR J BIOCHEM, V117, P201; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; RADIKA K, 1984, ANAL BIOCHEM, V141, P413, DOI 10.1016/0003-2697(84)90063-0; REDMAN K, 1981, J BIOL CHEM, V256, P3226; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHORTLE D, 1982, SCIENCE, V217, P371, DOI 10.1126/science.7046050; SPUDICH JA, 1974, J BIOL CHEM, V249, P6013; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1986, BIOCHEMISTRY-US, V25, P6186, DOI 10.1021/bi00368a053; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; SUTOH K, 1986, BIOCHEMISTRY-US, V25, P435, DOI 10.1021/bi00350a024; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P711; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; WAGNER PD, 1977, J MOL BIOL, V109, P455, DOI 10.1016/S0022-2836(77)80023-5; WEEDS AG, 1977, J MOL BIOL, V111, P129, DOI 10.1016/S0022-2836(77)80119-8	47	111	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2410	2415						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428914				2022-12-27	WOS:A1993KK81500027
J	KEETON, TP; BURK, SE; SHULL, GE				KEETON, TP; BURK, SE; SHULL, GE			ALTERNATIVE SPLICING OF EXONS ENCODING THE CALMODULIN-BINDING DOMAINS AND C-TERMINI OF PLASMA-MEMBRANE CA2+-ATPASE ISOFORM-1, ISOFORM-2, ISOFORM-3, AND ISOFORM-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP ISOFORMS; CA-2+ PUMP; MOLECULAR-CLONING; CA-2+-ATPASE GENE; SKELETAL-MUSCLE; SMOOTH-MUSCLE; EXPRESSION; SEQUENCE; ATPASE; KIDNEY	Rat plasma membrane Ca2+-ATPase (PMCA) mRNAs were examined by S1 nuclease protection (isoform 1) and polymerase chain reaction (isoforms 1, 2, 3, and 4) and the corresponding genes were analyzed to determine the tissue-specific splicing patterns involving exons encoding the calmodulin-binding domains and C termini. Splicing of PMCA1 involves a single 154-nucleotide exon that can be either included or excluded; when the exon is included four different splice donor sites, at positions 87, 114, 152, and 154, can be utilized. PMCA2 mRNAs are generated either by the inclusion of a 172-nucleotide exon, by the inclusion of both the 172-nucleotide exon and a 55-nucleotide exon, or by the exclusion of both exons. Four PMCA3 mRNAs arise by alternative splicing of a 154-nucleotide exon, in patterns that are analogous to those of PMCA1, and additional mRNAs are generated by the inclusion of a 68-nucleotide exon immediately before the 154-nucleotide exon. The simplest splicing pattern occurs in PMCA4, where a single 175-nucleotide exon is either included or excluded. The alternative mRNAs for each of the four genes are expressed in a tissue-specific manner and encode enzyme variants with different combinations of calmodulin-binding domains and C termini.			KEETON, TP (corresponding author), UNIV CINCINNATI,COLL MED,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267, USA.				NHLBI NIH HHS [HL41558] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041558] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMO HP, 1992, BIOCHEM J, V283, P355, DOI 10.1042/bj2830355; BRANDT P, 1992, J BIOL CHEM, V267, P4376; BURK SE, 1992, J BIOL CHEM, V267, P19683; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; DEJAEGERE S, 1990, BIOCHEM J, V271, P655, DOI 10.1042/bj2710655; ENYEDI A, 1991, J BIOL CHEM, V266, P8952; GREEB J, 1989, J BIOL CHEM, V264, P18569; GUNTESKIHAMBLIN AM, 1992, BIOCHEMISTRY-US, V31, P7600, DOI 10.1021/bi00148a023; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; HEIM R, 1992, EUR J BIOCHEM, V205, P333, DOI 10.1111/j.1432-1033.1992.tb16784.x; KHAN I, 1991, BIOCHEM J, V277, P345, DOI 10.1042/bj2770345; KORCZAK B, 1988, J BIOL CHEM, V263, P4813; LYTTON J, 1988, J BIOL CHEM, V263, P15024; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHULL GE, 1988, J BIOL CHEM, V263, P8646; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; STREHLER EE, 1991, J MEMBRANE BIOL, V120, P1, DOI 10.1007/BF01868586; STREHLER EE, 1989, P NATL ACAD SCI USA, V86, P6908, DOI 10.1073/pnas.86.18.6908; VERMA AK, 1988, J BIOL CHEM, V263, P14152; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012	24	149	156	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2740	2748						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428948				2022-12-27	WOS:A1993KK81500072
J	NARUO, K; SEKO, C; KUROSHIMA, K; MATSUTANI, E; SASADA, R; KONDO, T; KUROKAWA, T				NARUO, K; SEKO, C; KUROSHIMA, K; MATSUTANI, E; SASADA, R; KONDO, T; KUROKAWA, T			NOVEL SECRETORY HEPARIN-BINDING FACTORS FROM HUMAN GLIOMA-CELLS (GLIA-ACTIVATING FACTORS) INVOLVED IN GLIAL-CELL GROWTH - PURIFICATION AND BIOLOGICAL PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL NERVOUS-SYSTEM; OLIGODENDROCYTE DEVELOPMENT; COMMON PROGENITOR; MATURATION FACTOR; BRAIN; TRANSFORMATION; INVITRO; INTERLEUKIN-1; PROLIFERATION; STIMULATION	Growth factors for rat primary glial cells were identified in conditioned medium of a human glioma-derived cell line. The factors, designated glia-activating factors (GAFs), were purified to homogeneity by a combination of heparin affinity chromatography, gel filtration, and high performance liquid chromatography on a heparin affinity column and a C4 reversed-phase column. GAFs could be resolved into three peaks by C4 column chromatography. The M(r) values of these three proteins were estimated to be 30,000, 29,000, and 25,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. These M(r) values were in good agreement with the value of 26,000 +/- 3,000 estimated from the elution volume upon gel filtration chromatography under nondenaturing conditions. These data suggested that each of the GAFs consists of a single polypeptide chain and has no subunit structures. These three purified GAFs had almost the same growth-stimulating effect on glial cells in vitro, and the half-maximal dose was around 10(-11) M. Concanavalin A staining and glycopeptide N-glycosidase treatment of GAFs indicated that an asparagine-linked oligosaccharide chain(s) was attached to these three kinds of GAFs. Microsequencing of each GAF revealed a single amino-terminal sequence with no significant homology to any known protein, and the amino-terminal sequence of the 30-kDa GAF included that of the 29-kDa GAF. GAFs also stimulated the cell growth of oligodendrocyte type 2 astrocyte progenitor cells, BALB/c3T3 fibroblasts, and PC-12 cells but not that of human umbilical vein endothelial cells.	NATL MED CTR,DEPT NEUROSURG,SHINJUKU KU,TOKYO 162,JAPAN		NARUO, K (corresponding author), TAKEDA CHEM IND LTD,DIV RES & DEV,BIOL RES LABS,YODOGAWA KU,OSAKA 532,JAPAN.							BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BESNARD F, 1987, NEUROSCI LETT, V73, P287, DOI 10.1016/0304-3940(87)90260-6; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DEUEL TF, 1981, J BIOL CHEM, V256, P8896; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1986, J CELL BIOL, V102, P803, DOI 10.1083/jcb.102.3.803; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HELDIN CH, 1977, EXP CELL RES, V109, P429, DOI 10.1016/0014-4827(77)90023-4; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; KAKUNAGA T, 1980, SCIENCE, V209, P505, DOI 10.1126/science.7394516; KAN M, 1985, IN VITRO CELL DEV B, V21, P181; KATO T, 1981, BRAIN RES, V212, P393, DOI 10.1016/0006-8993(81)90471-6; KATO T, 1984, BRAIN RES, V301, P83, DOI 10.1016/0006-8993(84)90405-0; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; KIJIMOTOOCHIAI S, 1985, ANAL BIOCHEM, V147, P222, DOI 10.1016/0003-2697(85)90031-4; KIMURA H, 1990, NATURE, V348, P257, DOI 10.1038/348257a0; KNISS DA, 1988, BRAIN RES, V439, P281, DOI 10.1016/0006-8993(88)91485-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUDER J, 1986, ASTROCYTES BIOCH PHY, V2, P295; LEMKE GE, 1984, J NEUROSCI, V4, P75; LIBERMANN TA, 1987, EMBO J, V6, P1627, DOI 10.1002/j.1460-2075.1987.tb02410.x; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; MANTHORPE M, 1986, ASTROCYTES CELL BIOL, V2, P315; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; PRUSS RM, 1982, DEV BRAIN RES, V2, P19; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; SIMPSON DL, 1982, J NEUROSCI RES, V8, P453, DOI 10.1002/jnr.490080233; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0	40	85	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2857	2864						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428960				2022-12-27	WOS:A1993KK81500088
J	BLACHLYDYSON, E; ZAMBRONICZ, EB; YU, WH; ADAMS, V; MCCABE, ERB; ADELMAN, J; COLOMBINI, M; FORTE, M				BLACHLYDYSON, E; ZAMBRONICZ, EB; YU, WH; ADAMS, V; MCCABE, ERB; ADELMAN, J; COLOMBINI, M; FORTE, M			CLONING AND FUNCTIONAL EXPRESSION IN YEAST OF 2 HUMAN ISOFORMS OF THE OUTER MITOCHONDRIAL-MEMBRANE CHANNEL, THE VOLTAGE-DEPENDENT ANION CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PORE-FORMING PROTEIN; VDAC ION CHANNEL; GLYCEROL KINASE; BRAIN MITOCHONDRIA; HUMAN PORINS; 31 HL; HEXOKINASE; PURIFICATION; BINDING	The voltage-dependent anion channel (VDAC) of the outer mitochondrial membrane is a small abundant protein found in all eukaryotic kingdoms which forms a voltage-gated pore when incorporated into planar lipid bilayers. VDAC is also the site of binding of the metabolic enzymes hexokinase and glycerol kinase to the mitochondrion in what may be a significant metabolic regulatory interaction. Recently, there has been speculation that there may be multiple forms of VDAC in mammals which differ in their localization in the outer mitochondrial membrane and in their physiological function. In this report, we describe the identification and characterization of two human cDNAs encoding VDAC homologs (HVDAC1 and HVDAC2). To confirm VDAC function, each human protein has been expressed in yeast lacking the endogenous VDAC gene. Human proteins isolated from yeast mitochondria formed channels with the characteristics expected of VDAC when incorporated into planar lipid bilayers. In addition, expression of the human proteins in such strains can complement phenotypic defects associated with elimination of the endogenous yeast VDAC gene. Since VDAC is the site of binding of hexokinase to the outer mitochondrial membrane, the binding capacity of each VDAC isoform expressed in yeast mitochondria was assessed. When compared with the binding of hexokinase to mitochondria lacking VDAC, the results show that mitochondria expressing HVDAC1 are capable of specifically binding hexokinase, whereas mitochondria expressing HVDAC2 only bind hexokinase at background levels. The expression of each human cDNA has been assessed by Northern blot and polymerase chain reaction techniques. With one exception, each is expressed in all human cell lines and tissues examined.	OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT CELL BIOL & ANAT,PORTLAND,OR 97201; UNIV MARYLAND,DEPT ZOOL,CELL BIOL LAB,COLL PK,MD 20742; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	Oregon Health & Science University; Oregon Health & Science University; University System of Maryland; University of Maryland College Park; Baylor College of Medicine; Baylor College of Medicine			Colombini, Marco/A-1540-2014					ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; BABEL D, 1991, BIOL CHEM H-S, V372, P1027, DOI 10.1515/bchm3.1991.372.2.1027; BENZ R, 1985, CRC CR REV BIOCH MOL, V19, P145, DOI 10.3109/10409238509082542; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; BLACHLYDYSON E, 1989, J BIOENERG BIOMEMBR, V21, P471, DOI 10.1007/BF00762519; BLATZ AL, 1983, BIOPHYS J, V43, P237, DOI 10.1016/S0006-3495(83)84344-6; BRDICZKA D, 1990, EXPERIENTIA, V46, P161, DOI 10.1007/BF02027312; CHOU AC, 1972, ARCH BIOCHEM BIOPHYS, V151, P48, DOI 10.1016/0003-9861(72)90471-7; COLOMBINI M, 1983, J MEMBRANE BIOL, V74, P115, DOI 10.1007/BF01870500; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; DEPINTO V, 1987, BIOCHIM BIOPHYS ACTA, V894, P109, DOI 10.1016/0005-2728(87)90180-0; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DIHANICH M, 1987, EMBO J, V6, P723, DOI 10.1002/j.1460-2075.1987.tb04813.x; DIHANICH M, 1989, EUR J BIOCHEM, V181, P703, DOI 10.1111/j.1432-1033.1989.tb14780.x; DIHANICH M, 1990, EXPERIENTIA, V46, P146, DOI 10.1007/BF02027310; DORBANI L, 1987, ARCH BIOCHEM BIOPHYS, V252, P188, DOI 10.1016/0003-9861(87)90023-3; FELGNER PL, 1979, J BIOL CHEM, V254, P4944; FIEK C, 1982, BIOCHIM BIOPHYS ACTA, V688, P429, DOI 10.1016/0005-2736(82)90354-6; FORTE M, 1987, J MEMBRANE BIOL, V99, P65, DOI 10.1007/BF01870622; FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537; GUGGENHEIM MA, 1980, ANN NEUROL, V7, P441, DOI 10.1002/ana.410070509; GUO XJ, 1986, YEAST, V2, pS138; KABIR F, 1991, BIOCHIM BIOPHYS ACTA, V1057, P147, DOI 10.1016/S0005-2728(05)80095-7; KANEKO M, 1985, ARCH BIOCHEM BIOPHYS, V237, P135, DOI 10.1016/0003-9861(85)90262-0; KAYSER H, 1989, BIOL CHEM H-S, V370, P1265; KLEENE R, 1987, EMBO J, V6, P2627, DOI 10.1002/j.1460-2075.1987.tb02553.x; KOTTKE M, 1988, BIOCHIM BIOPHYS ACTA, V935, P807; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; MANNELLA CA, 1992, J BIOENERG BIOMEMBR, V24, P7, DOI 10.1007/BF00769525; MCENERY M, 1992, IN PRESS P NATL ACAD; MICHEJDA J, 1989, ANION CARRIERS OF MITOCHONDRIAL MEMBRANES, P225; MIHARA K, 1985, EMBO J, V4, P769, DOI 10.1002/j.1460-2075.1985.tb03695.x; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; OSTLUND AK, 1983, BIOCHEM MED METAB B, V30, P231, DOI 10.1016/0006-2944(83)90089-3; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; SELTZER WK, 1984, MOL CELL BIOCHEM, V64, P51, DOI 10.1007/BF00420928; THINNES FP, 1989, BIOL CHEM H-S, V370, P1253; TOWBIN JA, 1989, BIOCHEM MED METAB B, V42, P161, DOI 10.1016/0885-4505(89)90051-0	39	226	241	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1835	1841						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420959				2022-12-27	WOS:A1993KH62000053
J	JONAS, A; STEINMETZ, A; CHURGAY, L				JONAS, A; STEINMETZ, A; CHURGAY, L			THE NUMBER OF AMPHIPATHIC ALPHA-HELICAL SEGMENTS OF APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-E, AND APOLIPOPROTEIN-A-IV DETERMINES THE SIZE AND FUNCTIONAL-PROPERTIES OF THEIR RECONSTITUTED LIPOPROTEIN PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; DISCOIDAL COMPLEXES; STRUCTURAL DOMAINS; MULTIGENE FAMILY; AQUEOUS-SOLUTION; LIPID-BINDING; PROTEIN; PHOSPHATIDYLCHOLINE; EVOLUTION	The objective of this work was to determine the role of the amphipathic alpha-helical structural units of human apolipoproteins A-I, E, and A-IV in defining the sizes and reactivities with lecithin:cholesterol acyltransferase (LCAT) of their reconstituted lipoprotein particles. We prepared reconstituted high density lipoprotein (rHDL) particles with each of the three apolipoproteins in two weight ratios with lipid: 2.7/0.07/1 and 1.35/0.04/1, palmitoyloleoylphosphatidylcholine/cholesterol/apolipoprotein, by the sodium cholate dialysis procedure; and examined the rHDL product sizes and distributions by nondenaturing gradient gel electrophoresis. The rHDL particles were also incubated with low density lipoprotein (LDL), and with LDL plus LCAT, to observe any structural modifications due to phospholipid transfers to LDL and to cholesterol esterification by LCAT. In addition, we examined the average structural properties of the original rHDL by several fluorescence methods and circular dichroism spectroscopy, and determined their reaction kinetics with LCAT. The results indicate that the diameters of the largest rHDL particles, containing two apolipoproteins per particle, correlate with the maximum number of putative amphipathic alpha-helical segments in their sequences, and that smaller particles of this class may arise from the removal of one or more alpha-helical segments from contact with lipid. Furthermore, the larger particles may be converted into the smaller ones upon loss of phospholipid to LDL, and may form one or two well defined products when reacted with LCAT. In general, the subclasses of particles have distinct spectroscopic properties, consistent with a different apolipoprotein folding in particles containing different proportions of phospholipid to apolipoprotein. Furthermore, the different apolipoprotein structures lead to significant differences in reactivity with LCAT.	UNIV MARBURG,DIV ENDOCRINOL,W-3550 MARBURG,GERMANY	Philipps University Marburg	JONAS, A (corresponding author), UNIV ILLINOIS,COLL MED,DEPT BIOCHEM,URBANA,IL 61801, USA.				NHLBI NIH HHS [HL-16059] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016059] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; CHEUNG MC, 1987, J LIPID RES, V28, P913; DVORIN E, 1985, J LIPID RES, V26, P38; EDELSTEIN C, 1972, J BIOL CHEM, V247, P5842; GIANTURCO SH, 1987, PLASMA LIPOPROTEINS, P183; GONG EL, 1989, BIOCHIM BIOPHYS ACTA, V1006, P317, DOI 10.1016/0005-2760(89)90019-2; JONAS A, 1988, J LIPID RES, V29, P1349; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1991, J LIPID RES, V32, P97; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1085, P71, DOI 10.1016/0005-2760(91)90233-8; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; LI WH, 1988, J LIPID RES, V29, P245; LUO CC, 1986, J MOL BIOL, V187, P325, DOI 10.1016/0022-2836(86)90436-5; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MATZ CE, 1982, J BIOL CHEM, V257, P4541; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1984, BIOCHIM BIOPHYS ACTA, V793, P325, DOI 10.1016/0005-2760(84)90246-7; Pownall H. J., 1987, PLASMA LIPOPROTEINS, P95; POWNALL HJ, 1986, METHOD ENZYMOL, V128, P515; RIFICI VA, 1985, BIOCHIM BIOPHYS ACTA, V834, P205, DOI 10.1016/0005-2760(85)90157-2; RITTER MC, 1977, J BIOL CHEM, V252, P1208; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; STEINMETZ A, 1989, J CHROMATOGR-BIOMED, V487, P154, DOI 10.1016/S0378-4347(00)83018-2; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; UTERMANN G, 1975, H-S Z PHYSIOL CHEM, V356, P1113, DOI 10.1515/bchm2.1975.356.2.1113; WALD JH, 1990, J BIOL CHEM, V265, P20037; WEINBERG RB, 1990, J BIOL CHEM, V265, P18372; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375; ZORICH N, 1985, J BIOL CHEM, V260, P8831; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	40	63	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1596	1602						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420935				2022-12-27	WOS:A1993KH62000018
J	KOHDA, D; ODAKA, M; LAX, I; KAWASAKI, H; SUZUKI, K; ULLRICH, A; SCHLESSINGER, J; INAGAKI, F				KOHDA, D; ODAKA, M; LAX, I; KAWASAKI, H; SUZUKI, K; ULLRICH, A; SCHLESSINGER, J; INAGAKI, F			A 40-KDA EPIDERMAL GROWTH-FACTOR TRANSFORMING GROWTH FACTOR-ALPHA-BINDING DOMAIN PRODUCED BY LIMITED PROTEOLYSIS OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EGF RECEPTOR; PROTEIN-STRUCTURE DETERMINATION; TYROSINE KINASE-ACTIVITY; TWO-DIMENSIONAL H-1-NMR; LIGAND-BINDING; SIGNAL TRANSDUCTION; NMR-SPECTROSCOPY; CELLS; MOUSE; EXPRESSION	Elucidation of the three-dimensional structure of the complex of the epiderma. growth factor (EGF) and its receptor is essential for understanding the molecular mechanisms of the EGF-receptor interaction and EGF-induced receptor-receptor interaction. NMR is useful to investigate interactions in solution between macromolecules at atomic resolution, but has a limitation in molecular masses of target proteins: less than 300 residues. We have prepared a fragment with apparent molecular mass of 40 kDa in SDS gels from the soluble extracellular domain of the EGF receptor (sEGFR, 619 residues) by sequential limited proteolysis with proteinase K and bromelain. This fragment is a monomeric structural domain consisting of 202 amino acid residues (Cys302-Arg503 and 18-kDa sugar chains, and binds EGF and transforming growth factor-alpha (TGFalpha). This 40-kDa domain has a dissociation constant of about 1 muM for human TGFalpha, which is similar to that of the parental sEGFR. sEGFR oligomerizes in response to EGF and TGFalpha, while the 40-kDa domain does not, suggesting that the sequences other than this domain is required for receptor oligomerization. The 40-kDa ligand-binding domain described in this report is suitable for analysis by various physico-chemical approaches such as NMR.	TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC PHYSIOL,18-22 HONKOMAGOME 3-CHOME,BUNKYO KU,TOKYO 113,JAPAN; TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC BIOL,TOKYO 113,JAPAN; NYU MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; New York University; Max Planck Society			Odaka, Masafumi/C-2378-2013; Kawasaki, Hiroshi/C-3048-2011; Kohda, Daisuke/I-4990-2019	Kawasaki, Hiroshi/0000-0002-2517-159X; Kohda, Daisuke/0000-0001-8234-3776				BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARRAWAY KL, 1989, J BIOL CHEM, V264, P8699; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; HIGUCHI Y, 1988, J BIOCHEM-TOKYO, V103, P905, DOI 10.1093/oxfordjournals.jbchem.a122385; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; HURWITZ DR, 1991, J BIOL CHEM, V266, P22035; KLINE TP, 1990, BIOCHEMISTRY-US, V29, P7805, DOI 10.1021/bi00486a005; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOHDA D, 1989, BIOCHEMISTRY-US, V28, P953, DOI 10.1021/bi00429a005; KOHDA D, 1988, J BIOCHEM-TOKYO, V103, P554, DOI 10.1093/oxfordjournals.jbchem.a122307; KOHDA D, 1988, J BIOCHEM-TOKYO, V103, P741, DOI 10.1093/oxfordjournals.jbchem.a122338; LAX I, 1988, MOL CELL BIOL, V8, P1970, DOI 10.1128/MCB.8.5.1970; LAX I, 1991, CELL REGUL, V2, P337, DOI 10.1091/mbc.2.5.337; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LAX I, 1991, J BIOL CHEM, V266, P13828; MAYES ELV, 1984, EMBO J, V3, P531, DOI 10.1002/j.1460-2075.1984.tb01842.x; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; MONTELIONE GT, 1992, BIOCHEMISTRY-US, V31, P236, DOI 10.1021/bi00116a033; OKEEFE EJ, 1981, J SUPRAMOL STR CELL, V15, P15, DOI 10.1002/jsscb.1981.380150103; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WARD LD, 1985, METHOD ENZYMOL, V117, P400; WEBER W, 1984, J BIOL CHEM, V259, P4631; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WU DG, 1989, J BIOL CHEM, V264, P17469; WU DG, 1990, P NATL ACAD SCI USA, V87, P3151, DOI 10.1073/pnas.87.8.3151; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; ZIDOVETZKI R, 1986, EMBO J, V5, P247, DOI 10.1002/j.1460-2075.1986.tb04205.x; ZIDOVETZKI R, 1981, P NATL ACAD SCI-BIOL, V78, P6981, DOI 10.1073/pnas.78.11.6981	38	48	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1976	1981						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420971				2022-12-27	WOS:A1993KH62000073
J	CHAUHAN, SS; POPESCU, NC; RAY, D; FLEISCHMANN, R; GOTTESMAN, MM; TROEN, BR				CHAUHAN, SS; POPESCU, NC; RAY, D; FLEISCHMANN, R; GOTTESMAN, MM; TROEN, BR			CLONING, GENOMIC ORGANIZATION, AND CHROMOSOMAL LOCALIZATION OF HUMAN CATHEPSIN-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR EXCRETED PROTEIN; BONE-RESORPTION; MESSENGER-RNAS; ACID-PROTEASE; GROWTH-FACTOR; CELL LINES; GENE; EXPRESSION; SEQUENCES; MURINE	Cathepsin L is a lysosomal cysteine protease whose expression and secretion is induced by malignant transformation, growth factors, and tumor promoters. Many human tumors express high levels of cathepsin L, which is a broad spectrum protease with potent elastase and collagenase activities. Two published human cathepsin L cDNA sequences differ only in their 5'-untranslated regions. In this study, we demonstrate the concurrent expression of two distinct human cathepsin L mRNAs (hCATL-A and hCATL-B) in adenocarcinoma, hepatoma, and renal cancer cell lines. Cloning of the human cathepsin L gene by polymerase chain reaction amplification of genomic DNA and subsequent sequencing reveals that hCATL-A and hCATL-B mRNAs are encoded by a single gene. The 3' end of the first intron contains the 5' portion of hCATL-B and is contiguous to the second exon of the gene. These data suggest either the possibility of alternative splicing or the presence of a second promoter within the first intron of the hCATL gene. We mapped the hCATL gene to chromosome 9q21-22. Sequencing of both the mouse and human cathepsin L genes demonstrates almost complete conservation of exon and intron position, but significant divergence in intron structure, possibly reflecting differences in regulation of expression of the mouse and human cathepsin L genes.	UNIV NANCY 1, VET ADM MED CTR, CTR GERIATR RES EDUC & CLIN, INST GERONTOL, F-54506 VANDOEUVRE LES NANCY, FRANCE; NCI, CELL BIOL LAB, BETHESDA, MD 20892 USA; NCI, BIOL LAB, BETHESDA, MD 20892 USA	Geriatric Research Education & Clinical Center; Universite de Lorraine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Troen, Bruce R./ABB-4959-2021					AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; BANDO Y, 1986, J BIOCHEM-TOKYO, V100, P35, DOI 10.1093/oxfordjournals.jbchem.a121703; Bohley P., 1979, BIOL FUNCTIONS PROTE, P17; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRUZDZINSKI CJ, 1990, J BIOL CHEM, V265, P2078; CHAUHAN SS, 1991, CANCER RES, V51, P1478; COMINGS DE, 1972, NATURE, V238, P455, DOI 10.1038/238455a0; DARVILLE MI, 1989, P NATL ACAD SCI USA, V86, P6543, DOI 10.1073/pnas.86.17.6543; DELAISSE JM, 1986, BIOCHEM PHARMACOL, V35, P3091, DOI 10.1016/0006-2952(86)90391-6; DELAISSE JM, 1984, BIOCHEM BIOPH RES CO, V125, P441, DOI 10.1016/0006-291X(84)90560-6; ERICKSONLAWRENCE M, 1991, MOL ENDOCRINOL, V5, P1789, DOI 10.1210/mend-5-12-1789; ETHERINGTON DJ, 1988, BRIT J EXP PATHOL, V69, P281; FAN YS, 1989, CYTOGENET CELL GENET, V51, P996; FEN Z, 1991, ONCOGENE, V6, P953; GAL S, 1986, J BIOL CHEM, V261, P1760; GAL S, 1988, BIOCHEM J, V253, P303, DOI 10.1042/bj2530303; GOTTESMAN MM, 1978, P NATL ACAD SCI USA, V75, P2767, DOI 10.1073/pnas.75.6.2767; GOTTESMAN MM, 1980, CELL, V19, P449, DOI 10.1016/0092-8674(80)90519-X; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; ISHIDOH K, 1989, FEBS LETT, V259, P71, DOI 10.1016/0014-5793(89)81497-8; JOHNSON DA, 1986, J BIOL CHEM, V261, P4748; JOSEPH LJ, 1988, J CLIN INVEST, V81, P1621, DOI 10.1172/JCI113497; LOPEZ CF, 1991, EUR J BIOCHEM, V201, P119; LOWE WL, 1987, P NATL ACAD SCI USA, V84, P8946, DOI 10.1073/pnas.84.24.8946; MACIEWICZ RA, 1989, INT J CANCER, V43, P478, DOI 10.1002/ijc.2910430323; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MASON RW, 1986, BIOCHEM J, V233, P925, DOI 10.1042/bj2330925; MAYER RJ, 1986, FEBS LETT, V198, P181, DOI 10.1016/0014-5793(86)80403-3; MCCOY K, 1988, J CELL BIOL, V106, P1879, DOI 10.1083/jcb.106.6.1879; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V166, P637, DOI 10.1016/0006-291X(90)90856-I; POPESCU NC, 1985, SOMAT CELL MOLEC GEN, V11, P149, DOI 10.1007/BF01534703; PORTNOY DA, 1986, J BIOL CHEM, V261, P4697; RABIN MS, 1986, P NATL ACAD SCI USA, V83, P357, DOI 10.1073/pnas.83.2.357; REILLY JJ, 1989, BIOCHEM J, V257, P493, DOI 10.1042/bj2570493; ROGERS J, 1985, NATURE, V315, P458, DOI 10.1038/315458a0; ROMERO P, 1989, ONCOGENE, V4, P93; ROZHIN J, 1989, BIOCHEM BIOPH RES CO, V164, P556, DOI 10.1016/0006-291X(89)91755-5; SABINA RL, 1990, J BIOL CHEM, V265, P9423; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN DW, 1991, J CELL SCI, V98, P317; STAHL J, 1990, J BIOL CHEM, V265, P8833; TANABE O, 1988, J IMMUNOL, V141, P3875; Troen B R, 1987, Methods Enzymol, V151, P416, DOI 10.1016/S0076-6879(87)51033-3; TROEN BR, 1991, CELL GROWTH DIFFER, V2, P23; TROEN BR, 1987, BIOCHEM J, V246, P731, DOI 10.1042/bj2460731; TROEN BR, 1988, J BIOL CHEM, V263, P254; UEDA K, 1987, J BIOL CHEM, V262, P505; WRIGHT WW, 1989, ANN NY ACAD SCI, V564, P173, DOI 10.1111/j.1749-6632.1989.tb25896.x; YAGEL S, 1989, CANCER RES, V49, P3553	51	84	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1039	1045						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419312				2022-12-27	WOS:A1993KG07700044
J	WILBANKS, SM; GLAZER, AN				WILBANKS, SM; GLAZER, AN			ROD STRUCTURE OF A PHYCOERYTHRIN-II-CONTAINING PHYCOBILISOME .2. COMPLETE SEQUENCE AND BILIN ATTACHMENT SITE OF A PHYCOERYTHRIN GAMMA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM MASTIGOCLADUS-LAMINOSUS; MARINE UNICELLULAR CYANOBACTERIA; CRYSTAL-STRUCTURE ANALYSIS; C-PHYCOCYANIN; LINKER POLYPEPTIDES; PORPHYRIDIUM-CRUENTUM; FREMYELLA-DIPLOSIPHON; PHYCOUROBILIN CONTENT; B-PHYCOERYTHRIN; PROTEINS	The major phycoerythrins of marine unicellular cyanobacteria Synechococcus spp. and those of red algae are isolated as stable complexes with the composition (alphabeta)6gamma. The gamma subunits carry bilins and in this respect are unique among phycobilisome rod linker polypeptides. There has been no complete amino acid sequence data on any gamma subunit. Synechococcus sp. WH8020 phycoerythrin II (PE II) gamma subunit was isolated from purified PE II hexamers. Partial amino acid sequence determination showed that the gamma subunit was encoded by the mpeC gene, an open reading frame 275 base pairs 3' of mpeA and mpeB, which encode the alpha and beta subunits of PE II, respectively (Wilbanks, S. M., and Glazer, A. N. (1993) J. Biol. Chem. 268, 1226-1235). A single phycourobilin is attached through a thioether bond to gamma-Cys-49. Derivatization with 4-vinylpyridine showed that the only other cysteinyl residue, gamma-Cys-64, is unsubstituted. MpeC encodes a polypeptide of 293 residues with a predicted molecular weight of 32,100 and a pI of 8.9. These properties are like those of non-bilin-bearing linker polypeptides associated with C-phycoerythrin and hence the gamma subunit is designated gamma (L(R)32). Alignment of the sequence of the PE II-gamma with those of the latter polypeptides shows that PE II-gamma has a 49-residue extension at the N terminus, that encompasses the phycourobilin attachment site, and is shorter by a similar number of residues at the C terminus. These differences in linker polypeptide structure offer a possible explanation for the observed much higher stability of PE II hexamers relative to those of C-phycoerythrins.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Wilbanks, Sigurd/0000-0001-7565-8913	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM028994] Funding Source: NIH RePORTER; NIGMS NIH HHS [8T2 GM 08295, GM28994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bryant D.A., 1991, CELL CULTURE SOMATIC, V1st ed., P255; DEMARSAC NT, 1991, CELL CULTURE SOMAT B, V7, P417; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; FEDERSPIEL NA, 1990, J BACTERIOL, V172, P4072, DOI 10.1128/jb.172.7.4072-4081.1990; FICNER R, 1992, PHOTOSYNTHETIC LIGHT; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; FUGLISTALLER P, 1986, BIOL CHEM H-S, V367, P601, DOI 10.1515/bchm3.1986.367.2.601; FUGLISTALLER P, 1986, BIOL CHEM H-S, V367, P615, DOI 10.1515/bchm3.1986.367.2.615; Gantt E., 1980, INT REV CYTOL, V66, P45, DOI 10.1016/S0074-7696(08)61971-3; GINGRICH JC, 1982, J CELL BIOL, V95, P170, DOI 10.1083/jcb.95.1.170; GINGRICH JC, 1982, J CELL BIOL, V92, P261, DOI 10.1083/jcb.92.2.261; Glazer A. N., 1981, The biochemistry of plants. A comprehensive treatise. Volume 8. Photosynthesis., P51; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1977, J BIOL CHEM, V252, P32; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; GLAZER AN, 1982, BIOCHEM SYST ECOL, V10, P203, DOI 10.1016/0305-1978(82)90031-X; GROSSMAN AR, 1990, PLANT CELL ENVIRON, V13, P651, DOI 10.1111/j.1365-3040.1990.tb01081.x; HONSELL E, 1984, BOT MAR, V27, P1, DOI 10.1515/botm.1984.27.1.1; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGE W, 1990, BOT ACTA, V103, P250, DOI 10.1111/j.1438-8677.1990.tb00157.x; LOMAX TL, 1987, J BACTERIOL, V169, P2675, DOI 10.1128/jb.169.6.2675-2684.1987; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; SCHIRMER T, 1985, J MOL BIOL, V184, P257, DOI 10.1016/0022-2836(85)90379-1; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; SCHIRMER T, 1987, BIOCHIM BIOPHYS ACTA, V893, P379, DOI 10.1016/0005-2728(87)90090-9; SIEBZEHNRUBL S, 1987, Z NATURFORSCH C, V42, P258; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; SWANSON RV, 1990, ANAL BIOCHEM, V188, P295, DOI 10.1016/0003-2697(90)90609-D; WATERBURY JB, 1988, METHOD ENZYMOL, V167, P100; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; WEDEMAYER GJ, 1991, J BIOL CHEM, V266, P4731; WILBANKS SM, 1991, J BIOL CHEM, V266, P9535; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; YAMANAKA G, 1978, J BIOL CHEM, V253, P8303; YU MH, 1982, J BIOL CHEM, V257, P3429; YU MH, 1981, PLANT PHYSIOL, V68, P482, DOI 10.1104/pp.68.2.482	43	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1236	1241						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419326				2022-12-27	WOS:A1993KG07700071
J	KOHRER, K; EMR, SD				KOHRER, K; EMR, SD			THE YEAST VPS17 GENE ENCODES A MEMBRANE-ASSOCIATED PROTEIN REQUIRED FOR THE SORTING OF SOLUBLE VACUOLAR HYDROLASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; CARBOXYPEPTIDASE-Y; LYSOSOMAL-ENZYMES; KEX2 PROTEASE; ALKALINE-PHOSPHATASE; BIOGENESIS; TRANSPORT; TRANSFORMATION; SYSTEM	vps17 mutants missort and secrete several vacuolar hydrolases. To analyze the role of the VPS17 gene in vacuolar protein delivery, we have cloned this gene by complementation of the vacuolar protein sorting defects of a vps17-5 mutant. Disruption of the VPS17 gene had no effect on the viability of haploid yeast cells, although they show an obvious defect in vacuolar morphology. vps17-disrupted cells contain numerous small vacuole-like compartments and also exhibit a severe defect in the sorting of carboxypeptidase Y (CPY), a soluble vacuolar hydrolase. 95% of CPY is missorted and secreted from the mutant cells. Vacuolar sorting of two other soluble hydrolases, proteinase A and proteinase B, is also affected, but to a lesser extent. Delivery and maturation of the vacuolar membrane protein alkaline phosphatase does not appear to be affected in a DELTAvps17 strain. The DNA sequence of the VPS17 clone indicates that the gene encodes a 551-amino-acid protein with a calculated molecular mass of 63.1 kDa. The protein sequence is hydrophilic and contains no obvious N-terminal signal sequence or hydrophobic membrane-spanning domains, indicating that the Vps17p does not enter the secretory pathway. Using a Vps17p-specific polyclonal antiserum, we have demonstrated that the Vps17 protein is not modified with N-linked carbohydrates at any of its four potential N-linked glycosylation sites. The Vps17 protein, however, fractionates to a particulate fraction after centrifugation at 100,000 x g. Vps17p can be released from this particulate fraction by treatment with either Triton X-100 or urea, indicating that the Vps17p is peripherally associated with a crude membrane fraction. Based on these results, we propose that the Vps17p functions on the cytoplasmic surface of some intracellular organelle, possibly the Golgi complex or an intermediate in Golgi to vacuole transport, to facilitate the sorting and delivery of soluble vacuolar hydrolases. Vacuolar membrane protein traffic, however, appears to occur by a mechanism that is independent of Vps17p function.	CALTECH, DIV BIOL 14775, PASADENA, CA 91125 USA	California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032703] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-32703] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel FA, 1990, CURRENT PROTOCOLS MO; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BANTA LM, 1990, MOL CELL BIOL, V10, P4638, DOI 10.1128/MCB.10.9.4638; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; CLARK DW, 1982, J BACTERIOL, V152, P865; CUNNINGHAM KW, 1989, YEAST, V5, P25, DOI 10.1002/yea.320050105; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DULIC V, 1989, EMBO J, V8, P1349, DOI 10.1002/j.1460-2075.1989.tb03515.x; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; HURT EC, 1988, EUR J CELL BIOL, V46, P554; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MEISENHELDER J, 1991, METHOD ENZYMOL, V197, P288; MORTIMER RK, 1989, YEAST, V5, P321, DOI 10.1002/yea.320050503; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; PARAVICINI G, 1992, MOL BIOL CELL, V3, P415, DOI 10.1091/mbc.3.4.415; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRESTON RA, 1991, MOL CELL BIOL, V11, P5801, DOI 10.1128/MCB.11.12.5801; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; ROBINSON JS, 1991, MOL CELL BIOL, V11, P5813, DOI 10.1128/MCB.11.12.5813; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1989, TRENDS BIOCHEM SCI, V14, P347, DOI 10.1016/0968-0004(89)90170-9; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWAIGER H, 1982, BIOCHEM BIOPH RES CO, V104, P950, DOI 10.1016/0006-291X(82)91341-9; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; WALWORTH NC, 1989, METHOD CELL BIOL, V31, P335; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; WILIMZIG M, 1985, TRENDS GENET, V1, P158; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; WOOLFORD CA, 1990, GENETICS, V125, P739	74	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					559	569						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416961				2022-12-27	WOS:A1993KE60300085
J	TUCK, SF; GRAHAMLORENCE, S; PETERSON, JA; DEMONTELLANO, PRO				TUCK, SF; GRAHAMLORENCE, S; PETERSON, JA; DEMONTELLANO, PRO			ACTIVE-SITES OF THE CYTOCHROME-P450(CAM) (CYP101) F87W AND F87A MUTANTS - EVIDENCE FOR SIGNIFICANT STRUCTURAL REORGANIZATION WITHOUT ALTERATION OF CATALYTIC REGIOSPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENE; REARRANGEMENT; COMPLEXES	Ferricyanide oxidation of the aryl-iron complexes formed by the reaction of cytochrome P450 enzymes with arylhydrazines causes in situ migration of the aryl group from the iron to the porphyrin nitrogen atoms. The regiochemistry of this migration, defined by the ratio of the four possible N-arylprotoporphyrin IX isomers, provides a method for mapping the topologies of cytochrome P450 active sites. The method has been validated by using it to examine the active site of cytochrome P450cam (CYP101), for which a crystal structure is available. In agreement with the crystal structure, reaction with phenylhydrazine gives a 5:25:70 ratio of the N(A):N(C):N(D) (subscript indicates pyrrole ring) N-phenylprotoporphyrin IX isomers. Naphthylhydrazine, however, yields exclusively the N(C) regioisomer and 4-(phenyl)phenylhydrazine the N(A):N(C):N(D) isomers in a 14:40:46 ratio. These isomer ratio differences are readily explained by topological differences between the upper and lower reaches of the active site. Having validated the aryl-iron shift as a topological probe, we used it to investigate the structural changes caused by mutation of Phe-87, a residue that provides the ceiling over pyrrole ring D in the crystal structure of cytochrome P450cam. Mutation of Phe-87 to a tryptophan causes no detectable change in the regiochemistry of camphor hydroxylation and only minor changes in the N-aryl isomer ratios. However, mutation of Phe-87 to an alanine, which was expected to open up the region above pyrrole ring D, severely decreased the proportion of the N(D) in favor of the N(A) isomer. Less rather than more space is therefore available over pyrrole ring D in the F87A mutant despite the fact that the regiochemistry of camphor hydroxylation remains unchanged. These results provide evidence for significant structural reorganization in the upper regions of the substrate binding site without alteration of the camphor hydroxylation regiospecificity in the F87A mutant.	UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515, R01GM043479] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 P30 DK26743] Funding Source: Medline; NIGMS NIH HHS [GM43479, GM25515] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON LA, 1983, BIOCHIM BIOPHYS ACTA, V748, P341, DOI 10.1016/0167-4838(83)90178-4; ATKINS WM, 1989, J AM CHEM SOC, V111, P2715, DOI 10.1021/ja00189a057; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FRUETEL JA, 1992, J AM CHEM SOC, V114, P6987, DOI 10.1021/ja00044a006; Gunsalus I C, 1978, Methods Enzymol, V52, P166; HUNSBERGER IM, 1956, J ORG CHEM, V21, P394, DOI 10.1021/jo01110a004; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; MORRIS GM, 1991, BIOCHEM SOC T, V19, P793, DOI 10.1042/bst0190793; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NELSON SD, 1987, MAMMALIAN CYTOCHROME, V2, P19; OMURA T, 1964, J BIOL CHEM, V239, P2370; PAULSEN MD, 1991, J BIOMOL STRUCT DYN, V9, P187, DOI 10.1080/07391102.1991.10507906; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAAG R, 1990, BIOCHEMISTRY-US, V29, P8119, DOI 10.1021/bi00487a019; Sambrook J, 1989, MOL CLONING LABORATO; SLIGAR SG, 1986, CYTOCHROME P450 STRU, P429; SWANSON BA, 1991, J AM CHEM SOC, V113, P8146, DOI 10.1021/ja00021a046; SWANSON BA, 1992, ARCH BIOCHEM BIOPHYS, V292, P42, DOI 10.1016/0003-9861(92)90048-2; SWANSON BA, 1991, J BIOL CHEM, V266, P19258; TUCK SF, 1992, J BIOL CHEM, V267, P5614; TUCK SF, 1992, BIOCHEMISTRY-US, V31, P6911, DOI 10.1021/bi00145a007; TUCK SF, 1992, J BIOL CHEM, V267, P13175; UNGER BP, 1986, J BIOL CHEM, V261, P1158; Waterman MR, 1986, CYTOCHROME P450 STRU, P345; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468; ZVELEBIL MJJM, 1991, PROTEIN ENG, V4, P271, DOI 10.1093/protein/4.3.271	28	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					269	275						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416934				2022-12-27	WOS:A1993KE60300042
J	SLEPAK, VZ; QUICK, MW; ARAGAY, AM; DAVIDSON, N; LESTER, HA; SIMON, MI				SLEPAK, VZ; QUICK, MW; ARAGAY, AM; DAVIDSON, N; LESTER, HA; SIMON, MI			RANDOM MUTAGENESIS OF G-PROTEIN ALPHA-SUBUNIT G(O)ALPHA - MUTATIONS ALTERING NUCLEOTIDE-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE SYSTEM; BOVINE BRAIN; GUANINE-NUCLEOTIDES; ADP-RIBOSYLATION; MECHANISM; RECEPTOR; CELLS; MUTANT; TOXIN; MG-2+	Nucleotide binding properties of the G protein alpha subunit G(o)alpha were probed by mutational analysis in recombinant Escherichia coli. Thousands of random mutations generated by polymerase chain reaction were screened by in situ [S-35]GTPgammaS (guanosine 5'-(3-O-thio)triphosphate) binding on the colony lifts following transformation of bacteria with modified G(o)alpha cDNA. Clones that did not bind the nucleotide under these conditions were characterized by DNA sequence analysis, and the nucleotide binding properties were further studied in crude bacterial extracts. A number of novel mutations reducing the affinity of G(o)alpha for GTPgammaS or Mg2+ were identified. Some of the mutations substitute amino acid residues homologous to those known to interact with guanine nucleotides in p21ras proteins. Other mutations show that previously unstudied residues also participate in the nucleotide binding. Several mutants lost GTPgammaS binding but retained the capacity to interact with the betagamma subunit complex as determined by pertussis toxin-mediated ADP-ribosylation. One of these, mutant S47C, was functionally expressed in Xenopus laevis oocytes along with the G protein-coupled thyrotropin-releasing hormone (TRH) receptor. Whereas wild-type G(o)alpha increased TRH-promoted chloride currents, S47C significantly decreased the hormone-induced Cl- response, suggesting that this mutation resulted in a dominant negative phenotype.	CALTECH,DIV BIOL,147-75,PASADENA,CA 91125	California Institute of Technology			Aragay, Anna M/K-3813-2014	Aragay, Anna M/0000-0002-8240-4126				ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLITZER RD, 1993, J BIOL CHEM, V268, P7532; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; LEE E, 1992, J BIOL CHEM, V267, P1212; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; OSAWA S, 1991, J BIOL CHEM, V266, P4673; PADRELL E, 1991, J BIOL CHEM, V266, P9771; QUICK M W, 1992, Biotechniques, V13, P362; QUICK MW, 1993, METHODS NEUROSCIENCE; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324	28	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21889	21894						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408043				2022-12-27	WOS:A1993MC80900069
J	LIU, SH; MA, JT; YUEH, AY; LEESMILLER, SP; ANDERSON, CW; NG, SY				LIU, SH; MA, JT; YUEH, AY; LEESMILLER, SP; ANDERSON, CW; NG, SY			THE CARBOXYL-TERMINAL TRANSACTIVATION DOMAIN OF HUMAN SERUM RESPONSE FACTOR CONTAINS DNA-ACTIVATED PROTEIN-KINASE PHOSPHORYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; TERNARY COMPLEX-FORMATION; VIRUS-40 T-ANTIGEN; RNA POLYMERASE-II; C-FOS PROMOTER; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; ESCHERICHIA-COLI; BINDING ACTIVITY; KU-AUTOANTIGEN	The serum response factor (SRF) is a 67-kDa phosphoprotein that, together with auxiliary factors, modulates transcription of immediate early genes containing serum response elements in their promoters. Here we show that the carboxyl-terminal domain of human SRF is phosphorylated in vivo and is recognized in vitro by the double-stranded DNA-activated serine/threonine-specific protein kinase, DNA-PK. SRF phosphorylation by DNA-PK was stimulated by its cognate binding site. Protein microsequence analysis of a 22-amino acid synthetic SRF peptide and phosphopeptide analysis of genetically altered glutathione S-transferase-SRF fusion proteins identified Ser-435 and Ser-446 of human SRF as sites phosphorylated by DNA-PK. Both serines are followed by glutamine. Changing Gln-436 and Gln-447 to other residues reduced or eliminated phosphorylation by DNA-PK, confirming that these glutamines are important determinants for kinase recognition. The carboxyl-terminal transcription activation domain was mapped within a 71-amino acid region that contains both DNA-PK phosphorylation sites. Amino acid substitutions that interfered with phosphorylation by DNA-PK at Ser-435/446 in GAL4-SRF fusion proteins were reduced in transactivation potency. From these data we suggest that DNA-PK phosphorylation may modulate SRF activity in vivo.	ACAD SINICA, INST MOL BIOL, TAIPEI 11529, TAIWAN; NATL TSING HUA UNIV, INST LIFE SCI, HSINCHU 30043, TAIWAN; BROOKHAVEN NATL LAB, DEPT BIOL, UPTON, NY 11973 USA	Academia Sinica - Taiwan; National Tsing Hua University; United States Department of Energy (DOE); Brookhaven National Laboratory			Yueh, Andrew/D-2079-2010	Lees-Miller, Susan/0000-0001-5809-2516				Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; BLIER PR, 1993, J BIOL CHEM, V268, P7594; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CHEN YR, 1991, J VIROL, V65, P5131, DOI 10.1128/JVI.65.10.5131-5140.1991; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drapeau G R, 1977, Methods Enzymol, V47, P189; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; FLANNERY AV, 1989, PROTEOLYTIC ENZYMES, P145; Foulkes, 1991, HORMONAL CONTROL REG, P257; FUJII M, 1992, GENE DEV, V6, P2066, DOI 10.1101/gad.6.11.2066; GAUTHIERROUVIERE C, 1991, EMBO J, V10, P2921, DOI 10.1002/j.1460-2075.1991.tb07842.x; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GOLEMIS EA, 1992, MOL CELL BIOL, V12, P3006, DOI 10.1128/MCB.12.7.3006; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1991, CANCER CELL-MON REV, V3, P341; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MACGREGOR GR, 1989, METHODS MOL BIOL, V7; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOHUN TJ, 1991, EMBO J, V10, P933, DOI 10.1002/j.1460-2075.1991.tb08027.x; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PRYWES R, 1987, MOL CELL BIOL, V7, P3482, DOI 10.1128/MCB.7.10.3482; PRYWES R, 1988, P NATL ACAD SCI USA, V85, P7206, DOI 10.1073/pnas.85.19.7206; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; REASON AJ, 1992, J BIOL CHEM, V267, P16911; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHROTER H, 1990, EMBO J, V9, P1123, DOI 10.1002/j.1460-2075.1990.tb08218.x; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH DB, 1990, CURRENT PROTOCOLS MO; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231	56	60	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21147	21154						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407951				2022-12-27	WOS:A1993MA28800076
J	DUCANCEL, F; MATRE, V; DUPONT, C; LAJEUNESSE, E; WOLLBERG, Z; BDOLAH, A; KOCHVA, E; BOULAIN, JC; MENEZ, A				DUCANCEL, F; MATRE, V; DUPONT, C; LAJEUNESSE, E; WOLLBERG, Z; BDOLAH, A; KOCHVA, E; BOULAIN, JC; MENEZ, A			CLONING AND SEQUENCE-ANALYSIS OF CDNAS ENCODING PRECURSORS OF SARAFOTOXINS - EVIDENCE FOR AN UNUSUAL ROSARY-TYPE ORGANIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN ENDOTHELIN FAMILY; SNAKE AIPYSURUS-LAEVIS; AMINO-ACID-SEQUENCE; DISTANCE GEOMETRY; SOLUTION CONFORMATION; NUCLEOTIDE-SEQUENCE; 2 SUBUNITS; H-1-NMR; GENES; DNA	Sarafotoxins (SRTXs) are 21-amino acid peptides structurally and functionally similar to endothelins (ETs). To understand how SRTXs are overproduced in venom glands of the snakes Atractaspis engaddensis and hence used as toxins, we cloned cDNAs encoding SRTXs and elucidated their nucleotide sequences. We predict that SRTX precursors are large prepropolypeptide chains with an unusual ''rosary-type'' structure made of 12 successive similar stretches of 40 residues (39 in the first stretch). Each stretch begins with a ''spacer'' of 19 invariant residues (18 in the first stretch) immediately followed by the sequence of one SRTX isoform. Six different isoforms are identified within a single precursor molecule. Maturation of the precursor may require endopeptidases that cleave the Leu-Cys bond and the Trp-Arg/Lys bond invariably found at the SRTX N and C termini, respectively.	TEL AVIV UNIV,GEORGE S WISE FAC LIFE SCI,DEPT ZOOL,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University	DUCANCEL, F (corresponding author), CE SACLAY,DEPT INGN & ETUD PROT,F-91191 GIF SUR YVETTE,FRANCE.							ARINAMI T, 1991, AM J HUM GENET, V48, P990; AUMELAS A, 1991, NEUROCHEM INT, V18, P471, DOI 10.1016/0197-0186(91)90141-Y; Bdolah A., 1991, P415; BLOCH KD, 1989, J BIOL CHEM, V264, P10851; BOUCHIER C, 1991, BIOCHIM BIOPHYS ACTA, V1088, P401, DOI 10.1016/0167-4781(91)90132-6; BOUCHIER C, 1988, NUCLEIC ACIDS RES, V16, P9050, DOI 10.1093/nar/16.18.9050; BROWN SC, 1990, PEPTIDES CHEM STRUCT, P595; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALESSIO JM, 1988, NUCLEIC ACIDS RES, V16, P1999; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; DUCANCEL F, 1988, NUCLEIC ACIDS RES, V16, P9049, DOI 10.1093/nar/16.18.9049; DUCANCEL F, 1991, TOXICON, V29, P516, DOI 10.1016/0041-0101(91)90026-N; DUCANCEL F, 1990, TOXICON, V28, P119, DOI 10.1016/0041-0101(90)90013-W; Ducancel F., 1991, P385; DUCANCEL F, 1988, NUCLEIC ACIDS RES, V16, P9048, DOI 10.1093/nar/16.18.9048; ENDO S, 1989, FEBS LETT, V257, P149, DOI 10.1016/0014-5793(89)81808-3; GUBLER U, 1982, NATURE, V295, P206, DOI 10.1038/295206a0; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KOBAYASHI Y, 1990, PEPTIDES CHEM STRUCT, P552; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; LANDAN G, 1991, TOXICON, V29, P237, DOI 10.1016/0041-0101(91)90108-4; MILLS RG, 1991, FEBS LETT, V282, P247, DOI 10.1016/0014-5793(91)80488-O; OPGENORTH TJ, 1992, FASEB J, V6, P2653, DOI 10.1096/fasebj.6.9.1612289; RUBANYI GM, 1991, FASEB J, V5, P2713, DOI 10.1096/fasebj.5.12.1916094; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUDEK V, 1989, FEBS LETT, V257, P145, DOI 10.1016/0014-5793(89)81807-1; SMITH LA, 1990, J TOXICOL-TOXIN REV, V9, P243, DOI 10.3109/15569549009033116; TAMAOKI H, 1991, PROTEIN ENG, V4, P509, DOI 10.1093/protein/4.5.509; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZIGDONARAD T, 1992, TOXICON, V30, P439, DOI 10.1016/0041-0101(92)90540-L	31	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3052	3055						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428983				2022-12-27	WOS:A1993KM16100010
J	IWAMOTO, A; PARK, MY; MAEDA, M; FUTAI, M				IWAMOTO, A; PARK, MY; MAEDA, M; FUTAI, M			DOMAINS NEAR ATP GAMMA PHOSPHATE IN THE CATALYTIC SITE OF H+-ATPASE - MODEL PROPOSED FROM MUTAGENESIS AND INHIBITOR STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; PROTON-TRANSLOCATING ATPASE; NUCLEOTIDE-BINDING DOMAIN; GLYCINE-RICH SEQUENCE; ONCOGENE PRODUCT P21; BETA-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; SECONDARY-STRUCTURE; PROTEINS; ACID	The betaGly-149 residue is in a glycine-rich sequence (Gly-Gly-Ala-Gly-Val-Gly-Lys-Thr; residues 149-156) of the Escherichia coli H+-ATPase (ATP synthase) beta subunit. Substitution of betaGly-149 by Ser suppressed the effect of the betaSer-174 --> Phe mutation (Iwamoto, A., Omote, H., Hanada, H., Tomioka, N., Itai, A., Maeda, M., and Futai, M. (1991) J. Biol. Chem. 266, 16350-16355), suggesting that betaGly-149 is located near betaSer-174. In this study, we introduced different residues at position 149 and found that a single mutant betaCys-149 was defective. The effect of betaCys-149 mutation was suppressed by betaGly-172 --> Glu, betaSer-174 --> Phe, betaGlu-192 --> Val, or betaVal-198 --> Ala replacement. These results suggest that betaGly-149, betaGly-172, betaSer-174, betaGlu-192, and betaVal-198 residues are located close together in the catalytic site. From these findings we propose a model of the catalytic site of the enzyme near the gamma phosphate moiety of ATP. F1 enzymes with the double mutations betaCys-149/betaGlu-172, betaCys-149/betaPhe-174, betaCys-149/betaVal-192, and betaCys-149/betaAla-198 were less sensitive than wild-type F1 to dicyclohexylcarbodiimide and adenosine triphosphopyridoxal (an affinity analogue of ATP forming a Schiff base with the epsilon-amino group of betaLys-155 or betaLys-201), and became sensitive to N-ethylmaleimide in an ATP-protected manner. These results of inhibitor studies are consistent with the proposed model.			IWAMOTO, A (corresponding author), OSAKA UNIV,INST SCI & IND RES,DEPT ORGAN CHEM & BIOCHEM,IBARAKI,OSAKA 567,JAPAN.							ANDREWS WW, 1984, J BIOL CHEM, V259, P4378; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DUNCAN TM, 1986, FEBS LETT, V208, P1, DOI 10.1016/0014-5793(86)81519-8; DUNCAN TM, 1992, J BIOENERG BIOMEMBR, V24, P453, DOI 10.1007/BF00762362; FUTAI M, 1983, MICROBIOL REV, V47, P285, DOI 10.1128/MMBR.47.3.285-312.1983; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; GARBOCZI DN, 1988, J BIOL CHEM, V263, P812; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HSU SY, 1987, FEBS LETT, V218, P222, DOI 10.1016/0014-5793(87)81050-5; IDA K, 1991, J BIOL CHEM, V266, P5424; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IWAMOTO A, 1991, J BIOL CHEM, V266, P16350; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHMI N, 1988, J BIOL CHEM, V263, P14261; OMOTE H, 1992, J BIOL CHEM, V267, P20571; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; TAGAYA M, 1988, FEBS LETT, V233, P347, DOI 10.1016/0014-5793(88)80457-5; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; YOSHIDA M, 1981, J BIOL CHEM, V256, P148; YOSHIDA M, 1982, J BIOL CHEM, V257, P33	31	46	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3156	3160						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428992				2022-12-27	WOS:A1993KM16100024
J	LIN, CS; PARK, T; CHEN, ZP; LEAVITT, J				LIN, CS; PARK, T; CHEN, ZP; LEAVITT, J			HUMAN PLASTIN GENES - COMPARATIVE GENE STRUCTURE, CHROMOSOME LOCATION, AND DIFFERENTIAL EXPRESSION IN NORMAL AND NEOPLASTIC-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT BETA-ACTIN; TUMORIGENIC HUMAN-FIBROBLASTS; CULTURED-CELLS; 65-KILODALTON PHOSPHOPROTEIN; TRANSFORMATION; TROPOMYOSIN; PROTEIN; IDENTIFICATION; ORGANIZATION; PURIFICATION	Plastins are a family of actin-binding proteins that are conserved throughout eukaryote evolution and expressed in most tissues of higher eukaryotes. In humans, two ubiquitous plastin isoforms (L and T) have been identified. The L isoform is expressed only in hemopoietic cell lineages, while the T isoform has been found in all other normal cells of solid tissues that have replicative potential (fibroblasts, endothelial cells, epithelial cells, melanocytes, etc.). However, L-plastin has been found in many types of malignant human cells of non-hemopoietic origin suggesting that its expression is induced accompanying tumorigenesis in solid tissues. To learn more about the nature of plastin genes and their potential role in malignancy, the L- and T-plastin genes were cloned and sequenced to characterize their structure and mechanisms of regulation of expression. Each gene was found to be approximately 90 kilobases in size and was composed of 16 exons. All exon-intron junction sequences were identified and shown to conform to the canonical junction sequences. It was evident from their similar structure and coding homology that the two plastin genes have diverged from a common ancestor gene. L- and T-plastin genes were also mapped to chromosomes 13 and X, respectively, using polymerase chain reaction amplification with isoform-specific probes. An expanded survey of normal cell types and 50 tumor cell lines, demonstrated that 68% of carcinomas and 53% of other solid tumors of nonepithelial origin exhibited L-plastin expression, whereas the normal stem cell progenitors did not. Fibrosarcomas (n = 4), ovarian carcinomas (n = 9), breast carcinomas (n = 4), and choriocarcinomas (n = 2) combined exhibited the highest frequency and levels of L-plastin expression (95% frequency). In addition, 4 tumor cell lines that were L-plastin-negative exhibited evidence of defective T-plastin expression increasing the apparent co-incidence of plastin abnormalities associated with human tumorigenesis to 71%. Evidence is presented in support of a trans-activation mechanism for activation of L-plastin synthesis accompanying tumorigenesis. The induction of L-plastin expression accompanying SV40-mediated transformation of human embryonic lung MRC-5 fibroblasts was also confirmed. Finally, we present evidence that fimbrin is a third distinct plastin isoform which is specifically expressed at high levels in the small intestine.	PALO ALTO MED RES FDN,RES INST,CANC CELL BIOL LAB,PALO ALTO,CA 94301; ADEZA BIOMED,SUNNYVALE,CA 94089	Palo Alto Medical Foundation Research Institute					NATIONAL CANCER INSTITUTE [R01CA034763, R01CA049423] Funding Source: NIH RePORTER; NCI NIH HHS [CA34763, CA49423] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; BERNSTEIN L, 1992, AM J EPIDEMIOL, V135, P142, DOI 10.1093/oxfordjournals.aje.a116267; CELIS JE, 1990, ELECTROPHORESIS, V11, P1072, DOI 10.1002/elps.1150111203; CLARKE M, 1977, ANNU REV BIOCHEM, V46, P797, DOI 10.1146/annurev.bi.46.070177.004053; COULIER F, 1989, MOL CELL BIOL, V9, P15, DOI 10.1128/MCB.9.1.15; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Franza BR, 1984, CANC CELLS, V1, P137; GOLDSTEIN D, 1985, CANCER RES, V45, P5643; GOLDSTEIN D, 1985, CANCER RES, V45, P3256; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KONDO L, 1986, AM J HUM GENET, V37, P1106; LEAVITT J, 1982, CELL, V28, P259, DOI 10.1016/0092-8674(82)90344-0; LEAVITT J, 1982, CARCINOGENESIS, V3, P61, DOI 10.1093/carcin/3.1.61; LEAVITT J, 1985, NATURE, V316, P840, DOI 10.1038/316840a0; LEAVITT J, 1978, NATURE, V271, P262, DOI 10.1038/271262a0; LEAVITT J, 1986, MOL CELL BIOL, V6, P2721, DOI 10.1128/MCB.6.7.2721; LEAVITT J, 1987, MOL CELL BIOL, V7, P2467, DOI 10.1128/MCB.7.7.2467; LEAVITT J, 1987, MOL CELL BIOL, V7, P2457, DOI 10.1128/MCB.7.7.2457; LEAVITT J, 1980, J BIOL CHEM, V255, P1650; LIN CS, 1990, MOL CELL BIOL, V10, P1818, DOI 10.1128/MCB.10.4.1818; LIN CS, 1988, MOL CELL BIOL, V8, P4659, DOI 10.1128/MCB.8.11.4659; LIN CS, 1993, J BIOL CHEM, V268, P2793; LIN CS, 1988, MOL CELL BIOL, V8, P160, DOI 10.1128/MCB.8.1.160; LIN CS, 1985, P NATL ACAD SCI USA, V82, P6992; MANIATIS T, 1983, MOL CLONING; MANIATIS T, 1988, MOL CLONING; MARSUMURA F, 1983, J BIOL CHEM, V258, P13954; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATSUMURA F, 1985, J BIOL CHEM, V260, P3851; MATSUMURA F, 1983, J BIOL CHEM, V258, P6636; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; MCCORMICK JJ, 1988, CARCINOGENESIS, V9, P2073, DOI 10.1093/carcin/9.11.2073; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; POLLACK R, 1975, P NATL ACAD SCI USA, V72, P994, DOI 10.1073/pnas.72.3.994; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; VANDEKERCKHOVE J, 1980, CELL, V22, P893, DOI 10.1016/0092-8674(80)90566-8; VARMA M, 1987, EXP CELL RES, V173, P163, DOI 10.1016/0014-4827(87)90342-9; WEEDS A, 1982, NATURE, V296, P811, DOI 10.1038/296811a0; ZU Y, 1990, BIOCHEMISTRY-US, V29, P1055, DOI 10.1021/bi00456a030	39	140	149	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2781	2792						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428952				2022-12-27	WOS:A1993KK81500078
J	TOYOFUKU, T; KURZYDLOWSKI, K; TADA, M; MACLENNAN, DH				TOYOFUKU, T; KURZYDLOWSKI, K; TADA, M; MACLENNAN, DH			IDENTIFICATION OF REGIONS IN THE CA2+-ATPASE OF SARCOPLASMIC-RETICULUM THAT AFFECT FUNCTIONAL ASSOCIATION WITH PHOSPHOLAMBAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-5'-MONOPHOSPHATE-DEPENDENT PROTEIN KINASE; SITE-SPECIFIC MUTAGENESIS; AMINO-ACID-SEQUENCE; CALCIUM-TRANSPORT; ADENOSINE-TRIPHOSPHATASE; MONOCLONAL-ANTIBODY; ACTIVE-SITE; CA-2+ PUMP; PHOSPHORYLATION; CA-2+-ATPASE	When the SERCA 2 isoform of the Ca2+-ATPase of cardiac and slow-twitch muscle sarcoplasmic reticulum was coexpressed with phospholamban in COS-1 cells, a reduction in Ca2+ affinity (measured as Ca2+ dependence of Ca2+ transport) of 0.2-0.3 pCa units was observed. This inhibitory effect was reversed by phosphorylation of phospholamban with cAMP-dependent protein kinase A. SERCA 1 and SERCA 3, were also expressed in COS-1 cells, alone and together with phospholamban. SERCA 1 had high Ca2+ affinity which was reduced upon coexpression with phospholamban, but SERCA 3 had lower Ca2+ affinity, which was unaltered by coexpression with phospholamban. To identify which regions of the Ca2+ ATPase sequence determine its functional interaction with phospholamban, chimeric Ca2+-ATPases between SERCA 2 and SERCA 3 were constructed and coexpressed with phospholamban. Measurement of Ca2+ affinities for a series of chimeras showed that two separate regions of the cytoplasmic domain of SERCA 2 were required for manifestation of a functional interaction between phospholamban and the Ca2+-ATPase. The first is a region between amino acids 336 and 412 in the phosphorylation domain, which corresponds to a phospholamban interaction site identified earlier (James, P., Inui, M., Tada, M., Chiesi, M., and Carafoli, E. (1989) Nature 342, 90-92). The second region is the nucleotide binding/hinge domain (amino acids 467-762) which determines high Ca2+ affinity for SERCA type pumps (Toyofuku, T., Kurzydlowski, K., Lytton, J., and MacLennan, D. H. (1992) J. Biol. Chem. 267, 14490-14496).	UNIV TORONTO, CHARLES H BEST INST, BANTING & BEST DEPT MED RES, 112 COLL ST, TORONTO M5G 1L6, ONTARIO, CANADA; OSAKA UNIV, SCH MED, DEPT MED 1, OSAKA 565, JAPAN; OSAKA UNIV, SCH MED, DEPT PATHOPHYSIOL, OSAKA 565, JAPAN	University of Toronto; Osaka University; Osaka University								ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; CHIESI M, 1989, FEBS LETT, V244, P241, DOI 10.1016/0014-5793(89)81201-3; CHIESI M, 1991, BIOCHEMISTRY-US, V30, P7978, DOI 10.1021/bi00246a015; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DEMEIS L, 1981, SARCOPLASMIC RETICUL, V2; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; FUJII J, 1988, FEBS LETT, V227, P51, DOI 10.1016/0014-5793(88)81412-1; FUJII J, 1989, J BIOL CHEM, V264, P12950; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; FUJII J, 1990, FEBS LETT, V273, P232, DOI 10.1016/0014-5793(90)81092-3; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INUI M, 1986, J BIOL CHEM, V261, P1794; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; KIM HW, 1990, J BIOL CHEM, V265, P1702; KIRCHBERGER MA, 1974, J BIOL CHEM, V249, P6166; KIRCHBERGER MA, 1976, J BIOL CHEM, V251, P725; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5150, DOI 10.1021/bi00590a019; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MORRIS GL, 1991, J BIOL CHEM, V266, P11270; MOVSESIAN MA, 1984, J BIOL CHEM, V259, P8029; POST RL, 1973, J BIOL CHEM, V248, P6993; SASAKI T, 1992, J BIOL CHEM, V267, P1674; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SUZUKI T, 1986, J BIOL CHEM, V261, P7018; TADA M, 1975, J BIOL CHEM, V250, P2640; TADA M, 1974, J BIOL CHEM, V249, P6174; TADA M, 1978, PHYSIOL REV, V58, P1; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; TADA M, 1988, METHOD ENZYMOL, V157, P107; TOYOFUKU T, 1992, J BIOL CHEM, V267, P14490; VORHERR T, 1992, BIOCHEMISTRY-US, V31, P371, DOI 10.1021/bi00117a009; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; XU ZC, 1989, J BIOL CHEM, V264, P16644	39	131	134	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2809	2815						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428955				2022-12-27	WOS:A1993KK81500081
J	MOTOKI, K; KITAJIMA, Y; HORI, K				MOTOKI, K; KITAJIMA, Y; HORI, K			ISOZYME-SPECIFIC MODULES ON HUMAN ALDOLASE-A MOLECULE - ISOZYME GROUP-SPECIFIC SEQUENCE-1 AND SEQUENCE-4 ARE REQUIRED FOR SHOWING CHARACTERISTICS AS ALDOLASE-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; MUSCLE ALDOLASE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; DROSOPHILA-MELANOGASTER; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; B-GENE; CONSTRUCTION	Vertebrate aldolase molecules bear at least four stretches of isozyme group-specific sequences (referred to as IGS). The IGSs of the type A isozyme are known to endow the aldolase molecules with some characteristics typical of A. In order to locate the type A regions, 4 chimeric enzymes were constructed between human aldolases A and B and 5 mutant enzymes with single or double mutations in the IGS-1 region. Among engineered proteins, the chimeric enzymes bearing the type A IGS-1 to -4 (BABA34-108:306-363) and the IGS-1 and -4 (BABA34-55:306-363) exhibited similarities to isozyme A in many respects. On the other hand, neither chimeric enzyme bearing the type A IGS-1 to -3 (BAB34-108) nor that bearing the IGS-1 alone (BAB34-55) exhibited properties as isozyme A. Four mutant aldolases A (carrying single mutation in the IGS-1 region) maintained the original activity as A. Similarly, the BA306 chimera with the type B --> A substitution at positions 41 and 45 (BA306 N41K:R45S) failed to exhibit the A-like properties although the activities toward Fru-1,6-P2 and Fru-1-P significantly increased. Conclusively, the type A IGS-1, together with the IGS-4, act as indispensable modules in determining the characteristic properties of human aldolase A.	SAGA MED SCH,DEPT BIOCHEM,SAGA 849,JAPAN	Saga University								BRENNERHOLZACH O, 1982, J BIOL CHEM, V257, P1747; BURGESS DG, 1985, J BIOL CHEM, V260, P4604; CLARKE F, 1985, REGULATION CARBOHYDR, V2, P1; DRECHSLER ER, 1959, J BIOL CHEM, V234, P2627; GAMBLIN SJ, 1991, J MOL BIOL, V219, P573, DOI 10.1016/0022-2836(91)90650-U; GAMBLIN SJ, 1990, FEBS LETT, V262, P282, DOI 10.1016/0014-5793(90)80211-Z; HESTER G, 1991, FEBS LETT, V292, P237, DOI 10.1016/0014-5793(91)80875-4; Horecker B. L, 1972, ENZYMES, P213, DOI DOI 10.1016/S1874-6047(08)60450-3; JOH K, 1985, GENE, V39, P17; KAI T, 1992, J BIOCHEM-TOKYO, V112, P677, DOI 10.1093/oxfordjournals.jbchem.a123958; KIM J, 1992, MOL CELL BIOL, V12, P773, DOI 10.1128/MCB.12.2.773; KITAJIMA Y, 1990, J BIOL CHEM, V265, P17493; KITAJIMA Y, 1990, J BIOCHEM-TOKYO, V109, P544; KUKITA A, 1988, EUR J BIOCHEM, V171, P471, DOI 10.1111/j.1432-1033.1988.tb13813.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBHERZ HG, 1973, J BIOL CHEM, V248, P1650; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MASTERS C, 1984, J CELL BIOL, V99, pS222, DOI 10.1083/jcb.99.1.222s; MESSING J, 1983, METHOD ENZYMOL, V101, P20; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NAKAMURA K, 1982, EMBO J, V1, P771, DOI 10.1002/j.1460-2075.1982.tb01244.x; ONO K, 1990, BIOCHEM INT, V20, P921; PENHOET E, 1966, P NATL ACAD SCI USA, V56, P1275, DOI 10.1073/pnas.56.4.1275; Rajkumar T.V, 1966, METHOD ENZYMOL, V9, P491; ROTTMANN WH, 1987, BIOCHIMIE, V69, P137, DOI 10.1016/0300-9084(87)90246-X; RUTTER WJ, 1961, J BIOL CHEM, V236, P3193; SAKAKIBARA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P334, DOI 10.1016/0167-4781(89)90156-5; SAKAKIBARA M, 1985, NUCLEIC ACIDS RES, V13, P5055, DOI 10.1093/nar/13.14.5055; SAKAKIBARA M, 1985, BIOCHEM BIOPH RES CO, V131, P413, DOI 10.1016/0006-291X(85)91818-2; SHAWLEE R, 1992, J BIOL CHEM, V267, P3959; Susor W A, 1975, Methods Enzymol, V41, P66; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; TAKAHASHI I, 1989, J BIOCHEM, V105, P281, DOI 10.1093/oxfordjournals.jbchem.a122654; TAKASAKI Y, 1990, PROG CLIN BIOL RES, V344, P935; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8749, DOI 10.1093/nar/13.24.8749; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; TOLAN DR, 1984, J BIOL CHEM, V259, P1127; TSUTSUMI K, 1985, J MOL BIOL, V181, P153, DOI 10.1016/0022-2836(85)90081-6	38	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1677	1683						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420943				2022-12-27	WOS:A1993KH62000028
J	LOBELL, RB; ARM, JP; RAIZMAN, MB; AUSTEN, KF; KATZ, HR				LOBELL, RB; ARM, JP; RAIZMAN, MB; AUSTEN, KF; KATZ, HR			INTRACELLULAR DEGRADATION OF FC-GAMMA-RIII IN MOUSE BONE-MARROW CULTURE-DERIVED PROGENITOR MAST-CELLS PREVENTS ITS SURFACE EXPRESSION AND ASSOCIATED FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONNECTIVE-TISSUE-TYPE; MOLECULAR-CLONING; GROWTH-FACTOR; W/WV MICE; RECEPTORS; DIFFERENTIATION; ANTIBODIES; INVITRO; CHAIN; INTRAPERITONEAL	Although mouse interleukin-3-dependent, bone marrow culture-derived progenitor mast cells (BMMC) and a Kirsten sarcoma virus (KiSV)-immortalized mouse mast cell line (MC4w) both express on their surfaces receptors for the Fc portion of IgG (FcgammaR), only MC4w degranulate upon FcgammaR perturbation. As shown by surface iodination and SDS-polyacrylamide gel electrophoresis analysis of deglycosylated proteins immuno-precipitated with the FcgammaR-specific monoclonal antibody 2.4G2, a 26-kDa protein, identified as FcgammaRIII by immunoblotting with antibody to FcgammaRIII, was predominantly expressed on the surface of MC4w but minimally on BMMC. However, both BMMC and MC4w expressed mRNA for FcgammaRIII as determined by RNA blot analysis, and both translated FcgammaRIII as assessed by intrinsic radiolabeling and SDS-polyacrylamide gel electrophoresis analysis of deglycosylated monoclonal antibody 2.4G2 immunoprecipitates. Pulse-chase analysis showed that intrinsically radiolabeled FcgammaRIII was stable in MC4w cells but was degraded rapidly in BMMC and that newly synthesized FcgammaRIII remained sensitive to digestion by endoglycosidase H in BMMC but rapidly became resistant in MC4w. These data suggest that the deficiency in surface FcgammaRIII expression on BMMC is due to the degradation of FcgammaRIII in the endoplasmic reticulum. Immunoprecipitation of surface FcgammaR and Fc receptors for IgE (FcepsilonRI) from digitonin-extracted cells followed by immunoblotting with antibody to FcepsilonRI gamma-chain showed that gamma-chain is associated with surface FcepsilonRI and FcgammaR in MC4w, but only with FcepsilonRI in BMMC, which lack surface FcgammaRIII. Inasmuch as BMMC are progenitors of serosal mast cells, which, like MC4w, express surface FcgammaRIII and undergo FcgammaR-mediated activation, the data suggest that maturation of BMMC enables FcgammaRIII to bypass degradation in the endoplasmic reticulum, resulting in the acquisition of functional FcgammaRIII/gamma-chain complexes on the cell surface.	BRIGHAM & WOMENS HOSP,DEPT RHEUMATOL & IMMUNOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital	LOBELL, RB (corresponding author), HARVARD UNIV,SCH MED,DEPT MED,250 LONGWOOD AVE,RM 607,BOSTON,MA 02115, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022531, R01AI032101, R01AI022531] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36110] Funding Source: Medline; NIAID NIH HHS [AI-22531, AI-32101] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARM JP, 1991, J BIOL CHEM, V266, P15966; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BENHAMOU M, 1990, J IMMUNOL, V144, P3071; DAERON M, 1986, ANN INST PASTEUR IMM, VD137, P233; FOX PC, 1982, J IMMUNOL, V129, P314; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; KATZ HR, 1990, J IMMUNOL, V145, P3412; KATZ HR, 1992, J IMMUNOL, V148, P868; KENNY AJ, 1987, MAMMALIAN ECTOZYMES, P332; KUROSAKI T, 1991, P NATL ACAD SCI USA, V88, P3837, DOI 10.1073/pnas.88.9.3837; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; OVARY Z, 1970, IMMUNOLOGY, V19, P715; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RA C, 1989, J BIOL CHEM, V264, P15323; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SCHRADER JW, 1981, J IMMUNOL, V126, P452; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; SPRINGER TA, 1982, HYBRIDOMA, V1, P257, DOI 10.1089/hyb.1.1982.1.257; TERTIAN G, 1981, J IMMUNOL, V127, P788; TIGELAAR RE, 1971, J IMMUNOL, V106, P661; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580	28	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1207	1212						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419324				2022-12-27	WOS:A1993KG07700067
J	BARR, DP; SHAH, MM; AUST, SD				BARR, DP; SHAH, MM; AUST, SD			VERATRYL ALCOHOL-DEPENDENT PRODUCTION OF MOLECULAR-OXYGEN BY LIGNIN PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-ROT FUNGUS; PHANEROCHAETE-CHRYSOSPORIUM; OXALIC-ACID; OXIDATION; PURIFICATION; METHOXYBENZENES; BIODEGRADATION; BASIDIOMYCETE; CULTURE; OXIDASE	Veratryl alcohol- and H2O2-dependent production of oxygen by lignin peroxidase isozyme H2 (LiPH2) from Phanerochaete chrysosporium was investigated. Veratryl alcohol oxidation by LiPH2 decreased with increasing concentrations of H2O2 while oxygen evolution increased. The absorption spectrum of the LiPH2 in these experiments indicated that it was in the compound Il state. We propose that O2 production results from the one electron oxidation of H2O2 by the veratryl alcohol cation radical to yield superoxide, as the addition of superoxide dismutase stimulated oxygen production. It has been reported previously that oxygen is consumed in reaction mixtures containing lignin peroxidase, H2O2, veratryl alcohol, and oxalate (Popp, J. L., Kalyanaraman, B., and Kirk, T. K. (1990) Biochemistry 29, 10475-10480). In the presence of oxalate, we observed oxygen consumption that was dependent on the H2O2 concentration. The ability of other methoxybenzenes to mediate oxygen production appeared to be related to their redox potential. It was concluded that cation radicals can oxidize H2O2 by one electron which results in the production of superoxide and the evolution of molecular oxygen. Thus, the rates of LiPH2-catalyzed O2 Consumption or O2 production are dependent on the relative concentrations of H2O2 and oxalate.	UTAH STATE UNIV,CTR BIOTECHNOL,LOGAN,UT 84322	Utah System of Higher Education; Utah State University					NIEHS NIH HHS [ES04922] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004922] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKAMATSU Y, 1990, FEBS LETT, V269, P261, DOI 10.1016/0014-5793(90)81169-O; BANERJEE RK, 1986, J BIOL CHEM, V261, P592; BARLEV SS, 1981, BIOCHEM BIOPH RES CO, V99, P373, DOI 10.1016/0006-291X(81)91755-1; BARR DP, 1992, ARCH BIOCHEM BIOPHYS, V298, P480, DOI 10.1016/0003-9861(92)90438-3; BUMPUS JA, 1985, SCIENCE, V228, P1434, DOI 10.1126/science.3925550; FERNANDO T, 1990, APPL ENVIRON MICROB, V56, P1666, DOI 10.1128/AEM.56.6.1666-1671.1990; GOLD MH, 1984, ARCH BIOCHEM BIOPHYS, V234, P353, DOI 10.1016/0003-9861(84)90280-7; KELLEY RL, 1986, ARCH MICROBIOL, V144, P248, DOI 10.1007/BF00410957; KENNEDY DW, 1990, APPL ENVIRON MICROB, V56, P2346; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; KERSTEN PJ, 1985, J BIOL CHEM, V260, P2609; KHADAR V, 1990, BIOCHEMISTRY-US, V29, P8535; KIRK TK, 1978, ARCH MICROBIOL, V117, P277, DOI 10.1007/BF00738547; LUNDQUIST K, 1978, PHYTOCHEMISTRY, V17, P1676, DOI 10.1016/S0031-9422(00)94674-0; MAGNUSSON RP, 1984, J BIOL CHEM, V259, P197; POPP JL, 1991, ARCH BIOCHEM BIOPHYS, V288, P145, DOI 10.1016/0003-9861(91)90176-J; POPP JL, 1990, BIOCHEMISTRY-US, V29, P10475, DOI 10.1021/bi00498a008; RYAN TP, 1989, APPL MICROBIOL BIOT, V31, P302, DOI 10.1007/BF00258414; SAWYER DT, 1984, OXYGEN RADICALS CHEM, P25; SHAH MM, 1992, J BIOL CHEM, V267, P21564; TIEN M, 1986, J BIOL CHEM, V261, P1687; TIEN M, 1987, CRIT REV MICROBIOL, V15, P141, DOI 10.3109/10408418709104456; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; TUISEL H, 1990, ARCH BIOCHEM BIOPHYS, V279, P158, DOI 10.1016/0003-9861(90)90476-F; WARIISHI H, 1991, J BIOL CHEM, V266, P20694	25	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					241	244						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416932				2022-12-27	WOS:A1993KE60300038
J	BROWN, DT; SITTMAN, DB				BROWN, DT; SITTMAN, DB			IDENTIFICATION THROUGH OVEREXPRESSION AND TAGGING OF THE VARIANT TYPE OF THE MOUSE H1E AND H1C GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; HISTONE SUBTYPES; MODIFIED FORMS; H-1 HISTONES; CHROMATIN; DNA; DIFFERENTIATION; TRANSCRIPTION; PROLIFERATION; ORGANIZATION	Multiple, nonallelic forms of histone H1 are found in most mammalian tissues. Attempts to determine a functional significance to this diversity is hindered by a paucity of primary amino acid sequence data. Although numerous H1 genes have been cloned, the type of variant they encode cannot be determined by sequence analysis alone. We used transformation and overexpression methods to determine that two cloned mouse H1 genes, MH143 and MH175, encode H1c and H1e, respectively. Since these genes have been completely sequenced, these results establish the amino acid sequence of these variants. Assignment was accomplished by mutagenically ''tagging'' the genes by incorporation of a codon for methionine, which is not found in the major somatic H1 variants. These genes were placed under the control of the mouse metallothionein I promoter and introduced into 3T3 cells. Products of these mutagenized genes were detected by [S-35]methionine labeling and identified by high performance liquid chromatography and sodium dodecyl sulfate-acid polyacrylamide gel electrophoresis. We were also able to induce major alterations in the normal stoichiometry of chromatin-associated H1 variants through overproduction of H1c and H1e. This had little effect on the growth properties of these transformants.	UNIV MISSISSIPPI, MED CTR, DEPT BIOCHEM, 2500 N STATE ST, JACKSON, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center								ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; ALONSO A, 1988, EMBO J, V7, P3003, DOI 10.1002/j.1460-2075.1988.tb03163.x; AUBERT D, 1991, J CELL BIOL, V113, P497, DOI 10.1083/jcb.113.3.497; BROWN DT, 1988, MOL CELL BIOL, V8, P4406, DOI 10.1128/MCB.8.10.4406; CHENG GH, 1989, P NATL ACAD SCI USA, V86, P7002, DOI 10.1073/pnas.86.18.7002; COLE KD, 1990, GENE, V89, P265, DOI 10.1016/0378-1119(90)90015-J; COLE RD, 1989, METHOD ENZYMOL, V170, P524; COLE RD, 1987, INT J PEPT PROT RES, V30, P433; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; FASEL N, 1982, EMBO J, V1, P3, DOI 10.1002/j.1460-2075.1982.tb01115.x; KINGSTON RE, 1988, CURRENT PROTOCOLS MO, V1, P901; KISTLER WS, 1975, BIOCHEM BIOPH RES CO, V63, P378, DOI 10.1016/0006-291X(75)90699-3; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAW MF, 1983, MOL CELL BIOL, V3, P2110, DOI 10.1128/MCB.3.11.2110; LEA MA, 1987, CANCER BIOCHEM BIOPH, V9, P199; LENNOX RW, 1989, METHOD ENZYMOL, V170, P532; LENNOX RW, 1988, BIOCHEM CELL BIOL, V66, P636, DOI 10.1139/o88-073; LENNOX RW, 1984, HISTONE GENES STRUCT, P373; MARION C, 1985, BIOCHEMISTRY-US, V24, P6328, DOI 10.1021/bi00344a002; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEARLE PF, 1985, MOL CELL BIOL, V5, P1480, DOI 10.1128/MCB.5.6.1480; SEYEDIN SM, 1979, BIOCHEMISTRY-US, V18, P1371, DOI 10.1021/bi00574a038; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUN JM, 1990, EMBO J, V9, P1651, DOI 10.1002/j.1460-2075.1990.tb08285.x; SUN JM, 1989, SCIENCE, V245, P68, DOI 10.1126/science.2740916; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; VANHOLDE KE, 1989, CHROMATIN, P91; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; WELLS D, 1989, NUCLEIC ACIDS RES, V17, pR311, DOI 10.1093/nar/17.suppl.r311; Wu R.S., 1984, P457; YANG YS, 1987, J BIOL CHEM, V262, P17118; YANG YS, 1989, THESIS U MISSISSIPPI; ZLATANOVA J, 1990, TRENDS BIOCHEM SCI, V15, P273, DOI 10.1016/0968-0004(90)90053-E; Zweidler A, 1984, HISTONE GENES STRUCT, P339	39	31	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					713	718						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416974				2022-12-27	WOS:A1993KE60300107
J	SCHULDINER, S; LIU, YJ; EDWARDS, RH				SCHULDINER, S; LIU, YJ; EDWARDS, RH			RESERPINE BINDING TO A VESICULAR AMINE TRANSPORTER EXPRESSED IN CHINESE-HAMSTER OVARY FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC ACID; BRAIN SYNAPTIC VESICLES; CHROMAFFIN GRANULES; GLUTAMATE UPTAKE; PROTON PUMPS; RAT-BRAIN; GLYCINE; NEUROTOXIN; STORAGE; GABA	The potent antihypertensive drug reserpine inhibits the transport of biogenic amines into adrenal chromaffin granules and synaptic vesicles. Reserpine acts by binding almost irreversibly to the vesicular amine transporter, and this interaction has been used both to study the mechanism of transport and to purify the protein responsible. Recent isolation of a cDNA for the rat chromaffin granule amine transporter (CGAT) by selection in the neurotoxin 1-methyl-4-phenylpyridinium now permits an analysis of the interaction with reserpine at a molecular level. Using membranes from stable transformants expressing the transporter, we show that reserpine binds specifically and quantitatively to CGAT. As with the native protein in bovine chromaffin granules, a pH gradient accelerates reserpine binding, and amine substrates compete for binding with reserpine. However, 1-methyl-4-phenylpyridinium and tetrabenazine, the other principal inhibitor of vesicular amine transport, compete very poorly with reserpine for binding, suggesting that they interact with CGAT at distinct sites.	UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, DEPT NEUROL, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	SCHULDINER, S (corresponding author), HEBREW UNIV JERUSALEM, INST LIFE SCI, IL-91904 JERUSALEM, ISRAEL.		Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DC, 1982, BIOCHEMISTRY-US, V21, P3037, DOI 10.1021/bi00256a001; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; CARLSSON A, 1966, ACTA PHARMACOL TOX, V24, P112; CHRISTENSEN H, 1991, EUR J PHARM-MOLEC PH, V207, P73, DOI 10.1016/S0922-4106(05)80040-9; DANIELS AJ, 1988, J BIOL CHEM, V263, P5034; DARCHEN F, 1989, BIOCHEMISTRY-US, V28, P1692, DOI 10.1021/bi00430a040; DARCHEN F, 1988, BIOCHEM PHARMACOL, V37, P4381, DOI 10.1016/0006-2952(88)90621-1; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; Frize E.D., 1954, NEW ENGL J MED, V251, P1006; FYKSE EM, 1988, J NEUROCHEM, V50, P1237, DOI 10.1111/j.1471-4159.1988.tb10599.x; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; LIU Y, 1992, P NATL ACAD SCI USA, P539; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; NAITO S, 1983, J BIOL CHEM, V258, P696; NJUS D, 1986, BIOCHIM BIOPHYS ACTA, V853, P237, DOI 10.1016/0304-4173(87)90003-6; RUDNICK G, 1990, BIOCHEMISTRY-US, V29, P603, DOI 10.1021/bi00455a002; RUDNICK G, 1986, ANNU REV PHYSIOL, V48, P403; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; STERNBACH Y, 1992, IN PRESS P NATL ACAD; Stitzel R.E., 1977, PHARMACOL REV, V28, P179; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; WEAVER JA, 1982, EUR J PHARMACOL, V80, P437, DOI 10.1016/0014-2999(82)90093-0	32	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					29	34						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416935				2022-12-27	WOS:A1993KE60300007
J	SCHWEINLE, JE; NISHIYASU, M; DING, TQ; SASTRY, K; GILLIES, SD; EZEKOWITZ, RAB				SCHWEINLE, JE; NISHIYASU, M; DING, TQ; SASTRY, K; GILLIES, SD; EZEKOWITZ, RAB			TRUNCATED FORMS OF MANNOSE-BINDING PROTEIN MULTIMERIZE AND BIND TO MANNOSE-RICH SALMONELLA-MONTEVIDEO BUT FAIL TO ACTIVATE COMPLEMENT INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; CLASSICAL PATHWAY; FIRST COMPONENT; HUMAN-SERUM; RAT-LIVER; CLQ; LIPOPOLYSACCHARIDE; POLYSACCHARIDE; SPECIFICITY; HOMOLOGY	Human serum (MBP) and human recombinant (rMBP) mannose-binding protein bind to mannose-rich, serum-resistant Salmonella montevideo (SH5770), enhance C3 deposition, and render the organisms serum-sensitive. We investigated structural features of MBP necessary for this effect. MBP has a cysteine-rich amino-terminal region, a collagen-like region, and a carboxyl-terminal carbohydrate-recognition domain. We prepared carbohydrate-recognition domains lacking the other two domains either by deletion mutagenesis (DELTAMBP, 16 kDa) or by collagenase digestion of whole rMBP (cdMBP, 16-18 kDa). Whole and truncated MBP were detected on immunoblot by specific monoclonal antibodies that recognize both bound and free MBP. rMBP enhanced C3 deposition on SH5770 8-fold, while cdMBP and DELTAMBP did not increase C3 deposition over control levels. All forms of MBP bound to SH5770 by enzyme-linked immunosorbent assay and by measuring binding of radiolabeled whole and truncated MBP. Binding by I-125-DELTAMBP was inhibited by mannan and by MBP. Thus failure of truncated MBPs to enhance C3 deposition was not due to failure to specifically bind carbohydrate residues. To determine the molecular form of truncated MBP in nondenaturing conditions, I-125-DELTAMBP was centrifuged through a 5-20% sucrose-density gradient. The peak of I-125-DELTAMBP sedimented to estimated S20,w 2.01, but larger multimers also were present. Multimers bound SH5770 with higher affinity than monomers. We conclude that carbohydrate-recognition regions of MBP produced by collagenase digestion or by deletion mutagenesis are sufficient for ligand binding. However, the collagen-like region is necessary for MBP enhancement of C3 deposition on SH5770.	HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	SCHWEINLE, JE (corresponding author), YALE UNIV, SCH MED,DEPT INTERNAL MED,INFECT DIS SECT, POB 3333,LCI 810, 60 DAVENPORT ST, NEW HAVEN, CT 06510 USA.				NIAID NIH HHS [AI30286] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030286] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; EDSALL JT, 1953, PROTEINS CHEM BIOL A, V1, P550; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; FULLER NA, 1968, EUR J BIOCHEM, V4, P286, DOI 10.1111/j.1432-1033.1968.tb00207.x; GROSSMAN N, 1986, J IMMUNOL, V136, P2208; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; IKEDA K, 1987, J BIOL CHEM, V262, P7451; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; KNOBEL HR, 1974, J IMMUNOL, V112, P2094; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; KYOGASHIMA M, 1990, ARCH BIOCHEM BIOPHYS, V283, P217, DOI 10.1016/0003-9861(90)90634-B; LIANGTAKASAKI CJ, 1983, INFECT IMMUN, V41, P563, DOI 10.1128/IAI.41.2.563-569.1983; LU J, 1990, J IMMUNOL, V144, P2287; OHTA M, 1990, J BIOL CHEM, V265, P1980; REID KBM, 1972, BIOCHEM J, V130, P749, DOI 10.1042/bj1300749; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; SEIFTER S, 1971, ENZYMES, V3, P649; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUMMERFIELD JA, 1986, BIOCHIM BIOPHYS ACTA, V883, P197, DOI 10.1016/0304-4165(86)90309-0; SUPER M, 1992, NAT GENET, V2, P50, DOI 10.1038/ng0992-50; SUPER M, 1989, LANCET, V2, P1236; WEIS WI, 1991, J BIOL CHEM, V266, P20678; WILD J, 1983, BIOCHEM J, V210, P167, DOI 10.1042/bj2100167	26	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					364	370						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416944				2022-12-27	WOS:A1993KE60300056
J	SERRE, MC; ZHENG, L; JAYARAM, M				SERRE, MC; ZHENG, L; JAYARAM, M			DNA SPLICING BY AN ACTIVE-SITE MUTANT OF FLP RECOMBINASE - POSSIBLE CATALYTIC COOPERATIVITY BETWEEN THE INACTIVE PROTEIN AND ITS DNA SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEASE-P; MECHANISM; STEP; STEREOCHEMISTRY; SYNAPSIS	Each strand transfer catalyzed by the Flp recombinase is the composite of two transesterification reactions. The active nucleophilic species in the two reactions are the catalytic site tyrosine (Tyr-343) of Flp and the 5'-hydroxyl from the Flp-nicked DNA substrate, respectively. A ''half recombination site'' is capable of undergoing this pair of transesterifications in the presence of Flp. When the substrate is a half-site containing a chiral phosphorothioate at the exchange point, the Flp reaction yields a product in which the phosphate chirality is retained. A mutant of Flp that lacks the active site tyrosine, Flp(Y343F), is incapable of mediating strand transfer in a full-recombination site but can execute strand transfer in a half-site. The efficiency of this reaction is about 2% of that of the wild type reaction. The activity of Flp(Y343F) is critically dependent on the length of the half-site spacer. Furthermore, in this reaction, the strand cleavage and strand exchange steps cannot be uncoupled. These results strongly suggest a direct attack by the 5'-hydroxyl of the half-site spacer on the phosphodiester at the normal strand transfer point.			SERRE, MC (corresponding author), UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712, USA.		Serre, Marie-Claude/B-4159-2008	SERRE, Marie-Claude/0000-0002-7899-9833				ALTMAN S, 1990, J BIOL CHEM, V265, P20053; AMIN A, 1991, MOL CELL BIOL, V11, P4497, DOI 10.1128/MCB.11.9.4497; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BRUCKNER RC, 1986, J BIOL CHEM, V261, P1798; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CRAIG NL, 1988, ANNU REV GENET, V22, P77; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; EVANS BR, 1990, J BIOL CHEM, V265, P18504; FLOSS HG, 1984, TOP STEREOCHEM, V15, P253, DOI 10.1002/9780470147245.ch4; JAYARAM M, 1985, P NATL ACAD SCI USA, V82, P5875, DOI 10.1073/pnas.82.17.5875; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; Maniatis T., 1982, MOL CLONING; MCSWIGGEN JA, 1989, SCIENCE, V244, P679, DOI 10.1126/science.2470150; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; PACE NR, 1990, J BIOL CHEM, V265, P3587; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; QIAN XH, 1990, J BIOL CHEM, V265, P21779; QIAN XH, 1992, J BIOL CHEM, V267, P7794; SERRE MC, 1992, J MOL BIOL, V225, P643, DOI 10.1016/0022-2836(92)90391-V; SERRE MC, 1992, J MOL BIOL, V225, P621, DOI 10.1016/0022-2836(92)90390-6; WIRSCHING P, 1991, SCIENCE, V252, P680, DOI 10.1126/science.2024120	26	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					455	463						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416950				2022-12-27	WOS:A1993KE60300070
J	TOMIYA, N; AWAYA, J; KURONO, M; HANZAWA, H; SHIMADA, I; ARATA, Y; YOSHIDA, T; TAKAHASHI, N				TOMIYA, N; AWAYA, J; KURONO, M; HANZAWA, H; SHIMADA, I; ARATA, Y; YOSHIDA, T; TAKAHASHI, N			STRUCTURAL ELUCIDATION OF A VARIETY OF GALNAC-CONTAINING N-LINKED OLIGOSACCHARIDES FROM HUMAN URINARY KALLIDINOGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCANASE-RELEASED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; PITUITARY GLYCOPROTEIN HORMONES; SIALYLATED OLIGOSACCHARIDES; LUTROPIN; FOLLITROPIN; THYROTROPIN; KALLIKREIN; BOVINE; OVINE	Fifteen different structures of terminal GalNAc-containing N-linked oligosaccharides from human urinary kallidinogenase have been identified. These N-linked oligosaccharides were mostly neutral, because sialic acid content was lower than 0.13 mol of sialic acid/mol of sugar chain, and sulfate was not detected. The oligosaccharides were released from pepsin-digested protein by glycoamidase A (from almond) digestion. The reducing ends of the oligosaccharide chains were aminated with a fluorescent reagent, 2-aminopyridine. The resulting mixture of pyridylamino derivatives of the oligosaccharides were separated by high performance liquid chromatography on an ODS-silica column, and 15 oligosaccharides were isolated. The structure of each oligosaccharide fraction was analyzed by two-dimensional sugar mapping, component sugar analysis, high resolution proton nuclear magnetic resonance and methylation analysis. It was found that each N-linked oligosaccharide associated with human urinary kallidinogenase contains unsubstituted GalNAc residues at the nonreducing terminal. These 15 oligosaccharides include 5 biantennary, 7 triantennary, and 3 tetraantennary oligosaccharides.	NAKANO VINEGAR CO LTD,NAKANO CENT RES INST,GLYCOLAB,2-6 NAKAMURA CHO,HANDA,AICHI 475,JAPAN; SANWA KAGAKU KENKYUSHO CO LTD,MIE RES LAB,HOKUSEI,MIE 51104,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,TOKYO 113,JAPAN; NAGOYA UNIV,SCH MED,SHOWA KU,NAGOYA,AICHI 464,JAPAN	Sanwa Kagaku Kenkyusho Co., Ltd.; University of Tokyo; Nagoya University								BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; CHAN A L, 1991, Glycobiology, V1, P173, DOI 10.1093/glycob/1.2.173; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; GREEN ED, 1987, J BIOL CHEM, V262, P12018; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1987, J BIOL CHEM, V262, P12030; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; JOSEF K, 1988, PROTEIN SEQUENCES DA, V1, P177; LU HS, 1989, INT J PEPT PROT RES, V33, P237; MILLS IH, 1975, J PHYSIOL-LONDON, V251, P281, DOI 10.1113/jphysiol.1975.sp011092; NUSTAD K, 1975, BRIT J PHARMACOL, V53, P229, DOI 10.1111/j.1476-5381.1975.tb07353.x; NYAME K, 1989, J BIOL CHEM, V264, P3235; ROBLERO J, 1976, AM J PHYSIOL, V231, P1383, DOI 10.1152/ajplegacy.1976.231.5.1383; ROCKLIN RD, 1983, J LIQ CHROMATOGR, V6, P1577, DOI 10.1080/01483918308064876; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; TAKAHASHI N, 1992, PROTEIN NUCLEIC ACID, V37, P2117; TAKAHASHI S, 1988, J BIOCHEM-TOKYO, V104, P22, DOI 10.1093/oxfordjournals.jbchem.a122415; TOMIYA N, 1987, ANAL BIOCHEM, V163, P489, DOI 10.1016/0003-2697(87)90253-3; TOMIYA N, 1988, BIOCHEMISTRY-US, V27, P7146, DOI 10.1021/bi00418a072; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; TSUDA E, 1988, BIOCHEMISTRY-US, V27, P5646, DOI 10.1021/bi00415a038; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; WEISSHAAR G, 1990, EUR J BIOCHEM, V192, P741, DOI 10.1111/j.1432-1033.1990.tb19285.x	31	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					113	126						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416919				2022-12-27	WOS:A1993KE60300019
J	ADACHI, K; KONITZER, P; KIM, JY; WELCH, N; SURREY, S				ADACHI, K; KONITZER, P; KIM, JY; WELCH, N; SURREY, S			EFFECTS OF BETA-6 AROMATIC-AMINO-ACIDS ON POLYMERIZATION AND SOLUBILITY OF RECOMBINANT HEMOGLOBINS MADE IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE-CELL DISEASE; ESCHERICHIA-COLI; SUBUNIT DISSOCIATION; DEOXYHEMOGLOBIN-S; KINETICS; FLUORESCENCE; GELATION; HB; SUBSTITUTION; MUTAGENESIS	Valine, leucine, tryptophan, and phenylalanine substitutions at the beta6 position of hemoglobin (Hb) were made using a yeast expression system coupled with a polymerase chain reaction-based mutagenesis strategy. The oxygen affinity and absorption spectra of these mutants were similar to recombinant Hb A except for Hb betaE6W which had a higher absorbance at approximately 280 nm. The deoxy forms of Hb betaE6L and Hb S showed characteristic delay times prior to polymerization. Tetrameric deoxy-Hbs containing tryptophan or phenylalanine at the beta6 position had higher solubilities and polymerized less readily compared with deoxy-Hb S. However, when oversaturated, these Hbs polymerized without a delay time. These results suggest that Hb betaE6W and Hb betaE6F form polymers upon deoxygenation by a linear polymerization mechanism without nuclei formation. During polymerization, bulky hydrophobic amino acids, like phenylalanine and tryptophan at the beta6 position, might interact with the acceptor pocket on the surface of an adjacent Hb molecule but may not be able to form stable hydrophobic interactions like beta6 valine and leucine. Difficulty in insertion of the bulky side chains of these aromatic amino acids into the hydrophobic acceptor pocket on an adjacent tetramer may inhibit nuclei formation prior to polymerization.	UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; Childrens Hospital of Philadelphia	ADACHI, K (corresponding author), UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT PEDIAT,DIV HEMATOL,PHILADELPHIA,PA 19104, USA.				NHLBI NIH HHS [HL 32908, P60 HL 38632] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL038632, R01HL032908] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI K, 1980, J MOL BIOL, V144, P467, DOI 10.1016/0022-2836(80)90332-0; ADACHI K, 1979, J BIOL CHEM, V254, P2273; ADACHI K, 1991, HEMOGLOBIN, V15, P417, DOI 10.3109/03630269108998861; ADACHI K, 1987, J BIOL CHEM, V262, P12920; ADACHI K, 1988, J BIOL CHEM, V263, P5607; ADACHI K, 1979, J BIOL CHEM, V254, P7765; ADACHI K, 1993, FEBS LETT, V315, P47, DOI 10.1016/0014-5793(93)81130-R; ADACHI K, 1992, PROTEIN ENG, V5, P807, DOI 10.1093/protein/5.8.807; Antonini E., 1971, FRONT BIOL, V21, P19; BAUDINCHICH V, 1990, P NATL ACAD SCI USA, V87, P1845, DOI 10.1073/pnas.87.5.1845; BIHOREAU MT, 1992, PROTEIN SCI, V1, P145; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P452; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; COGHLAN D, 1992, EUR J BIOCHEM, V207, P931, DOI 10.1111/j.1432-1033.1992.tb17126.x; DELLANO JJM, 1993, P NATL ACAD SCI USA, V90, P918, DOI 10.1073/pnas.90.3.918; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; FERRONE FA, 1980, BIOPHYS J, V32, P361, DOI 10.1016/S0006-3495(80)84962-9; FERRONE FA, 1985, J MOL BIOL, V183, P591, DOI 10.1016/0022-2836(85)90174-3; FESTA RS, 1979, TRANSFUSION, V19, P107, DOI 10.1046/j.1537-2995.1979.19279160278.x; FRONTICELLI C, 1978, J BIOL CHEM, V253, P2288; GILL SJ, 1979, J MOL BIOL, V130, P175, DOI 10.1016/0022-2836(79)90425-X; HERNAN RA, 1992, BIOCHEMISTRY-US, V31, P8619, DOI 10.1021/bi00151a032; HIRSCH RE, 1983, BIOCHEM BIOPH RES CO, V116, P712, DOI 10.1016/0006-291X(83)90583-1; HIRSH RE, 1991, BLOOD, V78, P199; HOFFMAN SJ, 1990, P NATL ACAD SCI USA, V87, P8521, DOI 10.1073/pnas.87.21.8521; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; HOFRICHTER J, 1986, J MOL BIOL, V189, P553, DOI 10.1016/0022-2836(86)90324-4; IP SHC, 1976, BIOCHEMISTRY-US, V15, P654, DOI 10.1021/bi00648a032; JONES DH, 1992, BIOTECHNIQUES, V12, P528; KUEZERA K, 1990, P NATL ACAD SCI USA, V87, P8481; MONPLAISIR N, 1986, P NATL ACAD SCI USA, V83, P9363, DOI 10.1073/pnas.83.24.9363; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; Oosawa F., 1975, THERMODYNAMICS POLYM; PERUTZ M, 1968, NATURE, V288, P726; PERUTZ MF, 1950, NATURE, V166, P677, DOI 10.1038/166677a0; RUSSU IM, 1982, BIOCHEMISTRY-US, V21, P5044, DOI 10.1021/bi00263a030; SASAKI J, 1978, J BIOL CHEM, V253, P87; SCHECHTER AN, 1980, HEMOGLOBIN, V4, P335, DOI 10.3109/03630268008996215; SCHROEDER WA, 1984, HDB HPLC SEPARATION, V11, P287; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; TRIFILLIS P, 1991, BLOOD, V78, P3298; WAGENBACH M, 1991, BIO-TECHNOL, V9, P57, DOI 10.1038/nbt0191-57; WEBER G, 1953, ADV PROTEIN CHEM, V8, P415, DOI 10.1016/S0065-3233(08)60096-0; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	47	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21650	21656						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408017				2022-12-27	WOS:A1993MC80900036
J	SCHNEIDER, A; MCNALLY, KP; AGABIAN, N				SCHNEIDER, A; MCNALLY, KP; AGABIAN, N			SPLICING AND 3'-PROCESSING OF THE TYROSINE TRANSFER-RNA OF TRYPANOSOMA-BRUCEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-TRANSFER RNAS; SACCHAROMYCES-CEREVISIAE; GENE-CLUSTER; INTRON; IDENTIFICATION; ENDONUCLEASE; SEQUENCE; INVIVO; TRANSCRIPTION; ORGANIZATION	Trypanosoma brucei belongs to a family of protozoa that is characterized as having diverged early in the evolution of eukaryotes. Many unusual forms of RNA processing have been discovered in these cells, one of which is trans-splicing, and, although a great number of genes have been sequenced, no evidence for cis-splicing has yet been found. This study shows that tRNA(Tyr) of T. brucei contains an 11-nucleotide intron. tRNA of the size predicted for unspliced precursor was detected by Northern analysis using an oligonucleotide probe complementary to the putative intervening region. Direct sequence analysis of mature tRNA(Tyr) showed that the predicted intron region is absent from this form of the molecule. Mutated versions of the gene encoding tRNA(Tyr) were introduced into trypanosomes by DNA transformation and shown to be expressed in vivo. Introduction into the genome of a tRNA(Tyr) gene containing an amber suppressor mutation led to a significant accumulation of unspliced precursor molecules. Analysis of the tRNA(Tyr) species from both the wild type and transformed cells revealed unspliced and spliced processing intermediates. The relative abundance of each of these intermediates suggests that 3'-processing and splicing occur independently and that, in the wild type, splicing tends to precede 3'-processing and CCA addition.	UNIV CALIF SAN FRANCISCO,INTERCAMPUS PROGRAM MOLEC PARASITOL,SAN FRANCISCO,CA 94143; UNIV CALIF BERKELEY,BERKELEY,CA 94720	University of California System; University of California San Francisco; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021975] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21975] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABELSON J, 1992, SCIENCE, V255, P1390, DOI 10.1126/science.1542787; AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V37, P257, DOI 10.1016/0166-6851(89)90157-6; CAMPBELL DA, 1989, NUCLEIC ACIDS RES, V17, P9479, DOI 10.1093/nar/17.22.9479; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; DEROBERTIS EM, 1979, NATURE, V278, P137, DOI 10.1038/278137a0; EID JE, 1991, GENE DEV, P2024; GREER CL, 1987, MOL CELL BIOL, V7, P76, DOI 10.1128/MCB.7.1.76; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; HANCOCK K, 1992, NUCLEIC ACIDS RES, V20, P4567; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; JOHNSON PF, 1983, NATURE, V302, P681, DOI 10.1038/302681a0; KJEMS J, 1989, J BIOL CHEM, V264, P17834; MELTON DA, 1980, NATURE, V284, P143, DOI 10.1038/284143a0; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; MOTTRAM JC, 1991, NUCLEIC ACIDS RES, V19, P3995, DOI 10.1093/nar/19.14.3995; MOTTRAM JC, 1991, J BIOL CHEM, V266, P18313; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; PERELMAN D, 1990, MOL CELL BIOL, V10, P3284, DOI 10.1128/MCB.10.6.3284; PHIZICKY EM, 1993, TRENDS BIOCHEM SCI, V18, P31; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; SPRINZL M, 1987, NUCLEIC ACIDS RES, V15, pR53, DOI 10.1093/nar/15.suppl.r53; STANGE N, 1988, EMBO J, V7, P3823, DOI 10.1002/j.1460-2075.1988.tb03267.x; STROBEL MC, 1986, MOL CELL BIOL, V6, P2663, DOI 10.1128/MCB.6.7.2663; SZEKELY E, 1988, J BIOL CHEM, V263, P13839; SZWEYKOWSKAKULINSKA Z, 1991, NUCLEIC ACIDS RES, V19, P707, DOI 10.1093/nar/19.4.707; TENASBROEK ALMA, 1990, NATURE, V348, P174, DOI 10.1038/348174a0	33	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21868	21874						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408041				2022-12-27	WOS:A1993MC80900066
J	WRAY, JW; ABELES, RH				WRAY, JW; ABELES, RH			A BACTERIAL ENZYME THAT CATALYZES FORMATION OF CARBON-MONOXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BIOSYNTHESIS	We have isolated and purified an enzyme (E-2) from Klebsiella pneumoniae, which catalyzes the formation of CO from CH3-S-CH2-CH2-CO-C(OH)=CH-O- (III). This compound is an intermediate in the conversion of 5'-methylthioadenosine to methionine. Concomitant with CO formation, methylthiopropionic acid and formate are produced and O2 is consumed. E-2 also catalyzes the formation of CO, formate, and butyrate from CH3-CH2-CH2-CO-C(OH)=CH-O-(IIIa), the desthio analog of III. Experiments with isotopic IIIa have shown that formate is derived from 1-C, and CO from 2-C. E-2 has a M(r) = 18,500 and requires Mg2+, and no chromophoric cofactor has been detected.	BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254	Brandeis University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM012633, T32GM007596, R37GM012633] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32 GM07596-15, GM12633-30] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALAKRISHNAN R, 1993, IN PRESS J BIOL CHEM, V268; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; COREY EJ, 1971, J ORG CHEM, V36, P3553, DOI 10.1021/jo00822a019; DIEKERT G, 1986, ARCH MICROBIOL, V144, P386, DOI 10.1007/BF00409889; ELIEL EL, 1972, J ORG CHEM, V7, P505; HINO S, 1987, ARCH MICROBIOL, V148, P167, DOI 10.1007/BF00414807; MEYERS RW, 1993, IN PRESS J BIOL CHEM, V268; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; SEEBACH D, 1975, J ORG CHEM, V40, P231, DOI 10.1021/jo00890a018; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Waterman M R, 1978, Methods Enzymol, V52, P456	13	57	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21466	21469						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8407993				2022-12-27	WOS:A1993MC80900004
J	YORK, D; FILUTOWICZ, M				YORK, D; FILUTOWICZ, M			AUTOREGULATION-DEFICIENT MUTANT OF THE PLASMID R6K-ENCODED PI-PROTEIN DISTINGUISHES BETWEEN PALINDROMIC AND NONPALINDROMIC BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION INITIATOR PROTEIN; R6K DNA-REPLICATION; NUCLEOTIDE-SEQUENCES; ESCHERICHIA-COLI; ORIGIN; BACTERIOPHAGE-M2; ARRANGEMENT; TOPOGRAPHY; ACTIVATION; COMPLEXES	The autogenously regulated gene pir of Escherichia coli plasmid R6K encodes the replication protein pi. This protein binds to two sites in the operator region of the pir gene: a 22-base pair nonpalindromic sequence and a pair of palindromic 9-base pair sequences. These pi-binding sites are similar, suggesting that pi uses a single DNA-binding domain in recognizing them. We devised a plasmid system permitting isolation of mutants of the pi protein which are altered in autoregulation. A Ser87 to Asn substitution in one such mutant, designated pi87, reduces the protein's ability to repress the pir gene promoter in vivo. DNase I protection and gel retardation assays were carried out with highly purified pi87 protein. In these studies pi87 exhibited altered binding to the palindromic but not to the nonpalindromic part of the operator of the pir gene. Chemical cross-linking and gel filtration analyses have shown that the dimerization properties of wild type pi and pi87 proteins are similar in solution. We propose that the interaction of pi protein with the palindromic part of the pir operator is essential for autoregulation; we also propose that there is a fundamental difference in the mechanisms of pi protein recognition of palindromic and nonpalindromic sequences.	UNIV WISCONSIN, DEPT BACTERIOL, EB FRED HALL, 1550 LINDEN DR, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040314] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 40314] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DELUCIA AL, 1983, J VIROL, V46, P143, DOI 10.1128/JVI.46.1.143-150.1983; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FILUTOWICZ M, 1986, P NATL ACAD SCI USA, V83, P9645, DOI 10.1073/pnas.83.24.9645; FILUTOWICZ M, 1985, NUCLEIC ACIDS RES, V13, P103, DOI 10.1093/nar/13.1.103; FILUTOWICZ M, 1986, J MOL BIOL, V187, P225, DOI 10.1016/0022-2836(86)90230-5; FILUTOWICZ M, 1987, J CELL SCI, P15; Filutowicz M., 1985, PLASMIDS BACTERIA, P125; GERMINO J, 1983, CELL, V34, P125, DOI 10.1016/0092-8674(83)90142-3; GERMINO J, 1982, P NATL ACAD SCI-BIOL, V79, P5475, DOI 10.1073/pnas.79.18.5475; GERMINO J, 1983, P NATL ACAD SCI-BIOL, V80, P6848, DOI 10.1073/pnas.80.22.6848; GIRALDO R, 1989, NATURE, V342, P866, DOI 10.1038/342866a0; GREENER A, 1992, GENETICS, V130, P27; GREENER A, 1990, MOL GEN GENET, V224, P24, DOI 10.1007/BF00259447; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; KAMIO Y, 1988, J BACTERIOL, V170, P4411, DOI 10.1128/jb.170.9.4411-4414.1988; KELLEY W, 1985, P NATL ACAD SCI USA, V82, P2574, DOI 10.1073/pnas.82.9.2574; KLINE BC, 1988, CAN J MICROBIOL, V34, P526, DOI 10.1139/m88-090; KNIGHT JD, 1991, P NATL ACAD SCI USA, V88, P3204, DOI 10.1073/pnas.88.8.3204; KOBAYASHI H, 1991, MOL GEN GENET, V226, P65, DOI 10.1007/BF00273588; KOBAYASHI H, 1989, MOL GEN GENET, V220, P8, DOI 10.1007/BF00260848; KOLTER R, 1978, CELL, V15, P1199, DOI 10.1016/0092-8674(78)90046-6; MCEACHERN MJ, 1985, P NATL ACAD SCI USA, V82, P1480, DOI 10.1073/pnas.82.5.1480; MCEACHERN MJ, 1989, P NATL ACAD SCI USA, V86, P7942, DOI 10.1073/pnas.86.20.7942; MILLER JH, 1972, EXPT MOL GENETICS, P125; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, P NATL ACAD SCI USA, V85, P6287, DOI 10.1073/pnas.85.17.6287; MUKHERJEE S, 1985, CELL, V43, P189, DOI 10.1016/0092-8674(85)90023-6; MUROTSU T, 1981, GENE, V15, P257, DOI 10.1016/0378-1119(81)90135-9; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; RUIZ MDMV, 1991, EMBO J, V10, P3829, DOI 10.1002/j.1460-2075.1991.tb04952.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; SHAFFERMAN A, 1982, J MOL BIOL, V161, P57, DOI 10.1016/0022-2836(82)90278-9; STALKER DM, 1982, J MOL BIOL, V161, P33, DOI 10.1016/0022-2836(82)90276-5; TEGTMEYER P, 1983, J VIROL, V46, P151, DOI 10.1128/JVI.46.1.151-161.1983; ULANOVSKY LE, 1987, NATURE, V326, P720, DOI 10.1038/326720a0; WU F, 1992, NUCLEIC ACIDS RES, V20, P811, DOI 10.1093/nar/20.4.811; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YORK D, 1992, GENE, V116, P7, DOI 10.1016/0378-1119(92)90622-V	41	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21854	21861						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408040				2022-12-27	WOS:A1993MC80900064
J	FAN, Z; MENDELSOHN, J; MASUI, H; KUMAR, R				FAN, Z; MENDELSOHN, J; MASUI, H; KUMAR, R			REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN NIH3T3 HER14 CELLS BY ANTIRECEPTOR MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; HUMAN-BREAST CANCER; FACTOR-ALPHA; A431 CELLS; CARCINOMA-CELLS; EGF RECEPTOR; SIGNAL TRANSDUCTION; INDUCED ACTIVATION; PROTEIN; PHOSPHORYLATION	The mechanism(s) by which monoclonal antibodies (mAbs) against the epidermal growth factor (EGF) receptor regulate receptor function have been investigated with NIH3T3/HER14 fibroblasts expressing human EGF receptors. Bivalent 225 mAb or monovalent 225 Fab' inhibited transforming growth factor (TGF)-alpha-induced EGF receptor tyrosine phosphorylation and cell proliferation. Culture of HER14 cells with 225 mAb or 225 Fab' did not activate EGF receptor tyrosine kinase when assayed after lysis of cells in SDS sample buffer. However, when cells were cultured with bivalent 225 mAb, but not with monovalent 225 Fab', and were subsequently lysed and further incubated in Triton X-100 lysis buffer containing proteinase and phosphatase inhibitors, receptor phosphorylation was observed. Phosphorylation was confined to tyrosine residues and was inhibited by addition of genistein after lysis, indicating that it was due to the activation of protein tyrosine kinase. The activity of bivalent 225 mAb was unphysiologic, in contrast with TGF-alpha, in that receptor kinase activation occurred only after cell lysis and with delayed kinetics; serine and threonine phosphorylation did not occur; and down-regulation of EGF receptors was slower. Selective mAb-mediated phosphorylation of tyrosine residues on EGF receptors was sufficient to activate phosphorylation of a SH2 group-bearing substrate, phospholipase C-gamma, indicating that serine/threonine phosphorylation is not required for EGF receptor kinase activity. These studies provide novel insights into the capacity of bivalent mAb to modulate EGF receptor function.	MEM SLOAN KETTERING CANC CTR,RECEPTOR BIOL LAB,BOX 156,1275 YORK AVE,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University					NATIONAL CANCER INSTITUTE [U19CA037641, R37CA042060, R01CA042060, U01CA037641] Funding Source: NIH RePORTER; NCI NIH HHS [CA37641, CA42060] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABOUDPIRAK E, 1988, J NATL CANCER I, V80, P1605, DOI 10.1093/jnci/80.20.1605; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ARAKAKI N, 1992, BIOCHEM BIOPH RES CO, V185, P22, DOI 10.1016/S0006-291X(05)80949-0; ARTEAGA CL, 1988, MOL ENDOCRINOL, V2, P1064, DOI 10.1210/mend-2-11-1064; ATLAS I, 1992, CANCER RES, V52, P3335; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; DEFIZE LHK, 1987, CELL DIFFER DEV, V20, P87, DOI 10.1016/0045-6039(87)90423-4; DEMIGNOT S, 1989, J IMMUNOL METHODS, V121, P209, DOI 10.1016/0022-1759(89)90162-2; DIFIZE LH, 1986, EMBO J, V5, P1187; EK B, 1982, J BIOL CHEM, V257, P486; ENNIS BW, 1989, MOL ENDOCRINOL, V3, P1830, DOI 10.1210/mend-3-11-1830; FERNANDEZPOL JA, 1985, J BIOL CHEM, V260, P5003; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOLDBERG HJ, 1990, BIOCHEM J, V267, P461, DOI 10.1042/bj2670461; GOOI HC, 1985, BIOSCIENCE REP, V5, P83; HOFER DR, 1991, CANCER RES, V51, P2780; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KARNES WE, 1992, GASTROENTEROLOGY, V102, P474, DOI 10.1016/0016-5085(92)90093-E; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KAWAMOTO T, 1984, J BIOL CHEM, V259, P7761; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; MACHICAO F, 1982, FEBS LETT, V149, P96, DOI 10.1016/0014-5793(82)81079-X; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MASUI H, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P394; Mendelsohn J, 1987, Trans Assoc Am Physicians, V100, P173; MENDELSOHN J, 1988, CELLULAR MOL BIOL TU, P307; MENDELSOHN J, 1989, MOL DIAGNOSTICS HUMA, V7, P359; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; PARHAM P, 1983, J IMMUNOL, V131, P2895; REISS M, 1991, CANCER RES, V51, P6254; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; RODECK U, 1987, CANCER RES, V47, P3692; RUBIN RA, 1983, J BIOL CHEM, V258, P5177; SANSOM CE, 1990, BRIT J CANCER, V62, P505; Sato J D, 1983, Mol Biol Med, V1, P511; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; SPAARGAREN M, 1990, BIOCHEM BIOPH RES CO, V171, P882, DOI 10.1016/0006-291X(90)91228-K; SUNADA H, 1985, ANAL BIOCHEM, V149, P438, DOI 10.1016/0003-2697(85)90595-0; SUNADA H, 1990, J CELL PHYSIOL, V142, P284, DOI 10.1002/jcp.1041420210; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; TORTI M, 1992, J BIOL CHEM, V267, P8293; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; VERHEIJDEN GF, 1991, NATO ASI SERIES H, V52, P31; WATERFIELD MD, 1982, J CELL BIOCHEM, V20, P149, DOI 10.1002/jcb.240200207; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	50	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21073	21079						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407944				2022-12-27	WOS:A1993MA28800067
J	CROUCH, E; RUST, K; VEILE, R; DONISKELLER, H; GROSSO, L				CROUCH, E; RUST, K; VEILE, R; DONISKELLER, H; GROSSO, L			GENOMIC ORGANIZATION OF HUMAN SURFACTANT PROTEIN-D (SP-D) - SP-D IS ENCODED ON CHROMOSOME 10Q22.2-23.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; AMINO-ACID-SEQUENCE; GENE; DNA; EXPRESSION; ASSIGNMENT; LECTINS; REGION	Surfactant protein D (SP-D) is a member of the family of mammalian C-type lectins. SP-D is secreted into the pulmonary airspaces by lung epithelial cells and is believed to contribute to the lung's defense against inhaled microorganisms. We have previously characterized cDNAs specific for human SP-D (hSP-D). We now describe the partial characterization of genomic clones for hSP-D and present evidence for an SP-D gene with coding sequences spanning > 11 kilobases on the long arm of chromosome 10. Genomic sequencing demonstrated that the signal peptide/amino-terminal domain, the carbohydrate recognition domain, and the linking sequence between the collagen domain and carbohydrate recognition domain are each encoded by a single exon, as for surfactant protein A and the mannose-binding protein C. However, sequencing also demonstrated a unique intron-exon structure for the collagen domain which is encoded on five exons, including four tandem exons of 117 bp. The latter exons show marked conservation in the predicted distribution of hydrophilic amino acids, consistent with tandem replication of this collagen gene sequence during evolution. Segregation analysis of HindIII digests of genomic DNA using specific cDNA probes demonstrated selective hybridization of radiolabeled hSP-D cDNA to chromosome 10- and 10q-containing human/hamster somatic hybrids. The presence of SP-D gene sequences was confirmed by DNA amplification using oligomers specific for sequences within the collagen domain of the hSP-D gene. Fluorescence in situ hybridization of metaphase chromosomes using genomic probes gave selective labeling of 10q22.2-23.1. We speculate that SP-D is encoded at a locus on 10q that includes the genes for surfactant protein A.	WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	CROUCH, E (corresponding author), WASHINGTON UNIV, JEWISH HOSP ST LOUIS, MED CTR, DEPT PATHOL, 216 S KINGSHIGHWAY, ST LOUIS, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL044015] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000304] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG-00304] Funding Source: Medline; NHLBI NIH HHS [HL-44015, HL-29594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRUNS G, 1987, HUM GENET, V76, P58; CROUCH E, 1991, AM J PATHOL, V139, P765; CROUCH E, 1993, AM J PATHOL, V142, P241; CROUCH E, 1991, AM J RESP CELL MOL, V5, P13, DOI 10.1165/ajrcmb/5.1.13; CROUCH E, 1991, AM J PHYSIOL, V260, pL247, DOI 10.1152/ajplung.1991.260.4.L247; Davis LG, 1986, BASIC METHODS MOL BI, P58, DOI 10.1016/B978-0-444-01082-7.50022-9; DOYLE BB, 1975, J MOL BIOL, V91, P79, DOI 10.1016/0022-2836(75)90373-3; DRICKAMER K, 1989, CIBA F SYMP, V145, P45; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; EXPOSITO JY, 1991, J BIOL CHEM, V266, P21923; FISHER JH, 1987, AM J HUM GENET, V40, P503; FLOROS J, 1986, J BIOL CHEM, V261, P9029; HAWGOOD S, 1989, AM J PHYSIOL, V257, pL13, DOI 10.1152/ajplung.1989.257.2.L13; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HOFMANN H, 1980, J MOL BIOL, V141, P293, DOI 10.1016/0022-2836(80)90182-5; JONES C, 1975, SOMAT CELL GENET, V1, P345, DOI 10.1007/BF01538666; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; LI K, 1992, J BIOL CHEM, V266, P24604; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LU JH, 1992, BIOCHEM J, V284, P795, DOI 10.1042/bj2840795; PAJUNEN L, 1989, AM J HUM GENET, V45, P829; PERSSON A, 1989, BIOCHEMISTRY-US, V28, P6361, DOI 10.1021/bi00441a031; PERSSON A, 1990, J BIOL CHEM, V265, P5755; PERSSON A, 1988, BIOCHEMISTRY-US, V27, P8576, DOI 10.1021/bi00423a011; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RUNNEGAR B, 1985, J MOL EVOL, V22, P141, DOI 10.1007/BF02101692; RUST K, 1991, ARCH BIOCHEM BIOPHYS, V290, P116, DOI 10.1016/0003-9861(91)90597-C; SANDELL LJ, 1990, EXTRACELLULAR MATRIX, P1; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; SHIMIZU H, 1992, J BIOL CHEM, V267, P1853; SHOWS TB, 1989, GENOMICS, V5, P128, DOI 10.1016/0888-7543(89)90096-7; TAYLOR ME, 1989, BIOCHEM J, V262, P763, DOI 10.1042/bj2620763; THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0	36	103	117	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2976	2983						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428971				2022-12-27	WOS:A1993KK81500105
J	JUNG, S; LOWE, SE; HOLLINGSWORTH, RI; ZEIKUS, JG				JUNG, S; LOWE, SE; HOLLINGSWORTH, RI; ZEIKUS, JG			SARCINA-VENTRICULI SYNTHESIZES VERY LONG-CHAIN DICARBOXYLIC-ACIDS IN RESPONSE TO DIFFERENT FORMS OF ENVIRONMENTAL-STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; LIPID-COMPOSITION; 27-HYDROXYOCTACOSANOIC ACID; CLOSTRIDIUM-ACETOBUTYLICUM; THERMAL REGULATION; MEMBRANE FLUIDITY; ZYMOMONAS-MOBILIS; ETHANOL; ALCOHOLS	Changes in the composition of membrane lipids in a strictly anaerobic, facultative acidophilic eubacterium, Sarcina ventriculi, were studied in response to various forms of environmental stress. Changes in lipid composition and structure occurred in response to changes in environmental pH. At neutral pH, the predominant membrane fatty acids ranged in chain length from C-14 to C18. However, when cells were grown at pH 3.0, a family of unique very long chain fatty acids containing 32-36 carbon atoms was synthesized and accounted for 50% of the total membrane fatty acids. These acids were identified as very long chain alpha,omega-dicarboxylic acids ranging in length from 28 to 36 carbons by electron impact mass spectrometry of methyl and (perdeuterio) methyl ester derivatives. These methyl esters all bore a vicinal dimethyl group toward the center of the chain. The assignment of the structures was confirmed by isolating one of the very long chain unusual fatty acids as the ester form after methanolysis and performing further analyses including H-1 and C-13 NMR spectroscopy and Fourier transform infrared spectroscopy. Coupling this information with the data from gas chromatography/mass spectrometry analysis, the exact structure was confirmed as alpha,omega-15,16-dimethyltricotanedioate dimethyl ester. Addition of alcohols, either metabolic (0.25 M ethanol) or nonmetabolic (0.05 M butanol) to cells grown at pH 7.0, or thermal stress (growth temperature at pH 7.0 was raised from 37 to 45 or 55-degrees-C) also resulted in the synthesis of these very long chain fatty acids. Synthesis of these very long chain alpha,omega-dicarboxylic acids was reversed by reducing the temperature back to 37-degrees-C. S. ventriculi is also unusual in that the membrane components are not the usual phospholipid components but appear to be predominantly glycolipids.	MICHIGAN STATE UNIV, DEPT BIOCHEM, E LANSING, MI 48824 USA; MICHIGAN STATE UNIV, DEPT CHEM, E LANSING, MI 48824 USA; MICHIGAN STATE UNIV, DEPT MICROBIOL & PUBL HLTH, E LANSING, MI 48824 USA; MICHIGAN STATE UNIV, NATL SCI FDN CTR MICROBIOL ECOL, E LANSING, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; National Science Foundation (NSF)								BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; Canale-Parola E, 1986, BERGEYS MANUAL SYSTE, V2, P1100; CANALEPAROLA E, 1970, BACTERIOL REV, V34, P82, DOI 10.1128/MMBR.34.1.82-97.1970; CAREY VC, 1983, J BACTERIOL, V154, P1291, DOI 10.1128/JB.154.3.1291-1300.1983; DEMENDOZA D, 1983, TRENDS BIOCHEM SCI, V8, P49, DOI 10.1016/0968-0004(83)90388-2; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; DOMBEK KM, 1984, J BACTERIOL, V157, P233, DOI 10.1128/JB.157.1.233-239.1984; FOSTER JW, 1990, J BACTERIOL, V172, P771, DOI 10.1128/jb.172.2.771-778.1990; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; GOODWIN S, 1987, J BACTERIOL, V169, P2150, DOI 10.1128/jb.169.5.2150-2157.1987; HAZLEWOOD G, 1979, J GEN MICROBIOL, V112, P15, DOI 10.1099/00221287-112-1-15; HAZLEWOOD GP, 1980, BIOCHEM J, V191, P555, DOI 10.1042/bj1910555; HOLLINGSWORTH RI, 1989, J BIOL CHEM, V264, P14039; HOLLINGSWORTH RI, 1989, J BIOL CHEM, V264, P9300; HOLME JD, 1983, ANAL CHEM, P436; INGRAM LO, 1982, J BACTERIOL, V149, P166, DOI 10.1128/JB.149.1.166-172.1982; INGRAM LO, 1976, J BACTERIOL, V125, P670, DOI 10.1128/JB.125.2.670-678.1976; INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305; INGRAM LO, 1980, J BACTERIOL, V144, P481, DOI 10.1128/JB.144.2.481-488.1980; INGRAM LO, 1977, CAN J MICROBIOL, V23, P779, DOI 10.1139/m77-115; KELL DB, 1981, BIOCHEM BIOPH RES CO, V99, P81, DOI 10.1016/0006-291X(81)91715-0; KLEIN RA, 1979, BIOCHEM J, V183, P691, DOI 10.1042/bj1830691; LEPAGE C, 1987, J GEN MICROBIOL, V133, P103; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LOWE SE, 1989, J BACTERIOL, V171, P3775, DOI 10.1128/jb.171.7.3775-3781.1989; LOWE SE, 1991, ARCH MICROBIOL, V155, P325; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; MORRIS LJ, 1962, CHEM IND-LONDON, P1238; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; PLESSET J, 1982, BIOCHEM BIOPH RES CO, V108, P1340, DOI 10.1016/0006-291X(82)92147-7; Pond JL, 1986, THERMOPHILES GEN MOL, P107; REZANKA T, 1990, FEMS MICROBIOL ECOL, V73, P231, DOI 10.1016/0378-1097(90)90735-9; SCHMIDT A, 1986, APPL MICROBIOL BIOT, V25, P32; SPECTOR MP, 1986, J BACTERIOL, V173, P3907; SPROTT GD, 1991, J BACTERIOL, V173, P3907, DOI 10.1128/JB.173.12.3907-3910.1991; SULLIVAN KH, 1979, J BACTERIOL, V138, P133, DOI 10.1128/JB.138.1.133-138.1979; TERRACCIANO JS, 1988, APPL ENVIRON MICROB, V54, P1989, DOI 10.1128/AEM.54.8.1989-1995.1988; TILAK KVB, 1970, SCI CULT, V36, P399; UCHIDA K, 1974, BIOCHIM BIOPHYS ACTA, V348, P86; UCHIDA K, 1974, BIOCHIM BIOPHYS ACTA, V369, P146, DOI 10.1016/0005-2760(74)90248-3; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987	42	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2828	2835						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428957				2022-12-27	WOS:A1993KK81500084
J	SZE, JY; KOHLHAW, GB				SZE, JY; KOHLHAW, GB			PURIFICATION AND STRUCTURAL CHARACTERIZATION OF TRANSCRIPTIONAL REGULATOR LEU3 OF YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; POLYACRYLAMIDE GELS; SYNTHETIC PEPTIDES; GENE-EXPRESSION; ACTIVATOR LEU3; GAL4; PROTEINS; BINDING; REGION	The transcriptional regulatorv protein, Leu3 of Saccharomyces cerevisiae was enriched approximately 70-fold above wild type level in yeast cells carrying a pGAL1-LEU3 expression vector. Sustained overproduction of Leu3 following induction by galactose required elevated intracellular levels of alpha-isopropylmalate, a leucine pathway intermediate known to act as transcriptional co-activator. Starting with galactose-induced cells, the Leu3 protein was purified about 3,500-fold (i.e. 245,000-fold over wild type level) by a procedure that included treatment of the cell-free extract with polyethylenimine, fractionation with ammonium sulfate, heat treatment, and DNA affinity chromatography. Highly purified preparations still showed two protein bands when subjected to polyacrylamide electrophoresis under denaturing conditions. Their apparent molecular masses were about 104,000 and 110,000 kDa. The smaller of these values was very close to the maximum molecular weight obtained previously for Leu3 protein translated in vitro in a rabbit reticulocyte lysate. (The molecular weight deduced from the open reading frame of the LEU3 gene is 100,162.) Both protein bands reacted with antibodies raised against different portions of the Leu3 molecule and were, therefore, likely to represent two forms of Leu3. Treatment with calf intestinal phosphatase quantitatively converted the slower moving band into the faster moving one. Conversion was prevented by inorganic phosphate, a phosphatase inhibitor. These experiments showed that the two bands very likely correspond to phosphorylated and nonphosphorylated forms of Leu3. Phosphorylation did not appear to affect the DNA binding function of Leu3, but (indirect) effects on the activation function or effects on the modulation by alpha-isopropylmalate have not been ruled out. Electrophoretic mobility shift assays were used to estimate the apparent dissociation constants of the two specific Leu3-DNA complexes routinely seen in these assays. The values obtained were 1.1 and 2.6 nM. Finally, using size exclusion chromatography, native Leu3 protein was shown to have dimeric structure, irrespective of the state of phosphorylation.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIGMS NIH HHS [GM15102] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAI YL, 1991, NUCLEIC ACIDS RES, V19, P5991, DOI 10.1093/nar/19.21.5991; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; BELTZER JP, 1986, J BIOL CHEM, V261, P5160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISCO PRG, 1990, J BIOL CHEM, V265, P11667; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; DANKERT JR, 1985, BIOCHEMISTRY-US, V24, P2754, DOI 10.1021/bi00332a024; DAVIS RW, 1980, ADV BACTERIAL GENET, P201; FALCO SC, 1985, NUCLEIC ACIDS RES, V13, P4011, DOI 10.1093/nar/13.11.4011; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FRIDEN P, 1989, MOL CELL BIOL, V9, P4056, DOI 10.1128/MCB.9.9.4056; FRIDEN P, 1988, MOL CELL BIOL, V8, P2690, DOI 10.1128/MCB.8.7.2690; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON SA, 1986, P NATL ACAD SCI USA, V83, P6553, DOI 10.1073/pnas.83.17.6553; JONES EW, 1977, GENETICS, V85, P23; JUE R, 1978, BIOCHEMISTRY-US, V17, P5399, DOI 10.1021/bi00618a013; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LITSKE JG, 1986, NUCLEIC ACIDS RES, V14, P9631, DOI 10.1093/nar/14.24.9631; MANIATIS T, 1982, MOL CLONING LABORATO, P247; MARTINEZARIAS A, 1984, NATURE, V307, P740, DOI 10.1038/307740b0; MYLIN LM, 1989, GENE DEV, V3, P1157, DOI 10.1101/gad.3.8.1157; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; PETERS MH, 1990, ARCH BIOCHEM BIOPHYS, V276, P294, DOI 10.1016/0003-9861(90)90041-V; SADOWSKI I, 1991, P NATL ACAD SCI USA, V88, P10510, DOI 10.1073/pnas.88.23.10510; SHERMAN F, 1979, METHODS YEAST GENETI, P61; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZHOU K, 1987, NUCLEIC ACIDS RES, V15, P5261, DOI 10.1093/nar/15.13.5261; ZHOU K, 1990, J BIOL CHEM, V265, P17409; ZHOU K, 1991, MOL SWITCH STRUCTURE, V3, P28; ZHOU KM, 1990, NUCLEIC ACIDS RES, V18, P291, DOI 10.1093/nar/18.2.291	41	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2505	2512						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428928				2022-12-27	WOS:A1993KK81500041
J	DAVID, LL; SHEARER, TR; SHIH, M				DAVID, LL; SHEARER, TR; SHIH, M			SEQUENCE-ANALYSIS OF LENS BETA-CRYSTALLINS SUGGESTS INVOLVEMENT OF CALPAIN IN CATARACT FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT LENS; PROTEOLYSIS; PROTEIN	Abnormal activation of the protease calpain in the lens may be a cause of cataracts. Cataracts were induced in 10-day-old rats by a single overdose of sodium selenite. The water-insoluble protein from the opaque lens nucleus was separated by two-dimensional electrophoresis, electroblotted onto membranes, and the NH2-terminal sequence of partially degraded beta-crystallin polypeptides determined. Selenite cataractous lenses contained four major structural proteins, betaB1, betaB3, betaA3/A1, and betaA4 crystallins, missing from 5 to 49 amino acids from their NH2 termini. Incubation of intact beta-crystallins with calpain II in vitro produced identical cleavage sites. This provided further evidence for the role of calpain in the production of light scattering insoluble protein in cataractous lenses and also suggested that a similar process may lead to lens protein insolubilization during aging.	OREGON HLTH SCI UNIV,DEPT OPHTHALMOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	DAVID, LL (corresponding author), OREGON HLTH SCI UNIV,DEPT ORAL MOLEC BIOL,611 SW CAMPUS DR,PORTLAND,OR 97201, USA.				NATIONAL EYE INSTITUTE [R01EY003600, R01EY007755, R29EY007755] Funding Source: NIH RePORTER; NEI NIH HHS [EY07755, EY03600] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AZUMA M, 1992, FEBS LETT, V307, P313, DOI 10.1016/0014-5793(92)80703-J; AZUMA M, 1992, OPHTHALMIC RES, V24, P8, DOI 10.1159/000267138; BATEMAN OA, 1992, EXP EYE RES, V55, P127, DOI 10.1016/0014-4835(92)90100-7; BERBERS GAM, 1984, EUR J BIOCHEM, V139, P467, DOI 10.1111/j.1432-1033.1984.tb08029.x; DAVID L, UNPUB; DAVID LL, 1986, EXP EYE RES, V42, P227, DOI 10.1016/0014-4835(86)90057-6; DAVID LL, 1987, INVEST OPHTH VIS SCI, V28, P1148; DAVID LL, 1984, INVEST OPHTH VIS SCI, V25, P1275; DAVID LL, 1992, BIOCHIM BIOPHYS ACTA, V1139, P210, DOI 10.1016/0925-4439(92)90136-B; DENDUNNEN JT, 1985, BIOCHIM BIOPHYS ACTA, V824, P295, DOI 10.1016/0167-4781(85)90035-1; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; PETERSON CA, 1986, GENE, V45, P139, DOI 10.1016/0378-1119(86)90248-9; PIERSCIONEK B, 1988, CURR EYE RES, V7, P11, DOI 10.3109/02713688809047015; SHEARER TR, 1991, INVEST OPHTH VIS SCI, V32, P533; Takahashi K., 1990, INTRACELLULAR CALCIU, P56; VANRENS GLM, 1991, GENE, V102, P179, DOI 10.1016/0378-1119(91)90149-6	17	114	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1937	1940						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420967				2022-12-27	WOS:A1993KH62000067
J	LILIENBAUM, A; PAULIN, D				LILIENBAUM, A; PAULIN, D			ACTIVATION OF THE HUMAN VIMENTIN GENE BY THE TAX HUMAN T-CELL LEUKEMIA VIRUS-I - MECHANISMS OF REGULATION BY THE NF-KAPPA-B TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEINS; DNA-BINDING; MAMMALIAN-CELLS; INTERLEUKIN-6 GENE; REL ONCOGENE; EXPRESSION; PROMOTER; HTLV-1; SEQUENCE; PROLIFERATION	The molecular basis for transactivation of the human vimentin gene by the Tax protein from he human T-cell leukemia virus (HTLV-1) is analyzed in this report. We first demonstrate that the factor NF-kappaB binds to the vimentin promoter. Using gel retardation assays, we found the putative NF-kappaB protein. Specific antibodies and competition experiments between the NF-kappaB-binding site in the interleukin-2Ralpha and HIV-1 promoters and the vimentin promoter show that the three sites have identical affinity for the factor. We further show that the mechanisms of activation of NF-kappaB by the Tax protein involve a cellular inducer. Nuclear extract from lymphoid cells expressing Tax can induce in vitro a NF-kappaB binding activity in nonlymphoid cytosolic extract. This inducer, if preexisting in an inactive state in T-cells which are not expressing Tax, cannot be switched to an active state by addition of partially purified Tax protein. While found in the nucleus of Tax-expressing cells in our experiments, this inducer might be cytoplasmic as well. In a first attempt to identify and characterize the inducer, we present the results of fractionation assays of nuclear extract.	UNIV PARIS 07,BIOL MOLEC DIFFERENTIAT LAB,F-75221 PARIS 05,FRANCE	UDICE-French Research Universities; Universite Paris Cite	LILIENBAUM, A (corresponding author), INST PASTEUR,SCME,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.							ARIMA N, 1991, J VIROL, V65, P6892, DOI 10.1128/JVI.65.12.6892-6899.1991; ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; CEREGHINI S, 1988, I PASTEUR PRACTICAL, P10; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHERRINGTON JM, 1989, J VIROL, V63, P1435, DOI 10.1128/JVI.63.3.1435-1440.1989; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; FUJII M, 1988, P NATL ACAD SCI USA, V85, P8526, DOI 10.1073/pnas.85.22.8526; FUJII M, 1991, ONCOGENE, V6, P1023; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAZAN U, 1990, P NATL ACAD SCI USA, V87, P7861, DOI 10.1073/pnas.87.20.7861; HIRSCHHORN RR, 1984, P NATL ACAD SCI-BIOL, V81, P6004, DOI 10.1073/pnas.81.19.6004; INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; KACZMAREK L, 1985, P NATL ACAD SCI USA, V82, P5375, DOI 10.1073/pnas.82.16.5375; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LENARDO MJ, 1988, P NATL ACAD SCI USA, V85, P8825, DOI 10.1073/pnas.85.23.8825; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LILIENBAUM A, 1990, J VIROL, V64, P256, DOI 10.1128/JVI.64.1.256-263.1990; LILIENBAUM A, 1988, STRUCTURE FUNCTION C, V171, P151; LINDHOLM P F, 1990, New Biologist, V2, P1034; LINDHOLM PF, 1991, J BIOCHEM BIOPH METH, V22, P233, DOI 10.1016/0165-022X(91)90071-4; MARRIOTT SJ, 1991, NEW BIOL, V3, P678; MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5; Maxam A M, 1980, Methods Enzymol, V65, P499; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; PAULIN D, 1990, REPROD NUTR DEV, V30, P423, DOI 10.1051/rnd:19900316; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; RUBEN S M, 1989, New Biologist, V1, P275; RUBEN S M, 1990, New Biologist, V2, P894; SAX CM, 1988, NUCLEIC ACIDS RES, V16, P8057, DOI 10.1093/nar/16.16.8057; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shibuya H, 1989, INT IMMUNOL, V1, P43, DOI 10.1093/intimm/1.1.43; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; TRAUB P, 1985, ANN NY ACAD SCI, V455, P68, DOI 10.1111/j.1749-6632.1985.tb50404.x; ZABEL U, 1991, J BIOL CHEM, V266, P252	55	86	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2180	2188						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420985				2022-12-27	WOS:A1993KH62000102
J	WEMMER, DE; WEDEMAYER, GJ; GLAZER, AN				WEMMER, DE; WEDEMAYER, GJ; GLAZER, AN			PHYCOBILINS OF CRYPTOPHYCEAN ALGAE - NOVEL LINKAGE OF DIHYDROBILIVERDIN IN A PHYCOERYTHRIN-555 AND A PHYCOCYANIN-645	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROOMONAS SP CRYPTOPHYCEAE; CRYPTOMONAD BILIPROTEIN; I PHYCOERYTHRIN; ENERGY-TRANSFER; MULTIPLE FORMS; ALPHA-SUBUNITS; C-PHYCOCYANIN; ATTACHMENT; DIVERSITY; SEQUENCE	Cryptomonad strain IVF2 phycoerythrin 555 carries phycoerythrobilins attached through single thioether bonds at alpha-Cys-18, beta-Cys-82, and beta-Cys-158 and a doubly linked 15,16-dihydrobiliverdin (DBV) at beta-DiCys-50,61 (for sequence numbering, see Sidler, W., Nutt, H., Kumpf, B., Frank, G., Suter, F., Brenzel, A., Wehrmeyer, W., and Zuber, H. (1990) Biol. Chem. Hoppe-Seyler 371, 573-547). Analysis of the beta-DiCys-50,61-linked DBV by H-1 homonuclear and H-1-C-13 heteronuclear NMR spectroscopy establishes that the thioether bond from Cys-50 is to the 3''-carbon of the DBV ring A and that from Cys-61 is to the 18'-carbon of ring D, i.e. the peptide-linked bilin is an 8,12-bis(2-carboxyethyl)-3-(2-(cysteinyl-S)-ethyl)-18-(1-(cysteinyl-S)-ethyl)-2,,7,13,17-tetramethylbiladiene-ab-1,19(16H, 21H)-dione. DBV is also present at beta-DiCys-50,61 in cryptomonad strain UW374 phycocyanin 645 (Wedemayer, G. J., Kidd, D. G., Wemmer, D. E., and Glazer, A. N. (1992) J. Biol. Chem. 267, 7315-7331). NMR spectroscopy shows that the thioether bonds to this DBV are also at 3'' and 18'. Linkage of tetrapyrroles to polypeptides through the 3''-carbon has not hitherto been reported.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720; LAWRENCE BERKELEY LAB,DEPT CHEM,BERKELEY,CA 94720; LAWRENCE BERKELEY LAB,DIV CHEM BIODYNAM,BERKELEY,CA 94720	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory					NIGMS NIH HHS [GM28994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028994] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; BEALE SI, 1991, J BIOL CHEM, V266, P22341; BISHOP JE, 1986, J BIOL CHEM, V261, P6790; BROOKS C, 1973, ARCH MIKROBIOL, V88, P193, DOI 10.1007/BF00421845; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; GINGRICH JC, 1982, J CELL BIOL, V95, P170, DOI 10.1083/jcb.95.1.170; Glazer A. N, 1986, CURRENT COMMUNICATIO, P31; GLAZER AN, 1975, ARCH MICROBIOL, V104, P29, DOI 10.1007/BF00447296; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1971, ARCH MIKROBIOL, V80, P1, DOI 10.1007/BF00410574; GLAZER AN, 1973, J BIOL CHEM, V248, P663; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; HILL DRA, 1989, PHYCOLOGIA, V28, P455, DOI 10.2216/i0031-8884-28-4-455.1; HILLER RG, 1987, BIOCHIM BIOPHYS ACTA, V923, P98, DOI 10.1016/0304-4165(87)90131-0; JENKINS J, 1990, FEBS LETT, V273, P191, DOI 10.1016/0014-5793(90)81082-Y; KELLER MD, 1987, J PHYCOL, V23, P633; KLOTZ AV, 1986, J BIOL CHEM, V261, P6797; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; MACCOLL R, 1983, ARCH MICROBIOL, V135, P194, DOI 10.1007/BF00414479; MACCOLL R, 1990, BIOCHEMISTRY-US, V29, P430, DOI 10.1021/bi00454a018; MACCOLL R, 1983, BIOCHEMISTRY-US, V22, P5568, DOI 10.1021/bi00293a018; MACCOLL R, 1992, J LUMIN, V51, P21, DOI 10.1016/0022-2313(92)90015-2; MACCOLL R, 1983, J BIOL CHEM, V258, P4327; MACCOLL R, 1976, ARCH BIOCHEM BIOPHYS, V177, P265, DOI 10.1016/0003-9861(76)90436-7; MACCOLL R, 1973, J BIOL CHEM, V248, P7080; MARTIN CD, 1987, BIOCHIM BIOPHYS ACTA, V923, P88, DOI 10.1016/0304-4165(87)90130-9; MORSCHEL E, 1975, ARCH MICROBIOL, V105, P153, DOI 10.1007/BF00447130; MORSCHEL E, 1977, ARCH MICROBIOL, V113, P83, DOI 10.1007/BF00428585; NOLAN DN, 1967, BIOCHEM J, V103, pP39; OHEOCHA C, 1959, NATURE, V184, P1049, DOI 10.1038/1841049a0; OHEOCHA C, 1964, Proc R Ir Acad B, V63, P191; ONG LJ, 1991, J BIOL CHEM, V266, P9515; REITH M, 1990, PLANT MOL BIOL, V15, P585, DOI 10.1007/BF00017833; SCHEER H, 1977, Z NATURFORSCH C, V32, P513; SHELDRICK WS, 1976, J CHEM SOC PERK T 2, P1457, DOI 10.1039/p29760001457; SIDLER W, 1985, BIOL CHEM H-S, V366, P233, DOI 10.1515/bchm3.1985.366.1.233; SIDLER W, 1990, BIOL CHEM HOPPESEYLE, V371, P573; SIDLER WA, 1987, PROGR PHOTOSYNTHESIS, V2, P153; SWANSON RV, 1990, ANAL BIOCHEM, V188, P295, DOI 10.1016/0003-2697(90)90609-D; WEDEMAYER GJ, 1991, J BIOL CHEM, V266, P4731; WEDEMAYER GJ, 1992, J BIOL CHEM, V267, P7315; WILBANKS SM, 1989, J BIOL CHEM, V260, P17860	43	22	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1658	1669						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420941				2022-12-27	WOS:A1993KH62000026
J	LENDENFELD, T; GHALI, D; WOLSCHEK, M; KUBICEKPRANZ, EM; KUBICEK, CP				LENDENFELD, T; GHALI, D; WOLSCHEK, M; KUBICEKPRANZ, EM; KUBICEK, CP			SUBCELLULAR COMPARTMENTATION OF PENICILLIN BIOSYNTHESIS IN PENICILLIUM-CHRYSOGENUM - THE AMINO-ACID PRECURSORS ARE DERIVED FROM THE VACUOLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROSPORA-CRASSA; ISOPENICILLIN-N; ASPERGILLUS-NIDULANS; LYSINE BIOSYNTHESIS; DELTA-(L-ALPHA-AMINOADIPYL)-L-CYSTEINYL-D-VALINE; PROTEINS; MEMBRANE; STRAINS; ACYLTRANSFERASE; SYNTHETASE	The cellular localization of the origin of alpha-aminoadipate used in penicillin biosynthesis and the first enzymic step in Penicillium chrysogenum involved, delta-(alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS), has been studied. Subcellular fractions were obtained from protoplasts of a high penicillin-producing strain upon lysis by Triton X-100, and vacuoles purified from them. They were identified by the aid of alpha-mannosidase as a marker enzyme, by the presence of polyphosphate, and their ability to sequester [C-14]lysin, added to the protoplasts prior to subcellular fractionation. 15.6 and 26.5%, respectively, of 6-[C-14]alpha-aminoadipate, and 8.5 and 10.3%, respectively, of [C-14]valine added accordingly were also found in the vacuole, and the higher proportion was found in vacuoles isolated from penicillin-producing mycelia. ACVS protein was detected in the membrane as well as the soluble fraction of the purified vacuoles. We propose therefore that ACVS is located either within or bound to the vacuolar membrane, and that the precursor amino acids for penicillin biosynthesis are withdrawn from the vacuolar amino acid pool.	VIENNA TECH UNIV,INST BIOCHEM TECHNOL & MIKROBIOL,MIKROBIELLE BIOCHEM ABT,A-1060 VIENNA,AUSTRIA	Technische Universitat Wien								Abraham EP, 1981, RECENT ADV CHEM BETA, P125; AFFENZELLER K, 1991, J GEN MICROBIOL, V137, P1653, DOI 10.1099/00221287-137-7-1653; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; BOWMAN BJ, 1987, EXP MYCOL, V11, P197, DOI 10.1016/0147-5975(87)90005-3; BOWMAN EJ, 1982, J BACTERIOL, V151, P1326, DOI 10.1128/JB.151.3.1326-1337.1982; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARR LG, 1986, GENE AMST, V83, P291; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CRAMER CL, 1980, J BACTERIOL, V142, P945, DOI 10.1128/JB.142.3.945-952.1980; DIEZ B, 1990, J BIOL CHEM; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fawcett P, 1975, Methods Enzymol, V43, P471; FAWCETT PA, 1976, BIOSYNTHESIS, V4, P248; FRIEDRICH CG, 1978, ARCH MICROBIOL, V119, P43, DOI 10.1007/BF00407926; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HONLINGER C, 1988, J ANTIBIOT, V41, P255; HONLINGER C, 1989, FEMS MICROBIOL LETT, V65, P71, DOI 10.1016/0378-1097(89)90368-6; HONLINGER C, 1989, BIOCHIM BIOPHYS ACTA, V993, P204, DOI 10.1016/0304-4165(89)90165-7; HORAK J, 1986, BIOCHIM BIOPHYS ACTA, V864, P223, DOI 10.1016/0304-4157(86)90001-8; JAKLITSCH WM, 1987, EXP MYCOL, V11, P141, DOI 10.1016/0147-5975(87)90047-8; JAKLITSCH WM, 1986, CAN J MICROBIOL, V32, P473, DOI 10.1139/m86-087; KELLER U, 1984, APPL ENVIRON MICROB, V47, P710, DOI 10.1128/AEM.47.4.710-714.1984; KURYLOWICZ W, 1987, ARCH IMMUNOL THER EX, V35, P699; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdon RG, 1966, METHODS ENZYMOL, V9, DOI DOI 10.1016/0076-6879(66)09030-X; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MARTIN JF, 1991, J IND MICROBIOL, V9, P73; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; MULLER WH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P210, DOI 10.1016/0304-4165(92)90118-E; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; REVILLA G, 1986, J BACTERIOL, V168, P947, DOI 10.1128/jb.168.2.947-952.1986; Roos W, 1986, CELL METABOLISM GROW, P45; SMITH DJ, 1990, BIO-TECHNOL, V8, P39, DOI 10.1038/nbt0190-39; VANLIEMPT H, 1989, J BIOL CHEM, V264, P3680; VAUGHN LE, 1981, MOL CELL BIOL, V1, P797, DOI 10.1128/MCB.1.9.797; VEENSTRAA EA, 1989, GENETICS MOL BIOL IN, P262; WHITEMAN PA, 1990, FEBS LETT, V262, P342, DOI 10.1016/0014-5793(90)80224-7; WIEMKEN A, 1979, ARCH MICROBIOL, V123, P23, DOI 10.1007/BF00403499	40	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					665	671						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416970				2022-12-27	WOS:A1993KE60300100
J	ISMAIL, M; BROCK, JH				ISMAIL, M; BROCK, JH			BINDING OF LACTOFERRIN AND TRANSFERRIN TO THE HUMAN PROMONOCYTIC CELL-LINE U937 - EFFECT ON IRON UPTAKE AND RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL BRUSH-BORDER; HUMAN-MONOCYTES; RECEPTOR; LACTOTRANSFERRIN; FERRITIN; MACROPHAGES; ENDOCYTOSIS; LYMPHOCYTES; SURFACE; GROWTH	We have compared the ability of lactoferrin and transferrin to interact with and donate iron to the monocytic cell line U937. About 10 times more lactoferrin was bound than transferrin, but most lactoferrin bound nonspecifically, and the degree of specific binding was similar for both proteins (2-3 x 10(6) sites/cell). The binding affinity for lactoferrin (83 nM) was about 4-fold lower than for transferrin (21 nM). Lactoferrin did not inhibit binding of transferrin, or vice versa. Binding of lactoferrin was not inhibited by 30 mM glucose or fucose nor by incubating the cells with heparinase. Transferrin, but not lactoferrin, was internalized, and 3 mM primaquine caused intracellular accumulation of transferrin but not lactoferrin. The cells rapidly acquired iron from transferrin, but uptake from lactoferrin was 10-fold slower and probably resulted from transfer of Fe-59 from lactoferrin to unlabeled transferrin during culture. Lactoferrin, but not transferrin, released iron to the extracellular medium when bound to U937 cells. Lactoferrin inhibited cellular uptake of iron from Fe-nitrilotriacetate but not from transferrin. It is concluded that transferrin, but not lactoferrin, acts as an iron donor to U937 cells. Lactoferrin may regulate uptake of potentially toxic non-transferrin-bound iron.	UNIV GLASGOW,WESTERN INFIRM,DEPT IMMUNOL,GLASGOW G11 6NT,SCOTLAND	University of Glasgow				ISMAIL, MAZNAH/0000-0002-2378-0519				AISEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P314, DOI 10.1016/0005-2795(72)90283-8; AMOURIC M, 1984, IN VITRO CELL DEV B, V20, P543; BAKER EN, 1987, TRENDS BIOCHEM SCI, V12, P350, DOI 10.1016/0968-0004(87)90163-0; BALI PK, 1991, BIOCHEMISTRY-US, V30, P9947, DOI 10.1021/bi00105a019; BATES GW, 1973, J BIOL CHEM, V248, P3228; BAYNES R, 1986, SCAND J CLIN LAB INV, V46, P695, DOI 10.3109/00365518609083733; BENNETT RM, 1981, BIOCHEM BIOPH RES CO, V101, P88, DOI 10.1016/S0006-291X(81)80014-9; BIRGENS HS, 1983, BRIT J HAEMATOL, V54, P383, DOI 10.1111/j.1365-2141.1983.tb02113.x; BIRGENS HS, 1988, EUR J HAEMATOL, V41, P52; BRITIGAN BE, 1991, J IMMUNOL, V147, P4271; BROCK JH, 1981, IMMUNOLOGY, V43, P393; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; DJEHA A, 1992, BRIT J HAEMATOL, V80, P235, DOI 10.1111/j.1365-2141.1992.tb08906.x; GOAVEC M, 1985, CR ACAD SCI III-VIE, V301, P689; GORDEUK VR, 1988, J CLIN INVEST, V82, P1934, DOI 10.1172/JCI113812; HASHIZUME S, 1983, BIOCHIM BIOPHYS ACTA, V763, P377, DOI 10.1016/0167-4889(83)90099-X; HU WL, 1990, BIOCHEMISTRY-US, V29, P535, DOI 10.1021/bi00454a030; IMBER MJ, 1983, BIOCHEM J, V212, P249, DOI 10.1042/bj2120249; INTRAGUMTORNCHA.T, 1988, BLUT, V60, P249; ITURRALDE M, 1992, BIOCHIM BIOPHYS ACTA, V1133, P241, DOI 10.1016/0167-4889(92)90043-B; JOHANSSON BG, 1969, ACTA CHEM SCAND, V23, P683, DOI 10.3891/acta.chem.scand.23-0683; KAWAKAMI H, 1990, AM J PHYSIOL, V258, pG535, DOI 10.1152/ajpgi.1990.258.4.G535; LEE GR, 1983, SEMIN HEMATOL, V20, P61; MAZURIER J, 1989, EUR J BIOCHEM, V179, P481, DOI 10.1111/j.1432-1033.1989.tb14578.x; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; MCABEE DD, 1991, J BIOL CHEM, V266, P23624; METZBOUTIGUE MH, 1978, BIOCHIMIE PARIS, V60, P38; MOGUILEVSKY N, 1987, BRIT J HAEMATOL, V66, P129, DOI 10.1111/j.1365-2141.1987.tb06902.x; ORIA R, 1988, BIOCHEM J, V252, P221, DOI 10.1042/bj2520221; ORIA R, 1983, J DAIRY RES, V60, P363; PIPPARD MJ, 1989, IRON IMMUNITY CANCER, P361; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROCHARD E, 1989, FEBS LETT, V255, P201, DOI 10.1016/0014-5793(89)81091-9; ROIRON D, 1989, EUR J BIOCHEM, V186, P367, DOI 10.1111/j.1432-1033.1989.tb15218.x; ROIRONLAGROUX D, 1990, BIOCHEM BIOPH RES CO, V170, P837, DOI 10.1016/0006-291X(90)92167-X; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; SIPE DM, 1991, J BIOL CHEM, V266, P8002; SUN IL, 1991, BIOCHEM BIOPH RES CO, V176, P498, DOI 10.1016/0006-291X(91)90952-4; VANSNICK JL, 1974, J EXP MED, V140, P1068, DOI 10.1084/jem.140.4.1068; VANSNICK JL, 1977, J EXP MED, V146, P817, DOI 10.1084/jem.146.3.817; YAMADA Y, 1987, BLOOD, V70, P264	41	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21618	21625						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408013				2022-12-27	WOS:A1993MC80900031
J	KATAYANAGI, K; ISHIKAWA, M; OKUMURA, M; ARIYOSHI, M; KANAYA, S; KAWANO, Y; SUZUKI, M; TANAKA, I; MORIKAWA, K				KATAYANAGI, K; ISHIKAWA, M; OKUMURA, M; ARIYOSHI, M; KANAYA, S; KAWANO, Y; SUZUKI, M; TANAKA, I; MORIKAWA, K			CRYSTAL-STRUCTURES OF RIBONUCLEASE-HI ACTIVE-SITE MUTANTS FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; RNASE-H; 3-DIMENSIONAL STRUCTURE; DNA-POLYMERASE; IDENTIFICATION; RETROVIRUSES; REPLICATION; MUTAGENESIS; INITIATION; RESOLUTION	In order to investigate the relationships between the three-dimensional structure and the enzymic activity of E. coli RNase HI, three mutant proteins, which were completely inactivated by the replacements of three functional residues, Asp10 by Asn (D10N), Glu48 by Gln (E48Q), and Asp70 by Asn (D70N), were crystallized. Their three-dimensional structures were determined by x-ray crystallography. Although the entire backbone structures of these mutants were not affected by the replacements, very localized conformational changes were observed around the Mg2+-binding site. The substitution of an amide group for a negatively charged carboxyl group in common induces the formation of new hydrogen bond networks, presumably due to the cancellation of repulsive forces between carboxyl side chains with negative charges. These conformational changes can account for the loss of the enzymic activity in the mutants, and suggest a possible role for Mg2+ in the hydrolysis. Since the 3 replaced acidic residues are completely conserved in sequences of reverse transcriptases from retroviruses, including human immunodeficiency virus, the concepts of the catalytic mechanism deduced from this structural analysis can also be applied to RNase H activity in reverse transcriptases.	PROT ENGN RES INST,6-2-3 FURUEDAI,SUITA,OSAKA 565,JAPAN; HOKKAIDO UNIV,FAC SCI,SAPPORO,HOKKAIDO 060,JAPAN	Hokkaido University			Suzuki, Mamoru/G-6576-2016	Suzuki, Mamoru/0000-0001-7071-5093; Ariyoshi, Mariko/0000-0002-1361-2642				BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BERKOWER I, 1973, J BIOL CHEM, V248, P5914; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; CRAWFORD JL, 1973, P NATL ACAD SCI USA, V70, P538, DOI 10.1073/pnas.70.2.538; CROUCH R J, 1990, New Biologist, V2, P771; Crouch R. J., 1982, NUCLEASES, P211; CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HUBER R, 1985, J APPL CRYSTALLOGR, V18, P165, DOI 10.1107/S0021889885010044; ISHIKAWA K, 1993, J MOL BIOL, V230, P529, DOI 10.1006/jmbi.1993.1169; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JOU RW, 1991, J AM CHEM SOC, V113, P6685, DOI 10.1021/ja00017a056; KANAYA S, 1989, J BIOL CHEM, V264, P11546; KANAYA S, 1991, EUR J BIOCHEM, V198, P437, DOI 10.1111/j.1432-1033.1991.tb16033.x; KANAYA S, 1990, J BIOL CHEM, V265, P4615; KATAYANAGI K, 1992, J MOL BIOL, V223, P1029, DOI 10.1016/0022-2836(92)90260-Q; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; KATAYANAGI K, 1993, IN PRESS PROTEINS ST; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MORIKAWA K, 1992, B I PASTEUR, V90, P71; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; NORTH ACT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P351, DOI 10.1107/S0567739468000707; ODA Y, 1991, Journal of Biomolecular NMR, V1, P247, DOI 10.1007/BF01875518; ODA Y, 1993, J BIOL CHEM, V268, P88; STEIGEMANN W, 1974, THESIS TU MUNICH; TANAKA I, 1990, J APPL CRYSTALLOGR, V23, P334, DOI 10.1107/S0021889890004009; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; YANG W, 1990, J BIOL CHEM, V265, P13553; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648	40	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22092	22099						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408067				2022-12-27	WOS:A1993MC80900097
J	KONDO, T; YOSHIDA, T; MIURA, N; NAKANISHI, M				KONDO, T; YOSHIDA, T; MIURA, N; NAKANISHI, M			TEMPERATURE-SENSITIVE PHENOTYPE OF A MUTANT SENDAI VIRUS-STRAIN IS CAUSED BY ITS INSUFFICIENT ACCUMULATION OF THE M-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-GENE-THERAPY; GEL-ELECTROPHORESIS; VACCINIA VIRUS; RNA-POLYMERASE; MESSENGER-RNA; CDNA CLONING; EXPRESSION; DNA; SEQUENCES; HEPATITIS	We investigated the process interrupting the production of a temperature-sensitive mutant strain of Sendai virus, Cl.151, at the nonpermissive temperature (38-degrees-C). The amount of virus M protein increased up to 6-fold when the cells persistently infected with Cl.151 strain at 38-degrees-C are transferred to 32-degrees-C, while the amount of nucleocapsid proteins did not alter. Cl.151 strain could restore virus production at 38-degrees-C not only by the supplementation of M protein of wild type (Z) strain but also by the supplementation of M protein of Cl.151 strain. Neither the amount of M mRNA nor the rate of synthesis of M protein was altered by temperature in cells infected with the Cl.151 strain. However, we found that M protein of Cl.151 virus, which has 3-amino acid alterations from the wild type, was highly unstable at 38-degrees-C when expressed under the control of an actin promoter. These results clearly show that Sendai virus M protein has a critical role in the production of virus particles without affecting virus gene expression.	OSAKA UNIV,INST MOLEC & CELLULAR BIOL,1-3 YAMADA OKA,SUITA,OSAKA 565,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT BACTERIOL,HIROSHIMA 734,JAPAN	Osaka University; Hiroshima University			Kondo, Toru/F-9420-2012					BILLETER MA, 1991, PARAMYXOVIRUSES, P323; BLONDEL D, 1990, J VIROL, V64, P1716, DOI 10.1128/JVI.64.4.1716-1725.1990; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COCHRAN MA, 1985, P NATL ACAD SCI USA, V82, P19, DOI 10.1073/pnas.82.1.19; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; ISHIHARA H, 1990, ANAL BIOCHEM, V184, P207, DOI 10.1016/0003-2697(90)90670-5; KAN T, 1970, BIKEN J, V13, P183; KATO K, 1991, J BIOL CHEM, V266, P22071; KATO K, 1991, J BIOL CHEM, V266, P3361; KINGSBURY DW, 1970, VIROLOGY, V42, P857, DOI 10.1016/0042-6822(70)90335-1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mackett M., 1985, DNA CLONING PRACTICA, P191; MCSHARRY JJ, 1975, VIROLOGY, V67, P365, DOI 10.1016/0042-6822(75)90438-9; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; NAKANISHI M, 1985, EXP CELL RES, V195, P399; NGO TT, 1990, J CHROMATOGR, V510, P281, DOI 10.1016/S0021-9673(01)93762-8; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OKADA Y, 1961, BIKEN J, V4, P209; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; PORTNER A, 1974, J VIROL, V13, P298, DOI 10.1128/JVI.13.2.298-304.1974; PRINGLE CR, 1991, PARAMYXOVIRUSES, P1; RANDALL RE, 1991, PARAMYXOVIRUSES, P299; RE GG, 1986, J VIROL, V58, P578, DOI 10.1128/JVI.58.2.578-582.1986; RE GG, 1991, PARAMYXOVIRUSES, P275; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROUX L, 1982, CELL, V28, P293, DOI 10.1016/0092-8674(82)90347-6; SALK JE, 1944, J IMMUNOL, V69, P87; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMIZU K, 1975, VIROLOGY, V67, P427, DOI 10.1016/0042-6822(75)90444-4; SHIODA T, 1986, NUCLEIC ACIDS RES, V14, P1545, DOI 10.1093/nar/14.4.1545; SOKOL F, 1964, ACTA VIROL, V8, P59; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TADOKORO J, 1985, BIKEN J, V1, P118; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUFFEREAU C, 1988, VIROLOGY, V162, P417, DOI 10.1016/0042-6822(88)90482-5; YOSHIDA T, 1979, VIROLOGY, V92, P139, DOI 10.1016/0042-6822(79)90220-4; YOSHIDA T, 1976, VIROLOGY, V71, P143, DOI 10.1016/0042-6822(76)90101-X; YOSHIDA T, 1982, VIROLOGY, V120, P329, DOI 10.1016/0042-6822(82)90034-4	46	27	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21924	21930						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408048				2022-12-27	WOS:A1993MC80900074
J	THORNELL, A; HOLM, M; GRUNDSTROM, T				THORNELL, A; HOLM, M; GRUNDSTROM, T			PURIFICATION OF SEF1 PROTEINS BINDING TO TRANSCRIPTIONAL ENHANCER ELEMENTS ACTIVE IN T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE RETROVIRUS SL3-3; MURINE LEUKEMIA-VIRUS; SEQUENCE; IDENTIFICATION; SPECIFICITY; EXPRESSION; ACTIVATORS; DOMAIN; TUMOR; CORE	Binding sites for SL3-3 enhancer factor 1 (SEF1) are important for the transcriptional activity in T lymphocytes and the tumorigenicity of SL3-3 murine leukemia virus. SEF1 is also implicated in the activity of many other leukemia, lymphoma, and sarcoma virus enhancers, and enhancers of genes for T cell receptor-CD3 subunits. We have purified several proteins binding to SEF1 sites from bovine thymus using a five-step purification procedure. The proteins migrated as 19 distinct bands representing molecular masses from 23 kDa to about 200 kDa in SDS-polyacrylamide gel electrophoresis. Ten DNA binding proteins, with molecular masses between 23 and 67 kDa, could be isolated after separation by SDS-polyacrylamide gel electrophoresis. The DNA binding specificities of these proteins were similar and corresponded to that of the SEF1 binding activity in nuclear extracts. Each of these isolated SEF1 proteins also bound to the essential delta-E3 element of the human T cell receptor delta enhancer. Antibodies against one SEF1 protein only reacted with the protein used for immunization, which indicates a limited homology between at least some SEF1 proteins. We also present data suggesting that SEF1 proteins exist in multiple forms with differences in their DNA binding specificity, and that high affinity DNA binding of the SEF1 proteins requires protein phosphorylation.	UMEA UNIV, DEPT APPL CELL & MOLEC BIOL, S-90187 UMEA, SWEDEN	Umea University			Holm, Magnus/B-8932-2008					ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BERK AJ, 1989, BIOCHIM BIOPHYS ACTA, V1009, P103, DOI 10.1016/0167-4781(89)90087-0; CELANDER D, 1984, NATURE, V312, P159, DOI 10.1038/312159a0; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GARGIABLANCO MA, 1989, GENE DEV, V3, P739, DOI 10.1101/gad.3.6.739; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; GRANELLIPIPERNO A, 1991, P NATL ACAD SCI USA, V88, P11431, DOI 10.1073/pnas.88.24.11431; HALLBERG B, 1988, NUCLEIC ACIDS RES, V16, P5927, DOI 10.1093/nar/16.13.5927; HALLBERG B, 1991, J VIROL, V65, P4177, DOI 10.1128/JVI.65.8.4177-4181.1991; HALLBERG B, 1992, NUCLEIC ACIDS RES, V20, P6495, DOI 10.1093/nar/20.24.6495; JAKCOSN WP, 1992, TRENDS CELL BIOL, V2, P104; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LENZ J, 1984, NATURE, V308, P467, DOI 10.1038/308467a0; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; PEDERSEN FS, 1981, NATURE, V292, P167, DOI 10.1038/292167a0; REDONDO JM, 1991, MOL CELL BIOL, V11, P5671, DOI 10.1128/MCB.11.11.5671; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SPECK NA, 1990, GENE DEV, V4, P233, DOI 10.1101/gad.4.2.233; THORNELL A, 1988, MOL CELL BIOL, V8, P1625, DOI 10.1128/MCB.8.4.1625; THORNELL A, 1991, J VIROL, V65, P42, DOI 10.1128/JVI.65.1.42-50.1991; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG SW, 1992, MOL CELL BIOL, V12, P89, DOI 10.1128/MCB.12.1.89; WASYLYK B, 1988, P NATL ACAD SCI USA, V85, P7952, DOI 10.1073/pnas.85.21.7952	26	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21946	21954						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408051				2022-12-27	WOS:A1993MC80900077
J	ANDERSSON, H; VONHEIJNE, G				ANDERSSON, H; VONHEIJNE, G			POSITION-SPECIFIC ASP-LYS PAIRING CAN AFFECT SIGNAL SEQUENCE FUNCTION AND MEMBRANE-PROTEIN TOPOLOGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; CHARGED AMINO-ACIDS; ESCHERICHIA-COLI; CYTOPLASMIC MEMBRANE; HYDROPHOBIC DOMAIN; SECRETORY PROTEINS; INNER MEMBRANE; EXPORT; TRANSLOCATION; RESIDUES	Positively charged amino acids are major determinants of the topology of bacterial inner membrane proteins, whereas negatively charged residues by themselves have little or no influence on the transmembrane orientation. Further, positively charged amino acids can very efficiently block the function of signal sequences when placed immediately downstream, while negatively charged residues are much less potent also in this regard. Here, we show that a negatively charged aspartic acid situated close to a positively charged lysine can attenuate both of these effects in a position-specific manner, suggesting that intra- or intermolecular charge pairing can modulate the interactions between positively charged residues in the nascent chain and parts of the secretory machinery or membrane phospholipids. These observations further underscore the importance of charged amino acids during protein translocation and membrane protein assembly.	NOVUM,KAROLINSKA INST CTR STRUCT BIOCHEM,DEPT MOLEC BIOL,S-14157 HUDDINGE,SWEDEN	Karolinska Institutet			von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; 				AKITA M, 1990, J BIOL CHEM, V265, P8164; ANDERSSON H, 1991, P NATL ACAD SCI USA, V88, P9751, DOI 10.1073/pnas.88.21.9751; ANDERSSON H, 1992, J BIOL CHEM, V267, P1491; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; DALBEY RE, 1987, SCIENCE, V235, P783, DOI 10.1126/science.3544218; DALBEY RE, 1987, J BIOL CHEM, V262, P13241; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DALBEY RE, 1991, MOL MICROBIOL, V5, P2855, DOI 10.1111/j.1365-2958.1991.tb01844.x; DEMEL RA, 1990, BIOCHIM BIOPHYS ACTA, V1027, P155, DOI 10.1016/0005-2736(90)90079-4; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAWS JK, 1989, EMBO J, V8, P2095, DOI 10.1002/j.1460-2075.1989.tb03618.x; LEE JI, 1992, J BIOL CHEM, V267, P938; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; LISS LR, 1985, J BACTERIOL, V164, P925, DOI 10.1128/JB.164.2.925-928.1985; MACINTYRE S, 1990, MOL GEN GENET, V221, P466; MOORE KE, 1987, J BIOL CHEM, V262, P8806; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; PUZISS JW, 1992, J BACTERIOL, V174, P92, DOI 10.1128/jb.174.1.92-101.1992; PUZISS JW, 1989, J BACTERIOL, V171, P2303, DOI 10.1128/jb.171.5.2303-2311.1989; SASAKI S, 1990, J BIOL CHEM, V265, P4358; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SUMMERS RG, 1989, J BIOL CHEM, V264, P20082; VONHEIJNE G, 1988, P NATL ACAD SCI USA, V85, P3363; VONHEIJNE G, 1990, PROTEIN ENG, V4, P109, DOI 10.1093/protein/4.2.109; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WICKNER W, 1988, BIOCHEMISTRY-US, V27, P1081, DOI 10.1021/bi00404a001; WOLFE PB, 1983, J BIOL CHEM, V258, P2073; WOLFE PB, 1984, CELL, V36, P1067, DOI 10.1016/0092-8674(84)90056-4; YAMANE K, 1988, J BIOL CHEM, V263, P19690; ZHU HY, 1989, J BIOL CHEM, V264, P11833	40	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21389	21393						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407979				2022-12-27	WOS:A1993MA28800107
J	SAITO, Y; PETERSON, PA; MATSUMURA, M				SAITO, Y; PETERSON, PA; MATSUMURA, M			QUANTITATION OF PEPTIDE ANCHOR RESIDUE CONTRIBUTIONS TO CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; INFLUENZA NUCLEOPROTEIN; VIRAL PEPTIDES; INTACT-CELLS; AMINO-ACIDS; MHC-BINDING; ANTIGENS; ANTIBODIES; HLA-B27; H-2K(B)	Class I major histocompatibility complex molecules play an important role in cellular immunity by presenting antigenic peptides to cytotoxic T cells. Deep polymorphic pockets in the peptide-binding groove of class I major histocompatibility complex molecules provide structural complementarity for peptide ''anchor'' side chains. However, the minimum requirements of a peptide for high-affinity binding and the contribution of anchor side chains to binding have not been determined yet. To address these issues, we have compared the affinities of various octapeptides for purified, soluble H-2K(b) molecules. The results revealed that at least 2 anchor residues are necessary for high-affinity binding, and that high-affinity binding occurs only when anchor side chains are optimally packed within the groove. The estimated free energy contribution of two anchor side chains to binding is unexpectedly large and comparable with that of peptide backbone, suggesting a crucial role of anchor residues in high-affinity, and hence specific, binding to class I molecules.	Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Scripps Research Institute					NCI NIH HHS [CA-97489] Funding Source: Medline; NIAID NIH HHS [AI-31965] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031965] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARINAGA M, 1990, SCIENCE, V250, P1657, DOI 10.1126/science.2270477; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HARLOW E, 1988, ANTIBODIES LABORATOR; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KOZLOWSKI S, 1992, J EXP MED, V175, P1417, DOI 10.1084/jem.175.6.1417; LATRON F, 1992, SCIENCE, V257, P964, DOI 10.1126/science.1380181; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATSUMURA M, 1988, NATURE, V334, P406, DOI 10.1038/334406a0; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MULLER R, 1983, METHOD ENZYMOL, V92, P589; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; PARTHAM P, 1992, NATURE, V360, P300; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHERMAN LA, 1992, J EXP MED, V175, P1221, DOI 10.1084/jem.175.5.1221; SHIBATA K, 1992, P NATL ACAD SCI USA, V89, P3135, DOI 10.1073/pnas.89.7.3135; SIBILLE C, 1990, J EXP MED, V172, P35, DOI 10.1084/jem.172.1.35; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; VANBLEEK GM, 1990, NATURE, V348, P213; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	39	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21309	21317						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407969				2022-12-27	WOS:A1993MA28800097
J	BROWN, DG; SUN, XM; COHEN, GM				BROWN, DG; SUN, XM; COHEN, GM			DEXAMETHASONE-INDUCED APOPTOSIS INVOLVES CLEAVAGE OF DNA TO LARGE FRAGMENTS PRIOR TO INTERNUCLEOSOMAL FRAGMENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CELL-DEATH; ENDONUCLEASE; ACTIVATION; THYMOCYTES; INHIBITION	Apoptosis is a major form of cell death, characterized morphologically by chromatin condensation and biochemically by endonuclease cleavage of DNA into oligonucleosomal fragments. Recently, we reported that zinc arrested dexamethasone-induced apoptosis in thymocytes at an early stage, as characterized morphologically by condensation of heterochromatin into clumps abutting the nuclear membrane. In this study, we show that zinc completely inhibits endonuclease cleavage of DNA into oligonucleosomal fragments but does not prevent the cleavage of DNA into high molecular weight fragments. These results indicate that the formation of these high molecular weight fragments, which correlates with the very early morphological features of apoptosis, is a critical event in glucocorticoid-induced apoptosis. The formation of these high molecular weight fragments, despite the inhibition by zinc of the endonuclease cleavage of DNA, suggests that key enzyme(s), other than the Ca2+/Mg2+-dependent endonuclease, are involved at the earliest stages of induction of apoptosis.	MRC, TOXICOL UNIT, WOODMANSTERNE RD, CARSHALTON SM5 4EF, SURREY, ENGLAND				Cohen, Gerald M/A-1687-2008					ANAND R, 1990, GEL ELECTROPHORESIS, P101; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; BARBIERI D, 1992, BIOCHEM BIOPH RES CO, V187, P1256, DOI 10.1016/0006-291X(92)90438-Q; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; COHEN JJ, 1984, J IMMUNOL, V132, P38; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; Kerr J.F.R., 1987, P93; RAFFRAY M, 1991, ARCH TOXICOL, V65, P135, DOI 10.1007/BF02034940; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SHIMIZU T, 1990, BIOCHEM BIOPH RES CO, V169, P1172, DOI 10.1016/0006-291X(90)92019-V; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SOLOVYAN VT, 1991, MOL BIOL+, V25, P1159; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WALKER PR, 1991, CANCER RES, V51, P1078; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1982, AM J PATHOL, V109, P78; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	23	445	457	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3037	3039						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428979				2022-12-27	WOS:A1993KM16100006
J	BLEE, E; WILCOX, AL; MARNETT, LJ; SCHUBER, F				BLEE, E; WILCOX, AL; MARNETT, LJ; SCHUBER, F			MECHANISM OF REACTION OF FATTY-ACID HYDROPEROXIDES WITH SOYBEAN PEROXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN BOND-CLEAVAGE; IRON(III) PORPHYRINS; LINOLEIC-ACID; SUBSTRATE HYDROXYLATION; DEPENDENT EPOXIDATION; LIPOXYGENASE PATHWAY; CYTOCHROME-P-450; STEREOCHEMISTRY; IDENTIFICATION; MONOOXYGENASES	13(S)-Hydroperoxyoctadeca-9(Z),11(E),15(Z)-trienoic acid (13-HPOT) was used to probe the mechanism of the hydroperoxide O-O bond cleavage catalyzed by solubilized and partially purified soybean peroxygenase. When reacted with this ferrihemoprotein, it was converted to 13(S)-hydroxyoctadeca-9(Z),11(E), 15(Z)-trienoic acid (13-HOT) and a single epoxide regioisomer, i.e. 15,16-cis-epoxy-13(S)-hydroxyoctadeca-9(Z),11(E)-dienoic acid (15,16-EHOD). In the absence of co-oxidizable substrates, such as oleic acid or thiobenzamide, this latter compound accounted for about two-thirds of the reaction products. 13-HOT and 15,16-EHOD are products of heterolytic scission of the O-O bond of 13-HPOT; no products arising by homolytic scission could be detected. Therefore, soybean peroxygenase catalyzes hydroperoxide reduction exclusively by a heterolytic mechanism leading to a ferryl-oxo complex analogous to peroxidase compound I. In similar experiments, 13(S)-hydroperoxyoctadeca-9(Z),11(E)-dienoic acid gave 13(S)-hydroxyoctadeca-9(Z),11(E)-dienoic acid and 9,10 epoxy-13(S)-hydroxyoctadec-11(E)-enoic acid. Experiments with O-18-labeled 13-HPOT indicated that about 83% of the oxygen atom incorporated into the epoxide group of 15,16-EHOD, originated from the hydroperoxide group. Moreover, using mixtures of unlabeled and O-18-labeled 13-HPOT, it was established that this transfer takes place predominantly (about 3:1) by an intramolecular process. In the intermolecular reaction 13-HOT, formed after reduction of the hydroperoxide, diffuses from the active site and, after reassociation, is epoxidized at the 15,16-double bond. A unifying mechanistic scheme, which takes into account all of the reactions catalyzed by the peroxygenase, is proposed.	INST BOT,DEPT ENZYMOL CELLULAIRE & MOLEC,INST BIOL MOLEC PLANTES,CNRS,UPR 406,F-67083 STRASBOURG,FRANCE; VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,DEPT BIOCHEM,AB HANCOCK JR MEM LAB,NASHVILLE,TN 37232; FAC PHARM ILLKIRCH,CHIM BIOORGAN LAB,CNRS,URA 1386,F-67400 ILLKIRCH GRAFFENS,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS)					NCI NIH HHS [CA 47479] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047479] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLAKE RC, 1981, J BIOL CHEM, V256, P2127; BLEE E, 1990, J BIOL CHEM, V265, P12887; BLEE E, 1987, ARCH BIOCHEM BIOPHYS, V254, P43, DOI 10.1016/0003-9861(87)90079-8; BLEE E, 1989, BIOCHEMISTRY-US, V28, P4962, DOI 10.1021/bi00438a009; BLEE E, 1990, BIOCHEM BIOPH RES CO, V173, P1354, DOI 10.1016/S0006-291X(05)80937-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUICE TC, 1988, J AM CHEM SOC, V110, P7890, DOI 10.1021/ja00231a057; CASHMAN JR, 1981, BIOCHEM BIOPH RES CO, V98, P147, DOI 10.1016/0006-291X(81)91881-7; CLAEYS M, 1985, BIOCHIM BIOPHYS ACTA, V837, P35, DOI 10.1016/0005-2760(85)90083-9; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DIX TA, 1985, J BIOL CHEM, V260, P5351; GARDNER HW, 1991, PLANT PHYSIOL, V97, P1059, DOI 10.1104/pp.97.3.1059; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; GARDNER HW, 1984, CHEM PHYS LIPIDS, V35, P87, DOI 10.1016/0009-3084(84)90015-X; GARSSEN GJ, 1976, EUR J BIOCHEM, V62, P33, DOI 10.1111/j.1432-1033.1976.tb10094.x; GIBIAN MJ, 1987, ANAL BIOCHEM, V163, P434; GRAVELAND A, 1970, J AM OIL CHEM SOC, V47, P352, DOI 10.1007/BF02639001; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAMBERG M, 1975, LIPIDS, V10, P87, DOI 10.1007/BF02532161; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V283, P409, DOI 10.1016/0003-9861(90)90662-I; HAMBERG M, 1986, BIOCHIM BIOPHYS ACTA, V877, P447, DOI 10.1016/0005-2760(86)90211-0; LABEQUE R, 1988, BIOCHEMISTRY-US, V27, P7060, DOI 10.1021/bi00418a059; LABEQUE R, 1987, J AM CHEM SOC, V109, P2828, DOI 10.1021/ja00243a048; LEE WA, 1985, J AM CHEM SOC, V107, P513, DOI 10.1021/ja00288a046; MANSUY D, 1989, EUR J BIOCHEM, V184, P267, DOI 10.1111/j.1432-1033.1989.tb15017.x; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; POULOS TL, 1980, J BIOL CHEM, V255, P8199; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; THOMPSON JA, 1989, DRUG METAB REV, V20, P365, DOI 10.3109/03602538909103548; THOMPSON JA, 1985, J BIOL CHEM, V260, P637; TRAYLOR TG, 1989, J AM CHEM SOC, V111, P8009, DOI 10.1021/ja00202a049; WHITE RE, 1980, J BIOL CHEM, V255, P1108; WHITE RE, 1991, PHARMACOL THERAPEUT, V49, P21, DOI 10.1016/0163-7258(91)90020-M; WILCOX AL, 1991, 201ST AM CHEM SOC NA	34	53	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1708	1715						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420948				2022-12-27	WOS:A1993KH62000033
J	STEGMANN, T				STEGMANN, T			INFLUENZA HEMAGGLUTININ-MEDIATED MEMBRANE-FUSION DOES NOT INVOLVE INVERTED PHASE LIPID INTERMEDIATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-CONTAINING LIPOSOMES; VESICULAR STOMATITIS-VIRUS; HEXAGONAL HII PHASE; DIPALMITOYLPHOSPHATIDYLCHOLINE VESICLES; BILAYER-MEMBRANES; L-ALPHA; LOW PH; TRANSITIONS; LAMELLAR; FLUORESCENCE	Intermediate lipid structures such as inverted micelles and interlamellar attachments, which can form near liquid crystalline lamellar (L(alpha)) to inverted hexagonal (H(II)) phase boundaries, are thought to play a role in membrane fusion. To investigate whether these structures are also involved in influenza hemagglutinin-mediated membrane fusion, measurement of fusion under conditions where such structures could not form was attempted. It was found that the fusion of influenza virus with liposomal membranes containing phosphatidylcholine and gangliosides, which cannot form H(II) phases, was only slightly slower than fusion with liposomes that also contained the H(II) competent phosphatidylethanolamine. Furthermore, the virus fused efficiently with liposomes consisting either of pure saturated phosphatidylcholines or phosphatidylcholine/ganglioside mixtures, even when the liposomal membranes were in the gel (L(beta')) phase and thus far from L(alpha)/H(II) transitions. Isolated hemagglutinin, reconstituted into dimyristoylphosphatidylcholine membranes, induced fusion with liposomes composed of dimyristoylphosphatidylcholine and gangliosides at temperatures below the L(beta') to L(alpha) phase transition temperature of dimyristoylphosphatidylcholine. This latter finding excluded the possibility that the viral lipids alone could have formed inverted phase intermediates, thus enabling them to fuse with liposomes that do not contain lipids capable of forming inverted phases. Therefore, it is concluded that structures resembling intermediates in L(alpha)/H(II) transitions are most likely not involved in influenza hemagglutinin-mediated fusion.			STEGMANN, T (corresponding author), UNIV BASEL,BIOZENTRUM,BIOPHYS CHEM ABT,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND.							BENTZ J, 1990, FEBS LETT, V276, P1, DOI 10.1016/0014-5793(90)80492-2; BENTZ J, 1987, BIOCHEMISTRY-US, V26, P2105, DOI 10.1021/bi00382a008; BENTZ J, 1991, ADV MEMBRANE FLUIDIT, V5, P259; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; BRUNNER J, 1989, FEBS LETT, V257, P369, DOI 10.1016/0014-5793(89)81574-1; BURGER KNJ, 1990, NATO ADV SCI I H-CEL, V40, P185; BURGER KNJ, 1988, BIOCHIM BIOPHYS ACTA, V939, P89, DOI 10.1016/0005-2736(88)90050-8; CHAPMAN D, 1975, Q REV BIOPHYS, V8, P185, DOI 10.1017/S0033583500001797; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; CHERNOMORDIK LV, 1985, BIOCHIM BIOPHYS ACTA, V812, P643, DOI 10.1016/0005-2736(85)90257-3; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; DOMS RW, 1985, J BIOL CHEM, V260, P2973; ELLENS H, 1990, BIOCHEMISTRY-US, V29, P9697, DOI 10.1021/bi00493a027; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P4141, DOI 10.1021/bi00362a023; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREY S, 1990, BIOCHEM J, V272, P713, DOI 10.1042/bj2720713; GAGNE J, 1985, BIOCHEMISTRY-US, V24, P4400, DOI 10.1021/bi00337a022; HARDMAN PD, 1982, EUR J BIOCHEM, V124, P95, DOI 10.1111/j.1432-1033.1982.tb05910.x; HARTER C, 1989, J BIOL CHEM, V264, P6459; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; HUI SW, 1981, NATURE, V290, P427, DOI 10.1038/290427a0; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; MAEDA T, 1981, P NATL ACAD SCI-BIOL, V78, P4133, DOI 10.1073/pnas.78.7.4133; Markin V, 1984, GEN PHYSL BIOPHYS, V5, P361; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; MEERS P, 1992, BIOCHEMISTRY-US, V31, P6372, DOI 10.1021/bi00143a003; PETRI WA, 1980, BIOCHEMISTRY-US, V19, P3088, DOI 10.1021/bi00554a039; PETRI WA, 1981, BIOCHEMISTRY-US, V20, P2796, DOI 10.1021/bi00513a014; ROCK P, 1991, BIOCHEMISTRY-US, V30, P19, DOI 10.1021/bi00215a003; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; SIEGEL DP, 1986, CHEM PHYS LIPIDS, V42, P279, DOI 10.1016/0009-3084(86)90087-3; SIEGEL DP, 1986, BIOPHYS J, V49, P1171, DOI 10.1016/S0006-3495(86)83745-6; SIEGEL DP, 1989, BIOPHYS J, V56, P161, DOI 10.1016/S0006-3495(89)82661-X; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; SIEGEL DP, 1984, BIOPHYS J, V45, P399, DOI 10.1016/S0006-3495(84)84164-8; SIEGEL DP, 1992, VIRAL FUSION MECHANI; SPRUCE AE, 1989, NATURE, V342, P555, DOI 10.1038/342555a0; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STEGMANN T, 1985, BIOCHEMISTRY-US, V24, P3107, DOI 10.1021/bi00334a006; STEGMANN T, 1989, BIOCHEMISTRY-US, V28, P1698, DOI 10.1021/bi00430a041; STEGMANN T, 1987, EMBO J, V6, P2651, DOI 10.1002/j.1460-2075.1987.tb02556.x; STEGMANN T, 1986, J BIOL CHEM, V261, P966; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; STEGMANN T, 1987, J BIOL CHEM, V262, P17744; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; STEGMANN T, 1992, IN PRESS VIRAL FUSIO; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; TSURUDOME M, 1992, J BIOL CHEM, V267, P20225; VERKLEIJ AJ, 1984, BIOCHIM BIOPHYS ACTA, V779, P43, DOI 10.1016/0304-4157(84)90003-0; VERKLEIJ AJ, 1980, BIOCHIM BIOPHYS ACTA, V600, P620, DOI 10.1016/0005-2736(80)90465-4; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WONG M, 1982, BIOCHEMISTRY-US, V21, P4126, DOI 10.1021/bi00260a032	58	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1716	1722						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420949				2022-12-27	WOS:A1993KH62000034
J	SZCZESNASKORUPA, E; KEMPER, B				SZCZESNASKORUPA, E; KEMPER, B			AN N-TERMINAL GLYCOSYLATION SIGNAL ON CYTOCHROME-P450 IS RESTRICTED TO THE ENDOPLASMIC-RETICULUM IN A LUMINAL ORIENTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CYTOCHROME-P-450; TRANSMEMBRANE PROTEINS; MICROSOMAL MEMBRANE; RECYCLING PATHWAY; GOLGI-APPARATUS; ER PROTEINS; RETENTION; IDENTIFICATION; SEQUENCE; COMPARTMENT	The mechanism of retention of cytochrome P450 in the endoplasmic reticulum is unknown, and the membrane topology of the N-terminal region remains controversial. To address these problems, a sequence of 29 amino acids encoding an internal N-glycosylation site of rabbit cytochrome P450 2C2 was attached to the N terminus of cytochrome P450 2C1. This protein is glycosylated at a single site in a cell-free translation system containing microsomal membranes, as indicated by gel mobility and sensitivity to endoglycosidase H. When expressed in COS1 cells, an immunoreactive species with the same gel mobility as the in vitro synthesized glycosylated product was detected. Treatment with endoglycosidase H changed its mobility to that of unglycosylated hybrid cytochrome P450 2C1. These results indicate that in intact cells, as in the cell-free system, the N terminus of cytochrome P450 is luminally oriented which is not consistent with a hairpin loop conformation. Sensitivity of the glycosylated protein to endoglycosidase H suggests that the protein does not reach the Golgi compartments. When transfected cells were incubated at low temperatures to inhibit retrograde transport from the intermediate pre-Golgi compartment into the endoplasmic reticulum, localization of cytochrome P450 was not changed, as assayed by subcellular fractionation and immunofluorescent staining. These observations suggest that cytochrome P450 is restricted to the endoplasmic reticulum membrane by a mechanism different from recycling through the intermediate compartment, which is a pathway utilized by soluble endoplasmic reticulum proteins.	UNIV ILLINOIS, DEPT PHYSIOL & BIOPHYS, URBANA, IL 61801 USA; UNIV ILLINOIS, COLL MED, URBANA, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign					NIGMS NIH HHS [GM 35897] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNUN S, 1980, P NATL ACAD SCI USA, V84, P5783; BERNHARDT R, 1983, BIOCHIM BIOPHYS ACTA, V745, P140, DOI 10.1016/0167-4838(83)90042-0; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BRANDS R, 1985, J CELL BIOL, V101, P1724, DOI 10.1083/jcb.101.5.1724; BROWN CA, 1989, J BIOL CHEM, V264, P4442; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0; Ingelman-Sundberg M, 1986, CYTOCHROME P450 STRU, P119; IVESSA NE, 1992, J CELL BIOL, V117, P949, DOI 10.1083/jcb.117.5.949; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KABCENELL AK, 1985, J CELL BIOL, V101, P1270, DOI 10.1083/jcb.101.4.1270; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRONBACH T, 1991, BIOCHEMISTRY-US, V30, P6097, DOI 10.1021/bi00239a003; LARSON JR, 1991, J BIOL CHEM, V266, P7321; LEIGHTON JK, 1984, BIOCHEMISTRY-US, V23, P204, DOI 10.1021/bi00297a005; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NELSON DR, 1988, J BIOL CHEM, V263, P6038; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; ROSENFELD MG, 1984, J CELL BIOL, V99, P1076, DOI 10.1083/jcb.99.3.1076; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SETHUMADHAVAN K, 1991, MOL CELL ENDOCRINOL, V78, P25, DOI 10.1016/0303-7207(91)90182-R; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; SZCZESNASKORUPA E, 1991, METHOD ENZYMOL, V206, P64; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; SZCZESNASKORUPA E, 1989, J CELL BIOL, V108, P1237, DOI 10.1083/jcb.108.4.1237; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; VERGERES G, 1991, BIOCHIM BIOPHYS ACTA, V1063, P235, DOI 10.1016/0005-2736(91)90376-J; VERGERES G, 1989, BIOCHEMISTRY-US, V28, P3650, DOI 10.1021/bi00435a005; YAMAMOTO A, 1985, J CELL BIOL, V101, P1733, DOI 10.1083/jcb.101.5.1733; ZHAO J, 1990, DNA CELL BIOL, V9, P37, DOI 10.1089/dna.1990.9.37	42	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1757	1762						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420952				2022-12-27	WOS:A1993KH62000040
J	HORREVOETS, AJG; TANS, G; SMILDE, AE; VANZONNEVELD, AJ; PANNEKOEK, H				HORREVOETS, AJG; TANS, G; SMILDE, AE; VANZONNEVELD, AJ; PANNEKOEK, H			THROMBIN-VARIABLE REGION-1 (VR1) - EVIDENCE FOR THE DOMINANT CONTRIBUTION OF VR1 OF SERINE PROTEASES TO THEIR INTERACTION WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HEPARIN COFACTOR-II; HUMAN ALPHA-THROMBIN; CRYSTAL-STRUCTURE; VACCINIA VIRUS; REACTIVE SITE; VITRONECTIN; PROTHROMBIN; ACID; SPECIFICITY; POLYMERASE	The importance of a specific variable region in different serine proteases for the interaction with plasminogen activator inhibitor 1 (PAI-1) is studied. To that end, we have constructed a thrombin substitution variant, thrombin-VR1, in which the entire variable region 1 (VR1) of the protease domain (Phe-34 to Leu-40) has been replaced by the corresponding sequence (Phe-294 to Phe-305) of tissue-type plasminogen activator. The substitution resulted in a 2000-fold increase of the second-order rate constant of inhibition by PAI-1 (k2 = 2.2 x 10(6) M-1 s-1) as compared to alpha-thrombin (k2 = 1.1 x 10(3) M-1 s-1). Inhibition of thrombin-VR1 by PAI-1 is mediated by the formation of SDS-stable, enzyme-inhibitor complexes. The substitution did not affect the rate constant of inhibition by antithrombin III, whereas clotting efficiency and the rate of inhibition by heparin cofactor II were decreased 3-fold. These results demonstrate the importance and specificity of the protease domain VR1 region for the interaction of PAI-1 with its target proteases.	NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT MOLEC BIOL,PLESMANLAAN 125,1066 CX AMSTERDAM,NETHERLANDS				van Zonneveld, Anton Jan/D-8060-2018	van Zonneveld, Anton Jan/0000-0002-1676-7738				ADAMS DS, 1991, J BIOL CHEM, V266, P8476; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; DEGEN SJF, 1983, BIOCHEMISTRY-US, V22, P2087, DOI 10.1021/bi00278a008; DEGRYSE E, 1990, Thrombosis Research, V60, P433; DERECHIN VM, 1990, J BIOL CHEM, V265, P5623; EHRLICH HJ, 1991, J CELL BIOL, V115, P1773, DOI 10.1083/jcb.115.6.1773; EHRLICH HJ, 1991, BIOCHEMISTRY-US, V30, P1021, DOI 10.1021/bi00218a020; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; FERSHT A, 1984, ENZYME STRUCTURE MEC, P176; FURIE B, 1982, J BIOL CHEM, V257, P3875; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JACKMAN MP, 1992, J BIOL CHEM, V267, P15375; KEIJER J, 1991, BLOOD, V78, P1254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS SD, 1987, BIOCHEMISTRY-US, V26, P7597, DOI 10.1021/bi00398a010; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; RHEE MJ, 1982, BIOCHEMISTRY-US, V21, P3437, DOI 10.1021/bi00257a029; RUSSO G, 1991, BIOTECHNOL APPL BIOC, V14, P222; STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; VANDEERLIN VMD, 1991, J BIOL CHEM, V266, P20223; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0	27	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					779	782						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419354				2022-12-27	WOS:A1993KG07700007
J	JONSSON, CB; DONZELLA, GA; ROTH, MJ				JONSSON, CB; DONZELLA, GA; ROTH, MJ			CHARACTERIZATION OF THE FORWARD AND REVERSE INTEGRATION REACTIONS OF THE MOLONEY MURINE LEUKEMIA-VIRUS INTEGRASE PROTEIN PURIFIED FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV DNA INTEGRATION; RETROVIRAL DNA; VIRAL-DNA; INVITRO; POL; SEQUENCE; BINDING; PURIFICATION; CLEAVAGE; GENES	The forward and reverse reactions for integration were characterized for the Moloney murine leukemia virus integrase (M-MuLV IN) protein. The M-MuLV IN was recombinantly produced in Escherichia coli, and was purified to greater than 90% homogeneity by a one-step affinity purification scheme. M-MuLV IN was highly active for integration as measured by in vitro cleavage and strand transfer assays. Furthermore, the integration of a model viral substrate into lambda concatamers by IN correctly produced the flanking 4-base pair duplications characteristic of M-MuLV IN. The reverse reaction of integration, disintegration, was also catalyzed by the recombinant M-MuLV IN. Two products were generated, a 3'-recessed long terminal repeat and a ligated target DNA, from a model integration-intermediate substrate in the presence of M-MuLV IN. The requirements and optimal conditions for maximal integration and disintegration activity for M-MuLV IN were determined. The forward and reverse reactions required different concentrations of manganese ion and reductant. Salt was also titrated for the forward and reverse reactions. Sodium chloride inhibited integration, but had little affect on disintegration. Low concentrations of potassium chloride enhanced integration, but had no affect on disintegration. The dinucleotide cleavage, strand transfer, and the disintegration reactions each had a unique pH profile of activity.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center			Jonsson, Colleen/GPC-4424-2022; Roth, Monica/AAN-8742-2020	Jonsson, Colleen/0000-0002-2640-7672; 				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; DONEHOWER LA, 1988, J VIROL, V62, P3958, DOI 10.1128/JVI.62.11.3958-3964.1988; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; FUJIWARA T, 1989, P NATL ACAD SCI USA, V86, P3065, DOI 10.1073/pnas.86.9.3065; GOFF SP, 1987, BIOCHIM BIOPHYS ACTA, V907, P93, DOI 10.1016/0304-419X(87)90001-1; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; KULKOSKY J, 1990, J ACQ IMMUN DEF SYND, V3, P839; LIN TH, 1989, PROTEINS, V5, P156, DOI 10.1002/prot.340050210; ROTH MJ, 1991, J VIROL, V65, P2141, DOI 10.1128/JVI.65.4.2141-2145.1991; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; ROTH MJ, 1988, J MOL BIOL, V203, P131, DOI 10.1016/0022-2836(88)90097-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANESE N, 1986, J VIROL, V59, P328, DOI 10.1128/JVI.59.2.328-340.1986; TERRY R, 1988, J VIROL, V62, P2358, DOI 10.1128/JVI.62.7.2358-2365.1988; VANGENT DC, 1991, NUCLEIC ACIDS RES, V19, P3821, DOI 10.1093/nar/19.14.3821; VARMUS H, 1984, RNA TUMOR VIRUSES, P369; VARMUS H, 1989, MOBILE DNA, P53; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	33	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1462	1469						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419346				2022-12-27	WOS:A1993KG07700104
J	BARBOUR, SE; DENNIS, EA				BARBOUR, SE; DENNIS, EA			ANTISENSE INHIBITION OF GROUP-II PHOSPHOLIPASE-A(2) EXPRESSION BLOCKS THE PRODUCTION OF PROSTAGLANDIN-E(2) BY P388D(1) CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2; ARACHIDONOYL-HYDROLYZING PHOSPHOLIPASE-A2; MEMBRANE-ASSOCIATED PHOSPHOLIPASE-A2; RAT PLATELET PHOSPHOLIPASE-A2; MESSENGER-RNA SYNTHESIS; 2 DISTINCT MECHANISMS; SMOOTH-MUSCLE CELLS; EXTRACELLULAR PHOSPHOLIPASE-A2; ALVEOLAR MACROPHAGES	Macrophage-like P388D1 cells release [H-3]arachidonic acid and produce prostaglandin E2 (PGE2) upon stimulation with bacterial lipopolysaccharide (LPS) and platelet-activating factor (PAF). To determine whether group II phospholipase A2 (PLA2) is involved in this release, we treated P388D, cells with antisense inhibitors specific for group II PLA2 RNA. Treatment with oligonucleotide ASGII decreased PLA2 activity in P388D1 cell homogenates by approximately 60% and reduced the release of [H-3]arachidonic acid and PGE2 from activated cells to nearly resting cell levels. The inhibition by antisense oligonucleotide ASGII was blocked when its sense complement, SGII, was included in the incubation mixture. Stably transfected P388D1 cells expressing an antisense construct for group II PLA2 also produced reduced quantities of PGE2 in response to LPS and PAF. These data suggest that prostaglandin production by activated P388D1 cells involves phospholipid hydrolysis by group II PLA2. Oligonucleotide ASGII also blocked the appearance of a heparin-releasable group II PLA2 in the culture supernatants of P388D, cells. The disappearance of this protein correlated with reduced PGE2 production by activated cells, indicating that an extracellular heparin-associated pool of groUP II PLA2 is involved in prostaglandin production by P388D1 cells.	UNIV CALIF SAN DIEGO, DEPT CHEM, 0601, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego			Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015279] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 26171] Funding Source: Medline; NIGMS NIH HHS [GM 15279] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADEREM AA, 1986, J EXP MED, V164, P165, DOI 10.1084/jem.164.1.165; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CROWL RM, 1991, J BIOL CHEM, V266, P2647; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; Dennis EA, 1983, ENZYMES, P307; DICCIANNI MB, 1991, BIOCHEMISTRY-US, V30, P9090, DOI 10.1021/bi00101a026; FU JY, 1990, J BIOL CHEM, V265, P16737; GLASER KB, 1990, J BIOL CHEM, V265, P8658; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; HANASAKI K, 1992, J BIOL CHEM, V267, P6414; HARA S, 1991, J BIOCHEM, V110, P163, DOI 10.1093/oxfordjournals.jbchem.a123550; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HOFFMAN T, 1992, BIOCHEM PHARMACOL, V44, P955, DOI 10.1016/0006-2952(92)90128-6; HULKOWER KI, 1992, BIOCHEM BIOPH RES CO, V184, P712, DOI 10.1016/0006-291X(92)90648-5; INADA M, 1991, BIOCHEM BIOPH RES CO, V174, P1077, DOI 10.1016/0006-291X(91)91530-P; ISHIZAKI J, 1989, BIOCHEM BIOPH RES CO, V162, P1030, DOI 10.1016/0006-291X(89)90777-8; IYER RP, 1990, J AM CHEM SOC, V112, P1253, DOI 10.1021/ja00159a059; KNAUER MF, 1990, J CELL PHYSIOL, V142, P469, DOI 10.1002/jcp.1041420305; KOMADA M, 1989, J BIOCHEM-TOKYO, V106, P545, DOI 10.1093/oxfordjournals.jbchem.a122890; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; KUDO I, 1989, DERMATOLOGICA, V179, P72, DOI 10.1159/000248454; KURIHARA H, 1991, BIOCHIM BIOPHYS ACTA, V1082, P285, DOI 10.1016/0005-2760(91)90204-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1992, J BIOL CHEM, V267, P25934; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LYONSGIORDANO B, 1989, BIOCHEM BIOPH RES CO, V164, P488, DOI 10.1016/0006-291X(89)91746-4; MARSHALL LA, 1992, BIOCHEM PHARMACOL, V44, P1849, DOI 10.1016/0006-2952(92)90081-S; McLean L R, 1986, Methods Enzymol, V129, P738; MOHRI M, 1990, J IMMUNOL, V144, P2678; MURAKAMI M, 1989, BIOCHIM BIOPHYS ACTA, V1005, P270; MURAKAMI M, 1992, EUR J BIOCHEM, V209, P257, DOI 10.1111/j.1432-1033.1992.tb17284.x; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; NAKANO T, 1990, FEBS LETT, V273, P23, DOI 10.1016/0014-5793(90)81042-M; NEALE ML, 1988, IMMUNOLOGY, V64, P81; OKA S, 1991, J BIOL CHEM, V266, P9956; ONO T, 1988, J BIOL CHEM, V263, P5732; OSULLIVAN MG, 1992, J BIOL CHEM, V267, P14547; OSULLIVAN MG, 1992, BIOCHEM BIOPH RES CO, V187, P1123, DOI 10.1016/0006-291X(92)91313-F; PERNAS P, 1991, BIOCHEM BIOPH RES CO, V178, P1298, DOI 10.1016/0006-291X(91)91035-B; REYNOLDS LJ, 1991, METHOD ENZYMOL, V197, P3; ROSS MI, 1985, ARCH BIOCHEM BIOPHYS, V238, P247, DOI 10.1016/0003-9861(85)90162-6; Sambrook J, 1989, MOL CLONING LABORATO; SAUTES C, 1992, IMMUNOL RES, V11, P181, DOI 10.1007/BF02919125; SCHALKWIJK C, 1991, BIOCHEM BIOPH RES CO, V174, P268, DOI 10.1016/0006-291X(91)90515-9; SCHALKWIJK CG, 1992, EUR J BIOCHEM, V210, P169, DOI 10.1111/j.1432-1033.1992.tb17405.x; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SPAARGAREN M, 1992, BIOCHEM J, V287, P37, DOI 10.1042/bj2870037; Stout J T, 1987, Methods Enzymol, V151, P519; ULEVITCH RJ, 1988, J BIOL CHEM, V263, P3079; WASHBURN WN, 1991, J BIOL CHEM, V266, P5042; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; WIJKANDER J, 1991, EUR J BIOCHEM, V202, P873, DOI 10.1111/j.1432-1033.1991.tb16445.x; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675; YU L, 1990, J BIOL CHEM, V265, P2657	63	170	170	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21875	21882						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408042				2022-12-27	WOS:A1993MC80900067
J	STRAUB, P; LLOYD, M; JOHNSON, EF; KEMPER, B				STRAUB, P; LLOYD, M; JOHNSON, EF; KEMPER, B			CASSETTE MUTAGENESIS OF A POTENTIAL SUBSTRATE RECOGNITION REGION OF CYTOCHROME-P450-2C2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID 21-HYDROXYLASE DEFICIENCY; SITE-DIRECTED MUTAGENESIS; AMINO-ACID; CATALYTIC ACTIVITY; ELECTRON-TRANSFER; EXPRESSION; DEBRISOQUINE; MUTATIONS; PROTEINS; MEMBRANE	Cassette mutagenesis was used to analyze the effects of mutations at amino acid positions 107-120 in cytochrome P450 2C2 which are part of a predicted substrate recognition site, SRS-1 (Gotoh, O. (1992) J. BioL Chem. 267, 83-90), and terminate with a highly conserved tryptophan. All the mutant enzymes were expressed in COS1 cells at approximately the same level as wild type as determined by immunoprecipitation of radiolabeled products. Substitutions of amino acids from 107 to 110 and from 116 to 119 resulted in mutant enzymes that retained substantial lauric acid hydroxylase activity suggesting that these residues are not critical determinants of substrate specificity. In contrast, amino acids 112-115 were characterized by strong decreases in activity in at least one mutation tested. A substitution of phenylalanine for valine 112 reduced activity about 3-fold. At position 113, substitution of leucine for isoleucine had little effect, but activity was reduced 15-fold by substitution with cysteine. A conservative mutation at position 114 reduced activity 5-fold, a nonconservative mutation at position 115 resulted in a 30-fold reduction of lauric acid hydroxylation. Substitution of glutamic acid for glycine at position 109 had little effect on activity, while more conservative substitutions of valine for glycines at positions 111 and 117 resulted in about 50- and 7-fold reductions of activity, respectively. Substitution of leucine for tryptophan 120 resulted in a 7-fold reduction of activity indicating that tryptophan at this position contributes to, but is not essential for, enzymatic activity in spite of its presence in nearly all eukaryotic cytochromes P450. The results are consistent with a model in which amino acids 112-114, and possibly 115, align with a loop of bacterial P450cam sequence containing substrate contacting amino acids, tyrosine 96 and phenylalanine 98. Glycines at either end of the loop in cytochrome P450 2C2 appear to be critical for activity.	UNIV ILLINOIS, DEPT PHYSIOL & BIOPHYS, 524 BURRILL HALL, 407 S GOODWIN AVE, URBANA, IL 61801 USA; SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM NX4, LA JOLLA, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute					NIGMS NIH HHS [GM31001, GM35897] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001, R01GM035897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BALDWIN JE, 1991, P ROY SOC B-BIOL SCI, V245, P43, DOI 10.1098/rspb.1991.0086; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; CHIOU SH, 1990, J BIOL CHEM, V265, P3549; CHRISTOU M, 1992, BIOCHEMISTRY-US, V31, P2835, DOI 10.1021/bi00125a027; DAVIES MD, 1992, BIOCHEMISTRY-US, V31, P11383, DOI 10.1021/bi00161a016; EDWARDS RJ, 1989, BIOCHEMISTRY-US, V28, P3762, DOI 10.1021/bi00435a021; GOTOH O, 1992, J BIOL CHEM, V267, P83; GUENGERICH FP, 1987, MAMMALIAN CYTOCHROME, V1; HALPERT JR, 1993, J BIOL CHEM, V268, P4453; JOHNSON EF, 1992, FASEB J, V6, P700, DOI 10.1096/fasebj.6.2.1537459; JOHNSON EF, 1990, BIOCHEMISTRY-US, V29, P873, DOI 10.1021/bi00456a004; KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209; KRONBACH T, 1989, P NATL ACAD SCI USA, V86, P8262, DOI 10.1073/pnas.86.21.8262; KRONBACH T, 1991, BIOCHEMISTRY-US, V30, P6097, DOI 10.1021/bi00239a003; KRONBACH T, 1991, J BIOL CHEM, V266, P6215; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; LEWIS DFV, 1992, J COMPUT AID MOL DES, V6, P235, DOI 10.1007/BF00123379; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; MATSUNAGA E, 1990, J BIOL CHEM, V265, P17197; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; NELSON DR, 1988, J BIOL CHEM, V263, P6038; NELSON DR, 1989, BIOCHEMISTRY-US, V28, P656, DOI 10.1021/bi00428a036; OLIPHANT AR, 1987, METHOD ENZYMOL, V155, P568; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1991, METHOD ENZYMOL, V206, P11; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAYTON PS, 1990, BIOCHEMISTRY-US, V29, P7381, DOI 10.1021/bi00484a005; STAYTON PS, 1991, BIOCHEMISTRY-US, V30, P1845, DOI 10.1021/bi00221a017; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074; ZVELEBIL MJJ, 1991, PROTEIN ENG, V4, P172	36	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21997	22003						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408056				2022-12-27	WOS:A1993MC80900084
J	LIM, MY; DAILEY, D; MARTIN, GS; THORNER, J				LIM, MY; DAILEY, D; MARTIN, GS; THORNER, J			YEAST MCK1 PROTEIN-KINASE AUTOPHOSPHORYLATES AT TYROSINE AND SERINE BUT PHOSPHORYLATES EXOGENOUS SUBSTRATES AT SERINE AND THREONINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK-1 GENE-PRODUCT; MAP KINASE; SACCHAROMYCES-CEREVISIAE; CONSERVED FEATURES; IDENTIFICATION; PURIFICATION; ACTIVATION; RECEPTOR; ENCODES; DOMAIN	The product of the Saccharomyces cerevisiae MCK1 gene is a protein kinase that phosphorylates poly (Glu,Tyr) in vitro and is itself phosphorylated at both tyrosine and serine in vivo. To characterize the substrate specificity of Mck1, the enzyme was purified to apparent homogeneity from the soluble fraction of yeast cell extracts by ammonium sulfate precipitation, followed by ion exchange chromatography (Q- and S-Sepharose), dye-ligand affinity chromatography (Orange A-agarose), adsorption chromatography (hydroxylapatite), and ion exchange fast protein liquid chromatography (Mono-S). In the absence of an exogenous substrate, purified Mck1 was able to autophosphorylate on tyrosine and serine. A catalytically inactive mutant (K68R in conserved kinase domain II) expressed in an mck1DELTA strain did not contain detectable phosphotyrosine, confirming that the tyrosine phosphorylation observed in vivo is due to autophosphorylation, but did contain phosphoserine, suggesting that Mck1 is a target for other cellular protein kinases. Purified Mck1 phosphorylated a variety of proteins in heat-inactivated yeast extracts, primarily on serine (and threonine). The purified enzyme also used a number of mammalian proteins as phosphoacceptors, including myelin basic protein (MBP), microtubule-associated protein 2 (MAP-2), and tau protein. All of these substrates were phosphorylated on either serine or threonine (or both). Mck1 isolated from yeast extracts by immunoprecipitation with an anti-Mck1 antibody directed against its C terminus also phosphorylated MBP at serine. In the same immune complex kinase assay, the K68R mutant did not detectably phosphorylate MBP, indicating that the serine-specific phosphotransferase activity of Mck1 is intrinsic and not due to contamination by an associated kinase. These findings demonstrate that Mck1 is a member of a novel class of protein kinases that displays the ability to phosphorylate all three hydroxyamino acids in proteins.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL, RM 401,BARKER HALL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley			THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044173, R37GM021841, R01GM021841] Funding Source: NIH RePORTER; NCI NIH HHS [CA09041] Funding Source: Medline; NIGMS NIH HHS [GM44173, GM21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN S, 1984, J BIOL CHEM, V259, P2051; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; DAILEY D, 1990, MOL CELL BIOL, V10, P6244, DOI 10.1128/MCB.10.12.6244; DAILEY D, 1991, MOL CELL BIOL, V11, P2333; DAILEY D, 1992, THESIS U CALIFORNIA; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; LORINCZ AT, 1986, MOL CELL BIOL, V6, P4099; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; SCHIEVEN G, 1988, J BIOL CHEM, V263, P15590; SCHIEVEN G, 1986, SCIENCE, V231, P390, DOI 10.1126/science.2417318; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SEGER R, 1992, J BIOL CHEM, V267, P14373; SHERMAN F, 1986, LABORATORY COURSE MA; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987	47	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21155	21164						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407952				2022-12-27	WOS:A1993MA28800077
J	PARSONAGE, D; MILLER, H; ROSS, RP; CLAIBORNE, A				PARSONAGE, D; MILLER, H; ROSS, RP; CLAIBORNE, A			PURIFICATION AND ANALYSIS OF STREPTOCOCCAL NADH PEROXIDASE EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN REDOX CENTER; FAECALIS 10C1; MECHANISM; CLONING	Using the T7 RNA polymerase expression system, a modified plasmid vector has been developed which gives reliable, high level expression in Escherichia coli of the gene encoding streptococcal NADH peroxidase. The recombinant enzyme has been purified to homogeneity using a revised protocol which yields over 35 mg of pure protein per liter of culture. Recombinant NADH peroxidase is fully active and exhibits spectroscopic and redox properties identical to those for the enzyme purified from Streptococcus faecalis 10C1. Reductive titrations and thiol analyses confirm the presence of the unusual cysteine-sulfenic acid (Cys-SOH) redox center identified previously. N-terminal sequence analysis, analytical gel filtration, and preliminary x-ray diffraction data all confirm the structural identity of the recombinant and S. faecalis enzymes. Steady-state kinetic analysis of the peroxidase, coupled with results from static titration experiments is consistent with a limiting type of ternary complex mechanism and allows the determination of many of the corresponding kinetic constants. In addition, preliminary H-1 NMR spectra of the enzyme at millimolar concentrations show good dispersion in the amide region and indicate that the recombinant peroxidase is suitable for one-dimensional NMR work with labeled amino acids.			PARSONAGE, D (corresponding author), WAKE FOREST UNIV,MED CTR,DEPT BIOCHEM,MED CTR BLVD,WINSTON SALEM,NC 27157, USA.		Ross, Paul/A-7584-2015; Miller, Holly/I-6942-2015	Ross, Paul/0000-0003-4876-8839; Miller, Holly/0000-0002-9076-5335	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035394] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35394] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CLAIBORNE A, 1992, TRENDS BIOCHEM SCI, V17, P183, DOI 10.1016/0968-0004(92)90263-9; Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, DOI 10.1016/C2013-0-04130-8; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; DOLIN MI, 1982, EXPERIENCES BIOCH PE, P293; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MILLER H, 1990, J BIOL CHEM, V265, P9857; Palmer G, 1968, BIOL OXIDATIONS, P263; POOLE LB, 1989, J BIOL CHEM, V264, P12322; POOLE LB, 1989, J BIOL CHEM, V264, P12330; POOLE LB, 1986, J BIOL CHEM, V261, P4525; POOLE LB, 1988, BIOCHEM BIOPH RES CO, V153, P261; ROSS RP, 1992, J MOL BIOL, V227, P658, DOI 10.1016/0022-2836(92)90215-6; ROSS RP, 1991, J MOL BIOL, V221, P857, DOI 10.1016/0022-2836(91)80180-3; STEHLE T, 1991, J MOL BIOL, V221, P1325, DOI 10.1016/0022-2836(91)90936-Z; STOLL VS, 1988, ARCH BIOCHEM BIOPHYS, V260, P752, DOI 10.1016/0003-9861(88)90505-X; STOLL VS, 1991, BIOCHEMISTRY-US, V30, P942, DOI 10.1021/bi00218a009; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	18	50	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3161	3167						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428993				2022-12-27	WOS:A1993KM16100025
J	KUNAPULI, SP; DELACADENA, RA; COLMAN, RW				KUNAPULI, SP; DELACADENA, RA; COLMAN, RW			DELETION MUTAGENESIS OF HIGH-MOLECULAR-WEIGHT KININOGEN LIGHT CHAIN - IDENTIFICATION OF 2 ANIONIC SURFACE BINDING SUBDOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XII HAGEMAN-FACTOR; PLASMA PREKALLIKREIN; BLOOD-COAGULATION; ESCHERICHIA-COLI; MEDIATED ACTIVATION; HMW KININOGEN; EXPRESSION; GENE; KALLIKREIN; PROTEIN	The light chain (LC) of cleaved high molecular weight kininogen (HK) binds to anionic surfaces as well as the zymogens prekallikrein and factor XI and thus accelerates activation of the kallikrein-kinin, fibrinolytic, and coagulation pathways. The binding sites on HK LC for factor XI (amino acid residues 574631) and prekallikrein (residues 583-613) have been localized to domain 6. Domain 5 (residues 438-520) has been postulated to contain the anionic surface binding subdomain. In order to define this subdomain we have expressed HK LC (residues Lys438-Ser644) as a fusion protein with glutathione-S-transferase (GST) in Escherichia coli and generated various HK LC deletion mutants. The recombinant HK LC (rHK LC) and various HK LC fragments were purified as GST fusion proteins by glutathione-Sepharose affinity chromatography from bacterial cell extracts. The rHK LC and recombinant fragments His459-Ser644, Glu466-Ser644, Leu483-Ser644, His493-Ser644, Lys438-Asp492, Lys438-Ser531, and His493-Lys520 inhibited I-125-HKa binding to kaolin, a model anionic surface used in the contact system, in a concentration-dependent manner. Deletion mutant proteins lacking domain 5, Thr521-Ser644 and Ser583-Ser644, did not inhibit the radiolabeled HKa binding to kaolin. The rHK LC and recombinant fragments Lys438-Asp492, Lys438-Ser531, His493-Ser644, His493-Lys520, Thr521-Ser644, and Ser583-Ser644 were radiolabeled with I-125 and were then tested for their ability to bind to kaolin in the presence of fibrinogen and albumin. Except for the Thr521-Ser644 and Ser583-Ser644 fragments, all other radiolabeled HK LC deletion mutant proteins and rHK LC bound to kaolin in a concentration-dependent manner. This binding to kaolin was specific since it was inhibited by the addition of excess unlabeled HKa. The rHK LC, His493-Ser644 and DELTA493-520 HK LC have coagulant activity, while other deletion mutant proteins did not exhibit coagulant properties. We conclude that there are at least two anionic surface binding subdomains, one in the histidine-glycine-rich region (Lys438-Asp492) and the other in the histidine-glycine-lysine-rich region (His493-Lys520), in the domain 5 of HK LC. Either subdomain, in the presence of the zymogen binding domain 6, is sufficient to impart coagulant activity to HK LC, while the presence of both did not increase the coagulant activity of HK LC additively.			KUNAPULI, SP (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,SOL SHERRY THROMBOSIS RES CTR,PHILADELPHIA,PA 19140, USA.				NCRR NIH HHS [S07 RR05417] Funding Source: Medline; NHLBI NIH HHS [HL02681, HL45486] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL045486, K08HL002681] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOCK PE, 1985, J BIOL CHEM, V260, P2434; COCHRANE CG, 1973, J EXP MED, V138, P1564, DOI 10.1084/jem.138.6.1564; DELACADENA RA, 1992, PROTEIN SCI, V1, P151; DELACADENA RA, 1990, CLIN RES, V38, P267; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FREYRIA AM, 1987, INT ARCH ALLER A IMM, V83, P341, DOI 10.1159/000234366; GUSTAFSON EJ, 1986, J CLIN INVEST, V78, P310, DOI 10.1172/JCI112567; GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377; HEIMARK RL, 1980, NATURE, V286, P456, DOI 10.1038/286456a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IKARI N, 1981, J BIOCHEM, V89, P1699, DOI 10.1093/oxfordjournals.jbchem.a133370; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KANAPULI SP, 1992, THROMB HAEMOSTASIS, V67, P428; KITAGAWA H, 1987, J BIOL CHEM, V262, P2190; KITAMURA N, 1985, J BIOL CHEM, V260, P8610; KITAMURA N, 1983, NATURE, V305, P545, DOI 10.1038/305545a0; KOLAND JG, 1990, BIOCHEM BIOPH RES CO, V166, P90, DOI 10.1016/0006-291X(90)91915-F; MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754; MORI K, 1981, J BIOCHEM-TOKYO, V89, P1465, DOI 10.1093/oxfordjournals.jbchem.a133339; MULLERESTERL W, 1986, TRENDS BIOCHEM SCI, V11, P336, DOI 10.1016/0968-0004(86)90293-8; PIXLEY RA, 1992, AM J PATHOL, V140, P897; PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212; RATNOFF OD, 1983, BLOOD, V61, P132; RETZIOS AD, 1987, J BIOL CHEM, V262, P3074; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmaier AH, 1987, HEMOSTASIS THROMBOSI, P18; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUGO T, 1980, BIOCHEMISTRY-US, V19, P3215, DOI 10.1021/bi00555a018; TAIT JF, 1986, J BIOL CHEM, V261, P5396; TAIT JF, 1987, J BIOL CHEM, V262, P11651; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; TALLARIDA RJ, 1987, MANUAL PHARM CALCULA, P10; TANS G, 1983, J BIOL CHEM, V258, P8215; THOMPSON RE, 1979, P NATL ACAD SCI USA, V76, P4862, DOI 10.1073/pnas.76.10.4862; THOMPSON RE, 1978, J EXP MED, V147, P488, DOI 10.1084/jem.147.2.488; VOGEL R, 1990, J BIOL CHEM, V265, P12494; VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5; WACHTFOGEL YT, 1989, BLOOD, V73, P468; WACHTFOGEL YT, 1987, BLOOD, V69, P324; WACHTFOGEL YT, 1991, THROMB HAEMOSTASIS, V65, P46	44	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2486	2492						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428925				2022-12-27	WOS:A1993KK81500038
J	NARANDA, T; REMACHA, M; BALLESTA, JPG				NARANDA, T; REMACHA, M; BALLESTA, JPG			THE ACTIVITY-CONTROLLING PHOSPHORYLATION SITE IS NOT THE SAME IN THE 4 ACIDIC RIBOSOMAL-PROTEINS FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI; ARTEMIA-SALINA; RAT-LIVER; MONOCLONAL-ANTIBODIES; EUKARYOTIC CELLS; 60S RIBOSOMES; YEAST; SUBUNIT; SEQUENCE	By using site-directed mutagenesis and chemical analysis of phosphopeptides, a unique phosphorylation site has been shown at serine 73 in the amino acid sequence of the Saccharomyces cerevisiae acidic ribosomal protein YP1beta(L44'). The mutation in this position prevents in vitro phosphorylation by protein kinases that modify the wild-type polypeptide. The unphosphorylatable mutated protein is unable to bind to the ribosomes and to rescue the growth deficiency of yeast strains in which the corresponding original gene is inactivated by gene disruption. Sequencing of tryptic phosphopeptides has shown that acidic proteins YP1alpha and YP2alpha(L44) are also phosphorylated at positions near the carboxyl end. These results contrast with the data indicating that in the highly homologous protein YP2beta, phosphorylation takes place at serine 19, close to the amino terminus. The results show that phosphorylation is definitely required for the biological activity of these ribosomal proteins. However, the differences in the phosphorylation sites suggest that the effect of this modification is not the same in all of them, confirming the heterologous role of these peculiar ribosomal components. In fact, the different context of the modification sites in the four polypeptides suggests the existence of more than one protein kinase specific for this set of proteins.			NARANDA, T (corresponding author), UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC SEVERO OCHOA, CANTO BLANCO, E-28049 MADRID, SPAIN.		Remacha, Miguel/G-1250-2016					AMONS R, 1979, FEBS LETT, V104, P85, DOI 10.1016/0014-5793(79)81089-3; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BIELKA H, 1982, EUKARYOTIC RIBOSOME; CORREAS I, 1992, J BIOL CHEM, V267, P15721; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; GIRSHOVICH AS, 1986, FEBS LETT, V197, P192, DOI 10.1016/0014-5793(86)80325-8; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; HASLER P, 1991, J BIOL CHEM, V266, P13815; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Juan Vidales F, 1981, Biochem Biophys Res Commun, V98, P717, DOI 10.1016/0006-291X(81)91172-4; JUANVIDALES F, 1984, BIOCHEMISTRY-US, V23, P390; JUANVIDALES F, 1981, BIOCHIM BIOPHYS ACTA, V656, P28; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KUDLICKI W, 1980, BIOCHIM BIOPHYS ACTA, V633, P376, DOI 10.1016/0304-4165(80)90196-8; LILJAS A, 1991, INT REV CYTOL, V124, P103; LIN A, 1982, J BIOL CHEM, V257, P9189; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; MACCONNELL WP, 1982, J BIOL CHEM, V257, P5359; MITSUI K, 1989, BIOCHEM BIOPH RES CO, V161, P1001, DOI 10.1016/0006-291X(89)91342-9; MITSUI K, 1988, J BIOCHEM-TOKYO, V104, P908, DOI 10.1093/oxfordjournals.jbchem.a122581; MITSUI K, 1988, NUCLEIC ACIDS RES, V16, P3575, DOI 10.1093/nar/16.8.3575; MOLLER W, 1975, P NATL ACAD SCI USA, V72, P4744, DOI 10.1073/pnas.72.12.4744; MORINAGA Y, 1984, BIO-TECHNOL, V2, P636, DOI 10.1038/nbt0784-636; NARANDA T, 1991, P NATL ACAD SCI USA, V88, P10563, DOI 10.1073/pnas.88.23.10563; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; OLSON HM, 1986, J BIOL CHEM, V261, P6924; PILECKI M, 1992, EUR J BIOCHEM, V206, P259, DOI 10.1111/j.1432-1033.1992.tb16924.x; QIAN S, 1987, NUCLEIC ACIDS RES, V15, P987, DOI 10.1093/nar/15.3.987; REMACHA M, 1990, MOL CELL BIOL, V10, P2182, DOI 10.1128/MCB.10.5.2182; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1988, J BIOL CHEM, V263, P9094; REYES R, 1977, EUR J BIOCHEM, V73, P25, DOI 10.1111/j.1432-1033.1977.tb11288.x; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SAENZROBLES MT, 1988, EUR J BIOCHEM, V177, P531, DOI 10.1111/j.1432-1033.1988.tb14405.x; Sambrook J, 1989, MOL CLONING LABORATO; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANCHEZMADRID F, 1981, BIOCHEMISTRY-US, V20, P3263, DOI 10.1021/bi00514a043; SANCHEZMADRID F, 1981, EUR J BIOCHEM, V114, P609, DOI 10.1111/j.1432-1033.1981.tb05187.x; SCHIJMAN AG, 1990, NUCLEIC ACIDS RES, V18, P3399, DOI 10.1093/nar/18.11.3399; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; TRAUT RR, 1983, J BIOL CHEM, V258, P4592; TSURUGI K, 1978, J BIOL CHEM, V253, P946; VANAGTHOVEN A, 1978, EUR J BIOCHEM, V91, P553; VANAGTHOVEN AJ, 1977, BIOCHEM BIOPH RES CO, V77, P989, DOI 10.1016/S0006-291X(77)80075-2; VAZQUEZ MP, 1992, NUCLEIC ACIDS RES, V20, P2599, DOI 10.1093/nar/20.10.2599; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M; ZINKER S, 1976, J BIOL CHEM, V251, P1799	51	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2451	2457						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428920				2022-12-27	WOS:A1993KK81500033
J	PORTER, DJT; SPECTOR, T				PORTER, DJT; SPECTOR, T			ALTERNATIVE SUBSTRATES FOR CALF INTESTINAL ADENOSINE-DEAMINASE - A PRE-STEADY-STATE KINETIC-ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; FLUORESCENCE; MECHANISM; ANALOG; STABILIZATION; DERIVATIVES; INHIBITORS; ADENINE	The protein fluorescence of adenosine deaminase (ADA) was perturbed during the deamination of adenosine and four analogues of adenosine. The kineties for the approach to the steady-state during turnover were monitored by fluorescence changes associated with formation of enzymatic intermediates. These kinetic data and the steady-state kinetic data were analyzed in terms of the kinetic scheme as follows. [GRAPHICS] The steady-state turnover number was assigned to k2, which was 244 s-1 for adenosine and 1.1 x 10(-3) s-1 for 6-methylamino-2-aminopurine arabinoside (aMDAP). Values for the association rate constants, k1, and the dissociation rate constants, k-1, were calculated from the kinetics for the approach to the steady state. k1 varied from 31 x 10(6) M-1 s-1 for adenosine to 2.8 x 10(6) M-1 s-1 for N-6-methyladenine arabinoside. k-1 varied from 500 s-1 for adenosine to 31 s-1 for aMDAP. The latter value was confirmed (22 s-1) by spectrofluorometrically monitoring the trapping of ADA by excess erythro-9-(2-hydroxy-3-nonyl) adenine as aMDAP-ADA dissociated. The ratio of k2 to k-1, which determines the commitment to catalysis, decreased from 0.49 for adenosine to 3.5 x 10(-5) for aMDAP. The K(m) values calculated from k1, k-1, and k2 were similar to the values determined from steady-state kinetic data. The spectrum of enzyme-bound aMDAP resembled protonated aMDAP.			PORTER, DJT (corresponding author), WELLCOME RES LABS,DIV EXPTL THERAPY,3030 CORNWALLIS RD,RES TRIANGLE PK,NC 27709, USA.							CAIOLFA VR, 1990, FEBS LETT, V260, P19, DOI 10.1016/0014-5793(90)80055-N; CERCIGNANI G, 1991, ANAL BIOCHEM, V192, P312, DOI 10.1016/0003-2697(91)90541-Z; Chance B, 1943, J BIOL CHEM, V151, P553; Cleland W. W., 1986, INVESTIGATIONS RATES, V6, P791; FRICK L, 1986, BIOCHEMISTRY-US, V25, P1616, DOI 10.1021/bi00355a025; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; IKEHARA M, 1974, BIOCHIM BIOPHYS ACTA, V338, P512, DOI 10.1016/0304-4165(74)90313-4; JONES W, 1989, BIOCHEMISTRY-US, V28, P1242, DOI 10.1021/bi00429a043; KOSZALKA GW, 1991, ANTIMICROB AGENTS CH, V35, P1437, DOI 10.1128/AAC.35.7.1437; KRENITSKY TA, 1981, CARBOHYD RES, V97, P139, DOI 10.1016/S0008-6215(00)80531-5; KREYSZIG E, 1963, ADV ENG MATH, P95; KURZ LC, 1992, BIOCHEMISTRY-US, V31, P39, DOI 10.1021/bi00116a008; KURZ LC, 1987, BIOCHEMISTRY-US, V26, P8450, DOI 10.1021/bi00399a063; KURZ LC, 1985, BIOCHEMISTRY-US, V24, P1342, DOI 10.1021/bi00327a011; OROZCO M, 1989, MOL PHARMACOL, V35, P257; ORSI BA, 1972, BIOCHEMISTRY-US, V11, P3386, DOI 10.1021/bi00768a011; PHILIPS AV, 1989, BIOCHEMISTRY-US, V28, P2040, DOI 10.1021/bi00431a012; PHILIPS AV, 1987, BIOCHEMISTRY-US, V26, P2893, DOI 10.1021/bi00384a034; SCHAEFFER HJ, 1958, J AM CHEM SOC, V80, P3738, DOI 10.1021/ja01547a068; SPECTOR T, 1984, ANAL BIOCHEM, V138, P242, DOI 10.1016/0003-2697(84)90796-6; SPECTOR T, 1983, BIOCHEM PHARMACOL, V32, P2505, DOI 10.1016/0006-2952(83)90010-2; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; WEISS PM, 1987, BIOCHEMISTRY-US, V26, P7378, DOI 10.1021/bi00397a027; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	24	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2480	2485						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428924				2022-12-27	WOS:A1993KK81500037
J	BLACKSHEAR, PJ				BLACKSHEAR, PJ			THE MARCKS FAMILY OF CELLULAR PROTEIN-KINASE-C SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOSPHORYLATION SITE DOMAIN; MAJOR SPECIFIC SUBSTRATE; MOLECULAR-CLONING; RAT-BRAIN; INDEPENDENT PATHWAYS; CALMODULIN BINDING; MOUSE-BRAIN; EXPRESSION; SEQUENCE; 80-KDA		DUKE UNIV,MED CTR,DEPT MED,DIV ENDOCRINOL METAB & NUTR,DIABET & METAB SECT,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Duke University	BLACKSHEAR, PJ (corresponding author), DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710, USA.		Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529				ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; AMESS B, 1992, FEBS LETT, V297, P285; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; BLACKSHEAR PJ, 1991, J BIOL CHEM, V266, P10946; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BLACKSHEAR PJ, 1992, GENOMICS, V14, P168, DOI 10.1016/S0888-7543(05)80300-3; BLACKSHEAR PJ, 1987, J BIOL CHEM, V262, P7774; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; BROOKS SF, 1991, EMBO J, V10, P2497, DOI 10.1002/j.1460-2075.1991.tb07789.x; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; COLBURN C, 1993, IN PRESS BIOPHYS J; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; GEORGE DJ, 1992, J BIOL CHEM, V267, P24879; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; GRAFF JM, 1991, J BIOL CHEM, V266, P14390; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HINRICHSEN RD, 1993, IN PRESS P NATL ACAD; HORNBECK P, 1989, MOL CELL BIOL, V9, P3727, DOI 10.1128/MCB.9.9.3727; JAMES G, 1989, J BIOL CHEM, V264, P20928; KATO K, 1990, EUR J NEUROSCI, V2, P704, DOI 10.1111/j.1460-9568.1990.tb00460.x; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; LINDNER D, 1992, J BIOL CHEM, V267, P24; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; MACNICOL M, 1992, J BIOL CHEM, V267, P12197; MANENTI S, 1992, J BIOL CHEM, V267, P22310; MANGELS LA, 1990, MOL PHARMACOL, V37, P820; MCILHINNEY RAJ, 1990, BIOCHEM J, V271, P681, DOI 10.1042/bj2710681; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; MORRIS CMG, 1992, EXP CELL RES, V200, P149, DOI 10.1016/S0014-4827(05)80083-7; NIEDEL J E, 1986, P47; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PATEL J, 1987, J BIOL CHEM, V262, P16686; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; ROZENGURT E, 1983, P NATL ACAD SCI USA, V80, P6858; SAKAI K, 1992, GENOMICS, V14, P175, DOI 10.1016/S0888-7543(05)80301-5; SEYKORA JT, 1991, P NATL ACAD SCI USA, V88, P2505, DOI 10.1073/pnas.88.6.2505; SIMEK SL, 1989, P NATL ACAD SCI USA, V86, P7410, DOI 10.1073/pnas.86.19.7410; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; THELEN M, 1990, P NATL ACAD SCI USA, V87, P5603, DOI 10.1073/pnas.87.15.5603; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; WOODGETT JR, 1987, CELL MEMBRANES METHO, V3, P215; YANG HC, 1987, J CELL PHYSIOL, V133, P377, DOI 10.1002/jcp.1041330224	61	487	498	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					1501	1504						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420923				2022-12-27	WOS:A1993KH62000001
J	LEE, Y; MAHDAVI, V				LEE, Y; MAHDAVI, V			THE D-DOMAIN OF THE THYROID-HORMONE RECEPTOR-ALPHA-1 SPECIFIES POSITIVE AND NEGATIVE TRANSCRIPTIONAL REGULATION FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; C-ERB-A; CHICKEN PROGESTERONE-RECEPTOR; RETINOIC ACID RECEPTORS; HUMAN ESTROGEN-RECEPTOR; NUCLEAR-LOCALIZATION; V-ERBA; DNA-BINDING; SIGNAL TRANSDUCTION; GENE-TRANSCRIPTION	Four structural domains are characteristic of the members of the thyroid/steroid receptor superfamily. Of these, the A/B and D domains are the least conserved. We have investigated the role of two clusters of positively charged amino acids within the D domain of the thyroid hormone receptor alpha1 (TRalpha1). The sequences Lys134-Arg-Lys and Arg188-Arg-Lys, individually or together, were substituted to the neutral residues TIT in three mutants named alpha1-1, alpha1-2, and alpha1-3, respectively. Subcellular localization of transiently transfected wild-type and mutated TRs was monitored by immunostaining, using a TRalpha1-specific antibody. The wild-type and the alpha1-2 TRs were detected exclusively in the nucleus, in the presence or absence of thyroid hormone. In contrast, the alpha1-1 and alpha1-3 mutants accumulated in both cytoplasm and nucleus, underscoring the importance of the Lys134-Arg-Lys residues for correct nuclear targeting. More importantly, although the mutants had unimpaired DNA- and hormone-binding activities, all three had lost positive and negative transcriptional regulatory functions. Thus, transactivation and repression functions can be entirely dissociated from the other properties of the receptor. In addition, substitution of either one of the positively charged amino acid clusters was sufficient to convert the native TRalpha1 into a dominant, thyroid hormone-dependent receptor antagonist. These observations, which underline the functional relevance of the D domain for TRalpha1 function, may also have implications for the autosomal dominant syndrome of generalized resistance to thyroid hormone.	HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	LEE, Y (corresponding author), CHILDRENS HOSP MED CTR, DEPT CARDIOL, MOLEC & CELLULAR CARDIOL LAB, BOSTON, MA 02115 USA.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; BOUCHER P, 1988, J VIROL, V62, P534, DOI 10.1128/JVI.62.2.534-544.1988; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DANG CV, 1989, J BIOL CHEM, V264, P18019; DARLING DS, 1991, MOL ENDOCRINOL, V5, P73, DOI 10.1210/mend-5-1-73; DESBOIS C, 1991, CELL, V67, P731, DOI 10.1016/0092-8674(91)90068-A; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GLASS CK, 1987, NATURE, V329, P739; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; HOROWITZ ZD, 1989, MOL ENDOCRINOL, V3, P148, DOI 10.1210/mend-3-1-148; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; HUNT T, 1989, CELL, V59, P949, DOI 10.1016/0092-8674(89)90747-2; ICHIKAWA K, 1987, METABOLISM, V36, P392, DOI 10.1016/0026-0495(87)90214-9; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; LAZAR MA, 1989, P NATL ACAD SCI USA, V86, P7771, DOI 10.1073/pnas.86.20.7771; LEE YS, 1989, J BIOL CHEM, V264, P13701; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LIN KH, 1991, MOL ENDOCRINOL, V5, P485, DOI 10.1210/mend-5-4-485; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MAHDAVI V, 1989, UCLA S MOL CELL BIOL, V93, P369; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; Oppenheimer J., 1983, MOL BASS THYROID HOR, P1; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SILVER P, 1989, CRIT REV BIOCHEM MOL, V24, P419, DOI 10.3109/10409238909082557; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; USALA SJ, 1988, MOL ENDOCRINOL, V2, P1217, DOI 10.1210/mend-2-12-1217; Utiger R.D, 1989, ENDOCRINOLOGY, V1, P702; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	69	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2021	2028						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420976				2022-12-27	WOS:A1993KH62000080
J	ITOH, K; TAKIYAMA, N; KASE, R; KONDOH, K; SANO, A; OSHIMA, A; SAKURABA, H; SUZUKI, Y				ITOH, K; TAKIYAMA, N; KASE, R; KONDOH, K; SANO, A; OSHIMA, A; SAKURABA, H; SUZUKI, Y			PURIFICATION AND CHARACTERIZATION OF HUMAN LYSOSOMAL PROTECTIVE PROTEIN EXPRESSED IN STABLY TRANSFORMED CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPODOPTERA-FRUGIPERDA CELLS; HUMAN BETA-GALACTOSIDASE; ACTIVATOR PROTEIN; NEURAMINIDASE DEFICIENCY; GALACTOSIALIDOSIS; CDNA; GLOBOTRIAOSYLCERAMIDE; FIBROBLASTS; DEGRADATION; GLUCOSIDASE	Chinese hamster ovary cells were transfected with a recombinant DNA containing the entire coding sequence of human lysosomal protective protein cDNA under the control of mouse metallothionein I promoter. Neomycin and methotrexate-resistant stably transformed cell lines expressing this protein were isolated. Immunoprecipitation of the product with antiserum against human placental protective protein-beta-galactosidase complex revealed a 52-kDa protective protein precursor, which was then processed to mature form, a heterodimer of 32- and 20-kDa polypeptides. The precursor secreted in the culture medium was taken up by the mannose 6-phosphate receptor system and restored acid carboxypeptidase, beta-galactosidase, and neuraminidase activities in galactosialidosis fibroblasts. The expressed protein showed a granular pattern in intracellular distribution, was fractionated at the density of lysosomes, and had serine esterase activities; acid carboxypeptidase at pH 5.6, esterase at pH 7.0, and carboxyl-terminal deamidase at pH 7.0. They were inhibited simultaneously by phenylmethyl-sulfonyl fluoride, N-benzyloxycarbonyl-L-phenylalanine chloromethyl ketone, or iodoacetamide. The acid carboxypeptidase activity of the purified monomeric mature protective protein was labile in vitro under the acidic condition. Saposins (sphingolipid activator proteins) stabilized the activity at micromolar level concentrations.	EHIME UNIV, SCH MED, DEPT NEUROPSYCHIAT, SHIGENOBU, EHIME 79102, JAPAN	Ehime University	ITOH, K (corresponding author), TOKYO METROPOLITAN INST MED SCI, DEPT CLIN GENET, 3-18-22 HONKOMAGOME, BUNKYO KU, TOKYO 113, JAPAN.			Sano, Akira/0000-0001-5843-9786				BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; GALJART NJ, 1990, J BIOL CHEM, V265, P4678; GARTNER S, 1983, J BIOL CHEM, V258, P2378; HOGEVEEN AT, 1983, J BIOL CHEM, V258, P12143; INUI K, 1983, P NATL ACAD SCI-BIOL, V80, P3074, DOI 10.1073/pnas.80.10.3074; ITOH K, 1990, BIOCHEM BIOPH RES CO, V167, P746, DOI 10.1016/0006-291X(90)92088-H; ITOH K, 1991, J INHERIT METAB DIS, V14, P813, DOI 10.1007/BF01799955; ITOH K, 1991, JPN J HUM GENET, V36, P169; JACKMAN HL, 1992, J BIOL CHEM, V267, P2872; JACKMAN HL, 1990, J BIOL CHEM, V265, P11265; KASE R, 1990, BIOCHEM BIOPH RES CO, V172, P1175, DOI 10.1016/0006-291X(90)91572-A; KLEINSCHMIDT T, 1988, BIOL CHEM HOPPESEYLE, V369, P1351; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; KYLE JW, 1988, J BIOL CHEM, V263, P16230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI SC, 1985, J BIOL CHEM, V260, P1867; MORIMOTO S, 1988, BIOCHEM BIOPH RES CO, V156, P403, DOI 10.1016/S0006-291X(88)80855-6; NAKANO T, 1989, J BIOCHEM-TOKYO, V105, P152, DOI 10.1093/oxfordjournals.jbchem.a122629; NANBA E, 1987, BIOCHEM BIOPH RES CO, V144, P138, DOI 10.1016/S0006-291X(87)80486-2; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; POTIER M, 1990, BIOCHEM J, V267, P197, DOI 10.1042/bj2670197; SAKURABA H, 1982, CLIN CHIM ACTA, V125, P275; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; SHIMMOTO M, 1990, P JPN ACAD B-PHYS, V66, P217, DOI 10.2183/pjab.66.217; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SORENSEN SB, 1988, CARLSBERG RES COMMUN, V54, P193; Suzuki Y, 1988, BRAIN DYSFUNCT, V1, P285; Suzuki Y., 1985, DEV BRAIN ITS DISORD, P161; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRANCHEMONTAGNE J, 1990, BIOCHEM BIOPH RES CO, V168, P22, DOI 10.1016/0006-291X(90)91669-J; Umezawa H, 1976, Methods Enzymol, V45, P678; VANDERHORST GTJ, 1989, J BIOL CHEM, V264, P1317; VANDIGGELEN OP, 1981, BIOCHEM J, V200, P143, DOI 10.1042/bj2000143; VERHEIJEN FW, 1985, EUR J BIOCHEM, V149, P315, DOI 10.1111/j.1432-1033.1985.tb08928.x; WENGER DA, 1982, BIOCHIM BIOPHYS ACTA, V712, P639, DOI 10.1016/0005-2760(82)90293-4; ZHOU XY, 1991, EMBO J, V10, P4041, DOI 10.1002/j.1460-2075.1991.tb04980.x	43	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1180	1186						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419322				2022-12-27	WOS:A1993KG07700063
J	RONG, L; KLEIN, HL				RONG, L; KLEIN, HL			PURIFICATION AND CHARACTERIZATION OF THE SRS2 DNA HELICASE OF THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-PRODUCT; RAD3 PROTEIN; RECOMBINATION; MUTANTS; REPAIR; SEQUENCE; MUTATION; LOCALIZATION; REPLICATION	The SRS2 gene of Saccharomyces cerevisiae was identified through mutational analysis as a suppressor of radiation-sensitive mutations in the error-prone repair pathway and by a hyper-recombination phenotype. Comparison of the derived amino acid sequence revealed the gene to have high homology to the bacterial DNA helicases UvrD and Rep (Aboussekhra, A., Chanet, R., Zgaga, Z., Cassier-Chauvat, C., Heude, M., and Fabre, F. (1989) Nucleic Acids Res. 17, 7211-7219). We have purified the SRS2 protein from Escherichia coli extracts by tagging the SRS2 gene with 6 carboxyl-terminal histidine residues and overexpressing the tagged protein in a pET-3c vector. Extracts were passed over a metal-chelating affinity chromatography column followed by gel filtration to obtain an enriched protein fraction. Sephacryl gel filtration of pooled fractions containing the SRS2 protein yielded purified SRS2 protein by Coomassie Blue stain of SDS-polyacrylamide gel electrophoresis gels. The purified SRS2 protein was found to have in vitro DNA-dependent ATPase and DNA helicase activities. The polarity of the helicase activity was determined to be 3' to 5', the same polarity as that found for the UvrD and Rep proteins. The carboxyl-terminal region of the protein is shown to contain a sequence for nuclear localization. Expression of the SRS2 in yeast was examined and found to be extremely low.	NYU MED CTR, KAPLAN CANC CTR, NEW YORK, NY 10016 USA	New York University	RONG, L (corresponding author), NYU MED CTR, DEPT BIOCHEM, NEW YORK, NY 10016 USA.			Klein, Hannah/0000-0003-4228-8535				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; DUGUET M, 1979, COLD SPRING HARB SYM, V43, P335, DOI 10.1101/SQB.1979.043.01.040; EMERY HS, 1991, GENE, V104, P103, DOI 10.1016/0378-1119(91)90473-O; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Friedberg E., 1991, MOL CELLULAR BIOL YE; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; GENTZ R, 1989, P NATL ACAD SCI USA, V86, P821, DOI 10.1073/pnas.86.3.821; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; HARLOW E, 1988, ANTIBODIES LABORATOR; HAROSH I, 1986, BIOL CHEM, V264, P20532; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Johnson SL, 1991, THESIS U WASHINGTON; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; MARSTON FAO, 1990, METHOD ENZYMOL, V182, P264; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1986, J BIOL CHEM, V261, P169; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYLIN LM, 1990, METHOD ENZYMOL, V185, P308; NAEGELI H, 1992, J BIOL CHEM, V267, P392; PALLADINO F, 1992, GENETICS, V132, P23; RADMAN M, 1988, GENETIC RECOMBINATIO, P169; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; RONG L, 1991, GENETICS, V127, P75; Rose M. D., 1991, METHODS YEAST GENETI; SAMBROOK J, 1989, MOL CLONNG LABORATOR; SILVER PA, 1988, GENE DEV, V2, P707, DOI 10.1101/gad.2.6.707; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; TALIAN JC, 1983, J CELL BIOL, V97, P1277, DOI 10.1083/jcb.97.4.1277; TJIAN R, 1975, J BIOL CHEM, V250, P8824; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; WILCOX DR, 1981, J BACTERIOL, V148, P618, DOI 10.1128/JB.148.2.618-623.1981	49	131	134	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1252	1259						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419328				2022-12-27	WOS:A1993KG07700073
J	MELLGREN, RL; SONG, K; MERICLE, MT				MELLGREN, RL; SONG, K; MERICLE, MT			M-CALPAIN REQUIRES DNA FOR ACTIVITY ON NUCLEAR PROTEINS AT LOW CALCIUM CONCENTRATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE; PURIFICATION; PROTEOLYSIS; SUBUNIT; CA-2+	m-Calpain (calpain II, m-CANP), which normally requires millimolar Ca2+ for activity in vitro, was capable of proteolyzing a number of matrix proteins in isolated rat liver nuclei at Ca2+ concentrations as low as 3 muM (Mellgren, R. L. (1991) J. Biol. Chem. 266, 13920-13924). Treatment of nuclei with deoxyribonuclease I eliminated the activity of m-calpain at low Ca2+ concentrations, while ribonuclease A and phospholipase C had no effect. Addition of DNA to DNase-treated nuclei restored m-calpain activity at low Ca2+. RNA had little if any effect. Eukaryotic and prokaryotic DNA were equally effective, and synthetic poly-deoxyribonucleotides were also activators. m-Calpain did not bind to a DNA-cellulose column in the presence of 200 muM Ca2+, and m-calpain preincubated in the presence of DNA and 200 muM Ca2+ was not activated at low Ca2+ concentrations following removal of the DNA. DNA did not alter the Ca2+ requirement for m-calpain-catalyzed cleavage of casein. These results demonstrate that the Ca2+ requirement for proteolysis of nuclear matrix proteins by m-calpain can be dramatically decreased in the presence of DNA. Activation did not seem to be a result of DNA binding directly to calpain but appeared to require interaction of DNA, calpain, and calpain substrates in the nuclear matrix.	MED COLL OHIO, DEPT PHARMACOL & THERAPEUT, TOLEDO, OH 43699 USA						NHLBI NIH HHS [HL 36573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; COOLICAN SA, 1984, J BIOL CHEM, V259, P1627; DAYTON WR, 1976, BIOCHEMISTRY-US, V15, P2159, DOI 10.1021/bi00655a020; EARNSHAW WC, 1991, EUKARYOTIC NUCLEUS, P639; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HAKES DJ, 1991, J BIOL CHEM, V266, P11131; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCH K, 1991, Journal of the American College of Cardiology, V17, p24A; MELLGREN RL, 1988, BIOCHIM BIOPHYS ACTA, V954, P154, DOI 10.1016/0167-4838(88)90066-0; MELLGREN RL, 1982, J BIOL CHEM, V257, P7203; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; MELLGREN RL, 1988, PREP BIOCHEM, V18, P183, DOI 10.1080/00327488808062520; Murachi T, 1980, Adv Enzyme Regul, V19, P407; MURRAY AW, 1989, J CELL SCI, P65; PICARD A, 1985, DEV BIOL, V109, P311, DOI 10.1016/0012-1606(85)90458-0; PONTREMOLI S, 1984, BIOCHEM BIOPH RES CO, V123, P331, DOI 10.1016/0006-291X(84)90417-0; SCHOLLMEYER JE, 1988, SCIENCE, V240, P911, DOI 10.1126/science.2834825; SILLEN LG, 1964, SPECIAL PUBLICATION, V17; SORIMACHI H, 1990, BIOL CHEM H-S, V371, P171; SUZUKI K, 1988, ADV ENZYME REGUL, V27, P153; Suzuki K S, 1987, PROG CLIN BIOCH MED, V5, P44; TOKES ZA, 1989, J BIOL CHEM, V264, P15059; WATANABE N, 1989, NATURE, V342, P505, DOI 10.1038/342505a0	28	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					653	657						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416968				2022-12-27	WOS:A1993KE60300098
J	PEARCE, G; JOHNSON, S; RYAN, CA				PEARCE, G; JOHNSON, S; RYAN, CA			STRUCTURE-ACTIVITY OF DELETED AND SUBSTITUTED SYSTEMIN, AN 18-AMINO ACID POLYPEPTIDE INDUCER OF PLANT DEFENSIVE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE INHIBITOR-I; LEAVES	The primary structure-activity relationships of systemin, an 18-amino acid polypeptide from tomato leaves that regulates the expression of two wound-inducible proteinase inhibitor genes in tomato and potato plants, were investigated. Analogs of systemin, the only example of a polypeptide signal from plants, were synthesized with progressive deletions of amino acids from both the NH2 terminus and COOH terminus and assayed in young excised tomato plants. All of the analogs exhibited severely decreased proteinase inhibitor-inducing activities, indicating that the entire 18-amino acid sequence is necessary for maximal activity. Deletion of the COOH-terminal Asp abolished inducing activity. Progressive replacement of each amino acid of the entire polypeptide with Ala revealed two regions, near residues Pro13, where Ala substitution reduced activity to less than 0.2%, and Thr17, which totally inactivated the analog. Other replacements with Ala had little or only moderate effects on activity. The two inactive analogs, des-Asp18 systemin and Ala17 systemin, were potent inhibitors of the inducing activity of the native systemin. These analogs, therefore, contain structural conformations sufficient for competition with systemin, but they are not competent for proteinase inhibitor gene induction. A synthetic COOH-terminal tetrapeptide, Met-Gln-Thr-Asp, retained low proteinase inhibitor inducing activity, but virtually any replacements with other amino acids either eliminated activity or reduced the activity to very low or nearly undetectable levels. These results indicate that residues near the COOH terminus of systemin are necessary for activity, possibly involving a phosphorylation at Thr17 and that other regions of the systemin sequence are important for interacting with a receptor(s) but are not sufficient to activate proteinase inhibitor gene expression.	WASHINGTON STATE UNIV,INST BIOL CHEM,PULLMAN,WA 99164	Washington State University								BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; GRAHAM JS, 1986, PLANTA, V169, P399, DOI 10.1007/BF00392137; LEE JS, 1986, P NATL ACAD SCI USA, V83, P7277, DOI 10.1073/pnas.83.19.7277; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; PAULOT V, 1991, MOL PLANT MICROBE IN, V4, P284; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PLUNKETT G, 1982, ARCH BIOCHEM BIOPHYS, V213, P456; RUSSELL DJ, 1992, J PROTEIN CHEM, V11, P265, DOI 10.1007/BF01024865; RYAN CA, 1967, ANAL BIOCHEM, V19, P434, DOI 10.1016/0003-2697(67)90233-3; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; RYAN CA, 1991, ANNU REV PLANT PHYS, V42, P651, DOI 10.1146/annurev.pp.42.060191.003251; RYAN CA, 1977, BIOCHEM BIOPH RES CO, V77, P1004, DOI 10.1016/S0006-291X(77)80077-6; THORNBURG RW, 1987, P NATL ACAD SCI USA, V84, P744, DOI 10.1073/pnas.84.3.744; TRAUTMAN R, 1971, IMMUNOCHEMISTRY, V8, P901, DOI 10.1016/0019-2791(71)90429-0	15	82	87	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					212	216						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416929				2022-12-27	WOS:A1993KE60300033
J	YAO, KQ; FALICK, AM; PATEL, N; CORREIA, MA				YAO, KQ; FALICK, AM; PATEL, N; CORREIA, MA			CUMENE HYDROPEROXIDE-MEDIATED INACTIVATION OF CYTOCHROME-P450 2B1 - IDENTIFICATION OF AN ACTIVE-SITE HEME-MODIFIED PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATIC CYTOCHROME-P-450; LIVER CYTOCHROME-P-450; SUICIDE INACTIVATION; PROTEIN ADDUCTS; PROSTHETIC HEME; HEMOPROTEINS; DEGRADATION; METABOLISM; MYOGLOBIN; 3,5-DICARBETHOXY-2,6-DIMETHYL-4-ETHYL-1,4-DIHYDROPYRIDINE	Cumene hydroperoxide (CuOOH)-mediated inactivation of cytochromes P450 (P450) results in the degradation of their prosthetic heme to products that alkylate the apoprotein. Indirect approaches suggest that this alkylation occurs at the active site. in order to identify the specific apoprotein site(s) alkylated, purified H-3- or C-14-heme-labeled P450 2B1 was incubated with CuOOH and subjected to lysyl endopeptidase-C digestion. Two major peaks (L1 and L2) containing H-3- or C-14-labeled peptides were detected by reverse-phase high pressure liquid chromatography of the digest. L1 contained the highest specific radioactivity and after Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis yielded 3 peptide bands (M(r) almost-equal-to 3,500 (P1), 5,000 (P2), and 7,000 (P3)). Although all 3 bands were found radiolabeled, the yield of P1 was higher than that of P2 or P3. Amino acid sequence analysis of the first 13 N-terminal residues of P1 revealed the sequence RICLGEGIARNEL, corresponding to residues 434-446 of the reported 2B1 sequence. A species with the molecular mass of 3771 +/- 1 Da was detected in preliminary electrospray mass spectrometric analysis of L1. Since the theoretical average mass of the predicted peptide (residues 434-466) is 3721.99 Da, the additional 49 +/- 1 Da are considered to be contributed by the alkylating heme fragment. This alkylated 2B1 sequence contains not only Cys436, the conserved residue that provides the SH ligand for heme, but also other highly conserved residues, and therefore corresponds to the heme-sandwiching helix L of P450cam. To our knowledge, this is the first report to localize CuOOH-induced heme alkylation of 2B1 to its active site.	UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,BOX 0450,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NCRR NIH HHS [RR01614] Funding Source: Medline; NIDDK NIH HHS [DK 26743] Funding Source: Medline; NIGMS NIH HHS [GM 44037] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BORNHEIM LM, 1987, MOL PHARMACOL, V32, P299; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; CANTONI L, 1981, INT J BIOCHEM, V13, P823, DOI 10.1016/0020-711X(81)90102-6; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1989, DRUG METAB REV, V20, P615, DOI 10.3109/03602538909103565; DAVIES HW, 1986, ARCH BIOCHEM BIOPHYS, V244, P387, DOI 10.1016/0003-9861(86)90128-1; DECKER C, 1986, BIOCHEM BIOPH RES CO, V136, P1162, DOI 10.1016/0006-291X(86)90456-0; DECKER CJ, 1989, BIOCHEMISTRY-US, V28, P5128, DOI 10.1021/bi00438a033; DEMONTELANO PRO, 1986, CYTOCHROME, V450, P217; DEMONTELLANO PRO, 1989, CYTOCHROME P, V450, P273; FUJIIKURIYAMA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2793, DOI 10.1073/pnas.79.9.2793; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GUENGERICH FP, 1978, BIOCHEMISTRY-US, V17, P3633, DOI 10.1021/bi00610a033; GUENGERICH FP, 1986, BIOCHEM BIOPH RES CO, V138, P193, DOI 10.1016/0006-291X(86)90265-2; GUENGERICH FP, 1987, MAMMALIAN CYTOCHRO P, V2; GUENGERICH FP, 1987, MAMMALIAN CYTOCHRO P, V1; HALPERT J, 1983, MOL PHARMACOL, V23, P445; HALPERT J, 1981, BIOCHEM PHARMACOL, V30, P875, DOI 10.1016/S0006-2952(81)80010-X; LUNETTA JM, 1989, MOL PHARMACOL, V35, P10; NELSON DR, 1988, J BIOL CHEM, V263, P6038; OSAWA Y, 1990, J BIOL CHEM, V265, P10340; OSAWA Y, 1991, J BIOL CHEM, V266, P3208; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, CYTOCHROME P, V450, P505; POULOS TL, 1988, ADV INORG BIOCHEM, V7, P1; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; SUGIYAMA K, 1989, CHEM RES TOXICOL, V2, P400, DOI 10.1021/tx00012a008; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; WAXMAN DJ, 1982, J BIOL CHEM, V257, P446	31	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					59	65						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416964				2022-12-27	WOS:A1993KE60300011
J	MALLAMACI, MA; CHIZZONITE, R; GRIFFIN, M; NETTLETON, M; HAKIMI, J; TSIEN, WH; KOCHAN, JP				MALLAMACI, MA; CHIZZONITE, R; GRIFFIN, M; NETTLETON, M; HAKIMI, J; TSIEN, WH; KOCHAN, JP			IDENTIFICATION OF SITES ON THE HUMAN FC-EPSILON-RI-ALPHA SUBUNIT WHICH ARE INVOLVED IN BINDING HUMAN AND RAT IGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E; MONOCLONAL-ANTIBODIES; GAMMA SUBUNIT; GENE; CHAIN; CELLS; EXPRESSION; PRODUCTS	The high affinity IgE Fe receptor (FcepsilonRI), found on mast cells and basophils, is a tetrameric receptor complex. The extracellular portion of the FcepsilonRIalpha subunit consists of two immunoglobulin-like domains and binds IgE in the absence of the other subunits. To localize the high affinity IgE binding site within the FcepsilonRIalpha subunit, we generated a series of chimeric receptor constructs where one of the two immunoglobulin-like domains was either deleted or substituted with those from the human FcgammaRIIIAalpha or the rat FcepsilonRIalpha subunit. The chimeric receptors were monitored for their capacity to bind human and rat IgE, and their reactivity with different antireceptor antibodies. Domain I substitutions maintained high affinity human IgE binding. Domain II substitutions resulted in a total loss of both human and rat IgE binding. Single-domain alpha subunits could not bind IgE, suggesting that both extracellular domains are required for proper protein folding or IgE binding. To further localize the IgE binding sites, homolog-scanning mutagenesis was performed. At least three independent regions of domain II encompassing residues 118-129, 136-150, and 148-162 were required for IgE binding. Our results suggest that domain II of the human FcepsilonRIalpha confers most of the important contributions to the binding of the human IgE Fc molecule, whereas domain I of the rat FcepsilonRIalpha makes important contributions to the binding of rat IgE.	HOFFMANN LA ROCHE INC,DEPT BRONCHOPULM RES,340 KINGSLAND ST,NUTLEY,NJ 07110; HOFFMANN LA ROCHE INC,DEPT INFLAMMAT AUTOIMMUNE DIS,NUTLEY,NJ 07110	Roche Holding; Roche Holding								BANIYASH M, 1987, J IMMUNOL, V138, P2999; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1991, J BIOL CHEM, V266, P2639; CONRAD DH, 1983, J IMMUNOL, V130, P327; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; HELM B, 1988, NATURE, V331, P180, DOI 10.1038/331180a0; HOGARTH PM, 1992, IMMUNOL REV, V125, P21, DOI 10.1111/j.1600-065X.1992.tb00623.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KINET JP, 1987, BIOCHEMISTRY-US, V26, P4606; KOCHAN J, 1988, NUCLEIC ACIDS RES, V16, P3584, DOI 10.1093/nar/16.8.3584; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; KUSTER H, 1990, J BIOL CHEM, V265, P6448; KUSTER H, 1992, J BIOL CHEM, V267, P12782; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; NISSIM A, 1991, EMBO J, V10, P101, DOI 10.1002/j.1460-2075.1991.tb07925.x; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RISKE F, 1991, J BIOL CHEM, V266, P11245; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALLON BJ, 1989, P NATL ACAD SCI USA, V86, P5079, DOI 10.1073/pnas.86.13.5079; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHONEICH JT, 1992, J IMMUNOL, V148, P2181; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907	24	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22076	22083						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408065				2022-12-27	WOS:A1993MC80900095
J	SRIRAMARAO, P; STEFFNER, P; GEHLSEN, KR				SRIRAMARAO, P; STEFFNER, P; GEHLSEN, KR			BIOCHEMICAL-EVIDENCE FOR A HOMOPHILIC INTERACTION OF THE ALPHA-3-BETA-1 INTEGRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; LAMININ RECEPTOR; FIBRONECTIN RECEPTOR; BINDING-SITE; GPIIB-IIIA; ADHESION; ALPHA-2-BETA-1; FAMILY; LOCALIZATION; VITRONECTIN	The purpose of this study was to determine if the alpha3beta1 integrin could interact in a homophilic manner. Several earlier reports have shown that certain integrin adhesion receptors, namely alpha2beta1, alpha3beta1, and alpha6beta4 localize to intercellular adhesion structures and, therefore, may participate in cell-cell interactions (Carter, W. G., Wayner, E. A., Bouchard, T. S., and Kaur, P. (1990) J. Cell Biol. 110, 1387-1404; Kaufmann, R., Frosch, D., Westphal, C., Weber, L., and Klein, C. E. (1989) J. Cell Biol. 109, 1807-1815; Hynes, R. O. (1987) Cell 48, 549-554; Symington, B. E., Takada, Y., and Carter, W. G. (1993) J. Cell Biol. 120, 523-535). We present data herein suggesting that the integrin alpha3beta1 may interact homophilically in such cell-cell adhesion structures which contain this specific receptor or, alternatively, in receptor aggregates found in focal adhesions. The alpha3beta1 receptor was purified by affinity chromatography on either human laminin or peptide GD-6-Sepharose and subsequently used as a substrate in cell adhesion assays. The immobilized alpha3beta1 supported the adhesion of cells containing alpha3beta1, and this attachment was specifically inhibited by monoclonal antibodies to both beta1 and alpha3 subunits. In addition, an affinity matrix containing purified alpha3beta1 showed specific binding of only alpha3beta1 from detergent extracts of cell surface proteins and such binding was cation-dependent. Finally, using biosensor technology involving the principle of surface plasmon resonance (BIAcore(TM), Pharmacia Biosensor), alpha3beta1, when bound to a carboxymethyl dextran-modified gold surface, was found to bind only other soluble alpha3beta1 receptors and did not bind other purified integrins, including alpha5beta1 and alphavbeta3. These data strongly suggest that alpha3beta1 likely interacts in a homophilic manner under our experimental conditions.	CALIF INST BIOL RES, LA JOLLA, CA 92037 USA; PHARMACIA BIOSENSOR, PISCATAWAY, NJ 08855 USA					Rao, Srirama/0000-0001-9082-1029	NATIONAL CANCER INSTITUTE [R01CA057202] Funding Source: NIH RePORTER; NCI NIH HHS [CA 57202] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JC, 1991, J CELL BIOL, V115, P829, DOI 10.1083/jcb.115.3.829; ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; BREGMAN MD, 1983, PROSTAGLANDINS, V27, P17; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CHAN BMC, 1993, J CELL BIOL, V120, P537, DOI 10.1083/jcb.120.2.537; CULLEN DC, 1987, BIOSENSORS, V3, P211; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; Fagerstam L G, 1990, J Mol Recognit, V3, P208, DOI 10.1002/jmr.300030507; GEHLSEN KR, 1992, J CELL BIOL, V117, P449, DOI 10.1083/jcb.117.2.449; GEHLSEN KR, 1989, J BIOL CHEM, V264, P19034; GEHLSEN KR, 1992, CLIN EXP METASTAS, V10, P111, DOI 10.1007/BF00114587; GEHLSEN KR, 1988, SCIENCE, V241, P1228, DOI 10.1126/science.2970671; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KAUFMANN R, 1989, J CELL BIOL, V109, P1807, DOI 10.1083/jcb.109.4.1807; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; PLOW EF, 1989, PROG HEMOST THROMB, V9, P117; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; RUEGG C, 1992, J CELL BIOL, V117, P179, DOI 10.1083/jcb.117.1.179; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; SRIRAMARAO P, 1993, IN PRESS J CELL SCI; SYMINGTON BE, 1993, J CELL BIOL, V120, P523, DOI 10.1083/jcb.120.2.523; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211	35	94	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					22036	22041						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408061				2022-12-27	WOS:A1993MC80900089
J	UTAISINCHAROEN, P; MACKESSY, SP; MILLER, RA; TU, AT				UTAISINCHAROEN, P; MACKESSY, SP; MILLER, RA; TU, AT			COMPLETE PRIMARY STRUCTURE AND BIOCHEMICAL-PROPERTIES OF GILATOXIN, A SERINE-PROTEASE WITH KALLIKREIN-LIKE AND ANGIOTENSIN-DEGRADING ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MEXICAN BEADED LIZARD; AMINO-ACID-SEQUENCE; GILA MONSTER VENOM; HELODERMA-HORRIDUM; ACETYLCHOLINE-RECEPTORS; ENZYME; PURIFICATION; TOXIN; PHOSPHOLIPASE-A2	The activity and the complete primary structure of gilatoxin, a glycoprotein component from the venom of the Mexican beaded lizard (Heloderma horridum horridum) has been elucidated. Gilatoxin, a serine protease, showed kallikrein-like activity, releasing bradykinin from kininogen; toxin-treated kininogen also produced lowered blood pressure in rats and contraction of isolated rat uterus smooth muscle. Gilatoxin catalyzed the hydrolysis of various arginine ester substrates for trypsin and thrombin and degraded both angiotensin I and II by cleavage of the dipeptide Asp-Arg from the NH2-terminal end. Fibrinogen was degraded but a fibrin clot was not produced, indicating that gilatoxin has specificities different from thrombin and snake venom thrombin-like proteases. The complete amino acid sequence of gilatoxin (245 residues) was deduced from NH2-terminal sequencing of overlapping peptide fragments cleaved from the reduced and alkylated toxin by enzymatic and chemical methods. The toxin is extensively glycosylated, containing approximately 8 mol of monosaccharide/mol of toxin, but appears to lack O-glycosylation sites. Amino acid sequence alignment of gilatoxin with batroxobin, crotalase, kallikrein, thrombin, trypsin, and several partial sequences of other Heloderma toxins reveals that there is considerable homology between these enzymes, particularly in the regions of the presumed catalytic site. Gilatoxin contains an additional 7 residues in the highly conserved catalytic region of serine proteases (including Asp-96, in the basic specificity pocket of thrombin) which may contribute to the unusual substrate specificity of the toxin.	COLORADO STATE UNIV,DEPT BIOCHEM,FT COLLINS,CO 80523; UNIV NO COLORADO,DEPT BIOL SCI,GREELEY,CO 80639	Colorado State University; University of Northern Colorado			Mackessy, Stephen/GPT-0793-2022	Mackessy, Stephen/0000-0003-4515-2545	NIGMS NIH HHS [5R37 GM15591] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015591] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1986, J BIOL CHEM, V261, P4229; ALAGON A, 1986, J EXP MED, V164, P1835, DOI 10.1084/jem.164.6.1835; ALEXANDER G, 1988, TOXICON, V26, P953, DOI 10.1016/0041-0101(88)90260-7; BJARNASON JB, 1978, BIOCHEMISTRY-US, V17, P3395, DOI 10.1021/bi00609a033; BROCKES JP, 1975, BIOCHEMISTRY-US, V14, P2092, DOI 10.1021/bi00681a008; CHEN YH, 1982, BIOCHEMISTRY-US, V21, P2592, DOI 10.1021/bi00540a003; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; ELION J, 1977, CHEM BIOL THROMBIN, P97; Fontana A, 1972, Methods Enzymol, V25, P419, DOI 10.1016/S0076-6879(72)25037-6; GOMEZ F, 1989, EUR J BIOCHEM, V186, P23, DOI 10.1111/j.1432-1033.1989.tb15172.x; HENDON RA, 1981, BIOCHEMISTRY-US, V20, P3517, DOI 10.1021/bi00515a033; ITOH N, 1987, J BIOL CHEM, V262, P3132; Khosla M.C., 1974, HDB EXPT PHARMACOLOG, P126; KOMORI Y, 1988, BIOCHEM BIOPH RES CO, V154, P613, DOI 10.1016/0006-291X(88)90183-0; KOMORIY, 1988, BIOCHIM BIOPHYS ACTA, V967, P92; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDSTROM J, 1980, J BIOL CHEM, V255, P8340; MACKESSY S P, 1989, Toxicon, V27, P61; MAGNUSSON S, 1975, PROTEASES BIOL CONTR, P123; MARKLAND FS, 1982, P NATL ACAD SCI-BIOL, V79, P1688, DOI 10.1073/pnas.79.6.1688; MORRISON M, 1970, BIOCHEMISTRY-US, V9, P2995, DOI 10.1021/bi00817a010; MURPHY SA, 1976, ARK ACAD SCI P, V30, P60; NIKAI T, 1988, ARCH BIOCHEM BIOPHYS, V264, P270, DOI 10.1016/0003-9861(88)90594-2; PARKER DS, 1984, J BIOL CHEM, V259, P1751; PIRKLE H, 1981, BIOCHEM BIOPH RES CO, V99, P715, DOI 10.1016/0006-291X(81)91802-7; PIRKLE H, 1991, HDB NATURAL TOXINS, V5, P225; Pirkle H., 1988, HEMOSTASIS ANIMAL VE; RAUFMAN JP, 1991, J BIOL CHEM, V266, P2897; RAUFMAN JP, 1982, AM J PHYSIOL, V242, pG471; ROBERTS PS, 1958, J BIOL CHEM, V232, P285; SCHMIDT J, 1973, ANAL BIOCHEM, V52, P349, DOI 10.1016/0003-2697(73)90036-5; SHIEH JC, 1988, J BIOCHEM-TOKYO, V103, P596; SOSA BP, 1986, BIOCHEMISTRY-US, V25, P2927, DOI 10.1021/bi00358a029; SWIFT GH, 1982, P NATL ACAD SCI-BIOL, V79, P7263, DOI 10.1073/pnas.79.23.7263; TITANI K, 1975, BIOCHEMISTRY-US, V14, P1358, DOI 10.1021/bi00678a003; TRAUTSCHOLD I, 1970, HDB EXP PHARM, V5, P53; TU AT, 1967, COMP BIOCHEM PHYSIOL, V22, P389, DOI 10.1016/0010-406X(67)90602-0; TU AT, 1983, COMP BIOCHEM PHYS B, V76, P377, DOI 10.1016/0305-0491(83)90086-X; TU AT, 1991, HDB NATURAL TOXINS, V5, P755; VANDERMEEERS A, 1987, EUR J BIOCHEM, V164, P321, DOI 10.1111/j.1432-1033.1987.tb11061.x; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902; WILLIS TW, 1988, BIOCHEMISTRY-US, V53, P19; YABUKI Y, 1991, TOXICON, V29, P73, DOI 10.1016/0041-0101(91)90040-X	44	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21975	21983						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408054				2022-12-27	WOS:A1993MC80900081
J	ZDANOVSKY, AG; CHIRON, M; PASTAN, I; FITZGERALD, DJ				ZDANOVSKY, AG; CHIRON, M; PASTAN, I; FITZGERALD, DJ			MECHANISM OF ACTION OF PSEUDOMONAS EXOTOXIN - IDENTIFICATION OF A RATE-LIMITING STEP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2-MACROGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; CELLULAR PROTEASE; DIPHTHERIA-TOXIN; ESCHERICHIA-COLI; AERUGINOSA; SITE; GLYCOPROTEIN; CYTOTOXICITY; MUTAGENESIS	Pseudomonas exotoxin (PE) enters cells by receptor-mediated endocytosis and is cleaved by a cellular protease between Arg279 and Gly280 to produce an NH2-terminal fragment of 28 kDa which contains the toxin's binding domain and a COOH-terminal fragment of 37 kDa which has translocating and ADP-ribosylating activity. After proteolysis, the COOH-terminal fragment reaches the endoplasmic reticulum by retrograde transport where it translocates to the cytosol and inhibits protein synthesis by ADP-ribosylating elongation factor 2. To understand how the 37-kDa fragment functions, we focused on the role of specific amino acids located near its NH2 terminus. We found that there was a 4-250-fold loss in toxic activity when tryptophan 281, leucine 284, or tyrosine 289 were changed to other residues. Mutations at these three positions did not interfere with the receptor binding, cell-mediated proteolytic cleavage, or ADP-ribosylating activity. To determine the role of these amino acids, a competition assay was devised in which the addition of excess PEDELTA553, a mutant form of PE that lacks ADP-ribosylation activity, competed efficiently for the toxicity of PE. Excess PE with mutations near the NH2 terminus of the 37-kDa fragment competed poorly. This competition occurred after proteolysis since PEGly276, a mutant form of PE that is not cleaved, did not compete. We conclude that specific amino acids at the NH2 terminus of the 37-kDa fragment interact in a saturable manner with an unknown intracellular component.	NCI,DIV CANC BIOL DIAG & CTR,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270				ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; CHAUDRY GJ, 1989, J BIOL CHEM, V264, P15151; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; DOUGLAS CM, 1987, J BACTERIOL, V169, P4962, DOI 10.1128/jb.169.11.4962-4966.1987; FRYLING C, 1992, INFECT IMMUN, V60, P497, DOI 10.1128/IAI.60.2.497-502.1992; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; JIINO Y, 1988, J BIOL CHEM, V263, P13203; KASTURI S, 1992, J BIOL CHEM, V267, P23427; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LUKAC M, 1988, INFECT IMMUN, V56, P3095, DOI 10.1128/IAI.56.12.3095-3098.1988; MANHART MD, 1984, INFECT IMMUN, V45, P596, DOI 10.1128/IAI.45.3.596-603.1984; OGATA M, 1990, J BIOL CHEM, V265, P20678; OGATA M, 1992, J BIOL CHEM, V267, P25396; SEETHARAM S, 1991, J BIOL CHEM, V266, P17376; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THEUER CP, 1992, J BIOL CHEM, V267, P16872; THOMPSON MR, 1991, J BIOL CHEM, V266, P2390	22	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1993	268	29					21791	21799						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC809	8408034				2022-12-27	WOS:A1993MC80900057
J	SORCITHOMAS, M; KEARNS, MW; LEE, JP				SORCITHOMAS, M; KEARNS, MW; LEE, JP			APOLIPOPROTEIN-A-I DOMAINS INVOLVED IN LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVATION - STRUCTURE-FUNCTION-RELATIONSHIPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; SITE-DIRECTED MUTAGENESIS; PEPTIDES; SEGMENT; MODEL; SERUM; ACID; GENE	A series of mutant apolipoprotein (apoA-I) constructs were designed and then expressed in cell culture to identify structural domains within the mature native apoA-I protein that participate in the activation of the plasma enzyme, lecithin-cholesterol acyltransferase (LCAT). Evolutionary conservation analysis has shown previously that apoA-I contains eight repeats containing 22 amino acids and two repeats containing 11 amino acids that are highly conserved among species as well as within the apolipoprotein supergene family. These tandem repeats begin at residue 44 and are usually marked by a proline residue, with six of the 22-mer repeats showing high amphipathic alpha-helical character. To determine if specific 11- or 22-amino acid domains are essential for maximal LCAT activation within the entire native protein, each of the 10 repeats was sequentially deleted using a polymerase chain reaction based method of mutagenesis. The wild-type and mutant apoA-I gene constructs were expressed in Chinese hamster ovary (CHO) cells and stable lines established. Wild-type and mutant apoA-I protein were purified from 48-96-h conditioned serum-free medium and characterized by SDS-polyacrylamide gel electrophoresis and Western blot analysis. Wild-type apoA-I showed a single migrating band of 28,000 daltons that corresponded to the mobility of human plasma apoA-I, whereas apoA-I deletion mutants (lacking 22- or 11-mer repeats) showed the corresponding shift to lower molecular size. To measure the relative LCAT activation of all deletion mutant apoA-I proteins relative to wild-type apoA-I, an assay system utilizing small unilamellar vesicles as the lipid substrate was used. The results of these studies suggest that several central amphipathic alpha-helical regions within the mature protein are critical in LCAT activation.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,WINSTON SALEM,NC 27157	Wake Forest University; Wake Forest Baptist Medical Center	SORCITHOMAS, M (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT COMPARAT MED,MED CTR BLVD,WINSTON SALEM,NC 27157, USA.			Sorci-Thomas, Mary/0000-0002-6464-5006	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL041916, P01HL049373] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-49373, HL-41916] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albers J J, 1986, Methods Enzymol, V129, P763; ANANTHARAMAIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95, DOI 10.1161/01.ATV.10.1.95; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BANKA CL, 1991, J BIOL CHEM, V266, P23886; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BRUHN H, 1991, BIOL CHEM H-S, V372, P225, DOI 10.1515/bchm3.1991.372.1.225; DEEB SS, 1991, J BIOL CHEM, V266, P13654; FIELDING CJ, 1990, ADV CHOLESTEROL RES, P271; FITCH WM, 1977, GENETICS, V86, P623; FUKUSHIMA D, 1980, J BIOL CHEM, V255, P651; FUNKE H, 1991, J CLIN INVEST, V87, P371, DOI 10.1172/JCI114997; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JONAS A, 1991, J LIPID RES, V32, P97; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KORITNIK DL, 1983, J LIPID RES, V24, P1639; LUO CC, 1986, J MOL BIOL, V187, P325, DOI 10.1016/0022-2836(86)90436-5; MALLORY JB, 1987, J BIOL CHEM, V262, P4241; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MINNICH A, 1992, J BIOL CHEM, V267, P16553; NAKAGAWA SH, 1985, J AM CHEM SOC, V107, P7087, DOI 10.1021/ja00310a055; RALL SC, 1984, J BIOL CHEM, V259, P63; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1992, J LIPID RES, V33, P141; SORCITHOMAS M, 1992, J LIPID RES, V33, P1147; SORCITHOMAS M, 1991, J BIOL CHEM, V266, P18045; SORCITHOMAS M, 1988, J BIOL CHEM, V263, P5183; SORCITHOMAS M, 1990, J BIOL CHEM, V265, P2665; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; UTERMANN G, 1984, EUR J BIOCHEM, V144, P326; WALD JH, 1990, J BIOL CHEM, V265, P20044	35	119	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1993	268	28					21403	21409						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MA288	8407982				2022-12-27	WOS:A1993MA28800110
J	HARDIG, Y; REZAIE, A; DAHLBACK, B				HARDIG, Y; REZAIE, A; DAHLBACK, B			HIGH-AFFINITY BINDING OF HUMAN VITAMIN-K-DEPENDENT PROTEIN S TO A TRUNCATED RECOMBINANT BETA-CHAIN OF C4B-BINDING PROTEIN EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN C4-BINDING PROTEIN; HUMAN-COMPLEMENT; MOLECULAR-CLONING; C3B INACTIVATOR; HUMAN-PLASMA; FACTOR-VIII; C4B; PROTEOLYSIS; RECEPTOR; FAMILY	C4b-binding protein (C4BP) is a plasma glycoprotein that contains independent binding sites for complement component C4b and anticoagulant vitamin K-dependent protein S. C4BP is composed of seven alpha-chains (70 kDa) and one beta-chain (45 kDa) joined by disulfide bonds. In addition to non-repeat regions, the alpha- and beta-chains contain eight and three tandemly arranged modules, respectively, designated short consensus repeats (SCRs). C4b binds to the alpha-chains while it has been suggested, though not conclusively shown, that the beta-chain binds protein S. A truncated recombinant beta-chain composed of the three SCRs was expressed as a fusion protein with an epitope for a calcium-dependent monoclonal antibody (HPC4) in a procaryotic expression system. A signal peptide from the pelB gene of Erwinia carotovora directed expression to the medium from which the recombinant protein was purified using a HPC4 affinity column. On unreduced polyacrylamide gel electrophoresis in the presence of SDS, the recombinant protein demonstrated two closely spaced bands (M(r) = 19,000 and 20,000), whereas after reduction a broad band with an apparent molecular weight of 25,000 was obtained. On I-125-protein S ligand blotting, only one of the unreduced bands was found to bind protein S. The protein corresponding to this band bound protein S with almost as high affinity as intact C4BP, and it completely inhibited binding of protein S to intact C4BP. After reduction, the protein S binding ability was lost.The multiple carbohydrate side chains present in the native beta-chain of C4BP were apparently not required for protein S binding, as the recombinant beta-chain was not glycosylated. These results demonstrate that the protein S binding site of C4BP is contained within the three SCR modules of its beta-chain.	OKLAHOMA MED RES FDN,HOWARD HUGHES MED INST,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104	Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	HARDIG, Y (corresponding author), LUND UNIV,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN.			Dahlback, Bjorn/0000-0003-1546-0328				BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BLOBEL GG, 1975, J CELL BIOL, V17, P835; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; DAHLBACK B, 1984, J BIOL CHEM, V259, P1631; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1986, J BIOL CHEM, V261, P2022; DAHLBACK B, 1983, P NATL ACAD SCI-BIOL, V80, P3461, DOI 10.1073/pnas.80.11.3461; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; HILLARP A, 1987, J BIOL CHEM, V262, P11300; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; HILLARP A, 1988, J BIOL CHEM, V263, P12759; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; KRISTENSEN T, 1987, FASEB J, V46, P2463; LAW SKA, 1988, COMPLEMENT; LUBLIN DM, 1988, J EXP MED, V168, P181, DOI 10.1084/jem.168.1.181; Maizel JV, 1971, METHOD VIROL, V5, P179; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NAGASAWA S, 1983, FEBS LETT, V164, P135, DOI 10.1016/0014-5793(83)80036-2; NAGASAWA S, 1980, J IMMUNOL, V125, P578; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; PERKINS SJ, 1986, BIOCHEM J, V233, P799, DOI 10.1042/bj2330799; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207; SCHWALBE R, 1990, J BIOL CHEM, V265, P16074; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; SUZUKI K, 1988, J BIOL CHEM, V263, P17034; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047	42	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3033	3036						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428978				2022-12-27	WOS:A1993KM16100005
J	TOMKA, MA; CATALANO, CE				TOMKA, MA; CATALANO, CE			PHYSICAL AND KINETIC CHARACTERIZATION OF THE DNA PACKAGING ENZYME FROM BACTERIOPHAGE-LAMBDA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; COHESIVE END SITE; ESCHERICHIA-COLI; SECONDARY STRUCTURE; COS DNA; RESTRICTION ENDONUCLEASE; NUCLEOTIDE-SEQUENCE; TERMINASE; INVITRO; PROTEINS	Terminases are enzymes common to complex double-stranded DNA viruses and are required for packaging of the viral genome into a preformed capsid. The over-expression of bacteriophage lambda-terminase in Escherichia coli has been previously reported (Chow, S., Daub, E., and Murialdo, H. (1987) Gene (Amst.) 60, 277-289), and we present here a purification scheme for the isolation of milligram quantities of protein which is homogenous (>97%) as determined by SDS-polyacrylamide gel electrophoresis. Lambda-terminase is composed of the gene products of Nu1 and A. Using N-terminal amino acid sequence analysis of the purified protein, we have determined a subunit stoichiometry of 2 gpNu1 polypeptides/gpA molecule in terminase holoenzyme. The circular dichroism spectrum for the purified holoenzyme has been obtained and is consistent with a protein complex composed primarily of alpha-helical structure. The endonucleolytic activity of the enzyme (the TER reaction) has been optimized with respect to pH, salt, and polyamine concentrations. Divalent metal ion is strictly required for the reaction and may be satisfied by either magnesium or manganese, but not by any of the other metals examined. E. coli integration host factor in amounts stoichiometric with the DNA substrate stimulates the TER reaction, but only when the enzyme is present in limiting amounts. Increasing the enzyme/DNA ratio attenuates the observed stimulation by integration host factor. A kinetic analysis of the TER reaction suggests that the assembly of multiple terminase protomers is required for efficient cleavage of viral DNA and that this reaction appears to be stoichiometric, rather than catalytic under the reaction conditions utilized. The implications of these results with respect to the packaging of viral DNA by terminase enzymes are discussed.	UNIV COLORADO,DEPT CHEM & BIOCHEM,BOULDER,CO 80309; UNIV COLORADO,HLTH SCI CTR,SCH PHARM,DENVER,CO 80262	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Catalano, Carlos E./0000-0003-2349-5758				BECKER A, 1977, VIROLOGY, V78, P291, DOI 10.1016/0042-6822(77)90100-3; BECKER A, 1988, J MOL BIOL, V199, P219, DOI 10.1016/0022-2836(88)90391-9; BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; BECKER A, 1977, VIROLOGY, V78, P277, DOI 10.1016/0042-6822(77)90099-X; BECKER A, 1978, P NATL ACAD SCI USA, V75, P4199, DOI 10.1073/pnas.75.9.4199; BLACK LW, 1988, BACTERIOPHAGES, V2, P321; CHOW S, 1987, GENE, V60, P277, DOI 10.1016/0378-1119(87)90236-8; CID H, 1982, FEBS LETT, V150, P247, DOI 10.1016/0014-5793(82)81344-6; DAWSON RMC, 1986, DATA BIOCH RES, P542; Der Garabedian P A, 1991, Biochemistry, V30, P9940, DOI 10.1021/bi00105a018; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; ESTEBAN JA, 1992, BIOCHEMISTRY-US, V31, P350, DOI 10.1021/bi00117a006; FEISS M, 1986, TRENDS GENET, V2, P100, DOI 10.1016/0168-9525(86)90193-9; FEISS M, 1988, MOL GEN GENET, V212, P142, DOI 10.1007/BF00322457; FEISS M, 1983, GENE, V24, P207, DOI 10.1016/0378-1119(83)90081-1; Furth M., 1983, LAMBDA 2, P145; GAINIER J, 1978, J MOL BIOL, V120, P97; GAMAS P, 1986, MOL GEN GENET, V202, P855; GILADI H, 1990, J MOL BIOL, V213, P181; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GILL SC, 1990, ANAL BIOCHEM, V189, P283; GOLD M, 1983, J BIOL CHEM, V258, P4619; GOLD M, 1986, NUCLEIC ACIDS RES, V14, P9797, DOI 10.1093/nar/14.24.9797; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; GRIFFO G, 1989, J MOL BIOL, V209, P55, DOI 10.1016/0022-2836(89)90169-1; HAN H, 1991, BIOCHEMISTRY-US, V30, P11104, DOI 10.1021/bi00110a012; HIGGINS RR, 1988, CELL, V54, P765, DOI 10.1016/S0092-8674(88)91021-5; HSU MT, 1978, BIOCHEMISTRY-US, V17, P131, DOI 10.1021/bi00594a019; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KORNBERG A, 1992, DNA REPLICATION, P111; KOSTURKO LD, 1989, NUCLEIC ACIDS RES, V17, P317, DOI 10.1093/nar/17.1.317; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; MANIATIS T, 1982, MOL CLONING LABORATO, P466; MELGAR E, 1968, J BIOL CHEM, V243, P4409; MORISATO D, 1987, CELL, V51, P101, DOI 10.1016/0092-8674(87)90014-6; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; PARRIS W, 1988, J BIOL CHEM, V263, P8413; Record M T Jr, 1985, Adv Biophys, V20, P109; RICHEY B, 1987, J BIOL CHEM, V262, P7157; ROIZMAN B, 1991, FUNDAMENTAL VIROLOGY, V2, P863; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SHINDER G, 1988, J VIROL, V62, P387, DOI 10.1128/JVI.62.2.387-392.1988; SHINDER G, 1989, NUCLEIC ACIDS RES, V17, P2005, DOI 10.1093/nar/17.5.2005; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; WOOD WB, 1979, COMPREHENSIVE VIROLO, V13, P581; WOODHEAD JL, 1981, EUR J BIOCHEM, V115, P293, DOI 10.1111/j.1432-1033.1981.tb05237.x; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; WU R, 1971, J MOL BIOL, V57, P491, DOI 10.1016/0022-2836(71)90105-7; XIN W, 1988, NUCLEIC ACIDS RES, V16, P2015, DOI 10.1093/nar/16.5.2015; ZWELLING LA, 1988, BIOCHEM BIOPH RES CO, V152, P808, DOI 10.1016/S0006-291X(88)80110-4; [No title captured]	55	62	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1993	268	5					3056	3065						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM161	8428984				2022-12-27	WOS:A1993KM16100011
J	JOUNEAUX, C; AUDIGIER, Y; GOLDSMITH, P; PECKER, F; LOTERSZTAJN, S				JOUNEAUX, C; AUDIGIER, Y; GOLDSMITH, P; PECKER, F; LOTERSZTAJN, S			G(S) MEDIATES HORMONAL INHIBITION OF THE CALCIUM-PUMP IN LIVER PLASMA-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; CARBOXYL-TERMINAL DECAPEPTIDE; BETA-GAMMA-SUBUNITS; CA-2+ PUMP; ADENYLATE-CYCLASE; ALPHA-SUBUNIT; IDENTIFICATION; RECEPTOR; GS; CALCITONIN	We have reported that the calcium pump in liver plasma membranes is coupled to G(s) or a G(s)-like protein. However, we show here that isoproterenol, which activated adenylyl cyclase via G(s), had no effect on the calcium pump, while human calcitonin, human parathyroid hormone, and mini-glucagon, which inhibited this system, did not affect adenylyl cyclase activity. In order to determine the nature of the G protein coupled to the calcium pump, we used the RM antibody, raised against the carboxyl-terminal decapeptide of G(s)alpha, which antagonized adenylyl cyclase activation by isoproterenol or glucagon. The RM antibody specifically blocked calcium pump inhibition by mini-glucagon, calcitonin, or parathyroid hormone, while it did not affect guanosine 5'-O-(thiotriphosphate) inhibition. Its effect was mimicked the corresponding decapeptide RMHLRQYELL. The AS/7 antibody, reactive with G(t)alpha, G(i)1alpha, and G(i)2alpha, was ineffective. Complementation of liver plasma membranes with in vitro translated G(s)alpha-2, the large form of G(s)alpha, led to a 40% decrease in calcium pump activity, with a parallel 2-fold increase in adenylyl cyclase activity. In vitro translated G(i)1alpha did not affect the calcium pump activity, while it evoked a 40% inhibition of adenylyl cyclase activity. We conclude that a same G(s)alpha may be coupled either to the calcium pump or to adenylyl cyclase. However, G(s) is functionally specialized, since it does not ensure cross-talk between the two receptor-effector systems. These results point out the possible compartmentalization of G(s).	NIDDKD, MOLEC PATHOPHYSIOL BRANCH, BETHESDA, MD 20892 USA; CNRS, INSERM ENDOCRINOL, F-34094 MONTPELLIER, FRANCE	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	JOUNEAUX, C (corresponding author), HOP HENRI MONDOR, INSERM, U99, F-94010 CRETEIL, FRANCE.		Lotersztajn, Sophie/K-9160-2017	lotersztajn, Sophie/0000-0002-0053-7807				BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BLACHE P, 1990, J BIOL CHEM, V265, P21514; CERIONE RA, 1988, J BIOL CHEM, V263, P9345; CHASE LR, 1969, ENDOCRINOLOGY, V84, P761, DOI 10.1210/endo-84-4-761; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GOLDSMITH P, 1988, J BIOL CHEM, V263, P6476; JOURNOT L, 1991, J BIOL CHEM, V266, P9009; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; LOTERSZTAJN S, 1990, BIOL COUN S, P141; LOTERSZTAJN S, 1987, J BIOL CHEM, V262, P3114; LOTERSZTAJN S, 1990, J BIOL CHEM, V265, P9876; LOTERSZTAJN S, 1992, J BIOL CHEM, V267, P2375; LOTERSZTAJN S, 1981, J BIOL CHEM, V256, P1209; MALLAT A, 1987, NATURE, V325, P620, DOI 10.1038/325620a0; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MATTERA R, 1989, SCIENCE, V243, P804, DOI 10.1126/science.2536957; MCKENZIE FR, 1988, BIOCHEM J, V249, P653, DOI 10.1042/bj2490653; MCKENZIE RC, 1990, BIOCHEM J, V266, P817; MURPHY PM, 1992, J BIOL CHEM, V267, P883; NAIR BG, 1990, J BIOL CHEM, V265, P21317; PAVOINE C, 1987, J BIOL CHEM, V262, P5113; PRPIC V, 1984, J BIOL CHEM, V259, P1382; RALL T, 1987, FEBS LETT, V224, P365, DOI 10.1016/0014-5793(87)80486-6; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; SULLIVAN KA, 1987, NATURE, V330, P758, DOI 10.1038/330758a0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TEITELBAUM AP, 1982, ENDOCRINOLOGY, V111, P1524, DOI 10.1210/endo-111-5-1524; WISTOW GJ, 1986, FEBS LETT, V196, P23, DOI 10.1016/0014-5793(86)80207-1; YAMAGUCHI M, 1984, ENDOCRINOL JAPON, V31, P327	34	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2368	2372						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428911				2022-12-27	WOS:A1993KK81500021
J	KACZMAREK, E; LEE, MH; MCDONAGH, J				KACZMAREK, E; LEE, MH; MCDONAGH, J			INITIAL INTERACTION BETWEEN FIBRIN AND TISSUE PLASMINOGEN-ACTIVATOR (T-PA) - THE GLY-PRO-ARG-PRO BINDING-SITE ON FIBRIN(OGEN) IS IMPORTANT FOR T-PA ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY CHROMATOGRAPHY; MONOCLONAL-ANTIBODY; STRUCTURAL DOMAINS; KRINGLE-2 DOMAIN; LYS-PLASMINOGEN; HUMAN-PLASMA; ONE-CHAIN; POLYMERIZATION; FRAGMENTS; ACID	Gly-Pro-Arg-Pro (GPRP) is a potent inhibitor of fibrin polymerization. It also causes a concentration-dependent inhibition of the activation of plasminogen by t-PA when soluble desAABB-fibrinogen (fibrin II) or fibrinogen are used as promoters of t-PA. Fibrinogen has a much weaker promoter activity than does fibrin II. Experiments were undertaken to explain the mechanism of action of GPRP on plasminogen activation. Kinetic data indicated that when GPRP was present in the assay system, the fibrinogen)-GPRP complex was ineffective as a t-PA promoter. Only the free forms of fibrin II or fibrinogen were promoters of t-PA. GPRP specifically eluted t-PA, which was previously bound to a fibrin-Sepharose column, and also inhibited t-PA binding to fibrin-Sepharose in a concentration-dependent manner. These experiments were compared to those with other tetrapeptides: GHRP, GPGG, and GRGD. Only GHRP, which is known to hind more weakly to fibrinogen) than GPRP, had any effect. These results suggest that the GPRP binding site on the fibrinogen) molecule is important for t-PA activation and is a binding site for t-PA in the initial interaction between t-PA and fibrin. We propose that at or near the GPRP binding site on fibrin there is an initial binding site for t-PA. We hypothesize that kringle 1, which contains the sequence G128RRP, may be involved in the initial binding of t-PA to fibrin.	HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	KACZMAREK, E (corresponding author), BETH ISRAEL HOSP,DEPT PATHOL,330 BROOKLINE AVE,BOSTON,MA 02215, USA.				NHLBI NIH HHS [HL-33014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHYUTHAN KE, 1986, BIOCHIM BIOPHYS ACTA, V872, P261, DOI 10.1016/0167-4838(86)90279-7; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; Blomback B., 1956, ARK KEMI, V10, P415; BOSMA PJ, 1988, EUR J BIOCHEM, V172, P399, DOI 10.1111/j.1432-1033.1988.tb13900.x; COLLEN D, 1987, J CELL BIOCHEM, V33, P77, DOI 10.1002/jcb.240330202; DEMUNK GAW, 1989, BIOCHEMISTRY-US, V28, P7318, DOI 10.1021/bi00444a026; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; EASTMAN D, 1992, BIOCHEMISTRY-US, V31, P419, DOI 10.1021/bi00117a016; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; GAFFNEY PJ, 1988, P NATL ACAD SCI USA, V85, P3595, DOI 10.1073/pnas.85.10.3595; GARDELL SJ, 1989, J BIOL CHEM, V264, P17947; GETHING MJ, 1988, EMBO J, V7, P2731, DOI 10.1002/j.1460-2075.1988.tb03127.x; HIGGINS DL, 1987, BIOCHEMISTRY-US, V26, P7786, DOI 10.1021/bi00398a038; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUI KY, 1986, HYBRIDOMA, V5, P215, DOI 10.1089/hyb.1986.5.215; HUSAIN SS, 1989, BLOOD, V74, P999; IKENAKA Y, 1992, BLOOD COAGUL FIBRIN, V3, P381; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028; LEE MH, 1991, BLOOD, V78, P1744; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MATSUDA M, 1991, BIOMED PROGR, V4, P51; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; NIEUWENHUIZEN W, 1988, EUR J BIOCHEM, V174, P163, DOI 10.1111/j.1432-1033.1988.tb14077.x; NIEUWENHUIZEN W, 1983, BIOCHIM BIOPHYS ACTA, V748, P86, DOI 10.1016/0167-4838(83)90030-4; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; PETERSEN LC, 1985, BIOCHEM J, V225, P149, DOI 10.1042/bj2250149; POZDNJAKOVA TM, 1979, THROMB RES, V16, P283, DOI 10.1016/0049-3848(79)90292-5; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; ROOTBERNSTEIN RS, 1984, P NATL ACAD SCI-BIOL, V81, P4339, DOI 10.1073/pnas.81.14.4339; SHIMIZU A, 1989, THROMB HAEMOSTASIS, V62, P70; SHIMIZU A, 1992, P NATL ACAD SCI USA, V89, P2888, DOI 10.1073/pnas.89.7.2888; SUENSON E, 1986, BIOCHIM BIOPHYS ACTA, V870, P510, DOI 10.1016/0167-4838(86)90260-8; SUENSON E, 1988, BIOCHEMISTRY-US, V27, P2435, DOI 10.1021/bi00407a029; VANZONNEVELD AJ, 1986, P NATL ACAD SCI USA, V83, P4670; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; VARADI A, 1986, BIOCHEMISTRY-US, V25, P519, DOI 10.1021/bi00351a001; VERHEIJEN JH, 1986, EMBO J, V5, P3525, DOI 10.1002/j.1460-2075.1986.tb04678.x; WALLEN P, 1970, BIOCHIM BIOPHYS ACTA, V221, P20, DOI 10.1016/0005-2795(70)90194-7; WASSER MNJM, 1990, THROMB HAEMOSTASIS, V63, P39; YAMAZUMI K, 1992, P NATL ACAD SCI USA, V89, P2893, DOI 10.1073/pnas.89.7.2893; YONEKAWA O, 1992, BIOCHEM J, V283, P187, DOI 10.1042/bj2830187	42	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2474	2479						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428923				2022-12-27	WOS:A1993KK81500036
J	MOORE, JT; SILVERSMITH, RE; MALEY, GF; MALEY, F				MOORE, JT; SILVERSMITH, RE; MALEY, GF; MALEY, F			T4-PHAGE DEOXYCYTIDYLATE DEAMINASE IS A METALLOPROTEIN CONTAINING 2 ZINC ATOMS PER SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSITION-STATE ANALOG; METAL-BINDING DOMAINS; SINGLE HYDROXYL GROUP; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; ASPARTATE-TRANSCARBAMYLASE; ADENOSINE-DEAMINASE; QUATERNARY STRUCTURE; CYTIDINE DEAMINASE; AFFINITY	Deoxycytidylate (dCMP) deaminase, a hexameric allosteric enzyme induced on infection of Escherichia coli by bacteriophage T4, was shown to contain two atoms of zinc per subunit by atomic absorption spectroscopy. One zinc appears to be involved in catalysis, as described for adenosine deaminase (Sharaff, A. J., Wilson, D. K., Chang, Z., and Quiocho, F. A. (1992) J. Mol. Biol. 226, 917-921) and cytidine deaminase (Yang, C., Carlow, D., Wolfenden, R., and Short, S. A. (1992) Biochemistry 31, 4168-4174). This thesis is supported by the finding that the enzyme loses about 80% of its activity in the presence of o-phenanthroline. It has also been found that zinc is released when the enzyme is denatured in the presence of the metallochromic indicator, 4-(2-pyridylazo)resorcinol. Renaturation of the deaminase to an active form occurred in the presence but not in the absence of zinc. The second atom of zinc is proposed to be located in a region of T4-dCMP deaminase that resembles a zinc finger. This region, which has the sequence His-X3-Cys-X14-His-X3-His, would represent a zinc-binding motif that has not been described previously.	NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,BOX 509,ALBANY,NY 12201; SUNY ALBANY,SCH PUBL HLTH,DEPT BIOMED SCI,ALBANY,NY 12201; UNION COLL,DEPT CHEM,SCHENECTADY,NY 12308	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Union College					NCI NIH HHS [CA44355] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044355] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN JR, 1980, J BIOL CHEM, V225, P7583; ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; ASHLEY GW, 1984, J BIOL CHEM, V259, P3621; BERG JM, 1990, J BIOL CHEM, V265, P6513; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; CHIU CS, 1977, J BIOL CHEM, V252, P8603; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; DRAKE JC, 1980, BIOCHEM PHARMACOL, V29, P807, DOI 10.1016/0006-2952(80)90561-4; FRICK L, 1989, BIOCHEMISTRY-US, V28, P9423, DOI 10.1021/bi00450a027; FRICK L, 1987, BIOORG CHEM, V15, P100, DOI 10.1016/0045-2068(87)90011-3; GERHART JC, 1967, J BIOL CHEM, V242, P2886; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; JONES W, 1989, BIOCHEMISTRY-US, V28, P1242, DOI 10.1021/bi00429a043; KATI WM, 1989, BIOCHEMISTRY-US, V28, P7919, DOI 10.1021/bi00445a055; KATI WM, 1989, SCIENCE, V243, P1591, DOI 10.1126/science.2928795; KURTZ LC, 1985, BIOCHEMISTRY-US, V24, P1342; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maley F, 1990, Prog Nucleic Acid Res Mol Biol, V39, P49, DOI 10.1016/S0079-6603(08)60623-6; MALEY F, 1967, METHOD ENZYMOL, V12, P170; MALEY GF, 1983, J BIOL CHEM, V258, P8290; MALEY GF, 1990, J BIOL CHEM, V265, P47; MALEY GF, 1972, J BIOL CHEM, V247, P940; MALEY GF, 1972, J BIOL CHEM, V247, P931; MALEY GF, 1963, SCIENCE, V141, P1278, DOI 10.1126/science.141.3587.1278; MALEY GF, 1964, J BIOL CHEM, V239, P1168; MATHEWS CK, 1988, TRENDS BIOCHEM SCI, V13, P394, DOI 10.1016/0968-0004(88)90182-X; MATHEWS CK, 1983, BACTERIOPHAGE T4, P59; MCINTOSH EM, 1986, MOL CELL BIOL, V6, P1711, DOI 10.1128/MCB.6.5.1711; Moen L K, 1988, J Mol Recognit, V1, P48, DOI 10.1002/jmr.300010109; NELBACH ME, 1972, BIOCHEMISTRY-US, V11, P315, DOI 10.1021/bi00753a002; NOWLAN SF, 1985, J BIOL CHEM, V260, P4712; ROSENBUSCH JP, 1971, J BIOL CHEM, V246, P1644; SCARANO E, 1963, J BIOL CHEM, V238, P1556; SHARFF AJ, 1992, J MOL BIOL, V226, P917, DOI 10.1016/0022-2836(92)91040-V; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; WHEELER L, 1992, J BIOL CHEM, V267, P7664; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YANG C, 1992, BIOCHEMISTRY-US, V31, P4168, DOI 10.1021/bi00132a003	38	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2288	2291						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428902				2022-12-27	WOS:A1993KK81500006
J	QUINTANA, DG; GARRIGA, P; MANYOSA, J				QUINTANA, DG; GARRIGA, P; MANYOSA, J			QUANTITATIVE CHARACTERIZATION OF THE STRUCTURE OF RHODOPSIN IN DISC MEMBRANE BY MEANS OF FOURIER TRANSFORM INFRARED SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURES; CIRCULAR-DICHROISM; PURPLE MEMBRANE; GLOBULAR-PROTEINS; IR SPECTROSCOPY; ALPHA-HELICES; SPECTRA; BACTERIORHODOPSIN; WATER; POLYPEPTIDES	Fourier transform infrared (FTIR) spectroscopy has been used for the detailed characterization and quantification of the secondary structure of bovine rhodopsin in native disc membranes. FTIR spectra were obtained in aqueous media, both in (H2O)-H-1 and in (H2O)-H-2. Analysis of spectra by means of Fourier self-deconvolution, complemented with maximum likelihood restoration and Fourier derivative, has allowed the characterization of major amide I secondary structure-sensitive component bands of structural relevance which had not been detected before. In consequence, we show a richer secondary structure for rhodopsin than previously described. Our results indicate a total regular helix content around 51% which would include not only the main alpha1-type helix but also 3(10)-like helix. The presence of distorted helicoid sequences might furthermore increase to a certain extent the total helix amount. It is also indicated that a significant proportion of the amino acid residues are involved in extended/beta-structures and in reverse turns, as well as in ''random'' segments, which had not been directly demonstrated before. 61 +/- 4% of rhodopsin is determined to be solvent-accessible, which is a substantially higher value than previously reported. Helices account for most of the inaccessible moiety.			QUINTANA, DG (corresponding author), UNIV AUTONOMA BARCELONA, FAC MED, DEPT BIOQUIM & BIOL MOLEC, UNITAT BIOFIS, E-08193 BARCELONA, SPAIN.		Quintana, David G/M-5628-2018; Garriga, Pere/C-1949-2017	Garriga, Pere/0000-0003-4234-8382; Quintana, David G./0000-0002-4909-6686				ABBOTT TP, 1990, APPL SPECTROSC, V44, P899, DOI 10.1366/0003702904086966; ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; BUSTAMANTE C, 1983, P NATL ACAD SCI-BIOL, V80, P3568, DOI 10.1073/pnas.80.12.3568; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CAMERON DG, 1987, APPL SPECTROSC, V41, P539, DOI 10.1366/0003702874448445; CASAL HL, 1988, BIOCHIM BIOPHYS ACTA, V957, P11, DOI 10.1016/0167-4838(88)90152-5; CASTRESANA J, 1988, BIOCHEM BIOPH RES CO, V152, P69, DOI 10.1016/S0006-291X(88)80681-8; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHIRGADZE YN, 1975, BIOPOLYMERS, V14, P679, DOI 10.1002/bip.1975.360140402; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; DENOYER LK, 1990, AM LAB, V22, P21; DENOYER LK, 1991, AM LAB, V23; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; DRATZ EA, 1979, PHOTOCHEM PHOTOBIOL, V29, P661, DOI 10.1111/j.1751-1097.1979.tb07746.x; DWIVEDI AM, 1984, BIOPOLYMERS, V23, P2025, DOI 10.1002/bip.360231016; EARNEST TN, 1990, BIOPHYS J, V58, P1539, DOI 10.1016/S0006-3495(90)82498-X; EARNEST TN, 1987, THESIS BOSTON U; HARIS PI, 1989, BIOCHIM BIOPHYS ACTA, V995, P160, DOI 10.1016/0167-4838(89)90075-7; HARIS PI, 1988, BIOCHIM BIOPHYS ACTA, V943, P375, DOI 10.1016/0005-2736(88)90571-8; HOLLOWAY PW, 1989, BIOCHEMISTRY-US, V28, P931, DOI 10.1021/bi00429a002; KAMPS KMP, 1982, BIOCHIM BIOPHYS ACTA, V687, P296, DOI 10.1016/0005-2736(82)90558-2; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KRIMM S, 1982, SCIENCE, V216, P407, DOI 10.1126/science.6280277; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; MANTSCH HH, 1988, J MOL STRUCT, V173, P285, DOI 10.1016/0022-2860(88)80061-9; MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042; MOFFATT DJ, 1986, NRCC B, V18; NABEDRYK E, 1985, BIOPHYS J, V48, P873, DOI 10.1016/S0006-3495(85)83848-0; OSBORNE HB, 1977, FEBS LETT, V84, P217, DOI 10.1016/0014-5793(77)80691-1; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; PAK WL, 1988, PHOTOCHEM PHOTOBIOL, V47, P877, DOI 10.1111/j.1751-1097.1988.tb01670.x; PAPPIN DJC, 1984, INT J BIOL MACROMOL, V6, P73, DOI 10.1016/0141-8130(84)90066-7; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; PRESTRELSKI SJ, 1991, BIOCHEMISTRY-US, V30, P133, DOI 10.1021/bi00215a020; PRESTRELSKI SJ, 1991, ARCH BIOCHEM BIOPHYS, V285, P111, DOI 10.1016/0003-9861(91)90335-G; PRESTRELSKI SJ, 1991, PROTEIN ENG, V4, P739, DOI 10.1093/protein/4.7.739; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROTHSCHILD KJ, 1980, BIOCHIM BIOPHYS ACTA, V596, P338, DOI 10.1016/0005-2736(80)90121-2; ROTHSCHILD KJ, 1979, BIOPHYS J, V25, P473, DOI 10.1016/S0006-3495(79)85317-5; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P69; SHICHI H, 1974, Journal of Supramolecular Structure, V2, P7, DOI 10.1002/jss.400020103; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1986, METHOD ENZYMOL, V130, P290; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; THANKI N, 1991, J MOL BIOL, V221, P669, DOI 10.1016/0022-2836(91)80080-E; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YASUI SC, 1986, BIOPOLYMERS, V25, P79, DOI 10.1002/bip.360250107	49	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1993	268	4					2403	2409						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KK815	8428913				2022-12-27	WOS:A1993KK81500026
J	SIPPEL, CJ; SUCHY, FJ; ANANTHANARAYANAN, M; PERLMUTTER, DH				SIPPEL, CJ; SUCHY, FJ; ANANTHANARAYANAN, M; PERLMUTTER, DH			THE RAT-LIVER ECTO-ATPASE IS ALSO A CANALICULAR BILE-ACID TRANSPORT PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE PLASMA-MEMBRANE; CELL-ADHESION MOLECULE; COMPLEMENTARY-DNA; EXPRESSION; SYSTEM; RECEPTOR; SEQUENCE; SALT; TAUROCHOLATE; RETICULUM	A approximately 110-kDa glycoprotein purified from canalicular vesicles by bile acid affinity chromatography has been identified as the canalicular bile acid transport protein. Internal amino acid sequence and chemical and immunochemical characteristics of this protein were found to be identical to a rat liver canalicular ecto-ATPase. In order to definitively determine whether these were two activities of a single polypeptide, we examined the possibility that transfection of cDNA for the ecto-ATPase would confer bile acid transport characteristics, as well as ecto-ATPase activity, on heterologous cells. The results show that transfection of the ecto-ATPase cDNA conferred on COS cells de novo synthesis of a approximately 110-kDa polypeptide, as immunoprecipitated by antibody to the purified canalicular bile acid transport protein and conferred on COS cells the capacity to pump out [H-3]taurocholate with efflux characteristics comparable with those previously determined in canalicular membrane vesicles (K(m) = 100 muM; V(max) = 200 pmol/mg of protein/20 s). A truncated ecto-ATPase cDNA, missing the cytoplasmic tail, was targeted correctly to the cell surface but did not confer bile acid transport activity on COS cells. The results of this study also show that the canalicular ecto- ATPase/bile acid transport protein is phosphorylated on its cytoplasmic tail and that its phosphorylation is stimulated by activation of protein kinase C and inhibited by inhibitors of protein kinase C activation. Moreover, inhibition of protein kinase C activation by staurosporine completely abrogates bile acid transport but does not affect ATPase activity. This study, therefore, demonstrates that the rat liver canalicular ecto-ATPase is also a bile acid transport protein, that the capacitiy to pump out bile acid can be conferred on a heterologous cell by DNA-mediated gene transfer, and that phosphorylation within the cytoplasmic tail of the transporter is essential for bile acid efflux activity but not for ATPase activity.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PHYSIOL,ST LOUIS,MO 63110; YALE UNIV,SCH MED,DEPT PEDIAT,NEW HAVEN,CT 06510	Washington University (WUSTL); Washington University (WUSTL); Yale University	SIPPEL, CJ (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PEDIAT,400 S KINGSHIGHWAY BLVD,ST LOUIS,MO 63110, USA.				NICHD NIH HHS [KO8 HD00954-01, T32 HD07409, HD20632] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000954, T32HD007409, R01HD020632, R37HD020632] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADACHI Y, 1991, HEPATOLOGY, V14, P655, DOI 10.1016/0270-9139(91)90053-X; ANANTHANARAYANA.M, 1991, AM J PHYSIOL, V261, pG2810; AURIVILLIUS M, 1990, FEBS LETT, V264, P267, DOI 10.1016/0014-5793(90)80264-J; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; CULLEN BR, 1987, METHOD ENZYMOL, V152, P692; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HARRISON BC, 1991, J NEUROCHEM, V56, P1723, DOI 10.1111/j.1471-4159.1991.tb02073.x; HINDO Y, 1988, P NATL ACAD SCI USA, V85, P6959; HIXSON DC, 1985, CANCER RES, V45, P3742; JENNINGS ML, 1989, ANNU REV BIOCHEM, V58, P999; KACZMAREK LK, 1991, NEW BIOL, V3, P315; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LIN SH, 1989, J BIOL CHEM, V264, P14408; LIN SH, 1989, J BIOL CHEM, V264, P14403; LIN SH, 1985, J BIOL CHEM, V260, P976; LIN SH, 1992, FASEB J, V6, P353; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; MULLER M, 1991, J BIOL CHEM, V266, P18920; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; NOVAK DA, 1991, AM J PHYSIOL, V260, pG743, DOI 10.1152/ajpgi.1991.260.5.G743; OCKLIND C, 1982, J BIOL CHEM, V257, P6788; PERLMUTTER DH, 1988, J BIOL CHEM, V263, P16499; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; RUETZ S, 1987, J BIOL CHEM, V262, P11324; RUETZ S, 1988, P NATL ACAD SCI USA, V85, P6147, DOI 10.1073/pnas.85.16.6147; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SIPPEL CJ, 1990, AM J PHYSIOL, V258, pG728, DOI 10.1152/ajpgi.1990.258.5.G728; SKEHEL JJ, 1992, NATURE, V358, P110, DOI 10.1038/358110b0; SKORSGAARD T, 1978, CANCER RES, V38, P1785; STUTTS MJ, 1992, P NATL ACAD SCI USA, V89, P1621, DOI 10.1073/pnas.89.5.1621; SWEETSER DA, 1986, J BIOL CHEM, V261, P5553; THOMAS P, 1990, BIOCHIM BIOPHYS ACTA, V1032, P177, DOI 10.1016/0304-419X(90)90003-J	38	120	124	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1993	268	3					2083	2091						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KH620	8420979				2022-12-27	WOS:A1993KH62000088
J	BARLOWE, C; DENFERT, C; SCHEKMAN, R				BARLOWE, C; DENFERT, C; SCHEKMAN, R			PURIFICATION AND CHARACTERIZATION OF SAR1P, A SMALL GTP-BINDING PROTEIN REQUIRED FOR TRANSPORT VESICLE FORMATION FROM THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; MEMBRANE GLYCOPROTEIN; GUANINE-NUCLEOTIDES; POLYACRYLAMIDE GELS; ADENYLATE-CYCLASE; GOLGI TRANSPORT; BOVINE BRAIN; RAS	SEC12 encodes an integral membrane glycoprotein essential for vesicle formation from the endoplasmic reticulum (ER) in yeast. The SAR1 gene was discovered as a multicopy suppressor of a sec12t8 strain and encodes a 21-kDa GTP-binding protein also required for protein transport from the ER to the Golgi apparatus (Nakano, A., and Muramatsu, M. (1989) J. Cell Biol. 109, 2677-2691). We have purified Sar1p to apparent homogeneity from cells harboring a galactose-regulated recombinant SAR1. Purified Sar1p binds guanine nucleotides specifically and exhibits GTPase activity (0.001 min-1). Nucleotide exchange and hydrolysis rates are greatly increased in the presence of Mg2+ and nonionic detergents or phospholipids. An assay that measures the formation of a vesicle intermediate in ER to Golgi transport was devised that is dependent on the addition of purified Sar1p. This assay employs membranes prepared from wild-type cells and cytosol fractions depleted of Sar1p due to overproduction of Sec12p or by gel filtration chromatography. The gel-filtered cytosol requires the addition of Sar1p and GTP to support vesicle budding. Sar1p prebound with GTPgammaS inhibits Sar1p function in the vesicle formation assay. The results indicate a role for Sar1p in vesicle budding from the ER and suggest that GTP hydrolysis by Sar1p is required for this event.	UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,401 BARKER HALL,BERKELEY,CA 94720; INST PASTEUR,UNITE MYCOL,F-75824 PARIS 15,FRANCE	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				d'Enfert, Christophe/0000-0002-6235-3886				BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DENFERT C, 1991, MOL CELL BIOL, V11, P5727, DOI 10.1128/MCB.11.11.5727; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; GROESCH ME, 1990, J CELL BIOL, V111, P45, DOI 10.1083/jcb.111.1.45; HARLOW E, 1988, ANTIBODIES LABORATOR; HICKE L, 1992, MOL BIOL CELL, V3, P667, DOI 10.1091/mbc.3.6.667; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NEAL SE, 1988, J BIOL CHEM, V263, P19718; NISHIKAWA S, 1991, BIOCHIM BIOPHYS ACTA, V1093, P135, DOI 10.1016/0167-4889(91)90114-D; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SIKORSKI RS, 1989, GENETICS, V122, P19; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; UEDA T, 1990, J BIOL CHEM, V265, P9373; WAGNER P, 1987, EMBO J, V6, P2373, DOI 10.1002/j.1460-2075.1987.tb02514.x; WEISS O, 1989, J BIOL CHEM, V264, P21066; WUESTEHUBE LJ, 1992, IN PRESS METHODS ENZ	38	142	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					873	879						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419365				2022-12-27	WOS:A1993KG07700021
J	HIRATA, R; UMEMOTO, N; HO, MN; OHYA, Y; STEVENS, TH; ANRAKU, Y				HIRATA, R; UMEMOTO, N; HO, MN; OHYA, Y; STEVENS, TH; ANRAKU, Y			VMA12 IS ESSENTIAL FOR ASSEMBLY OF THE VACUOLAR H+-ATPASE SUBUNITS ONTO THE VACUOLAR MEMBRANE IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; PROTON MOTIVE FORCE; NUCLEAR GENE; CATALYTIC SUBUNIT; ACTIVE-TRANSPORT; PET PHENOTYPE; YEAST VACUOLE; AMINO-ACIDS; CELL-CYCLE; PROTEIN	vma12 mutants of the yeast Saccharomyces cerevisiae, which were originally identified as calcium-sensitive (cls) mutants that were also respiratory deficient (Pet-), have a defect in vacuolar membrane H+-ATPase activity (Ohya, Y., Umemoto, N., Tanida, I., Ohta, A., Iida, H., and Anraku, Y. (1991) J. Biol. Chem. 266, 13971-13977). The VMA12 gene was cloned by complementation of the growth defects of vma12 mutants. The nucleotide sequence of the gene predicts a polypeptide of 215 amino acids (25.2 kDa) with two putative membrane-spanning domains. A null vma12 mutant, constructed by chromosomal deletion of the gene, is viable but has completely lost the vacuolar membrane H+-ATPase activity and exhibits the same growth defects as observed for the original vma12 mutants. Synthesis and targeting of the subunits of the H+-ATPase in the DELTAvma12 mutant cells were examined by Western blotting analyses of whole cell and vacuolar membrane protein extracts. None of the peripheral membrane subunits that we analyzed (the 69-, 60-, 42-, and 27-kDa subunits) was detected in the vacuolar membrane fractions, although the cellular levels of these polypeptides appeared to be normal. The 100- and 17-kDa integral membrane subunits of the enzyme were absent or present at a substantially reduced level in mutant vacuolar membrane fractions. Anti-Vma12p antibodies recognized a vacuolar protein with the expected molecular mass of 25 kDa. However, the Vma12 protein was not detected in the vacuolar membrane ATPase complex that had been solubilized with a zwitterionic detergent, ZW3-14, and purified by glycerol gradient centrifugation (Kane, P. M., Yamashiro, C. T., and Stevens, T. H. (1989) J. Biol. Chem. 264, 19236-19244). These results indicate that the VMA12 gene product is not a component of the active vacuolar ATPase complex and instead suggest that this protein is required during the process of assembly and/or targeting of the enzyme complex to the vacuolar membrane.	UNIV TOKYO, FAC SCI, DEPT BIOL, BUNKYO KU, TOKYO 113, JAPAN; UNIV OREGON, INST MOLEC BIOL, EUGENE, OR 97403 USA	University of Tokyo; University of Oregon			Umemoto, Naoyuki/C-9712-2017; Hirata, Ryogo/C-7424-2017	Umemoto, Naoyuki/0000-0001-5507-0848; Stevens, Tom/0000-0001-6427-6848	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038006] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38006] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; ACKERMAN SH, 1991, FEBS LETT, V278, P234, DOI 10.1016/0014-5793(91)80124-L; ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; Anraku Y, 1987, PLANT VACUOLES, P255; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BELTRAN C, 1992, J BIOL CHEM, V267, P774; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; BURGERS PMJ, 1987, ANAL BIOCHEM, V163, P391, DOI 10.1016/0003-2697(87)90240-5; DULIC V, 1989, EMBO J, V8, P1349, DOI 10.1002/j.1460-2075.1989.tb03515.x; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FOURY F, 1990, J BIOL CHEM, V265, P18554; GALONS JP, 1990, EUR J BIOCHEM, V193, P111, DOI 10.1111/j.1432-1033.1990.tb19311.x; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HIRATA R, 1989, FEBS LETT, V244, P397, DOI 10.1016/0014-5793(89)80571-X; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1992, J BIOL CHEM, V267, P447; KITAMOTO K, 1988, J BACTERIOL, V170, P2687, DOI 10.1128/jb.170.6.2687-2691.1988; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; NELSON H, 1989, FEBS LETT, V247, P147, DOI 10.1016/0014-5793(89)81259-1; NELSON H, 1989, J BIOL CHEM, V264, P1775; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OHYA Y, 1986, J GEN MICROBIOL, V132, P979; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PRESTON RA, 1992, GENETICS, V131, P551; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Rodriguez R.L., 1983, RECOMBINANT DNA TECH; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1984, J BIOL CHEM, V259, P1505; SAUREZRENDUELS MP, 1981, FEBS LETT, V131, P296; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; UCHIDA E, 1988, J BIOL CHEM, V263, P45; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5	62	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					961	967						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419376				2022-12-27	WOS:A1993KG07700033
J	PASCO, DS; BOYUM, KW; ELBI, C; SIU, CS; FAGAN, JB				PASCO, DS; BOYUM, KW; ELBI, C; SIU, CS; FAGAN, JB			INDUCER-DEPENDENT TRANSCRIPTIONAL ACTIVATION OF THE P4501A2 GENE INVIVO AND IN ISOLATED HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; GEL-ELECTROPHORESIS; MESSENGER-RNAS; AH LOCUS; DNA; RAT; CDNA; 3-METHYLCHOLANTHRENE; CYTOCHROME-P1-450; EXPRESSION	In vitro nuclear run-on transcription analysis using probes directed against different regions of CYP1A2 revealed that the 70-100-fold induction of CYP1A2 mRNA by polycyclic aromatic compounds is associated with a corresponding increase in the transcriptional activation of this gene in rat liver. Probes from regions of the 1st, 2nd, and 4th introns detected approximately 50-100-fold higher CYP1A2 run-on transcription in liver nuclei from inducer-treated animals than in nuclei from untreated animals. The run-on signals from untreated rats were 3-5-fold above background signals. Additional experiments using single-stranded DNA probes and a probe from a region 5' to the CYP1A2 transcription start site revealed that the inducer-dependent transcripts were colinear with the CYP1A2 mRNA and that they did not result from read through of an inititation event 5' to CYP1A2. Run-on transcription analyses were also carried out with nuclei from isolated hepatocytes using the same series of probes spanning CYP1A2. These analyses indicated that the inducer-dependent accumulation of CYP1A2 mRNA in hepatocytes is associated with at least a 20-fold increase in CYP1A2 transcription. In contrast to liver and hepatocytes, these probes failed to detect run-on transcripts from kidney nuclei, indicating that the lack of CYP1A2 mRNA in this tissue is due to the lack of transcriptional activation of this gene by polycyclic aromatic compounds.			PASCO, DS (corresponding author), MAHARISHI INT UNIV,MOLEC BIOL LAB,1000 N 4TH ST,FAIRFIELD,IA 52557, USA.				NCI NIH HHS [R01-CA38655] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038655] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; AOYAMA T, 1990, P NATL ACAD SCI USA, V87, P4790, DOI 10.1073/pnas.87.12.4790; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; BUTLER MA, 1989, P NATL ACAD SCI USA, V86, P7696, DOI 10.1073/pnas.86.20.7696; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENISON MS, 1988, P NATL ACAD SCI USA, V85, P2528, DOI 10.1073/pnas.85.8.2528; DENISON MS, 1988, J BIOL CHEM, V263, P17221; FAGAN JB, 1986, ARCH BIOCHEM BIOPHYS, V244, P261, DOI 10.1016/0003-9861(86)90116-5; FALETTO MB, 1988, J BIOL CHEM, V263, P12187; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GONZALEZ FJ, 1984, MOL PHARMACOL, V26, P117; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; KADLUBAR FF, 1987, MAMMALIAN CYTOCHROME, V2, P81; KAWAJIRI K, 1984, P NATL ACAD SCI-BIOL, V81, P1649, DOI 10.1073/pnas.81.6.1649; KIMURA S, 1986, MOL CELL BIOL, V6, P1471, DOI 10.1128/MCB.6.5.1471; KIMURA S, 1984, J BIOL CHEM, V259, P705; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LU AYH, 1980, PHARMACOL REV, V31, P277; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NEWHOLD LA, 1989, MOL CELL BIOL, V9, P2378; OKINO ST, 1992, J BIOL CHEM, V267, P6991; PASCO DS, 1988, J BIOL CHEM, V263, P8671; PELKONEN O, 1982, PHARMACOL REV, V34, P190; SILVER G, 1990, J BIOL CHEM, V265, P3134; SILVER G, 1988, J BIOL CHEM, V263, P11802; SOGAWA K, 1985, J BIOL CHEM, V260, P5026; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0	30	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					1053	1057						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419313				2022-12-27	WOS:A1993KG07700046
J	SCHRODER, I; DARIE, S; GUNSALUS, RP				SCHRODER, I; DARIE, S; GUNSALUS, RP			ACTIVATION OF THE ESCHERICHIA-COLI NITRATE REDUCTASE (NARGHJI) OPERON BY NARL AND FNR REQUIRES INTEGRATION HOST FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GENE-PRODUCT; FUMARATE REDUCTASE; ANAEROBIC RESPIRATION; HIMA GENE; DNA; EXPRESSION; PROTEIN; BINDING; OXYGEN; SITE	Integration host factor protein (IHF) was shown to be required for Fnr- and NarL-dependent activation of the nitrate reductase (narGHJI) operon of Escherichia coli in response to nitrate availability and anaerobiosis. Using a narG-lacZ reporter fusion to evaluate narGHJI expression in vivo both the nitrate and anaerobic dependent controls were severely impaired in a himA mutant compared with the wild type strain. IHF was also required for Fnr-independent anaerobic control of narGHJI expression. In vitro, purified IHF protein was shown to bind to a narG promoter fragment with an apparent dissociation value of 5 nM by use of a gel shift assay. DNase I footprinting studies revealed that IHF protects a 37-base pair region centered 125 base pairs 5' of the narG transcription site. These studies suggest that the IHF protein performs a DNA bending function at the narG promoter to allow nitrate-dependent activation by the NarL regulatory protein, and second, it enhances the Fnr-dependent expression from the narG promoter under anaerobic cell growth conditions. A model whereby three transcriptional activators, NarL, IHF, and Fnr, induce expression of a sigma70-dependent promoter for the narGHJI operon is discussed.	UNIV CALIF LOS ANGELES,DEPT MICROBIOL & MOLEC GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021678] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21678] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHIANG RC, 1992, MOL MICROBIOL, V6, P1913, DOI 10.1111/j.1365-2958.1992.tb01364.x; CLAVERIEMARTIN F, 1991, P NATL ACAD SCI USA, V88, P1631, DOI 10.1073/pnas.88.5.1631; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; COTTER PA, 1989, J BACTERIOL, V171, P3817, DOI 10.1128/jb.171.7.3817-3823.1989; COTTER PA, 1992, FEMS MICROBIOL LETT, V91, P31; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; DEVARGAS LM, 1989, SCIENCE, V244, P1457; DONG XR, 1992, J BIOL CHEM, V267, P14122; FILUTOWICZ M, 1991, J BIOL CHEM, V266, P24077; FRIEDMAN DI, 1984, J BACTERIOL, V157, P484, DOI 10.1128/JB.157.2.484-489.1984; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; HUANG L, 1990, J BACTERIOL, V172, P5293, DOI 10.1128/jb.172.9.5293-5298.1990; IUCHI S, 1987, P NATL ACAD SCI USA, V84, P3901, DOI 10.1073/pnas.84.11.3901; JONES HM, 1987, J BACTERIOL, V169, P3340, DOI 10.1128/jb.169.7.3340-3349.1987; KALMAN LV, 1988, J BACTERIOL, V170, P623, DOI 10.1128/jb.170.2.623-629.1988; KALMAN LV, 1990, J BACTERIOL, V172, P7049, DOI 10.1128/jb.172.12.7049-7056.1990; KALMAN LV, 1989, J BACTERIOL, V171, P3810, DOI 10.1128/jb.171.7.3810-3816.1989; KOLESNIKOW T, 1992, J BACTERIOL, V174, P7104, DOI 10.1128/jb.174.22.7104-7111.1992; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; MILLER HI, 1984, COLD SPRING HARB SYM, V49, P691, DOI 10.1101/SQB.1984.049.01.078; MILLER HI, 1981, NATURE, V290, P523, DOI 10.1038/290523a0; MILLER HI, 1979, COLD SPRING HARB SYM, V43, P1121, DOI 10.1101/SQB.1979.043.01.125; PAGEL JM, 1991, J BIOL CHEM, V266, P1985; PERBAL B, 1988, PRACTICAL GUIDE MOL, P550; PRENTKI P, 1987, EMBO J, V6, P2479, DOI 10.1002/j.1460-2075.1987.tb02529.x; ROBERTSON CA, 1988, J BIOL CHEM, V263, P3554; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SHAW DJ, 1983, J MOL BIOL, V166, P241, DOI 10.1016/S0022-2836(83)80011-4; SILHAVY TJ, 1984, EXPT GENE FUSIONS, pR11; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; STEWART V, 1982, J BACTERIOL, V151, P1320, DOI 10.1128/JB.151.3.1320-1325.1982; STEWART V, 1988, MICROBIOL REV, V52, P190, DOI 10.1128/MMBR.52.2.190-232.1988; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; WALKER MS, 1991, MOL MICROBIOL, V5, P353, DOI 10.1111/j.1365-2958.1991.tb02116.x; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; WU YF, 1992, J BACTERIOL, V174, P233, DOI 10.1128/jb.174.1.233-240.1992	40	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1993	268	2					771	774						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG077	8419352				2022-12-27	WOS:A1993KG07700005
J	TAYLOR, ME; DRICKAMER, K				TAYLOR, ME; DRICKAMER, K			STRUCTURAL REQUIREMENTS FOR HIGH-AFFINITY BINDING OF COMPLEX LIGANDS BY THE MACROPHAGE MANNOSE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; ASIALOGLYCOPROTEIN RECEPTOR; RAT; PROTEINS; GLYCOPROTEINS; CONTAINS	The mannose receptor of macrophage and hepatic endothelial cells discriminates between endogenous and exogenous sugar-bearing structures. Previous competition studies have indicated that the receptor binds the monosaccharides mannose, fucose, and N-acetylglucosamine but displays much higher affinity for multivalent oligosaccharides, such as those found on the surface of potentially pathogenic microorganisms. The hydrodynamic properties of the receptor have been examined, revealing that the receptor is a monomer. This result suggests that multiple carbohydrate recognition domains (CRDs) in the extracellular domain of a single receptor polypeptide cooperate to achieve high affinity binding of complex ligands. In order to determine the importance of individual CRDs, properties of receptor segments containing groups of CRDs expressed in insect cells have been examined. The results indicate that two of the CRDs (4 and 5) form a protease-resistant, ligand-binding core but that five CRDs in tandem (4-8) are required to match the affinity of the intact receptor for yeast mannan. A consequence of the organization of the receptor is that both valency and geometry of glycoconjugates are important determinants of binding affinity.	COLUMBIA UNIV, DEPT BIOCHEM & MOLEC BIOPHYS, 630 W 168TH ST, NEW YORK, NY 10032 USA	Columbia University				Taylor, Maureen/0000-0001-8300-4987	NIGMS NIH HHS [GM 42628] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042628] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEZOUSKA K, 1991, J BIOL CHEM, V266, P11604; CHIACCHIA KB, 1984, J BIOL CHEM, V259, P5440; CLARKE S, 1975, J BIOL CHEM, V250, P5459; COHN EJ, 1943, PROTEINS AMINO ACIDS, P372; DRICKAMER K, 1989, CIBA F SYMP, V145, P45; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1992, IN PRESS NATURE; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; GIBBONS RA, 1972, GLYCOPROTEINS A, V5, P29; HSUEH EC, 1986, J BIOL CHEM, V261, P4940; KIM SJ, 1992, IN PRESS GENOMICS; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; LENNARTZ MR, 1989, J BIOL CHEM, V264, P2385; LOEB JA, 1987, J BIOL CHEM, V262, P3022; Maniatis T., 1982, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; OTTER M, 1991, J BIOL CHEM, V266, P13931; QUESENBERRY M S, 1991, Glycobiology, V1, P615, DOI 10.1093/glycob/1.6.615; RICE KG, 1990, J BIOL CHEM, V265, P18429; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; STAHL PD, 1990, AM J RESP CELL MOL, V2, P317, DOI 10.1165/ajrcmb/2.4.317; STAHL PD, 1980, TRENDS BIOCHEM SCI, V5, P194, DOI 10.1016/0968-0004(80)90238-8; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; Summers MD, 1987, MANUAL METHODS BACUL; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; WARR GA, 1980, BIOCHEM BIOPH RES CO, V93, P737, DOI 10.1016/0006-291X(80)91139-0; WEIS WI, 1991, J BIOL CHEM, V266, P20678; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, IN PRESS NATURE; WILSON ME, 1986, J IMMUNOL, V136, P4681	34	199	207	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1993	268	1					399	404						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE603	8416946				2022-12-27	WOS:A1993KE60300061
